PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Anzo, M; Inokuchi, M; Matsuo, N; Takayama, JI; Hasegawa, T				Anzo, Makoto; Inokuchi, Mikako; Matsuo, Nobutake; Takayama, John I.; Hasegawa, Tomonobu			Waist circumference centiles by age and sex for Japanese children based on the 1978-1981 cross-sectional national survey data	ANNALS OF HUMAN BIOLOGY			English	Article						BMI; central obesity; childhood obesity; nationally representative data; trends	ADOLESCENTS; CURVES	Aim: The aim of this study was to establish reference values for waist circumference among Japanese youths using the 1978-1981 nationally representative data. Subject and methods: Growth charts were derived using Cole's LMS method, which adjusts the waist circumference distribution for skewness and allows waist circumference to be expressed as centile or standard deviation score. The sample population consisted of 19 233 children aged 6-18 years. Waist circumference was measured at the level of maximum waist narrowing in girls and at the level of the top of the iliac crest in boys. Results: Comparison was made between the 1978-1981 and 1992-1994 waist circumference charts, showing a large increase in waist circumference over time; the mean difference was 1.1 and 0.5 SD score units in boys and girls, respectively. Defining cut-offs for central fatness as the 90th and 95th centiles of the 1978-1981 reference, the prevalences in 1992-1994 were, respectively, 42.3% and 25.2% in boys and 19.1% and 10.9% in girls. The corresponding prevalences in 1978-1981 were 10% and 5% by definition. Conclusion: This study showed increasing trends in waist circumference, particularly in boys during the period of the two surveys and that the 1978-1981 charts serve as better baseline references for waist circumference among Japanese youth.	[Anzo, Makoto; Inokuchi, Mikako; Matsuo, Nobutake; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Inokuchi, Mikako] Keio Univ, Ctr Hlth, Tokyo 1608582, Japan; [Matsuo, Nobutake] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Takayama, John I.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	Hasegawa, T (reprint author), Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	thaseg@a6.keio.jp					Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Inokuchi M, 2007, EUR J PEDIATR, V166, P655, DOI 10.1007/s00431-006-0296-8; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cole TJ, 2005, LMSCHARTMAKER PRO VE; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Inokuchi M, 2006, ANN HUM BIOL, V33, P444, DOI 10.1080/03014460600802353; Japanese Ministry of Education Culture Sports Science and Technology, 1979, REP 1978 1981 NAT GR; Japanese Standards Association, 1984, REP JAP BOD SIZ MEAS; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Ministry of Health Labour and Welfare, 1978, NAT HLTH NUTR SURV; Research Institute of Human Engineering for Quality Life, 1997, JAP BOD SIZ DAT 1992; Takimoto H, 2004, AM J PUBLIC HEALTH, V94, P1592, DOI 10.2105/AJPH.94.9.1592	13	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0301-4460	1464-5033		ANN HUM BIOL	Ann. Hum. Biol.	JAN	2015	42	1					56	61		10.3109/03014460.2014.928368		6	Anthropology; Biology; Public, Environmental & Occupational Health	Anthropology; Life Sciences & Biomedicine - Other Topics; Public, Environmental & Occupational Health	AW4LU	WOS:000346253400008		
J	Takahara, T; Wakabayashi, G; Hasegawa, Y; Nitta, H				Takahara, Takeshi; Wakabayashi, Go; Hasegawa, Yasushi; Nitta, Hiroyuki			Minimally Invasive Donor Hepatectomy: Evolution From Hybrid to Pure Laparoscopic Techniques	ANNALS OF SURGERY			English	Letter							LIVING DONOR; LIVER-TRANSPLANTATION; ADULTS; RISK		[Takahara, Takeshi; Wakabayashi, Go; Hasegawa, Yasushi; Nitta, Hiroyuki] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan	Takahara, T (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	gowaka@iwate-med.ac.jp					Samstein B, 2013, AM J TRANSPLANT, V13, P2462, DOI 10.1111/ajt.12360; Troisi RI, 2013, AM J TRANSPLANT, V13, P2472, DOI 10.1111/ajt.12362; Cheah YL, 2013, LIVER TRANSPLANT, V19, P499, DOI 10.1002/lt.23575; Soubrane O, 2013, AM J TRANSPLANT, V13, P2467, DOI 10.1111/ajt.12361; Rotellar F, 2013, AM J TRANSPLANT, V13, P3269, DOI 10.1111/ajt.12471; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Cohen E, ORGAN DONORS SURG DE; Makabe K, 2014, J HEPATO-BIL-PAN SCI, V21, P592, DOI 10.1002/jhbp.103; Salvalaggio PRO, 2004, TRANSPLANTATION, V77, P1765, DOI 10.1097/01.TP.0000129406.35825.6D	9	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JAN	2015	261	1					E3	E4		10.1097/SLA.0000000000000898		2	Surgery	Surgery	AW6XS	WOS:000346409600003		
J	Takahashi, S; Katayama, K; Tatsugawa, T; Sueda, T				Takahashi, Shinya; Katayama, Keijiro; Tatsugawa, Takaharu; Sueda, Taijiro			A Successful Hybrid Repair for Vertebral Arteriovenous Fistula with Extracranial Vertebral Artery Aneurysm	ANNALS OF VASCULAR SURGERY			English	Article							ENDOVASCULAR TREATMENT	A 40-year-old female presented with general fatigue. Echocardiography and computed tomography revealed a cervical vertebral arteriovenous fistula (VAF) with an extracranial vertebral artery aneurysm (VAA). She had closure of an atrial septal defect via right jugular vein catheterization at 5 years of age. Considering the anatomical location, a hybrid endovascular and surgical procedure was successfully performed to exclude both the VAF and VAA from the arterial circulation. This procedure may be considered an alternative to treat vertebral arterial pathology.	[Takahashi, Shinya; Katayama, Keijiro; Sueda, Taijiro] Hiroshima Univ Hosp, Dept Cardiovasc Surg, Hiroshima 7348551, Japan; [Tatsugawa, Takaharu] Hiroshima Univ Hosp, Dept Otolaryngol, Hiroshima 7348551, Japan	Takahashi, S (reprint author), Hiroshima Univ Hosp, Dept Cardiovasc Surg, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	shiny@mte.biglobe.ne.jp					Morasch MD, 2013, ANN VASC SURG, V27, P418, DOI 10.1016/j.avsg.2012.08.002; BEAUJEUX RL, 1992, RADIOLOGY, V183, P361; Becker G J, 1991, J Vasc Interv Radiol, V2, P225, DOI 10.1016/S1051-0443(91)72286-0; BERGUER R, 1982, ANN SURG, V196, P65, DOI 10.1097/00000658-198207000-00014; BERTHELOT JL, 1982, NEUROCHIRURGIE, V28, P315; DEBRAY JM, 1986, REV MED INTERNE, V7, P133, DOI 10.1016/S0248-8663(86)80103-5; Kasirajan K, 2003, J ENDOVASC THER, V10, P647, DOI 10.1583/1545-1550(2003)010<0647:CSFTSA>2.0.CO;2; Merland J J, 1986, Ann Vasc Surg, V1, P73, DOI 10.1016/S0890-5096(06)60706-1; NAGASHIMA C, 1977, J NEUROSURG, V46, P681, DOI 10.3171/jns.1977.46.5.0681; Schittek A, 1999, TEX HEART I J, V26, P90; Shang EK, 2013, J VASC SURG, V58, P1391, DOI 10.1016/j.jvs.2013.01.040; SHUMACKE.HB, 1966, J TRAUM, V6, P3, DOI 10.1097/00005373-196601000-00001; Sultan Sherif, 2002, Vasc Endovascular Surg, V36, P389, DOI 10.1177/153857440203600510; Tenjin H, 2005, SURG NEUROL, V63, P80, DOI 10.1016/j.surneu.2004.01.026	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	JAN	2015	29	1							126.e5	10.1016/j.avsg.2014.07.038		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AW4GS	WOS:000346239900031		
J	Liang, Y; Hoshino, K				Liang, Y.; Hoshino, K.			Thermodynamic calculations of AuxAg1-x - Fluid equilibria and their applications for ore-forming conditions	APPLIED GEOCHEMISTRY			English	Article							PAPUA-NEW-GUINEA; HEMLO GOLD DEPOSIT; AG-AU-S; COPPER-MOLYBDENUM DEPOSIT; WALL-ROCK ALTERATION; WESTERN-AUSTRALIA; NATIVE GOLD; TELLURIDE MINERALIZATION; HYDROTHERMAL ALTERATION; EPITHERMAL DEPOSITS	Concentrations of dissolved gold and silver species in hydrothermal fluids equilibrated with Au-Ag solid solutions have been calculated at wide conditions on the well known fO(2)-pH spaces. Ratios of the total concentrations of dissolved gold and silver species (Sigma Au/Sigma Ag) are higher as pH higher and fO(2) lower. The ratios are constant at very low and high pH conditions where major dissolved species of both gold and silver are chloride complexes and thio complexes, respectively, while the ratios practically depend only on pH at intermediate pH conditions where Au(HS)(2) and AgCl2 are major. The calculated results indicate that the solid solutions of high gold finenesses may precipitate from the fluids of low ratios of the total concentrations of dissolved gold and silver species when the conditions are (1) low pH's and/or (2) high concentration ratios of dissolved chlorine and sulfur and/or (3) high temperatures. (C) 2014 Elsevier Ltd. All rights reserved.	[Liang, Y.; Hoshino, K.] Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima, Hiroshima 7398526, Japan	Liang, Y (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	D122873@hiroshima-u.ac.jp					Akira I., 2001, RESOUR GEOL, V51, P71; Akira I., 2000, RESOUR GEOL, V50, P151; Akira I., 2002, RESOUR GEOL, V52, P381; Akira I., 1998, RESOUR GEOL, V48, P159; Akira I., 2005, RESOUR GEOL, V55, P73; Rasmussen B, 2009, CONTRIB MINERAL PETR, V157, P559, DOI 10.1007/s00410-008-0352-7; Wang JZ, 2008, INT GEOL REV, V50, P392, DOI 10.2747/0020-6814.50.4.392; ZAW K, 1992, ECON GEOL BULL SOC, V87, P931; Bateman R, 2004, MINER DEPOSITA, V39, P536, DOI 10.1007/s00126-004-0431-2; Cocker HA, 2013, MINER DEPOSITA, V48, P249, DOI 10.1007/s00126-012-0410-y; Seo JH, 2009, EARTH PLANET SC LETT, V282, P323, DOI 10.1016/j.epsl.2009.03.036; Pal'yanova G, 2008, CHEM GEOL, V255, P399, DOI 10.1016/j.chemgeo.2008.07.010; Rusk BG, 2008, ECON GEOL, V103, P307, DOI 10.2113/gsecongeo.103.2.307; Mueller AG, 2013, MINER DEPOSITA, V48, P295, DOI 10.1007/s00126-012-0425-4; PAN YM, 1995, ORE GEOL REV, V9, P455, DOI 10.1016/0169-1368(95)00003-K; Prendergast K, 2005, ECON GEOL, V100, P1021, DOI 10.2113/100.5.1021; LAWRANCE LM, 1994, MINER DEPOSITA, V29, P391, DOI 10.1007/BF01886956; CAMERON EM, 1985, GEOCHIM COSMOCHIM AC, V49, P2041, DOI 10.1016/0016-7037(85)90062-6; Kreuzer OP, 2006, MINER DEPOSITA, V40, P639, DOI 10.1007/s00126-005-0010-1; HAYASHI K, 1991, GEOCHIM COSMOCHIM AC, V55, P2111, DOI 10.1016/0016-7037(91)90091-I; BOWELL RJ, 1992, MINERAL MAG, V56, P545, DOI 10.1180/minmag.1992.056.385.10; Ulrich T, 1999, NATURE, V399, P676; Simmons SF, 2006, SCIENCE, V314, P288, DOI 10.1126/science.1132866; Bonev IK, 2002, MINER DEPOSITA, V37, P614, DOI 10.1007/s00126-002-0273-8; WHITE JL, 1957, ACTA METALL MATER, V5, P747, DOI 10.1016/0001-6160(57)90078-0; Landtwing MR, 2010, ECON GEOL, V105, P91; Murakami H, 2010, MINER DEPOSITA, V45, P11, DOI 10.1007/s00126-009-0255-1; RICHARDS JP, 1991, GEOCHIM COSMOCHIM AC, V55, P565, DOI 10.1016/0016-7037(91)90013-U; Meinert LD, 1997, ECON GEOL BULL SOC, V92, P509; ANTWEILER JC, 1977, J GEOCHEM EXPLOR, V8, P17, DOI 10.1016/0375-6742(77)90041-3; BARTON PB, 1964, GEOCHIM COSMOCHIM AC, V28, P619, DOI 10.1016/0016-7037(64)90082-1; Binu-Lal SS, 2003, J ASIAN EARTH SCI, V22, P171, DOI 10.1016/S1367-9120(03)00003-8; BOWELL RJ, 1990, MINERAL MAG, V54, P617, DOI 10.1180/minmag.1990.054.377.15; Bucci LA, 2002, ORE GEOL REV, V19, P23, DOI 10.1016/S0169-1368(01)00032-4; Caddey S. W., 1991, GEOL RESOUR GOLD US, pJ1; Chryssoulis SL, 2001, JOM-J MIN MET MAT S, V53, P48, DOI 10.1007/s11837-001-0015-x; DESBOROU.GA, 1971, MINER DEPOSITA, V6, P321; Espi JO, 2007, RESOUR GEOL, V57, P249, DOI 10.1111/j.1751-3928.2007.00021.x; Etoh J, 2002, RESOUR GEOL, V52, P73, DOI 10.1111/j.1751-3928.2002.tb00119.x; Fisher N.H., 1945, ECON GEOL, V40, P449; Frimmel HE, 1997, MINER DEPOSITA, V32, P523, DOI 10.1007/s001260050119; Frimmel HE, 1999, MINER PETROL, V66, P55, DOI 10.1007/BF01161722; GAMMONS CH, 1989, GEOCHIM COSMOCHIM AC, V53, P279, DOI 10.1016/0016-7037(89)90380-3; GAMMONS CH, 1995, GEOCHIM COSMOCHIM AC, V59, P3453, DOI 10.1016/0016-7037(95)00234-Q; Gan SF, 1994, INT GEOL REV, V36, P850; GREEN AH, 1982, MINER DEPOSITA, V17, P175; Greffie C, 2002, ECON GEOL BULL SOC, V97, P561, DOI 10.2113/97.3.561; Gurevich VM, 2011, GEOCHEM INT+, V49, P422, DOI 10.1134/S0016702911040057; Harris D. C., 1986, CURRENT RES A, V86, P49; Henley R. W., 1984, REV EC GEOLOGY, V1, P115; Hu H., 2001, MINERAL DEPOSITS, V20, P86; Huston D.L., 1989, ORE GEOL REV, V4, P171, DOI 10.1016/0169-1368(89)90017-6; HUSTON DL, 1992, ECON GEOL BULL SOC, V87, P542; IZAWA E, 1990, J GEOCHEM EXPLOR, V36, P1, DOI 10.1016/0375-6742(90)90050-K; JOHNSON JW, 1992, COMPUT GEOSCI, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Kajiwara Y., 1971, GEOCHEM J, V4, P157; Kreuzer OP, 2007, ORE GEOL REV, V32, P37, DOI 10.1016/j.oregeorev.2006.12.001; KRUPP RE, 1992, MINER DEPOSITA, V27, P268; LANG JR, 1988, ECON GEOL, V83, P551; Lu HZ, 2000, ACTA PETROL SIN, V16, P465; Maeda H, 1998, RESOUR GEOL, V48, P197, DOI 10.1111/j.1751-3928.1998.tb00017.x; Maglambayan VB, 1998, RESOUR GEOL, V48, P87, DOI 10.1111/j.1751-3928.1998.tb00009.x; Mariam M. G., 1993, MINER DEPOSITA, V28, P375; Mclnnes B. I. A., 1999, SCIENCE, V286, P512; Mernagh TP, 2004, CAN MINERAL, V42, P1383, DOI 10.2113/gscanmin.42.5.1383; Moritz R, 2006, J GEOCHEM EXPLOR, V89, P284, DOI 10.1016/j.gexplo.2005.11.068; Morrison G.W., 1991, ORE GEOL REV, V6, P333, DOI 10.1016/0169-1368(91)90009-V; Mueller A. G., 2012, ECON GEOL, V107, P11; Mueller AG, 2007, MINER DEPOSITA, V42, P737, DOI 10.1007/s00126-007-0132-8; Muir TL, 2002, ORE GEOL REV, V21, P1, DOI 10.1016/S0169-1368(02)00066-5; Muller D, 2002, MINER DEPOSITA, V37, P61, DOI 10.1007/s00126-001-0230-y; NAIR NGK, 1987, CHEM GEOL, V60, P309, DOI 10.1016/0009-2541(87)90137-9; NRM Department of Natural Resources and Mines geological survey of Queensland, 2012, QUEENSL SIGN MIN MIN; O'Dea T. R., 1980, P AUSTRALASIAN I MIN, P9; Pal'yanova GA, 2011, RUSS GEOL GEOPHYS+, V52, P443, DOI 10.1016/j.rgg.2011.03.006; Pal'yanova GA, 2008, THEOR FOUND CHEM EN+, V42, P749, DOI 10.1134/S0040579508050485; Pal'yanova GA, 2007, GEOCHEM INT+, V45, P744, DOI 10.1134/S0016702907080022; Petersen S, 2002, ECON GEOL BULL SOC, V97, P1795, DOI 10.2113/97.8.1795; Qian Jianping, 2011, Chinese Journal of Geochemistry, V30, DOI 10.1007/s11631-011-0538-y; Rae AJ, 2011, ECON GEOL, V106, P1425; REID AM, 1988, MINER DEPOSITA, V23, P211; RICHARDS JP, 1990, J GEOCHEM EXPLOR, V35, P141, DOI 10.1016/0375-6742(90)90038-C; Rubin JN, 1997, ECON GEOL BULL SOC, V92, P535; Rusk BG, 2004, CHEM GEOL, V210, P173, DOI 10.1016/j.chemgeo.2004.06.011; SAAGER R, 1969, ECON GEOL, V64, P445; SANTOSH M, 1992, MINER DEPOSITA, V27, P336; Sasaki M., 1995, RESOUR GEOL, V45, P1; Sato J., 1974, MINING GEOL, P323; SHEETS RW, 1995, CAN MINERAL, V33, P137; SHIKAZONO N, 1987, MINER DEPOSITA, V22, P309; Simmons S. F., 2007, GEOLOGY, V35, P1009; Singer D.A., 2005, 20051060 US GEOL SUR; SPYCHER NF, 1989, ECON GEOL, V84, P328; Tagirov BR, 2006, GEOCHIM COSMOCHIM AC, V70, P3689, DOI 10.1016/j.gca.2006.05.006; Tanimura S., 1983, EC GEOL MON, V5, P24; Ulrich T, 2002, ECON GEOL, V97, P1889, DOI 10.2113/97.8.1889; Uzunlar N., 2010, ROCK MOUNT 62 ANN M; Wolfram S., 1991, MATH SYSTEM DOING MA; Yamada R., 1987, MINING GEOLOGY, V37, P109; Yang XN, 2008, ACTA PETROL SIN, V24, P1889; Zaw K, 1999, ECON GEOL BULL SOC, V94, P529; Zaw K, 1996, MINER PETROL, V57, P97, DOI 10.1007/BF01161624; Zhai W, 2009, ORE GEOL REV, V36, P265, DOI 10.1016/j.oregeorev.2009.04.003	103	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0883-2927			APPL GEOCHEM	Appl. Geochem.	JAN	2015	52						109	117		10.1016/j.apgeochem.2014.11.019		9	Geochemistry & Geophysics	Geochemistry & Geophysics	AX3PG	WOS:000346850700011		
J	Menasri, R; Nakib, A; Daachi, B; Oulhadj, H; Siarry, P				Menasri, R.; Nakib, A.; Daachi, B.; Oulhadj, H.; Siarry, P.			A trajectory planning of redundant manipulators based on bilevel optimization	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Redundant manipulators; Bilevel optimization; Bi-genetic algorithm; Trajectory planning	ROBOT MANIPULATORS; GENETIC ALGORITHMS; COLLISION-AVOIDANCE; INDUSTRIAL ROBOTS; OBSTACLES; CONTROLLER	In this paper, a novel trajectory planning approach is proposed for redundant manipulators in the case of several obstacles. The trajectory is discretized and at each step, we search for a new position of the end effector in the Cartesian space to reach the final position. Because of the redundancy, this position can be achieved by an infinity of configurations in the joint space. Thus, we use this property to find the best configuration that allows to avoid obstacles and singularities of the robot. The proposed method is based on a bilevel optimization formulation of the problem and bi-genetic algorithm to solve it. In order to avoid obstacles, we also proposed to manage constraints of the problem dynamically. This technique adapts the number of constraints in the formulation of the problem with the position of the obstacles. Simulation results showed the effectiveness of the proposed method. (C) 2014 Elsevier Inc. All rights reserved.	[Menasri, R.; Nakib, A.; Daachi, B.; Oulhadj, H.; Siarry, P.] Univ Paris Est Creteil, LISSI Lab, F-94400 Vitry Sur Seine, France; [Daachi, B.] CNRS AIST Joint Robot Lab JRL, CRT UMI3218, Tsukuba, Ibaraki, Japan	Siarry, P (reprint author), Univ Paris Est Creteil, LISSI Lab, 122 Rue Paul Armangot, F-94400 Vitry Sur Seine, France.	riad.menasri@u-pec.fr; nakib@u-pec.fr; daachi.boubaker@aist.go.jp; oulhadj@u-pec.fr; siarry@u-pec.fr					Jiang Y, 2013, APPL MATH COMPUT, V219, P4332, DOI 10.1016/j.amc.2012.10.010; Tian LF, 2004, MECHATRONICS, V14, P455, DOI 10.1016/j.mechatronics.2003.10.001; Lv YB, 2007, APPL MATH COMPUT, V188, P808, DOI 10.1016/j.amc.2006.10.045; Hejazi SR, 2002, COMPUT OPER RES, V29, P1913, DOI 10.1016/S0305-0548(01)00066-1; Shukla A, 2013, ROBOT AUTON SYST, V61, P209, DOI 10.1016/j.robot.2012.08.012; Daachi B, 2012, NEUROCOMPUTING, V79, P50, DOI 10.1016/j.neucom.2011.10.001; Marcos MD, 2012, APPL SOFT COMPUT, V12, P589, DOI 10.1016/j.asoc.2011.11.006; Lin CJ, 2004, MECHATRONICS, V14, P281, DOI 10.1016/S0957-4158(03)00032-1; Chettibi T, 2004, EUR J MECH A-SOLID, V23, P703, DOI 10.1016/j.euromechsol.2004.02.006; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; Pires EJS, 2007, APPL SOFT COMPUT, V7, P659, DOI 10.1016/j.asoc.2005.06.009; Liu HS, 2013, ROBOT CIM-INT MANUF, V29, P309, DOI 10.1016/j.rcim.2012.08.002; Bard J.F., 1998, PRACTICAL BILEVEL OP; Calvete HI, 2008, EUR J OPER RES, V188, P14, DOI 10.1016/j.ejor.2007.03.034; Chakraborti T, 2011, LECT NOTES COMPUT SC, V7077, P89, DOI 10.1007/978-3-642-27242-4_11; Dempe S., 2002, FDN BILEVEL PROGRAMM; Garg DP, 2002, ENG APPL ARTIF INTEL, V15, P241, DOI 10.1016/S0952-1976(02)00067-2; Gasparetto A, 2007, MECH MACH THEORY, V42, P455, DOI 10.1016/j.mechmachtheory.2006.04.002; Gasparetto A, 2010, ADV ENG SOFTW, V41, P548, DOI 10.1016/j.advengsoft.2009.11.001; Kucuk S, 2006, ROBOT AUTON SYST, V54, P567, DOI 10.1016/j.robot.2006.04.002; Kuffner J.J., 2000, P 2000 IEEE INT C RO; Le Boudec B, 2006, MATH COMPUT SIMULAT, V71, P395, DOI 10.1016/j.matcom.2006.02.010; Li HC, 2006, LECT NOTES COMPUT SC, V4247, P408; Machmudah A, 2013, APPL SOFT COMPUT, V13, P1099, DOI 10.1016/j.asoc.2012.09.025; Madani T, 2013, ROBOT AUTON SYST, V61, P555, DOI 10.1016/j.robot.2013.02.010; Marcos MD, 2009, COMMUN NONLINEAR SCI, V14, P2858, DOI 10.1016/j.cnsns.2008.10.014; Oduguwa V., 2002, P 2002 IEEE INT C AR; PIRES EJS, 2004, GEN EV COMP C SEATTL, V3102, P615, DOI 10.1007/978-3-540-24854-5_64; POURAZADY M, 1991, MECH MACH THEORY, V26, P603, DOI 10.1016/0094-114X(91)90042-3; Sanchez G, 2002, INT J ROBOT RES, V21, P5, DOI 10.1177/027836402320556458; Talbi E-G., 2009, METAHEURISTICS DESIG; TSAI MJ, 1990, MECH MACH THEORY, V25, P575, DOI 10.1016/0094-114X(90)90071-Q; Yu JS, 1996, MATH COMPUT SIMULAT, V41, P627, DOI 10.1016/0378-4754(95)00106-9; Zhongping W., 2011, ACTA MATH SCI B, V31B, P652, DOI 10.1016/S0252-9602(11)60265-8	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	JAN 1	2015	250						934	947		10.1016/j.amc.2014.10.101		14	Mathematics, Applied	Mathematics	AW4HE	WOS:000346241000080		
J	Lee, BL; Kawabata, S; Wang, CS; Kim, Y				Lee, Bok Luel; Kawabata, Shun-Ichiro; Wang, Chengshu; Kim, Yonggyun			Preface to the Special Issue	ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY			English	Editorial Material									[Lee, Bok Luel] Busan Natl Univ, Pusan, South Korea; [Kawabata, Shun-Ichiro] Kyushu Univ, Fukuoka 812, Japan; [Wang, Chengshu] Chinese Acad Sci, Shanghai Inst, Shanghai, Peoples R China; [Kim, Yonggyun] Andong Natl Univ, Andong, South Korea	Lee, BL (reprint author), Busan Natl Univ, Pusan, South Korea.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0739-4462	1520-6327		ARCH INSECT BIOCHEM	Arch. Insect Biochem. Physiol.	JAN	2015	88	1			SI		1	3		10.1002/arch.21220		3	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	AW8FF	WOS:000346495500002		
J	Ishii, K; Hamamoto, H; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Sekimizu, Kazuhisa			PARALYTIC PEPTIDE: AN INSECT CYTOKINE THAT MEDIATES INNATE IMMUNITY	ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY			English	Article						insect cytokine; silkworm; nitric oxide; bacterial infection; metalloprotease	SILKWORM BOMBYX-MORI; DORSAL-VENTRAL POLARITY; GENOME-WIDE ANALYSIS; TOLL GENE-PRODUCT; FLESH-FLY LARVAE; NITRIC-OXIDE; SERRATIA-MARCESCENS; DROSOPHILA EMBRYO; MANDUCA-SEXTA; PEPTIDOGLYCAN RECOGNITION	Host animals combat invading pathogens by activating various immune responses. Modulation of the immune pathways by cytokines is critical for efficient pathogen elimination. Insects and mammals possess common innate immune systems, and individual immune pathways have been intensively studied over the last two decades. Relatively less attention, however, has been focused on the functions of cytokines in insect innate immunity. Here, we summarize our recent findings from studies of the insect cytokine, paralytic peptide, in the silkworm Bombyx mori. The content of this report was presented at the First Asian Invertebrate Immunity Symposium. Acute activation of paralytic peptide occurs via proteolysis after stimulation with the cell wall components of pathogens, leading to the induction of a wide range of cellular and humoral immune responses. The pathogenic bacterium Serratia marcescens suppresses paralytic peptide-dependent immune activation, which impairs host resistance. Studies of insect cytokines will broaden our understanding of the basic mechanisms underlying the interaction between host innate immunity and pathogenic agents. (C) 2014 Wiley Periodicals, Inc.	[Ishii, Kenichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan	Sekimizu, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp					Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Lavine MD, 2002, INSECT BIOCHEM MOLEC, V32, P1295, DOI 10.1016/S0965-1748(02)00092-9; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Srikanth K, 2011, ARCH INSECT BIOCHEM, V78, P145, DOI 10.1002/arch.20450; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Kurokawa K, 2011, DEV COMP IMMUNOL, V35, P835, DOI 10.1016/j.dci.2011.03.001; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Ishii K, 2014, J BIOL CHEM, V289, P5876, DOI 10.1074/jbc.M113.544536; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Imler JL, 2014, DEV COMP IMMUNOL, V42, P3, DOI 10.1016/j.dci.2013.08.018; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Imamura M, 2003, GENETICS, V165, P1329; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BOMAN HG, 1974, INFECT IMMUN, V10, P136; CHADWICK JS, 1990, J INVERTEBR PATHOL, V55, P133, DOI 10.1016/0022-2011(90)90044-7; Eleftherianos I, 2009, INSECT MOL BIOL, V18, P507, DOI 10.1111/j.1365-2583.2009.00899.x; Fadel MP, 1999, J BIOL CHEM, V274, P15085, DOI 10.1074/jbc.274.21.15085; FAYE I, 1975, INFECT IMMUN, V12, P1426; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; Hamamoto H, 2005, RES ADV ANTIMICROB A, V5, P1; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; HARA S, 1995, J BIOL CHEM, V270, P29923; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2013, DEV COMP IMMUNOL, V39, P147, DOI 10.1016/j.dci.2012.10.014; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Jiang R, 2011, J BIOL CHEM, V286, P35087, DOI 10.1074/jbc.M111.277343; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Matsumoto Y, 2012, J APPL MICROBIOL, V112, P138, DOI 10.1111/j.1365-2672.2011.05186.x; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Miyashita A, 2012, FEMS MICROBIOL LETT, V333, P59, DOI 10.1111/j.1574-6968.2012.02599.x; OKADA M, 1983, BIOCHEM J, V211, P727; OKADA M, 1985, J BIOL CHEM, V260, P7174; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; Osanai-Futahashi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2312; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	77	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0739-4462	1520-6327		ARCH INSECT BIOCHEM	Arch. Insect Biochem. Physiol.	JAN	2015	88	1			SI		18	30		10.1002/arch.21215		13	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	AW8FF	WOS:000346495500004		
J	Usui, F; Shirasuna, K; Kimura, H; Tatsumi, K; Kawashima, A; Karasawa, T; Yoshimura, K; Aoki, H; Tsutsui, H; Noda, T; Sagara, J; Taniguchi, S; Takahashi, M				Usui, Fumitake; Shirasuna, Koumei; Kimura, Hiroaki; Tatsumi, Kazuki; Kawashima, Akira; Karasawa, Tadayoshi; Yoshimura, Koichi; Aoki, Hiroki; Tsutsui, Hiroko; Noda, Tetsuo; Sagara, Junji; Taniguchi, Shun'ichiro; Takahashi, Masafumi			Inflammasome Activation by Mitochondrial Oxidative Stress in Macrophages Leads to the Development of Angiotensin II-Induced Aortic Aneurysm	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						cytokines; inflammation; macrophages; oxidative stress	CHRONIC GRANULOMATOUS-DISEASE; E-DEFICIENT MICE; ATHEROSCLEROSIS; CASPASE-1; APOPTOSIS	Objective-Abdominal aortic aneurysm (AAA) is considered a chronic inflammatory disease; however, the molecular basis underlying the sterile inflammatory response involved in the process of AAA remains unclear. We previously showed that the inflammasome, which regulates the caspase-1-dependent interleukin-1 beta production, mediates the sterile cardiovascular inflammatory responses. Therefore, we hypothesized that the inflammasome is a key mediator of initial inflammation in AAA formation. Approach and Results-Apoptosis-associated speck-like protein containing a caspase recruitment domain is highly expressed in adventitial macrophages in human and murine AAA tissues. Using an established mouse model of AAA induced by continuous infusion of angiotensin II in Apoe(-/-) mice, NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase recruitment domain, and caspase-1 deficiency in Apoe(-/-) mice were shown to decrease the incidence, maximal diameter, and severity of AAA along with adventitial fibrosis and inflammatory responses significantly, such as inflammatory cell infiltration and cytokine expression in the vessel wall. NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain, and caspase-1 deficiency in Apoe(-/-) mice also reduced elastic lamina degradation and metalloproteinase activation in the early phase of AAA formation. Furthermore, angiotensin II stimulated generation of mitochondria-derived reactive oxygen species in the adventitial macrophages, and this mitochondria-derived reactive oxygen species generation was inhibited by NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain, and caspase-1 deficiency. In vitro experiments revealed that angiotensin II stimulated the NLRP3 inflammasome activation and subsequent interleukin-1 beta release in macrophages, and this activation was mediated through an angiotensin type I receptor/mitochondria-derived reactive oxygen species-dependent pathway. Conclusions-Our results demonstrate the importance of the NLRP3 inflammasome in the initial inflammatory responses in AAA formation, indicating its potential as a novel therapeutic target for preventing AAA progression.	[Usui, Fumitake; Shirasuna, Koumei; Kimura, Hiroaki; Tatsumi, Kazuki; Kawashima, Akira; Karasawa, Tadayoshi; Takahashi, Masafumi] Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Sagara, Junji; Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo 6638501, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan	Takahashi, M (reprint author), Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	masafumi2@jichi.ac.jp			Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy; Vehicle Racing Commemorative Foundation; Daiichi-Sankyo Foundation of Life Science; Yakult Bio-Science Foundation; Banyu Life Science Foundation International	This study was granted by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (Dr Takahashi), the Vehicle Racing Commemorative Foundation (Dr Takahashi), the Daiichi-Sankyo Foundation of Life Science (Dr Takahashi), Yakult Bio-Science Foundation (Dr Takahashi), and Grant-in-Aid for Research Activity Start-up (Dr Usui) and Banyu Life Science Foundation International (Dr Usui).	Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; KOCH AE, 1990, AM J PATHOL, V137, P1199; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.000011013.72016.ea; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; [Anonymous], 1998, LANCET, V352, P1649; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Dai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028903; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765	36	7	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JAN	2015	35	1					127	136		10.1161/ATVBAHA.114.303763		10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AW9EU	WOS:000346561100020		
J	Emrich, FC; Okamura, H; Dalal, AR; Penov, K; Merk, DR; Raaz, U; Hennigs, JK; Chin, JT; Miller, MO; Pedroza, AJ; Craig, JK; Koyano, TK; Blankenberg, FG; Connolly, AJ; Mohr, FW; Alvira, CM; Rabinovitch, M; Fischbein, MP				Emrich, Fabian C.; Okamura, Homare; Dalal, Alex R.; Penov, Kiril; Merk, Denis R.; Raaz, Uwe; Hennigs, Jan K.; Chin, Jocelyn T.; Miller, Miquell O.; Pedroza, Albert J.; Craig, Juliana K.; Koyano, Tiffany K.; Blankenberg, Francis G.; Connolly, Andrew J.; Mohr, Friedrich W.; Alvira, Cristina M.; Rabinovitch, Marlene; Fischbein, Michael P.			Enhanced Caspase Activity Contributes to Aortic Wall Remodeling and Early Aneurysm Development in a Murine Model of Marfan Syndrome	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						aneurysm; apoptosis; caspases; extracellular matrix; Marfan syndrome	MUSCLE-CELL APOPTOSIS; EXTRACELLULAR-MATRIX; MOUSE MODEL; DEATH; EXPRESSION; MICE	Objective-Rupture and dissection of aortic root aneurysms remain the leading causes of death in patients with the Marfan syndrome, a hereditary connective tissue disorder that affects 1 in 5000 individuals worldwide. In the present study, we use a Marfan mouse model (Fbn1(C1039G/+)) to investigate the biological importance of apoptosis during aneurysm development in Marfan syndrome. Approach and Results-Using in vivo single-photon emission computed tomographic-imaging and ex vivo autoradiography for Tc99m-annexin, we discovered increased apoptosis in the Fbn1(C1039G/+) ascending aorta during early aneurysm development peaking at 4 weeks. Immunofluorescence colocalization studies identified smooth muscle cells (SMCs) as the apoptotic cell population. As biological proof of concept that early aortic wall apoptosis plays a role in aneurysm development in Marfan syndrome, Fbn1(C1039G/+) mice were treated daily from 2 to 6 weeks with either (1) a pan-caspase inhibitor, Q-V-D-OPh (20 mg/kg), or (2) vehicle control intraperitoneally. Q-VD-OPh treatment led to a significant reduction in aneurysm size and decreased extracellular matrix degradation in the aortic wall compared with control mice. In vitro studies using Fbn1(C1039G/+) ascending SMCs showed that apoptotic SMCs have increased elastolytic potential compared with viable cells, mostly because of caspase activity. Moreover, in vitro (1) cell membrane isolation, (2) immunofluorescence staining, and (3) scanning electron microscopy studies illustrate that caspases are expressed on the exterior cell surface of apoptotic SMCs. Conclusions-Caspase inhibition attenuates aneurysm development in an Fbn1(C1039G/+) Marfan mouse model. Mechanistically, during apoptosis, caspases are expressed on the cell surface of SMCs and likely contribute to elastin degradation and aneurysm development in Marfan syndrome.	[Emrich, Fabian C.; Okamura, Homare; Dalal, Alex R.; Penov, Kiril; Merk, Denis R.; Chin, Jocelyn T.; Miller, Miquell O.; Pedroza, Albert J.; Craig, Juliana K.; Koyano, Tiffany K.; Fischbein, Michael P.] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Raaz, Uwe] Stanford Univ, Dept Cardiovasc Med, Stanford, CA 94305 USA; [Hennigs, Jan K.; Alvira, Cristina M.; Rabinovitch, Marlene] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Blankenberg, Francis G.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Connolly, Andrew J.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Emrich, Fabian C.; Penov, Kiril; Merk, Denis R.; Mohr, Friedrich W.] Univ Leipzig, Ctr Heart, Dept Cardiothorac Surg, D-04109 Leipzig, Germany; [Okamura, Homare] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan	Fischbein, MP (reprint author), Stanford Univ, Sch Med, Dept Cardiothorac Surg, 300 Pasteur Dr,Falk Bldg, Stanford, CA 94305 USA.	mfischbe@stanford.edu			Marfan Foundation; American Heart Association; ProCordis, Verein zur Forderung der Forschung in der Herzchirurgie e.V., Leipzig, Germany	M.P. Fischbein was funded by The Marfan Foundation and American Heart Association (Grant-in-Aid). F.C. Emrich was partially funded by ProCordis, Verein zur Forderung der Forschung in der Herzchirurgie e.V., Leipzig, Germany.	Bunton TE, 2001, CIRC RES, V88, P37; Lesauskaite V, 2001, HUM PATHOL, V32, P1003, DOI 10.1053/hupa.2001.27107; Kovacevic M, 2010, MED HYPOTHESES, V74, P908, DOI 10.1016/j.mehy.2009.10.021; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Henderson EL, 1999, CIRCULATION, V99, P96; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Kenagy RD, 2011, J VASC SURG, V54, P182, DOI 10.1016/j.jvs.2010.12.070; Nagashima H, 2001, CIRCULATION, V104, pI282; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Cowan KN, 2005, FASEB J, V19, P1848, DOI 10.1096/fj.05-3706fje; Gomez D, 2013, ARTERIOSCL THROM VAS, V33, P2222, DOI 10.1161/ATVBAHA.113.301327; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020138; Leeper NJ, 2013, ARTERIOSCL THROM VAS, V33, pE1, DOI 10.1161/ATVBAHA.112.300399; Mohamed SA, 2010, ANN ANAT, V192, P145, DOI 10.1016/j.aanat.2010.02.006; Okamura H, 2014, CIRC CARDIOVASC IMAG, V7; Schmid FX, 2003, EUR J CARDIO-THORAC, V23, P537, DOI 10.1016/S1010-7940(02)00833-3; Umeda H, 2011, BIOCHEM BIOPH RES CO, V411, P281, DOI 10.1016/j.bbrc.2011.06.124	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JAN	2015	35	1					146	154		10.1161/ATVBAHA.114.304364		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AW9EU	WOS:000346561100022		
J	Ohashi, Y				Ohashi, Yoshihiro			On Run-preventing Contract Design	B E JOURNAL OF THEORETICAL ECONOMICS			English	Article						deposit contracts; bank runs; mechanism design; strategy-proof; implementation	BANK RUNS; DEPOSIT INSURANCE; LIQUIDITY; IMPLEMENTATION	This study considers how to implement an efficient allocation of a financial intermediation model, including liquidation costs. The main result shows that there is a mechanism such that, for any liquidation cost, an efficient allocation is implementable in strictly dominant strategies. There is no need for third-party assistance, such as deposit insurance. In addition, the mechanism is tolerant of a small, unexpected shock caused by premature withdrawals.	Waseda Univ, Ctr Finance Res, Chuo Ku, Tokyo, Japan	Ohashi, Y (reprint author), Waseda Univ, Ctr Finance Res, Chuo Ku, 1-4-1 Nihonbashi, Tokyo, Japan.	yoshi.ohashi@gmail.com					ABREU D, 1992, ECONOMETRICA, V60, P993, DOI 10.2307/2951536; Andolfatto D, 2008, J ECON THEORY, V142, P28, DOI 10.1016/j.jet.2007.07.011; Ennis HM, 2009, AM ECON REV, V99, P1588, DOI 10.1257/aer.99.4.1588; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Allen F, 1998, J FINANC, V53, P1245, DOI 10.1111/0022-1082.00052; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Brunnermeier M., 2001, ASSET PRICING ASYMME; Cipriani M., 2012, FINANCE EC DISCUSSIO; Cooper R, 1998, J MONETARY ECON, V41, P27, DOI 10.1016/S0304-3932(97)00070-6; Cooper R, 2002, INT ECON REV, V43, P55, DOI 10.1111/1468-2354.t01-1-00003; ENGINEER M, 1989, J MONETARY ECON, V24, P443, DOI 10.1016/0304-3932(89)90031-7; Ennis HM, 2009, J ECON THEORY, V144, P1996, DOI 10.1016/j.jet.2009.05.001; Green EJ, 2003, J ECON THEORY, V109, P1, DOI 10.1016/S0022-0531(02)00017-0; Martin A, 2006, ECON THEOR, V28, P197, DOI 10.1007/s00199-005-0613-x; MOORE J, 1988, ECONOMETRICA, V56, P1191, DOI 10.2307/1911364; Peck J, 2003, J POLIT ECON, V111, P103, DOI 10.1086/344803; Boot AWA, 2008, HANDB FINANC, pXV, DOI 10.1016/B978-044451558-2.50002-7; Wallace Neil, 1988, FEDERAL RESERVE BANK, V12, P3	18	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1935-1704			BE J THEOR ECON	B E J. Theor. Econ.	JAN	2015	15	1					63	72		10.1515/bejte-2014-0007		10	Economics	Business & Economics	AW5WS	WOS:000346342400004		
J	Noguchi, T				Noguchi, Takumi			Fourier transform infrared difference and time-resolved infrared detection of the electron and proton transfer dynamics in photosynthetic water oxidation	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						FTIR; Time-resolved infrared spectroscopy; Photosynthesis; Water oxidation; Oxygen evolution; Proton transfer	OXYGEN-EVOLVING COMPLEX; S-STATE CYCLE; INDUCED STRUCTURAL-CHANGES; TYROSINE Y-Z; PHOTOSYSTEM-II; D1 POLYPEPTIDE; OXIDIZING COMPLEX; UNDERGOES OXIDATION; MN CLUSTER; VIBRATIONAL SPECTROSCOPY	Photosynthetic water oxidation, which provides the electrons necessary for CO2 reduction and releases O-2 and protons, is performed at the Mn4CaO5 cluster in photosystem II (PSII). In this review, studies that assessed the mechanism of water oxidation using infrared spectroscopy are summarized focusing on electron and proton transfer dynamics. Structural changes in proteins and water molecules between intermediates known as Si states (i = 0-3) were detected using flash-induced Fourier transform infrared (FTIR) difference spectroscopy. Electron flow in PSII and proton release from substrate water were monitored using the infrared changes in ferricyanide as an exogenous electron acceptor and Mes buffer as a proton acceptor. Time-resolved infrared (TRIR) spectroscopy provided information on the dynamics of proton-coupled electron transfer during the S-state transitions. In particular, a drastic proton movement during the lag phase (similar to 200 mu s) before electron transfer in the S-3 --> S-0 transition was detected directly by monitoring the infrared absorption of a polarizable proton in a hydrogen bond network. Furthermore, the proton release pathways in the PSII proteins were analyzed by FTIR difference measurements in combination with site-directed mutagenesis, isotopic substitutions, and quantum chemical calculations. Therefore, infrared spectroscopy is a powerful tool for understanding the molecular mechanism of photosynthetic water oxidation. This article is part of a Special Issue entitled: Vibrational spectroscopies and bioenergetic systems. (C) 2014 Elsevier B.V. All rights reserved.	Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Noguchi, T (reprint author), Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	tnoguchi@bio.phys.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24000018, 24107003, 25291033]	I thank Richard Debus for the valuable discussion and sending me a preprint of his work. This study was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (24000018, 24107003, and 25291033).	Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Linke K, 2014, BBA-BIOENERGETICS, V1837, P14, DOI 10.1016/j.bbabio.2013.08.003; Hou LH, 2011, BIOCHEMISTRY-US, V50, P9248, DOI 10.1021/bi200943q; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Isgandarova S, 2003, BIOCHEMISTRY-US, V42, P8929, DOI 10.1021/bi034744b; Boussac A, 2012, BBA-BIOENERGETICS, V1817, P802, DOI 10.1016/j.bbabio.2012.02.031; Schlodder E, 1999, J BIOL CHEM, V274, P30387, DOI 10.1074/jbc.274.43.30387; Bao H, 2013, PHOTOSYNTH RES, V116, P215, DOI 10.1007/s11120-013-9907-1; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Shimada Y, 2011, J AM CHEM SOC, V133, P3808, DOI 10.1021/ja200186h; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; Vogel R, 2000, CURR OPIN CHEM BIOL, V4, P518, DOI 10.1016/S1367-5931(00)00125-3; Wincencjusz H, 1997, BIOCHEMISTRY-US, V36, P3663, DOI 10.1021/bi9626719; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; Ogata K, 2013, J AM CHEM SOC, V135, P15670, DOI 10.1021/ja404317d; Suzuki H, 2008, BIOCHEMISTRY-US, V47, P11024, DOI 10.1021/bi801580e; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Siegbahn PEM, 2012, PHYS CHEM CHEM PHYS, V14, P4849, DOI 10.1039/c2cp00034b; Kawakami K, 2011, J PHOTOCH PHOTOBIO B, V104, P9, DOI 10.1016/j.jphotobiol.2011.03.017; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P15706, DOI 10.1021/bi020603i; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Noguchi T, 2007, PHOTOSYNTH RES, V91, P59, DOI 10.1007/s11120-007-9137-5; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Hillier W, 2005, ADV PHOTO RESPIRAT, V22, P567; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Berthomieu C, 2009, PHOTOSYNTH RES, V101, P157, DOI 10.1007/s11120-009-9439-x; Ido K, 2012, J BIOL CHEM, V287, P26377, DOI 10.1074/jbc.M112.385286; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Debus RJ, 2014, BIOCHEMISTRY-US, V53, P2941, DOI 10.1021/bi500309f; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Noguchi T, 2005, ADV PHOTO RESPIRAT, V22, P367; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Nishimura T, 2014, BBA-BIOENERGETICS, V1837, P1447, DOI 10.1016/j.bbabio.2013.12.012; Clausen J, 2004, BBA-BIOENERGETICS, V1655, P184, DOI 10.1016/j.bbabio.2003.06.001; Pokhrel R, 2011, BIOCHEMISTRY-US, V50, P2725, DOI [10.1021/bi2000388, 10.1021/b12000388]; Bernat G, 2002, BIOCHEMISTRY-US, V41, P5830, DOI 10.1021/bi011691u; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Christen G, 1998, FEBS LETT, V429, P49, DOI 10.1016/S0014-5793(98)00552-3; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Chu HA, 2004, BIOCHEMISTRY-US, V43, P10877, DOI 10.1021/bi0499260; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Chu HA, 2001, BIOCHEMISTRY-US, V40, P2312, DOI 10.1021/bi0022994; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; de Grotthuss C. J. T., 1806, ANN CHIM, V58, P54; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Debus R.J., BIOCH BIOPHYS, V1847, P19; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; de Wijn R, 2002, BBA-BIOENERGETICS, V1553, P302, DOI 10.1016/S0005-2728(02)00183-4; de Wijn R, 2002, PHOTOSYNTH RES, V72, P217, DOI 10.1023/A:1016128632704; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P5821, DOI 10.1021/bi002824z; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Fang CH, 2005, BIOCHEMISTRY-US, V44, P9758, DOI 10.1021/bi050030k; FORSTER V, 1985, PHOTOCHEM PHOTOBIOL, V41, P183, DOI 10.1111/j.1751-1097.1985.tb03469.x; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; Han GY, 2012, J BIOL CHEM, V287, P13422, DOI 10.1074/jbc.M112.342543; Hasegawa K, 2004, BIOPHYS J, V86, P1042; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13839, DOI 10.1021/bi026595n; HAUMANN M, 1996, ADV PHOTOSYNTH, V4, P165; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Ishikita H, 2006, BIOCHEMISTRY-US, V45, P2063, DOI 10.1021/bi051615h; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Kimura Y, 2002, BIOCHEMISTRY-US, V41, P5844, DOI 10.1021/bi016093u; Kimura Y, 2005, J BIOL CHEM, V280, P2078, DOI 10.1074/jbc.M410627200; Kimura Y, 2005, J BIOL CHEM, V280, P37895, DOI 10.1074/jbc.M505887200; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P16072, DOI 10.1021/bi051306r; Kimura Y, 2003, BIOCHEMISTRY-US, V42, P13170, DOI 10.1021/bi035420q; MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q; Messinger J., 2012, MOL SOLAR FUELS, P163; Messinger J., 2008, PRIMARY PROCESSES 2, P291; Mizusawa N, 2004, BIOCHEMISTRY-US, V43, P14644, DOI 10.1021/bi0486076; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; NOGUCHI T, 1995, BBA-BIOENERGETICS, V1228, P189, DOI 10.1016/0005-2728(94)00171-Z; Noguchi T, 2000, BIOCHEMISTRY-US, V39, P10943, DOI 10.1021/bi001040i; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Noguchi T., 2013, BIOMED SPECTROSC IMA, V2, P115; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; O'Malley PJ, 2002, BBA-BIOENERGETICS, V1553, P212, DOI 10.1016/S0005-2728(01)00222-5; O'Malley PJ, 2000, CHEM PHYS LETT, V325, P69, DOI 10.1016/S0009-2614(00)00618-7; Polander BC, 2013, P NATL ACAD SCI USA, V110, P10634, DOI 10.1073/pnas.1306532110; Service RJ, 2013, BIOCHEMISTRY-US, V52, P8452, DOI 10.1021/bi401339f; Service RJ, 2014, BIOCHEMISTRY-US, V53, P1001, DOI 10.1021/bi401450y; Service RJ, 2011, BIOCHEMISTRY-US, V50, P63, DOI 10.1021/bi1015937; Shimada Y, 2009, BIOCHEMISTRY-US, V48, P6095, DOI 10.1021/bi900317a; SINCLAIR J, 1984, BIOCHIM BIOPHYS ACTA, V764, P247, DOI 10.1016/0005-2728(84)90034-3; Strickler MA, 2007, BIOCHEMISTRY-US, V46, P3151, DOI 10.1021/bi062195e; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Strickler MA, 2008, PHILOS T R SOC B, V363, P1179, DOI 10.1098/rstb.2007.2213; Strickler MA, 2006, BIOCHEMISTRY-US, V45, P8801, DOI 10.1021/bi060583a; Styring S, 2012, BBA-BIOENERGETICS, V1817, P76, DOI 10.1016/j.bbabio.2011.03.016; Suzuki H, 2006, BIOCHEMISTRY-US, V45, P13454, DOI 10.1021/bi061232z; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Suzuki H, 2013, BIOCHEMISTRY-US, V52, P4748, DOI 10.1021/bi301699h; Suzuki H, 2012, BIOCHEMISTRY-US, V51, P6776, DOI 10.1021/bi300708a; Taguchi Y, 2007, BBA-BIOENERGETICS, V1767, P535, DOI 10.1016/j.bbabio.2006.11.002; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Tsuno M, 2011, BIOCHEMISTRY-US, V50, P2506, DOI 10.1021/bi101952g; Uno C, 2013, BIOCHEMISTRY-US, V52, P5705, DOI 10.1021/bi4009787; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Wang JP, 2001, BIOPHYS J, V80, P961; Wincencjusz H, 1999, BIOCHEMISTRY-US, V38, P3719, DOI 10.1021/bi982295n	128	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	JAN	2015	1847	1			SI		35	45		10.1016/j.bbabio.2014.06.009		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW5PA	WOS:000346325500005		
J	Hashimoto, H; Sugisaki, M; Yoshizawa, M				Hashimoto, Hideki; Sugisaki, Mitsuru; Yoshizawa, Masayuki			Ultrafast time-resolved vibrational spectroscopies of carotenoids in photosynthesis	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Carotenoid; Photosynthesis; Time-resolved stimulated Raman spectroscopy; Coherent spectroscopy; Four-wave mixing spectroscopy	TRANS-BETA-CAROTENE; PUMP-PROBE SPECTROSCOPY; STIMULATED RAMAN-SPECTROSCOPY; LIGHT-HARVESTING COMPLEX; BACTERIAL REACTION CENTERS; EXCITED-STATE RELAXATION; PHOTON-ECHO MEASUREMENTS; ENERGY-TRANSFER; RHODOBACTER-SPHAEROIDES; S-1 STATE	This review discusses the application of time-resolved vibrational spectroscopies to the studies of carotenoids in photosynthesis. The focus is on the ultrafast time regime and the study of photophysics and photochemistry of carotenoids by femtosecond time-resolved stimulated Raman and four-wave mixing spectroscopies. This article is part of a Special Issue entitled: Vibrational spectroscopies and bioenergetic systems. (C) 2014 Elsevier B.V. All rights reserved.	[Hashimoto, Hideki] Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 5588585, Japan; [Hashimoto, Hideki; Sugisaki, Mitsuru] Osaka City Univ, Grad Sch Sci, Dept Phys, Sumiyoshi Ku, Osaka 5588585, Japan; [Yoshizawa, Masayuki] Tohoku Univ, Grad Sch Sci, Dept Phys, Aoba Ku, Sendai, Miyagi 9808578, Japan	Hashimoto, H (reprint author), Osaka City Univ, Grad Sch Sci, Dept Phys, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	hassy@ocarina.osaka-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24107002H]	HH thanks Scientific Research on Inovative Areas "All Nippon Artificial Photosynthesis Project for Living Earth (AnApple)" (No. 24107002H) from the Japan Society for the Promotion of Science (JSPS) for finacial support.	Kosumi D, 2005, CHEM PHYS LETT, V408, P89, DOI 10.1016/j.cplett.2005.04.006; Kosumi D, 2011, J LUMIN, V131, P515, DOI 10.1016/j.jlumin.2010.09.018; Kosumi D, 2014, CHEM PHYS LETT, V602, P75, DOI 10.1016/j.cplett.2014.04.022; TAVAN P, 1986, J CHEM PHYS, V85, P6602, DOI 10.1063/1.451442; Sashima T, 2000, J PHYS CHEM B, V104, P5011, DOI 10.1021/jp994185b; Frank HA, 2000, J PHYS CHEM B, V104, P4569, DOI 10.1021/jp000079u; McCamant DW, 2003, J PHYS CHEM A, V107, P8208, DOI 10.1021/jp030147n; Polivka T, 2001, J PHYS CHEM B, V105, P1072, DOI 10.1021/jp002206s; Hornung T, 2005, CHEM PHYS LETT, V402, P283, DOI 10.1016/j.cplett.2004.11.135; Sugisaki M, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000679; Billsten HH, 2002, CHEM PHYS LETT, V355, P465, DOI 10.1016/S0009-2614(02)00268-3; Wohlleben W, 2005, CHEMPHYSCHEM, V6, P850, DOI 10.1002/cphc.200400414; Martins JBL, 2009, INT J QUANTUM CHEM, V109, P739, DOI 10.1002/qua.21845; Konradi J, 2006, J RAMAN SPECTROSC, V37, P697, DOI 10.1002/jrs.1502; Kosumi D, 2009, CHEM PHYS LETT, V483, P95, DOI 10.1016/j.cplett.2009.10.077; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; Sugisaki M, 2009, J LUMIN, V129, P1908, DOI 10.1016/j.jlumin.2009.01.027; Siebert T, 2002, J RAMAN SPECTROSC, V33, P844, DOI 10.1002/jrs.926; Kosumi D, 2011, PHYS CHEM CHEM PHYS, V13, P10762, DOI 10.1039/c0cp02568b; Pastirk I, 2001, CHEM PHYS LETT, V333, P76, DOI 10.1016/S0009-2614(00)01334-8; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Grimberg BI, 2002, J PHYS CHEM A, V106, P697, DOI 10.1021/jp0104511; Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685; ANDERSSON PO, 1995, J CHEM PHYS, V103, P2509, DOI 10.1063/1.469672; Hauer J, 2007, J PHYS CHEM A, V111, P10517, DOI 10.1021/jp073727j; Challa JR, 2012, APPL SPECTROSC, V66, P227, DOI 10.1366/11-06457; Kosumi D, 2014, J PHYS CHEM LETT, V5, P792, DOI 10.1021/jz5000287; Siebert T, 2006, J RAMAN SPECTROSC, V37, P397, DOI 10.1002/jrs.1441; Onaka K, 1999, CHEM PHYS LETT, V315, P75, DOI 10.1016/S0009-2614(99)01212-9; Hauer J, 2008, CHEM PHYS, V350, P220, DOI 10.1016/j.chemphys.2008.03.021; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; VOS MH, 1991, P NATL ACAD SCI USA, V88, P8885, DOI 10.1073/pnas.88.20.8885; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; Siebert T, 2002, J AM CHEM SOC, V124, P6242, DOI 10.1021/ja0173831; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Buckup T, 2009, ARCH BIOCHEM BIOPHYS, V483, P219, DOI 10.1016/j.abb.2008.10.031; Fujiwara M, 2009, J LUMIN, V129, P1808, DOI 10.1016/j.jlumin.2009.04.098; Walla PJ, 2002, J PHYS CHEM A, V106, P1909, DOI 10.1021/jp011495x; Papagiannakis E, 2003, J PHYS CHEM B, V107, P11216, DOI 10.1021/jp034931j; Papagiannakis E, 2003, J PHYS CHEM B, V107, P5642, DOI 10.1021/jp027174i; Sugisaki M, 2008, PHOTOSYNTH RES, V95, P299, DOI 10.1007/s11120-007-9265-y; Frank HA, 2001, ARCH BIOCHEM BIOPHYS, V385, P53, DOI 10.1006/abbi.2000.2091; Fraser NJ, 2001, PHOTOSYNTH RES, V70, P249, DOI 10.1023/A:1014715114520; Zigmantas D, 2001, J PHYS CHEM A, V105, P10296, DOI 10.1021/jp010022n; Kosumi D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213601; VOS MH, 1993, NATURE, V363, P320, DOI 10.1038/363320a0; Zigmantas D, 2002, P NATL ACAD SCI USA, V99, P16760, DOI 10.1073/pnas.262537599; Polli D, 2008, CHEM PHYS, V350, P45, DOI 10.1016/j.chemphys.2007.12.021; Shelly KR, 2006, J PHYS CHEM B, V110, P20586, DOI 10.1021/jp062909v; AUERBACH RA, 1981, J CHEM PHYS, V74, P4, DOI 10.1063/1.440857; Siebert T, 2003, J PHYS CHEM A, V107, P8355, DOI 10.1021/jp022650q; VOS MH, 1994, P NATL ACAD SCI USA, V91, P12701, DOI 10.1073/pnas.91.26.12701; HASHIMOTO H, 1989, CHEM PHYS LETT, V154, P321, DOI 10.1016/0009-2614(89)85363-1; Kosumi D, 2014, PHOTOSYNTH RES, V121, P61, DOI 10.1007/s11120-014-9995-6; Lanzani G, 2001, SYNTHETIC MET, V116, P1, DOI 10.1016/S0379-6779(00)00502-6; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; McCamant DW, 2002, J PHYS CHEM A, V106, P6030, DOI 10.1021/jp0203595; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Kosumi D, 2012, J PHYS CHEM LETT, V3, P2659, DOI 10.1021/jz300612c; Jimenez R, 1997, J PHYS CHEM B, V101, P7350, DOI 10.1021/jp970299g; Macpherson AN, 2001, BIOPHYS J, V80, P923; Hauer J, 2006, CHEM PHYS LETT, V421, P523, DOI 10.1016/j.cplett.2006.01.115; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Frontiera RR, 2011, LASER PHOTONICS REV, V5, P102, DOI 10.1002/lpor.200900048; Bautista JA, 1999, J PHYS CHEM B, V103, P8751, DOI 10.1021/jp9916135; Savolainen J, 2008, P NATL ACAD SCI USA, V105, P7641, DOI 10.1073/pnas.0711927105; Yoshizawa M, 2002, B CHEM SOC JPN, V75, P949, DOI 10.1246/bcsj.75.949; HASHIMOTO H, 1989, CHEM PHYS LETT, V163, P251, DOI 10.1016/0009-2614(89)80045-4; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Kosumi D, 2010, CHEM PHYS, V373, P33, DOI 10.1016/j.chemphys.2009.12.013; PATEL CKN, 1968, PHYS REV LETT, V20, P1087, DOI 10.1103/PhysRevLett.20.1087; Ostroumov EE, 2013, SCIENCE, V340, P52, DOI 10.1126/science.1230106; Gradinaru CC, 2001, P NATL ACAD SCI USA, V98, P2364, DOI 10.1073/pnas.051501298; Shelly KR, 2003, J AM CHEM SOC, V125, P11810, DOI 10.1021/ja0366890; Wohlleben W, 2004, J PHYS CHEM B, V108, P3320, DOI 10.1021/jp036145k; Agarwal R, 2001, J PHYS CHEM B, V105, P1887, DOI 10.1021/jp0031146; Ishii K, 2003, CHEM PHYS LETT, V367, P672, DOI 10.1016/S0009-2614(02)01740-2; Kurashige Y, 2004, CHEM PHYS LETT, V400, P425, DOI 10.1016/j.cplett.2004.10.141; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Cerullo G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.241104; Christensson N, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245118; Frank H. A., 1999, ADV PHOTOSYNTHESIS, V8; Fujiwara M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205118; Kleinschmidt M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3062842; Kosumi D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4737129; Koyama Y., 1993, CAROTENOIDS PHOTOSYN, P327; Koyama Y., 2008, PRIMARY PROCESSES 1, P151; Mukamel S., 1995, PRINCIPLES NONLINEAR; Sugisaki M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155110; Sugisaki M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035118; Sugisaki M, 2011, PHYSCS PROC, V13, DOI 10.1016/j.phpro.2011.02.018; Sugisaki M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245112; Yoshizawa M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174302; Yoshizawa M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.180301; Yoshizawa M., 1999, PHYS REV A, V61, DOI DOI 10.1103/PHYSREVA.61.013808; Young A., 1993, CAROTENOIDS PHOTOSYN; Zewail A.H., 2000, J PHYS CHEM A, V104	97	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	JAN	2015	1847	1			SI		69	78		10.1016/j.bbabio.2014.09.001		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW5PA	WOS:000346325500008		
J	Nakashima, S; Ogura, T; Kitagawa, T				Nakashima, Satoru; Ogura, Takashi; Kitagawa, Teizo			Infrared and Raman spectroscopic investigation of the reaction mechanism of cytochrome c oxidase	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Cytochrome c oxidase; Proton-pumping mechanism; Time-resolved infrared and Raman spectroscopy	ATR-FTIR SPECTROSCOPY; HEME-COPPER OXIDASES; PHOTOACTIVE YELLOW PROTEIN; PROTON-PUMPING GATE; P-M INTERMEDIATE; PARACOCCUS-DENITRIFICANS; DIFFERENCE SPECTROSCOPY; OXYGEN ACTIVATION; ELECTRON-TRANSFER; CARBON-MONOXIDE	Recent progress in studies on the proton-pumping and O-2 reduction mechanisms of cytochrome c oxidase (CcO) elucidated by infrared (IR) and resonance Raman (rR) spectroscopy, is reviewed. CcO is the terminal enzyme of the respiratory chain and its O-2 reduction reaction is coupled with H+ pumping activity across the inner mitochondrial membrane. The former is catalyzed by heme a(3) and its mechanism has been determined using a rR technique, while the latter used the protein moiety and has been investigated with an IR technique. The number of H+ relative to e(-) transferred in the reaction is 1:1, and their coupling is presumably performed by heme a and nearby residues. To perform this function, different parts of the protein need to cooperate with each other spontaneously and sequentially. It is the purpose of this article to describe the structural details on the coupling on the basis of the vibrational spectra of certain specified residues and chromophores involved in the reaction. Recent developments in time-resolved IR and Raman technology concomitant with protein manipulation methods have yielded profound insights into such structural changes. In particular, the new IR techniques that yielded the breakthrough are reviewed and assessed in detail. This article is part of a Special Issue entitled: Vibrational spectroscopies and bioenergetic systems. (C) 2014 Published by Elsevier B.V.	[Nakashima, Satoru; Ogura, Takashi; Kitagawa, Teizo] Univ Hyogo, RSC UH Leading Program Ctr, Sch Life Sci, Picobiol Inst, Sayo, Hyogo 6795148, Japan; [Ogura, Takashi] Univ Hyogo, RSC UH Leading Program Ctr, Grad Sch Life Sci, Dept Life Sci, Sayo, Hyogo 6795148, Japan	Kitagawa, T (reprint author), Univ Hyogo, RSC UH Leading Program Ctr, Sch Life Sci, Picobiol Inst, 1-1-1 Koto, Sayo, Hyogo 6795148, Japan.	teizo@sci.u-hyogo.ac.jp					Aki M, 2000, J PHYS CHEM B, V104, P10765, DOI 10.1021/jp000357p; ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Rich PR, 2008, BBA-BIOENERGETICS, V1777, P912, DOI 10.1016/j.bbabio.2008.04.035; Yu MA, 2012, J AM CHEM SOC, V134, P4753, DOI 10.1021/ja210535w; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Groot ML, 2003, BIOCHEMISTRY-US, V42, P10054, DOI 10.1021/bi034878p; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Herbst J, 2002, SCIENCE, V297, P822, DOI 10.1126/science.1072144; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Nyquist RM, 2003, P NATL ACAD SCI USA, V100, P8715, DOI 10.1073/pnas.1530408100; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Ikemura K, 2008, J AM CHEM SOC, V130, P14384, DOI 10.1021/ja805735g; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; Yoshikawa S, 2011, BBA-BIOENERGETICS, V1807, P1279, DOI 10.1016/j.bbabio.2011.06.008; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Iwaki M, 2006, BIOCHEMISTRY-US, V45, P10873, DOI 10.1021/bi061114b; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341; Hellwig P, 1998, BIOCHEMISTRY-US, V37, P7390, DOI 10.1021/bi9725576; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Iwaki M, 2004, BIOCHEMISTRY-US, V43, P14370, DOI 10.1021/bi048545j; Sakaguchi M, 2010, J BIOENERG BIOMEMBR, V42, P241, DOI 10.1007/s10863-010-9282-y; BABCOCK GT, 1984, J AM CHEM SOC, V106, P8305, DOI 10.1021/ja00338a056; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; Bailey JA, 2002, BIOCHEMISTRY-US, V41, P2675, DOI 10.1021/bi010823g; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Behr J, 2000, BIOCHEMISTRY-US, V39, P1356, DOI 10.1021/bi991504g; Brzezinski P, 2006, CURR OPIN STRUC BIOL, V16, P465, DOI 10.1016/j.sbi.2006.06.012; Chalmers J. M., 2002, HDB VIBRATIONAL SPEC, V1-5; Dodson ED, 1996, BIOCHEMISTRY-US, V35, P444, DOI 10.1021/bi951313n; Donato M. D., 2011, BIOCHEMISTRY-US, V50, P480; DYER RB, 1991, J AM CHEM SOC, V113, P6276, DOI 10.1021/ja00016a057; DYER RB, 1989, J AM CHEM SOC, V111, P7657, DOI 10.1021/ja00201a080; DYER RB, 1994, BIOCHEMISTRY-US, V33, P500, DOI 10.1021/bi00168a015; Egawa T, 2009, ANAL BIOCHEM, V394, P141, DOI 10.1016/j.ab.2009.06.035; Egawa T., 2013, PLOS ONE, V8, P1; EINARSDOTTIR O, 1989, J BIOL CHEM, V264, P2405; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; FINDSEN EW, 1987, J AM CHEM SOC, V109, P5367, DOI 10.1021/ja00252a011; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P13141, DOI 10.1021/bi701614w; Gorbikova EA, 2008, J BIOL CHEM, V283, P34907, DOI 10.1074/jbc.M803511200; Gorbikova EA, 2008, P NATL ACAD SCI USA, V105, P10733, DOI 10.1073/pnas.0802512105; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P4177, DOI 10.1021/bi602523a; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; Heitbrink D, 2002, BIOPHYS J, V82, P1; Hellwig Petra, 1999, FEBS Letters, V458, P83, DOI 10.1016/S0014-5793(99)01133-3; Hellwig P, 1996, FEBS LETT, V385, P53, DOI 10.1016/0014-5793(96)00342-0; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r; Hellwig P, 2003, BIOCHEMISTRY-US, V42, P6179, DOI 10.1021/bi0205348; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P9648, DOI 10.1021/bi9903401; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; Hellwig P, 1998, BBA-BIOENERGETICS, V1409, P107, DOI 10.1016/S0005-2728(98)00151-0; Hosier J.P., 2006, ANNU REV BIOCHEM, V75, P165; Ishigami I, 2012, CHEM LETT, V41, P178, DOI 10.1246/cl.2012.178; Iwaki M, 2004, J AM CHEM SOC, V126, P2386, DOI 10.1021/ja039320j; Iwaki M, 2003, BIOCHEMISTRY-US, V42, P8809, DOI 10.1021/bi034522d; Kitagawa T, 1997, PROG INORG CHEM, V45, P431; Koutsoupakis C, 2003, J AM CHEM SOC, V125, P14728, DOI 10.1021/ja036107; Koutsoupakis C, 2004, BBA-BIOENERGETICS, V1655, P347, DOI 10.1016/j.bbabio.2003.06.004; Kubo M, 2013, J BIOL CHEM, V288, P30259, DOI 10.1074/jbc.M113.473983; Magana D, 2011, APPL SPECTROSC, V65, P535, DOI 10.1366/10-06179; Marechal A, 2011, P NATL ACAD SCI USA, V108, P8634, DOI 10.1073/pnas.1019419108; MARRERO H, 1987, FEBS LETT, V223, P289, DOI 10.1016/0014-5793(87)80306-X; MATSUKAWA S, 1985, J AM CHEM SOC, V107, P1108, DOI 10.1021/ja00291a004; McMahon BH, 2004, BBA-BIOENERGETICS, V1655, P321, DOI 10.1016/j.bbabio.2004.01.007; Mitchell DM, 1996, BIOCHEMISTRY-US, V35, P9446, DOI 10.1021/bi960392f; Mitchell DM, 1996, BIOCHEMISTRY-US, V35, P16782, DOI 10.1021/bi961722z; Mizutani Y, 2001, J PHYS CHEM B, V105, P10992, DOI 10.1021/jp010923w; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; Nakamoto K., 2009, INFRARED RAMAN SPECT; Nakashima S., 2014, TIME RESOLVED RESONA; Nakashima S., 2014, HIGH SENSITIVI UNPUB; Nomura T., 2014, EFFECTS PROTON MOTIV; Oda K, 2004, FEBS LETT, V570, P161, DOI 10.1016/j.febslet.2004.06.036; OGURA T, 1985, BIOCHEMISTRY-US, V24, P7746, DOI 10.1021/bi00347a037; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; OGURA T, 1989, BIOCHEMISTRY-US, V28, P8022, DOI 10.1021/bi00446a008; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OGURA T, 1990, J AM CHEM SOC, V112, P5630, DOI 10.1021/ja00170a032; Ogura T, 2012, BBA-BIOENERGETICS, V1817, P575, DOI 10.1016/j.bbabio.2011.11.016; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; Papa S, 2006, BBA-BIOENERGETICS, V1757, P428, DOI 10.1016/j.bbabio.2006.03.015; Pereira MM, 2006, FEBS LETT, V580, P1350, DOI 10.1016/j.febslet.2006.01.055; Puustinen A, 1997, BIOCHEMISTRY-US, V36, P13195, DOI 10.1021/bi971091o; Rich PR, 2001, BIOCHEMISTRY-US, V40, P6441, DOI 10.1021/bi0027332; Rich PR, 2005, RSC BIOMOLEC SCI, P314; Rich PR, 2000, BBA-BIOENERGETICS, V1459, P475, DOI 10.1016/S0005-2728(00)00186-9; Rich PR, 2007, MOL BIOSYST, V3, P398, DOI 10.1039/b702328f; Rost B, 1999, BIOCHEMISTRY-US, V38, P7565, DOI 10.1021/bi990225q; Takahashi T, 2005, J AM CHEM SOC, V127, P9970, DOI 10.1021/ja051761a; TORII H, 1992, J CHEM PHYS, V97, P92, DOI 10.1063/1.463528; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; VAROTSIS C, 1989, J AM CHEM SOC, V111, P6439, DOI 10.1021/ja00198a075; VAROTSIS CA, 1995, J AM CHEM SOC, V117, P11260, DOI 10.1021/ja00150a025; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028	106	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	JAN	2015	1847	1			SI		86	97		10.1016/j.bbabio.2014.08.002		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW5PA	WOS:000346325500010		
J	Kandori, H; Furutani, Y; Murata, T				Kandori, Hideki; Furutani, Yuji; Murata, Takeshi			Infrared spectroscopic studies on the V-ATPase	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						V-1/V-o-ATPase; ATR-FTIR spectroscopy; X-ray crystallography; Sodium binding; Protonation; Conformation change	CYTOCHROME-C-OXIDASE; ATR-FTIR SPECTROSCOPY; NICOTINIC ACETYLCHOLINE-RECEPTOR; NA+-TRANSLOCATING ATPASE; INTERNAL WATER-MOLECULES; ENTEROCOCCUS-HIRAE; DIFFERENCE SPECTROSCOPY; STRUCTURAL-CHANGES; REACTION-MECHANISMS; ROTOR RING	V-ATPase is an ATP-driven rotary motor that vectorially transports ions. Together with F-ATPase, a homologous protein, several models on the ion transport have been proposed, but their molecular mechanisms are yet unknown. V-ATPase from Enterococcus hirae forms a large supramolecular protein complex (total molecular weight: -700,000) and physiologically transports Na+ and Li+ across a hydrophobic lipid bilayer. Stabilization of these cations in the binding site has been discussed on the basis of X-ray crystal structures of a membrane-embedded domain, the K-ring (Na+ and Li+ bound forms). Sodium or lithium ion binding-induced difference FTIR spectra of the intact E. hirae V-ATPase have been measured in aqueous solution at physiological temperature. The results suggest that sodium or lithium ion binding induces the deprotonation of Glu139, a hydrogen-bonding change in the tyrosine residue and rigid a-helical structures. Identical difference FTIR spectra between the entire V-ATPase complex and K-ring strongly suggest that protein interaction with the I subunit does not cause large structural changes in the K-ring. This result supports the previously proposed Na+ transport mechanism by V-ATPase stating that a flip-flop movement of a carboxylate group of Glu139 without large conformational changes in the K-ring accelerates the replacement of a Na+ ion in the binding site. This article is part of a Special Issue entitled: Vibrational spectroscopies and bioenergetic systems. (C) 2014 Elsevier B.V. All rights reserved.	[Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Furutani, Yuji] Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan; [Murata, Takeshi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan	Kandori, H (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22247024, 25104009, 22770159, 22018030, 21026016, 21023014, 18074003]; Japanese Ministry of Education, Culture, Sports, Science, and Technology (Platform for Drug Discovery, Informatics, and Structural Life Science) [18074003]; Japanese Ministry of Education, Culture, Sports, Science, and Technology (Targeted Proteins Research Program) [18074003]	This study was partly supported by grants from Japanese Ministry of Education, Culture, Sports, Science, and Technology to H.K. (22247024, 25104009) and Y.F. (22770159, 22018030, 21026016, 21023014) and T. M. (18074003, Targeted Proteins Research Program, and Platform for Drug Discovery, Informatics, and Structural Life Science).	Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Furutani Y, 2014, BBA-BIOENERGETICS, V1837, P598, DOI 10.1016/j.bbabio.2013.09.004; Ataka K, 2003, J AM CHEM SOC, V125, P4986, DOI 10.1021/ja0346532; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; Furutani Y, 2012, J PHYS CHEM LETT, V3, P3806, DOI 10.1021/jz301721f; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Schartner J, 2013, J AM CHEM SOC, V135, P4079, DOI 10.1021/ja400253p; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Nie BN, 2005, BIOPHYS J, V88, P2833, DOI 10.1529/biophysj.104.047639; Nyquist RM, 2003, P NATL ACAD SCI USA, V100, P8715, DOI 10.1073/pnas.1530408100; Nara M, 1996, J PHYS CHEM-US, V100, P19812, DOI 10.1021/jp9615924; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Rastogi VK, 1999, NATURE, V402, P263; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Jiang X, 2008, P NATL ACAD SCI USA, V105, P12113, DOI 10.1073/pnas.0802289105; Scheirlinckx F, 2004, BIOCHEM J, V382, P121; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Guijarro J, 2006, BIOCHEMISTRY-US, V45, P11578, DOI 10.1021/bi060753j; DEACON GB, 1980, COORDIN CHEM REV, V33, P227, DOI 10.1016/S0010-8545(00)80455-5; Iwaki M, 2004, BIOCHEMISTRY-US, V43, P14370, DOI 10.1021/bi048545j; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Baenziger JE, 1997, BIOCHEMISTRY-US, V36, P3617, DOI 10.1021/bi962845m; BAENZIGER JE, 1993, BIOCHEMISTRY-US, V32, P5448, DOI 10.1021/bi00071a022; Breton J, 2001, BBA-BIOENERGETICS, V1507, P180, DOI 10.1016/S0005-2728(01)00206-7; Fukuda T., 2013, BIOPHYSICS-USSR, V9, P167; Furutani Y., 2013, BIOPHYSICS-USSR, V9, P123, DOI [10.2142/biophysics.9.123, DOI 10.2142/BIOPHYSICS.9.123]; Furutani Y, 2011, J AM CHEM SOC, V133, P2860, DOI 10.1021/ja1116414; Furutani Y, 2005, PHOTOCH PHOTOBIO SCI, V4, P661, DOI 10.1039/b416698a; Gavriljuk K, 2013, P NATL ACAD SCI USA, V110, P13380, DOI 10.1073/pnas.1307655110; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Iwaki M, 2006, J AM CHEM SOC, V128, P2621, DOI 10.1021/ja0556272; Iwaki M, 2003, BIOCHEMISTRY-US, V42, P11109, DOI 10.1021/bi0343020; Jiang X, 2010, J AM CHEM SOC, V132, P10808, DOI 10.1021/ja102295g; Kaim G, 1998, EMBO J, V17, P688, DOI 10.1093/emboj/17.3.688; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kitade Y, 2009, BIOCHEMISTRY-US, V48, P1595, DOI 10.1021/bi801984u; le Coutre J, 2002, BIOCHEMISTRY-US, V41, P8082, DOI 10.1021/bi025692d; Lin YB, 2013, BBA-BIOMEMBRANES, V1828, P1690, DOI 10.1016/j.bbamem.2013.03.003; Lorenz-Fonfria VA, 2009, J AM CHEM SOC, V131, P15094, DOI 10.1021/ja906324z; MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q; Marechal A, 2013, J AM CHEM SOC, V135, P5802, DOI 10.1021/ja4005706; Marechal A, 2011, P NATL ACAD SCI USA, V108, P8634, DOI 10.1073/pnas.1019419108; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Murata T, 1996, J BIOL CHEM, V271, P23661; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Nyquist RM, 2004, CHEMBIOCHEM, V5, P431, DOI 10.1002/cbic.200300687; Rich PR, 2007, MOL BIOSYST, V3, P398, DOI 10.1039/b702328f; Ryan SE, 1996, J BIOL CHEM, V271, P24590; SIEBERT F, 1995, METHOD ENZYMOL, V246, P501; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P11699, DOI 10.1021/bi901517n; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; Whitehead SJ, 2009, BBA-BIOENERGETICS, V1787, P1276, DOI 10.1016/j.bbabio.2009.06.001	64	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	JAN	2015	1847	1			SI		134	141		10.1016/j.bbabio.2014.07.020		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW5PA	WOS:000346325500015		
J	Konagaya, S; Iwata, H				Konagaya, Shuhei; Iwata, Hiroo			Microencapsulation of dopamine neurons derived from human induced pluripotent stem cells	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Induced pluripotent stem cell; Dopamine neuron; Microencapsulation	PARKINSONS-DISEASE; BIOARTIFICIAL PANCREAS; HUMAN FIBROBLASTS; IPS CELLS; RAT MODEL; TRANSPLANTATION; THERAPY; AGAROSE; DIFFERENTIATION; GENERATION	Background: Dopamine neurons derived from induced pluripotent stem cells have been widely studied for the treatment of Parkinson's disease. However, various difficulties remain to be overcome, such as tumor formation, fragility of dopamine neurons, difficulty in handling large numbers of dopamine neurons, and immune reactions. In this study, human induced pluripotent stem cell-derived precursors of dopamine neurons were encapsulated in agarose microbeads. Dopamine neurons in microbeads could be handled without specific protocols, because the microbeads protected the fragile dopamine neurons from mechanical stress. Methods: hiPS cells were seeded on a Matrigel-coated dish and cultured to induce differentiation into a dopamine neuronal linage. On day 18 of culture, cells were collected from the culture dishes and seeded into U-bottom 96-well plates to induce cell aggregate formation. After 5 days, cell aggregates were collected from the plates and microencapsulated in agarose microbeads. The microencapsulated aggregates were cultured for an additional 45 days to induce maturation of dopamine neurons. Results: Approximately 60% of all cells differentiated into tyrosine hydroxylase-positive neurons in agarose microbeads. The cells released dopamine for more than 40 days. In addition, microbeads containing cells could be cryopreserved. Conclusion: hiPS cells were successfully differentiated into dopamine neurons in agarose microbeads. General significance: Agarose microencapsulation provides a good supporting environment for the preparation and storage of dopamine neurons. (C) 2014 Elsevier B.V. All rights reserved.	[Konagaya, Shuhei; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Iwata, H (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kuoyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23107008, 24240078, 23650257]; MEXT [4864]	This study was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23107008), by Scientific Research (A) (No. 24240078), and by Challenging Exploratory Research (No. 23650257) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. SK was financially supported by the program of the Promotion of Science Fellows (No. 4864) from MEXT.	Ando T, 2007, TISSUE ENG, V13, P2539, DOI 10.1089/ten.2007.0045; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Agudelo CA, 2009, TRANSPLANTATION, V87, P29, DOI 10.1097/TP.0b013e318191b24b; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Taylor CJ, 2011, PHILOS T R SOC B, V366, P2312, DOI 10.1098/rstb.2011.0030; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2006-0393; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Cools R., 2003, NEUROSCI BIOBEHAV R, V30, P1; Emgard M, 2002, NEUROSCIENCE, V115, P1177, DOI 10.1016/S0306-4522(02)00480-3; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711; Kim J, 2013, STEM CELL RES, V11, P978, DOI 10.1016/j.scr.2013.06.005; Lei Y., 2013, P NATL ACAD SCI USA, V110, P5039; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Nishigaki T, 2011, INT J DEV BIOL, V55, P305, DOI 10.1387/ijdb.103145tn; Nurt J.G., 2005, NEW ENGL J MED, V353, P1021	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	JAN	2015	1850	1					22	32		10.1016/j.bbagen.2014.09.025		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW5PG	WOS:000346326100003		
J	Ekyalongo, RC; Nakayama, H; Kina, K; Kaga, N; Iwabuchi, K				Ekyalongo, Roudy C.; Nakayama, Hitoshi; Kina, Katsunari; Kaga, Naoko; Iwabuchi, Kazuhisa			Organization and functions of glycolipid-enriched microdomains in phagocytes	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Review						Neutrophil; Lactosylceramide; Phosphatidylglucoside; Phagocytosis; Apoptosis; Acute promyelocytic leukemia	CELL LINE HL-60; IC3B-OPSONIZED TARGET-CELLS; BINDING LECTIN SITE; BETA-GLUCAN; NEUTROPHIL APOPTOSIS; MEMBRANE DOMAINS; RETINOIC ACID; GRANULOCYTIC DIFFERENTIATION; MONOCYTIC DIFFERENTIATION; 1,25-DIHYDROXYVITAMIN D-3	Populations of glycolipids change markedly during leukocyte differentiation, suggesting that these molecules are involved in biological functions. About 70% of the glycosphingolipids in human neutrophils are lactosylceramide, a molecule also expressed on monocytes and dendritic cells, but not on lymphocytes. In contrast, phosphatidylglucoside is mainly expressed on neutrophils. STED microscopic analysis showed that phosphatidylglucoside and lactosylceramide form different domains on plasma membranes of neutrophils, with phosphatidylglucoside preferentially expressed along the neutrophil differentiation pathway. Phosphatidylglucoside was found to mediate the differentiation of HL-60 cells into the neutrophilic lineage, and to be involved in FAS-dependent neutrophil apoptosis. In contrast, lactosylceramide was only expressed on mature neutrophils. Complexes of lactosylceramide and the Src family kinase Lyn form membrane microdomains. LacCer-enriched membrane microdomains mediate neutrophil innate immune responses; e.g. chemotaxis, phagocytosis, and superoxide generation. C24 fatty acid chains of LacCer are indispensable for the formation of LacCer-Lyn complexes and for LacCer-dependent functions. Moreover, Lyn-coupled LacCer-enriched microdomains serve as signal transduction platforms for alpha M beta 2 integrin-mediated phagocytosis. This review describes the organization and potential functions of glycolipids in phagocytes, as well as the roles of both phosphatidylglucoside and lactosylceramide in neutrophils. This article is part of a Special Issue entitled Linking transcription to physiology in lipidomics. (C) 2014 Elsevier B.V. All rights reserved.	[Ekyalongo, Roudy C.; Nakayama, Hitoshi; Kina, Katsunari; Iwabuchi, Kazuhisa] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba 2790021, Japan; [Nakayama, Hitoshi; Iwabuchi, Kazuhisa] Juntendo Univ, Sch Hlth Care & Nursing, Biochem Lab, Urayasu, Chiba 2790021, Japan; [Kaga, Naoko] Juntendo Univ, Grad Sch Med, BioMed Res Ctr, Div Prote & Biomol Sci, Urayasu, Chiba 2790021, Japan; [Iwabuchi, Kazuhisa] Juntendo Univ, Sch Hlth Care & Nursing, Urayasu, Chiba 2790021, Japan	Iwabuchi, K (reprint author), Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, 2-1-1 Tomioka, Urayasu, Chiba 2790021, Japan.	iwabuchi@juntendo.ac.jp			Foundation of Strategic Research Projects in Private Universities [S0991013, S1311011]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24659293]	This study was supported in part by Grants-in-Aid (S0991013, S1311011) from the Foundation of Strategic Research Projects in Private Universities and by a Grant-in-Aid for Exploratory Research (24659293) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; TILLACK TW, 1983, BIOCHIM BIOPHYS ACTA, V733, P15, DOI 10.1016/0005-2736(83)90086-X; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309; Xia Y, 1999, J IMMUNOL, V162, P2281; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Iwabuchi K, 2002, BLOOD, V100, P1454; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; RIETSCHEL ET, 1994, FASEB J, V8, P217; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Nakayama H, 2008, J LEUKOCYTE BIOL, V83, P728, DOI 10.1189/jlb.0707478; Nimrichter L, 2004, MICROBES INFECT, V6, P657, DOI 10.1016/j.micinf.2004.03.004; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156; Lin L, 2014, LIFE SCI, V100, P1, DOI 10.1016/j.lfs.2014.01.062; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Thornton BP, 1996, J IMMUNOL, V156, P1235; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Peguet-Navarro J, 2003, J IMMUNOL, V170, P3488; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Kaga N, 2005, ANAL BIOCHEM, V337, P316, DOI 10.1016/j.ab.2004.11.003; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Piccardoni P, 2004, BIOCHEM J, V380, P57, DOI 10.1042/BJ20040151; BRACKMAN D, 1995, LEUKEMIA RES, V19, P57, DOI 10.1016/0145-2126(94)00061-E; BRACKMAN D, 1995, J LEUKOCYTE BIOL, V58, P547; Bronnum H, 2005, SCAND J IMMUNOL, V61, P551, DOI 10.1111/j.1365-3083.2005.01566.x; Daigle I, 2001, INT ARCH ALLERGY IMM, V126, P147, DOI 10.1159/000049506; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hugosson S, 1998, J BIOCHEM-TOKYO, V124, P1138; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; KAN CC, 1992, J BIOL CHEM, V267, P9663; Kina K, 2011, J IMMUNOL, V186, P5323, DOI 10.4049/jimmunol.1002100; KITAGAWA S, 1989, J BIOL CHEM, V264, P16149; Kniep B, 1998, J LEUKOCYTE BIOL, V63, P83; Kolli D, 2013, PATHOGENS, V2, P2, DOI DOI 10.3390/PATHOGENS2020232; KONTANI K, 1993, J BIOL CHEM, V268, P16895; Li XM, 2002, BIOPHYS J, V83, P1535; LUNDJOHANSEN F, 1992, J IMMUNOL, V148, P3221; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Nagatsuka Y, 2003, P NATL ACAD SCI USA, V100, P7454, DOI 10.1073/pnas.1232503100; Nagatsuka Y, 2006, BIOCHEMISTRY-US, V45, P8742, DOI 10.1021/bi0606546; NAKAMURA M, 1992, J BIOL CHEM, V267, P23507; NAKAMURA M, 1989, BIOCHEM BIOPH RES CO, V161, P782, DOI 10.1016/0006-291X(89)92668-5; NOJIRI H, 1984, BLOOD, V64, P534; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; Oka S, 2009, LEUKEMIA LYMPHOMA, V50, P1190, DOI 10.1080/10428190902934928; RABB H, 1993, J IMMUNOL, V151, P990; ROCK P, 1991, BIOCHEMISTRY-US, V30, P19, DOI 10.1021/bi00215a003; Sato T, 2006, J LEUKOCYTE BIOL, V80, P204, DOI 10.1189/jlb.0106069; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P461, DOI 10.1042/BST0320461; Shen WP, 2002, CELL IMMUNOL, V220, P125, DOI 10.1016/S0008-8749(03)00004-2; Spychalska J, 2003, CELL MOL BIOL LETT, V8, P911; SYMINGTON FW, 1985, J IMMUNOL, V134, P2498; Watson RWG, 2002, ANTIOXID REDOX SIGN, V4, P97, DOI 10.1089/152308602753625898; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490	69	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	JAN	2015	1851	1			SI		90	97		10.1016/j.bbalip.2014.06.009		8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AW5PE	WOS:000346325900012		
J	Inokuchi, JI; Nagafuku, M; Ohno, I; Suzuki, A				Inokuchi, Jin-ichi; Nagafuku, Masakazu; Ohno, Isao; Suzuki, Akemi			Distinct selectivity of gangliosides required for CD4(+) T and CD8(+) T cell activation	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						Gangliosides; Lipid rafts; T cell activation; Asthma	IMMUNOLOGICAL SYNAPSE; LIPID RAFTS; GLYCOSPHINGOLIPID LEVELS; MEMBRANE MICRODOMAINS; CYTOKINE PRODUCTION; INSULIN-RESISTANCE; MICE; SEGREGATION; RECEPTOR; ASTHMA	T cells compose a crucial part of the immune system and require activation. The first step of T cell activation is triggered by the movement of one of their surface molecules, known as T cell receptor, into localized regions of cell membrane known as lipid rafts. Molecules called gangliosides are known to be major components of lipid rafts, but their role in T-cell activation remains to be elucidated. This review summarizes recent findings that different types of T cells require distinct ganglioside types for the activation. Control of ganglioside expression would offer a strategy targeting for specific T-cell subpopulations to treat immune diseases. This article is part of a Special Issue entitled Linking transcription to physiology in lipodomics. (C) 2014 Elsevier B.V. All rights reserved.	[Inokuchi, Jin-ichi; Nagafuku, Masakazu] Tohoku Pharmaceut Univ, Div Glycopathol, Inst Mol Biomembranes & Glycobiol, Sendai, Miyagi 9818558, Japan; [Ohno, Isao] Tohoku Pharmaceut Univ, Dept Pathophysiol, Sendai, Miyagi 9818558, Japan; [Suzuki, Akemi] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan	Inokuchi, JI (reprint author), Tohoku Pharmaceut Univ, Div Glycopathol, Inst Mol Biomembranes & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jin@tohoku-pharm.ac.jp			Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Mizutani Research Foundation for Glycoscience; Naito Science and Foundation; ONO Medical Research Foundation	This work was supported by research grants from the Core Research for Evolutional Science and Technology (CREST), 2006-2012 of Japan Science and Technology Agency (JST), a Grant-in-Aid for Scientific Research (B), the Mizutani Research Foundation for Glycoscience, 2013, The Naito Science and Foundation, 2011-12 and the ONO Medical Research Foundation, 2009.	Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Huang GH, 2012, CELL MOL IMMUNOL, V9, P287, DOI 10.1038/cmi.2012.10; Pang DJ, 2007, J BIOL CHEM, V282, P13884, DOI 10.1074/jbc.M701027200; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Monks CRF, 1998, NATURE, V395, P82; Iwabuchi K, 2002, BLOOD, V100, P1454; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Shalaby KH, 2010, CURR OPIN PHARMACOL, V10, P218, DOI 10.1016/j.coph.2010.03.004; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Balamuth F, 2004, J IMMUNOL, V172, P5887; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Kovacs B, 2002, P NATL ACAD SCI USA, V99, P15006, DOI 10.1073/pnas.232058599; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; de Mello CV, 2004, BMC IMMUNOL, V5, P2; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Krishnan S, 2004, J IMMUNOL, V172, P7821; Marusic A, 2004, CARBOHYD RES, V339, P77, DOI 10.1016/j.carres.2003.09.024; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; NAKAMURA K, 1995, J BIOL CHEM, V270, P3876; NAKAMURA K, 1987, J BIOCHEM-TOKYO, V101, P825; Nashar TO, 1996, INT IMMUNOL, V8, P731, DOI 10.1093/intimm/8.5.731; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; POPPE L, 1994, BIOPHYS J, V66, P1642; Salmond RJ, 2002, EUR J IMMUNOL, V32, P1737, DOI 10.1002/1521-4141(200206)32:6<1737::AID-IMMU1737>3.0.CO;2-J; Wong J., 2009, J IMMUNOL, V182, P4036; Wu G., 2009, DIABETES, V60, P2341; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610	45	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	JAN	2015	1851	1			SI		98	106		10.1016/j.bbalip.2014.07.013		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AW5PE	WOS:000346325900013		
J	Matsumoto, M; Sugama, J; Nemoto, T; Kurita, T; Matsuo, J; Dai, M; Ueta, M; Okuwa, M; Nakatani, T; Tabata, K; Sanada, H				Matsumoto, Masaru; Sugama, Junko; Nemoto, Tetsu; Kurita, Toshiharu; Matsuo, Junko; Dai, Misako; Ueta, Miyuki; Okuwa, Mayumi; Nakatani, Toshio; Tabata, Keiko; Sanada, Hiromi			The Nature of Sleep in 10 Bedridden Elderly Patients With Disorders of Consciousness in a Japanese Hospital	BIOLOGICAL RESEARCH FOR NURSING			English	Article						bedridden elderly; disorders of consciousness; gerontological nursing; sleep	UNRESPONSIVE WAKEFULNESS SYNDROME; VEGETATIVE STATE PATIENTS; TRAUMATIC BRAIN-INJURY; COMA	No previous study has satisfactorily clarified the nature of sleep in elderly bedridden people with disorders of consciousness (DOC). The objective of the present study was to clarify the sleep states of 10 elderly bedridden patients with DOC in a Japanese hospital to facilitate provision of evidence-based nursing care and appropriate adjustment of patients' environments. Nocturnal polysomnography recordings were analyzed according to the standard scoring criteria, and the patients' sleep stages and quality were investigated. Of the 10 patients, 9 showed slow wave sleep (SWS), 4 showed very high values for sleep efficiency (96-100%), and in 3 of these patients, the percentage of SWS was 20%. Furthermore, three of these four patients had 200 or more changes in sleep stage. Although the mechanism is unknown, the amount of SWS combined with the value of sleep efficiency suggests that the quality of sleep is poor in elderly bedridden patients with DOC. Further study is needed to determine better indicators of good sleep in this population.	[Matsumoto, Masaru] Kanazawa Univ, Grad Sch Med, Div Hlth Sci, Dept Clin Nursing, Kanazawa, Ishikawa 9201192, Japan; [Sugama, Junko; Nemoto, Tetsu; Dai, Misako; Okuwa, Mayumi; Nakatani, Toshio] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Sugama, Junko] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa 9200942, Japan; [Kurita, Toshiharu] East Medic Corp, Kanazawa, Ishikawa, Japan; [Matsuo, Junko] Osaka Med Coll, Fac Nursing, Osaka, Japan; [Ueta, Miyuki] Gen Hosp, Kobe City Med Ctr, Kobe, Hyogo, Japan; [Ueta, Miyuki] Sengi Hosp, Kanazawa, Ishikawa, Japan; [Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan	Sugama, J (reprint author), Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	junkosgm@mhs.mp.kanazawa-u.ac.jp	OKUWA, Mayumi/L-3687-2015; 中谷, 壽男/C-3220-2015	中谷, 壽男/0000-0003-4949-5123			Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Mishima K, 2001, J CLIN ENDOCR METAB, V86, P129, DOI 10.1210/jc.86.1.129; Himanen SL, 2000, SLEEP MED REV, V4, P149, DOI 10.1053/smrv.1999.0086; Unruh ML, 2008, J AM GERIATR SOC, V56, P1218, DOI 10.1111/j.1532-5415.2008.01755.x; JENNETT B, 1977, LANCET, V1, P878; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Jacobs JV, 2008, CLIN NEUROPHYSIOL, V119, P1431, DOI 10.1016/j.clinph.2008.02.015; Giacino JT, 2002, NEUROLOGY, V58, P349; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Bekinschtein T, 2009, PROG BRAIN RES, V177, P171, DOI 10.1016/S0079-6123(09)17712-9; Campbell SS, 2007, J SLEEP RES, V16, P24, DOI 10.1111/j.1365-2869.2007.00567.x; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Iida Hideharu, 2001, Journal of Saitama Medical School, V28, P131; Inumaru T., 2007, J TSURUMA HLTH SCI S, V31, P27; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kurita T., 2006, J TSURUMA HLTH SCI S, V29, P65; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Ministry of Health Labour and Welfare, 1991, CRIT JUDG IND PEND L; Noda A., 1996, JPN J EEG EMG, V24, P381; Oksenberg A, 2000, SLEEP, V23, P953; Oksenberg A, 2001, SLEEP, V24, P703; PRIMAVERA A, 1990, NEUROPSYCHOBIOLOGY, V23, P74, DOI 10.1159/000119430; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Suzuki A., 1987, JAPANESE J CLIN ELEC, V29, P113; Takaichi Y., 2001, SOC TREATMENT COMA, V10, P101; Tanaka H., 1996, AUTONOMIC NERVOUS SY, V33, P546; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JAN	2015	17	1					13	20		10.1177/1099800414523118		8	Nursing	Nursing	AW4OO	WOS:000346260700003		
J	Sakurai, S; Onishi, J; Hirai, M				Sakurai, Shihomi; Onishi, Joji; Hirai, Makoto			Impaired Autonomic Nervous System Activity During Sleep in Family Caregivers of Ambulatory Dementia Patients in Japan	BIOLOGICAL RESEARCH FOR NURSING			English	Article						actigraphy; autonomic nervous system activity; caregiver; dementia; sleep	HEART-RATE-VARIABILITY; ALZHEIMERS-DISEASE; POOR SLEEP; D-DIMER; DISTURBANCE; QUALITY; STRESS; IDENTIFICATION; PARENTS; PEOPLE	The number of dementia patients requiring care is rapidly increasing in Japan. Consequently, a large percentage of family members, including spouses and children of those with dementia, are assuming the role of primary caregiver. Many caregivers develop health problems including sleep disorders. Some report poor quality of sleep even when sleep duration is normal. In the present study, we used actigraphy and heart rate variability spectral analysis to assess autonomic nervous system activity and quality of sleep in family caregivers of people with ambulatory dementia. The 20 caregivers who participated in our study exhibited significantly higher levels of sympathetic nervous system activity during sleep than noncaregivers. This abnormal activity was most prominent during the first half of the sleep period and was not related to overall sleep duration. We propose that relaxation is inhibited during the first half of the sleep period in this caregiver population. This may be due to increased stress, as caregivers of people with ambulatory dementia may worry about their patients waking and wandering at night, potentially injuring themselves. Our findings indicate a need for increased support for caregivers of people with dementia, including the assessment and treatment of sleep disorders.	[Sakurai, Shihomi; Hirai, Makoto] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi 4618673, Japan; [Sakurai, Shihomi] Kanazawa Med Univ, Sch Nursing, Dept Community Nursing, Kanazawa, Ishikawa, Japan; [Onishi, Joji] Nara Med Univ, Dept Community Med, Kashihara, Nara 634, Japan	Sakurai, S (reprint author), Nagoya Univ, Grad Sch Med, Higasi Ku, 1-1,Daikominami, Nagoya, Aichi 4618673, Japan.	sakurai@kanazawa-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19592563]; Japan Society for the Promotion of Science	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a 2007-2009 grant-in-aid for scientific research (C), no. 19592563 from the Japanese Ministry of Education, Culture, Sports, Science and Technology; and the Japan Society for the Promotion of Science.	Abekura H, 2011, BIOMED RES-TOKYO, V32, P395; Schwartz J, 2013, ARCH GERONTOL GERIAT, V57, P70, DOI 10.1016/j.archger.2013.02.008; Mills PJ, 2009, BRAIN BEHAV IMMUN, V23, P605, DOI 10.1016/j.bbi.2008.09.014; von Kanel R, 2006, J AM GERIATR SOC, V54, P431, DOI 10.1111/j.1532-5415.2005.00642.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; de la Morena MJE, 2013, ACTA NEUROL SCAND, V127, P413, DOI 10.1111/ane.12061; von Kanel R, 2010, GERONTOLOGY, V56, P41, DOI 10.1159/000264654; Tochikubo O, 1996, HYPERTENSION, V27, P1318; McCurry SM, 2007, SLEEP MED REV, V11, P143, DOI 10.1016/j.smrv.2006.09.002; Gallagher S, 2010, J PEDIATR PSYCHOL, V35, P728, DOI 10.1093/jpepsy/jsp093; COLE RJ, 1992, SLEEP, V15, P461; Otzenberger H, 1998, AM J PHYSIOL-HEART C, V275, pH946; McCurry SM, 2008, SLEEP, V31, P741; BAUMGARTEN M, 1990, J AM GERIATR SOC, V38, P221; Beaudreau SA, 2008, J GERIATR PSYCH NEUR, V21, P159, DOI 10.1177/0891988708316857; CASADEI B, 1995, ACTA PHYSIOL SCAND, V153, P125, DOI 10.1111/j.1748-1716.1995.tb09843.x; Doi Y, 1998, JAPANESE J PSYCHIAT, V13, P755; Kokubo Takeshi, 2013, Biopsychosoc Med, V7, P6, DOI 10.1186/1751-0759-7-6; MAHONEY F I, 1965, Md State Med J, V14, P61; Mausbach BT, 2006, SLEEP, V29, P1347; McCurry S., 2009, SLEEP MED CLIN, V4, P519; Ministry of Health Labour and Welfare, 2008, KON SEIK KIS CHOUS 2; Naruse T, 2012, BIOSCI TRENDS, V6, P10, DOI 10.5582/bst.2012.v6.1.10; Organisation for Economic Co-operation and Development, 2011, SOC GLANC 2011 OECD; Pagani M., 1991, CIRCULATION, V83, P1143; Rowe Meredeth A, 2008, J Clin Sleep Med, V4, P362; SAKAKIBARA M, 1994, PSYCHOPHYSIOLOGY, V31, P223, DOI 10.1111/j.1469-8986.1994.tb02210.x; Simpson C, 2013, J CLIN NURS, V22, P3042, DOI 10.1111/jocn.12127; Takahara M, 2008, SLEEP BIOL RHYTHMS, V6, P215, DOI 10.1111/j.1479-8425.2008.00370.x; Task Force, 1996, EUR HEART J, V17, P354, DOI DOI 10.1093/0XF0RDJ0URNALS.EURHEARTJ.A014868; WIDGREN BR, 1992, HYPERTENSION, V20, P606; Wu SD, 2008, BIOMED RES-TOKYO, V29, P245, DOI 10.2220/biomedres.29.245; Yamamoto K, 2008, Complement Ther Clin Pract, V14, P195, DOI 10.1016/j.ctcp.2008.04.001	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JAN	2015	17	1					21	28		10.1177/1099800414524050		8	Nursing	Nursing	AW4OO	WOS:000346260700004		
J	Hozumi, K; Fujimori, C; Katagiri, F; Kikkawa, Y; Nomizu, M				Hozumi, Kentaro; Fujimori, Chikara; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi			Suppression of cell adhesion through specific integrin crosstalk on mixed peptide-polysaccharide matrices	BIOMATERIALS			English	Article						Cell adhesion; Crosstalk; Integrin; Peptide; Polysaccharide; ECM (extracellular matrix)	CONJUGATED CHITOSAN MEMBRANES; CHAIN LG4 MODULE; BIOLOGICAL-ACTIVITIES; BASEMENT-MEMBRANE; GENE-EXPRESSION; IN-VIVO; LAMININ; MIGRATION; BEHAVIOR; TALK	Crosstalk of different integrins, which bind to distinct types of extracellular matrix proteins, promotes specific functions. This crosstalk has not been investigated in depth. Previously, we demonstrated that integrin-syndecan crosstalk accelerated cell adhesion. Here, we evaluated the crosstalk of two different integrins using mixed peptide-polysaccharide (chitosan or alginate) matrices. Two different integrin binding peptides, FIB1 (integrin alpha v beta 3), EF1zz (integrin alpha 2 beta 1), and 531 (integrin alpha 3 beta 1), were mixed in various molar ratios (9:1, 4:1, 1:1) and conjugated on a polysaccharide matrix. The mixture of FIB1/EF1zz- and FIB1/531-polysaccharide matrices did not show any difference in human dermal fibroblast (HDF) adhesion against the mono polysaccharide matrices. Interestingly, the EF1zz/531-polysaccharide matrix (molar ratio = 1:4) exhibited significantly decreased cell adhesion, but other EF1zz/531-polysaccharide matrices did not show any difference. When we examined the signal transduction of the EF1zz/531(1:4), Y397 phosphorylation of FAK significantly decreased but Y514 phosphorylation of Src did not exhibit any differences. Further investigation revealed that this suppression was mediated by PI3K signaling through the activation of integrin, and PKA signaling modulated suppression of HDF attachment. These findings suggest that a mixed peptide-polysaccharide matrix using receptor specific ligands can regulate cellular functions through receptor-specific crosstalk and is a useful approach to understand receptor specific crosstalk. (C) 2014 Elsevier Ltd. All rights reserved.	[Hozumi, Kentaro; Fujimori, Chikara; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Biochem, Hachioji, Tokyo 1920392, Japan	Hozumi, K (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hozumi@toyaku.ac.jp			Ministry of Education, Cultures, Sports, Science and Technology of Japan [24500530, 25560228]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Cultures, Sports, Science and Technology of Japan (24500530 and 25560228).	Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Smiley AK, 2005, J INVEST DERMATOL, V125, P1286, DOI 10.1111/j.0022-202X.2005.23971.x; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Otagiri D, 2013, BIOPOLYMERS, V100, P751, DOI 10.1002/bip.22303; Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011; MILES AJ, 1995, J BIOL CHEM, V270, P29047; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kikkawa Y, 2013, CELL ADHES MIGR, V7, P150, DOI 10.4161/cam.22827; Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044; Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; FURTADO GD, 1992, INFECT IMMUN, V60, P4925; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Gonzalez AM, 2008, J BIOL CHEM, V283, P31849, DOI 10.1074/jbc.M801345200; Gonzalez AM, 2010, CELL SIGNAL, V22, P578, DOI 10.1016/j.cellsig.2009.10.009; Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hozumi K, 2012, J BIOL CHEM, V287, P25111, DOI 10.1074/jbc.M112.348151; Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012; Jaworski J, 2006, BIOMATERIALS, V27, P4212, DOI 10.1016/j.biomaterials.2006.03.026; Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684; Pankov R, 2002, J CELL SCI, V115; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Ruoslahti E, 1997, KIDNEY INT, V51, P1413, DOI 10.1038/ki.1997.193; Sreejalekshmi KG, 2011, J BIOMED MATER RES A, V96A, P477, DOI 10.1002/jbm.a.32980; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006	47	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2015	37						73	81		10.1016/j.biomaterials.2014.10.005		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW8WW	WOS:000346541100007		
J	Hashimoto, Y; Mukai, S; Sawada, S; Sasaki, Y; Akiyoshi, K				Hashimoto, Yoshihide; Mukai, Sada-atsu; Sawada, Shin-ichi; Sasaki, Yoshihiro; Akiyoshi, Kazunari			Nanogel tectonic porous gel loading biologics, nanocarriers, and cells for advanced scaffold	BIOMATERIALS			English	Article						Biocompatibility; Biodegradation; Hydrogel; Nanoparticle; Polysaccharide; Porosity	PROTEIN-DELIVERY; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; HYDROGELS; DESIGN; INHIBITION; SYSTEMS; GROWTH; ICE	We developed a new self-assembled amphiphilic nanogel-crosslinked porous (NanoCliP) gel that can trap proteins, liposomes, and cells. The NanoCliP gel was prepared by Michael addition of a self-assembled nanogel of acryloyl group-modified cholesterol-bearing pullulan to pentaerythritol tetra (mercaptoethyl) polyoxyethylene, followed by freezing-induced phase separation. Dynamic rheological analysis revealed that the storage modulus (G') of the NanoCliP gel was approximately 10 times greater than that of a nonporous nanogel-crosslinked gel. Two-photon excitation deep imaging revealed that the NanoCliP gel comprises interconnected pores of several hundred micrometers in diameter. The NanoCliP gel trapped proteins and liposomes via hydrophobic interactions because its amphiphilic nanogels exhibit chaperone-like activity. Mouse embryonic fibroblasts penetrated the interconnected pores and adhered to the porous surface of fibronectin-complexed NanoCliP gel. In vivo, the NanoCliP gel enhanced cell infiltration, tissue ingrowth, and neovascularization without requiring exogenous growth factors, suggesting that the NanoCliP gel is a promising scaffold for tissue engineering. (C) 2014 Elsevier Ltd. All rights reserved.	[Hashimoto, Yoshihide; Mukai, Sada-atsu; Sawada, Shin-ichi; Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Hashimoto, Yoshihide; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Katsura Inttech Ctr, Bionanotransporter Project,Nishikyo Ku, Kyoto 6158530, Japan	Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	akiyoshi@bio.polym.kyoto-u.ac.jp			Exploratory Research for Advanced Technology of the Japan Science and Technology Agency (JST-ERATO)	We wish to thank K. Umesaki and S. Ikeda of Kyoto University for preparing the liposomes. This work was supported by the Exploratory Research for Advanced Technology of the Japan Science and Technology Agency (JST-ERATO).	Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Abdurrahmanoglu S, 2009, POLYMER, V50, P5449, DOI 10.1016/j.polymer.2009.09.042; Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046; Ayame H, 2008, BIOCONJUGATE CHEM, V19, P882, DOI 10.1021/bc700422s; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/nmat3758, 10.1038/NMAT3758]; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Cochet N, 2000, APPL MICROBIOL BIOT, V54, P153, DOI 10.1007/s002530000377; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje; Nomura Y, 2003, FEBS LETT, V553, P271, DOI 10.1016/S0014-5793(03)01028-7; Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243; Plieva F, 2006, J MATER CHEM, V16, P4065, DOI 10.1039/b606734d; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]; Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001; Hou YP, 2010, BIOMACROMOLECULES, V11, P648, DOI 10.1021/bm9012293; Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024; Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Sekine Y, 2012, ADV HEALTHC MATER, V1, P722, DOI 10.1002/adhm.201200175; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Atala A., 1997, SYNTHETIC BIODEGRADA; Hobbs P.V., 1974, ICE PHYS; Ikeda S, 2001, J AGR FOOD CHEM, V49, P4436, DOI 10.1021/jf0103065; RAYMOND JA, 1989, P NATL ACAD SCI USA, V86, P881, DOI 10.1073/pnas.86.3.881; ROSSMURPHY SB, 1983, FARADAY SYMP CHEM S, P115; Saul JM, 2013, HDB POLYM APPL MED M, P279; Shimoda A, 2012, MACROMOL RES, V20, P266, DOI 10.1007/s13233-012-0054-x	36	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2015	37						107	115		10.1016/j.biomaterials.2014.10.045		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW8WW	WOS:000346541100010		
J	Matsugaki, A; Aramoto, G; Ninomiya, T; Sawada, H; Hata, S; Nakano, T				Matsugaki, Aira; Aramoto, Gento; Ninomiya, Takafumi; Sawada, Hiroshi; Hata, Satoshi; Nakano, Takayoshi			Abnormal arrangement of a collagen/apatite extracellular matrix orthogonal to osteoblast alignment is constructed by a nanoscale periodic surface structure	BIOMATERIALS			English	Article						Microbeam X-ray diffraction; Osteoblast; Collagen structure; Apatite orientation; Laser-induced periodic surface structures (LIPSS)	FOCAL ADHESION DYNAMICS; INTEGRIN FUNCTION; ORIENTATION; CELLS; BONE; RECRUITMENT; ACTIVATION; MORPHOLOGY; MIGRATION; TITANIUM	Morphological and directional alteration of cells is essential for structurally appropriate construction of tissues and organs. In particular, osteoblast alignment is crucial for the realization of anisotropic bone tissue microstructure. In this article, the orientation of a collagen/apatite extracellular matrix (ECM) was established by controlling osteoblast alignment using a surface geometry with nanometer-sized periodicity induced by laser ablation. Laser irradiation induced self-organized periodic structures (laser-induced periodic surface structures; LIPSS) with a spatial period equal to the wavelength of the incident laser on the surface of biomedical alloys of Ti-6Al-4V and Co-Cr-Mo. Osteoblast orientation was successfully induced parallel to the grating structure. Notably, both the fibrous orientation of the secreted collagen matrix and the c-axis of the produced apatite crystals were orientated orthogonal to the cell direction. To the best of our knowledge, this is the first report demonstrating that bone tissue anisotropy is controllable, including the characteristic organization of a collagen/apatite composite orthogonal to the osteoblast orientation, by controlling the cell alignment using periodic surface geometry. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsugaki, Aira; Aramoto, Gento; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Osaka 5650871, Japan; [Ninomiya, Takafumi; Sawada, Hiroshi] Canon Machinery Inc, Kusatsu, Shiga 5258511, Japan; [Hata, Satoshi] Kyushu Univ, Dept Elect & Mat Sci, Kasuga, Fukuoka 8168580, Japan	Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Osaka 5650871, Japan.	nakano@mat.eng.osaka-u.ac.jp			Japan Society for Promotion of Science [25220912]	This work was supported by Grants-in-Aid for Scientific Research (S) from the Japan Society for Promotion of Science (Grant No. 25220912).	Andersson AS, 2003, EXP CELL RES, V288, P177, DOI 10.1016/S0014-4827(03)00159-9; Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035; Vorobyev AY, 2007, APPL SURF SCI, V253, P7272, DOI 10.1016/j.apsusc.2007.03.006; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.05-3574fje; Janko M, 2010, OPT LETT, V35, P2765, DOI 10.1364/OL.35.002765; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Nakano T, 2012, BONE, V51, P741, DOI 10.1016/j.bone.2012.07.003; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Oliveira V, 2009, APPL SURF SCI, V255, P7556, DOI 10.1016/j.apsusc.2009.04.027; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Vorobyev AY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2432288; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Lamers E, 2010, EUR CELLS MATER, V20, P329; Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005; Birk DE, 1986, J CELL BIOL, V103, P230; Fisher N. I., 1993, STAT ANAL CIRCULAR D; Franco D, 2011, SOFT MATTER, V7, P7313, DOI 10.1039/c1sm05191a; Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g; Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129; JONES SJ, 1975, CELL TISSUE RES, V159, P73; JONES SJ, 1976, ISRAEL J MED SCI, V12, P98; Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015; Matsugaki A, 2014, J BIOMED MAT RES; Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022; Schernthaner M, 2013, J NANOMATER, DOI 10.1155/2013/251063; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; Wu LY, 2011, LANGMUIR, V27, P9490, DOI 10.1021/la201580v; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	40	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2015	37						134	143		10.1016/j.biomaterials.2014.10.025		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW8WW	WOS:000346541100013		
J	Mori, K; Kodama, T; Obika, S				Mori, Kazuto; Kodama, Tetsuya; Obika, Satoshi			Synthesis and hybridization property of a boat-shaped pyranosyl nucleic acid containing an exocyclic methylene group in the sugar moiety	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Nucleic acids; Carbohydrates; Oligonucleotides	CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE; MODIFIED OLIGONUCLEOTIDES; GRISEOLIC ACID; NUCLEOSIDES; DESIGN; INHIBITOR; MONOMERS	A boat-shaped pyranosyl nucleic acid (BsNA) having an exocyclic methylene group in the sugar moiety was synthesized to investigate the possibility that the axial H3' of original BsNA is the cause of its duplex destabilization. The synthesized BsNA analog was chemically stable against various nucleophiles. From the thermal stability of duplex oligonucleotides including the BsNA analog, it was found that the duplex-forming ability can be sensitive to the size of functional groups at the 3'-position. (C) 2014 Elsevier Ltd. All rights reserved.	[Mori, Kazuto; Obika, Satoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kodama, Tetsuya] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kodama, T (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kodama@ps.nagoya-u.ac.jp; obika@phs.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); JSPS	This study was supported by the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT), and the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO). K.M. is grateful for a Research Fellowship for Young Scientist from JSPS.	Matsuda A, 2004, CANCER SCI, V95, P105, DOI 10.1111/j.1349-7006.2004.tb03189.x; Obika S, 2010, HETEROCYCLES, V81, P1347, DOI 10.3987/REV-10-667; Yamamoto T, 2011, FUTURE MED CHEM, V3, P339, DOI [10.4155/fmc.11.2, 10.4155/FMC.11.2]; Mitsuoka Y, 2009, NUCLEIC ACIDS RES, V37, P1225, DOI 10.1093/nar/gkn1062; TAKAHASHI S, 1985, J ANTIBIOT, V38, P830; Seth PP, 2010, J AM CHEM SOC, V132, P14942, DOI 10.1021/ja105875e; Prakash TP, 2011, CHEM BIODIVERS, V8, P1616, DOI 10.1002/cbdv.201100081; Hari Y, 2006, BIOORGAN MED CHEM, V14, P1029, DOI 10.1016/j.bmc.2005.09.020; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Ostergaard ME, 2011, CHEM SOC REV, V40, P5771, DOI 10.1039/c1cs15014f; Bomholt N, 2011, BIOORG MED CHEM LETT, V21, P7376, DOI 10.1016/j.bmcl.2011.10.005; Buchanan J. G., 1982, TOPICS ANTIBIOTIC CH, V6, P229; Hanessian S, 2012, ANGEW CHEM INT EDIT, V51, P11242, DOI 10.1002/anie.201203680; Madsen AS, 2012, J ORG CHEM, V77, P3878, DOI 10.1021/jo300222q; Migawa M. T., 2011, PCT Int. Appl., Patent No. [WO 2011/017521A2, 2011017521]; Mori K, 2011, ORG LETT, V13, P6050, DOI 10.1021/ol2025229; Morihiro K, 2013, ANGEW CHEM INT EDIT, V52, P5074, DOI 10.1002/anie.201300555; NAKAGAWA F, 1985, J ANTIBIOT, V38, P823; Rahman SMA, 2009, CHEM LETT, V38, P512, DOI 10.1246/cl.2009.512; Seth PP, 2011, BIOORG MED CHEM LETT, V21, P588, DOI 10.1016/j.bmcl.2010.10.025; Singh S. K., 1998, J CHEM SOC CHEM COMM, P455; TAKENUKI K, 1988, J MED CHEM, V31, P1063, DOI 10.1021/jm00401a001	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JAN 1	2015	23	1					33	37		10.1016/j.bmc.2014.11.030		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AW9OH	WOS:000346586400003		
J	Kikuchi, H; Suzuki, T; Ogura, M; Homma, MK; Homma, Y; Oshima, Y				Kikuchi, Haruhisa; Suzuki, Toshiyuki; Ogura, Masato; Homma, Miwako K.; Homma, Yoshimi; Oshima, Yoshiteru			Synthesis of prenylated quinolinecarboxylic acid derivatives and their anti-obesity activities	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Mitochondrial uncoupling; Anti-obesity drugs; Metabolic diseases; Quinolinecarboxylate; Structure-activity relationship	MITOCHONDRIAL; DINITROPHENOL	Mitochondrial uncoupling is one of the therapeutic strategies used to control energy metabolism in various metabolic diseases and in obesity. Ppc-1 (1), a prenylated quinolinecarboxylic acid isolated from cellular slime molds, shows uncoupling activity in vitro and anti-obesity activity in vivo. In this study, we synthesized Ppc-1 (1) and its derivatives, and revealed the structure-activity relationship of uncoupling activities. The triprenylated compound 18 showed mitochondrial uncoupling activity that was more potent than that of Ppc-1 (1). Compound 18 also suppressed weight gain in mice without undesired effects such as lesions on tissues. These results indicate that compound 18 could be used as a seed compound for new anti-obesity drugs. (C) 2014 Elsevier Ltd. All rights reserved.	[Kikuchi, Haruhisa; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suzuki, Toshiyuki; Ogura, Masato; Homma, Miwako K.; Homma, Yoshimi] Fukushima Med Univ, Sch Med, Fukushima 9601295, Japan	Kikuchi, H (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	hal@mail.pharm.tohoku.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [25350959]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25350959) from the Ministry of Education, Science, Sports, and Culture of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Astellas Foundation for Research on Metabolic Disorders.	Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Takeda Y, 2012, ORG LETT, V14, P4874, DOI 10.1021/ol302201q; Kikuchi H, 2010, TETRAHEDRON, V66, P6000, DOI 10.1016/j.tet.2010.06.029; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; d'Hardemare AD, 2004, BIOMETALS, V17, P691; Grundlingh Johann, 2011, J Med Toxicol, V7, P205, DOI 10.1007/s13181-011-0162-6; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Homma Y., [No title captured], Patent No. [WO2014061647 A1, 2014061647]; Katou Y, 2014, LIFE SCI, V103, P1, DOI 10.1016/j.lfs.2014.03.023; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Ogura M., 2010, BIOCHEM J, V447, P281; PARASCAN.J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JAN 1	2015	23	1					66	72		10.1016/j.bmc.2014.11.024		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AW9OH	WOS:000346586400007		
J	Hakamata, W; Miura, K; Hirano, T; Nishio, T				Hakamata, Wataru; Miura, Kazuki; Hirano, Takako; Nishio, Toshiyuki			Identification of a novel glycan processing enzyme with exo-acting beta-allosidase activity in the Golgi apparatus using a new platform for the synthesis of fluorescent substrates	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						beta-Allosidase; Golgi apparatus; Fluorescent substrate; Protein glycosylation; Glycan processing; Post-translational modification; Quinone methide cleavage	ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL MODIFICATIONS; QUALITY-CONTROL; PROTEINS; ACCUMULATION; STRATEGIES; DESIGN; PROBES	The majority of eukaryotic proteins undergo post-translational modifications (PTMs) involving the attachment of complex glycans, predominantly through N-glycosylation and O-glycosylation. PTMs play important roles in virtually all cellular processes, and aberrant regulation of protein glycosylation and glycan processing has been implicated in various diseases. However, glycan processing on proteins in various cellular contexts has not been visualized. We had previously developed a quinone methide cleavage (QMC) platform for enhanced substrate design. This platform was applied here to screen for novel glycan-processing enzymes. We designed and synthesized fluorescent substrates with beta-allopyranoside residues using the QMC platform. When applied in cell-based assays, the fluorescent substrates allowed rapid and clear visualization of beta-allosidase activity in the Golgi apparatus of human cultured cells. The QMC platform will likely find broad applications in visualizing the activities of glycan processing enzymes in living cells and in studying PTMs. (C) 2014 Elsevier Ltd. All rights reserved.	[Hakamata, Wataru; Miura, Kazuki; Hirano, Takako; Nishio, Toshiyuki] Nihon Univ, Dept Chem & Life Sci, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Hakamata, W (reprint author), Nihon Univ, Dept Chem & Life Sci, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	hakamata.wataru@nihon-u.ac.jp			JSPS KAKENHI Grant [26460157]	The authors wish to express their sincere thanks to Mrs. T. Kiuchi of the General Research Institute of the College of Bioresource Sciences of Nihon University for performing FABMS measurements and Mrs. A. Sato of A-Rabbit-Science Japan Co., Ltd for performing the elemental analyses. This work was partly supported by JSPS KAKENHI Grant Number 26460157.	Advanced Chemistry Development Inc, STRUCT DES SUIT VER; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Hakamata W, 2009, CURR TOP MED CHEM, V9, P3; Brooks SA, 2008, ANTI-CANCER AGENT ME, V8, P2, DOI 10.2174/187152008783330860; Siman P, 2012, ORG BIOMOL CHEM, V10, P5684, DOI 10.1039/c2ob25149c; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Hakamata W, 2011, BIOORG MED CHEM LETT, V21, P3206, DOI 10.1016/j.bmcl.2011.04.066; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Kamiya M, 2011, J AM CHEM SOC, V133, P12960, DOI 10.1021/ja204781t; Mottram LF, 2006, ORG LETT, V8, P581, DOI 10.1021/ol052655g; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Ichikawa Y, 2014, ANGEW CHEM INT EDIT, V53, P6772, DOI 10.1002/anie.201403221; CLC bio, MOL VIRT DOCK VER 6; Hakamata W, 2004, J CARBOHYD CHEM, V23, P27, DOI 10.1081/CAR-120030022; Hakamata W, 2014, ACS MED CHEM LETT, V5, P321, DOI 10.1021/ml400398t; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Pan S, 2011, MOL CELL PROTEOMICS, V10, pR110, DOI DOI 10.1074/MCP.R110.003251; Yanagita RC, 2014, BIOSCI BIOTECH BIOCH, V78, P190, DOI 10.1080/09168451.2014.882747; Ye D, 2009, ACTA CRYSTALLOGR E, V65, pO1338, DOI 10.1107/S1600536809018248	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JAN 1	2015	23	1					73	79		10.1016/j.bmc.2014.11.023		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AW9OH	WOS:000346586400008		
J	Matsufuji, T; Shimada, K; Kobayashi, S; Ichikawa, M; Kawamura, A; Fujimoto, T; Arita, T; Hara, T; Konishi, M; Abe-Ohya, R; Izumi, M; Sogawa, Y; Nagai, Y; Yoshida, K; Abe, Y; Kimura, T; Takahashi, H				Matsufuji, Tetsuyoshi; Shimada, Kousei; Kobayashi, Shozo; Ichikawa, Masanori; Kawamura, Asuka; Fujimoto, Teppei; Arita, Tsuyoshi; Hara, Takashi; Konishi, Masahiro; Abe-Ohya, Rie; Izumi, Masanori; Sogawa, Yoshitaka; Nagai, Yoko; Yoshida, Kazuhiro; Abe, Yasuyuki; Kimura, Takako; Takahashi, Hisashi			Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Anti-obesity; Antedrug; Bombesin receptor subtype-3 (BRS-3); Brain penetration; Diazepine	TERT-BUTANESULFINYL IMINES; ASYMMETRIC-SYNTHESIS; BODY-TEMPERATURE; NERVOUS-SYSTEM; OBESE SUBJECTS; WEIGHT-LOSS; DISCOVERY; OVERWEIGHT; MK-5046; AMINES	Novel compounds based on the lead BRS-3 agonists from our HTS compounds 2a and 2b have been synthesized with the focus on obtaining peripheral BRS-3 agonists. To identify potent anti-obesity compounds without adverse effects on the central nerve system, a labile carboxylic ester with an antedrug functionality was introduced onto the terminal position. Through the extensive synthetic exploration and the pharmacokinetic studies of oral administration in mice, the phenol ester 17c was selected due to the most suitable pharmacological profile. In the evaluation of food intake suppression in B6 mice, 17c showed significant in vivo efficacy and no clear adverse effect on heart rate and blood pressure change in dog iv infusion. Our study paved the way for development of anti-diabetes and obesity drugs with a safer profile. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsufuji, Tetsuyoshi; Shimada, Kousei; Kobayashi, Shozo; Ichikawa, Masanori; Kawamura, Asuka; Fujimoto, Teppei; Arita, Tsuyoshi; Takahashi, Hisashi] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Hara, Takashi; Konishi, Masahiro; Abe-Ohya, Rie; Izumi, Masanori; Sogawa, Yoshitaka] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Nagai, Yoko; Yoshida, Kazuhiro] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Abe, Yasuyuki] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan; [Kimura, Takako] Daiichi Sankyo RD NOVARE Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan	Matsufuji, T (reprint author), Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	matsufuji.tetsuyoshi.nf@daiichisankyo.co.jp					OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Reitman ML, 2012, J CLIN PHARMACOL, V52, P1306, DOI 10.1177/0091270011419854; Ladenheim EE, 2008, ENDOCRINOLOGY, V149, P971, DOI 10.1210/en.2007-1319; Liu GC, 1997, J AM CHEM SOC, V119, P9913, DOI 10.1021/ja972012z; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Liu J, 2002, BIOCHEMISTRY-US, V41, P8954, DOI 10.1021/bi0202777; OhkiHamazaki H, 1997, BRAIN RES, V762, P165, DOI 10.1016/S0006-8993(97)00380-6; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Fong TM, 2009, INT J OBESITY, V33, P947, DOI 10.1038/ijo.2009.132; Clark DE, 2003, DRUG DISCOV TODAY, V8, P927, DOI 10.1016/S1359-6446(03)02827-7; Sun XW, 2008, ORG LETT, V10, P1259, DOI 10.1021/ol8001514; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Guan XM, 2011, J PHARMACOL EXP THER, V336, P356, DOI 10.1124/jpet.110.174763; Sebhat IK, 2011, ACS MED CHEM LETT, V2, P43, DOI 10.1021/ml100196d; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; Ellman JA, 2002, ACCOUNTS CHEM RES, V35, P984, DOI 10.1021/ar020066u; Davenport RJ, 2014, DRUG DISCOV TODAY, V19, P845, DOI 10.1016/j.drudis.2013.10.025; Faulconbridge LF, 2009, OBESITY, V17, P1009, DOI 10.1038/oby.2008.647; KRAUS GA, 1980, J ORG CHEM, V45, P4825, DOI 10.1021/jo01312a004; Feng Y, 2011, ENDOCRINOLOGY, V152, P4106, DOI 10.1210/en.2011-1440; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Porcher C, 2005, CELL TISSUE RES, V320, P21, DOI 10.1007/s00441-004-1032-1; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Chobanian HR, 2012, ACS MED CHEM LETT, V3, P252, DOI 10.1021/ml200304j; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hasumi K, 2014, BIOORGAN MED CHEM, V22, P4162, DOI 10.1016/j.bmc.2014.05.045; Krolczyk D.G., 2001, J PHYSIOL PHARMACOL, V52, P705; Kunishima K., 2001, TETRAHEDRON, V57, P1551; Lateef DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE681, DOI 10.1152/ajpendo.00615.2013; Liu P, 2011, ACS MED CHEM LETT, V2, P933, DOI 10.1021/ml200207w; Matsufuji T., 2014, BIOORG MED CHEM LETT, V22, P750; McNeely W, 1998, DRUGS, V56, P241, DOI 10.2165/00003495-199856020-00007; Metzger JM, 2010, AM J PHYSIOL-ENDOC M, V299, pE816, DOI 10.1152/ajpendo.00404.2010; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Procopiou PA, 2011, BIOORGAN MED CHEM, V19, P6026, DOI 10.1016/j.bmc.2011.08.043; Shimizu K, 2006, BIOORG MED CHEM LETT, V16, P3323, DOI 10.1016/j.bmcl.2006.03.014; Warren KR, 2013, J CLIN PSYCHOPHARM, V33, P118, DOI 10.1097/JCP.0b013e3182793843; World Health Organization, 2004, OB PREV MAN GLOB EP	41	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JAN 1	2015	23	1					89	104		10.1016/j.bmc.2014.11.018		16	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AW9OH	WOS:000346586400010		
J	Shirai, J; Nakamura, M; Tarui, N; Hashimoto, T; Ikeura, Y				Shirai, Junya; Nakamura, Minoru; Tarui, Naoki; Hashimoto, Tadatoshi; Ikeura, Yoshinori			3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis (Retraction of vol 19, pg 5175, 2011)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Shirai, Junya; Nakamura, Minoru; Tarui, Naoki; Hashimoto, Tadatoshi; Ikeura, Yoshinori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan	Shirai, J (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, 2-17-85 Jusohonmachi, Osaka 5328686, Japan.						Shirai J, 2011, BIOORGAN MED CHEM, V19, P5175, DOI 10.1016/j.bmc.2011.07.014	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JAN 1	2015	23	1					272	272		10.1016/j.bmc.2014.11.026		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AW9OH	WOS:000346586400027		
J	Sakimoto, T				Sakimoto, Tohru			Granular corneal dystrophy type 2 is associated with morphological abnormalities of meibomian glands	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							BIGH3 GENE; MEIBOGRAPHY; RECURRENCE; MUTATIONS; LIPIDS	Aims To investigate morphological changes in meibomian glands in patients with granular corneal dystrophy type 2 (GCD2) using non-invasive meibography. Methods Eleven patients (3 men and 8 women) with GCD2, and sex-matched and age-matched healthy volunteers as a controls were enrolled in this study. The diagnosis of GCD2 was confirmed by transforming growth factor beta-induced (TGFBI) gene analysis using direct sequencing in exon 4 of TGFBI gene. Meibography was performed in the right eye of the studied cases. Meiboscore was determined according to the morphology of meibomian gland and classified into four grades; grade 0 (no meibomian gland loss), grade 1 (loss less than one-third the total area of meibomian glands), grade 2 (area loss between one-third and two-thirds of the total area), and grade 3 (area loss greater than two-thirds of the total). Results R124H mutation was detected in all patients with GCD2. Extinguishing or shortening of the meibomian glands was observed in patients with GCD2. The meiboscore was 3.8 +/- 1.3 in patients with GCD2 and 1.3 +/- 1.1 in the control group, showing significant difference between two groups (Mann-Whitney U-test, p=0.042). Conclusions In GCD2, corneal deposits, and also morphological abnormalities of meibomian glands, such as obstruction or shortening, were found. Since abnormal phospholipid deposition is noted in GCD2, these results are interesting because phospholipid is possibly secreted from the meibomian gland.	Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol,Itabashi Ku, Tokyo 1738610, Japan	Sakimoto, T (reprint author), Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol,Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	torusaki@gmail.com					Butovich IA, 2009, PROG RETIN EYE RES, V28, P483, DOI 10.1016/j.preteyeres.2009.07.002; Shine WE, 2003, CURR EYE RES, V26, P89, DOI 10.1076/ceyr.26.2.89.14515; Bron AJ, 1998, ADV EXP MED BIOL, V438, P281; Mashima Y, 2000, AM J OPHTHALMOL, V130, P516, DOI 10.1016/S0002-9394(00)00571-7; Ohashi Y, 2006, CLIN CHIM ACTA, V369, P17, DOI 10.1016/j.cca.2005.12.035; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Arita R, 2013, CORNEA, V32, P242, DOI 10.1097/ICO.0b013e31825425ef; TIFFANY JM, 1978, EXP EYE RES, V27, P289, DOI 10.1016/0014-4835(78)90164-1; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI [10.1016/j.ophtha.2007.06.031, 10.1016/j.ophtha.2007.06.03]; Saville JT, 2011, EXP EYE RES, V92, P238, DOI 10.1016/j.exer.2010.12.012; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; Konishi M, 1998, AM J OPHTHALMOL, V126, P450, DOI 10.1016/S0002-9394(98)00105-6; Mashima Y, 2002, BRIT J OPHTHALMOL, V86, P273, DOI 10.1136/bjo.86.3.273; Mashima Y, 2003, EYE, V17, P975, DOI 10.1038/sj.eye.6700572; Shinya C, 1991, GANKA, V33, P919	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JAN	2015	99	1					26	28		10.1136/bjophthalmol-2014-305039		3	Ophthalmology	Ophthalmology	AW6CW	WOS:000346358000007		
J	Sayanagi, K; Gomi, F; Akiba, M; Sawa, M; Hara, C; Nishida, K				Sayanagi, Kaori; Gomi, Fumi; Akiba, Masahiro; Sawa, Miki; Hara, Chikako; Nishida, Kohji			En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							EXUDATIVE MACULAR DISEASES; VASCULAR HYPERPERMEABILITY; VISUALIZATION; ANGIOGRAPHY; THICKNESS; FEATURES; LESIONS	Aim To observe the choroidal microstructure in polypoidal choroidal vasculopathy (PCV) using high-penetration optical coherence tomography (HP-OCT) with a long-wavelength light source that visualises tissue beneath the retinal pigment epithelium (RPE) and deep choroid, and to compare the findings with those of indocyanine green angiography (ICGA). Methods In this retrospective, non-invasive, observational case series, 19 eyes (18 patients) with PCV were observed using HP-OCT (swept source, 100 000 A-scans/s, 1060 nm wavelength) and ICGA. The HP-OCT scan protocol was a 3x3-mm or 6x6-mm square containing 256x256 or 512x128 A-scans. The choroidal thickness (CT) was measured using HP-OCT. Results ICGA showed 43 polypoidal lesions in 14 eyes and a vascular network in 17 eyes. HP-OCT showed 41 of the 43 polypoidal lesions visualised by ICGA as RPE rings with inner reflectivity and 15 eyes with a vascular network. Six eyes with RPE rings with inner reflectivity on HP-OCT were not visualised on ICGA images. The choroidal vascular network was dilated in 14 (33%) of 43 polypoidal lesions and 22 (47%) of 47 polypoidal lesions on ICGA and HP-OCT images, respectively. The mean CT at the fovea was 250 mu m. The CT at the dilated choroidal vessels beneath the polypoidal lesions was significantly (p = 0.0095) thicker than that of the undilated choroidal vessels beneath the polypoidal lesions. Conclusions HP-OCT can visualise choroidal vascular abnormalities in eyes with PCV and should be useful for understanding the pathogenesis of these abnormalities.	[Sayanagi, Kaori; Gomi, Fumi; Sawa, Miki; Hara, Chikako; Nishida, Kohji] Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 565, Japan; [Gomi, Fumi] Sumitomo Hosp, Dept Ophthalmol, Osaka 5300005, Japan; [Akiba, Masahiro] Topcon Corp, Tokyo, Japan	Gomi, F (reprint author), Sumitomo Hosp, Dept Ophthalmol, Kita Ku, 5-3-20 Nakanoshima, Osaka 5300005, Japan.	gomi.fumi@gmail.com					Hong YJ, 2013, INVEST OPHTH VIS SCI, V54, P3621, DOI 10.1167/iovs.12-11184; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Yannuzzi LA, 2000, OPHTHALMOLOGY, V107, P767, DOI 10.1016/S0161-6420(99)00173-6; MACCUMBER MW, 1994, RETINA-J RET VIT DIS, V14, P143, DOI 10.1097/00006982-199414020-00007; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Tsujikawa A, 2007, AM J OPHTHALMOL, V143, P102, DOI 10.1016/j.ajo.2006.08.025; Sato T, 2007, RETINA-J RET VIT DIS, V27, P589, DOI 10.1097/01.iae.0000249386.63482.05; Okubo A, 2005, OPHTHALMOLOGY, V112, P1436, DOI 10.1016/j.ophtha.2005.03.017; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Yang LH, 2013, RETINA-J RET VIT DIS, V33, P1584, DOI 10.1097/IAE.0b013e318285cbb3; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ellabban Abdallah A, 2012, Clin Ophthalmol, V6, P837, DOI 10.2147/OPTH.S30907; Iijima H, 2000, AM J OPHTHALMOL, V129, P21, DOI 10.1016/S0002-9394(99)00253-6; Kameda T, 2007, CLIN EXP OPHTHALMOL, V35, P596, DOI 10.1111/j.1442-9071.2007.01554.x; Ojima Y, 2009, RETINA-J RET VIT DIS, V29, P52, DOI 10.1097/IAE.0b013e3181884fbf; Otsuji T, 2000, OPHTHALMIC SURG LAS, V31, P210; Saito M, 2008, RETINA-J RET VIT DIS, V28, P459, DOI 10.1097/IAE.0b013e318156db60; Sugano Y, 2013, JPN J OPHTHALMOL, V57, P294, DOI 10.1007/s10384-013-0230-3; Ueno C, 2012, RETINA-J RET VIT DIS, V32, P2006, DOI 10.1097/IAE.0b013e31825c1c31; Ueta T, 2009, OPHTHALMOLOGY, V116, P2004; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yasuno Y, 2009, INVEST OPHTH VIS SCI, V50, P405, DOI 10.1167/iovs.08-2272	26	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JAN	2015	99	1					29	35		10.1136/bjophthalmol-2013-304658		7	Ophthalmology	Ophthalmology	AW6CW	WOS:000346358000008		
J	Koizumi, N; Inatomi, T; Suzuki, T; Shiraishi, A; Ohashi, Y; Kandori, M; Miyazaki, D; Inoue, Y; Soma, T; Nishida, K; Takase, H; Sugita, S; Mochizuki, M; Kinoshita, S				Koizumi, Noriko; Inatomi, Tsutomu; Suzuki, Takashi; Shiraishi, Atsushi; Ohashi, Yuichi; Kandori, Michiko; Miyazaki, Dai; Inoue, Yoshitsugu; Soma, Takeshi; Nishida, Kohji; Takase, Hiroshi; Sugita, Sunao; Mochizuki, Manabu; Kinoshita, Shigeru		Japan Corneal Endotheliitis Study	Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							PENETRATING KERATOPLASTY; CONFOCAL MICROSCOPY; ANTERIOR-CHAMBER; PATIENT; ENDOTHELIOPATHY; INFECTION; EYE; DNA	Aims The purpose of this study is to elucidate the clinical manifestations and the current treatment status of cytomegalovirus (CMV) endotheliitis via a large case series obtained from a national survey conducted in Japan. Methods The Japan Corneal Endotheliitis Study Group proposed diagnostic criteria for CMV endotheliitis based on a viral examination by PCR of aqueous humour, in combination with clinical manifestations. A national survey was then retrospectively conducted among 1160 members of the Japan Cornea Society. The study reviewed the patient profiles, clinical manifestations, and treatment modalities of individuals who met the diagnostic criteria for CMV endotheliitis. Results The study included 109 eyes of 106 patients. Mean patient age was 66.9 +/- 10.9 years (85 males (80.2%), 21 females (19.8%)). Patients were commonly diagnosed with anterior uveitis and ocular hypertension prior to confirmation of CMV endotheliitis. Coin-shaped lesions were observed in 70.6%, and linear keratic precipitates in 8.3% of the patients, respectively. 95% of cases were treated with anti-CMV drugs. Conclusions CMV endotheliitis is most common in middle-aged and elderly men. CMV endotheliitis should be suspected when patients present with corneal endotheliitis involving coin-shaped lesions accompanied by anterior uveitis and ocular hypertension.	[Koizumi, Noriko; Inatomi, Tsutomu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan; [Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Suzuki, Takashi; Shiraishi, Atsushi; Ohashi, Yuichi] Ehime Univ, Sch Med, Dept Ophthalmol, Matsuyama, Ehime 790, Japan; [Kandori, Michiko; Miyazaki, Dai; Inoue, Yoshitsugu] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Tottori 680, Japan; [Soma, Takeshi; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Takase, Hiroshi; Sugita, Sunao; Mochizuki, Manabu] Tokyo Med & Dent Univ, Grad Sch Med, Dept Ophthalmol & Vis Sci, Tokyo, Japan	Koizumi, N (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	norikoiz@koto.kpu-m.ac.jp			Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan.	OHASHI Y, 1991, AM J OPHTHALMOL, V112, P419; Kandori M, 2013, JPN J OPHTHALMOL, V57, P497, DOI 10.1007/s10384-013-0268-2; Chee SP, 2011, AM J OPHTHALMOL, V152, P449, DOI 10.1016/j.ajo.2011.03.003; Kobayashi A, 2012, AM J OPHTHALMOL, V153, P445, DOI 10.1016/j.ajo.2011.07.026; Hwang YS, 2011, GRAEF ARCH CLIN EXP, V249, P103, DOI 10.1007/s00417-010-1510-y; Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053; Koizumi N, 2006, AM J OPHTHALMOL, V141, P564, DOI 10.1016/j.ajo.2005.09.021; Singh K, 2004, CORNEA, V23, P400, DOI 10.1097/00003226-200405000-00017; Miyanaga M, 2010, BRIT J OPHTHALMOL, V94, P336, DOI 10.1136/bjo.2008.156422; Anshu A, 2009, OPHTHALMOLOGY, V116, P624, DOI 10.1016/j.ophtha.2008.10.031; Chee SP, 2012, GRAEF ARCH CLIN EXP, V250, P383, DOI 10.1007/s00417-011-1813-7; Chee SP, 2007, OPHTHALMOLOGY, V114, P798, DOI 10.1016/j.ophtha.2006.07.057; Chu HY, 2012, BRIT J OPHTHALMOL, V96, P300, DOI 10.1136/bjo.2010.182378; Kandori M, 2010, OPHTHALMOLOGY, V117, P216, DOI 10.1016/j.ophtha.2009.06.059; KHODADOUST AA, 1982, AM J OPHTHALMOL, V93, P718; Lusthaus JA, 2011, CORNEA, V30, P1054, DOI 10.1097/ICO.0b013e3182120f73; Maudgal P C, 1980, Bull Soc Belge Ophtalmol, V190, P71; OHASHI Y, 1985, ARCH OPHTHALMOL-CHIC, V103, P1666; ROBIN JB, 1985, AM J OPHTHALMOL, V100, P336; Shimazaki J, 2010, EYE, V24, P1105, DOI 10.1038/eye.2009.240; Shiraishi A, 2007, AM J OPHTHALMOL, V143, P715, DOI 10.1016/j.ajo.2006.11.026; Suzuki T, 2007, CORNEA, V26, P370, DOI 10.1097/ICO.0b013e31802d82fa; Suzuki T, 2008, SEMIN OPHTHALMOL, V23, P235; Yamauchi Y, 2007, OCUL IMMUNOL INFLAMM, V15, P399, DOI 10.1080/09273940701486795; Zheng XD, 2000, INVEST OPHTH VIS SCI, V41, P377	25	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JAN	2015	99	1					54	58				5	Ophthalmology	Ophthalmology	AW6CW	WOS:000346358000012		
J	Ogura, Y; Terasaki, H; Gomi, F; Yuzawa, M; Iida, T; Honda, M; Nishijo, K; Sowade, O; Komori, T; Schmidt-Erfurth, U; Simader, C; Chong, V				Ogura, Yuichiro; Terasaki, Hiroko; Gomi, Fumi; Yuzawa, Mitsuko; Iida, Tomohiro; Honda, Miki; Nishijo, Koichi; Sowade, Olaf; Komori, Tetsushi; Schmidt-Erfurth, Ursula; Simader, Christian; Chong, Victor		VIEW 2 Investigators	Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; EXTEND-I; RANIBIZUMAB; NEOVASCULARIZATION; BEVACIZUMAB; POPULATION; PREVALENCE; EYE	Background/aims To evaluate efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with wet age-related macular degeneration (wAMD) from the VIEW 2 trial. Methods In this double-masked study, patients were randomised to: 0.5 mg IVT-AFL every 4 weeks (0.5q4); 2 mg IVT-AFL every 4 weeks (2q4); 2 mg IVT-AFL every 8 weeks (2q8) after 3 monthly injections; or 0.5 mg ranibizumab every 4 weeks (Rq4). Main efficacy outcomes included vision maintenance and best-corrected visual acuity (BCVA) at week 52. Results At week 52, all Japanese patients in the IVTAFL groups (n=70) maintained vision, compared with 96% of Japanese patients (n=23/24) treated with ranibizumab. Japanese patients in all treatment groups showed improvement in BCVA after treatment. The Rq4, 2q4 and 2q8 groups experienced similar gains in BCVA from baseline. The 0.5q4 group had higher gains due to an unexpected drop in BCVA between screening and baseline. Central retinal thickness and mean area of choroidal neovascularisation decreased in all treatment groups with similar magnitude. Ocular treatment-emergent adverse events were balanced across treatment groups. Conclusions IVT-AFL was effective and well tolerated in Japanese patients. Outcomes in this population were consistent with those in the overall VIEW 2 population.	[Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678602, Japan; [Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Gomi, Fumi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Yuzawa, Mitsuko] Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan; [Honda, Miki] Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Chiba, Japan; [Nishijo, Koichi; Komori, Tetsushi] Bayer Yakuhin Ltd, Osaka, Japan; [Sowade, Olaf] Bayer HealthCare Pharmaceut, Berlin, Germany; [Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria; [Simader, Christian] Med Univ Vienna, Vienna Reading Ctr VRC, Vienna, Austria; [Chong, Victor] Univ Oxford, Oxford Eye Hosp, Oxford, England	Ogura, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678602, Japan.	vitreous.surgeon@gmail.com		Chong, Victor/0000-0002-7693-522X	HealthCare Pharmaceuticals, Berlin, Germany; Regeneron Pharmaceuticals, Inc. Tarrytown, New York, USA	The VIEW 2 study was supported by Bayer HealthCare Pharmaceuticals, Berlin, Germany, and Regeneron Pharmaceuticals, Inc. Tarrytown, New York, USA.	Saito M, 2012, RETINA-J RET VIT DIS, V32, P1250, DOI 10.1097/IAE.0b013e318236e503; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Tano Y, 2011, ACTA OPHTHALMOL, V89, P208, DOI 10.1111/j.1755-3768.2010.02065.x; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Kawasaki R, 2011, OPHTHAL EPIDEMIOL, V18, P253, DOI 10.3109/09286586.2011.602505; Matsumiya W, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-10; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Suzuki M, 2010, JPN J OPHTHALMOL, V54, P124, DOI 10.1007/s10384-009-0775-3; Tano Y, 2010, ACTA OPHTHALMOL, V88, P309, DOI 10.1111/j.1755-3768.2009.01843.x	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JAN	2015	99	1					92	97		10.1136/bjophthalmol-2014-305076		6	Ophthalmology	Ophthalmology	AW6CW	WOS:000346358000019		
J	Okada, H; Maru, M; Maeda, R; Iwasaki, F; Nagasawa, M; Takahashi, M				Okada, Hiromi; Maru, Mitsue; Maeda, Rumi; Iwasaki, Fuminori; Nagasawa, Masayuki; Takahashi, Miyako			Impact of Childhood Cancer on Maternal Employment in Japan	CANCER NURSING			English	Article						Childhood cancer; Maternal employment; Social support; Stress; Work motivation	PEDIATRIC CANCER; SOCIAL SUPPORT; POSTTRAUMATIC STRESS; ADOLESCENT SURVIVORS; CHILDREN; PARENTS; ADJUSTMENT; MOTHERS; DISTRESS; FAMILIES	Background: Family members of children with cancer experience various long-term effects as a result of cancer diagnosis and treatment. Therefore, comprehensive and long-term support is needed. As the employment rate of women has increased in recent years, support for working mothers with children diagnosed with cancer is also required. Objective: We investigated the following issues and relevant changes that working mothers of children diagnosed with cancer must deal with: (1) work change, (2) stress, (3) social support, (4) work motivation, and (5) employment status after diagnosis. Methods: A cross-sectional exploratory study design was used. Data were collected from 62 mothers of children who were diagnosed with cancer using self-report questionnaires. Results: Of the 32 mothers who worked at the time of diagnosis, 10 continued to work, 12 took an extended leave, and 10 quit working, and 70% lost motivation for work following diagnosis. Half of mothers who continued to work during treatment reported financial reasons. Conclusions: These findings indicate that mothers who quit work following diagnosis did not initially consider a long leave of absence. Even mothers who continued to work during treatment desired a long leave of absence to care for their children. Implications for Practice: Nurses should provide mothers with explanations of the prospects after the completion of cancer treatment and determine their expectations for their lifestyle and work during treatment. We recommend that nurses confirm mothers' willingness to take a long leave of absence from work and give relevant advice about seeking financial assistance.	[Okada, Hiromi; Maru, Mitsue; Maeda, Rumi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo 1138519, Japan; [Iwasaki, Fuminori] Kanagawa Childrens Med Ctr, Div Hematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Nagasawa, Masayuki] Tokyo Med & Dent Univ, Dept Pediat, Tokyo 1138519, Japan; [Takahashi, Miyako] Natl Canc Ctr, Div Canc Survivorship Res, Tokyo 104, Japan	Okada, H (reprint author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	ohiromi0912@gmail.com			Ministry of Health, Labour and Welfare, Japan: Building a Comprehensive Employment Support System for Working Patients With Cancer and Their Family Members [H22-Ippan-008]	This study was supported by Grant-in-Aid for Cancer Research (H22-Ippan-008) from the Ministry of Health, Labour and Welfare, Japan: Building a Comprehensive Employment Support System for Working Patients With Cancer and Their Family Members (principal investigator: Dr Takahashi).	Hoekstra-Weebers JEHM, 2001, J PEDIATR PSYCHOL, V26, P225, DOI 10.1093/jpepsy/26.4.225; Heath JA, 2006, PEDIATR HEMAT ONCOL, V23, P439, DOI 10.1080/08880010600692526; Latham GP, 2005, ANNU REV PSYCHOL, V56, P485, DOI 10.1146/annurev.psych.55.090902.142105; Limburg H, 2008, PEDIATR BLOOD CANCER, V51, P93, DOI 10.1002/pbc.21448; Sloper P, 2000, J PEDIATR PSYCHOL, V25, P79, DOI 10.1093/jpepsy/25.2.79; Eiser C, 2007, CHILD CARE HLTH DEV, V33, P455, DOI 10.1111/j.1365-2214.2006.00710.x; Ozono S, 2007, SUPPORT CARE CANCER, V15, P309, DOI 10.1007/s00520-006-0139-1; Miedema B, 2008, CURR ONCOL, V15, P173; Dolgin MJ, 2007, J PEDIATR PSYCHOL, V32, P771, DOI 10.1093/jpepsy/jsm013; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Aung L, 2012, ANN ACAD MED SINGAP, V41, P170; Thyen U, 1999, PEDIATRICS, V103, P1235, DOI 10.1542/peds.103.6.1235; Barrera M, 2005, CANCER, V104, P1751, DOI 10.1002/cncr.21390; Wakefield CE, 2011, PEDIATR BLOOD CANCER, V56, P524, DOI 10.1002/pbc.22725; Barrera M, 2004, PSYCHO-ONCOL, V13, P630, DOI 10.1002/pon.765; Centers for Disease Control and Prevention, 2004, NAT ACT PLAN CANC SU, P1; Pedro ICDS, 2008, REV LAT-AM ENFERM, V16, P477, DOI 10.1590/S0104-11692008000300023; Fujiwara C, 2004, J JPN SOC CHILD HLTH, V13, P40; Han HR, 2003, J ADV NURS, V44, P499, DOI 10.1046/j.0309-2402.2003.02833.x; Ishida Y, 2010, J JPN PEDIAT SOC, V114, P665; Kobayashi K, 2008, J JPN SOC PEDIAT ONO, V3, P45; Madan-Swain A, 2000, J PEDIATR PSYCHOL, V25, P105, DOI 10.1093/jpepsy/25.2.105; Maru M, 2001, J CHILD HLTH, V60, P787; Meiji Yasuda Institute of Life and Wellness, 2007, ATT SURV LIF DES MAR, P21; Mizuno T, 2003, J JPN SOC CHILD HLTH, V12, P8; Mori M, 2007, J JPN SOC PEDIAT ONO, V2, P27; MORROW GR, 1984, J PEDIATR PSYCHOL, V9, P317, DOI 10.1093/jpepsy/9.3.317; Mutoh T, 2012, GAKUBUNNSYA, P82; Nakamura M, 1997, J JAPAN ACAD NURSING, V17, P40; Nara Prefecture, 2010, SURV WOM ATT WORK, P173; National Institute of Population and Social Security Research, 2008, 4 NATL SURVEY FAMILY, V27, P26; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Patel SK, 2012, PSYCHOONCOLOGY; Patistea E, 2000, EUR J CANCER CARE, V9, P86, DOI 10.1046/j.1365-2354.2000.00204.x; Steele RG, 2003, J PEDIATR PSYCHOL, V28, P447, DOI 10.1093/jpepsy/jsg035; Syse A, 2011, CANCER EPIDEMIOL, V35, P298, DOI 10.1016/j.canep.2010.08.002; The Japan Institute for Labour Policy and Training, 2010, 122 JILPT; VANDONGENMELMAN JEWM, 1995, J PEDIATR PSYCHOL, V20, P567, DOI 10.1093/jpepsy/20.5.567; Yamada Etsuko, 2005, Journal of UOEH, V27, P41	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0162-220X	1538-9804		CANCER NURS	Cancer Nurs.	JAN-FEB	2015	38	1					23	30		10.1097/NCC.0000000000000123		8	Oncology; Nursing	Oncology; Nursing	AW3BU	WOS:000346161400009		
J	Daidoji, H; Takahashi, H; Otaki, Y; Tamura, H; Arimoto, T; Shishido, T; Miyashita, T; Miyamoto, T; Watanabe, T; Kubota, I				Daidoji, Hyuma; Takahashi, Hiroki; Otaki, Yoichiro; Tamura, Harutoshi; Arimoto, Takanori; Shishido, Tetsuro; Miyashita, Takehiko; Miyamoto, Takuya; Watanabe, Tetsu; Kubota, Isao			A Combination of Plaque Components Analyzed by Integrated Backscatter Intravascular Ultrasound and Serum Pregnancy-Associated Plasma Protein A Levels Predict the No-Reflow Phenomenon During Percutaneous Coronary Intervention	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						no-reflow phenomenon; integrated backscatter intravascular ultrasound; pregnancy-associated plasma protein A	ACUTE MYOCARDIAL-INFARCTION; VIRTUAL HISTOLOGY; DISTAL PROTECTION; PROGNOSTIC VALUE; IMPACT; DISEASE; IVUS	AimsPrevious studies reported that integrated backscatter intravascular ultrasound (IB-IVUS) provides high diagnostic accuracy for tissue characterization of coronary plaques and that pregnancy-associated plasma protein A (PAPP-A) could be a marker of adverse cardiac outcome in patients with cardiovascular disease. We examined whether IB-IVUS and PAPP-A levels could predict the incidence of no-reflow during percutaneous coronary intervention (PCI) Methods and ResultsAbout 176 consecutive patients (138 men, mean age 6811 years) who underwent PCI with IB-IVUS were prospectively enrolled. Combined no-reflow, including transient filter no-reflow by using distal protection devices, was observed in 31 patients. The percentages of coronary lipid volume (%LV) analyzed by IB-IVUS and serum PAPP-A were significantly higher in patients with combined no-reflow than normal-reflow. To predict no-reflow, a receiver operating characteristic (ROC) analysis determined cut-off values of %LV as 62% and serum PAPP-A as 7.71 ng/mL. The multivariate logistic regression analysis showed that %LV (hazard ratio 4.5, 95% confidence interval 1.6-13.4, P<0.01) and PAPP-A (hazard ratio 4.32, 95% confidence interval 1.5-12.7, P<0.01) were independent predictors of combined no-reflow Conclusions%LV analyzed by IB-IVUS and serum PAPP-A levels were closely associated with the coronary no-reflow phenomenon. (c) 2014 Wiley Periodicals, Inc.	[Daidoji, Hyuma; Takahashi, Hiroki; Otaki, Yoichiro; Tamura, Harutoshi; Arimoto, Takanori; Shishido, Tetsuro; Miyashita, Takehiko; Miyamoto, Takuya; Watanabe, Tetsu; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan	Takahashi, H (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan.	hitakaha@med.id.yamagata-u.ac.jp					Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Kelbaek H, 2008, J AM COLL CARDIOL, V51, P899, DOI 10.1016/j.jacc.2007.10.047; Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034; Iwakura K, 2006, EUR HEART J, V27, P534, DOI 10.1093/eurheartj/ehi715; Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Porto I, 2006, INT J CARDIOL, V109, P53, DOI 10.1016/j.ijcard.2005.05.071; Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822; Miyamoto Y, 2011, JACC-CARDIOVASC IMAG, V4, P638, DOI 10.1016/j.jcmg.2011.03.014; ELLIS SG, 1990, CIRCULATION, V82, P1193; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; Ndrepepa G, 2010, CIRC-CARDIOVASC INTE, V3, P27, DOI 10.1161/CIRCINTERVENTIONS.109.896225; Bayes-Genis A, 2000, CIRC RES, V86, P125; Elesber AA, 2006, EUR HEART J, V27, P1678, DOI 10.1093/eurheartj/ehl042; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Endo M, 2010, JACC-CARDIOVASC INTE, V3, P540, DOI 10.1016/j.jcin.2010.01.015; Iversen KK, 2011, ATHEROSCLEROSIS, V214, P203, DOI 10.1016/j.atherosclerosis.2010.10.025; Rossen M, 2007, CLIN BIOCHEM, V40, P478, DOI 10.1016/j.clinbiochem.2006.11.025; The TIMI IIIB Investigators, 1994, CIRCULATION, V89, P545	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	JAN 1	2015	85	1					43	50		10.1002/ccd.25294		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW7ZI	WOS:000346479900015		
J	Hirata, Y				Hirata, Yoshihiro			Theoretical analyses of thermal shock and thermal expansion coefficients of metals and ceramics	CERAMICS INTERNATIONAL			English	Article						Thermal expansion; Thermal properties; Thermal shock resistance	DOPED CERIA CERAMICS	The theoretical expression for the critical flux (I-f) of energy input to fracture a solid material was derived using available material parameters. The I-f value becomes larger in the material with larger kappa (thermal conductivity) and K-IC (fracture toughness) values and smaller beta (thermal expansion coefficient), E (Young's modulus), a (size of fracture origin) and x (thickness of material). The following useful relationship was also derived for beta, E and C-p (heat capacity at a constant pressure): beta=C-p/3E. This relation agreed with the experimentally measured beta value in the material with a low Debye temperature and a small temperature dependence of Young's modulus at a high temperature. The theoretical equation representing the temperature dependence of beta value was derived. This equation gives the interpretation that the gradual increase of the measured beta value is due to the decrease of Young's modulus at a high temperature. Further discussion provided a more accurate equation which does not contain a Young's modulus and is composed of C-v (heat capacity at a constant volume), C-p, nu (Poisson's ratio) and temperature. A very good agreement was observed between the measured and calculated beta values of some metals. It was also found that the measured beta of alumina ceramics was very close to the average value calculated using Young's modulus in each direction of single crystal Al2O3. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan	Hirata, Y (reprint author), Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	hirata@apc.kagoshima-u.ac.jp					Sameshima S, 1999, MATER CHEM PHYS, V61, P31, DOI 10.1016/S0254-0584(99)00109-1; Hirata Y, 2009, CERAM INT, V35, P2921, DOI 10.1016/j.ceramint.2009.03.038; Hirata Y, 2009, CERAM INT, V35, P3259, DOI 10.1016/j.ceramint.2009.05.026; Asby M.F., 1980, ENG MAT, P75; Courtney T. H., 1990, MECH BEHAV MAT, P46; Davis R.F., 1971, MULLITE HIGH TEMP OX, P37; Hashiguchi T., 2004, T MAT RES SOC JPN, V29, P3461; HASSELMA.DP, 1970, J AM CERAM SOC, V53, P490, DOI 10.1111/j.1151-2916.1970.tb15997.x; HASSELMA.PH, 1969, J AM CERAM SOC, V52, P600, DOI 10.1111/j.1151-2916.1969.tb15848.x; Hata K., 1984, CHEM HDB BASIC 2, P21; Hirata Y., 2000, P 9 S REFR AL IND MI, P95; Kingery W.D., 1976, INTRO CERAMICS, P583; Nagasaki S., 1984, METAL HDB, P12; Nakamura T., 1985, CERAMIC SCI SERIES, P25; Nakazono T., 2004, T MAT RES SOC JPN, V29, P3465; Nye J. F., 1985, PHYS PROPERTIES CRYS, P131; Sameshima S, 2002, J CERAM SOC JPN, V110, P597, DOI 10.2109/jcersj.110.597; Sameshita S, 2000, J CERAM SOC JPN, V108, P985, DOI 10.2109/jcersj.108.1263_985; Swalin R.A., 1972, THERMDYNAMICS SOLIDS, V2n, P53	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	JAN	2015	41	1	B				1145	1153		10.1016/j.ceramint.2014.09.042		9	Materials Science, Ceramics	Materials Science	AW3XM	WOS:000346216500034		
J	Kobayashi, R; Oh-Ishi, K; Tu, R; Goto, T				Kobayashi, Ryota; Oh-Ishi, Katsuyoshi; Tu, Rong; Goto, Takashi			Sintering behavior, microstructure, and thermal conductivity of dense AIM ceramics processed by spark plasma sintering with Y2O3-CaO-B additives	CERAMICS INTERNATIONAL			English	Article						Thermal conductivity; Aluminum nitride; SPS; Ceramics; Densification	ALUMINUM NITRIDE; ALN CERAMICS; CONSOLIDATION	We fabricated dense aluminum nitride ceramics by spark plasma sintering (SPS) with Y2O3-CaO-B sintering additives and evaluated their microstructures and thermal conductivities. Samples were perfectly densified after 5 min of SPS at 1650 or 1600 degrees C, or 10 min at 1550 degrees C and had the microstructures. Thermal conductivities of the samples were 80-90 W m(-1) K-1 and tended to increase with increasing sintering temperature. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Kobayashi, Ryota] Tokyo City Univ, Fac Engn, Dept Chem & Energy Engn, Setagaya Ku, Tokyo 1588557, Japan; [Oh-Ishi, Katsuyoshi] Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1128551, Japan; [Tu, Rong; Goto, Takashi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kobayashi, R (reprint author), Tokyo City Univ, Fac Engn, Dept Chem & Energy Engn, Setagaya Ku, 1-28-1 Tamazutsumi, Tokyo 1588557, Japan.	rkobaya@tcu.ac.jp			Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP), Japan Science and Technology Agency (JST), Japan [A5231Z01267C]	This work was partly supported by the Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP), Japan Science and Technology Agency (JST), Japan (No. A5231Z01267C).	SLACK GA, 1973, J PHYS CHEM SOLIDS, V34, P321, DOI 10.1016/0022-3697(73)90092-9; TROCZYNSKI TB, 1989, J AM CERAM SOC, V72, P1488, DOI 10.1111/j.1151-2916.1989.tb07684.x; Munir ZA, 2011, J AM CERAM SOC, V94, P1, DOI 10.1111/j.1551-2916.2010.04210.x; VIRKAR AV, 1989, J AM CERAM SOC, V72, P2031, DOI 10.1111/j.1151-2916.1989.tb06027.x; Ohyanagi M, 2004, SCRIPTA MATER, V50, P111, DOI 10.1016/j.scriptamat.2003.09.027; Watari K, 1999, J MATER RES, V14, P1409, DOI 10.1557/JMR.1999.0191; NISHIMURA T, 1995, J MATER SCI LETT, V14, P1046, DOI 10.1007/BF00258160; Kasori M, 1998, CERAM TRANS, V83, P485; Khor KA, 2005, J EUR CERAM SOC, V25, P1057, DOI 10.1016/j.jeurceramsoc.2003.12.020; Kingery W. D., 1960, INTRO CERAMICS; Kobayashi R, 2011, J CERAM SOC JPN, V119, P291, DOI 10.2109/jcersj2.119.291; Kobayashi R, 2008, J AM CERAM SOC, V91, P1548, DOI 10.1111/j.1551-2916.2008.02307.x; Kobayashi R, 2011, J AM CERAM SOC, V94, P4150, DOI 10.1111/j.1551-2916.2011.04901.x; Komeya K., 1981, Yogyo-Kyokai-Shi, V89; LONG G, 1959, J AM CERAM SOC, V42, P53, DOI 10.1111/j.1151-2916.1959.tb14066.x; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; Qiao L, 2003, MAT SCI ENG B-SOLID, V99, P102, DOI 10.1016/S0921-5107(02)00429-4; Shinozald K., 1986, B CERAM SOC JPN, V21, P1130; Watari K, 1996, J AM CERAM SOC, V79, P3103, DOI 10.1111/j.1151-2916.1996.tb08083.x	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	JAN	2015	41	1	B				1897	1901		10.1016/j.ceramint.2014.09.040		5	Materials Science, Ceramics	Materials Science	AW3XM	WOS:000346216500123		
J	Kim, IY; Koichi, K; Ohtsuki, C				Kim, Ill Yong; Koichi, Kikuta; Ohtsuki, Chikara			Hydroxyapatite formation through dissolution-precipitation reaction: Effects of solubility of starting materials (vol 40, pg 14385, 2014)	CERAMICS INTERNATIONAL			English	Correction									[Kim, Ill Yong; Koichi, Kikuta; Ohtsuki, Chikara] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kim, IY (reprint author), Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, B2-3 611 Furo Cho, Nagoya, Aichi 4648603, Japan.	kim.ill-yong@apchem.nagoya-u.ac.jp	Ohtsuki, Chikara/E-4973-2010				Kim IY, 2014, CERAM INT, V40, P14385, DOI 10.1016/j.ceramint.2014.06.031	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	JAN	2015	41	1	B				1927	1928		10.1016/j.ceramint.2014.09.004		2	Materials Science, Ceramics	Materials Science	AW3XM	WOS:000346216500129		
J	Koch, E; Takise, R; Studer, A; Yamaguchi, J; Itami, K				Koch, Eva; Takise, Ryosuke; Studer, Armido; Yamaguchi, Junichiro; Itami, Kenichiro			Ni-Catalyzed alpha-arylation of esters and amides with phenol derivatives	CHEMICAL COMMUNICATIONS			English	Article							C-O BOND; ARYL HALIDES; NICKEL CATALYSIS; ACID-DERIVATIVES; SUZUKI-MIYAURA; OXINDOLES; AZOLES; CLEAVAGE; CARBONYL; CHLOROARENES	A nickel-catalyzed alpha-arylation of esters and amides with phenol derivatives has been accomplished. In the presence of our unique nickel catalyst, prepared in situ from Ni(cod)(2), 3,4-bis(dicyclohexyl-phosphino) thiophene (dcypt), and K3PO4, various esters and amides undergo alpha-arylation with O-arylpivalates or O-arylcarbamates to afford the corresponding coupling products. The thus obtained alpha-aryl esters and amides are useful precursors of privileged motifs such as alpha-arylcarboxylic acids and beta-arylamines.	[Koch, Eva; Studer, Armido] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Takise, Ryosuke; Yamaguchi, Junichiro; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Takise, Ryosuke; Yamaguchi, Junichiro; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Itami, Kenichiro] Nagoya Univ, Itami Mol Nanocarbon Project, JST,ERATO, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Yamaguchi, J (reprint author), Nagoya Univ, Grad Sch Sci, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	junichiro@chem.nagoya-u.ac.jp; itami@chem.nagoya-u.ac.jp	Itami, Kenichiro/B-5110-2011; Yamaguchi, Junichiro/D-4198-2009	Yamaguchi, Junichiro/0000-0002-3896-5882	JSPS [220GR049]; MEXT [25105720, 25708005]; International Research Training Group Munster/Nagoya; World Premier International Research Center (WPI) Initiative, Japan	This work was supported by the Funding Program for Next Generation World-Leading Researchers from JSPS (220GR049 to K.I.), a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis'' (25105720 to J.Y.), and KAKENHI (25708005 to J.Y.) from MEXT. E.K. thanks the International Research Training Group Munster/Nagoya for support. ITbM is supported by the World Premier International Research Center (WPI) Initiative, Japan.	Hama T, 2008, ORG LETT, V10, P1549, DOI 10.1021/ol800258u; Meng LK, 2013, ANGEW CHEM INT EDIT, V52, P10048, DOI 10.1002/anie.201304492; Takise R, 2014, ANGEW CHEM INT EDIT, V53, P6791, DOI 10.1002/anie.201403823; Durbin MJ, 2008, ORG LETT, V10, P1413, DOI 10.1021/ol800141t; Zarate C, 2014, J AM CHEM SOC, V136, P2236, DOI 10.1021/ja412107b; Bellina F, 2010, CHEM REV, V110, P1082, DOI 10.1021/cr9000836; Taylor AM, 2009, J AM CHEM SOC, V131, P9900, DOI 10.1021/ja903880q; Gaertzen O, 2002, J ORG CHEM, V67, P465, DOI 10.1021/jo0107756; Nguyen HN, 2003, J AM CHEM SOC, V125, P11818, DOI 10.1021/ja036947t; Spielvogel DJ, 2002, J AM CHEM SOC, V124, P3500, DOI 10.1021/ja017545t; Muto K, 2012, J AM CHEM SOC, V134, P169, DOI 10.1021/ja210249h; Ackermann L, 2009, ORG LETT, V11, P4274, DOI 10.1021/ol901597d; Moradi WA, 2001, J AM CHEM SOC, V123, P7996, DOI 10.1021/ja010797+; Hama T, 2008, ORG LETT, V10, P1545, DOI 10.1021/ol8002578; Johansson CCC, 2010, ANGEW CHEM INT EDIT, V49, P676, DOI 10.1002/anie.200903424; Xu HY, 2014, J AM CHEM SOC, V136, P14834, DOI [10.1021/ja5071174, 10.1021/ja50711741]; Satoh T, 1998, B CHEM SOC JPN, V71, P2239, DOI 10.1246/bcsj.71.2239; Yu DG, 2011, ANGEW CHEM INT EDIT, V50, P7097, DOI 10.1002/anie.201101461; Shaughnessy KH, 1998, J ORG CHEM, V63, P6546, DOI 10.1021/jo980611y; Culkin DA, 2003, ACCOUNTS CHEM RES, V36, P234, DOI 10.1021/ar0201106; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Hama T, 2006, J AM CHEM SOC, V128, P4976, DOI 10.1021/ja056076i; Muto K, 2013, J AM CHEM SOC, V135, P16384, DOI 10.1021/ja409803x; Amaike K, 2012, J AM CHEM SOC, V134, P13573, DOI 10.1021/ja306062c; Zheng B, 2014, ADV SYNTH CATAL, V356, P165, DOI 10.1002/adsc.201300851; Jorgensen M, 2002, J AM CHEM SOC, V124, P12557, DOI 10.1021/ja027643u; Yip SF, 2007, ORG LETT, V9, P3469, DOI 10.1021/ol701473p; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Peng B, 2014, ANGEW CHEM INT EDIT, V53, P5462, DOI 10.1002/anie.201402229; [Anonymous], 2008, CHEM COMMUN; Lee S, 2001, J ORG CHEM, V66, P3402, DOI 10.1021/jo005761z; Correa A, 2014, J AM CHEM SOC, V136, P1062, DOI 10.1021/ja410883p; Novak P, 2011, CURR ORG CHEM, V15, P3233; Beare NA, 2002, J ORG CHEM, V67, P541, DOI 10.1021/jo016226h; Lee S, 2001, J AM CHEM SOC, V123, P8410, DOI 10.1021/ja016032j; Bercot EA, 2008, ORG LETT, V10, P5251, DOI 10.1021/ol8021758; Cornella J, 2014, CHEM SOC REV, V43, P8081, DOI 10.1039/c4cs00206g; Jiang L, 2009, ORG LETT, V11, P1543, DOI 10.1021/ol900131q; Quasdorf, 2011, J AM CHEM SOC, V133, P6352; Sole D, 2008, J ORG CHEM, V73, P2476, DOI 10.1021/jo800034m; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Yamaguchi J, 2013, EUR J ORG CHEM, P19, DOI 10.1002/ejoc.201200914	42	10	10	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	5					855	857		10.1039/c4cc08426h		3	Chemistry, Multidisciplinary	Chemistry	AW6XK	WOS:000346408800008		
J	Tao, J; Song, PS; Sato, Y; Nishizawa, S; Teramae, N; Tong, AJ; Xiang, Y				Tao, Jing; Song, Panshu; Sato, Yusuke; Nishizawa, Seiichi; Teramae, Norio; Tong, Aijun; Xiang, Yu			A label-free and sensitive fluorescent method for the detection of uracil-DNA glycosylase activity	CHEMICAL COMMUNICATIONS			English	Article							BASE-EXCISION-REPAIR; ABASIC SITE; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; MOLECULAR BEACON; ENZYME-ACTIVITY; ASSAY; REMOVAL; PROBES; AMPLIFICATION	The activity of uracil-DNA glycosylase (UDG), an enzyme in the base excision repair, is detected at a high sensitivity by a DNA substrate containing only one uracil through a label-free fluorescent approach, which is also successfully applied for the measurement of UDG inhibitors.	[Tao, Jing; Tong, Aijun; Xiang, Yu] Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Dept Chem,Minist Educ, Beijing 100084, Peoples R China; [Song, Panshu] Natl Inst Metrol, Beijing 100029, Peoples R China; [Sato, Yusuke; Nishizawa, Seiichi; Teramae, Norio] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Xiang, Y (reprint author), Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Dept Chem,Minist Educ, Beijing 100084, Peoples R China.	xiang-yu@tsinghua.edu.cn			National Natural Science Foundation of China [2142200199, 21390410, 21375074]; National Key Scientific Instrument and Equipment Development Project [2012YQ030111]; Tsinghua University Initiative Scientific Research Program [20131089220]; Recruitment Program of Global Youth Experts of China	We acknowledge the financial support from the National Natural Science Foundation of China (No. 2142200199, 21390410 and 21375074), the National Key Scientific Instrument and Equipment Development Project (No 2012YQ030111), the Tsinghua University Initiative Scientific Research Program (No. 20131089220), and the Recruitment Program of Global Youth Experts of China.	Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; Ono T, 2012, ANGEW CHEM INT EDIT, V51, P1689, DOI 10.1002/anie.201108135; Xiang Y, 2010, ANAL CHEM, V82, P4122, DOI 10.1021/ac100244h; Zhao CQ, 2011, CHEM COMMUN, V47, P5461, DOI 10.1039/c1cc11396h; Yoshimoto K, 2003, J AM CHEM SOC, V125, P8982, DOI 10.1021/ja029786m; Stivers JT, 1998, NUCLEIC ACIDS RES, V26, P3837, DOI 10.1093/nar/26.16.3837; Leung CH, 2013, CHEM SCI, V4, P3781, DOI 10.1039/c3sc51228b; Sato Y, 2012, ANGEW CHEM INT EDIT, V51, P6369, DOI 10.1002/anie.201201790; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Zhang H, 2013, ANAL SCI, V29, P193; Leung KH, 2013, CHEM COMMUN, V49, P5630, DOI 10.1039/c3cc41129j; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Nguyen VT, 2012, TALANTA, V100, P303, DOI 10.1016/j.talanta.2012.07.065; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Xiang Y, 2009, J AM CHEM SOC, V131, P15352, DOI 10.1021/ja905854a; Ma DL, 2013, CHEM SOC REV, V42, P3427, DOI 10.1039/c2cs35472a; Song PS, 2012, ANAL CHEM, V84, P2916, DOI 10.1021/ac203488p; Ihara T, 2009, J AM CHEM SOC, V131, P1386, DOI 10.1021/ja809023n; Xiang Y, 2012, ANAL CHEM, V84, P9981, DOI 10.1021/ac302424f; Zhang LL, 2012, CHEM COMMUN, V48, P8820, DOI 10.1039/c2cc34531e; Zhou DM, 2013, BIOSENS BIOELECTRON, V41, P359, DOI 10.1016/j.bios.2012.08.053; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Liu B, 2007, ANAL BIOCHEM, V366, P237, DOI 10.1016/j.ab.2007.04.049; Hu D, 2011, CHEM-EUR J, V17, P1635, DOI 10.1002/chem.201001331; Anders CK, 2010, CLIN CANCER RES, V16, P4702, DOI 10.1158/1078-0432.CCR-10-0939; SEAL G, 1988, P NATL ACAD SCI USA, V85, P2339, DOI 10.1073/pnas.85.7.2339; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Bellamy SRW, 2007, NUCLEIC ACIDS RES, V35, P1478, DOI 10.1093/nar/gkm018; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Jiang YL, 2005, J AM CHEM SOC, V127, P17412, DOI 10.1021/ja055846n; KROKAN H, 1981, NUCLEIC ACIDS RES, V9, P2599, DOI 10.1093/nar/9.11.2599; Matsumoto N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq022; Xia LQ, 2001, ANAL BIOCHEM, V298, P322, DOI 10.1006/abio.2001.5400; Ono T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt309; Yang X, 2011, MOL CELL PROBE, V25, P219, DOI 10.1016/j.mcp.2011.09.001	37	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	5					929	932		10.1039/c4cc06170e		4	Chemistry, Multidisciplinary	Chemistry	AW6XK	WOS:000346408800025		
J	Nakata, E; Dinh, H; Ngo, TA; Saimura, M; Morii, T				Nakata, Eiji; Dinh, Huyen; Ngo, Tien Anh; Saimura, Masayuki; Morii, Takashi			A modular zinc finger adaptor accelerates the covalent linkage of proteins at specific locations on DNA nanoscaffolds	CHEMICAL COMMUNICATIONS			English	Article							NANOSTRUCTURES; ORIGAMI; NANOTECHNOLOGY; REACTIVITY; MOLECULES; SCAFFOLDS; COMPLEX	A modular adaptor consisting of a sequence-specific DNA binding zinc finger protein and a self-ligating protein-tag was developed to expedite efficient formation of a covalent linkage between an individual protein molecule and the programmed address modified with a tag-substrate on the DNA nanostructure.	[Nakata, Eiji; Dinh, Huyen; Ngo, Tien Anh; Saimura, Masayuki; Morii, Takashi] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan	Morii, T (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan.	t-morii@iae.kyoto-u.ac.jp	Nakata, Eiji/G-5523-2013	Nakata, Eiji/0000-0001-9564-6805	Ministry of Education, Culture, Sports, Science and Technology, Japan [24651150, 25248038]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan to E. N. (No. 24651150) and T. M. (No. 25248038).	Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931; Yoshidome T, 2012, J AM CHEM SOC, V134, P4654, DOI 10.1021/ja209023u; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Fu JL, 2012, ACCOUNTS CHEM RES, V45, P1215, DOI 10.1021/ar200295q; NIEMEYER CM, 1994, NUCLEIC ACIDS RES, V22, P5530, DOI 10.1093/nar/22.25.5530; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Niemeyer CM, 2010, ANGEW CHEM INT EDIT, V49, P1200, DOI 10.1002/anie.200904930; Rosen CB, 2014, NAT CHEM, V6, P804, DOI [10.1038/nchem.2003, 10.1038/NCHEM.2003]; Wei XX, 2014, ACCOUNTS CHEM RES, V47, P1861, DOI 10.1021/ar5000665; Nakata E, 2012, ANGEW CHEM INT EDIT, V51, P2421, DOI 10.1002/anie.201108199; Fu JL, 2014, NAT NANOTECHNOL, V9, P531, DOI [10.1038/nnano.2014.100, 10.1038/NNANO.2014.100]; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Endo M, 2009, CHEMBIOCHEM, V10, P2420, DOI 10.1002/cbic.200900286; Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/nnano.2009.50, 10.1038/NNANO.2009.50]; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Pei H, 2014, ACCOUNTS CHEM RES, V47, P550, DOI 10.1021/ar400195t; Rajendran A, 2012, ANGEW CHEM INT EDIT, V51, P874, DOI 10.1002/anie.201102113; Mollwitz B, 2012, BIOCHEMISTRY-US, V51, P986, DOI 10.1021/bi2016537; Fu YM, 2013, J AM CHEM SOC, V135, P696, DOI 10.1021/ja3076692; Wang ZG, 2014, ACCOUNTS CHEM RES, V47, P1654, DOI 10.1021/ar400305g; Endo M, 2013, BIOMATER SCI-UK, V1, P347, DOI 10.1039/c2bm00154c; Kuzuya A, 2010, NANOSCALE, V2, P310, DOI 10.1039/b9nr00246d; Liu MH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3127; Ngo TA, 2014, METHODS, V67, P142, DOI 10.1016/j.ymeth.2013.10.014	29	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	6					1016	1019		10.1039/c4cc08167f		4	Chemistry, Multidisciplinary	Chemistry	AW9GL	WOS:000346565300006		
J	Kettling, F; Vonhoren, B; Krings, JA; Saito, S; Ravoo, BJ				Kettling, Friederike; Vonhoeren, Benjamin; Krings, Jennifer A.; Saito, Susumu; Ravoo, Bart Jan			One-step synthesis of patterned polymer brushes by photocatalytic microcontact printing	CHEMICAL COMMUNICATIONS			English	Article							TRANSFER RADICAL POLYMERIZATION; INITIATED POLYMERIZATION; SURFACE; LITHOGRAPHY; NANOPARTICLES; CHEMISTRY; SUNLIGHT; LAYERS; LIGHT	A novel method to prepare microstructured polymer brushes using TiO2 nanoparticles and photocatalytic microcontact printing is described. It is shown that ethanol amine can be polymerized to linear polyethyleneimine (PEI) driven by the photocatalytic action of TiO2. Upon UV irradiation during microcontact printing of ethanol amine with a stamp coated with TiO2 nanoparticles, patterned polymer brushes with a length of around 50 nm are obtained.	[Kettling, Friederike; Vonhoeren, Benjamin; Krings, Jennifer A.; Ravoo, Bart Jan] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Saito, Susumu] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Saito, Susumu] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Ravoo, BJ (reprint author), Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	saito.susumu@f.mbox.nagoya-u.ac.jp; b.j.ravoo@uni-muenster.de	Saito, Susumu/E-9282-2012	Saito, Susumu/0000-0003-0749-2020	DFG [IRTG 1143]; European Regional Development Fund (ERDF); state of North Rhine-Westphalia, Germany, under the Operational Programme "Regional Competitiveness and Employment''	We thank the DFG (IRTG 1143 Munster-Nagoya) and the Sustainable Chemical Systems (SusChemSys) program cofinanced by the European Regional Development Fund (ERDF) and the state of North Rhine-Westphalia, Germany, under the Operational Programme "Regional Competitiveness and Employment'' (2007-2013) for funding.	SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025; Wendeln C, 2012, LANGMUIR, V28, P5527, DOI 10.1021/la204721x; Li B, 2014, MACROMOL RAPID COMM, V35, P1287, DOI 10.1002/marc.201400121; Rossi LM, 2005, LANGMUIR, V21, P4277, DOI 10.1021/la0504098; Dillon EP, 2008, ACS NANO, V2, P156, DOI 10.1021/nn7002713; Maillard D, 2011, NANO LETT, V11, P4569, DOI 10.1021/nl202651u; Kwon OH, 2003, BIOMATERIALS, V24, P1223; Wendeln C, 2010, LANGMUIR, V26, P15966, DOI 10.1021/la102966j; Yan JF, 2013, ACS MACRO LETT, V2, P592, DOI 10.1021/mz400237w; Perl A, 2009, ADV MATER, V21, P2257, DOI 10.1002/adma.200801864; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Ahn SJ, 2004, ADV MATER, V16, P2141, DOI 10.1002/adma.200401055; Prucker O, 1998, ADV MATER, V10, P1073, DOI 10.1002/(SICI)1521-4095(199810)10:14<1073::AID-ADMA1073>3.0.CO;2-D; Escobar CA, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400055; Han K, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/035010; Li XM, 2003, NANO LETT, V3, P1449, DOI 10.1021/nl034423l; Li XM, 2003, J AM CHEM SOC, V125, P4279, DOI 10.1021/ja0271431; Mizuno H, 2010, ACS APPL MATER INTER, V2, P2301, DOI 10.1021/am100348f; Morris CJ, 2011, LANGMUIR, V27, P6486, DOI 10.1021/la200374k; Rahn K, 1996, ANGEW MAKROMOL CHEM, V238, P143, DOI 10.1002/apmc.1996.052380113; Rodriguez-Emmenegger C, 2013, ADV MATER, V25, P6123, DOI 10.1002/adma.201302492; Roling O, 2014, ORG BIOMOL CHEM, V12, P7828, DOI 10.1039/c4ob01379d; Sidorenko A, 1999, LANGMUIR, V15, P8349, DOI 10.1021/la990869z; Snyder PW, 2007, J ORG CHEM, V72, P7459, DOI 10.1021/jo0711541; Spruell JM, 2008, ANGEW CHEM INT EDIT, V47, P9927, DOI 10.1002/anie.200803480; Xiao P, 2013, CHEM COMMUN, V49, P11167, DOI 10.1039/c3cc46037a; Zhang D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01399	28	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	6					1027	1030		10.1039/c4cc08646e		4	Chemistry, Multidisciplinary	Chemistry	AW9GL	WOS:000346565300009		
J	Yoshii, Y; Otsu, T; Hosokawa, N; Takasu, K; Okano, K; Tokuyama, H				Yoshii, Yu; Otsu, Takanori; Hosokawa, Norihiko; Takasu, Kiyosei; Okano, Kentaro; Tokuyama, Hidetoshi			Synthetic studies toward penitrem E: enantiocontrolled construction of B-E rings	CHEMICAL COMMUNICATIONS			English	Article							TREMORGENIC MYCO-TOXINS; SILYL ENOL ETHERS; CLAVICEPS-PASPALI STEVENS; PENICILLIUM-CRUSTOSUM; ABSOLUTE-CONFIGURATION; STRUCTURE ELUCIDATION; A-F; (-)-PASPALINE; BIOSYNTHESIS; CYCLOBUTANES	Enantiocontrolled construction of B-E rings of penitrem E was accomplished from 4-iodoindole in 13 steps with an overall yield of 1.7%. Diastereoselective Tf2NH-catalyzed (2+2)-cycloaddition between silyl enol ether and methyl acrylate furnished a tetracyclic product possessing the characteristic cyclobutane ring bearing a hydroxyl group.	[Yoshii, Yu; Otsu, Takanori; Hosokawa, Norihiko; Takasu, Kiyosei; Okano, Kentaro; Tokuyama, Hidetoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tokuyama, H (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Aoba 6-3, Sendai, Miyagi 9808578, Japan.	tokuyama@mail.pharm.tohoku.ac.jp	Okano, Kentaro/J-8165-2014	Okano, Kentaro/0000-0003-2029-8505	Cabinet Office, Government of Japan, through its "Funding Program for Next Generation World-Leading Researchers'' [LS008]; JSPS KAKENHI; JSPS predoctoral fellowship; Tohoku University Campus Asia Project;  [26253001];  [25460003];  [25105705]	This work was financially supported by the Cabinet Office, Government of Japan, through its "Funding Program for Next Generation World-Leading Researchers'' (LS008), the JSPS KAKENHI, and a Grant-in-Aid for Scientific Research (A) (26253001) for H.T., a Grant-in-Aid for Scientific Research (C) (25460003) and a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis'' (25105705) for K.O., and JSPS predoctoral fellowship and Tohoku University Campus Asia Project for Y.Y.	SMITH AB, 1990, J AM CHEM SOC, V112, P8197, DOI 10.1021/ja00178a071; CATELLANI M, 1994, ANGEW CHEM INT EDIT, V33, P2421; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; GRIECO PA, 1976, J ORG CHEM, V41, P1485, DOI 10.1021/jo00870a052; WILSON BJ, 1968, NATURE, V220, P77, DOI 10.1038/220077b0; SMITH AB, 1985, J AM CHEM SOC, V107, P1769, DOI 10.1021/ja00292a058; Inanaga K, 2004, J AM CHEM SOC, V126, P1352, DOI 10.1021/ja039808k; PAPPO R, 1956, J ORG CHEM, V21, P478, DOI 10.1021/jo01110a606; [Anonymous], 2000, J AM CHEM SOC; CAPUTO R, 1995, TETRAHEDRON, V51, P12337, DOI 10.1016/0040-4020(95)00778-7; SPRINGER JP, 1980, TETRAHEDRON LETT, V21, P231, DOI 10.1016/S0040-4039(00)71176-2; FEHR T, 1966, HELV CHIM ACTA, V49, P1907, DOI 10.1002/hlca.19660490626; Mathieu B, 1997, TETRAHEDRON LETT, V38, P5497, DOI 10.1016/S0040-4039(97)01208-2; Inanaga K, 2005, J AM CHEM SOC, V127, P3668, DOI 10.1021/ja042661s; Garcia-Urdiales E, 2005, CHEM REV, V105, P313, DOI 10.1021/cr040640a; SHARPLESS KB, 1975, J ORG CHEM, V40, P947, DOI 10.1021/jo00895a030; Lautens M, 2000, ANGEW CHEM INT EDIT, V39, P1045, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1045::AID-ANIE1045>3.0.CO;2-Q; Takasu K, 2004, J ORG CHEM, V69, P517, DOI 10.1021/jo034989u; SMITH AB, 1992, J AM CHEM SOC, V114, P1438, DOI 10.1021/ja00030a046; Enomoto M, 2012, ANGEW CHEM INT EDIT, V51, P12833, DOI 10.1002/anie.201206299; Catellani M, 2008, ACCOUNTS CHEM RES, V41, P1512, DOI 10.1021/ar800040u; SMITH AB, 1989, J AM CHEM SOC, V111, P5761, DOI 10.1021/ja00197a039; MEWSHAW RE, 1989, J ORG CHEM, V54, P3449, DOI 10.1021/jo00275a035; Ritter T, 2004, ORG LETT, V6, P1513, DOI 10.1021/ol049514j; Smith AB, 2003, J AM CHEM SOC, V125, P8228, DOI 10.1021/ja034842k; Okano K, 2012, HETEROCYCLES, V84, P1325, DOI 10.3987/COM-11-S(P)67; APPEL R, 1975, ANGEW CHEM INT EDIT, V14, P801, DOI 10.1002/anie.197508011; Catellani M, 2003, SYNLETT, P298, DOI 10.1055/s-2003-37102; DE JESUS AE, 1981, J CHEM SOC CHEM COMM, P289, DOI 10.1039/c39810000289; DE JESUS AE, 1982, J CHEM SOC CHEM COMM, P837, DOI 10.1039/c39820000837; DE JESUS AE, 1983, J CHEM SOC PERK T 1, P1847, DOI 10.1039/p19830001847; DOWD PF, 1988, J ANTIBIOT, V41, P1868; GALLAGHER RT, 1980, TETRAHEDRON LETT, V21, P235, DOI 10.1016/S0040-4039(00)71177-4; Gonzalez MC, 2003, J AGR FOOD CHEM, V51, P2156, DOI 10.1021/jf020983e; DE JESUS AE, 1983, J CHEM SOC PERK T 1, P1863, DOI 10.1039/p19830001863; Han-ya Y, 2011, ANGEW CHEM INT EDIT, V50, P4884, DOI 10.1002/anie.201100981; Hata K, 2014, ASIAN J ORG CHEM, V3, P706, DOI 10.1002/ajoc.201402042; Hayashi H., 1993, Chemistry Express, V8, P177; Hayashi H., 1998, Recent Research Developments in Agricultural & Biological Chemistry, V2, P511; Hendrickson JB, 2004, ORG LETT, V6, P3, DOI 10.1021/ol0354369; Ishihara K, 2001, SYNLETT, P1851; Lautens M, 2001, J ORG CHEM, V66, P8127, DOI 10.1021/jo0107296; Nagamoto Y, 2013, CHEM COMMUN, V49, P2622, DOI 10.1039/c3cc39246e; Rivkin A, 2004, J ORG CHEM, V69, P3719, DOI 10.1021/jo049873s; SELLS TB, 1994, TETRAHEDRON, V50, P117, DOI 10.1016/S0040-4020(01)80740-7; Siqueira FA, 2010, TETRAHEDRON LETT, V51, P2102, DOI 10.1016/j.tetlet.2010.02.011; DE JESUS AE, 1983, J CHEM SOC PERK T 1, P1857, DOI 10.1039/p19830001857; Takasu K, 2006, ORG SYNTH, V83, P193; Takasu K, 2008, J SYN ORG CHEM JPN, V66, P554; Takasu K, 2009, SYNLETT, P1905, DOI 10.1055/s-0029-1217522; Wang JS, 2004, ORG LETT, V6, P1939, DOI 10.1021/010495624	51	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	6					1070	1073		10.1039/c4cc08505a		4	Chemistry, Multidisciplinary	Chemistry	AW9GL	WOS:000346565300020		
J	Koga, M; Hirata, T; Kasayama, S; Ishizaka, Y; Yamakado, M				Koga, Masafumi; Hirata, Takumi; Kasayama, Soji; Ishizaka, Yuko; Yamakado, Minoru			Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus	CLINICA CHIMICA ACTA			English	Article						Glycated albumin; HbA1c; Type 2 diabetes mellitus; Body mass index; Insulin secretion	C-REACTIVE PROTEIN; BETA-CELL FUNCTION; GLUCOSE EXCURSION; HEMOGLOBIN LEVELS; PLASMA-GLUCOSE; SERUM; ASSOCIATION; INFLAMMATION; GLYCEMIA; IMPACT	Background: Glycated albumin (GA) is known to be negatively regulated by body mass index (BMI) in nondiabetic subjects and patients with type 2 diabetes mellitus (T2DM). In non-diabetic subjects, a mechanism has been proposed in which chronic inflammation associated with obesity increases albumin metabolism and negatively regulates GA levels. However, whether this same mechanism exists in T2DM is unclear. We investigated the factor(s) which influence GA levels in T2DM patients. Methods: This study included 179 T2DM patients from among people undergoing complete medical examinations. Correlations between GA and the following variables were examined among fasting samples for T2DM patients: BMI, C-reactive protein (CRP), homeostasis model assessment for beta-cell function (HOMA-beta) and homeostasis model assessment for insulin resistance (HOMA-R). Results: BMI was significantly positively correlated with CRP, but CRP was not significantly correlated with GA. HOMA-beta was significantly positively correlated with BMI and significantly negatively correlated with GA. Multivariate analysis showed that HOMA-beta was a significant explanatory variable for GA, but not CRP and HOMA-R. Conclusions: Our findings suggest that insulin secretion plays a greater role than chronic inflammation in the mechanism by which BMI negatively regulates GA in T2DM patients. (C) 2014 Elsevier B.V. All rights reserved.	[Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo, Japan; [Hirata, Takumi] Fdn Biomed Res & Innovat, Kobe, Hyogo, Japan; [Kasayama, Soji] Nissay Hosp, Dept Med, Osaka, Japan; [Ishizaka, Yuko; Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo, Japan.	m-koga@kawanishi-city-hospital.com					Koga M, 2010, ENDOCR J, V57, P751; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; DAS I, 1985, CLIN CHIM ACTA, V153, P9, DOI 10.1016/0009-8981(85)90133-0; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Kitamura T, 2013, CLIN CHIM ACTA, V424, P164, DOI 10.1016/j.cca.2013.06.011; Kim D, 2012, CLIN ENDOCRINOL, V77, P679, DOI 10.1111/j.1365-2265.2011.04312.x; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Miyashita Y, 2007, DIABETES RES CLIN PR, V78, P51, DOI 10.1016/j.diabres.2007.02.021; Suwa T, 2010, ENDOCR J, V57, P135; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Arvangat AV, 2010, VASC HLTH RISK MANAG, V24, P145; Cohen M P, 1988, J Diabet Complications, V2, P214, DOI 10.1016/S0891-6632(88)80012-6; Funakoshi S, 2008, DIABETES RES CLIN PR, V82, P353, DOI 10.1016/j.diabres.2008.09.010; Hashimoto K, 2004, DIABETIC MED, V21, P581, DOI 10.1111/j.1464-5491.2004.01212.x; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Koga M, 2010, ANN CLIN BIOCHEM, V47, P39, DOI 10.1258/acb.2009.009127; Koga M, 2006, ENDOCR J, V53, P387, DOI 10.1507/endocrj.K05-137; Koga M, 2010, ACTA DIABETOL, V47, P173, DOI 10.1007/s00592-009-0168-6; Motomura T, 2009, J ATHEROSCLER THROMB, V16, P546; Nishimura R, 2006, DIABETES RES CLIN PR, V71, P334, DOI 10.1016/j.diabres.2005.07.008; Ogawa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046517; Saisho Y., 2011, DIABETOL INT, V2, P146	30	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2015	438						19	23		10.1016/j.cca.2014.07.035		5	Medical Laboratory Technology	Medical Laboratory Technology	AX0AT	WOS:000346616800004		
J	Kikkawa, K; Nakajima, K; Shimomura, Y; Tokita, Y; Machida, T; Sumino, H; Murakami, M				Kikkawa, Koji; Nakajima, Katsuyuki; Shimomura, Younosuke; Tokita, Yoshiharu; Machida, Tetsuo; Sumino, Hiroyuki; Murakami, Masami			Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver	CLINICA CHIMICA ACTA			English	Article						Homogeneous sdLDL-C assay; Preliminary-metabolic syndrome (pre-MetS); MetS; Preliminary-type 2 diabetes mellitus (pre-T2DM); T2DM; Fatty Liver; Coronary heart disease (CHD)	FAMILIAL COMBINED HYPERLIPIDEMIA; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; ARTERY-DISEASE; PARTICLE-SIZE; MEN; RISK	Background: Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. Methods: The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, were determined in controls, MetS and T2DM patients (n = 5255). The cases with MetS and preliminary MetS (pre-MetS) as well as 12DM and preliminary T2DM (pre-DM) were selected based on the Japanese criteria for MetS and T2DM. Fatty liver was diagnosed using the ultrasonography. Results: The 75th percentile values for sdLDL-C were 27.5 mg/dl for men and 23.3 mg/dl for women and increased with age. The concentrations of sdLDL-C and sdLDL-C/LDL-C were significantly higher in pre-MetS and pre-T2DM patients than healthy controls as well as in MetS and T2DM patients. Significantly higher sdLDL-C was found in cases with a fatty liver than without a fatty liver in all five groups. Conclusions: Significantly elevated sdLDL-C levels were found in pre-MetS, MetS and pre-T2DM, T2DM patients compared to the healthy controls. Fatty liver significantly enhanced serum sdLDL-C levels and the multiple regression analyses ascertained that fatty liver was an independent determinant for sdLDL-C. (C) 2014 Published by Elsevier B.V.	[Kikkawa, Koji; Nakajima, Katsuyuki; Shimomura, Younosuke; Murakami, Masami] Hidaka Hosp, Diabet & Metab Dis Res Ctr, Takasaki, Gumma, Japan; [Nakajima, Katsuyuki; Tokita, Yoshiharu] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gumma 371, Japan; [Kikkawa, Koji; Machida, Tetsuo; Sumino, Hiroyuki] Gunma Univ, Grad Sch Hlth Sci, Dept Clin Lab Med, Maebashi, Gumma 371, Japan	Kikkawa, K (reprint author), Hidaka Hosp, Diabet & Metab Dis Res Ctr, 886 Nakao Machi, Takasaki, Gumma, Japan.	kojikkw@yahoo.co.jp					Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Nakajima K, 2010, ANN CLIN BIOCHEM, V47, P423, DOI 10.1258/acb.2010.009307; Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Arai H, 2013, J ATHEROSCLER THROMB, V20, P195; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; KRAUSS RM, 1982, J LIPID RES, V23, P97; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Albers JJ, 2011, CLIN CHIM ACTA, V412, P556, DOI 10.1016/j.cca.2010.12.003; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1; Hirano T, 2003, J LIPID RES, V44, P2193, DOI 10.1194/jlr.D300007-JLR200; Griffin BA, 1999, P NUTR SOC, V58, P163, DOI 10.1079/PNS19990022; Li ZS, 2012, BIOCHEM PHARMACOL, V84, P821, DOI 10.1016/j.bcp.2012.06.020; Bjornheden T, 1996, ATHEROSCLEROSIS, V123, P43, DOI 10.1016/0021-9150(95)05770-6; OTVOS JD, 1991, CLIN CHEM, V37, P377; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579; Sugino I, 2011, J ATHEROSCLER THROMB, V18, P1; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298; Lucero D, 2011, CLIN CHIM ACTA, V412, P587, DOI 10.1016/j.cca.2010.12.012; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Ayyobi AF, 2003, ARTERIOSCL THROM VAS, V23, P1289, DOI 10.1161/01.ATV.0000077220.44620.9B; Bellentani S, 2005, J HEPATOL, V49, P300; Burnt EM, 1999, AM J GASTROENTEROL, V94, P2467; De Vries R, 2005, CLIN LAB, V51, P403; GOLDSTEI.JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Hirano T, 2009, ATHEROSCLEROSIS, V205, P603, DOI 10.1016/j.atherosclerosis.2009.01.009; Hosoyamada K, 2012, DIABETOL METAB SYNDR, V18, P34; Ito Y, 2011, CLIN CHEM, V57, P57, DOI 10.1373/clinchem.2010.149559; Koba S, 2006, ATHEROSCLEROSIS, V189, P206, DOI 10.1016/j.atherosclerosis.2005.12.002; Koba S, 2000, ANN INTERN MED, V132, P762; Koba S, 2002, ATHEROSCLEROSIS, V160, P249, DOI 10.1016/S0021-9150(01)00580-9; Koba Shinji, 2008, J Atheroscler Thromb, V15, P250; Larmarche B, 1997, CIRCULATION, V95, P69; Nakamuta M, 2005, INT J MOL MED, V16, P631; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Packard C, 2000, INT J CARDIOL, V74, pS17, DOI 10.1016/S0167-5273(99)00107-2; Salerno AG, 2009, BIOCHEM J, V419, P629, DOI 10.1042/BJ20081299; Sancho-Rodriguez N, 2011, CLIN CHIM ACTA, V10, P162; Skoglund-Andersson C, 2003, ATHEROSCLEROSIS, V167, P311, DOI 10.1016/S0021-9150(03)00016-9; Tsai MY, 2014, ARTERIOSCL THROM VAS, V34, P196, DOI 10.1161/ATVBAHA.113.302401; Vakkilainen J, 2002, J LIPID RES, V43, P598; Yatsuzuka S, 2014, ANN CLIN BIOCHEM, V51, P68, DOI 10.1177/0004563213487892; Zago V, 2010, ANN NUTR METAB, V56, P198, DOI 10.1159/000276596	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2015	438						70	79		10.1016/j.cca.2014.07.017		10	Medical Laboratory Technology	Medical Laboratory Technology	AX0AT	WOS:000346616800013		
J	Okubo, M; Toromanovic, A; Ebara, T; Murase, T				Okubo, Minoru; Toromanovic, Alma; Ebara, Tetsu; Murase, Toshio			Apolipoprotein C-IITuzla: A novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency	CLINICA CHIMICA ACTA			English	Article						Alu repetitive element; Apolipoprotein C-II; Chylomicronemia; Hypertriglyceridemia; Large deletion; Homologous recombination	FAMILIAL CHYLOMICRONEMIA SYNDROME; DONOR SPLICE-SITE; CII GENE; LIPOPROTEIN-LIPASE; NONSENSE MUTATION; MOLECULAR-BASIS; PATIENT; HYPERTRIGLYCERIDEMIA; IDENTIFICATION; HAMBURG	Backgrounds: Familial apolipoprotein (apo) C-II deficiency is a very rare inherited disorder characterized by chylomicronemia. Since the discovery in 1978, reports on apo C-II deficient patients have been limited and only 13 different mutations in APOC2, a gene encoding apo C-II protein, were identified. Objectives: The objective is to investigate the biochemical and genetic features of a 3-month-old Bosniak girl with chylomicronemia whose apo C-II protein was undetectable in her plasma. Methods: APOC2, LPL, APOA5, and GPIHBP1 were sequenced. Isoelectrofocusing and irnmunoblotting of chylomicrons and VLDL fraction from the patient were performed. Results: Sequence analysis demonstrated a large deletion of 2978 base pairs in APOC2, which encompassed exons 2, 3, and 4. The patient was homozygous for the deletion. The 5' part of the breakpoint was located in an Alu Sx repetitive element in intron 1 of APOC2, whereas the 3' part of the breakpoint was in another Alu Sx between APOC2 and CLPTM1, a gene flanking APOC2. We speculate that the deletion was caused by a homologous recombination between two Alu Sx elements. No mutations were detected in LPL, APOA5, and GPIHBP1. Isoelectrofocusing and immunoblotting confirmed the absence of apo C-II protein. Conclusions: We diagnosed the patient as having apo C-II deficiency and designated the novel large deletion as apo C-IITuzla. This is the first description of apo C-II deficiency caused by Alu-Alu recombination in APOC2. (C) 2014 Elsevier B.V. All rights reserved.	[Okubo, Minoru; Ebara, Tetsu; Murase, Toshio] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Okubo, Minoru] Toranomon Gen Hosp, Dept Endocrinol & Metab, Minato Ku, Tokyo 1058470, Japan; [Toromanovic, Alma] Univ Clin Ctr Tuzla, Dept Pediat, Tuzla 75000, Bosnia & Herceg	Okubo, M (reprint author), Okinaka Mem Inst Med Res, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	QFG00550@nifty.com					Ebara T, 2001, ATHEROSCLEROSIS, V159, P375, DOI 10.1016/S0021-9150(01)00510-X; FOJO SS, 1988, J CLIN INVEST, V82, P1489, DOI 10.1172/JCI113756; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Nauck MS, 1998, CLIN CHEM, V44, P1388; Sakurabayashi I, 2001, CLIN CHIM ACTA, V312, P87, DOI 10.1016/S0009-8981(01)00591-5; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; INADERA H, 1993, BIOCHEM BIOPH RES CO, V193, P1174, DOI 10.1006/bbrc.1993.1749; HIXSON JE, 1990, J LIPID RES, V31, P545; Okubo M, 1997, ATHEROSCLEROSIS, V130, P153, DOI 10.1016/S0021-9150(96)06061-3; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472; Johansen CT, 2012, BBA-MOL CELL BIOL L, V1821, P833, DOI 10.1016/j.bbalip.2011.10.007; FOJO SS, 1989, J BIOL CHEM, V264, P20839; Lam CW, 2006, CLIN CHIM ACTA, V364, P256, DOI 10.1016/j.cca.2005.07.025; Brunzell JD, 2006, SCRIVERS ONLINE META; CONNELLY PW, 1987, J CLIN INVEST, V80, P1597, DOI 10.1172/JCI113246; COX DW, 1988, J MED GENET, V25, P649, DOI 10.1136/jmg.25.10.649; COX DW, 1978, NEW ENGL J MED, V299, P1421, DOI 10.1056/NEJM197812282992601; CRECCHIO C, 1990, BIOCHEM BIOPH RES CO, V168, P1118, DOI 10.1016/0006-291X(90)91145-I; de Graaf J, 2000, BIOCHEM BIOPH RES CO, V273, P1084, DOI 10.1006/bbrc.2000.3075; FOJO SS, 1989, J CLIN INVEST, V84, P1215, DOI 10.1172/JCI114287; FOJO SS, 1988, J BIOL CHEM, V263, P17913; HEGELE RA, 1992, CLIN BIOCHEM, V25, P309, DOI 10.1016/0009-9120(92)80003-Y; Okubo M, 2009, ATHEROSCLEROSIS, V207, P24, DOI 10.1016/j.atherosclerosis.2009.03.046; PARROTT CL, 1992, J LIPID RES, V33, P361; REINA M, 1992, J LIPID RES, V33, P1823; Streicher R, 1996, J LIPID RES, V37, P2599; Wang J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-23; XIONG WJ, 1991, AM J HUM GENET, V48, P383; YAMAMURA T, 1979, ATHEROSCLEROSIS, V34, P53, DOI 10.1016/0021-9150(79)90106-0	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2015	438						148	153		10.1016/j.cca.2014.08.022		6	Medical Laboratory Technology	Medical Laboratory Technology	AX0AT	WOS:000346616800025		
J	Hirata, T; Koga, M; Kasayama, S; Morimoto, J; Maruyama, T				Hirata, Takumi; Koga, Masafumi; Kasayama, Soji; Morimoto, Jiro; Maruyama, Taro			Glycated albumin is not significantly correlated with body mass index in patients with acute-onset type 1 diabetes	CLINICA CHIMICA ACTA			English	Article						Glycated albumin; Glycated hemoglobin; Body mass index; Type 1 diabetes; C-peptide immunoreactivity	BETA-CELL FUNCTION; GLUCOSE EXCURSION; INSULIN-SECRETION; IRON-DEFICIENCY; LATE PREGNANCY; C-PEPTIDE; HEMOGLOBIN; HEMODIALYSIS; INDICATOR; CHILDREN	Background: No previous reports have clarified the relationship between glycated albumin (GA) and BMI in patients with acute-onset type 1 diabetes. Methods: We conducted a cross-sectional study evaluating the correlation between GA and BMI in 209 patients with acute-onset type 1 diabetes and in 159 patients with type 2 diabetes who were designated as the control group. The correlation between fasting serum C-peptide immunoreactivity (CPR) and GA or BMI was also evaluated to clarify the impact of insulin secretion capacity on the relationship between GA and BMI. Results: GA was significantly inversely correlated with BMI in patients with type 2 diabetes (r = -0.317, p < 0.001) but not in patients with type I diabetes (r = 0.031, p = NS). In patients with type 2-diabetes, GA was significantly inversely correlated with fasting CPR, and BMI was significantly correlated with fasting CPR. In patients with type 1 diabetes, GA was significantly inversely correlated with fasting CPR (r = -0.291, p < 0.001), but BMI was not correlated with fasting CPR (r = -0.010, p = NS). Conclusions: Unlike in patients with type 2 diabetes, GA was not significantly correlated with BMI in patients with acute-onset type 1 diabetes. (C) 2014 Elsevier B.V. All rights reserved.	[Hirata, Takumi] Fdn Biomed Res & Innovat, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo, Japan; [Kasayama, Soji] Nissay Hosp, Dept Med, Osaka, Japan; [Morimoto, Jiro; Maruyama, Taro] Saitama Social Insurance Hosp, Dept Internal Med, Saitama, Japan	Hirata, T (reprint author), Fdn Biomed Res & Innovat, Chuo Ku, 1-6-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	t-hirata@fbri.org					Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Hashimoto K, 2008, DIABETES CARE, V31, P1945, DOI 10.2337/dc08-0352; Kim D, 2012, CLIN ENDOCRINOL, V77, P679, DOI 10.1111/j.1365-2265.2011.04312.x; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Scheen AJ, 1996, DIABETES METAB, V22, P397; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; Miyashita Y, 2007, DIABETES RES CLIN PR, V78, P51, DOI 10.1016/j.diabres.2007.02.021; Suwa T, 2010, ENDOCR J, V57, P135; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Liu LL, 2009, DIABETES CARE, V32, pS133, DOI [10.2337/dc09-S205, 10.2337/dc09.S205]; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ludvigsson J, 2013, DIABETES RES CLIN PR, V100, P203, DOI 10.1016/j.diabres.2013.03.003; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Hashimoto K, 2010, DIABETES CARE, V33, P509, DOI 10.2337/dc09-1954; Hirata T, 2013, J GENET SYNDR GENE T, V4, P168; Huh JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089478; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Kawasaki E, 2013, DIABETOL INT, V4, P221; Koga M, 2014, CLIN CHIM ACTA, V438, P19; Koga M, 2006, ENDOCR J, V53, P387, DOI 10.1507/endocrj.K05-137; Nishimura R, 2006, DIABETES RES CLIN PR, V71, P334, DOI 10.1016/j.diabres.2005.07.008; Palmer Jerry P., 2004, Diabetes, V53, P250; Picardi A, 2006, HORM METAB RES, V38, P668, DOI 10.1055/s-2006-954586; Saisho Y., 2011, DIABETOL INT, V2, P146; Sherr JL, 2014, DIABETES-METAB RES, V30, P154, DOI 10.1002/dmrr.2478	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2015	438						248	251		10.1016/j.cca.2014.08.038		4	Medical Laboratory Technology	Medical Laboratory Technology	AX0AT	WOS:000346616800045		
J	Wakabayashi, I; Daimon, T				Wakabayashi, Ichiro; Daimon, Takashi			The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus	CLINICA CHIMICA ACTA			English	Article						Diabetes; Dyslipidemia; HDL cholesterol; Obesity; Triglycerides; Waist circumference	LOW-DENSITY-LIPOPROTEIN; OPERATING CHARACTERISTIC CURVES; CORONARY-HEART-DISEASE; TO-HEIGHT RATIO; METABOLIC SYNDROME; ABDOMINAL OBESITY; PARTICLE-SIZE; RISK-FACTORS; BMI; LDL	Background: Patients with type 2 diabetes are prone to have obesity and dyslipidemia. The purpose of this study was to evaluate the usefulness of cardiometabolic index (CMI), anew index calculated as the product of waist-to-height ratio and triglycerides-to-HDL cholesterol ratio, for discrimination of diabetes. Methods: Subjects were 10,196 Japanese women and men who had received annual health checkups at their workplaces. Receiver-operating characteristic (ROC) analysis and logistic regression analysis were performed to determine relationships of CMI with hyperglycemia and diabetes. Results: In women and men, hemoglobin A1c was significantly higher in the highest quartile of CMI than in the other lower quartiles. By using ROC analysis, the cutoff values of CMI for hyperglycemia and diabetes were determined to be 0.799 and 0.800, respectively, in women and to be 1.625 and 1.748, respectively, in men. When these cutoff values were used in logistic regression analysis, there were strong associations of CMI with hyperglycemia and diabetes in women and men (odds ratio with 95% confidence interval of subjects with vs. subjects without high CMI: 6.98 [4.68-10.42] for hyperglycemia and 14.61 [5.95-35.88] for diabetes in women; 4.42 [3.66-535] for hyperglycemia and 538 [3.89-7.44] for diabetes in men). Conclusion: The results suggest that CMI is a useful new index, reflecting both adiposity and blood lipids, for discrimination of diabetes. (C) 2014 Elsevier B.V. All rights reserved.	[Wakabayashi, Ichiro] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Daimon, Takashi] Hyogo Coll Med, Div Biostat, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp			Japan Society for the Promotion of Science [24390171]	This work was supported by a Grant-in-Aid for Scientific Research (No. 24390171) from the Japan Society for the Promotion of Science (to LW.).	Anber V, 1996, ATHEROSCLEROSIS, V124, P261, DOI 10.1016/0021-9150(96)05842-X; Sekikawa A, 2000, J DIABETES COMPLICAT, V14, P78, DOI 10.1016/S1056-8727(00)00074-X; Jeppesen J, 1997, ARTERIOSCL THROM VAS, V17, P1114; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.01.06.dc05-1805; [Anonymous], 2005, J JPN SOC INT MED, V94, P794; Gaziano JM, 1997, CIRCULATION, V96, P2520; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; [Anonymous], 2010, DIAB CAR S1, V33, P562; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5; Dunn FL, 2010, REV ENDOCR METAB DIS, V11, P41, DOI 10.1007/s11154-010-9132-6; GALEANO NF, 1994, J BIOL CHEM, V269, P511; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SIMMONS D, 1990, DIABETIC MED, V7, P238	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2015	438						274	278		10.1016/j.cca.2014.08.042		5	Medical Laboratory Technology	Medical Laboratory Technology	AX0AT	WOS:000346616800051		
J	Toyokawa, G; Takenoyama, M; Ichinose, Y				Toyokawa, Gouji; Takenoyama, Mitsuhiro; Ichinose, Yukito			Multimodality Treatment With Surgery for Locally Advanced Non-Small-Cell Lung Cancer With N2 Disease: A Review Article	CLINICAL LUNG CANCER			English	Review						Mediastinal lymph node metastasis; Non-small-cell lung cancer; Preoperative chemoradiotherapy; Randomized control trial; Surgery	RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE GUIDELINES; PHASE-II TRIAL; PREOPERATIVE CONCURRENT CHEMORADIOTHERAPY; COMPARING PERIOPERATIVE CHEMOTHERAPY; ED AMERICAN-COLLEGE; INDUCTION CHEMOTHERAPY; NEOADJUVANT THERAPY; SURGICAL RESECTION; CONFORMAL RADIOTHERAPY	Stage III nonesmall-cell lung cancer (NSCLC) is composed of a heterogeneous population of lesions (ie, T4N0-3, T3N1-3, and T1a-2aN2-3), which makes it difficult to establish a definitive treatment strategy. Although several retrospective and prospective studies have been conducted to investigate the significance of multimodality treatments with surgery for patients with resectable stage III NSCLC, the role of surgery still remains controversial. In this article, we review the results of retrospective and prospective studies that have investigated the significance of multimodality treatment with surgery for patients with stage III NSCLC, particularly those with mediastinal lymph node metastasis, and the implications for the treatment of this controversial subset of patients.	[Toyokawa, Gouji; Takenoyama, Mitsuhiro; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan	Toyokawa, G (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	gouji104kawa@gmail.com					Yokomise H, 2007, J THORAC CARDIOV SUR, V133, P1179, DOI 10.1016/j.jtcvs.2006.12.039; Decaluwe H, 2009, EUR J CARDIO-THORAC, V36, P433, DOI 10.1016/j.ejcts.2009.04.013; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Barnett SA, 2011, J THORAC ONCOL, V6, P1530, DOI 10.1097/JTO.0b013e318228a0d8; Bradley J, 2005, INT J RADIAT ONCOL, V61, P318, DOI 10.1016/j.ijrobp.2004.06.020; Stephens RJ, 2005, LUNG CANCER-J IASLC, V49, P395, DOI 10.1016/j.lungcan.2005.04.001; MARTINI N, 1987, SURG CLIN N AM, V67, P1037; Storelli E, 2012, EUR J CARDIO-THORAC, V42, P77, DOI 10.1093/ejcts/ezr291; Fernandes AT, 2010, RADIOTHER ONCOL, V95, P178, DOI 10.1016/j.radonc.2010.02.007; Shah AA, 2013, ANN THORAC SURG, V95, P1700, DOI 10.1016/j.athoracsur.2013.02.044; Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Johnstone DW, 2002, INT J RADIAT ONCOL, V54, P365, DOI 10.1016/S0360-3016(02)02943-7; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Yamamoto N, 2010, J CLIN ONCOL, V28, P3739, DOI 10.1200/JCO.2009.24.5050; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Andre F, 2000, J CLIN ONCOL, V18, P2981; Stefani A, 2010, J THORAC CARDIOV SUR, V140, P356, DOI 10.1016/j.jtcvs.2010.02.018; Ng T, 2010, ANN SURG ONCOL, V17, P476, DOI 10.1245/s10434-009-0810-0; Hammoud ZT, 1999, J THORAC CARDIOV SUR, V118, P894, DOI 10.1016/S0022-5223(99)70059-0; Milman S, 2009, ANN THORAC SURG, V88, P945, DOI 10.1016/j.athoracsur.2009.05.084; Rosell R, 1999, LUNG CANCER-J IASLC, V26, P7, DOI 10.1016/S0169-5002(99)00045-8; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; Suntharalingam M, 2012, INT J RADIAT ONCOL, V84, P456, DOI 10.1016/j.ijrobp.2011.11.069; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Pezzetta E, 2005, EUR J CARDIO-THORAC, V27, P1092, DOI 10.1016/j.ejcts.2005.02.035; Koshy M, 2013, J THORAC ONCOL, V8, P915, DOI 10.1097/JTO.0b013e31828f68b4; Daly BDT, 2006, ANN THORAC SURG, V82, P227, DOI 10.1016/j.athoracsur.2006.02.061; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; Yoshino I, 2012, J THORAC ONCOL, V7, P850, DOI 10.1097/JTO.0b013e31824c945b; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; van Meerbeeck JP, 2007, J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093; Ichinose Y, 2001, J THORAC CARDIOV SUR, V122, P803, DOI 10.1067/mtc.2001.116473; ROTH JA, 1994, J NATL CANCER I, V86, P673, DOI 10.1093/jnci/86.9.673; Heon S, 2012, J THORAC CARDIOV SUR, V144, pS39, DOI 10.1016/j.jtcvs.2012.03.039; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037; Weder W, 2010, J THORAC CARDIOV SUR, V139, P1424, DOI 10.1016/j.jtcvs.2010.02.039; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Friedel G, 2010, J CLIN ONCOL, V28, P942, DOI 10.1200/JCO.2008.21.7810; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Gomez-Caro A, 2012, EUR J CARDIO-THORAC, V41, P1052, DOI 10.1093/ejcts/ezr184; Dooms C, 2008, J CLIN ONCOL, V26, P1128, DOI 10.1200/JCO.2007.13.9550; ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880; Katayama H, 2004, BRIT J CANCER, V90, P979, DOI 10.1038/sj.bjc.6601624; Suzuki K, 1999, J THORAC CARDIOV SUR, V118, P145, DOI 10.1016/S0022-5223(99)70153-4; Tournoy KG, 2012, LANCET ONCOL, V13, pE221, DOI 10.1016/S1470-2045(11)70407-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Asamura H, 2011, J THORAC ONCOL, V6, P1458, DOI 10.1097/JTO.0b013e318229407f; BONOMI P, 1995, LUNG CANCER-J IASLC, V12, pS41, DOI 10.1016/S0169-5002(10)80005-4; Burkes RL, 2005, LUNG CANCER-J IASLC, V47, P103, DOI 10.1016/j.lungcan.2004.06.004; Caglar HB, 2009, CANCER, V115, P4156, DOI 10.1002/cncr.24492; Cerfolio RJ, 2005, ANN THORAC SURG, V80, P1224, DOI 10.1016/j.athoracsur.2005.02.091; Choi NC, 1997, J CLIN ONCOL, V15, P712; Detterbeck FC, 2013, CHEST, V143, p7S, DOI 10.1378/chest.12-2377; Edelman MJ, 2008, ANN THORAC SURG, V86, P903, DOI 10.1016/j.athoracsur.2008.06.022; Elias AD, 1997, LUNG CANCER-J IASLC, V17, P147, DOI 10.1016/S0169-5002(97)00658-2; FUNATSU T, 1992, J THORAC CARDIOV SUR, V104, P1688; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; GINSBERG RJ, 1995, LUNG CANCER-J IASLC, V12, pS33, DOI 10.1016/S0169-5002(10)80004-2; Ginsberg RJ, 1995, ANN THORAC SURG, V60, P622; Goya T, 2005, LUNG CANCER-J IASLC, V50, P227, DOI 10.1016/j.luncan.2005.05.021; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Kim AW, 2009, ANN THORAC SURG, V88, P937, DOI 10.1016/j.athoracsur.2009.04.102; Milman S, 2009, ANN THORAC SURG, V88, P950; Non-Small Cell Lung Cancer Collaborative Group, 2010, COCHRANE DB SYST REV; PEARSON FG, 1982, J THORAC CARDIOV SUR, V83, P1; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Rice TW, 1998, ANN THORAC SURG, V66, P1909, DOI 10.1016/S0003-4975(98)01187-4; Roth JA, 1998, LUNG CANCER-J IASLC, V21, P1, DOI 10.1016/S0169-5002(98)00046-4; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Steger V, 2009, ANN THORAC SURG, V87, P1676, DOI 10.1016/j.athoracsur.2009.03.068; Tada T, 2012, INT J RADIAT ONCOL, V83, P327, DOI 10.1016/j.ijrobp.2011.06.1991; Takeda S, 2006, EUR J CARDIO-THORAC, V30, P184, DOI 10.1016/j.ejcts.2006.03.054; WATANABE Y, 1991, ANN THORAC SURG, V51, P253; Yamaguchi M, 2013, ANN THORAC SURG, V96, P1783, DOI 10.1016/j.athoracsur.2013.06.036	80	1	2	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	JAN	2015	16	1					6	14		10.1016/j.cllc.2014.07.007		9	Oncology	Oncology	AW8CW	WOS:000346489300002		
J	Takenaka, T; Takenoyama, M; Toyozawa, R; Inamasu, E; Yoshida, T; Toyokawa, G; Shiraishi, Y; Hirai, F; Yamaguchi, M; Seto, T; Ichinose, Y				Takenaka, Tomoyoshi; Takenoyama, Mitsuhiro; Toyozawa, Ryo; Inamasu, Eiko; Yoshida, Tsukihisa; Toyokawa, Gouji; Shiraishi, Yoshimasa; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Ichinose, Yukito			Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non-Small-Cell Lung Cancer	CLINICAL LUNG CANCER			English	Article						Concurrent chemoradiotherapy; Non-small cell lung cancer; Postoperative recurrence Postrecurrence survival; Prognostic factors	PHASE-II TRIAL; THORACIC RADIOTHERAPY; LOCAL RECURRENCE; POSTRECURRENCE SURVIVAL; DISTANT METASTASIS; CISPLATIN; OLIGOMETASTASES; URACIL/TEGAFUR; CHEMOTHERAPY; COMBINATION	The effect of concurrent chemoradiotherapy (CRT) for recurrent non-small-cell lung cancer has not yet been established. Thirty-five patients received concurrent CRT as an initial treatment in our study. The median progression-free survival and postrecurrence survival after CRT was 13 and 31 months, respectively. The ECOG performance status, surgical procedure, and types of platinum agents used were independent prognostic factors. Background: A few reports have evaluated the outcomes of concurrent chemoradiotherapy (CRT) for patients with postoperative recurrence of non-small-cell lung cancer (NSCLC). Patients and Methods: From 2000 through 2011, 1237 consecutive patients with NSCLC underwent pulmonary resection at our institution. Of those, 280 patients had experienced postoperative recurrence by the end of 2012. Thirty-five patients received concurrent CRT as initial treatment of the recurrent disease. We retrospectively reviewed these cases, analyzed the outcomes of concurrent CRT after surgical resection, and examined the factors that predict long-term postrecurrence survival. Results: The most common sites of recurrence in this cohort were the lymph nodes in 24 patients, followed by the lung in 5 patients and bone in 6 patients. The median radiation dose given as the initial treatment of recurrence was 60 Gy (range, 30-60 Gy). Chemotherapy included a platinum agent in all cases; cisplatin-based chemotherapy was administered in 23 cases, and a carboplatin-based chemotherapy regimen was administered in 12. The median progression-free and postrecurrence survival after CRT was 13 months (range, 4-127 months) and 31 months (range, 5-127 months), respectively. Seven patients were still alive without evidence of disease for > 3 years after the recurrence diagnosis. The ECOG performance status (PS), surgical procedure, and types of platinum agents used were independent prognostic factors for postrecurrence survival. Conclusion: Concurrent CRT for recurrent NSCLC is a promising therapy for selected patients. A poor PS and postpneumonectomy state were poor prognostic factors for patients who received concurrent CRT. (C) 2015 Elsevier Inc. All rights reserved.	[Takenaka, Tomoyoshi; Takenoyama, Mitsuhiro; Toyozawa, Ryo; Inamasu, Eiko; Yoshida, Tsukihisa; Toyokawa, Gouji; Shiraishi, Yoshimasa; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan; [Ichinose, Yukito] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka 8111395, Japan	Takenaka, T (reprint author), Kyushu Natl Canc Ctr, Minami Ku, Notame 3-1-1, Fukuoka 8111395, Japan.	ttake@surg2.med.kyushu-u.ac.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Furuse K, 1999, J CLIN ONCOL, V17, P2692; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Yamamoto N, 2010, J CLIN ONCOL, V28, P3739, DOI 10.1200/JCO.2009.24.5050; Yano T, 2010, J SURG ONCOL, V102, P852, DOI 10.1002/jso.21750; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Hung JJ, 2009, THORAX, V64, P192, DOI 10.1136/thx.2007.094912; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Hung JJ, 2012, J THORAC ONCOL, V7, P1115, DOI 10.1097/JTO.0b013e31824cbad8; MacDermed DM, 2008, J SURG ONCOL, V98, P202, DOI 10.1002/jso.21102; Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046; Hishida T, 2006, J THORAC CARDIOV SUR, V131, P838, DOI 10.1016/j.jtcvs.2005.11.028; Williams BA, 2006, ANN THORAC SURG, V81, P1021, DOI 10.1016/j.athoracsur.2005.09.020; [Anonymous], 2013, NONSM CELL LUNG CANC; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Endo C, 2012, ANN THORAC SURG, V93, P1061, DOI 10.1016/j.athoracsur.2012.01.004; Segawa Y, 2010, J CLIN ONCOL, V28, P3299, DOI 10.1200/JCO.2009.24.7577; Hung JJ, 2010, THORAX, V65, P241, DOI 10.1136/thx.2008.110825; Bar J, 2013, CLIN LUNG CANCER, V14, P200, DOI 10.1016/j.cllc.2012.05.008; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Ichinose Y, 2004, CLIN CANCER RES, V10, P4369, DOI 10.1158/1078-0432.CCR-04-0143; Kelsey CR, 2006, CANCER J, V12, P283, DOI 10.1097/00130404-200607000-00006; Ohyanagi F, 2009, BRIT J CANCER, V101, P225, DOI 10.1038/sj.bjc.6605152; Sugawara S, 2013, LUNG CANCER, V81, P91, DOI 10.1016/j.lungcan.2013.04.010; World Health Organization, 1999, HIST TYP LUNG PLEUR	25	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	JAN	2015	16	1					51	56		10.1016/j.dlc.2014.06.001		6	Oncology	Oncology	AW8CW	WOS:000346489300008		
J	Hao, J; Acharya, A; Chen, K; Chou, J; Kasugai, S; Lang, NP				Hao, J.; Acharya, A.; Chen, K.; Chou, J.; Kasugai, S.; Lang, N. P.			Novel bioresorbable strontium hydroxyapatite membrane for guided bone regeneration	CLINICAL ORAL IMPLANTS RESEARCH			English	Article						bioresorbable membrane; calvarial defect; guided bone regeneration membranes; strontium hydroxyapatite	DERMAL SHEEP COLLAGEN; TISSUE REGENERATION; RANELATE TREATMENT; IN-VITRO; OSTEOPOROSIS; MECHANISMS; DEFECTS; RISK	Objectives: Membrane materials have been widely used for guided bone regeneration (GBR). However, due to bio-functional limitation of the current membranes, the ideal resorbable membrane that can stimulate bone regeneration has yet to be developed. This study seeks to investigate the effects of a strontium hydroxyapatite (SrHA)-containing membrane for GBR. Material and methods: Strontium hydroxyapatite powder was synthesized and mixed with gelatin solution to the final concentration of 10 mg/ml (Sr10) and 20 mg/ml (Sr20). Approximately 100-mu m-thick membranes were fabricated, and the mechanical properties and strontium ion release pattern were analyzed. Rat bone marrow stromal cell (BMSC) responses were investigated in vitro. Bilaterial rat calvarial defects were used in vivo to compare the SrHA membranes against commercially available collagen membranes and evaluated radiologically and histologically. Results: Strontium hydroxyapatite membranes exhibited higher elasticity and strength than the collagen membrane, and slow strontium ion release was also confirmed. No BMSC cytotoxicity was found on the SrHA membranes, and the alkaline phosphatase positively stained area was significantly greater than the collagen membrane at earlier time point. At 4 weeks, both micro-CT and histological analyses revealed that the Sr20 group yielded significantly greater bone formation. Conclusions: The SrHA-containing membrane developed in this study was found to be a biocompatible material that can stimulate BMSC differentiation as well as bone regeneration and maturation in rat calvarial defects at early time point compared with collagen membrane. The best result was observed in Sr20 group, which can be potentially effective for GBR.	[Hao, J.; Chen, K.; Kasugai, S.] Tokyo Med Dent Univ, Tokyo 1138510, Japan; [Acharya, A.; Lang, N. P.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Chou, J.] Univ Technol Sydney, Sch Med & Mol Biosci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia	Hao, J (reprint author), Tokyo Med Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	haoirm@tmd.ac.jp			Clinical Research Foundation (CRF/SKF), Brienz, Switzerland	This study was supported by Clinical Research Foundation (CRF/SKF), Hauptstrasse 95, CH - 3855 Brienz, Switzerland.	Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461; Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6; Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412; LINDE A, 1993, J PERIODONTOL, V64, P1116; DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004; GOTTLOW J, 1993, J PERIODONTOL, V64, P1157; Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006; VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310; Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Fujikura K, 2013, J BIOMED MATER RES B, V101, P1350, DOI 10.1002/jbm.b.32952; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670; Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646; Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x; Caverzasio J, 2008, BONE, V42, P1131, DOI 10.1016/j.bone.2008.02.010; Kohal RJ, 1999, CLIN ORAL IMPLAN RES, V10, P226, DOI 10.1034/j.1600-0501.1999.100306.x; Lee Chang-Kyun, 2010, J Periodontal Implant Sci, V40, P232, DOI 10.5051/jpis.2010.40.5.232; Lorenzoni M, 1998, INT J ORAL MAX IMPL, V13, P639; Noritake K., 2011, J ORAL TISSUE ENG, V9, P53; Norowski Jr P. A., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1648, DOI 10.1002/TERM.1648]; Parrish Lawrence C, 2009, J Oral Sci, V51, P383; VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7161	1600-0501		CLIN ORAL IMPLAN RES	Clin. Oral Implant. Res.	JAN	2015	26	1					1	7		10.1111/clr.12289		7	Dentistry, Oral Surgery & Medicine; Engineering, Biomedical	Dentistry, Oral Surgery & Medicine; Engineering	AW5XL	WOS:000346344200004		
J	Arezzo, A; Matsuda, T; Rembacken, B; Miles, WFA; Coccia, G; Saito, Y				Arezzo, A.; Matsuda, T.; Rembacken, B.; Miles, W. F. A.; Coccia, G.; Saito, Y.			Piecemeal mucosectomy, submucosal dissection or transanal microsurgery for large colorectal neoplasm	COLORECTAL DISEASE			English	Article							ENDOSCOPIC MUCOSAL RESECTION; CARBON-DIOXIDE INSUFFLATION; MINIMALLY INVASIVE SURGERY; PT2 RECTAL-CANCER; LONG-TERM RISK; COLONOSCOPY SURVEILLANCE; PROSPECTIVE MULTICENTER; LOCAL RESECTION; TASK-FORCE; POLYPECTOMY		[Arezzo, A.] Univ Turin, Dept Surg Sci, I-10126 Turin, Italy; [Matsuda, T.; Saito, Y.] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Rembacken, B.] Gen Infirm, Dept Gastroenterol, Leeds LS1 3EX, W Yorkshire, England; [Miles, W. F. A.] Dept Gen & Laparoscop Colorectal Surg, Worthing, W Sussex, England; [Coccia, G.] Galliera Hosp, Dept Gastroenterol, Genoa, Italy	Arezzo, A (reprint author), Univ Turin, Dept Surg Sci, Corso AM Dogliotti 14, I-10126 Turin, Italy.	alberto.arezzo@mac.com		Arezzo, Alberto/0000-0002-2110-4082			Farhat S, 2011, ENDOSCOPY, V43, P664, DOI 10.1055/s-0030-1256413; Middleton PF, 2005, DIS COLON RECTUM, V48, P270, DOI 10.1007/s10350-004-0804-8; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Sakamoto T, 2011, DIS COLON RECTUM, V54, P1307, DOI 10.1097/DCR.0b013e3182282ab0; Tajika M, 2011, EUR J GASTROEN HEPAT, V23, P1042, DOI 10.1097/MEG.0b013e32834aa47b; Lin GL, 2006, ASIAN J SURG, V29, P227, DOI 10.1016/S1015-9584(09)60093-2; Miller HL, 2010, J CLIN GASTROENTEROL, V44, pE162, DOI 10.1097/MCG.0b013e3181e5cd22; Fujii T, 2001, ENDOSCOPY, V33, P1036; Doornebosch PG, 2007, COLORECTAL DIS, V9, P553, DOI 10.1111/j.1463-1318.2006.01186.x; Panteris V, 2009, ENDOSCOPY, V41, P941, DOI 10.1055/s-0029-1215179; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Ahmad NA, 2002, GASTROINTEST ENDOSC, V55, P390, DOI 10.1067/mge.2002.121881; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Morino M, 2013, SURG ENDOSC, V27, P181, DOI 10.1007/s00464-012-2418-x; Fujishiro M, 2008, WORLD J GASTROENTERO, V14, P4289, DOI 10.3748/wjg.14.4289; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Hotta K, 2009, INT J COLORECTAL DIS, V24, P225, DOI 10.1007/s00384-008-0596-8; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Soetikno RM, 2003, GASTROINTEST ENDOSC, V57, P567, DOI 10.1067/mge.2003.130; Saito Y, 2007, GASTROINTEST ENDOSC, V65, P537, DOI 10.1016/j.gie.2006.11.002; Endreseth BH, 2005, DIS COLON RECTUM, V48, P1380, DOI 10.1007/s10350-005-0044-6; Lezoche E, 2002, WORLD J SURG, V26, P1170, DOI 10.1007/s00268-002-6359-8; Yamamoto H, 2008, GASTROINTEST ENDOSC, V67, P830, DOI 10.1016/j.gie.2007.07.039; JORGENSEN OD, 1995, SCAND J GASTROENTERO, V30, P686, DOI 10.3109/00365529509096314; Kikuchi T, 2010, SURG ENDOSC, V24, P2231, DOI 10.1007/s00464-010-0939-8; Brenner H, 2012, ANN INTERN MED, V157, P225, DOI 10.7326/0003-4819-157-4-201208210-00002; Brooker JC, 2002, GASTROINTEST ENDOSC, V55, P371, DOI 10.1067/mge.2002.121597; Dias AR, 2009, TECH COLOPROCTOL, V13, P105, DOI 10.1007/s10151-009-0466-6; Marusch F, 2011, ENDOSCOPY, V43, P425, DOI 10.1055/s-0030-1256111; Lezoche E, 2005, BRIT J SURG, V92, P1546, DOI 10.1002/bjs.5178; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Borschitz T, 2007, DIS COLON RECTUM, V50, P292, DOI 10.1007/s10350-006-0816-7; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Hsieh YH, 2001, HEPATO-GASTROENTEROL, V48, P1379; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; Zauber AG, 2008, ANN INTERN MED, V149, P659; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Atallah S, 2010, SURG ENDOSC, V24, P2200, DOI 10.1007/s00464-010-0927-z; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Winde G, 1996, DIS COLON RECTUM, V39, P969, DOI 10.1007/BF02054683; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; Uraoka T, 2005, GASTROINTEST ENDOSC, V61, P736, DOI 10.1016/S0016-5107(05)00321-4; Khashab M, 2009, GASTROINTEST ENDOSC, V70, P344, DOI 10.1016/j.gie.2008.10.037; BUESS G, 1984, CHIRURG, V55, P677; Sakamoto T, 2012, CLIN GASTROENTEROL H, V10, P22, DOI 10.1016/j.cgh.2011.10.007; Arezzo A, 2009, SURG ENDOSC, V23, P1065, DOI 10.1007/s00464-008-0133-4; Arezzo A, 2014, SURG ENDOSC, V28, P427, DOI 10.1007/s00464-013-3238-3; Brenner H, 2007, AM J GASTROENTEROL, V102, P1739, DOI 10.1111/j.1572-0241.2007.01231.x; de Melo SW, 2011, GASTROINTEST ENDOSC, V73, P349, DOI 10.1016/j.gie.2010.10.030; HERMANEK P, 1989, DIS COLON RECTUM, V32, P593, DOI 10.1007/BF02554180; Huang YL, 2010, J GASTROENTEROL, V45, P838, DOI 10.1007/s00535-010-0227-3; KARITA M, 1991, GASTROINTEST ENDOSC, V37, P128, DOI 10.1016/S0016-5107(91)70669-X; Keighley MRB, 2003, ALIMENT PHARM THERAP, V18, P7, DOI 10.1046/j.0953-0673.2003.01722.x; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Marusch F, 2002, ENDOSCOPY, V34, P385, DOI 10.1055/s-2002-25292; Matsuda T, 2010, GASTROEN CLIN BIOL, V34, P367, DOI 10.1016/j.gcb.2010.05.002; Morino M, 2011, COLORECTAL DIS, V13, P47, DOI 10.1111/j.1463-1318.2011.02779.x; Pohl H, 2013, GASTROENTEROLOGY, V144, P78; Rimonda R, 2013, SURG ENDOSC, V27, P3762, DOI 10.1007/s00464-013-2962-z; Rokke O, 2005, DIGEST SURG, V22, P189; Rokke O, 2005, DIGEST SURG, V22, P182, DOI 10.1159/000087972; Royal College of Surgeons of England and Association of Coloproctology of Great Britain and Ireland, 1996, GUID MAN COL CANC; Sano Y, 2006, ENDOSCOPY, V38, pE95, DOI 10.1055/s-2006-944622; Varadarajulu S, 2006, ENDOSCOPY, V38, P907, DOI 10.1055/s-2006-944664; Waye J D, 2001, Gastrointest Endosc Clin N Am, V11, P537	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8910	1463-1318		COLORECTAL DIS	Colorectal Dis.	JAN	2015	17			1	SI		44	51		10.1111/codi.12821		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW7RZ	WOS:000346463400010		
J	Meisami, MH; Mostofinejad, D; Nakamura, H				Meisami, M. Hasan; Mostofinejad, Davood; Nakamura, Hikaru			Strengthening of flat slabs with FRP fan for punching shear	COMPOSITE STRUCTURES			English	Article						Carbon fiber; Debonding; Analytical modeling; Slab strengthening	CONNECTIONS	The results of an experimental program on two-way flat slabs with central loading are presented in this paper. All the slabs were designed according to ACI 318-08 code provisions. One slab served as control without any modification while three slabs were strengthened in different ways with an innovative technique of using FRP fans after casting to increase shear capacity and provide sufficient anchorage. For strengthening in each case, 8, 16 and 24 strengtheners were used. The results of the experiments showed that the presented strengthening method is capable of enhancing both maximum loading capacity and deformation capacity as well as avoiding brittle failures that may occur under vertical loading. The dominant failure mode for flat slabs strengthened with FRP fans was deboning of PEP fans due to the small depth of slabs and simultaneously with separation of end anchorage from the concrete surface. It was shown that this method of strengthening not only can increase the shear capacity of the slab up to a high value around twice of that of controlled slab but also may change the slab failure mode from shear to shear-flexural and also flexural. The test results were also compared with the codes predictions to show the efficiency of the presented strengthening. The comparison showed that the ACI 318 code predictions are more conservative than those of JSCE code for results of this study. (C) 2014 Elsevier Ltd. All rights reserved.	[Meisami, M. Hasan] Univ Shahid Ashrafi, Dept Civil Engn, Esfahan, Iran; [Mostofinejad, Davood] Isfahan Univ Technol, Dept Civil Engn, Esfahan, Iran; [Nakamura, Hikaru] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan	Meisami, MH (reprint author), Univ Shahid Ashrafi, Dept Civil Engn, Post Box 49999-81798, Esfahan, Iran.	meisami@ashrafi.ac.ir; dmostofi@cc.iut.ac.ir; hikaru@nagoya-u.jp					Adetifa B, 2005, ACI STRUCT J, V102, P268; El-Salakawy EF, 2003, ACI STRUCT J, V100, P297; Binici B, 2003, THESIS U TEXAS AUSTI; Chen CC, 2005, ACI STRUCT J, V102, P535; El-Salakawy E, 2004, J COMPOS CONSTR, V8, P384, DOI 10.1061/(ASCE)1090-0268(2004)8:5(384); Japan Society of Civil Engineers (JSCE), 2007, GUID CONCR STAND SPE; Meisami MH, 2013, COMPOS STRUCT, V99, P112, DOI 10.1016/j.compstruct.2012.11.028; Meisami MH, 2014, J COMPOS CONSTR, V18, DOI 10.1061/(ASCE)CC.1943-5614.0000443; Mostafa AAEB, 2005, THESIS CARLETON U OT, P201; Scott TS, 2011, ENG STRUCT, V33, P1075; Stark AD, 2003, THESIS U TEXAS AUSTI; Teng JG, 2000, J COMPOS CONSTR, V4, P75, DOI 10.1061/(ASCE)1090-0268(2000)4:2(75); Zhang HW, 2012, COMPOS PART B-ENG, V43, P3516, DOI 10.1016/j.compositesb.2011.11.072	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-8223	1879-1085		COMPOS STRUCT	Compos. Struct.	JAN	2015	119						305	314		10.1016/j.compstruct.2014.08.041		10	Materials Science, Composites	Materials Science	AW9AW	WOS:000346551100027		
J	Li, JQ; Narita, YS; Wang, ZH				Li, Jinqiang; Narita, Yoshihiro; Wang, Zhihua			The effects of non-uniform temperature distribution and locally distributed anisotropic properties on thermal buckling of laminated panels	COMPOSITE STRUCTURES			English	Article						Fiber reinforced laminated panel; Non-uniform temperature; Thermal buckling; Critical buckling temperature; Short fiber	STIFFNESS COMPOSITE PANELS; POSTBUCKLING BEHAVIOR; RECTANGULAR-PLATES; LOAD OPTIMIZATION; LAYERWISE THEORY; OPTIMAL-DESIGN; SHELLS; FLOW	The present paper is concerned with the optimal design problem of thermal buckling for fiber reinforced laminated panels. The effects of non-uniform temperature fields and locally distributed anisotropic properties on the thermal buckling behavior are studied. In this analysis, based on the classical lamination theory in conjunction with the Hamilton's principle, the critical thermal buckling temperature difference is deduced. The numerical results show that under the non-uniform thermal loads the isotropic panel performs as anisotropic structure and it also show that the center of panel is more sensitive to the thermal effects than the edges. The effects of thermal load on panels with different boundary conditions are also investigated and it is found that the panel edges with loose constraint are more sensitive to temperature effect than with strict constraint. In the optimal fiber design problem for thermal buckling, by comparing the critical thermal buckling temperature difference of nine types of panels with different fiber distribution, it is found that the short fiber distribution can largely improve the critical thermal buckling temperature difference of fiber reinforced laminated panels. Finally, using the genetic algorithm the optimal fiber distribution is obtained for an eight-layer symmetrical panel. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Jinqiang] Taiyuan Univ Technol, Coll Mech, Taiyuan, Peoples R China; [Narita, Yoshihiro] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 060, Japan; [Wang, Zhihua] Taiyuan Univ Technol, Inst Appl Mech & Biomed Engn, Taiyuan, Peoples R China	Li, JQ (reprint author), Taiyuan Univ Technol, Coll Mech, Taiyuan, Peoples R China.	lijinqiang@yahoo.com			National Natural Science Foundation of China [11390362]; Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province	This work was supported by the National Natural Science Foundation of China (No. 11390362) and the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province.	Li JQ, 2013, COMPOS PART B-ENG, V45, P972, DOI 10.1016/j.compositesb.2012.09.014; Malekzadeh P, 2014, J AEROSPACE ENG, V27, P64, DOI 10.1061/(ASCE)AS.1943-5525.0000220; Abdalla MM, 2007, COMPOS STRUCT, V81, P283, DOI 10.1016/j.compstruct.2006.08.018; Li JQ, 2014, COMPOS STRUCT, V111, P530, DOI 10.1016/j.compstruct.2014.01.026; Shariyat M, 2007, THIN WALL STRUCT, V45, P439, DOI 10.1016/j.tws.2007.03.004; Jones RM, 2005, COMPOS PART A-APPL S, V36, P1355, DOI 10.1016/j.compositesa.2005.01.028; Honda S, 2011, COMPOS STRUCT, V93, P902, DOI 10.1016/j.compstruct.2010.07.003; Matsunaga H, 2006, COMPOS STRUCT, V72, P177, DOI [10.1016/j.compstruct.2004.11.016, 10.1016/j.comstruct.2004.11.016]; Setoodeh S, 2009, COMPOS STRUCT, V87, P109, DOI 10.1016/j.compstruct.2008.01.008; Parnas L, 2003, COMPOS SCI TECHNOL, V63, P1071, DOI 10.1016/S0266-3538(02)00312-3; Shiau LC, 2010, COMPOS STRUCT, V92, P508, DOI 10.1016/j.compstruct.2009.08.035; Honda S, 2012, J SOUND VIB, V331, P180, DOI 10.1016/j.jsv.2011.08.019; Avci A, 2006, COMPOS SCI TECHNOL, V66, P2965, DOI 10.1016/j.compscitech.2006.02.009; Barut A, 2000, INT J SOLIDS STRUCT, V37, P3681, DOI 10.1016/S0020-7683(99)00119-5; CHEN LW, 1987, J THERM STRESSES, V10, P345, DOI 10.1080/01495738708927017; CHEN WJ, 1991, COMPUT STRUCT, V41, P637, DOI 10.1016/0045-7949(91)90176-M; Ghomshei MMM, 2010, J MECH SCI TECHNOL, V24, P2519, DOI 10.1007/s12206-010-0918-y; Gossard ML, 1952, 19522771 NACA TND, P2771; Lee J, 1997, COMPUT STRUCT, V65, P917, DOI 10.1016/S0045-7949(96)00232-5; Lee JJ, 2002, COMPOS STRUCT, V55, P137; Li JQ, 2013, COMPOS STRUCT, V101, P35, DOI 10.1016/j.compstruct.2013.01.022; Li ZM, 2014, COMPOS STRUCT, V108, P924, DOI 10.1016/j.compstruct.2013.10.028; Muc A, 2010, COMPOS STRUCT, V92, P1728, DOI 10.1016/j.compstruct.2009.12.015; Nath Y., 2001, Communications in Nonlinear Science & Numerical Simulation, V6, DOI 10.1016/S1007-5704(01)90022-X; PRABHU MR, 1994, COMPUT STRUCT, V53, P1193, DOI 10.1016/0045-7949(94)90166-X; Shi YC, 1999, J THERM STRESSES, V22, P595, DOI 10.1080/014957399280779; Song ZG, 2014, COMPOS PART B-ENG, V56, P830, DOI 10.1016/j.compositesb.2013.09.019; Spallino R, 2000, COMPUT STRUCT, V78, P691, DOI 10.1016/S0045-7949(00)00050-X; TAUCHERT TR, 1987, J THERM STRESSES, V10, P113, DOI 10.1080/01495738708927000; Topal U, 2009, MATER DESIGN, V30, P532, DOI 10.1016/j.matdes.2008.05.052; Topal U, 2008, THIN WALL STRUCT, V46, P667, DOI 10.1016/j.tws.2007.11.005	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-8223	1879-1085		COMPOS STRUCT	Compos. Struct.	JAN	2015	119						610	619		10.1016/j.compstruct.2014.09.011		10	Materials Science, Composites	Materials Science	AW9AW	WOS:000346551100055		
J	Okabe, T; Imamura, H; Sato, Y; Higuchi, R; Koyanagi, J; Talreja, R				Okabe, T.; Imamura, H.; Sato, Y.; Higuchi, R.; Koyanagi, J.; Talreja, R.			Experimental and numerical studies of initial cracking in CFRP cross-ply laminates	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Laminates; Transverse cracking; Computational modeling; Finite element analysis (FEA)	FIBER-REINFORCED COMPOSITES; MULTIPLE MATRIX CRACKING; TRANSVERSE CRACKING; VOID NUCLEATION; STRESS FIELDS; FAILURE; PREDICTION; SOLIDS; DEFORMATION; STATE	This work is concerned with the conditions for formation of the first (initial) cracks in composite laminates with cutouts or ply drop-offs subjected to in-plane loading. We study here the crack formation on the free edge of CFRP cross-ply laminates experimentally and by numerical stress and failure analysis. The free-edge surface strains are measured by the digital image correlation (DIC) technique. The numerical analysis consists of a two-scale approach, where the macro-level analysis is performed with a three-dimensional finite-element method (3D FEM) and the micro-level analysis uses a periodic unit-cell (PUC) in the transverse plies. The constitutive assumption made for the macro-level analysis is an orthotropic linear thermo-elastic solid for the unidirectional plies with a thin isotropic viscoplastic layer between the longitudinal and transverse plies. In the PUC, the fibers are assumed linear elastic, while the matrix is modeled as an elastic viscoplastic solid. Crack formation is assumed to occur in the matrix by the dilatation induced brittle failure mechanism for which the dilatation energy density criterion is used. (C) 2014 Elsevier Ltd. All rights reserved.	[Okabe, T.; Imamura, H.; Sato, Y.; Higuchi, R.] Tohoku Univ, Dept Aerosp Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Koyanagi, J.] Tokyo Univ Sci, Dept Mat Sci & Technol, Katsusika Ku, Tokyo 1250051, Japan; [Talreja, R.] Texas A&M Univ, Dept Aerosp Engn, College Stn, TX 77843 USA; [Talreja, R.] Lulea Univ Technol, Dept Engn Sci & Math, SE-97187 Lulea, Sweden	Okabe, T (reprint author), Tohoku Univ, Dept Aerosp Engn, Aoba Ku, 6-6-01 Aoba Yama, Sendai, Miyagi 9808579, Japan.	okabe@plum.mech.tohoku.ac.jp			Toray Industries, Inc.; Toray Composites (America), Inc.; JSPS Core-to-Core Program, A. Advanced Research Networks, "International research core on smart layered materials and structures for energy saving"	T.O. thanks Toray Industries, Inc. and Toray Composites (America), Inc. for support of this study. In addition, this work was partly supported by the JSPS Core-to-Core Program, A. Advanced Research Networks, "International research core on smart layered materials and structures for energy saving".	Matsuda T, 2002, JSME INT J A-SOLID M, V45, P538, DOI 10.1299/jsmea.45.538; Pagano NJ, 1998, COMPOS SCI TECHNOL, V58, P1811, DOI 10.1016/S0266-3538(98)00047-5; PIPES RB, 1970, J COMPOS MATER, V4, P538; Ohno N, 2002, J MECH PHYS SOLIDS, V50, P1125, DOI 10.1016/S0022-5096(01)00106-5; PARVIZI A, 1978, J MATER SCI, V13, P195, DOI 10.1007/BF00739291; Canal LP, 2009, INT J SOLIDS STRUCT, V46, P2265, DOI 10.1016/j.ijsolstr.2009.01.014; Asp LE, 1996, COMPOS SCI TECHNOL, V56, P1291, DOI 10.1016/S0266-3538(96)00090-5; WANG SS, 1982, J APPL MECH-T ASME, V49, P549; LAWS N, 1988, J COMPOS MATER, V22, P900, DOI 10.1177/002199838802201001; ZHANG J, 1992, COMPOSITES, V23, P299, DOI 10.1016/0010-4361(92)90328-R; Hosoi A, 2010, INT J FATIGUE, V32, P29, DOI 10.1016/j.ijfatigue.2009.02.028; Boniface L, 1997, J COMPOS MATER, V31, P1080; Asp LE, 1996, COMPOS SCI TECHNOL, V56, P1089, DOI 10.1016/0266-3538(96)00074-7; Matous K, 2006, INT J NUMER METH ENG, V65, P190, DOI 10.1002/nme.1446; Okabe T, 2011, INT J SOLIDS STRUCT, V48, P2948, DOI 10.1016/j.ijsolstr.2011.06.012; PAGANO NJ, 1978, INT J SOLIDS STRUCT, V14, P385, DOI 10.1016/0020-7683(78)90020-3; Totry E, 2008, COMPOS SCI TECHNOL, V68, P829, DOI 10.1016/j.compscitech.2007.08.023; ZHANG J, 1992, COMPOSITES, V23, P291, DOI 10.1016/0010-4361(92)90327-Q; Canal LP, 2012, COMPOS PART A-APPL S, V43, P1630, DOI 10.1016/j.compositesa.2011.07.014; Aveston A. J., 1973, J MATER SCI, V8, P352; Christensen RM, 1979, MECH COMPOSITE MAT; DVORAK GJ, 1986, ENG FRACT MECH, V25, P763, DOI 10.1016/0013-7944(86)90039-1; FLAGGS DL, 1985, J COMPOS MATER, V19, P29, DOI 10.1177/002199838501900103; GURSON AL, 1977, J ENG MATER-T ASME, V99, P2; HAN YM, 1988, COMPOS SCI TECHNOL, V31, P165, DOI 10.1016/0266-3538(88)90008-5; Jeong HY, 2002, INT J SOLIDS STRUCT, V39, P1385, DOI 10.1016/S0020-7683(01)00260-8; LIM SG, 1989, J COMPOS MATER, V23, P695, DOI 10.1177/002199838902300704; LIM SG, 1989, COMPOS SCI TECHNOL, V34, P145, DOI 10.1016/0266-3538(89)90102-4; NAIRN JA, 1989, J COMPOS MATER, V23, P1106, DOI 10.1177/002199838902301102; PAGANO NJ, 1978, INT J SOLIDS STRUCT, V14, P401, DOI 10.1016/0020-7683(78)90021-5; PEIRCE D, 1984, COMPUT STRUCT, V18, P875, DOI 10.1016/0045-7949(84)90033-6; Sato Y, ADV COMPOS IN PRESS; Tohgo K, 2002, JSME INT J A-SOLID M, V45, P545, DOI 10.1299/jsmea.45.545; WANG SS, 1982, J APPL MECH-T ASME, V49, P541; XIA ZC, 1993, ACTA METALL MATER, V41, P2365, DOI 10.1016/0956-7151(93)90316-K; Zhao FM, 2000, THESIS U TOKYO	36	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						81	89		10.1016/j.compositesa.2014.09.020		9	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400010		
J	Kurita, H; Estili, M; Kwon, H; Miyazaki, T; Zhou, W; Silvain, JF; Kawasaki, A				Kurita, Hiroki; Estili, Mehdi; Kwon, Hansang; Miyazaki, Takamichi; Zhou, Weiwei; Silvain, Jean-Francois; Kawasaki, Akira			Load-bearing contribution of multi-walled carbon nanotubes on tensile response of aluminum	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Metal-matrix composites (MMCs); Mechanical properties; Extrusion; Powder processing	MATRIX COMPOSITES; HOT EXTRUSION; THERMAL-EXPANSION; IMPROVEMENTS; COMBINATION; GRAPHITE; STRENGTH	We fabricated a uniformly dispersed and aligned multi-walled carbon nanotube reinforced aluminum matrix (Al-MWCNT) composite with minimal work hardening and without interfacial chemical compounds. In this paper, the direct load-bearing contribution of MWCNTs on the Al-MWCNT composite was investigated in detail for various volume fractions of MWCNTs. For up to 0.6 vol% of MWCNTs, the ultimate tensile strength (UTS) of the Al-MWCNT composite increased with the conservation of the remarkable failure elongation of Al. These UTS values are consistent with shear lag model. We also observed an uncommon multi-wall-type failure of MWCNTs during the hot extrusion process. However, owing to the agglomeration of MWCNTs in the Al matrix, the UTS deviated significantly from the shear lag model and the remarkable failure elongation of Al decreased. The possibility of strengthening, without degrading ductility, was demonstrated by exploiting directly the load-bearing ability of individually and uniformly dispersed aligned MWCNTs. (C) 2014 Elsevier Ltd. All rights reserved.	[Kurita, Hiroki] CEA Saclay, DEN, DANS, DMN,SRMA,LTMEx, F-91191 Gif Sur Yvette, France; [Kurita, Hiroki; Zhou, Weiwei; Kawasaki, Akira] Tohoku Univ, Dept Mat Proc, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Estili, Mehdi] Natl Inst Mat Sci, Int Ctr Young Scientists, Tsukuba, Ibaraki 3050047, Japan; [Kwon, Hansang] Pukyong Natl Univ, Dept Mat Syst Engn, Pusan 608739, South Korea; [Miyazaki, Takamichi] Tohoku Univ, Sch Engn, Tech Div, Sendai, Miyagi 9808579, Japan; [Silvain, Jean-Francois] CNRS, Inst Chim Mat Condensee Bordeaux, F-33608 Pessac, France	Kurita, H (reprint author), CEA Saclay, DEN, DANS, DMN,SRMA,LTMEx, F-91191 Gif Sur Yvette, France.	hiroki.kurita@live.com; ESTILL.Mehdi@nims.go.jp	Silvain, Jean-Francois/B-9416-2015				Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543; Kurita H, 2011, MATER TRANS, V52, P1960, DOI 10.2320/matertrans.M2011146; George R, 2005, SCRIPTA MATER, V53, P1159, DOI 10.1016/j.scriptamat.2005.07.022; ARSENAULT RJ, 1986, MATER SCI ENG, V81, P175, DOI 10.1016/0025-5416(86)90261-2; Ogata S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165409; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Huang JY, 2006, NATURE, V439, P281, DOI 10.1038/439281a; Estili M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/15/155702; Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211; Choi HJ, 2008, SCRIPTA MATER, V59, P360, DOI 10.1016/j.scriptamat.2008.04.006; Estili M, 2010, ADV MATER, V22, P607, DOI 10.1002/adma.200902140; Estili M, 2012, ADV MATER, V24, P4322, DOI 10.1002/adma.201201134; Kwon H, 2009, CARBON, V47, P570, DOI 10.1016/j.carbon.2008.10.041; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Esawi AMK, 2009, MAT SCI ENG A-STRUCT, V508, P167, DOI 10.1016/j.msea.2009.01.002; Cho S, 2011, CARBON, V49, P3865, DOI 10.1016/j.carbon.2011.05.023; Estili M, 2011, J MATER CHEM, V21, P4272, DOI 10.1039/c0jm03906c; Kelly A, 1966, STRONG SOLIDS, P264; KELLY A, 1965, J MECH PHYS SOLIDS, V13, P329, DOI 10.1016/0022-5096(65)90035-9; Kwon H, 2011, J NANOSCI NANOTECHNO, V11, P4119, DOI 10.1166/jnn.2011.3866; Kwon H, 2009, J NANOSCI NANOTECHNO, V9, P6542, DOI 10.1166/jnn.2009.1357; Lalet G, 2014, J MATER SCI, V49, P3268, DOI 10.1007/s10853-014-8032-7; Lalet G, 2014, J MATER SCI, V49, P397, DOI 10.1007/s10853-013-7717-7; NAKAMIZO M, 1978, CARBON, V16, P281, DOI 10.1016/0008-6223(78)90043-X; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; PAI BC, 1976, MATER SCI ENG, V24, P31, DOI 10.1016/0025-5416(76)90092-6; Xie GQ, 2003, MAT SCI ENG A-STRUCT, V359, P384, DOI 10.1016/S0921-5093(03)00393-9	27	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						133	139		10.1016/j.compositesa.2014.09.014		7	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400015		
J	Sato, N; Hojo, M; Nishikawa, M				Sato, N.; Hojo, M.; Nishikawa, M.			Intralaminar fatigue crack growth properties of conventional and interlayer toughened CFRP laminate under mode I loading	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Fracture toughness; Fatigue; Delamination; Prepreg	INTERLAMINAR FRACTURE-TOUGHNESS; DELAMINATION GROWTH; COMPOSITE-MATERIALS; UNIDIRECTIONAL CFRP; INTERFACE; STRESSES; MATRIX; DAMAGE	Intralaminar and interlaminar fatigue crack growth behaviours under mode I loading were investigated with conventional and interlayer toughened unidirectional CFRP laminates. For intralaminar crack growth tests, initial defects were introduced using "intralaminar film insertion method", in which a release film is inserted inside a single lamina prepreg. A fatigue test under a constant maximum energy release rate, G(max), was carried out using DCB specimens. It was found that the intralaminar fatigue crack growth property of the interlayer toughened CFRP laminates was the same as that of the conventional CFRP laminates. For the interlayer toughened CFRP laminates, the Gmax with a given crack growth rate, da/dN, was much lower for intralaminar crack growth than for interlaminar crack growth. The da/dN-G(max) curve at zero crack extension, Delta a = 0, which was estimated by extrapolating the da/dN-Delta a relationship, was not affected by bridging fibres, and most conservative for the interlayer toughened CFRP laminates. (C) 2014 Elsevier Ltd. All rights reserved.	[Sato, N.] Toray Industries Ltd, Masaki, Ehime, Japan; [Sato, N.; Hojo, M.; Nishikawa, M.] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto, Japan	Sato, N (reprint author), Toray Industries Ltd, 1515 Tsutsui, Masaki, Ehime, Japan.	Narumichi_sato@nts.toray.co.jp					Advani SG, 2003, PROCESS MODELING COM; Zhang JY, 2012, INT J FATIGUE, V40, P7, DOI 10.1016/j.ijfatigue.2012.01.008; HINE PJ, 1993, COMPOS SCI TECHNOL, V47, P65, DOI 10.1016/0266-3538(93)90097-Z; [Anonymous], 2001, 15024 ISO; Liebig WV, 2013, COMPOS SCI TECHNOL, V84, P72, DOI 10.1016/j.compscitech.2013.04.011; Brunner AJ, 2009, ENG FRACT MECH, V76, P2678, DOI 10.1016/j.engfracmech.2009.07.014; Hojo M, 2006, INT J FATIGUE, V28, P1154, DOI 10.1016/j.ijfatigue.2006.02.004; SHEN CH, 1976, J COMPOS MATER, V10, P2, DOI 10.1177/002199837601000101; Hojo M, 2006, COMPOS SCI TECHNOL, V66, P665, DOI 10.1016/j.compscitech.2005.07.038; Stelzer S, 2012, COMPOS SCI TECHNOL, V72, P1102, DOI 10.1016/j.compscitech.2011.11.033; [Anonymous], 2011, D611597 ASTM; Czabaj MW, 2013, COMPOS SCI TECHNOL, V89, P15, DOI 10.1016/j.compscitech.2013.09.008; HOJO M, 1987, COMPOS SCI TECHNOL, V29, P273, DOI 10.1016/0266-3538(87)90076-5; Andersons J, 2004, COMPOS SCI TECHNOL, V64, P2139, DOI 10.1016/j.compscitech.2004.03.007; Hou JP, 2000, COMPOS SCI TECHNOL, V60, P273, DOI 10.1016/S0266-3538(99)00126-8; Tsotsis TK, 2009, POLYM COMPOSITE, V30, P70, DOI 10.1002/pc.20535; Laffan MJ, 2012, POLYM TEST, V31, P481, DOI 10.1016/j.polymertesting.2012.01.002; Maillet I, 2013, COMPOS STRUCT, V97, P353, DOI 10.1016/j.compstruct.2012.10.024; Yokozeki T, 2009, COMPOS SCI TECHNOL, V69, P2268, DOI 10.1016/j.compscitech.2008.12.017; Stevanovic D, 2003, COMPOS SCI TECHNOL, V63, P1949, DOI 10.1016/S0266-3538(03)00162-3; Groleau MR, 1996, COMPOS SCI TECHNOL, V56, P1223, DOI 10.1016/S0266-3538(96)00080-2; [Anonymous], 1988, ASTM STP; SELA N, 1989, COMPOSITES, V20, P423, DOI 10.1016/0010-4361(89)90211-5; Brunner AJ, 2008, ENG FRACT MECH, V75, P2779, DOI 10.1016/j.engfracmech.2007.03.012; [Anonymous], 1993, K7086 JIS; BASCOM WD, 1980, COMPOSITES, V11, P9, DOI 10.1016/0010-4361(80)90016-6; DAVIDSON BD, 1990, J COMPOS MATER, V24, P1124, DOI 10.1177/002199839002401101; Fink BK, 2000, THERMAL DEGRADATION; Gallagher J. P., 1971, Engineering Fracture Mechanics, V3, DOI 10.1016/0013-7944(71)90049-X; GARG AC, 1986, ENG FRACT MECH, V23, P1031, DOI 10.1016/0013-7944(86)90146-3; Gornet L, 2011, INT J DAMAGE MECH, V20, P783, DOI 10.1177/1056789510374166; Hojo M, 1994, P EUR C COMP TEST ST, P553; Hojo M, 1987, ADV MAT SEVERE SERVI, P353; Hojo M, 1995, T JPN SOC MECH ENG, V61, P516; HOJO M, 1995, COMPOSITES, V26, P243, DOI 10.1016/0010-4361(95)93668-A; Iwamoto M, 1999, ENG FRACT MECH, V64, P721, DOI 10.1016/S0013-7944(99)00096-X; Kageyama K, 1987, T JPN SOC MECH ENG, V53, P1898; Kageyama K, 1995, ASTM STP, V1230, P19; Kageyama K, 1990, J SOC NAVAL ARCHITEC, V168, P499; Kalbermatten TD, 1992, J MATER SCI LETT, V11, P543, DOI 10.1007/BF00728603; Kishi H, 1997, J MATER SCI, V32, P761, DOI 10.1023/A:1018512507960; Laffan MJ, 2010, COMPOS SCI TECHNOL, V70, P606, DOI 10.1016/j.compscitech.2009.12.016; Lee JJ, 1995, J MATER SCI, V30, P6179, DOI 10.1007/BF00369665; Lorriot T, 2003, COMPOS PART B-ENG, V34, P459, DOI 10.1016/S1359-8368(03)00016-7; Martin RH, 1990, ASTM STP, V1059, P251; Moura MFSF, 2010, COMPOS STRUCT, V92, P144; Murri GB, 1993, ASTM STP, VFourth, P239; Nakai Y., 1994, Journal of the Society of Materials Science, Japan, V43; O'Brien TK., 2007, 16 INT C COMP MAT IC; Odagiri N, 1996, ADV COMPOS MATER, V5, P249, DOI 10.1163/156855196X00301; Ozdil F, 1992, J COMPOS MATER, V26, P257; Paul K, 2002, J AIRCRAFT, V39, P18; Pinho ST, 2009, COMPOS SCI TECHNOL, V69, P1303, DOI 10.1016/j.compscitech.2009.03.007; Robinson P, 1996, ADV COMPOS LETT, V5, P159; Sato N, 2014, COMPOS PART B-ENG, V65, P89, DOI 10.1016/j.compositesb.2013.10.021; SCOTT JM, 1975, J MATER SCI, V10, P551, DOI 10.1007/BF00566560; Tanaka K., 1995, Journal of the Society of Materials Science, Japan, V44; Tay T. E., 2003, Applied Mechanics Review, V56, DOI 10.1115/1.1504848; Thomas M, 2008, COMPOS SCI TECHNOL, V68, P3184, DOI 10.1016/j.compscitech.2008.07.015	59	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						202	211		10.1016/j.compositesa.2014.09.031		10	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400023		
J	Ning, HM; Li, Y; Li, JH; Hu, N; Liu, YL; Wu, LK; Liu, F				Ning, Huiming; Li, Yuan; Li, Jinhua; Hu, Ning; Liu, Yaolu; Wu, Liangke; Liu, Feng			Toughening effect of CB-epoxy interleaf on the interlaminar mechanical properties of CFRP laminates	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Laminates; Particle-reinforcement; Fracture toughness; Mechanical properties	FIBER-REINFORCED COMPOSITES; FRACTURE-TOUGHNESS; CARBON-BLACK; ELECTRICAL-CONDUCTIVITY; TRANSVERSE LOADS; MODE-I; DELAMINATION; NANOCOMPOSITES; INTERFACE; BEHAVIOR	Carbon black (CB) reinforced epoxy (i.e., CB-epoxy) interleaf was employed to improve the interlaminar mechanical properties of carbon fiber reinforced plastic (CFRP) laminates. Double cantilever beam tests showed that the Mode-I fracture toughness was increased with addition of CB-epoxy interleaf. With 15 g/m(2) addition of CB, the CFRP laminates demonstrated the highest Mode-I fracture toughness and resistance, which were 50.3% and 88.6% higher than those of pristine CFRP laminates, respectively. End notched flexure tests demonstrated the similar toughening effect of CB-epoxy interleaf on the Mode-II fracture toughness of CFRP laminates. With 10 g/m(2) addition of CB, the CFRP laminates demonstrated the highest Mode-II fracture toughness, which was 145% higher than those of pristine CFRP laminates. Fracture surfaces were observed to explore the enhancement mechanisms. Moreover, finite element analyses based on the cohesive zone model were performed, which indicated the increased interlaminar tensile and shear strengths. (C) 2014 Elsevier Ltd. All rights reserved.	[Ning, Huiming; Hu, Ning; Liu, Yaolu; Wu, Liangke] Chongqing Univ, Coll Aerosp Engn, Dept Engn Mech, Chongqing Key Lab Heterogeneous Mat Mech, Chongqing 400044, Peoples R China; [Li, Yuan] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Li, Jinhua] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan; [Liu, Feng] Hunan Univ, Coll Mech & Vehicle Engn, Changsha 412008, Hunan, Peoples R China	Hu, N (reprint author), Chongqing Univ, Coll Aerosp Engn, Dept Engn Mech, Chongqing Key Lab Heterogeneous Mat Mech, Chongqing 400044, Peoples R China.	ninghu@cqu.edu.cn			NSF of China [11372104]	This work is supported by the Research Funds from NSF of China (No. 11372104).	Alderliesten R.C., 2005, FATIGUE CRACK PROPAG; Yan C, 2002, J MATER SCI, V37, P921, DOI 10.1023/A:1014335511515; Gojny FH, 2005, COMPOS PART A-APPL S, V36, P1525, DOI 10.1016/j.compositesa.2005.02.007; Han S, 2008, CARBON, V46, P1060, DOI 10.1016/j.carbon.2008.03.023; Hu N, 2008, MECH MATER, V40, P920, DOI 10.1016/j.mechmat.2008.05.003; Njuguna J, 2007, ADV ENG MATER, V9, P835, DOI 10.1002/adem.200700118; Hojo M, 2006, INT J FATIGUE, V28, P1154, DOI 10.1016/j.ijfatigue.2006.02.004; Kobayashi H, 2007, J APPL POLYM SCI, V106, P152, DOI 10.1002/app.26685; Zhang DH, 2012, COMPOS SCI TECHNOL, V72, P412, DOI 10.1016/j.compscitech.2011.12.002; Arai M, 2008, COMPOS SCI TECHNOL, V68, P516, DOI 10.1016/j.compscitech.2007.06.007; Zaman I, 2011, POLYMER, V52, P1603, DOI 10.1016/j.polymer.2011.02.003; Byrd LW, 2006, COMPOS PART B-ENG, V37, P365, DOI 10.1016/j.compositesb.2005.05.019; Hu N, 2007, COMPOS SCI TECHNOL, V67, P752, DOI 10.1016/j.compscitech.2006.04.014; Ma PC, 2009, ACS APPL MATER INTER, V1, P1090, DOI 10.1021/am9000503; Wichmann MHG, 2006, ENG FRACT MECH, V73, P2346, DOI 10.1016/j.engfracmech.2006.05.015; Yokozeki T, 2009, COMPOS SCI TECHNOL, V69, P2268, DOI 10.1016/j.compscitech.2008.12.017; Khan SU, 2012, CARBON, V50, P5265, DOI 10.1016/j.carbon.2012.07.011; Mouritz AP, 1999, COMPOS PART A-APPL S, V30, P1445, DOI 10.1016/S1359-835X(99)00034-2; Lee SH, 2012, COMPOS SCI TECHNOL, V73, P1, DOI 10.1016/j.compscitech.2012.09.011; Kim BC, 2008, COMPOS STRUCT, V86, P69, DOI 10.1016/j.compstruct.2008.03.005; Rafiee MA, 2009, ACS NANO, V3, P3884, DOI 10.1021/nn9010472; [Anonymous], 1993, K7086 JIS; Li Y, 2009, COMPOS PART A-APPL S, V40, P2004, DOI 10.1016/j.compositesa.2009.09.002; Liang W, 2010, COMPOS STRUCT, V92, P1410; SHU DW, 1993, COMPOS SCI TECHNOL, V49, P165, DOI 10.1016/0266-3538(93)90056-M	25	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						226	234		10.1016/j.compositesa.2014.09.030		9	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400026		
J	Muramatsu, M; Harada, Y; Suzuki, T; Niino, H				Muramatsu, M.; Harada, Y.; Suzuki, T.; Niino, H.			Infrared stress measurements of thermal damage to laser-processed carbon fiber reinforced plastics	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Polymer-matrix composites (PMCs); Non-destructive testing; Cutting; Machining	LOCK-IN THERMOGRAPHY; COMPOSITE-MATERIALS; CFRP; PARAMETERS; STRENGTH	Recently, the laser processing of carbon fiber reinforced plastics (CFRPs) has attracted attention owing to the high processing speed and less tool wear. A problem in the laser processing of CFRPs is the lower strength than that of CFRPs processed by machines. This is considered to be due to the heat-affected zone (HAZ) generated during laser processing. In this study, the stress distributions of CFRPs processed by a laser obtained was evaluated by using infrared thermography. X-ray CT images were also obtained, which enabled us to discuss the stress distribution in terms of the HAZ. The stress distribution showed that the area with reduced stress generated in the HAZ which was introduced by laser processing. The region of low stress in the HAZ was visualized by infrared thermography. It is shown that the regions with reduced stress induce the conventionally reported decrease in strength of laser-processed CFRPs. (C) 2014 Elsevier Ltd. All rights reserved.	[Muramatsu, M.; Harada, Y.; Suzuki, T.] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Tsukuba, Ibaraki 3058564, Japan; [Niino, H.] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan; [Muramatsu, M.; Harada, Y.; Suzuki, T.; Niino, H.] Adv Laser & Proc Technol Res Assoc ALPROT, Minato Ku, Tokyo 1050001, Japan	Muramatsu, M (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	muramatsu@ee.mech.tohoku.ac.jp			High-Power Pulsed Fiber Laser and Processing Technology Project from New Energy and Industrial Technology Development Organization (NEDO) of Japan	This research was partially supported by High-Power Pulsed Fiber Laser and Processing Technology Project from New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Abrate S, 1992, COMPOS MANUF, V3, P95; ABRATE S, 1992, COMPOS MANUF, V3, P75, DOI 10.1016/0956-7143(92)90119-F; Sakagami T, 2002, INFRARED PHYS TECHN, V43, P211, DOI 10.1016/S1350-4495(02)00141-X; Leone C, 2014, OPT LASER ENG, V53, P43, DOI 10.1016/j.optlaseng.2013.07.027; Wolynski A, 2011, PHYSCS PROC, V12, P292, DOI 10.1016/j.phpro.2011.03.136; Pendhari SS, 2008, COMPOS STRUCT, V84, P114, DOI 10.1016/j.compstruct.2007.06.007; Weber R, 2011, PHYSCS PROC, V12, P302, DOI 10.1016/j.phpro.2011.03.137; BUSSE G, 1992, J APPL PHYS, V71, P3962, DOI 10.1063/1.351366; Mathew J, 1999, J MATER PROCESS TECH, V90, P198; CAPRINO G, 1988, INT J MACH TOOL MANU, V28, P389, DOI 10.1016/0890-6955(88)90052-1; Herzog D, 2008, INT J MACH TOOL MANU, V48, P1464, DOI 10.1016/j.ijmachtools.2008.04.007; Teti R, 2002, CIRP ANN-MANUF TECHN, V51, P611, DOI 10.1016/S0007-8506(07)61703-X; Mouritz AP, 1999, COMPOS PART A-APPL S, V30, P1445, DOI 10.1016/S1359-835X(99)00034-2; Cenna AA, 2002, INT J MACH TOOL MANU, V42, P105, DOI 10.1016/S0890-6955(01)00090-6; Baruchel J, 2000, XRAY TOMOGRAPHY MAT, P16; Breitenstein O, 2010, LOCKIN THERMOGRAPHY, P22; Harada Y, 2012, MATER SCI FORUM, V706-709, P649, DOI 10.4028/www.scientific.net/MSF.706-709.649; Jaeschke P, 2011, P SAMPE 2011; Jaeschke P, 2012, P LPCC 2012, V4-1, P1; Jaeschke P, 2000, EXPRESS POLYM LETT, V5, P238; Japan Society of Thermophysical Properties Ed, 1990, THERM PROP HDB, P308; Kawai K, 2012, P 2012 ANN C JSME 20; Leone C, 2013, COMPOS PART A-APPL S, V55, P129, DOI 10.1016/j.compositesa.2013.08.004; Leone C, 2009, P 17 INT C COMP MAT, P1; Maldague X, 2001, THEORY PRACTICE INFR, P355; Negarestani R, 2009, P IMECHE, V224, P1017; Niino H, 2012, P INT S LAS PROC CFR, V4-5, P1; Niino H., 2012, P 31 INT C APPL LAS, V105, P31; Niino H, 2011, PROC SPIE, V7920, DOI 10.1117/12.876231; Sakagami T, 2002, INFRARED PHYS TECHN, V43, P311, DOI 10.1016/S1350-4495(02)00157-3; Steen WM, 1991, LASER MAT PROCESSING, P70; Uenoya T., 2000, Journal of the Society of Materials Science, Japan, V49; WONG AK, 1988, NATURE, V332, P613, DOI 10.1038/332613a0; WONG AK, 1987, J PHYS CHEM SOLIDS, V48, P749, DOI 10.1016/0022-3697(87)90071-0	34	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						242	250		10.1016/j.compositesa.2014.08.033		9	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400028		
J	Hosoi, A; Sakuma, S; Fujita, Y; Kawada, H				Hosoi, Atsushi; Sakuma, Shigeyoshi; Fujita, Yuzo; Kawada, Hiroyuki			Prediction of initiation of transverse cracks in cross-ply CFRP laminates under fatigue loading by fatigue properties of unidirectional CFRP in 90 degrees direction	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Polymer-matrix composites (PMCs); Fatigue; Transverse cracking; Laminate mechanics	GROWTH; COMPOSITES; STRENGTH; BEHAVIOR	A fatigue life to the initiation of transverse cracks in cross-ply carbon fiber-reinforced plastic (CFRP) laminates has been predicted using properties of the fatigue strength of unidirectional CFRP in the 90 degrees direction. In the experiments, unidirectional [90](12) laminates were used to obtain a plot of maximum stress versus number of cycles to breaking, and two types of cross-ply laminates of [0/90(4)](s) and [0/90(6)](s) were used to evaluate the initiation and multiplication of transverse cracks under fatigue loading. Transverse cracks were studied by optical microscopy and soft X-ray photography. Analytical and experimental results showed good agreement, and the fatigue life for transverse crack initiation in cross-ply laminates was predicted successfully from the fatigue strength properties of the unidirectional CFRP in the 90 degrees direction. The prediction results showed a conservative fatigue life than the experimental results. (C) 2014 Elsevier Ltd. All rights reserved.	[Hosoi, Atsushi; Kawada, Hiroyuki] Waseda Univ, Dept Appl Mech & Aerosp Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Sakuma, Shigeyoshi] Waseda Univ, Grad Sch Fundamental Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Fujita, Yuzo] Toray Industries Ltd, Composite Mat Res Labs, Masaki, Ehime 7913193, Japan	Hosoi, A (reprint author), Waseda Univ, Dept Appl Mech & Aerosp Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	hos@aoni.waseda.jp	Hosoi, Atsushi/F-6060-2015				BONIFACE L, 1989, J COMPOS MATER, V23, P735, DOI 10.1177/002199838902300706; Nairn JA, 2000, INT J FRACTURE, V105, P243, DOI 10.1023/A:1007666426275; Sihn S, 2007, COMPOS SCI TECHNOL, V67, P996, DOI 10.1016/j.compscitech.2006.06.008; Saito H, 2012, ADV COMPOS MATER, V21, P57, DOI 10.1163/156855112X629522; Tong J, 2002, INT J FATIGUE, V24, P291, DOI 10.1016/S0142-1123(01)00084-6; Yokozeki T, 2002, J COMPOS MATER, V36, P2085, DOI 10.1106/002199802026978; Bazant ZP, 2004, J ENG MATER-T ASME, V126, P29, DOI 10.1115/1.1631031; Berthelot J.-M., 2003, Applied Mechanics Review, V56, DOI 10.1115/1.1519557; Case SW, 2003, COMPREHENSIVE STRUCT, P405; Harris B, 2003, FATIGUE COMPOSITES; Henaff-Gardin C, 2002, INT J FATIGUE, V24, P389, DOI 10.1016/S0142-1123(01)00094-9; HOJO M, 1994, COMPOSITES, V25, P786, DOI 10.1016/0010-4361(94)90139-2; Hosoi A, 2013, P ICAF 2013 S JER JU, V2, P925; Hosoi A, 2012, T JPN SOC MECH ENG A, V78, P1000; Hosoi A, 2014, INT J I MAT IN PRESS, V1; Kageyama K, 2002, J JAPAN SOC COMPOSIT, V28, P11; Kawai M, 2008, INT J FATIGUE, V30, P1743, DOI 10.1016/j.ijfatigue.2008.02.009; Kawai M, 2006, INT J FATIGUE, V28, P1297, DOI 10.1016/j.ijfatigue.2006.02.013; Kawai M, 2007, P POW ENG SOC GEN M, P1; Kobayashi S, 2002, COMPOS PART B-ENG, V33, P471, DOI 10.1016/S1359-8368(02)00028-8; Kurihara K, 2013, T JPN SOC MECH ENG A, V79, P249; Liu S, 1990, P 5 TECHN C COMP MAT, P287; Nairn JA, 2000, COMPREHENSIVE COMPOS, V2, P403; Nairn JA, 1990, J COMPOS MATER, V24, P223; NAIRN JA, 1989, J COMPOS MATER, V23, P1106, DOI 10.1177/002199838902301102; Ogi K, 2009, J JPN SOC COMPOS MAT, V35, P212; Takamura K, 2011, T JPN SOC MECH ENG A, V77, P1123; Takeda N, 1997, ADV COMPOS MATER, V6, P309, DOI 10.1163/156855197X00166; TAKEDA N, 1995, COMPOSITES, V26, P859, DOI 10.1016/0010-4361(95)90879-5; Takeuchi Hiroki, 2012, Journal of the Japan Society for Composite Materials, V38; Talreja R, 2000, COMPREHENSIVE COMPOS, P529; Wisnom MR, 1999, COMPOS SCI TECHNOL, V59, P1957	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	JAN	2015	68						398	405		10.1016/j.compositesa.2014.10.022		8	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AW7OE	WOS:000346452400044		
J	Unsever, YS; Matsumoto, T; Ozkan, MY				Unsever, Y. S.; Matsumoto, T.; Ozkan, M. Y.			Numerical analyses of load tests on model foundations in dry sand	COMPUTERS AND GEOTECHNICS			English	Article						Piled raft; Vertical load test; Horizontal load test; Numerical modelling; Hardening soil model	PILE; BEHAVIOR	In this study, a series of vertical and cyclic horizontal load tests on 3-pile piled raft model were carried out in dry sand to investigate the piled raft behaviour under combined loads. Also, numerical modelling of experiments were carried out by using FEM software, PLAXIS 3D. Hardening soil model was employed to model the sand, and elastic model was used for the pile and the raft. Soil parameters were estimated from consolidated drained triaxial tests carried on the sand samples and pile parameters were estimated from simple bending tests. It is seen that the behaviour of piled raft is considerably influenced by the interaction of the raft and the piles, and that it is not possible to estimate piled raft behaviour by examining its components individually. (C) 2014 Elsevier Ltd. All rights reserved.	[Unsever, Y. S.; Ozkan, M. Y.] Middle E Tech Univ, Dept Civil Engn, TR-06531 Ankara, Turkey; [Matsumoto, T.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Matsumoto, T (reprint author), Middle E Tech Univ, Dept Civil Engn, Geotech Engn Div, TR-06531 Ankara, Turkey.	ysunsever@gmail.com					Tokimatsu K, 2005, SOIL DYN EARTHQ ENG, V25, P753, DOI 10.1016/j.soildyn.2004.11.018; [Anonymous], 2012, SPEC HIGHW BRIDG 4 S; Yamashita K, 2011, SOILS FOUND, V51, P513; El-Mossallamy Y, 1999, P 7 INT S NUM MOD GE, P443; Franke E., 1994, ASCE GEOT SPEC PUB, V40, P1325; Hecht T, 2001, PFAHL S, V2001, P21; Horikoshi K., 2003, INT J PHYS MODEL GEO, V3, P37; Horikoshi K., 2003, INT J PHYS MODEL GEO, V3, P51; Ishizaki S, 2012, P 9 INT C TEST DES M, P13; Katzenbach R, 2013, INT C STAT ART PIL F; Kimura M., 2000, SOILS FOUND, V40, P113; Matsumoto T, 2010, SOILS FOUND, V50, P63, DOI 10.3208/sandf.50.63; Matsumoto T., 2004, INT J PHYS MODEL GEO, V4, P1; Matsumoto T, 2004, INT J PHYS MODEL GEO, V4, P20; Matsumoto T, 2013, P INT S ADV FDN ENG, P113; Murono T, 1997, P 24 S JAP EARTHQ EN, P625; Plaxis BV, 2013, NETHERLANDS USER MAN; Poulos HG, 2011, GEOTECH ENG J SEAGS, V46, P78; Poulos HG, 2005, CAN GEOTECH J, V42, P716, DOI 10.1139/T05-004; Reul O, 2004, INT J GEOMECH, V4, P59, DOI 10.1061/(ASCE)1532-3641(2004)4:2(59); Schanz T., 1999, 2000 COMPUTATIONAL G, P281; Shibata T, 1989, SOILS FOUND, V29, P31; Tokimatsu K, 2004, SOILS FOUND, V44, P101; Uesugi M., 1986, SOILS FOUND, V26, P139; Unsever YS, 2014, GEOTECH ENG J SEAGS, V45, P40; Yamada T, 2001, P 5 INT C DEEP FDN P, P411; Yamashita K, 2011, GEOTECHNICAL ENG J S, V42, P1; Yamashita K., 2012, P 9 INT C TEST DES M, V1, P79; Yamashita K, 2011, SOILS FOUND, V52, P1000	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	JAN	2015	63						255	266		10.1016/j.compgeo.2014.10.005		12	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	AW6SC	WOS:000346397700021		
J	Hu, Y; Hashimoto, H; Imahori, S; Yagiura, M				Hu, Y.; Hashimoto, H.; Imahori, S.; Yagiura, M.			Efficient implementations of construction heuristics for the rectilinear block packing problem	COMPUTERS & OPERATIONS RESEARCH			English	Article						Strip packing; Rectilinear blocks; Construction heuristics; Efficient implementation	SEQUENCE-PAIR; SEARCH; ALGORITHM	The rectilinear block packing problem is a problem of packing a set of rectilinear blocks into a larger rectangular container, where a rectilinear block is a polygonal block whose interior angle is either 90 degrees or 270 degrees. There exist many applications of this problem, such as VLSI design, timber/glass cutting, and newspaper layout. In this paper, we design efficient implementations of two construction heuristics for rectilinear block packing. The proposed algorithms are tested On a series of instances, which are generated from nine benchmark instances. The computational results show that the proposed algorithms are especially efficient for large instances with repeated shapes. (C) 2014 Elsevier Ltd. All rights reserved.	[Hu, Y.; Hashimoto, H.; Yagiura, M.] Nagoya Univ, Grad Sch Informat Sci, Dept Comp Sci & Math Informat, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Imahori, S.] Nagoya Univ, Grad Sch Engn, Dept Computat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Hu, Y (reprint author), Nagoya Univ, Grad Sch Informat Sci, Dept Comp Sci & Math Informat, Chikusa Ku, Furocho, Nagoya, Aichi 4648601, Japan.	yannanhu@nagoya-u.jp; hasimoto@nagoya-u.jp; imahori@na.cse.nagoya-u.ac.jp; yagiura@nagoya-u.jp					Wascher G, 2007, EUR J OPER RES, V183, P1109, DOI 10.1016/j.ejor.2005.12.047; Burke E, 2006, OPER RES, V54, P587, DOI 10.1287/opre.1060.0293; Nakatake S, 1998, IEEE T COMPUT AID D, V17, P519, DOI 10.1109/43.703832; Imahori S, 2010, COMPUT OPER RES, V37, P325, DOI 10.1016/j.cor.2009.05.008; Hopper E, 2001, EUR J OPER RES, V128, P34, DOI 10.1016/S0377-2217(99)00357-4; BAKER BS, 1980, SIAM J COMPUT, V9, P846, DOI 10.1137/0209064; ALBANO A, 1980, IEEE T SYST MAN CYB, V10, P242, DOI 10.1109/TSMC.1980.4308483; Burke EK, 2004, OPER RES, V52, P655, DOI 10.1287/opre.1040.0109; Bennell JA, 2001, MANAGE SCI, V47, P1160, DOI 10.1287/mnsc.47.8.1160.10230; Imamichi T, 2009, DISCRETE OPTIM, V6, P345, DOI 10.1016/j.disopt.2009.04.002; Art RC, 1966, APPROACH 2 DIMENSION; Bennell JA, 2001, COMPUT OPER RES, V28, P271, DOI 10.1016/S0305-0548(00)00021-6; CHAZELLE B, 1983, IEEE T COMPUT, V32, P697; Chen DB, 2010, COMPUT OPER RES, V37, P1068, DOI 10.1016/j.cor.2009.09.011; DOWSLAND KA, 1993, EUR J OPER RES, V68, P389, DOI 10.1016/0377-2217(93)90195-S; Egeblad J, 2007, EUR J OPER RES, V183, P1249, DOI 10.1016/j.ejor.2005.11.063; Fujiyoshi K, 2007, INTEGRATION, V40, P274, DOI 10.1016/j.vlsi.2006.01.003; Fujiyoshi K, 2000, IEEE T COMPUT AID D, V19, P224, DOI 10.1109/43.828551; Gomes AM, 2006, EUR J OPER RES, V171, P811, DOI 10.1016/j.ejor.2004.09.008; Goncalves JF, 2007, EUR J OPER RES, V183, P1212, DOI 10.1016/j.ejor.2005.11.062; Imahori Shinji, 2014, Journal of the Operations Research Society of Japan, V57; Kang M., 1997, Proceedings of the ASP-DAC '97. Asia and South Pacific Design Automation Conference 1997 (Cat. No.97TH8231), DOI 10.1109/ASPDAC.1997.600145; Kang MZ, 1998, P ICCAD, P259, DOI 10.1145/288548.288623; Lin JM, 2002, IEEE T VLSI SYST, V10, P886, DOI 10.1109/TVLSI.2002.808431; Ma Y, 2003, P 2003 INT S CIRC SY, V5, P493; Pang Y, 2001, P ISPD, P156, DOI 10.1145/369691.369758; Umetani S, 2009, INT T OPER RES, V16, P661, DOI 10.1111/j.1475-3995.2009.00707.x; Wu GM, 2003, ACM T DES AUTOMAT EL, V8, P188, DOI 10.1145/762488.762490; Wu YL, 2002, EUR J OPER RES, V141, P341, DOI 10.1016/S0377-2217(02)00129-7; Xu J, 1998, P ISPD, P173, DOI 10.1145/274535.274561	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0305-0548	1873-765X		COMPUT OPER RES	Comput. Oper. Res.	JAN	2015	53						206	222		10.1016/j.cor.2014.06.021		17	Computer Science, Interdisciplinary Applications; Engineering, Industrial; Operations Research & Management Science	Computer Science; Engineering; Operations Research & Management Science	AW8XL	WOS:000346542600017		
J	Liu, Y; Shimoda, M				Liu, Yang; Shimoda, Masatoshi			Non-parametric shape optimization method for natural vibration design of stiffened shells	COMPUTERS & STRUCTURES			English	Article						Natural vibration; Eigenvalue maximization; Volume minimization; Shape optimization; Non-parametric; Stiffened shells	OPTIMUM DESIGN; PLATES; PANELS; COMPRESSION; FREQUENCY; LAYOUT	In this paper, we newly present an effective shape optimization method for natural vibration design of stiffened thin-walled or shell structures. Both the stiffeners and their basic structures are optimized by solving two kinds of optimization problems. The first is a specified eigenvalue maximization problem subject to a volume constraint, and the second is its reciprocal volume minimization problem subject to a specified eigenvalue constraint. The boundary shapes of a thin-walled structure are determined under the condition where the stiffeners and the basic structure are movable in the in-plane direction to their surface. Both problems are formulated as distributed-parameter shape optimization problems, and the shape gradient functions are derived using the material derivative method and the adjoint variable method. The optimal free-boundary shapes are determined by applying the derived shape gradient function to the H-1 gradient method for shells, which is a parameter-free shape optimization method proposed by one of the authors. Several design examples are presented to validate the proposed method and demonstrate its practical usages. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Yang] Osaka Univ, Dept Mech Engn, Suita, Osaka 5670047, Japan; [Shimoda, Masatoshi] Toyota Technol Inst, Dept Adv Sci & Technol, Tenpaku Ku, Nagoya, Aichi 4688511, Japan	Liu, Y (reprint author), Osaka Univ, Dept Mech Engn, 2-1 Yamadaoka, Suita, Osaka 5670047, Japan.	liuyang60212@gmail.com; shimoda@toyota-ti.ac.jp			Yazaki Memorial Foundation for Science and Technology in Japan	This research was supported by grants-in-aid from the Yazaki Memorial Foundation for Science and Technology in Japan.	Alejandro RD, 1992, INT J NUMER METH ENG, V35, P1487; Bojczuk D, 2008, COMPUT STRUCT, V86, P1436, DOI 10.1016/j.compstruc.2007.05.005; MA ZD, 1995, COMPUT METHOD APPL M, V121, P259, DOI 10.1016/0045-7825(94)00714-X; Luo J, 2003, J VIB ACOUST, V125, P267, DOI 10.1115/1.1569512; BRAIBANT V, 1984, COMPUT METHOD APPL M, V44, P247, DOI 10.1016/0045-7825(84)90132-4; Ding X, 2004, STRUCT MULTIDISCIP O, V26, P99, DOI 10.1007/s00158-003-0309-4; Allemang RJ, 2003, SOUND VIB, V37, P14; Herencia JE, 2007, AIAA J, V45, P2497, DOI 10.2514/1.26321; Zhao CB, 1996, STRUCT OPTIMIZATION, V11, P244, DOI 10.1007/BF01197040; CHENG KT, 1981, INT J SOLIDS STRUCT, V17, P305, DOI 10.1016/0020-7683(81)90065-2; Azegami H, 1994, T JPN SOC MECH ENG A, V60, P1479; AZEGAMI H, 1997, COMPUTER AIDED OPTIM, V5, P309; Bletzinger KU, 2014, STRUCT MULTIDISCIP O, V49, P873, DOI 10.1007/s00158-013-1031-5; Chen BS, 2008, STRUCT MULTIDISCIP O, V36, P83, DOI 10.1007/s00158-007-0174-7; Cheng B, 2010, J CONSTR STEEL RES, V66, P1218, DOI 10.1016/j.jcsr.2010.04.003; Choi KK, 2005, STRUCTURAL SENSITIVI; ELDRED MS, 1995, AIAA J, V33, P1926, DOI 10.2514/3.12747; Haug E. J., 1986, DESIGN SENSITIVITY A; Hughes T. J. R, 1987, FINITE ELEMENT METHO; Ladyzhenskaya O.A., 1968, LINEAR QUASILINEAR E; Liu WL, 2008, STRUCT MULTIDISCIP O, V36, P235, DOI 10.1007/s00158-007-0156-9; Liu Y, 2013, INVERSE PROBLEMS SCI; Liu Y, 2014, STRUCT MULTIDISCIP O, V49, P39, DOI 10.1007/s00158-013-0954-1; Liu ZS, 1998, STRUCT OPTIMIZATION, V16, P155, DOI 10.1007/s001580050016; Luo J, 1998, STRUCT OPTIMIZATION, V16, P280, DOI 10.1007/s001580050029; MacNeal R. H., 1994, FINITE ELEMENTS THEI; PATNAIK SN, 1976, INT J NUMER METH ENG, V10, P283, DOI 10.1002/nme.1620100205; Pironneau O., 1984, OPTIMAL SHAPE DESIGN; REISSNER E, 1945, J APPL MECH-T ASME, V12, pA69; Shimoda M., 2007, SAE J PASSENGER CARS, P483; Shimoda M, 2009, P 8 WORLD C STRUCT M; Shimoda M, 2012, 53 AIAA ASME ASCE AH; Virag Z., 2004, J COMPUT APPL MECH, V5, P165; Yamazaki K, 1988, T JPN SOC MECH ENG A, V54, P1430; Yamazaki K, 1991, T JPN SOC MECH ENG A, V57, P412	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-7949	1879-2243		COMPUT STRUCT	Comput. Struct.	JAN	2015	146						20	31		10.1016/j.compstruc.2014.08.003		12	Computer Science, Interdisciplinary Applications; Engineering, Civil	Computer Science; Engineering	AW9AJ	WOS:000346549900003		
J	Hou, YH; Li, YP; Onodera, E; Zhang, C; Koizumi, YB; Chiba, AB				Hou, Yuhang; Li, Yunping; Onodera, Emi; Zhang, Chen; Koizumi, Yuichiro; Chiba, Akihiko			Ex-situ observation on the dissolution behaviour of Ni-16Cr-15Mo and Ni-30Co-16Cr-15Mo alloys in hydrofluoric acid	CORROSION SCIENCE			English	Article						Interfaces; Alloy; Acid solutions; Acid corrosion; Cobalt; Nickel	NI-BASED ALLOYS; CORROSION-RESISTANCE; PITTING CORROSION; STAINLESS-STEEL; HIGH-STRENGTH; NICKEL; WATER; CU; ENVIRONMENT	Ex-situ observation by laser microscopy was used to investigate the effect of plastic deformation induced by a micro-hardness tester on the corrosion resistance of both Ni-16Cr-15Mo-6Fe-0.5Si (NiCrMo) and Ni-30Co-16Cr-15Mo-6Fe-0.5Si (NiCoCrMo) alloys during immersion in hydrofluoric acid. This found that although the indentation in NiCrMo became slightly deeper and broader following immersion, this effect was far more pronounced with NiCoCrMo. Growth observed in the size of voids is attributed to preferential dissolution of SiO2 particles, as well as an accumulation of dislocations and other defects around them, with these defects also playing a key role in the subsequent coalescence of voids on the sample surface. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.	[Hou, Yuhang; Zhang, Chen] Tohoku Univ, Sch Engn, Sendai, Miyagi 9808577, Japan; [Li, Yunping; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Onodera, Emi] Eiwa Co Ltd, Kamaishi, Iwate 0260001, Japan	Li, YP (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	lyping@imr.tohoku.ac.jp	Li, Yunping/A-8109-2011; Koizumi, Yuichiro/C-2697-2011	Li, Yunping/0000-0002-4657-2923; Koizumi, Yuichiro/0000-0001-7061-7135	Industry Innovation Centre of Iwate Prefecture, Japan	This research was mainly supported by a Program of Industry Innovation Centre of Iwate Prefecture, Japan.	Nakhaie D, 2014, CORROS SCI, V80, P290, DOI 10.1016/j.corsci.2013.11.039; Honesty NR, 2013, CORROS SCI, V67, P67, DOI 10.1016/j.corsci.2012.10.002; Zhang C, 2014, CORROS SCI, V89, P81, DOI 10.1016/j.corsci.2014.08.010; Ye HZ, 2008, J MATER PROCESS TECH, V200, P12, DOI 10.1016/j.jmatprotec.2007.10.066; Wang YX, 2011, CORROS SCI, V53, P2761, DOI 10.1016/j.corsci.2011.05.011; Hou YH, 2014, CORROS SCI, V89, P258, DOI 10.1016/j.corsci.2014.09.004; Wang F, 2014, MATER DESIGN, V64, P441, DOI 10.1016/j.matdes.2014.08.027; Liu SJ, 2007, POLYM TEST, V26, P232, DOI 10.1016/j.polymertesting.2006.10.008; PAWEL SJ, 1994, CORROSION, V50, P963; Vignal V, 2013, CORROS SCI, V68, P275, DOI 10.1016/j.corsci.2012.11.013; Li WJ, 2013, CORROS SCI, V68, P25, DOI 10.1016/j.corsci.2012.10.027; Alizadeh M, 2013, CORROS SCI, V70, P170, DOI 10.1016/j.corsci.2013.01.026; Lu ZP, 2012, CORROS SCI, V58, P211, DOI 10.1016/j.corsci.2012.01.029; Cheng CQ, 2013, CORROS SCI, V70, P235, DOI 10.1016/j.corsci.2013.01.035; Hou J, 2011, CORROS SCI, V53, P1137, DOI 10.1016/j.corsci.2010.11.022; [Anonymous], 1968, INCO CORROSION ENGIN, V5; Yang YG, 2013, CORROS SCI, V73, P250, DOI 10.1016/j.corsci.2013.04.013; Ter-Ovanessian B, 2013, CORROS SCI, V67, P11, DOI 10.1016/j.corsci.2012.09.048; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Gray JJ, 2006, SURF SCI, V600, P2488, DOI 10.1016/j.susc.2006.04.002; Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1767, DOI 10.1016/j.electacta.2005.02.103; Wang FL, 2014, MATER DESIGN, V61, P70, DOI 10.1016/j.matdes.2014.04.034; Jakupi P, 2011, ELECTROCHIM ACTA, V56, P6251, DOI 10.1016/j.electacta.2010.07.064; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Critchlow GW, 2006, INT J ADHES ADHES, V26, P577, DOI 10.1016/j.ijadhadh.2005.09.003; Avramovic Z, 2004, CORROS SCI, V46, P2793, DOI 10.1016/j.corsci.2004.03.010; Bouchaud B, 2013, CORROS SCI, V68, P176, DOI 10.1016/j.corsci.2012.11.010; Kamoutsi H, 2014, CORROS SCI, V80, P139, DOI 10.1016/j.corsci.2013.11.021; Ortiz MR, 2013, CORROS SCI, V68, P72, DOI 10.1016/j.corsci.2012.10.037; Pande AA, 2011, IEEE T SEMICONDUCT M, V24, P104, DOI 10.1109/TSM.2010.2085457; Rebak RB, 2001, MATER CORROS, V52, P289, DOI 10.1002/1521-4176(200104)52:4<289::AID-MACO289>3.0.CO;2-0; Yanagihara K., 2012, JIM AUTUMN MEETING	32	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	JAN	2015	90						133	139		10.1016/j.corsci.2014.10.003		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AW9AC	WOS:000346549200013		
J	Samusawa, I; Shiotani, K				Samusawa, Itaru; Shiotani, Kazuhiko			Influence and role of ethanol minor constituents of fuel grade ethanol on corrosion behavior of carbon steel	CORROSION SCIENCE			English	Article						Carbon steel; AES; XPS; Anodic dissolution; Pitting corrosion	FATIGUE-CRACK PROPAGATION; STORAGE-TANK STEELS; METHANOL; PIPELINE; SUSCEPTIBILITY; ELECTRODE; CHLORIDE; WATER; ACID	The influences of organic acids, chloride and water on the corrosion behavior of carbon steel in fuel grade ethanol (FGE) environments were investigated by immersion testing in simulated FGE. The roles of acetic acid, chloride and water in pitting corrosion were studied by using X-ray photoelectron spectroscopy (XPS), auger electron spectroscopy (AES) and electrochemical experiments. The results indicated that iron acetate is generated on oxide film. Iron(II) acetate shows high solubility in FGE environments. The sites where iron(II) acetate is existed become preferential anodic sites, and chloride promotes anodic dissolution at such sites. (C) 2014 Elsevier Ltd. All rights reserved.	[Samusawa, Itaru; Shiotani, Kazuhiko] JFE Steel Corp, Steel Res Lab, Kurashiki, Okayama 7128511, Japan	Samusawa, I (reprint author), JFE Steel Corp, Steel Res Lab, Kawasakidori 1 Chome, Kurashiki, Okayama 7128511, Japan.	i-samusawa@jfe-steel.co.jp; k-shiotani@jfe-steel.co.jp					Sridhar N, 2006, CORROSION, V62, P687; Lou XY, 2010, CORROS SCI, V52, P2303, DOI 10.1016/j.corsci.2010.03.034; Baena LM, 2012, FUEL, V95, P320, DOI 10.1016/j.fuel.2011.12.002; Lou X, 2009, CORROSION, V65, P785; DESOUZA JP, 1987, CORROS SCI, V27, P1351, DOI 10.1016/0010-938X(87)90130-2; Oelssner W, 2006, MATER CORROS, V57, P455, DOI 10.1002/maco.200603982; ASTM International, 2010, 480610 ASTM; Beavers J. A., 2011, CORROSION, V67; BELLUCCI F, 1988, CORROS SCI, V28, P371, DOI 10.1016/0010-938X(88)90057-1; Bhola SM, 2013, J MATER ENG PERFORM, V22, P316, DOI 10.1007/s11665-012-0235-y; Bhola S.M., 2010, J MATER ENG PERFORM, V20, P409; Brossia CS, 1996, ELECTROCHIM ACTA, V41, P2579, DOI 10.1016/0013-4686(96)00072-2; Cao L, 2013, CORROSION, V69, P851, DOI 10.5006/0895; Cao L, 2013, CORROSION, V69, P768; Cao L, 2013, ELECTROCHIM ACTA, V104, P255, DOI 10.1016/j.electacta.2013.04.112; Capobianco G., 1984, P 9 INT C MET CORR, V3, P532; Goodman LR, 2012, CORROS SCI, V65, P238, DOI 10.1016/j.corsci.2012.08.030; Goodman L.R., 2012, CORROSION 2012; Goodman L.R., 2011, CORROSION 2011; Gui F., 2010, CORROSION, V66; JAHNKE H, 1985, WERKST KORROS, V36, P561; Jain L.A., 2013, CORROSION 2013; Kane R. D., 2003, STRESS CORROSION CRA; Kane RD, 2005, MATER PERFORMANCE, V44, P50; Kane R.D., 2004, CORROSION 2004; Lou X., 2011, CORROSION 2011; Lou X., 2009, CORROSION 2009; Lou XY, 2010, J ELECTROCHEM SOC, V157, pC86, DOI 10.1149/1.3269927; Mazza F., 1984, P 9 INT C MET CORR T, V1, P102; Monteiro MR, 2010, MATER SCI FORUM, V636-637, P1024, DOI 10.4028/www.scientific.net/MSF.636-637.1024; Moulder J. F., 1992, HDB XRAY PHOTOELECTR; SIMBI DJ, 1993, CORROS SCI, V34, P1743, DOI 10.1016/0010-938X(93)90046-J; Simbi DJ, 1997, CORROSION, V53, P298; Singh R, 2009, MATER PERFORMANCE, V48, P53; Sowards JW, 2013, CORROS SCI, V75, P415, DOI 10.1016/j.corsci.2013.06.026; Sowards JW, 2014, CORROS SCI, V79, P128, DOI 10.1016/j.corsci.2013.10.036	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	JAN	2015	90						266	275		10.1016/j.corsci.2014.10.020		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AW9AC	WOS:000346549200026		
J	Robinson, MK; Mogensen, KM; Casey, JD; McKane, CK; Moromizato, T; Rawn, JD; Christopher, KB				Robinson, Malcolm K.; Mogensen, Kris M.; Casey, Jonathan D.; McKane, Caitlin K.; Moromizato, Takuhiro; Rawn, James D.; Christopher, Kenneth B.			The Relationship Among Obesity, Nutritional Status, and Mortality in the Critically Ill	CRITICAL CARE MEDICINE			English	Article						body mass index; critical illness; malnutrition; mortality; nutrition; obesity	BODY-MASS INDEX; INTENSIVE-CARE-UNIT; BLUNT TRAUMA PATIENTS; ADULT MALNUTRITION UNDERNUTRITION; OBSTRUCTIVE PULMONARY-DISEASE; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; HOSPITAL MORTALITY; MECHANICAL VENTILATION; PARENTERAL-NUTRITION	Introduction: The association between obesity and mortality in critically ill patients is unclear based on the current literature. To clarify this relationship, we analyzed the association between obesity and mortality in a large population of critically ill patients and hypothesized that mortality would be impacted by nutritional status. Methods: We performed a single-center observational study of 6,518 adult patients treated in medical and surgical ICUs between 2004 and 2011. All patients received a formal, in-person, and standardized evaluation by a registered dietitian. Body mass index was determined at the time of dietitian consultation from the estimated dry weight or hospital admission weight and categorized a priori as less than 18.5 kg/m(2) (underweight), 18.5-24.9 kg/m(2) (normal/referent), 25-29.9 kg/m(2) (overweight), 30-39.9 kg/m(2) (obesity class I and II), and more than or equal to 40.0 kg/m(2) (obesity class III). Malnutrition diagnoses were categorized as nonspecific malnutrition, protein-energy malnutrition, or well nourished. The primary outcome was all-cause 30-day mortality determined by the Social Security Death Master File. Associations between body mass index groups and mortality were estimated by bivariable and multivariable logistic regression models. Adjusted odds ratios were estimated with inclusion of covariate terms thought to plausibly interact with both body mass index and mortality. We utilized propensity score matching on baseline characteristics and nutrition status to reduce residual confounding of the body mass index category assignment. Results: In the cohort, 5% were underweight, 36% were normal weight, 31% were overweight, 23% had class I/II obesity, and 5% had class III obesity. Nonspecific malnutrition was present in 56%, protein-energy malnutrition was present in 12%, and 32% were well nourished. The 30-day and 90-day mortality rate for the cohort was 19.1 and 26.6%, respectively. Obesity is a significant predictor of improved 30-day mortality following adjustment for age, gender, race, medical versus surgical patient type, Deyo-Charlson index, acute organ failure, vasopressor use, and sepsis: underweight odds ratio 30-day mortality is 1.09 (95% CI, 0.80-1.48), overweight 30-day mortality odds ratio is 0.93 (95% CI, 0.80-1.09), class I/II obesity 30-day mortality odds ratio is 0.80 (95% CI, 0.67-0.96), and class III obesity 30-day mortality odds ratio is 0.69 (95% CI, 0.49-0.97), all relative to patients with body mass index 18.5-24.9 kg/m(2). Importantly, there is confounding of the obesity-mortality association on the basis of malnutrition. Adjustment for only nutrition status attenuates the obesity-30-day mortality association: underweight odds ratio is 0.74 (95% CI, 0.54-1.00), overweight odds ratio is 1.05 (95% CI, 0.90-1.23), class I/II obesity odds ratio is 0.96 (95% CI, 0.81-1.15), and class III obesity odds ratio is 0.81 (95% CI, 0.59-1.12), all relative to patients with body mass index 18.5-24.9 kg/m(2). In a subset of patients with body mass index more than or equal to 30.0 kg/m(2) (n = 1,799), those with either nonspecific or protein-energy malnutrition have increased mortality relative to well-nourished patients with body mass index more than or equal to 30.0 kg/m(2): odds ratio of 90-day mortality is 1.67 (95% CI, 1.29-2.15; p < 0.0001), fully adjusted. In a cohort of propensity score matched patients (n = 3,554), the body mass index-mortality association was not statistically significant, likely from matching on nutrition status. Conclusions: In a large population of critically ill adults, the association between improved mortality and obesity is confounded by malnutrition status. Critically ill obese patients with malnutrition have worse outcomes than obese patients without malnutrition.	[Robinson, Malcolm K.; Rawn, James D.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Mogensen, Kris M.] Brigham & Womens Hosp, Dept Nutr, Boston, MA 02115 USA; [Casey, Jonathan D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [McKane, Caitlin K.] Brigham & Womens Hosp, Dept Nursing, Boston, MA 02115 USA; [Moromizato, Takuhiro] Hokubu Prefectural Hosp, Dept Med, Kunigami Dist, Okinawa, Japan; [Christopher, Kenneth B.] Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA	Christopher, KB (reprint author), Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA.	kbchristopher@partners.org					Abhyankar S, 2012, CRIT CARE, V16, DOI 10.1186/cc11903; Al-Alwan A, 2014, INTENS CARE MED, V40, P556, DOI 10.1007/s00134-014-3247-2; Alban RF, 2006, AM SURGEON, V72, P966; Aldawood A, 2006, ANAESTH INTENS CARE, V34, P629; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Varon J, 2001, CRIT CARE CLIN, V17, P187, DOI 10.1016/S0749-0704(05)70159-7; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Swails WS, 1996, J AM DIET ASSOC, V96, P370, DOI 10.1016/S0002-8223(96)00101-0; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233; Druml W, 2010, INTENS CARE MED, V36, P1221, DOI 10.1007/s00134-010-1844-2; [Anonymous], 1998, WMJ, V97, P24; Ciesla DJ, 2006, J AM COLL SURGEONS, V203, P539, DOI 10.1016/j.jamcollsurg.2006.06.029; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.2009.2014; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Dreyfus B, 2013, CANCER EPIDEMIOL, V37, P191, DOI 10.1016/j.canep.2012.11.001; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Phang PT, 1996, CAN J SURG, V39, P212; Caregaro L, 1996, AM J CLIN NUTR, V63, P602; Kumar G, 2013, CHEST, V144, P48, DOI 10.1378/chest.12-2310; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Ferguson M, 1999, NUTRITION, V15, P458, DOI 10.1016/S0899-9007(99)00084-2; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; White JV, 2012, J ACAD NUTR DIET, V112, P730, DOI 10.1016/j.jand.2012.03.012; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; [Anonymous], 1998, WMJ, V97, P27; Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Kaidar-Person O, 2008, OBES SURG, V18, P1028, DOI 10.1007/s11695-007-9350-5; SIMOPOULOS AP, 1986, ANNU REV PUBL HEALTH, V7, P481, DOI 10.1146/annurev.publhealth.7.1.481; Hutagalung R, 2011, INTENS CARE MED, V37, P1793, DOI 10.1007/s00134-011-2321-2; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Dardaine V, 2001, J AM GERIATR SOC, V49, P564, DOI 10.1046/j.1532-5415.2001.49114.x; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; GRAY DS, 1990, AM J CLIN NUTR, V51, P571; REILLY JJ, 1988, JPEN-PARENTER ENTER, V12, P371, DOI 10.1177/0148607188012004371; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; GallagherAllred CR, 1996, J AM DIET ASSOC, V96, P361, DOI 10.1016/S0002-8223(96)00099-5; Jordao AA, 2004, INT J OBESITY, V28, P1451, DOI 10.1038/sj.ijo.0802781; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; De Lima JJG, 1998, RENAL FAILURE, V20, P581, DOI 10.3109/08860229809045150; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; [Anonymous], 1998, WMJ, V97, P20; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Jacobs DG, 2004, J TRAUMA, V57, P660, DOI 10.1097/01.TA.0000135348.48525.A0; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; INGENBLEEK Y, 1985, INT J VITAM NUTR RES, V55, P91; van Venrooij LMW, 2011, J AM DIET ASSOC, V111, P1924, DOI 10.1016/j.jada.2011.09.009; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; HERRMANN FR, 1992, ARCH INTERN MED, V152, P125, DOI 10.1001/archinte.152.1.125; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185; Kaidar-Person O, 2008, OBES SURG, V18, P870, DOI 10.1007/s11695-007-9349-y; Peake SL, 2006, CRIT CARE MED, V34, P2929, DOI 10.1097/01.CCM.0000248726.75699.B1; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Jensen GL, 2010, JPEN-PARENTER ENTER, V34, P156, DOI 10.1177/0148607110361910; Lawson JA, 2001, J RENAL NUTR, V11, P16, DOI 10.1053/jren.2001.19735; Schweiger C, 2010, OBES SURG, V20, P193, DOI 10.1007/s11695-009-0008-3; Nasraway SA, 2006, CRIT CARE MED, V34, P964, DOI 10.1097/01.CCM.0000205758.18891.70; [Anonymous], 2013, ACUTE INPATIENT PROS; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Blackburn G L, 1977, JPEN J Parenter Enteral Nutr, V1, P11, DOI 10.1177/014860717700100111; BOULANGER BR, 1994, CRIT CARE CLIN, V10, P613; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; BUTTERWO.CE, 1974, JAMA-J AM MED ASSOC, V230, P879; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chlebowski RT, 1995, J AM DIET ASSOC, V95, P433; CHLEBOWSKI RT, 1995, J AM DIET ASSOC, V95, P428, DOI 10.1016/S0002-8223(95)00115-8; Cooke CR, 2012, CRIT CARE MED, V40, P1532, DOI 10.1097/CCM.0b013e31824518f2; DEMPSEY DT, 1988, AM J CLIN NUTR, V47, P352; Fiaccadori E, 1999, J AM SOC NEPHROL, V10, P581; FLEISCH A., 1951, HELVETICA MED ACTA, V18, P23; Gallagher-Allred CR, 1996, J AM DIET ASSOC, V96, P367, DOI DOI 10.1016/S0002-8223(96)00099-5; Gallagher-Allred CR, 1996, J AM DIET ASSOC, V96, P369; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Incalzi RA, 1996, ARCH INTERN MED, V156, P425, DOI 10.1001/archinte.156.4.425; Karkeck J, 1984, AM DIETETIC ASS RENA, V3, P6; Laporte M, 2001, J Nutr Health Aging, V5, P292; Leuven E, 2003, PSMATCH2 STATA MODUL; Marik P, 2003, CRIT CARE SHOCK, V6, P156; Marik P, 1998, CHEST, V113, P492, DOI 10.1378/chest.113.2.492; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Middleton MH, 2001, INTERN MED J, P31455; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; Murphy SN, 2002, P AMIA S, V2002, P552; DeMaria EJ, 2007, J AM COLL SURGEONS, V204, P1062; POTTER JF, 1988, J GERONTOL, V43, pM59; Rubin DB, 1997, ANN INTERN MED, V127, P757; Schisterman EF, 2004, POPUL HEALTH METR, V2, P2, DOI 10.1186/1478-7954-2-2; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group, 1991, N ENGL J MED, V325, P525; Wang HE, 2013, OBESITY, V21, pE762, DOI 10.1002/oby.20468; WILSON AT, 1993, INT J OBESITY, V17, P427	108	9	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2015	43	1					87	100		10.1097/CCM.0000000000000602		14	Critical Care Medicine	General & Internal Medicine	AW6XN	WOS:000346409100032		
J	Nakada, TA; Russell, JA; Boyd, JH; Thair, SA; Walley, KR				Nakada, Taka-aki; Russell, James A.; Boyd, John H.; Thair, Simone A.; Walley, Keith R.			Identification of a Nonsynonymous Polymorphism in the SVEP1 Gene Associated With Altered Clinical Outcomes in Septic Shock	CRITICAL CARE MEDICINE			English	Article						critical care; genetics; genome-wide association study; organ dysfunction; polymorphisms; severe sepsis	GENOME-WIDE ASSOCIATION; CONTROL PROTEIN MODULE; MISSENSE MUTATIONS; CELLULAR ADHESION; EXPRESSION; IL-8; SNPS; STRATIFICATION; SEPSIS; ALPHA	Objectives: Mortality from septic shock is highly heritable. The identification of causal genetic factors is insufficient. To discover key contributors, we first identified nonsynonymous single-nucleotide polymorphisms in conserved genomic regions that are predicted to have significant effects on protein function. We then test the hypothesis that these nonsynonymous single-nucleotide polymorphisms across the genome alter clinical outcome of septic shock. Design: Genetic-association study plus in vitro experiment using primary cells plus in silico analysis using genomic DNA and protein database. Setting: Twenty-seven ICUs at academic teaching centers in Canada, Australia, and the United States. Patients: Patients with septic shock of European ancestry (n = 520). Interventions: Patients with septic shock were genotyped for 843 nonsynonymous single-nucleotide polymorphisms in conserved regions of the genome and are predicted to have damaging effects from the protein sequence. Measurements and Main Results: The primary outcome variable was 28-day mortality. Secondary outcome variables were organ dysfunction. Productions of adhesion molecules including interleukin-8, growth-regulated oncogene-alpha, monocyte chemoattractant protein-1, and monocyte chemoattractant protein-3 were measured in human umbilical vein endothelial cells after SVEP1 gene silencing by RNA interference. Patients with septic shock having the SVEP1 C allele of nonsynonymous single-nucleotide polymorphism, SVEP1 c.2080A>C (p. Gln581His, rs10817033), had a significant increase in the hazard of death over the 28 days (hazard ratio, 1.72; 95% CI, 1.31-2.26; p = 9.7 x 10-5) and increased organ dysfunction and needed more organ support (p < 0.05). Silencing SVEP1 significantly increased interleukin-8, growth-regulated oncogene-alpha, monocyte chemoattractant protein-1, monocyte chemoattractant protein-3 production in human umbilical vein endothelial cells under lipopolysaccharide stimulation (p < 0.01). Conclusions: C allele of SVEP1 c.2080A>C (p. Gln581His) single-nucleotide polymorphism, a non-synonymous single-nucleotide polymorphism in conserved regions and predicted to have damaging effects on protein structure, was associated with increased 28-day mortality and organ dysfunction of septic shock. SVEP1 appears to regulate molecules of the leukocyte adhesion pathway.	[Nakada, Taka-aki; Russell, James A.; Boyd, John H.; Thair, Simone A.; Walley, Keith R.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Crit Care Res Labs, Vancouver, BC V5Z 1M9, Canada; [Nakada, Taka-aki] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Walley, KR (reprint author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Crit Care Res Labs, Vancouver, BC V5Z 1M9, Canada.	keith.walley@hli.ubc.ca					Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; Livaditi O, 2006, CYTOKINE, V36, P283, DOI 10.1016/j.cyto.2007.02.007; Kasvosve I, 2005, AM J CLIN NUTR, V82, P1102; Kotepui M, 2012, ASIAN PAC J CANCER P, V13, P5879, DOI 10.7314/APJCP.2012.13.11.5879; Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Gerszten RE, 1999, NATURE, V398, P718; Sato-Nishiuchi R, 2012, J BIOL CHEM, V287, P25615, DOI 10.1074/jbc.M112.355016; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Arbour NC, 2000, NAT GENET, V25, P187; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; Callebaut I, 2000, PROTEIN SCI, V9, P1382; Chou KC, 1997, J PROTEIN CHEM, V16, P765, DOI 10.1023/A:1026363816730; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Kwa LG, 2008, MOL MICROBIOL, V67, P63, DOI 10.1111/j.1365-2958.2007.06017.x; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Schwanzer-Pfeiffer D, 2010, CELL IMMUNOL, V263, P65, DOI 10.1016/j.cellimm.2010.02.017; Seo SM, 2001, AM J PHYSIOL-CELL PH, V281, pC1568; Shur I, 2006, J CELL PHYSIOL, V206, P420, DOI 10.1002/jcp.20497; Shur I, 2007, J CELL PHYSIOL, V210, P732, DOI 10.1002/jcp.20895; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Turner SD, ANNOTATED MANHATTAN; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P1114	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2015	43	1					101	108		10.1097/CCM.0000000000000604		8	Critical Care Medicine	General & Internal Medicine	AW6XN	WOS:000346409100033		
J	Uchiyama, H; Nakanishi, S; Kozuka, H				Uchiyama, H.; Nakanishi, S.; Kozuka, H.			Biomimetic synthesis of nanostructured SnO particles from Sn6O4(OH)(4) in aqueous solution of gelatin	CRYSTENGCOMM			English	Article							ION-STORAGE MATERIAL; PERIODIC PRECIPITATION; CALCITE CRYSTALS; OXIDE; MATRIX; NANOPARTICLES; NANOCRYSTALS; ARCHITECTURE; NANOSCALE; EMERGENCE	Nanostructured SnO particles were produced by aging Sn6O4(OH)(4) in aqueous solutions containing HCl and gelatin at 60 degrees C, where the morphologies of the SnO products depended on the pH value and the gelatin concentration of the solutions. Flower-like and spherical architectures consisting of radially-branched platy units were obtained by the addition of gelatin, where the branching of SnO crystals was promoted with decreasing pH value and with increasing gelatin contents. The branched structures thus obtained could be formed via diffusion-controlled growth of SnO crystals in viscous solutions.	[Uchiyama, H.; Nakanishi, S.; Kozuka, H.] Kansai Univ, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan	Uchiyama, H (reprint author), Kansai Univ, Dept Chem & Mat Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	h_uchi@kansai-u.ac.jp					ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Sakaushi K, 2010, NANOSCALE, V2, P2424, DOI 10.1039/c0nr00370k; Seto J, 2004, J STRUCT BIOL, V148, P123, DOI 10.1016/j.jsb.2004.04.001; SUDA J, 1995, J PHYS SOC JPN, V64, P348, DOI 10.1143/JPSJ.64.348; Wang ZJ, 2010, ACTA MATER, V58, P4950, DOI 10.1016/j.actamat.2010.05.022; Uchiyama H, 2014, J SOLID STATE CHEM, V217, P87, DOI 10.1016/j.jssc.2014.05.023; Imai H, 2004, ANGEW CHEM INT EDIT, V43, P1363, DOI 10.1002/anie.200352891; Ning JJ, 2009, J PHYS CHEM C, V113, P14140, DOI 10.1021/jp905668p; MULLER SC, 1982, SCIENCE, V216, P635, DOI 10.1126/science.216.4546.635; Sakaushi K, 2010, SMALL, V6, P776, DOI 10.1002/smll.200902207; Yang WD, 2010, CERAM INT, V36, P135, DOI 10.1016/j.ceramint.2009.07.011; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; Oaki Y, 2006, SMALL, V2, P66, DOI 10.1002/smll.200500246; Uchiyama H, 2008, LANGMUIR, V24, P9038, DOI 10.1021/la800955r; Schnepp Z, 2013, ANGEW CHEM INT EDIT, V52, P1096, DOI 10.1002/anie.201206943; Yang W, 2013, ADV MATER, V25, P31, DOI 10.1002/adma.201202713; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Varga J, 1997, COLLOID POLYM SCI, V275, P511, DOI 10.1007/s003960050113; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Zhang JK, 2011, J PHYS CHEM C, V115, P20710, DOI 10.1021/jp206245m; Uchiyama H, 2006, CRYST GROWTH DES, V6, P2186, DOI 10.1021/cg060328p; Aurbach D, 2002, CHEM MATER, V14, P4155, DOI 10.1021/cm021137m; Liu B, 2012, APPL PHYS A-MATER, V107, P437, DOI 10.1007/s00339-012-6760-6; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; Sethmann I, 2006, J INORG BIOCHEM, V100, P88, DOI 10.1016/j.jinorgbio.2005.10.005; DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2; Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821; Tsai FS, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.025002; Uchiyama H, 2007, CRYST GROWTH DES, V7, P841, DOI 10.1021/cg070205k; Avila H. A., 2009, J NONCRYST SOLIDS, V355, P885; Hosono H., 2011, ELECTROCHEM SOLID ST, V14, pII13; Imai H, 2003, CHEM COMMUN, P1952, DOI 10.1039/b304367c; Jouhannaud J, 2008, J SOLID STATE CHEM, V181, P1439, DOI 10.1016/j.jssc.2008.02.040; KELSALL GH, 1990, J ELECTROANAL CHEM, V280, P267, DOI 10.1016/0022-0728(90)87003-3; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Oaki Y, 2007, CHEM COMMUN, P2841, DOI 10.1039/b704129b; Takahashi K, 2004, CHEM COMMUN, P996, DOI 10.1039/b315478e; Uchiyama H, 2009, J MATER CHEM, V19, P4012, DOI 10.1039/b900397e; Uchiyama H, 2013, RSC ADV, V3, P20106, DOI 10.1039/c3ra43580f; Uchlyama H, 2008, ELECTROCHEM COMMUN, V10, P52, DOI 10.1016/j.elecom.2007.10.018; Ning JJ, 2009, LANGMUIR, V25, P1818, DOI 10.1021/la8037473	41	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1466-8033			CRYSTENGCOMM	Crystengcomm		2015	17	3					628	632		10.1039/c4ce01829j		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AW9GP	WOS:000346565700023		
J	Ohta, H; Hamaya, E; Taketsuna, M; Sowa, H				Ohta, Hiroaki; Hamaya, Etsuro; Taketsuna, Masanori; Sowa, Hideaki			Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study	CURRENT MEDICAL RESEARCH AND OPINION			English	Article						Japan; Osteoporosis; postmenopausal; Paln; Quality of life; Raloxifene; Vitamin D	RANDOMIZED CLINICAL-TRIAL; SERUM 25-HYDROXYVITAMIN D; VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; SECONDARY HYPERPARATHYROIDISM; D DEFICIENCY; BACK-PAIN; OUTCOMES; HEALTH; METAANALYSIS	Objectives: To assess the effect of active vitamin D3 on quality of life (QOL) and pain in raloxifene-treated Japanese women with postmenopausal osteoporosis. Research design and methods: This is a post hoc analysis of a previous prospective postmarketing observational study conducted without a comparator group. This study was conducted in 60 Japanese hospitals from September 2007 to February 2009. We compared changes from baseline in QOL and pain in patients receiving raloxifene plus active vitamin D3 with those in patients receiving raloxifene monotherapy at 8 and 24 weeks after treatment. Clinical trial registration: Japan Pharmaceutical Information Center (JapicCTI-070465). Main outcome measures: QOL and pain were assessed using Short Form-8 (SF-8), European Quality of Life Instrument 5 Dimensions (EQ-5D), Japanese Osteoporosis Quality of Life Questionnaire (JOQOL), visual analogue pain scales (VAS pain), and pain frequency scores. Results: A total of 506 patients were included in the post hoc analysis. Both raloxifene monotherapy (RLX, n = 354) and active vitamin D3 cotreatment (COMBI, n = 152) significantly improved QOL and reduced pain from the baseline at Week 8 and Week 24. The COMBI group had significantly greater improvements in JOQOL total score and activity of daily living (total) domain at Week 24 and last observation carried forward (LOCF) than the RLX group. The COMBI group also had significantly greater improvements in SF-8 domains of general health (at Week 8, Week 24, and LOCF), role physical (at Week 24 and LOCF), and mental health (at LOCF) than the RLX group. The COMBI group also had significantly greater reduction in VAS pain at LOCF than the RLX group (mean [SD]: RLX = -0.99 [2.72], COMBI = -1.54 [2.21], P = 0.042). Conclusions: Active vitamin D3 supplementation to raloxifene treatment for 24 weeks may have additional benefits in improving QOL and relieving pain in Japanese women with postmenopausal osteoporosis.	[Ohta, Hiroaki] Int Univ Hlth & Welf, Womens Med Ctr, Sanno Med Ctr, Clin Med Res Ctr, Tokyo, Japan; [Hamaya, Etsuro; Taketsuna, Masanori; Sowa, Hideaki] Eli Lilly Japan KK, Med Dev Unit Japan, Kobe, Hyogo 6510086, Japan	Sowa, H (reprint author), Eli Lilly Japan KK, Med Dev Unit Japan, Chuo Ku, 7-1-5 Isogamidori, Kobe, Hyogo 6510086, Japan.	sowa_hideaki@lilly.com			Eli Lilly Japan KK. ProScribe's services	The authors acknowledge the medical writing assistance provided by Ying Ke PhD and Rebecca Lew PhD CMPP of ProScribe, part of the Envision Pharma Group, funded by Eli Lilly Japan KK. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2).	Adami S, 2009, OSTEOPOROSIS INT, V20, P239, DOI 10.1007/s00198-008-0650-y; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lim SK, 2008, CURR MED RES OPIN, V24, P99, DOI 10.1185/030079908X253429; Kanis JA, 2010, BONE, V47, P729, DOI 10.1016/j.bone.2010.06.009; Barone A, 2007, J AM GERIATR SOC, V55, P752, DOI 10.1111/j.1532-5415.2007.01161.x; Kumamoto K, 2010, J BONE MINER METAB, V28, P1, DOI 10.1007/s00774-009-0125-z; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Boye NDA, 2013, J AM GERIATR SOC, V61, P1948, DOI 10.1111/jgs.12499; Takada J, 2010, J BONE MINER METAB, V28, P561, DOI 10.1007/s00774-010-0164-5; Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Kushida K, 2004, J BONE MINER METAB, V22, P469, DOI 10.1007/s00774-004-0509-z; Scharla S, 2006, CURR MED RES OPIN, V22, P2393, DOI 10.1185/030079906X154097; Andersen SJ, 2007, CLIN OBSTET GYNECOL, V50, P752, DOI 10.1097/GRF.0b013e3180dba614; Motsinger S, 2012, MATURITAS, V71, P267, DOI 10.1016/j.maturitas.2011.12.005; Nakamura K, 2011, OSTEOPOROSIS INT, V22, P97, DOI 10.1007/s00198-010-1213-6; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Haegerstam GAT, 2001, ACTA ORTHOP SCAND, V72, P308, DOI 10.1080/00016470152846682; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Janssen HCJP, 2002, AM J CLIN NUTR, V75, P611; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Fujita T, 2010, J BONE MINER METAB, V28, P477, DOI 10.1007/s00774-009-0155-6; Gallagher JC, 2011, MENOPAUSE, V18, P109, DOI 10.1097/gme.0b013e3181e324a6; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Basaran S, 2007, QUAL LIFE RES, V16, P1491, DOI 10.1007/s11136-007-9257-6; Cranney A, 2005, DRUG SAFETY, V28, P721, DOI 10.2165/00002018-200528080-00006; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Francis R, 2013, VITAMIN D BONE HLTH; Geller Jordan L, 2008, Endocr Pract, V14, P293; Gorai I, 2012, J BONE MINER METAB, V30, P349, DOI 10.1007/s00774-011-0325-1; Lewiecki EM, 2009, J WOMENS HEALTH, V18, P1615, DOI 10.1089/jwh.2008.1086; Maricic M, 2002, ARCH INTERN MED, V162, P1140, DOI 10.1001/archinte.162.10.1140; Morii H, 2003, OSTEOPOROSIS INT, V14, P793, DOI 10.1007/s00198-003-1424-1; Nakamura Toshitaka, 2007, Nihon Rinsho, V65 Suppl 9, P29; Nakamura T, 2006, J BONE MINER METAB, V24, P414, DOI 10.1007/s00774-006-0702-3; NAM Society, 2006, MENOPAUSE, V13, P878; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Heaney RP, 2006, MENOPAUSE, V13, P862, DOI 10.1097/01.gme.0000243566.25205.0b; Ohta H, 2014, CLIN THER, V36, P225, DOI 10.1016/j.clinthera.2013.12.007; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Orimo H, 2000, J BONE MINER METAB, V18, P126, DOI 10.1007/PL00010636; Ringe JD, 2007, CURR MED RES OPIN, V23, P2677, DOI 10.1185/03007X226357; Ringe JD, 2003, OSTEOLOGIE, V12, P23, DOI 10.1024/1019-1291.12.1.23; Seeman E, 2006, OSTEOPOROSIS INT, V17, P313, DOI 10.1007/s00198-005-2030-1; Silverman SL, 2005, J RHEUMATOL, V32, P2405; Stewart JW, 2009, MENOPAUSE, V16, P1093, DOI 10.1097/gme.0b013e3181a8f7ed; Takahashi Hideaki, 2002, Nihon Rinsho, V60 Suppl 3, P479; The EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Treede RD, 1999, OSTEOLOGIE, V4, P195; Ware JE, 2001, SCORE INTERPRET SING; Yoh K, 2012, CURR MED RES OPIN, V28, P1757, DOI 10.1185/03007995.2012.736860; Yoh K, 2005, J BONE MINER METAB, V23, P167, DOI 10.1007/s00774-004-0556-5	56	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-7995	1473-4877		CURR MED RES OPIN	Curr. Med. Res. Opin.	JAN	2015	31	1					85	94		10.1185/03007995.2014.975339		10	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AW8BL	WOS:000346485600012		
J	Asayama, S				Asayama, Shinichiro			Catastrophism toward 'opening up' or 'closing down'? Going beyond the apocalyptic future and geoengineering	CURRENT SOCIOLOGY			English	Article						Catastrophism; climate change; cosmopolitanism; democracy; geoengineering	CLIMATE-CHANGE; DISCOURSES; POLITICS; SCIENCE	Climate change is socially constructed by the way we imagine the future. Catastrophism and the fear of future climate risk dominate public discourse and constitute how we respond to climate change now. In the debate on climate change, there are two competing catastrophisms: one is emancipatory catastrophism, coined by Ulrich Beck; and the other is what the author of this article calls apocalyptic catastrophism - the dystopian imagination of the future climate and a discourse serving to feed the idea of a techno-fix', namely geoengineering the Earth's climate. The two catastrophisms are different in their view on climate change and democracy. This article explores the discursive contours of these two catastrophisms.	Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki 3058506, Japan	Asayama, S (reprint author), Natl Inst Environm Studies, Ctr Social & Environm Syst Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	asayama.shinichiro@nies.go.jp					Hulme M, 2008, GEOGR J, V174, P5, DOI 10.1111/j.1475-4959.2008.00266.x; Rayner S, 2010, CLIM POLICY, V10, P615, DOI 10.3763/cpol.2010.0138; Nerlich B, 2012, METAPHOR SYMBOL, V27, P131, DOI 10.1080/10926488.2012.665795; Szerszynski B, 2013, ENVIRON PLANN A, V45, P2809, DOI 10.1068/a45649; Corner A, 2010, ENVIRONMENT, V52, P24, DOI 10.1080/00139150903479563; Weingart P, 2000, PUBLIC UNDERST SCI, V9, P261, DOI 10.1088/0963-6625/9/3/304; Beck U, 2013, GLOBAL NETW, V13, P1, DOI 10.1111/glob.12001; Beck U, 2014, SEOUL C 2014 CLIM CH; Bulkeley H, 2012, LOCAL ENV, V17, P545; Hamilton C, 2013, NATURE, V496, P139, DOI 10.1038/496139a; Hamilton C, 2014, B ATOM SCI, V70, P17, DOI 10.1177/0096340214531173; Hulme M, 2009, WHY WE DISAGREE ABOUT CLIMATE CHANGE: UNDERSTANDING CONTROVERSY, INACTION AND OPPORTUNITY, P1; Markusson N, 2014, WIRES CLIM CHANGE, V5, P281, DOI 10.1002/wcc.263; Rayner S, 2006, J BEAL MEM LECT GLOB; Royal Society, 2009, GEOENG CLIM SCI GOV; Stirling A, 2014, ENERGY RES SOC SCI, V1, P83, DOI DOI 10.1016/J.ERSS.2014.02.001	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0011-3921	1461-7064		CURR SOCIOL	Curr. Sociol.	JAN	2015	63	1					89	93		10.1177/0011392114559849		5	Sociology	Sociology	AW7BY	WOS:000346420700006		
J	Ogawa, T; Suzuki, T; Hein, NM; Pick, FS; Fryzuk, MD				Ogawa, Takahiko; Suzuki, Tatsuya; Hein, Nicholas M.; Pick, Fraser S.; Fryzuk, Michael D.			Cleavage of an aryl carbon-nitrogen bond of a phosphazido iron(II) complex promoted by hydride metathesis	DALTON TRANSACTIONS			English	Article							STAUDINGER REACTION; MACROBICYCLIC TRIPHOSPHAZIDES; METAL-COMPLEXES; CAGE COMPOUNDS; REACTIVITY; POLYMERIZATION; PHOSPHINIMINE; LIGAND; STABILIZATION; 3-COORDINATE	Upon reaction with KBEt3H, the pseudo tetrahedral Fe(II) complex 5 with a bulky enamido-phosphazide ligand set undergoes elimination of N-2 and 1,3-Me2C6H4 to generate the dinuclear Fe(II) derivative 6 with bridging phosphinimido units. When the reaction is performed using KBEt3D, no deuterium is incorporated into the eliminated 1,3-Me2C6H4; all of the deuterium ends up as D-2. When the reaction is performed in THF-d(8), only 2-d-1,3-Me2C6H3D was detected by GCMS. These studies are consistent with a radical mechanism.	[Ogawa, Takahiko; Suzuki, Tatsuya] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan; [Hein, Nicholas M.; Pick, Fraser S.; Fryzuk, Michael D.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	Fryzuk, MD (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	fryzuk@chem.ubc.ca	Fryzuk, Michael/B-7440-2015		NSERC of Canada for a Discovery grant; Japan Society for the Promotion of Science	We thank NSERC of Canada for a Discovery grant to M. D. F. We also thank the Japan Society for the Promotion of Science for the grant "Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation" to T. O. and T. S.	Alajarin M, 1997, ANGEW CHEM INT EDIT, V36, P67, DOI 10.1002/anie.199700671; Alajarin M, 2006, TETRAHEDRON, V62, P6190, DOI 10.1016/j.tet.2006.04.056; Alajarin M, 1998, CHEM-EUR J, V4, P2558; Alajarin M, 2007, TETRAHEDRON, V63, P2078, DOI 10.1016/j.tet.2006.12.027; Broderick EM, 2011, INORG CHEM, V50, P2870, DOI 10.1021/ic102076g; Guan ZB, 2002, ORGANOMETALLICS, V21, P3580, DOI 10.1021/om020240i; SCRIVEN EFV, 1988, CHEM REV, V88, P297, DOI 10.1021/cr00084a001; Ballmann J, 2010, CHEM COMMUN, V46, P1013, DOI 10.1039/b922853e; Alajarin M, 1999, J CHEM SOC PERK T 2, P1811, DOI 10.1039/a904474d; Wooles AJ, 2010, ORGANOMETALLICS, V29, P2315, DOI 10.1021/om100104s; LePichon L, 2001, INORG CHEM, V40, P3827, DOI 10.1021/ic001303x; Kennedy RD, 2010, CHEM COMMUN, V46, P4782, DOI 10.1039/c0cc00426j; Fortman GC, 2009, INORG CHEM, V48, P1808, DOI 10.1021/ic8024205; CHIDESTER CG, 1988, ACTA CRYSTALLOGR C, V44, P1080, DOI 10.1107/S0108270188002173; Babu RPK, 2000, ORGANOMETALLICS, V19, P3462; Bebbington MWP, 2009, COORDIN CHEM REV, V253, P1248, DOI 10.1016/j.ccr.2008.08.009; Cao TPA, 2012, INORG CHEM, V51, P2157, DOI 10.1021/ic202015z; GOLOLOBOV YG, 1992, TETRAHEDRON, V48, P1353, DOI 10.1016/S0040-4020(01)92229-X; GOLOLOBOV YG, 1981, TETRAHEDRON, V37, P437, DOI 10.1016/S0040-4020(01)92417-2; Molina P, 1996, TETRAHEDRON, V52, P9629, DOI 10.1016/0040-4020(96)00499-1; Li DF, 2011, DALTON T, V40, P2151, DOI 10.1039/c0dt01030h; Yu Y, 2008, J AM CHEM SOC, V130, P6624, DOI 10.1021/ja710669w; Tian WQ, 2004, J ORG CHEM, V69, P4299, DOI 10.1021/jo049702n; Keim W, 2002, J ORGANOMET CHEM, V662, P150, DOI 10.1016/S0022-328X(02)01903-4; Fang GM, 2009, ACTA CHIM SINICA, V67, P2335; Zhu T, 2011, INORG CHEM, V50, P11212, DOI 10.1021/ic201762r; Bebbington MWP, 2007, ANGEW CHEM INT EDIT, V46, P3333, DOI 10.1002/anie.200605078; Bieger K, 1996, J AM CHEM SOC, V118, P1038, DOI 10.1021/ja9531440; Cadierno V, 2000, CHEM-EUR J, V6, P345, DOI 10.1002/(SICI)1521-3765(20000117)6:2<345::AID-CHEM345>3.0.CO;2-Q; Cantat T., 2008, DALTON T, P1957; Cariou R, 2011, DALTON T, V40, P5419, DOI 10.1039/c1dt10341e; Cooper OJ, 2010, DALTON T, V39, P5074, DOI 10.1039/c0dt00152j; Ding KY, 2009, J AM CHEM SOC, V131, P10804, DOI 10.1021/ja902812y; Gamer MT, 2007, ORGANOMETALLICS, V26, P651, DOI 10.1021/om0608307; HILLHOUSE GL, 1982, INORG CHEM, V21, P2064, DOI 10.1021/ic00135a068; LAPLAZA CE, 1995, J AM CHEM SOC, V117, P4999, DOI 10.1021/ja00122a033; Liu B, 2009, ORGANOMETALLICS, V28, P1453, DOI 10.1021/om801004r; Liu Jiongyu, 2007, Chinese Journal of Applied and Environmental Biology, V13, P834; Ma GB, 2011, INORG CHEM, V50, P6500, DOI 10.1021/ic102537q; Ong CM, 1999, ORGANOMETALLICS, V18, P4197, DOI 10.1021/om9904044; Stute A, 2012, CHEM COMMUN, V48, P11739, DOI 10.1039/c2cc36782c; Tian WQ, 2005, J CHEM THEORY COMPUT, V1, P353, DOI 10.1021/ct049918x; Welch GC, 2004, ORGANOMETALLICS, V23, P1811, DOI 10.1021/om034302w; Widauer C, 1999, EUR J INORG CHEM, P1659; Wiecko M, 2009, ORGANOMETALLICS, V28, P1266, DOI 10.1021/om800989x; Wooles AJ, 2011, ORGANOMETALLICS, V30, P5314, DOI 10.1021/om200553s	46	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					54	57		10.1039/c4dt03136a		4	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900007		
J	Mikata, Y; Kizu, A; Konno, H				Mikata, Yuji; Kizu, Asako; Konno, Hideo			TQPHEN (N,N,N ',N '-tetrakis(2-quinolylmethyl)-1,2-phenylenediamine) derivatives as highly selective fluorescent probes for Cd2+	DALTON TRANSACTIONS			English	Article							ZINC SENSORS; IN-VIVO; DISTINGUISHING CADMIUM; ENHANCED FLUORESCENCE; OXIDATIVE STRESS; AQUEOUS-SOLUTION; QUANTUM DOTS; METAL-IONS; CHEMOSENSOR; WATER	TQPHEN (N,N,N',N'-tetrakis(2-quinolylmethyl)-1,2-phenylenediamine) and its methoxy-substituted derivatives, 6-MeOTQPHEN (N,N,N',N'-tetrakis(6-methoxy-2-quinolylmethyl)-1,2-phenylenediamine) and TriMeOTQPHEN (N,N,N',N'-tetrakis(5,6,7-trimethoxy-2-quinolylmethyl)-1,2-phenylenediamine), were examined as fluorescent Cd2+ sensors. Although the TQPHEN exhibits a negligible fluorescence response toward Zn2+ due to weak binding affinity in DMF-H2O (1 : 1), a 6-fold fluorescence enhancement at 392 nm was observed in the presence of 1 equiv. of Cd2+. Comprehensive X-ray crystallographic analyses of TQPHEN-Zn2+ and TQPHEN-Cd2+ complexes reveal that significant distortion in the Zn2+ complex plays a key role in the Cd2+ specificity of TQPHEN. The TriMeOTQPHEN exhibits excellent sensitivity and selectivity for Cd2+ detection (I-Cd/I-0 = 44, I-Cd/I-Zn = 20 and LODCd = similar to 10 nM (LOD = limit of detection)). On the other hand, the trans-1,2-cyclohexanediamine derivative TQDACH (N,N,N',N'-tetrakis(2-quinolylmethyl)-trans-1,2-cyclohexanediamine) exhibits high Zn2+ specificity in the fluorescence response and extremely high Zn2+ binding affinity (Dalton Trans., 2013, 42, 9688). Subtle differences in the PHEN and DACH backbone significantly alter the stability with a specific metal and the fluorescence response of tetrakisquinoline-based fluorescent probes.	[Mikata, Yuji] Nara Womens Univ, KYOUSEI Sci Ctr, Nara 6308506, Japan; [Mikata, Yuji; Kizu, Asako] Nara Womens Univ, Fac Sci, Dept Chem, Nara 6308506, Japan; [Konno, Hideo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Mikata, Y (reprint author), Nara Womens Univ, KYOUSEI Sci Ctr, Nara 6308506, Japan.	mikata@cc.nara-wu.ac.jp			Research for Promoting Technological Seeds, JST; Adaptable and Seamless Technology Transfer Program through Target-driven RD, JST; MEXT, Japan; Nara Women's University Intramural Grant for Project Research	This work was supported by the Research for Promoting Technological Seeds, JST, Adaptable and Seamless Technology Transfer Program through Target-driven R&D, JST, Grant-in Aid for Scientific Research from the MEXT, Japan and the Nara Women's University Intramural Grant for Project Research.	Tang XL, 2008, ORG LETT, V10, P3653, DOI 10.1021/ol801382f; Cockrell GM, 2008, J AM CHEM SOC, V130, P1420, DOI 10.1021/ja077141m; Meng XM, 2012, CHEM COMMUN, V48, P4196, DOI 10.1039/c2cc30471f; Cheng TY, 2008, J AM CHEM SOC, V130, P16160, DOI 10.1021/ja806928n; Lu CL, 2007, J ORG CHEM, V72, P3554, DOI 10.1021/jo070033y; Gao CJ, 2013, SENSOR ACTUAT B-CHEM, V176, P775, DOI 10.1016/j.snb.2012.09.052; Wang HH, 2007, ORG LETT, V9, P4995, DOI 10.1021/ol702192m; Hyman LM, 2012, COORDIN CHEM REV, V256, P2333, DOI 10.1016/j.ccr.2012.03.009; Xue L, 2011, INORG CHEM, V50, P3680, DOI 10.1021/ic200032e; Cheng TY, 2011, ORG LETT, V13, P3656, DOI 10.1021/ol201305d; Aragoni MC, 2013, DALTON T, V42, P14516, DOI 10.1039/c3dt51292d; Taki M, 2008, J AM CHEM SOC, V130, P12564, DOI 10.1021/ja803429z; Kim JH, 2013, DALTON T, V42, P5500, DOI 10.1039/c3dt33024a; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Jeong Y, 2012, INORG CHIM ACTA, V381, P2, DOI 10.1016/j.ica.2011.09.011; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Williams NJ, 2009, INORG CHEM, V48, P1407, DOI 10.1021/ic801403s; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Xue L, 2008, INORG CHEM, V47, P4310, DOI 10.1021/ic702393z; Callan JF, 2005, TETRAHEDRON, V61, P8551, DOI 10.1016/j.tet.2005.05.043; Mikata Y, 2013, DALTON T, V42, P9688, DOI 10.1039/c3dt50719j; Hancock RD, 2013, CHEM SOC REV, V42, P1500, DOI 10.1039/c2cs35224a; Xue L, 2009, ORG LETT, V11, P1655, DOI 10.1021/ol900315r; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Zhou XY, 2012, INORG CHEM, V51, P9226, DOI 10.1021/ic300661c; Peng XJ, 2007, J AM CHEM SOC, V129, P1500, DOI 10.1021/ja0643319; Jarup L, 2002, NEPHROL DIAL TRANSPL, V17, P35; Mikata Y, 2014, DALTON T, V43, P10751, DOI 10.1039/c4dt01054j; Li YM, 2012, DALTON T, V41, P6189, DOI 10.1039/c2dt30192j; Zhang Y, 2008, ORG LETT, V10, P473, DOI 10.1021/ol702869w; Cai YL, 2013, TETRAHEDRON LETT, V54, P1125, DOI 10.1016/j.tetlet.2012.12.054; Smith AM, 2008, ADV DRUG DELIVER REV, V60, P1226, DOI 10.1016/j.addr.2008.03.015; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Costero AM, 2004, TETRAHEDRON, V60, P6327, DOI 10.1016/j.tet.2004.05.075; Li ZP, 2011, INORG CHEM COMMUN, V14, P1241, DOI 10.1016/j.inoche.2011.04.031; Mikata Y, 2006, INORG CHEM, V45, P9262, DOI 10.1021/ic060810x; Mikata Y, 2014, DALTON T, V43, P1684, DOI 10.1039/c3dt52107a; Mikata Y, 2009, DALTON T, P3800, DOI 10.1039/b820763a; Mikata Y, 2014, RSC ADV, V4, P12849, DOI 10.1039/c4ra00010b; Turba S, 2008, INORG CHEM, V47, P9612, DOI 10.1021/ic800244g	40	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					104	109		10.1039/c4dt02177k		6	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900016		
J	Dutta, S; Sahoo, R; Ray, C; Sarkar, S; Jana, J; Negishi, Y; Pal, T				Dutta, Soumen; Sahoo, Ramakrishna; Ray, Chaiti; Sarkar, Sougata; Jana, Jayasmita; Negishi, Yuichi; Pal, Tarasankar			Biomolecule-mediated CdS-TiO2-reduced graphene oxide ternary nanocomposites for efficient visible light-driven photocatalysis	DALTON TRANSACTIONS			English	Article							HYDROGEN GENERATION; CDS NANOCOMPOSITES; CRYSTAL-STRUCTURE; CADMIUM-SULFIDE; TIO2; DEGRADATION; PERFORMANCE; REDUCTION; COMPOSITE; CARBON	We report an environmentally friendly synthetic strategy to fabricate reduced graphene oxide (rGO)based ternary nanocomposites, in which glutathione (GSH) acts both as a reducing agent for graphene oxide and sulfur donor for CdS synthesis under modified hydrothermal (MHT) conditions. The report becomes interesting as pH variation evolves two distinctly different semiconducting nanocrystals of anatase/rutile TiO2 and hexagonal yellow/cubic red CdS, and their packaging makes them suitable photocatalysts for dye degradation. Herein, a titanium peroxo compound, obtained from commercial TiO2, is hydrolyzed to TiO2 nanostructures without any additives. The yellow colored CdS-TiO2-rGO (YCTG), one of the ternary photocatalysts, shows maximum efficiency compared to the corresponding red ternary CdS-TiO2-rGO or binary photocatalysts (CdS-rGO, TiO2-rGO and CdS-TiO2) for dye degradation under visible light irradiation. Systematic characterizations reveal that TiO2 presents at the interface of rGO and CdS in YCTG and thus makes a barrier that inhibits the direct interaction between rGO and CdS. This leads to a relatively higher bandgap value for CdS in YCTG (2.15 eV vs. 2.04 eV for CdS-rGO) but with better photocatalytic activity simply by diminishing the possibility of the charge-recombination process. In the present situation, rGO in the YCTG also supports faster dye degradation through higher dye adsorption and rapid internal electron transfer (CdS -> TiO2 -> rGO) in the YCTG nanocomposite. Thus, a simple aqueous phase and a greener synthetic procedure results in a low-cost, highly effective visible light-responsive material for environmental application.	[Dutta, Soumen; Sahoo, Ramakrishna; Ray, Chaiti; Sarkar, Sougata; Jana, Jayasmita; Pal, Tarasankar] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India; [Negishi, Yuichi] Tokyo Univ Sci, Dept Appl Chem, Tokyo 1628601, Japan	Pal, T (reprint author), Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India.	tpal@chem.iitkgp.ernet.in	Dutta, Soumen/N-9610-2014		CSIR, New Delhi, India, and IIT Kharagpur	The authors are thankful to CSIR, New Delhi, India, and IIT Kharagpur for financial and instrumental assistance. The authors are thankful to Prof. Kumar Biradha, IIT Kharagpur, for providing the facility for the BET surface area measurements.	Yang HH, 2013, J PHYS CHEM C, V117, P20406, DOI 10.1021/jp405227t; Shih CJ, 2012, LANGMUIR, V28, P235, DOI 10.1021/la203607w; Gao HC, 2013, ACS APPL MATER INTER, V5, P425, DOI 10.1021/am302500v; Zhang N, 2012, J PHYS CHEM C, V116, P18023, DOI 10.1021/jp303503c; Khan Z, 2012, RSC ADV, V2, P12122, DOI 10.1039/c2ra21596a; Dutta S, 2013, RSC ADV, V3, P21475, DOI 10.1039/c3ra44069a; Lin YM, 2012, J PHYS CHEM C, V116, P5764, DOI 10.1021/jp211222w; Yu JG, 2014, J MATER CHEM A, V2, P3407, DOI 10.1039/c3ta14493c; Yu JG, 2007, J PHYS CHEM C, V111, P10582, DOI 10.1021/jp0707889; George S, 2011, J AM CHEM SOC, V133, P11270, DOI 10.1021/ja202836s; Schneider J, 2013, J PHYS CHEM LETT, V4, P3479, DOI 10.1021/jz4018199; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Chang K, 2011, ACS NANO, V5, P4720, DOI 10.1021/nn200659w; Xiang QJ, 2012, J AM CHEM SOC, V134, P6575, DOI 10.1021/ja302846n; Zhang H, 2011, ENVIRON SCI TECHNOL, V45, P5731, DOI 10.1021/es2002919; Sahoo R, 2014, J PHYS CHEM C, V118, P11485, DOI 10.1021/jp503393x; Liu YJ, 2008, J COLLOID INTERF SCI, V322, P497, DOI 10.1016/j.jcis.2008.03.034; Qian T, 2013, J MATER CHEM A, V1, P6539, DOI 10.1039/c3ta11146f; Li Q, 2011, J AM CHEM SOC, V133, P10878, DOI 10.1021/ja2025454; Ma JK, 2013, J MATER CHEM A, V1, P2192, DOI 10.1039/c2ta00340f; Liu SQ, 2012, ACS APPL MATER INTER, V4, P6378, DOI 10.1021/am302074p; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Xiang QJ, 2013, J PHYS CHEM LETT, V4, P753, DOI 10.1021/jz302048d; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Qu YQ, 2013, CHEM SOC REV, V42, P2568, DOI 10.1039/c2cs35355e; Sinha AK, 2013, ENVIRON SCI TECHNOL, V47, P2339, DOI 10.1021/es303413q; Fu ZL, 2005, MATER RES BULL, V40, P1591, DOI 10.1016/j.materresbull.2005.04.039; Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Pham TA, 2011, COLLOID SURFACE A, V384, P543, DOI 10.1016/j.colsurfa.2011.05.019; Liu SQ, 2014, J MATER CHEM A, V2, P430, DOI 10.1039/c3ta13892e; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068; Li CL, 2011, INT J HYDROGEN ENERG, V36, P4271, DOI 10.1016/j.ijhydene.2011.01.022; Zhou XJ, 2011, J PHYS CHEM C, V115, P11957, DOI 10.1021/jp202575j; Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d; Robel I, 2005, ADV MATER, V17, P2458, DOI 10.1002/adma.200500418; Zhao XM, 2012, ANALYST, V137, P3697, DOI 10.1039/c2an35658a; Wang Y, 2014, J MATER CHEM A, V2, P3847, DOI 10.1039/c3ta14908k; Sinha AK, 2009, CRYSTENGCOMM, V11, P1210, DOI 10.1039/b906041n; Peng TY, 2012, J PHYS CHEM C, V116, P22720, DOI 10.1021/jp306947d; Lv T, 2012, CATAL SCI TECHNOL, V2, P754, DOI 10.1039/c2cy00452f; Yang YC, 2013, ACS APPL MATER INTER, V5, P6201, DOI 10.1021/am401167y; Mondal A, 2014, ACS CATAL, V4, P593, DOI 10.1021/cs401032p; Stengl V, 2011, J PHYS CHEM C, V115, P25209, DOI 10.1021/jp207515z; Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j; Zhang J, 2012, NANO LETT, V12, P4584, DOI 10.1021/nl301831h; Fang J, 2013, ACS APPL MATER INTER, V5, P8088, DOI 10.1021/am4021654; Wei QS, 2006, CHEM MATER, V18, P5080, DOI 10.1021/cm061697b; Chen Z, 2013, ACS APPL MATER INTER, V5, P13353, DOI 10.1021/am4043068; Dutta S, 2013, ACS APPL MATER INTER, V5, P8724, DOI 10.1021/am4025017; Lightcap I.V., 2012, ACCOUNTS CHEM RES, V46, P2235; Liu JP, 2011, TRANSPL INFECT DIS, V13, P24, DOI 10.1111/j.1399-3062.2010.00556.x; Liu XJ, 2012, INT J HYDROGEN ENERG, V37, P1375, DOI 10.1016/j.ijhydene.2011.10.030; Milligan WO, 1934, J PHYS CHEM-US, V38, P797, DOI 10.1021/j150357a009; Ray C, 2013, RSC ADV, V3, P24313, DOI 10.1039/c3ra44102d; SPERLING S, 1979, ACTA OPHTHALMOL, V57, P891	56	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					193	201		10.1039/c4dt02749c		9	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900027		
J	Jana, A; Gobeze, HB; Ishida, M; Mori, T; Ariga, K; Hill, JP; D'Souza, F				Jana, Atanu; Gobeze, Habtom B.; Ishida, Masatoshi; Mori, Toshiyuki; Ariga, Katsuhiko; Hill, Jonathan P.; D'Souza, Francis			Breaking aggregation in a tetrathiafulvalene-fused zinc porphyrin by metal-ligand coordination to form a donor-acceptor hybrid for ultrafast charge separation and charge stabilization	DALTON TRANSACTIONS			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ARTIFICIAL PHOTOSYNTHETIC SYSTEMS; PHOTOSYSTEM-II; FLUORESCENCE; ABSORPTION; DERIVATIVES; ASSEMBLIES; COMPLEXES; SWITCH; DYADS	A novel electron rich, tetrathiafulvalene fused zinc porphyrin, (TTF)(4)PZn, has been newly synthesized and characterized using spectral and electrochemical methods. In spite of the presence of eight t-butyl groups, (TTF)(4)PZn exhibited appreciable aggregation in solution. Scanning electron microscopic (SEM) imaging of the aggregates revealed their spherical particulate morphology. Attenuation of intermolecular aggregation was possible by metal-ligand coordination of a nitrogenous ligand. Further, using this strategy, a donor-acceptor hybrid was formed by coordinating imidazole functionalized fullerene as an electron acceptor. The occurrence of intrasupramolecular ultrafast photoinduced charge separation has been established using fluorescence and transient absorption spectroscopic techniques. The determined rate of charge separation, k(CS), and rate of charge recombination, k(CR) were found to be 1.4 x 10(11) s(-1) and 2.5 x 10(6) s(-1), respectively. The lower k(CR) values indicate charge stabilization in the assembled donor-acceptor conjugate via an electron transfer-hole transfer mechanism.	[Jana, Atanu; Ariga, Katsuhiko; Hill, Jonathan P.] Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, Supermol Grp, Tsukuba, Ibaraki 3050044, Japan; [Gobeze, Habtom B.; D'Souza, Francis] Univ N Texas, Dept Chem, Denton, TX 76203 USA; [Ishida, Masatoshi] Kyushu Univ, Educ Ctr Global Leaders Mol Syst Devices, Fukuoka 8190395, Japan; [Mori, Toshiyuki] Natl Inst Mat Sci, Fuel Cell Mat Grp, Tsukuba, Ibaraki 3050044, Japan; [Ariga, Katsuhiko; Hill, Jonathan P.] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan	Hill, JP (reprint author), Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, Supermol Grp, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	jonathan.hill@nims.go.jp; Francis.DSouza@UNT.edu	ARIGA, Katsuhiko/H-2695-2011		World Premier International Research Center Initiative on Materials Nanoarchitectonics from MEXT, Japan; Core Research for Evolutional Science and Technology (CREST) program of JST, Japan; NSF [1110942, 1401188]	This research was partly supported by the World Premier International Research Center Initiative on Materials Nanoarchitectonics from MEXT, Japan, and by the Core Research for Evolutional Science and Technology (CREST) program of JST, Japan. FD acknowledges support from the NSF (grant no. 1110942 and 1401188).	Das SK, 2014, J PHYS CHEM C, V118, P3994, DOI 10.1021/jp4118166; Nielsen KA, 2009, CHEM-EUR J, V15, P506, DOI 10.1002/chem.200801636; Imahori H, 2001, J PHYS CHEM A, V105, P1750, DOI 10.1021/jp003207n; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Fukuzumi S, 2008, J MATER CHEM, V18, P1427, DOI 10.1039/b717958h; Ito O, 2012, MOLECULES, V17, P5816, DOI 10.3390/molecules17055816; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Jelley EE, 1936, NATURE, V138, P1009, DOI 10.1038/1381009a0; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Jeppesen JO, 2000, J ORG CHEM, V65, P5794, DOI 10.1021/jo000742a; D'Souza F, 2002, J PHYS CHEM A, V106, P3243, DOI 10.1021/jp013165i; Maiti NC, 1998, J PHYS CHEM B, V102, P1528, DOI 10.1021/jp9723372; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Bill NL, 2013, J AM CHEM SOC, V135, P10852, DOI 10.1021/ja404830y; Claessens CG, 2002, CHEM REV, V102, P835, DOI 10.1021/cr0101454; ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; El-Khouly ME, 2014, CHEMPHYSCHEM, V15, P30, DOI 10.1002/cphc.201300715; Wang CS, 1998, SYNTHESIS-STUTTGART, P1615; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m; Jia HP, 2012, CHEMPHYSCHEM, V13, P3370, DOI 10.1002/cphc.201200350; Sgobba V, 2009, CHEM SOC REV, V38, P165, DOI 10.1039/b802652c; Fukuzumi S, 2012, CHEM COMMUN, V48, P9801, DOI 10.1039/c2cc32848h; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Satake A, 2007, ORG BIOMOL CHEM, V5, P1679, DOI 10.1039/b703405a; Schuster DI, 2006, CR CHIM, V9, P892, DOI 10.1016/j.crci.2005.11.013; Wijesinghe CA, 2013, CHEM-EUR J, V19, P9629, DOI 10.1002/chem.201300877; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; El-Khouly ME, 2004, J PHOTOCH PHOTOBIO C, V5, P79, DOI 10.1016/j.jphotochemrev.2004.01.003; Fukuzumi S, 2011, J AM CHEM SOC, V133, P15938, DOI 10.1021/ja207588c; D'Souza F, 2012, CHEM SOC REV, V41, P86, DOI 10.1039/c1cs15201g; BARBER DC, 1991, J PHYS CHEM-US, V95, P4074, DOI 10.1021/j100163a035; Becher J, 2001, ANGEW CHEM INT EDIT, V40, P2497, DOI 10.1002/1521-3773(20010702)40:13<2497::AID-ANIE2497>3.0.CO;2-F; D'Souza F, 2013, ORGANIC NANOMATERIALS: SYNTHESIS, CHARACTERIZATION, AND DEVICE APPLICATIONS, P187; Fleming AJ, 2003, J PHYS CHEM B, V107, P37, DOI 10.1021/jp0262618; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Imahori H, 2002, J AM CHEM SOC, V124, P5165, DOI 10.1021/ja016655x; Jana A, 2013, CHEM-EUR J, V19, P338, DOI 10.1002/chem.201202727; Li HC, 2003, CHEM COMMUN, P846, DOI 10.1039/b212456d; Rubio-Pons O, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178790; Scheibe G, 1937, ANGEW CHEM-GER EDIT, V50, P0212, DOI 10.1002/ange.19370501103; Steed J. W., 2009, SUPRAMOLECULAR CHEM; Utschig LM, 2004, ACCOUNTS CHEM RES, V37, P439, DOI 10.1021/ar020197v; WELLER A, 1982, Z PHYS CHEM NEUE FOL, V133, P93; White W. I., 1978, THE PORPHYRIN, V5; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010	45	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					359	367		10.1039/c4dt03157a		9	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900044		
J	Ohno, K; Nagasawa, A; Fujihara, T				Ohno, Keiji; Nagasawa, Akira; Fujihara, Takashi			Dinuclear nickel(II) complexes with 2,5-diamino-1,4-benzoquinonediimine ligands as precatalysts for the polymerization of styrene: electronic and steric substituent effects	DALTON TRANSACTIONS			English	Article							CONTROLLED RADICAL POLYMERIZATION; ALPHA-DIIMINE; BRIDGING 2,5-DIAMINO-1,4-BENZOQUINONEDIIMINES; ETHYLENE POLYMERIZATION; OLEFIN POLYMERIZATION; PALLADIUM COMPLEXES; CATALYTIC BEHAVIOR; ACRYLATE MONOMERS; BINUCLEAR NICKEL; METAL	Catalytic polymerization of styrene with a series of dinuclear nickel(II) complexes [{Ni(acac)}(2){mu-C6H2-(N-Ph-R)(4)}] (R = 4-Et (1a), 4-OEt (1b), 2-OEt (1c), 2-Et (1d), and 2,6-Et-2 (1e)) in the presence of methyl-aluminoxane was studied under various conditions to evaluate the substituent effect. The activity of 1a-1e, except 1c, increased with an increase in the reaction temperature, and the highest activity (7.46 x 10(5) g PS mol(-1) Ni h(-1)) was obtained using 1e at 70 degrees C. The electronic and steric properties of the ligand influenced the activity at room temperature, 50 degrees C, and 60 degrees C, steric factors barely, whereas electronic factors slightly dominated the activity at 70 degrees C. The activity with 1c remained constant at all temperatures, probably due to the masking of the active center by the formation of inactive N,N',O-chelate species. The obtained polymers were atactic polystyrenes with molecular weights and molecular weight distributions in the range of 15 000-43 400 and 1.71-2.14, respectively. While a clear dependence of the molecular weight and molecular weight distribution on the temperature was observed, no significant dependence on the substituent was noted.	[Ohno, Keiji; Nagasawa, Akira] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Fujihara, Takashi] Saitama Univ, Comprehens Anal Ctr Sci, Sakura Ku, Saitama 3388570, Japan	Fujihara, T (reprint author), Saitama Univ, Comprehens Anal Ctr Sci, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	fuji@chem.saitama-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23510115]	This work was supported by Grant-in-Aid for Scientific Research(C) (23510115 to T.F.) from the Japan Society for the Promotion of Science (JSPS). We thank Enago (http://www.enago.jp) for the English language review.	Deibel N, 2014, ORGANOMETALLICS, V33, P4756, DOI 10.1021/om500035c; Schweinfurth D, 2013, INORG CHEM, V52, P10332, DOI 10.1021/ic400955c; NATTA G, 1955, J AM CHEM SOC, V77, P1708, DOI 10.1021/ja01611a109; Gao B, 2011, ORGANOMETALLICS, V30, P5480, DOI 10.1021/om200733e; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Ohno K, 2014, POLYHEDRON, V81, P715, DOI 10.1016/j.poly.2014.07.030; Meinhard D, 2007, J AM CHEM SOC, V129, P9182, DOI 10.1021/ja070224i; Wenderski T, 2004, TETRAHEDRON LETT, V45, P6851, DOI 10.1016/j.tetlet.2004.07.116; Jeon IR, 2013, J AM CHEM SOC, V135, P16845, DOI 10.1021/ja409927v; Allan LEN, 2011, MACROMOLECULES, V44, P4072, DOI 10.1021/ma200734g; Bialek M, 2005, EUR POLYM J, V41, P2678, DOI 10.1016/j.eurpolymj.2005.05.024; Zhu L, 2014, DALTON T, V43, P2900, DOI 10.1039/c3dt51782a; Su YT, 2012, INORG CHEM, V51, P5889, DOI 10.1021/ic3004867; Feldman J, 1997, ORGANOMETALLICS, V16, P1514, DOI 10.1021/om960968x; Taquet JP, 2006, INORG CHEM, V45, P4668, DOI 10.1021/ic060019o; O'Reilly RK, 2007, MACROMOLECULES, V40, P7441, DOI 10.1021/ma070756j; Krupski S, 2012, ORGANOMETALLICS, V31, P2078, DOI 10.1021/om3000604; ZAMBELLI A, 1987, MACROMOLECULES, V20, P2035, DOI 10.1021/ma00174a063; Qiao YL, 2013, ORGANOMETALLICS, V32, P1932, DOI 10.1021/om400033n; Zhang D, 2004, ORGANOMETALLICS, V23, P3270, DOI 10.1021/om0499658; Guo YT, 2012, J ORGANOMET CHEM, V716, P222, DOI 10.1016/j.jorganchem.2012.06.024; Huang YB, 2008, ORGANOMETALLICS, V27, P259, DOI 10.1021/om700901x; Rall J, 1998, ANGEW CHEM INT EDIT, V37, P2681, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2681::AID-ANIE2681>3.0.CO;2-9; Radlauer MR, 2012, ORGANOMETALLICS, V31, P2231, DOI 10.1021/om2011694; Frantz S, 2004, CHEM-EUR J, V10, P149, DOI 10.1002/chem.200305369; Boffa LS, 2000, CHEM REV, V100, P1479, DOI 10.1021/cr990251u; Bourget-Merle L, 2002, CHEM REV, V102, P3031, DOI 10.1021/cr010424r; Siri O, 2005, CHEM-EUR J, V11, P7247, DOI 10.1002/chem.200500283; Takeuchi D, 2013, ANGEW CHEM INT EDIT, V52, P12536, DOI 10.1002/anie.201307741; ISHIHARA N, 1986, MACROMOLECULES, V19, P2464, DOI 10.1021/ma00163a027; Xing QF, 2014, DALTON T, V43, P7830, DOI 10.1039/c4dt00503a; Li YF, 2008, APPL ORGANOMET CHEM, V22, P659, DOI 10.1002/aoc.1456; Bhattacharjee M, 2004, POLYMER, V45, P3111, DOI 10.1016/j.polymer.2004.03.018; Braunstein P, 2004, CR CHIM, V7, P909, DOI 10.1016/j.crci.2004.02.012; Choi YY, 2010, POLYMER, V51, P4713, DOI 10.1016/j.polymer.2010.08.030; De S. K., 2011, POLYM CHEM, V49, P3920; Gao HY, 2007, EUR POLYM J, V43, P908, DOI 10.1016/j.eurpolymj.2006.11.026; Gibson VC, 2002, J CHEM SOC DALTON, P2261, DOI 10.1039/b202386e; Hagen H, 2001, EUR J INORG CHEM, P117; Kaminsky W, 1997, MACROMOLECULES, V30, P7647, DOI 10.1021/ma970601j; Kimich C., 1875, BER DTSCH CHEM GES, V8, P1026, DOI 10.1002/cber.18750080241; Li LD, 2011, EUR POLYM J, V47, P1636, DOI 10.1016/j.eurpolymj.2011.05.015; MERCHANT JR, 1984, B CHEM SOC JPN, V57, P1405, DOI 10.1246/bcsj.57.1405; Ohno Keiji, 2014, Acta Crystallogr Sect E Struct Rep Online, V70, po303, DOI 10.1107/S1600536814002906; Ohno Keiji, 2014, Acta Crystallogr Sect E Struct Rep Online, V70, po495, DOI 10.1107/S1600536814006254; Shi XC, 2012, ORGANOMETALLICS, V31, P4748, DOI 10.1021/om3003202; Siri O, 2007, DALTON T, P1481, DOI 10.1039/b618567c; Siri O., 2003, J AM CHEM SOC, V125, P1; Siri O, 2000, CHEM COMMUN, P2223, DOI 10.1039/b005952h; Skinner MEG, 2005, ORGANOMETALLICS, V24, P5586, DOI 10.1021/om0506365; Sun TX, 2010, POLYMER, V51, P3091, DOI 10.1016/j.polymer.2010.04.050; Tobisch S, 2005, CHEM-EUR J, V11, P3113, DOI 10.1002/chem.200401102; Walther D, 2001, EUR J INORG CHEM, P2049; Wang YY, 2011, J APPL POLYM SCI, V122, P545, DOI 10.1002/app.34122; Yang QZ, 2006, TETRAHEDRON LETT, V47, P5727, DOI 10.1016/j.tetlet.2006.06.025; Yliheikkila K, 2006, EUR POLYM J, V42, P92, DOI 10.1016/j.eurpolymj.2005.07.009; Yu SX, 2007, J APPL POLYM SCI, V105, P500, DOI 10.1002/app.26179; Zang D., 2003, ORGANOMETALLICS, V22, P2851	58	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					368	376		10.1039/c4dt02858a		9	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900045		
J	Nishikawa, M; Sawamura, S; Haraguchi, A; Morikubo, J; Takao, K; Tsubomura, T				Nishikawa, Michihiro; Sawamura, Shota; Haraguchi, Aya; Morikubo, Jun; Takao, Koichiro; Tsubomura, Taro			Highly emissive copper(I) complexes bearing diimine and bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane	DALTON TRANSACTIONS			English	Article							EMITTING ELECTROCHEMICAL-CELLS; PHOTOINDUCED ELECTRON-TRANSFER; CU-I COMPLEXES; PHOTOPHYSICAL PROPERTIES; DIPHOSPHINE LIGANDS; CUPROUS COMPLEXES; CU(I) COMPLEXES; EXCITED-STATES; RING ROTATION; LUMINESCENCE	A highly emissive copper(I) complex bearing (4R,5R)-(-)-4,5-bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane (diop) and 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (dmpp), [Cu(dmpp)(diop)]PF6 (1.PF6), was newly synthesized. The quantum yield of the luminescence of 1.PF6 in degassed dichloromethane is 0.38, which is one of the highest values among all copper(I) complexes bearing two bidentate ligands, diimine and diphosphine, under the same conditions. The long lifetime (26 mu s) and high intensity of the emission come from the small non-radiative decay rate of the excited states. The TD-DFT study indicates that the charge transfer transition from both copper and diphosphine to diimine orbitals plays an important role in the photophysical properties. Photophysics of [Cu(dmp)(diop)]PF6 (2.PF6, dmp = 2,9-dimethyl-1,10-phenanthroline) was also studied in order to reveal the effects of the introduction of the phenyl group at 4- and 7-positions of phenanthroline.	[Nishikawa, Michihiro; Sawamura, Shota; Haraguchi, Aya; Morikubo, Jun; Tsubomura, Taro] Seikei Univ, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan; [Takao, Koichiro] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Tsubomura, T (reprint author), Seikei Univ, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan.	tsubomura@st.seikei.ac.jp		Tsubomura, Taro/0000-0002-2850-4636	MEXT of Japan [26410077]; Promotion and Mutual Aid Corporation for Private Schools of Japan; Seikei University	This work was partially supported by Grants-in-Aid from MEXT of Japan (26410077), the Promotion and Mutual Aid Corporation for Private Schools of Japan, and a Grant from Seikei University.	Cuttell DG, 2002, J AM CHEM SOC, V124, P6, DOI 10.1021/ja012247h; Liu XH, 2012, DALTON T, V41, P10199, DOI 10.1039/c2dt30618b; Linfoot CL, 2010, DALTON T, V39, P8945, DOI 10.1039/c0dt00190b; Luo SP, 2013, ANGEW CHEM INT EDIT, V52, P419, DOI 10.1002/anie.201205915; Smith CS, 2010, J AM CHEM SOC, V132, P14079, DOI 10.1021/ja103112m; Doucet H, 1998, ANGEW CHEM INT EDIT, V37, P1703, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1703::AID-ANIE1703>3.0.CO;2-I; Andres-Tome I, 2012, DALTON T, V41, P8669, DOI 10.1039/c2dt30698k; Baldo MA, 2000, NATURE, V403, P750; Nishikawa M, 2012, J AM CHEM SOC, V134, P10543, DOI 10.1021/ja3028873; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; Sandroni M, 2013, DALTON T, V42, P14628, DOI 10.1039/c3dt51288f; Armaroli N, 2006, ADV MATER, V18, P1313, DOI 10.1002/adma.200502365; Lavie-Cambot A, 2008, COORDIN CHEM REV, V252, P2572, DOI 10.1016/j.ccr.2008.03.013; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Kuang SM, 2002, INORG CHEM, V41, P3313, DOI 10.1021/ic0201809; Costa RD, 2011, J MATER CHEM, V21, P16108, DOI 10.1039/c1jm12607e; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; Hsu CW, 2011, J AM CHEM SOC, V133, P12085, DOI 10.1021/ja2026568; Bozic-Weber B, 2013, DALTON T, V42, P12293, DOI 10.1039/c3dt51416a; Nishikawa M, 2013, PHYS CHEM CHEM PHYS, V15, P10549, DOI 10.1039/c3cp44710c; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; McMillin DR, 1998, CHEM REV, V98, P1201, DOI 10.1021/cr9601167; Baldo MA, 1998, NATURE, V395, P151; Zhang QS, 2004, ADV MATER, V16, P432, DOI 10.1002/adma.200306414; Siddique ZA, 2003, INORG CHEM, V42, P6366, DOI 10.1021/ic034412v; Zhang QS, 2012, ADV FUNCT MATER, V22, P2327, DOI 10.1002/adfm.201101907; Min JH, 2011, DALTON T, V40, P686, DOI 10.1039/c0dt01031f; Nishikawa M, 2014, B CHEM SOC JPN, V87, P912, DOI 10.1246/bcsj.20140069; Crestani MG, 2011, INORG CHEM, V50, P7172, DOI 10.1021/ic2007588; KIRCHHOFF JR, 1983, INORG CHEM, V22, P2380, DOI 10.1021/ic00159a008; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Armaroli N, 2007, TOP CURR CHEM, V280, P69, DOI 10.1007/128_2007_128; Asano MS, 2010, CHEM LETT, V39, P376, DOI 10.1246/cl.2010.376; Barbieri A, 2008, CHEM COMMUN, P2185, DOI 10.1039/b716650h; Becke A. D. J, 1992, CHEM PHYS, V96, P2155; Becke AD, 1993, CHEM PHYS, V98, P5648, DOI DOI 10.1063/1.464913; Collin JP, 2001, ACCOUNTS CHEM RES, V34, P477, DOI 10.1021/ar0001766; Coppens P, 2004, J AM CHEM SOC, V126, P5980, DOI 10.1021/ja049781k; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Gorelsky S. I., 2011, AOMIX PROGRAM MOL OR; Kubas G. J., 1979, INORG SYNTH, V19, P90, DOI 10.1002/9780470132500.ch18; Li JX, 2009, J MOL STRUCT, V935, P161, DOI 10.1016/j.molstruc.2009.07.006; Liu XH, 2012, DALTON T, V41, P1312, DOI 10.1039/c1dt11777g; MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001; Rigaku, 2000, CRYSTALCLEAR; Ruthkosky M, 1996, INORG CHEM, V35, P6406, DOI 10.1021/ic960503z; Saito K, 2006, DALTON T, P4444, DOI 10.1039/b608641a; SAKAKI S, 1986, NEW J CHEM, V10, P145; Sakaki S, 1996, J CHEM SOC DALTON, P1909, DOI 10.1039/dt9960001909; Sauvage J.-P., 2010, B JPN SOC COORD CHEM, V55, P3; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tsubomura T., 2008, B JPN SOC COORD CHEM, V52, P29; Tsukuda T, 2006, B CHEM SOC JPN, V79, P288, DOI 10.1246/bcsj.79.288; Varetto U., MOLEKEL	55	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	1					411	418		10.1039/c4dt03176h		8	Chemistry, Inorganic & Nuclear	Chemistry	AW6XL	WOS:000346408900050		
J	Higashino, T; Imahori, H				Higashino, Tomohiro; Imahori, Hiroshi			Porphyrins as excellent dyes for dye-sensitized solar cells: recent developments and insights	DALTON TRANSACTIONS			English	Article							QUINOXALINE-FUSED PORPHYRINS; TRIDENTATE ANCHORING GROUP; LIGHT-HARVESTING ANTENNAS; HIGHLY EFFICIENT; PHOTOVOLTAIC PROPERTIES; RUTHENIUM SENSITIZERS; MULTIPORPHYRIN ARRAYS; ZINC-PORPHYRIN; ORGANIC-DYES; CONVERSION EFFICIENCIES	Dye-sensitized solar cells (DSSCs) have attracted much attention as an alternative to silicon-based solar cells because of their low-cost production and high power conversion efficiency. Among various sensitizers, numerous research activities have been focused on porphyrins due to their strong absorption bands in the visible region, versatile modifications of their core, and facile tuning of the electronic structures. In 2005-2007, Officer and Gratzel et al. had achieved a rapid increase in the power conversion efficiency of porphyrin DSSCs from a few percent to as much as 7%. Encouraged by these pioneering works, further high-performance porphyrin dyes have been developed in the last decade. These studies have provided us profound hints for the rational design of sensitizers toward highly efficient DSSCs. Push-pull structures and/or pi-extensions have made porphyrins panchromatic in visible and even near-infrared regions. Consequently, porphyrin sensitizers have exhibited power conversion efficiencies that are comparable to or even higher than those of well-established highly efficient DSSCs based on ruthenium complexes. So far the power conversion efficiency has increased up to ca. 13% by using a push-pull porphyrin with a cobalt-based redox shuttle. In this perspective, we review the recent developments in the synthetic design of porphyrins for highly efficient DSSCs.	[Higashino, Tomohiro; Imahori, Hiroshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Imahori, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Nishikyo Ku, Kyoto 6158510, Japan	Imahori, H (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	imahori@scl.kyoto-u.ac.jp	HIGASHINO, Tomohiro/F-7845-2013; Imahori, Hiroshi/B-5574-2013	Imahori, Hiroshi/0000-0003-3506-5608	ALCA, JST	This work was supported by ALCA, JST. The authors thank Prof. Seigo Ito (University of Hyogo) for the DSSC fabrications and Prof. Villy Sundstrom (Lund University), Prof. Helge Lemmetyinen, and Prof. Nikolai Tkachenko (Tampere University of Technology) for the photophysical measurements.	Wang Q, 2005, J PHYS CHEM B, V109, P15397, DOI 10.1021/jp052877w; Liu YZ, 2012, PHYS CHEM CHEM PHYS, V14, P16703, DOI 10.1039/c2cp43165c; Burrell AK, 2001, CHEM REV, V101, P2751, DOI 10.1021/cr0000426; Hamamura T, 2014, CHEM LETT, V43, P655, DOI 10.1246/cl.131217; Tanaka T, 2015, CHEM SOC REV, V44, P943, DOI 10.1039/c3cs60443h; Kurotobi K, 2013, CHEM-EUR J, V19, P17075, DOI 10.1002/chem.201303460; Boschloo G, 2009, ACCOUNTS CHEM RES, V42, P1819, DOI 10.1021/ar900138m; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Lo CF, 2010, J PHYS CHEM C, V114, P12018, DOI 10.1021/jp103561c; Kobuke Y, 2003, B CHEM SOC JPN, V76, P689; Ye S, 2013, J PHYS CHEM C, V117, P6066, DOI 10.1021/jp400336r; Li LL, 2013, CHEM SOC REV, V42, P291, DOI 10.1039/c2cs35257e; Sunahara K, 2013, ACS APPL MATER INTER, V5, P10824, DOI 10.1021/am403022d; Chang S, 2013, J MATER CHEM A, V1, P11553, DOI 10.1039/c3ta12714a; Wu CH, 2014, J MATER CHEM A, V2, P991, DOI 10.1039/c3ta14208f; Nazeeruddin MK, 2001, J AM CHEM SOC, V123, P1613, DOI 10.1021/ja003299u; Gao F, 2008, J AM CHEM SOC, V130, P10720, DOI 10.1021/ja801942j; Ishida M, 2011, J PHYS CHEM C, V115, P19343, DOI 10.1021/jp202307b; Polander LE, 2013, ANGEW CHEM INT EDIT, V52, P8731, DOI 10.1002/anie.201304608; Ambre RB, 2013, CHEM-ASIAN J, V8, P2144, DOI 10.1002/asia.201300328; Gou FL, 2013, ACS APPL MATER INTER, V5, P12631, DOI 10.1021/am403987b; Kang MS, 2013, J MATER CHEM A, V1, P9848, DOI 10.1039/c3ta11818e; Campbell WM, 2007, J PHYS CHEM C, V111, P11760, DOI 10.1021/jp0750598; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Sauvage F, 2009, CHEMSUSCHEM, V2, P761, DOI 10.1002/cssc.200900058; Imahori H, 2011, J PHYS CHEM A, V115, P3679, DOI 10.1021/jp103747t; Mishra A, 2009, ANGEW CHEM INT EDIT, V48, P2474, DOI 10.1002/anie.200804709; Ambre RB, 2014, CHEM COMMUN, V50, P725, DOI 10.1039/c3cc47985d; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Lin CY, 2010, J PHYS CHEM C, V114, P687, DOI 10.1021/jp909232b; Liu YZ, 2011, CHEM COMMUN, V47, P4010, DOI 10.1039/c0cc03306e; Hayashi S, 2008, J PHYS CHEM C, V112, P15576, DOI 10.1021/jp805122z; Wagner K, 2011, J PHYS CHEM C, V115, P317, DOI 10.1021/jp107615h; Luo J, 2014, J AM CHEM SOC, V136, P265, DOI 10.1021/ja409291g; Lu HP, 2009, PHYS CHEM CHEM PHYS, V11, P10270, DOI 10.1039/b917271h; Brennan BJ, 2013, PHYS CHEM CHEM PHYS, V15, P16605, DOI 10.1039/c3cp52156g; Holten D, 2002, ACCOUNTS CHEM RES, V35, P57, DOI 10.1021/ar970264z; Tanaka M, 2007, CHEM COMMUN, P2069, DOI 10.1039/b702501g; Pelleja L, 2014, J PHYS CHEM C, V118, P16504, DOI 10.1021/jp411715n; Wu HP, 2012, ENERG ENVIRON SCI, V5, P9843, DOI 10.1039/c2ee22870j; Smestad GP, 2008, SOL ENERG MAT SOL C, V92, P371, DOI 10.1016/j.solmat.2008.01.003; Nazeeruddin MK, 2005, J AM CHEM SOC, V127, P16835, DOI 10.1021/ja052467l; Subbaiyan NK, 2009, J AM CHEM SOC, V131, P14646, DOI 10.1021/ja9067113; Griffith MJ, 2013, J PHYS CHEM C, V117, P11885, DOI 10.1021/jp3067712; Mozer AJ, 2009, J AM CHEM SOC, V131, P15621, DOI 10.1021/ja9057713; Wang YQ, 2014, ANGEW CHEM INT EDIT, V53, P10779, DOI 10.1002/anie.201406190; Kira A, 2010, J PHYS CHEM C, V114, P11293, DOI 10.1021/jp1004049; Lewtak JP, 2012, CHEM COMMUN, V48, P10069, DOI 10.1039/c2cc31279d; Hamann TW, 2012, DALTON T, V41, P3111, DOI 10.1039/c2dt12362b; Ball JM, 2012, RSC ADV, V2, P6846, DOI 10.1039/c2ra20952g; Zeng WD, 2010, CHEM MATER, V22, P1915, DOI 10.1021/cm9036988; Ladomenou K, 2014, RSC ADV, V4, P21379, DOI 10.1039/c4ra00985a; Hamamura T, 2014, PHYS CHEM CHEM PHYS, V16, P4551, DOI [10.1039/c3cp55184a, 10.1039/c3cp55184]; Jiao CJ, 2011, ORG LETT, V13, P3652, DOI 10.1021/ol201303h; Wang CL, 2014, ENERG ENVIRON SCI, V7, P1392, DOI 10.1039/c3ee44168g; Chen CY, 2009, ACS NANO, V3, P3103, DOI 10.1021/nn900756s; Lu JF, 2013, J MATER CHEM A, V1, P10008, DOI 10.1039/c3ta11870c; Chang YC, 2011, CHEM COMMUN, V47, P8910, DOI 10.1039/c1cc12764k; Wang Q, 2008, J PHYS CHEM C, V112, P7084, DOI 10.1021/jp800426y; Park JK, 2009, J PHYS CHEM C, V113, P21956, DOI 10.1021/jp905675x; Wu CH, 2012, CHEM COMMUN, V48, P4329, DOI 10.1039/c2cc30892d; Di Carlo G, 2013, CHEM-EUR J, V19, P10723, DOI 10.1002/chem.201300219; Campbell WM, 2004, COORDIN CHEM REV, V248, P1363, DOI 10.1016/j.ccr.2004.01.007; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; Lu HP, 2009, J PHYS CHEM C, V113, P20990, DOI 10.1021/jp908100v; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; Song BJ, 2011, CHEM-EUR J, V17, P11115, DOI 10.1002/chem.201100813; Bessho T, 2010, ANGEW CHEM INT EDIT, V49, P6646, DOI 10.1002/anie.201002118; Imahori H, 2010, J PHYS CHEM C, V114, P10656, DOI 10.1021/jp102486b; Wang CL, 2011, ENERG ENVIRON SCI, V4, P1788, DOI 10.1039/c0ee00767f; Feldt SM, 2010, J AM CHEM SOC, V132, P16714, DOI 10.1021/ja1088869; Martinez-Diaz MV, 2010, CHEM COMMUN, V46, P7090, DOI 10.1039/c0cc02213f; Eu S, 2008, J PHYS CHEM C, V112, P4396, DOI 10.1021/jp710400p; Warnan J, 2012, CHEM COMMUN, V48, P675, DOI 10.1039/c1cc16066d; Kang MS, 2012, CHEM COMMUN, V48, P9349, DOI 10.1039/c2cc31384g; Ooyama Y, 2009, EUR J ORG CHEM, P2903, DOI 10.1002/ejoc.200900236; Mori H, 2013, J MATER CHEM C, V1, P2500, DOI 10.1039/c3tc00932g; Griffith MJ, 2012, CHEM COMMUN, V48, P4145, DOI 10.1039/c2cc30677h; Imahori H, 2011, CHEMSUSCHEM, V4, P797, DOI 10.1002/cssc.201100029; He HS, 2012, CHEM COMMUN, V48, P5910, DOI 10.1039/c2cc31440a; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; Tsao HN, 2011, CHEMSUSCHEM, V4, P591, DOI 10.1002/cssc.201100120; Kumar SA, 2014, J PHYS CHEM LETT, V5, P501, DOI 10.1021/jz402612h; Mai CL, 2010, CHEM COMMUN, V46, P809, DOI 10.1039/b917316a; Imahori H, 2009, J PHYS CHEM C, V113, P18406, DOI 10.1021/jp907288h; Imahori H, 2004, J PHYS CHEM B, V108, P6130, DOI 10.1021/jp038036b; Nakamura Y, 2007, CHEM SOC REV, V36, P831, DOI 10.1039/b618854k; Hart AS, 2013, ACS APPL MATER INTER, V5, P5314, DOI 10.1021/am401201q; Tan LL, 2014, J MATER CHEM A, V2, P8988, DOI 10.1039/c4ta01351d; Ferrere S, 2001, J PHYS CHEM B, V105, P7602, DOI 10.1021/jp011612o; Gou FL, 2014, ACS APPL MATER INTER, V6, P6697, DOI 10.1021/am500391w; Hayashi H, 2013, CHEMSUSCHEM, V6, P508, DOI 10.1002/cssc.201200869; Ishida M, 2013, CHEM COMMUN, V49, P9164, DOI 10.1039/c3cc44847a; Jiao C., 2011, SYNLETT, P171; Lee CW, 2009, CHEM-EUR J, V15, P1403, DOI 10.1002/chem.200801572; Lee MJ, 2011, TETRAHEDRON LETT, V52, P3879, DOI 10.1016/j.tetlet.2011.05.074; Planells M, 2011, ENERG ENVIRON SCI, V4, P528, DOI 10.1039/c0ee00406e; Si LP, 2014, J PHYS CHEM A, V118, P3410, DOI 10.1021/jp412609k; Si LP, 2014, NEW J CHEM, V38, P1565, DOI 10.1039/c3nj01643a; Yella A, 2014, ANGEW CHEM INT EDIT, V53, P2973, DOI 10.1002/anie.201309343	102	48	48	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	2					448	463		10.1039/c4dt02756f		16	Chemistry, Inorganic & Nuclear	Chemistry	AW6YW	WOS:000346412500002		
J	Zhang, YZ; Gao, S; Sato, O				Zhang, Yuan-Zhu; Gao, Song; Sato, Osamu			In situ tetrazole templated chair-like decanuclear azido-cobalt(II) SMM containing both tetra- and octa-hedral Co(II) ions	DALTON TRANSACTIONS			English	Article							SINGLE-MOLECULE MAGNET; COORDINATION POLYMERS; ZERO-FIELD; RELAXATION; LIGANDS; CO; ANISOTROPY; CLUSTERS; NUCLEARITY; COMPLEX	An azido-bridged chair-like decanuclear cluster: [Co-10(II)(bzp)(8)-(Metz)(2)(N-3)(18)]center dot 4MeOH center dot 3H(2)O (1, bzp = 2-benzoylpyridine and HMetz = 5-methyl-1H-tetrazole) was prepared with in situ tetrazolate anions as templates in a sealed system. 1 containing both octahedral and tetrahedral Co(II) ions exhibited slow relaxation of magnetization with an effective barrier of 26 K under an applied dc field of 1 kOe.	[Zhang, Yuan-Zhu; Gao, Song] Peking Univ, Coll Chem & Mol Engn, State Key Lab Rare Earth Mat Chem & Applicat, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Zhang, Yuan-Zhu; Sato, Osamu] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8168580, Japan	Zhang, YZ (reprint author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Rare Earth Mat Chem & Applicat, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	yuanzhuzhang@gmail.com; sato@cm.kyushu-u.ac.jp	zhang, yuanzhu/D-4023-2014		Ministry of Education, Culture, Sports, Science, and Technology, Japan [20036040, 24108731]; Mitsubishi Foundation, Japan; NSFC [21321001]; National Basic Research Program of China [2013CB933400]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 20036040, "Coordination Programming" Area 2107, no. 24108731) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; the Mitsubishi Foundation, Japan; NSFC (21321001) and the National Basic Research Program of China (2013CB933400).	Liu TF, 2003, J AM CHEM SOC, V125, P13976, DOI 10.1021/ja0380751; Zadrozny JM, 2012, CHEM COMMUN, V48, P3927, DOI 10.1039/c2cc16430b; Schmidt S, 2013, CHEM COMMUN, V49, P1696, DOI 10.1039/c2cc38006d; Plenk C, 2014, CHEM COMMUN, V50, P3871, DOI 10.1039/c4cc00895b; Yang EC, 2002, J APPL PHYS, V91, P7382, DOI 10.1063/1.1450813; Zhu YY, 2013, CHEM SCI, V4, P1802, DOI 10.1039/c3sc21893g; Zhao H, 2008, CHEM SOC REV, V37, P84, DOI 10.1039/b616738c; Demko ZP, 2001, J ORG CHEM, V66, P7945, DOI 10.1021/jo010635w; Kapoor P, 2010, DALTON T, V39, P7951, DOI 10.1039/c0dt00245c; Wu T, 2005, INORG CHEM, V44, P4130, DOI 10.1021/ic050063o; Sun HL, 2009, CHEM-EUR J, V15, P1757, DOI 10.1002/chem.200801685; Ibrahim M, 2011, ANGEW CHEM INT EDIT, V50, P4708, DOI 10.1002/anie.201100280; Herchel R, 2014, INORG CHEM, V53, P5896, DOI 10.1021/ic500916u; Aubin SMJ, 1999, INORG CHEM, V38, P5329, DOI 10.1021/ic990613g; Zeng MH, 2007, ANGEW CHEM INT EDIT, V46, P1832, DOI 10.1002/anie.200602922; Zadrozny JM, 2011, J AM CHEM SOC, V133, P20732, DOI 10.1021/ja2100142; Gatteschi D, 2003, ANGEW CHEM INT EDIT, V42, P268, DOI 10.1002/anie.200390099; Wu D, 2009, INORG CHEM, V48, P854, DOI 10.1021/ic8012188; Murrie M, 2010, CHEM SOC REV, V39, P1986, DOI 10.1039/b913279c; Bi YF, 2013, CHEM COMMUN, V49, P6785, DOI 10.1039/c3cc43347a; Kostakis GE, 2012, COORDIN CHEM REV, V256, P1246, DOI 10.1016/j.ccr.2012.02.002; Zhang YZ, 2006, CHEM COMMUN, P3302, DOI 10.1039/b605459e; Bi YF, 2010, INORG CHEM, V49, P7735, DOI 10.1021/ic1005105; Li QP, 2014, DALTON T, V43, P3238, DOI 10.1039/c3dt53214c; Zadrozny JM, 2013, POLYHEDRON, V64, P209, DOI 10.1016/j.poly.2013.04.008; Bai YL, 2014, EUR J INORG CHEM, V2014, P1275, DOI 10.1002/ejic.201301530; Boudalis AK, 2006, ANGEW CHEM INT EDIT, V45, P432, DOI 10.1002/anie.200502519; Deng H, 2008, CHEM COMMUN, P2239, DOI 10.1039/b800938d; Escuer A, 2006, EUR J INORG CHEM, P4721, DOI 10.1002/ejic.200600552; Ganzhorn M, 2014, NANOSCI TECHNOL, P319, DOI 10.1007/978-3-642-40609-6_13; Kahn O., 1993, MOL MAGNETISM; Langley SK, 2012, DALTON T, V41, P12807, DOI 10.1039/c2dt31612a; Li M, 2008, CHEM COMMUN, P3390, DOI 10.1039/b803636e; Peng Y, 2012, DALTON T, V41, P4740, DOI 10.1039/c2dt12487d; Petit S, 2007, DALTON T, P4582, DOI 10.1039/b708926k; Stamatatos TC, 2009, INORG CHEM, V48, P807, DOI 10.1021/ic8020645; Wang F., 2009, INT J QUANTUM CHEM, V109, P11; Wang L, 2012, DALTON T, V41, P6242, DOI 10.1039/c2dt30102d	38	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	2					480	483		10.1039/c4dt03211j		4	Chemistry, Inorganic & Nuclear	Chemistry	AW6YW	WOS:000346412500007		
J	Rollet, AL; Matsuura, H; Bessada, C				Rollet, Anne-Laure; Matsuura, Haruaki; Bessada, Catherine			An in situ spectroscopic study of the local structure of oxyfluoride melts: NMR insights into the speciation in molten LiF-LaF3-Li2O systems	DALTON TRANSACTIONS			English	Article							HIGH-TEMPERATURE NMR; NEUTRON-DIFFRACTION DATA; SOLID-STATE NMR; LANTHANUM OXYFLUORIDE; RARE-EARTH; NAF-ALF3-AL2O3 MELTS; IONIC-CONDUCTIVITY; VIBRATIONAL-MODES; CRYSTAL-STRUCTURE; ALKALI FLUORIDES	The local structure of molten LaF3-LiF-Li2O has been investigated by high temperature NMR spectroscopy. The La-139 and F-19 chemical shifts have been measured as a function of temperature and composition. The NMR spectra show that Li2O reacts completely with LaF3 to form a LaOF compound in the solid state below the melting temperature of the sample. LaOF is not completely dissolved in the fluoride melt and solid LaOF is observed in the F-19 spectra for Li2O concentrations above 10 mol%. We discuss the local environment of lanthanum ions in molten LaF3-LiF-Li2O and compare the results to those with the LaF3-LiF-CaO system. The analysis of the temperature and Li2O concentration dependences of the La-139 and F-19 chemical shifts suggests that several kinds of lanthanum oxyfluoride long-lived LaOxFy3-x-y units are present in the melt.	[Rollet, Anne-Laure] PHENIX CNRS UPMC, F-75252 Paris 05, France; [Rollet, Anne-Laure; Matsuura, Haruaki; Bessada, Catherine] CEMHTI CNRS, F-45071 Orleans 2, France; [Matsuura, Haruaki] Tokyo Inst Technol, Res Lab Nucl Reactors, Meguro Ku, Tokyo 1528550, Japan	Rollet, AL (reprint author), PHENIX CNRS UPMC, Case 51,4 Pl Jussieu, F-75252 Paris 05, France.	anne-laure.rollet@upmc.fr; hmatsuur@nr.titech.ac.jp; catherine.bessada@cnrs-orleans.fr			JSPS; CNRS	We express our special thanks to Emmanuel Veron for X-ray diffraction, to Sandra Ory for DSC, to Eric Labrude for machining special NMR crucibles and to Aydar Rakhmatullin for valuable discussion (CEMHTI). We are also grateful to the JSPS and CNRS for the financial support of the Joint Project between the Japanese and French partners under the "Japan-France (JSPS-CNRS) Research Cooperative Program". HM wishes to thank the colleagues and staff of le STUDIUM for encouragement to continue the collaboration research both in France and Japan.	Agulyanskii A. I., 1982, RUSS J INORG CHEM, V27, P579; AGULYANSKII AI, 1982, ZH NEORG KHIM+, V27, P1029; Ambrova M, 2008, J THERM ANAL CALORIM, V91, P569, DOI 10.1007/s10973-007-8533-6; MAXIMOV B, 1985, ACTA CRYSTALLOGR B, V41, P88, DOI 10.1107/S0108768185001677; Pauvert O, 2010, J PHYS CHEM B, V114, P6472, DOI 10.1021/jp912195j; Bessada C, 2006, CR CHIM, V9, P374, DOI 10.1016/j.crci.2005.06.007; Kergoat M, 2014, ELECTROCHIM ACTA, V120, P258, DOI 10.1016/j.electacta.2013.12.035; PETZEL T, 1993, J ALLOY COMPD, V200, P27, DOI 10.1016/0925-8388(93)90466-Z; Greaves GN, 2008, SCIENCE, V322, P566, DOI 10.1126/science.1160766; Chamelot P, 2007, J NUCL MATER, V360, P64, DOI 10.1016/j.jnucmat.2006.08.015; DUPREE R, 1989, J AM CHEM SOC, V111, P5125, DOI 10.1021/ja00196a016; Rollet AL, 2012, J FLUORINE CHEM, V134, P44, DOI 10.1016/j.jfluchem.2011.04.002; Sarou-Kanian V, 2009, PHYS CHEM CHEM PHYS, V11, P11501, DOI 10.1039/b912532a; TOSI MP, 1993, ANNU REV PHYS CHEM, V44, P173; Dracopoulos V, 1998, J CHEM SOC FARADAY T, V94, P2601, DOI 10.1039/a802812e; Auguste F, 2003, INORG CHEM, V42, P6338, DOI 10.1021/ic026222a; Delpech S, 2010, MATER TODAY, V13, P34, DOI 10.1016/S1369-7021(10)70222-4; Ribeiro MCC, 2003, J PHYS CHEM B, V107, P4392, DOI 10.1021/jp027261a; Salanne M, 2011, MOL PHYS, V109, P2299, DOI 10.1080/00268976.2011.617523; Watanabe S, 2006, J ALLOY COMPD, V408, P71, DOI 10.1016/j.jallcom.2005.04.105; Salanne M, 2007, J PHYS CHEM B, V111, P4678, DOI 10.1021/jp067073a; Fergus JW, 2000, J ELECTROCHEM SOC, V147, P4696, DOI 10.1149/1.1394126; ZALKIN A, 1985, ACTA CRYSTALLOGR B, V41, P91, DOI 10.1107/S0108768185001689; Chen GZ, 2000, NATURE, V407, P361, DOI 10.1038/35030069; Landron C, 2001, PHYS REV LETT, V86, P4839, DOI 10.1103/PhysRevLett.86.4839; Rollet AL, 2012, INORG CHEM, V51, P2272, DOI 10.1021/ic202301e; ZACHARIASEN WH, 1951, ACTA CRYSTALLOGR, V4, P231, DOI 10.1107/S0365110X51000787; ROOS A, 1983, SOLID STATE IONICS, V9-10, P571, DOI 10.1016/0167-2738(83)90297-7; Taxil P, 2009, J FLUORINE CHEM, V130, P94, DOI 10.1016/j.jfluchem.2008.07.004; Jacob KT, 2006, INT J APPL CERAM TEC, V3, P312, DOI 10.1111/j.1744-7402.2006.02086.x; Abdoun F, 1997, J PHASE EQUILIB, V18, P6, DOI 10.1007/BF02646755; Rollet AL, 2011, ANNU REP PROG CHEM C, V107, P88, DOI 10.1039/c1pc90003j; Rollet AL, 2004, NUCL INSTRUM METH B, V226, P447, DOI 10.1016/j.nimb.2004.06.034; Privalov AF, 1997, SOLID STATE IONICS, V101, P393, DOI 10.1016/S0167-2738(97)00134-3; Massiot D, 2008, J NON-CRYST SOLIDS, V354, P249, DOI 10.1016/j.jnoncrysol.2007.06.097; Bieber AL, 2011, ELECTROCHIM ACTA, V56, P5022, DOI 10.1016/j.electacta.2011.03.099; Dracopoulos V, 2005, J NON-CRYST SOLIDS, V351, P640, DOI 10.1016/j.jnoncrysol.2005.01.063; Spencer L, 2011, CAN J CHEM, V89, P1105, DOI 10.1139/V11-049; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Merlet C, 2010, PHYS CHEM CHEM PHYS, V12, P14109, DOI 10.1039/c0cp01412e; STEBBINS JF, 1992, SCIENCE, V255, P586, DOI 10.1126/science.255.5044.586; Dracopoulos V, 1997, J CHEM SOC FARADAY T, V93, P3081, DOI 10.1039/a701864i; BARANYAI A, 1986, J PHYS C SOLID STATE, V19, P453, DOI 10.1088/0022-3719/19/4/008; Matsuura H, 2009, J FLUORINE CHEM, V130, P53, DOI 10.1016/j.jfluchem.2008.07.012; Rollet AL, 2008, PHYS CHEM CHEM PHYS, V10, P3222, DOI 10.1039/b719158h; Levesque M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802986; Ooms KJ, 2005, SOLID STATE NUCL MAG, V28, P125, DOI 10.1016/j.ssniur.2005.07.002; Hoff C, 1997, SOLID STATE IONICS, V101, P445, DOI 10.1016/S0167-2738(97)00140-9; Rollet AL, 2013, ANNU REP NMR SPECTRO, V78, P149, DOI 10.1016/B978-0-12-404716-7.00004-3; Bessada C, 2009, J FLUORINE CHEM, V130, P45, DOI 10.1016/j.jfluchem.2008.07.010; Lacassagne V, 2002, J PHYS CHEM B, V106, P1862, DOI 10.1021/jp0131141; Rollet AL, 2012, J NUCL MATER, V429, P40, DOI 10.1016/j.jnucmat.2012.05.010; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; WILSON M, 1993, J PHYS-CONDENS MAT, V5, P2687, DOI 10.1088/0953-8984/5/17/004; Kruk D, 2006, J PHYS-CONDENS MAT, V18, P1725, DOI 10.1088/0953-8984/18/5/025; Bastow TJ, 2004, SOLID STATE IONICS, V175, P129, DOI 10.1016/j.ssi.2004.09.028; Beilmann M, 2011, J CHEM THERMODYN, V43, P1515, DOI 10.1016/j.jct.2011.05.002; Brooker MH, 2000, INORG CHEM, V39, P4725, DOI 10.1021/ic000489x; Dracopoulos V, 2001, J CHEM SOC DALTON, P1117, DOI 10.1039/b008433f; Fedorov PP, 1999, RUSS J INORG CHEM+, V44, P1703; Gibilaro M, 2011, ELECTROCHIM ACTA, V56, P5410, DOI 10.1016/j.electacta.2011.02.109; HASSAN AK, 1992, PHYS REV B, V45, P12797, DOI 10.1103/PhysRevB.45.12797; Hennet L, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455210; Hennet L, 2007, J NON-CRYST SOLIDS, V353, P1705, DOI 10.1016/j.jnoncrysol.2007.01.040; Jahn S, 2007, J NON-CRYST SOLIDS, V353, P3500, DOI 10.1016/j.jnoncrysol.2007.05.104; Jahn S, 2008, CONDENS MATTER PHYS, V11, P169; Kirillov SA, 2002, J CHEM PHYS, V116, P9341, DOI 10.1063/1.1473810; Klemm W, 1941, Z ANORG ALLG CHEM, V248, P167; Lacassagne V, 1997, CR ACAD SCI II B, V325, P91, DOI 10.1016/S1251-8069(97)83251-4; Lee J, 2003, J ALLOY COMPD, V348, P214, DOI 10.1016/S0925-8388(02)00837-X; Lee J, 2001, J AM CERAM SOC, V84, P863, DOI 10.1111/j.1151-2916.2001.tb00753.x; MADDEN PA, 1991, J CHEM PHYS, V94, P918, DOI 10.1063/1.459982; MANSMANN M, 1965, Z KRISTALLOGR KRIST, V122, P375, DOI 10.1524/zkri.1965.122.5-6.375; Nakano J., 2012, ASIA PAC B, P163; Papatheodorou GN, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/205101; Pauvert O, 2011, J PHYS CHEM B, V115, P9160, DOI 10.1021/jp203137h; Rollet AL, 2005, INT J THERMOPHYS, V26, P1115, DOI 10.1007/s10765-005-6688-6; Salanne M, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1143-9; Schoonman J., 1980, Solid State Ionics, V1, DOI 10.1016/0167-2738(80)90005-3; Simon P, 2003, J RAMAN SPECTROSC, V34, P497, DOI 10.1002/jrs.1020; Sinitsyn VV, 2003, J PHYS CHEM SOLIDS, V64, P1201, DOI 10.1016/S0022-3697(03)00050-7; Sorokin NI, 1996, KRISTALLOGRAFIYA+, V41, P310; Stefanidaki E, 2002, J CHEM SOC DALTON, P2302, DOI 10.1039/b111563b; Uhlir J, 2007, J NUCL MATER, V360, P6, DOI 10.1016/j.jnucmat.2006.08.008; van der Meer JPM, 2006, CHEM MATER, V18, P510, DOI 10.1021/cm051531v; XIAO HM, 1995, ACTA CHEM SCAND, V49, P96, DOI 10.3891/acta.chem.scand.49-0096	86	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	2					522	529		10.1039/c4dt00926f		8	Chemistry, Inorganic & Nuclear	Chemistry	AW6YW	WOS:000346412500016		
J	Takasaki, F; Fujiwara, K; Nakajima, Y; Nishikawa, T; Masu, H; Imanari, M; Hidaka, Y; Ogawa, N				Takasaki, Fumiyuki; Fujiwara, Kazuhiko; Nakajima, Yasushi; Nishikawa, Taku; Masu, Hyuma; Imanari, Mamoru; Hidaka, Yuki; Ogawa, Nobuaki			A monomeric [Zr(CO3)(4)](4-) complex in an ammonium zirconium carbonate aqueous solution studied by extended X-ray absorption fine structure, Raman and nuclear magnetic resonance spectroscopy	DALTON TRANSACTIONS			English	Article							MULTIPLE-SCATTERING; CROSS-LINKING; ACID; EQUILIBRIUM; HYDROLYSIS; SPECIATION; CARBAMATE; CHEMISTRY; SPECTRA; SYSTEM	The speciation of zirconium complexes in ammonium zirconium carbonate (AZC) solutions should be further studied in order to develop high-performance AZC complexes for use in elaborate industrial materials. Thus, the speciation and the structure of various zirconium species in ammonium zirconium carbonate solutions were investigated over a wide range of total carbonate and ammonium concentrations. By employing extended X-ray absorption fine structure analysis, and Raman and C-13 NMR spectroscopy, it was found that four carbonate ions coordinate bidentately to the zirconium ion. In addition, the exact concentration ranges of carbonate and ammonium in AZC necessary to generate the monomeric zirconium carbonate complex [Zr(CO3)(4)](4-) were determined.	[Takasaki, Fumiyuki; Nakajima, Yasushi; Nishikawa, Taku] Daiichi Kigenso Kagaku Kogyo Co Ltd, Suminoe Ku, Osaka, Japan; [Takasaki, Fumiyuki; Fujiwara, Kazuhiko; Ogawa, Nobuaki] Akita Univ, Grad Sch Engn & Resource Sci, Akita 010, Japan; [Masu, Hyuma; Imanari, Mamoru; Hidaka, Yuki] Chiba Univ, Ctr Analyt Instrumentat, Inage Ku, Chiba, Japan	Takasaki, F (reprint author), Daiichi Kigenso Kagaku Kogyo Co Ltd, Suminoe Ku, 1-6-38 Hirabayashi Minami, Osaka, Japan.	takasaki-f@zr.dkkk.co.jp; kfuji@gipc.akita-u.ac.jp; ogawa@gipc.akita-u.ac.jp			Japan Synchrotron Radiation Research Institute (JASRI)	The synchrotron radiation EXAFS experiments were performed with the approval and support of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2007B1920, 2010B1961, 2011B1826 and 2012A1777). We would like to thank Prof. Iwao Watanabe (Ritsumeikan University), Dr Hiroshi Oji, Dr Yosuke Taniguchi and Dr Masafumi Takagaki (JASRI) for help in EXAFS measurements and analyses.	Catalano JG, 2004, AM MINERAL, V89, P1004; Southon PD, 2002, CHEM MATER, V14, P4313, DOI 10.1021/cm0211913; Cho HR, 2005, ANAL BIOANAL CHEM, V383, P28, DOI 10.1007/s00216-005-3354-6; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Song DL, 2011, J APPL POLYM SCI, V122, P1019, DOI 10.1002/app.34215; Mikkonen KS, 2013, J MATER SCI, V48, P4205, DOI 10.1007/s10853-013-7233-9; MUHA GM, 1960, J CHEM PHYS, V33, P194, DOI 10.1063/1.1731077; Jiang J, 2005, J SOLUTION CHEM, V34, P443, DOI 10.1007/s10953-005-5194-6; Hagfeldt C, 2004, DALTON T, P2142, DOI 10.1039/b402804j; Hu YJ, 2013, J AM CHEM SOC, V135, P14240, DOI 10.1021/ja405555h; Mani F, 2006, GREEN CHEM, V8, P995, DOI 10.1039/b602051h; Singhal A, 1996, J AM CHEM SOC, V118, P11529, DOI 10.1021/ja9602399; CLEARFIELD A, 1964, REV PURE APPL CHEM, V14, P91; CHRISTENSSON F, 1978, ACTA CHEM SCAND A, V32, P15, DOI 10.3891/acta.chem.scand.32a-0015; Clearfield A., 1970, INORG CHIM ACTA, V4, P166, DOI 10.1016/S0020-1693(00)93263-8; Farnworth E., 1981, SPECIALITY INORGANIC, V40, P247; Karlysheva K. F., 1982, RUSS J INORG CHEM, V27, P1582; Kelly SD, 2007, GEOCHIM COSMOCHIM AC, V71, P821, DOI 10.1016/j.gca.2006.10.013; MAK TCW, 1968, CAN J CHEMISTRY, V46, P3491; Malinko L. A., 1980, RUSS J INORG CHEM, V25, P1184; Monpean F. J., 2005, CHEM THERMODYNAMICS; Nabivanets B. I., 1961, J INORG CHEM, V20, P5785; Nomiya K, 2009, DALTON T, P5504, DOI 10.1039/b902296a; OGAWA N, 1986, BUNSEKI KAGAKU, V35, P785; Ricardo NMPS, 1999, POLYM ENG SCI, V39, P543, DOI 10.1002/pen.11444; Sako R, 2013, SURF COAT TECH, V219, P42, DOI 10.1016/j.surfcoat.2012.12.050; Saku Y, 2009, DALTON T, P805, DOI 10.1039/b813710m; Takasaki F, 2014, CHEM LETT, V43, P196, DOI 10.1246/cl.130892; Takasaki F, 2010, BUNSEKI KAGAKU, V59, P447; Veyland A, 2000, HELV CHIM ACTA, V83, P414; Veyland A, 1999, HELV CHIM ACTA, V82, P2003, DOI 10.1002/(SICI)1522-2675(19991110)82:11<2003::AID-HLCA2003>3.0.CO;2-B; Walther C, 2007, ANAL BIOANAL CHEM, V388, P409, DOI 10.1007/s00216-007-1223-1; Zhao Q, 2011, IND ENG CHEM RES, V50, P5316, DOI 10.1021/ie1010178; ZIELEN AJ, 1956, J AM CHEM SOC, V78, P5785, DOI 10.1021/ja01603a019	34	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	2					645	652		10.1039/c4dt02022g		8	Chemistry, Inorganic & Nuclear	Chemistry	AW6YW	WOS:000346412500029		
J	Fujita, W				Fujita, Wataru			Ferromagnetic ordering in the organic radical cation salt BBDTA center dot Au(CN)(2) at 8.2 K	DALTON TRANSACTIONS			English	Article							MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURE; THIAZYL RADICALS; PHASE-TRANSITIONS; TEMPERATURE; PRESSURE; BISTABILITY	An organic radical cation salt, BBDTA center dot Au(CN)(2), with a slipped pi-stacking columnar structure and intercolumnar short contacts, shows ferromagnetic ordering at 8.2 K, the highest reported temperature among the BBDTA(+) cation salts.	Nagoya City Univ, Dept Informat & Biol Sci, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan	Fujita, W (reprint author), Nagoya City Univ, Dept Informat & Biol Sci, Grad Sch Nat Sci, Mizuho Ku, Yamanohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	fujitaw@nsc.nagoya-cu.ac.jp			SEI Group SCI Foundation	The author thanks Motoyasu Fujiwara of Institute for Molecular Science for the magnetic and ESR measurements, Takashi Kawakami of Osaka University for the molecular orbital calculations, and, Kohki Satoh of Quantum Design Japan Co., Ltd. and Masaki Mito of Kyushu Institute of Technology for the heat capacity measurements. This study was partially supported by the SEI Group SCI Foundation.	Allemand M. P., 1991, SCIENCE, V253, P301; Fujita W, 2006, J AM CHEM SOC, V128, P6016, DOI 10.1021/ja060979+; Fujita W, 2004, CHEM PHYS LETT, V388, P186, DOI [10.1016/j.cplett.2004.02.084, 10.1016/j.cplett.2007.02.084]; Okamoto K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075328; Awaga K, 2006, B CHEM SOC JPN, V79, P25, DOI 10.1246/bcsj.79.25; Fujita W, 2002, CHEM PHYS LETT, V362, P97, DOI 10.1016/S0009-2614(02)01056-4; Matsuzaki H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017403; Fujita W, 1999, SCIENCE, V286, P261, DOI 10.1126/science.286.5438.261; Fujita W, 2011, CRYST GROWTH DES, V11, P575, DOI 10.1021/cg101481c; TAKAHASHI M, 1991, PHYS REV LETT, V67, P746, DOI 10.1103/PhysRevLett.67.746; Miller JS, 2011, CHEM SOC REV, V40, P3266, DOI 10.1039/c0cs00166j; Mito M, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.124705; Sorai M, 2006, CHEM REV, V106, P976, DOI 10.1021/cr960049g; Lekin K, 2014, J AM CHEM SOC, V136, P8050, DOI 10.1021/ja502753t; Fujita W, 2008, ANGEW CHEM INT EDIT, V47, P9480, DOI 10.1002/anie.200803249; BAKER GA, 1964, PHYS REV A-GEN PHYS, V135, P1272; Suzuki K, 2010, CHEM LETT, V39, P1096, DOI 10.1246/cl.2010.1096; Fujita W, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064434; Lekin K, 2010, J AM CHEM SOC, V132, P16212, DOI 10.1021/ja106768z; Mito M, 2009, J AM CHEM SOC, V131, P16012, DOI 10.1021/ja908238w; Awaga K, 2014, B CHEM SOC JPN, V87, P234, DOI 10.1246/bcsj.20130248; Brusso JL, 2004, J AM CHEM SOC, V126, P14692, DOI 10.1021/ja044979q; Leitch AA, 2011, J AM CHEM SOC, V133, P6051, DOI 10.1021/ja200391j; Banister AJ, 1996, ANGEW CHEM INT EDIT, V35, P2533, DOI 10.1002/anie.199625331; Robertson CM, 2008, J AM CHEM SOC, V130, P14791, DOI [10.1021/ja8054436, 10.1021/ja8654436]; Fujita W, 2009, CHEM-ASIAN J, V4, P400, DOI 10.1002/asia.200800362; Shuku Y, 2013, INORG CHEM, V52, P9921, DOI 10.1021/ic401078z; Thomson RI, 2012, CHEM-EUR J, V18, P8629, DOI 10.1002/chem.201200760; AWAGA K, 1988, SYNTHETIC MET, V27, pB631; Barclay TM, 1997, J AM CHEM SOC, V119, P2633, DOI 10.1021/ja9636294; Carlin L. R., 1986, MAGNETOCHEMISTRY; DORMANN E, 1987, J AM CHEM SOC, V109, P2594, DOI 10.1021/ja00243a009; Fujita W, 2002, CHEM PHYS LETT, V352, P348, DOI 10.1016/S0009-2614(01)01477-4; Fujita W, 2014, EUR J INORG CHEM, V2014, P93, DOI 10.1002/ejic.201300811; Hattfield W. E., 1981, J APPL PHYS, V52, P1985; KINOSHITA M, 1991, CHEM LETT, P1225, DOI 10.1246/cl.1991.1225; Leitch AA, 2007, CHEM COMMUN, P3368, DOI 10.1039/b708756j; Winter SM, 2009, CHEM COMMUN, P7306, DOI 10.1039/b917213k; WOLMERSHAUSER G, 1992, Z NATURFORSCH B, V47, P675; Wolmershauser G., 1988, J CHEM RES SYNOP, P358; Zakrassov A, 2004, J MATER CHEM, V14, P1827, DOI 10.1039/b400299g	41	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	3					903	907		10.1039/c4dt03208j		5	Chemistry, Inorganic & Nuclear	Chemistry	AW6ZD	WOS:000346413200006		
J	Patel, J; Majee, K; Ahmad, E; Tanaka, K; Padhi, SK				Patel, Jully; Majee, Karunamay; Ahmad, Ejaz; Tanaka, Koji; Padhi, Sumanta Kumar			[Ru-V(NCN-Me)(bpy)(=O)](3+) Mediates efficient C-H bond oxidation from NADH analogs in aqueous media rather than water oxidation	DALTON TRANSACTIONS			English	Article							COUPLED ELECTRON-TRANSFER; NAD(+)/NADH FUNCTION; TRANSFER PATHWAYS; HYDRIDE-TRANSFER; RADICAL CATIONS; COMPLEXES; RUTHENIUM; ACTIVATION; CATALYST; BEHAVIOR	[(RuO)-O-V=](3+) and [Ru-VI=O](4+) generated from [Ru-II(NCN-Me)(bpy)-(H2O)](PF6)(2) (where NCN-Me is the neutral N-methyl-3,5-di-( 2-pyridyl)-pyridinium iodide after deprotonation of the C-H bond) play a selective role in the C-H bond oxidation of 2-(pyridin-2-yl)-9,10-dihydroacridine (PADHH) and water oxidation, respectively.	[Patel, Jully; Majee, Karunamay; Ahmad, Ejaz; Padhi, Sumanta Kumar] Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Bihar, India; [Tanaka, Koji] Adv Chem Technol Ctr Kyoto ACT Kyoto, Inst Integrated Cell Mat Sci, Fushimi Ku, Kyoto 6128374, Japan	Tanaka, K (reprint author), Adv Chem Technol Ctr Kyoto ACT Kyoto, Inst Integrated Cell Mat Sci, Fushimi Ku, Jibuchou 105, Kyoto 6128374, Japan.	koji.tanaka@icems.kyoto-u.ac.jp; padhi.sk.ac@ismdhanbad.ac.in			Department of Science and Technology (DST) [DST(105)/2014-2015/392/AC]; ISM;  [FRS (45)/2013-2014/AC]	This work was supported by the Department of Science and Technology (DST) under Grant DST(105)/2014-2015/392/AC for S. K. P. ISM Dhanbad is acknowledged for the partial support by the Grant (FRS (45)/2013-2014/AC). J. P., K. M. and E. A. are grateful to ISM for institute fellowships. S. K. P. acknowledges CRF ISM, CIF IIT Guwahati, and CDRI, Lucknow, for analytical facilities.	Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; MOYER BA, 1981, INORG CHEM, V20, P436, DOI 10.1021/ic50216a024; Matsuo T, 2005, INORG CHEM, V44, P2150, DOI 10.1021/ic048170q; Padhi SK, 2011, INORG CHEM, V50, P10718, DOI 10.1021/ic201207x; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Bryant JR, 2003, J AM CHEM SOC, V125, P10351, DOI 10.1021/ja035276w; Lewis JC, 2007, J AM CHEM SOC, V129, P5332, DOI 10.1021/ja070388z; Wiedemann SH, 2006, J AM CHEM SOC, V128, P2452, DOI 10.1021/ja0576684; Duan LL, 2012, NAT CHEM, V4, P418, DOI [10.1038/nchem.1301, 10.1038/NCHEM.1301]; Padhi SK, 2012, INORG CHEM, V51, P5386, DOI 10.1021/ic3003542; FUKUZUMI S, 1993, J AM CHEM SOC, V115, P8960, DOI 10.1021/ja00073a010; Fukuzumi S, 2008, J AM CHEM SOC, V130, P15134, DOI 10.1021/ja804969k; Toyama M, 2006, B CHEM SOC JPN, V79, P1525, DOI 10.1246/bcsj.79.1525; Meyer TJ, 2003, INORG CHEM, V42, P8140, DOI 10.1021/ic020731v; Bockman TM, 1998, J AM CHEM SOC, V120, P2826, DOI 10.1021/ja974205s; CHE CM, 1996, ADV TRANSIT MET COOR, V1, P209; DOBSON JC, 1989, INORG CHEM, V28, P2200, DOI 10.1021/ic00310a037; EBERSON L, 1990, ACTA CHEM SCAND, V44, P1062, DOI 10.3891/acta.chem.scand.44-1062; Fromme P., 2008, PHOTOSYNTHETIC PROTE; Koizumi TA, 2003, B CHEM SOC JPN, V76, P1969, DOI 10.1246/bcsj.76.1969; Padhi SK, 2011, INORG CHEM, V50, P5321, DOI 10.1021/ic200315f; Padhi SK, 2012, INORG CHEM, V51, P8091, DOI 10.1021/ic300449q; Zhang MT, 2011, J AM CHEM SOC, V133, P13224, DOI 10.1021/ja203483j	23	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	3					920	923		10.1039/c4dt02827a		4	Chemistry, Inorganic & Nuclear	Chemistry	AW6ZD	WOS:000346413200010		
J	Nakane, T; Naka, T; Sato, K; Taguchi, M; Nakayama, M; Mitsui, T; Matsushita, A; Chikyow, T				Nakane, Takayuki; Naka, Takashi; Sato, Koichi; Taguchi, Minori; Nakayama, Minako; Mitsui, Tadashi; Matsushita, Akiyuki; Chikyow, Toyohiro			Spectroscopic and crystallographic anomalies of (Co1-xZnx)Al2O4 spinel oxide	DALTON TRANSACTIONS			English	Article							COAL2O4 SPINEL; SUPERCRITICAL WATER; CATION DISTRIBUTION; LATTICE-VIBRATIONS; SINGLE-CRYSTALS; SOL-GEL; SPECTRA; RAMAN; NANOCRYSTALS; ABSORPTION	This work investigates the spectroscopic properties of (Co1-xZnx)Al2O4 with a range of x of 0 <= x <= 1. Spectroscopic and crystallographic evaluations using XRD, Raman, FT-IR and UV-Vis spectroscopy reveal that Zn2+ substitution systematically changes the lattice constant, which mainly depends on the Co-O bonds, and the related optical characteristics of this material. The x dependence of these properties shows two trends, and the mutation point seems to be at x approximate to 0.5. This implies that the electronic structure of (Co1-xZnx)Al2O4 is not changed monotonically by Zn2+ substitution. Interestingly, some of the optical phenomena observed in this study become prominent for samples with x >= 0.5. That is, we observed sideband peaks near the main peaks in the Raman spectra, and their relative intensities systematically and significantly increased with increasing Zn2+ substitution. The rates of increase are not constant, and are fast for samples with x >= 0.5. The sideband peaks are considered to reflect the unique changes in the local electronic structure of (Co1-xZnx)Al2O4, and they are useful for evaluating the substitution level without the influence of the site change phenomenon. Thus, clarifying them is expected to be important for understanding and controlling the electronic structure of the spinel oxide. On the other hand, investigation of the visible light absorption due to the d-d transition of Co2+ reveals that the efficiency is also high for samples with high Zn2+ substitution (x >= 0.5). This is also considered to be valuable information for investigation of the optical properties and/or the catalytic function of the spinel oxide. Moreover, the fluorescence of the (Co1-xZnx)Al2O4 samples is also identified as a novel functional property of this material. The intensity of the fluorescence peak also dramatically increases for samples with x >= 0.7. The effect of Zn2+ substitution on the local electronic structure of (Co1-xZnx)Al2O4 has not been clarified yet. However, some of the interesting characteristics reviewed in this study are worth investigating from the viewpoint of materials science and applications.	[Nakane, Takayuki; Naka, Takashi; Nakayama, Minako; Mitsui, Tadashi; Matsushita, Akiyuki; Chikyow, Toyohiro] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Sato, Koichi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Taguchi, Minori] Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Bunkyo Ku, Hachioji, Tokyo 1128551, Japan	Nakane, T (reprint author), Natl Inst Mat Sci, Sengen 1-2-1, Tsukuba, Ibaraki 3050047, Japan.				 [25246013]	This work was partially supported by a Grant-in-Aid for Scientific Research (A) (KAKENHI) no. 25246013.	Ahn KS, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3183585; Suzuki T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/14/145265; Walsh A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165119; Brik MG, 2007, J ALLOY COMPD, V432, P61, DOI 10.1016/j.jallcom.2006.06.025; Zayat M, 2000, CHEM MATER, V12, P2763, DOI 10.1021/cm001061z; Rangappa D, 2007, J MATER CHEM, V17, P4426, DOI 10.1039/b705760a; SHIRAI H, 1982, J PHYS SOC JPN, V51, P592, DOI 10.1143/JPSJ.51.592; Tristan N, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174404; Nakatsuka A, 2003, SOLID STATE COMMUN, V128, P85, DOI 10.1016/S0038-1098(03)00652-5; GRIMES NW, 1971, PHYS STATUS SOLIDI B, V43, P591, DOI 10.1002/pssb.2220430218; TANABE Y, 1954, J PHYS SOC JPN, V9, P766, DOI 10.1143/JPSJ.9.766; Popovic J, 2009, AM MINERAL, V94, P771, DOI 10.2138/am.2009.3173; TANABE Y, 1954, J PHYS SOC JPN, V9, P753, DOI 10.1143/JPSJ.9.753; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Tristan N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094412; RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558; Ardit M, 2012, AM MINERAL, V97, P1394, DOI 10.2138/am.2012.4093; Rangappa D, 2007, J AM CHEM SOC, V129, P11061, DOI 10.1021/ja0711009; Bersuker I. B., 1996, ELECT STRUCTURE PROP; Bethe H, 1929, ANN PHYS-BERLIN, V3, P133; Broussell I, 1998, J APPL PHYS, V84, P533, DOI 10.1063/1.368057; Buxbaum G, 2005, IND INORGANIC PIGMEN; Cox P.A., 1992, TRANSITION METAL OXI; DEWAAL D, 2004, ASIAN CHEM LETT, V8, P57; Dixit H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174101; El Habra N, 2007, CHEM MATER, V19, P3381, DOI 10.1021/cm0615931; Faulkner E., 2009, HIGH PERFORMANCE PIG; Garcia P., 1984, J SOLID STATE CHEM, V52, P187; Gaudon M, 2009, INORG CHEM, V48, P9085, DOI 10.1021/ic900482v; Hagiwara M, 2010, J LOW TEMP PHYS, V159, P11, DOI 10.1007/s10909-009-0081-y; Hanashima K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.024702; Ji L, 2001, APPL CATAL A-GEN, V207, P247, DOI 10.1016/S0926-860X(00)00659-1; Julien CM, 2006, MAT SCI ENG B-SOLID, V130, P41, DOI 10.1016/j.mseb.2006.02.003; Kock LD, 2007, J RAMAN SPECTROSC, V38, P1480, DOI 10.1002/jrs.1805; Kubelka P., 1931, Zeitschrift fur Technische Physik, V12; LUTZ HD, 1991, J SOLID STATE CHEM, V90, P54, DOI 10.1016/0022-4596(91)90171-D; Maljuk A, 2009, J CRYST GROWTH, V311, P3997, DOI 10.1016/j.jcrysgro.2009.06.005; Stanojevic ZVM, 2007, J EUR CERAM SOC, V27, P903, DOI 10.1016/j.jeurceramsoc.2006.04.057; MAYER F, 1999, J MATER CHEM, V9, P1755; NAKA T, UNPUB; ONEILL HSC, 1994, EUR J MINERAL, V6, P603; Racah G, 1942, PHYS REV, V62, P438, DOI 10.1103/PhysRev.62.438; Sato K., UNPUB; Sato K, 2014, J MAGN MAGN MATER, V350, P161, DOI 10.1016/j.jmmm.2013.09.012; de Souza LKC, 2009, DYES PIGMENTS, V81, P187, DOI 10.1016/j.dyepig.2008.09.017; Taguchi M, 2013, DALTON T, V42, P7167, DOI 10.1039/c3dt32828g; TANABE Y, 1956, J PHYS SOC JPN, V11, P864, DOI 10.1143/JPSJ.11.864; Tielens F, 2006, J PHYS CHEM B, V110, P988, DOI 10.1021/jp0533751; Walsh A, 2008, J PHYS CHEM C, V112, P12044, DOI 10.1021/jp711566k; WOHLFARTH EP, 1982, FERROMAGNETIC MAT HD, V3; Xu ZP, 1998, J MATER CHEM, V8, P2499, DOI 10.1039/a804767g	51	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	3					997	1008		10.1039/c4dt01599a		12	Chemistry, Inorganic & Nuclear	Chemistry	AW6ZD	WOS:000346413200018		
J	Suzuki, T; Matsumoto, J; Kajita, Y; Inomata, T; Ozawa, T; Masuda, H				Suzuki, Tatsuya; Matsumoto, Jun; Kajita, Yuji; Inomata, Tomohiko; Ozawa, Tomohiro; Masuda, Hideki			Nitrosyl and carbene iron complexes bearing a kappa(3)-SNS thioamide pincer type ligand	DALTON TRANSACTIONS			English	Article							N-HETEROCYCLIC CARBENES; HIGHLY-ACTIVE IRON; NITRIC-OXIDE; RUTHENIUM COMPLEXES; PLATINUM COMPLEXES; CATALYSTS; POLYMERIZATION; COBALT; ATOM; DEPROTONATION/PROTONATION	The previously reported monochelate iron complex with kappa(3) SNS thioamide pincer ligand, 2,6-bis(N-2,6-bis(diphenylmethyl)-4-isopropylphenyliminothiolate)pyridine (L-DPM), [Fe(THF)(2)(kappa(3)-L-DPM)], gave novel complexes, [Fe(NHC)(kappa(3)-L-DPM)] and [Fe(NO)(2)(kappa(3)-L-DPM)], by substitution reactions with N-heterocyclic carbene (NHC) and NO molecules, respectively. The X-ray crystal structure of the [Fe(NHC)(kappa(3)-L-DPM)] complex revealed a unique square planar iron(II) complex, which was determined to be in an intermediate spin state (S = 1) in benzene from the Evans method. The [Fe(NO)(2)(kappa(3)-LDPM)] complex was determined to have a trigonal bipyramidal geometry from X-ray analysis and was indicated to be diamagnetic from the H-1 NMR spectrum. The upsilon(NO) stretching vibration of this complex showed two peaks at 1840 cm(-1) and 1790 cm(-1), and also the Fe-N-O bond angles were 168.9(2)degrees and 168.03(19)degrees. These findings suggest that the two coordinated NO molecules have neutral radical character, and they are antiferromagnetically coupled with the high-spin iron center.	[Suzuki, Tatsuya; Matsumoto, Jun; Inomata, Tomohiko; Ozawa, Tomohiro; Masuda, Hideki] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Kajita, Yuji] Aichi Inst Technol, Dept Appl Chem, Toyota 4700392, Japan	Masuda, H (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	masuda.hideki@nitech.ac.jp			Ministry of Education, Culture, Sports, Science; Japan Society for the Promotion of Science "Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation"	We gratefully acknowledge Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Japan Society for the Promotion of Science "Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation" for the support of this work.	Castro LCM, 2012, CHEM COMMUN, V48, P151, DOI 10.1039/c1cc14403k; Hawrelak EJ, 2005, INORG CHEM, V44, P3103, DOI 10.1021/ic048202+; Danopoulos AA, 2011, ORGANOMETALLICS, V30, P6514, DOI 10.1021/om200951m; Wang QQ, 2012, INORG CHEM, V51, P760, DOI 10.1021/ic202087u; Arduengo AJ, 1999, TETRAHEDRON, V55, P14523, DOI 10.1016/S0040-4020(99)00927-8; Small BL, 1999, MACROMOLECULES, V32, P2120, DOI 10.1021/ma981698s; Hashimoto T, 2012, ORGANOMETALLICS, V31, P4474, DOI 10.1021/om300298q; Gao HH, 2010, ORGANOMETALLICS, V29, P4189, DOI 10.1021/om100482w; Xiang L, 2011, ORGANOMETALLICS, V30, P2018, DOI 10.1021/om2000663; Liu YZ, 2013, CHEM COMMUN, V49, P6412, DOI 10.1039/c3cc43833c; Wurtz S, 2008, ACCOUNTS CHEM RES, V41, P1523, DOI 10.1021/ar8000876; Creutz SE, 2014, J AM CHEM SOC, V136, P1105, DOI 10.1021/ja4114962; Meyer S, 2011, ORGANOMETALLICS, V30, P6692, DOI 10.1021/om200870w; Wyllie GRA, 2003, INORG CHEM, V42, P5722, DOI 10.1021/ic034473t; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; Hu XL, 2003, ORGANOMETALLICS, V22, P612, DOI 10.1021/om020935j; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; SCHUBERT EM, 1992, J CHEM EDUC, V69, P62; Liu B, 2009, ANGEW CHEM INT EDIT, V48, P5513, DOI 10.1002/anie.200901850; Zlatogorsky S, 2011, ORGANOMETALLICS, V30, P4974, DOI 10.1021/om200605b; Honda H, 2014, EUR J INORG CHEM, V2014, P1865, DOI 10.1002/ejic.201301404; Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l; Przyojski JA, 2012, ORGANOMETALLICS, V31, P3264, DOI 10.1021/om300106u; IBERS JA, 1964, ACTA CRYSTALLOGR, V17, P781, DOI 10.1107/S0365110X64002067; Berthon-Gelloz G, 2010, DALTON T, V39, P1444, DOI 10.1039/b921894g; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Ray M, 1997, INORG CHEM, V36, P3568, DOI 10.1021/ic961118c; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Begum RA, 2006, INORG CHEM, V45, P964, DOI 10.1021/ic051775h; Britovsek GJP, 1998, CHEM COMMUN, P849, DOI 10.1039/a801933i; Britovsek GJP, 1999, J AM CHEM SOC, V121, P8728, DOI 10.1021/ja990449w; Corberan R, 2009, EUR J INORG CHEM, P1700, DOI 10.1002/ejic.200801095; Creagh D. C., 1992, INT TABLES CRYSTALLO, VC, P219; Creagh D. C., 1992, INT TABLES CRYSTALLO, VC, P200; Cromer D. T., 1974, INT TABLES XRAY CRYS; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; Hossain MA, 2004, INORG CHEM, V43, P7275, DOI 10.1021/ic0489645; Kanbara T, 2004, J ORGANOMET CHEM, V689, P1860, DOI 10.1016/j.jorganchem.2004.03.003; Kantchev A. B. E., 2007, ANGEW CHEM INT EDIT, V46, P2768; Komiyama Y, 2014, ORGANOMETALLICS, V33, P885, DOI 10.1021/om400969p; Lancaster M., 2011, SCIENCE, V334, P974; Louie J, 2000, CHEM COMMUN, P1479, DOI 10.1039/b003957h; Okamoto K, 2009, ORGANOMETALLICS, V28, P3307, DOI 10.1021/om800894j; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Small BL, 1998, J AM CHEM SOC, V120, P4049, DOI 10.1021/ja9802100; Suzuki T, 2014, DALTON T, V43, P9732, DOI 10.1039/c4dt00524d; Teratani T, 2011, DALTON T, V40, P8879, DOI 10.1039/c0dt01283a; Tsou CC, 2013, INORG CHEM, V52, P1631, DOI 10.1021/ic302537d; Wang RM, 2009, INORG CHEM, V48, P9779, DOI 10.1021/ic901368t	51	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	3					1017	1022		10.1039/c4dt03128h		6	Chemistry, Inorganic & Nuclear	Chemistry	AW6ZD	WOS:000346413200020		
J	Habata, Y; Kizaki, J; Hosoi, Y; Ikeda, M; Kuwahara, S				Habata, Yoichi; Kizaki, Juli; Hosoi, Yasuhiro; Ikeda, Mari; Kuwahara, Shunsuke			Argentivorous molecules bearing three aromatic side arms: synthesis of triple-armed cyclens and their complexing property towards Ag+	DALTON TRANSACTIONS			English	Article							SILVER(I) COMPLEXES; PI INTERACTIONS; COORDINATION POLYMERS; METAL-COMPLEXES; FRAMEWORK; LIGANDS; DESIGN; CH/PI; WATER	Triple-armed cyclens bearing three aromatic side-arms were prepared in three steps from (3R,5S)-3,5-dimethyl-1,4,7,10-tetraazacyclododecane-2,6-dione, and the Ag+-ion-induced H-1 NMR and UV-vis spectral changes and X-ray structures suggested that the aromatic side-arms cover the Ag+ incorporated into the ligand cavities like an insectivorous plant (Venus flytrap).	[Habata, Yoichi; Kizaki, Juli; Hosoi, Yasuhiro; Kuwahara, Shunsuke] Toho Univ, Fac Sci, Dept Chem, Funabashi, Chiba 2748510, Japan; [Habata, Yoichi; Ikeda, Mari; Kuwahara, Shunsuke] Toho Univ, Res Ctr Mat Integrated Properties, Funabashi, Chiba 2748510, Japan; [Ikeda, Mari] Chiba Inst Technol, Fac Engn, Educ Ctr, Narashino, Chiba 2750023, Japan	Habata, Y (reprint author), Toho Univ, Fac Sci, Dept Chem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	habata@chem.sci.toho-u.ac.jp			High-Tech Research Center project [08026969, 11011761, 26410100]; Supported Program for Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Professor Masatoshi Hasegawa for the TG DTA measurements. This research was supported by Grants-in-Aid 08026969, 11011761 and 26410100, a High-Tech Research Center project (2005-2009), and the Supported Program for Strategic Research Foundation at Private Universities (2012-2016) from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Y.H.	Abe M, 2012, TETRAHEDRON, V68, P3566, DOI 10.1016/j.tet.2012.03.005; Wu H, 2011, INORG CHIM ACTA, V373, P19, DOI 10.1016/j.ica.2011.03.041; NISHIO M, 1995, TETRAHEDRON, V51, P8665, DOI 10.1016/0040-4020(94)01066-9; Yang G, 2013, CRYST GROWTH DES, V13, P264, DOI 10.1021/cg301411j; Ahamed BN, 2011, INORG CHEM, V50, P4772, DOI 10.1021/ic102363y; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; Bowmaker GA, 2005, INORG CHIM ACTA, V358, P4327, DOI 10.1016/j.ica.2005.04.002; Shinoda S, 2013, CHEM SOC REV, V42, P1825, DOI 10.1039/c2cs35295h; [Anonymous], SPART 10; Williams NJ, 2009, INORG CHEM, V48, P1407, DOI 10.1021/ic801403s; Senchyk GA, 2012, INORG CHEM, V51, P8025, DOI 10.1021/ic3000894; Habata Y, 2013, INORG CHEM, V52, P2542, DOI 10.1021/ic302511e; Habata Y, 2012, ORG LETT, V14, P4576, DOI 10.1021/ol3019538; BROWN RW, 1990, J AGR FOOD CHEM, V38, P269, DOI 10.1021/jf00091a060; Burke BP, 2014, J LABELLED COMPD RAD, V57, P239, DOI 10.1002/jlcr.3146; Constable EC, 2013, INORG CHEM COMMUN, V27, P159, DOI 10.1016/j.inoche.2012.10.001; Deng ZP, 2008, CRYST GROWTH DES, V8, P3277, DOI 10.1021/cg800091y; Fang SM, 2010, INORG CHEM COMMUN, V13, P139, DOI 10.1016/j.inoche.2009.10.029; Habata Y, 2013, DALTON T, V42, P8212, DOI 10.1039/c3dt00034f; Habata Y, 2013, INORG CHEM, V52, P11697, DOI 10.1021/ic4021417; Habata Y, 2013, ORG BIOMOL CHEM, V11, P4265, DOI 10.1039/c3ob40125a; Hehre W. J., 1998, BRIEF GUIDE MOL MECH, P159; Insaf SS, 2000, TETRAHEDRON, V56, P2359, DOI 10.1016/S0040-4020(00)00103-4; Jakusch T, 2003, EUR J INORG CHEM, P2113; Jin F, 2012, CRYSTENGCOMM, V14, P8409, DOI 10.1039/c2ce26145f; Laye RH, 2007, INORG CHIM ACTA, V360, P439, DOI 10.1016/j.ica.2006.07.068; Lee TY, 2009, PURE APPL CHEM, V81, P255, DOI 10.1351/PAC-CON-08-07-02; Liu JY, 2013, CRYSTENGCOMM, V15, P6413, DOI 10.1039/c3ce40672e; Luo GG, 2012, J MOL STRUCT, V1014, P92, DOI 10.1016/j.molstruc.2012.02.003; Mochida T, 2006, DALTON T, P693, DOI 10.1039/b511286a; Platas-Iglesias C., 2012, EUR J INORG CHEM, V2012, P2023; Rodriguez-Rodriguez A, 2012, INORG CHEM, V51, P2509, DOI 10.1021/ic202436j; Santra R, 2013, CHEM-EUR J, V19, P488, DOI 10.1002/chem.201201797; Shanan-Atidi H., 1970, Journal of Physical Chemistry, V74, DOI 10.1021/j100699a054; Sharma C. V., 1998, CRYST ENG, V1, P19, DOI 10.1016/S0025-5408(98)00032-4; Sheldrick G.M., 1996, SADABS VERSION 2 03; SHELXTLTM, 1997, SHELXTLTM VERS 5 1; Stephenson A, 2012, CHEM COMMUN, V48, P3605, DOI 10.1039/c2cc30197k; Sun QZ, 2007, DALTON T, P4089, DOI 10.1039/b706183h; Wang DZ, 2009, J MOL STRUCT, V929, P128, DOI 10.1016/j.molstruc.2009.04.013; Wang L, 2011, CRYSTENGCOMM, V13, P747, DOI 10.1039/c0ce00689k; Wen M, 2004, POLYHEDRON, V23, P2117, DOI 10.1016/j.poly.2004.03.026; Xie YB, 2004, DALTON T, P562, DOI 10.1039/b315320g; Xu Jing, 2012, Acta Crystallogr Sect E Struct Rep Online, V68, pm639, DOI 10.1107/S160053681201625X; Yang G, 2000, INORG CHIM ACTA, V303, P86, DOI 10.1016/S0020-1693(99)00522-8; Zheng GL, 2008, EUR J INORG CHEM, P1756, DOI 10.1002/ejic.200701264	46	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	3					1170	1177		10.1039/c4dt02954b		8	Chemistry, Inorganic & Nuclear	Chemistry	AW6ZD	WOS:000346413200037		
J	Kajikawa, M; Nakashima, A; Fujimura, N; Maruhashi, T; Iwamoto, Y; Iwamoto, A; Matsumoto, T; Oda, N; Hidaka, T; Kihara, Y; Chayama, K; Goto, C; Aibara, Y; Noma, K; Takeuchi, M; Matsui, T; Yamagishi, S; Higashi, Y				Kajikawa, Masato; Nakashima, Ayumu; Fujimura, Noritaka; Maruhashi, Tatsuya; Iwamoto, Yumiko; Iwamoto, Akimichi; Matsumoto, Takeshi; Oda, Nozomu; Hidaka, Takayuki; Kihara, Yasuki; Chayama, Kazuaki; Goto, Chikara; Aibara, Yoshiki; Noma, Kensuke; Takeuchi, Masayoshi; Matsui, Takanori; Yamagishi, Sho-ichi; Higashi, Yukihito			Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function	DIABETES CARE			English	Article							GLYCATION END-PRODUCTS; FLOW-MEDIATED DILATION; CARDIOVASCULAR-DISEASE; VASCULAR INFLAMMATION; DIABETIC-NEPHROPATHY; DEPENDENT DILATION; BIOCHEMICAL BASIS; BRACHIAL-ARTERY; PLASMA-LEVELS; RISK	OBJECTIVE Advanced glycation end products (AGEs) and their specific receptor, the receptor for AGEs (RAGE), play an important role in atherosclerosis. Recently, a soluble form of RAGE (sRAGE) has been identified in human serum. However, the role of sRAGE in cardiovascular disease is still controversial. There is no information on the association between simultaneous measurements of AGEs and sRAGE and vascular function. In this study, we evaluated the associations between serum levels of AGEs and sRAGE, ratio of AGEs to sRAGE, and vascular function. RESEARCH DESIGN AND METHODS We measured serum levels of AGEs and sRAGE and assessed vascular function by measurement of flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation in 110 subjects who underwent health examinations. Multivariate regression analyses were performed to identify factors associated with vascular function. RESULTS Univariate regression analysis revealed that FMD correlated with age, BMI, systolic blood pressure, diastolic blood pressure, heart rate, triglycerides, HDL cholesterol, glucose, smoking pack-years, nitroglycerine-induced vasodilation, serum levels of AGEs and sRAGE, and ratio of AGEs to sRAGE. Multivariate analysis revealed that the ratio of AGEs to sRAGE remained an independent predictor of FMD, while serum level of AGEs alone or sRAGE alone was not associated with FMD. CONCLUSIONS These findings suggest that sRAGE may have a counterregulatory mechanism that is activated to counteract the vasotoxic effect of the AGE-RAGE axis. The ratio of AGEs to sRAGE may be a new chemical biomarker of endothelial function.	[Kajikawa, Masato; Maruhashi, Tatsuya; Iwamoto, Yumiko; Iwamoto, Akimichi; Matsumoto, Takeshi; Oda, Nozomu; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Nakashima, Ayumu; Higashi, Yukihito] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan; [Fujimura, Noritaka] Chugoku Rosai Hosp, Dept Cardiol, Hiroshima, Japan; [Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Goto, Chikara] Hiroshima Int Univ, Hiroshima, Japan; [Aibara, Yoshiki; Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cardiovasc Regenerat & Med, Hiroshima, Japan; [Takeuchi, Masayoshi] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa, Japan; [Matsui, Takanori; Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Higashi, Y (reprint author), Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan.	yhigashi@hiroshima-u.ac.jp			Ministry of Education, Science and Culture of Japan [1859081500, 21590898]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (1859081500 and 21590898).	American Diabetes Association, 1999, DIABETES CARE S1, V22, pS1; Santilli F, 2009, CURR MED CHEM, V16, P940; Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Chiang KH, 2009, CORONARY ARTERY DIS, V20, P267, DOI 10.1097/MCA.0b013e32832c459c; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Takeuchi M, 2000, MOL MED, V6, P114; Yan SF, 2007, CURR MOL MED, V7, P699; Adams MR, 1998, J AM COLL CARDIOL, V32, P123, DOI 10.1016/S0735-1097(98)00206-X; Nin JWM, 2010, DIABETES, V59, P2027, DOI 10.2337/db09-1509; Nakamura K, 2008, MICROVASC RES, V76, P52, DOI 10.1016/j.mvr.2007.09.004; [Anonymous], 2001, JAMA, V285, P2486; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Fukami K, 2008, CURR PHARM DESIGN, V14, P946, DOI 10.2174/138161208784139710; Uribarri J, 2007, DIABETES CARE, V30, P2579, DOI 10.2337/dc07-0320; Kajikawa M, 2014, CIRC J, V78, P950, DOI 10.1253/circj.CJ-13-1330; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Gokce N, 2002, J AM COLL CARDIOL, V40, P761, DOI 10.1016/S0735-1097(02)02034-X; Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528; Fujisawa K, 2013, ATHEROSCLEROSIS, V227, P425, DOI 10.1016/j.atherosclerosis.2013.01.016; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Rahbar S, 2003, ARCH BIOCHEM BIOPHYS, V419, P63, DOI 10.1016/j.abb.2003.08.009; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; HASHIMOTO M, 1995, CIRCULATION, V92, P3431; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468; Tan KCB, 2002, DIABETES CARE, V25, P1055, DOI 10.2337/diacare.25.6.1055; Ross R, 1999, NEW ENGL J MED, V340, P115; Tahara N, 2012, INT J CARDIOL, V158, P461, DOI 10.1016/j.ijcard.2012.05.015; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184; Yamagishi S, 2011, PHARMACOL RES, V64, P187, DOI 10.1016/j.phrs.2011.05.009	39	9	9	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	JAN	2015	38	1					119	125		10.2337/dc14-1435		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AX2GT	WOS:000346762300023		
J	Ayano-Takahara, S; Ikeda, K; Fujimoto, S; Hamasaki, A; Harashima, S; Toyoda, K; Fujita, Y; Nagashima, K; Tanaka, D; Inagaki, N				Ayano-Takahara, Shiho; Ikeda, Kaori; Fujimoto, Shimpei; Hamasaki, Akihiro; Harashima, Shin-ichi; Toyoda, Kentaro; Fujita, Yoshihito; Nagashima, Kazuaki; Tanaka, Daisuke; Inagaki, Nobuya			Glycemic Variability Is Associated With Quality of Life and Treatment Satisfaction in Patients With Type 1 Diabetes	DIABETES CARE			English	Editorial Material							GLUCOSE VARIABILITY		[Ayano-Takahara, Shiho; Ikeda, Kaori; Fujimoto, Shimpei; Hamasaki, Akihiro; Harashima, Shin-ichi; Toyoda, Kentaro; Fujita, Yoshihito; Nagashima, Kazuaki; Tanaka, Daisuke; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Kochi 780, Japan	Inagaki, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp					Kuenen JC, 2011, DIABETES CARE, V34, P1843, DOI 10.2337/dc10-2217; Bradley C, 1994, HDB PSYCHOL DIABETES, P111; DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610; Sato F, 2013, DIABETOL INT, V5, P21, DOI 10.1007/s13340-013-0125-z; DCCT Res Grp, 1988, DIABETES CARE, V11, P725	5	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	JAN	2015	38	1					E1	E2		10.2337/dc14-1801		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AX2GT	WOS:000346762300001		
J	Yano, T; Miki, T; Itoh, T; Ohnishi, H; Asari, M; Chihiro, S; Yamamoto, A; Aotsuka, K; Kawakami, N; Ichikawa, J; Hirota, Y; Miura, T				Yano, T.; Miki, T.; Itoh, T.; Ohnishi, H.; Asari, M.; Chihiro, S.; Yamamoto, A.; Aotsuka, K.; Kawakami, N.; Ichikawa, J.; Hirota, Y.; Miura, T.			IQ is an independent predictor of glycated haemoglobin level in young and middle-aged adults with intellectual disability	DIABETIC MEDICINE			English	Article							PRADER-WILLI-SYNDROME; INSULIN-RESISTANCE; OBESITY	AimsHere we examined whether intellectual disability is independently associated with hyperglycaemia. MethodsWe recruited 233 consecutive young and middle-aged adults with intellectual disability. After exclusion of subjects on medication for metabolic diseases or with severe intellectual disability (IQ<35), 121 subjects were divided by IQ into a group with moderate intellectual disability (35IQ50), a mild intellectual disability group (51IQ70) and a borderline group (IQ>70). ResultsHbA(1c) level was higher in subjects with moderate intellectual disability (429mmol/mol; 6.00.8%) than those in the borderline group (364mmol/mol; 5.5 +/- 0.3%) and mild intellectual disability group (37 +/- 5mmol/mol; 5.5 +/- 0.5%) groups. HbA(1c) level was correlated with age, BMI, blood pressure, serum triglycerides and IQ in simple linear regression analysis. Multiple regression analysis indicated that IQ, age, BMI and diastolic blood pressure were independent explanatory factors of HbA(1c) level. ConclusionsAn unfavourable effect of intellectual disability on lifestyle and untoward effect of hyperglycaemia on cognitive function may underlie the association of low IQ with hyperglycaemia. What's new? <list list-type="bulleted" id="dme12547-list-0001"> This study tested whether there is any association of IQ with variables of glucose and lipid metabolism in subjects with intellectual disability. We found for the first time that low IQ level, in addition to BMI, is independently associated with high HbA(1c) level.	[Yano, T.; Asari, M.; Chihiro, S.; Yamamoto, A.; Aotsuka, K.; Kawakami, N.; Ichikawa, J.; Hirota, Y.] Counseling Ctr Handicapped Hokkaido, Sapporo, Hokkaido, Japan; [Yano, T.; Miki, T.; Itoh, T.; Ohnishi, H.; Miura, T.] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, H.] Sapporo Med Univ, Dept Publ Hlth, Sch Med, Sapporo, Hokkaido, Japan	Miki, T (reprint author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	tmiki@sapmed.ac.jp					Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Spauwen PJJ, 2013, DIABETES CARE, V36, P1554, DOI 10.2337/dc12-0746; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x; Rimmer JH, 2006, MENT RETARD DEV D R, V12, P22, DOI 10.1002/mrdd.20091; Cyganek K, 2011, DIABETIC MED, V28, P755, DOI 10.1111/j.1464-5491.2011.03280.x; Senda M, 2012, ENDOCR J, V59, P889; Shimada M, 2001, PSYCHIAT CLIN NEUROS, V55, P559, DOI 10.1046/j.1440-1819.2001.00906.x; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	JAN	2015	32	1					129	132		10.1111/dme.12547		4	Endocrinology & Metabolism	Endocrinology & Metabolism	AW5TJ	WOS:000346336400019		
J	Kobayashi, M; Uehara, T; Horikawa, M; Kobayashi, T; Sakai, H; Honda, T				Kobayashi, Mikiko; Uehara, Takeshi; Horikawa, Mieko; Kobayashi, Tatsuya; Sakai, Hitoshi; Honda, Takayuki			Flower-Like/Clover Leaf Lymphocytes Appear in Various Diseases: Cerebrospinal Fluid Cytology Case With Review of the Literature	DIAGNOSTIC CYTOPATHOLOGY			English	Letter							CENTRAL-NERVOUS-SYSTEM; NON-HODGKINS-LYMPHOMA; CELL LYMPHOMA; ATYPICAL LYMPHOCYTES; DIAGNOSIS; LEUKEMIA; INVOLVEMENT; NUCLEI		[Kobayashi, Mikiko; Uehara, Takeshi; Horikawa, Mieko; Honda, Takayuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Kobayashi, Tatsuya] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Sakai, Hitoshi] Shinshu Univ, Sch Med, Dept Internal Med, Div Hematol, Matsumoto, Nagano 3908621, Japan	Uehara, T (reprint author), Shinshu Univ, Sch Med, Dept Lab Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	tuehara@shinshu-u.ac.jp					HUHN KM, 1995, AM J HEMATOL, V49, P360, DOI 10.1002/ajh.2830490424; Chang ST, 2008, PATHOL RES PRACT, V204, P23, DOI 10.1016/j.prp.2007.08.008; Dahmoush L, 2002, CANCER CYTOPATHOL, V96, P110, DOI 10.1002/cncr.10480; Deckert M., 2007, WHO CLASSIFICATION T, P188; Finn WG, 1998, AM J CLIN PATHOL, V110, P341; Galoin S, 1997, BRIT J HAEMATOL, V99, P122, DOI 10.1046/j.1365-2141.1997.3423153.x; Gleissner B, 2002, NEUROLOGY, V58, P390; HANSON CA, 1989, AM J SURG PATHOL, V13, P671, DOI 10.1097/00000478-198908000-00005; HOEFNAGELS WAJ, 1986, CLIN NEUROL NEUROSUR, V88, P45, DOI 10.1016/0303-8467(86)90006-5; INOUE S, 1988, BRIT J HAEMATOL, V70, P381, DOI 10.1111/j.1365-2141.1988.tb02499.x; LI CY, 1986, CANCER, V57, P737, DOI 10.1002/1097-0142(19860215)57:4<737::AID-CNCR2820570410>3.0.CO;2-6; Sacher RA, 1999, BRIT J HAEMATOL, V105, P758, DOI 10.1046/j.1365-2141.1999.01408.x; Teng R J, 1990, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V31, P379; Valdez R, 2002, MODERN PATHOL, V15, P1073, DOI 10.1097/01.MP.0000030088.28684.5B; WIN N, 1990, CLIN LAB HAEMATOL, V12, P111; Yaghmour G, 2013, INT J HEMATOL, V97, P679, DOI 10.1007/s12185-013-1349-1	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	JAN	2015	43	1					88	90		10.1002/dc.23147		3	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AW4LN	WOS:000346252700021		
J	Boonanuntanasarn, S; Jangprai, A; Yoshizaki, G				Boonanuntanasarn, S.; Jangprai, A.; Yoshizaki, G.			Characterization of proopiomelanocortin in the snakeskin gourami (Trichopodus pectoralis) and its expression in relation to food intake	DOMESTIC ANIMAL ENDOCRINOLOGY			English	Article						Proopiomelanocortin; Fasting; POMC expression; Gourami; K-a/K-s ratio	MESSENGER-RNA EXPRESSION; HYPOTHALAMIC-PITUITARY AXIS; TROUT ONCORHYNCHUS-MYKISS; MELANOCORTIN 4 RECEPTOR; ZEBRAFISH DANIO-RERIO; CARP CYPRINUS-CARPIO; RAY-FINNED FISH; MOLECULAR-CLONING; NUCLEOTIDE-SEQUENCE; NEUROPEPTIDE-Y	Proopiomelanocortin (POMC) is the precursor of several hormones involved in physiological systems including feed intake. The snakeskin gourami (Trichopodus pectoralis) POMC complementary DNA (TpPOMC) was cloned and characterized. Phylogenetic analysis showed that TpPOMC was clustered in a major POMC lineage in fish. Analysis of the Ka to K-s ratios for the entire POMC sequence and for each hormonal segment suggested that different POMCderived peptide segments were subject to different evolutionary pressures. High expression level of TpPOMC was observed in all brain regions, with the highest levels in the diencephalon and pituitary gland. In situ hybridization also revealed that TpPOMC-expressing cells were distributed in discrete brain regions. The transcription level of TpPOMC was also found at moderate levels in several peripheral tissues, including gills, liver, head kidney, trunk kidney, stomach, intestine, spleen, ovary and testis, and at a low level in muscle. The expression level of TpPOMC was evaluated in each brain region (telencephalon, mesencephalon, metencephalon, and diencephalon together with the pituitary gland) at 1 h before the first and the last meals of the day and compared with expression levels at a time interval between the first and the last meals of the day. Low expression levels of TpPOMC were found at 1 h before the last meal of the day (P < 0.05). These finding suggest that decreased POMC expression level may lead to reduced melanocyte-stimulating hormones, which may in part be responsible for stimulating food intake. The effect of short-term fasting (24 h) on TpPOMC expression level in each brain region was also investigated. In telencephalon and diencephalon together with the pituitary gland, TpPOMC messenger RNA reached a nadir at 12 h of fasting, whereas TpPOMC transcript showed a nadir at 6 h of fasting in metencephalon and mesencephalon. A peak of TpPOMC level was observed at 18 h of fasting in metencephalon and diencephalon together with the pituitary gland. These findings suggest that TpPOMC expression is affected by nutritional status. (C) 2015 Elsevier Inc. All rights reserved.	[Boonanuntanasarn, S.; Jangprai, A.] Suranaree Univ Technol, Sch Anim Prod Technol, Inst Agr Technol, Muang 30000, Nakhon Ratchasi, Thailand; [Yoshizaki, G.] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan	Boonanuntanasarn, S (reprint author), Suranaree Univ Technol, Sch Anim Prod Technol, Inst Agr Technol, 111 Univ Ave, Muang 30000, Nakhon Ratchasi, Thailand.	surinton@sut.ac.th			Suranaree University of Technology; Higher Education Research Promotion, and National Research University Project of Thailand, Office of the Higher Education Commission; National Research Council of Thailand [SUT3-303-50-12-16]; Thailand Research Fund-Master Research;  [MRG-WII525S066]	This study was supported by grants from Suranaree University of Technology, the Higher Education Research Promotion, and National Research University Project of Thailand, Office of the Higher Education Commission, and the National Research Council of Thailand (SUT3-303-50-12-16). This work was also supported by the Suranaree University of Technology and Thailand Research Fund-Master Research co-funding grants (MRG-WII525S066). The authors acknowledge the help of Mr Sunai Plymee (SUT Farm) for maintaining the fish throughout the study. We also thank Mrs Misako Miwa and Ms Shoko Ihara (Tokyo University of Marine Science and Technology) for their technical assistance.	Alrubaian J, 1999, PEPTIDES, V20, P431, DOI 10.1016/S0196-9781(99)00021-2; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; Stutz AM, 2007, OBESITY, V15, P607, DOI 10.1038/oby.2007.564; Takeuchi S, 1999, BBA-MOL CELL RES, V1450, P452, DOI 10.1016/S0167-4889(99)00046-4; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Cardoso JCR, 2011, GEN COMP ENDOCR, V173, P396, DOI 10.1016/j.ygcen.2010.12.001; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Berghman LR, 1998, MOL CELL ENDOCRINOL, V142, P119, DOI 10.1016/S0303-7207(98)00112-9; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; Chen CP, 2004, J NEUROCHEM, V88, P1547, DOI 10.1046/j.1471-4159.2003.02300.x; Wunderink YS, 2012, GEN COMP ENDOCR, V175, P407, DOI 10.1016/j.ygcen.2011.11.026; Treier M, 1996, CURR OPIN CELL BIOL, V8, P833, DOI 10.1016/S0955-0674(96)80085-8; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Arends RJ, 1998, MOL CELL ENDOCRINOL, V143, P23, DOI 10.1016/S0303-7207(98)00139-7; Bagrosky B, 2003, GEN COMP ENDOCR, V134, P339, DOI 10.1016/j.ygcen.2003.09.014; BALM PHM, 1995, GEN COMP ENDOCR, V98, P279, DOI 10.1006/gcen.1995.1070; Bertile FR, 2006, PEPTIDES, V27, P291, DOI 10.1016/j.peptides.2005.03.063; Boonanuntanasarn S, 2012, GEN COMP ENDOCR, V179, P184, DOI 10.1016/j.ygcen.2012.07.024; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Breen TL, 2005, BRAIN RES, V1032, P141, DOI 10.1016/j.brainres.2004.11.008; COOL DR, 1995, J BIOL CHEM, V270, P8723; Danielson PB, 1999, GEN COMP ENDOCR, V116, P164, DOI 10.1006/gcen.1999.7353; Denaf C, 2001, CLIN EXP PHARM PHYSL, V28, P239; DEYEBENES EG, 1995, BRAIN RES, V674, P112; Dores RM, 2005, GEN COMP ENDOCR, V142, P81, DOI 10.1016/j.ygcen.2005.02.003; DORES RM, 1994, PEPTIDES, V15, P1497, DOI 10.1016/0196-9781(94)90129-5; Eipper B A, 1980, Endocr Rev, V1, P1; Gonzalez-Nunez V, 2003, MOL BRAIN RES, V120, P1, DOI 10.1016/j.molbrainres.2003.09.012; Hansen IA, 2003, BIOCHEM BIOPH RES CO, V303, P1121, DOI 10.1016/S0006-291X(03)00475-3; HEIJNEN C J, 1987, Brain Behavior and Immunity, V1, P284, DOI 10.1016/0889-1591(87)90031-6; Jangprai A, 2011, GEN COMP ENDOCR, V173, P27, DOI 10.1016/j.ygcen.2011.04.021; Karsi A, 2004, GEN COMP ENDOCR, V137, P312, DOI 10.1016/j.ygcen.2004.03.012; Kioussi C, 1999, MECH DEVELOP, V81, P23, DOI 10.1016/S0925-4773(98)00229-9; KITAHARA N, 1988, COMP BIOCHEM PHYS B, V91, P365, DOI 10.1016/0305-0491(88)90155-1; Leder EH, 2006, J ENDOCRINOL, V188, P355, DOI 10.1677/joe.1.06283; Lee J, 1999, PEPTIDES, V20, P1391, DOI 10.1016/S0196-9781(99)00148-5; MAINS RE, 1983, TRENDS NEUROSCI, V6, P229, DOI 10.1016/0166-2236(83)90100-5; Makimura H, 2003, BMC PHYSL, P3; Martens GJM, 1985, J BIOL CHEM, V260, P685; Okuta A, 1996, ZOOL SCI, V13, P421, DOI 10.2108/zsj.13.421; Perello M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1348, DOI 10.1152/ajpendo.00466.2006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SALBERT G, 1992, MOL ENDOCRINOL, V6, P1605, DOI 10.1210/me.6.10.1605; Schwyzer R, 1977, Ann N Y Acad Sci, V297, P3, DOI 10.1111/j.1749-6632.1977.tb41843.x; Shen ST, 2003, GEN COMP ENDOCR, V131, P192, DOI 10.1016/S0016-6480(03)00028-5; de Souza FSJ, 2005, MOL BIOL EVOL, V22, P2417, DOI 10.1093/molbev/msi236; Takahashi A, 2004, GEN COMP ENDOCR, V135, P159, DOI 10.1016/j.ygcen.2003.08.007; Takahashi A, 2006, GEN COMP ENDOCR, V148, P85, DOI 10.1016/j.ygcen.2005.09.020; Takahashi A, 2005, GEN COMP ENDOCR, V141, P291, DOI 10.1016/j.ygcen.2005.01.010; TAKAHASHI A, 1995, BIOCHEM BIOPH RES CO, V213, P490, DOI 10.1006/bbrc.1995.2158; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; UHLER M, 1983, J BIOL CHEM, V258, P257; van den Burg EH, 2001, J ENDOCRINOL, V169, P271, DOI 10.1677/joe.0.1690271; Varsamos S, 2003, J ENDOCRINOL, V176, P405, DOI 10.1677/joe.0.1760405; Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868; ZHOU A, 1993, J BIOL CHEM, V268, P1763	57	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0739-7240	1879-0054		DOMEST ANIM ENDOCRIN	Domest. Anim. Endocrinol.	JAN	2015	50						1	13		10.1016/j.domaniend.2014.06.004		13	Agriculture, Dairy & Animal Science; Endocrinology & Metabolism	Agriculture; Endocrinology & Metabolism	AW4CC	WOS:000346228000001		
J	Maruyama, A; Shimonaka, H; Ito, T				Maruyama, Atsushi; Shimonaka, Hiroyuki; Ito, Takuya			Quick change in delta N-15 values of fish mucus confirmed in the field using a migratory goby	ECOLOGY OF FRESHWATER FISH			English	Letter							CARBON ISOTOPES; STABLE NITROGEN; RHINOGOBIUS SP; ORANGE FORM; DIET; TISSUE; DELTA-C-13; ANIMALS; FOOD		[Maruyama, Atsushi; Shimonaka, Hiroyuki; Ito, Takuya] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 5202194, Japan	Maruyama, A (reprint author), Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 5202194, Japan.	maruyama@rins.ryukoku.ac.jp					TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Maruyama A, 2001, CAN J FISH AQUAT SCI, V58, P2125, DOI 10.1139/cjfas-58-11-2125; Kohzu A, 2009, ECOL RES, V24, P127, DOI 10.1007/s11284-008-0489-x; Church MR, 2009, CAN J FISH AQUAT SCI, V66, P1, DOI 10.1139/F08-206; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Kawanabe H, 1989, FRESHWATER FISHES JA; Maruyama A, 2001, ECOL RES, V16, P697, DOI 10.1046/j.1440-1703.2001.00427.x; Yamada Yoshihiro, 1996, Japanese Journal of Limnology, V57, P467; Yuma M, 2000, ICHTHYOL RES, V47, P379, DOI 10.1007/BF02674266	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6691	1600-0633		ECOL FRESHW FISH	Ecol. Freshw. Fish	JAN	2015	24	1					162	164		10.1111/eff.12124		3	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AW5YP	WOS:000346347100015		
J	Uchino, H; Kuriyama, A; Echigoya, R				Uchino, Hayaki; Kuriyama, Akira; Echigoya, Ryosuke			Complete urethral transection	EMERGENCY MEDICINE JOURNAL			English	Editorial Material							INJURIES		[Uchino, Hayaki; Echigoya, Ryosuke] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama 7108602, Japan; [Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama 7108602, Japan	Kuriyama, A (reprint author), Kurashiki Cent Hosp, Dept Gen Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	nrk40448@nifty.com					Gomez RG, 2013, PELVIC FRACTURES INJ, DOI [10.1016/j.urology.2013.09.023, DOI 10.1016/J.UROLOGY.2013.09.023]; Ingram MD, 2008, RADIOGRAPHICS, V28, P1631, DOI 10.1148/rg.286085501; Ziran BH, 2005, J TRAUMA, V58, P533, DOI 10.1097/01.TA.0000152561.57646.80	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2015	32	1					8	8		10.1136/emermed-2013-203551		1	Emergency Medicine	Emergency Medicine	AW5UU	WOS:000346340000003		
J	Takada, T; Kuriyama, A				Takada, Tadaaki; Kuriyama, Akira			Lung torsion	EMERGENCY MEDICINE JOURNAL			English	Editorial Material									[Takada, Tadaaki] Urasoe Gen Hosp, Dept Emergency & Crit Care Med, Urasoe, Okinawa, Japan; [Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama 7108602, Japan	Kuriyama, A (reprint author), Kurashiki Cent Hosp, Dept Gen Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	nrk40448@nifty.com					Banki Farzaneh, 2005, J Trauma, V59, P478, DOI 10.1097/01.ta.0000183596.26670.db; Kim EA, 2002, RADIOGRAPHICS, V22, P67; Ohde Yasuhisa, 2005, Interact Cardiovasc Thorac Surg, V4, P59	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2015	32	1					14	14		10.1136/emermed-2013-203421		1	Emergency Medicine	Emergency Medicine	AW5UU	WOS:000346340000005		
J	Trein, CA; Shirato, H; Matsumoto, M				Trein, Cristiano Augusto; Shirato, Hiromichi; Matsumoto, Masaru			On the effects of the gap on the unsteady pressure characteristics of two-box bridge girders	ENGINEERING STRUCTURES			English	Article						Flutter stability; Unsteady pressure characteristics; Two-box girder	SPAN SUSPENSION BRIDGE; FULL AEROELASTIC MODEL; FREE-STREAM TURBULENCE; SLOTTED BOX-GIRDER; FLUTTER DERIVATIVES; AERODYNAMIC CHARACTERISTICS; SEPARATION BUBBLE; FORCES; PRISMS	This experimental study focuses on the unsteady pressure characteristics of two-box bridge decks. Models with vertical plates and gratings in several gap length configurations are investigated and compared with single-box cross sections. The results demonstrate that, with respect to unsteady pressure characteristics, the upstream box is barely affected by the slot and behaves similarly to the single-box model. In contrast, the unsteady pressure characteristics of the dowstream box are defined mainly by the characteristics of the slot and the geometry of its cross section. The upstream box geometric configuration plays only a minor role in the definition of the unsteady pressure characteristics of the dowstream box. An equivalent Theodorsen function to be used in the calculation of aerodynamic derivatives of two-box girders is proposed. Using this function, it is demonstrated that the only aerodynamic derivative that is aerodynamically dependent on the gap length is A. These findings suggest that the results of single-box investigations can be extended to two-box cross sections. (C) 2014 Elsevier Ltd. All rights reserved.	[Trein, Cristiano Augusto; Shirato, Hiromichi; Matsumoto, Masaru] Kyoto Univ, Dept Civil & Earth Resources Engn, Kyoto, Japan	Trein, CA (reprint author), Kyoto Univ, Dept Civil & Earth Resources Engn, Katsura Campus C1-3,Room 452, Kyoto, Japan.	cristiano.trein@mme.gov.br					Matsumoto M, 1996, J WIND ENG IND AEROD, V60, P227, DOI 10.1016/0167-6105(96)00036-0; Ogawa K, 2002, J WIND ENG IND AEROD, V90, P2033, DOI 10.1016/S0167-6105(02)00319-7; Sato H, 2002, J WIND ENG IND AEROD, V90, P2023, DOI 10.1016/S0167-6105(02)00318-5; DIANA G, 1995, J WIND ENG IND AEROD, V54, P101, DOI 10.1016/0167-6105(94)00034-B; Sato H, 2000, J WIND ENG IND AEROD, V88, P297, DOI 10.1016/S0167-6105(00)00055-6; Matsumoto M, 1996, J WIND ENG IND AEROD, V59, P159, DOI 10.1016/0167-6105(96)00005-0; Chen XZ, 2002, J ENG MECH-ASCE, V128, P1193, DOI 10.1061/(ASCE)0733-9399(2002)128:11(1193); Bartoli G, 2008, J WIND ENG IND AEROD, V96, P229, DOI 10.1016/j.jweia.2007.06.001; BORRI C, 1993, J WIND ENG IND AEROD, V48, P317, DOI 10.1016/0167-6105(93)90143-C; Bruno L, 2008, J FLUID STRUCT, V24, P1058, DOI 10.1016/j.jfluidstructs.2008.03.001; Chamey G, 1976, J FLUIDS ENG, V98, P278; Gaunna M, 2006, RISOR1478EN; Haan F., 2000, THESIS U NOTRE DAME; Kimura K, 2007, J WIND ENG IND AEROD, V96, P954; KIYA M, 1983, J WIND ENG IND AEROD, V14, P375, DOI 10.1016/0167-6105(83)90039-9; Matsuda K, 2007, IHI ENG REV, V40, P12; Matsuda K, 2001, J WIND ENG IND AEROD, V89, P619, DOI 10.1016/S0167-6105(01)00062-9; Matsumoto M, 2001, J WIND ENG IND AEROD, V89, P1487, DOI 10.1016/S0167-6105(01)00143-X; Matsumoto M, 2004, P 8 INT C FLOW IND V, VII, P403; Munshi SR, 1997, J FLUID STRUCT, V11, P873, DOI 10.1006/jfls.1997.0108; PECORA M, 1993, J WIND ENG IND AEROD, V48, P343, DOI 10.1016/0167-6105(93)90145-E; Price K, 2000, ADV TECHNOL STRUCT E, P1; Richardson J, 1981, DEV CONCEPT TWIN SUS, V1; Saathoff PJ, 1997, J FLUID MECH, V337, P1, DOI 10.1017/S0022112096004594; Sato H, 1995, P BRIDG 21 CENT HONG, P721; Scanlan R, 1971, J ENGINEERING MECHAN, V97, P1717; Scanlan RH, 1997, J WIND ENG IND AEROD, V71, P829; Shirai S, 2003, J WIND ENG IND AEROD, V91, P279, DOI 10.1016/S0167-6105(02)00351-3; Theodorsen T, 1935, 496 NACA; Trein CA, 2011, J WIND ENG IND AEROD, V99, P114, DOI 10.1016/j.jweia.2010.12.003; von Karman Th., 1938, J AERONAUT SCI, V5, P379, DOI [DOI 10.2514/8.674, 10.2514/8.674]; Yamaguchi H, 1997, J WIND ENG IND AEROD, V72, P289, DOI 10.1016/S0167-6105(97)00249-3; Yang Yongxin, 2007, Frontiers of Architecture and Civil Engineering in China, V1, DOI 10.1007/s11709-007-0039-6; Zasso A, 1996, J WIND ENG IND AEROD, V60, P17, DOI 10.1016/0167-6105(96)00021-9	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-0296	1873-7323		ENG STRUCT	Eng. Struct.	JAN 1	2015	82						121	133		10.1016/j.engstruct.2014.10.036		13	Engineering, Civil	Engineering	AW8YT	WOS:000346545900012		
J	Adenle, AA; Stevens, C; Bridgewater, P				Adenle, Ademola A.; Stevens, Casey; Bridgewater, Peter			Global conservation and management of biodiversity in developing countries: An opportunity for a new approach	ENVIRONMENTAL SCIENCE & POLICY			English	Article						Biodiversity conservation; Management; Funding; Developing countries	INTERNATIONAL AID; PATTERNS; DECLINES	The twelfth Conference of the Parties for the Convention on Biological Diversity (CBD) meets in the Republic of Korea, 6-17 October 2014. That meeting marks the half-way point for implementation of the decade-long set of targets (the Aichi Targets) agreed at the tenth Conference of the Parties (Nagoya, Japan, October 2010), and poses a real test for the parties. We contend it also offers considerable opportunity to redefine ways and means for funding and awareness raising for the conservation and management of biodiversity, especially in developing countries. Using the adopted, but as yet poorly implemented, mechanism of National Biodiversity Strategy and Action Plans (NBSAPs) we argue much can be accelerated to ensure that by 2020 the Aichi Targets will have been implemented and that the vision that "by 2050, biodiversity is valued, conserved, restored and wisely used, maintaining ecosystem services, sustaining a healthy planet and delivering benefits essential for all people" will be within reach. On the other hand, lack or loss of momentum on outreach about, and funding for, biodiversity especially in the global south could see continued declines in the health of ecosystems. (C) 2014 Elsevier Ltd. All rights reserved.	[Stevens, Casey; Bridgewater, Peter] United Nations Univ, Inst Adv Study Sustainabil IAS, Tokyo, Japan; [Adenle, Ademola A.] Univ Oxford, Blavatnik Sch Govt, Oxford OX1 2JD, England; [Stevens, Casey] Tokyo Inst Technol, Tokyo, Japan; [Bridgewater, Peter] Beijing Forestry Univ, Beijing, Peoples R China	Adenle, AA (reprint author), 5-53-70 Jingumae,Shibuya Ku, Tokyo 1508925, Japan.	adenle@unu.edu					Adenle AA, 2012, BIODIVERS CONSERV, V21, P2435, DOI 10.1007/s10531-012-0325-z; Adenle A.A., 2014, 32 EARTH SYST GOV PR; Schomers S, 2013, ECOSYST SERV, V6, P16, DOI 10.1016/j.ecoser.2013.01.002; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Melick D. R., 2012, Conservation and Society, V10, P344, DOI 10.4103/0972-4923.105559; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Giam X, 2010, BIOL CONSERV, V143, P1594, DOI 10.1016/j.biocon.2010.04.019; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Miller DC, 2013, CONSERV LETT, V6, P12, DOI 10.1111/j.1755-263X.2012.00270.x; Barber PH, 2014, B MAR SCI, V90, P187, DOI 10.5343/bms.2012.1108; CBD, 2010, LIF HARM FUT C PART; Cosquer A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04955-170402; Fisher M, 2009, ORYX, V43, P449, DOI 10.1017/S0030605309990755; GEF, 2013, GLOB ENV FAC TRUST F; Halpern B., 2005, CONSERV BIOL, V20, P56; Herkenrath P, 2002, REV EUROPEAN COMMUNI, V11, P29, DOI 10.1111/1467-9388.00300; Holmes G, 2012, CONSERV BIOL, V26, P602, DOI 10.1111/j.1523-1739.2012.01879.x; Miller DC, 2014, WORLD DEV, V59, P341, DOI 10.1016/j.worlddev.2014.01.004; Parker C., 2012, LITTLE BIODIVERSITY; Raustiala K., 1997, ENVIRONMENT, V38, P17; Rodriguez-Labajos B, 2013, CONSERV SOC, V11, P326, DOI 10.4103/0972-4923.125744; Secretariat of the Convention on Biological Diversity, 2011, NBSAP TRAIN MOD VERS; TEEB, 2009, EC EC BIOD NAT INT P; The World Bank, 2012, EXP FIN BIOD CONS EX; Underwood E.C., 2008, PLOS ONE, P1; UNEP/CBD/COP, 2010, AICH BIOD TARG; UNEP/CBD/COP6, 2002, REP 6 M C PART CONV	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-9011	1873-6416		ENVIRON SCI POLICY	Environ. Sci. Policy	JAN	2015	45						104	108		10.1016/j.envsci.2014.10.002		5	Environmental Sciences	Environmental Sciences & Ecology	AW8ZP	WOS:000346548000010		
J	Rehm, J; Anderson, P; Barry, J; Dimitrov, P; Elekes, Z; Feijao, F; Frick, U; Gual, A; Gmel, G; Kraus, L; Marmet, S; Raninen, J; Rehm, MX; Scafato, E; Shield, KD; Trapencieris, M; Gmel, G				Rehm, Juergen; Anderson, Peter; Barry, Joe; Dimitrov, Plamen; Elekes, Zsuzsanna; Feijao, Fernanda; Frick, Ulrich; Gual, Antoni; Gmel, Gerrit, Jr.; Kraus, Ludwig; Marmet, Simon; Raninen, Jonas; Rehm, Maximilien X.; Scafato, Emanuele; Shield, Kevin D.; Trapencieris, Marcis; Gmel, Gerhard			Prevalence of and Potential Influencing Factors for Alcohol Dependence in Europe	EUROPEAN ADDICTION RESEARCH			English	Article						Alcohol; Alcohol dependence; Alcohol use disorders; Heavy drinking; Prevalence; Liver cirrhosis; Injury; Europe	SUBSTANCE USE DISORDERS; MENTAL-HEALTH SURVEY; GENERAL-POPULATION; GLOBAL BURDEN; PSYCHIATRIC-DISORDER; SYSTEMATIC ANALYSIS; NORTHERN-IRELAND; UNITED-STATES; RISK-FACTOR; 21 REGIONS	Alcohol use disorders (AUDs), and alcohol dependence (AD) in particular, are prevalent and associated with a large burden of disability and mortality. The aim of this study was to estimate prevalence of AD in the European Union (EU), Iceland, Norway, and Switzerland for the year 2010, and to investigate potential influencing factors. The 1-year prevalence of AD in the EU was estimated at 3.4% among people 18-64 years of age in Europe (women 1.7%, men 5.2%), resulting in close to 11 million affected people. Taking into account all people of all ages, AD, abuse and harmful use resulted in an estimate of 23 million affected people. Prevalence of AD varied widely between European countries, and was significantly impacted by drinking cultures and social norms. Correlations with level of drinking and other drinking variables and with major known outcomes of heavy drinking, such as liver cirrhosis or injury, were moderate. These results suggest a need to rethink the definition of AUDs. (C) 2014 S. Karger AG, Basel	[Rehm, Juergen; Gmel, Gerrit, Jr.; Shield, Kevin D.] Ctr Addict & Mental Hlth, SER Dept, Toronto, ON M5S 2S1, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Rehm, Juergen; Shield, Kevin D.] PAHO WHO Collaborating Ctr Mental Hlth & Addict, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Klin Psychol & Psychotherapie, Epidemiol Res Unit, D-01062 Dresden, Germany; [Rehm, Juergen; Shield, Kevin D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Anderson, Peter] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anderson, Peter] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Barry, Joe] Trinity Coll Dublin, Dublin, Ireland; [Dimitrov, Plamen] Natl Ctr Publ Hlth & Anal, Sofia, Bulgaria; [Elekes, Zsuzsanna] Corvinus Univ Budapest, Budapest, Hungary; [Feijao, Fernanda] Gen Directorate Intervent Addict Behav & Dependen, Lisbon, Portugal; [Frick, Ulrich] HSD Univ Appl Sci, Cologne, Germany; [Gual, Antoni] Hosp Clin Barcelona, IDIBAPS, Inst Neurosci, Addict Unit,Psychiat Dept, Barcelona, Spain; [Gmel, Gerrit, Jr.] Univ New S Wales, Sch Elect Engn & Telecommun, Kensington, NSW 2033, Australia; [Gmel, Gerrit, Jr.] Natl Informat & Commun Technol Australia, Eveleigh, NSW, Australia; [Kraus, Ludwig] IFT Inst Therapieforsch, Munich, Germany; [Kraus, Ludwig] Stockholm Univ SORAD, Ctr Social Res Alcohol & Drugs, Stockholm, Sweden; [Marmet, Simon; Gmel, Gerhard] Addict Switzerland, Lausanne, Switzerland; [Raninen, Jonas] STAD Project Stockholm Prevents Alcohol & Drug Pr, Stockholm, Sweden; [Raninen, Jonas] Swedish Council Informat Alcohol & Other Drugs CA, Stockholm, Sweden; [Raninen, Jonas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Rehm, Maximilien X.] Ritsumeikan Univ, Grad Sch Int Relat, Kyoto, Japan; [Scafato, Emanuele] Ist Super Sanita, Natl Observ Alcohol, Populat Hlth Unit, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, I-00161 Rome, Italy; [Scafato, Emanuele] Ist Super Sanita, Natl Observ Alcohol, Hlth Determinants Unit, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, I-00161 Rome, Italy; [Trapencieris, Marcis] Univ Latvia, Inst Philosophy & Sociol, Riga, Latvia; [Gmel, Gerhard] Univ W England, Bristol BS16 1QY, Avon, England; [Gmel, Gerhard] Alcohol Treatment Ctr, Lausanne, Switzerland; [Gmel, Gerhard] Univ Lausanne Hosp, Lausanne, Switzerland	Rehm, J (reprint author), Ctr Addict & Mental Hlth, 33 Russell St, Toronto, ON M5S 2S1, Canada.	jrehm@gmail.com			European Community [266813]; Ontario Ministry of Health and Long-Term Care	The research leading to these results has been conducted in the context of the European Community's Seventh Framework Programme under grant agreement No. 266813 - Addiction and Lifestyles in Contemporary Europe-Reframing Addictions Project (ALICE-RAP). Participant organizations in ALICE-RAP can be found at http://www.alicerap.eu/about-alice-rap/partners.html. We would like to thank all members of the WP5 on counting addictions for contributing to this research. The Ontario Ministry of Health and Long-Term Care has provided support to CAMH for the salary of J.R. The contents of this paper are solely the responsibility of the authors, and do not necessarily represent the official views of the Ministry of Health and Long-Term Care or other funders.	American Psychiatric Association, 2013, DESK REF DIAGN CRIT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Bryden A, 2013, HEALTH PLACE, V21, P70, DOI 10.1016/j.healthplace.2013.01.012; Roerecke M, 2014, INT J EPIDEMIOL, V43, P906, DOI 10.1093/ije/dyu018; Rehm J, 2014, ALCOHOL CLIN EXP RES, V38, P1068, DOI 10.1111/acer.12331; de Graaf R, 2012, SOC PSYCH PSYCH EPID, V47, P203, DOI 10.1007/s00127-010-0334-8; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Kim W, 2008, SUBST USE MISUSE, V43, P1078, DOI 10.1080/10826080801914212; Grant BF, 2007, ARCH GEN PSYCHIAT, V64, P379, DOI 10.1001/archpsyc.64.3.379; Fotiadou M, 2006, INT J LAW PSYCHIAT, V29, P68, DOI 10.1016/j.ijlp.2004.06.009; Roche AM, 2006, DRUG ALCOHOL DEPEN, V83, P1, DOI 10.1016/j.drugalcdep.2005.10.011; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Nutt DJ, 2014, J PSYCHOPHARMACOL, V28, P3, DOI 10.1177/0269881113512038; Lepine JP, 2005, ENCEPHALE, V31, P182; Rehm J, 2005, EUR NEUROPSYCHOPHARM, V15, P377, DOI 10.1016/j.euroneuro.2005.04.005; Roerecke M, 2013, ADDICTION, V108, P1562, DOI 10.1111/add.12231; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P509, DOI 10.1093/alcalc/agt021; Bunting B, 2013, SOC PSYCH PSYCH EPID, V48, P81, DOI 10.1007/s00127-012-0518-5; [Anonymous], 2004, ACTA PSYCHIAT SCAN S; Ustun B, 1997, DRUG ALCOHOL DEPEN, V47, P161, DOI 10.1016/S0376-8716(97)00087-2; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Schomerus G, 2013, PSYCHIAT RES, V209, P665, DOI 10.1016/j.psychres.2013.02.006; Room R, 2006, ADDICTION, V101, P31, DOI 10.1111/j.1360-0443.2006.01597.x; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Pull CB, 1997, DRUG ALCOHOL DEPEN, V47, P207, DOI 10.1016/S0376-8716(97)00091-4; Jacobi F, 2014, NERVENARZT, V85, P77, DOI 10.1007/s00115-013-3961-y; Hasin D, 2003, ALCOHOL RES HEALTH, V27, P5; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Rehm J, 2014, ALCOHOL ALCOHOLISM, V49, P118, DOI 10.1093/alcalc/agt171; Rehm J, 2014, ADDICTION, V109, P880, DOI 10.1111/add.12498; Schmidt LA, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P11; Haro JM, 2006, MED CLIN-BARCELONA, V126, P445, DOI 10.1157/13086324; Langle G, 2005, SOC PSYCH PSYCH EPID, V40, P382, DOI 10.1007/s00127-005-0902-5; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; McConnell P, 2002, BRIT J PSYCHIAT, V181, P214, DOI 10.1192/bjp.181.3.214; Aromaa A, 2002, HLTH FUNCTIONAL CAPA; Babor T. F., 2001, AUDIT ALCOHOL USE DI; Balsa C, 2013, INQUERITO NACL CONSU; Chikritzhs T, 2007, NATL DRUG LAW ENFORC, V28; De Graaf R, 2011, SOCIAL PSYCHIAT PSYC, V47, P203; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Drummond C, 2013, ALCOHOL POLICY EUROP, V2nd; Dzurova L, 2000, DUSEVNI ZDRAVI SOCIO; Edwards G., 2001, ALCOHOL EUROPEAN REG; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Florescu S, 2009, MANAGEMENT HLTH, V13, P23; Fuller E, 2009, ADULT PSYCHIAT MORBI; Gisle L, 2010, 2 I SCI SANT PUBL; Gmel G, 2013, SUCHTMONITORING SCHW; Hallstrom T., 2003, PART STUDY POPULATIO; Hansen ABG, 2011, SCAND J PUBLIC HEALT, V39, P128, DOI 10.1177/1403494810393556; Hoeck S, 2012, EUR J PUBLIC HEALTH, V23, P1069; International Monetary Fund, 2013, WORLD EC OUTL DAT; Jacobi F, 2013, INT J METH PSYCH RES, V22, P83, DOI 10.1002/mpr.1387; Jacobi F, 2002, INT J METH PSYCH RES, V11, P1, DOI 10.1002/mpr.118; Jacobi F., 2004, PSYCHOL MED, V34, P1, DOI DOI 10.1017/S0033291703001399; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Jones GY, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-33; Kehoe T, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-6; Kessler RC, 2008, GLOBAL PERSPECTIVES; Kraus L., 2013, SUCHT, V59, P333; Kraus L, 2013, SUCHT, V59, P309; Kringlen E, 2001, ALCOHOL, V158, P1091; Kringlen E, 2006, SOC PSYCH PSYCH EPID, V41, P713, DOI 10.1007/s00127-006-0080-0; Kuendig H, 2010, EUR ADDICT RES, V16, P185, DOI 10.1159/000317247; Latvala A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-73; Lawless M, 2005, DRUG USE HOMELESS PO; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linehan Sally A., 2005, Irish Journal of Psychological Medicine, V22, P128; Maniere-Haesebaert J, 2008, REV EPIDEMIOL SANTE, V56, P189, DOI 10.1016/j.respe.2008.03.115; Manwell LB, 2002, EUR J PUBLIC HEALTH, V12, P139, DOI 10.1093/eurpub/12.2.139; Murray C, 2003, HLTH SYSTEMS PERFORM, P797; National Institute for Health and Clinical Excellence, 2011, ALC US DIS DIAGN ASS; Notari L, 2009, ZUSAM MENFASSENDE ER; Okoliyski M, 2010, BULG J PUBLIC HLTH, VII, P2; Powell AJ, 2004, RELIG ALCOHOL SOBERI, P95; R Development Core Team, 2013, LANG ENV STAT COMP V; Rehm J., 2012, ALCOHOL CONSUMPTION; Rehm J, 2004, COMP QUANTIFICATION, V1, P959; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P633, DOI 10.1093/alcalc/agt127; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Rehm J, 2004, COMP QUANTIFICATION, P959; Room R, 2007, YOUTH DRINKING CULTU, P17; Scafato E, 2005, WHO COLLABORATIVE PR, P131; Shield K, 2013, STATUS REPORT ALCOHO; Shield K., 2011, SUCHT, V57, P99; Shield KD, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-21; Shield KD, 2012, ALCOHOL EUROPEAN UNI, P10; Shield KD, 2012, INT J METH PSYCH RES, V21, P17, DOI 10.1002/mpr.1345; Snikere S, 2011, ATKARI BU IZRAISOSO; Springer A, 2009, HDB ALKOHOL OSTERREI; Stefansson JG, 2009, LAEKNABLADID, V95, P559; Tengstrom A, 2012, SLUTRAPPORTERING PIL; Tomov T, 2008, SOC MED, V4, P16; Toro PA, 2007, J SOC ISSUES, V63, P2007; United Nations Population Division, 2009, WORLD POP PROSP 2008; Ustun T., 2003, HLTH SYSTEMS PERFORM; Vollm B, 2004, PSYCHIAT PRAX, V31, P236, DOI 10.1055/s-2003.815014; WHO, 2008, GLOB BURD DIS 2004 U; WHO (World Health Organization), 2000, INT GUID MON ALC CON; World Health Organization, 2010, INT STAT CLASS DIS R; World Health Organization, 2004, GLOB STAT REP ALC HL; World Health Organization, 2009, MORT BURD DIS ATTR S; World Health Organization, 1990, COMP INT DIAGN INT A; World Health Organization Regional Office for Europe, 2010, EUR STAT REP ALC HLT; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	119	8	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1022-6877	1421-9891		EUR ADDICT RES	Eur. Addict. Res.		2015	21	1					6	18		10.1159/000365284		13	Substance Abuse; Psychiatry	Substance Abuse; Psychiatry	AW4FK	WOS:000346236400002		
J	Lei, J; Zhang, CZ; Bui, TQ				Lei, Jun; Zhang, Chuanzeng; Tinh Quoc Bui			Transient dynamic interface crack analysis in magnetoelectroelastic bi-materials by a time-domain BEM	EUROPEAN JOURNAL OF MECHANICS A-SOLIDS			English	Article						Magnetoelectroelastic materials; Interfacial cracks; Impact loading	DISCRETIZED OPERATIONAL CALCULUS; PENNY-SHAPED CRACK; FRACTURE-ANALYSIS; CONVOLUTION QUADRATURE; BOUNDARY-CONDITIONS; ELEMENT-METHOD; SOLIDS; COMPOSITES; BIMATERIALS; BEHAVIOR	This paper aims to gain a deeper insight into the effects of the poling directions, the volume fractions and the combined loading parameters on the dynamic field intensity factors at the interfacial crack-tips in two dimensional, piecewise homogeneous and magnetoelectroelastic composite bi-materials under the combined magnetoelectromechanical impact loadings. For this purpose, a time-domain boundary element method (BEM) together with the sub-domain technique is applied. The present time-domain BEM uses a quadrature formula for the temporal discretization to approximate the convolution integrals and a collocation method for the spatial discretization. Quadratic quarter-point elements are implemented at the interfacial crack-tips. An explicit displacement extrapolating formula is proposed to determine the dynamic field intensity factors of stresses, electrical displacements and magnetic inductions at the interfacial crack-tips. Numerical examples for different poling directions, different volume fractions and different combined loading parameters are presented and discussed. Based on these numerical results, some useful conclusions are drawn on the effects of various material and loading combinations on the dynamic field intensity factors. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Lei, Jun] Beijing Univ Technol, Dept Engn Mech, Beijing 100124, Peoples R China; [Zhang, Chuanzeng] Univ Siegen, Dept Civil Engn, D-57068 Siegen, Germany; [Tinh Quoc Bui] Tokyo Inst Technol, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan	Lei, J (reprint author), Beijing Univ Technol, Dept Engn Mech, Beijing 100124, Peoples R China.	leijun@bjut.edu.cn	Bui, Tinh Quoc/H-6752-2014	Bui, Tinh Quoc/0000-0002-6426-6639	Funding Project for Academic Human Resources Development in Institutions of Higher Learning; Japan Society for the Promotion of Science (JSPS) [26-04055]; German Research Foundation [ZH 15/14-1]	This work is supported by the Funding Project (No. 067135300100) for Academic Human Resources Development in Institutions of Higher Learning under the jurisdiction of Beijing Municipality, the Japan Society for the Promotion of Science (JSPS) under Grant No. 26-04055 and the German Research Foundation under the project number ZH 15/14-1, which are gratefully acknowledged.	Zhao MH, 2006, PHILOS MAG, V86, P4397, DOI 10.1080/14786430600724439; LUBICH C, 1988, NUMER MATH, V52, P413, DOI 10.1007/BF01462237; Zhong XC, 2009, INT J SOLIDS STRUCT, V46, P2950, DOI 10.1016/j.ijsolstr.2009.03.023; Wang BL, 2007, INT J SOLIDS STRUCT, V44, P387, DOI 10.1016/j.ijsolstr.2006.04.028; SUO Z, 1992, J MECH PHYS SOLIDS, V40, P739, DOI 10.1016/0022-5096(92)90002-J; Niraula OP, 2006, ACTA MECH, V187, P151, DOI 10.1007/s00707-006-0394-8; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63; LUBICH C, 1988, NUMER MATH, V52, P129, DOI 10.1007/BF01398686; Feng WJ, 2009, INT J SOLIDS STRUCT, V46, P3346, DOI 10.1016/j.ijsolstr.2009.05.003; Wang BL, 2003, EUR J MECH A-SOLID, V22, P591, DOI [10.1016/S0997-7538(03)00062-7, 10.1016/S0997-7538(03)0062-7]; Zhou ZG, 2004, INT J ENG SCI, V42, P1155, DOI 10.1016/j.ijengsci.2004.01.005; Garcia-Sanchez F, 2007, THEOR APPL FRACT MEC, V47, P192, DOI 10.1016/j.tafmec.2007.01.008; Hu KQ, 2006, MECH RES COMMUN, V33, P482, DOI 10.1016/j.mechrescom.2005.06.016; Huang GY, 2009, J INTEL MAT SYST STR, V20, P963, DOI 10.1177/1045389X08101564; Lei J, 2014, EUR J MECH A-SOLID, V46, P12, DOI 10.1016/j.euromechsol.2014.01.001; Lei J., 2014, INT J SOLIDS S UNPUB; Li R, 2006, J APPL MECH-T ASME, V73, P220, DOI 10.1015/1.2073328; Ou ZC, 2003, INT J FRACTURE, V119, pL41, DOI 10.1023/A:1023956309624; Rise J.R., 1988, J APPL MECH, V55, P98; Rogowski B., 2012, SMART MAT RES, V786190; Rojas-Diaz R, 2012, EUR J MECH A-SOLID, V31, P152, DOI 10.1016/j.euromechsol.2011.08.002; Rojas-Diaz R, 2011, COMPUT METHOD APPL M, V200, P2931, DOI 10.1016/j.cma.2011.06.004; Rojas-Diaz R, 2008, INT J SOLIDS STRUCT, V45, P144, DOI 10.1016/j.ijsolstr.2007.07.024; Rojas-Diaz R, 2011, INT J NUMER METH ENG, V88, P1238, DOI 10.1002/nme.3219; Sladek J, 2008, COMPUT MECH, V42, P697, DOI 10.1007/s00466-008-0269-z; Song ZF, 2003, THEOR APPL FRACT MEC, V39, P189, DOI 10.1016/S0167-8442(03)00002-8; Su RKL, 2008, ARCH APPL MECH, V78, P343, DOI 10.1007/s00419-007-0165-6; Tian WY, 2004, EUR J MECH A-SOLID, V23, P599, DOI 10.1016/j.euromechsol.2004.02.002; Tian WY, 2005, INT J FRACTURE, V131, P311, DOI 10.1007/s10704-004-5103-9; Wang BL, 2004, MECH RES COMMUN, V31, P65, DOI 10.1016/j.mechrescom.2003.08.002; Wang BL, 2007, COMPUT METHOD APPL M, V196, P2044, DOI 10.1016/j.cma.2006.11.006; Wang BL, 2006, J APPL MECH-T ASME, V73, P281, DOI 10.1115/1.20838271; WINZER SR, 1989, J AM CERAM SOC, V72, P2246, DOI 10.1111/j.1151-2916.1989.tb06069.x; Wunsche M, 2012, EUR J MECH A-SOLID, V32, P118, DOI 10.1016/j.euromechsol.2011.07.007; Zhang CL, 2011, J APPL PHYS, V110, DOI 10.1063/1.3671400	35	3	3	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0997-7538	1873-7285		EUR J MECH A-SOLID	Eur. J. Mech. A-Solids	JAN-FEB	2015	49						146	157		10.1016/j.euromechsol.2014.07.010		12	Mechanics	Mechanics	AW8XG	WOS:000346542100013		
J	Yu, HJ; Kitamura, T				Yu, Hongjun; Kitamura, Takayuki			A new domain-independent interaction integral for solving the stress intensity factors of the materials with complex thermo-mechanical interfaces	EUROPEAN JOURNAL OF MECHANICS A-SOLIDS			English	Article						Domain-independent interaction integral (DII-integral); Stress intensity factors (SIFs); Thermo-mechanical interface	FUNCTIONALLY GRADED MATERIALS; FRACTURE-MECHANICS; CRACK-PROPAGATION; ELEMENT-METHOD; COMPUTATION; XFEM; FIELDS	Thanks to the feature of being domain-independent for the interfaces with discontinuous mechanical properties, the domain-independent interaction integral (DII-integral) has become a quite effective method to solve the stress intensity factors (SIFs) of the materials with complex interfaces. However, the DII-integral loses its domain-independence feature for the interface with a discontinuous thermal expansion coefficient, which causes a great difficulty in applying the DII-integral to deal with the materials with complex thermo-mechanical interfaces under thermal loading. In order to overcome this difficulty, this paper proposes a zero-mean stress auxiliary field and employs it to establish a new DII-integral. The new DII-integral is domain-independent for the interface with discontinuous mechanical properties as well as discontinuous thermal expansion coefficient, and its expression does not contain any thermal property parameters. These features greatly facilitate its practical application in solving the SIFs of the material with complex thermo-mechanical interfaces. Finally, the DII-integral combined with the extended finite element method (XFEM) are used to solve the SIFs of adiabatic cracks in order to verify its effectiveness. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Yu, Hongjun] Harbin Inst Technol, Inst Appl Math, Harbin 150001, Peoples R China; [Yu, Hongjun; Kitamura, Takayuki] Kyoto Univ, Dept Mech Engn & Sci, Kyoto 6158540, Japan	Yu, HJ (reprint author), Harbin Inst Technol, Inst Appl Math, Harbin 150001, Peoples R China.	yuhongjun@hit.edu.cn			NSFC [11072068, 11202058]; Japan Society of the Promotion of Science [P13055, 25000012]; China Postdoctoral Science Foundation [20110491071, 2012T50338]; Fundamental Research Funds for the Central Universities [HIT. NSRIF. 2013082]	The present study was supported in part by the NSFC (Grant Nos. 11072068 and 11202058), by a Grant-in-Aid for Scientific Research (No. 25000012) and a Research Fellowship (No. P13055) from the Japan Society of the Promotion of Science, by the China Postdoctoral Science Foundation (Grant Nos. 20110491071 and 2012T50338), and by Fundamental Research Funds for the Central Universities (Grant No. HIT. NSRIF. 2013082).	Anandakumar G, 2010, COMPOS STRUCT, V92, P1358, DOI 10.1016/j.compstruct.2009.11.020; Gosz M, 2002, ENG FRACT MECH, V69, P299, DOI 10.1016/S0013-7944(01)00080-7; Yu HJ, 2009, INT J SOLIDS STRUCT, V46, P3710, DOI 10.1016/j.ijsolstr.2009.06.019; Gosz M, 1998, INT J SOLIDS STRUCT, V35, P1763, DOI 10.1016/S0020-7683(97)00132-7; Birman V, 2007, APPL MECH REV, V60, P195, DOI 10.1115/1.2777164; Dolbow JE, 2002, INT J SOLIDS STRUCT, V39, P2557, DOI 10.1016/S0020-7683(02)00114-2; Duflot M, 2008, INT J NUMER METH ENG, V74, P827, DOI 10.1002/nme.2197; Guo LC, 2012, INT J SOLIDS STRUCT, V49, P355, DOI 10.1016/j.ijsolstr.2011.10.012; Pathak H, 2012, INT J MECH MATER DES, V8, P9, DOI 10.1007/s10999-011-9173-3; Guo LC, 2007, INT J SOLIDS STRUCT, V44, P6768, DOI 10.1016/j.ijsolstr.2007.03.012; Guo LC, 2004, EUR J MECH A-SOLID, V23, P219, DOI 10.1016/j.euromechsol.2003.12.006; Bayesteh H, 2013, COMPOS PART B-ENG, V44, P8, DOI 10.1016/j.compositesb.2012.07.055; Hosseini SS, 2013, MAT SCI ENG A-STRUCT, V561, P285, DOI 10.1016/j.msea.2012.10.043; Cahill LMA, 2014, COMPOS STRUCT, V107, P119, DOI 10.1016/j.compstruct.2013.05.039; Ashari SE, 2011, INT J NUMER METH ENG, V86, P1507, DOI 10.1002/nme.3114; RICE JR, 1968, J APPL MECH, V35, P379; Bhattacharya S, 2013, COMPUT MECH, V52, P799, DOI 10.1007/s00466-013-0845-8; Kim JH, 2005, J APPL MECH-T ASME, V72, P351, DOI 10.1115/1.1876395; MORAN B, 1987, INT J FRACTURE, V35, P295; PRASAD NNV, 1994, INT J FRACTURE, V66, P255, DOI 10.1007/BF00042588; Yu HJ, 2010, MECH MATER, V42, P435, DOI 10.1016/j.mechmat.2010.01.001; Yu HJ, 2012, INT J NUMER METH ENG, V90, P1393, DOI 10.1002/nme.4263; Kim JH, 2003, COMPUT METHOD APPL M, V192, P1463, DOI 10.1016/S0045-7825(02)00652-7; CHEN FHK, 1977, Z ANGEW MATH PHYS, V28, P1, DOI 10.1007/BF01590704; CHO YJ, 1994, INT J FRACTURE, V65, P63, DOI 10.1007/BF00017143; Gdoutos EE, 2005, FRACTURE MECH INTRO; Gonzalez J, 2013, EXP MECH, V53, P619, DOI 10.1007/s11340-012-9668-3; Johnson J, 2007, ENG FRACT MECH, V74, P2282, DOI 10.1016/j.engfracmech.2006.10.008; Kc A., 2008, ENG FRACT MECH, V75, P2542, DOI 10.1016/j.engfracmech.2007.07.011; KFOURI AP, 1986, INT J FRACTURE, V30, P301, DOI 10.1007/BF00019710; Murakami Y., 1987, STRESS INTENSITY FAC; Nairn JA, 1997, J APPL MECH-T ASME, V64, P804, DOI 10.1115/1.2788985; NAKAMURA T, 1991, J APPL MECH-T ASME, V58, P939, DOI 10.1115/1.2897711	33	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0997-7538	1873-7285		EUR J MECH A-SOLID	Eur. J. Mech. A-Solids	JAN-FEB	2015	49						500	509		10.1016/j.euromechsol.2014.09.007		10	Mechanics	Mechanics	AW8XG	WOS:000346542100042		
J	Fang, H; Matsumoto, K; Sumigawa, T; Kitamura, T				Fang, H.; Matsumoto, K.; Sumigawa, T.; Kitamura, T.			Anisotropic elastic properties of chiral sculptured thin films at micro-scale evaluated by resonance frequency spectra	EUROPEAN JOURNAL OF MECHANICS A-SOLIDS			English	Article						Mechanical anisotropy; Vibration testing; Micro-scale	ULTRASOUND SPECTROSCOPY; NANOSPRINGS; VIBRATION; COATINGS	Chiral sculptured thin films (STFs) are nano-engineered to meet the requirements of a variety of applications such as micro filters, sensors, and waveguides due to their unique frequency characteristics which cannot be achieved by conventional solid materials. For the design, it is necessary to understand the elastic properties of STFs. To facilitate this, we developed an advanced micro-scale vibration testing process. In the testing, specially designed micro-specimens with surface areas of tens by tens of microns are excited using a piezoelectric (PZT) actuator and the resonance frequencies are detected by a laser device in the vertical or lateral directions successfully. The anisotropy elastic modulus of STFs composed of helical nano-springs are identified on the basis of vibration testing. The thin film shows strong characteristic anisotropy that the solid one hardly can attain. The micro-scale testing technique can be extended to other materials and microstructures. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Fang, H.; Matsumoto, K.; Sumigawa, T.; Kitamura, T.] Kyoto Univ, Dept Mech Engn & Sci, Sakyo Ku, Kyoto 6068501, Japan; [Fang, H.] China Acad Engn Phys, Inst Syst Engn, Mianyang 621900, Peoples R China	Fang, H (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Sakyo Ku, Yoshidahommachi, Kyoto 6068501, Japan.	fanghui@caep.ac.cn			Japan Society for the Promotion of Science [21226005]; China Academy of Engineering Physics; Institute of Systems Engineering at China Academy of Engineering Physics [2013KJZ02]; National Natural Science Funds of China [11002133]	This work was supported in part by a Grant-in-Aid for Scientific Research (S) (Grant No. 21226005) from the Japan Society for the Promotion of Science, by a Grant-in-Aid for International cooperation from China Academy of Engineering Physics, by RONPAKU Program from the Japan Society for the Promotion of Science, by Special Fund from Institute of Systems Engineering at China Academy of Engineering Physics (2013KJZ02), and by National Natural Science Funds of China (No. 11002133).	ROBBIE K, 1995, J VAC SCI TECHNOL A, V13, P2991, DOI 10.1116/1.579626; Sumigawa T, 2009, ENG FRACT MECH, V76, P1336, DOI 10.1016/j.engfracmech.2009.02.002; GORRY PA, 1990, ANAL CHEM, V62, P570, DOI 10.1021/ac00205a007; Tan Y, 2010, ACTA MATER, V58, P5305, DOI 10.1016/j.actamat.2010.06.003; Ge M, 2005, COMPUT STRUCT, V83, P2185, DOI 10.1016/j.compstruc.2005.05.002; Hirakata H, 2007, INT J SOLIDS STRUCT, V44, P4030, DOI 10.1016/j.ijsolstr.2006.11.005; Friswell M.I., 1995, FINITE ELEMENT MODEL; Gregori G, 2007, MAT SCI ENG A-STRUCT, V466, P256, DOI 10.1016/j.msea.2007.02.047; Lakhtakia A, 2002, MAT SCI ENG C-BIO S, V19, P427, DOI 10.1016/S0928-4931(01)00438-6; Lakhtakia A, 2000, MODEL SIMUL MATER SC, V8, P677, DOI 10.1088/0965-0393/8/5/303; Lakhtakia A, 2002, J COMPOS MATER, V36, P1277, DOI 10.1106/002199802023169; Nakamura N, 2004, ACTA MATER, V52, P765, DOI 10.1016/j.actamat.2003.10.1012; Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562; Sumigawa T, 2012, MAT SCI ENG A-STRUCT, V556, P429, DOI 10.1016/j.msea.2012.07.009; Suzuki M, 2001, JPN J APPL PHYS 2, V40, pL358, DOI 10.1143/JJAP.40.L358	15	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0997-7538	1873-7285		EUR J MECH A-SOLID	Eur. J. Mech. A-Solids	JAN-FEB	2015	49						510	517		10.1016/j.euromechsol.2014.09.011		8	Mechanics	Mechanics	AW8XG	WOS:000346542100043		
J	Ooi, S; Tanaka, T; Osuka, A				Ooi, Shota; Tanaka, Takayuki; Osuka, Atsuhiro			Synthesis and Characterization of cis-A(2)B-Type meso-Triaryl-Substituted Corroles	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Porphyrinoids; Corroles; Cyclization; Cyclic voltammetry	CORE-MODIFIED CORROLES; FREE-BASE CORROLES; MESOSUBSTITUTED TRANS-A(2)B-CORROLES; MANGANESE CORROLES; BEARING; CONDENSATION; DIPYRROMETHANES; CATALYSIS; PYRROLE; ARYLDIPYRROMETHANES	A practical synthesis of cis-A(2)B-type 5,10,15-triarylcorroles has been developed that involves [2+2]-type acid-catalyzed condensation of 5-aryldipyrromethane and 5-(pentafluorophenyl)dipyrromethane-1-carbinol and subsequent 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) induced oxidative cyclization. All the corroles thus synthesized were structurally well-characterized, and their optical and electrochemical properties were also studied.	[Ooi, Shota; Tanaka, Takayuki; Osuka, Atsuhiro] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Tanaka, T (reprint author), Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	taka@kuchem.kyoto-u.ac.jp; osuka@kuchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [25220802, 25620031, 20705446]	This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI), grant number numbers 25220802, 25620031, and 20705446.	Andrioletti B, 2002, J CHEM SOC PERK T 1, P715, DOI 10.1039/b200188h; Tasior M, 2007, NEW J CHEM, V31, P247, DOI 10.1039/b613640k; Ngo TH, 2010, J ORG CHEM, V75, P2127, DOI 10.1021/jo902709c; Lemon CM, 2011, J PORPHYR PHTHALOCYA, V15, P809, DOI 10.1142/S1088424611003896; Paolesse R, 2003, J PORPHYR PHTHALOCYA, V7, P25; Tasior M, 2010, CHEM-ASIAN J, V5, P130, DOI 10.1002/asia.200900345; Paolesse R, 2001, J ORG CHEM, V66, P550, DOI 10.1021/jo005661t; Gryko DT, 2003, ORG BIOMOL CHEM, V1, P350, DOI 10.1039/b208950e; Ding T, 2005, J PHYS CHEM A, V109, P7411, DOI 10.1021/jp052047i; Gross Z, 2004, ADV SYNTH CATAL, V346, P165, DOI 10.1002/adsc.200303145; Gross Z, 1999, ORG LETT, V1, P599, DOI 10.1021/ol990739h; Golubkov G, 2001, ANGEW CHEM INT EDIT, V40, P2132, DOI 10.1002/1521-3773(20010601)40:11<2132::AID-ANIE2132>3.0.CO;2-5; Shen J, 2006, INORG CHEM, V45, P2251, DOI 10.1021/ic051729h; Geier GR, 2004, J ORG CHEM, V69, P4159, DOI 10.1021/jo0496493; Graham DJ, 2012, CHEM COMMUN, V48, P4175, DOI 10.1039/c2cc30580a; Dogutan DK, 2011, J AM CHEM SOC, V133, P9178, DOI 10.1021/ja202138m; Simkhovich L, 2001, CHEM-EUR J, V7, P1041, DOI 10.1002/1521-3765(20010302)7:5<1041::AID-CHEM1041>3.0.CO;2-8; Gryko DT, 2001, J ORG CHEM, V66, P4267, DOI 10.1021/jo010146w; Aviv I, 2008, CHEM-EUR J, V14, P3995, DOI 10.1002/chem.200701885; Haber A, 2008, ANGEW CHEM INT EDIT, V47, P7896, DOI 10.1002/anie.200801149; Mahammed A, 2006, ANGEW CHEM INT EDIT, V45, P6544, DOI 10.1002/anie.200601399; Rohand T, 2007, ARKIVOC, P307; Tasior M, 2007, HETEROCYCLES, V71, P2735, DOI 10.1016/S0385-5414(07)81209-3; Gross Z, 1999, ANGEW CHEM INT EDIT, V38, P1427, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1427::AID-ANIE1427>3.0.CO;2-1; Gross Z, 2000, ANGEW CHEM INT EDIT, V39, P4045, DOI 10.1002/1521-3773(20001117)39:22<4045::AID-ANIE4045>3.0.CO;2-P; Asokan CV, 2001, TETRAHEDRON LETT, V42, P4483, DOI 10.1016/S0040-4039(01)00762-6; Aviv I, 2007, CHEM COMMUN, P1987, DOI 10.1039/b618482k; BENTO MF, 1993, J ELECTROANAL CHEM, V345, P273, DOI 10.1016/0022-0728(93)80484-Y; Braaten KC, 2008, TETRAHEDRON, V64, P9828, DOI 10.1016/j.tet.2008.08.025; Cho WS, 2000, TETRAHEDRON LETT, V41, P697, DOI 10.1016/S0040-4039(99)02142-5; Decreau RA, 2003, TETRAHEDRON LETT, V44, P3323, DOI 10.1016/S0040-4039(03)00617-8; Egorova OA, 2009, INORG CHEM, V48, P4634, DOI 10.1021/ic900393v; Geier GR, 2004, J ORG CHEM, V69, P6404, DOI 10.1021/jo049131z; Goldschmidt R, 2006, J PORPHYR PHTHALOCYA, V10, P76; Golubkov G., 2001, ANGEW CHEM, V113, P2190, DOI 10.1002/1521-3757(20010601)113:11<2190::AID-ANGE2190>3.0.CO;2-H; Gross Z, 1999, CHEM COMMUN, P599, DOI 10.1039/a900571d; Gross Z., 1999, ANGEW CHEM, V111, P1530; Gross Z., 2000, ANGEW CHEM, V112, P4211, DOI 10.1002/1521-3757(20001117)112:22<4211::AID-ANGE4211>3.0.CO;2-E; Gryko DT, 2004, SYNTHESIS-STUTTGART, P2205, DOI 10.1055/s-2004-829179; Gryko DT, 2008, J PORPHYR PHTHALOCYA, V12, P906; Gryko DT, 2002, EUR J ORG CHEM, P1735; Gryko DT, 2002, J PORPHYR PHTHALOCYA, V6, P81; Gryko DT, 2004, J PORPHYR PHTHALOCYA, V8, P1091; Guilard R., 2003, PORPHYRIN HDB, V18, P303; Guilard R, 2002, ORG LETT, V4, P4491, DOI 10.1021/ol27003w; Haber A., 2008, ANGEW CHEM, V120, P8014, DOI 10.1002/ange.200801149; Koszarna B, 2007, SYNTHESIS-STUTTGART, P1339, DOI 10.1055/s-2007-965988; Lee CH, 2000, B KOR CHEM SOC, V21, P429; Mahammed A., 2006, ANGEW CHEM, V118, P6694, DOI 10.1002/ange.200601399; Montforts F-P, 1998, HOUBENWEYL METHO E D, VE9d, P665; Ngo TH, 2010, CHEM-EUR J, V16, P5691, DOI 10.1002/chem.201000008; Paolesse R, 1999, CHEM COMMUN, P1307, DOI 10.1039/a903247i; Paolesse R., 2000, PORPHYRIN HDB, V2, P201; Paolesse R, 2008, SYNLETT, P2215, DOI 10.1055/s-2008-1078687; Saltsman I, 2008, TETRAHEDRON LETT, V49, P4163, DOI 10.1016/j.tetlet.2008.04.113; Strachan J.-P., 2000, J ORG CHEM, V65, P3150; Szymanski S, 2014, CHEM-EUR J, V20, P1720, DOI 10.1002/chem.201303406; Tanaka T, 2012, ORG LETT, V14, P2694, DOI 10.1021/ol300865s; Zhan HY, 2009, TETRAHEDRON LETT, V50, P2196, DOI 10.1016/j.tetlet.2009.02.140	59	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	JAN	2015		1					130	134		10.1002/ejoc.201403217		5	Chemistry, Organic	Chemistry	AW8CR	WOS:000346488900015		
J	Noda, Y; Kanematsu, M; Goshima, S; Kondo, H; Watanabe, H; Kawada, H; Kawai, N; Tanahashi, Y; Miyoshi, TRT; Bae, KT				Noda, Yoshifumi; Kanematsu, Masayuki; Goshima, Satoshi; Kondo, Hiroshi; Watanabe, Haruo; Kawada, Hiroshi; Kawai, Nobuyuki; Tanahashi, Yukichi; Miyoshi, Toshiharu R. T.; Bae, Kyongtae T.			Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube-voltage and adaptive statistical iterative reconstruction	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Contrast material; Liver; Computed tomography; Low-tube-voltage; Adaptive statistical iterative reconstruction technique	INITIAL CLINICAL-EXPERIENCE; CONTRAST-ENHANCED CT; 256-DETECTOR ROW CT; IMAGE QUALITY; ABDOMINAL CT; DUAL-ENERGY; HEPATOCELLULAR-CARCINOMA; PANCREATIC TUMORS; DOSE REDUCTION; IODIZED OIL	Purpose: To prospectively assess the effect of reduced iodine load to contrast enhancement, image quality, and detectability of hepatocellular carcinomas (HCCs) in hepatic CT with a combination of 80 kVp tube voltage setting and adaptive statistical iterative reconstruction (ASIR) technique in patients with chronic liver disease. Materials and methods: This HIPAA-compliant study was approved by our institutional review board and written informed consent was obtained in all patients. During a recent 9-month period, 170 consecutive patients (114 men and 56 women; age range, 40-85 years; mean, 67.7 years) with suspected chronic liver diseases were randomized into three CT groups according to the following iodine-load and tube-voltage protocols: 600 milligram per kilogram body weight (mg/kg) iodine load and 120 peak kilovolt (kVp) tube voltage setting (600-120 group), 500 mg/kg and 80 kVp (500-80 group), and 400 mg/kg and 80 kVp (40080 group). Analysis of variance was conducted to evaluate differences in CT number, background noise, signal-to-noise ratio (SNR), effective dose, HCC-to-liver contrast-to-noise ratio (CNR), and figure of merit (FOM). Sensitivity, specificity, and area under the receiver-operating-characteristic curve (AUC) were compared to assess the detectability of HCCs. Results: Vascular and hepatic enhancement in the 400-80 and 500-80 groups was comparable to or greater than that in the 600-120 group (P <.05). Subjective image quality was comparable among the three groups. Sensitivity, specificity, and AUC for detecting HCCs were comparable among the groups. The effective dose was kept low (3.3-4.1 mSv) in all three groups. Conclusion: Iodine load can be reduced by 33% in CT of the liver with a combination of 80 kVp tube voltage setting and ASIR technique, without compromising the contrast enhancement, image quality, and detection of HCCs. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Noda, Yoshifumi; Kanematsu, Masayuki; Goshima, Satoshi; Kondo, Hiroshi; Watanabe, Haruo; Kawada, Hiroshi; Kawai, Nobuyuki; Tanahashi, Yukichi] Gifu Univ Hosp, Dept Radiol & Serv, Gifu 5011194, Japan; [Kanematsu, Masayuki; Miyoshi, Toshiharu R. T.] Gifu Univ Hosp, Dept Radiol Serv, Gifu 5011194, Japan; [Bae, Kyongtae T.] Univ Pittsburgh, Dept Radiol, Med Ctr, Pittsburgh, PA 15260 USA	Kanematsu, M (reprint author), Gifu Univ Hosp, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	masa_gif@yahoo.co.jp					Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Nguyen SA, 2008, RADIOLOGY, V248, P97, DOI 10.1148/radiol.2481071484; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Lu DSK, 1996, RADIOLOGY, V199, P697; Marin D, 2010, RADIOLOGY, V256, P450, DOI 10.1148/radiol.10091819; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Foley WD, 2000, AM J ROENTGENOL, V175, P679; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; OHISHI H, 1985, RADIOLOGY, V154, P25; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Kanematsu M, 2006, EUR J RADIOL, V58, P217, DOI 10.1016/j.ejrad.2005.11.041; Fletcher JG, 2009, RADIOL CLIN N AM, V47, P41, DOI 10.1016/j.rcl.2008.10.003; Kondo H, 2007, AM J ROENTGENOL, V188, P751, DOI 10.2214/AJR.06.0372; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Christner JA, 2010, AM J ROENTGENOL, V194, P1404; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; MERINE D, 1990, RADIOLOGY, V175, P707; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; Oliver JH, 1996, RADIOLOGY, V201, P1; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JAN	2015	84	1					11	18		10.1016/j.ejrad.2014.10.008		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW6NL	WOS:000346386100002		
J	Okada, M; Kunihiro, Y; Nakashima, Y; Nomura, T; Kudomi, S; Yonezawa, T; Suga, K; Matsunaga, N				Okada, Munemasa; Kunihiro, Yoshie; Nakashima, Yoshiteru; Nomura, Takafumi; Kudomi, Shohei; Yonezawa, Teppei; Suga, Kazuyoshi; Matsunaga, Naofumi			Added value of lung perfused blood volume images using dual-energy CT for assessment of acute pulmonary embolism	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Lung perfused blood volume; Dual energy CT; CT pulmonary angiography; Pulmonary embolism; Added value	COMPUTER-AIDED DETECTION; MULTIDETECTOR-ROW CT; INITIAL-EXPERIENCE; DIAGNOSIS; ANGIOGRAPHY; TOMOGRAPHY; RADIOLOGISTS; THROMBOEMBOLISM; FEASIBILITY; PERFORMANCE	Purpose: To investigate the added value of lung perfused blood volume (LPBV) using dual-energy CT for the evaluation of intrapulmonary clot (IPC) in patients suspected of having acute pulmonary embolism (PE). Materials and methods: Institutional review board approval was obtained for this retrospective study. Eighty-three patients suspected of having PE who underwent CT pulmonary angiography (CTPA) using a dual-energy technique were enrolled in this study. Two radiologists who were blinded retrospectively and independently reviewed CTPA images alone and the combined images with color-coded LPBV over a 4-week interval, and two separate sessions were performed with a one-month interval. Inter- and intraobserver variability and diagnostic accuracy were evaluated for each reviewer with receiver operating characteristic (ROC) curve analysis. Results: Values for inter- and intraobserver agreement, respectively, were better for CTPA combined with LPBV (ICC = 0.847 and 0.937) than CTPA alone (ICC = 0.748 and 0.861). For both readers, diagnostic accuracy (area under the ROC curve [A,]) were also superior, when CTPA alone (A(z) = 0.888 [reader 1] and 0.912 [reader 2]) was compared with that after the combination with LPBV images (A(z) = 0.966 [reader 1] and 0.959 [reader 2]) (p < 0.001). However, A, values of both images might not have significant difference in statistics, because Az value of CTPA alone was high and 95% confidence intervals overlapped in both images. Conclusion: Addition of dual-energy perfusion CT to CTPA improves detection of peripheral IPCs with better interobserver agreement. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Okada, Munemasa; Kunihiro, Yoshie; Nomura, Takafumi; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Nakashima, Yoshiteru] Yamaguchi Grand Med Ctr, Dept Radiol, Hofu, Yamaguchi 7478511, Japan; [Kudomi, Shohei; Yonezawa, Teppei] Yamaguchi Univ, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Suga, Kazuyoshi] St Hills Hosp, Dept Radiol, Ube, Yamaguchi 7550155, Japan	Okada, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Radiol, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	radokada@yamaguchi-u.ac.jp					Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Das M, 2008, EUR RADIOL, V18, P1350, DOI 10.1007/s00330-008-0889-x; REMYJARDIN M, 1992, RADIOLOGY, V185, P381; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Lee CW, 2011, EUR RADIOL, V21, P54, DOI 10.1007/s00330-010-1903-7; Rathbun SW, 2000, ANN INTERN MED, V132, P227; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Ghaye B, 2001, RADIOLOGY, V219, P629; Pontana F, 2008, ACAD RADIOL, V15, P1494, DOI 10.1016/j.acra.2008.05.018; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415; Schoepf UJ, 2004, RADIOLOGY, V230, P329, DOI 10.1148/radiol.2302021489; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Brunot S, 2005, EUR RADIOL, V15, P2057, DOI 10.1007/s00330-005-2844-4; Buhmann S, 2007, ACAD RADIOL, V14, P651, DOI 10.1016/j.acra.2007.02.007; Engelke C, 2008, EUR RADIOL, V18, P298, DOI 10.1007/s00330-007-0770-3; Ghanima W, 2007, ACTA RADIOL, V48, P165, DOI 10.1080/02841850601100859; Kang MJ, 2010, AM J ROENTGENOL, V195, pW325, DOI 10.2214/AJR.09.3241; Le Gal G, 2006, J THROMB HAEMOST, V4, P724, DOI 10.1111/j.1538-7836.2006.01819.x; Maizlin ZV, 2007, J THORAC IMAG, V22, P324; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Patel S, 2003, RADIOLOGY, V227, P455, DOI 10.1148/radiol.2272011139; Schoepf UJ, 2000, RADIOLOGY, V217, P693; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191; Tang CX, 2013, EUR J RADIOL; WAGENVOORT CA, 1995, CHEST, V107, pS10, DOI 10.1378/chest.107.1_Supplement.10S; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744	28	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JAN	2015	84	1					172	177		10.1016/j.cjrad.2014.09.009		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW6NL	WOS:000346386100023		
J	Yamazaki, M; Ishikawa, H; Kunii, R; Tasaki, A; Sato, S; Ikeda, Y; Yoshimura, N; Hashimoto, T; Tsuchida, M; Aoyama, H				Yamazaki, Motohiko; Ishikawa, Hiroyuki; kunii, Ryosuke; Tasaki, Akiko; Sato, Suguru; Ikeda, Yohei; Yoshimura, Norihiko; Hashimoto, Takehisa; Tsuchida, Masanori; Aoyama, Hidefumi			A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Chest CT imaging; Lung adenocarcinoma; Lung cancer; Serum CEA levels; Prognosis	CARCINOEMBRYONIC ANTIGEN LEVELS; THIN-SECTION CT; HISTOLOGIC PROGNOSTIC-FACTORS; HIGH-RESOLUTION CT; PULMONARY-FIBROSIS; CANCER; CARCINOMA; SURVIVAL; FEATURES	Objectives: To assess the prognostic value of combined evaluation of preoperative CT findings and pre/postoperative serum carcinoembryonic antigen (CEA) levels for pathological stage I lung adenocarcinoma. Methods: This retrospective study included 250 consecutive patients who underwent complete resection for <= 3-cm pathological stage I (T1-2aNOMO) adenocarcinomas (132 men, 118 women; mean age, 67.8 years). Radiologists evaluated following CT findings: maximum tumor diameter, percentage of solid component (%solid), air bronchogram, spiculation, adjacency of bullae or interstitial pneumonia (IP) around the tumor, notch, and pleural indent. These CT findings, pre/postoperative CEA levels, age, gender, and Brinkman index were assessed by Cox proportional hazards model to determine the best prognostic model. Prognostic accuracy was examined using the area under the receiver operating characteristic curve (AUC). Results: Median follow-up period was 73.2 months. In multivariate analysis, high %solid, adjacency of bullae or IP around the tumor, and high postoperative CEA levels comprised the best combination for predicting recurrence (P < 0.05). A combination of these three findings had a greater accuracy in predicting 5-year disease-free survival than did %solid alone (AUC = 0.853 versus 0.792; P = 0.023), with a sensitivity of 85.7% and a specificity of 74.3% at the optimal threshold. The best cut-off values of %solid and postoperative CEA levels for predicting high-risk patients were >= 48% and >= 3.7 ng/mL, respectively. Conclusion: Compared to %solid alone, combined evaluation of %solid, adjacency of bullae or IP change around the tumor, and postoperative CEA levels improves recurrence prediction for stage I lung adenocarcinoma. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yamazaki, Motohiko; Ishikawa, Hiroyuki; Tasaki, Akiko; Sato, Suguru; Ikeda, Yohei; Yoshimura, Norihiko; Aoyama, Hidefumi] Niigata Univ, Grad Sch Med & Dental Sci, Dept Radiol, Niigata 95021, Japan; [kunii, Ryosuke] Niigata Univ, Grad Sch Med & Dental Sci, Div Cellular & Mol Pathol, Niigata 95021, Japan; [Hashimoto, Takehisa; Tsuchida, Masanori] Niigata Univ, Grad Sch Med & Dental Sci, Div Thorac & Cardiovasc Surg, Niigata 95021, Japan	Yamazaki, M (reprint author), 754 Banchi,1 Bancho,Asahimachi Dori,Chuo Ku, Niigata 9518510, Japan.	xackey2001@gmail.com					YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Higashi K, 2009, EUR J NUCL MED MOL I, V36, P373, DOI 10.1007/s00259-008-0961-4; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Hanaoka N, 2002, LUNG CANCER-J IASLC, V38, P185, DOI 10.1016/S0169-5002(02)00186-1; Okada M, 2004, ANN THORAC SURG, V78, P216, DOI 10.1016/j.athoracsur.2004.02.009; ZWIREWICH CV, 1991, RADIOLOGY, V179, P469; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Kondo T, 2002, LUNG CANCER-J IASLC, V36, P49, DOI 10.1016/S0169-5002(01)00448-2; Matsuguma H, 2008, J THORAC CARDIOV SUR, V135, P44, DOI 10.1016/j.jtcvs.2007.09.032; Takashima S, 2003, RESPIRATION, V70, P36, DOI 10.1159/000068410; Ikehara M, 2012, EUR J RADIOL, V81, P189, DOI 10.1016/j.ejrad.2010.09.026; Watanabe A, 2008, J THORAC CARDIOV SUR, V136, P1357, DOI 10.1016/j.jtcvs.2008.07.016; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; GLOBOCAN, 2012, EST CANC INC MORT PR; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kakinuma R, 2008, J COMPUT ASSIST TOMO, V32, P792, DOI 10.1097/RCT.0b013e31815688ae; Kaneda M, 2010, INTERACT CARDIOV TH, V10, P940, DOI 10.1510/icvts.2010.233551; Sawabata N, 2004, CANCER, V101, P803, DOI 10.1002/cncr.20421; Shimizu K, 2005, CHEST, V127, P871, DOI 10.1378/chest.127.3.871; Takamochi K, 2004, EUR J CARDIO-THORAC, V25, P877, DOI 10.1016/j.ejcts.2004.01.049; Wang CY, 2010, J SURG RES, V163, pE45, DOI 10.1016/j.jss.2010.04.039; Yamazaki M, 2014, CLIN RADIOL, V69, P559, DOI 10.1016/j.crad.2013.12.009	24	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JAN	2015	84	1					178	184		10.1016/j.cjrad.2014.10.009		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW6NL	WOS:000346386100024		
J	Matsushita, K; Ishii, Y; Takasu, S; Kuroda, K; Kijima, A; Tsuchiya, T; Kawaguchi, H; Miyoshi, N; Nohmi, T; Ogawa, K; Nishikawa, A; Umemura, T				Matsushita, Kohei; Ishii, Yuji; Takasu, Shinji; Kuroda, Ken; Kijima, Aki; Tsuchiya, Takuma; Kawaguchi, Hiroaki; Miyoshi, Noriaki; Nohmi, Takehiko; Ogawa, Kumiko; Nishikawa, Akiyoshi; Umemura, Takashi			A medium-term gpt delta rat model as an in vivo system for analysis of renal carcinogenesis and the underlying mode of action	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Medium-term animal model; Chemical carcinogenicity; Kidney; gpt Delta rat; In vivo mutagenicity; Tumor-promoting activity	ETHYL-N-HYDROXYETHYLNITROSAMINE; OXIDATIVE DNA-DAMAGE; ARISTOLOCHIC ACID I; CHEMICAL CARCINOGENICITY; CELL-PROLIFERATION; POTASSIUM BROMATE; KIDNEY TUMORS; BONE-MARROW; LONG-TERM; F344 RATS	The kidney is a major target site of chemical carcinogenesis. However, a reliable in vivo assay for rapid identification of renal carcinogens has not been established. The purpose of this study was to develop a new medium-term gpt delta rat model (the GNP model) to facilitate identification of renal carcinogens. In this model, we carried out an in vivo mutation assay using unilaterally nephrectomized kidney tissue and a tumor-promoting assay using residual kidney tissue, with diethylnitrosamine (DEN) as the renal tumor initiator. To clarify the optimal time of DEN injection after nephrectomy, time-dependent changes in bromodeoxyuridine-labeling indices in the tubular epithelium of nephrectomized rats were examined. The optimal dose of DEN injection and sufficient duration of subsequent nitrilotriacetic acid treatment were determined for detection of renal preneoplastic lesions. The standard protocol for the GNP model was determined as follows. Six-week-old female gpt delta rats were treated with test chemicals for 4 weeks, followed by a 2-week washout period, and 40 mg/kg DEN was administered intraperitoneally to initiate renal carcinogenesis. Unilateral nephrectomy was performed 48 h before DEN injection, followed by gpt assays using excised kidney tissues. One week after DEN injection, rats were further exposed to test chemicals for 12 weeks, and histopathological analysis of renal preneoplastic lesions was performed as an indicator of tumor-promoting activity in residual kidney tissue. Validation studies using aristolochic acid, potassium dibasic phosphate, phenylbutazone, and d-limonene indicated the reliability of the GNP model for predicting renal carcinogens and the underlying mode of action. (C) 2014 Elsevier GmbH. All rights reserved.	[Matsushita, Kohei; Ishii, Yuji; Takasu, Shinji; Kuroda, Ken; Kijima, Aki; Tsuchiya, Takuma; Ogawa, Kumiko; Umemura, Takashi] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Matsushita, Kohei; Kawaguchi, Hiroaki; Miyoshi, Noriaki] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Histopathol, Kagoshima 8908508, Japan; [Nohmi, Takehiko; Nishikawa, Akiyoshi] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan	Umemura, T (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	umemura@nihs.go.jp			Ministry of Health, Labor, and Welfare ofJapan [H-24-shokuhin-ippan-012]	We appreciate the expert technical assistance of Ms. Ayako Kaneko and Ms. Yoshimi Komatsu. This work was supported by a Grant-in-Aid for Research on Food Sanitation from the Ministry ofHealth, Labor, and Welfare of Japan (H-24-shokuhin-ippan-012).	Mei N, 2006, MUTAT RES-FUND MOL M, V602, P83, DOI 10.1016/j.mrfmmm.2006.08.004; MENGS U, 1982, ARCH TOXICOL, V51, P107, DOI 10.1007/BF00302751; Kuroda K, 2013, TOXICOLOGY, V311, P216, DOI 10.1016/j.tox.2013.07.003; Mizerovska J, 2011, MUTAT RES-GEN TOX EN, V720, P34, DOI 10.1016/j.mrgentox.2010.12.003; Ito N, 2003, CANCER SCI, V94, P3; Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365; Umemura T, 2004, CANCER SCI, V95, P393, DOI 10.1111/j.1349-7006.2004.tb03221.x; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; [Anonymous], 1997, TEST CARC PHARM ICH; Athar M, 1998, CARCINOGENESIS, V19, P1133, DOI 10.1093/carcin/19.6.1133; Priestap HA, 2012, CHEM RES TOXICOL, V25, P130, DOI 10.1021/tx200333g; KARI F, 1995, JPN J CANCER RES, V86, P252; Xing GZ, 2012, MUTAT RES-GEN TOX EN, V743, P52, DOI 10.1016/j.mrgentox.2011.12.021; DIETRICH DR, 1991, CANCER RES, V51, P3512; Ishii Y, 2014, ANAL BIOANAL CHEM, V406, P2467, DOI 10.1007/s00216-014-7621-2; CHARLES D, 1978, TOXICOL LETT, V2, P225, DOI 10.1016/0378-4274(78)90071-1; DIETRICH DR, 1991, MUTAT RES, V248, P239, DOI 10.1016/0027-5107(91)90060-2; Doi AM, 2007, TOXICOL PATHOL, V35, P533, DOI 10.1080/01926230701338941; GEBHART E, 1973, MUTAT RES, V17, P283, DOI 10.1016/0027-5107(73)90179-6; GOYER RA, 1981, J NATL CANCER I, V66, P869; Hard GC, 1998, TOXICOL PATHOL, V26, P104; HIASA Y, 1992, JPN J CANCER RES, V83, P688; Kakehashi Anna, 2013, Cancers (Basel), V5, P1332, DOI 10.3390/cancers5041332; Kawamura Y, 2012, GENES ENV, V34, P18; Kobayashi K, 1997, CANCER LETT, V118, P55, DOI 10.1016/S0304-3835(97)00222-X; KONISHI N, 1995, TOXICOL PATHOL, V23, P606; MACHEMER L, 1971, EXPERIENTIA, V27, P1050, DOI 10.1007/BF02138874; MAEKAWA A, 1987, J NATL CANCER I, V79, P577; Matsushita K, 2013, J TOXICOL PATHOL, V26, P19, DOI 10.1293/tox.26.19; Matsushita K, 2014, EXP TOXICOL PATHOL, V66, P313, DOI 10.1016/j.etp.2014.05.002; MULLER D, 1971, MUTAT RES, V13, P377, DOI 10.1016/0027-5107(71)90049-2; Mulroney SE, 1996, ENDOCRINOLOGY, V137, P839, DOI 10.1210/en.137.3.839; Mulroney SE, 2000, ENDOCRINOLOGY, V141, P932, DOI 10.1210/en.141.3.932; National Toxicology Program, 1990, NAT TOX PROGR TECH R, V367, P1; National Toxicology Program, 1990, NATL TOXICOL PROGRAM, V347, P1; National Toxicology Program, 2014, CHEM ASS SIT SPEC NE; NOGUEIRA E, 1987, VIRCHOWS ARCH B, V53, P365, DOI 10.1007/BF02890265; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; Radford R, 2013, INT J MOL SCI, V14, P19416, DOI 10.3390/ijms141019416; RATHENBE.R, 1972, AGENTS ACTIONS, V2, P180, DOI 10.1007/BF01965857; RUTENBUR.AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517; Tasaki M, 2013, J APPL TOXICOL, V33, P1433, DOI 10.1002/jat.2807; TSUDA H, 1980, CANCER RES, V40, P1157; Tsuda H, 2010, TOXICOL PATHOL, V38, P182, DOI 10.1177/0192623309356451; Umemura T, 2009, TOXICOLOGY, V257, P46, DOI 10.1016/j.tox.2008.12.007; Umemura T, 2000, ARCH TOXICOL, V74, P54, DOI 10.1007/s002040050652	46	1	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	JAN	2015	67	1					31	39		10.1016/j.etp.2014.09.006		9	Pathology; Toxicology	Pathology; Toxicology	AW6QE	WOS:000346392900004		
J	Suzuki, Y; Yamaguchi, I; Myojo, K; Kimoto, N; Imaizumi, M; Takada, C; Sanada, H; Takaba, K; Yamate, J				Suzuki, Yui; Yamaguchi, Itaru; Myojo, Kensuke; Kimoto, Naoya; Imaizumi, Minami; Takada, Chie; Sanada, Hiroko; Takaba, Katsumi; Yamate, Jyoji			Histopathological characterization of renal tubular and interstitial changes in 5/6 nephrectomized marmoset monkeys (Callithrix jacchus)	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Marmoset monkey; Partial nephrectomy; Tubular damage; Tubulointerstitial change; Immunohistochemistry; Lymphocytes	CHRONIC PROGRESSIVE NEPHROPATHY; TUBULOINTERSTITIAL FIBROSIS; B-CELLS; KIDNEY; RATS; MYOFIBROBLAST; MECHANISMS; INDUCTION; DISEASE; TRANSDIFFERENTIATION	Common marmosets (Callithrix jacchus) have become a useful animal model, particularly for development of biopharmaceuticals. While various renal failure models have been established in rodents, there is currently no acceptable model in marmosets. We analyzed the damaged renal tubules and tubulointerstitial changes (inflammation and fibrosis) of 5/6 nephrectomized (Nx) common marmosets by histopathological/immunohistochemical methods, and compared these findings to those in 5/6 Nx SD rats. In Nx marmosets and rats sacrificed at 5 and 13 weeks after Nx, variously dilated and atrophied renal tubules were seen in the cortex in common; however, the epithelial proliferating activity was much less in Nx marmosets. Furthermore, the degrees of inflammation and fibrosis seen in the affected cortex were more severe and massive in Nx marmosets with time-dependent increase. Interestingly, inflammation in Nx marmosets, of which degree was less in Nx rats, consisted of a large number of CD3-positive T cells and CD20-positive B cells (occasionally forming follicles), and a few CD68-positive macrophages. Based on these findings, lymphocytes might contribute to the progressive renal lesions in Nx marmosets. Fibrotic areas in Nx marmosets comprised myofibroblasts expressing vimentin and alpha-smooth muscle actin (alpha-SMA), whereas along with vimentin and alpha-SMA expressions, desmin was expressed in myofibroblasts in Nx rats. This study shows that there are some differences in renal lesions induced by Nx between marmosets and rats, which would provide useful, base-line information for pharmacology and toxicology studies using Nx marmosets. (C) 2014 Elsevier GmbH. All rights reserved.	[Suzuki, Yui; Yamaguchi, Itaru; Myojo, Kensuke; Imaizumi, Minami; Takada, Chie; Takaba, Katsumi] Kyowa Hakko Kirin Co Ltd, Div Res & Dev, Translat Res Unit, Kyoto, Japan; [Kimoto, Naoya; Sanada, Hiroko] Kyowa Hakko Kirin Co Ltd, Div Res & Dev, Res Funct Unit, Kyoto, Japan; [Suzuki, Yui; Yamate, Jyoji] Osaka Prefecture Univ, Osaka, Japan	Suzuki, Y (reprint author), 1188 Shimotogari, Nagaizumi, Shizuoka 4118731, Japan.	yui.manabe@kyowa-kirin.co.jp					Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; YOO TJ, 1988, J EXP MED, V168, P777, DOI 10.1084/jem.168.2.777; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; SAPPINO AP, 1990, LAB INVEST, V63, P144; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Segerer S, 2008, KIDNEY INT, V73, P533, DOI 10.1038/sj.ki.5002734; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Cohen CD, 2005, J NEPHROL, V18, P328; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Burne-Taney MJ, 2006, AM J PHYSIOL-RENAL, V291, pF981, DOI 10.1152/ajprenal.00229.2005; Heller F, 2007, AM J PATHOL, V170, P457, DOI 10.2353/ajpath.2007.060554; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; RISDON RA, 1968, LANCET, V2, P363; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; THOMAS J, 1987, TRANSPLANTATION, V43, P332, DOI 10.1097/00007890-198703000-00002; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Gross ML, 2004, LAB INVEST, V84, P452, DOI 10.1038/labinvest.3700052; Nikolic-Paterson DJ, 2010, KIDNEY INT, V78, P333, DOI 10.1038/ki.2010.182; Bourgiognie JJ, 1992, CONT ISSUES NEPHROL, V26, P149; Brennan FR, 2004, MOL BIOTECHNOL, V27, P59, DOI 10.1385/MB:27:1:59; Fleck C, 2006, EXP TOXICOL PATHOL, V57, P195, DOI 10.1016/j.etp.2005.09.005; Hard G. C., 1999, GUIDES TOXICOLOGIC P, P1; Hard GC, 2005, TOXICOL PATHOL, V33, P641, DOI 10.1080/01926230500299716; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; MULLER GA, 1992, J AM SOC NEPHROL, V2, pS198; Nakatsuji S, 1998, VIRCHOWS ARCH, V433, P359, DOI 10.1007/s004280050260; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Suzuki Y, 2013, EXP TOXICOL PATHOL, V65, P667, DOI 10.1016/j.etp.2012.08.001; Yamaguchi I, 2014, J TOXICOL PATHOL, V27, P183, DOI [10.1293/tox.2013-0055, 10.1293/tox.27.2013.0055]; Yamate J, 2007, J TOXICOL PATHOL, V20, P185, DOI 10.1293/tox.20.185; Yamate J, 2005, EXP TOXICOL PATHOL, V57, P135, DOI 10.1016/j.etp.2005.07.001; ZHANG G, 1995, EXP NEPHROL, V3, P308; Zühlke U, 2003, Toxicol Pathol, V31 Suppl, P123, DOI 10.1080/01926230309767	40	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	JAN	2015	67	1					41	51		10.1016/j.etp.2014.09.007		11	Pathology; Toxicology	Pathology; Toxicology	AW6QE	WOS:000346392900005		
J	Tennakoon, AH; Izawa, T; Wijesundera, KK; Murakami, H; Katou-Ichikawa, C; Tanaka, M; Golbar, HM; Kuwamura, M; Yamate, J				Tennakoon, Anusha Hemamali; Izawa, Takeshi; Wijesundera, Kavindra Kumara; Murakami, Hiroshi; Katou-Ichikawa, Chisa; Tanaka, Miyuu; Golbar, Hossain M.; Kuwamura, Mitsuru; Yamate, Jyoji			Immunohistochemical characterization of glial fibrillary acidic protein (GFAP)-expressing cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Glial fibrillary acidic protein; Liver cirrhosis; Thioacetamide; Myofibroblasts; Stem cells	HEPATIC STELLATE CELLS; MARROW STEM-CELLS; TISSUE INHIBITOR; GROWTH-FACTOR; IN-VIVO; FIBROSIS; ACTIVATION; EXPRESSION; INJURY; MYOFIBROBLASTS	Hepatic stellate cells, the principal fibrogenic cell type in the liver, are known to express the astrocyte marker glial fibrillary acidic protein (GFAP). However, the exact role of GFAP-expressing cells in liver fibrosis remains to be elucidated. In this study, cellular properties of GFAP-expressing cells were investigated in a rat model of liver cirrhosis. Six-week-old male F344 rats were injected intraperitoneally with thioacetamide (100 mg/kg BW, twice a week) and examined at post first injection weeks 5, 10, 15, 20 and 25. Appearance of GFAP-expressing myofibroblasts peaked at week 15, associated with fibrosis progression. The majority of GFAP-expressing myofibroblasts co-expressed vimentin, desmin and alpha-smooth muscle actin. Some GFAP-positive myofibroblasts co-expressed nestin (neural stem cell marker), while a few co-expressed A3 (mesenchymal stem cell marker) and Thy-1 (immature mesenchymal cell marker). A few GFAP expressing cells underwent both mitosis and apoptosis. These results indicate that there is a dynamic participation of GFAP-expressing myofibroblasts in rat liver cirrhosis, and that they are mainly derived from hepatic stellate cells, and partly from cells in the stem cell lineage. These findings, which were shown for the first time in detail, would be useful to understand the role of GFAP-expressing myofibroblasts in the pathogenesis of chemically induced liver cirrhosis. (C) 2014 Elsevier GmbH. All rights reserved.	[Tennakoon, Anusha Hemamali; Izawa, Takeshi; Wijesundera, Kavindra Kumara; Murakami, Hiroshi; Katou-Ichikawa, Chisa; Tanaka, Miyuu; Golbar, Hossain M.; Kuwamura, Mitsuru; Yamate, Jyoji] Osaka Prefecture Univ, Lab Vet Pathol, Div Vet Sci, Grad Sch Life & Environm Sci, Izumisano, Osaka 5980012, Japan	Yamate, J (reprint author), Osaka Prefecture Univ, Lab Vet Pathol, Div Vet Sci, Grad Sch Life & Environm Sci, 1-58 Rinku Ourai Kita, Izumisano, Osaka 5980012, Japan.	yamate@vet.osakafu-u.ac.jp			JSPS KAKENHI [2238017, 23658265, 26292152, 24780288]	This work was supported in part by JSPS KAKENHI Grant Numbers 2238017, 23658265, and 26292152 to Jyoji Yamate and 24780288 to Takeshi Izawa.	Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Tennakoon AH, 2013, EXP TOXICOL PATHOL, V65, P1159, DOI 10.1016/j.etp.2013.05.008; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Yamate J, 2007, EUR J CANCER, V43, P2747, DOI 10.1016/j.ejca.2007.10.021; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Sicklick JK, 2005, LAB INVEST, V85, P1368, DOI 10.1038/labinvest.3700349; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Pinzani M, 1996, AM J PATHOL, V148, P785; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; NOZU F, 1992, HEPATOLOGY, V15, P1099, DOI 10.1002/hep.1840150621; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Cheng F, 2008, TRANSPL P, V40, P2167, DOI 10.1016/j.transproceed.2008.06.052; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Guyot C, 2006, INT J BIOCHEM CELL B, V38, P135, DOI 10.1016/j.biocel.2005.08.021; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Orfila C, 1999, HISTOCHEM J, V31, P677, DOI 10.1023/A:1003851821487; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Bae SH, 2008, HEPATOL INT, V2, P63, DOI 10.1007/s12072-007-9031-4; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Dezso K, 2007, AM J PATHOL, V171, P1529, DOI 10.2353/ajpath.2007.070273; GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4; Morini Sergio, 2005, Italian Journal of Anatomy and Embryology, V110, P193; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; NAGY P, 1991, HEPATOLOGY, V14, P269, DOI 10.1016/0270-9139(91)91414-V; Namiki J., 2012, STEM CELLS INT, V2012; Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232; Noda S, 1996, HEPATOLOGY, V24, P412; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/bep.20425; PINZANI M, 1991, AM J PHYSIOL, V260, pC485; Suzuki Masami, 2002, J Toxicol Sci, V27, P165, DOI 10.2131/jts.27.165; Yuasa T, 2013, EXP TOXICOL PATHOL, V65, P651, DOI 10.1016/j.etp.2012.07.005	46	2	3	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	JAN	2015	67	1					53	63		10.1016/j.etp.2014.09.008		11	Pathology; Toxicology	Pathology; Toxicology	AW6QE	WOS:000346392900006		
J	Kuwabara, S; Misawa, S				Kuwabara, Satoshi; Misawa, Sonoko			Acquired and genetic channelopathies: In vivo assessment of axonal excitability	EXPERIMENTAL NEUROLOGY			English	Editorial Material						Axonal excitability; Potassium channel; Acquired channelopathy; Genetic channelopathy; Limbic encephalitis; Neuromyotonia	GUILLAIN-BARRE-SYNDROME; POTASSIUM CHANNEL; NERVE EXCITABILITY; PERIPHERAL-NERVE; HUMAN DIABETICS; NA+ CURRENTS; DYSFUNCTION; ANTIBODIES; CONDUCTION; PATTERNS	Neuronal or axonal ion channel function can be impaired or altered in a number of disorders, such as acquired (autoantibody-mediated, toxic, and metabolic) and genetic channelopathies, and even neurodegenerative (motor neuron disease) or inflammatory diseases (multiple sclerosis, immune-mediated neuropathies). When specific channels are affected, axonal/neuronal excitability primarily alters according to original function of the corresponding channels. Separately, in the 1990s, axonal excitability testing was developed to assess ion channel function, membrane potential, and passive membrane properties non-invasively in human subjects. Using this technique, numerous papers on altered axonal excitability in a variety of disorders have been published since 2000. In a recent issue of Experimental Neurology, Park et al. demonstrated changes in peripheral axonal excitability in limbic encephalitis and acquired neuromyotonia with anti-voltage gated potassium channel antibodies. Unexpectedly, the results were not consistent with those caused by simple potassium channel blockade, suggesting that multiple other factors contribute to altered axonal excitability. In contrast it was reported that patients with episodic ataxia type 1 (genetic channelopathy with mutation of Kv1.1 channel gene) show prominent excitability changes exactly compatible with fast potassium channel blockade. This commentary aims to highlight findings of this study in a broader context, and provides possible explanations for the discrepancy of patterns of axonal excitability changes in acquired and genetic potassium channelopathies. (C) 2014 Elsevier Inc. All rights reserved.	[Kuwabara, Satoshi; Misawa, Sonoko] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan	Kuwabara, S (reprint author), Chiba Univ, Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kuwabara-s@faculty.chiba-u.jp					Park SB, 2014, EXP NEUROL, V261, P337, DOI 10.1016/j.expneurol.2014.06.002; BROWN WF, 1991, J NEUROL NEUROSUR PS, V54, P768, DOI 10.1136/jnnp.54.9.768; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; OLSSON Y, 1990, CRIT REV NEUROBIOL, V5, P265; Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Kitano Y, 2004, ANN NEUROL, V56, P462, DOI 10.1002/ana.20232; Reid G, 1999, J PHYSIOL-LONDON, V518, P681, DOI 10.1111/j.1469-7793.1999.0681p.x; Misawa S, 2006, CLIN NEUROPHYSIOL, V117, P815, DOI 10.1016/j.clinph.2005.11.019; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Hart IK, 2002, BRAIN, V125, P1887, DOI 10.1093/brain/awf178; Kiernan MC, 2002, BRAIN, V125, P1366, DOI 10.1093/brain/awf123; Kuwabara S, 2002, MUSCLE NERVE, V26, P283, DOI 10.1002/mus.10169; Kuwabara S, 2004, CURR NEUROVASC RES, V1, P373, DOI 10.2174/1567202043362162; Kuwabara Satoshi, 2008, Curr Mol Pharmacol, V1, P61; Misawa S, 2006, NEUROLOGY, V66, P1545, DOI 10.1212/01.wnl.0000216260.39452.bf	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2015	263						368	371		10.1016/j.expneurol.2014.11.001		4	Neurosciences	Neurosciences & Neurology	AX0EM	WOS:000346626100038		
J	Sakurai, Y; Kajimoto, K; Hatakeyama, H; Harashima, H				Sakurai, Yu; Kajimoto, Kazuaki; Hatakeyama, Hiroto; Harashima, Hideyoshi			Advances in an active and passive targeting to tumor and adipose tissues	EXPERT OPINION ON DRUG DELIVERY			English	Review						active targeting; anti-obese effect; antitumor; enhanced permeability and retention effect; passive targeting; vascular targeting	MICROVASCULAR ENDOTHELIAL-CELLS; ANTI-ANGIOGENIC THERAPY; DRUG-DELIVERY; IN-VIVO; SIRNA DELIVERY; LIPOSOMAL CHEMOTHERAPY; GENE DELIVERY; INTRACELLULAR TRAFFICKING; CLINICAL-APPLICATIONS; CONJUGATED LIPOSOMES	Introduction: Data reported during the last decade of the twentieth century indicate that passive targeting is an efficient strategy for delivering nanocarrier systems to tumor tissues. The focus of this review is on active targeting as a next-generation strategy for extending the capacity of a drug delivery system (DDS). Areas covered: Tumor vasculature targeting was achieved using arginine-glycine-aspartic acid, asparagine-glycine-arginine and other peptides, which are well-known peptides, as ligand against tumor vasculature. An efficient system for delivering small interfering RNA to the tumor vasculature involved the use of a multifunctional envelope-type nanodevice based on a pH-modified cationic lipid and targeting ligands. The active-targeting system was extended from tumor delivery to adipose tissue delivery, where endothelial cells are tightly linked and are impermeable to nanocarriers. In mice, prohibitin-targeted nanoparticles can be used to successfully deliver macromolecules to induce anti-obese effects. Finally, the successful delivery of nanocarriers to adipose tissue in obese mice via the enhanced permeability and retention-effect is reported, which can be achieved in tumor tissue. Expert opinion: Unlike tumor tissues, only a few reports have appeared on how liposomal carriers accumulate in adipose tissues after systemic injection. This finding, as well as active targeting to the adipose vasculature, promises to extend the capacity of DDS to adipose tissue. Since the site of action of nucleic acids is the cytosol, the intracellular trafficking of carriers and their cargoes as well as cellular uptake must be taken into consideration.	[Sakurai, Yu; Kajimoto, Kazuaki; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Hatakeyama, Hiroto] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77054 USA	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Kita 12, Sapporo, Hokkaido 060, Japan.	harasima@pharm.hokudai.ac.jp			Ministry of Health, Labour and Welfare (MHLW) of Japan [25893001]; Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device and Regenerative Medicine of the MHLW of Japan	This work was supported, in part, by a Grant-in-Aid for Research Activity Start-up (Grant Number 25893001), a Grant-in-Aid for Research on Medical Device Development from the Ministry of Health, Labour and Welfare (MHLW) of Japan, the Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device and Regenerative Medicine of the MHLW of Japan.	Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Immordino ML, 2006, INT J NANOMED, V1, P297; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Kim DH, 2010, DIABETES, V59, P907, DOI 10.2337/db09-1141; Kibria G, 2013, BIOMATERIALS, V34, P5617, DOI 10.1016/j.biomaterials.2013.03.094; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Liu XH, 2009, CELL STRESS CHAPERON, V14, P311, DOI 10.1007/s12192-008-0086-5; Nellis DF, 2005, BIOTECHNOL PROGR, V21, P221, DOI 10.1021/bp049839z; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Loi M, 2010, J CONTROL RELEASE, V145, P66, DOI 10.1016/j.jconrel.2010.03.015; Pasqualini R, 2000, CANCER RES, V60, P722; Sakurai Y, 2013, MOL THER, V21, P1195, DOI 10.1038/mt.2013.57; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Chen ZY, 2012, INT J NANOMED, V7, P3803, DOI 10.2147/IJN.S33541; Alam MR, 2011, BIOCONJUGATE CHEM, V22, P1673, DOI 10.1021/bc200235q; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Zalba S, 2012, EUR J PHARM BIOPHARM, V81, P273, DOI 10.1016/j.ejpb.2012.02.007; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Wicki A, 2012, CLIN CANCER RES, V18, P454, DOI 10.1158/1078-0432.CCR-11-1102; Mann AP, 2011, ONCOTARGET, V2, P298; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Pastorino F, 2003, CANCER RES, V63, P7400; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Hausman GJ, 2004, J ANIM SCI, V82, P925; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Lijnen HR, 2010, OBESITY, V18, P2241, DOI 10.1038/oby.2009.503; Sakurai Y, 2014, J CONTROL RELEASE, V173, P110, DOI 10.1016/j.jconrel.2013.10.003; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Takara K, 2010, INT J PHARMACEUT, V396, P143, DOI 10.1016/j.ijpharm.2010.05.002; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Sato Y, 2012, J CONTROL RELEASE, V163, P267, DOI 10.1016/j.jconrel.2012.09.009; Suzuki R, 2008, INT J PHARM, V346, P143, DOI 10.1016/j.ijpharm.2007.06.010; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; GABIZON A, 1989, J NATL CANCER I, V81, P1484, DOI 10.1093/jnci/81.19.1484; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Crielaard BJ, 2012, J CONTROL RELEASE, V161, P225, DOI 10.1016/j.jconrel.2011.12.014; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Ellerby HM, 1999, NAT MED, V5, P1032; Hatakeyama H, 2013, BIOL PHARM BULL, V36, P892; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Gosk S, 2008, BBA-BIOMEMBRANES, V1778, P854, DOI 10.1016/j.bbamem.2007.12.021; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/nmat3765, 10.1038/NMAT3765]; BANGHAM AD, 1965, J MOL BIOL, V13, P238; Kagaya H, 2012, GENE THER, V19, P61, DOI 10.1038/gt.2011.74; Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Nakamura T, 2012, ACCOUNTS CHEM RES, V45, P1113, DOI 10.1021/ar200254s; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2338/db06-0526; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JC132239; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Kibria G, 2011, J CONTROL RELEASE, V153, P141, DOI 10.1016/j.jconrel.2011.03.012; Hayman SR, 2012, CURR ONCOL REP, V14, P285, DOI 10.1007/s11912-012-0242-z; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6; Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124; Asai T, 2008, CANCER SCI, V99, P1029, DOI 10.1111/j.1349-7006.2008.00758.x; Azhdarinia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3472; Barnhart KF, 2011, SCI TRANSL MED, V3; Elice F, 2012, HROMB RES S1, V129, pS50; Emanuel N, 1996, PHARMACEUT RES, V13, P861, DOI 10.1023/A:1016096910822; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gentile Francesco, 2008, Journal of Nanobiotechnology, V6, P9, DOI 10.1186/1477-3155-6-9; Hatakeyama H, 2013, J CONTROL RELEASE, V173, P45; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, pe154; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hossen MN, 2013, MOL THER, V21, P533, DOI 10.1038/mt.2012.256; Hossen MN, 2012, J CONTROL RELEASE, V163, P101, DOI 10.1016/j.jconrel.2012.09.002; Hossen MN, 2013, J CONTROL RELEASE, V171, P104, DOI 10.1016/j.jconrel.2013.07.013; Hossen MN, 2014, J DRUG TARGET, V22, P600, DOI 10.3109/1061186X.2014.915552; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00143; Iinuma H, 2002, INT J CANCER, V99, P130, DOI 10.1002/ijc.10242; Kajimoto K, 2013, NANOMEDICINE-UK, V8, P671, DOI [10.2217/nnm.13.27, 10.2217/NNM.13.27]; Kajimoto K, 2010, J IMMUNOL METHODS, V357, P43, DOI 10.1016/j.jim.2010.03.011; Kamiya H, 2003, DRUG DISCOV TODAY, V8, P990, DOI 10.1016/S1359-6446(03)02889-7; Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2; Kiss AL, 2009, J CELL MOL MED, V13, P1228, DOI 10.1111/j.1582-4934.2009.00754.x; Kolonin MG, 2012, STEM CELL RES, V8, P312, DOI 10.1016/j.scr.2011.11.005; Lee NK, 2011, J DRUG TARGET, V19, P805, DOI 10.3109/1061186X.2011.572974; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037789; MURPHY EJ, 2008, P NATL ACAD SCI USA, V43, P105; Sadzuka Y, 2002, INT J PHARM, V238, P171, DOI 10.1016/S0378-5173(02)00075-3; Staquicini FI, 2011, P NATL ACAD SCI USA, V108, P18637, DOI 10.1073/pnas.1114503108; Takara K, 2012, J CONTROL RELEASE, V162, P225, DOI 10.1016/j.jconrel.2012.06.019; Takimoto CH, 2009, TARGET ONCOL, V4, P143, DOI 10.1007/s11523-009-0108-y; van Hensbergen Y, 2002, BIOCHEM PHARMACOL, V63, P897, DOI 10.1016/S0006-2952(01)00928-5; VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5; Willis M, 1998, ADV DRUG DELIV REV, V29, P249, DOI DOI 10.1016/S0169-409X(97)00083-5; Yurugi H, 2012, BIOCHEM BIOPH RES CO, V420, P275, DOI 10.1016/j.bbrc.2012.02.149	106	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5247	1744-7593		EXPERT OPIN DRUG DEL	Expert Opin. Drug Deliv.	JAN	2015	12	1					41	52		10.1517/17425247.2015.955847		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW6YG	WOS:000346411000004		
J	Nakamura, H; Jun, F; Maeda, H				Nakamura, Hideaki; Jun, Fang; Maeda, Hiroshi			Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls	EXPERT OPINION ON DRUG DELIVERY			English	Review						application of EPR effect to PDT; augmentation of EPR effect; barriers to tumor delivery; enhanced permeability and retention effect of solid tumor; macromolecular drug; nanomedicine; tumor selective drug delivery	TUMOR-NECROSIS-FACTOR; ELEVATING BLOOD-PRESSURE; OILY CONTRAST-MEDIUM; ABL-POSITIVE CELLS; NITRIC-OXIDE; VASCULAR-PERMEABILITY; CANCER-CHEMOTHERAPY; SOLID TUMORS; POLYETHYLENE-GLYCOL; CARBON-MONOXIDE	Introduction: A major problem with conventional antitumor therapeutics is nonselective delivery of cytotoxic drugs to normal vital organs and tissues but little delivery to tumor tissues. Areas covered: Here, the authors describe the tumor selective delivery of antitumor drugs by taking advantage of nano-sized drugs and the means to augment it further. Based on the enhanced permeability and retention (EPR) effect, the mechanism for more efficient universal tumor delivery using macromolecular drugs to cover wider tumor types than single molecular target is discussed. Unique properties of solid tumor vasculature in the tumor tissue are discussed, especially leakiness of the blood vessels and factors involved and impaired clearance of macromolecular drugs from the tumor interstitium via the lymphatic system. The criteria for such macromolecular drugs or nanomedicines for effective accumulation at tumor sites is commented on as well as the importance of long plasma retention time of such drugs and a need to release active principles from nanoparticles at target sites. Methods to augment the EPR effect and tumor delivery (2 - 3 times) and its application to photodynamic therapy are also discussed. Expert opinion: Tumor selective delivery of antitumor drugs based on the EPR effect can be accomplished and augmented by modulating the tumor environment. This methodology is favorable not only for tumor therapy but also for tumor imaging.	[Nakamura, Hideaki; Jun, Fang; Maeda, Hiroshi] Sojo Univ, Inst Drug Delivery Sci, Nishi Ku, Kumamoto 8600082, Japan; [Nakamura, Hideaki; Jun, Fang] Sojo Univ, Fac Pharmaceut Sci, Lab Microbiol & Oncol, Nishi Ku, Kumamoto 8600082, Japan	Maeda, H (reprint author), Sojo Univ, Inst Drug Delivery Sci, Kumamoto, Japan.	hirmaeda@ph.sojo-u.ac.jp			Government of Japan from MEXT [08011717, 26860031, 25430162]; Cancer Specialty Grant from MHWL	The authors have received research grants from the Government of Japan: Grant-in-Aids from MEXT, No. 08011717 for H Maeda, No. 26860031 for H Nakamura, No. 25430162 for J Fang, and Cancer Specialty Grant from MHWL, H23-3rd Cancer Project-General-001 for H Maeda.	ABE I, 1988, JPN J CANCER RES, V79, P874; Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Failli P, 2012, CARDIOVASC DRUG THER, V26, P285, DOI 10.1007/s10557-012-6400-6; GILMAN A, 1946, SCIENCE, V103, P409, DOI 10.1126/science.103.2675.409; Kong G, 2001, CANCER RES, V61, P3027; Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Maeda H, 2013, CANCER SCI, V104, P779, DOI 10.1111/cas.12152; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Venditto VJ, 2013, ADV DRUG DELIVER REV, V65, P80, DOI 10.1016/j.addr.2012.09.038; Ricciardi S, 2009, CLIN LUNG CANCER, V10, P28, DOI 10.3816/CLC.2009.n.004; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Lammers T, 2010, ADV DRUG DELIVER REV, V62, P203, DOI 10.1016/j.addr.2009.11.028; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55; Mishra B, 2010, NANOMED-NANOTECHNOL, V6, P9, DOI 10.1016/j.nano.2009.04.008; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038; Flygare JA, 2013, CHEM BIOL DRUG DES, V81, P113, DOI 10.1111/cbdd.12085; Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; Lammers T, 2012, J CONTROL RELEASE, V161, P151, DOI 10.1016/j.jconrel.2012.05.019; Fang J, 2012, CANCER SCI, V103, P535, DOI 10.1111/j.1349-7006.2011.02178.x; Kong G, 2000, CANCER RES, V60, P4440; Seki T, 2011, J CONTROL RELEASE, V156, P381, DOI 10.1016/j.jconrel.2011.08.022; Nagamitsu A, 2009, JPN J CLIN ONCOL, V39, P756, DOI 10.1093/jjco/hyp074; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Yasuda H, 2008, NITRIC OXIDE-BIOL CH, V19, P205, DOI 10.1016/j.niox.2008.04.026; Seki T, 2009, CANCER SCI, V100, P2426, DOI 10.1111/j.1349-7006.2009.01323.x; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncoloost.12-7-864; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; LI CJ, 1993, BRIT J CANCER, V67, P975, DOI 10.1038/bjc.1993.179; Motterlini R, 2013, PHARMACOL RES, V68, P108, DOI 10.1016/j.phrs.2012.12.001; Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53; Maeda H, 2001, ADV DRUG DELIVER REV, V46, P169, DOI 10.1016/S0169-409X(00)00134-4; Deininger MWN, 1997, BLOOD, V90, P3691; Gong J, 2012, J CONTROL RELEASE, V159, P312, DOI 10.1016/j.jconrel.2011.12.012; YUAN F, 1995, CANCER RES, V55, P3752; KONNO T, 1984, CANCER, V54, P2367, DOI 10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F; Yasuda H, 2006, J CLIN ONCOL, V24, P688, DOI 10.1200/JCO.2005.04.0436; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; MAKI S, 1985, CANCER, V56, P751, DOI 10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y; GABIZON A, 1994, CANCER RES, V54, P987; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; MAEDA H, 1979, INT J PEPT PROT RES, V14, P81; Daruwalla J, 2010, CANCER SCI, V101, P1866, DOI 10.1111/j.1349-7006.2010.01619.x; Wu J, 1998, CANCER RES, V58, P159; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Noguchi Y, 1998, JPN J CANCER RES, V89, P307; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Buckway B, 2014, NUCL MED BIOL, V41, P282, DOI 10.1016/j.nucmedbio.2013.12.002; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbtl340, 10.1038/nbt1340]; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; SUZUKI M, 1981, J NATL CANCER I, V67, P663; BARTH G, 1952, Strahlentherapie, V88, P1; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; BROWN LF, 1989, AM REV RESPIR DIS, V140, P1104; Eggermont AMM, 1996, ANN SURG, V224, P756, DOI 10.1097/00000658-199612000-00011; Eggermont AM, 1996, ANN SURG, V224, P764; ESTRADA C, 1992, BIOCHEM BIOPH RES CO, V186, P475, DOI 10.1016/S0006-291X(05)80832-0; Fechtenbaum M, 2014, EXPERT OPIN BIOL TH, V14, P841, DOI 10.1517/14712598.2014.900043; Ferrero E, 1996, CANCER RES, V56, P3211; GABIZON AA, 1993, PHARMACEUT RES, V10, P703, DOI 10.1023/A:1018907715905; HORI K, 1994, MICROVASC RES, V48, P246, DOI 10.1006/mvre.1994.1052; Huang M, 2014, TRENDS PHARMACOL SCI, V35, P41, DOI 10.1016/j.tips.2013.11.004; IWAI K, 1984, CANCER RES, V44, P2115; Janssens MY, 1998, CANCER RES, V58, P5646; Kobayashi Hisataka, 2003, Mol Imaging, V2, P1, DOI 10.1162/153535003765276237; MACLEOD CM, 1945, B NEW YORK ACAD MED, V21, P375; Maeda H, 1986, CANC SELECTIVE MACRO; Marketou ME, 2012, HELL J CARDIOL, V53, P91; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; MURPHY BJ, 1993, CANCER RES, V53, P2700; NOGUCHI A, 1992, JPN J CANCER RES, V83, P240; PETERSON HI, 1973, EUR J CANCER, V9, P543, DOI 10.1016/0014-2964(73)90142-4; Shannon JA, 2012, ANN PHARMACOTHER, V46, P368, DOI 10.1345/aph.1Q593; SKINNER SA, 1990, CANCER RES, V50, P2411; VANETTEN EWM, 1995, ANTIMICROB AGENTS CH, V39, P1954	81	8	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5247	1744-7593		EXPERT OPIN DRUG DEL	Expert Opin. Drug Deliv.	JAN	2015	12	1					53	64		10.1517/17425247.2014.955011		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW6YG	WOS:000346411000005		
J	Kiyonari, S; Kadomatsu, K				Kiyonari, Shinichi; Kadomatsu, Kenji			Neuroblastoma models for insights into tumorigenesis and new therapies	EXPERT OPINION ON DRUG DISCOVERY			English	Review						anaplastic lymphoma kinase; genetically engineered mouse; MYCN; neural crest; neuroblastoma	MYCN-AMPLIFIED NEUROBLASTOMA; ISLAND METHYLATOR PHENOTYPE; ANAPLASTIC LYMPHOMA KINASE; TUMOR-SUPPRESSOR GENE; IN-VIVO; GROWTH-FACTOR; MALIGNANT PROGRESSION; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; TRANSGENIC MOUSE	Introduction: Neuroblastoma is the most common extracranial solid tumor in children. It occurs in the adrenosympathetic lineage, which is derived from the neural crest. MYCN amplification is found in about 20% of cases and is the most powerful prognostic factor. Anaplastic lymphoma kinase (ALK) mutation is also found in 7% of sporadic neuroblastomas and 50% of familial neuroblastomas. Although several mutations other than ALK are also found, about 70% of neuroblastomas show no mutations. Another important feature of neuroblastoma is that it sometimes spontaneously regresses. These features collectively suggest that neuroblastoma is caused by aberrations in the normal development processes of the neural crest. Areas covered: This review highlights a number of models of neuroblastoma including genetically engineered mouse models (GEMMs). The main GEMMs described here are: tyrosine hydroxylase (TH)-MYCN, TH-MYCN/Trp53(+/-), TH-MYCN/TH-Cre/Casp8(flox/flox), TH-MYCN/TH-ALK(F1174L) and DBH-iCre/CAG-LSL-Lin28b. Expert opinion: The current mouse models available are very useful for investigating the mechanisms of tumorigenesis and for developing therapeutics. However, many aspects have not yet been addressed. These include immediate early events after tumor initiation, epigenetic changes, spontaneous regression and metastasis. On the other hand, the current models do not perfectly recapitulate features of human neuroblastoma. Therefore, humanized mice and new GEMMs should be also considered for future research.	[Kiyonari, Shinichi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Kadomatsu, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	Kiyonari, Shinichi/I-7329-2014; Kadomatsu, Kenji/G-8083-2012		National Cancer Center Research and Development Fund [22-4]; Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare [H26-applied-general-006]	K Kadomatsu is supported by a Grant-in-Aid from the National Cancer Center Research and Development Fund (22-4), and the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (H26-applied-general-006). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Accorsi R, 2003, PEDIATR RADIOL, V33, P688, DOI 10.1007/s00247-003-1006-6; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Santilli G, 2013, CLIN CANCER RES, V19, P1116, DOI 10.1158/1078-0432.CCR-12-2528; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.040163101; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walton MI, 2012, CLIN CANCER RES, V18, P5650, DOI 10.1158/1078-0432.CCR-12-1322; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Teitz T, 2013, CANCER RES, V73, P4086, DOI 10.1158/0008-5472.CAN-12-2681; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Faisal A, 2011, MOL CANCER THER, V10, P2115, DOI 10.1158/1535-7163.MCT-11-0333; Burkhart CA, 2009, CANCER RES, V69, P6573, DOI 10.1158/0008-5472.CAN-09-1075; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Ikematsu S, 2003, BRIT J CANCER, V88, P1522, DOI 10.1038/sj.bjc.6600938; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Abe M, 2007, CANCER LETT, V247, P253, DOI 10.1016/j.canlet.2006.05.001; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Buechner J, 2012, MOL CANCER RES, V10, P1243, DOI 10.1158/1541-7786.MCR-12-0244; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Hackett CS, 2003, CANCER RES, V63, P5266; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Carlson LM, 2013, CARCINOGENESIS, V34, P1081, DOI 10.1093/carcin/bgt009; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Asada K, 2013, JPN J CLIN ONCOL, V43, P641, DOI 10.1093/jjco/hyt058; Teitz T, 2000, NAT MED, V6, P529; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Abe M, 2005, CANCER RES, V65, P828; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Pasquier E, 2013, BRIT J CANCER, V108, P2485, DOI 10.1038/bjc.2013.205; Quarta C, 2013, MOL IMAGING BIOL, V15, P194, DOI 10.1007/s11307-012-0576-9; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; CASTLEBERRY RP, 1994, J CLIN ONCOL, V12, P2378; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Cao DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086813; Chayka O, 2009, J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Evans A E, 1976, Natl Cancer Inst Monogr, V44, P49; Haraguchi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006902; Hero B, 2000, MED PEDIATR ONCOL, V35, P683, DOI 10.1002/1096-911X(20001201)35:6<683::AID-MPO43>3.0.CO;2-F; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Ikematsu S, 2008, CANCER SCI, V99, P2070, DOI 10.1111/j.1349-7006.2008.00957.x; Jamin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092886; Kim E, 2009, J NATL CANCER I, V101, P1527, DOI 10.1093/jnci/djp376; Kim PY, 2014, J PROTEOMICS, V96, P1, DOI 10.1016/j.jprot.2013.10.032; Kishida S, 2013, CANCER RES, V73, P1318, DOI 10.1158/0008-5472.CAN-12-3070; Kishida S, 2014, BRIT J PHARMACOL, V171, P896, DOI 10.1111/bph.12442; Kroesen M, 2014, INT J CANCER, V134, P1335, DOI 10.1002/ijc.28463; Liu PY, 2014, JNCI-J NATL CANCER I, V106; Morowitz MJ, 2005, CLIN CANCER RES, V11, P2680, DOI 10.1158/1078-0432.CCR-04-1917; Rasmuson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051297; Suenaga Y, 2014, PLOS GENET, V10; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Terrile M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028356; Van Maerken T, 2009, J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355	87	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1746-0441	1746-045X		EXPERT OPIN DRUG DIS	Expert. Opin. Drug Discov.	JAN	2015	10	1					53	62		10.1517/17460441.2015.974544		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW7TS	WOS:000346467800005		
J	Kinoshita, S; Kondo, K				Kinoshita, Shuji; Kondo, Kazuoki			Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY			English	Review						canagliflozin; DPP-4 inhibitor; drug-drug interaction; SGLT2 inhibitor; teneligliptin	TYPE-2 DIABETES-MELLITUS; GLUCOSE COTRANSPORTER 2; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; OPEN-LABEL; SAFETY; EFFICACY	Objectives: To investigate the pharmacokinetic/pharmacodynamic interactions of the antidiabetic agents canagliflozin (a sodium-glucose cotransporter- 2 inhibitor) and teneligliptin (a dipeptidyl peptidase-4 inhibitor) in Japanese healthy adult men. Methods: Open-label, one-way crossover study used canagliflozin (200 mg/day p.o.) and teneligliptin (40mg/day p.o). A single dose of object drug (either canagliflozin or teneligliptin) was administered on day 1 followed by washout and continuous administration of precipitant drug (days 1 - 9). Both drugs were concomitantly administered on day 7. Results: No changes in AUC(0 - 72h) and C-max were observed for canagliflozin+teneligliptin versus monotherapy; geometric mean ratios for AUC(0 - 72h) and C-max were 0.982 and 0.982 for the plasma concentration of canagliflozin and 0.983 and 0.976 for the plasma concentration of teneligliptin, respectively. Plasma concentrations of active and total glucagon-like peptide-1 (GLP-1) increased with canagliflozin+teneligliptin versus teneligliptin alone. Mean AUC(0.5 - 4h) increased post-meal, on combination therapy, from 9.6 to 12.5 pmol.h/l (active GLP-1) and from 21.5 to 32.3 pmol.h/l (total GLP-1). Adverse events developed in four subjects; all were mild and resolved but one subject withdrew due to generalized erythema. Conclusions: GLP-1 levels increased with the canagliflozin+teneligliptin combination, and no PK interaction was observed. This combination may show favorable antidiabetic effects without increasing systemic exposure.	[Kinoshita, Shuji] Mitsubishi Tanabe Pharma Corp, Dept Clin Pharmacol, Dev Div, Chuo Ku, Tokyo 1038405, Japan; [Kondo, Kazuoki] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo 1038405, Japan	Kinoshita, S (reprint author), Mitsubishi Tanabe Pharma Corp, Dept Clin Pharmacol, Dev Div, Chuo Ku, 17-10 Nihonbashi Koamicho, Tokyo 1038405, Japan.	Kinoshita.Shuji@mc.mt-pharma.co.jp			Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan	This study was funded by Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan. The authors thank Takashi Eto and Ippei Ikushima of Medical Co. LTA Hakata Clinic and Medical Co. LTA Sumida Hospital, respectively, for participating as investigators in the clinical trial. Data management and statistical analysis were undertaken by InCROM CRO Inc. Laboratory tests and measurements of active and total GLP-1 were done by the Mitsubishi Chemical Medience Corporation. The measurements of plasma concentration of canagliflozin and teneligliptin were carried out by JCL Bioassay Corporation and Sumika Chemical Analysis Service, Ltd., respectively. The Medical Co. LTA Hakata Clinic and Medical Co. LTA Sumida Hospital participated in this study as study centers.	Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Brand T, 2012, ADV THER, V29, P889, DOI 10.1007/s12325-012-0055-3; Nakamaru Y, 2014, CLIN THER, V36, P760, DOI 10.1016/j.clinthera.2014.03.002; Tanizawa Y, 2014, EXPERT OPIN PHARMACO, V15, P749, DOI 10.1517/14656566.2014.887680; Kadowaki T, 2013, DIABETES OBES METAB, V15, P810, DOI 10.1111/dom.12092; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Eto T, 2012, DIABETES OBES METAB, V14, P1040, DOI 10.1111/j.1463-1326.2012.01662.x; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Lamos EM, 2013, EXPERT OPIN DRUG MET, V9, P763, DOI 10.1517/17425255.2013.791282; Nakamaru Y, 2014, XENOBIOTICA, V44, P242, DOI 10.3109/00498254.2013.816891; Abdul-Ghani MA, 2011, ENDOCR REV, V32, P515, DOI 10.1210/er.2010-0029; Friedrich C, 2013, CLIN THER, V35, pA33, DOI 10.1016/j.clinthera.2012.12.002; Clar C, 2012, BMJ OPEN, V2, P5; Janssen Pharmaceuticals Inc, 2014, INV PACK INS; Kaushal Shaveta, 2014, N Am J Med Sci, V6, P107, DOI 10.4103/1947-2714.128471; Kishimoto Miyako, 2013, Diabetes Metab Syndr Obes, V6, P187, DOI 10.2147/DMSO.S35682; Kuhre RE, 2014, DIABETES; US Department of Health and Human Services. Food and Drug Administration. Guidance for Industry, 2012, GUID IND DRUG INT ST	18	6	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5255	1744-7607		EXPERT OPIN DRUG MET	Expert Opin. Drug Metab. Toxicol.	JAN	2015	11	1					7	14		10.1517/17425255.2015.982531		8	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AW4EZ	WOS:000346235200002		
J	Hayashizaki, Y; Usui, A; Hosokai, Y; Sakai, J; Funayama, M				Hayashizaki, Yoshie; Usui, Akihito; Hosokai, Yoshiyuki; Sakai, Jun; Funayama, Masato			Sex determination of the pelvis using Fourier analysis of postmortem CT images	FORENSIC SCIENCE INTERNATIONAL			English	Article						Sex determination; Subpubic; Greater sciatic notch; Pelvis; Fourier analysis; Computed tomography	GREATER SCIATIC NOTCH; HUMAN HIP BONE; GEOMETRIC MORPHOMETRIC-ANALYSIS; DISCRIMINANT-ANALYSIS; ANTERIOR BORDER; METRIC ANALYSIS; DIMORPHISM; MORPHOLOGY; ACCURACY; TRAITS	Background: The Fourier transform (FT) is an image-processing tool that can be used to analyze space or linear systems. We used the FT to analyze the shape of the subpubic line (SL) and the right greater sciatic notch area line (GSNAL) of the pelvis to identify sexing in computed tomographic (CT) images. Methods: 120 bodies (60 male, 60 female) were scanned by multislice CT before autopsy. SL and GSNAL images were reconstructed using an image workstation. The range of the SL is between the bottom ends of the bilateral acetabulum, and the range of the right GSNAL is from the posterior superior iliac spine to the ischial tuberosity. Coordinates (x, y) of the bone outline were extracted from CT images and calculated by fast FT. The Mann-Whitney U test comparing the amplitude of each frequency was used to determine significant differences between the two populations. Multiple regression analyses were performed to find statistically significant amplitudes of each frequency. We verified the accuracy of prediction of the regression equation, and a Cohen's kappa coefficient was measured. Results: Statistically significant differences of amplitude were found in the 2nd, 3rd, and 4th frequencies of the SL and the 1st, 3rd, and 4th frequencies of GSNAL. Adjusted R-2 using all amplitudes having a significant difference was 0.772. The accuracy was 0.983. Kappa coefficient was 0.983. Conclusion: We could determine sexing from SL and GSNAL of the pelvis using FT with high accuracy. FT is a useful tool to analyze the curved shape of human bone. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hayashizaki, Yoshie; Sakai, Jun; Funayama, Masato] Tohoku Univ, Grad Sch Med, Dept Forens Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Usui, Akihito; Hosokai, Yoshiyuki] Tohoku Univ, Grad Sch Med, Dept Diagnost Image Anal, Aoba Ku, Sendai, Miyagi 9808575, Japan	Hayashizaki, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Forens Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yoshie@forensic.med.tohoku.ac.jp					Allen E.P., 1943, BRIT J RADIOL, V16, P279; ANDERSON BE, 1990, AM J PHYS ANTHROPOL, V83, P449, DOI 10.1002/ajpa.1330830406; ROGERS T, 1994, J FORENSIC SCI, V39, P1047; PELLICO LG, 1992, J ANAT, V181, P417; Patriquin ML, 2005, FORENSIC SCI INT, V147, P119, DOI 10.1016/j.forsciint.2004.09.074; Steyn M, 2004, HOMO, V54, P197, DOI 10.1078/0018-442X-00076; Dar G, 2006, J FORENSIC SCI, V51, P480, DOI 10.1111/j.1556-4029.2006.00119.x; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Pretorius E, 2006, AM J PHYS ANTHROPOL, V129, P64, DOI 10.1002/ajpa.20251; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; SURI RK, 1987, MED SCI LAW, V27, P294; Walker PL, 2005, AM J PHYS ANTHROPOL, V127, P385, DOI 10.1002/ajpa.10422; SINGH S, 1978, J ANAT, V125, P619; Scheuer L, 2002, CLIN ANAT, V15, P297, DOI 10.1002/ca.10028; Albanese J, 2008, J FORENSIC SCI, V53, P1283, DOI 10.1111/j.1556-4029.2008.00855.x; Caldwell WE, 1932, SCIENCE, V76, P37, DOI 10.1126/science.76.1958.37; Adams DC, 2004, ITAL J ZOOL, V71, P5; Takahashi H, 2006, ANTHROPOL SCI, V114, P187, DOI 10.1537/ase.051111; Kanabur V, 2012, BIOMED RES-INDIA, V23, P211; Decker SJ, 2011, J FORENSIC SCI, V56, P1107, DOI 10.1111/j.1556-4029.2011.01803.x; Barrett H.H., 1981, RADIOLOGICAL IMAGING, V1; Bass W.M., 2006, SPITZ FISHERS MEDICO, P240; Biwasaka H., 2012, FORENSIC SCI INT, V219, p288e1; Biwasaka Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS260, DOI 10.1016/j.legalmed.2009.02.052; Bracewell R. N., 2000, FOURIER TRANSFORM IT; Brogdon B.G., 2011, BROGDONS FORENSIC RA, P85; Dirnhofer R, 2009, VIRTOPSY APPROACH 3D, P19, DOI DOI 10.1201/9780849381898; Dixit S G, 2007, J Forensic Leg Med, V14, P429, DOI 10.1016/j.jflm.2007.03.009; Gomez-Valdes JA, 2012, FORENSIC SCI INT, V221, DOI 10.1016/j.forsciint.2012.04.027; Gonzalez R. C., 2001, DIGITAL IMAGE PROCES; Goris M.L., 1983, MATH INTRO COMPUTER; JOVANOVIC SLAVOLJUB, 1965, ACTA ANAT, V61, P101; Kersnic B., 1996, Pfluegers Archiv European Journal of Physiology, V431, pR207, DOI 10.1007/BF02346341; LAVELLE M, 1995, AM J PHYS ANTHROPOL, V98, P59, DOI 10.1002/ajpa.1330980106; Lim J. S., 1990, 2 DIMENSIONAL SIGNAL; Macaluso PJ, 2010, J FORENSIC LEG MED, V17, P348, DOI 10.1016/j.jflm.2010.04.011; McBride DG, 2001, J FORENSIC SCI, V46, P427; Patriquin ML, 2003, HOMO, V53, P255, DOI 10.1078/0018-442X-00049; SCHULTERELLIS FP, 1983, J FORENSIC SCI, V28, P169; SCHULTERELLIS FP, 1985, J FORENSIC SCI, V30, P178; Shah S., 2011, NJIRM, V2, P27; Small C., 2012, FORENSIC SCI INT, V222; Spitz D.J., 2006, SPITZ FISHERS MED LE, P184; Steyn M., 2008, FORENSIC SCI INT, V179, p86e1; Steyn M, 2009, FORENSIC SCI INT, V191, P113, DOI 10.1016/j.forsciint.2009.07.009; Vacca E., 2012, FORENSIC SCI INT, V222, p401e1; Veleminska J, 2013, AM J PHYS ANTHROPOL, V152, P558, DOI 10.1002/ajpa.22373; White T. D., 2011, HUMAN OSTEOLOGY; Zech WD, 2012, FORENSIC SCI INT, V221, P39, DOI 10.1016/j.forsciint.2012.03.022	49	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JAN	2015	246									10.1016/j.forsciint.2014.10.008		9	Medicine, Legal	Legal Medicine	AW7DC	WOS:000346423800019		
J	Yorifuji, N; Kakimoto, K; Higuchi, K				Yorifuji, Naoki; Kakimoto, Kazuki; Higuchi, Kazuhide			Recurrent Abdominal Pain Accompanied by Small Intestinal Lesions - Familial Mediterranean Fever	GASTROENTEROLOGY			English	Editorial Material							CHILDREN		[Yorifuji, Naoki; Kakimoto, Kazuki; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan	Yorifuji, N (reprint author), Osaka Med Coll, Dept Internal Med 2, Osaka, Japan.						SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Gurkan OE, 2013, J PEDIATR GASTR NUTR, V57, P319, DOI 10.1097/MPG.0b013e318295fc65; Padeh S, 2010, J RHEUMATOL, V37, P865, DOI 10.3899/jrheum.090687	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JAN	2015	148	1					24	25		10.1053/j.gastro.2014.08.006		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9LT	WOS:000346579500014		
J	Ishibashi, H; Yasuda, I; Fukita, Y				Ishibashi, Hiroyuki; Yasuda, Ikuma; Fukita, Yosho			Multiple Tumor-like Lesions of the Liver in a Patient With a History of Pancreaticoduodenectomy - Asymptomatic Isolated Tuberculosis of the Liver	GASTROENTEROLOGY			English	Editorial Material									[Ishibashi, Hiroyuki; Yasuda, Ikuma; Fukita, Yosho] Seirei Yokohama Gen Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan	Ishibashi, H (reprint author), Seirei Yokohama Gen Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan.						Huang WT, 2003, J CLIN PATHOL, V56, P835, DOI 10.1136/jcp.56.11.835; Chong VH, 2008, SOUTH MED J, V101, P356, DOI 10.1097/SMJ.0b013e318164ddbb; Talwani R, 2011, CLIN LIVER DIS, V15, P111, DOI 10.1016/j.cld.2010.09.002	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JAN	2015	148	1					E6	E7		10.1053/j.gastro.2014.07.038		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9LT	WOS:000346579500003		
J	Itoi, T; Kawakami, H; Katanuma, A; Irisawa, A; Sofuni, A; Itokawa, F; Tsuchiya, T; Tanaka, R; Umeda, J; Ryozawa, S; Doi, S; Sakamoto, N; Yasuda, I				Itoi, Takao; Kawakami, Hiroshi; Katanuma, Akio; Irisawa, Atsushi; Sofuni, Atsushi; Itokawa, Fumihide; Tsuchiya, Takayoshi; Tanaka, Reina; Umeda, Junko; Ryozawa, Shomei; Doi, Shinpei; Sakamoto, Naoya; Yasuda, Ichiro			Endoscopic nasogallbladder tube or stent placement in acute cholecystitis: a preliminary prospective randomized trial in Japan (with videos)	GASTROINTESTINAL ENDOSCOPY			English	Article							ACUTE SUPPURATIVE CHOLANGITIS; PERCUTANEOUS CHOLECYSTOSTOMY; GALLBLADDER ASPIRATION; BILIARY DECOMPRESSION; NASOBILIARY DRAINAGE; CRITERIA; SAFETY	Background: There are currently no prospective, controlled trials of endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis. Objective: We evaluated the technical success rate and efficacy of endoscopic transpapillary gallbladder drainage by using either endoscopic nasogallbladder drainage (ENGBD) or endoscopic gallbladder stenting (EGBS) for patients with acute cholecystitis. Design: Randomized, controlled study. Setting: Tertiary-care referral centers. Patients: Seventy-three consecutive patients with acute cholecystitis were randomized. Interventions: ENGBD by using a 5F or 7F tube (n = 37) or EGBS (n = 36) by using a 7F stent. Main Outcome and Measurements: Technical success, clinical success, adverse events, and procedure-related pain score. Results: The overall technical success rates in the ENGBD and EGBS groups were 91.9% and 86.1%, respectively (P O.05). The mean procedure times of ENGBD and EGBS were 20.3 +/- 12.1 and 22.2 +/- 14.5 minutes, respectively (P O.05). The overall clinical success rates by per protocol analysis were 94.1% and 90.3% in the ENGBD and EGBS groups, respectively, whereas the rates by intention-to-treat analysis were 86.5% and 77.8%, respectively (P O.05). Moderate adverse events were observed in the ENGBD (n = 2) and EGBS (n = 1) groups. The mean visual analog score of postprocedure pain in the ENGBD group was significantly higher than that in the EGBS group (1.3 +/- 1.1 vs 0.4 +/- 0.8, respectively; P < .001). Limitations: Small sample size and the participation of multiple endoscopists who may have different levels of experience in endoscopic transpapillary gallbladder drainage. Conclusions: Both ENGBD and EGBS appear to be suitable for the treatment of acute cholecystitis in patients who are poor candidates for emergency cholecystectomy.	[Itoi, Takao; Sofuni, Atsushi; Itokawa, Fumihide; Tsuchiya, Takayoshi; Umeda, Junko] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Kawakami, Hiroshi; Doi, Shinpei; Sakamoto, Naoya] Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Katanuma, Akio] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Irisawa, Atsushi] Fukushima Prefectural Med Coll, Aizu Med Ctr, Dept Gastroenterol, Fukushima, Japan; [Tanaka, Reina] Toda Chuo Gen Hosp, Dept Gastroenterol, Saitama, Japan; [Ryozawa, Shomei] Saitama Med Univ, Int Med Ctr, Dept Gastroenterol, Saitama, Japan; [Yasuda, Ichiro] Teikyo Univ, Mizonokuchi Hosp, Dept Gastroenterol, Kawasaki, Kanagawa, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp			Japanese Foundation for Research and Promotion of Endoscopy	All authors disclosed no financial relationships relevant to this article. This work was financially supported in part by the Japanese Foundation for Research and Promotion of Endoscopy.	Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; Park SY, 2008, GASTROINTEST ENDOSC, V68, P1076, DOI 10.1016/j.gie.2008.04.025; Chopra S, 2001, AM J ROENTGENOL, V176, P1025; Lee DWH, 2002, GASTROINTEST ENDOSC, V56, P361, DOI 10.1067/mge.2002.126886; Itoi T, 2010, GASTROINTEST ENDOSC, V71, P1038, DOI 10.1016/j.gie.2010.01.026; Yamashita Y, 2013, J HEPATO-BIL-PAN SCI, V20, P89, DOI 10.1007/s00534-012-0567-x; Itoi T, 2008, GASTROINTEST ENDOSC, V68, P84, DOI 10.1016/j.gie.2007.11.050; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Sharma BC, 2005, ENDOSCOPY, V37, P439, DOI 10.1055/s-2005-861054; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Ito K, 2004, AM J ROENTGENOL, V183, P193; FRAZEE RC, 1989, MAYO CLIN PROC, V64, P163; Hasan Muhammad K, 2013, Gastrointest Endosc Clin N Am, V23, P453, DOI 10.1016/j.giec.2012.12.010; HOUGHTON PWJ, 1985, BRIT J SURG, V72, P220, DOI 10.1002/bjs.1800720327; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P71, DOI 10.1007/s00534-012-0569-8; KOZAREK RA, 1984, J CLIN GASTROENTEROL, V6, P37	17	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					111	118		10.1016/j.gie.2014.09.046		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900012		
J	Nakai, Y; Isayama, H; Sasahira, N; Kogure, H; Sasaki, T; Yamamoto, N; Saito, K; Umefune, G; Akiyama, D; Kawahata, S; Matsukawa, M; Saito, T; Hamada, T; Takahara, N; Mizuno, S; Miyabayashi, K; Mohri, D; Hirano, K; Tada, M; Koike, K				Nakai, Yousuke; Isayama, Hiroyuki; Sasahira, Naoki; Kogure, Hirofumi; Sasaki, Takashi; Yamamoto, Natsuyo; Saito, Kei; Umefune, Gyotane; Akiyama, Dai; Kawahata, Shuhei; Matsukawa, Miho; Saito, Tomotaka; Hamada, Tsuyoshi; Takahara, Naminatsu; Mizuno, Suguru; Miyabayashi, Koji; Mohri, Dai; Hirano, Kenji; Tada, Minoru; Koike, Kazuhiko			Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP	GASTROINTESTINAL ENDOSCOPY			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILE-DUCT CANNULATION; RANDOMIZED CONTROLLED-TRIAL; TOKYO TRIAL; MULTICENTER; PREVENTION; SPHINCTEROTOMY; METAANALYSIS; PLACEMENT; COMPLICATIONS	Background: Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective: To evaluate the incidence and risk factors of PEP in WGC. Design: Single-center retrospective study. Setting: Academic center. Patients: A total of 800 consecutive patients with a native papilla. Interventions: Biliary therapeutic ERCP by using WGC. Main Outcome Measurements: The rate of PEP and its risk factors. Results: Biliary cannulation was successful by using WGC alone in 70.5%, and the final cannulation rate was 96.1%. Unintentional guidewire insertion and contrast material injection into the pancreatic duct (PD) during cannulation occurred in 55.3% and 21.8%, respectively. The incidence of PEP was 9.5% (mild 5.6%, moderate 2.9%, severe 1.0%). Multivariate analysis revealed a common bile duct (CBD) diameter of! 9 mm (odds ratio [OR] 2.03; P = .006) and unintentional guidewire insertion into the PD (OR 2.25; P = .014) as risk factors for PEP. PD opacification was not a risk factor for PEP (OR 1.15; P = .642), but the incremental increase of the PEP rate was seen in patients with CBDs < 9 mm: 4.6% without any PD manipulation, 8.3% with contrast material alone, 16.9% with guidewire alone, and 22.1% with both contrast material and guidewire. Limitations: Retrospective design in a single center. Conclusion: Unintentional PD manipulation was not uncommon in WGC. Guidewire insertion into the PD and a small CBD were risk factors for PEP in biliary therapeutic ERCP with the use of WGC.	[Nakai, Yousuke; Isayama, Hiroyuki; Sasahira, Naoki; Kogure, Hirofumi; Sasaki, Takashi; Yamamoto, Natsuyo; Saito, Kei; Umefune, Gyotane; Akiyama, Dai; Kawahata, Shuhei; Matsukawa, Miho; Saito, Tomotaka; Hamada, Tsuyoshi; Takahara, Naminatsu; Mizuno, Suguru; Miyabayashi, Koji; Mohri, Dai; Hirano, Kenji; Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Angsuwatcharakon P, 2012, J GASTROEN HEPATOL, V27, P356, DOI 10.1111/j.1440-1746.2011.06927.x; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Tse F, 2013, ENDOSCOPY, V45, P605, DOI 10.1055/s-0032-1326640; Maeda S, 2003, ENDOSCOPY, V35, P721; Ito K, 2008, WORLD J GASTROENTERO, V14, P5595, DOI 10.3748/wjg.14.5595; Kawakami H, 2012, GASTROINTEST ENDOSC, V75, P362, DOI 10.1016/j.gie.2011.10.012; Artifon ELA, 2007, AM J GASTROENTEROL, V102, P2147, DOI 10.1111/j.1572-0241.2007.01378.x; Bailey AA, 2008, ENDOSCOPY, V40, P296, DOI 10.1055/s-2007-995566; de Tejada AH, 2009, GASTROINTEST ENDOSC, V70, P700, DOI 10.1016/j.gie.2009.03.031; Kobayashi G, 2013, DIGEST ENDOSC, V25, P295, DOI 10.1111/j.1443-1661.2012.01372.x; Cennamo V, 2009, AM J GASTROENTEROL, V104, P2343, DOI 10.1038/ajg.2009.269; Lella F, 2004, GASTROINTEST ENDOSC, V59, P830, DOI 10.1016/S0016-5107(04)00363-3; Sofuni A, 2011, CLIN GASTROENTEROL H, V9, P851, DOI 10.1016/j.cgh.2011.06.033; Dickinson RJ, 1998, EUR J GASTROEN HEPAT, V10, P423, DOI 10.1097/00042737-199805000-00012; Katsinelos P, 2008, ENDOSCOPY, V40, P302, DOI 10.1055/s-2007-995483; Dumonceau JM, 2010, ENDOSCOPY, V42, P503, DOI 10.1055/s-0029-1244208; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Cheung J, 2009, GASTROINTEST ENDOSC, V70, P1211, DOI 10.1016/j.gie.2009.08.007; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; CHEN YK, 1994, AM J GASTROENTEROL, V89, P327; Freeman ML, 2002, GASTROINTEST ENDOSC, V56, pS273, DOI 10.1067/mge.2002.129028; Ito K, 2013, DIGEST ENDOSC, V26, P442; Ito K, 2010, J GASTROENTEROL, V45, P1183, DOI 10.1007/s00535-010-0268-7; Nakai Y, 2011, J GASTROEN HEPATOL, V26, P1552, DOI 10.1111/j.1440-1746.2011.06788.x; Sasahira N, 2013, GASTROINTEST ENDOSC, V77, pAB183; Tanaka R, 2013, J GASTROEN HEPATOL, V28, P1787, DOI 10.1111/jgh.12303; Tsujino T, 2013, J GASTROENTEROL, V48, P982, DOI 10.1007/s00535-012-0698-5; Uchino R, 2013, GASTROINTEST ENDOSC, V78, P842, DOI 10.1016/j.gie.2013.06.028	29	7	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					119	126		10.1016/j.gie.2014.06.005		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900013		
J	Iwashita, T; Yasuda, I; Mukai, T; Doi, S; Nakashima, M; Uemura, S; Mabuchi, M; Shimizu, M; Hatano, Y; Hara, A; Moriwaki, H				Iwashita, Takuji; Yasuda, Ichiro; Mukai, Tsuyoshi; Doi, Shinpei; Nakashima, Masanori; Uemura, Shinya; Mabuchi, Masatoshi; Shimizu, Masahito; Hatano, Yuichiro; Hara, Akira; Moriwaki, Hisataka			Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: a single-center prospective pilot study (MOSE study)	GASTROINTESTINAL ENDOSCOPY			English	Article							ASPIRATION BIOPSY; TISSUE ACQUISITION; PANCREATIC MASSES; YIELD; ENDOSONOGRAPHERS; FEASIBILITY; SUCTION; TRIAL	Background: Although rapid on-site cytologic evaluation provides high efficacy of EUS-guided FNA (EUS-FNA), its availability is limited. Alternatively, macroscopic on-site quality evaluation (MOSE) may increase the efficacy of EUS-FNA. Objective: To assess the efficacy of MOSE in estimating the adequacy of histologic core specimens obtained by EUS-FNA using a standard 19-gauge needle (19GN) for solid lesions. Design: A prospective pilot study. Setting: Tertiary-care referral center. Patients: One hundred patients with solid lesions (n = 111 lesions). Interventions: EUS-FNA using 19GN Main Outcome Measurements: The relation of a macroscopic visible core (MVC) in the FNA specimens on MOSE with histologic core and the diagnostic yields were studied. Results: The feasibility of EUS-FNA using a 19GN was 99%. The final diagnoses were malignancy in 83 lesions and benign in 28. MOSE revealed MVC in 91.1% with the median length of 8 mm. Histologic core was confirmed in 78.9%. The receiver-operating characteristic curve of the length of MVC for the presence of histologic core showed the cut-off MVC length of 4 mm with area under the curve of .893. Comparisons of per-pass diagnostic yields showed significantly superior histologic, cytologic, and overall diagnostic yields in MVC >= 4 mm as compared with < 4 mm. The multivariate analysis for false-negative pass identified lesion in the pancreas and MVC < 4 mm as significant risk factors. No adverse events were seen. Limitations: Single center, limited operators Conclusion: MVC of >= 4 mm on MOSE can be an indicator of specimen adequacy and can improve diagnostic yield; however, additional FNA may be recommended for pancreatic lesions.	[Iwashita, Takuji; Mukai, Tsuyoshi; Nakashima, Masanori; Uemura, Shinya; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ Hosp, Dept Internal Med 1, Gifu 5011194, Japan; [Hatano, Yuichiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Yasuda, Ichiro; Doi, Shinpei; Mabuchi, Masatoshi] Teikyo Univ, Mizonokuchi Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan	Iwashita, T (reprint author), Gifu Univ Hosp, Dept Internal Med 1, 1-1 Yanagido, Gifu 5011194, Japan.	takuji@w7.dion.ne.jp	Hatano, Yuichiro/K-7454-2013	Hatano, Yuichiro/0000-0002-5121-6325			Larghi A, 2011, GASTROINTEST ENDOSC, V74, P504, DOI 10.1016/j.gie.2011.05.014; Iwashita T, 2013, GASTROINTEST ENDOSC, V77, P909, DOI 10.1016/j.gie.2013.01.001; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; CHANG KJ, 1994, GASTROINTEST ENDOSC, V40, P694; Song TJ, 2010, AM J GASTROENTEROL, V105, P1739, DOI 10.1038/ajg.2010.108; Hikichi T, 2009, J GASTROENTEROL, V44, P322, DOI 10.1007/s00535-009-0001-6; Iglesias-Garcia J, 2011, GASTROINTEST ENDOSC, V73, P1189, DOI 10.1016/j.gie.2011.01.053; Iwashita T, 2012, CLIN GASTROENTEROL H, V10, P316, DOI 10.1016/j.cgh.2011.09.032; Savoy AD, 2007, GASTROINTEST ENDOSC, V65, P953, DOI 10.1016/j.gie.2006.11.014; Nakai Y, 2014, DIGEST DIS SCI, V59, P1578, DOI 10.1007/s10620-013-3019-9; Cleveland P, 2010, GASTROINTEST ENDOSC, V71, P1194, DOI 10.1016/j.gie.2010.01.029; Eloubeidi MA, 2006, AM J GASTROENTEROL, V101, P2841, DOI 10.1111/j.1572-0241.2006.00852.x; Iglesias-Garcia J, 2011, AM J GASTROENTEROL, V106, P1705, DOI 10.1038/ajg.2011.119; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; Yasuda I, 2012, AM J GASTROENTEROL, V107, P397, DOI 10.1038/ajg.2011.350; CHANG KJ, 1994, AM J GASTROENTEROL, V89, P263; Bang JY, 2013, ENDOSCOPY, V45, P445, DOI 10.1055/s-0032-1326268; Hayashi T, 2013, J GASTROEN HEPATOL, V28, P656, DOI 10.1111/jgh.12122; Iwashita T, 2008, ENDOSCOPY, V40, P400, DOI 10.1055/s-2007-995593; Larghi A, 2005, GASTROINTEST ENDOSC, V62, P768, DOI 10.1016/j.gie.2005.05.014; Nguyen YP, 2009, GASTROINTEST ENDOSC, V69, P1264, DOI 10.1016/j.gie.2008.08.030; Yasuda I, 2006, ENDOSCOPY, V38, P919, DOI 10.1055/s-2006-944665	23	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					177	185		10.1016/j.gie.2014.08.040		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900021		
J	Samarasena, JB; Nakai, Y; Shinoura, S; Lee, JG; Chang, KJ				Samarasena, Jason B.; Nakai, Yousuke; Shinoura, Susumu; Lee, John G.; Chang, Kenneth J.			EUS-guided, through-the-needle forceps biopsy: a novel tissue acquisition technique	GASTROINTESTINAL ENDOSCOPY			English	Article									[Samarasena, Jason B.; Nakai, Yousuke; Shinoura, Susumu; Lee, John G.; Chang, Kenneth J.] Univ Calif Irvine, Div Gastroenterol & Hepatol, Orange, CA 92668 USA; [Nakai, Yousuke] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shinoura, Susumu] Okinawa Hokubu Hosp, Dept Gastroenterol, Nago, Okinawa, Japan	Samarasena, JB (reprint author), Univ Calif Irvine, Div Gastroenterol & Hepatol, Orange, CA 92668 USA.				Cook Medical	J. Lee and K. Chang received educational grants from Cook Medical, and K. Chang is a consultant for Cook Medical. All other authors disclosed no financial relationships relevant to this article.		0	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					225	226		10.1016/j.gie.2014.04.029		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900032		
J	Ikeura, T; Shimatani, M; Takaoka, M; Masuda, M; Hayashi, K; Okazaki, K				Ikeura, Tsukasa; Shimatani, Masaaki; Takaoka, Makoto; Masuda, Masataka; Hayashi, Keiji; Okazaki, Kazuichi			Reintervention for an occluded metal stent under the guidance of peroral direct cholangioscopy by using an ultra-slim enteroscope	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Ikeura, Tsukasa; Shimatani, Masaaki; Takaoka, Makoto; Masuda, Masataka; Hayashi, Keiji; Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Osaka, Japan	Ikeura, T (reprint author), Kansai Med Univ, Dept Internal Med 3, Osaka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					226	227		10.1016/j.gie.2014.04.037		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900033		
J	Kobara, H; Mori, H; Rafiq, K; Fujihara, S; Nishiyama, N; Morishita, A; Goda, Y; Kanenishi, K; Hata, T; Masaki, T				Kobara, Hideki; Mori, Hirohito; Rafiq, Kazi; Fujihara, Shintaro; Nishiyama, Noriko; Morishita, Asahiro; Goda, Yasuhiro; Kanenishi, Kenji; Hata, Toshiyuki; Masaki, Tsutomu			Application of endoscopic hemostatic forceps for uterine cervical bleeding	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Kobara, Hideki; Mori, Hirohito; Fujihara, Shintaro; Nishiyama, Noriko; Morishita, Asahiro; Goda, Yasuhiro; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan; [Rafiq, Kazi] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Kanenishi, Kenji; Hata, Toshiyuki] Kagawa Univ, Fac Med, Dept Gynecol, Takamatsu, Kagawa 760, Japan	Kobara, H (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JAN	2015	81	1					234	235		10.1016/j.gie.2014.04.023		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7KL	WOS:000346442900041		
J	Rashid, T; Takebe, T; Nakauchi, H				Rashid, Tamir; Takebe, Takanori; Nakauchi, Hiromitsu			Novel strategies for liver therapy using stem cells	GUT			English	Article							HEPATOCYTE-LIKE CELLS; TRANSPLANTATION; EXPANSION; PANCREAS; MOUSE; RAT		[Rashid, Tamir] Kings Coll London, Ctr Stem Cells & Regenerat Med, London WC2R 2LS, England; [Rashid, Tamir] Kings Coll London, Inst Liver Studies, London WC2R 2LS, England; [Takebe, Takanori] Yokohama City Univ, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan; [Nakauchi, Hiromitsu] Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA USA	Rashid, T (reprint author), Guys Hosp, Kings Coll London, Ctr Stem Cells & Regenerat Med, 28th Floor,Tower Wing, London SE1 9RT, England.	tamir.rashid@kcl.ac.uk					Knight M, 2012, LIVER TRANSPLANT, V18, P549, DOI 10.1002/lt.23380; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Bhatia SN, 1999, FASEB J, V13, P1883; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Tritto G, 2012, SEMIN RESP CRIT CARE, V33, P70, DOI 10.1055/s-0032-1301736; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; GUMUCIO JJ, 1986, HEPATOLOGY, V6, P932, DOI 10.1002/hep.1840060521; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708; Knobeloch D, 2012, METHODS MOL BIOL, V806, P99, DOI 10.1007/978-1-61779-367-7_8; Li CY, 2014, TISSUE ENG A; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Rashid ST, 2013, J HEPATOL, V58, P625, DOI 10.1016/j.jhep.2012.10.026; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Vallier L, 2014, CELL STEM CELL, V14, P267, DOI 10.1016/j.stem.2014.02.010; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034	24	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	JAN	2015	64	1					1	4		10.1136/gutjnl-2014-307480		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW3EE	WOS:000346167700001		
J	Sung, JJY; Ng, SC; Chan, FKL; Chiu, HM; Kim, HS; Matsuda, T; Ng, SSM; Lau, JYW; Zheng, S; Adler, S; Reddy, N; Yeoh, KG; Tsoi, KKF; Ching, JYL; Kuipers, EJ; Rabeneck, L; Young, GP; Steele, RJ; Lieberman, D; Goh, KL				Sung, J. J. Y.; Ng, S. C.; Chan, F. K. L.; Chiu, H. M.; Kim, H. S.; Matsuda, T.; Ng, S. S. M.; Lau, J. Y. W.; Zheng, S.; Adler, S.; Reddy, N.; Yeoh, K. G.; Tsoi, K. K. F.; Ching, J. Y. L.; Kuipers, E. J.; Rabeneck, L.; Young, G. P.; Steele, R. J.; Lieberman, D.; Goh, K. L.			An updated Asia Pacific Consensus Recommendations on colorectal cancer screening	GUT			English	Article							OCCULT BLOOD-TEST; RANDOMIZED-CONTROLLED-TRIAL; ADENOMA DETECTION RATE; SOCIETY-TASK-FORCE; FECAL IMMUNOCHEMICAL TEST; AVERAGE-RISK CHINESE; BODY-MASS INDEX; CT-COLONOGRAPHY; ADVANCED NEOPLASIA; FAMILY-HISTORY	Objective Since the publication of the first Asia Pacific Consensus on Colorectal Cancer (CRC) in 2008, there are substantial advancements in the science and experience of implementing CRC screening. The Asia Pacific Working Group aimed to provide an updated set of consensus recommendations. Design Members from 14 Asian regions gathered to seek consensus using other national and international guidelines, and recent relevant literature published from 2008 to 2013. A modified Delphi process was adopted to develop the statements. Results Age range for CRC screening is defined as 5075 years. Advancing age, male, family history of CRC, smoking and obesity are confirmed risk factors for CRC and advanced neoplasia. A risk-stratified scoring system is recommended for selecting high-risk patients for colonoscopy. Quantitative faecal immunochemical test (FIT) instead of guaiac-based faecal occult blood test (gFOBT) is preferred for average-risk subjects. Ancillary methods in colonoscopy, with the exception of chromoendoscopy, have not proven to be superior to high-definition white light endoscopy in identifying adenoma. Quality of colonoscopy should be upheld and quality assurance programme should be in place to audit every aspects of CRC screening. Serrated adenoma is recognised as a risk for interval cancer. There is no consensus on the recruitment of trained endoscopy nurses for CRC screening. Conclusions Based on recent data on CRC screening, an updated list of recommendations on CRC screening is prepared. These consensus statements will further enhance the implementation of CRC screening in the Asia Pacific region.	[Sung, J. J. Y.; Ng, S. C.; Chan, F. K. L.] Chinese Univ Hong Kong, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Ng, S. C.; Chan, F. K. L.; Ching, J. Y. L.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chiu, H. M.] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Kim, H. S.] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Matsuda, T.] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Ng, S. S. M.; Lau, J. Y. W.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Zheng, S.] Zhejiang Univ, Canc Inst, Hanggzhou, Zhejiang, Peoples R China; [Adler, S.] Bikur Holim Hosp, Div Gastroenterol, Jerusalem, Israel; [Reddy, N.] Asian Healthcare Fdn, Asian Inst Gastroenterol, Hyderabad, Andhra Pradesh, India; [Yeoh, K. G.] Natl Univ Singapore, Asian Healthcare Fdn, Dept Med, Singapore 117548, Singapore; [Tsoi, K. K. F.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Kuipers, E. J.] Erasmus Univ, Med Ctr, Dept Med & Therapeut, Rotterdam, Netherlands; [Rabeneck, L.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M5S 1A1, Canada; [Young, G. P.] Flinders Med Ctr, Dept Gastroenterol, Adelaide, SA, Australia; [Steele, R. J.] Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland; [Lieberman, D.] Portland VA Med Ctr, Portland, OR USA; [Goh, K. L.] Univ Malaya, Dept Gastroenterol & Hepatol, Kuala Lumpur, Malaysia	Sung, JJY (reprint author), Chinese Univ Hong Kong, Inst Digest Dis, Shatin, Hong Kong, Peoples R China.	jjysung@cuhk.edu.hk	Goh, Khean-Lee/B-6404-2009; Ng, Siew Chien/N-4733-2015; 	Ng, Siew Chien/0000-0002-6850-4454; CHIU, HAN-MO/0000-0003-2786-8056	Olympus Medical System Corporation; Given Imaging	An unrestricted education grant was received from Olympus Medical System Corporation and Given Imaging. In order to avoid conflict of interest, industrial partners were not allowed to provide input for the statements, add references in the literature search, participate in the discussion and vote in the consensus conference. None of the sponsors contributed towards the development of the consensus statements or in their voting.	Adler A, 2012, CLIN GASTROENTEROL H, V10, P155, DOI 10.1016/j.cgh.2011.10.026; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Hong SN, 2012, GASTROINTEST ENDOSC, V75, P1011, DOI 10.1016/j.gie.2011.11.040; Baxter NN, 2009, ANN INTERN MED, V150, P1; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Lane JM, 2010, GASTROENTEROLOGY, V139, P1918, DOI 10.1053/j.gastro.2010.08.005; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Gavin DR, 2013, GUT, V62, P242, DOI 10.1136/gutjnl-2011-301848; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Rabeneck L, 2010, AM J GASTROENTEROL, V105, P1627, DOI 10.1038/ajg.2010.83; Pohl J, 2009, GUT, V58, P73, DOI 10.1136/gut.2008.153601; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.002; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; Chiu HM, 2013, CLIN GASTROENTEROL H, V11, P832, DOI 10.1016/j.cgh.2013.01.013; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI 10.1056/NEJMoa1108895; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Leung WK, 2009, AM J GASTROENTEROL, V104, P2028, DOI 10.1038/ajg.2009.202; Cole SR, 2003, J MED SCREEN, V10, P117, DOI 10.1258/096914103769011003; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; Takeuchi Y, 2010, GASTROINTEST ENDOSC, V72, P1006, DOI 10.1016/j.gie.2010.06.055; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Chung SJ, 2010, GASTROINTEST ENDOSC, V72, P136, DOI 10.1016/j.gie.2010.01.055; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Barclay RL, 2008, CLIN GASTROENTEROL H, V6, P1091, DOI 10.1016/j.cgh.2008.04.018; Kahi CJ, 2010, AM J GASTROENTEROL, V105, P1301, DOI 10.1038/ajg.2010.51; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; McGill SK, 2013, GUT, V62, P1704, DOI 10.1136/gutjnl-2012-303965; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168; Lee TJW, 2013, ENDOSCOPY, V45, P20, DOI 10.1055/s-0032-1325803; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Limoges-Gonzalez M, 2011, GASTROENTEROL NURS, V34, P210, DOI 10.1097/SGA.0b013e31821ab5e6; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Tsoi KKF, 2009, CLIN GASTROENTEROL H, V7, P682, DOI 10.1016/j.cgh.2009.02.016; van Heijningen EMB, 2013, GASTROENTEROLOGY, V144, P1410, DOI 10.1053/j.gastro.2013.03.002; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Adler A, 2013, ENDOSCOPY, V45, P813, DOI 10.1055/s-0033-1344583; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1016/S0002-9270(01)03239-7; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Leufkens AM, 2011, GASTROINTEST ENDOSC, V73, P480, DOI 10.1016/j.gie.2010.09.004; de Haan MC, 2011, EUR RADIOL, V21, P1747, DOI 10.1007/s00330-011-2104-8; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Subramanian V, 2011, ENDOSCOPY, V43, P499, DOI 10.1055/s-0030-1256207; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Pasha SF, 2012, AM J GASTROENTEROL, V107, P363, DOI 10.1038/ajg.2011.436; Beaulieu D, 2012, WORLD J GASTROENTERO, V18, P3551, DOI 10.3748/wjg.v18.i27.3551; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pohl J, 2011, GUT, V60, P485, DOI 10.1136/gut.2010.229534; Siersema PD, 2012, WORLD J GASTROENTERO, V18, P3400, DOI 10.3748/wjg.v18.i26.3400; Tung SY, 2000, AM J GASTROENTEROL, V95, P3624, DOI 10.1111/j.1572-0241.2000.03380.x; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Jover R, 2013, GASTROINTEST ENDOSC, V77, P381, DOI 10.1016/j.gie.2012.09.027; Goh KL, 2005, ALIMENT PHARM THERAP, V22, P859, DOI 10.1111/j.1365-2036.2005.02646.x; Rostom A, 2006, GASTROINTEST ENDOSC, V64, P544, DOI 10.1016/j.gie.2005.09.030; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baglietto L, 2006, J CLIN EPIDEMIOL, V59, P114, DOI 10.1016/j.jclinepi.2005.07.018; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; de Wijkerslooth TR, 2012, GUT, V61, P1552, DOI 10.1136/gutjnl-2011-301308; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; Williams JE, 2011, GASTROINTEST ENDOSC, V73, P498, DOI 10.1016/j.gie.2010.08.008; Cole SR, 2001, MED J AUSTRALIA, V175, P195; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Austin GL, 2011, CLIN GASTROENTEROL H, V9, P308, DOI 10.1016/j.cgh.2011.01.004; Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006439.pub3; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Ferlay J, 2004, IARC CANCERBASE, V5; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Hirabayashi Y, 2007, JPN J CLIN ONCOL, V37, P325, DOI 10.1093/jjco/hym028; Hoff G, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1846; Johns LE, 2002, DIS COLON RECTUM, V45, P681, DOI 10.1007/s10350-004-6267-0; Koo JH, 2008, CLIN GASTROENTEROL H, V6, P1016, DOI 10.1016/j.cgh.2008.03.018; Lieberman D, 2012, GASTROENTEROLOGY, V142, P194, DOI 10.1053/j.gastro.2011.12.016; Lieberman D, 2010, GASTROENTEROLOGY, V138, P2115, DOI 10.1053/j.gastro.2010.02.006; Liou JM, 2007, DIS COLON RECTUM, V50, P630, DOI 10.1007/s10350-006-0857-y; Lucidarme O, 2012, EUR J RADIOL, V81, P1413, DOI 10.1016/j.ejrad.2011.03.027; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI 10.1093/jjco/hyp047; MAULE WF, 1994, NEW ENGL J MED, V330, P183, DOI 10.1056/NEJM199401203300307; Nagorni A, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD008361.PUB2; Ng SC, 2013, GASTROENTEROLOGY, V144, P544, DOI 10.1053/j.gastro.2012.11.011; Pickhardt PJ, 2007, RADIOLOGY, V244, P316, DOI 10.1148/radiol.2441061192; Ramsoekh D, 2010, GUT, V59, P785, DOI 10.1136/gut.2008.151589; Rex DK, 2013, GASTROENTEROLOGY, V144, P907; Roslani AC, 2012, ASIAN PAC J CANCER P, V13, P237, DOI 10.7314/APJCP.2012.13.1.237; Shaukat A, 2010, DIGEST DIS SCI, V55, P2352, DOI 10.1007/s10620-010-1182-9; Singh H, 2006, JAMA-J AM MED ASSOC, V296, P2438, DOI 10.1001/jama.296.20.2438-a; Steele RJC, 2012, ENDOSCOPY, V44, pSE140, DOI 10.1055/s-0032-1309802; Steele RJC, 2012, ENDOSCOPY, V44, pSE106, DOI 10.1055/s-0032-1309796; Sung JJY, 2013, GASTROENTEROLOGY, V144, P906; Sung JJY, 2011, CLIN GASTROENTEROL H, V9, P47, DOI 10.1016/j.cgh.2010.10.005; Calonge N, 2008, ANN INTERN MED, V149, P627; van DL, 2013, ENDOSCOPY, V45, P182; Van GA, 2009, NEW ENGL J MED, V361, P264; van Putten PG, 2012, ENDOSCOPY, V44, P1127, DOI 10.1055/s-0032-1310154; Wong BCY, 2003, ALIMENT PHARM THERAP, V18, P941, DOI 10.1046/j.0269-2813.2003.01783.x; Wong M. C., 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070209	123	10	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	JAN	2015	64	1					121	132		10.1136/gutjnl-2013-306503		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW3EE	WOS:000346167700017		
J	Yamauchi, K; Kogashiwa, Y; Nakamura, T; Moro, Y; Nagafuji, H; Kohno, N				Yamauchi, Kohichi; Kogashiwa, Yasunao; Nakamura, Takehiro; Moro, Yorihisa; Nagafuji, Hiroshi; Kohno, Naoyuki			Diagnostic evaluation of sentinel lymph node biopsy in early head and neck squamous cell carcinoma: A meta-analysis	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Review						sentinel lymph node; meta-analysis; sensitivity; head and neck cancer; squamous cell carcinoma	NUCLEIC-ACID AMPLIFICATION; CLINICALLY NEGATIVE NECK; BREAST-CANCER PATIENTS; ORAL-CAVITY; MULTICENTER TRIAL; GASTRIC-CANCER; DISSECTION; METASTASES; IMMUNOHISTOCHEMISTRY; MANAGEMENT	BackgroundThe purpose of this study was to evaluate the efficacy of sentinel lymph node biopsy (SLNB) in early head and neck squamous cell carcinoma (HNSCC). MethodsThe PubMed database was searched for studies published before October 31, 2012. Pooled values for the sentinel lymph node identification rate, sensitivity, false-negative rate, negative predictive value, and accuracy were calculated. ResultsA total of 16 studies (987 patients) was included. The pooled identification rate, sensitivity, false-negative rate, negative predictive value, and accuracy were 95.2%, 86.3%, 13.7%, 94.2%, and 95.0%, respectively. The subgroup with high methodological quality showed a mean identification rate of 95.4% for SLNB validation trials and 94.2% for SLNB alone trials, and mean sensitivity of 91.0% for SLNB validation trials and 84.2% for SLNB alone trials. ConclusionThe SLNB procedure has shown a high sensitivity rate, but the pooled sensitivity and false-negative rate were worse in SLNB alone trials than in SLNB validation trials. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 127-133, 2015	[Yamauchi, Kohichi; Kogashiwa, Yasunao; Nakamura, Takehiro; Moro, Yorihisa; Nagafuji, Hiroshi; Kohno, Naoyuki] Kyorin Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Mitaka, Tokyo 1818611, Japan	Kohno, N (reprint author), Kyorin Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	sukohno@ks.kyorin-u.ac.jp					Alkureishi LWT, 2010, ANN SURG ONCOL, V17, P2459, DOI 10.1245/s10434-010-1111-3; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Terada A, 2008, ORAL ONCOL, V44, P838, DOI 10.1016/j.oraloncology.2007.11.006; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Wang Z, 2012, ANN SURG ONCOL, V19, P1541, DOI 10.1245/s10434-011-2124-2; Rodrigo JP, 2011, HEAD NECK-J SCI SPEC, V33, P1210, DOI 10.1002/hed.21505; Civantos FJ, 2010, J CLIN ONCOL, V28, P1395, DOI 10.1200/JCO.2008.20.8777; Kovacs AF, 2009, ANN SURG ONCOL, V16, P233, DOI 10.1245/s10434-008-0150-5; Ross GL, 2004, ANN SURG ONCOL, V11, P690, DOI 10.1245/ASO.2004.09.001; Psychogios G, 2013, J SURG ONCOL, V107, P384, DOI 10.1002/jso.23221; Visser M, 2008, INT J CANCER, V122, P2562, DOI 10.1002/ijc.23451; Moody LC, 2012, SURGERY, V152, P389, DOI 10.1016/j.surg.2012.06.017; Fasunla AJ, 2011, ORAL ONCOL, V47, P320, DOI 10.1016/j.oraloncology.2011.03.009; Ishikawa K, 2007, SURG ENDOSC, V21, P1131, DOI 10.1007/s00464-006-9062-2; Valsecchi ME, 2011, J CLIN ONCOL, V29, P1479, DOI 10.1200/JCO.2010.33.1884; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Ferlito A, 2006, ORAL ONCOL, V42, P14, DOI 10.1016/j.oraloncology.2005.03.009; Alkureishi LWT, 2009, ANN SURG ONCOL, V16, P3190, DOI 10.1245/s10434-009-0726-8; Hart RD, 2005, ARCH OTOLARYNGOL, V131, P34, DOI 10.1001/archotol.131.1.34; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI [10.7326/0003-4819-155-1-201107050-00006, 10.1059/0003-4819-155-1-201107050-00006]; Melkane AE, 2012, LARYNGOSCOPE, V122, P1782, DOI 10.1002/lary.23383; Ferris RL, 2011, CLIN CANCER RES, V17, P1858, DOI 10.1158/1078-0432.CCR-10-3110; Burcia V, 2010, OTOLARYNG HEAD NECK, V142, P592, DOI 10.1016/j.otohns.2009.12.016; Yamauchi K, 2011, ANN SURG ONCOL, V18, P2042, DOI 10.1245/s10434-010-1499-9; Bilde A, 2008, LARYNGOSCOPE, V118, P408, DOI 10.1097/MLG.0b013e31815d8e15; Cammilleri Serge, 2004, Bull Cancer, V91, pE1; Chone CT, 2013, EUR ARCH OTO-RHINO-L, V270, P313, DOI 10.1007/s00405-012-2032-5; Civantos FJ, 2003, HEAD NECK-J SCI SPEC, V25, P1, DOI 10.1002/hed.10213; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FAKIH AR, 1989, SEMIN SURG ONCOL, V5, P327, DOI 10.1002/ssu.2980050507; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Giuliano AE, 1994, ANN SURG, V220, P398; Goudakos JK, 2009, EJSO-EUR J SURG ONC, V35, P223, DOI 10.1016/j.ejso.2008.04.001; Hoft S, 2004, BRIT J CANCER, V91, P124, DOI 10.1038/sj.bjc.6601877; Kitagawa Y, 2002, BRIT J SURG, V89, P604, DOI 10.1046/j.1365-2168.2002.02065.x; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Kohno N, 2003, ORL J OTO-RHINO-LARY, V65, P66, DOI 10.1159/000068655; Loveless Vivian S, 2010, J Nucl Med Technol, V38, P49, DOI 10.2967/jnmt.109.068973; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Noura S, 2009, ANN SURG ONCOL, V17, P144; Paleri V, 2005, HEAD NECK-J SCI SPEC, V27, P739, DOI 10.1002/hed.20228; Psychogios G, 2013, HEAD NECK; Rigual N, 2005, LARYNGOSCOPE, V115, P2217, DOI 10.1097/01.mlg.0000187870.82699.ed; Shoaib T, 1999, HEAD NECK-J SCI SPEC, V21, P728, DOI 10.1002/(SICI)1097-0347(199912)21:8<728::AID-HED8>3.0.CO;2-P; SPIRO RH, 1986, HEAD NECK-J SCI SPEC, V9, P27, DOI 10.1002/hed.2890090106; Stoeckh SJ, 2007, LARYNGOSCOPE, V117, P1539, DOI 10.1097/MLG.0b013e318093ee67; Trivedi NP, 2010, HEAD NECK-J SCI SPEC, V32, P1437, DOI 10.1002/hed.21345; Vigili MG, 2007, EUR ARCH OTO-RHINO-L, V264, P163, DOI 10.1007/s00405-006-0150-7; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Yamauchi K, 2010, HEAD NECK-J SCI SPEC, V34, P568; Yen CY, 2006, ANN SURG ONCOL, V13, P1130, DOI 10.1245/ASO.2006.09.023	51	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	JAN	2015	37	1					127	133		10.1002/hed.23526		7	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	AW4LI	WOS:000346252200023		
J	Tomar, A; Polygalov, D; Chattarji, S; McHugh, TJ				Tomar, Anupratap; Polygalov, Denis; Chattarji, Sumantra; McHugh, Thomas J.			The Dynamic Impact of Repeated Stress on the Hippocampal Spatial Map	HIPPOCAMPUS			English	Article						place cell; chronic stress; CA1; generalization; context discrimination	LONG-TERM POTENTIATION; PLACE CELLS; RESTRAINT STRESS; RAT HIPPOCAMPUS; DENTATE GYRUS; ENTORHINAL CORTEX; FIRING PROPERTIES; NMDA RECEPTORS; MEMORY; PLASTICITY	Stress alters the function of many physiological processes throughout the body, including in the brain. A neural circuit particularly vulnerable to the effects of stress is the hippocampus, a key component of the episodic and spatial memory system in both humans and rodents. Earlier studies have provided snapshots of morphological, molecular, physiological and behavioral changes in the hippocampus following either acute or repeated stress. However, the cumulative impact of repeated stress on in vivo hippocampal physiology remains unexplored. Here we report the stress-induced modulation of the spatially receptive fields of the hippocampal CA1 place cells' as mice explore familiar and novel tracks after 5 and 10 days of immobilization stress. We find that similar to what has been observed following acute stress, five days of repeated stress results in decreased excitability of CA1 pyramidal cells. Following ten days of chronic stress, however, this decreased hippocampal excitability is no longer evident, suggesting adaptation may have occurred. In addition to these changes in neuronal excitability, we find deficient context discrimination, wherein both short-term and chronic stress impair the ability of the hippocampus to unambiguously distinguish novel and familiar environments. These results suggest that a loss of network flexibility may underlie some of the behavioral deficits accompanying chronic stress. (c) 2014 Wiley Periodicals, Inc.	[Tomar, Anupratap; Chattarji, Sumantra] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Tomar, Anupratap] Manipal Univ, Manipal, Karnataka, India; [Polygalov, Denis; McHugh, Thomas J.] RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama 3510198, Japan	McHugh, TJ (reprint author), RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	jmchugh@brain.riken.jp					Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037//0735-7044.113.5.902; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Harris KD, 2000, J NEUROPHYSIOL, V84, P401; Elizalde N, 2010, PSYCHOPHARMACOLOGY, V210, P393, DOI 10.1007/s00213-010-1835-6; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284; Valente MM, 2012, MOL PHARMACOL, V82, P271, DOI 10.1124/mol.112.077636; Vyas A, 2002, J NEUROSCI, V22, P6810; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Kim JJ, 2001, J NEUROSCI, V21, P5222; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; McEwen BS, 1998, NEW ENGL J MED, V338, P171; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Kallarackal AJ, 2013, J NEUROSCI, V33, P15669, DOI 10.1523/JNEUROSCI.2588-13.2013; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Narayanan R, 2010, J NEUROPHYSIOL, V103, P3070, DOI 10.1152/jn.00913.2009; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schmidt MV, 2010, J NEUROSCI, V30, P16949, DOI 10.1523/JNEUROSCI.4668-10.2010; Krugers HJ, 1997, HIPPOCAMPUS, V7, P427, DOI 10.1002/(SICI)1098-1063(1997)7:4<427::AID-HIPO8>3.3.CO;2-L; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Kim EJ, 2012, J NEUROSCI, V32, P11424, DOI 10.1523/JNEUROSCI.1108-12.2012; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; desQuervain DJ-F, 2009, FRONT NEUROENDOCRIN, V30, P358; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Passecker J, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00066; Rao RP, 2009, POSTTRAUMATIC STRESS, P151, DOI DOI 10.1007/978-1-60327-329-9_7; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shors TJ, 1997, SYNAPSE, V26, P209, DOI 10.1002/(SICI)1098-2396(199707)26:3<209::AID-SYN2>3.0.CO;2-B; Skaggs WE, 1993, ADV NEURAL INFORMATI, V5, P1030	66	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	JAN	2015	25	1					38	50		10.1002/hipo.22348		13	Neurosciences	Neurosciences & Neurology	AW4MP	WOS:000346255600004		
J	Urano, M; Nagao, T; Miyabe, S; Ishibashi, K; Higuchi, K; Kuroda, M				Urano, Makoto; Nagao, Toshitaka; Miyabe, Satoru; Ishibashi, Kenichiro; Higuchi, Kayoko; Kuroda, Makoto			Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers	HUMAN PATHOLOGY			English	Article						Mammary analogue secretory carcinoma; Acinic cell carcinoma; Cystadenocarcinoma; Salivary gland; ETV6-NTRK3; Immunohistochemistry	INTERCALATED DUCT DIFFERENTIATION; ACINIC CELL-CARCINOMA; GENE FUSION; BREAST; TUMORS; DIAGNOSIS; EXPRESSION; SPECTRUM; PROTEIN; DOG1	Mammary analogue secretory carcinoma (MASC) is a recently recognized salivary gland tumor harboring an ETV6-NTRK3 translocation similar to secretory carcinoma of the breast. Histologically, MASC mimics papillary-cystic, microcystic, and follicular-type acinic cell carcinoma (AciCC) and low-grade cribriform cystadenocarcinoma (LGCCC) of the salivary gland. Using histology, immunohistochemistry (IHC), and molecular genetic techniques, we reevaluated 18 cases originally diagnosed as AciCC between 1993 and 2012. The last of these methods was used to detect the ETV6-NTRK3 translocation. The results reconfirmed 6 cases as AciCC (3 men; average age, 63 years) and helped us reclassify 10 cases as MASC (6 men; mean age, 46 years) and 2 as LGCCC (2 women; mean age, 48 years). Using MC, we identified the 3 histologic types according to the expression patterns of vimentin, high-molecular-weight cytokeratin, cytokeratin 19, S-100, mammaglobin, MUC1, GATA-binding protein 3, adipophilin, a-amylase, DOG-1, SOX-10, and p63. The number of tumors diagnosed as MASC indicates that AciCC includes bona fide MASC cases. Because differential diagnosis among zymogen granule-poor AciCC, MASC, and LGCCC tumors is challenging, we recommend using. molecular genetic tests for ETV6-NTRK3 for accurate diagnosis. Furthermore, detailed analyses of hematoxylin and eosin-stained tissues and IHC studies using the markers described here should be incorporated into routine practices. (C) 2014 Elsevier Inc. All rights reserved.	[Urano, Makoto; Kuroda, Makoto] Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol, Toyoake, Aichi 4701192, Japan; [Nagao, Toshitaka] Tolgo Med Univ, Dept Anat Pathol, Tokyo 1600023, Japan; [Miyabe, Satoru; Ishibashi, Kenichiro] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Aichi 4648651, Japan; [Higuchi, Kayoko] Aizawa Hosp, Sect Anat Pathol, Nagano 3908510, Japan	Urano, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	uranom@fujita-hu.ac.jp					Lae M, 2009, MODERN PATHOL, V22, P291, DOI 10.1038/modpathol.2008.184; Miettinen M, 2009, AM J SURG PATHOL, V33, P1401, DOI 10.1097/PAS.0b013e3181a90e1a; Bishop JA, 2013, HUM PATHOL, V44, P1982, DOI 10.1016/j.humpath.2013.03.017; Chiosea SI, 2012, AM J SURG PATHOL, V36, P343, DOI 10.1097/PAS.0b013e318242a5b0; Chenevert J, 2012, MODERN PATHOL, V25, P919, DOI 10.1038/modpathol.2012.57; Chiosea SI, 2012, HISTOPATHOLOGY, V61, P387, DOI 10.1111/j.1365-2559.2012.04232.x; Laco J, 2013, PATHOL RES PRACT, V209, P167, DOI 10.1016/j.prp.2012.12.005; Weinreb I, 2006, AM J SURG PATHOL, V30, P1014, DOI 10.1097/00000478-200608000-00013; Tognon CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096; Delgado R, 1996, CANCER, V78, P958, DOI 10.1002/(SICI)1097-0142(19960901)78:5<958::AID-CNCR4>3.0.CO;2-8; Chi HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/j.bbrc.2012.10.087; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Skalova A, 2014, AM J SURG PATHOL, V38, P23, DOI 10.1097/PAS.0000000000000088; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Ohtomo R, 2013, MODERN PATHOL, V26, P1041, DOI 10.1038/modpathol.2013.54; Xia HJ, 2011, HUM PATHOL, V42, P1297, DOI 10.1016/j.humpath.2010.11.022; Connor A, 2012, AM J SURG PATHOL, V36, P27, DOI 10.1097/PAS.0b013e318231542a; Griffith C, 2011, VIRCHOWS ARCH, V459, P117, DOI 10.1007/s00428-011-1098-6; Hirokawa M, 2002, HISTOPATHOLOGY, V40, P223, DOI 10.1046/j.1365-2559.2002.01346.x; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Bourgeois JM, 2000, AM J SURG PATHOL, V24, P937, DOI 10.1097/00000478-200007000-00005; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Pia-Foschini M, 2003, J CLIN PATHOL, V56, P497, DOI 10.1136/jcp.56.7.497; Brandwein-Gensler M, 2004, AM J SURG PATHOL, V28, P1040, DOI 10.1097/01.pas.0000128662.66321.be; Brandwein-Gensler MS, 2005, WHO CLASSIFICATION T, P233; ELLIS GL, 1983, CANCER, V52, P542, DOI 10.1002/1097-0142(19830801)52:3<542::AID-CNCR2820520326>3.0.CO;2-A; Ellis GL, 2008, AFIP ATLAS TUMOR PAT, V4, P204; Ito S, 2012, PATHOL INT, V62, P149, DOI 10.1111/j.1440-1827.2011.02759.x; Mariano FV, 2013, HISTOPATHOLOGY, V63, P558, DOI 10.1111/his.12192; Pinto A, 2014, MODERN PATHOL, V27, P30, DOI 10.1038/modpathol.2013.84; Schwartz Lauren E, 2013, Head Neck Pathol, V7, P311, DOI 10.1007/s12105-013-0442-3; Schwarz S, 2012, HISTOPATHOLOGY, V61, P395, DOI 10.1111/j.1365-2559.2012.04233.x; Skalova A, 2013, HEAD NECK PATHOL S1, V7, P30, DOI DOI 10.1007/S12105-013-0455-Y; Tsuji S, 1998, AM J PATHOL, V153, P1807, DOI 10.1016/S0002-9440(10)65695-7	34	4	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JAN	2015	46	1					94	103		10.1016/j.humpath.2014.09.012		10	Pathology	Pathology	AW8WL	WOS:000346540100012		
J	Nagashima, H; Iwatani, S; Cruz, M; Abreu, JAJ; Tronilo, L; Rodriuez, E; Disla, M; Terao, H; Uchida, T; Mahachai, V; Vilaichone, RK; Tshering, L; Mitsui, T; Shiota, S; Graham, DY; Yamaoka, Y				Nagashima, Hiroyuki; Iwatani, Shun; Cruz, Modesto; Abreu, Jose A. Jimenez; Tronilo, Lourdes; Rodriguez, Eduardo; Disla, Mildre; Terao, Hideo; Uchida, Tomohisa; Mahachai, Varocha; Vilaichone, Ratha-korn; Tshering, Lotay; Mitsui, Takahiro; Shiota, Seiji; Graham, David Y.; Yamaoka, Yoshio			Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic	HUMAN PATHOLOGY			English	Article						Helicobacter pylori; IL-8; CagA genotype; Bhutan; Dominican Republic	EAST-ASIAN-TYPE; GASTRODUODENAL DISEASES; VIRULENCE FACTORS; HIGH PREVALENCE; CAGA; JAPAN; MECHANISMS; INDUCTION; ANTIGEN; STRAINS	The outcomes of Helicobacter pylori infection vary geographically. H pylori strains, disease presentation, and environments differ markedly in Bhutan and Dominican Republic. The aims were to compare the strains, histology, and expression of interleukin (IL) 8 and IL-10 from gastric mucosa from the 2 countries. H pylori status was assessed by the combination of rapid urease test, culture, and histology. Histology was evaluated using the updated Sydney System, and cytokines in gastric biopsies were measured using real-time polymerase chain reaction (PCR). There were 138 subjects from Bhutan and 155 from Dominican Republic. The prevalence of H pylori infection was 65% and 59%, respectively. The genotype of cagA was predominantly East Asian type in Bhutan versus Western type in Dominican Republic. Gastritis severity was significantly higher in H pylori-infected subjects from Bhutan than those from Dominican Republic. IL-8 expression by H pylori infection was 5.5-fold increased in Bhutan versus 3-fold in Dominican Republic (P < .001); IL-10 expression was similar. IL-8 expression levels among H pylori-infected cases tended to be positively correlated with polymorphonuclear leucocyte and monocyte infiltration scores in both countries. IL-8 expression among those with grade 2 and 3 polymorphonuclear leucocyte and monocyte infiltration was significantly higher in Bhutan than in Dominican Republic. The difference in IL-8 expression in the 2 countries is reflected in the different disease pattern between them. Whether the dominant factor is differences in H pylori virulence, in host-H pylori-environmental interactions, genetic factors or all remains unclear. However, severity of inflammation appears to be a critical factor in disease pathogenesis. We compared IL-8 messenger RNA levels between the high gastric cancer risk country, Bhutan (mainly East Asian-type H pylori), and the lower gastric cancer risk country, Dominican Republic (mainly Western-type H pylori). (C) 2014 Elsevier Inc. All rights reserved.	[Nagashima, Hiroyuki; Iwatani, Shun; Mitsui, Takahiro; Shiota, Seiji; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu City, Oita 8795593, Japan; [Nagashima, Hiroyuki; Iwatani, Shun; Graham, David Y.; Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Dept Med Gastroenterol, Houston, TX 77030 USA; [Nagashima, Hiroyuki; Iwatani, Shun; Graham, David Y.; Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA; [Cruz, Modesto] Autonomous Univ Santo Domingo, Inst Microbiol & Parasitol, Dept Sci, Santo Domingo 1355, Dominican Rep; [Cruz, Modesto] Santiago Technol Univ, Sch Med, Dept Biomed Res, Santo Domingo 685, Dominican Rep; [Abreu, Jose A. Jimenez; Tronilo, Lourdes; Rodriguez, Eduardo] Dr Luis E Aybar Hlth & Hyg City, Dominican Japanese Digest Dis Ctr, Santo Domingo, Dominican Rep; [Disla, Mildre] Dr Luis E Aybar Hlth & Hyg City, Dominkan Japanese Friendship Med Educ Ctr, Santo Domingo 1355, Dominican Rep; [Terao, Hideo] Oita Univ, Ctr Hlth Sci, Oita 8701192, Japan; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Yufu 8795593, Japan; [Mahachai, Varocha] Bangkok Hosp, Dept Gastroenterol, Bangkok 10310, Thailand; [Vilaichone, Ratha-korn] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Pathum Thani 12120, Thailand; [Tshering, Lotay] Dorji Wangchuk Natl Referral Hosp, Dept Surg, Thimphu, Bhutan	Yamaoka, Y (reprint author), Oita Univ, Fac Med, Dept Environm & Prevent Med, 1-1 Idaigaoka, Yufu City, Oita 8795593, Japan.	yyamaoka@oita-u.ac.jp			National Institutes of Health [DK62813, DK56338]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22390085, 22659087, 24406015, 24659200, 23790798]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation for Japan Society for the Promotion of Science; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency; National Fund for Innovation and Scientific and Technological Development from the Ministry of Higher Education Science and Technology of the Dominican Republic	This article is based on the work supported in part by grants from the National Institutes of Health (DK62813) (Y. Y.) and DK56338 (D. Y. G.), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22390085, 22659087, 24406015, and 24659200 [Y. Y.] and 23790798 [S. S.]), Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation for Japan Society for the Promotion of Science, the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency, and the National Fund for Innovation and Scientific and Technological Development from the Ministry of Higher Education Science and Technology of the Dominican Republic (M. C.).	Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamaoka Y, 1999, GUT, V45, P804; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Serrano C, 2013, MUCOSAL IMMUNOL, V6, P950, DOI 10.1038/mi.2012.133; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Shiota S, 2013, J MED MICROBIOL, V62, P1571, DOI 10.1099/jmm.0.060905-0; Yamaoka Y, 1997, GUT, V41, P442; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Takahashi A, 2013, HELICOBACTER, V18, P66, DOI 10.1111/j.1523-5378.2012.00994.x; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Bodger K, 2001, J CLIN PATHOL, V54, P285, DOI 10.1136/jcp.54.4.285; Fu HY, 2007, J GASTROEN HEPATOL, V22, P355, DOI 10.1111/j.1440-1746.2006.04531.x; Gil JH, 2014, J PEDIAT GASTROENTER, V58, P252; Lee KH, 2004, J CLIN MICROBIOL, V42, P3518, DOI 10.1128/JCM.42.8.3518-3524.2004; Shiota S, 2013, EXPERT REV GASTROENT, V7, P35, DOI [10.1586/egh.12.67, 10.1586/EGH.12.67]; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799; Yasuda A, 2009, APMIS, V117, P893, DOI 10.1111/j.1600-0463.2009.02548.x	19	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JAN	2015	46	1					129	136		10.1016/j.humpath.2014.10.006		8	Pathology	Pathology	AW8WL	WOS:000346540100016		
J	Kiguchi, M; Shen, YJ; Kanae, S; Oki, T				Kiguchi, Masashi; Shen, Yanjun; Kanae, Shinjiro; Oki, Taikan			Re-evaluation of future water stress due to socio-economic and climate factors under a warming climate	HYDROLOGICAL SCIENCES JOURNAL-JOURNAL DES SCIENCES HYDROLOGIQUES			English	Article						uncertainty; SRES; water stress assessment; IPCC	INTEGRATED MODEL; SRES SCENARIOS; RESOURCES; VULNERABILITY; AVAILABILITY; POPULATION; PROJECTION; THREATS	We re-evaluated a method to estimate water stress changes as a function of increasing global mean temperature. Trends in the total population under high water stress (defined as when the annual water withdrawal divided by the annual water availability is higher than 0.4) now and in the future (total HWSP) and the population exposed to high water stress in the future but not now (add_HWSP) are dependent on differences in each scenario, not the global mean temperature increase. The ensemble mean of the total HWSP and its ratio for emissions scenarios A1B and B1 are close to constant values and decreased when the global mean temperature increase exceeded 1.9 degrees C and 1.3 degrees C, respectively. If the global mean temperature increase reaches a maximum ensemble-mean value in each scenario, the total HWSP (its ratio) in scenarios A1B, A2 and B1 was about 4.5 billion (0.54), 8.6 billion (0.64) and 4.1 billion (0.49), respectively. We estimated the contributions of climate change to runoff, water withdrawal and population growth on total HWSP and add_HWSP to separate the influences of climate change and socio-economic change. Climate change and socio-economic factors (water withdrawal and population growth) decreased and increased add_HWSP, respectively. [GRAPHICS] Editor Z.W. Kundzewicz	[Kiguchi, Masashi; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Shen, Yanjun] Chinese Acad Sci, Ctr Agr Resources Res, Shijiazhuang, Peoples R China; [Kanae, Shinjiro] Tokyo Inst Technol, Tokyo 152, Japan	Kiguchi, M (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	kiguchi@rainbow.iis.u-tokyo.ac.jp	Oki, Taikan/E-5778-2010; Kanae, Shinjiro/E-5606-2010	Oki, Taikan/0000-0003-4067-4678; Kanae, Shinjiro/0000-0002-3176-4957	Ministry of the Environment of Japan [S-5, S-10]	We thank two anonymous reviewers and the editor for their useful comments. This study was based on the results of projects "S-5' and "S-10', research topics of the Global Environment Research Fund (GERF) of the Ministry of the Environment of Japan. All of the GCM outputs were provided by the Program for Climate Model Diagnosis and Intercomparison (PCMDI).	Bengtsson M, 2006, POPUL ENVIRON, V28, P113, DOI 10.1007/s11111-007-0035-8; van Beek LPH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009791; FALKENMARK M, 1989, NAT RESOUR FORUM, V13, P258; Oki T, 2001, HYDROLOG SCI J, V46, P983, DOI 10.1080/02626660109492890; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, pS31, DOI 10.1016/S0959-3780(99)00017-5; Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1027; Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1007; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Shen YJ, 2008, HYDROLOG SCI J, V53, P11, DOI 10.1623/hysj.53.1.11; Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Parish ES, 2012, COMPUT GEOSCI-UK, V42, P79, DOI 10.1016/j.cageo.2012.01.019; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; Wada Y, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009792; Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Arnell NW, 2011, GLOBAL ENVIRON CHANG, V21, P592, DOI 10.1016/j.gloenvcha.2011.01.015; AQUASTAT, 2012, FAOS INF SYST WAT AG; Arnell NW, 2002, CLIMATIC CHANGE, V53, P413, DOI 10.1023/A:1015277014327; Bouwman AF, 2006, INTEGRATED MODELLING; CIESIN, 2002, COUNTR LEV POP DOWNS; CIESIN, 2002, COUNTR LEV GDP DOWNS; Cosgrove W. J., 2000, WORLD WATER VISION M; Doll P, 2002, WATER RESOUR RES, V38, P1, DOI DOI 10.1029/2001WR000355; IPCC, 2000, SPEC REP EM SCEN; Jia SF, 2006, J WATER RES PL-ASCE, V132, P183, DOI 10.1061/(ASCE)0733-9496(2006)132:3(183); Oki T., 1998, EARTH INTERACT, V2, P1, DOI DOI 10.1175/1087-3562(1998)002<0001:D0TRIP>2.3.C0;2; Parry M, 2001, GLOBAL ENVIRON CHANG, V11, P181, DOI 10.1016/S0959-3780(01)00011-5; Parry ML, 2007, CLIMATE CHANGE 2007; Rockstrom J., 2004, BALANCING WATER HUMA, P247; Shen YJ, 2014, HYDROLOG SCI J, V59, P1775, DOI 10.1080/02626667.2013.862338; Utsumi N., 2006, THESIS U TOKYO TOKYO; WMO (World Meteorological Organisation), 1997, COMPR ASS FRESHW RES; World Bank, 2005, WORLD DEV IND 2005 C	35	4	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0262-6667	2150-3435		HYDROLOG SCI J	Hydrol. Sci. J.-J. Sci. Hydrol.	JAN	2015	60	1					14	29		10.1080/02626667.2014.888067		16	Water Resources	Water Resources	AW9OZ	WOS:000346588200002		
J	Franklin, SS; O'Brien, E; Thijs, L; Asayama, K; Staessen, JA				Franklin, Stanley S.; O'Brien, Eoin; Thijs, Lutgarde; Asayama, Kei; Staessen, Jan A.			Masked Hypertension A Phenomenon of Measurement	HYPERTENSION			English	Article							AMBULATORY BLOOD-PRESSURE; WHITE-COAT HYPERTENSION; ISOLATED NOCTURNAL HYPERTENSION; CHRONIC KIDNEY-DISEASE; TARGET ORGAN DAMAGE; INTERNATIONAL DATABASE; ANTIHYPERTENSIVE TREATMENT; GENERAL-POPULATION; EUROPEAN-SOCIETY; PROGNOSTIC VALUE		[Franklin, Stanley S.] Univ Calif Irvine, Heart Dis Prevent Program, Div Cardiol, Irvine, CA 92697 USA; [O'Brien, Eoin] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Thijs, Lutgarde; Asayama, Kei; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, Studies Coordinating Ctr, Res Unit Hypertens & Cardiovasc Epidemiol,KU Leuv, Leuven, Belgium; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Staessen, Jan A.] Maastricht Univ, Maastricht, Netherlands; [Staessen, Jan A.] Maastricht Univ, Vitak Res & Dev, Maastricht, Netherlands	Franklin, SS (reprint author), Univ Calif Irvine, Heart Dis Prevent Program, Dept Med, Med Sci Off C340A B C240, Irvine, CA 92697 USA.	ssfranklinmd@earthlink.net	Staessen, Jan/A-1065-2011	Staessen, Jan/0000-0002-3026-1637	European Union [HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE]; European Union (European Research Council) [2011-294713-EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013]; International Zinc and Lead Research Organization	The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EPLORE), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013), and the International Zinc and Lead Research Organization currently support the Studies Coordinating Centre in Leuven.	Agarwal R, 2013, J AM SOC HYPERTENS, V7, P236, DOI 10.1016/j.jash.2013.02.005; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; Hanninen MRA, 2013, J HYPERTENS, V31, P1136, DOI 10.1097/HJH.0b013e32835fa5dc; Hanninen MRA, 2011, J HYPERTENS, V29, P1880, DOI 10.1097/HJH.0b013e32834a98ba; Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2012.301153; Niiranen TJ, 2014, HYPERTENSION, V64, P281, DOI 10.1161/HYPERTENSIONAHA.114.03292; Trudel X, 2010, PSYCHOSOM MED, V72, P786, DOI 10.1097/PSY.0b013e3181eaf327; Pickering TG, 2008, J HYPERTENS, V26, P2259, DOI 10.1097/HJH.0b013e32831313c4; Schultz MG, 2011, BLOOD PRESSURE, V20, P284, DOI 10.3109/08037051.2011.566251; Kario K, 2014, J HUM HYPERTENS, V28, P176, DOI 10.1038/jhh.2013.73; Cacciolati C, 2013, AM J HYPERTENS, V26, P367, DOI 10.1093/ajh/hps054; Hermida RC, 2012, AM J HYPERTENS, V25, P297, DOI 10.1038/ajh.2011.208; Mancia G, 2004, J HYPERTENS, V22, P435, DOI 10.1097/01.hjh.0000098263.58662.13; Viera AJ, 2010, AM J HYPERTENS, V23, P1190, DOI 10.1038/ajh.2010.158; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Niiranen TJ, 2013, HYPERTENSION, V61, P27, DOI 10.1161/HYPERTENSIONAHA.111.00100; Owens P, 1999, HYPERTENSION, V34, P267; Li Y, 2013, HYPERTENSION, V61, P278, DOI 10.1161/HYPERTENSIONAHA.111.00217; Sharman JE, 2011, AM J HYPERTENS, V24, P898, DOI 10.1038/ajh.2011.75; Minutolo R, 2011, ARCH INTERN MED, V171, P1090, DOI 10.1001/archinternmed.2011.230; Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Bangash F, 2009, CLIN J AM SOC NEPHRO, V4, P656, DOI 10.2215/CJN.05391008; Franklin SS, 2013, HYPERTENSION, V61, P964, DOI 10.1161/HYPERTENSIONAHA.111.00289; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Asayama K, 2014, PLOS MED, V11, P1; Banegas JR, 2014, EUR HEART J, V35, P3304, DOI 10.1093/eurheartj/ehu016; Banegas JR, 2009, AM J MED, V122, P1136, DOI 10.1016/j.amjmed.2009.05.020; Brguljan-Hitij J, 2014, AM J HYPERTENS, V27, P956, DOI 10.1093/ajh/hpu002; del la Sierra A, 2012, J HYPERTENS, V39, P713; Del la Sierra A, 2013, AM J HYPERTENS, V27, P680; Hanninen MR, 2014, J HUM HYPERTENS, V28, P1; Hodgkinson J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3621; Kikuya M, 2007, CIRCULATION, V115, P2125; Myers MG, 2011, BMJ-BRIT MED J, V342, P286; Oe Y, 2013, AM J HYPERTENS, V26, P808, DOI 10.1093/ajh/hpt021; Ohira T, 2009, HYPERTENSION, V53, P13, DOI 10.1161/HYPERTENSIONAHA.108.114835; Parati G, 2000, HYPERTENSION, V35, P614; Schmieder RE, 2014, HYPERTENSION, V64, P1067, DOI 10.1161/HYPERTENSIONAHA.113.03140; Seki M, 2010, J HYPERTENS, V28, P1814, DOI 10.1097/HJH.0b013e32833a3911; Staessen JA, 2008, BLOOD PRESS MONIT, V13, P352, DOI 10.1097/MBP.0b013e3283108f93; Tabara Y, 2014, J HYPERTENS, V32, P1084, DOI 10.1097/HJH.0000000000000150; Trudel X., 2013, INT J HYPERTENS, V2013, DOI DOI 10.1155/2013/836387	44	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JAN	2015	65	1					16	20		10.1161/HYPERTENSIONAHA.114.04522		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW4KA	WOS:000346248800004		
J	Hara, A; Thijs, L; Asayama, K; Gu, YM; Jacobs, L; Zhang, ZY; Liu, YP; Nawrot, TS; Staessen, JA				Hara, Azusa; Thijs, Lutgarde; Asayama, Kei; Gu, Yu-Mei; Jacobs, Lotte; Zhang, Zhen-Yu; Liu, Yan-Ping; Nawrot, Tim S.; Staessen, Jan A.			Blood Pressure in Relation to Environmental Lead Exposure in the National Health and Nutrition Examination Survey 2003 to 2010	HYPERTENSION			English	Article						blood pressure; environmental medicine; hypertension; lead; toxicology	CARDIOVASCULAR-DISEASE; NHANES 1999-2006; UNITED-STATES; BONE LEAD; HYPERTENSION; ASSOCIATION; ADULTS; MORTALITY; DECLINE; METALS	In view of the declining environmental lead exposure in the United States, we analyzed the National Health and Nutrition Examination Survey (2003-2010) for association of blood pressure and hypertension with blood lead. The 12 725 participants included 21.1% blacks, 20.5% Hispanics, 58.4% whites, and 48.7% women. Blacks compared with non-Blacks had higher systolic and diastolic pressures (126.5 versus 123.9 and 71.9 versus 69.6 mm Hg) and higher hypertension prevalence (44.7 versus 36.8%). Blood lead was lower in whites than in non-whites (1.46 versus 1.57 mu g/dL) and in women than in men (1.25 versus 1.80 mu g/dL). In multivariable analyses of all participants, blood lead doubling was associated with higher (P <= 0.0007) systolic and diastolic pressure (+0.76 mm Hg; 95% confidence interval, 0.38-1.13 and +0.43 mm Hg; 0.18-0.68), but not with the odds of hypertension (0.95; 0.90-1.01; P=0.11). Associations with blood lead were nonsignificant (P >= 0.09) for systolic pressure in women and for diastolic pressure in non-whites. Among men, systolic pressure increased with blood lead (P <= 0.060) with effect sizes associated with blood lead doubling ranging from +0.65 mm Hg in whites to +1.61 mm Hg in blacks. For systolic pressure, interactions of ethnicity and sex with blood lead were all significant (P <= 0.019). In conclusion, small and inconsistent effect sizes in the associations of blood pressure with blood lead likely exclude current environmental lead exposure as a major hypertension cause in the United States.	[Hara, Azusa; Thijs, Lutgarde; Gu, Yu-Mei; Jacobs, Lotte; Zhang, Zhen-Yu; Liu, Yan-Ping; Staessen, Jan A.] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, BE-3000 Leuven, Belgium; [Asayama, Kei] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Nawrot, Tim S.] Univ Hasselt, Ctr Environm Sci, Hasselt, Belgium; [Staessen, Jan A.] Maastricht Univ, Res Dev Grp VitaK, Maastricht, Netherlands	Staessen, JA (reprint author), Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Campus Sint Rafael,Kapucijnenvoer 35,Box 7001, BE-3000 Leuven, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan/A-1065-2011	Staessen, Jan/0000-0002-3026-1637	Japan Society for the Promotion of Science; European Union [FP7-HEALTH-2007-A-201550, IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093-InGenious HyperCare, HEALTH-2007-2.1.1-2-HyperGenes, HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE]; HYPERGENES; InterOmics (MIUR-CNR Italian Flagship Project) [PB05]; European Union (European Research Council) [2011-294713-EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.0880.13]; International Lead and Zinc Organization (Durham, NC)	The Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad supported Dr. Hara's fellowship in Leuven. The European Union (grant FP7-HEALTH-2007-A-201550), HYPERGENES, and InterOmics (PB05 MIUR-CNR Italian Flagship Project) provided financial support for the genotyping studies. The European Union (grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093-InGenious HyperCare, HEALTH-2007-2.1.1-2-HyperGenes, HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE, and the European Research Council Advanced Researcher Grant-2011-294713-EPLORE) gave support to the Studies Coordinating Centre, Leuven, Belgium. The Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.0880.13) also supported the Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO) study. The International Lead and Zinc Organization (Durham, NC) provided a nonbinding grant to the Studies Coordinating Centre for a cohort study in lead exposed workers. The funding sources had no role in study design, data extraction, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data in the study and had the responsibility for the decision to submit for publication.	Den Hond E, 2002, J HUM HYPERTENS, V16, P563, DOI 10.1038/sj.jhh.1001452; Hu H, 2007, ENVIRON HEALTH PERSP, V115, P455, DOI 10.1289/ehp.9783; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091; Nawrot TS, 2002, J HUM HYPERTENS, V16, P123, DOI 10.1038/sj/jhh/1001300; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Glenn BS, 2006, EPIDEMIOLOGY, V17, P538, DOI 10.1097/01.ede.0000231284.19078.4b; Weisskopf MG, 2009, CIRCULATION, V120, P1056, DOI 10.1161/CIRCULATIONAHA.108.827121; Scinicariello F, 2011, ENVIRON RES, V111, P1249, DOI 10.1016/j.envres.2011.08.011; Jain NB, 2007, ENVIRON HEALTH PERSP, V115, P871, DOI 10.1289/ehp.9629; Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; Agarwal S, 2011, ANGIOLOGY, V62, P422, DOI 10.1177/0003319710395562; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Conway JM, 2004, J AM DIET ASSOC, V104, P595, DOI 10.1016/j.jada.2004.01.007; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; CDC (Centers for Disease Control and Prevention), 4 CDCP; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; GARTSIDE PS, 1988, ENVIRON HEALTH PERSP, V78, P31, DOI 10.2307/3430495; Hu H, 1996, JAMA-J AM MED ASSOC, V275, P1171, DOI 10.1001/jama.275.15.1171; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Staessen JA, 1996, JAMA-J AM MED ASSOC, V275, P1563, DOI 10.1001/jama.275.20.1563; Taylor JK, 1987, QUALITY ASSURANCE CH; The National Center for Health Statistics, 2007, SURV OP MAN 2007 200; The National Center for Health Statistics, 2005, SURV OP MAN 2005 200; The National Center for Health Statistics, 2009, SURV OP MAN 2009 201; The National Center for Health Statistics, 2003, SURV OP MAN 2003 200; Vupputuri S, 2003, HYPERTENSION, V41, P463, DOI 10.1161/01.HYP.0000055015.39788.29	32	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JAN	2015	65	1					62	+		10.1161/HYPERTENSIONAHA.114.04023		27	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW4KA	WOS:000346248800017		
J	Theuerkauf, J; Haneda, T; Sato, NJ; Ueda, K; Kuehn, R; Gula, R; Watanabe, I				Theuerkauf, Joern; Haneda, Tokushi; Sato, Nozomu J.; Ueda, Keisuke; Kuehn, Ralph; Gula, Roman; Watanabe, Izumi			Naturally high heavy metal concentrations in feathers of the flightless Kagu Rhynochetos jubatus	IBIS			English	Article						bird feather; serpentine soil; toxic thresholds; ultramafic rock	ULTRAMAFIC SOILS; NEW-CALEDONIA; CHROMIUM; NICKEL; RATS	We assessed heavy metal concentrations in feathers of 38 Kagus Rhynochetos jubatus living on ultramafic soils in New Caledonia. Concentrations of heavy metals in down feathers were similar to concentrations in shafts of primary or secondary feathers, whereas the concentrations in vanes were much higher, indicating that concentrations in down feathers were not due to external contamination but rather to ingestion. Although there was no anthropogenic pollution in our study area, concentrations of iron (Fe), zinc (Zn), manganese (Mn), chromium (Cr), selenium (Se), strontium (Sr) and cobalt (Co) in feathers were 1.2-21 times higher in Kagu than the average in other bird species studied, the majority of those from polluted environments. Kagus may have specific adaptations that enable them to live in environments with naturally high heavy metal concentrations.	[Theuerkauf, Joern; Sato, Nozomu J.; Gula, Roman] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Haneda, Tokushi; Sato, Nozomu J.; Ueda, Keisuke] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; [Kuehn, Ralph] New Mexico State Univ, Dept Fish, Wildlife & Conservat Ecol & Mol Biol Program, Las Cruces, NM 88003 USA; [Kuehn, Ralph] Tech Univ Munich, Dept Anim Sci, Unit Mol Zool, Chair Zool, D-85354 Freising Weihenstephan, Germany; [Watanabe, Izumi] Tokyo Univ Agr & Technol, Lab Environm Toxicol, Fuchu, Tokyo 1838509, Japan	Theuerkauf, J (reprint author), Polish Acad Sci, Museum & Inst Zool, Wilcza 64, PL-00679 Warsaw, Poland.	jtheuer@miiz.eu	Theuerkauf, Jorn/B-6823-2009; Gula, Roman/C-9269-2009; Watanabe, Izumi/C-2086-2013	Theuerkauf, Jorn/0000-0002-7273-3073; Watanabe, Izumi/0000-0003-2319-9713	Polish National Science Centre [NCN 2011/01/M/NZ8/03344]	This study was financed by the Polish National Science Centre (grant NCN 2011/01/M/NZ8/03344). The Province Sud (New Caledonia) issued all permits for this study. We thank H. Bloc, N. Emura, P. Guichard, Y. Okahisa and N. Petit for help during field work.	Dauwe T, 2003, ENVIRON POLLUT, V124, P429, DOI 10.1016/S0269-7491(03)00044-7; Burger J, 2000, SCI TOTAL ENVIRON, V257, P37, DOI 10.1016/S0048-9697(00)00496-4; Dai J, 2004, SOIL BIOL BIOCHEM, V36, P91, DOI 10.1016/j.soilbio.2003.09.001; Becquer T, 2003, SCI TOTAL ENVIRON, V301, P251, DOI 10.1016/S0048-9697(02)00298-X; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; LAUWERYS R, 1985, AM J IND MED, V7, P171, DOI 10.1002/ajim.4700070208; Amir H, 2007, PLANT SOIL, V293, P23, DOI 10.1007/s11104-007-9238-0; Gula R, 2010, EUR J WILDLIFE RES, V56, P803, DOI 10.1007/s10344-010-0392-y; ASHER C J, 1991, P703; Burger J, 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; FIGONI RA, 1975, RES COMMUN CHEM PATH, V11, P335; GOEDE AA, 1984, ENVIRON POLLUT B, V8, P281, DOI 10.1016/0143-148X(84)90028-4; GRAHAM JA, 1978, ENVIRON RES, V16, P77, DOI 10.1016/0013-9351(78)90144-5; Heinz Gary H., 1996, P447; Jaffre T., 1976, SCIENCE, V193, P573, DOI DOI 10.1126/SCIENCE.193.4253.579; Jaffré T., 1991, Bulletin du Museum National d'Histoire Naturelle. Section B, Adansonia, V12, P243; Proctor J., 1975, ADV ECOL RES, V9, P256; Shahmansouri M. R., 2005, Iranian Journal of Environmental Health Science & Engineering, V2, P28; Stoeckle BC, 2012, J ORNITHOL, V153, P249, DOI 10.1007/s10336-011-0736-8; Theuerkauf J, 2009, AUK, V126, P371, DOI 10.1525/auk.2009.08092; TREINEN KA, 1995, TERATOLOGY, V52, P109, DOI 10.1002/tera.1420520207; Wang Zhen-Zhong, 1998, Journal of Environmental Sciences (China), V10, P437; Zeisler R, 2008, J RADIOANAL NUCL CH, V278, P783, DOI 10.1007/s10967-008-1701-8	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-1019	1474-919X		IBIS	Ibis	JAN	2015	157	1					177	180		10.1111/ibi.12216		4	Ornithology	Zoology	AW5YU	WOS:000346347700018		
J	Yu, S; Guo, S; Stojmenovic, I				Yu, Shui; Guo, Song; Stojmenovic, Ivan			Fool Me If You Can: Mimicking Attacks and Anti-Attacks in Cyberspace	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Mimicking; flash crowd attack; detection; second order metrics	BROWSING BEHAVIOR; SERVICE ATTACKS; DDOS ATTACKS; MARKOV MODEL; WEB; DISTRIBUTIONS; USERS	Botnets have become major engines for malicious activities in cyberspace nowadays. To sustain their botnets and disguise their malicious actions, botnet owners are mimicking legitimate cyber behavior to fly under the radar. This poses a critical challenge in anomaly detection. In this paper, we use web browsing on popular web sites as an example to tackle this problem. First of all, we establish a semi-Markov model for browsing behavior. Based on this model, we find that it is impossible to detect mimicking attacks based on statistics if the number of active bots of the attacking botnet is sufficiently large (no less than the number of active legitimate users). However, we also find it is hard for botnet owners to satisfy the condition to carry out a mimicking attack most of the time. With this new finding, we conclude that mimicking attacks can be discriminated from genuine flash crowds using second order statistical metrics. We define a new fine correntropy metrics and show its effectiveness compared to others. Our real world data set experiments and simulations confirm our theoretical claims. Furthermore, the findings can be widely applied to similar situations in other research fields.	[Yu, Shui; Stojmenovic, Ivan] Deakin Univ, Sch Informat Technol, Burwood, Vic 3125, Australia; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima 9658580, Japan; [Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Stojmenovic, Ivan] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON K1N N5, Canada	Yu, S (reprint author), Deakin Univ, Sch Informat Technol, Burwood, Vic 3125, Australia.	syu@deakin.edu.au; sguo@u-aizu.ac.jp; ivan@site.uottawa.ca			National Natural Science Foundation of China [61379041]; NSERC Canada Discovery grant [41801-2010]; KAU Distinguished Scientists Program	Dr. Yu's work is partially supported by the National Natural Science Foundation of China (Grant no. 61379041), Prof. Stojmenovic's work is partially supported by NSERC Canada Discovery grant (Grant No. 41801-2010), and KAU Distinguished Scientists Program.	Hefeeda M, 2008, IEEE ACM T NETWORK, V16, P1447, DOI 10.1109/TNET.2008.918081; Breslau L, 1999, IEEE INFOCOM SER, P126, DOI 10.1109/INFCOM.1999.749260; Thing VLL, 2007, INT FED INFO PROC, V232, P229; Wang HN, 2007, IEEE ACM T NETWORK, V15, P40, DOI 10.1109/TNET.2006.890133; Yu S, 2011, IEEE T PARALL DISTR, V22, P412, DOI 10.1109/TPDS.2010.97; Reed WJ, 2004, COMMUN STAT-THEOR M, V33, P1733, DOI 10.1081/STA-120037438; Carl G, 2006, IEEE INTERNET COMPUT, V10, P82, DOI 10.1109/MIC.2006.5; Scherrer A, 2007, IEEE T DEPEND SECURE, V4, P56, DOI 10.1109/TDSC.2007.12; Chen Y, 2006, J PARALLEL DISTR COM, V66, P1137, DOI 10.1016/j.jpdc.2006.04.007; Xie Y, 2009, IEEE ACM T NETWORK, V17, P54, DOI 10.1109/TNET.2008.923716; Crovella ME, 1997, IEEE ACM T NETWORK, V5, P835, DOI 10.1109/90.650143; Wang P, 2010, IEEE T DEPEND SECURE, V7, P113, DOI 10.1109/TDSC.2008.35; Xiang Y, 2009, IEEE T PARALL DISTR, V20, P567, DOI 10.1109/TPDS.2008.132; Li ZC, 2011, IEEE T INF FOREN SEC, V6, P175, DOI 10.1109/TIFS.2010.2086445; Kim Y, 2006, IEEE T DEPEND SECURE, V3, P141; Awad MA, 2012, IEEE T SYST MAN CY B, V42, P1131, DOI 10.1109/TSMCB.2012.2187441; Bailey M., 2009, P CYB APPL TECHN C H; Borgnat P, 2009, IEEE INFOCOM SER, P711, DOI 10.1109/INFCOM.2009.5061979; Burklen S, 2005, PROC ANNU SIMUL SYMP, P149, DOI 10.1109/ANSS.2005.44; Cho C. Y., 2010, P USENIX WORKSH LARG; Dagon D., 2006, P 13 NETW DISTR SYST; Duan ZH, 2008, IEEE T DEPEND SECURE, V5, P22, DOI 10.1109/TDSC.2007.70224; Edman M., 2009, ACM COMPUT SURV, V42; El-Atawy A., 2009, P IEEE C COMP COMM I; Fomenkov M., 2004, P INT S INF COMM TEC; He R, 2011, IEEE T PATTERN ANAL, V33, P1561, DOI 10.1109/TPAMI.2010.220; Huberman B., 1998, SCIENCE, V280; Ianelli N., 2006, P 18 ANN 1 C; Jiang N., 2010, P IEEE INT C NETW PR, P144; Jung J, 2002, P INT WORLD WID WEB, P252; Kandula S., 2005, P S NETW SYST DES IM; Klemm A., 2004, P 4 ACM SIGCOMM C IN, P55, DOI 10.1145/1028788.1028796; Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065; Mitzenmacher M., 2004, INTERNET MATH, V1; NLANR, PASS MEAS AN PMA PRO; Oikonomou G., 2009, P IEEE C COMP COMM; Peng T., 2007, ACM COMPUT SURV, V39; Rajab M. A., 2007, P 1 C WORKSH HOT TOP; Shue CA, 2012, IEEE ACM T NETWORK, V20, P220, DOI 10.1109/TNET.2011.2157699; Silagadze Z., 1997, COMPLEX SYSTEMS, V11, P487; Stone-Gross B., 2009, P ACM C COMP COMM SE; Yadav S., 2010, P 10 ANN C INT MEAS, P48, DOI 10.1145/1879141.1879148; Yu S., 2013, P IEEE GLOB TEL C G; Yu S, 2010, 2010 IEEE INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATIONS, NETWORKING AND INFORMATION SECURITY (WCNIS), VOL 1, P658; Yu S., 2012, P IEEE C COMP COMM I, P3133; Yu S, 2008, IEEE COMMUN LETT, V12, P319, DOI 10.1109/LCOMM.2008.072049; Yu S., 2011, P IEEE C COMP COMM I; Zhou Chenfeng Vincent, 2009, Journal of Networks, V4	48	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JAN	2015	64	1					139	151		10.1109/TC.2013.191		13	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AW9JB	WOS:000346572100013		
J	Muramatsu, D; Shiraishi, A; Makihara, Y; Uddin, MZ; Yagi, Y				Muramatsu, Daigo; Shiraishi, Akira; Makihara, Yasushi; Uddin, Md. Zasim; Yagi, Yasushi			Gait-Based Person Recognition Using Arbitrary View Transformation Model	IEEE TRANSACTIONS ON IMAGE PROCESSING			English	Article						Gait recognition	MULTIPLE VIEWS; IDENTIFICATION; PERFORMANCE; WEIGHT; IMAGE	Gait recognition is a useful biometric trait for person authentication because it is usable even with low image resolution. One challenge is robustness to a view change (cross-view matching); view transformation models (VTMs) have been proposed to solve this. The VTMs work well if the target views are the same as their discrete training views. However, the gait traits are observed from an arbitrary view in a real situation. Thus, the target views may not coincide with discrete training views, resulting in recognition accuracy degradation. We propose an arbitrary VTM (AVTM) that accurately matches a pair of gait traits from an arbitrary view. To realize an AVTM, we first construct 3D gait volume sequences of training subjects, disjoint from the test subjects in the target scene. We then generate 2D gait silhouette sequences of the training subjects by projecting the 3D gait volume sequences onto the same views as the target views, and train the AVTM with gait features extracted from the 2D sequences. In addition, we extend our AVTM by incorporating a part-dependent view selection scheme (AVTM_PdVS), which divides the gait feature into several parts, and sets part-dependent destination views for transformation. Because appropriate destination views may differ for different body parts, the part-dependent destination view selection can suppress transformation errors, leading to increased recognition accuracy. Experiments using data sets collected in different settings show that the AVTM improves the accuracy of cross-view matching and that the AVTM_PdVS further improves the accuracy in many cases, in particular, verification scenarios.	[Muramatsu, Daigo; Shiraishi, Akira; Makihara, Yasushi; Uddin, Md. Zasim; Yagi, Yasushi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Muramatsu, D (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	muramatsu@am.sanken.osaka-u.ac.jp; shiraishi@am.sanken.osaka-u.ac.jp; makihara@am.sanken.osaka-u.ac.jp; zasim@am.sanken.osaka-u.ac.jp; yagi@am.sanken.osaka-u.ac.jp			Japan Society for the Promotion of Science [21220003]; Ministry of Education, Culture, Sports, Science and Technology; Japanese Government	This work was supported in part by the Grant-in-Aid for Scientific Research (S) through the Japan Society for the Promotion of Science under Grant 21220003, in part by the Research and Development Program for Implementation of AntiCrime and AntiTerrorism Technologies for a Safe and Secure Society, in part by the Funds for Integrated Promotion of Social System Reform and Research and Development through the Ministry of Education, Culture, Sports, Science and Technology, in part by the Japanese Government, and in part by the Japan Science and Technology Agency CREST Project entitled Behavior Understanding Based on Intention-Gait Model. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Xilin Chen.	Han J, 2006, IEEE T PATTERN ANAL, V28, P316, DOI 10.1109/TPAMI.2006.38; Bobick AF, 2001, PROC CVPR IEEE, P423; Liu NN, 2011, IEEE SIGNAL PROC LET, V18, P431, DOI 10.1109/LSP.2011.2157143; Hossain MA, 2010, PATTERN RECOGN, V43, P2281, DOI 10.1016/j.patcog.2009.12.020; Jean F, 2009, IMAGE VISION COMPUT, V27, P1272, DOI 10.1016/j.imavis.2008.11.009; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Chapelle O, 2010, INFORM RETRIEVAL, V13, P201, DOI 10.1007/s10791-009-9109-9; Lam THW, 2011, PATTERN RECOGN, V44, P973, DOI 10.1016/j.patcog.2010.10.011; Iwama H, 2012, IEEE T INF FOREN SEC, V7, P1511, DOI 10.1109/TIFS.2012.2204253; Yam CY, 2004, PATTERN RECOGN, V37, P1057, DOI 10.1016/j.patcog.2003.09.012; Lu JW, 2010, PATTERN RECOGN LETT, V31, P382, DOI 10.1016/j.patrec.2009.11.006; Kusakunniran W, 2010, PROC CVPR IEEE, P974, DOI 10.1109/CVPR.2010.5540113; Sarkar S, 2005, IEEE T PATTERN ANAL, V27, P162, DOI 10.1109/TPAMI.2005.39; Kusakunniran W, 2012, IEEE T CIRC SYST VID, V22, P966, DOI 10.1109/TCSVT.2012.2186744; Bodor R, 2009, IMAGE VISION COMPUT, V27, P1194, DOI 10.1016/j.imavis.2008.11.008; Ariyanto G, 2012, P INT C BIOM ICB, P354; Goffredo M, 2010, IEEE T SYST MAN CY B, V40, P997, DOI 10.1109/TSMCB.2009.2031091; Fierrez-Aguilar J, 2005, IEEE T SYST MAN CY C, V35, P418, DOI 10.1109/TSMCC.2005.848181; Han J., 2005, P IEEE INT C IM PROC, V3; Iwashita Yumi, 2010, Proceedings of the 2010 International Conference on Emerging Security Technologies (EST 2010), DOI 10.1109/EST.2010.19; Jain Anil K., 2008, HDB BIOMETRICS; Kale A., 2003, Proceedings IEEE Conference on Advanced Video and Signal Based Surveillance. AVSS 2003, DOI 10.1109/AVSS.2003.1217914; Kusakunniran W., 2009, P IEEE INT C COMP VI, P1058; Kusakunniran Worapan, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), DOI 10.1109/ICPR.2010.535; Lee L., 2002, THESIS MIT CAMBRIDGE; Makihara Y, 2006, LECT NOTES COMPUT SC, V3953, P151; Makihara Y., 2008, PATT REC 2008 ICPR 2, P1; Makihara Y., 2010, P 23 IEEE C COMP VIS, P717; MARTIN WN, 1983, IEEE T PATTERN ANAL, V5, P150; Martin-Felez R, 2012, LECT NOTES COMPUT SC, V7572, P328, DOI 10.1007/978-3-642-33718-5_24; Muramatsu D., 2014, P 20 KOR JAP WORKSH, P222; Muramatsu D., 2012, P 2012 IEEE 5 INT C, P85; Nixon MS, 2005, INT SERIES BIOMETRIC; Sagawa R., 2005, P IEEE RSJ INT C INT, P832; Shakhnarovich G, 2001, PROC CVPR IEEE, P439; Urtasun R., 2004, Proceedings. Sixth IEEE International Conference on Automatic Face and Gesture Recognition; Utsumi A., 2004, P 6 AS C COMP VIS, V2, P794; Yang HD, 2006, LECT NOTES COMPUT SC, V3832, P619	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7149	1941-0042		IEEE T IMAGE PROCESS	IEEE Trans. Image Process.	JAN	2015	24	1					140	154		10.1109/TIP.2014.2371335		15	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	AW9RS	WOS:000346595500001		
J	Yu, S; Gu, GF; Barnawi, A; Guo, S; Stojmenovic, I				Yu, Shui; Gu, Guofei; Barnawi, Ahmed; Guo, Song; Stojmenovic, Ivan			Malware Propagation in Large-Scale Networks	IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING			English	Article						Malware; propagation; modelling; power law	WORMS; CONTAINMENT	Malware is pervasive in networks, and poses a critical threat to network security. However, we have very limited understanding of malware behavior in networks to date. In this paper, we investigate how malware propagates in networks from a global perspective. We formulate the problem, and establish a rigorous two layer epidemic model for malware propagation from network to network. Based on the proposed model, our analysis indicates that the distribution of a given malware follows exponential distribution, power law distribution with a short exponential tail, and power law distribution at its early, late and final stages, respectively. Extensive experiments have been performed through two real-world global scale malware data sets, and the results confirm our theoretical findings.	[Yu, Shui; Stojmenovic, Ivan] Deakin Univ, Sch Informat Technol, Burwood, Vic 3125, Australia; [Gu, Guofei] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Barnawi, Ahmed] King Abdulaziz Univ, Fac Comp & IT, Jeddah 21413, Saudi Arabia; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan; [Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Stojmenovic, Ivan] Univ Ottawa, Sch EECS, Ottawa, ON K1N 6N5, Canada	Yu, S (reprint author), Deakin Univ, Sch Informat Technol, Burwood, Vic 3125, Australia.	syu@deakin.edu.au; guofei@cse.tamu.edu; ambarnawi@kau.edu.sa; sguo@u-aizu.ac.jp; ivan@site.uottawa.ca			National Natural Science Foundation of China [61379041]; NSERC Canada [41801-2010]; KAU Distinguished Scientists Program	Dr Yu's work is partially supported by the National Natural Science Foundation of China (grant No. 61379041), Prof. Stojmenovic's work is partially supported by NSERC Canada Discovery grant (grant No. 41801-2010), and KAU Distinguished Scientists Program.	Gao C, 2013, IEEE T MOBILE COMPUT, V12, P529, DOI 10.1109/TMC.2012.29; Zou CC, 2005, IEEE ACM T NETWORK, V13, P961, DOI 10.1109/TNET.2005.857113; Ganesh A, 2005, IEEE INFOCOM SER, P1455; Stone-Gross B, 2009, CCS'09: PROCEEDINGS OF THE 16TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P635; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Zhou YJ, 2012, P IEEE S SECUR PRIV, P95, DOI 10.1109/SP.2012.16; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Omic J, 2009, IEEE INFOCOM SER, P1485, DOI 10.1109/INFCOM.2009.5062065; Sellke SH, 2008, IEEE T DEPEND SECURE, V5, P71, DOI 10.1109/TDSC.2007.70230; Chen ZS, 2009, IEEE T INF FOREN SEC, V4, P530, DOI 10.1109/TIFS.2009.2025847; Dagon D., 2006, P 13 NETW DISTR SYST; Daley D. J., 1999, EPIDEMIC MODELLING I; Dantu R, 2007, IEEE T DEPEND SECURE, V4, P119, DOI [10.1109/Tait2007.1002, 10.1109/TDSC.2007.1002]; De P, 2009, IEEE T MOBILE COMPUT, V8, P413, DOI 10.1109/TMC.2008.115; Jeffrey AM, 2003, IEEE T BIO-MED ENG, V50, P1213, DOI 10.1109/TBME.2003.818465; Kleinrock L, 1975, QUEUEING SYSTEMS; Mieghem P.V., 2009, IEEE ACM T NETWORK, V17, P1; Mitzenmacher M., 2004, INTERNET MATH, V1, P129; Newman M E J, 2010, NETWORKS INTRO; Peng SC, 2014, IEEE COMMUN SURV TUT, V16, P925, DOI 10.1109/SURV.2013.070813.00214; Rajab M., 2007, P 1 C 1 WORKSH HOT T, P5; Rajab M. A., 2006, P 6 ACM SIGCOMM C IN, P41; Shin S, 2012, IEEE T INF FOREN SEC, V7, P676, DOI 10.1109/TIFS.2011.2173486; Silagadze Z., 1997, COMPLEX SYSTEMS, V11, P487; Willinger W., 2009, NOT AM MATH SOC, V56, P586; Yan GH, 2009, IEEE T MOBILE COMPUT, V8, P353, DOI 10.1109/TMC.2008.129	26	2	2	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1041-4347	1558-2191		IEEE T KNOWL DATA EN	IEEE Trans. Knowl. Data Eng.	JAN	2015	27	1					170	179		10.1109/TKDE.2014.2320725		10	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AW3EF	WOS:000346167800014		
J	Kasamatsu, J; Takahashi, S; Azuma, M; Matsumoto, M; Morii-Sakai, A; Imamura, M; Teshima, T; Takahashi, A; Hirohashi, Y; Torigoe, T; Sato, N; Seya, T				Kasamatsu, Jun; Takahashi, Shojiro; Azuma, Masahiro; Matsumoto, Misako; Morii-Sakai, Akiko; Imamura, Masahiro; Teshima, Takanori; Takahashi, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Sato, Noriyuki; Seya, Tsukasa			PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+T cell response to autologous survivin in HLA-A*2402 transgenic mice	IMMUNOBIOLOGY			English	Article						Survivin; PolyI:C; CD4 epitope; Peptide vaccine; Th1 response; Interferon-gamma; Tumor immunity	CD4(+) T-CELLS; SPLICE VARIANTS; DENDRITIC CELLS; APOPTOSIS PROTEIN; CANCER-PATIENTS; ACTIVATION; INHIBITOR; HELPER; VACCINE; IFN	CD4(+) T cell effectors are crucial for establishing antitumor immunity. Dendritic cell maturation by immune adjuvants appears to facilitate subset-specific CD4(+) T cell proliferation, but the adjuvant effect for CD4 T on induction of cytotoxic T lymphocytes (CTLs) is largely unknown. Self-antigenic determinants with low avidity are usually CD4 epitopes in mutated proteins with tumor-associated class I-antigens (TAAs). In this study, we made a chimeric version of survivin, a target of human CTLs. The chimeric survivin, where human survivin-2B containing a TAA was embedded in the mouse survivin frame (MmSVN2B), was used to immunize HLA-A-2402/K-b-transgenic (HLA24(b)-Tg) mice. Subcutaneous administration of MmSVN2B or xenogeneic human survivin (control HsSNV2B) to HLA24(b)-Tg mice failed to induce an immune response without co-administration of an RNA adjuvant polyI:C, which was required for effector induction in vivo. Although HLA-A-2402/K-b presented the survivin-2B peptide in C57BL/6 mice, 2B-specific tetramer assays showed that no CD8(+) T CTLs specific to survivin-2B proliferated above the detection limit in immunized mice, even with polyI:C treatment. However, the CD4(+) T cell response, as monitored by IFN-gamma, was significantly increased in mice given polyI:C+ MmSVN2B. The Th1 response and antibody production were enhanced in the mice with polyI:C. The CD4 epitope responsible for effector function was not Hs/MmSNV(13-27), a nonconserved region between human and mouse survivin, but region 53-67, which was identical between human and mouse survivin. These results suggest that activated, self-reactive CD4(+) helper T cells proliferate in MmSVN2B + polyI:C immunization and contribute to Thl polarization followed by antibody production, but hardly participate in CTL induction. (C) 2014 Elsevier GmbH. All rights reserved.	[Kasamatsu, Jun; Takahashi, Shojiro; Azuma, Masahiro; Matsumoto, Misako; Morii-Sakai, Akiko; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Shojiro; Imamura, Masahiro; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan	Seya, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp			Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; MEXT; National Cancer Center Research and Development Fund [23-A-44]; Takeda Science Foundation; Yasuda Cancer Research Foundation; Ono Foundation	We are grateful to members in our laboratories. JK is a Research Fellow of the Japan Society for the Promotion of Science. This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture and the Ministry of Health, Labor, and Welfare of Japan, and by a MEXT Grant-in-Project 'the Carcinogenic Spiral', 'the National Cancer Center Research and Development Fund (23-A-44)'. Financial support by the Takeda Science Foundation, the Yasuda Cancer Research Foundation and the Ono Foundation are gratefully acknowledged.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Mahotka C, 2002, CELL DEATH DIFFER, V9, P1334, DOI 10.1038/sj.cdd.4401091; Danke NA, 2004, J IMMUNOL, V172, P5967; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Gebe JA, 2003, EUR J IMMUNOL, V33, P1409, DOI 10.1002/eji.200323871; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Idenoue S, 2005, CLIN CANCER RES, V11, P1474, DOI 10.1158/1078-0432.CCR-03-0817; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Charalambous A, 2006, J IMMUNOL, V177, P8410; Kameshima H, 2013, CANCER SCI, V104, P124, DOI 10.1111/cas.12046; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Schmitz M, 2000, CANCER RES, V60, P4845; Azuma M, 2012, ONCOIMMUNOLOGY, V1, P581; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Mahotka C, 1999, CANCER RES, V59, P6097; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Ciesielski MJ, 2008, CANCER IMMUNOL IMMUN, V57, P1827, DOI 10.1007/s00262-008-0510-9; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Andersen MH, 2001, CANCER RES, V61, P869; AZUMA M, 2013, P JPN CANC ASS, V72, P126; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Casares N, 2001, EUR J IMMUNOL, V31, P1780, DOI 10.1002/1521-4141(200106)31:6<1780::AID-IMMU1780>3.0.CO;2-I; Chua BY, 2014, IMMUNOL CELL BIOL, V92, P377, DOI 10.1038/icb.2013.102; Gotoh M, 2002, INT J CANCER, V100, P565, DOI 10.1002/ijc.10509; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; Honma I, 2009, CANCER IMMUNOL IMMUN, V58, P1803, DOI 10.1007/s00262-009-0691-x; Lee MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074698; Li F, 2005, BRIT J CANCER, V92, P212, DOI 10.1038/sj.bjc.6602340; Nishiguchi M, 2001, J IMMUNOL, V166, P2610; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Sawahata R, 2011, MICROBES INFECT, V13, P350, DOI 10.1016/j.micinf.2010.12.003; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Seya T, 2013, EXPERT OPIN THER TAR, V17, P533, DOI 10.1517/14728222.2013.765407; Topalian SL, 1996, J EXP MED, V183, P1965, DOI 10.1084/jem.183.5.1965; Tsuruma T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-24; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833	48	0	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	JAN	2015	220	1					74	82		10.1016/j.imbio.2014.08.017		9	Immunology	Immunology	AW6QK	WOS:000346393500011		
J	Odkhuu, E; Mendjargal, A; Koide, N; Naiki, Y; Komatsu, T; Yokochi, T				Odkhuu, Erdenezaya; Mendjargal, Adilsaikhan; Koide, Naoki; Naiki, Yoshikazu; Komatsu, Takayuki; Yokochi, Takashi			Lipopolysaccharide downregulates the expression of p53 through activation of MDM2 and enhances activation of nuclear factor-kappa B	IMMUNOBIOLOGY			English	Article						Lipopolysaccharide; MDM2; NF-kappa B; Nutlin-3; P53	TUMOR-SUPPRESSOR P53; UBIQUITINATION; CELLS; PHOSPHORYLATION; DEGRADATION; GENE; INFLAMMATION; PROMOTES; PATHWAY	The effect of lipopolysaccharide (LPS) on the expression of p53 protein in RAW 264.7 macrophage cells was examined. LPS downregulated the expression of p53 protein 4-24 h after the stimulation. LPS-induced p53 inhibition was restored with pharmacological inhibitors of c-jun N-terminal kinase (JNK) and phosphatidylinositol 3-kinase (PI3K). It was also restored by inhibitors of MDM2 activation and proteasome. LPS-induced p53 inhibition corresponded to activation of MDM2. LPS-induced MDM2 activation was prevented by inhibitors of JNK and PI3K. The expression of p65 NF-kappa B at a late stage after LPS stimulation was downregulated in the presence of a MDM2 inhibitor. Nutlin-3 as a MDM2 inhibitor reduced LPS-induced production of nitric oxide but not tumor necrosis factor-alpha. Administration of LPS into mice downregulated the in vivo expression of p53 in the livers. Taken together, LPS was suggested to downregulate the expression of p53 via activation of MDM2 and enhance the activation of NF-kappa B at a late stage. (C) 2014 Elsevier GmbH. All rights reserved.	[Odkhuu, Erdenezaya; Koide, Naoki; Naiki, Yoshikazu; Komatsu, Takayuki; Yokochi, Takashi] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Odkhuu, Erdenezaya] Mongolian Natl Univ Med Sci, Dept Anat, Ulaanbaatar 210648, Mongol Peo Rep; [Mendjargal, Adilsaikhan] Mongolian Natl Univ Med Sci, Ulaanbaatar 210648, Mongol Peo Rep	Odkhuu, E (reprint author), Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan.	zayamgl@aichi-med-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT); Strategic Research Foundation Grant-aided Project for Private Universities from MEXT [S1101027]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) and a grant of Strategic Research Foundation Grant-aided Project for Private Universities from MEXT, 2011-2015 (S1101027). We are grateful to K. Takahashi for the technical assistance.	Ak P., 2010, FASEB J, V24, p[53, 3643]; Moll UM, 2003, MOL CANCER RES, V1, P1001; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Mayo LD, 1997, CANCER RES, V57, P5013; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; FRITSCHE M, 1993, ONCOGENE, V8, P307; Menendez D, 2013, CURR OPIN ONCOL, V25, P85, DOI 10.1097/CCO.0b013e32835b6386; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Dijsselbloem N, 2007, J IMMUNOL, V178, P5048; Dregoesc D, 2007, DNA REPAIR, V6, P588, DOI 10.1016/j.dnarep.2006.11.008; Froh M., 2003, CURR PROTOC TOXICOL; Herce Henry D, 2013, Nat Commun, V4, P2660, DOI 10.1038/ncomms3660; Odkhuu E., 2014, INNATE IMMUN; Shao J, 2000, ONCOGENE, V19, P726, DOI 10.1038/sj.onc.1203383; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	32	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	JAN	2015	220	1					136	141		10.1016/j.imbio.2014.08.010		6	Immunology	Immunology	AW6QK	WOS:000346393500018		
J	Nakamura, M; Nakagawa, M; Watanabe, J				Nakamura, Morihiko; Nakagawa, Mai; Watanabe, Jun			Ubiquitin-like protein MNSF beta negatively regulates T Cell function and survival	IMMUNOLOGICAL INVESTIGATIONS			English	Article						Bcl-G; ERK; T cell; ubiquitin-like protein	NONSPECIFIC SUPPRESSOR FACTOR; RECEPTOR TYROSINE KINASE; UBIQUITYLATION; LYMPHOCYTES; ACTIVATION; MECHANISMS; PATHWAY; COMPLEX; JUNB	Monoclonal non-specific suppressor factor beta (MNSF beta) is a ubiquitously expressed member of the ubiquitin-like family that is involved in various biological functions. Previous studies have demonstrated that MNSFb covalently binds to intracellular pro-apoptotic protein Bcl-G and regulates apoptosis in macrophages. In this study, we demonstrate that MNSF beta negatively regulates T cell function. In murine T-helper type 2 clone, D10.G4.1 (D10) cells transfected with MNSF beta cDNA, CD3/CD28-induced ERK1/2 phosphorylation leading to IL-4 production was significantly inhibited. The formation of MNSF beta-Bcl-G complex was induced by the CD3/CD28 stimulation. Co-transfection with MNSF beta and Bcl-G greatly enhanced CD3/CD28-induced apoptosis in D10 cells. Similarly, co-over-expression of MNSF beta and Bcl-G caused a marked enhancement of apoptosis in purified splenic T cells. Interestingly, this MNSF beta adduct was also induced in T cells derived from DO11.10 mice stimulated with antigen. Collectively, CD3/CD28-inducible MNSF beta-Bcl-G complex may be involved in the regulation of T cell function and survival.	[Nakamura, Morihiko; Nakagawa, Mai; Watanabe, Jun] Shimane Univ, Dept Cooperat Med Res, Ctr Collaborat, Izumo, Shimane 6938501, Japan	Nakamura, M (reprint author), Shimane Univ, Dept Cooperat Med Res, Ctr Collaborat, Izumo, Shimane 6938501, Japan.	nkmr0515@med.shimane-u.ac.jp					Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Stummvoll GH, 2008, J IMMUNOL, V181, P1908; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Egerton M, 1998, INT IMMUNOL, V10, P223, DOI 10.1093/intimm/10.2.223; Garaude J, 2008, J IMMUNOL, V180, P5983; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Marx J, 2005, SCIENCE, V307, P836, DOI 10.1126/science.307.5711.836; Watanabe J, 2013, FEBS J, V280, P1281, DOI 10.1111/febs.12120; NAKAMURA M, 1995, P NATL ACAD SCI USA, V92, P3463, DOI 10.1073/pnas.92.8.3463; NAKAMURA M, 1986, J IMMUNOL, V136, P2904; Nakamura M, 2006, J BIOL CHEM, V281, P16861, DOI 10.1074/jbc.M509907200; Nakamura M, 2009, FEBS J, V276, P6355, DOI 10.1111/j.1742-4658.2009.07348.x; NAKAMURA M, 1987, J IMMUNOL, V138, P1799; Nakamura M, 2003, EUR J BIOCHEM, V270, P4052, DOI 10.1046/j.1432-1033.2003.03790.x; Nakamura M, 1999, J BIOL CHEM, V274, P19026; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Shimosaki S, 2011, NAT PROD RES, V25, P374, DOI 10.1080/14786411003774320; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Solito S, 2011, IMMUNOL INVEST, V41, P722	26	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0882-0139	1532-4311		IMMUNOL INVEST	Immunol. Invest.		2015	44	1					1	12		10.3109/08820139.2014.909454		12	Immunology	Immunology	AW4WK	WOS:000346278100001		
J	Hayashi, H; Shiomi, Y				Hayashi, Hajimu; Shiomi, Yuki			Do children understand that people selectively conceal or express emotion?	INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT			English	Article						display rules; elementary school children; theory of mind	DISPLAY RULES; APPARENT EMOTION; 2ND-ORDER BELIEFS; DISTINCTION; REAL; ATTRIBUTION; BEHAVIOR; STATES; IRONY; LIES	This study examined whether children understand that people selectively conceal or express emotion depending upon the context. We prepared two contexts for a verbal display task for 70 first-graders, 80 third-graders, 64 fifth-graders, and 71 adults. In both contexts, protagonists had negative feelings because of the behavior of the other character. In the prosocial context, children were instructed that the protagonist wished to spare the other character's feelings. In contrast, in the real-emotion context, children were told that the protagonist was fed up with the other character's behavior. Participants were asked to imagine what the protagonists would say. Adults selected utterances with positive or neutral emotion in the prosocial context but chose utterances with negative emotion in the real-emotion context, whereas first-graders selected utterances with negative emotion in both contexts. In the prosocial context, the proportion of utterances with negative emotion decreased from first-graders to adults, whereas in the real-emotion context the proportion was U-shaped, decreasing from first- to third-graders and increasing from fifth-graders to adults. Further, performance on both contexts was associated with second-order false beliefs as well as second-order intention understanding. These results indicate that children begin to understand that people selectively conceal or express emotion depending upon context after 8 to 9 years. This ability is also related to second-order theory of mind.	[Hayashi, Hajimu] Kobe Univ, Kobe, Hyogo 6578501, Japan; [Shiomi, Yuki] Tatsuno Elementary Sch, Tatsuno, Japan	Hayashi, H (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	hajimu@port.kobe-u.ac.jp					Broomfield KA, 2002, BRIT J DEV PSYCHOL, V20, P47, DOI 10.1348/026151002166316; Talwar V, 2002, MERRILL PALMER QUART, V48, P160, DOI 10.1353/mpq.2002.0009; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257; Banerjee R, 1999, BRIT J DEV PSYCHOL, V17, P111, DOI 10.1348/026151099165186; JOSEPHS IE, 1994, J NONVERBAL BEHAV, V18, P301, DOI 10.1007/BF02172291; Filippova E, 2008, CHILD DEV, V79, P126, DOI 10.1111/j.1467-8624.2007.01115.x; Lewis M, 2010, INT J BEHAV DEV, V34, P53, DOI 10.1177/0165025409348559; HESS RD, 1980, INT J PSYCHOL, V15, P259, DOI 10.1080/00207598008246996; SAARNI C, 1979, DEV PSYCHOL, V15, P424, DOI 10.1037//0012-1649.15.4.424; HARRIS PL, 1986, CHILD DEV, V57, P895, DOI 10.1111/j.1467-8624.1986.tb00253.x; Zeman J, 1996, CHILD DEV, V67, P957, DOI 10.1111/j.1467-8624.1996.tb01776.x; GNEPP J, 1986, DEV PSYCHOL, V22, P103, DOI 10.1037/0012-1649.22.1.103; SULLIVAN K, 1994, DEV PSYCHOL, V30, P395, DOI 10.1037//0012-1649.30.3.395; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Bok S., 1978, LYING MORAL CHOICES; COLE PM, 1986, CHILD DEV, V57, P1309, DOI 10.1111/j.1467-8624.1986.tb00459.x; Ekman P., 1969, SEMIOTICA, V1, P49; GARDNER D, 1988, INT J BEHAV DEV, V11, P203; GROSS D, 1988, INT J BEHAV DEV, V11, P475; Harris P. L., 1988, DEV THEORIES MIND, P295; Hayashi H, 2007, JPN PSYCHOL RES, V49, P261, DOI 10.1111/j.1468-5884.2007.00352.x; Hendry Joy, 1986, BECOMING JAPANESE WO; JOSHI MS, 1994, CHILD DEV, V65, P1372, DOI 10.1111/j.1467-8624.1994.tb00822.x; LANGSTON CA, 1994, J PERS SOC PSYCHOL, V67, P1112, DOI 10.1037//0022-3514.67.6.1112; LEEKAM SR, 1994, J CHILD PSYCHOL PSYC, V35, P901, DOI 10.1111/j.1469-7610.1994.tb02301.x; Matsumoto D., 2006, HDB NONVERBAL COMMUN, P219; Matsumoto D., 2009, ENCY HUMAN RELATIONS, P432; Miller S. A., 2012, THEORY MIND PRESCHOO; Mizokawa A, 2011, BRIT J DEV PSYCHOL, V29, P489, DOI 10.1348/026151010X519964; Mizokawa A., 2008, JAPANESE J DEV PSYCH, V19, P209; Naito M, 2009, DEVELOPMENTAL SCI, V12, P150, DOI 10.1111/j.1467-7687.2008.00748.x; SUTTON RI, 1991, ADMIN SCI QUART, V36, P245, DOI 10.2307/2393355	32	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0165-0254	1464-0651		INT J BEHAV DEV	Int. J. Behav. Dev.	JAN	2015	39	1					1	8		10.1177/0165025414548777		8	Psychology, Developmental	Psychology	AW9LJ	WOS:000346578400001		
J	Silleto, MN; Yoon, SJ; Arakawa, K				Silleto, Matthew N.; Yoon, Sang-Jae; Arakawa, Kazuo			Piezoelectric cable macro-fiber composites for use in energy harvesting	INTERNATIONAL JOURNAL OF ENERGY RESEARCH			English	Article						piezoelectrics; piezoelectric cable; PVDF film; energy harvesting; electrical power generation	MODE	Piezoelectric cable is a commercial electronic sensor that incorporates the piezoelectric polymer polyvinylidene fluoride. This paper investigated a potential application of piezoelectric cable for energy harvesting. A method for testing the electrical output using the tensile load was developed and used to determine the output properties of the cable. A design for a piezoelectric cable fiber composite is presented, along with recommendations for potential applications and further research. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Silleto, Matthew N.] Royal Australian Mint, Engn Serv, Kingston, ACT 2604, Australia; [Yoon, Sang-Jae] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Arakawa, Kazuo] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Yoon, SJ (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga Koen 6-1, Kasuga, Fukuoka 8168580, Japan.	ar-s-yoon@mms.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Society for the Promotion of Science [23656605]	This work was partly supported by a research grant from the Japan Society for the Promotion of Science (#23656605).	Ottman GK, 2003, IEEE T POWER ELECTR, V18, P696, DOI 10.1109/TPEL.2003.809379; Turner J, 2008, INT J ENERG RES, V32, P379, DOI 10.1002/er.1372; KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975; SHIRANE G, 1951, PHYS REV, V84, P476, DOI 10.1103/PhysRev.84.476; Jeon YB, 2005, SENSOR ACTUAT A-PHYS, V122, P16, DOI 10.1016/j.sna.2004.12.032; Chalasanis S, 2008, SURVEY ENERGY HARVES, P442; Ckms T, 2014, INT J ENERG RES, DOI [10.1002/er.3149, DOI 10.1002/ER.3149]; Curie J, 1880, CR HEBD ACAD SCI, V91, P294; Foxs D, 1991, FERROELECTRICS, V115, P215; Keijis M, 2010, SENSOR ACTUAT A-PHYS, V163, P428; Kwon K, 2014, INT J ENERG RES, V38, P530, DOI 10.1002/er.3111; Ohs SJ, 2010, INT J ENERG RES, V34, P431; Ohya Y, 2010, ENERGIES, V3, P637; Oudenhoven JFM, 2012, INT J ENERG RES, V36, P1139, DOI 10.1002/er.2949; Rednams A., 2007, COMP COSTS CALIFORNI; Roundy S., 2003, ENERGY SCAVENGING WI, P51; Shencks NS., 1999, THESIS MIT CAMBRIDGE; Sodano H. A., 2004, Shock and Vibration Digest, V36, DOI 10.1177/0583102404043275	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-907X	1099-114X		INT J ENERG RES	Int. J. Energy Res.	JAN	2015	39	1					120	127		10.1002/er.3227		8	Energy & Fuels; Nuclear Science & Technology	Energy & Fuels; Nuclear Science & Technology	AW8FY	WOS:000346497700009		
J	Rodrigues, G; Oberije, C; Senan, S; Tsujino, K; Wiersma, T; Moreno-Jimenez, M; Kim, TH; Marks, LB; Rengan, R; De Petris, L; Ramella, S; DeRuyck, K; De Dios, NR; Warner, A; Bradley, JD; Palma, DA				Rodrigues, George; Oberije, Cary; Senan, Suresh; Tsujino, Kayoko; Wiersma, Terry; Moreno-Jimenez, Marta; Kim, Tae Hyun; Marks, Lawrence B.; Rengan, Ramesh; De Petris, Luigi; Ramella, Sara; DeRuyck, Kim; Rodriguez De Dios, Nuria; Warner, Andrew; Bradley, Jeffrey D.; Palma, David A.			Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer Beneficial? A Multi-Institutional Propensity Score Matched Analysis	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							3-DIMENSIONAL CONFORMAL RADIOTHERAPY; PATIENT DATA METAANALYSIS; CHEMORADIATION THERAPY; SMOKING STATUS; MONTE-CARLO; PHASE-III; SURVIVAL; CARCINOMA; TRIAL; PERFORMANCE	Purpose: The clinical benefits and risks of dose escalation (DE) for stage III non-small-cell lung cancer (NSCLC) remain uncertain despite the results from Radiation Therapy Oncology Group (RTOG) protocol 0617. There is significant heterogeneity of practice, with many clinicians prescribing intermediate dose levels between the 0617 study arms of 60 and 74 Gy. This study investigated whether this strategy is associated with any survival benefits/risks by analyzing a large multi-institutional database. Methods and Materials: An individual patient database of stage III NSCLC patients treated with radical intent concurrent chemoradiation therapy was created (13 institutions, n=1274 patients). Patients were divided into 2 groups based on tumor Biological Effective Dose at 10 Gy (BED 10): those receiving standard dose (SD; n=552), consisting of 72Gy <= BED 10 <= 76.8 Gy (eg 60-64 Gy/30-32 fractions [fr]), and those receiving intermediate dose (ID; n=497), consisting of 76.8Gy<BED 10<100.8 Gy (eg>64Gy/32 fr and <74 Gy/37 fr), with lower-dose patients (n=225) excluded from consideration. Patients were then matched using propensity scores, leading to 2 matched groups of 196 patients. Outcomes were compared using various statistics including interquartile range (IQR), Kaplan-Meier curves, and adjusted Cox regression analysis. Results: Matched groups were found to be balanced except for N stage (more N3 disease in SD), median treatment year (SD in 2003; ID in 2007), platinum and taxane chemotherapy (SD in 28%; ID in 39%), and median follow-up (SD were 89 months; ID were 40 months). Median dose fractionation was 60 Gy/30 fr in SD (BED 10 IQR: 72.0-75.5 Gy) and 66 Gy/33 fr (BED 10 IQR: 78.6-79.2 Gy) in ID. Survival curves for SD and ID matched cohorts were statistically similar (P=.27); however, a nonstatistically significant trend toward better survival for ID was observed after 15 months (median survival SD: 19.3 months; ID: 21.0 months). There was an increase in grades III to V lung toxicity associated with ID (13.0% vs 4.9%, respectively). Conclusions: No significant overall survival benefits were found with intermediate DE; however, more grade III or greater lung toxicity was observed. The separation of survival curves after 15 months of follow-up suggests that a small overall survival improvement associated with intermediate DE cannot be excluded. (C) 2015 Elsevier Inc.	[Rodrigues, George; Warner, Andrew; Palma, David A.] London Hlth Sci Ctr, London, ON, Canada; [Oberije, Cary; Wiersma, Terry] MAASTRO Clin, Maastricht, Netherlands; [Senan, Suresh] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Tsujino, Kayoko] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Moreno-Jimenez, Marta] Univ Navarra, E-31080 Pamplona, Spain; [Kim, Tae Hyun] Natl Canc Ctr, Goyang Si, Gyeonggi, South Korea; [Marks, Lawrence B.] Univ N Carolina, Chapel Hill, NC USA; [Rengan, Ramesh] Univ Washington, Seattle, WA 98195 USA; [De Petris, Luigi] Karolinska Univ Hosp, Stockholm, Sweden; [Ramella, Sara] Campus Biomed Univ, Rome, Italy; [DeRuyck, Kim] Univ Ghent, B-9000 Ghent, Belgium; [Rodriguez De Dios, Nuria] Univ Pompeu Fabra, Barcelona, Spain; [Bradley, Jeffrey D.] Washington Univ, Sch Med, St Louis, MO USA	Rodrigues, G (reprint author), A3-808 790 Commissioners Rd E, London, ON N6A 4L6, Canada.	george.rodrigues@lhsc.on.ca		Ramella, Sara/0000-0002-5782-7717	Ontario Institute for Cancer Research; National Institutes of Health [CA69579]; Lance Armstrong Foundation	This research was supported by a clinician-scientist grant from the Ontario Institute for Cancer Research (DAP). One database used by this investigation was supported by National Institutes of Health grant CA69579 (LBM) and a grant from the Lance Armstrong Foundation (LBM).	Bradley J, 2005, INT J RADIAT ONCOL, V61, P318, DOI 10.1016/j.ijrobp.2004.06.020; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Furuse K, 1999, J CLIN ONCOL, V17, P2692; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Ferketich AK, 2013, CANCER-AM CANCER SOC, V119, P847, DOI 10.1002/cncr.27824; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Palma DA, 2013, INT J RADIAT ONCOL, V87, P690, DOI 10.1016/j.ijrobp.2013.07.029; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Bradley JD, 2010, J CLIN ONCOL, V28, P2475, DOI 10.1200/JCO.2009.27.1205; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Dillman RO, 1996, J NATL CANCER I, V88, P1210, DOI 10.1093/jnci/88.17.1210; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Verstegen NE, 2013, ANN ONCOL, V24, P1543, DOI 10.1093/annonc/mdt026; Sura S, 2007, CANCER J, V13, P238, DOI 10.1097/PPO.0b013e31813ffd7b; van Baardwijk A, 2012, EUR J CANCER, V48, P2339, DOI 10.1016/j.ejca.2012.04.014; Bradley JD, 2010, INT J RADIAT ONCOL, V77, P367, DOI 10.1016/j.ijrobp.2009.04.029; Rosenzweig KE, 2005, CANCER, V103, P2118, DOI 10.1002/cncr.21007; Cox JD, 2012, INT J RADIAT ONCOL, V82, P1042, DOI 10.1016/j.ijrobp.2011.12.032; Bradley JD, 2013, J CLIN ONCOL S, V31; Rosenbaum RP, 1985, AM STAT, V39, P33; ROSWIT B, 1968, RADIOLOGY, V90, P688	26	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	JAN 1	2015	91	1					133	139		10.1016/j.ijrobp.2014.09.033		7	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	AW7AA	WOS:000346415500020		
J	Yagishita, S; Horinouchi, H; Taniyama, TK; Nakamichi, S; Kitazono, S; Mizugaki, H; Kanda, S; Fujiwara, Y; Nokihara, H; Yamamoto, N; Sumi, M; Shiraishi, K; Kohno, T; Furuta, K; Tsuta, K; Tamura, T				Yagishita, Shigehiro; Horinouchi, Hidehito; Taniyama, Tomoko Katsui; Nakamichi, Shinji; Kitazono, Satoru; Mizugaki, Hidenori; Kanda, Shintaro; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Sumi, Minako; Shiraishi, Kouya; Kohno, Takashi; Furuta, Koh; Tsuta, Koji; Tamura, Tomohide			Epidermal Growth Factor Receptor Mutation Is Associated With Longer Local Control After Definitive Chemoradiotherapy in Patients With Stage III Nonsquamous Non-Small-Cell Lung Cancer	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							CONCURRENT THORACIC RADIOTHERAPY; PHASE-III; DOCETAXEL CONSOLIDATION; CLINICAL-OUTCOMES; BRAIN METASTASES; ADVANCED NSCLC; GEFITINIB; EGFR; ADENOCARCINOMA; CHEMOTHERAPY	Purpose: To determine the frequency and clinical significance of epidermal growth factor receptor (EGFR) mutations in patients with potentially curable stage III non-small-cell lung cancer (NSCLC) who are eligible for definitive chemoradiotherapy (CRT). Patients and Methods: Between January 2001 and December 2010, we analyzed the EGFR mutational status in consecutive NSCLC patients who were treated by CRT. The response rate, relapse-free survival, 2-year relapse-free rate, initial relapse sites, and overall survival of the patients were investigated. Results: A total of 528 patients received CRT at our hospital during the study period. Of these, 274 were diagnosed as having nonsquamous NSCLC. Sufficient specimens for mutational analyses could be obtained from 198 of these patients. The proportion of patients with EGFR activating mutations was 17%. In addition to the well-known characteristics of patients carrying EGFR mutations (female, adenocarcinoma, and never/light smoker), the proportion of cases with smaller primary lesions (T1/2) was found to be higher in patients with EGFR mutations than in those with wild-type EGFR. Patients with EGFR mutations showed similar response rate, relapse-free survival, and 2-year relapse-free rates as compared to patients with wild-type EGFR. Local relapses as the site of initial relapse occurred significantly less frequently in patients with EGFR mutation (4% vs 21%; P=.045). Patients with EGFR mutations showed longer local control (adjusted hazard ratio 0.49; P=.043). After disease progression, a majority of the patients with EGFR mutations received EGFR tyrosine kinase inhibitors (62%), and these patients showed longer postprogression survival than those with wild-type EGFR. Conclusions: Our study is the first to show radiosensitive biology of EGFR-mutated tumors in definitive CRT with curative intent. This finding could serve as a credible baseline estimate of EGFR-mutated population in stage III nonsquamous NSCLC. (C) 2015 Elsevier Inc.	[Yagishita, Shigehiro; Horinouchi, Hidehito; Taniyama, Tomoko Katsui; Nakamichi, Shinji; Kitazono, Satoru; Mizugaki, Hidenori; Kanda, Shintaro; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Sumi, Minako] Natl Canc Ctr, Dept Radiat Oncol, Tokyo 1040045, Japan; [Furuta, Koh] Natl Canc Ctr, Dept Clin Labs, Tokyo 1040045, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan; [Shiraishi, Kouya; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan	Horinouchi, H (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	hhorinou@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-30, 24-A-1]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22131006]	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-30, 24-A-1) and by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas (22131006).	Sekine I, 2012, INT J RADIAT ONCOL, V82, P953, DOI 10.1016/j.ijrobp.2011.01.008; Ready N, 2010, J THORAC ONCOL, V5, P1382, DOI 10.1097/JTO.0b013e3181eba657; Mak RH, 2011, ONCOLOGIST, V16, P886, DOI 10.1634/theoncologist.2011-0040; Sekine I, 2006, J THORAC ONCOL, V1, P810, DOI 10.1097/01243894-200610000-00009; Govindan R, 2008, J THORAC ONCOL, V3, P917, DOI 10.1097/JTO.0b013e318180270b; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Horinouchi H, 2013, CANCER SCI, V104, P93, DOI 10.1111/cas.12028; Blackstock AW, 2007, J CLIN ONCOL, V25, P4146, DOI 10.1200/JCO.2007.12.6581; Yamamoto N, 2010, J CLIN ONCOL, V28, P3739, DOI 10.1200/JCO.2009.24.5050; Akamatsu H, 2014, AM J CLIN ONCOL-CANC, V37, P144, DOI 10.1097/COC.0b013e31826e04f9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; She YH, 2003, CLIN CANCER RES, V9, P3773; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Tanvetyanon T, 2008, J CLIN ONCOL, V26, P1142, DOI 10.1200/JCO.2007.14.2091; Hayashi H, 2012, ANTICANCER RES, V32, P4533; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Gow CH, 2008, CLIN CANCER RES, V14, P162, DOI 10.1158/1078-0432.CCR-07-1468; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Segawa Y, 2010, J CLIN ONCOL, V28, P3299, DOI 10.1200/JCO.2009.24.7577; Johung KL, 2013, CLIN CANCER RES, V19, P5523, DOI 10.1158/1078-0432.CCR-13-0836; Niho S, 2012, ANN ONCOL, V23, P2253, DOI 10.1093/annonc/mds012; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Tanaka T, 2008, CLIN CANCER RES, V14, P1266, DOI 10.1158/1078-0432.CCR-07-1606; Flannery TW, 2003, LUNG CANCER-J IASLC, V42, P327, DOI 10.1016/S0169-5002(03)00357-X; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; GLOBOCAN WHO, 2012, CANC FACT SHEETS LUN; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360	31	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	JAN 1	2015	91	1					140	148		10.1016/j.ijrobp.2014.08.344		9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	AW7AA	WOS:000346415500021		
J	Yamazaki, H; Nakamura, S; Aibe, N; Nishimura, T; Nakashima, A; Yoshida, K				Yamazaki, Hideya; Nakamura, Satoaki; Aibe, Norihiro; Nishimura, Takuya; Nakashima, Akihiro; Yoshida, Ken			Does Good Initial Response During Radiation Therapy Inversely Imply Poor Survival Outcome in NSCLC?	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Editorial Material							COMPUTED-TOMOGRAPHY; LUNG-CANCER; RADIOTHERAPY; REGRESSION		[Yamazaki, Hideya; Nakamura, Satoaki; Aibe, Norihiro; Nishimura, Takuya; Nakashima, Akihiro; Yoshida, Ken] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto, Japan	Yamazaki, H (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto, Japan.						Aibe N, ANTICANCER IN PRESS; Brink C, 2014, INT J RADIAT ONCOL, V89, P916, DOI 10.1016/j.ijrobp.2014.03.038; Nam H, 2007, GYNECOL ONCOL, V107, P320, DOI 10.1016/j.ygyno.2007.06.022; Bral S, 2011, INT J RADIAT ONCOL, V80, P1338, DOI 10.1016/j.ijrobp.2010.04.002; Inoue T., 1993, Strahlentherapie und Onkologie, V169, P584	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	JAN 1	2015	91	1					244	245		10.1016/j.ijrobp.2014.09.002		3	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	AW7AA	WOS:000346415500036		
J	Sanjo, Y				Sanjo, Yasuo			The role of firm ownership in policy competition for foreign direct investment between asymmetric countries	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Foreign direct investment; Policy competition; Role of firm ownership; Location choice	TAX COMPETITION; SIZE	This study develops a two-country policy competition model for foreign direct investment between asymmetric countries. It analyzes how firm ownership via foreign capital affects the investment location choice of the foreign firm, and policy competition between the potential host countries. The findings show that the inflow of foreign capital changes the investment location choice of the foreign firm, as does policy competition between the host countries. Further, an increase in the inflow of foreign capital to a domestic firm in the host country heightens the country's attractiveness as an investment location. (C) 2014 Elsevier Inc. All rights reserved.	Nagoya Univ, Sch Econ, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Sanjo, Y (reprint author), Nagoya Univ, Sch Econ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	sanjo.yasuo@h.mbox.nagoya-u.ac.jp					Faeth I, 2009, J ECON SURV, V23, P165, DOI 10.1111/j.1467-6419.2008.00560.x; Bjorvatn K, 2006, EUR ECON REV, V50, P1891, DOI 10.1016/j.euroecorev.2005.07.002; Haufler A, 1999, J PUBLIC ECON, V71, P121, DOI 10.1016/S0047-2727(98)00055-3; Barros P. P., 2000, REV INT ECON, V8, P360, DOI DOI 10.1111/1467-9396.00227; Bjorvatn K., 2005, MULTINATIONALS FOREI, P85; Dembour C., 2008, Journal of Industry, Competition and Trade, V8, DOI 10.1007/s10842-007-0013-y; Ferrett B., 2014, 20141 LOUGHB U SCH B; Fuest C, 2005, J PUBLIC ECON, V89, P1823, DOI 10.1016/j.jpubeco.2004.10.002; Fumagalli C, 2003, EUR ECON REV, V47, P963, DOI 10.1016/S0014-2921(02)00228-3; Hao Q, 2009, INT REV ECON FINANC, V18, P680, DOI 10.1016/j.iref.2009.03.001; Haufler A, 2011, INT TAX PUBLIC FINAN, V18, P121, DOI 10.1007/s10797-010-9149-5; Haufler Andreas, 2001, TAXATION GLOBAL EC T; Mittermaier F, 2009, FINANZARCHIV, V65, P297, DOI 10.1628/001522109X477787; Sanjo Y, 2013, INT REV ECON FINANC, V27, P37, DOI 10.1016/j.iref.2012.09.002; Ferrett B, 2010, INT TAX PUBLIC FINAN, V17, P518, DOI 10.1007/s10797-009-9126-z	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	JAN	2015	35						110	121		10.1016/j.iref.2014.09.009		12	Business, Finance; Economics	Business & Economics	AW6RY	WOS:000346397300009		
J	Nakamura, Y				Nakamura, Yasuhiko			Endogenous choice of strategic incentives in a mixed duopoly with a new managerial delegation contract for the public firm	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Mixed duopoly; Strategic delegation; Price competition; Quantity competition	NETWORK EXTERNALITIES; QUANTITY COMPETITION; PRICE-COMPETITION; OLIGOPOLY; UNCERTAINTY	This paper revisits the endogenous choice problem of the strategic contracts in a mixed duopoly of one public firm and one managerial private firm, with differentiated goods. This paper considers the situation wherein the separation between ownership and management exists in both the public firm and the private firm. In particular, we focus on a new type of managerial delegation contract in the public firm that is a weighted sum of social welfare and the difference between consumer surplus and producer surplus (sum of each firm's absolute profit). On the other hand, in this paper, the classical sales delegation contract is employed in the private firm. In the above setting, we show that similar to the case wherein both the public firm and the private firm simultaneously use their sales delegation contracts, there does not exist any equilibrium market structure under the class of pure strategies of both the firms. Thus, even if the government as the owner of the public firm provides to her/his manager a strategic delegation contract such that it is easier to manipulate social welfare, we find that it is likely that the indeterminacy in the equilibrium market structure(s) under the class of pure strategies cannot be resolved. Therefore, in this paper, we conclude that the government must devise another style of managerial delegation contract of the public firm in order to assure the equilibrium market structure under the pure strategy class. (C) 2014 Elsevier Inc. All rights reserved.	Nihon Univ, Coll Econ, Chiyoda Ku, Tokyo 1018360, Japan	Nakamura, Y (reprint author), Nihon Univ, Coll Econ, Chiyoda Ku, 1-3-2 Misaki Cho, Tokyo 1018360, Japan.	yasuhiko.r.nakamura@gmail.com					KATZ ML, 1985, AM ECON REV, V75, P424; SINGH N, 1984, RAND J ECON, V15, P546, DOI 10.2307/2555525; Wang LFS, 2014, INT REV ECON FINANC, V31, P138, DOI 10.1016/j.iref.2014.01.017; Reisinger M, 2009, J ECON MANAGE STRAT, V18, P1155; Matsumura T, 2012, ECON LETT, V116, P174, DOI 10.1016/j.econlet.2012.02.012; Ishida J, 2009, J PUBLIC ECON, V93, P634, DOI 10.1016/j.jpubeco.2008.11.004; Barcena-Ruiz JC, 2007, EC B, V12, P1; BARROS F, 1995, INT J IND ORGAN, V13, P373, DOI 10.1016/0167-7187(94)00461-A; Chirco A, 2013, ECON LETT, V121, P482, DOI 10.1016/j.econlet.2013.10.003; Chirco A, 2014, JPN ECON REV, V65, P521, DOI 10.1111/jere.12046; FERSHTMAN C, 1987, AM ECON REV, V77, P927; Goering GE, 2008, ECON SYST, V32, P326, DOI 10.1016/j.ecosys.2008.06.002; Goering G.E., 2007, MANAGERIAL DECISION, V28, P83, DOI 10.1002/mde.1307; Heywood JS, 2009, MANAGERIAL DECISION, V30, P71, DOI DOI 10.1002/MDE.1436; Hoernig S, 2012, ECON LETT, V117, P487, DOI 10.1016/j.econlet.2012.06.045; KLEMPERER P, 1986, RAND J ECON, V17, P618, DOI 10.2307/2555486; Kopel M, 2012, ECON MODEL, V29, P982, DOI 10.1016/j.econmod.2012.02.008; Matsumura T, 2014, SOUTH ECON J, V81, P457, DOI 10.4284/0038-4038-2012.182; Matsumura T., 2013, ECON LETT, V116, P174; Mukherjee A., 2014, INTERNATIONAL REVIEW, V31, P138; Nakamura Y., 2012, MANAGERIAL DECISION, V33, P249; Nakamura Y., 2013, MODERN EC, V4, P776; Nakamura Y, 2014, INT REV ECON FINANC, V34, P105, DOI 10.1016/j.iref.2014.07.004; Nishimori A., 2004, EC B, V12, P1; Ogawa Y., 2006, EC B, V12, P1; SKLIVAS SD, 1987, RAND J ECON, V18, P452, DOI 10.2307/2555609; Tanaka Y, 2001, J MATH ECON, V35, P409, DOI 10.1016/S0304-4068(00)00072-0; TANAKA Y, 2001, ECON THEOR, V17, P639; Tasnadi A, 2006, INT J IND ORGAN, V24, P541, DOI 10.1016/j.ijindorg.2005.07.009; Tomaru Y, 2012, AUST ECON PAP, V51, P38, DOI 10.1111/j.1467-8454.2012.00421.x; Van Witteloostuijn A. V., 2007, MANAGERIAL DECISION, V28, P897, DOI 10.1002/mde.1366; VICKERS J, 1985, ECON J, V95, P138, DOI 10.2307/2232877; Wang LFS, 2012, B ECON RES, V64, P56, DOI 10.1111/j.1467-8586.2010.00382.x; White MD, 2001, EUROPEAN J POLITICAL, V17, P877, DOI 10.1016/S0176-2680(01)00060-X	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	JAN	2015	35						262	277		10.1016/j.iref.2014.10.008		16	Business, Finance; Economics	Business & Economics	AW6RY	WOS:000346397300020		
J	Fantong, WY; Kamtchueng, BT; Yamaguchi, K; Ueda, A; Issa; Ntchantcho, R; Wirmvem, MJ; Kusakabe, M; Ohba, T; Zhang, J; Aka, FT; Tanyileke, G; Hell, JV				Fantong, Wilson Y.; Kamtchueng, Brice T.; Yamaguchi, Kohei; Ueda, Akira; Issa; Ntchantcho, Romaric; Wirmvem, Mengnjo J.; Kusakabe, Minoru; Ohba, Takeshi; Zhang, Jing; Aka, Festus T.; Tanyileke, Gregory; Hell, Joseph V.			Characteristics of chemical weathering and water-rock interaction in Lake Nyos dam (Cameroon): Implications for vulnerability to failure and re-enforcement	JOURNAL OF AFRICAN EARTH SCIENCES			English	Article						Chemical weathering; Water-rock interaction; Dam failure; Simulation; Temporal monitoring; Lake Nyos dam (Cameroon)	CO2 CONSUMPTION; NATURAL-WATERS; GAS DISASTER; WEST-AFRICA; MONOUN; CHEMISTRY; BASIN; RIVER; MAAR; AGE	For the first time, comprehensive study of hydrogeochemistry of water seeps, role of chemical weathering on dam failure, estimation of minimum width of dam to resist failure and simulation of changes in dissolved ions and secondary mineral was conducted on the Lake Nyos dam. The salient results and conclusions were; the dam spring water represented a mixture of 60-70% rainwater and 30-40% Lake water (from 0 to -40 m). The chemistry of the observed waters was Ca-HCO3 for rainwater, Ca-Mg-HCO3 in boreholes, and Mg-Ca-HCO3- for spring water. The relative rate at which ions dissolved in water was HCO3- > Mg2+> Ca2+ > Na+> SiO2 > K > NO3- > SO42- > Cl-. Weathering of rocks resulted in the formation of clay minerals such as kaolinite and smectite. Relative mobility of elements compared to Alumina (Al2O3) indicated that in monzonites there was a loss of CaO, Na2O, K2O, P2O5 and gain of SiO2, Fe2O3, TiO2, MnO and MgO, while in basalts there was a loss of SiO2, Fe2O3, Ca2O, NaO, MgO and gain of TiO2, K2O and P2O5. Values of chemical alteration index that ranged from 49 to 82 suggest a weak to intermediate categories of chemical weathering that occurred at a rate of 5.7 mm/year. Paired to that rate, which suggests that the dam is not vulnerable to failure at the previously thought time scale, some other processes (physical weathering, secondary mineral formation and lake overflow) can cause instant failure. Hydrostatic pressure of 1.6 GN generated by Lake water can be supported only when the width of the dam is greater than 19 m. PHREEQC-based simulation for 10 years indicates decoupling of Ca and Mg, and Na and Mg. Multidisciplinary monitoring of the dam is advocated. (C) 2014 Elsevier Ltd. All rights reserved.	[Fantong, Wilson Y.; Ntchantcho, Romaric; Aka, Festus T.; Tanyileke, Gregory; Hell, Joseph V.] IRGM, Hydrol Res Ctr, Yaounde, Cameroon; [Fantong, Wilson Y.; Kamtchueng, Brice T.; Ueda, Akira; Kusakabe, Minoru; Zhang, Jing] Toyama Univ, Grad Sch Sci & Engn Educ, Gofuku, Toyama 9308555, Japan; [Yamaguchi, Kohei] Mitsubishi Mat Corp, Omiya Ku, Saitama 3308508, Japan; [Issa; Wirmvem, Mengnjo J.; Ohba, Takeshi] Tokai Univ, Sch Sci, Dept Chem, Hiratsuka, Kanagawa 2591211, Japan	Fantong, WY (reprint author), IRGM, Hydrol Res Ctr, Box 4110, Yaounde, Cameroon.	fyetoh@yahoo.com					Adedeji A.A., 2010, WORLD RUR OBSERV, V2, P13; Aka FT, 2008, J VOLCANOL GEOTH RES, V176, P212, DOI 10.1016/j.jvolgeores.2008.04.009; Aka FT, 2013, NAT HAZARDS, V65, P875, DOI 10.1007/s11069-012-0401-4; Boeglin JL, 1998, CHEM GEOL, V148, P137, DOI 10.1016/S0009-2541(98)00025-4; Chadha DK, 1999, HYDROGEOL J, V7, P431, DOI 10.1007/s100400050216; Kusakabe M, 2008, GEOCHEM J, V42, P93; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Piper AM, 1944, EOS T AM GEOPHYS UN, V25, P914; EGGLETON RA, 1987, CLAY CLAY MINER, V35, P161, DOI 10.1346/CCMN.1987.0350301; Dalai TK, 2002, GEOCHIM COSMOCHIM AC, V66, P3397, DOI 10.1016/S0016-7037(02)00937-7; Gurumurthy GP, 2012, CHEM GEOL, V300, P61, DOI 10.1016/j.chemgeo.2012.01.016; Shao JQ, 2012, SEDIMENT GEOL, V265, P110, DOI 10.1016/j.sedgeo.2012.03.020; Fantong WY, 2009, ENVIRON GEOL, V58, P1281, DOI 10.1007/s00254-008-1629-x; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; PARKER A, 1970, GEOL MAG, V107, P501; Goldberg K, 2010, PALAEOGEOGR PALAEOCL, V293, P175, DOI 10.1016/j.palaeo.2010.05.015; NESBITT HW, 1989, J GEOL, V97, P129; Asai K, 2009, HYDROL PROCESS, V23, P559, DOI 10.1002/hyp.7185; CLARIDGE GGC, 1984, NEW ZEAL J GEOL GEOP, V27, P537; Evans W., 2012, PRELIMINARY REPORT J, P19; Fantong WY, 2010, ENVIRON EARTH SCI, V60, P107, DOI 10.1007/s12665-009-0173-7; Fantong W. Y., 2013, African Journal of Environmental Science and Technology, V7, P175; Faure G, 1991, PRINCIPLES APPL INOR, P626; Freeth SJ, 2000, J VOLCANOL GEOTH RES, V97, P261, DOI 10.1016/S0377-0273(99)00172-9; Garrels R M, 1965, SOLUTIONS MINERALS E, P450; Garrels R.M., 1967, ADV CHEM SER, V67, P222, DOI DOI 10.1021/BA-1967-0067.CH010; Garrels R. M., 1967, RESEARCHES GEOCHEMIS, P405; GIGGENBACH WF, 1990, J VOLCANOL GEOTH RES, V42, P337, DOI 10.1016/0377-0273(90)90031-A; Goni I.B., 2006, HYDROGEOL J, V14, P4331; Itai T, 2004, GEOCHEM J, V38, P435; Kamtchueng B.T., 2014, ENV EARTH SCI; Kazahaya K., 1994, J JPN ASS HYDROL SCI, V24, P107; Kim S., 2003, B ENG GEOL ENVIRON, V62, P207, DOI 10.1007/s10064-003-0192-7; Kling GW, 2005, P NATL ACAD SCI USA, V102, P14185, DOI 10.1073/pnas.0502274102; KUSAKABE M, 1989, J VOLCANOL GEOTH RES, V39, P167, DOI 10.1016/0377-0273(89)90056-5; LOCKWOOD JP, 1991, NATURE, V351, P195, DOI 10.1038/351195b0; LOCKWOOD JP, 1989, J VOLCANOL GEOTH RES, V39, P117, DOI 10.1016/0377-0273(89)90052-8; Lockwood J.P., 1988, EOS T AM GEOPHYS UN, V69, P776; LOCKWOOD JP, 1988, B VOLCANOL, V50, P340, DOI 10.1007/BF01073590; Nagao K, 2010, GEOCHEM J, V44, P519; Nkounkou R.R., 1987, MITT GEOL PALAONT I, V64, P483; Parkhurst D.L., 1999, USERS GUIDE PHREEQC, P99; PEDRO G, 1966, CR ACAD SCI D NAT, V262, P1828; Ruxton P.P., 1968, J GEOL, V76, P518; Sigurdsson H., 1987, J VOLCANOL GEOHERM R, V311, P1; SIGVALDASON GE, 1989, J VOLCANOL GEOTH RES, V39, P97, DOI 10.1016/0377-0273(89)90050-4; Tanyileke G.Z., 1994, THESIS OKAYAMA U JAP; TARDY Y, 1971, CHEM GEOL, V7, P253, DOI 10.1016/0009-2541(71)90011-8; Tassi F., 2014, J LIMNOL, DOI 10:4081/jlimnol.2014.836; Tchindjang M., 2001, AFR J SCI TECHNOL SC, V2, P50; Tuttle M.L., 1987, FINAL REPORT US SCI, P58; TUTTLE ML, 1992, WATER-ROCK INTERACTION, VOLS 1 AND 2, P449; Vuai SAH, 2007, CHEM GEOL, V236, P199, DOI 10.1016/j.chemgeo.2006.09.009; White F.M., 2001, FLUID MECH, P826	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1464-343X	1879-1956		J AFR EARTH SCI	J. Afr. Earth Sci.	JAN	2015	101						42	55		10.1016/j.jafrearsci.2014.08.011		14	Geosciences, Multidisciplinary	Geology	AX0CZ	WOS:000346622300004		
J	Chaudhuri, T; Mazumder, R; Arima, M				Chaudhuri, Trisrota; Mazumder, Rajat; Arima, Makoto			Petrography and geochemistry of Mesoarchaean komatiites from the eastern Iron Ore belt, Singhbhum craton, India, and its similarity with 'Barberton type komatiite'	JOURNAL OF AFRICAN EARTH SCIENCES			English	Article						Palaeoarchaean; Mesoarchaean; Greenstone belt; Komatiite; Singhbhum craton; India	GREENSTONE-BELT; ARCHEAN KOMATIITES; WESTERN-AUSTRALIA; OLDEST GREENSTONE; VOLCANIC-ROCKS; MANTLE PLUME; SOUTH-AFRICA; SCHIST BELT; ORISSA; EVOLUTION	The Mesoarchaean supracrustals of the Gorumahishani-Badampahar belt, eastern India record sedimentation-volcanism like most other contemporary greenstone belts over the world. The current study reports unambiguous komatiitic rocks from Tua-Dungri hill, Gorumahishani-Badampahar belt, Jharkhand and presents a petrological and geochemical inventory of these very interesting rocks. The Tua-Dungri komatiites are characterised by a well distinguishable cumulate, platy and random spinifex zone. These Tua-Dungri komatiites are rich in SiO2 (47-50 wt%) like Barberton type komatiite or modern day boninite. Their Al depleted nature (Al2O3 = 1.36-2.95 wt%) with very low Al2O3/Tio(2) (3.4-6.5) and high CaO/Al2O3 (2-3), high LREE/HREE ratios show further resemblance with the Barberton komatiite. The Tua Dungri komatiite data along with published geochemical, sedimentological and stratigraphic data from the Iron Ore Group of rocks suggest mantle plume activity during the Mesoarchaean on the Singhbhum craton. (C) 2014 Elsevier Ltd. All rights reserved.	[Chaudhuri, Trisrota; Mazumder, Rajat] Indian Stat Inst, Geol Studies Unit, Kolkata 700108, India; [Chaudhuri, Trisrota] Jadavpur Univ, Dept Geol Sci, Kolkata 700032, India; [Mazumder, Rajat] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Arima, Makoto] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Mazumder, R (reprint author), Curtin Univ Sarawak, Sch Sci & Engn, Dept Appl Geol, CDT 250, Miri 98009, Sarawak, Malaysia.	rajatunsw@gmail.com			Council of Scientific and Industrial Research, Government of India; University of New South Wales	TC is grateful to the Council of Scientific and Industrial Research, Government of India for financial support in form of a research fellowship and to the Geological Studies Unit, Indian Statistical Institute Kolkata for providing necessary infrastructural facilities for petrographic analyses; RM is grateful to the University of New South Wales for a Post Doctoral Fellowship (2012-2013) and subsequently a research fellowship (2014) to complete this work. MA and RM are grateful to the Yokohama National University for infrastructural facilities for electron microprobe analysis. The authors are grateful to four anonymous reviewers and the Editor-in-chief, Prof. P.G. Eriksson for their constructive critical comments.	Acharyya S. K., 1993, P NAT ACAD SCI IND A, V63, P211; Saha A, 2004, EARTH PLANET SC LETT, V220, P91, DOI 10.1016/S0012-821X(04)00056-1; Mukhopadhyay D, 2001, GONDWANA RES, V4, P307, DOI 10.1016/S1342-937X(05)70331-2; Parman SW, 2001, GEOPHYS RES LETT, V28, P2513, DOI 10.1029/2000GL012713; SUN SS, 1978, CONTRIB MINERAL PETR, V65, P301, DOI 10.1007/BF00375516; Nesbitt RW, 1979, CAN MINERAL, V17, P165; Le Bas MJ, 2000, J PETROL, V41, P1467; Bose MK, 2009, J GEOL SOC INDIA, V73, P13, DOI 10.1007/s12594-009-0002-3; Mukhopadhyay J, 2008, J GEOL, V116, P449, DOI 10.1086/590133; Robin-Popieul CCM, 2012, J PETROL, V53, P2191, DOI 10.1093/petrology/egs042; Acharyya SK, 2010, GEOCHEM J, V44, P81; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Polat A, 2003, PRECAMBRIAN RES, V126, P197, DOI 10.1016/S0301-9268(03)00095-0; Bhattacharya HN, 2007, J EARTH SYST SCI, V116, P245, DOI 10.1007/s12040-007-0024-4; Sengupta S, 1997, P INDIAN AS-EARTH, V106, P327; NESBITT RW, 1976, EARTH PLANET SC LETT, V31, P433, DOI 10.1016/0012-821X(76)90125-4; Condie KC, 2005, LITHOS, V79, P491, DOI 10.1016/j.lithos.2004.09.014; [Anonymous], 1997, GREENSTONE BELTS; Misra S, 2006, J GEOL SOC INDIA, V67, P356; NISBET EG, 1993, LITHOS, V30, P291, DOI 10.1016/0024-4937(93)90042-B; Hanski E, 2001, J PETROL, V42, P855, DOI 10.1093/petrology/42.5.855; Parman SW, 2004, S AFR J GEOL, V107, P107, DOI 10.2113/107.1-2.107; Prabhakar N, 2013, PRECAMBRIAN RES, V231, P106, DOI 10.1016/j.precamres.2013.03.009; SHARMA M, 1994, CONTRIB MINERAL PETR, V117, P45, DOI 10.1007/BF00307728; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Mukhopadhyay J, 2012, GEOL J, V47, P284, DOI 10.1002/gj.1314; HERZBERG C, 1995, CHEM GEOL, V126, P1, DOI 10.1016/0009-2541(95)00099-4; Parman SW, 1997, EARTH PLANET SC LETT, V150, P303, DOI 10.1016/S0012-821X(97)00104-0; Lahaye Y, 1996, J PETROL, V37, P1261, DOI 10.1093/petrology/37.6.1261; Fitton JG, 1997, EARTH PLANET SC LETT, V153, P197, DOI 10.1016/S0012-821X(97)00170-2; CAMPBELL IH, 1989, NATURE, V339, P697, DOI 10.1038/339697a0; XIE Q, 1993, GEOCHIM COSMOCHIM AC, V57, P4111, DOI 10.1016/0016-7037(93)90357-3; Arndt N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002157; Arndt N.T., 1994, ARCHEAN CRUSTAL EVOL, P11; Arndt N.T., 1997, GREENSTONE BELTS, P233; Arndt N.T., 1982, KOMATIITES, P19; Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; Basu A.R., 2008, GEOCHIMICA COSABORTM, V72, pA59; Bickle M.J., 1993, GEOLOGY BELINGWE GRE, P175; CATTELL A, 1987, CONTRIB MINERAL PETR, V97, P218, DOI 10.1007/BF00371241; CHAKRABORTY KL, 1986, J GEOL SOC INDIA, V28, P109; Chakraborty K.L., 1996, INDIAN J GEOLOGY, V68, P211; Clarke D.B., 1970, CONTRIB MINERAL PETR, V25, P203, DOI DOI 10.1007/BF00371131; De Wit M.J., 1997, GREEN STONE BELTS, P9; Ghosh G, 2007, GONDWANA RES, V12, P525, DOI 10.1016/j.gr.2007.04.002; Glikson A, 2007, DEV PREC G, V15, P1087, DOI 10.1016/S0166-2635(07)15085-4; Glikson A, 2006, EARTH PLANET SC LETT, V241, P11, DOI 10.1016/j.epsl.2005.10.022; Goswami JN, 1995, CURR SCI INDIA, V69, P1008; GREEN DH, 1975, GEOLOGY, V3, P15, DOI 10.1130/0091-7613(1975)3<15:GOAPMA>2.0.CO;2; Grove T.L., 1999, MANTLE PETROLOGY FIE, V6, P155; Grove T.L., 1994, EOS T AM GEOPHYS UN, V75, P354; GRUAU G, 1987, EARTH PLANET SC LETT, V85, P105, DOI 10.1016/0012-821X(87)90025-2; JAHN B, 1982, CONTRIB MINERAL PETR, V80, P25, DOI 10.1007/BF00376732; Jayananda M., 2008, PRECAMBRIAN RES, V162, P160, DOI DOI 10.1016/J.PRECAMRES.2007.07.010; Jochum K.P., 2001, EOS T, V82, pF1214; Lowe DR, 2007, DEV PREC G, V15, P481, DOI 10.1016/S0166-2635(07)15053-2; LOWE DR, 1989, SCIENCE, V245, P959, DOI 10.1126/science.245.4921.959; Mazumder R., 2012, SPECIAL PUBLICATION, V365, P49; NESBITT RW, 1982, J VOLCANOL GEOTH RES, V14, P31, DOI 10.1016/0377-0273(82)90041-5; OHTANI E, 1989, CONTRIB MINERAL PETR, V103, P263, DOI 10.1007/BF00402913; Parman SW, 2003, CONTRIB MINERAL PETR, V144, P383, DOI 10.1007/s00410-002-0406-1; Pedersen A.K., 1985, B GRONLANDS GEOLOGIS, V152, P126; Putchel I.S., 1999, GEOCHIM COSMOCHIM AC, V63, P3579; Rao DVS, 1999, J GEOL SOC INDIA, V53, P347; Reddy S. M., 2009, PALEOPROTEROZOIC SUP, V9, P17; Saha A.K., 1994, GEOL SOC IND MEM, P27; Sahu NK, 2001, J GEOL SOC INDIA, V57, P529; SRIKANTIA SV, 1985, J GEOL SOC INDIA, V26, P407; STOREY M, 1991, GEOLOGY, V19, P376, DOI 10.1130/0091-7613(1991)019<0376:AOPSOK>2.3.CO;2; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Sun S.S., 1989, BONINITES RELATED RO, P148; Tait J, 2011, GEOL MAG, V148, P340, DOI 10.1017/S0016756810000920; Viljoen M. J., 1969, GEOL SOC S AFR SPEC, V2, P87; Viljoen M.J., 1969, AFRICAN MAGMATISM TE, P27; Viljoen R.P., 1969, GEOLOGICAL SOC S AFR, V2, P29; VISWANATHA MN, 1977, J GEOL SOC INDIA, V18, P194	78	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1464-343X	1879-1956		J AFR EARTH SCI	J. Afr. Earth Sci.	JAN	2015	101						135	147		10.1016/j.jafrearsci.2014.09.014		13	Geosciences, Multidisciplinary	Geology	AX0CZ	WOS:000346622300011		
J	Obiora, DN; Okeke, FN; Yumoto, K				Obiora, Daniel N.; Okeke, Francisca N.; Yumoto, K.			Electrical conductivity of mantle in the North Central region of Nigeria	JOURNAL OF AFRICAN EARTH SCIENCES			English	Article						Electrical conductivity profile; North Central region of Nigeria; Quiet-day ionospheric current; Mantle; Spherical harmonic analysis; Transfer function	IONOSPHERIC CURRENTS; GEOMAGNETIC-FIELD; EARTH; PROFILE; AUSTRALIA; ASTHENOSPHERE; TRANSITION; INDUCTION; VELOCITY; AMERICA	The mantle electrical conductivity profile of the North Central region of Nigeria was determined using the quiet day ionospheric current variations (Sq). The employed magnetic averaged hourly data were obtained from Magnetic Data Acquisition System (MAGDAS) ground based observatories at two Nigerian stations located at Ilorin (8 degrees 30'N, 4 degrees 33'E) and Abuja (8 degrees 59'N, 7 degrees 23'E) for the year 2009 and 2010. The magnetometer data from Pankshin (9 degrees 20'N, 9 degrees 27'E) and Katsina-Ala (7 degrees 10'N, 9 degrees 17'E) for the same years were equally employed. The separation of both the internal and external field contributions to the Sq variations was successfully carried out employing spherical harmonic analysis (SHA). Transfer function was performed in computing the conductivity-depth profile for North Central region of Nigeria from the paired external and internal coefficients of the SHA. The conductivity value of approximately 0.039 S/m was estimated at a depth of 100 km which rose gradually to 0.087 S/m at 207 km depth and 0.142 S/m at 367 km (close to the base of upper mantle). Subsequently, the conductivity profile continued rising to a value of 0.144 S/m at 442 km, 0.164 S/m at 653 km and 0.174 S/m at 710 km. Finally, value of approximately 0.195 S/m at a depth of 881 km and 0.240 S/m at 1100 km depth were recorded at the lower mantle with no indication of leveling off. Some evidence of discontinuities near 100-214 km, 214-420 km, 420-640 km, 640-900 km and 900-1100 km were clearly obvious. The sharp increase in conductivity from about 100 km depth to 230 km was interpreted to correspond to the global seismic low velocity zone - the asthenosphere. (C) 2014 Elsevier Ltd. All rights reserved.	[Obiora, Daniel N.; Okeke, Francisca N.] Univ Nigeria, Dept Phys & Astron, Nsukka, Enugu State, Nigeria; [Yumoto, K.] Kyushu Univ, Space Environm Res Ctr, Fukuoka 812, Japan	Obiora, DN (reprint author), Univ Nigeria, Dept Phys & Astron, Nsukka, Enugu State, Nigeria.	daniel.obiora@unn.edu.ng					ADAM A, 1980, GEOPHYS SURV, V4, P43, DOI 10.1007/BF01452957; Agha S.O., 2007, NIGERIAN J SPACE RES, V3, P57; Ajibade AC., 1989, GEOLOGY NIGERIA, P57; Anderson D L, 1989, THEORY OF THE EARTH; ANDERSON DL, 1984, SCI AM, V251, P58; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; MECHIE J, 1993, PHYS EARTH PLANET IN, V79, P269, DOI 10.1016/0031-9201(93)90151-X; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; KAWAKATSU H, 1994, NATURE, V371, P301, DOI 10.1038/371301a0; ITO E, 1989, GEOPHYS RES LETT, V16, P425, DOI 10.1029/GL016i005p00425; ARORA BR, 1995, J GEOMAGN GEOELECTR, V47, P653; Burke K.C., 1972, AFRICAN GEOLOGY, P583; Caby R., 1981, PRECAMBRIAN PLATE TE, P407; Campbell W H., 1997, INTRO GEOMAGNETIC FI; Campbell W. H., 1989, GEOMAGN AERON, V3, P385; Campbell W. H., 2003, INTRO GEOMAGNETIC FI; CAMPBELL WH, 1988, J GEOMAGN GEOELECTR, V40, P1387; CAMPBELL WH, 1986, J GEOPHYS-Z GEOPHYS, V59, P56; CAMPBELL WH, 1987, PURE APPL GEOPHYS, V125, P427, DOI 10.1007/BF00874505; Campbell WH, 1998, EARTH PLANETS SPACE, V50, P347; CAMPBELL WH, 1987, AUST J PHYS, V40, P73; CAMPBELL WH, 1983, J GEOMAGN GEOELECTR, V35, P367; Chandrasekhar E, 2011, IAGA SPEC SOPRON, V1, P31, DOI 10.1007/978-94-007-0323-0_3; Chapman S., 1919, Philosophical Transactions of the Royal Society of London, V218, DOI 10.1098/rsta.1919.0001; Chapman S, 1930, PHILOS T R SOC LOND, V229, P0427, DOI 10.1098/rsta.1930.0010; Chapman S., 1940, GEOMAGNETISM; DRURY MJ, 1978, PHYS EARTH PLANET IN, V17, P16; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fowler C.M.R., 1990, SOLID EARTH INTRO GL; Gauss CF, 1838, SCI MEM SELECT T FOR, V2, P184; LILLEY FEM, 1981, PHYS EARTH PLANET IN, V25, P202, DOI 10.1016/0031-9201(81)90062-5; LILLEY FEM, 1981, PHYS EARTH PLANET IN, V25, P419, DOI 10.1016/0031-9201(81)90053-4; Lowrie W., 2007, FUNDAMENTALS GEOPHYS; McCurry P., 1989, GEN LINEAR MODELS, P13; Obiekezie TN, 2010, INT J PHYS SCI, V5, P637; Obiora DN, 2014, J EARTH SYST SCI, V123, P827; OMURA K, 1991, PHYS EARTH PLANET IN, V65, P292, DOI 10.1016/0031-9201(91)90136-6; PATTON H, 1980, REV GEOPHYS, V18, P605, DOI 10.1029/RG018i003p00605; Picher W.S., 1979, J GEOL SOC LONDON, V136, P627; PRICE AT, 1970, Q J ROY ASTRON SOC, V11, P23; ROKITYANSKY II, 1982, GEOELECTROMAGNETIC I; Schmucker U., 1970, J GEOMAGN GEOELECTR, V2, P9; SCHMUCKE.U, 1972, TECTONOPHYSICS, V13, P233, DOI 10.1016/0040-1951(72)90022-4; Schuster A., 1902, PHILOS T R SOC A, VA200, P181; Schuster A., 1889, PHILOS T R SOC A, VA180, P467, DOI DOI 10.1098/RSTA.1889.0015; TAKEDA M, 1991, GEOPHYS J INT, V104, P381, DOI 10.1111/j.1365-246X.1991.tb02518.x; Tarits P., 1992, 11 WORKSH EL IND EAR; TOZER DC, 1981, PHYS EARTH PLANET IN, V25, P280, DOI 10.1016/0031-9201(81)90072-8; Vestine E.H., 1960, PHYS UPPER ATMOSPHER, P471; Wait J. R., 1982, GEO ELECTROMAGNETISM	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1464-343X	1879-1956		J AFR EARTH SCI	J. Afr. Earth Sci.	JAN	2015	101						274	281		10.1016/j.jafrearsci.2014.10.002		8	Geosciences, Multidisciplinary	Geology	AX0CZ	WOS:000346622300021		
J	Taylor, RN; Ishizuka, O; Michalik, A; Milton, JA; Croudace, IW				Taylor, Rex N.; Ishizuka, Osamu; Michalik, Agnieszka; Milton, J. Andrew; Croudace, Ian W.			Evaluating the precision of Pb isotope measurement by mass spectrometry	JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY			English	Article							COLLECTOR ICP-MS; SCIENTIFIC DRILLING PROJECT; PB-207-PB-204 DOUBLE SPIKE; LEAD ISOTOPES; RATIO MEASUREMENT; MANTLE; EVOLUTION; RIDGE; HF; GEOCHEMISTRY	Analytical precision for Pb isotope measurement by thermal and plasma source mass spectrometry has improved by an order of magnitude in the last 20 years. Much of this improvement relates to a shift away from the external method of correcting instrumental mass fractionation - where samples are assumed to fractionate to the same extent as an average value of a working measurement standard. Implementation of a variety of techniques, including thallium spiking, sample-standard bracketing and double/triple spiking has provided more robust methods of fractionation correction. Isotope laboratories use one or more of these procedures, but an assessment of the measurement precision and relative merits of each system is needed to determine which is the most appropriate for the purpose. This study reviews each of these methods and provides a comparison based on an extensive analytical record covering 18 years, and using a variety of mass spectrometers. As two or three of the methods have been applied to most measurements, direct and robust comparisons can be made between correction protocols. In particular the effects of sample purity and variable sample matrices on measurement precision and accuracy have been examined. Data acquired from the measurement of rock, soil and metal are used to provide a statistical comparison of the analytical uncertainty of each technique, guiding the choice of the most appropriate method. Isotope standard data acquired over this period is also compared with other high-precision laboratories to generate a set of concordant working ratios for the NIST SRM 981 Pb standard: Pb-206/Pb-204 = 16.9412; Pb-207/Pb-204 = 15.4988; Pb-208/Pb-204 = 36.7233.	[Taylor, Rex N.; Michalik, Agnieszka; Milton, J. Andrew; Croudace, Ian W.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Ishizuka, Osamu] Geol Survey Japan, AIST, Inst Earthquake & Volcano Geol, Tsukuba, Ibaraki 3058567, Japan	Taylor, RN (reprint author), Univ Southampton, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	rex@soton.ac.uk			JSPS; Royal Society	The authors thank all users of the isotope facilities at Southampton for their contribution to the standards dataset. In particular the assistance in the laboratory from Matt Cooper, Posy Boella, Tina Hayes, April Lloyd, Laura Hepburn and Loraine Foley. Laure Dosso collaborated in the creation of SBL74. Leah Carwithen and Sarah Munday carefully analysed the comparative samples during studies at Southampton. The authors appreciate a Japan-UK bilateral grant provided by JSPS, and a Royal Society travel grant to RNT. This paper also benefited from discussions with the Southampton geochemistry group and from the comments of two anonymous reviewers.	Adams JR, 2013, INT J NAUT ARCHAEOL, V42, P60, DOI 10.1111/1095-9270.12001; Amelin Y, 2006, J ANAL ATOM SPECTROM, V21, P1053, DOI 10.1039/b606842a; Woodhead J, 2002, J ANAL ATOM SPECTROM, V17, P1381, DOI 10.1039/b205045e; Johnson CM, 1999, INT J MASS SPECTROM, V193, P87, DOI 10.1016/S1387-3806(99)00158-X; Elliott T, 2007, GEOCHIM COSMOCHIM AC, V71, P219, DOI 10.1016/j.gca.2006.07.043; Fekiacova Z, 2007, EARTH PLANET SC LETT, V261, P65, DOI 10.1016/j.epsl.2007.06.005; Nielsen SG, 2007, EARTH PLANET SC LETT, V264, P332, DOI [10.1016/j.epsl.2007.10.008, 10.1016/j.epsi.2007.10.008]; Abouchami W, 2000, CHEM GEOL, V169, P187, DOI 10.1016/S0009-2541(00)00328-4; Kuritani T, 2003, J ANAL ATOM SPECTROM, V18, P1464, DOI 10.1039/b310294g; Hoernle K, 2011, EARTH PLANET SC LETT, V306, P86, DOI 10.1016/j.epsl.2011.03.032; Taylor RN, 1998, CHEM GEOL, V144, P73, DOI 10.1016/S0009-2541(97)00118-6; Albarede F, 2004, GEOCHIM COSMOCHIM AC, V68, P2725, DOI 10.1016/j.gca.2003.11.024; Chu NC, 2002, J ANAL ATOM SPECTROM, V17, P1567, DOI 10.1039/b206707b; Gerstenberger H, 1997, CHEM GEOL, V136, P309, DOI 10.1016/S0009-2541(96)00033-2; Ishizuka O, 2003, EARTH PLANET SC LETT, V211, P221, DOI 10.1016/S0012-821X(03)00201-2; Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; Makishima A, 2010, J ANAL ATOM SPECTROM, V25, P1712, DOI 10.1039/c0ja00015a; Thirlwall MF, 2004, GEOCHIM COSMOCHIM AC, V68, P361, DOI 10.1016/S0016-7037(03)00424-1; Bizzarro M, 2003, NATURE, V421, P931, DOI 10.1038/nature01421; Belshaw NS, 1998, INT J MASS SPECTROM, V181, P51, DOI 10.1016/S1387-3806(98)14150-7; Straub SM, 2010, J PETROL, V51, P993, DOI 10.1093/petrology/egq009; Feigenson MD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000621; BlichertToft J, 1997, CONTRIB MINERAL PETR, V127, P248, DOI 10.1007/s004100050278; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Regelous M, 2003, J PETROL, V44, P113, DOI 10.1093/petrology/44.1.113; Thirlwall MF, 2000, CHEM GEOL, V163, P299, DOI 10.1016/S0009-2541(99)00135-7; HAMELIN B, 1985, GEOCHIM COSMOCHIM AC, V49, P173, DOI 10.1016/0016-7037(85)90202-9; Nauret F, 2006, EARTH PLANET SC LETT, V245, P137, DOI 10.1016/j.epsl.2006.03.015; Baker J, 2004, CHEM GEOL, V211, P275, DOI 10.1016/j.chemgeo.2004.06.030; WOODHEAD JD, 1995, ANALYST, V120, P35, DOI 10.1039/an9952000035; Kamenov GD, 2004, J ANAL ATOM SPECTROM, V19, P1262, DOI 10.1039/b403222e; Koornneef JM, 2014, ANAL CHIM ACTA, V819, P49, DOI 10.1016/j.aca.2014.02.007; Murton BJ, 2002, J PETROL, V43, P1987, DOI 10.1093/petrology/43.11.1987; Eisele J, 2002, EARTH PLANET SC LETT, V196, P197, DOI 10.1016/S0012-821X(01)00601-X; Barling J, 2008, J ANAL ATOM SPECTROM, V23, P1017, DOI 10.1039/b717418g; Thirlwall MF, 2002, CHEM GEOL, V184, P255, DOI 10.1016/S0009-2541(01)00365-5; DODSON MH, 1963, J SCI INSTRUM, V40, P289, DOI 10.1088/0950-7671/40/6/307; Vance D, 2002, CHEM GEOL, V185, P227, DOI 10.1016/S0009-2541(01)00402-8; Galer SJG, 1999, CHEM GEOL, V157, P255, DOI 10.1016/S0009-2541(98)00203-4; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Rehkamper M, 2000, J ANAL ATOM SPECTROM, V15, P1451, DOI 10.1039/b005262k; Moore J, 2011, J VOLCANOL GEOTH RES, V207, P47, DOI 10.1016/j.jvolgeores.2011.07.005; Baker J, 2006, ARCHAEOMETRY, V48, P45, DOI 10.1111/j.1475-4754.2006.00242.x; CATANZAR.EJ, 1968, J RES NBS A PHYS CH, VA 72, P261; DUNSTAN LP, 1980, J RES NAT BUR STAND, V85, P1, DOI 10.6028/jres.085.001; Elliott T, 1997, J GEOPHYS RES-SOL EA, V102, P14991, DOI 10.1029/97JB00788; Gale N. H., 1970, CHEM GEOL, V6, P305, DOI 10.1016/0009-2541(70)90031-8; Galer S., 1998, MINERAL MAG A, V62A, P491, DOI DOI 10.1180/MINMAG.1998.62A.1.260; HOFMANN A, 1971, EARTH PLANET SC LETT, V10, P397, DOI 10.1016/0012-821X(71)90087-2; Janney PE, 1999, J GEOPHYS RES-SOL EA, V104, P10571, DOI 10.1029/1998JB900061; Ludwig K. R., 1999, SPECIAL PUBLICATIO A, V1a, P47; LUDWIG KR, 1980, EARTH PLANET SC LETT, V46, P212, DOI 10.1016/0012-821X(80)90007-2; Meyzen CM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000979; Miller H, 2014, ENVIRON SCI TECHNOL, V48, P7254, DOI 10.1021/es5008998; Niu YL, 1999, J GEOPHYS RES-SOL EA, V104, P7067, DOI 10.1029/1998JB900037; Silva IGN, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002537; OVERSBY VM, 1973, GEOCHIM COSMOCHIM AC, V37, P2693, DOI 10.1016/0016-7037(73)90275-5; Pichat S, 2014, EARTH PLANET SC LETT, V388, P293, DOI 10.1016/j.epsl.2013.11.035; Rehkamper M, 1998, INT J MASS SPECTROM, V181, P123, DOI 10.1016/S1387-3806(98)14170-2; Suzuki D, 2010, INT J MASS SPECTROM, V294, P23, DOI 10.1016/j.ijms.2010.04.007; Taylor R. N., 2001, EOS T AM GEOPHYS UNI, V82; Taylor RN, 2003, J ANAL ATOM SPECTROM, V18, P480, DOI 10.1039/b300432e; Taylor RN, 2001, J ANAL ATOM SPECTROM, V16, P279, DOI 10.1039/b009078f; Taylor RN, 1997, EARTH PLANET SC LETT, V148, pE1, DOI 10.1016/S0012-821X(97)00038-1; White WM, 2000, CHEM GEOL, V167, P257, DOI 10.1016/S0009-2541(99)00182-5; Todt W., 1996, EARTH PROCESSES READ, P429; Todt W., 1984, TERRA COGNITA, V4, P209; Vlastelic I, 2001, GEOCHIM COSMOCHIM AC, V65, P4303, DOI 10.1016/S0016-7037(01)00713-X; Warneke T, 2002, EARTH PLANET SC LETT, V203, P1047, DOI 10.1016/S0012-821X(02)00930-5	69	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0267-9477	1364-5544		J ANAL ATOM SPECTROM	J. Anal. At. Spectrom.		2015	30	1					198	213		10.1039/c4ja00279b		16	Chemistry, Analytical; Spectroscopy	Chemistry; Spectroscopy	AW4LE	WOS:000346251800015		
J	Sakai, K; Miyake, S; Iwama, K; Inoue, D; Soda, S; Ike, M				Sakai, K.; Miyake, S.; Iwama, K.; Inoue, D.; Soda, S.; Ike, M.			Polyhydroxyalkanoate (PHA) accumulation potential and PHA-accumulating microbial communities in various activated sludge processes of municipal wastewater treatment plants	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						activated sludge; microbial community analysis; phaC gene; polyhydroxyalkanoate-accumulating organism; polyhydroxyalkanoate accumulation potential	POLYHYDROXYBUTYRATE PRODUCTION; CULTURES; MICROORGANISMS; SUBSTRATE; STOICHIOMETRY; BIOREACTOR; ORGANISMS; KINETICS; INFLUENT; STORAGE	AimsTo clarify the polyhydroxyalkanoate (PHA) accumulation potential and the PHA-accumulating microbial community structure in activated sludge in municipal wastewater treatment plants (WWTPs) and to identify their influential factors. Methods and ResultsNine activated sludge samples were collected from municipal WWTPs employing various biological treatment processes. In acetate-fed 24-h batch experiments under aerobic and nitrogen- and phosphorus-limited conditions, polyhydroxybutyrate (PHB) content of activated sludge increased from 0-13wt% to 79-24wt%, with PHB yields of 022-050C-mol 3-hydroxybutyrate (C-mol acetate)(-1). Microbial community analyses found that activated sludge samples that accumulated >20wt% of PHB after 24-h PHA accumulation experiments had >50x10(8)copies g(-1)-mixed liquor-suspended solid of phaC genes. ConclusionsResults indicated that (i) activated sludge in municipal WWTPs can accumulate up to approx. 20wt% of PHA without enrichment processes, (ii) PHA accumulation potential of activated sludge varied depending on the operational conditions (treatment processes) of WWTPs, and (iii) phaC gene number can provide a simple indication of PHA accumulation potential. Significance and Impact of the StudyThis is the first study to compare the PHA accumulation potential and PHA-accumulating microbial communities in activated sludge of various treatment processes. Our findings may be useful for enhancing the resource recovery potential of wastewater treatment systems.	[Sakai, K.; Miyake, S.; Iwama, K.; Soda, S.; Ike, M.] Osaka Univ, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan; [Inoue, D.] Kitasato Univ, Dept Hlth Sci, Sagamihara, Kanagawa 228, Japan	Ike, M (reprint author), Osaka Univ, Div Sustainable Energy & Environm Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ike@see.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24681010]	We appreciate the anonymous WWTP officials for allowing us to collect the samples used in this study and for providing helpful information. This study was partly supported by Grants-in-Aid for Young Scientists (A) (No. 24681010) from the Japan Society for the Promotion of Science (JSPS).	American Public Health Association, 1998, STANDARD METHODS EXA; Beun JJ, 2000, BIOTECHNOL BIOENG, V68, P496, DOI 10.1002/(SICI)1097-0290(20000605)68:5<496::AID-BIT3>3.0.CO;2-S; Reddy SV, 2008, WORLD J MICROB BIOT, V24, P2949, DOI 10.1007/s11274-008-9839-7; Sang NN, 2008, J BIOSCI BIOENG, V106, P425, DOI 10.1263/jbb.106.425; Mishima D, 2008, BIORESOURCE TECHNOL, V99, P2495, DOI 10.1016/j.biortech.2007.04.056; Serafim LS, 2004, BIOTECHNOL BIOENG, V87, P145, DOI 10.1002/bit.20085; MINO T, 1995, WATER SCI TECHNOL, V31, P25, DOI 10.1016/0273-1223(95)00177-O; Johnson K, 2009, BIOMACROMOLECULES, V10, P670, DOI 10.1021/bm8013796; Michinaka A, 2007, BIOTECHNOL BIOENG, V96, P871, DOI 10.1002/bit.21085; Lemos PC, 2006, J BIOTECHNOL, V122, P226, DOI 10.1016/j.jbiotec.2005.09.006; AMANN RI, 1995, MICROBIOL REV, V59, P143; Albuquerque MGE, 2010, WATER RES, V44, P3419, DOI 10.1016/j.watres.2010.03.021; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Fenu A, 2010, WATER RES, V44, P4272, DOI 10.1016/j.watres.2010.06.007; Jiang Y, 2011, BIOTECHNOL BIOENG, V108, P2022, DOI 10.1002/bit.23148; Sheu DS, 2000, MICROBIOL-UK, V146, P2019; Dias JML, 2006, MACROMOL BIOSCI, V6, P885, DOI 10.1002/mabi.200600112; Oshiki M, 2013, MICROBES ENVIRON, V28, P96, DOI 10.1264/jsme2.ME12141; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Sipma J, 2010, DESALINATION, V250, P653, DOI 10.1016/j.desal.2009.06.073; Chua ASM, 2003, WATER RES, V37, P3602, DOI 10.1016/S0043-1354(03)00252-5; Delrue F, 2011, DESALINATION, V272, P9, DOI 10.1016/j.desal.2010.12.056; Takabatake H, 2002, WATER SCI TECHNOL, V45, P119; Peng YZ, 2007, J ENVIRON SCI-CHINA, V19, P284, DOI 10.1016/S1001-0742(07)60046-1; VISHNIAC W, 1957, BACTERIOL REV, V21, P195; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Bengtsson S, 2009, BIOTECHNOL BIOENG, V104, P698, DOI 10.1002/bit.22444; Bitton G, 2005, WASTEWATER MICROBIOLOGY, 3RD EDITION, P1, DOI 10.1002/0471717967; Huda S. M. S., 2013, Journal of Water and Environment Technology, V11, P429, DOI 10.2965/jwet.2013.429; Jiang Y, 2011, INT J SYST EVOL MICR, V61, P2314, DOI 10.1099/ijs.0.021410-0; Matsuda M, 2010, WATER SCI TECHNOL, V61, P2843, DOI 10.2166/wst.2010.212; Moralejo-Garate H, 2011, APPL MICROBIOL BIOT, V92, P631, DOI 10.1007/s00253-011-3359-3; Oshiki M, 2008, WATER SCI TECHNOL, V58, P13, DOI 10.2166/wst.2008.652; Pramanik B. K., 2012, J ENG SCI TECHNOL, V7, P428; Satoh H, 1999, INT J BIOL MACROMOL, V25, P105, DOI 10.1016/S0141-8130(99)00021-5; SMOLDERS GJF, 1995, BIOTECHNOL BIOENG, V47, P277, DOI 10.1002/bit.260470302; STEINBUECHEL A, 1992, Current Opinion in Biotechnology, V3, P291, DOI 10.1016/0958-1669(92)90107-T; Victorio L, 1996, WATER RES, V30, P1077, DOI 10.1016/0043-1354(95)00269-3	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	JAN	2015	118	1					255	266		10.1111/jam.12683		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AW5UP	WOS:000346339500026		
J	Koyano, G; Jinno, T; Koga, D; Hoshino, C; Muneta, T; Okawa, A				Koyano, Gaku; Jinno, Tetsuya; Koga, Daisuke; Hoshino, Chisato; Muneta, Takeshi; Okawa, Atsushi			Is Closed Suction Drainage Effective in Early Recovery of Hip Joint Function? Comparative Evaluation in One-Stage Bilateral Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						closed suction drainage; one-stage bilateral THA; thermography; hip joint function; early recovery	TOTAL KNEE ARTHROPLASTY; CONTROLLED-TRIAL; WOUND DRAINAGE; PREVENTION; EFFICACY	One-stage primary bilateral cementless total hip arthroplasty with unilateral closed suction drainage (CSD) was prospectively performed for 51 patients (102 hips), and local effects of CSD were quantitatively evaluated. Postoperatively, pain scores evaluated by visual analog scale and periwound temperatures measured by thermography were lower in the CSD side than the non-CSD side. CT measurements also showed that postoperative cross-sectional area of the thigh was smaller in the CSD side. Active straight leg raising and weight bearing were more accelerated in the CSD side., showing earlier recovery of hip joint function. CSD for hip arthroplasty has an advantage in reducing postoperative local inflammation and be recommended from the viewpoint of postoperative pain relief and early recovery of hip joint function. (C) 2014 Elsevier Inc. All rights reserved.	[Koyano, Gaku; Jinno, Tetsuya; Koga, Daisuke; Hoshino, Chisato; Muneta, Takeshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Tokyo 1138519, Japan	Jinno, T (reprint author), Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						Johansson T, 2005, J ARTHROPLASTY, V20, P967, DOI 10.1016/j.arth.2005.02.004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; WAUGH TR, 1961, J BONE JOINT SURG AM, V43, P939; Walmsley PJ, 2005, J BONE JOINT SURG BR, V87B, P1397, DOI 10.1302/0301-62OX.87B10.16221; Della Valle AG, 2004, ACTA ORTHOP SCAND, V75, P30; Patel VP, 2007, J BONE JOINT SURG AM, V89A, P33, DOI 10.2106/JBJS.F.00163; Parker MJ, 2004, J BONE JOINT SURG AM, V86A, P1146; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Ovadia D, 1997, J ARTHROPLASTY, V12, P317, DOI 10.1016/S0883-5403(97)90029-2; Esler CNA, 2003, J BONE JOINT SURG BR, V85B, P215, DOI 10.1302/0301-620X.85B2.13357; Horstmann WG, 2012, INT ORTHOP, V36, P2033, DOI 10.1007/s00264-012-1613-7; Peters CL, 2006, J ARTHROPLASTY, V21, P132, DOI 10.1016/j.arth.2006.04.017; Niskanen RO, 2000, J ARTHROPLASTY, V15, P567, DOI 10.1054/arth.2000.6616; Kim YH, 1998, J ARTHROPLASTY, V13, P156, DOI 10.1016/S0883-5403(98)90093-6; BEER KJ, 1991, J BONE JOINT SURG AM, V73A, P584; Bjerke-Kroll BT, 2014, J ARTHROPLASTY, V29, P895, DOI 10.1016/j.arth.2013.10.027; Dora C, 2008, ACTA ORTHOP TRAUMA S, V127, P919; Goroll AH, 2009, PRIMARY CARE MED OFF; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Holt BT, 1997, ORTHOPEDICS, V20, P1121; Hosaka K, 2013, ORTHOPEDICS, V36, pE428, DOI 10.3928/01477447-20130327-17; Strahovnik A, 2010, J ARTHROPLASTY, V25, P244, DOI 10.1016/j.arth.2008.08.014; von Roth P, 2012, ORTHOPEDICS, V35, pE1592, DOI 10.3928/01477447-20121023-14	23	2	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	JAN	2015	30	1					74	78		10.1016/j.arth.2014.08.007		5	Orthopedics	Orthopedics	AW6OE	WOS:000346387900015		
J	Hara, Y; Ikoma, K; Arai, Y; Ohashi, S; Maki, M; Kubo, T				Hara, Yusuke; Ikoma, Kazuya; Arai, Yuji; Ohashi, Suzuyo; Maki, Masahiro; Kubo, Toshikazu			Alteration of Hindfoot Alignment After Total Knee Arthroplasty Using a Novel Hindfoot Alignment View	JOURNAL OF ARTHROPLASTY			English	Article						hind foot; TKA; coronal alignment; hindfoot view; X-ray	CORONAL ALIGNMENT; GENU-VARUM; FOOT	This study examined the coronal alignment of the hindfoot in varus osteoarthritis of the knee before and after total knee arthroplasty (TKA) in 100 legs using a novel imaging method. We categorized the preoperative hindfoot alignment into varus (30 legs) and valgus (70 legs) groups; imaging of the hindfoot was conducted preoperatively and postoperatively, and the varus-valgus angle (VVA) was measured as the hindloot alignment. The femorotibial angle improved significantly after TKA. We found that the VVA improved significantly after TKA in the hindfoot valgus group (P < 0.001), but not in the yams group (P = 0.554), and we speculate that the hindfoot alignment in the valgus group improved as a result of a residual compensatory capacity in the hindfoot. (C) 2014 Elsevier Inc. All rights reserved.	[Hara, Yusuke; Ikoma, Kazuya; Arai, Yuji; Ohashi, Suzuyo; Maki, Masahiro; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Dept Orthopaed, Grad Sch Med Sci, Kyoto 6028566, Japan	Ikoma, K (reprint author), Kyoto Prefectural Univ Med, Dept Orthopaed, Grad Sch Med Sci, Kamigyo Ku, 465 Kajiicho, Kyoto 6028566, Japan.						SALTZMAN CL, 1995, FOOT ANKLE INT, V16, P572; Mullaji A, 2011, CLIN ORTHOP RELAT R, V469, P1154, DOI 10.1007/s11999-010-1703-z; Desai SS, 2007, KNEE, V14, P452, DOI 10.1016/j.knee.2007.07.009; Nunley RM, 2012, CLIN ORTHOP RELAT R, V470, P895, DOI 10.1007/s11999-011-2222-2; KEENAN MAE, 1991, J BONE JOINT SURG AM, V73A, P237; Chandler JT, 2004, J ARTHROPLASTY, V19, P211, DOI 10.1016/j.arth.2003.09.007; Guichet JM, 2003, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000092973.12414.ec; Bouysset M, 2006, RHEUMATOID FOOT PATH, P9; COBEY JC, 1976, CLIN ORTHOP RELAT R, P202; Cobey J C, 1981, Foot Ankle, V2, P30; Deakin AH, 2012, KNEE, V19, P120, DOI 10.1016/j.knee.2011.02.001; Ikoma K, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-48; Johnson JE, 1999, FOOT ANKLE INT, V20, P818; Kelikian AS, 2011, SARRAFIANS ANATOMY F, P541; Lee ST, 2007, J BONE JOINT SURG BR, V89B, P57, DOI 10.1302/0301-620X.89B1.18223; Meding JB, 2005, J BONE JOINT SURG AM, V87A, P59, DOI 10.2106/JBJS.E,00484; Souter WA, 2006, SURG STRATEGY SURG L, P229	17	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	JAN	2015	30	1					126	129		10.1016/j.arth.2014.07.026		4	Orthopedics	Orthopedics	AW6OE	WOS:000346387900025		
J	Nakayama, Y; Takewa, Y; Sumikura, H; Yamanami, M; Matsui, Y; Oie, T; Kishimoto, Y; Arakawa, M; Ohmuma, K; Tajikawa, T; Kanda, K; Tatsumi, E				Nakayama, Yasuhide; Takewa, Yoshiaki; Sumikura, Hirohito; Yamanami, Masashi; Matsui, Yuichi; Oie, Tomonori; Kishimoto, Yuichiro; Arakawa, Mamoru; Ohmuma, Kentaro; Tajikawa, Tsutomu; Kanda, Keiichi; Tatsumi, Eisuke			In-body tissue-engineered aortic valve (Biovalve type VII) architecture based on 3D printer molding	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						tissue engineering; heart valve; 3D printer; connective tissue; surgery	CONDUIT BIOVALVE; MODEL; REPLACEMENT; TECHNOLOGY; DESIGN; SINUS; VITRO	In-body tissue architecturea novel and practical regeneration medicine technologycan be used to prepare a completely autologous heart valve, based on the shape of a mold. In this study, a three-dimensional (3D) printer was used to produce the molds. A 3D printer can easily reproduce the 3D-shape and size of native heart valves within several processing hours. For a tri-leaflet, valved conduit with a sinus of Valsalva (Biovalve type VII), the mold was assembled using two conduit parts and three sinus parts produced by the 3D printer. Biovalves were generated from completely autologous connective tissue, containing collagen and fibroblasts, within 2 months following the subcutaneous embedding of the molds (success rate, 27/30). In vitro evaluation, using a pulsatile circulation circuit, showed excellent valvular function with a durability of at least 10 days. Interposed between two expanded polytetrafluoroethylene grafts, the Biovalves (N=3) were implanted in goats through an apico-aortic bypass procedure. Postoperative echocardiography showed smooth movement of the leaflets with minimal regurgitation under systemic circulation. After 1 month of implantation, smooth white leaflets were observed with minimal thrombus formation. Functional, autologous, 3D-shaped heart valves with clinical application potential were formed following in-body embedding of specially designed molds that were created within several hours by 3D printer. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1-11, 2015.	[Nakayama, Yasuhide; Yamanami, Masashi; Matsui, Yuichi; Oie, Tomonori] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Osaka, Japan; [Takewa, Yoshiaki; Sumikura, Hirohito; Kishimoto, Yuichiro; Arakawa, Mamoru; Ohmuma, Kentaro; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, Osaka, Japan; [Yamanami, Masashi; Kanda, Keiichi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto, Japan; [Matsui, Yuichi; Tajikawa, Tsutomu] Kansai Univ, Dept Mech & Syst Engn, Osaka, Japan	Nakayama, Y (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Osaka, Japan.	ny@ncvc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [B23360374]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan; contract grant number: B23360374	Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1; Gagg G, 2013, MAT SCI ENG C-MATER, V33, P3858, DOI 10.1016/j.msec.2013.05.021; Sumikura H, 2014, ARTIF ORGANS, V38, P282, DOI 10.1111/aor.12173; Gandaglia A, 2011, EUR J CARDIO-THORAC, V39, P523, DOI 10.1016/j.ejcts.2010.07.030; Hayashida K, 2008, J BIOMED MATER RES B, V86B, P1, DOI 10.1002/jbm.b.30981; Meseguer-Olmo L, 2013, J BIOMED MATER RES A, V101, P2038, DOI 10.1002/jbm.a.34511; Nakayama Y, 2009, J BIOMED MATER RES B, V91B, P813, DOI 10.1002/jbm.b.31460; Butscher A, 2013, ACTA BIOMATER, V9, P9149, DOI 10.1016/j.actbio.2013.07.019; Yamanami M, 2010, J ARTIF ORGANS, V13, P106, DOI 10.1007/s10047-010-0491-2; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427; Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087; Berry JL, 2010, ANN BIOMED ENG, V38, P3272, DOI 10.1007/s10439-010-0148-6; Gheorghe C, 2007, J GASTROINTEST LIVER, V16, P309; Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005; Le Tourneau T, 1999, CIRCULATION, V100, P11; Mizuno T, J BIOMED B IN PRESS; Mol A, 2006, CIRCULATION, V114, P1, DOI 10.1161/CIRCULATIONAHA.105.001123; Moriwaki T, 2011, J ARTIF ORGANS, V14, P276, DOI 10.1007/s10047-011-0596-2; Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1; Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P135, DOI 10.1002/jbm.b.31880; Oie T, 2010, J ARTIF ORGANS, V13, P121, DOI 10.1007/s10047-010-0503-2	25	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	JAN	2015	103	1					1	11		10.1002/jbm.b.33186		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW3MT	WOS:000346191600001		
J	Du, DJ; Ushida, T; Furukawa, KS				Du, Dajiang; Ushida, Takashi; Furukawa, Katsuko S.			Influence of cassette design on three-dimensional perfusion culture of artificial bone	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						tissue engineering; osteogenesis; tissue culture; bone graft	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; OSTEOBLAST-LIKE CELLS; TRICALCIUM PHOSPHATE SCAFFOLDS; MINERALIZED MATRIX DEPOSITION; FLOW SHEAR-STRESS; DEPENDENT MANNER; IN-VITRO; BIOREACTOR; DIFFERENTIATION	Media perfusion is often required to maintain cell viability within topographically complex 3-dimensional scaffold cultures. Osteoblast-seeded scaffolds for bone regeneration require robust cell proliferation and survival both within the scaffold and over the exterior for optimal osteogenic capacity. Conventional press-fitting cassettes ensure internal fluid flow through the scaffold but may restrict external flow around the scaffold, resulting in a barren (cell-free) external scaffold surface. In this study, we aimed to solve this problem by modifying the cassette structure to enhance external flow in an oscillatory perfusion culture system. Mouse osteoblast-like MC 3T3-E1 cells were seeded in porous ceramic scaffolds and incubated for 3 days either under static culture conditions or in an oscillatory perfusion bioreactor. Scaffolds were held in the bioreactor with either conventional press-fitting cassettes or cassettes with rings to separate the scaffold exterior from the internal cassette wall. The external surfaces of scaffolds maintained under static conditions were well seeded, but cells failed to grow deeply into the core, reflecting poor internal chemotransport. Alternatively, scaffolds cultured by perfusion with press-fitting cassettes had poor cell viability at the cassette-external scaffold surface interface, but cells were widely distributed within the scaffold core. Scaffolds cultured using the modified cassettes with 1 or 2 rings exhibited uniformly distributed living cells throughout the internal pores and over the entire external surface, possibly because of the improved medium flow over the scaffold surface. This modified oscillatory perfusion culture system may facilitate the production of engineered bone with superior osteogenic capacity for grafting. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 84-91, 2015.	[Du, Dajiang] Harbin Med Univ, Sino Russian Inst Hard Tissue Dev & Regenerat, Dept Orthopaed Surg, Harbin 150086, Peoples R China; [Ushida, Takashi] Univ Tokyo, Sch Med, Div Biomed Mat & Syst, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; [Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan; [Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Biomed Engn Lab,Bunkyo Ku, Tokyo 1138656, Japan; [Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Du, DJ (reprint author), Harbin Med Univ, Sino Russian Inst Hard Tissue Dev & Regenerat, Dept Orthopaed Surg, Harbin 150086, Peoples R China.	dudajiang@gmail.com			Funding Program for Next Generation World-Leading Researchers [LR010]; Natural Science Foundation of China [31000433]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Natural Science Foundation of Heilongjiang Province [LC201020]	Contract grant sponsor: Funding Program for Next Generation World-Leading Researchers; contract grant number: LR010; Contract grant sponsor: Natural Science Foundation of China; contract grant number: 31000433; Contract grant sponsor: Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Contract grant sponsor: Natural Science Foundation of Heilongjiang Province; contract grant number: LC201020	Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967; Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028; Gardel LS, 2013, J BIOMED MATER RES B, V101, P1377, DOI 10.1002/jbm.b.32955; Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251; Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI 10.1089/ten.TEA.2008.0540; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI 10.1089/ten.TEA.2009.0164; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011; Du DJ, 2009, BIOTECHNOL BIOENG, V102, P1670, DOI 10.1002/bit.22214; Bjerre L, 2008, BIOMATERIALS, V29, P2616, DOI 10.1016/j.biomaterials.2008.03.003; Du DJ, 2009, ANN BIOMED ENG, V37, P146, DOI 10.1007/s10439-008-9586-9; Wang TW, 2009, J BIOMED MATER RES A, V88A, P935, DOI 10.1002/jbm.a.31914; Bjerre L, 2011, J BIOMED MATER RES A, V97A, P251, DOI 10.1002/jbm.a.33051; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5; Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126; Du DJ, 2008, J BIOMED MATER RES A, V86A, P796, DOI 10.1002/ibm.a.31641; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kreke MR, 2004, TISSUE ENG, V10, P780, DOI 10.1089/1076327041348455; Lan CW, 2003, J BIOMED MATER RES A, V66A, P38, DOI 10.1002/jbm.a.10507; Qian Xu, 2013, J Biomed Mater Res B Appl Biomater, V101, P893, DOI 10.1002/jbm.b.32894	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	JAN	2015	103	1					84	91		10.1002/jbm.b.33188		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW3MT	WOS:000346191600010		
J	Yazawa, M; Mori, T; Nakayama, Y; Kishi, K				Yazawa, Masaki; Mori, Taisuke; Nakayama, Yasuhide; Kishi, Kazuo			Basic study of soft tissue augmentation by adipose-inductive biomaterial	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						adipose; biomaterial; augmentation; soft tissue	ACTIVATED RECEPTOR-GAMMA; SALMON COLLAGEN; GROWTH-FACTOR; PPAR-GAMMA; ADIPOGENESIS; ADIPOCYTES; DIFFERENTIATION; GEL	Reconstructive surgery for tumor resection, trauma, and congenital anomaly involves volume augmentation with autologous tissue transfer. However, a healthy region is damaged as a donor site, and the autologous tissue is transferred like a patchwork to the recipient site. We have attempted to induce adipogenesis activity in artificial biomaterial that is injectable with an injection needle for soft tissue augmentation. First of all, the optimal dose of pioglitazone hydrochloride was examined with adipo-precursor cells in terms of the proliferator-activated receptor- mRNA expression levels affected by reagent in vitro. Then, salmon collagen with pioglitazone was adjusted in terms of the dose and the salmon collagen was injected into mouse back using an injection needle in vivo. At 4 weeks after implantation, the pioglitazone collagen gel was substituted by mature adipocytes in comparison with the case for control collagen gel without pioglitazone. These results are indicative of the possibility of promoting adipogenesis using collagen with pioglitazone as an adipose-inductive substance. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 92-96, 2015.	[Yazawa, Masaki; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Mori, Taisuke] Natl Canc Ctr Lab, Dept Pathol, Tokyo, Japan; [Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Osaka, Japan	Yazawa, M (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.	prsyazawa@gmail.com			Japan Society for the Promotion of Science [KAKENHI 23792059]	Contract grant sponsor: Japan Society for the Promotion of Science; contract grant number: KAKENHI 23792059	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Phulpin B, 2009, PLAST RECONSTR SURG, V123, P1187, DOI 10.1097/PRS.0b013e31819f2928; Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023; Kawaguchi Y, 2011, J MATER SCI-MATER M, V22, P397, DOI 10.1007/s10856-010-4215-1; Higashi Y, 2010, J BIOL CHEM, V285, P36361, DOI 10.1074/jbc.M110.137661; Rosen ED, 2000, GENE DEV, V14, P1293; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8; Bodles AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1100, DOI 10.1152/ajpendo.00187.2006; Findlay MW, 2009, PLAST RECONSTR SURG, V124, P1077, DOI 10.1097/PRS.0b013e3181b59ff6; Kelly JL, 2006, TISSUE ENG, V12, P2041, DOI 10.1089/ten.2006.12.2041; KERN PA, 1985, J CLIN INVEST, V75, P199, DOI 10.1172/JCI111675; Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121; Nagai N, 2008, J BIOSCI BIOENG, V106, P412, DOI 10.1263/jbb.106.412; Nagai N, 2009, J ARTIF ORGANS, V12, P61, DOI 10.1007/s10047-008-0446-z; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, P1195; Yamanouchi K, 2007, J REPROD DEVELOP, V53, P563, DOI 10.1262/jrd.18169; Youm YH, 2010, AGING CELL, V9, P478, DOI 10.1111/j.1474-9726.2010.00574.x; Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1016/S1389-1723(04)70240-6	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	JAN	2015	103	1					92	96		10.1002/jbm.b.33180		5	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW3MT	WOS:000346191600011		
J	Togami, W; Sei, A; Okada, T; Taniwaki, T; Fujimoto, T; Tahata, S; Nagamura, K; Nakanishi, Y; Mizuta, H				Togami, Wakana; Sei, Akira; Okada, Tatsuya; Taniwaki, Takuya; Fujimoto, Toru; Tahata, Shogo; Nagamura, Kazuma; Nakanishi, Yoshitaka; Mizuta, Hiroshi			Effects of the water-holding capability of polyvinyl formal sponges on osteogenic ability in in vivo experiments	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						coated polyvinyl formal sponge; high water-holding capability; osteogenic ability; bone tissue engineering; microcomputed tomography	CREST BONE-GRAFT; COMPOSITE SCAFFOLD; TISSUE FABRICATION; CELL-ADHESION; CARTILAGE; BIOCOMPATIBILITY; POLYSACCHARIDE; BIOMATERIALS; HYDROGELS; REPAIR	In this study, dextran-coated polyvinyl formal (PVF) sponges with high water-holding capability were developed to increase the osteogenic response in the PVF sponge. The study aimed to estimate the effect of the increased water-holding capability of the sponges on osteogenic capacity at a bone defect site in the rabbit femur epiphysis. Bone formation was evaluated using radiography, microcomputed tomography (CT), and histological analysis at 2, 4, and 6 weeks after implantation. As shown by radiography and micro-CT findings, the dextran-coated PVF sponge without water-holding capability showed little bone formation at all evaluated time points. However, the dextran-coated PVF sponge with high water-holding capability showed increasing bone formation around the implant at 4 and 6 weeks after implantation. Furthermore, as shown by micro-CT quantitative analysis, the grafted PVF sponge with high water-holding capability showed significantly greater values for percentage of bone volume per total volume and mean bone mineral density compared with the grafted PVF sponge without water-holding capability at 4 and 6 weeks after implantation. These results suggest that the dextran-coated PVF sponge with high water-holding capability promoted osteogenesis in vivo. The PVF sponge might be a new biomaterial to be used as a fill material for bone defects. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 188-194, 2015.	[Togami, Wakana; Sei, Akira; Okada, Tatsuya; Taniwaki, Takuya; Fujimoto, Toru; Tahata, Shogo; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan; [Nagamura, Kazuma; Nakanishi, Yoshitaka] Kumamoto Univ, Grad Sch Sci & Technol, Dept Adv Mech Syst, Chuo Ku, Kumamoto, Japan	Togami, W (reprint author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan.	wakana@fc.kuh.kumamoto-u.ac.jp					Albert Adrien, 2006, Acta Orthop Belg, V72, P734; CHENU C, 1993, GEODERMA, V56, P143, DOI 10.1016/0016-7061(93)90106-U; Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I; Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3; Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9; ROBINSON BP, 1995, OTOLARYNG HEAD NECK, V112, P707; Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0; Flory PJ, 1939, J AM CHEM SOC, V61, P1518, DOI 10.1021/ja01875a053; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094; Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013; Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I; Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014; Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259; Cadee JA, 2000, J BIOMED MATER RES, V50, P397; Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031; Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5; Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038; Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77; Beirne JC, 1996, INT J ORAL MAX SURG, V25, P268, DOI 10.1016/S0901-5027(06)80053-6; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300; Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5; FLORY PJ, 1950, J AM CHEM SOC, V72, P5052, DOI 10.1021/ja01167a064; LesGuehennec L, 2005, J BIOMED MATER RES B, V72, P69; Liu JM, 2000, ANTICANCER RES, V20, P3265; Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1; Nakanishi Y., 2009, J BIOMECH SCI ENG, V4, P249; Nodarian T, 2010, ORTHOP TRAUMATOL-SUR, V96, P593, DOI 10.1016/j.otsr.2010.03.016; Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008; Quezada Gallo J, 2005, ACTA HORTIC, V628, P1709; Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9; Togami W, 2014, J BIOMED MATER RES A, V102, P247, DOI 10.1002/jbma.34695; Yamaguchi Manae, 2004, J Artif Organs, V7, P187; Yoshikawa M, 2009, WORLD ACAD SCI ENG T, V54, P580; Yoshikawa Masataka, 2010, Journal of Biomedical Science & Engineering, V3, DOI 10.4236/jbise.2010.38100	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	JAN	2015	103	1					188	194		10.1002/jbm.b.33200		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW3MT	WOS:000346191600022		
J	Inoue, K; Tsuchiya, H; Takayama, T; Akatsu, H; Hashizume, Y; Yamamoto, T; Matsukawa, N; Toyo'oka, T				Inoue, Koichi; Tsuchiya, Hirofumi; Takayama, Takahiro; Akatsu, Hiroyasu; Hashizume, Yoshio; Yamamoto, Takayuki; Matsukawa, Noriyuki; Toyo'oka, Toshimasa			Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						HILIC/MS; Alzheimer's disease; Blood; Metabolomics	PREDICTIVE MODEL; LC-MS; BIOMARKERS; IDENTIFICATION; DEMENTIA; MARKERS	Early and definitive diagnosis of Alzheimer's disease (AD) can lead to a better and more-targeted treatment and/or prevention for patients. In the diagnostic biomarkers of AD, the blood sample represents a more non-invasive, inexpensive and acceptable sources for repeated measurements than the cerebrospinal fluid. In this study, the fingerprinting metabolomics was proposed for the challenge of the blood-based diagnosis of defined AD by hydrophilic interaction liquid chromatography mass spectrometry (HILIC/MS). These plasma samples were selected from postmortem specimens based on these pathological examinations. Firstly, we compared these HILIC columns for the non-targeted metabolic assay using pooled plasma. The principal component analysis plot of these seven columns was performed using the repeatability of these chromatograms, and can be used to visualize trends in data sets by three-dimensional dispersion, contributory standard deviation and the number of detections. Based on these results, TSK-Amide 80 and TSKgel-NH2 columns are used as a reliable HILIC/MS assay of blood-based AD metabolomics that showed metabolic profiling of the AD pathology in MS chromatograms that ranged from 1182 to 2284 compounds. A total of 54 peaks were evaluated in order to identify useful ion signal candidates using an orthogonal partial least-squares-discriminant analysis. These peaks were then specifically analyzed using the HILIC-tandem MS assay by a receiver operating characteristic curve and linear discriminant analysis for the diagnosis of the defined AD. The fingerprinting metabolomics can overcome the limitations of previous challenging blood-based diagnosis of AD, and directly evaluates the specific comparative statistical values from the raw data. (C) 2014 Elsevier B.V. All rights reserved.	[Inoue, Koichi; Tsuchiya, Hirofumi; Takayama, Takahiro; Toyo'oka, Toshimasa] Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Shizuoka 4228526, Japan; [Akatsu, Hiroyasu] Nagoya City Univ, Grad Sch Med Sci, Dept Med Aging Pl Community Hlth Care Community B, Nagoya, Aichi, Japan; [Hashizume, Yoshio; Yamamoto, Takayuki] Fukushimura Hosp, Choju Med Inst, Dept Neuropathol, Toyohashi, Aichi, Japan; [Matsukawa, Noriyuki] Univ Shizuoka, Grad Sch Med Sci, Dept Neurol, Shizuoka 4228526, Japan	Toyo'oka, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	toyooka@u-shizuoka-ken.ac.jp	Todoroki, Kenichiro/D-6152-2011		Japanese Brain Bank Network for Neuroscience Research and the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590061]	This study was supported by grants from the Japanese Brain Bank Network for Neuroscience Research and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant no. 24590061). We thank Norihiro Ogawa, Takeshi Kanesaka and Chie Taniguchi for their technical assistance in the clinical and pathological study, and all patients and relatives of the patients for the organ donation.	Akatsu Hiroyasu, 2010, Brain and Nerve (Tokyo), V62, P1043; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; Kawachi Y, 2011, J CHROMATOGR A, V1218, P5903, DOI 10.1016/j.chroma.2011.06.048; Snyder HM, 2014, ALZHEIMERS DEMENT, V10, P109, DOI 10.1016/j.jalz.2013.10.007; Xiao JF, 2012, TRAC-TREND ANAL CHEM, V32, P1, DOI 10.1016/j.trac.2011.08.009; Graff-Radford J, 2013, NEUROPSYCH DIS TREAT, V9, P687, DOI 10.2147/NDT.S35440; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Blennow K, 2013, MED CLIN N AM, V97, P369, DOI 10.1016/j.mcna.2012.12.012; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Li NJ, 2010, CLIN BIOCHEM, V43, P992, DOI 10.1016/j.clinbiochem.2010.04.072; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Jandera P, 2011, ANAL CHIM ACTA, V692, P1, DOI 10.1016/j.aca.2011.02.047; Spagou K, 2010, J SEP SCI, V33, P716, DOI 10.1002/jssc.200900803; Knopman DS, 2001, NEUROLOGY, V56, P1143; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Arevalo-Rodriguez I, 2013, AM J ALZHEIMERS DIS, V28, P111, DOI 10.1177/1533317512470209; Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x; Ibanez C, 2012, ANAL CHEM, V84, P8532, DOI 10.1021/ac301243k; Ibanez C, 2013, J CHROMATOGR A, V1302, P65, DOI 10.1016/j.chroma.2013.06.005; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Lista S., 2013, ALZHEIMERS DEMEN, V13, pS1552; Patti GJ, 2011, J SEP SCI, V34, P3460, DOI 10.1002/jssc.201100532; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Trushina E., 2013, PLOS ONE; Tumani H, 2012, CURR PHARM DESIGN, V18, P4556; Van Dorpe S, 2010, J SEP SCI, V33, P728, DOI 10.1002/jssc.200900476	27	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	JAN 1	2015	974						24	34		10.1016/j.jchromb.2014.10.022		11	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AW8WS	WOS:000346540800004		
J	Arita, M; Kilpatrick, DR; Nakamura, T; Burns, CC; Bukbuk, D; Oderinde, SB; Oberste, MS; Kew, OM; Pallansch, MA; Shimizu, H				Arita, Minetaro; Kilpatrick, David R.; Nakamura, Tomofumi; Burns, Cara C.; Bukbuk, David; Oderinde, Soji B.; Oberste, M. Steven; Kew, Olen M.; Pallansch, Mark A.; Shimizu, Hiroyuki			Development of an Efficient Entire-Capsid-Coding-Region Amplification Method for Direct Detection of Poliovirus from Stool Extracts	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							DEOXYINOSINE RESIDUES; CODON DEGENERACY; MIXED-BASE; RT-PCR; IDENTIFICATION; PRIMERS; SEROTYPE; POSITIONS	Laboratory diagnosis has played a critical role in the Global Polio Eradication Initiative since 1988, by isolating and identifying poliovirus (PV) from stool specimens by using cell culture as a highly sensitive system to detect PV. In the present study, we aimed to develop a molecular method to detect PV directly from stool extracts, with a high efficiency comparable to that of cell culture. We developed a method to efficiently amplify the entire capsid coding region of human enteroviruses (EVs) including PV. cDNAs of the entire capsid coding region (3.9 kb) were obtained from as few as 50 copies of PV genomes. PV was detected from the cDNAs with an improved PV-specific real-time reverse transcription-PCR system and nucleotide sequence analysis of the VP1 coding region. For assay validation, we analyzed 84 stool extracts that were positive for PV in cell culture and detected PV genomes from 100% of the extracts (84/84 samples) with this method in combination with a PV-specific extraction method. PV could be detected in 2/4 stool extract samples that were negative for PV in cell culture. In PV-positive samples, EV species C viruses were also detected with high frequency (27% [23/86 samples]). This method would be useful for direct detection of PV from stool extracts without using cell culture.	[Arita, Minetaro; Nakamura, Tomofumi; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Kilpatrick, David R.; Burns, Cara C.; Oberste, M. Steven; Kew, Olen M.; Pallansch, Mark A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Bukbuk, David; Oderinde, Soji B.] Univ Maiduguri, Teaching Hosp, WHO Natl Polio Lab, Maiduguri, Nigeria	Arita, M (reprint author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	minetaro@nih.go.jp			World Health Organization	This report is based on research funded by a grant from the World Health Organization for a collaborative research project of the Global Polio Eradication Initiative.	Kilpatrick DR, 1996, J CLIN MICROBIOL, V34, P2990; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.0.CO;2-H; Kilpatrick DR, 2011, J VIROL METHODS, V174, P128, DOI 10.1016/j.jviromet.2011.03.020; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kilpatrick DR, 1998, J CLIN MICROBIOL, V36, P352; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; Kilpatrick DR, 2014, J VIROL METHODS, V197, P25, DOI 10.1016/j.jviromet.2013.11.017; Arita M, 2013, J CLIN MICROBIOL, V51, P2717, DOI 10.1128/JCM.00499-13; Arita M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-208; BODIAN D, 1951, Am J Hyg, V54, P191; Laassri M, 2013, J VIROL METHODS, V189, P7, DOI 10.1016/j.jviromet.2012.12.015; Racaniello VR., 2013, FIELDS VIROLOGY, V1, P453; WHO, 2004, WHOIVB0410	13	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	JAN	2015	53	1					73	78		10.1128/JCM.02384-14		6	Microbiology	Microbiology	AW8HM	WOS:000346502200013		
J	Kishishita, N; Sasayama, M; Takeda, N; Sa-ngasang, A; Anuegoonpipat, A; Anantapreecha, S				Kishishita, Natsuko; Sasayama, Mikiko; Takeda, Naokazu; Sa-ngasang, Areerat; Anuegoonpipat, Atchareeya; Anantapreecha, Surapee			Neutralization Activity of Patient Sera Collected during the 2008-2009 Chikungunya Outbreak in Thailand	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							VIRUS-INFECTION; ARTHRALGIA; ANTIBODIES; DISEASE; PHASE	Chikungunya virus (CHIKV) infection typically causes fever, rash, myalgia, and arthralgia and sometimes results in recurrent joint pain or, in severe cases, neurological disorders or death. How CHIKV infection leads to prolonged or severe symptoms is still not well understood. In this study, we examined the neutralization (NT) titer of 98 serum samples collected from patients during the 2008-2009 chikungunya outbreak in Thailand. While all serum samples showed neutralizing activity, virus was detected in 58% of the serum samples. When we analyzed a possible association between virus and antibody titers and the presence of typical symptoms of CHIKV infection, fever and joint pain, there was no significant association except that the number of patients with fever was over three times more than the number of those without fever when CHIKV was detectable in serum. This study indicates that although neutralizing antibody is critical to eliminate CHIKV, it appears not to be the main factor associated with clinical symptoms in some cases, so that other aspects of immune responses, such as those involving proinflammatory mediators and adaptive immune cells, should be considered altogether.	[Kishishita, Natsuko; Takeda, Naokazu] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Kishishita, Natsuko; Sasayama, Mikiko; Takeda, Naokazu] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Sasayama, Mikiko] MOCID, Bangkok, Thailand; [Sa-ngasang, Areerat; Anuegoonpipat, Atchareeya; Anantapreecha, Surapee] NIH, Dept Med Sci, Minist Publ Hlth, Nonthaburi, Thailand	Kishishita, N (reprint author), Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Ibaraki, Osaka, Japan.	nkishishita@nibio.go.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Department of Medical Sciences, Ministry of Public Health, Thailand	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), sponsored by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This study was also supported by the Department of Medical Sciences, Ministry of Public Health, Thailand.	Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674; Butler D, 2012, NATURE, V489, P187, DOI 10.1038/489187a; Chusri Sarunyou, 2014, Am J Trop Med Hyg, V90, P410, DOI 10.4269/ajtmh.12-0681; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Kishishita N, 2013, J CLIN MICROBIOL, V51, P1389, DOI 10.1128/JCM.03109-12; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Roth A, 2014, EMERG INFECT DIS, V20; Sasayama M, 2010, VIRUS GENES; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sreekumar E, 2010, VIRUS GENES, V40, P14, DOI 10.1007/s11262-009-0411-9; Wanlapakorn N, 2014, EMERG INFECT DIS, V20, P1404, DOI 10.3201/eid2008.140481	24	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	JAN	2015	53	1					184	190		10.1128/JCM.02744-14		7	Microbiology	Microbiology	AW8HM	WOS:000346502200028		
J	Toriyama, K; Suzuki, T; Inoue, T; Eguchi, H; Hoshi, S; Inoue, Y; Aizawa, H; Miyoshi, K; Ohkubo, M; Hiwatashi, E; Tachibana, H; Ohashi, Y				Toriyama, Koji; Suzuki, Takashi; Inoue, Tomoyuki; Eguchi, Hiroshi; Hoshi, Saichi; Inoue, Yoshitsugu; Aizawa, Hideki; Miyoshi, Kazutomi; Ohkubo, Michio; Hiwatashi, Eiji; Tachibana, Hiroshi; Ohashi, Yuichi			Development of an Immunochromatographic Assay Kit Using Fluorescent Silica Nanoparticles for Rapid Diagnosis of Acanthamoeba Keratitis	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							POLYMERASE-CHAIN-REACTION; INFECTIONS; MASQUERADE; GROWTH; MEDIA; PCR	We developed an immunochromatographic assay kit that uses fluorescent silica nanoparticles bound to anti-Acanthamoeba antibodies (fluorescent immunochromatographic assay [FICGA]) and evaluated its efficacy for the detection of Acanthamoeba and diagnosis of Acanthamoeba keratitis (AK). The sensitivity of the FICGA kit was evaluated using samples of Acanthamoeba trophozoites and cysts diluted to various concentrations. A conventional immunochromatographic assay kit with latex labels (LICGA) was also evaluated to determine its sensitivity in detecting Acanthamoeba trophozoites. To check for cross-reactivity, the FICGA was performed by using samples of other common causative pathogens of infectious keratitis, such as Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, and Candida albicans. Corneal scrapings from patients with suspected AK were tested with the FICGA kit to detect the presence of Acanthamoeba, and the results were compared with those of real-time PCR. The FICGA kit detected organisms at concentrations as low as 5 trophozoites or 40 cysts per sample. There were no cross-reactivities with other pathogens. The FICGA was approximately 20 times more sensitive than the LICGA for the detection of Acanthamoeba trophozoites. The FICGA kit yielded positive results for all 10 patients, which corresponded well with the real-time PCR results. The FICGA kit demonstrated high sensitivity for the detection of Acanthamoeba and may be useful for the diagnosis of AK.	[Toriyama, Koji; Suzuki, Takashi; Inoue, Tomoyuki; Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Matsuyama, Ehime 790, Japan; [Eguchi, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 770, Japan; [Hoshi, Saichi] Fujieda Municipal Gen Hosp, Shizuoka, Japan; [Inoue, Yoshitsugu] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Tottori 680, Japan; [Aizawa, Hideki; Miyoshi, Kazutomi; Ohkubo, Michio] Furukawa Elect Corp Ltd, Tokyo, Japan; [Hiwatashi, Eiji] Ofuna Chuo Hosp, Dept Ophthalmol, Kanagawa, Japan; [Tachibana, Hiroshi] Tokai Univ, Sch Med, Dept Infect Dis, Kanagawa 2591100, Japan	Suzuki, T (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol, Matsuyama, Ehime 790, Japan.	t-suzuki@m.ehime-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [H23-Shinkosaiko-ippan-014]	This study was supported in part by a grant for research on emerging and reemerging infectious diseases from the Ministry of Health, Labor and Welfare of Japan (H23-Shinkosaiko-ippan-014).	Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Illingworth CD, 1998, SURV OPHTHALMOL, V42, P493, DOI 10.1016/S0039-6257(98)00004-6; Hammersmith KM, 2006, CURR OPIN OPHTHALMOL, V17, P327, DOI 10.1097/01.icu.0000233949.56229.7d; WILHELMUS KR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1309; Claerhout I, 2004, GRAEF ARCH CLIN EXP, V242, P648, DOI 10.1007/s00417-003-0805-7; Shiraishi A, 2009, BRIT J OPHTHALMOL, V93, P1563, DOI 10.1136/bjo.2009.158113; Ikeda Y, 2012, OPHTHALMOLOGY, V119, P1111, DOI 10.1016/j.ophtha.2011.12.023; BACON AS, 1993, EYE, V7, P719; BACON AS, 1993, OPHTHALMOLOGY, V100, P1238; Battaglioli G, 2012, J CLIN VIROL, V53, P262, DOI 10.1016/j.jcv.2011.12.007; BYERS TJ, 1980, J PROTOZOOL, V27, P216, DOI 10.1111/j.1550-7408.1980.tb04684.x; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P532; CHAGLA AH, 1974, J GEN MICROBIOL, V85, P139; Goldschmidt P, 2008, BRIT J OPHTHALMOL, V92, P112, DOI 10.1136/bjo.2007.125898; Hahn TW, 1998, JPN J OPHTHALMOL, V42, P108, DOI 10.1016/S0021-5155(97)00127-5; Hiwatashi Eiji, 1997, Parasitology International, V46, P197, DOI 10.1016/S1383-5769(97)00029-9; Hoshino T, 2002, OPHTHALMOLOGY, V109, P808, DOI 10.1016/S0161-6420(01)01028-4; Hotomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033620; HOUGH EA, 1969, VISION RES, V9, P313, DOI 10.1016/0042-6989(69)90009-1; Inoue Y, 2013, BRIT J OPHTHALMOL, V97, P1108, DOI 10.1136/bjophthalmol-2012-302254; Itahashi M, 2011, CORNEA, V30, P1233, DOI 10.1097/ICO.0b013e3182032196; JOHNS KJ, 1987, CURR EYE RES, V6, P207, DOI 10.3109/02713688709020092; Kandori M, 2010, CORNEA, V29, P228, DOI 10.1097/ICO.0b013e3181a39020; Lehmann OJ, 1998, INVEST OPHTH VIS SCI, V39, P1261; MERGERYAN H, 1991, REV INFECT DIS, V13, pS390; Mitamura K, 2013, J VIROL METHODS, V194, P123, DOI 10.1016/j.jviromet.2013.08.018; Mito T, 2012, INVEST OPHTH VIS SCI, V53, P6305, DOI 10.1167/iovs.12-9828; Pasricha G, 2003, J CLIN MICROBIOL, V41, P3206, DOI 10.1128/JCM.41.7.3206-3211.2003; Penland RL, 1997, J CLIN MICROBIOL, V35, P915; Radford CF, 2002, BRIT J OPHTHALMOL, V86, P536, DOI 10.1136/bjo.86.5.536; TAYKEARNEY ML, 1993, AUST NZ J OPHTHALMOL, V21, P237, DOI 10.1111/j.1442-9071.1993.tb00962.x; Thebpatiphat Nuthida, 2007, Cornea, V26, P701, DOI 10.1097/ICO.0b013e31805b7e63; Uchio E, 1997, OPHTHALMOLOGY, V104, P1294; Yera H, 2007, EUR J CLIN MICROBIOL, V26, P221, DOI 10.1007/s10096-007-0268-6	34	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	JAN	2015	53	1					273	277		10.1128/JCM.02595-14		5	Microbiology	Microbiology	AW8HM	WOS:000346502200039		
J	Maeda, E; Murakami, K; Etoh, Y; Onozuka, D; Sera, N; Asoshima, N; Honda, M; Narimatsu, H; Iyoda, S; Watahiki, M; Fujimoto, S				Maeda, Eriko; Murakami, Koichi; Etoh, Yoshiki; Onozuka, Daisuke; Sera, Nobuyuki; Asoshima, Nanami; Honda, Mikiko; Narimatsu, Hiroshi; Iyoda, Sunao; Watahiki, Masanori; Fujimoto, Shuji			Does Sequence Type 33 of Shiga Toxin-Producing Escherichia coli O91 Cause Only Mild Symptoms?	JOURNAL OF CLINICAL MICROBIOLOGY			English	Letter									[Maeda, Eriko; Murakami, Koichi; Etoh, Yoshiki; Onozuka, Daisuke; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka, Japan; [Asoshima, Nanami; Honda, Mikiko] Fukuoka City Inst Hyg & Environm, Jigyohama, Fukuoka, Japan; [Narimatsu, Hiroshi] Oita Prefectural Inst Hlth & Environm, Microbiol Lab, Oita, Japan; [Iyoda, Sunao] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Watahiki, Masanori] Toyama Inst Hlth, Imizu, Toyama, Japan; [Fujimoto, Shuji] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Maidashi, Fukuoka, Japan	Murakami, K (reprint author), Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka, Japan.	murakami@fihes.pref.fukuoka.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188			Bonnet R, 1998, J CLIN MICROBIOL, V36, P1777; Mellmann A, 2009, EMERG INFECT DIS, V15, P1474, DOI 10.3201/eid1509.090161; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; National Institute of Infectious Diseases, 2010, INFECT AGENTS SURVEI, V31, P169	4	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	JAN	2015	53	1					362	364		10.1128/JCM.02335-14		3	Microbiology	Microbiology	AW8HM	WOS:000346502200063		
J	Greaves, G; Koolen, J; Munemasa, A; Sano, Y; Taniguchi, T				Greaves, Gary; Koolen, Jack; Munemasa, Akihiro; Sano, Yoshio; Taniguchi, Tetsuji			Edge-signed graphs with smallest eigenvalue greater than - 2	JOURNAL OF COMBINATORIAL THEORY SERIES B			English	Article						Signed graphs; Line graphs; Smallest eigenvalue; Hoffman graphs; Hoffman conjecture	FAT HOFFMAN GRAPHS	We give a structural classification of edge-signed graphs with smallest eigenvalue greater than -2. We prove a conjecture of Hoffman about the smallest eigenvalue of the line graph of a tree that was stated in the 1970s. Furthermore, we prove a more general result extending Hoffman's original statement to all edge-signed graphs with smallest eigenvalue greater than -2. Our results give a classification of the special graphs of fat Hoffman graphs with smallest eigenvalue greater than -3. (C) 2014 Elsevier Inc. All rights reserved.	[Greaves, Gary; Munemasa, Akihiro] Tohoku Univ, Res Ctr Pure & Appl Math, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Koolen, Jack] Chinese Acad Sci, Sch Math Sci, USTC, Hefei 230026, Anhui, Peoples R China; [Koolen, Jack] Chinese Acad Sci, Wen Tsun Wu Key Lab, Hefei 230026, Anhui, Peoples R China; [Sano, Yoshio] Univ Tsukuba, Fac Engn Informat & Syst, Div Informat Engn, Ibaraki 3058573, Japan; [Taniguchi, Tetsuji] Matsue Coll Technol, Matsue, Shimane 6908518, Japan	Greaves, G (reprint author), Tohoku Univ, Res Ctr Pure & Appl Math, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan.	grwgrvs@ims.is.tohoku.ac.jp; koolen@ustc.edu.cn; munemasa@math.is.tohoku.ac.jp; sano@cs.tsukuba.ac.jp; tetsuzit@matsue-ct.ac.jp		Munemasa, Akihiro/0000-0002-2635-0733; Greaves, Gary/0000-0002-7342-4790; Koolen, Jack/0000-0002-8623-5681	JSPS KAKENHI [24.02789, 25887007, 25400217]; JSPS; '100 talents' program of the Chinese Academy of Sciences	GG was supported by JSPS KAKENHI; grant number: 24.02789.; Part of this work was done while JHK was visiting Tohoku University with a JSPS visitors grant. He also greatly appreciates the support of the '100 talents' program of the Chinese Academy of Sciences.; YS was supported by JSPS KAKENHI; grant number: 25887007.; TT was supported by JSPS KAKENHI; grant number: 25400217.	Bosma W., 2013, HDB MAGMA FUNCTIONS; Brouwer AE, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-1939-6; BUSSEMAKER FC, 1992, MATH COMPUT, V59, P583, DOI 10.2307/2153076; CAMERON PJ, 1976, J ALGEBRA, V43, P305, DOI 10.1016/0021-8693(76)90162-9; Cvetkovic D., 2004, LONDON MATH SOC LECT, V314; DOOB M, 1979, LINEAR ALGEBRA APPL, V27, P17, DOI 10.1016/0024-3795(79)90028-4; Doob M., 1973, Journal of Combinatorial Theory, Series B, V15, DOI 10.1016/0095-8956(73)90030-0; Gleitz A.-S., ARXIV13072738V1; Godsil C.D., 2000, GRADUATE TEXTS MATH; HOFFMAN AJ, 1977, LINEAR ALGEBRA APPL, V16, P153, DOI 10.1016/0024-3795(77)90027-1; Hoffman A.J., 1977, ARS COMBINATORIA, V3, P3; Ishihara T., 2002, J MATH U TOKUSHIMA, V36, P1; Jang HJ, 2014, ARS MATH CONTEMP, V7, P105; Johnson C. R., 1985, MATRIX ANAL; Mckee J, 2007, J ALGEBRA, V317, P260, DOI 10.1016/j.jalgebra.2007.05.019; Munemasa A, 2014, DISCRETE APPL MATH, V176, P78, DOI 10.1016/j.dam.2014.01.008; Munemasa A, 2014, ARS MATH CONTEMP, V7, P247; VIJAYAKUMAR GR, 1987, EUR J COMBIN, V8, P103; VIJAYAKUMAR GR, 1993, ARS COMBINATORIA, V35, P173; WOO R, 1995, LINEAR ALGEBRA APPL, V226, P577, DOI 10.1016/0024-3795(95)00245-M	20	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0095-8956	1096-0902		J COMB THEORY B	J. Comb. Theory Ser. B	JAN	2015	110						90	111		10.1016/j.jctb.2014.07.006		22	Mathematics	Mathematics	AW6PZ	WOS:000346392400006		
J	Nakada, M; Miyano, Y				Nakada, Masayuki; Miyano, Yasushi			Advanced accelerated testing methodology for long-term life prediction of CFRP laminates	JOURNAL OF COMPOSITE MATERIALS			English	Article						Carbon fiber-reinforced plastics; life prediction; accelerated testing; time-temperature superposition principle	FATIGUE-STRENGTH; MARINE USE; TEMPERATURE; STRESS; FORMULATION; COMPOSITES; RESIN	An advanced accelerated testing methodology (ATM-2) for long-term life prediction of CFRP laminates exposed to actual loading with a general stress and temperature history is proposed based on the conventional accelerated testing methodology (ATM-1) established for the long-term life prediction of CFRP laminates exposed to stress and temperature. The most important condition for ATM-1 is that the time-temperature superposition principle held for the viscoelastic behavior of matrix resin holds also for the static, creep, and fatigue strengths of CFRP laminates. Furthermore, three conditions that form the basis of ATM-2 are introduced along with their scientific bases. The long-term fatigue strength of CFRP laminates under an actual loading is formulated based on the three conditions. The viscoelastic coefficients of matrix resin, which perform an important role for the time and temperature dependence of long-term life of CFRP laminates, are also formulated based on the time-temperature superposition principle. The applicability of ATM-2 is demonstrated by predicting the long-term fatigue strengths of four typical directions of unidirectional CFRP laminates.	[Nakada, Masayuki; Miyano, Yasushi] Kanazawa Inst Technol, Mat Syst Res Lab, Haku San, Ishikawa 9240838, Japan	Nakada, M (reprint author), Kanazawa Inst Technol, Mat Syst Res Lab, 3-1 Yatsukaho, Haku San, Ishikawa 9240838, Japan.	nakada@neptune.kanazawa-it.ac.jp			Office of Naval Research; Verification of Accelerated Testing Methodology for Long-Term Durability of CFRP laminates for Marine Use [N000140611139]	The authors thank the Office of Naval Research for supporting this work through an ONR award with Dr Yapa Rajapakse as the ONR Program Officer. Our award, numbered as N000140611139, is "Verification of Accelerated Testing Methodology for Long-Term Durability of CFRP laminates for Marine Use''. The authors thank Professor Richard Christensen, Stanford University as a consultant of this project.	Miyano Y, 2005, J COMPOS MATER, V39, P5, DOI 10.1177/0021998305046430; Miyano Y, 1999, ADV COMPOS MATER, V8, P235, DOI 10.1163/156855199X00236; Christensen R, 2006, INT J FRACTURE, V137, P77, DOI 10.1007/s10704-005-9062-6; Miyano Y, 1997, J COMPOS MATER, V31, P619; Nakada M, 2009, COMPOS SCI TECHNOL, V69, P805, DOI 10.1016/j.compscitech.2008.02.030; Miyano Y, 2008, J COMPOS MATER, V42, P1897, DOI 10.1177/0021998308093913; Cai HN, 2013, MECH TIME-DEPEND MAT, V17, P137, DOI 10.1007/s11043-012-9174-0; Christensen RM, 1982, THEORY VISCOELASTICI; Miyano Y., 1999, Mechanics of Time-Dependent Materials, V3, DOI 10.1023/A:1009873124095; MIYANO Y, 1982, EXP MECH, V22, P310, DOI 10.1007/BF02327249; Nakada M, 2013, J COMPOS MATER, V47, P1897, DOI 10.1177/0021998312452025; Nakada M, 2011, MECH TIME-DEPEND MAT, V15, P309, DOI 10.1007/s11043-011-9139-8; Tsai S.W., 1992, THEORY COMPOSITES DE	13	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	JAN	2015	49	2					163	175		10.1177/0021998313515019		13	Materials Science, Composites	Materials Science	AW9RA	WOS:000346593600003		
J	Takeda, T; Shindo, Y; Narita, F				Takeda, Tomo; Shindo, Yasuhide; Narita, Fumio			Flexural stiffness variations of woven carbon fiber composite/shape memory polymer hybrid layered beams	JOURNAL OF COMPOSITE MATERIALS			English	Article						Mesomechanics; mechanical testing finite element analysis; functional composites; polymer-matrix composites; shape memory polymers; deformation; resistance heating; morphing	WEAVE FABRIC COMPOSITES; THERMOMECHANICAL BEHAVIOR; TEMPERATURES; AIRCRAFT	This paper studies the flexural stiffness controllability of hybrid layered beams with woven carbon fiber reinforced polymer composite and shape memory polymer layers. The temperature of the shape memory polymer layer was controlled using electrical resistive heating of the woven carbon fiber reinforced polymer layers. Flexure tests were then conducted on the layered cantilever beams, and the temperature dependence of the beam flexural stiffness was examined. A three-dimensional finite element analysis was also performed to predict the flexural response of the layered beams, and a good correlation was observed between the predicted and measured results for the flexural stiffness. In addition, the deformation states in the layered beams were determined numerically and discussed in detail.	[Takeda, Tomo; Shindo, Yasuhide; Narita, Fumio] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan	Shindo, Y (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Aoba Yama 6-6-02, Sendai, Miyagi 9808579, Japan.	shindo@material.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under the Grant-in-Aid for Young Scientists (B).	Thill C, 2008, AERONAUT J, V112, P117; Sofla AYN, 2010, MATER DESIGN, V31, P1284, DOI 10.1016/j.matdes.2009.09.011; Mcknight G, 2010, J INTEL MAT SYST STR, V21, P1783, DOI 10.1177/1045389X10386399; Qi HJ, 2008, J MECH PHYS SOLIDS, V56, P1730, DOI 10.1016/j.jmps.2007.12.002; Takeda T, 2004, MECH ADV MATER STRUC, V11, P109, DOI 10.1080/15376490490277312; Ramrakhyani DS, 2005, J AIRCRAFT, V42, P1615; Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001; [Anonymous], 2000, D3039D3039M00 ASTM; Gandhi F, 2007, SMART MATER STRUCT, V16, P1179, DOI 10.1088/0964-1726/16/4/028; Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k; Barbarino S, 2011, J INTEL MAT SYST STR, V22, P823, DOI 10.1177/1045389X11414084; Kwok N, 2007, J COMPOS MATER, V41, P1635, DOI 10.1177/0021998306069876; HAHN HT, 1994, J ENG MATER-T ASME, V116, P517, DOI 10.1115/1.2904322; Kawai M, 2006, COMPOS PART A-APPL S, V37, P243, DOI 10.1016/j.compositesa.2005.07.003; Naik NK, 1997, J MATER SCI, V32, P267, DOI 10.1023/A:1018524626673	15	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	JAN	2015	49	2					209	216		10.1177/0021998313515458		8	Materials Science, Composites	Materials Science	AW9RA	WOS:000346593600007		
J	Miura, R; Haneda, S; Kayano, M; Matsui, M				Miura, R.; Haneda, S.; Kayano, M.; Matsui, M.			Short communication: Development of the first follicular wave dominant follicle on the ovary ipsilateral to the corpus luteum is associated with decreased conception rate in dairy cattle	JOURNAL OF DAIRY SCIENCE			English	Article						first-wave dominant follicle; corpus luteum; conception rate	HUMAN CHORIONIC-GONADOTROPIN; ESTROUS-CYCLE; COWS; PROGESTERONE; INSEMINATION; DYNAMICS; HEIFERS	In this study, we examined the effect of the locations of the first-wave dominant follicle (DF) and corpus luteum (CL) on fertility. In total, 350 artificial insemination (AI) procedures were conducted (lactating dairy cows: n = 238, dairy heifers: n = 112). Ovulation was confirmed 24 h after AI. The locations of the first-wave DF and CL were examined 5 to 9 d after AT using rectal palpation or transrectal ultrasonography. Lactating dairy cows and dairy heifers were divided into 2 groups: (1) the ipsilateral group (IG), in which the DF was ipsilateral to the CL; and (2) the contralateral group (CG), in which the DF was contralateral to the CL. Pregnancy was diagnosed using transrectal ultrasonography 40 d after AI. Conception rates were 54.0% in all cattle: 48.9% in lactating dairy cows, and 58.9% in dairy heifers. The incidence of the first-wave DF location did not differ between IG and CC (all cattle: 184 vs. 166; lactating cows: 129 vs. 109; heifers: 55 vs. 57 for IC vs. CG). Conception rates were lower in IG than in CG (all cattle: 40.2 vs. 69.3%; lactating dairy cows: 38.0 vs. 67.0%; dairy heifers: 45.5 vs. 73.7%, for IC vs. CG). Conception rate was not affected by season or live weight in heifers and lactating cows. In addition, days in milk at AI, milk production, body condition score, and parity did not affect conception in lactating cows. In summary, development of the first-wave DF in the ovary ipsilateral to the CL was associated with reduced conception rates in both lactating cows and heifers.	[Miura, R.] Gifu Univ, United Grad Sch Vet Sci, Yanagi, Gifu 5011193, Japan; [Miura, R.; Haneda, S.; Matsui, M.] Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan; [Kayano, M.] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan	Matsui, M (reprint author), Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan.	mmatsui@obihiro.ac.jp			Japan Society for the Promotion of Science (JSPS) [26660234]	This study was supported by the Grant-in-Aid for Scientific Research (26660234) from the Japan Society for the Promotion of Science (JSPS).	Ulbrich SE, 2003, J STEROID BIOCHEM, V84, P279, DOI 10.1016/S0960-0760(03)00039-6; SIROIS J, 1988, BIOL REPROD, V39, P308, DOI 10.1095/biolreprod39.2.308; GINTHER OJ, 1989, J REPROD FERTIL, V87, P223; Nascimento AB, 2013, J DAIRY SCI, V96, P2873, DOI 10.3168/jds.2012-5895; Santos JEP, 2001, J ANIM SCI, V79, P2881; Adams GP, 2008, THERIOGENOLOGY, V69, P72, DOI 10.1016/j.theriogenology.2007.09.026; BADINGA L, 1992, BIOL REPROD, V47, P871, DOI 10.1095/biolreprod47.5.871; CERBITO WA, 1994, THERIOGENOLOGY, V42, P941, DOI 10.1016/0093-691X(94)90117-2; GINTHER OJ, 1989, THERIOGENOLOGY, V32, P787, DOI 10.1016/0093-691X(89)90467-6; Hanlon DW, 2005, THERIOGENOLOGY, V63, P1938, DOI 10.1016/j.theriogenology.2004.09.002; SAVIO JD, 1993, J REPROD FERTIL, V97, P197; Wijayagunawardane MPB, 1998, THERIOGENOLOGY, V49, P607, DOI 10.1016/S0093-691X(98)00011-9; Xiao CW, 1999, J REPROD FERTIL, V115, P101	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	JAN	2015	98	1					318	321		10.3168/jds.2014-8388		4	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	AX0DC	WOS:000346622600035		
J	Nakao, Y; Konno-Nagasaka, M; Toriya, N; Arakawa, T; Kashio, H; Takuma, T; Mizoguchi, I				Nakao, Y.; Konno-Nagasaka, M.; Toriya, N.; Arakawa, T.; Kashio, H.; Takuma, T.; Mizoguchi, I.			Proteoglycan Expression Is Influenced by Mechanical Load in TMJ Discs	JOURNAL OF DENTAL RESEARCH			English	Article						temporomandibular joint; biglycan; decorin; chondroadherin; versican; glycosaminoglycan (GAG)	TEMPOROMANDIBULAR-JOINT DISC; EXTRACELLULAR-MATRIX; ARTICULAR DISK; PROTEIN; RAT; GLYCOSAMINOGLYCAN; CARTILAGE; VERSICAN; ATTACHMENT; LOCALIZATION	The expression and assembly of the extracellular matrix are profoundly associated with adaptive and pathological responses of the temporomandibular joint (TMJ). To better understand the adaptive responses of the TMJ disc to mechanical loading, we examined the expression of 2 modular proteoglycans and 10 small leucine-rich proteoglycans (SLRPs) at the mRNA and protein levels and determined the contents of proteoglycan-related glycosaminoglycans (GAGs) in rat TMJ discs in response to altered mechanical loading caused by an incisal bite plane. One hundred thirty 7-week-old male Wistar rats were assigned to control and bite plane groups. TMJ disc thickness and the intensity of toluidine blue staining of metachromasia increased in the posterior band after 2 weeks of wearing the bite plane. GAG content increased significantly in the bite plane group after 2 weeks. Quantitative real-time RT-PCR (reverse transcription polymerase chain reaction) analysis indicated that biglycan and chondroadherin mRNA levels increased after 2 weeks and that the level of decorin mRNA increased at 4 weeks. Versican mRNA levels increased after 3 weeks, particularly for the V0 and V1 versican isoforms, which carry more GAG attachment sites than do the V2 and V3 isoforms. Western analysis demonstrated a corresponding increase in the levels of versican, biglycan, and decorin core proteins at 4 weeks in the bite plane group. These results indicate that mechanical loading differentially influences proteoglycan mRNA expression and protein accumulation in the TMJ disc. The change in proteoglycan mRNA and protein levels may lead to the modulation of matrix-matrix and cell-matrix interactions and has important biological significance for adaptation to complicated biomechanical requirements and for tissue maintenance in the TMJ disc.	[Nakao, Y.; Konno-Nagasaka, M.; Toriya, N.; Kashio, H.; Mizoguchi, I.] Hlth Sci Univ Hokkaido, Sch Dent, Div Orthodont & Dentofacial Orthoped, Dept Oral Growth & Dev, Ishikari, Hokkaido 0610293, Japan; [Arakawa, T.; Takuma, T.] Hlth Sci Univ Hokkaido, Sch Dent, Div Biochem, Dept Oral Biol, Ishikari, Hokkaido 0610293, Japan	Nakao, Y (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Div Orthodont & Dentofacial Orthoped, Dept Oral Growth & Dev, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	y-nakao@hoku-iryo-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [20390525, 25293421]	The authors would like to thank Dr. P.G. Scott and Dr. F. Rahemtulla for their generous gifts of decorin (3B3) and versican antibodies (5D5), respectively. We thank Dr. K. Irie, Department of Histology, and Dr. M. Saito, Department of Pedodontics, Health Sciences University of Hokkaido, for their helpful advice. This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (Nos. 20390525 and 25293421). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	MILLS DK, 1988, ARCH ORAL BIOL, V33, P195, DOI 10.1016/0003-9969(88)90045-3; Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436; ZAKO M, 1995, J BIOL CHEM, V270, P3914; FISHER LW, 1989, J BIOL CHEM, V264, P4571; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Stegenga B, 2001, J OROFAC PAIN, V15, P193; Detamore MS, 2005, MATRIX BIOL, V24, P45, DOI 10.1016/j.matbio.2004.11.006; MILAM SB, 1991, J ORAL MAXIL SURG, V49, P381, DOI 10.1016/0278-2391(91)90376-W; EVANKO SP, 1993, ARCH BIOCHEM BIOPHYS, V307, P153, DOI 10.1006/abbi.1993.1574; Theocharis AD, 2001, ATHEROSCLEROSIS, V154, P367, DOI 10.1016/S0021-9150(00)00504-9; Tanaka E, 2008, J DENT RES, V87, P296; Wang XD, 2012, J DENT RES, V91, P499, DOI 10.1177/0022034512441946; Iozzo RV, 1996, FASEB J, V10, P598; Mao JJ, 1998, J DENT RES, V77, P1520; MERRILEES MJ, 1980, AM J ANAT, V157, P87, DOI 10.1002/aja.1001570109; NAKANO T, 1989, ARCH ORAL BIOL, V34, P749, DOI 10.1016/0003-9969(89)90082-4; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; BLAUSTEIN DI, 1986, PLAST RECONSTR SURG, V78, P756; CARVALHO RS, 1995, AM J ORTHOD DENTOFAC, V107, P401, DOI 10.1016/S0889-5406(95)70093-5; Haglund L, 2013, J BIOL CHEM, V288, P995, DOI 10.1074/jbc.M112.430512; Herring S. W., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P391; Herring SW, 2003, J MUSCULOSKEL NEURON, V3, P406; Hiiemae KM, 1971, J DENT RES, V46, P883; HINTON RJ, 1988, ACTA ANAT, V131, P136; Huddleston Slater J. J. R., 1999, Journal of Dental Research, V78, P1815; Hylander WL, 1985, DEV ASPECTS TEMPOROM, P19; Katzberg RW, 1993, DIAGNOSIS TEMPOROMAN, P25; Korioth Tom W. P., 1994, Journal of Orofacial Pain, V8, P178; Kuwabara M, 2002, ARCH ORAL BIOL, V47, P473, DOI 10.1016/S0003-9969(02)00021-3; LARSSON T, 1991, J BIOL CHEM, V266, P20428; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; O'Connor JJ, 1993, MICROMOVEMENT ORTHOP, P244; OSBORN JW, 1985, J ORAL REHABIL, V12, P279, DOI 10.1111/j.1365-2842.1985.tb01283.x; SCOTT PG, 1995, BBA-GEN SUBJECTS, V1244, P121, DOI 10.1016/0304-4165(94)00209-G; Shen ZX, 1998, BIOCHEM J, V330, P549; Sindelar BJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P64, DOI 10.1006/abbi.2000.1855; Sun L, 2009, ANGLE ORTHOD, V79, P51, DOI 10.2319/091907-450.1; Toriya N, 2006, HISTOCHEM CELL BIOL, V125, P205, DOI 10.1007/s00418-005-0020-1; WEIJS WA, 1975, J MORPHOL, V146, P1, DOI 10.1002/jmor.1051460102; Willard VP, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005763	41	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JAN	2015	94	1					93	100		10.1177/0022034514553816		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW8IW	WOS:000346506200013		
J	Nakaki, T; Saito, K; Ida-Yonemochi, H; Nakagawa, E; Kenmotsu, S; Ohshima, H				Nakaki, T.; Saito, K.; Ida-Yonemochi, H.; Nakagawa, E.; Kenmotsu, S.; Ohshima, H.			Contribution of Donor and Host Mesenchyme to the Transplanted Tooth Germs	JOURNAL OF DENTAL RESEARCH			English	Article						bromodeoxyuridine; cell differentiation; cell proliferation; dental pulp; odontoblasts; mice (inbred B6)	DENTAL-PULP CELLS; STEM-CELLS; MOUSE MOLARS; RAT MOLARS; MICE; DIFFERENTIATION; CAPACITY; PROLIFERATION; MORPHOGENESIS; REPLANTATION	Autologous tooth germ transplantation of immature teeth is an alternative method of tooth replacement that could be used instead of dental implants in younger patients. However, it is paramount that the dental pulp remain vital and that root formation continue in the transplanted location. The goal of this study is to characterize the healing of allogenic tooth grafts in an animal model using GFP-labeled donor or host postnatal mice. In addition, the putative stem cells were labeled before transplantation with a pulse-chase paradigm. Transplanted molars formed cusps and roots and erupted into occlusion by 2 wk postoperatively. Host label-retaining cells (LRCs) were maintained in the center of pulp tissue associating with blood vessels. Dual labeling showed that a proportion of LRCs were incorporated into the odontoblast layer. Host cells, including putative dendritic cells and the endothelium, also immigrated into the pulp tissue but did not contribute to the odontoblast layer. Therefore, LRCs or putative mesenchymal stem cells are retained in the transplanted pulps. Hertwig's epithelial root sheath remains vital, and epithelial LRCs are present in the donor cervical loops. Thus, the dynamic donor-host interaction occurred in the developing transplant, suggesting that these changes affect the characteristics of the dental pulp.	[Nakaki, T.; Saito, K.; Ida-Yonemochi, H.; Nakagawa, E.; Kenmotsu, S.; Ohshima, H.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Anat & Cell Biol Hard Tissue, Niigata 9518514, Japan	Ohshima, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Anat & Cell Biol Hard Tissue,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	histoman@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science [23593026]	We are grateful to Professor Masaru Okabe for providing GFP mice. This work was supported by a Grant-in-Aid for Scientific Research (type C; grant 23593026) from the Japan Society for the Promotion of Science. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Bradford GB, 1997, EXP HEMATOL, V25, P445; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13; Kallu R, 2005, INT J ORAL MAX SURG, V34, P745, DOI 10.1016/j.ijom.2005.03.009; Saito K, 2013, J ENDODONT, V39, P1250, DOI 10.1016/j.joen.2013.06.017; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013; Ohazama A, 2004, J DENT RES, V83, P518; Lovschall H, 2007, INT J DEV BIOL, V51, P715, DOI 10.1387/ijdb.072393hl; Chai Y, 2000, DEVELOPMENT, V127, P1671; Balic A, 2010, BONE, V46, P1639, DOI 10.1016/j.bone.2010.02.019; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Janebodin K, 2013, J DENT RES, V92, P524, DOI 10.1177/0022034513485599; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Hasegawa T, 2007, CELL TISSUE RES, V329, P259, DOI 10.1007/s00441-007-0424-4; Ishikawa Y, 2010, HISTOCHEM CELL BIOL, V134, P227, DOI 10.1007/s00418-010-0727-5; Ishikawa Y, 2012, CELL TISSUE RES, V348, P95, DOI 10.1007/s00441-012-1347-2; Keller LV, 2012, INT J DEV BIOL, V56, P737, DOI 10.1387/ijdb.120076hl; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; MAKSUDOV MM, 1980, ACTA CHIR PLAST, V22, P220; Mutoh N, 2011, HISTOCHEM CELL BIOL, V136, P649, DOI 10.1007/s00418-011-0868-1; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119; Saito K, 2011, BIOMED RES-TOKYO, V32, P247; Shimizu A, 2000, CELL TISSUE RES, V302, P221, DOI 10.1007/s004410000263; Takamori Y, 2008, J HISTOCHEM CYTOCHEM, V56, P1075, DOI 10.1369/jhc.2008.951558; Tsukamoto-Tanaka H, 2006, CELL TISSUE RES, V325, P219, DOI 10.1007/s00441-005-0138-4; Tsuruga E, 1999, HISTOCHEM CELL BIOL, V112, P193, DOI 10.1007/s004180050407; Unno H, 2009, ANAT REC, V292, P570, DOI 10.1002/ar.20831; Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6	31	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JAN	2015	94	1					112	120		10.1177/0022034514556536		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW8IW	WOS:000346506200015		
J	Blackburn, J; Kawasaki, K; Porntaveetus, T; Kawasaki, M; Otsuka-Tanaka, Y; Miake, Y; Ota, MS; Watanabe, M; Hishinuma, M; Nomoto, T; Oommen, S; Ghafoor, S; Harada, F; Nozawa-Inoue, K; Maeda, T; Peterkova, R; Lesot, H; Inoue, J; Akiyama, T; Schmidt-Ullrich, R; Liu, B; Hu, Y; Page, A; Ramirez, A; Sharpe, PT; Ohazama, A				Blackburn, J.; Kawasaki, K.; Porntaveetus, T.; Kawasaki, M.; Otsuka-Tanaka, Y.; Miake, Y.; Ota, M. S.; Watanabe, M.; Hishinuma, M.; Nomoto, T.; Oommen, S.; Ghafoor, S.; Harada, F.; Nozawa-Inoue, K.; Maeda, T.; Peterkova, R.; Lesot, H.; Inoue, J.; Akiyama, T.; Schmidt-Ullrich, R.; Liu, B.; Hu, Y.; Page, A.; Ramirez, A.; Sharpe, P. T.; Ohazama, A.			Excess NF-kappa B Induces Ectopic Odontogenesis in Embryonic Incisor Epithelium	JOURNAL OF DENTAL RESEARCH			English	Article						Ikk beta; tooth development; Wnt signaling; enamel; cervical loop; wise	SIGNALING PATHWAYS; TOOTH DEVELOPMENT; STEM-CELLS; MOUSE; TEETH; MICE; SOSTDC1; NUMBER; ALPHA; MSX1	Nuclear factor kappa B (NF-kappa B) signaling plays critical roles in many physiological and pathological processes, including regulating organogenesis. Down-regulation of NF-kappa B signaling during development results in hypohidrotic ectodermal dysplasia. The roles of NF-kappa B signaling in tooth development, however, are not fully understood. We examined mice overexpressing IKK beta, an essential component of the NF-kappa B pathway, under keratin 5 promoter (K5-Ikk beta). K5-Ikk beta mice showed supernumerary incisors whose formation was accompanied by up-regulation of canonical Wnt signaling. Apoptosis that is normally observed in wild-type incisor epithelium was reduced in K5-Ikk beta mice. The supernumerary incisors in K5-Ikk beta mice were found to phenocopy extra incisors in mice with mutations of Wnt inhibitor, Wise. Excess NF-kappa B activity thus induces an ectopic odontogenesis program that is usually suppressed under physiological conditions.	[Blackburn, J.; Kawasaki, K.; Porntaveetus, T.; Kawasaki, M.; Otsuka-Tanaka, Y.; Oommen, S.; Ghafoor, S.; Harada, F.; Nozawa-Inoue, K.; Sharpe, P. T.; Ohazama, A.] Kings Coll London, Craniofacial Dev & Stem Cell Biol & Biomed Res Ct, London SE1 9RT, England; [Kawasaki, K.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Niigata 9518514, Japan; [Porntaveetus, T.] Chulalongkorn Univ, Fac Dent, Dept Physiol, Bangkok, Thailand; [Kawasaki, M.] Niigata Univ, Grad Sch Med & Dent Sci, Course Oral Life Sci, Div Bioprosthodont,Dept Oral Hlth Sci, Niigata 9518514, Japan; [Otsuka-Tanaka, Y.; Hishinuma, M.; Nomoto, T.] Nihon Univ, Sch Dent, Dept Special Needs Dent, Matsudo, Chiba 271, Japan; [Miake, Y.] Tokyo Dent Coll, Dept Ultrastruct Sci, Chiyoda Ku, Tokyo, Japan; [Ota, M. S.] Japan Womens Univ, Dept Food & Nutr, Lab Food Biol Sci, Bunkyo Ku, Tokyo, Japan; [Watanabe, M.; Maeda, T.; Ohazama, A.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Oral Anat, Niigata 9518514, Japan; [Peterkova, R.] Acad Sci CR, Inst Expt Med, Dept Teratol, Prague, Czech Republic; [Lesot, H.] Univ Strasbourg, Fac Chirurg Dent, Team Osteoarticular & Dent Regenerat NanoMed, INSERM UMR S1109,FMTS,Fac Med, Strasbourg, France; [Inoue, J.; Akiyama, T.] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo, Japan; [Schmidt-Ullrich, R.] Max Delbruck Ctr Mol Med, Dept Signal Transduct Tumor Cells, Berlin, Germany; [Liu, B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Hu, Y.] NCI, Lab Expt Immunol, Inflammat & Tumorigenesis Sect, Frederick, MD 21701 USA; [Page, A.; Ramirez, A.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Dept Epithelial Biomed, Madrid, Spain	Sharpe, PT (reprint author), Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England.	paul.sharpe@kcl.ac.uk; atsushiohazama@dent.niigata-u.ac.jp			Grant Agency of the Czech Republic (CZ:GA) [CR:14-37368G]; Thailand Research Fund [TRG5780209]; Ratchadaphiseksomphot Endowment Fund [RES560530253-AS]; Faculty Research Grant of Faculty of Dentistry Chulalongkorn University [DRF56018]; Japan Society for the Promotion of Science (JSPS) [26293421]; Nihon University; JSPS;  [MRC-GR-200709]	We would like to thank Tony Brain for scanning electron microscope analysis, Chris Healy for micro-CT analysis, Dr. Koyama for HistoneH4C plasmid, Alasdair Edgar and Alex Huhn for their technical help, and K. Lochovska, S. Vojtechova, M. Hovorakova, S. Kieffer, and T. Boran for help with 3-dimensional reconstructions. This research was funded by grant MRC-GR-200709, Grant Agency of the Czech Republic (CZ:GA CR:14-37368G); Thailand Research Fund (TRG5780209); Ratchadaphiseksomphot Endowment Fund (RES560530253-AS) and Faculty Research Grant (DRF56018) of Faculty of Dentistry Chulalongkorn University; and the Japan Society for the Promotion of Science (JSPS; 26293421). Y.O.-T. is supported by Nihon University. M.K. and K.K. are supported by the JSPS International Program for Young Researcher Overseas Visits. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Page A, 2010, J INVEST DERMATOL, V130, P1598, DOI 10.1038/jid.2010.28; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Lomada D, 2007, J IMMUNOL, V178, P829; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Lesot H, 1996, INT J DEV BIOL, V40, P1017; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Blackburn J, 2012, DEV BIOL, V365, P61, DOI 10.1016/j.ydbio.2012.02.009; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Kaler Pawan, 2009, Cancer Microenviron, V2, P69, DOI 10.1007/s12307-009-0030-y; Lapthanasupkul P, 2012, DEV BIOL, V367, P140, DOI 10.1016/j.ydbio.2012.04.029; HIRSCHFE.Z, 1973, J DENT RES, V52, P377, DOI 10.1177/00220345730520023201; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Ohazama A, 2004, DEV CELL, V6, P219, DOI 10.1016/S1534-5807(04)00024-3; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Peterková R, 2002, Orthod Craniofac Res, V5, P215, DOI 10.1034/j.1600-0544.2002.02226.x; Rose KD, 2005, RISE PLACENTAL MAMMA; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106	30	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JAN	2015	94	1					121	128		10.1177/0022034514556707		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW8IW	WOS:000346506200016		
J	Kikuta, J; Yamaguchi, M; Shimizu, M; Yoshino, T; Kasai, K				Kikuta, J.; Yamaguchi, M.; Shimizu, M.; Yoshino, T.; Kasai, K.			Notch Signaling Induces Root Resorption via RANKL and IL-6 from hPDL Cells	JOURNAL OF DENTAL RESEARCH			English	Article						Notch signal; orthodontic force; tooth movement; inflammatory cytokines; odontoclasts; osteoclastogenesis	PERIODONTAL-LIGAMENT CELLS; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS	In this study, we first investigated the expressions of Jagged1, Notch2, the receptor activator of nuclear factor-kappa B ligand (RANKL), and interleukin (IL)-6 in areas of root resorption during experimental tooth movement in rats in vivo. We then assessed the effects of compression force (CF) with or without GSI (an inhibitor of Notch signaling) on Jagged1, RANKL, and IL-6 release from human periodontal ligament (hPDL) cells. Twelve male 6-wk-old Wistar rats were subjected to an orthodontic force of 50 g to induce mesially tipping movement of the upper first molars for 7 d. The expression levels of tartrate-resistant acid phosphatase, Jagged1, Notch2, IL-6, and RANKL proteins in the dental root were determined using an immunohistochemical analysis. Furthermore, the effects of the CF on Jagged1, IL-6, and RANKL production were investigated using hPDL cells in vitro. The effects of the cell-conditioned medium obtained from the hPDL cells subjected to CF (CFM) and Jagged 1 on osteoclastogenesis of human osteoclast precursor cells (hOCPs) were also investigated. Under the conditions of experimental tooth movement in vivo, resorption lacunae with multinucleated cells were observed in the 50 g group. In addition, immunoreactivity for Jagged1, Notch2, IL-6, and RANKL was detected on day 7 in the PDL tissue subjected to the orthodontic force. In the in vitro study, the compression force increased the production of Jagged1, IL-6, and RANKL from the hPDL cells, whereas treatment with GSI inhibited the production of these factors in vitro. The osteoclastogenesis increased with the CFM and rhJagged1, and the increase in the osteoclastogenesis was almost inhibited by GSI. These results suggest that the Notch signaling response to excessive orthodontic forces stimulates the process of root resorption via RANKL and IL-6 production from hPDL cells.	[Kikuta, J.; Yamaguchi, M.; Shimizu, M.; Yoshino, T.; Kasai, K.] Nihon Univ, Sch Dent, Dept Orthodont, Matsudo, Chiba 2718587, Japan	Yamaguchi, M (reprint author), Nihon Univ, Sch Dent, Dept Orthodont, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	yamaguchi.masaru@nihon-u.ac.jp			Japan Society for the Promotion of Science [C:25463200]	This research was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C:25463200). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Yamaguchi M, 2009, ORTHOD CRANIOFAC RES, V12, P113, DOI 10.1111/j.1601-6343.2009.01444.x; Hayashi N, 2012, ORAL DIS, V18, P375, DOI 10.1111/j.1601-0825.2011.01886.x; KALEY J, 1991, ANGLE ORTHOD, V61, P125; Nakajima R, 2008, J PERIODONTAL RES, V43, P168, DOI 10.1111/j.1600-0765.2007.01008.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Yamaguchi M, 2006, J DENT RES, V85, P751; Souilhol C, 2006, MOL CELL BIOL, V26, P4769, DOI 10.1128/MCB.00319-06; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Asano M, 2011, ORAL DIS, V17, P489, DOI 10.1111/j.1601-0825.2010.01780.x; Duan L, 2013, EUR J ORTHODONT, V35, P175, DOI 10.1093/ejo/cjs002; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Henrikson T, 2009, SWED DENT J, V33, P59; Kunii R, 2013, KOREAN J ORTHOD, V43, P294, DOI 10.4041/kjod.2013.43.6.294; Li Y, 2014, CELL BIOL INT, V38, P729, DOI 10.1002/cbin.10257; Nakano Y, 2010, EUR J ORTHODONT, V33, P335; Nakao A, 2009, J DENT RES, V88, P551, DOI 10.1177/0022034509337899; Nobuta M, 2005, J BIOL CHEM, V280, P15842; Osathanon T, 2012, J BIOMED MATER RES A, V101, P358; Ugarte F, 2009, EXP HEMATOL, V37, P867, DOI 10.1016/j.exphem.2009.03.007; Yamada K, 2013, ORAL DIS, V19, P683, DOI 10.1111/odi.12053; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JAN	2015	94	1					140	147		10.1177/0022034514555364		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW8IW	WOS:000346506200018		
J	Hashimoto, N; Kurita, Y; Murakami, K; Wada, H				Hashimoto, Naoki; Kurita, Yoshihisa; Murakami, Kana; Wada, Hiroshi			Cleavage Pattern and Development of Isolated D Blastomeres in Bivalves	JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION			English	Article							BITHYNIA-TENTACULATA PROSOBRANCHIA; CENTROSOME-ATTRACTING BODY; ASYMMETRIC CELL-DIVISION; GASTROPOD ILYANASSA; ASCIDIAN EMBRYO; CILIARY BANDS; MICROMERES; OBSOLETA; MOLLUSCA; POLARITY	Although bivalves develop through spiral cleavage patterns, similar to other lophotrochozoans, the cleavage pattern of D lineage blastomeres is unique, since 2d shows four rounds of stereotypic unequal cleavage before bilateral cleavage of the largest derivative of 2d: 2d(1121). This unique modification of spiral cleavage is directly associated with the characteristic morphology of bivalves, namely, bilaterally separated shell plates, because the bilateral shell plates are thought to be derived from the bilateral derivatives of 2d(1121). In this report, to determine whether the unique cleavage pattern of bivalves is regulated depending on the interaction with other cells or by cell autonomous mechanisms, we performed cell isolation experiments and observed subsequent cleavage patterns of isolated blastomeres. When focusing on the largest derivatives of D blastomeres, 8% of isolated D blastomeres followed the cleavage pattern of normal development up to bilateral cleavage. Importantly, the remainder of the partial embryos ended cleavage before that stage, and none of the isolated blastomeres showed abnormal cleavage patterns. We also examined the development of isolated blastomeres and found that isolated D blastomeres could develop shell plates, whereas larvae developed from AB blastomeres never had shell plates. Based on these observations, we concluded that D blastomeres control their unique cleavage pattern through intrinsic mechanisms and develop shell glands autonomously without any cell-cell interaction with other lineages. J. Exp. Zool. (Mol. Dev. Evol.) 324B: 13-21, 2015. (c) 2014 Wiley Periodicals, Inc.	[Hashimoto, Naoki; Kurita, Yoshihisa; Murakami, Kana; Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kurita, Yoshihisa] Kyushu Univ, Fishery Res Lab, Fukutsu, Japan	Hashimoto, N (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	jin3c@yahoo.co.jp			JSPS [12J01644]	Grant sponsor: Grant-in-Aid for JSPS Fellows; grant number: 12J01644.	Alford LM, 2009, DEV BIOL, V330, P12, DOI 10.1016/j.ydbio.2009.02.039; Kin K, 2009, DEV BIOL, V329, P152, DOI 10.1016/j.ydbio.2009.01.021; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Hashimoto N, 2012, DEV BIOL, V366, P367, DOI 10.1016/j.ydbio.2012.04.010; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nielsen C, 2004, J EXP ZOOL PART B, V302B, P35, DOI 10.1002/jez.b.20001; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Hejnol A, 2007, DEV BIOL, V305, P63, DOI 10.1016/j.ydbio.2007.01.044; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BERG WE, 1950, BIOL BULL, V98, P128, DOI 10.2307/1538574; CATHER JN, 1976, AM ZOOL, V16, P455; CATHER JN, 1967, J EXP ZOOL, V166, P205, DOI 10.1002/jez.1401660204; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1967, J EXP ZOOL, V166, P77, DOI 10.1002/jez.1401660109; Conklin EG, 1897, J MORPHOL, V13, P3; CRAMPTON H.E., 1896, ARCH ENTW MECH, V3, P1, DOI 10.1007/BF02156309; DAN K, 1979, DEV GROWTH DIFFER, V21, P527; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; GUERRIER P, 1970, J EMBRYOL EXP MORPH, V23, P667; Hess O., 1956, ROUX ARCH ENTW MECH, V148, P336; Hibino T, 1998, DEV GROWTH DIFFER, V40, P85; Kurita Y, 2009, ZOOL SCI, V26, P814, DOI 10.2108/zsj.26.814; Lillie FR, 1895, J MORPHOL, V10, P1, DOI DOI 10.1002/JMOR.1050100102; MCCAIN ER, 1992, DEV DYNAM, V195, P188; Meisenheimer J, 1901, Z WISS ZOOL ABT A, V69, P1; RATTENBURY JC, 1954, J MORPHOL, V95, P393, DOI 10.1002/jmor.1050950302; RENDER J, 1991, DEVELOPMENT, V113, P495; SATOH N, 1981, J EMBRYOL EXP MORPH, V61, P1; VERDONK NH, 1973, J EXP ZOOL, V186, P47, DOI 10.1002/jez.1401860108; Waller Thomas R., 1998, P1; Wilson EB, 1904, J EXP ZOOL, V1, P197, DOI 10.1002/jez.1400010202	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5007	1552-5015		J EXP ZOOL PART B	J. Exp. Zool. Part B	JAN	2015	324	1					13	21		10.1002/jez.b.22585		9	Evolutionary Biology; Developmental Biology; Zoology	Evolutionary Biology; Developmental Biology; Zoology	AW4RC	WOS:000346267300002		
J	Kawaguchi, M; Tomita, K; Sano, K; Kaneko, T				Kawaguchi, Mari; Tomita, Kenji; Sano, Kaori; Kaneko, Toyoji			Molecular Events in Adaptive Evolution of the Hatching Strategy of Ovoviviparous Fishes	JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION			English	Article							INTRON-LOSS EVOLUTION; EGG ENVELOPE CHORION; ORYZIAS-LATIPES; GENE-EXPRESSION; ENZYME GENES; PRECURSOR PROTEIN; TELEOST; CLONING; COMPONENT; SUBUNIT	Ovoviviparous fish, whose embryonic development and hatching take place in the maternal body, is one of the good model organisms for studying adaptive evolution. Using genome database of the ovoviviparous platy Xiphophorus maculatus, we tried to search hatching enzyme genes (high choriolytic enzyme HCE and low choriolytic enzyme LCE) and egg envelope protein genes (choriogenin H, Hm, and L). Analysis of genes co-localized with them confirmed that shared synteny was found between platy and medaka genome. Both hatching enzyme genes HCE and LCE were pseudogenized in platy. In addition, one of the three choriogenin genes Hm was completely lost from the genome, the other two genes H and L encoded functional proteins. On the other hand, the expression of H and L was very low as compared to oviparous fishes, and the platy egg envelope was extremely thinner. Considering that ovoviviparous fish embryos are protected in the maternal body, an importance of egg envelope for protection of egg/embryo would be reduced in the ovoviviparous fishes. Platy embryos would escape from their thin egg envelope without help of hatching enzymes. In another ovoviviparous fish, black rockfish belonging to different order from the platy, one of the hatching enzyme genes has been reported to be pseudogenized, that is, the embryo of black rockfish can escape from egg envelope by only one hatching enzyme HCE. Adaptive evolution of the hatching strategy of ovoviviparous teleosts may be established by pseudogenization of hatching enzyme genes and/or lowering of expression and/or pseudogenization of hatching enzyme and egg envelope genes. J. Exp. Zool. (Mol. Dev. Evol.) 324B: 41-50, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kawaguchi, Mari] Sophia Univ, Dept Mat & Life Sci, Fac Sci & Technol, Tokyo 1028554, Japan; [Tomita, Kenji] Univ Tokyo, Technol Advancement Ctr, Grad Sch Agr & Life Sci, Tokyo, Japan; [Sano, Kaori] Josai Univ, Dept Chem, Fac Sci, Saitama, Japan; [Kaneko, Toyoji] Univ Tokyo, Dept Aquat Biosci, Grad Sch Agr & Life Sci, Tokyo, Japan	Kawaguchi, M (reprint author), Sophia Univ, Dept Mat & Life Sci, Fac Sci & Technol, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	k-mari@sophia.ac.jp			JSPS [23870025, 24770231]	Grant sponsor: JSPS KAKENHI; grant numbers: 23870025, 24770231.	Murata K, 1997, P NATL ACAD SCI USA, V94, P2050, DOI 10.1073/pnas.94.5.2050; Sano K, 2010, FEBS J, V277, P4674, DOI 10.1111/j.1742-4658.2010.07874.x; Hyde JR, 2007, MOL PHYLOGENET EVOL, V44, P790, DOI 10.1016/j.ympev.2006.12.026; YAMAGAMI K, 1992, INT REV CYTOL, V136, P51; Kawaguchi M, 2007, GENE, V392, P77, DOI 10.1016/j.gene.2006.11.012; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Yasumasu S, 2010, J BIOCHEM, V148, P439, DOI 10.1093/jb/mvq086; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Kawaguchi M, 2006, DEV GENES EVOL, V216, P769, DOI 10.1007/s00427-006-0104-5; Ueno T, 2004, MECH DEVELOP, V121, P803, DOI 10.1016/j.mod.2004.03.027; FLEGLER C, 1977, CELL TISSUE RES, V179, P255; HAMAZAKI TS, 1987, J EXP ZOOL, V242, P343, DOI 10.1002/jez.1402420313; Kawaguchi M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-231; Kawaguchi M, 2013, J EXP ZOOL PART B, V320B, P140, DOI 10.1002/jez.b.22490; Kawaguchi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-260; Kawaguchi M, 2008, FEBS J, V275, P2884, DOI [10.1111/j.1742-4658.2008.06427.x, 10.1111/j.1742-4658.2008.06427.xd]; MURATA K, 1995, DEV BIOL, V167, P9, DOI 10.1006/dbio.1995.1002; Nelson JS, 2006, FISHES WORLD; Sugiyama H, 1998, DEV GROWTH DIFFER, V40, P35; TAVOLGA WILLIAM N., 1949, BULL AMER MUS NAT HIST, V94, P161; WOURMS JP, 1981, AM ZOOL, V21, P473; YASUMASU S, 1989, J BIOCHEM-TOKYO, V105, P204; YASUMASU S, 1988, ZOOL SCI, V5, P191; YASUMASU S, 1989, J BIOCHEM-TOKYO, V105, P212	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5007	1552-5015		J EXP ZOOL PART B	J. Exp. Zool. Part B	JAN	2015	324	1					41	50		10.1002/jez.b.22601		10	Evolutionary Biology; Developmental Biology; Zoology	Evolutionary Biology; Developmental Biology; Zoology	AW4RC	WOS:000346267300005		
J	Hoshino, K; Nakaba, S; Inoue, H; Iwabuchi, K				Hoshino, Keita; Nakaba, Satoshi; Inoue, Hiroki; Iwabuchi, Kikuo			Structure and Development of Male Pheromone Gland of Longicorn Beetles and its Phylogenetic Relationships Within the Tribe Clytini	JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION			English	Article							MALE SEX-PHEROMONE; NEOCLYTUS-ACUMINATUS-ACUMINATUS; PYRRHODERUS BATES COLEOPTERA; AGGREGATION PHEROMONE; CERAMBYCID BEETLES; FINE-STRUCTURE; IDENTIFICATION; ULTRASTRUCTURE; PSYCHODIDAE; COMPONENTS	The male sex pheromone of the longicorn beetle, Xylotrechus pyrrhoderus pyrrhoderus Bates (Cerambycidae: Tribe Clytini) plays an important role in attracting females. This pheromone is produced by the pheromone gland located in the prothorax. However, the detailed structure and underlying developmental process of this gland are still unknown. We investigated the gland structure by using histological analysis and confirmed that the gland consists of the following parts: gland cell mass, a unique spherical space in the cuticle layer, and ductules connecting the gland cells with the spherical space and conducting canals to the outer opening. The gland structure first appeared male-specific in the late pupal stage, during which the epidermal cells began depositing the exocuticle; the development of the gland was completed after adult emergence. Furthermore, we verified the structural equivalents of the X. p. pyrrhoderus male pheromone gland in 11 species of 2 tribes, Clytini and Anaglyptini. The glands of these insects could be classified into four types on the basis of the absence or presence of the spherical space and the division of the gland cell mass layer. Most noteworthy, all the species with the spherical space and division-type gland were restricted to the Xylotrechus clade, as inferred from the molecular phylogenetic analysis. These results suggest that Clytini and Anaglyptini species share a fundamental process of male pheromone gland development, and that the Japanese Xylotrechus species might have established their current status by developing distinct structural features in the male pheromone gland. J. Exp. Zool. (Mol. Dev. Evol.) 324B: 68-76, 2015. (c) 2014 Wiley Periodicals, Inc.	[Hoshino, Keita; Nakaba, Satoshi; Inoue, Hiroki; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan	Hoshino, K (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan.	khoshino@cc.tuat.ac.jp	Nakaba, Satoshi/C-3482-2013; Iwabuchi, Kikuo/I-7530-2012		Japan Society for the Promotion of Science (JSPS) [25870210]	Grant sponsor: Japan Society for the Promotion of Science (JSPS); grant number: 25870210.	NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Pajares JA, 2013, ENTOMOL EXP APPL, V149, P118, DOI 10.1111/eea.12113; Hanks LM, 2007, J CHEM ECOL, V33, P889, DOI 10.1007/s10886-007-9275-4; Lacey ES, 2004, J CHEM ECOL, V30, P1493, DOI 10.1023/B:JOEC.0000042064.25363.42; Teale SA, 2011, J ECON ENTOMOL, V104, P1592, DOI 10.1603/EC11076; Silk PJ, 2007, NATURWISSENSCHAFTEN, V94, P697, DOI 10.1007/s00114-007-0244-0; Ray AM, 2006, NATURWISSENSCHAFTEN, V93, P543, DOI 10.1007/s00114-006-0142-x; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Fierke MK, 2012, J ECON ENTOMOL, V105, P2029, DOI 10.1603/EC12101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Chapman RF., 1998, INSECTS; CORBET SA, 1977, J ZOOL, V181, P377; CROSSLEY A C, 1969, Tissue and Cell, V1, P525, DOI 10.1016/S0040-8166(69)80020-0; De Kamp T, 2010, ENTOMOLOGIE HEUTE, V22, P191; Duffy E. A. J., 1953, MONOGRAPH IMMATURE S; Fonseca MG, 2010, J CHEM ECOL, V36, P1132, DOI 10.1007/s10886-010-9850-y; Galford JR, 1977, NE240 USDA, P1; IWABUCHI K, 1982, APPL ENTOMOL ZOOL, V17, P494; IWABUCHI K, 1986, APPL ENTOMOL ZOOL, V21, P21; Iwabuchi K., 1999, ENV ENTOMOLOGY BEHAV, P436; Kojima K, 2011, FOOD PLANTS CERAMBYC; Lacey ES, 2007, J INSECT BEHAV, V20, P117, DOI 10.1007/s10905-006-9068-6; LAI-FOOK J, 1970, Tissue and Cell, V2, P119, DOI 10.1016/S0040-8166(70)80011-8; LEAL WS, 1994, EXPERIENTIA, V50, P853, DOI 10.1007/BF01956471; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; Nakamuta Kiyoshi, 1994, Japanese Journal of Entomology, V62, P371; Nardi JB, 1996, TISSUE CELL, V28, P43, DOI 10.1016/S0040-8166(96)80043-7; Neville AC, 1975, BIOL ARTHROPOD CUTIC; NOLDT U, 1995, INT J INSECT MORPHOL, V24, P223, DOI 10.1016/0020-7322(95)93345-D; Ohbayashi N., 2007, LONGICORN BEETLES JA; Percy-Cunningham J.E., 1987, P27; Ray AM, 2012, J CHEM ECOL, V38, P1151, DOI 10.1007/s10886-012-0181-z; Ray AM, 2012, J CHEM ECOL, V38, P157, DOI 10.1007/s10886-012-0070-5; Ray AM, 2011, J CHEM ECOL, V37, P173, DOI 10.1007/s10886-011-9908-5; Rodstein J, 2011, J CHEM ECOL, V37, P114, DOI 10.1007/s10886-010-9890-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Spiegel CN, 2002, ARTHROPOD STRUCT DEV, V30, P219, DOI 10.1016/S1467-8039(01)00033-0; Spiegel CN, 2004, ARTHROPOD STRUCT DEV, V33, P399, DOI 10.1016/j.asd.2004.02.002; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; WATTEBLED S, 1978, CELL TISSUE RES, V194, P481; Wigglesworth VB, 1972, PRINCIPLES INSECT PH	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5007	1552-5015		J EXP ZOOL PART B	J. Exp. Zool. Part B	JAN	2015	324	1					68	76		10.1002/jez.b.22606		9	Evolutionary Biology; Developmental Biology; Zoology	Evolutionary Biology; Developmental Biology; Zoology	AW4RC	WOS:000346267300007		
J	Kawada, T				Kawada, Tomoyuki			Urinary creatinine adjustment for uranium and kidney outcomes from lead workers	JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY			English	Letter							SAMPLES		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.						Akerstrom M, 2014, J EXPO SCI ENV EPID, V24, P171, DOI 10.1038/jes.2013.58; Shelley R, 2014, J EXPO SCI ENV EPID, V24, P58, DOI 10.1038/jes.2013.18; Kawada T, 1987, Sangyo Igaku, V29, P386; Kawada T, 2014, CLIN CHIM ACTA, V437, P220, DOI 10.1016/j.cca.2014.04.017; Kawada T, 2014, AM J KIDNEY DIS, V63, P859, DOI 10.1053/j.ajkd.2014.02.008; Kawada T, 1995, Asia Pac J Public Health, V8, P91	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1559-0631	1559-064X		J EXPO SCI ENV EPID	J. Expo. Sci. Environ. Epidemiol.	JAN-FEB	2015	25	1					119	120		10.1038/jes.2014.77		3	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	AW7GB	WOS:000346431500019		
J	Kawada, T				Kawada, Tomoyuki			Cadmium exposure in inhabitants living in non-polluted area	JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY			English	Letter							URINARY CADMIUM; PROTEINS		Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.						Adams SV, 2013, ENVIRON HEALTH PERSP, V121, pA296, DOI 10.1289/ehp.1307376; Adams SV, 2014, J EXPO SCI ENV EPID, V24, P163, DOI 10.1038/jes.2013.55; Chaumont A, 2013, ENVIRON HEALTH PERSP, V121, P1047, DOI 10.1289/ehp.1306607; Liang YH, 2012, ENVIRON HEALTH PERSP, V120, P223, DOI 10.1289/ehp.1103699; Huang M, 2013, ENVIRON TOXICOL, V28, P563, DOI 10.1002/tox.20750; KAWADA T, 1990, INT ARCH OCC ENV HEA, V62, P95; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P1	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1559-0631	1559-064X		J EXPO SCI ENV EPID	J. Expo. Sci. Environ. Epidemiol.	JAN-FEB	2015	25	1					119	119		10.1038/jes.2014.37		1	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	AW7GB	WOS:000346431500018		
J	Kato, G; Suzuki, K; Sakai, T; Kawakami, M; Takano, T; Matsuyama, T; Nakayasu, C				Kato, G.; Suzuki, K.; Sakai, T.; Kawakami, M.; Takano, T.; Matsuyama, T.; Nakayasu, C.			The role of a specific antibody against Flavobacterium psychrophilum infection in ayu sweetfish, Plecoglossus altivelis altivelis (Temminck & Schlegel, 1846)	JOURNAL OF FISH DISEASES			English	Article						passive immunization; opsonization; phagocytic rate; vaccine	BACTERIAL COLDWATER DISEASE; ONCORHYNCHUS-MYKISS SERUM; RAINBOW-TROUT; RESPIRATORY BURST; IN-VITRO; FISH; JAPAN; FRY		[Kato, G.; Sakai, T.; Kawakami, M.; Nakayasu, C.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Tamaki Lab, Watarai, Mie, Japan; [Kato, G.] Japan Soc Promot Sci, Tokyo, Japan; [Suzuki, K.] Gunma Prefectural Fisheries Expt Stn, Gunma, Japan; [Takano, T.; Matsuyama, T.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Watarai, Mie, Japan	Nakayasu, C (reprint author), Hiruta 224-1, Watarai, Mie 5190423, Japan.	cnakayas@affrc.go.jp			Japan Society for the Promotion of Science [12J04812]	This work was supported in part by a Grant-in-Aid (Number 12J04812) for Fellows of the Japan Society for the Promotion of Science.	Moritomo T, 2003, FISH SHELLFISH IMMUN, V15, P29, DOI 10.1016/S1050-4648(02)00136-5; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Arai H, 2007, J FISH DIS, V30, P345, DOI 10.1111/j.1365-2761.2007.00809.x; Kato G, 2014, DIS AQUAT ORGAN, V108, P103, DOI 10.3354/dao02679; Serada K, 2005, FISH SHELLFISH IMMUN, V19, P363, DOI 10.1016/j.fsi.2005.01.007; WAKABAYASHI H, 1994, FISH PATHOL, V29, P101; Lorenzen E, 2010, FISH SHELLFISH IMMUN, V28, P440, DOI 10.1016/j.fsi.2009.11.025; Izumi S, 1999, FISH PATHOL, V34, P89; Iida Y, 1996, FISH PATHOL, V31, P157; Kintsuji H, 2007, FISH PATHOL, V42, P159, DOI 10.3147/jsfp.42.159; Miwa S, 2005, DIS AQUAT ORGAN, V67, P93, DOI 10.3354/dao067093; Boesen HT, 1999, INFECT IMMUN, V67, P294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Lu J. X., 2013, FISH SHELLFISH IMMUN, V34, P497; Secombes C. J., 1992, Annual Review of Fish Diseases, V2, P53, DOI 10.1016/0959-8030(92)90056-4; Shotts E. B. J., 1999, FISH DIS DISORDERS, V3, P559; WAKABAYA.H, 1974, B JPN SOC SCI FISH, V40, P751; Wiklund T, 2002, FISH SHELLFISH IMMUN, V12, P141, DOI 10.1006/fsim.2001.0360; Wiklund T, 2003, FISH SHELLFISH IMMUN, V15, P387, DOI 10.1016/S1050-4648(03)00009-3	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7775	1365-2761		J FISH DIS	J. Fish Dis.	JAN	2015	38	1					107	112		10.1111/jfd.12258		6	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	AW9MC	WOS:000346580400013		
J	Yoshimura, I; Ichimura, R; Kanazawa, K; Ida, T; Hagio, T; Karashima, H; Naito, M				Yoshimura, Ichiro; Ichimura, Ryuji; Kanazawa, Kazuki; Ida, Takahiro; Hagio, Tomonobu; Karashima, Hirotaka; Naito, Masatoshi			Simultaneous Use of Lateral Calcaneal Ostectomy and Subtalar Arthroscopic Debridement for Residual Pain After a Calcaneal Fracture	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						arthroscopy; Bohler's angle; calcaneus; complication; revision surgery; Sanders classification	OS CALCIS FRACTURES; INTRAARTICULAR FRACTURES; LATE COMPLICATIONS; SURGICAL REPAIR; RATING-SCALE; RELIABILITY; MALUNIONS; SYSTEM; ANKLE	Inadequate primary treatment of calcaneal fractures frequently results in persistent, residual pain. This can be caused by subtalar arthritis, an increased calcaneal width, and/or calcaneal fibular impingement of the peroneal tendons. Many patients experience multiple disorders simultaneously, requiring a combination of procedures to treat the injury. The purpose of the present study was to evaluate the clinical outcomes of arthroscopic debridement with lateral calcaneal ostectomy for residual pain after a calcaneal fracture. Four feet (4 patients) were treated with arthroscopic debridement and lateral calcaneal ostectomy. The patients were 3 males and 1 female, with a mean age of 55.3 +/- 14.1 years. The mean follow-up duration was 33.5 +/- 10.5 months postoperatively. Three patients received worker's compensation as a result of their condition. The patients were examined for improvement in pain levels using the numeric pain intensity scale and healing was assessed using the Japanese Society of Surgery of the Foot score. The mean Japanese Society of Surgery of the Foot score improved from 64.5 +/- 13.8 preoperatively to 82.5 +/- 7.1 postoperatively. The mean postoperative numeric pain intensity scale score was 2.3 +/- 1.9. No complications, such as deep infection or problems with wound healing, were observed in any of the patients. The simultaneous use of arthroscopic subtalar debridement and lateral calcaneal ostectomy is a valuable intervention for the treatment of residual pain after a calcaneal fracture in patients who present with increased calcaneal width and mild or no degenerative changes in the subtalar joint. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Yoshimura, Ichiro; Kanazawa, Kazuki; Ida, Takahiro; Hagio, Tomonobu; Karashima, Hirotaka; Naito, Masatoshi] Fukuoka Univ, Fac Med, Dept Orthoped Surg, Fukuoka 8140180, Japan; [Ichimura, Ryuji] Shin Beppu Hosp, Dept Orthopaed Surg, Oita, Japan	Yoshimura, I (reprint author), Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	ichiroy813@gmail.com					Ahn JH, 2009, ORTHOPEDICS, V32, DOI 10.3928/01477447-20091020-12; Lui TH, 2007, ARCH ORTHOP TRAUM SU, V127, P265, DOI 10.1007/s00402-006-0194-6; Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; Lui TH, 2013, KNEE SURG SPORT TR A, V21, P1293, DOI 10.1007/s00167-012-2086-3; Sanders R, 2000, J BONE JOINT SURG AM, V82A, P225; Chandler JT, 1999, FOOT ANKLE INT, V20, P18; Bauer T, 2011, KNEE SURG SPORT TR A, V19, P131, DOI 10.1007/s00167-010-1149-6; MYERSON M, 1993, J BONE JOINT SURG AM, V75A, P331; Beebe A, 1993, PAIN CLIN MANUAL NUR; BRALY WG, 1985, FOOT ANKLE, V6, P90; Buckley RB, 2001, J BONE JOINT SURG AM, V84, P1733; Clare MP, 2005, J BONE JOINT SURG AM, V87A, P963, DOI 10.2106/JBJS.C.01603; Cotton FJ, 1921, ANN SURG, V74, P294, DOI 10.1097/00000658-192109000-00005; Elgafy H, 1999, FOOT ANKLE INT, V20, P422; Lee KB, 2008, J BONE JOINT SURG BR, V90B, P1457, DOI 10.1302/0301-620X.90B11.20744; Potter MQ, 2009, J BONE JOINT SURG AM, V91, P854; Sahota RK, 2014, J FOOT ANKLE SURG, V53, P259, DOI 10.1053/j.jfas.2014.01.013; Savva N, 2006, J BONE JOINT SURG BR, V89, P919; Schepers T, 2011, INT ORTHOP, V35, P697, DOI 10.1007/s00264-011-1223-9; Stephens HM, 1996, FOOT ANKLE INT, V17, P395; Takao M, 2012, AM J SPORT MED, V40, P447, DOI 10.1177/0363546511428581; Thomas F B, 1967, J Bone Joint Surg Br, V49, P93; Tufescu TV, 2001, J ORTHOP TRAUMA, V15, P275, DOI 10.1097/00005131-200105000-00007	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	JAN-FEB	2015	54	1					37	40		10.1053/j.jfas.2014.09.049		4	Orthopedics; Surgery	Orthopedics; Surgery	AW7CH	WOS:000346421600008		
J	Cunanan, J; Kobayashi, M; Sugimoto, M				Cunanan, Jayson; Kobayashi, Masaharu; Sugimoto, Mitsuru			Inclusion relations between L-P-Sobolev and Wiener amalgam spaces	JOURNAL OF FUNCTIONAL ANALYSIS			English	Article						Inclusions; L-P-Sobolev; Wiener amalgam spaces; Littlewood-Paley	UNIMODULAR FOURIER MULTIPLIERS; MODULATION SPACES; PSEUDODIFFERENTIAL CALCULUS; CONTINUITY PROPERTIES	We determined optimal inclusion relations between L-P-Sobolev and Wiener amalgam spaces. For applications, we discuss mapping properties of unimodular Fourier multipliers e(i vertical bar D vertical bar alpha) between L-P-Sobolev and Wiener amalgam spaces and derive some Littlewood-Paley type inequalities. (C) 2014 Elsevier Inc. All rights reserved.	[Cunanan, Jayson; Sugimoto, Mitsuru] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kobayashi, Masaharu] Yamagata Univ, Fac Sci, Dept Math Sci, Yamagata 9908560, Japan	Cunanan, J (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	d12005n@math.nagoya-u.ac.jp; kobayashi@sci.k.j.yamagata-u.s.c.jp; sugimoto@math.nagoya-u.ac.jp					Cordero E, 2010, J FOURIER ANAL APPL, V16, P311, DOI 10.1007/s00041-009-9111-z; Sugimoto M, 2007, J FUNCT ANAL, V248, P79, DOI 10.1016/j.jfa.2007.03.015; Benyi A, 2007, J FUNCT ANAL, V246, P366, DOI 10.1016/j.jfa.2006.12.019; Ruzhansky M, 2011, MATH NACHR, V284, P2078, DOI 10.1002/mana.200910199; Wiener N, 1932, ANN MATH, V33, P1, DOI 10.2307/1968102; Wang BX, 2007, J DIFFER EQUATIONS, V239, P213, DOI 10.1016/j.jde.2007.04.009; Cordero E, 2009, B AUST MATH SOC, V80, P105, DOI 10.1017/S0004972709000070; Toft J, 2004, J FUNCT ANAL, V207, P399, DOI 10.1016/j.jfa.2003.10.003; Cowling M, 2001, MATH ANN, V321, P885, DOI 10.1007/s002080100256; Cunanan J, 2014, J MATH ANAL APPL, V419, P738, DOI 10.1016/j.jmaa.2014.05.001; Feichtinger H. G., 1981, INT SER NUM MATH, V69, P153; Feichtinger H.G., 1983, TECHNICAL REPORT; Feichtinger H.G., 1983, C MATH SOC J BOLYAI, V35, P509; FEICHTINGER HG, 1990, CAN J MATH, V42, P395, DOI 10.4153/CJM-1990-022-6; Heil C., 1990, THESIS U MARYLAND CO; HORMANDER L, 1960, ACTA MATH-DJURSHOLM, V104, P93, DOI 10.1007/BF02547187; Kobayashi M, 2011, J FUNCT ANAL, V260, P3189, DOI 10.1016/j.jfa.2011.02.015; Kobayashi M, 2009, STUD MATH, V192, P79, DOI 10.4064/sm192-1-7; Miyachi A, 2009, P AM MATH SOC, V137, P3869; Rubio de Francia J.-L., 1985, REV MAT IBEROAM, V1, P1; Stein EM, 1993, HARMONIC ANAL; Toft J, 2004, ANN GLOB ANAL GEOM, V26, P73, DOI 10.1023/B:AGAG.0000023261.94488.f4; Triebel H, 1992, THEORY FUNCTION SPAC; Wiener N, 1926, MATH Z, V24, P575, DOI 10.1007/BF01216799; Wiener N., 1933, FOURIER INTEGRAL CER	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-1236	1096-0783		J FUNCT ANAL	J. Funct. Anal.	JAN 1	2015	268	1					239	254		10.1016/j.jfa.2014.10.017		16	Mathematics	Mathematics	AX0BD	WOS:000346617700008		
J	Itoi, T				Itoi, Takao			Highlights of topic "Creations and innovations in interventional endoscopy"	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material									Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Binmoeller KF, 2015, J HEPATOBILIARY PANC, V22, P44; Fuccio L, 2015, J HEPATOBILIARY PANC, V22, P27; Fujii-Lau LL, 2015, J HEPATOBILIARY PANC, V22, P51; Holt B, 2015, J HEPATOBILIARY PANC, V22, P12; Itoi T, 2015, J HEPATOBILIARY PANC, V22, P3; Oh HC, 2015, J HEPATOBILIARY PANC, V22, P16; Penas-Herrero I, 2015, J HEPATOBILIARY PANC, V22, P35; Voermans RP, 2015, J HEPATOBILIARY PANC, V22, P20	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					1	2		10.1002/jhbp.188		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200003		
J	Itoi, T; Ishii, K; Tanaka, R; Umeda, J; Tonozuka, R				Itoi, Takao; Ishii, Kentaro; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke			Current status and perspective of endoscopic ultrasonography-guided gastrojejunostomy: endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy (with videos)	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Biflanged metal stent; Double-balloon tube; Endoscopic ultrasonography; Endoscopic ultrasonography-guided gastrojejunostomy	MALIGNANT GASTRODUODENAL OBSTRUCTION; GASTRIC OUTLET OBSTRUCTION; EXPANDABLE METAL STENTS; PORCINE MODEL; FLEXIBLE ENDOSCOPY; PALLIATION; SURGERY; ANASTOMOSIS; DEVICE	Surgical intervention and, more recently, endoscopic intervention have been performed for the treatment of malignant gastric outlet obstruction. Recently, endoscopic ultrasonography (EUS)-guided gastrojejunostomy using special devices has been established. In line with this, we have developed a novel EUS-guided double-balloon-occluded gastrojejunostomy (EBOG) using a lumen-apposing biflanged metal stent. Herein, we describe the technique and outcome of EBOG.	[Itoi, Takao; Ishii, Kentaro; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Ly J, 2010, SURG ENDOSC, V24, P290, DOI 10.1007/s00464-009-0577-1; Itoi T, 2012, GASTROINTEST ENDOSC, V75, P870, DOI 10.1016/j.gie.2011.10.020; Bessoud B, 2005, J VASC INTERV RADIOL, V16, P247, DOI 10.1097/01.RVI.0000145227.90754.76; Binmoeller KF, 2012, ENDOSCOPY, V44, P499, DOI 10.1055/s-0032-1309382; Espinel J, 2001, DIGEST DIS SCI, V46, P2322, DOI 10.1023/A:1012378509762; Ryou M, 2011, GASTROINTEST ENDOSC, V73, P353, DOI 10.1016/j.gie.2010.10.024; Kantsevoy SV, 2005, GASTROINTEST ENDOSC, V62, P287, DOI 10.1016/S0016-5107(05)01565-8; van Hooft JE, 2010, GASTROINTEST ENDOSC, V72, P530, DOI 10.1016/j.gie.2010.05.025; Fritscher-Ravens A, 2002, GASTROINTEST ENDOSC, V56, P737, DOI 10.1067/mge.2002.129084; Itoi T, 2013, GASTROINTEST ENDOSC, V78, P934, DOI 10.1016/j.gie.2013.09.025; Teoh AYB, 2014, GASTROINTEST ENDOSC, V80, P1171, DOI 10.1016/j.gie.2014.03.038; Fritscher-Ravens A, 2003, GASTROINTEST ENDOSC, V58, P585; Maetani I, 2004, ENDOSCOPY, V36, P73; Lesurtel M, 2006, J GASTROINTEST SURG, V10, P286, DOI 10.1016/j.gassur.2005.05.011; Ausania F, 2012, ANN ROY COLL SURG, V94, P563, DOI 10.1308/003588412X13373405386934; Baron TH, 2001, NEW ENGL J MED, V344, P1681, DOI 10.1056/NEJM200105313442206; Bergstrom M, 2006, GASTROINTEST ENDOSC, V63, P307, DOI 10.1016/j.gie.2005.09.035; Chopita N, 2005, ENDOSCOPY, V37, P313, DOI 10.1055/s-2005-861049; Jeurnink SM, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-18; Nuzzo G, 2004, HEPATO-GASTROENTEROL, V51, P1282; Razzaq R, 2001, CARDIOVASC INTER RAD, V24, P313, DOI 10.1007/s00270-001-0031-9; Song TJ, 2013, WORLD J GASTROENTERO, V19, P3447, DOI 10.3748/wjg.v19.i22.3447; Swain CP, 1991, GASTROINTEST ENDOSC, V37, P626; Yi SW, 2014, SURG ENDOSC, V28, P1439, DOI 10.1007/s00464-013-3371-z	25	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					3	11		10.1002/jhbp.148		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200004		
J	Yoshikawa, T; Hakamada, K; Ogasawara, H; Kimura, N; Kudo, D; Sakamoto, Y; Ishido, K; Toyoki, Y; Morohashi, S; Kijima, H				Yoshikawa, Toru; Hakamada, Kenichi; Ogasawara, Hiroshi; Kimura, Norihisa; Kudo, Daisuke; Sakamoto, Yoshiyuki; Ishido, Keinosuke; Toyoki, Yoshikazu; Morohashi, Satoko; Kijima, Hiroshi			Ex vivo application of endocytoscopy for determining the longitudinal extent of bile duct cancer: a pathological analysis of 28 resected cases	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Bile duct cancer; Cholangiocarcinoma; Endocytoscopy; Endomicroscopy	HILAR CHOLANGIOCARCINOMA; IN-VIVO; HISTOLOGIC ANALYSIS; CELL-CARCINOMA; HEPATECTOMY; INFILTRATION; MORTALITY; SURVIVAL; LESIONS; BIOPSY	BackgroundThe aim was to examine the diagnostic ability of an endocytoscope system (ECS) for detecting the longitudinal extent of bile duct cancer. MethodsWe observed the surfaces of the bile duct of 28 consecutive patients undergoing biliary surgery both directly and under methylene blue staining by using an ECS. Based on the change in the microvascular caliber, abnormal vascularity, structural atypia, and cellular atypia, we created an ECS score. ResultsThe ECS score produced a median value of 1 (range 0-3) point in normal bile ducts, 3 (0-6) points in cholangitis, 9 (1-10) points in carcinoma in situ (CIS), and 8 (3-11) points in invasive cancer. A significant difference in the scores between cancerous and non-cancerous lesions was found (P < 0.001). The ECS score was able to distinguish non-cancerous lesions from cancerous lesions using the cut-off value of a score less than 5, the accuracy being 92.1%, with a sensitivity of 91.1% and specificity of 93.5%. ConclusionsWith ECS observation of bile duct specimens, the newly created ECS score was able to clearly distinguish non-cancerous lesions from cancerous lesions. This ECS score method should be validated in the differentiation of various BilIN lesions in the future.	[Yoshikawa, Toru; Hakamada, Kenichi; Ogasawara, Hiroshi; Kimura, Norihisa; Kudo, Daisuke; Sakamoto, Yoshiyuki; Ishido, Keinosuke; Toyoki, Yoshikazu] Hirosaki Univ, Dept Surg Gastroenterol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan; [Morohashi, Satoko; Kijima, Hiroshi] Hirosaki Univ, Dept Pathol & Biosci, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Hakamada, K (reprint author), Hirosaki Univ, Dept Surg Gastroenterol, Grad Sch Med, Zaifu Cho 5, Hirosaki, Aomori 0368562, Japan.	hakamada@cc.hirosaki-u.ac.jp					Sasajima K, 2006, GASTROINTEST ENDOSC, V63, P1010, DOI 10.1016/j.gie.2006.01.021; Nagino M, 2006, ANN SURG, V243, P28, DOI 10.1097/01.sla.0000193604.72436.63; Unno M, 2007, J HEPATO-BILIARY-PAN, V14, P434, DOI 10.1007/s00534-006-1191-4; Sakamoto E, 1998, ANN SURG, V227, P405, DOI 10.1097/00000658-199803000-00013; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; BISMUTH H, 1992, ANN SURG, V215, P31; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; HAYASHI S, 1994, CANCER, V73, P2922, DOI 10.1002/1097-0142(19940615)73:12<2922::AID-CNCR2820731208>3.0.CO;2-K; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Park MS, 2004, RADIOLOGY, V233, P234, DOI 10.1148/radiol.2331031446; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Rotondano G, 2010, INT J COLORECTAL DIS, V25, P1111, DOI 10.1007/s00384-010-0969-7; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Miyazaki M, 1999, J AM COLL SURGEONS, V189, P575, DOI 10.1016/S1072-7515(99)00219-7; Kitajima Y, 2007, J GASTROEN HEPATOL, V22, P1615, DOI 10.1111/j.1440-1746.2007.05037.x; Ebata T, 2012, ANN SURG, V256, P297, DOI 10.1097/SLA.0b013e31826029ca; Nakanishi Y, 2010, J HEPATO-BIL-PAN SCI, V17, P166, DOI 10.1007/s00534-009-0127-1; Zen Y, 2005, PATHOL INT, V55, P180, DOI 10.1111/j.1440-1827.2005.01816.x; Seyama Y, 2003, ANN SURG, V238, P73, DOI 10.1097/01.SLA.0000074960.55004.72; Ebata T, 2002, BRIT J SURG, V89, P1260, DOI 10.1046/j.1365-2168.2002.02211.x; Fasoli A, 2009, ENDOSCOPY, V41, pE65, DOI 10.1055/s-0028-1119475; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kumagai Y, 2009, DIS ESOPHAGUS, V22, P505, DOI 10.1111/j.1442-2050.2009.00952.x; Nagino M, 2001, WORLD J SURG, V25, P1277; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; NIMURA Y, 1990, WORLD J SURG, V14, P535; Nimura Y, 1990, WORLD J SURG, V14, P4; SHIMADA H, 1988, INT SURG, V73, P87; Tamada K, 1999, J GASTROEN HEPATOL, V14, P691, DOI 10.1046/j.1440-1746.1999.01894.x; Tamada Kiichi, 2011, World J Clin Oncol, V2, P203, DOI 10.5306/wjco.v2.i5.203; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					58	67		10.1002/jhbp.167		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200012		
J	Itokawa, F; Kamisawa, T; Nakano, T; Itoi, T; Hamada, Y; Ando, H; Fujii, H; Koshinaga, T; Yoshida, H; Tamoto, E; Noda, T; Kimura, Y; Maguchi, H; Urushihara, N; Horaguchi, J; Morotomi, Y; Sato, M; Hanada, K; Tanaka, M; Takahashi, A; Yamaguchi, T; Arai, Y; Horiguchi, A; Igarashi, Y; Inui, K				Itokawa, Fumihide; Kamisawa, Terumi; Nakano, Toshiaki; Itoi, Takao; Hamada, Yoshinori; Ando, Hisami; Fujii, Hideki; Koshinaga, Tsugumichi; Yoshida, Hitoshi; Tamoto, Eiji; Noda, Takuo; Kimura, Yasutoshi; Maguchi, Hiroyuki; Urushihara, Naoto; Horaguchi, Jun; Morotomi, Yoshiki; Sato, Masahito; Hanada, Keiji; Tanaka, Masao; Takahashi, Astushi; Yamaguchi, Taketo; Arai, Yuuki; Horiguchi, Akihiko; Igarashi, Yoshinori; Inui, Kazuo		Japanese Study Gr	Exploring the length of the common channel of pancreaticobiliary maljunction on magnetic resonance cholangiopancreatography	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Common channel; Magnetic resonance cholangiopancreatography; Pancreaticobiliary maljunction	CHOLEDOCHAL CYSTS; MR CHOLANGIOPANCREATOGRAPHY; COMPUTED-TOMOGRAPHY; JUNCTION	BackgroundIn the revised diagnostic criteria for pancreaticobiliary maljunction (PBM), PBM can be diagnosed from a long common channel by magnetic resonance cholangiopancreatography (MRCP). However, it is necessary to differentiate from high confluence of pancreaticobiliary ducts (HCPBD) with a relatively long common channel (6mm) and effect of the sphincter in the pancreaticobiliary junction. This multicenter study aimed to explore definite value of the length of an abnormally long common channel, which enables to distinguish PBM from HCPBD on MRCP. MethodsIn 184 PBM patients and 22 HCPBD patients who were diagnosed by direct cholangiography and underwent MRCP, the length of the common channel was measured. ResultsThe length of the common channel was 16.2 6.9mm on direct cholangiography and 13.9 +/- 6.2mm on MRCP in PBM patients, and 7.7 +/- 1.5mm and 6.6 +/- 1.4mm in HCPBD patients. The optimal cut off value of the length of the common channel to distinguish PBM from HCPBD was identified to be 9mm. ConclusionsPancreaticobiliary maljunction can be diagnosed from an abnormally long common channel on MRCP, but in cases of the common channel 9mm on MRCP, direct cholangiography is needed to confirm PBM.	[Itokawa, Fumihide; Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, Tokyo 1138677, Japan; [Nakano, Toshiaki] Kansai Med Univ, Univ Informat Ctr, Osaka, Japan; [Hamada, Yoshinori] Kansai Med Univ, Div Pediat Surg, Dept Surg, Osaka, Japan; [Ando, Hisami] Aichi Prefectural Colony, Welf Ctr Persons Dev Disabil, Kasugai, Aichi, Japan; [Fujii, Hideki] Yamanashi Univ, Dept Surg 1, Kofu, Yamanashi 400, Japan; [Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Yoshida, Hitoshi] Showa Univ, Dept Gastroenterol, Tokyo, Japan; [Tamoto, Eiji] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan; [Noda, Takuo] Okayama Univ, Dept Pediat Surg, Okayama, Japan; [Kimura, Yasutoshi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Maguchi, Hiroyuki] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan; [Horaguchi, Jun] Sendai City Med Ctr, Dept Gastroenterol, Sendai, Miyagi, Japan; [Morotomi, Yoshiki] Osaka City Univ, Dept Pediat Surg, Osaka, Japan; [Sato, Masahito] Kitano Hosp, Dept Pediat Surg, Osaka, Japan; [Hanada, Keiji] Onomichi Gen Hosp, Ctr Gastroenterol, Onomichi, Japan; [Tanaka, Masao] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan; [Takahashi, Astushi] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan; [Yamaguchi, Taketo] Chiba Canc Ctr, Dept Gastroenterol, Chiba, Japan; [Arai, Yuuki] Niigata Univ, Dept Pediat Surg, Niigata, Japan; [Horiguchi, Akihiko] Fujita Hlth Univ, Sch Med, Dept Biliary Pancreat Surg, Toyoake, Aichi, Japan; [Igarashi, Yoshinori] Toho Univ, Omori Med Ctr, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Inui, Kazuo] Fujita Hlth Univ, Teaching Hosp 2, Dept Gastroenterol, Nagoya, Aichi, Japan	Kamisawa, T (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	kamisawa@cick.jp					Kamisawa T, 2014, J HEPATO-BIL-PAN SCI, V21, P159, DOI 10.1002/jhbp.57; Kim MJ, 2002, AM J ROENTGENOL, V179, P209; Park DH, 2005, GASTROINTEST ENDOSC, V62, P360, DOI 10.1016/j.gie.2005.04.026; Sugiyama M, 1998, SURGERY, V123, P391, DOI 10.1067/msy.1998.86581; Kamisawa T, 2002, PANCREATOLOGY, V2, P122, DOI 10.1159/000055902; BABBITT D P, 1969, Annales de Radiologie, V12, P231; Fumino S, 2011, J PEDIATR SURG, V46, P1373, DOI 10.1016/j.jpedsurg.2011.01.026; Hellerhoff KJ, 2002, AM J ROENTGENOL, V179, P121; Horaguchi J, 2014, J GASTROENTEROL, V49, P875, DOI 10.1007/s00535-013-0837-7; Irie H, 1998, AM J ROENTGENOL, V171, P1381; Ito K, 2001, EUR J RADIOL, V38, P78, DOI 10.1016/S0720-048X(01)00293-5; Kamisawa T, 2007, ABDOM IMAGING, V32, P129, DOI 10.1007/s00261-006-9005-3; Kamisawa T, 2009, CLIN GASTROENTEROL H, V7, pS84, DOI 10.1016/j.cgh.2009.08.024; Kamisawa T, 2012, J GASTROENTEROL, V47, P731, DOI 10.1007/s00535-012-0611-2; Morine Y, 2013, J HEPATO-BIL-PAN SCI, V20, P472, DOI 10.1007/s00534-013-0606-2; Nakamoto A, 2010, J COMPUT ASSIST TOMO, V34, P725, DOI 10.1097/RCT.0b013e3181e23ff2; The Japanese Study Group on Pancreaticobiliary Maljunction (JSPBM) The Committee of JSPBM for Diagnostic Criteria, 1994, J HEPATOBILIARY PANC, V1, P219	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					68	73		10.1002/jhbp.168		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200013		
J	Kawakubo, K; Kawakami, H; Toyokawa, Y; Otani, K; Kuwatani, M; Abe, Y; Kawahata, S; Kubo, K; Kubota, Y; Sakamoto, N				Kawakubo, Kazumichi; Kawakami, Hiroshi; Toyokawa, Yoshihide; Otani, Koichi; Kuwatani, Masaki; Abe, Yoko; Kawahata, Shuhei; Kubo, Kimitoshi; Kubota, Yoshimasa; Sakamoto, Naoya			Risk factors for technical failure of endoscopic double self-expandable metallic stent placement by partial stent-in-stent method	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Endoscopic biliary drainage; Malignant hilar biliary obstruction; Self-expandable metallic stent; Stent-in-stent method	HILAR BILIARY OBSTRUCTION; SIDE-BY-SIDE; REVISION EFFICACY; CHOLANGIOCARCINOMA; DEPLOYMENT; DRAINAGE; STRICTURES; METASTASES; MANAGEMENT	BackgroundEndoscopic double self-expandable metallic stent (SEMS) placement by the partial stent-in-stent (PSIS) method has been reported to be useful for the management of unresectable hilar malignant biliary obstruction. However, it is technically challenging, and the optimal SEMS for the procedure remains unknown. The aim of this study was to identify the risk factors for technical failure of endoscopic double SEMS placement for unresectable malignant hilar biliary obstruction (MHBO). MethodsBetween December 2009 and May 2013, 50 consecutive patients with MHBO underwent endoscopic double SEMS placement by the PSIS method. We retrospectively evaluated the rate of successful double SEMS placement and identified the risk factors for technical failure. ResultsThe technical success rate for double SEMS placement was 82.0% (95% confidence interval [CI]: 69.2-90.2). On univariate analysis, the rate of technical failure was high in patients with metastatic disease and unilateral placement. Multivariate analysis revealed that metastatic disease was a significant risk factor for technical failure (odds ratio: 9.63, 95% CI: 1.11-105.5). The subgroup analysis after double guidewire insertion showed that the rate of technical success was higher in the laser-cut type SEMS with a large mesh and thick delivery system than in the braided type SEMS with a small mesh and thick delivery system. ConclusionsMetastatic disease was a significant risk factor for technical failure of double SEMS placement for unresectable MHBO. The laser-cut type SEMS with a large mesh and thin delivery system might be preferable for the PSIS procedure.	[Kawakubo, Kazumichi; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Kawakami, Hiroshi; Abe, Yoko; Kawahata, Shuhei; Kubo, Kimitoshi; Kubota, Yoshimasa] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Kuwatani, Masaki] Hokkaido Univ Hosp, Div Endoscopy, Sapporo, Hokkaido 0608648, Japan; [Toyokawa, Yoshihide; Otani, Koichi] Piolax Med Devices Inc, Ctr Res & Dev, Yokohama, Kanagawa, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hiropon@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Kawakami H, 2011, J HEPATO-BIL-PAN SCI, V18, P630, DOI 10.1007/s00534-011-0404-7; De Palma GD, 2001, GASTROINTEST ENDOSC, V53, P547, DOI 10.1067/mge.2001.113381; Freeman ML, 2003, GASTROINTEST ENDOSC, V58, P41, DOI 10.1067/mge.2003.292; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Isayama H, 2009, GASTROINTEST ENDOSC, V70, P37, DOI 10.1016/j.gie.2008.09.032; Kawakami H, 2009, ENDOSCOPY, V41, P959, DOI 10.1055/s-0029-1215178; BISMUTH H, 1988, WORLD J SURG, V12, P39; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Van Laethem JL, 2003, AM J GASTROENTEROL, V98, P1271, DOI 10.1016/S0002-9270(03)00284-3; Sangchan A, 2012, GASTROINTEST ENDOSC, V76, P93, DOI 10.1016/j.gie.2012.02.048; Raju RP, 2011, DIGEST DIS SCI, V56, P1557, DOI 10.1007/s10620-010-1550-5; Chennat J, 2010, GASTROINTEST ENDOSC, V72, P632, DOI 10.1016/j.gie.2010.04.037; Dumas R, 2000, GASTROINTEST ENDOSC, V51, P334, DOI 10.1016/S0016-5107(00)70364-6; Iwanos H, 2012, DIGEST ENDOSC, V23, P43; Kawakubo K, 2013, GASTROINTEST ENDOSC, V77, pAB305; Kawamoto H, 2008, CLIN GASTROENTEROL H, V6, P401, DOI 10.1016/j.cgh.2007.12.036; Kogure H, 2011, SURG ENDOSC, V25, P463, DOI 10.1007/s00464-010-1194-8; Kogure H, 2014, DIGEST ENDOSC, V26, P93, DOI 10.1111/den.12055; Law R, 2013, DIGEST DIS SCI, V58, P2667, DOI 10.1007/s10620-013-2671-4; Lee JH, 2007, GASTROINTEST ENDOSC, V66, P364, DOI 10.1016/j.gie.2006.12.061; Lee TH, 2013, DIGEST DIS SCI, V58, P547, DOI 10.1007/s10620-012-2346-6; Lee TH, 2013, ENDOSCOPY, V45, P106, DOI 10.1055/s-0032-1325928; Mukai T, 2011, J HEPATO-BIL-PAN SCI, V18, P646, DOI 10.1007/s00534-011-0406-5; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Okamoto T, 2006, J SURG ONCOL, V94, P614, DOI 10.1002/jso.20614	28	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					79	85		10.1002/jhbp.170		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200015		
J	Kubo, S				Kubo, Shoji			Re: Occupational cholangiocarcinoma	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Letter							PRINTING COMPANY; WORKERS; 1,2-DICHLOROPROPANE; DICHLOROMETHANE; JAPAN		Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	Kubo, S (reprint author), Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m7696493@msic.med.osaka-cu.ac.jp					Benbrahim-Tallaa L, 2014, LANCET ONCOL, V15, P924, DOI 10.1016/S1470-2045(14)70316-X; Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P479, DOI 10.1002/jhbp.86; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; Sithithaworn P, 2014, J HEPATO-BIL-PAN SCI, V21, P301, DOI 10.1002/jhbp.62; Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P809, DOI 10.1002/jhbp.137; Ministry of Heath Labour and Welfare, 2013, OCC BIL TRACT CANC C; Vlaanderen J, 2013, OCCUP ENVIRON MED, V70, P828, DOI 10.1136/oemed-2013-101500	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JAN	2015	22	1					E2	E3		10.1002/jhbp.191		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9MS	WOS:000346582200002		
J	Kokudo, T; Hasegawa, K; Kokudo, N				Kokudo, Takashi; Hasegawa, Kiyoshi; Kokudo, Norihiro			Reply to: "ALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: A new opportunity?''	JOURNAL OF HEPATOLOGY			English	Letter							RESECTION		[Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Minagawa M, 2001, ANN SURG, V233, P379, DOI 10.1097/00000658-200103000-00012; Kokudo T, 2014, J HEPATOL, V61, P583, DOI 10.1016/j.jhep.2014.04.032; Aoki T, 2004, ARCH SURG-CHICAGO, V139, P766, DOI 10.1001/archsurg.139.7.766; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Vennarecci G, 2014, EJSO-EUR J SURG ONC, V40, P982, DOI 10.1016/j.ejso.2014.04.002; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Inoue Y, 2009, SURGERY, V145, P9, DOI 10.1016/j.surg.2008.09.005; Schadde E, 2014, WORLD J SURG, V38, P1510, DOI 10.1007/s00268-014-2513-3	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	JAN	2015	62	1					243	243				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW6BM	WOS:000346354500037		
J	Inagi, T; Suzuki, M; Osumi, M; Bito, H				Inagi, T.; Suzuki, M.; Osumi, M.; Bito, H.			Remifentanil-based anaesthesia increases the incidence of postoperative surgical site infection	JOURNAL OF HOSPITAL INFECTION			English	Article						Immunosuppression; Remifentanil; Surgical site infection	INDUCED IMMUNOSUPPRESSION; GASTROINTESTINAL SURGERY; WITHDRAWAL HYPERALGESIA; RISK-FACTORS; TOTAL HIP; COMPLICATIONS; SURVEILLANCE; STRESS; SYSTEM; OXYGEN	Background: Surgical site infection (SSI) after colorectal surgery is the leading cause of postoperative morbidity. Opioids induce immunosuppression through activation of mu-opioid receptors expressed on leucocytes, and through opioid withdrawal. A high dose of opioid administered as remifentanil during surgery may induce immunosuppression, leading to the development of SSI. Aim: The purpose of this study was to investigate the influence of remifentanil on the development of SSI. Methods: Adult patients who underwent elective colorectal surgery from January 2009 to December 2012 (N = 286) were prospectively investigated according to the guidelines of the US Centers for Disease Control and Prevention. After exclusion of 51 patients, propensity matching was performed in 235 patients. To reduce the influence of selection on SSIs, propensity score pairwise matching was performed for patients maintained with remifentanil and for patients maintained with fentanyl. Findings: The number of patients who developed SSI was higher after remifentanil-based anaesthesia compared with fentanyl-based anaesthesia [11.6% (17/146) vs 3.4% (3/ 89), remifentanil vs fentanyl, P = 0.03] before propensity matching. Propensity matching yielded 61 pairs of patients anaesthetized with remifentanil or fentanyl, and corrected several biases in the preoperative patient characteristics. After propensity matching, the number of patients who developed SSI was still higher after remifentanil-based anaesthesia than after fentanyl-based anaesthesia [16.4% (10/61) vs 3.3% (2/61), remifentanil vs fentanyl, P = 0.029]. Conclusion: Remifentanil-based anaesthesia increased the incidence of SSI. A possible reason may be opioid-induced immunosuppression or opioid withdrawal-induced immunosuppression. (C) 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Inagi, T.; Suzuki, M.; Osumi, M.; Bito, H.] Nippon Med Sch, Musashikosugi Hosp, Dept Anaesthesiol, Kawasaki, Kanagawa 2118533, Japan	Suzuki, M (reprint author), Nippon Med Sch, Musashikosugi Hosp, Dept Anaesthesiol, Nakahara Ku, 1-396 Kosugi Machi, Kawasaki, Kanagawa 2118533, Japan.	manzo@nms.ac.jp					Anannamcharoen Sahaphol, 2012, Journal of the Medical Association of Thailand, V95, P42; El Solh AA, 2006, RESP MED, V100, P729, DOI 10.1016/j.rmed.2005.07.011; CHUANG TK, 1995, BIOCHEM BIOPH RES CO, V216, P922, DOI 10.1006/bbrc.1995.2709; Ahlers O, 2008, BRIT J ANAESTH, V101, P781, DOI 10.1093/bja/aen287; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Volk T, 2004, ANESTH ANALG, V98, P1086, DOI 10.1213/01.ANE.0000104586.12700.3A; Meyhoff CS, 2012, CURR OPIN ANESTHESIO, V25, P363, DOI 10.1097/ACO.0b013e328352b402; Watanabe A, 2008, SURG TODAY, V38, P404, DOI 10.1007/s00595-007-3637-y; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Chang CC, 2010, ANESTHESIOLOGY, V113, P279, DOI 10.1097/ALN.0b013e3181e2c1c3; Winterhalter M, 2008, EUR J ANAESTH, V25, P326, DOI 10.1017/S0265021507003043; [Anonymous], 2004, AM J INFECT CONTROL, V32, P470; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Sorensen LT, 2005, ANN SURG, V241, P654, DOI 10.1097/01.sla.0000157131.84130.12; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; Cong ZJ, 2009, WORLD J SURG, V33, P1292, DOI 10.1007/s00268-009-0008-4; Ata A, 2010, ARCH SURG-CHICAGO, V145, P858, DOI 10.1001/archsurg.2010.179; De Oliveira AC, 2006, AM J INFECT CONTROL, V34, P201, DOI 10.1016/j.ajic.2005.12.011; Eisenstein TK, 2006, J NEUROIMMUNE PHARM, V1, P237, DOI 10.1007/s11481-006-9019-1; Fakhry SM, 2012, SURG INFECT, V13, P228, DOI 10.1089/sur.2012.122; Feng P, 2006, INFECT IMMUN, V74, P5221, DOI 10.1128/IAI.00208-06; FLORES LR, 1995, J PHARMACOL EXP THER, V272, P1246; Hasegawa A, 2011, SURG TODAY, V41, P1617, DOI 10.1007/s00595-010-4457-z; Huenger F, 2005, AM J INFECT CONTROL, V33, P455, DOI 10.1016/j.ajic.2005.05.008; Ishida R, 2012, ANESTH ANALG, V114, P224, DOI 10.1213/ANE.0b013e318237f678; Kawagoe Izumi, 2011, Masui, V60, P416; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P96; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P133; Meyhoff CS, 2012, ANESTH ANALG, V115, P734, DOI 10.1213/ANE.0b013e31825d3a67; Nseir S, 2009, CRIT CARE, V13, DOI 10.1186/cc7788; Sato Keita, 2011, Masui, V60, P441; Schwacha MG, 2006, AM J SURG, V192, P82, DOI 10.1016/j.amjsurg.2006.01.001; Shimizu K, 2010, J HOSP INFECT, V74, P129, DOI 10.1016/j.jhin.2009.10.011; Tabuchi Y, 1989, J Anesth, V3, P123, DOI 10.1007/s0054090030123; Wang JH, 2005, J IMMUNOL, V174, P426	36	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	JAN	2015	89	1			SI		61	68		10.1016/j.jhin.2014.10.001		8	Infectious Diseases	Infectious Diseases	AX0ID	WOS:000346635200008		
J	Atrabi, HB; Hosoda, T; Tada, A				Atrabi, Hamid Bashiri; Hosoda, Takashi; Tada, Akihide			Simulation of Air Cavity Advancing into a Straight Duct	JOURNAL OF HYDRAULIC ENGINEERING			English	Article						Pressurized flow; Transient flow; Free surface flow; Hydrostatic pressure; Boussinesq model; Solitary wave	GRAVITY CURRENTS; MIXED FLOWS; MOTION; BUBBLES; TUBES	Two fundamental one-dimensional (1D) models are proposed and applied to simulate the transient flows with the propagation of an interface in a water-filled duct. The proposed models are developed to simulate the unsteady open channel flows based on finite-volume method (FVM). The models presented herein are based on the continuity and momentum equations of free surface and pressurized flows and the momentum equation of an interface between both flows. However, the highly simplified marker and cell (HSMAC) method with pressure iteration procedures is applied to the pressurized flow region. The numerical simulations are performed under the hydraulic conditions of previous experiments, and then simulated results were compared with the experimental data. It is pointed out that the solitary wave solution is able to reproduce the air cavity profile. In contrast to the hydrostatic model, results of the Boussinesq model compare reasonably well to the experimental observations. (C) 2014 American Society of Civil Engineers.	[Atrabi, Hamid Bashiri; Hosoda, Takashi] Kyoto Univ, Grad Sch Engn, Dept Urban Management, Kyoto 6158540, Japan; [Tada, Akihide] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan	Atrabi, HB (reprint author), Kyoto Univ, Grad Sch Engn, Dept Urban Management, Kyoto 6158540, Japan.	bashiri.hamid.33u@stu.kyoto-u.ac.jp; hosoda.takashi.4w@kyoto-u.ac.jp; atada@nagasaki-u.ac.jp					HIRT CW, 1972, J COMPUT PHYS, V10, P324, DOI 10.1016/0021-9991(72)90070-8; Bousso S, 2013, J HYDRAUL ENG-ASCE, V139, P385, DOI 10.1061/(ASCE)HY.1943-7900.0000680; Leon AS, 2010, J HYDRAUL RES, V48, P44, DOI 10.1080/00221680903565911; BENJAMIN TB, 1968, J FLUID MECH, V31, P209, DOI 10.1017/S0022112068000133; Azis K., 1972, FLOW COMPLEX MIXTURE; Baines W. D., 1986, J HYDRAUL RES, V25, P157; BAINES WD, 1991, J HYDRAUL ENG-ASCE, V117, P1600, DOI 10.1061/(ASCE)0733-9429(1991)117:12(1600); BAINES WD, 1985, J FLUID MECH, V161, P313, DOI 10.1017/S0022112085002956; Boussinesq J., 1877, MEMOIRES PRESENTES D, V23, P1; Chaudhry M. F., 1993, OPEN CHANNEL FLOW; Fischer H. B., 1979, MIXING INLAND COASTA; GARDNER GC, 1970, J FLUID MECH, V43, P247, DOI 10.1017/S0022112070002343; Hager WH, 1999, INT J MULTIPHAS FLOW, V25, P349, DOI 10.1016/S0301-9322(98)00046-9; HARTEN A, 1983, J COMPUT PHYS, V49, P357, DOI 10.1016/0021-9991(83)90136-5; Hosoda T., 1994, J HYDRAUL COAST ENV, V503, P89; Hosoda T., 1993, P INT S COMP FLUID D, V1, P291; Inoue K., 1986, THESIS KYOTO U JAPAN; Iwasa Y., 1955, P 5 JAP NAT C APPL M, V14, P315; Kimura I, 2009, J HYDRAUL ENG-ASCE, V135, P118, DOI 10.1061/(ASCE)0733-9429(2009)135:2(118); Rodi W., 1993, TURBULENCE MODELS TH; Rouse H, 1946, ELEMENTARY MECH FLUI; Sandover J. A., 1957, J WATER POWER, V9, P418; SUNDQUIST MJ, 1983, J TRANSP ENG-ASCE, V109, P232; Vasconcelos JG, 2008, J HYDRAUL ENG-ASCE, V134, P984, DOI 10.1061/(ASCE)0733-9429(2008)134:7(984); WILKINSON DL, 1982, J FLUID MECH, V118, P109, DOI 10.1017/S0022112082000986; Yen B. C., 1980, 149 U ILL URB CHAMP; ZUKOSKI EE, 1966, J FLUID MECH, V25, P821, DOI 10.1017/S0022112066000442	27	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9429	1943-7900		J HYDRAUL ENG	J. Hydraul. Eng.-ASCE	JAN	2015	141	1							04014068	10.1061/(ASCE)HY.1943-7900.0000953		9	Engineering, Civil; Engineering, Mechanical; Water Resources	Engineering; Water Resources	AW5SQ	WOS:000346334600005		
J	Leong, CR; Oshiumi, H; Okamoto, M; Azuma, M; Takaki, H; Matsumoto, M; Chayama, K; Seya, T				Leong, Chean Ring; Oshiumi, Hiroyuki; Okamoto, Masaaki; Azuma, Masahiro; Takaki, Hiromi; Matsumoto, Misako; Chayama, Kazuaki; Seya, Tsukasa			A MAVS/TICAM-1-Independent Interferon-Inducing Pathway Contributes to Regulation of Hepatitis B Virus Replication in the Mouse Hydrodynamic Injection Model	JOURNAL OF INNATE IMMUNITY			English	Article						Type I interferon; Hepatitis B virus regulation; Toll/IL-1R homology domain-containing adaptor molecule 1; Mitochondrial antiviral signaling protein; Pathogen-associated molecular patterns	INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; RIG-I; HBV REPLICATION; BETA INDUCTION; STRANDED-RNA; X PROTEIN; INFECTION; DNA; RECOGNITION	Toll-like receptors (TLRs) and cytoplasmic RNA sensors have been reported to be involved in the regulation of hepatitis B virus (HBV) replication, but remain controversial due to the lack of a natural infectious model. Our current study sets out to characterize aspects of the role of the innate immune system in eliminating HBV using hydrodynamic-based injection of HBV replicative plasmid and knockout mice deficient in specific pathways of the innate system. The evidence indicated that viral replication was not affected by MAVS or TICAM-1 knockout, but absence of interferon regulatory factor 3 (IRF-3) and IRF-7 transcription factors, as well as the interferon (IFN) receptor, had an adverse effect on the inhibition of HBV replication, demonstrating the dispensability of MAVS and TICAM-1 pathways in the early innate response against HBV. Myd88(-/-) mice did not have a significant increase in the initial viremia, but substantial viral antigen persisted in the mice sera, a response similar to Rag2(-/-) mice, suggesting that the MyD88-dependent pathway participated in evoking an adaptive immune response against the clearance of intrahepatic HBV. Taken together, we show that the RNA-sensing pathways do not participate in the regulation of HBV replication in a mouse model; meanwhile MyD88 is implicated in the HBV clearance. (C) 2014 S. Karger AG, Basel	[Leong, Chean Ring; Oshiumi, Hiroyuki; Okamoto, Masaaki; Azuma, Masahiro; Takaki, Hiromi; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 0608638, Japan; [Chayama, Kazuaki] Hokkaido Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Sapporo, Hokkaido 0608638, Japan	Seya, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp	OSHIUMI, HIROYUKI/G-1645-2012		Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Yasuda Cancer Foundation; Ono Foundation; MEXT; National Cancer Center Research and Development Fund [23-A-44]; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture and the Ministry of Health, Labor, and Welfare of Japan, and the Yasuda Cancer Foundation (T. S.) and the Ono Foundation (T. S.). Financial support by a MEXT Grant-in-Project 'The Carcinogenic Spiral', 'The National Cancer Center Research and Development Fund (23-A-44)', and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) are gratefully acknowledged. We are grateful to Drs. H. Shime, J. Kasamatsu, K. Funami, and M. Tatematsu in our laboratory for their fruitful discussions. We thank Dr. F. V. Chisari (Scripps Research Institute, La Jolla, Calif., USA) for providing us with HBV plasmid and sleeping beauty.	Aly HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021284; Diebold SS, 2008, ADV DRUG DELIVER REV, V60, P813, DOI 10.1016/j.addr.2007.11.004; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Zuckerman JN, 2000, J INFECTION, V41, P130, DOI 10.1053/jinf.2000.0720; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Wang XM, 2010, CELL MOL IMMUNOL, V7, P341, DOI 10.1038/cmi.2010.36; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Tan AT, 2014, J HEPATOL, V60, P54, DOI 10.1016/j.jhep.2013.08.020; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Oshiumi H, 2011, J IMMUNOL, V187, P5320, DOI 10.4049/jimmunol.1101503; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Lv SJ, 2014, HEPATOLOGY, V59, P385, DOI 10.1002/hep.26654; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083639; ter Borg MJ, 2008, J CLIN VIROL, V42, P160, DOI 10.1016/j.jcv.2008.02.007; Tian YJ, 2012, J VIROL, V86, P9599, DOI 10.1128/JVI.01087-12	40	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1662-811X	1662-8128		J INNATE IMMUN	J. Innate Immun.		2015	7	1					47	58		10.1159/000365113		12	Immunology	Immunology	AW4FC	WOS:000346235500006		
J	Dinale, A; Hirata, K; Zoppi, M; Murakami, T				Dinale, Aiko; Hirata, Kazuya; Zoppi, Matteo; Murakami, Toshiyuki			Parameter Design of Disturbance Observer for a Robust Control of Two-Wheeled Wheelchair System	JOURNAL OF INTELLIGENT & ROBOTIC SYSTEMS			English	Article						Two-wheeled wheelchair; Robust motion control; Disturbance observer; Inverted pendulum; Inertia parameters calibration; Stability analysis	POWER-ASSISTED WHEELCHAIR; MANIPULATOR; MOBILE	The wheelchair system presented in this research has only two wheels. This mechanical choice increases the maneuverability of the wheelchair itself, making the system more agile and able to overcome small obstacles (e.g. step, bump, rough terrain, etc.) in different kinds of environments. In addition, the user is able to train her/his body, since it is necessary to lean the body forward and backward to drive the wheelchair along the corresponding direction. Besides these advantages, there is a big drawback: the system is naturally unstable. For this reason, a motion controller is necessary to keep the wheelchair balanced. Furthermore, it is not possible to have a direct control along the pitch direction and a stable configuration is reached only through the actuation of the wheels. In order to estimate the torque acting on the pitch direction, the synthesized pitch angle disturbance observer (SPADO) is introduced. The results collected by SPADO combined with a Lyapunov controller makes the stabilization possible. During the design phase, particular attention should be paid to the inertia parameters variation, otherwise the performance of the entire system decreases. A detailed stability analysis is carried on to identify, from a theoretical point of view, the best parameter tuning. Then, the results from the experiments on the real platform are presented to verify the theoretical results.	[Dinale, Aiko; Zoppi, Matteo] Univ Genoa, Dept Mech Engn, Genoa, Italy; [Hirata, Kazuya; Murakami, Toshiyuki] Keio Univ, Yokohama, Kanagawa 223, Japan	Dinale, A (reprint author), Univ Genoa, Dept Mech Engn, Genoa, Italy.	dinale@dimec.unige.it; hirata@sum.sd.keio.ac.jp; zoppi@dimec.unige.it; mura@sd.keio.ac.jp		Zoppi, Matteo/0000-0003-0122-3196			Abeygunawardhana PKW, 2010, IEEE T IND ELECTRON, V57, P4137, DOI 10.1109/TIE.2010.2044115; Acar C., 2011, THESIS KEIO U; Ahmad S, 2008, C IND ELECT APPL, P461; AHMAD S, 2008, NATL GEOGR, V213, P8; Sawatzky B, 2007, ARCH PHYS MED REHAB, V88, P1423, DOI 10.1016/j.apnir.2007.08.005; Simpson RC, 2005, J REHABIL RES DEV, V42, P423, DOI 10.1682/JRRD.2004.08.0101; Cooper RA, 2002, IEEE T CONTR SYST T, V10, P121, DOI 10.1109/87.974345; Grasser F, 2002, IEEE T IND ELECTRON, V49, P107, DOI 10.1109/41.982254; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Murakami T., 1993, Asia-Pacific Workshop on Advances in Motion Control Proceedings (Cat. No.93TH0541-3), DOI 10.1109/APWAM.1993.316177; Nakamura A, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P4863, DOI 10.1109/IROS.2009.5353911; Ohnishi K., 1993, J ROBOT SOC JPN; Takahashi Y, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P364, DOI 10.1109/ISDA.2005.67; Tashiro S, 2008, IEEE T IND ELECTRON, V55, P1715, DOI 10.1109/TIE.2008.917061; YUN XP, 1993, IROS 93 : PROCEEDINGS OF THE 1993 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOL 1-3, P1288, DOI 10.1109/IROS.1993.583753	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-0296	1573-0409		J INTELL ROBOT SYST	J. Intell. Robot. Syst.	JAN	2015	77	1			SI		135	148		10.1007/s10846-014-0142-6		14	Computer Science, Artificial Intelligence; Robotics	Computer Science; Robotics	AW3FX	WOS:000346172800010		
J	Morisaka, H; Motosugi, U; Ichikawa, S; Sano, K; Ichikawa, T; Enomoto, N				Morisaka, Hiroyuki; Motosugi, Utaroh; Ichikawa, Shintaro; Sano, Katsuhiro; Ichikawa, Tomoaki; Enomoto, Nobuyuki			Association of Splenic MR Elastographic Findings With Gastroesophageal Varices in Patients With Chronic Liver Disease	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MR elastography; liver cirrhosis; portal hypertension; spleen stiffness; phase-contrast MRI	MAGNETIC-RESONANCE ELASTOGRAPHY; HCV-RELATED CIRRHOSIS; PLATELET RATIO INDEX; CHRONIC HEPATITIS-C; PORTAL-HYPERTENSION; ESOPHAGEAL-VARICES; NONINVASIVE PREDICTION; STIFFNESS MEASUREMENTS; HEALTHY-VOLUNTEERS; TISSUE ELASTICITY	PurposeTo identify magnetic resonance imaging (MRI)-based parameters associated with gastroesophageal varices (GEVs) in patients with chronic liver disease. Materials and MethodsNinety-three patients were divided into three groups based on endoscopic findings: group 1 with no GEVs (n=49), group 2 with mild GEVs (n=30), and group 3 with severe GEVs (n=14). We used a multivariate logistic regression analysis to assess liver stiffness, aspartate aminotransferase-to-platelet ratio index, spleen stiffness and volume, portal vein velocity, cross-sectional area, and flow volumes potential independent associators of any (mild and severe) GEVs or severe GEVs. ResultsThe analysis showed that spleen and liver stiffness and spleen volume were independently associated with any GEVs (spleen stiffness, odds ratio [95% confidence interval], 1.25 [1.04-1.68], P=0.018; liver stiffness, 1.52 [1.13-2.17], P=0.006; spleen volume, 1.01 [1.00-1.01], P=0.016), whereas spleen stiffness was associated with severe GEVs (1.82 [1.25-2.95]; P=0.005). Conclusion:Liver and spleen stiffness and spleen volume are associated with GEVs in patients with chronic liver disease. Compared with liver stiffness and spleen volume, spleen stiffness is more strongly associated with severe GEVs. J. Magn. Reson. Imaging 2015;41:117-124. (c) 2013 Wiley Periodicals, Inc.	[Morisaka, Hiroyuki; Motosugi, Utaroh; Ichikawa, Shintaro; Sano, Katsuhiro; Ichikawa, Tomoaki] Univ Yamanashi, Dept Radiol, Chuo, Yamanashi 4093898, Japan; [Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo, Yamanashi 4093898, Japan	Motosugi, U (reprint author), Univ Yamanashi, Dept Radiol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	utaroh-motosugi@nifty.com					Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Warner L, 2011, INVEST RADIOL, V46, P509, DOI 10.1097/RLI.0b013e3182183a95; Stankovic Z, 2012, RADIOLOGY, V262, P862, DOI 10.1148/radiol.11110127; Mannelli L, 2010, AM J ROENTGENOL, V195, P387, DOI 10.2214/AJR.09.3390; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Stankovic Z, 2010, J MAGN RESON IMAGING, V32, P466, DOI 10.1002/jmri.22248; Reiberger T, 2012, WIEN KLIN WOCHENSCHR, V124, P395, DOI 10.1007/s00508-012-0190-5; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; Yetter EM, 2003, AM J ROENTGENOL, V181, P1615; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Yin M, 2013, J MAGN RESON IMAGING, V38, P809, DOI 10.1002/jmri.24049; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Berzigotti A, 2008, AM J GASTROENTEROL, V103, P1159, DOI 10.1111/j.1572-0241.2008.01826.x; Kim YJ, 2007, AM J ROENTGENOL, V188, P139, DOI 10.2214/AJR.05.1737; Nedredal GI, 2011, J MAGN RESON IMAGING, V34, P79, DOI 10.1002/jmri.22610; Baig WW, 2008, CAN J GASTROENTEROL, V22, P825; BURKART DJ, 1995, RADIOLOGY, V194, P801; desFranchis R, 2010, J HEPATOL, V53, P762; Fontana RJ, 2010, GASTROENTEROLOGY, V138, P2321, DOI 10.1053/j.gastro.2010.02.058; Fontana RJ, 2010, GASTROENTEROLOGY, V138; Francois CJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-16; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Goshima S, 2009, MAGN RESON IMAGING, V27, P1230, DOI 10.1016/j.mri.2009.05.030; Gouya H, 2011, RADIOLOGY, V261, P144, DOI 10.1148/radiol.11101541; Hirooka M, 2011, RADIOLOGY, V261, P960, DOI 10.1148/radiol.11110156; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291; Joseph T, 2011, SAUDI J GASTROENTERO, V17, P36, DOI 10.4103/1319-3767.74465; Lee YJ, 2013, J MAGN RESON IMAGING; Li FH, 2005, WORLD J GASTROENTERO, V11, P4560; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; Min Yang Won, 2012, Clin Mol Hepatol, V18, P178, DOI 10.3350/cmh.2012.18.2.178; Morisaka H, 2013, MAGN RESON MED SCI, V12, P77, DOI 10.2463/mrms.2012-0052; Plestina S, 2005, WIEN KLIN WOCHENSCHR, V117, P711, DOI 10.1007/s00508-005-0424-x; Sarangapani Arulprakash, 2010, Saudi J Gastroenterol, V16, P38, DOI 10.4103/1319-3767.58767; Singh IK, 2011, PEDIATR SURG INT, V27, P467, DOI 10.1007/s00383-010-2847-3; Tsukuda T, 2005, J MAGN RESON IMAGING, V22, P527, DOI 10.1002/jmri.20419; Yin M, 2011, AM J ROENTGENOL, V197, P64, DOI 10.2214/AJR.10.5989; de Mattos AZ, 2013, ANN HEPATOL, V12, P810	45	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JAN	2015	41	1					117	124		10.1002/jmri.24505		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW7EP	WOS:000346427800013		
J	Oki, H; Hayashida, Y; Oki, H; Kakeda, S; Aoki, T; Taguchi, M; Harada, M; Korogi, Y				Oki, Hodaka; Hayashida, Yoshiko; Oki, Haruka; Kakeda, Shingo; Aoki, Takatoshi; Taguchi, Masashi; Harada, Masaru; Korogi, Yukunori			DWI Findings of Autoimmune Pancreatitis: Comparison Between Symptomatic and Asymptomatic Patients	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						magnetic resonance imaging; autoimmune pancreatitis; diffusion-weighted image; fat-suppressed T1-weighted images; apparent diffusion coefficient	MR-IMAGING FINDINGS; FEATURES; CT; DIAGNOSIS; INVOLVEMENT; THERAPY	PurposeTo compare the MR findings including diffusion-weighted imaging (DWI) between symptomatic and asymptomatic patients with autoimmune pancreatitis (AIP) and to determine whether DWI can be used as an objective biomarker for symptomatic AIP, which is considered an indication for steroid therapy. Materials and MethodsThis retrospective study was approved by our institutional review board. MRI scans from 37 patients with AIP (symptomatic, n=19; asymptomatic, n=18) were retrospectively evaluated. The imaging studies were performed on a 1.5 Tesla scanner and assessed for parenchymal enlargement, narrowing of the main pancreatic duct, hypointensity on fat-suppressed T1-weighted images (FS-T1WI), a capsule-like rim, extrapancreatic lesions, and hyperintensity on DWI. The findings were compared by univariate and multivariate logistic regression analysis. Apparent diffusion coefficient (ADC) values were also calculated. ResultsMultivariate analysis showed that hyperintensity on DWI were most significantly associated with the symptoms of AIP (odds ratio=28.2; P=0.003). Interobserver agreement for DWI was also high. The ADC values were significantly lower in symptomatic than in asymptomatic patients (0.940.17 versus 1.16 +/- 0.16 x 10(-3) mm(2)/s, P<0.001). Receiver operating characteristic curve analysis of the ADC values to differentiate between symptomatic and asymptomatic patients showed that sensitivity was 68.4%, specificity 83.3%, and AUC 0.74. ConclusionSignal intensity on DWI and ADC value were well correlated with the active symptoms of AIP patients. DWI may be useful as an objective biomarker for determining the indication for steroid therapy. J. Magn. Reson. Imaging 2015;41:125-131. (c) 2013 Wiley Periodicals, Inc.	[Oki, Hodaka; Hayashida, Yoshiko; Oki, Haruka; Kakeda, Shingo; Aoki, Takatoshi; Korogi, Yukunori] Univ Occupat & Environm Hlth, Dept Radiol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Taguchi, Masashi; Harada, Masaru] Univ Occupat & Environm Hlth, Dept Internal Med 3, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Oki, H (reprint author), Univ Occupat & Environm Hlth, Dept Radiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	h-ooki@med.uoeh-u.ac.jp					Nishino T, 2005, PANCREAS, V30, P76; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Kloppel G, 2003, PANCREAS, V27, P14, DOI 10.1097/00006676-200307000-00002; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; Manfredi R, 2011, RADIOLOGY, V260, P428, DOI 10.1148/radiol.11101729; Kamisawa T, 2010, J GASTROENTEROL, V45, P471, DOI 10.1007/s00535-010-0221-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Sahani DV, 2004, RADIOLOGY, V233, P345, DOI 10.1148/radiol.2332031436; Okazaki K, 2010, J GASTROENTEROL, V45, P249, DOI 10.1007/s00535-009-0184-x; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Suda K, 2007, J GASTROENTEROL, V42, P22, DOI 10.1007/s00535-007-2047-7; SVANHOLM H, 1989, APMIS, V97, P689; Chari ST, 2009, PANCREAS, V38, P846, DOI 10.1097/MPA.0b013e3181bba281; Takahashi N, 2007, RADIOLOGY, V242, P791, DOI 10.1148/radiol.2423060003; Sahani DV, 2009, RADIOLOGY, V250, P118, DOI 10.1148/radiol.2493080279; Kamisawa T, 2010, AM J GASTROENTEROL, V105, P1870, DOI 10.1038/ajg.2010.87; Manfredi R, 2008, RADIOLOGY, V247, P435, DOI 10.1148/radiol.2472070598; Carbognin G, 2009, RADIOL MED, V114, P1214, DOI 10.1007/s11547-009-0452-0; Eerens I, 2001, EUR RADIOL, V11, P1401, DOI 10.1007/s003300000742; Irie H, 1998, AM J ROENTGENOL, V170, P1323; Kamisawa T, 2004, GASTROINTEST ENDOSC, V59, P865, DOI 10.1016/S0016-5107(04)00344-X; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P2919; Kloppel G, 2007, J GASTROENTEROL, V42, P28, DOI 10.1007/s00535-007-2048-6; Okazaki K, 2009, PANCREAS, V38, P849, DOI 10.1097/MPA.0b013e3181b9ee1c; Procacci C, 2001, PANCREATOLOGY, V1, P246, DOI 10.1159/000055819; Taniguchi T, 2009, JPN J RADIOL, V27, P138, DOI 10.1007/s11604-008-0311-2; Yang DH, 2006, ABDOM IMAGING, V31, P94, DOI 10.1007/s00261-005-0047-8	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JAN	2015	41	1					125	131		10.1002/jmri.24508		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW7EP	WOS:000346427800014		
J	Ishikawa, T; Takehara, Y; Yamashita, S; Iwashima, S; Sugiyama, M; Wakayama, T; Johnson, K; Wieben, O; Sakahara, H; Ogata, T				Ishikawa, Takamichi; Takehara, Yasuo; Yamashita, Shuhei; Iwashima, Satoru; Sugiyama, Masataka; Wakayama, Tetsuya; Johnson, Kevin; Wieben, Oliver; Sakahara, Harumi; Ogata, Tsutomu			Hemodynamic Assessment in a Child With Renovascular Hypertension Using Time-Resolved Three-Dimensional Cine Phase-Contrast MRI	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						flow analysis; magnetic resonance imaging; renovascular hypertension; percutaneous balloon angioplasty; children	RENAL-ARTERY STENOSIS; ANGIOPLASTY; ANGIOGRAPHY	Renovascular hypertension (RVH) is an important cause of hypertension in children. It is essential to assess the hemodynamics of RVH lesions in detail. We herein report the case of a 9-year-old female with RVH caused by left renal artery stenosis in which the hemodynamics of the lesions were assessed with time-resolved three-dimensional cine phase-contrast MRI (3D cine PC MRI) with a vastly undersampled 3D radial projection imaging trajectory before and after percutaneous transluminal renal angioplasty (PTRA). The utility of 3D cine PC MRA for diagnosing RVH and evaluating the renal blood flow pre- and post-PTRA is presented. J. Magn. Reson. Imaging 2015;41:165-168. (c) 2014 Wiley Periodicals, Inc.	[Ishikawa, Takamichi; Iwashima, Satoru; Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan; [Takehara, Yasuo; Yamashita, Shuhei; Sugiyama, Masataka; Sakahara, Harumi] Hamamatsu Univ Sch Med, Dept Radiol, Hamamatsu, Shizuoka 4313192, Japan; [Wakayama, Tetsuya] GE Healthcare, Tokyo, Japan; [Johnson, Kevin; Wieben, Oliver] Univ Wisconsin, Dept Radiol, Sch Med, Madison, WI 53706 USA	Takehara, Y (reprint author), Hamamatsu Univ Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	takehara@hama-med.ac.jp					Bernstein EJ, 2012, BEST PRACT RES CL RH, V26, P489, DOI 10.1016/j.berh.2012.07.008; Bley TA, 2011, RADIOLOGY, V261, P266, DOI 10.1148/radiol.11101175; Courtel JV, 1998, PEDIATR RADIOL, V28, P59, DOI 10.1007/s002470050294; Francois CJ, 2011, RADIOLOGY, V258, P254, DOI 10.1148/radiol.10100443; Haas NA, 2002, CATHETER CARDIO INTE, V56, P227, DOI 10.1002/ccd.10171; Lum DP, 2007, RADIOLOGY, V245, P751, DOI 10.1148/radiol.2453061946; Shroff R, 2006, PEDIATRICS, V118, P268, DOI 10.1542/peds.2005-2642	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JAN	2015	41	1					165	168		10.1002/jmri.24522		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW7EP	WOS:000346427800019		
J	Inoue, C; Fujii, S; Kaneda, S; Fukunaga, T; Kaminou, T; Kigawa, J; Harada, T; Ogawa, T				Inoue, Chie; Fujii, Shinya; Kaneda, Sachi; Fukunaga, Takeru; Kaminou, Toshio; Kigawa, Junzo; Harada, Tasuku; Ogawa, Toshihide			Correlation of Apparent Diffusion Coefficient Value With Prognostic Parameters of Endometrioid Carcinoma	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MR; diffusion; apparent diffusion coefficient; ADC; endometrioid carcinoma; prognostic parameters	MYOMETRIAL INVASION; WEIGHTED MRI; DIAGNOSTIC-ACCURACY; TUMOR GRADE; INITIAL-EXPERIENCE; HISTOGRAM ANALYSIS; CERVICAL-CANCER; RENAL LESIONS; CELLULARITY; BENIGN	PurposeTo correlate the apparent diffusion coefficient (ADC) of endometrioid carcinoma with histological tumor grade and degree of myometrial invasion. Materials and Methods3T diffusion-weighted (DW) magnetic resonance (MR) images of 63 patients were retrospectively reviewed. Two readers measured tumor ADC according to a freehand region of interest (ROI) and a round ROI. Mean and minimum ADCs were correlated with prognostic parameters. ResultsThe minimum ADC was 0.64 x 10(-3)mm(2)/s for grade 1 (G1, n=42), 0.62 for grade 2 (G2, n=14), 0.46 for grade 3 (G3, n=7) on freehand ROI. There were significant differences between G1 and G3 (P=0.007), and G2 and G3 (P=0.038). No significant correlation was found between tumor grade and mean ADC (0.85 for G1, 0.82 for G2, and 0.72 for G3, P=0.166). The minimum ADC was significantly lower for patients with deep (n=21, 0.54) than for those with superficial (n=39, 0.65) myometrial invasion. Conversely, mean ADC did not differ significantly (0.84 for superficial and 0.78 for deep myometrial invasion, P=0.081). The same tendency was shown on round ROI. ConclusionThe minimum ADC correlates with prognostic parameters of endometrial carcinoma more strongly than mean ADC. Lower minimum ADC is associated with higher histological tumor grade and higher degree of myometrial invasion. J. Magn. Reson. Imaging 2015;41:213-219. (c) 2013 Wiley Periodicals, Inc.	[Inoue, Chie; Fujii, Shinya; Kaneda, Sachi; Fukunaga, Takeru; Kaminou, Toshio; Ogawa, Toshihide] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 6838504, Japan; [Kigawa, Junzo; Harada, Tasuku] Tottori Univ, Fac Med, Dept Surg, Div Reprod Perinatal Med & Gynecol Oncol, Yonago, Tottori 6838504, Japan	Inoue, C (reprint author), Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	inoue.c@med.tottori-u.ac.jp					Fujii S, 2008, J MAGN RESON IMAGING, V28, P1149, DOI 10.1002/jmri.21575; Nagar H, 2006, GYNECOL ONCOL, V103, P431, DOI 10.1016/j.ygyno.2006.03.016; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Heo SH, 2013, KOREAN J RADIOL, V14, P616, DOI 10.3348/kjr.2013.14.4.616; Squillaci E, 2004, ANTICANCER RES, V24, P4175; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Beddy P, 2012, RADIOLOGY, V262, P530, DOI 10.1148/radiol.11110984; Nakamura K, 2012, GYNECOL ONCOL, V124, P335, DOI 10.1016/j.ygyno.2011.10.014; Cao K, 2012, EUR J RADIOL, V81, P1926, DOI 10.1016/j.ejrad.2011.04.019; Shen SH, 2008, AM J ROENTGENOL, V190, P481, DOI 10.2214/AJR.07.2155; Takeuchi M, 2009, ACTA RADIOL, V50, P947, DOI 10.1080/02841850903099981; Dogan D, 2013, ABDOM IMAGING, V38, P388, DOI 10.1007/s00261-012-9915-1; Lin G, 2009, RADIOLOGY, V250, P784, DOI 10.1148/radiol.2503080874; Taouli B, 2009, RADIOLOGY, V251, P398, DOI 10.1148/radiol.2512080880; Matsuki M, 2007, EUR RADIOL, V17, P201, DOI 10.1007/s00330-006-0281-7; Lin G, 2008, J MAGN RESON IMAGING, V28, P128, DOI 10.1002/jmri.21412; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; Manfredi R, 2004, RADIOLOGY, V231, P372, DOI 10.1148/radiol.2312021184; Rechichi G, 2010, EUR RADIOL, V20, P754, DOI 10.1007/s00330-009-1597-x; Kyriazi S, 2011, RADIOLOGY, V261, P182, DOI 10.1148/radiol.11110577; Naganawa S, 2005, EUR RADIOL, V15, P71, DOI 10.1007/s00330-004-2529-4; Kinkel K, 1999, RADIOLOGY, V212, P711; Nasu K, 2006, RADIOLOGY, V239, P122, DOI 10.1148/radiol.2383041384; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Sato C, 2005, J MAGN RESON IMAGING, V21, P258, DOI 10.1002/jmri.20251; Hayashida Y, 2006, EUR RADIOL, V16, P2637, DOI 10.1007/s00330-006-0342-y; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Tamai K, 2007, J MAGN RESON IMAGING, V26, P682, DOI 10.1002/jmri.20997; Rechichi G, 2011, AM J ROENTGENOL, V197, P256, DOI 10.2214/AJR.10.5584; Fujii S, 2008, EUR RADIOL, V18, P18, DOI 10.1007/s00330-007-0732-9; Manenti G, 2008, RADIOL MED, V113, P199, DOI 10.1007/s11547-008-0246-9; Whittaker CS, 2009, RADIOGRAPHICS, V29, P759, DOI 10.1148/rg.293085130; Bharwani N, 2011, BRIT J RADIOL, V84, P997, DOI 10.1259/bjr/14980811; Choi HJ, 2006, AM J ROENTGENOL, V187, P538; Cova M, 2004, BRIT J RADIOL, V77, P851, DOI 10.1259/bjr/26525081; Ichikawa T, 2006, AM J ROENTGENOL, V187, P181, DOI 10.2214/AJR.05.1005; Inoue C, 2013, J MAGN RESO IN PRESS; Manfredi R, 2009, RADIOL MED, V114, P960, DOI 10.1007/s11547-009-0397-3; Padhani Anwar R, 2009, Neoplasia, V11, P102; Rechichi G, 2013, EUR RADIOL, V23, P65, DOI 10.1007/s00330-012-2575-2; Wang JP, 2010, J COMPUT ASSIST TOMO, V34, P332, DOI 10.1097/RCT.0b013e3181d0f666; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JAN	2015	41	1					213	219		10.1002/jmri.24534		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW7EP	WOS:000346427800025		
J	Mikie, T; Saeki, A; Masuda, H; Ikuma, N; Kokubo, K; Seki, S				Mikie, Tsubasa; Saeki, Akinori; Masuda, Hiroyuki; Ikuma, Naohiko; Kokubo, Ken; Seki, Shu			New efficient (thio)acetalized fullerene monoadducts for organic solar cells: characterization based on solubility, mobility balance, and dark current	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							OPEN-CIRCUIT VOLTAGE; POWER CONVERSION EFFICIENCY; POLYMER PHOTOVOLTAIC CELLS; OPTOELECTRONIC PROPERTIES; INDENE-C-60 BISADDUCT; CONJUGATED POLYMERS; HOLE TRANSPORT; PERFORMANCE; ELECTRON; ACCEPTORS	We report a systematic study of organic photovoltaic cells using novel spiro-acetalized and (thio)acetalized [60]fullerene monoadducts bearing five-to seven-membered rings. One of these compounds had power-conversion efficiencies of 5.8% with PTB7 and 4.0% with poly(3-hexylthiophene); the latter is comparable to that of the commonly used [6,6]-phenyl-C-61-butyric acid methyl ester. We investigated the precise factor that governs the device performance by examining the solubility, space-charge-limited current mobility balance of holes and electrons, morphology, and dark current. Single-crystal X-ray diffraction highlighted the key role of compact and flexible spiro ring folding in the rim space in fullerene packing.	[Mikie, Tsubasa; Saeki, Akinori; Masuda, Hiroyuki; Ikuma, Naohiko; Kokubo, Ken; Seki, Shu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Saeki, A (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	saeki@chem.eng.osaka-u.ac.jp; kokubo@chem.eng.osaka-u.ac.jp; seki@chem.eng.osaka-u.ac.jp	Saeki, Akinori/B-7756-2011; Seki, Shu/E-5346-2010; Ikuma, Naohiko/O-1157-2015	Seki, Shu/0000-0001-7851-4405; Ikuma, Naohiko/0000-0002-8282-9407	JSPS; PRESTO program of JST; KAKENHI from MEXT, Japan; Foundation for the Promotion Ion Engineering, Japan	This work was supported by the JSPS Funding Program for NEXT Program, the PRESTO program of JST, and KAKENHI from MEXT, Japan. T. M. acknowledges the financial support of a JSPS scholarship. A.S. acknowledges the grant-in-aid from The Foundation for the Promotion Ion Engineering, Japan.	Ye L, 2014, CHEM MATER, V26, P3603, DOI 10.1021/cm501513n; Perez MD, 2009, J AM CHEM SOC, V131, P9281, DOI 10.1021/ja9007722; Li YF, 2013, CHEM-ASIAN J, V8, P2316, DOI 10.1002/asia.201300600; Kim KH, 2012, CHEM MATER, V24, P2373, DOI 10.1021/cm3010369; Faist MA, 2013, ADV ENERGY MATER, V3, P744, DOI 10.1002/aenm.201200673; Guo XG, 2013, NAT PHOTONICS, V7, P825, DOI 10.1038/NPHOTON.2013.207; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; He YJ, 2010, J AM CHEM SOC, V132, P1377, DOI 10.1021/ja908602j; Liu MS, 2002, MACROMOLECULES, V35, P3532, DOI 10.1021/ma011790f; Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Backer SA, 2007, CHEM MATER, V19, P2927, DOI 10.1021/cm070893v; Yamamoto S, 2012, ADV ENERGY MATER, V2, P229, DOI 10.1002/aenm.201100549; Janssen RAJ, 2013, ADV MATER, V25, P1847, DOI 10.1002/adma.201202873; Ide M, 2013, J PHYS CHEM C, V117, P26859, DOI 10.1021/jp4104728; Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574; Nguyen TL, 2014, ENERG ENVIRON SCI, V7, P3040, DOI 10.1039/c4ee01529k; Zhang CY, 2012, ORG LETT, V14, P1508, DOI 10.1021/ol3002392; Schilinsky P, 2002, APPL PHYS LETT, V81, P3885, DOI 10.1063/1.1521244; Park SH, 2009, J MATER CHEM, V19, P5624, DOI 10.1039/b904535j; Li G, 2012, NAT PHOTONICS, V6, P153, DOI 10.1038/NPHOTON.2012.11; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Matsuo Y, 2013, ADV MATER, V25, P6266, DOI 10.1002/adma.201302607; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Cardona CM, 2011, ADV MATER, V23, P2367, DOI 10.1002/adma.201004554; Liang YY, 2009, J AM CHEM SOC, V131, P56, DOI 10.1021/ja808373p; Troshin PA, 2009, ADV FUNCT MATER, V19, P779, DOI 10.1002/adfm.200801189; He D, 2014, ORG LETT, V16, P612, DOI 10.1021/ol4035275; Kong J, 2014, ADV MATER, V26, P6275, DOI 10.1002/adma.201402182; Guo X, 2012, ADV MATER, V24, P6536, DOI 10.1002/adma.201202719; Kang H, 2012, ACS APPL MATER INTER, V4, P110, DOI 10.1021/am201075y; Melzer C, 2004, ADV FUNCT MATER, V14, P865, DOI 10.1002/adfm.200305156; Cheng P, 2014, ENERG ENVIRON SCI, V7, P2005, DOI 10.1039/c3ee44202k; Lenes M, 2008, ADV MATER, V20, P2116, DOI 10.1002/adma.200702438; Matsuo Y, 2012, CHEM COMMUN, V48, P3878, DOI 10.1039/c2cc30262d; Zhou HX, 2011, ANGEW CHEM INT EDIT, V50, P2995, DOI 10.1002/anie.201005451; Kooistra FB, 2007, ORG LETT, V9, P551, DOI 10.1021/ol062666p; Mi D, 2014, J NANOSCI NANOTECHNO, V14, P1064, DOI 10.1166/jnn.2014.9007; Li K, 2013, J AM CHEM SOC, V135, P13549, DOI 10.1021/ja406220a; Chen LM, 2009, ADV MATER, V21, P1434, DOI 10.1002/adma.200802854; Nardes AM, 2012, ADV FUNCT MATER, V22, P4115, DOI 10.1002/adfm.201200336; Dimitrov SD, 2014, CHEM MATER, V26, P616, DOI 10.1021/cm402403z; Cabanetos C, 2013, J AM CHEM SOC, V135, P4656, DOI 10.1021/ja400365b; Kirner S, 2014, ADV MATER, V26, P1482, DOI 10.1002/adma.201304928; Zhao GJ, 2010, ADV MATER, V22, P4355, DOI 10.1002/adma.201001339; Zhao HY, 2010, J MATER CHEM, V20, P3092, DOI 10.1039/b925089a; Matsuo Y, 2008, CHEM REV, V108, P3016, DOI 10.1021/cr0684218; Li WW, 2013, J AM CHEM SOC, V135, P5529, DOI 10.1021/ja401434x; Xin H, 2012, CHEM MATER, V24, P1995, DOI 10.1021/cm300355e; Mihailetchi VD, 2006, ADV FUNCT MATER, V16, P699, DOI 10.1002/adfm.200500420; Honda S, 2011, ADV ENERGY MATER, V1, P588, DOI 10.1002/aenm.201100094; Zhang Y, 2011, J AM CHEM SOC, V133, P8086, DOI 10.1021/ja201267t; Blom PWM, 1996, APPL PHYS LETT, V68, P3308, DOI 10.1063/1.116583; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Saeki A, 2011, ADV ENERGY MATER, V1, P661, DOI 10.1002/aenm.201100143; Saeki A, 2014, J MATER CHEM A, V2, P6075, DOI 10.1039/c3ta14109h; Chen CP, 2011, CHEM COMMUN, V47, P1845, DOI 10.1039/c0cc04246c; He YJ, 2012, J MATER CHEM, V22, P13391, DOI 10.1039/c2jm31712e; Kokubo K, 2013, TETRAHEDRON LETT, V54, P3510, DOI 10.1016/j.tetlet.2013.04.093; Kotlarki JD, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3663860; Lu SR, 2013, ORG LETT, V15, P5674, DOI 10.1021/ol4026606; Rispens MT, 2003, CHEM COMMUN, P2116, DOI 10.1039/b305988j; Vijayakumar C, 2012, CHEM-ASIAN J, V7, P1845, DOI 10.1002/asia.201200082; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	64	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	3					1152	1157		10.1039/c4ta05965d		6	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW6YB	WOS:000346410400029		
J	Han, DL; Shinoda, K; Sato, S; Majima, M; Uda, T				Han, Donglin; Shinoda, Kozo; Sato, Shigeo; Majima, Masatoshi; Uda, Tetsuya			Correlation between electroconductive and structural properties of proton conductive acceptor-doped barium zirconate	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							EFFECTIVE IONIC-RADII; CERAMIC FUEL-CELLS; CATION NONSTOICHIOMETRY; CHEMICAL EXPANSION; SITE OCCUPANCY; BAZRO3; BACEO3; MICROSTRUCTURE; HYDROGEN; BEHAVIOR	Various dopants were added to BaZrO3 and the conductivities, the proton concentrations, the site occupancy of the dopants and the change in lattice volume as a result of chemical expansion were investigated. Lanthanide group dopants occupied both the Ba and Zr sites, but the amount of these dopants in the Ba site was too limited to significantly influence the conductivity. The samples doped with Yb, Tm, Er, Y and Ho showed both high proton concentrations and high conductivities, together with a relatively large lattice expansion as a result of hydration. We therefore suggest that, in most instances, the proton concentration, proton conductivity and lattice change as a result of chemical expansion were all correlated in proton conductive acceptor-doped BaZrO3. However, Sc-doped BaZrO3 seemed to be different. Its proton concentration was high, but the conductivity and lattice change as a result of chemical expansion were relatively small. This indicates that the conductivity was strongly related to the lattice expansion resulting from hydration rather than simply the proton concentration.	[Han, Donglin; Uda, Tetsuya] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Shinoda, Kozo] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Shigeo] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Majima, Masatoshi] Sumitomo Elect Ind Ltd, Itami, Hyogo 6640016, Japan	Han, DL (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan.	han.donglin.8n@kyoto-u.ac.jp	Han, Donglin/D-4348-2013	Han, Donglin/0000-0003-1692-8850			Yamazaki Y, 2013, NAT MATER, V12, P647, DOI [10.1038/nmat3638, 10.1038/NMAT3638]; Han DL, 2010, SOLID STATE IONICS, V181, P1601, DOI 10.1016/j.ssi.2010.09.009; Hiraiwa C, 2013, J AM CERAM SOC, V96, P879, DOI 10.1111/jace.12172; Yamazaki Y, 2009, CHEM MATER, V21, P2755, DOI 10.1021/cm900208w; Blanc F, 2014, J PHYS CHEM LETT, V5, P2431, DOI 10.1021/jz5007669; Wu J, 2005, CHEM MATER, V17, P846, DOI 10.1021/cm048763z; Pergolesi D, 2010, NAT MATER, V9, P846, DOI [10.1038/nmat2837, 10.1038/NMAT2837]; Han D, 2014, J MATER CHEM A, V2, P12552, DOI 10.1039/c4ta01689k; Coors WG, 2003, J POWER SOURCES, V118, P150, DOI 10.1016/S0378-7753(03)00072-7; Yamazaki Y, 2010, J MATER CHEM, V20, P8158, DOI 10.1039/c0jm02013c; Han DL, 2013, J SOLID STATE CHEM, V205, P122, DOI 10.1016/j.jssc.2013.07.010; KNOP O, 1974, CAN J CHEM, V52, P2175, DOI 10.1139/v74-315; Han DL, 2014, J AM CERAM SOC, V97, P643, DOI 10.1111/jace.12681; Andersson AKE, 2014, J AM CERAM SOC, V97, P2654, DOI 10.1111/jace.12990; Azad AK, 2008, J MATER CHEM, V18, P3414, DOI 10.1039/b806190d; Han DL, 2014, J ELECTROCHEM SOC, V161, pF977, DOI 10.1149/2.0211410jes; Han DL, 2013, J MATER CHEM A, V1, P3027, DOI 10.1039/c2ta00675h; Han DL, 2012, SOLID STATE IONICS, V213, P2, DOI 10.1016/j.ssi.2011.09.005; Han DL, 2014, RSC ADV, V4, P31589, DOI 10.1039/c4ra04488f; Han DL, 2012, ADV MATER, V24, P2051, DOI 10.1002/adma.201200127; Imashuku S, 2009, J ELECTROCHEM SOC, V156, pB1, DOI 10.1149/1.2999335; Jones CY, 2005, J APPL PHYS, V97, DOI 10.1063/1.1922590; Norby T, 2004, DALTON T, P3012, DOI 10.1039/b403011g; Okumura Y, 2011, J ELECTROCHEM SOC, V158, pB1067, DOI 10.1149/1.3606374; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Slade RCT, 1995, SOLID STATE IONICS, V82, P135, DOI 10.1016/0167-2738(95)00212-8; Thundathil MA, 2005, CHEM MATER, V17, P5146, DOI 10.1021/cm0505895k; Yamaguchi S, 2003, SOLID STATE IONICS, V162, P23, DOI 10.1016/S0167-2738(03)00249-2	28	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	3					1243	1250		10.1039/c4ta05701e		8	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW6YB	WOS:000346410400041		
J	Nakano, M; Osaka, I; Takimiya, K				Nakano, Masahiro; Osaka, Itaru; Takimiya, Kazuo			Dibenzo[a,e]pentalene-embedded dicyanomethylene-substituted thienoquinoidals for n-channel organic semiconductors: synthesis, properties, and device characteristics	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; TERTHIOPHENE-BASED QUINODIMETHANE; ELECTRON-ACCEPTORS BEARING; HIGH-PERFORMANCE; QUINOIDAL OLIGOTHIOPHENES; HETEROQUINONOID SYSTEM; CONDUCTIVE COMPLEXES; DERIVATIVES; NAPHTHALENE	Dibenzo[a,e]pentalene-embedded thienoquinoidals with dicyanomethylene termini were synthesized as new pi-extended thienoquinoidals for n-type organic semiconductors. Single crystal X-ray analysis demonstrated that the target molecule has an all trans-polyene structure with reasonable bond-length alternation in the thienoquinoidal strand, indicative of effective extension of the pi-conjugation system. Thanks to their pi-extended structures, not just the low-lying LUMO energy levels (-4.2 to -4.3 eV) but also relatively high HOMO energy levels (similar to-5.6 eV) were characterized by means of cyclic voltammetry. Interestingly, depending on the position of the solubilizing long alkyl groups, they formed H- or J-aggregate-like structures in the thin-film state testified by the thin film absorption spectra. These distinct intermolecular interactions in the thin film state could cause different behaviours in thin-film field-effect transistors; for the former ambipolar characteristics were observed, whereas only n-type response was detected for the latter.	[Nakano, Masahiro; Osaka, Itaru; Takimiya, Kazuo] RIKEN, CEMS, Emergent Mol Funct Res Grp, Wako, Saitama 3510198, Japan; [Takimiya, Kazuo] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Takimiya, K (reprint author), RIKEN, CEMS, Emergent Mol Funct Res Grp, Wako, Saitama 3510198, Japan.	takimiya@riken.jp	Nakano, Masahiro/A-2328-2014; Takimiya, Kazuo/A-5841-2010; Osaka, Itaru/B-3153-2010	Takimiya, Kazuo/0000-0002-6001-1129; 	MEXT, Japan [23245041, 25.1759]; Japan Society for the Promotion of Science (JSPS)	This work was financially supported by Grants-in-Aid for Scientific Research (nos 23245041 and 25.1759) from MEXT, Japan. HRMSs were carried out at the Natural Science Centre for Basic Research and Development (N-BARD), Hiroshima University. We also thank Rigaku Corp. for the single crystal X-ray analysis. One of the authors (M.N.) is grateful for the Postdoctoral Fellowship of the Japan Society for the Promotion of Science (JSPS).	Wurthner F, 2011, CHEM COMMUN, V47, P5109, DOI 10.1039/c1cc10321k; Sakamoto Y, 2004, J AM CHEM SOC, V126, P8138, DOI 10.1021/ja0476258; Suzuki Y, 2010, J AM CHEM SOC, V132, P10453, DOI 10.1021/ja103171y; Anthony JE, 2010, ADV MATER, V22, P3876, DOI 10.1002/adma.200903628; Menard E, 2004, ADV MATER, V16, P2097, DOI 10.1002/adma.200401017; Liu ZT, 2014, ADV MATER, V26, P6965, DOI 10.1002/adma.201305718; Wu QH, 2011, CHEM MATER, V23, P3138, DOI 10.1021/cm201326c; Ribierre JC, 2010, ADV MATER, V22, P1722, DOI 10.1002/adma.200903152; Wu QH, 2013, ADV FUNCT MATER, V23, P2277, DOI 10.1002/adfm.201202744; Mori T, 2014, ORG LETT, V16, P1334, DOI 10.1021/ol5000567; Ong BS, 2004, J AM CHEM SOC, V126, P3378, DOI 10.1021/ja039772w; Suzuki Y, 2011, CHEM MATER, V23, P795, DOI 10.1021/cm102109p; Pappenfus TM, 2002, J AM CHEM SOC, V124, P4184, DOI 10.1021/ja025553j; Singh TB, 2005, J APPL PHYS, V97, DOI 10.1063/1.1895466; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; YUI K, 1989, B CHEM SOC JPN, V62, P1547, DOI 10.1246/bcsj.62.1547; Suraru SL, 2011, CHEM COMMUN, V47, P11504, DOI 10.1039/c1cc15144d; Yang JT, 2000, J ORG CHEM, V65, P6739, DOI 10.1021/jo991140y; Zhan XW, 2011, ADV MATER, V23, P268, DOI 10.1002/adma.201001402; Gao XK, 2014, J MATER CHEM C, V2, P3099, DOI 10.1039/c3tc32046d; BROWN AR, 1994, SYNTHETIC MET, V66, P257, DOI 10.1016/0379-6779(94)90075-2; Bao ZA, 1998, J AM CHEM SOC, V120, P207, DOI 10.1021/ja9727629; Waldauf C, 2003, ADV MATER, V15, P2084, DOI 10.1002/adma.200305623; Casado J, 2012, CHEM SOC REV, V41, P5672, DOI 10.1039/c2cs35079c; Yanai N, 2014, ORG LETT, V16, P240, DOI 10.1021/ol403234q; FERRARIS J, 1973, J AM CHEM SOC, V95, P948, DOI 10.1021/ja00784a066; deLeeuw DM, 1997, SYNTHETIC MET, V87, P53, DOI 10.1016/S0379-6779(97)80097-5; Handa S, 2007, J AM CHEM SOC, V129, P11684, DOI 10.1021/ja074607s; Mishra A, 2000, CHEM REV, V100, P1973, DOI 10.1021/cr990402t; Qiao YL, 2012, J AM CHEM SOC, V134, P4084, DOI 10.1021/ja3003183; Zhong HL, 2012, ADV MATER, V24, P3205, DOI 10.1002/adma.201200859; Facchetti A, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70017-2; HADDON RC, 1995, APPL PHYS LETT, V67, P121, DOI 10.1063/1.115503; Laquindanum JG, 1996, J AM CHEM SOC, V118, P11331, DOI 10.1021/ja962461j; Klapars A, 2002, J AM CHEM SOC, V124, P14844, DOI 10.1021/ja028865v; Burla MC, 2007, J APPL CRYSTALLOGR, V40, P609, DOI 10.1107/S0021889807010941; Bao Z., 2007, ORGANIC FIELD EFFECT; Berlin A, 2005, J PHYS CHEM B, V109, P22308, DOI 10.1021/jp054204j; Casado J, 2002, J AM CHEM SOC, V124, P12380, DOI 10.1021/ja027161i; Chesterfield RJ, 2003, ADV MATER, V15, P1278, DOI 10.1002/adma.200305200; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Fukutomi Y., 2014, J AM CHEM SOC, V135, P11445; GRONOWITZ S, 1974, ACTA CHEM SCAND B, VB 28, P981, DOI 10.3891/acta.chem.scand.28b-0981; Guo XG, 2014, CHEM REV, V114, P8943, DOI 10.1021/cr500225d; Handa S, 2009, CHEM COMMUN, P3919, DOI 10.1039/b905472c; INOKUCHI H, 1986, CHEM LETT, P1263, DOI 10.1246/cl.1986.1263; Kashiki T, 2009, CHEM LETT, V38, P568, DOI 10.1246/cl.2009.568; Klauk H., 2006, ORGANIC ELECTRONICS; Klauk H., 2012, ORGANIC ELECTRONICS; Kunugi Y, 2004, J MATER CHEM, V14, P1367, DOI 10.1039/b401209g; Martin N, 1997, J MATER CHEM, V7, P1661, DOI 10.1039/a702314f; Nakano M, 2014, J MATER CHEM C, V2, P64, DOI 10.1039/c3tc31630k; Ribierre JC, 2011, J PHYS CHEM C, V115, P20703, DOI 10.1021/jp206129g; Rigaku, 2011, CRYSTALSTRUCTURE VER; Rudebusch GE, 2014, CHEM SCI, V5, P3627, DOI 10.1039/c4sc01432d; Sommer M., 2014, J MATER CHEM C, P3088; Suraru SL, 2014, ANGEW CHEM INT EDIT, V53, P7428, DOI 10.1002/anie.201309746; UNO M, 1984, J CHEM SOC CHEM COMM, P932, DOI 10.1039/c39840000932; Usta H., 2011, ACCOUNTS CHEM RES, P501; YUI K, 1987, CHEM LETT, P2339, DOI 10.1246/cl.1987.2339; YUI K, 1989, B CHEM SOC JPN, V62, P1539, DOI 10.1246/bcsj.62.1539; YUI K, 1987, J CHEM SOC CHEM COMM, P1816, DOI 10.1039/c39870001816	62	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	2					283	290		10.1039/c4tc02164a		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AW9HO	WOS:000346568200010		
J	Chiba, M; Thanh, MN; Hasegawa, Y; Obora, Y; Kawasaki, H; Yonezawa, T				Chiba, Masashi; Mai Nguyen Thanh; Hasegawa, Yasuchika; Obora, Yasushi; Kawasaki, Hideya; Yonezawa, Tetsu			Synthesis of binary solid solution Cu-Pd nanoparticles by DMF reduction for enhanced photoluminescence properties	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							ELECTRONIC-STRUCTURE; BIMETALLIC CLUSTERS; METAL-CLUSTERS; QUANTUM DOTS; NOBLE-METAL; FORMIC-ACID; NANOCLUSTERS; PALLADIUM; CATALYSIS; SILVER	We report the use of a DMF reduction method for straightforward synthesis of binary solid solution Cu-Pd nanoparticles (NPs) over the entire range of composition. The resulting NPs were uniform in size (less than 2.5 nm), tunable in composition, and exhibited photoluminescence properties that were nonlinear in composition. These binary solid solution NPs showed enhanced photoluminescence intensity and quantum yield compared to those of the single-metal NPs and their mixtures. The highest quantum yield of 3.10% for Cu-Pd alloy NPs synthesized using equimolar feeding ratio versus 2.75% for Cu and 0.71% for Pd NPs was obtained. These enhancements make the alloy NPs promising materials for optical applications.	[Chiba, Masashi; Mai Nguyen Thanh; Yonezawa, Tetsu] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Div Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Obora, Yasushi; Kawasaki, Hideya] Kansai Univ, Dept Chem, Suita, Osaka, Japan	Yonezawa, T (reprint author), Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	tetsu@eng.hokudai.ac.jp	Yonezawa, Tetsu/E-5514-2012		MEXT, Japan [TY 25102501, YH 24102012]	The authors thank Dr Takayuki Nakanishi in Hokkaido Univ. for experimental assistance of QY measurements of our sample and also thank Drs S. Maenosono and K. Higashimine in JAIST for taking HAADF images of our sample. This work is partially supported by Grant-in-Aid for Scientific Research in Priority Area "New Polymeric Materials Based on Element-Blocks" from MEXT, Japan (to TY 25102501 and to YH 24102012).	Kurashige W, 2013, CHEM COMMUN, V49, P5447, DOI 10.1039/c3cc41210e; Muniz-Miranda M, 2011, J PHYS CHEM C, V115, P5021, DOI 10.1021/jp1086027; Diez I, 2012, NANOSCALE, V4, P4434, DOI 10.1039/c2nr30642e; Chen PC, 2014, NANOSCALE, V6, P3503, DOI 10.1039/c3nr06123j; WERTHEIM GK, 1986, PHYS REV B, V33, P5384, DOI 10.1103/PhysRevB.33.5384; Zhang H, 2012, CHEM COMMUN, V48, P567, DOI 10.1039/c1cc16088e; Andolina CM, 2013, J AM CHEM SOC, V135, P5266, DOI 10.1021/ja400569u; Atesin AC, 2012, J AM CHEM SOC, V134, P14682, DOI 10.1021/ja306309u; Zheng J, 2007, ANNU REV PHYS CHEM, V58, P409, DOI 10.1146/annurev.physchem.58.032806.104546; McFarland AD, 2003, NANO LETT, V3, P1057, DOI 10.1021/nl034372s; Chen M, 2013, BIOMATERIALS, V34, P4284, DOI 10.1016/j.biomaterials.2013.02.032; Zhang S, 2013, ANGEW CHEM INT EDIT, V52, P3681, DOI 10.1002/anie.201300276; Lee Y, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/41/415604; Yuan X, 2011, ACS NANO, V5, P8800, DOI 10.1021/nn202860s; Gu XJ, 2011, J AM CHEM SOC, V133, P11822, DOI 10.1021/ja200122f; Isomura Y, 2012, CHEM COMMUN, V48, P3784, DOI 10.1039/c2cc30975k; Liu XF, 2008, J PHYS CHEM C, V112, P10778, DOI 10.1021/jp8028227; Wilson OM, 2006, J AM CHEM SOC, V128, P4510, DOI 10.1021/ja058217m; MARTENSSON N, 1981, PHYS REV B, V24, P1725, DOI 10.1103/PhysRevB.24.1725; Teranishi T, 1998, CHEM MATER, V10, P594, DOI 10.1021/cm9705808; Tong YY, 1996, J PHYS CHEM-US, V100, P730, DOI 10.1021/jp951656v; Paramanik B, 2014, J MATER CHEM C, V2, P3005, DOI 10.1039/c3tc32434f; Vilar-Vidal N, 2010, J PHYS CHEM C, V114, P15924, DOI 10.1021/jp911380s; Hyotanishi M, 2011, CHEM COMMUN, V47, P5750, DOI 10.1039/c1cc11487e; Negishi Y, 2012, J PHYS CHEM LETT, V3, P2209, DOI 10.1021/jz300892w; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; MASON MG, 1983, PHYS REV B, V27, P748, DOI 10.1103/PhysRevB.27.748; Ganguly M, 2012, CHEM-EUR J, V18, P15845, DOI 10.1002/chem.201201242; JACOBS JWM, 1987, J CATAL, V103, P436, DOI 10.1016/0021-9517(87)90135-7; Kawasaki H, 2010, CHEM COMMUN, V46, P3759, DOI 10.1039/b925117k; Kobayashi Y, 2011, SOLID STATE SCI, V13, P553, DOI 10.1016/j.solidstatesciences.2010.12.025; Nakagawa K, 2013, J PHYS CONF SER, V417, DOI 10.1088/1742-6596/417/1/012038; Subramanian P., 1991, J PHASE EQUILIB, V12, P231, DOI 10.1007/BF02645723; TOSHIMA N, 1989, CHEM LETT, P1769, DOI 10.1246/cl.1989.1769; TOSHIMA N, 1990, CHEM LETT, P815, DOI 10.1246/cl.1990.815; Yamauchi M, 2005, SYNTHETIC MET, V153, P353, DOI 10.1016/j.synthmet.2005.07.296	36	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	3					514	520		10.1039/c4tc02129k		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AW9ID	WOS:000346569700005		
J	Gon, M; Morisaki, Y; Chujo, Y				Gon, Masayuki; Morisaki, Yasuhiro; Chujo, Yoshiki			Optically active cyclic compounds based on planar chiral [2.2]paracyclophane: extension of the conjugated systems and chiroptical properties	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							CIRCULARLY-POLARIZED LUMINESCENCE; SPACE CHARGE-TRANSFER; ENANTIOSELECTIVE SYNTHESIS; AXIAL CHIRALITY; MOLECULAR WIRE; THIN-FILMS; POLYMERS; DERIVATIVES; PARACYCLOPHANE; ELECTROLUMINESCENCE	A series of optically active cyclic compounds based on the planar chiral tetrasubstituted [2.2]paracyclophane core were synthesized to obtain luminescent materials with excellent chiroptical properties in both the ground and excited states. The optical resolution of tetrasubstituted [2.2]paracyclophane was carried out using our previously reported method. The obtained cyclic compounds were composed of the optically active propeller-shaped structures created by the [2.2]paracyclophane core with p-phenylene-ethynylene moieties. The compounds exhibited good optical profiles, with a large molar extinction coefficient (epsilon) and photoluminescence quantum efficiency (Phi(lum)). The emission occurred mainly from the propeller-shaped cyclic structures. This optically active higher-ordered structure provided chiroptical properties of high performance, such as a large specific rotation ([alpha](D)) and molar ellipticity ([theta]) in the ground state and intense circularly polarized luminescence (CPL) with large dissymmetry factors (g(lum)) in the excited state. The results suggest that planar chiral [2.2]paracyclophane- based optically active higher-ordered structures, such as the propeller-shaped cyclic structure, are promising scaffolds for obtaining CPL and that appropriate modifications can enhance the CPL characteristics.	[Gon, Masayuki; Morisaki, Yasuhiro; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Morisaki, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	ymo@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24685018]; Japan Society for the Promotion of Science [26-2514]	This work was supported by Grant-in-Aid for Young Scientists (A) (no. 24685018) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. M.G. appreciates Research Fellowships (no. 26-2514) from the Japan Society for the Promotion of Science for Young Scientists. The authors are grateful to Professor Kazuo Akagi and Mr Kazuyoshi Watanabe (Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University) for CPL data analysis and valuable discussions.	Amako T, 2013, TETRAHEDRON, V69, P2753, DOI 10.1016/j.tet.2013.01.084; Amako T, 2013, RSC ADV, V3, P6939, DOI 10.1039/c3ra23198d; Nagata Y, 2014, CHEM COMMUN, V50, P9951, DOI 10.1039/c4cc03944k; Kimoto T, 2012, CHEM-ASIAN J, V7, P2836, DOI 10.1002/asia.201200725; Watanabe K, 2014, POLYM CHEM-UK, V5, P712, DOI 10.1039/c3py01442h; Field JE, 2003, J AM CHEM SOC, V125, P11808, DOI 10.1021/ja035626e; Rowlands GJ, 2008, ORG BIOMOL CHEM, V6, P1527, DOI 10.1039/b800698a; Yu JM, 2011, CHEM COMMUN, V47, P3799, DOI 10.1039/c0cc05564f; Satrijo A, 2006, J AM CHEM SOC, V128, P9030, DOI 10.1021/ja063027c; Kumar J, 2014, J PHYS CHEM LETT, V5, P316, DOI 10.1021/jz402615n; Seferos DS, 2004, J ORG CHEM, V69, P1110, DOI 10.1021/jo035664g; Sawada Y, 2012, J AM CHEM SOC, V134, P4080, DOI 10.1021/ja300278e; Tsumatori H, 2010, ORG LETT, V12, P2362, DOI 10.1021/ol100701w; Zyss J, 2000, J AM CHEM SOC, V122, P11956, DOI 10.1021/ja0022526; Gibson SE, 2003, ORG BIOMOL CHEM, V1, P1256, DOI 10.1039/b300717k; Yang Y, 2013, ADV MATER, V25, P2624, DOI 10.1002/adma.201204961; Bartholomew GP, 2001, ACCOUNTS CHEM RES, V34, P30, DOI 10.1021/ar9901568; Morisaki Y, 2014, CHEM-EUR J, V20, P8386, DOI 10.1002/chem.201402930; Watanabe K, 2011, CHEM COMMUN, V47, P10996, DOI 10.1039/c1cc13711e; Kimoto T, 2013, ASIAN J ORG CHEM, V2, P404, DOI 10.1002/ajoc.201300034; Peeters E, 1997, J AM CHEM SOC, V119, P9909, DOI 10.1021/ja971912c; Morisaki Y, 2012, POLYM CHEM-UK, V3, P2727, DOI 10.1039/c2py20530k; CRAM DJ, 1955, J AM CHEM SOC, V77, P6289, DOI 10.1021/ja01628a067; Oda M, 2000, ADV MATER, V12, P362, DOI 10.1002/(SICI)1521-4095(200003)12:5<362::AID-ADMA362>3.0.CO;2-P; Morisaki Y, 2014, J AM CHEM SOC, V136, P3350, DOI 10.1021/ja412197j; Maeda H, 2011, J AM CHEM SOC, V133, P9266, DOI 10.1021/ja203206g; Zapf A, 2000, ANGEW CHEM INT EDIT, V39, P4153, DOI 10.1002/1521-3773(20001117)39:22<4153::AID-ANIE4153>3.0.CO;2-T; Kawagoe Y, 2010, NEW J CHEM, V34, P637, DOI 10.1039/b9nj00733d; Bartholomew GP, 2004, J AM CHEM SOC, V126, P11529, DOI 10.1021/ja038743i; Hong JW, 2005, J AM CHEM SOC, V127, P7435, DOI 10.1021/ja044326+; BROWN CJ, 1949, NATURE, V164, P915, DOI 10.1038/164915b0; Bazan GC, 1998, J AM CHEM SOC, V120, P9188, DOI 10.1021/ja973816h; Shiraki T, 2014, CHEM-ASIAN J, V9, P218, DOI 10.1002/asia.201301216; Bazan GC, 2007, J ORG CHEM, V72, P8615, DOI 10.1021/jo071176n; Bartholomew GP, 2002, J AM CHEM SOC, V124, P5183, DOI 10.1021/ja0121383; Kawai T, 2007, CHEMPHYSCHEM, V8, P1465, DOI 10.1002/cphc.200600747; Kumar J, 2013, CHEM-EUR J, V19, P14090, DOI 10.1002/chem.201302146; Morisaki Y, 2012, CHEM LETT, V41, P840, DOI 10.1246/cl.2012.840; Kaseyama T, 2011, ANGEW CHEM INT EDIT, V50, P3684, DOI 10.1002/anie.201007849; Oyama H, 2013, ORG LETT, V15, P2104, DOI 10.1021/ol4005036; Aly AA, 2009, TETRAHEDRON, V65, P8055, DOI 10.1016/j.tet.2009.06.034; Nakano Y, 2010, POLYM CHEM-UK, V1, P460, DOI 10.1039/b9py00288j; Wilson JN, 2002, J AM CHEM SOC, V124, P6830, DOI 10.1021/ja026532s; Hinrichs H, 2006, CHEM-EUR J, V12, P7103, DOI 10.1002/chem.200600498; Morisaki Y, 2012, CHEM-EUR J, V18, P4216, DOI 10.1002/chem.201103653; CRAM DJ, 1951, J AM CHEM SOC, V73, P5691, DOI 10.1021/ja01156a059; Haketa Y, 2012, ANGEW CHEM INT EDIT, V51, P7967, DOI 10.1002/anie.201202196; RIEHL JP, 1986, CHEM REV, V86, P1, DOI 10.1021/cr00071a001; Nakamura K, 2014, J AM CHEM SOC, V136, P5555, DOI 10.1021/ja500841f; Morisaki Y, 2006, ANGEW CHEM INT EDIT, V45, P6430, DOI 10.1002/anie.200600752; Bartholomew GP, 2002, SYNTHESIS-STUTTGART, P1245; Wang SJ, 2000, J AM CHEM SOC, V122, P1289, DOI 10.1021/ja991611y; Brabec C., 2008, ORGANIC PHOTOVOLTAIC; Fukao S, 2009, MACROMOLECULES, V42, P8062, DOI 10.1021/ma901427v; Gleiter R., 2004, MODERN CYCLOPHANE CH; Goto H, 2005, ANGEW CHEM INT EDIT, V44, P4322, DOI 10.1002/anie.200462859; Groza J. R., 2007, ORGANIC FIELD EFFECT; Hayasaka H, 2010, ADV FUNCT MATER, V20, P1243, DOI 10.1002/adfm.200902059; Hirahara T, 2012, CHEM LETT, V41, P905, DOI 10.1246/cl.2012.905; Kitayama Y, 2014, ORG BIOMOL CHEM, V12, P4342, DOI 10.1039/c4ob00340c; LangeveldVoss BMW, 1996, J AM CHEM SOC, V118, P4908, DOI 10.1021/ja9600643; Maeda H, 2013, PURE APPL CHEM, V85, P1967, DOI 10.1351/PAC-CON-12-11-09; Morisaki Y, 2011, POLYM CHEM-UK, V2, P1249, DOI 10.1039/c0py00421a; Morisaki Y, 2014, CHEM-ASIAN J, V9, P2891, DOI 10.1002/asia.201402653; Muellen K., 2006, ORGANIC LIGHT EMITTI; Oda M, 2002, MACROMOLECULES, V35, P6792, DOI 10.1021/ma020630g; Paradies J, 2011, SYNTHESIS-STUTTGART, P3749, DOI 10.1055/s-0031-1289296; Riehl J P, 2012, COMPREHENSIVE CHIROP; Rozenberg V., 2004, MODERN CYCLOPHANE CH, P435, DOI DOI 10.1002/3527603964.CH17; Sanchez-Carnerero EM, 2014, J AM CHEM SOC, V136, P3346, DOI 10.1021/ja412294s; Sandmeyer T., 1884, BER DTSCH CHEM GES, V17, P2650, DOI 10.1002/cber.188401702202; Sandmeyer T., 1884, BER DTSCH CHEM GES, V17, P1633, DOI 10.1002/cber.18840170219; Skotheim T. A., 2006, HANDBOOK OF CONDUCTI; Sonogashira K., 2002, HDB ORGANOPALLADIUM, P493, DOI DOI 10.1002/04712I2466.CH22; Tohda Y., 1975, TETRAHEDRON LETT, V16, P4467; Vogtle F., 1993, CYCLOPHANE CHEMISTRY; Vorontsova NV, 2008, CHEM-EUR J, V14, P4600, DOI 10.1002/chem.200701683	77	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	3					521	529		10.1039/c4tc02339k		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AW9ID	WOS:000346569700006		
J	Wang, JX; Yan, CY; Lin, MF; Tsukagoshi, K; Lee, PS				Wang, Jiangxin; Yan, Chaoyi; Lin, Meng-Fang; Tsukagoshi, Kazuhito; Lee, Pooi See			Solution-assembled nanowires for high performance flexible and transparent solar-blind photodetectors	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							THIN-FILM TRANSISTORS; ULTRAVIOLET PHOTODETECTORS; ZN2GEO4 NANOWIRES; ELECTRONICS; EFFICIENCY; NANOBELTS; NETWORKS	Solar-blind photodetectors based on Zn2GeO4 (ZGO) nanowires (NWs) with high transparency and good flexibility were successfully fabricated on a polyethylene terephthalate (PET) substrate using a facile all solution-processible method. The electrodes and functional channels are constructed with silver NWs (Ag NWs) and ZGO NWs, respectively, using a spray coating method. The spray-coated all-NW device exhibited high transparency, good mechanical bending stability, high photoresponse, and short cutoff wavelength. The Schottky barrier between the Ag-ZGO NWs together with the junction barrier between interconnecting ZGO NWs contributed to a high photoresponse and improved switching time in the devices. We propose that the unique energy band structure of the ZGO NW networks provides an additional mechanism to further reduce the cutoff wavelength in solar-blind photodetectors.	[Wang, Jiangxin; Yan, Chaoyi; Lee, Pooi See] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Lin, Meng-Fang; Tsukagoshi, Kazuhito] Natl Inst Mat Sci, Internat Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Lee, PS (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	pslee@ntu.edu.sg	LEE, Pooi See/D-4551-2009; TSUKAGOSHI, Kazuhito/H-2688-2011	LEE, Pooi See/0000-0003-1383-1623; 	NTU-A*Star Silicon Technologies Centre of Excellence [112 3510 0003]; Nanyang Technological University; Japan Society for the Promotion of Science (JSPS)	The authors would like to acknowledge the funding support from NTU-A*Star Silicon Technologies Centre of Excellence under the program grant no. 112 3510 0003. The work is also funded by the joint program between Singapore and Japan, with the support from Nanyang Technological University and Japan Society for the Promotion of Science (JSPS).	Wu H, 2010, NANO LETT, V10, P4242, DOI 10.1021/nl102725k; Liao CH, 2014, J PHYS CHEM C, V118, P8194, DOI 10.1021/jp500830x; van de Groep JV, 2012, NANO LETT, V12, P3138, DOI 10.1021/nl301045a; Liu XQ, 2014, ADV MATER, V26, P2919, DOI 10.1002/adma.201305073; Hou YN, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3563705; Yan CY, 2012, SCI ADV MATER, V4, P241, DOI 10.1166/sam.2012.1280; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Zhang JL, 2012, ACS NANO, V6, P7412, DOI 10.1021/nn3026172; Tian W, 2013, ADV MATER, V25, P4625, DOI 10.1002/adma.201301828; Garnett EC, 2012, NAT MATER, V11, P241, DOI [10.1038/nmat3238, 10.1038/NMAT3238]; Zou RJ, 2014, SMALL, V10, P1848, DOI 10.1002/smll.201302705; Hussain AA, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876450; Hu YF, 2010, ADV MATER, V22, P3327, DOI 10.1002/adma.201000278; Liu Z, 2013, J MATER CHEM C, V1, P131, DOI 10.1039/c2tc00055e; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/nnano.2012.224, 10.1038/NNANO.2012.224]; Wang JX, 2014, NANOSCALE, V6, P10734, DOI 10.1039/c4nr02462a; Kind H, 2002, ADV MATER, V14, P158, DOI 10.1002/1521-4095(20020116)14:2<158::AID-ADMA158>3.0.CO;2-W; Hu LF, 2011, SMALL, V7, P1012, DOI 10.1002/smll.201002379; Madaria AR, 2010, NANO RES, V3, P564, DOI 10.1007/s12274-010-0017-5; Liu Z, 2012, OPT EXPRESS, V20, P2982, DOI 10.1364/OE.20.002982; Soci C, 2010, J NANOSCI NANOTECHNO, V10, P1430, DOI 10.1166/jnn.2010.2157; Li L, 2010, ADV MATER, V22, P5145, DOI 10.1002/adma.201002608; Zhou J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133358; Razeghi M, 2002, P IEEE, V90, P1006, DOI 10.1109/JPROC.2002.1021565; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Aksoy B, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/32/325202; Wang JJ, 2009, J AM CHEM SOC, V131, P15602, DOI 10.1021/ja9072386; Chen PC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3069277; Li L, 2011, NANOSCALE, V3, P1120, DOI 10.1039/c0nr00702a; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Lee MS, 2013, NANO LETT, V13, P2814, DOI 10.1021/nl401070p; Walker D, 1999, APPL PHYS LETT, V74, P762, DOI 10.1063/1.123303; Li C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491212; Luo LB, 2012, CRYSTENGCOMM, V14, P1942, DOI 10.1039/c2ce06420k; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Tang J., 2008, ACS NANO, V3, P331; Wang JX, 2013, ACS APPL MATER INTER, V5, P6793, DOI 10.1021/am401234a; Wei TY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3285178; Yan C., 2010, APPL PHYS LETT, V96; Yan C., 2013, ADV MATER, V26, P943; Yu G, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/9/095703	41	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	3					596	600		10.1039/c4tc02297a		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AW9ID	WOS:000346569700014		
J	Mizuno, M; Matsumoto, A; Hamada, N; Ito, H; Miyauchi, A; Jimbo, EF; Momoi, MY; Tabata, H; Yamagata, T; Nagata, K				Mizuno, Makoto; Matsumoto, Ayumi; Hamada, Nanako; Ito, Hidenori; Miyauchi, Akihiko; Jimbo, Eriko F.; Momoi, Mariko Y.; Tabata, Hidenori; Yamagata, Takanori; Nagata, Koh-ichi			Role of an adaptor protein Lin-7B in brain development: possible involvement in autism spectrum disorders	JOURNAL OF NEUROCHEMISTRY			English	Article						autism; cerebral cortex; development; Lin-7B; neuronal migration	CELL-CELL JUNCTIONS; NEURONAL MIGRATION; RHO-EFFECTOR; PDZ PROTEINS; COMPLEX; CORTEX; IDENTIFICATION; DOUBLECORTIN; ASSOCIATION; COCHAPERONE	Using comparative genomic hybridization analysis for an autism spectrum disorder (ASD) patient, a 73-Kb duplication at 19q13.33 (nt. 49562755-49635956) including LIN7B and 5 other genes was detected. We then identified a novel frameshift mutation in LIN7B in another ASD patient. Since LIN7B encodes a scaffold protein essential for neuronal function, we analyzed the role of Lin-7B in the development of cerebral cortex. Acute knockdown of Lin-7B with in utero electroporation caused a delay in neuronal migration during corticogenesis. When Lin-7B was knocked down in cortical neurons in one hemisphere, their axons failed to extend efficiently into the contralateral hemisphere after leaving the corpus callosum. Meanwhile, enhanced expression of Lin-7B had no effects on both cortical neuron migration and axon growth. Notably, silencing of Lin-7B did not affect the proliferation of neuronal progenitors and stem cells. Taken together, Lin-7B was found to play a pivotal role in corticogenesis through the regulation of excitatory neuron migration and interhemispheric axon growth, while further analyses are required to directly link functional defects of Lin-7B to ASD pathophysiology.	[Mizuno, Makoto; Hamada, Nanako; Ito, Hidenori; Tabata, Hidenori; Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi 4800392, Japan; [Matsumoto, Ayumi; Miyauchi, Akihiko; Jimbo, Eriko F.; Momoi, Mariko Y.; Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan	Nagata, K (reprint author), Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, 713-8 Kamiya, Kasugai, Aichi 4800392, Japan.	takanori@jichi.ac.jp; knagata@inst-hsc.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [24390271, 23390275]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Takeda Science Foundation; Novartis Foundation Grants from The Japan Science Society	We thank Dr Giovanna Lalli (King's College London, UK) for critical reading of the manuscript. This work was supported in part by grants from Ministry of Education, Science, Technology, Sports and Culture of Japan (grant number 24390271 and 23390275), MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2011-2015 (Cooperative Basic and Clinical Research on Circadian Medicine), Takeda Science Foundation and the Novartis Foundation Grants from The Japan Science Society. The authors have no conflicts of interest to declare.	Corbo JC, 2002, J NEUROSCI, V22, P7548; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Inaguma Y, 2014, EMBO MOL MED, V6, P414, DOI 10.1002/emmm.201303069; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Reiner O, 2009, MOL NEUROBIOL, V40, P1, DOI 10.1007/s12035-009-8065-0; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Shinoda T, 2010, MOL BIOL CELL, V21, P1324, DOI 10.1091/mbc.E09-10-0869; Lanktree M, 2008, AM J MED GENET B, V147B, P945, DOI 10.1002/ajmg.b.30723; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Nagata K, 2009, MED MOL MORPHOL, V42, P9, DOI 10.1007/s00795-008-0433-8; Ito H, 2010, MOL PSYCHIATR, V15, P976, DOI 10.1038/mp.2010.69; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Crespi A, 2012, J CELL SCI, V125, P4543, DOI 10.1242/jcs.106484; Irie M, 1999, ONCOGENE, V18, P2811, DOI 10.1038/sj.onc.1202652; Jo K, 1999, J NEUROSCI, V19, P4189; Matsumoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092695; Misawa H, 2001, J BIOL CHEM, V276, P9264, DOI 10.1074/jbc.M009334200; Mizutani Y, 2013, BIOL CHEM, V394, P281, DOI 10.1515/hsz-2012-0258; Nishimura V. Y., 2012, MED MOL MORPHOL, V45, P1; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Straight SW, 2001, MOL BIOL CELL, V12, P1329; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Zucker B, 2010, J NEUROPATH EXP NEUR, V69, P880, DOI 10.1097/NEN.0b013e3181ed7a41	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2015	132	1					61	69		10.1111/jnc.12943		9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW8EB	WOS:000346492300007		
J	Nakamori, T; Sato, K; Kinoshita, M; Kanamatsu, T; Sakagami, H; Tanaka, K; Ohki-Hamazaki, H				Nakamori, Tomoharu; Sato, Katsushige; Kinoshita, Masae; Kanamatsu, Tomoyuki; Sakagami, Hiroyuki; Tanaka, Kohichi; Ohki-Hamazaki, Hiroko			Positive feedback of NR2B-containing NMDA receptor activity is the initial step toward visual imprinting: a model for juvenile learning	JOURNAL OF NEUROCHEMISTRY			English	Article						juvenile learning; LTP; NR2B; positive feedback; visual imprinting; visual Wulst	LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; ELECTRICAL-ACTIVITY; SUBUNIT COMPOSITION; NERVE-TERMINALS; STRIATE CORTEX; IN-VIVO; RAT; CHICK	Imprinting in chicks is a good model for elucidating the processes underlying neural plasticity changes during juvenile learning. We recently reported that neural activation of a telencephalic region, the core region of the hyperpallium densocellulare (HDCo), was critical for success of visual imprinting, and that N-Methyl-D-aspartic (NMDA) receptors containing the NR2B subunit (NR2B/NR1) in this region were essential for imprinting. Using electrophysiological and multiple-site optical imaging techniques with acute brain slices, we found that long-term potentiation (LTP) and enhancement of NR2B/NR1 currents in HDCo neurons were induced in imprinted chicks. Enhancement of NR2B/NR1 currents as well as an increase in surface NR2B expression occurred even following a brief training that was too weak to induce LTP or imprinting behavior. This means that NR2B/NR1 activation is the initial step of learning, well before the activation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors which induces LTP. We also showed that knockdown of NR2B/NR1 inhibited imprinting, and inversely, increasing the surface NR2B expression by treatment with a casein kinase 2 inhibitor successfully reduced training time required for imprinting. These results suggest that imprinting stimuli activate post-synaptic NR2B/NR1 in HDCo cells, increase NR2B/NR1 signaling through up-regulation of its expression, and induce LTP and memory acquisition.	[Nakamori, Tomoharu; Ohki-Hamazaki, Hiroko] Kitasato Univ, Coll Liberal Arts & Sci, Sagamihara, Kanagawa 2520373, Japan; [Nakamori, Tomoharu; Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2520373, Japan; [Nakamori, Tomoharu; Sato, Katsushige] Komazawa Womens Univ, Fac Human Hlth, Dept Hlth & Nutr Sci, Human Frontier Sci Program, Tokyo, Japan; [Kinoshita, Masae] RIKEN BSI, Lab Dev Gene Regulat, Wako, Saitama, Japan; [Kanamatsu, Tomoyuki] Soka Univ, Dept Environm Engn Symbiosis, Fac Engn, Hachioji, Tokyo, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Lab Mol Neurosci, Bunkyo Ku, Tokyo, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan	Ohki-Hamazaki, H (reprint author), Kitasato Univ, Coll Liberal Arts & Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	hamazaki@kitasato-u.ac.jp			JSPS KAKENHI [24500385, 25.10484]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by JSPS KAKENHI (Grants 24500385 to H.O.-H., 25.10484 to T. N.), and by Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Human Frontier Science Program. We thank M. Watanabe supplying anti-NR2B antibody. Kitasato University School of Medicine for the experimental facility, and the laboratory members for their help and discussions. The authors declare no competing financial interests.	MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; PARSONS TD, 1991, J NEUROPHYSIOL, V66, P316; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; Clayton DA, 2002, J NEUROSCI, V22, P3628; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; OBAID AL, 1985, J GEN PHYSIOL, V85, P481, DOI 10.1085/jgp.85.4.481; Momose-Sato Y, 2004, J NEUROSCI, V24, P1366, DOI 10.1523/JNEUROSCI.4457-03.2004; MCCABE BJ, 1982, EXP BRAIN RES, V48, P13; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; BEAR MF, 1990, J NEUROSCI, V10, P909; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; WATANABE M, 1983, J COMP NEUROL, V213, P188, DOI 10.1002/cne.902130206; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Quinlan EM, 1999, NAT NEUROSCI, V2, P352; ORBACH HS, 1985, J NEUROSCI, V5, P1886; SALZBERG BM, 1983, NATURE, V306, P36, DOI 10.1038/306036a0; MOMOSESATO Y, 1994, J NEUROSCI, V14, P7572; Nakamori T, 2010, J NEUROSCI, V30, P4467, DOI 10.1523/JNEUROSCI.3532-09.2010; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bradley PM, 1996, BRAIN RES, V727, P125; BRADLEY PM, 1991, P ROY SOC B-BIOL SCI, V243, P19, DOI 10.1098/rspb.1991.0004; FISCHBAC.GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Kiyosue K, 2002, EUR J NEUROSCI, V16, P1587, DOI 10.1046/j.1460-9568.2002.02217.x; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Maekawa F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-75; Maekawa F, 2007, J NEUROCHEM, V102, P1645, DOI 10.1111/j.1471-4159.2007.04733.x; Miyakawa N, 2003, NEUROIMAGE, V18, P622, DOI 10.1016/S1053-8119(02)00056-3; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Suzuki K, 2012, J NEUROCHEM, V123, P800, DOI 10.1111/jnc.12039; Yanagihara S, 1998, BRAIN RES, V779, P240, DOI 10.1016/S0006-8993(97)01129-3	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2015	132	1					110	123		10.1111/jnc.12954		14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW8EB	WOS:000346492300011		
J	Mitsui, Y; Kusunoki, S; Arimura, K; Kaji, R; Kanda, T; Kuwabara, S; Sonoo, M; Takada, K				Mitsui, Yoshiyuki; Kusunoki, Susumu; Arimura, Kimiyoshi; Kaji, Ryuji; Kanda, Takashi; Kuwabara, Satoshi; Sonoo, Masahiro; Takada, Kazuo		Japanese GBS Study Grp	A multicentre prospective study of Guillain-Barre Syndrome in Japan: a focus on the incidence of subtypes	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CAMPYLOBACTER-JEJUNI INFECTION; N-ACETYLGALACTOSAMINYL GD1A; MILLER-FISHER-SYNDROME; CLINICAL-FEATURES; ELECTROPHYSIOLOGICAL SUBTYPES; ANTIGANGLIOSIDE ANTIBODIES; PROGNOSIS; PATTERNS; CRITERIA; VARIANT	Objective Guillain-Barre Syndrome (GBS) is classified into the two major subtypes; acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). Previous studies have suggested that AIDP is predominant and AMAN is rare in Western countries, whereas AMAN is not always uncommon in East Asia. We aimed to clarify the incidence of the subtypes of GBS in Japan. Methods We performed a prospective multicentre survey over 3 years (2007-2010). Clinical and electrophysiological findings were collected from 184 patients with GBS in 23 tertiary neurology institutes. Anti-ganglioside antibodies were measured by ELISA. We also surveyed the incidence of Fisher syndrome (FS). Results By electrodiagnostic criteria of Ho et al, patients were classified as having AIDP (40%), or AMAN (22%), or unclassified (38%). Anti-GM1 IgG antibodies were found for 47% of AMAN patients, and 18% of AIDP patients (p<0.001). There were no specific regional trends of the electrodiagnosis and anti-GM1 positivity. During the same study period, 79 patients with FS were identified; the percentage of FS cases out of all cases (FS/(GBS+FS)) was 26%. Conclusions The frequency of GBS patients with the electrodiagnosis of AMAN by single nerve conduction studies is approximately 20% in Japan, and the AMAN pattern is closely associated with anti-GM1 antibodies. The incidence of FS appears to be much higher in Japan than in Western countries.	[Mitsui, Yoshiyuki; Kusunoki, Susumu; Takada, Kazuo] Kinki Univ, Dept Neurol, Fac Med, Osaka, Japan; [Arimura, Kimiyoshi] Ookatsu Hosp, Dept Neurol, Kagoshima, Japan; [Kaji, Ryuji] Univ Tokushima, Dept Neurol, Grad Sch Med, Tokushima 770, Japan; [Kanda, Takashi] Yamaguchi Univ, Dept Neurol, Grad Sch Med, Yamaguchi, Japan; [Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan; [Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Tokyo 173, Japan	Kusunoki, S (reprint author), 377-2 Ohno Higashi, Osaka 5898511, Japan.	kusunoki-tky@umin.ac.jp			Ministry of Health, Labour, and Welfare, Japan [H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24390225]	Supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H23-Nanchi-Ippan-017) from the Ministry of Health, Labour, and Welfare, Japan, and a Scientific Research B Grant (No. 24390225) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Akbayram S, 2011, ANN INDIAN ACAD NEUR, V14, P98, DOI 10.4103/0972-2327.82793; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Bogliun G, 2004, ACTA NEUROL SCAND, V110, P100, DOI 10.1111/j.1600-0404.2004.00272.x; Nagasawa K, 2006, MUSCLE NERVE, V33, P766, DOI 10.1002/mus.20520; Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309; Mori M, 2001, NEUROLOGY, V56, P1104; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Capasso R, 2011, J NEUROL NEUROSUR PS, V82, P664; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Gupta Deepak, 2008, J Clin Neuromuscul Dis, V10, P42, DOI 10.1097/CND.0b013e31818e9510; Hiraga A, 2003, NEUROLOGY, V61, P471; Kaida K, 2000, BRAIN, V123, P116, DOI 10.1093/brain/123.1.116; Kalita J, 2008, J NEUROL NEUROSUR PS, V79, P289, DOI 10.1136/jnnp.2007.118000; Koga M, 2001, J NEUROL NEUROSUR PS, V70, P693, DOI 10.1136/jnnp.70.5.693; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1471-4422(07)70130-8; Kushnir M, 2008, ACTA NEUROL SCAND, V117, P347, DOI 10.1111/j.1600-0404.2007.00949.x; KUSUNOKI S, 1994, ANN NEUROL, V35, P570, DOI 10.1002/ana.410350510; Lyu RK, 1997, J NEUROL NEUROSUR PS, V63, P494, DOI 10.1136/jnnp.63.4.494; Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7; Ye YQ, 2013, MUSCLE NERVE, V47, P68, DOI 10.1002/mus.23477; Yuan CL, 2000, EUR NEUROL, V44, P79, DOI 10.1159/000008201; Yuki N, 2005, CURR OPIN IMMUNOL, V17, P577, DOI 10.1016/j.coi.2005.09.004	28	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2015	86	1					110	114		10.1136/jnnp-2013-306509		5	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AW8AH	WOS:000346482500020		
J	Matsuura, E; Kubota, R; Tanaka, Y; Takashima, H; Izumo, S				Matsuura, Eiji; Kubota, Ryuji; Tanaka, Yuetsu; Takashima, Hiroshi; Izumo, Shuji			Visualization of HTLV-1-Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Apoptosis; Cytotoxic T lymphocyte; Demyelination; HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP); Human T-lymphotropic virus type-1 (HTLV-1)	VIRUS-TYPE-I; INCLUSION-BODY MYOSITIS; CENTRAL-NERVOUS-SYSTEM; HTLV-I; CELL LEUKEMIA; PERIPHERAL-BLOOD; CEREBROSPINAL-FLUID; NEUROLOGIC DISEASE; SITU HYBRIDIZATION; INFECTION	Activated human T-lymphotropic virus type-1 (HTLV-1)-specific CD8-positive cytotoxic T lymphocytes (CTLs) are markedly increased in the periphery of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-1-induced inflammatory disease of the CNS. Although virus-specific CTLs play a pivotal role to eliminate virus-infected cells, the potential role of HTLV-1-specific CTLs in the pathogenesis of HAM/TSP remains unclear. To address this issue, we evaluated the infiltration of HTLV-1-specific CTLs and the expression of HTLV-1 proteins in the spinal cords of 3 patients with HAM/TSP. Confocal laser scanning microscopy with our unique staining procedure made it possible to visualize HTLV-1-specific CTLs infiltrating the CNS of the HAM/TSP patients. The frequency of HTLV-1-specific CTLs was more than 20% of CD8-positive cells infiltrating the CNS. In addition, HTLV-1 proteins were detected in CD4-positive infiltrating T lymphocytes but not CNS resident cells. Although neurons were generally preserved, apoptotic oligodendrocytes were frequently in contact with CD8-positive cells; this likely resulted in demyelination. These findings suggest that the immune responses of the CTLs against HTLV-1-infected CD4-positive lymphocytes migrating into the CNS resulted in bystander neural damage.	[Matsuura, Eiji; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 8908544, Japan; [Kubota, Ryuji; Izumo, Shuji] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Kagoshima 8908544, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Okinawa, Japan	Kubota, R (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	kubotar@m2.kufm.kagoshima-u.ac.jp	Kubota, Ryuji/A-7139-2009		Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [25293205, 24133701]	This work was supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan and JSPS KAKENHI Grants 25293205 and 24133701 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Haring JS, 2002, J IMMUNOL, V169, P1550; MORGAN OS, 1989, LANCET, V2, P1184; Matsuoka E, 1998, ACTA NEUROPATHOL, V96, P340; Skinner PJ, 2000, J IMMUNOL, V165, P613; OSAME M, 1986, LANCET, V1, P1031; Marcondes MCG, 2001, J IMMUNOL, V167, P5429; UCHIYAMA T, 1977, BLOOD, V50, P481; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; NISHIOKA K, 1989, LANCET, V1, P441; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; GESSAIN A, 1985, LANCET, V2, P407; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Biddison WE, 1997, J IMMUNOL, V159, P2018; Matsuura E, 2008, J NEUROPATH EXP NEUR, V67, P41, DOI 10.1097/nen.0b013e31815f38b7; Hanon E, 2000, AIDS RES HUM RETROV, V16, P1711, DOI 10.1089/08892220050193191; Hayashi D, 2008, J NEUROIMMUNOL, V200, P115, DOI 10.1016/j.jneuroim.2008.06.005; Hayashi D, 2008, J NEUROVIROL, V14, P459, DOI 10.1080/13550280802178538; HIGUCHI I, 1992, MUSCLE NERVE, V15, P43, DOI 10.1002/mus.880150108; IJICHI S, 1993, MED HYPOTHESES, V41, P542, DOI 10.1016/0306-9877(93)90111-3; JACOBSON S, 1990, ANN NEUROL, V27, P149, DOI 10.1002/ana.410270209; KANNAGI M, 1994, LEUKEMIA, V8, pS54; Kozako T, 2006, J IMMUNOL, V177, P5718; Kubota R, 1998, J IMMUNOL, V161, P482; Kubota R, 2003, BLOOD, V101, P3074, DOI 10.1182/blood-2002-08-2477; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Levin MC, 1997, NEW ENGL J MED, V336, P839, DOI 10.1056/NEJM199703203361205; Moritoyo T, 1996, ANN NEUROL, V40, P84, DOI 10.1002/ana.410400114; NAGASATO K, 1991, J NEUROIMMUNOL, V32, P105, DOI 10.1016/0165-5728(91)90002-O; NAKAO K, 1989, JPN J OPHTHALMOL, V33, P383; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; Ozden S, 2001, CLIN INFECT DIS, V32, P510, DOI 10.1086/318506; Seki M, 2000, CLIN EXP IMMUNOL, V120, P488, DOI 10.1046/j.1365-2249.2000.01237.x; SUGIMOTO M, 1987, LANCET, V2, P1220; Yashiki S, 2001, AIDS RES HUM RETROV, V17, P1047, DOI 10.1089/088922201300343735	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JAN	2015	74	1					2	14				13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AX0IA	WOS:000346634900001		
J	Tsubamoto, H; Takeuchi, S; Ito, K; Miyagi, Y; Toyoda, S; Inoue, K; Kanazawa, R; Hosoda, Y; Shibahara, H				Tsubamoto, H.; Takeuchi, S.; Ito, K.; Miyagi, Y.; Toyoda, S.; Inoue, K.; Kanazawa, R.; Hosoda, Y.; Shibahara, H.			Feasibility and efficacy of intraperitoneal docetaxel administration as salvage chemotherapy for malignant gynaecological ascites	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Docetaxel; endometrial cancer; intraperitoneal chemotherapy; ovarian cancer; salvage chemotherapy	CLEAR-CELL CARCINOMA; EPITHELIAL OVARIAN-CANCER; PHASE-II TRIAL; ONCOLOGY-GROUP; 2ND-LINE CHEMOTHERAPY; ENDOMETRIAL CANCER; BREAST-CANCER; PACLITAXEL; RECURRENT; PLATINUM	Ovarian and endometrial cancers diagnosed at advanced stages are often associated with malignant ascites. This study aimed to determine the safety, feasibility and efficacy of intraperitoneal (IP) docetaxel (TXT) for the treatment of ascites. A phase I study, including nine patients, was undertaken to determine the maximum tolerable dose. Efficacy was retrospectively assessed in 18 patients treated with 40-70 mg/m(2) IP TXT between 2005 and 2012. In a phase I study, the dose was safely escalated to a maximum of 70 mg/m(2), at which level no patients had grade >= 3 haematological adverse events. In a retrospective study of 18 patients, seven had an Eastern Cooperative Oncology Group performance status of 3; 16 had prior paclitaxel administration and two, with doses of 40 and 70 mg/m(2), experienced a serological response and a decrease in paracentesis. Thus, palliative treatment of recurrent OC should be further studied with 40 mg/m(2) among more patients, and 70 mg/m(2) could be evaluated for first-line IP chemotherapy.	[Tsubamoto, H.; Inoue, K.; Kanazawa, R.; Hosoda, Y.; Shibahara, H.] Hyogo Coll Med, Dept Obstet, Nishinomiya, Hyogo 6638501, Japan; [Tsubamoto, H.; Inoue, K.; Kanazawa, R.; Hosoda, Y.; Shibahara, H.] Hyogo Coll Med, Dept Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Takeuchi, S.] Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan; [Ito, K.] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan; [Miyagi, Y.] Okayama Ohfuku Clin, Okayama, Japan; [Toyoda, S.] Nara Prefectural Nara Hosp, Nara, Japan	Tsubamoto, H (reprint author), Hyogo Coll Med, Dept Obstet & Gynecol, Mukogawa 1-1, Nishinomiya, Hyogo 6638501, Japan.	tsuba@hyo-med.ac.jp					Adachi S, 1999, JPN J CLIN ONCOL, V29, P434, DOI 10.1093/jjco/29.9.434; Harvey V, 2006, J CLIN ONCOL, V24, P4963, DOI 10.1200/JCO.2005.05.0294; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Lincoln S, 2003, GYNECOL ONCOL, V88, P277, DOI 10.1016/S0090-8258(02)00068-9; Markman M, 2003, LANCET ONCOL, V4, P277, DOI 10.1016/S1470-2045(03)01074-X; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Miller D, 2012, GYNECOL ONCOL, V125, P771, DOI 10.1016/j.ygyno.2012.03.034; FRANCIS P, 1994, J CLIN ONCOL, V12, P2301; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; MARKMAN M, 1992, J CLIN ONCOL, V10, P1485; Orezzoli JP, 2008, GYNECOL ONCOL, V110, P336, DOI 10.1016/j.ygyno.2008.05.025; Fujiwara Y, 2012, J SURG ONCOL, V105, P38, DOI 10.1002/jso.22057; Fushida S, 2013, CANCER CHEMOTH PHARM, V71, P1265, DOI 10.1007/s00280-013-2122-0; Fushida Sachio, 2002, Gan To Kagaku Ryoho, V29, P1759; Hryniuk W M, 1988, Important Adv Oncol, P121; Kajiyama H, 2012, INT J GYNECOL CANCER, V22, P801, DOI 10.1097/IGC.0b013e3182540145; Katsumata N, 2005, BRIT J CANCER, V93, P999, DOI 10.1038/sj.bjc.6602817; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Kavanagh JJ, 1996, CLIN CANCER RES, V2, P837; Krasner CN, 2007, J CLIN ONCOLOGY, V25, P5521; Markman M, 2009, INT J GYNECOL CANCER, V19, P223, DOI 10.1111/IGC.0b013e31819bdc7e; MARKMAN M, 1994, SEMIN SURG ONCOL, V10, P299, DOI 10.1002/ssu.2980100411; Moore KN, 2010, CANCER-AM CANCER SOC, V116, P5407, DOI 10.1002/cncr.25480; Morgan RJ, 2003, CLIN CANCER RES, V9, P5896; MUGGIA FM, 1993, GYNECOL ONCOL, V50, P232, DOI 10.1006/gyno.1993.1198; Sartori E, 2003, INT J GYNECOL CANCER, V13, P458, DOI 10.1046/j.1525-1438.2003.13328.x; Takano M, 2008, INT J GYNECOL CANCER, V18, P937, DOI 10.1111/j.1525-1438.2007.01158.x; Verschraegen CF, 2000, J CLIN ONCOL, V18, P2733	32	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	JAN	2015	35	1					69	73		10.3109/01443615.2014.935719		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AW5FA	WOS:000346300100018		
J	Ono, M; Nishijima, S; Amagata, T; Ikeda, T; Yakubo, K; Akatsuka, S; Fukuiya, T				Ono, M.; Nishijima, S.; Amagata, T.; Ikeda, T.; Yakubo, K.; Akatsuka, S.; Fukuiya, T.			Two consecutive births after ovarian preservation in a Gorlin syndrome patient	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article							CELL CARCINOMA SYNDROME; CANCER		[Ono, M.; Nishijima, S.; Amagata, T.; Ikeda, T.; Yakubo, K.; Fukuiya, T.] Saitama City Hosp, Dept Obstet & Gynaecol, Midori Ku, Saitama, Japan; [Akatsuka, S.] Saitama City Hosp, Dept Pathol, Midori Ku, Saitama, Japan	Ono, M (reprint author), Saitama City Hosp, Dept Obstet & Gynaecol, Midori Ku, 2460 Mimuro, Saitama, Japan.	masaoriono@gmail.com					Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Morse CB, 2011, FERTIL STERIL, V96, pE47, DOI 10.1016/j.fertnstert.2011.04.028; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460; Fonseca Ricardo B, 2008, Radiology, V246, P318; FOX R, 1994, BRIT J OBSTET GYNAEC, V101, P1015, DOI 10.1111/j.1471-0528.1994.tb13054.x; Johnston RJ, 2009, PEDIATR BLOOD CANCER, V53, P296, DOI 10.1002/pbc.22012; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Lo Muzio L, 1999, CLIN GENET, V55, P34, DOI 10.1034/j.1399-0004.1999.550106.x; Tanioka M, 2005, ARCH DERMATOL RES, V296, P303, DOI 10.1007/s00403-004-0520-1	10	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	JAN	2015	35	1					96	+		10.3109/01443615.2014.937682		2	Obstetrics & Gynecology	Obstetrics & Gynecology	AW5FA	WOS:000346300100029		
J	Yashiro, K; Yamamoto, K; Takada, K; Murakami, S; Uchiyama, Y; Furukawa, S				Yashiro, K.; Yamamoto, K.; Takada, K.; Murakami, S.; Uchiyama, Y.; Furukawa, S.			Influence of balancing-side occlusal interference on smoothness of working-side condylar movement and intra-articular space in chewing efforts	JOURNAL OF ORAL REHABILITATION			English	Article						kinematics; mastication; normalised jerk cost; motor adaptation; intra-articular space	TEMPOROMANDIBULAR-JOINT; COMPUTED-TOMOGRAPHY; MUSCLE-ACTIVITY; DISPLACEMENT; CONTACT	Response of temporomandibular joint (TMJ) articulation adapting to occlusal alteration has been sparsely known. For 10 healthy adults with acceptably good occlusion, an artificial occlusal interference (OI) was introduced to the lower molar on the balancing side of unilateral chewing. Subjects were asked to chew a gum on their preferred side. The chewing jaw movements with/without the OI were recorded using a video-based optoelectronic system. The mandibular movements were generated in each individual's TMJ model reconstructed by magnetic resonance images. The smoothness of local condylar point movements towards the normal direction of the condylar surface and interarticular space on the working side was measured. Overall, the smoothness of condylar point movements in the closing phase was impaired immediately after introduction of the OI. In the intercuspal phase, the OI increased the joint space. After about 60 chewing cycles, the movement smoothness and joint space began to recover. These findings suggest that OI on the balancing side induced irregular stress field translation on the working-side condylar surface followed by acute recovery process.	[Yashiro, K.; Yamamoto, K.] Osaka Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Yashiro, K.; Yamamoto, K.] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Takada, K.] Natl Univ Singapore, Fac Dent, Discipline Orthodont & Paediat Dent, Singapore 117548, Singapore; [Murakami, S.; Uchiyama, Y.] Osaka Univ, Dept Oral & Maxillofacial Radiol, Grad Sch Dent, Suita, Osaka 5650871, Japan	Yashiro, K (reprint author), Osaka Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yashiro@dent.osaka-u.ac.jp			Japanese Ministry of Education, Science and Culture [C-05671706]	The Ethics Committee of the Dental School approved the experiment (permission #H16-4-1). There is no conflict of interests. This work was partially supported by a Grant-in-Aid for Scientific Research (C-05671706) from the Japanese Ministry of Education, Science and Culture.	Ikeda T, 1998, J ORAL REHABIL, V25, P589; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Rodrigues AF, 2009, AM J ORTHOD DENTOFAC, V136, P199, DOI 10.1016/j.ajodo.2007.07.033; RUGH JD, 1984, J PROSTHET DENT, V51, P548, DOI 10.1016/0022-3913(84)90312-3; RANDOW K, 1976, ODONTOL REVY, V27, P245; SHIAU YY, 1995, J ORAL REHABIL, V22, P145, DOI 10.1111/j.1365-2842.1995.tb00248.x; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; Clark GT, 1999, J PROSTHET DENT, V82, P704, DOI 10.1016/S0022-3913(99)70012-0; Ettlin DA, 2008, J DENT RES, V87, P877; CHRISTENSEN LV, 1995, J ORAL REHABIL, V22, P521, DOI 10.1111/j.1365-2842.1995.tb01198.x; Colombo V, 2008, CELLS TISSUES ORGANS, V187, P295, DOI 10.1159/000113408; Daniels C, 2000, J Orthod, V27, P149, DOI 10.1093/ortho/27.2.149; Gossi DB, 2004, J DENT RES, V83, P480; HANNAM AG, 1981, ARCH ORAL BIOL, V26, P387, DOI 10.1016/0003-9969(81)90034-0; KARLSSON S, 1992, Journal of Craniomandibular Disorders, V6, P177; Komuro A, 2001, NEUROSCI RES, V39, P21, DOI 10.1016/S0168-0102(00)00192-9; Krisjane Zane, 2009, Stomatologija, V11, P32; Lebiedowska MK, 2011, J NEUROSCI METH, V198, P255, DOI 10.1016/j.jneumeth.2011.04.018; Ohta M, 2003, J ORAL REHABIL, V30, P30, DOI 10.1046/j.1365-2842.2003.01000.x; Okano N, 2005, J ORAL REHABIL, V32, P714, DOI 10.1111/j.1365-2842.2005.01501.x; Roberts D, 2013, P I MECH ENG H, V227, P1104, DOI 10.1177/0954411913493724; Sakata K, 2010, GAIT POSTURE, V31, P27, DOI 10.1016/j.gaitpost.2009.08.239; Uemura Naoya, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P494; Yashiro K, 2010, J ORAL REHABIL, V37, P163, DOI 10.1111/j.1365-2842.2009.02034.x; Yashiro K, 2014, ADV BIOMED ENG, V3, P44	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	JAN	2015	42	1					10	17		10.1111/joor.12225		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW5XQ	WOS:000346344700003		
J	Kurushima, Y; Ikebe, K; Matsuda, K; Enoki, K; Ogata, S; Yamashita, M; Murakami, S; Hayakawa, K; Maeda, Y				Kurushima, Y.; Ikebe, K.; Matsuda, K.; Enoki, K.; Ogata, S.; Yamashita, M.; Murakami, S.; Hayakawa, K.; Maeda, Y.			Influence of genetic and environmental factors on oral diseases and function in aged twins	JOURNAL OF ORAL REHABILITATION			English	Article						geriatric dentistry; genetics; oral function; periodontal disease(s); periodontitis; caries; twins	DENTAL-CARIES; REARED APART; ADULT TWINS; HEALTH; PERIODONTITIS; ASSOCIATION; ADOLESCENTS; REGISTRY	This study was conducted to quantify the genetic and environmental contributions to oral disease and function in twins. Participants were middle-aged and old twins, 116 monozygotic and 16 dizygotic pairs whose mean age was 661 +/- 103 (SD) years. Number of teeth, percentage of decayed, filled and missing teeth and periodontal status were recorded as indicators of oral disease. The widths of upper and lower dental arch served as indicators of morphological figures. Furthermore, stimulated salivary flow rate, occlusal force and masticatory performance were measured as indicators of oral function. Univariate genetic analysis with monozygotic and dizygotic twin pairs was conducted to detect the fittest structural equation model of each outcome. Both number of teeth and periodontal status fitted the model composed of common environmental factor and unique environmental factor. Decayed, filled and missing teeth, morphological figures and measurements of oral function fitted the model composed of additive genetic factor and unique environmental factor. The model fitting of each measurement suggested that periodontal disease was mainly affected by environmental factors, while morphological figures and oral functions were influenced by both genetic and environmental factors.	[Kurushima, Y.; Ikebe, K.; Matsuda, K.; Enoki, K.; Maeda, Y.] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan; [Ogata, S.; Hayakawa, K.] Osaka Univ, Grad Sch Med, Ctr Twin Res, Suita, Osaka 5650871, Japan; [Yamashita, M.; Murakami, S.] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka 5650871, Japan	Ikebe, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ikebe@dent.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science [23249086, 24659857, 24792080]	This research was supported by university grants from the Ministry of Education, Science, Sports and Culture of Japan and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 23249086, 24659857 and 24792080). Laboratory tests in this research were performed by Beckman Coulter, Inc.	BORAAS JC, 1988, J DENT RES, V67, P1150, DOI 10.1177/00220345880670090201; MICHALOWICZ BS, 1991, J PERIODONTOL, V62, P293; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Loe H, 2000, INT DENT J, V50, P129; Mucci LA, 2005, J DENT RES, V84, P800; Frederiksen H, 2003, SCAND J MED SCI SPOR, V13, P9, DOI 10.1034/j.1600-0838.2003.20219.x; Goodman HS, 2004, PEDIATR DENT, V26, P369; Hayakawa K, 2006, TWIN RES HUM GENET, V9, P808, DOI 10.1375/183242706779462471; Hayakawa K, 2006, TWIN RES HUM GENET, V9, P806, DOI 10.1375/183242706779462796; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; Hayakawa K, 2002, TWIN RES, V5, P387, DOI 10.1375/136905202320906147; Hodge P, 2001, PERIODONTOL 2000, V26, P113, DOI 10.1034/j.1600-0757.2001.2260106.x; Ikebe K, 2005, J DENT, V33, P131, DOI 10.1016/j.jdent.2004.09.002; Ikebe K, 2006, J ORAL REHABIL, V33, P36, DOI 10.1111/j.1365-2842.2006.01527.x; Kallio P, 1996, COMMUNITY DENT ORAL, V24, P128, DOI 10.1111/j.1600-0528.1996.tb00829.x; Neale M. C., 2003, MX STAT MODELING; Neale MC, 1992, METHODOLOGY GENETIC; Neale M. C., 1997, MX STAT MODELING; Nokubi T, 2013, GERODONTOLOGY, V30, P76, DOI 10.1111/j.1741-2358.2012.00647.x; Ostberg AL, 2003, ACTA ODONTOL SCAND, V61, P19; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P3; Richards W, 2002, BRIT DENT J, V193, P697, DOI 10.1038/sj.bdj.4801664; Rintakoski K, 2010, J DENT RES, V89, P700, DOI 10.1177/0022034510366795; Schei J., 1959, J PERIODONTOL, V30, P7	26	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	JAN	2015	42	1					49	56		10.1111/joor.12228		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW5XQ	WOS:000346344700008		
J	Aartsen, MG; Abbasi, R; Ackermann, M; Adams, J; Aguilar, JA; Ahlers, M; Altmann, D; Arguelles, C; Auffenberg, J; Bai, X; Baker, M; Barwick, SW; Baum, V; Bay, R; Beatty, JJ; Tjus, JB; Becker, KH; BenZvi, S; Berghaus, P; Berley, D; Bernardini, E; Bernhard, A; Besson, DZ; Binder, G; Bindig, D; Bissok, M; Blaufuss, E; Blumenthal, J; Boersma, DJ; Bohm, C; Bose, D; Boser, S; Botner, O; Brayeur, L; Bretz, HP; Brown, AM; Bruijn, R; Casey, J; Casier, M; Chirkin, D; Christov, A; Christy, B; Clark, K; Classen, L; Clevermann, F; Coenders, S; Cohen, S; Cowen, DF; Silva, AHC; Danninger, M; Daughhetee, J; Davis, JC; Day, M; De Clercq, C; De Ridder, S; Desiati, P; de Vries, KD; de With, M; DeYoung, T; Diaz-Velez, JC; Dunkman, M; Eagan, R; Eberhardt, B; Eichmann, B; Eisch, J; Euler, S; Evenson, PA; Fadiran, O; Fazely, AR; Fedynitch, A; Feintzeig, J; Feusels, T; Filimonov, K; Finley, C; Fischer-Wasels, T; Flis, S; Franckowiak, A; Frantzen, K; Fuchs, T; Gaisser, TK; Gallagher, J; Gerhardt, L; Gladstone, L; Glusenkamp, T; Goldschmidt, A; Golup, G; Gonzalez, JG; Goodman, JA; Gora, D; Grandmont, DT; Grant, D; Gretskov, P; Groh, JC; Gross, A; Ha, C; Ismail, AH; Hallen, P; Hallgren, A; Halzen, F; Hanson, K; Hebecker, D; Heereman, D; Heinen, D; Helbing, K; Hellauer, R; Hickford, S; Hill, GC; Hoffman, KD; Hoffmann, R; Homeier, A; Hoshina, K; Huang, F; Huelsnitz, W; Hulth, PO; Hultqvist, K; Hussain, S; Ishihara, A; Jacobi, E; Jacobsen, J; Jagielski, K; Japaridze, GS; Jero, K; Jlelati, O; Kaminsky, B; Kappes, A; Karg, T; Karle, A; Kauer, M; Kelley, JL; Kiryluk, J; Klas, J; Klein, SR; Kohne, JH; Kohnen, G; Kolanoski, H; Kopke, L; Kopper, C; Kopper, S; Koskinen, DJ; Kowalski, M; Krasberg, M; Kriesten, A; Krings, K; Kroll, G; Kunnen, J; Kurahashi, N; Kuwabara, T; Labare, M; Landsman, H; Larson, MJ; Lesiak-Bzdak, M; Leuermann, M; Leute, J; Lunemann, J; Macias, O; Madsen, J; Maggi, G; Maruyama, R; Mase, K; Matis, HS; McNally, F; Meagher, K; Merck, M; Merino, G; Meures, T; Miarecki, S; Middell, E; Milke, N; Miller, J; Mohrmann, L; Montaruli, T; Morse, R; Nahnhauer, R; Naumann, U; Niederhausen, H; Nowicki, SC; Nygren, DR; Obertacke, A; Odrowski, S; Olivas, A; Omairat, A; O'Murchadha, A; Paul, L; Pepper, JA; de los Heros, CP; Pfendner, C; Pieloth, D; Pinat, E; Posselt, J; Price, PB; Przybylski, GT; Quinnan, M; Radel, L; Rae, I; Rameez, M; Rawlins, K; Redl, P; Reimann, R; Resconi, E; Rhode, W; Ribordy, M; Richman, M; Riedel, B; Rodrigues, JP; Rott, C; Ruhe, T; Ruzybayev, B; Ryckbosch, D; Saba, SM; Sander, HG; Santander, M; Sarkar, S; Schatto, K; Scheriau, F; Schmidt, T; Schmitz, M; Schoenen, S; Schoneberg, S; Schonwald, A; Schukraft, A; Schulte, L; Schultz, D; Schulz, O; Secke, D; Sestayo, Y; Seunarine, S; Shanidze, R; Sheremata, C; Smith, MWE; Soldin, D; Spiczak, GM; Spiering, C; Stamatikos, M; Stanev, T; Stanisha, NA; Stasik, A; Stezelberger, T; Stokstad, RG; Stossl, A; Strahler, EA; Strom, R; Strotjohann, NL; Sullivan, GW; Taavola, H; Taboada, I; Tamburro, A; Tepe, A; Ter-Antonyan, S; Tesic, G; Tilav, S; Toale, PA; Tobin, MN; Toscano, S; Tselengidou, M; Unger, E; Usner, M; Vallecorsa, S; van Eijndhoven, N; van Overloop, A; van Santen, J; Vehring, M; Voge, M; Vraeghe, M; Walck, C; Waldenmaier, T; Wallraff, M; Weaver, C; Wellons, M; Wendt, C; Westerhoff, S; Whitehorn, N; Wiebe, K; Wiebusch, CH; Williams, DR; Wissing, H; Wolf, M; Wood, TR; Woschnagg, K; Xu, DL; Xu, XW; Yanez, JP; Yodh, G; Yoshida, S; Zarzhitsky, P; Ziemann, J; Zierke, S; Zoll, M				Aartsen, M. G.; Abbasi, R.; Ackermann, M.; Adams, J.; Aguilar, J. A.; Ahlers, M.; Altmann, D.; Arguelles, C.; Auffenberg, J.; Bai, X.; Baker, M.; Barwick, S. W.; Baum, V.; Bay, R.; Beatty, J. J.; Tjus, J. Becker; Becker, K. -H.; BenZvi, S.; Berghaus, P.; Berley, D.; Bernardini, E.; Bernhard, A.; Besson, D. Z.; Binder, G.; Bindig, D.; Bissok, M.; Blaufuss, E.; Blumenthal, J.; Boersma, D. J.; Bohm, C.; Bose, D.; Boeser, S.; Botner, O.; Brayeur, L.; Bretz, H. -P.; Brown, A. M.; Bruijn, R.; Casey, J.; Casier, M.; Chirkin, D.; Christov, A.; Christy, B.; Clark, K.; Classen, L.; Clevermann, F.; Coenders, S.; Cohen, S.; Cowen, D. F.; Silva, A. H. Cruz; Danninger, M.; Daughhetee, J.; Davis, J. C.; Day, M.; De Clercq, C.; De Ridder, S.; Desiati, P.; de Vries, K. D.; de With, M.; DeYoung, T.; Diaz-Velez, J. C.; Dunkman, M.; Eagan, R.; Eberhardt, B.; Eichmann, B.; Eisch, J.; Euler, S.; Evenson, P. A.; Fadiran, O.; Fazely, A. R.; Fedynitch, A.; Feintzeig, J.; Feusels, T.; Filimonov, K.; Finley, C.; Fischer-Wasels, T.; Flis, S.; Franckowiak, A.; Frantzen, K.; Fuchs, T.; Gaisser, T. K.; Gallagher, J.; Gerhardt, L.; Gladstone, L.; Glusenkamp, T.; Goldschmidt, A.; Golup, G.; Gonzalez, J. G.; Goodman, J. A.; Gora, D.; Grandmont, D. T.; Grant, D.; Gretskov, P.; Groh, J. C.; Gross, A.; Ha, C.; Ismail, A. Haj; Hallen, P.; Hallgren, A.; Halzen, F.; Hanson, K.; Hebecker, D.; Heereman, D.; Heinen, D.; Helbing, K.; Hellauer, R.; Hickford, S.; Hill, G. C.; Hoffman, K. D.; Hoffmann, R.; Homeier, A.; Hoshina, K.; Huang, F.; Huelsnitz, W.; Hulth, P. O.; Hultqvist, K.; Hussain, S.; Ishihara, A.; Jacobi, E.; Jacobsen, J.; Jagielski, K.; Japaridze, G. S.; Jero, K.; Jlelati, O.; Kaminsky, B.; Kappes, A.; Karg, T.; Karle, A.; Kauer, M.; Kelley, J. L.; Kiryluk, J.; Klaes, J.; Klein, S. R.; Koehne, J. -H.; Kohnen, G.; Kolanoski, H.; Koepke, L.; Kopper, C.; Kopper, S.; Koskinen, D. J.; Kowalski, M.; Krasberg, M.; Kriesten, A.; Krings, K.; Kroll, G.; Kunnen, J.; Kurahashi, N.; Kuwabara, T.; Labare, M.; Landsman, H.; Larson, M. J.; Lesiak-Bzdak, M.; Leuermann, M.; Leute, J.; Luenemann, J.; Macias, O.; Madsen, J.; Maggi, G.; Maruyama, R.; Mase, K.; Matis, H. S.; McNally, F.; Meagher, K.; Merck, M.; Merino, G.; Meures, T.; Miarecki, S.; Middell, E.; Milke, N.; Miller, J.; Mohrmann, L.; Montaruli, T.; Morse, R.; Nahnhauer, R.; Naumann, U.; Niederhausen, H.; Nowicki, S. C.; Nygren, D. R.; Obertacke, A.; Odrowski, S.; Olivas, A.; Omairat, A.; O'Murchadha, A.; Paul, L.; Pepper, J. A.; de los Heros, C. Perez; Pfendner, C.; Pieloth, D.; Pinat, E.; Posselt, J.; Price, P. B.; Przybylski, G. T.; Quinnan, M.; Raedel, L.; Rae, I.; Rameez, M.; Rawlins, K.; Redl, P.; Reimann, R.; Resconi, E.; Rhode, W.; Ribordy, M.; Richman, M.; Riedel, B.; Rodrigues, J. P.; Rott, C.; Ruhe, T.; Ruzybayev, B.; Ryckbosch, D.; Saba, S. M.; Sander, H. -G.; Santander, M.; Sarkar, S.; Schatto, K.; Scheriau, F.; Schmidt, T.; Schmitz, M.; Schoenen, S.; Schoeneberg, S.; Schoenwald, A.; Schukraft, A.; Schulte, L.; Schultz, D.; Schulz, O.; Secke, D.; Sestayo, Y.; Seunarine, S.; Shanidze, R.; Sheremata, C.; Smith, M. W. E.; Soldin, D.; Spiczak, G. M.; Spiering, C.; Stamatikos, M.; Stanev, T.; Stanisha, N. A.; Stasik, A.; Stezelberger, T.; Stokstad, R. G.; Stoessl, A.; Strahler, E. A.; Stroem, R.; Strotjohann, N. L.; Sullivan, G. W.; Taavola, H.; Taboada, I.; Tamburro, A.; Tepe, A.; Ter-Antonyan, S.; Tesic, G.; Tilav, S.; Toale, P. A.; Tobin, M. N.; Toscano, S.; Tselengidou, M.; Unger, E.; Usner, M.; Vallecorsa, S.; van Eijndhoven, N.; van Overloop, A.; van Santen, J.; Vehring, M.; Voge, M.; Vraeghe, M.; Walck, C.; Waldenmaier, T.; Wallraff, M.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.; Wiebe, K.; Wiebusch, C. H.; Williams, D. R.; Wissing, H.; Wolf, M.; Wood, T. R.; Woschnagg, K.; Xu, D. L.; Xu, X. W.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Zarzhitsky, P.; Ziemann, J.; Zierke, S.; Zoll, M.			The IceProd framework: Distributed data processing for the IceCube neutrino observatory	JOURNAL OF PARALLEL AND DISTRIBUTED COMPUTING			English	Article						Data management; Grid computing; Monitoring; Distributed computing		IceCube is a one-gigaton instrument located at the geographic South Pole, designed to detect cosmic neutrinos, identify the particle nature of dark matter, and study high-energy neutrinos themselves. Simulation of the IceCube detector and processing of data require a significant amount of computational resources. This paper presents the first detailed description of IceProd, a lightweight distributed management system designed to meet these requirements. It is driven by a central database in order to manage mass production of simulations and analysis of data produced by the IceCube detector. IceProd runs as a separate layer on top of other middleware and can take advantage of a variety of computing resources, including grids and batch systems such as CREAM, HTCondor, and PBS. This is accomplished by a set of dedicated daemons that process job submission in a coordinated fashion through the use of middleware plugins that serve to abstract the details of job submission and job management from the framework. (C) 2014 Elsevier Inc. All rights reserved.	[Bissok, M.; Blumenthal, J.; Coenders, S.; Euler, S.; Gretskov, P.; Hallen, P.; Heinen, D.; Jagielski, K.; Kriesten, A.; Krings, K.; Leuermann, M.; Paul, L.; Raedel, L.; Reimann, R.; Schoenen, S.; Schukraft, A.; Vehring, M.; Wallraff, M.; Wiebusch, C. H.; Zierke, S.] Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; [Aartsen, M. G.; Hill, G. C.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Rawlins, K.] Univ Alaska Anchorage, Dept Phys & Astron, Anchorage, AK 99508 USA; [Japaridze, G. S.] Clark Atlanta Univ, CTSPS, Atlanta, GA 30314 USA; [Bruijn, R.; Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Bruijn, R.; Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Ctr Relativist Astrophys, Atlanta, GA 30332 USA; [Fazely, A. R.; Ter-Antonyan, S.; Xu, X. W.] Southern Univ, Dept Phys, Baton Rouge, IA 70813 USA; [Bay, R.; Binder, G.; Filimonov, K.; Gerhardt, L.; Ha, C.; Klein, S. R.; Miarecki, S.; Price, P. B.; Woschnagg, K.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Binder, G.; Gerhardt, L.; Goldschmidt, A.; Ha, C.; Klein, S. R.; Matis, H. S.; Miarecki, S.; Nygren, D. R.; Przybylski, G. T.; Stezelberger, T.; Stokstad, R. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [de With, M.; Kolanoski, H.; Waldenmaier, T.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Tjus, J. Becker; Eichmann, B.; Fedynitch, A.; Saba, S. M.; Schoeneberg, S.; Unger, E.] Ruhr Univ Bochum, Fak Phys & Astron, D-44780 Bochum, Germany; [Boeser, S.; Franckowiak, A.; Hebecker, D.; Homeier, A.; Kowalski, M.; Schulte, L.; Stasik, A.; Strotjohann, N. L.; Usner, M.; Voge, M.] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Hanson, K.; Heereman, D.; Meures, T.; O'Murchadha, A.; Pinat, E.] Univ Libre Bruxelles, Sci Fac CP230, B-1050 Brussels, Belgium; [Brayeur, L.; Casier, M.; De Clercq, C.; de Vries, K. D.; Golup, G.; Kunnen, J.; Maggi, G.; Miller, J.; Strahler, E. A.; van Eijndhoven, N.] Vrije Univ Brussel, Dienst ELEM, B-1050 Brussels, Belgium; [Ishihara, A.; Mase, K.; Yoshida, S.] Chiba Univ, Dept Phys, Chiba 260, Japan; [Adams, J.; Hickford, S.; Macias, O.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [Brayeur, L.; Casier, M.; De Clercq, C.; de Vries, K. D.; Golup, G.; Kunnen, J.; Maggi, G.; Miller, J.; Olivas, A.; Strahler, E. A.; van Eijndhoven, N.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Beatty, J. J.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Sarkar, S.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Clevermann, F.; Frantzen, K.; Fuchs, T.; Koehne, J. -H.; Milke, N.; Pieloth, D.; Rhode, W.; Ruhe, T.; Scheriau, F.; Schmitz, M.; Ziemann, J.] TU Dortmund Univ, Dept Phys, D-44221 Dortmund, Germany; [Grandmont, D. T.; Grant, D.; Nowicki, S. C.; Odrowski, S.; Sheremata, C.; Wood, T. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Altmann, D.; Classen, L.; Gora, D.; Kappes, A.; Tselengidou, M.] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Aguilar, J. A.; Christov, A.; Montaruli, T.; Rameez, M.; Vallecorsa, S.] Univ Geneva, Dept Phys Nucl & Corpusculaire, CH-1211 Geneva, Switzerland; [De Ridder, S.; Feusels, T.; Ismail, A. Haj; Jlelati, O.; Labare, M.; Ryckbosch, D.; van Overloop, A.; Vraeghe, M.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Barwick, S. W.; Yodh, G.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Brown, A. M.; Cohen, S.; Ribordy, M.] Ecole Polytech Fed Lausanne, Lab High Energy Phys, CH-1015 Lausanne, Switzerland; [Besson, D. Z.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Gallagher, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Abbasi, R.; Ahlers, M.; Arguelles, C.; Auffenberg, J.; Baker, M.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kopper, C.; Krasberg, M.; Kurahashi, N.; Landsman, H.; Maruyama, R.; McNally, F.; Merck, M.; Merino, G.; Morse, R.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Schultz, D.; Tobin, M. N.; Toscano, S.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Abbasi, R.; Ahlers, M.; Arguelles, C.; Auffenberg, J.; Baker, M.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kopper, C.; Krasberg, M.; Kurahashi, N.; Landsman, H.; Maruyama, R.; McNally, F.; Merck, M.; Merino, G.; Morse, R.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Schultz, D.; Tobin, M. N.; Toscano, S.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Wisconsin IceCube Particle Astrophys Ctr, Madison, WI 53706 USA; [Rae, I.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Baum, V.; Eberhardt, B.; Koepke, L.; Kroll, G.; Luenemann, J.; Sander, H. -G.; Schatto, K.; Wiebe, K.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Kohnen, G.] Univ Mons, B-7000 Mons, Belgium; [Bernhard, A.; Gross, A.; Leute, J.; Resconi, E.; Schulz, O.; Sestayo, Y.] Tech Univ Munich, D-85748 Garching, Germany; [Bai, X.; Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Secke, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Bai, X.; Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Secke, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Sarkar, S.] Univ Oxford, Dept Phys, Oxford OX1 3NP, England; [Bernhard, A.; Madsen, J.; Seunarine, S.; Spiczak, G. M.] Univ Wisconsin, Dept Phys, River Falls, WI 54022 USA; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Kiryluk, J.; Lesiak-Bzdak, M.; Niederhausen, H.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Bose, D.; Rott, C.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Clark, K.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Larson, M. J.; Pepper, J. A.; Toale, P. A.; Williams, D. R.; Xu, D. L.; Zarzhitsky, P.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Cowen, D. F.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Cowen, D. F.; DeYoung, T.; Dunkman, M.; Eagan, R.; Groh, J. C.; Huang, F.; Quinnan, M.; Smith, M. W. E.; Stanisha, N. A.; Tesic, G.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Boersma, D. J.; Botner, O.; Hallgren, A.; de los Heros, C. Perez; Stroem, R.; Taavola, H.] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Becker, K. -H.; Bindig, D.; Fischer-Wasels, T.; Helbing, K.; Hoffmann, R.; Klaes, J.; Kopper, S.; Naumann, U.; Obertacke, A.; Omairat, A.; Posselt, J.; Soldin, D.; Tepe, A.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Ackermann, M.; Berghaus, P.; Bernardini, E.; Bretz, H. -P.; Silva, A. H. Cruz; Glusenkamp, T.; Jacobi, E.; Kaminsky, B.; Karg, T.; Middell, E.; Mohrmann, L.; Nahnhauer, R.; Schoenwald, A.; Shanidze, R.; Spiering, C.; Stoessl, A.; Yanez, J. P.] DESY, D-15735 Zeuthen, Germany	Desiati, P (reprint author), Univ Wisconsin, Dept Phys, Madison, WI 53706 USA.	desiati@icecube.wisc.edu; juancarlos@wipac.wisc.edu; ofadiran@icecube.wisc.edu; ian@cs.wisc.edu; dschultz@icecube.wisc.edu	Auffenberg, Jan/D-3954-2014; Maruyama, Reina/A-1064-2013; Beatty, James/D-9310-2011; Koskinen, David/G-3236-2014; Aguilar Sanchez, Juan Antonio/H-4467-2015; Taavola, Henric/B-4497-2011	Auffenberg, Jan/0000-0002-1185-9094; Maruyama, Reina/0000-0003-2794-512X; Koskinen, David/0000-0002-0514-5917; Aguilar Sanchez, Juan Antonio/0000-0003-2252-9514; Taavola, Henric/0000-0002-2604-2810	U.S. National Science Foundation-Office of Polar Programs; U.S. National Science Foundation-Physics Division; University of Wisconsin Alumni Research Foundation; Grid Laboratory Of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin Madison; Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy, and National Energy Research Scientific Computing Center; Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada; WestGrid and Compute/Calcul Canada; Swedish Research Council; Swedish Polar Research Secretariat; Swedish National Infrastructure for Computing (SNIC); Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG); Helmholtz Alliance for Astroparticle Physics (HAP); Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO); FWO Odysseus programme; Flanders Institute to encourage scientific and technological research in industry (IWT); Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF)	We acknowledge the support from the following agencies: U.S. National Science Foundation-Office of Polar Programs, U.S. National Science Foundation-Physics Division, University of Wisconsin Alumni Research Foundation, the Grid Laboratory Of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin Madison, the Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy, and National Energy Research Scientific Computing Center, the Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada, WestGrid and Compute/Calcul Canada; Swedish Research Council, Swedish Polar Research Secretariat, Swedish National Infrastructure for Computing (SNIC), and Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Helmholtz Alliance for Astroparticle Physics (HAP), Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO), FWO Odysseus programme, Flanders Institute to encourage scientific and technological research in industry (IWT), Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); the Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF).	Allcock W., 2003, GRIDFTP PROTOCOL EXT; Halzen F, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480478; Abeysekara AU, 2012, ASTROPART PHYS, V35, P641, DOI 10.1016/j.astropartphys.2012.02.001; Aartsen MG, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.062002; Aartsen MG, 2013, NUCL INSTRUM METH A, V711, P73, DOI 10.1016/j.nima.2013.01.054; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; Buncic P., 2003, ARXIVCS0306067; Chirkin D, 2013, NUCL INSTRUM METH A, V725, P141, DOI 10.1016/j.nima.2012.11.170; Chirkin D., 2011, P 32 INT COSM RAY C, V4, P161; Couvares P, 2007, WORKFLOWS E SCI, P357, DOI DOI 10.1007/978-1-84628-757-2_22; DeYoung T., 2005, INT C COMP HIGH EN P, P463; Ellis R., CODEIGNITER USER GUI; Halzen F., 2003, ASP C SERIES, V13, P13; Pavlo A., 2006, Proceedings of the 20th Large Installation System Administration Conference (LISA'06); Protopopescu D, 2011, J PHYS CONF SER, V331, DOI 10.1088/1742-6596/331/7/072028; The Globus Security Team, 2005, GLOB TOOLK VERS 4 GR; Weisgarber T., 2013, HAWC COLL M MA UNPUB; Winer D., 1999, XML RPC SPECIFICATIO	18	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0743-7315	1096-0848		J PARALLEL DISTR COM	J. Parallel Distrib. Comput.	JAN	2015	75						198	211		10.1016/j.jpdc.2014.08.001		14	Computer Science, Theory & Methods	Computer Science	AW9BK	WOS:000346552500017		
J	Adachi, N; Deie, M; Nakamae, A; Okuhara, A; Kamei, G; Ochi, M				Adachi, Nobuo; Deie, Masataka; Nakamae, Atsuo; Okuhara, Atsushi; Kamei, Goki; Ochi, Mitsuo			Functional and Radiographic Outcomes of Unstable Juvenile Osteochondritis Dissecans of the Knee Treated With Lesion Fixation Using Bioabsorbable Pins	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						osteochondritis dissecans; knee; fixation; bioabsorbable pin	LATERAL FEMORAL CONDYLE; BONE PEG FIXATION; CARTILAGE DEFECTS; MOSAICPLASTY; JOINT; TRANSPLANTATION; FRAGMENTS; MENISCUS; LIGAMENT; MR	Background: The purpose of this study was to evaluate the functional and radiographic outcome of fixation of unstable juvenile osteochondritis dissecans lesions of the knee after a minimum of 2 years of follow-up. Methods: A total of 33 unstable juvenile osteochondritis dissecans lesions in 30 patients underwent fixation using bioabsorbable pins through arthrotomy or under arthroscopy. The patients consisted of 23 males and 7 females, and the average age at the time of operation was 14.4 years (range, 11 to 17 y). The functional outcomes were evaluated using the Lysholm score and Hughston's criteria at a mean follow-up of 3.3 years (range, 2.1 to 6.3 y). Healing of the osteochondritis dissecans lesions were confirmed by plain radiographs and magnetic resonance imaging. Results: The Lysholm score improved significantly at 3 months after the surgery, and was maintained until the final follow-up. Radiographically, 32 of 33 lesions healed after fixation of the lesion (healing rate was 97.0%). Healing was achieved at an average of 2.4 months on plain radiographs and 4.2 months on magnetic resonance imaging. According to Hughston's criteria, 25 patients were graded as excellent, 4 as good, and 1 as poor at the final follow-up. Conclusions: The fixation of the unstable juvenile osteochondritis dissecans lesions with bioabsorbable pins demonstrated improved clinical outcomes and radiographic high healing rates at a mean of 3.3 years of follow-up. We advocate this procedure for patients with unstable juvenile osteochondritis dissecans lesions of sufficient quality to enable fixation which will preserve the normal contour of the distal femur. Level of Evidence: Level IV-retrospective case series.	[Adachi, Nobuo; Deie, Masataka; Nakamae, Atsuo; Okuhara, Atsushi; Kamei, Goki; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan	Adachi, N (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nadachi@hiroshima-u.ac.jp					Adachi N, 2009, ARTHROSCOPY, V25, P145, DOI 10.1016/j.arthro.2008.09.008; Adachi N, 2009, J BONE JOINT SURG BR, V91B, P823, DOI 10.1302/0301-620X.91B6.20957; AGLIETTI P, 1994, ARTHROSCOPY, V10, P286, DOI 10.1016/S0749-8063(05)80113-6; Anderson AF, 1997, ARTHROSCOPY, V13, P319, DOI 10.1016/S0749-8063(97)90028-1; Miniaci A, 2007, ARTHROSCOPY, V23, P845, DOI 10.1016/j.arthro.2007.02.017; Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25; HUGHSTON JC, 1984, J BONE JOINT SURG AM, V66A, P1340; Berlet GC, 1999, ARTHROSCOPY, V15, P312, DOI 10.1016/S0749-8063(99)70041-1; Mizuta H, 2001, ARTHROSCOPY, V17, P608, DOI 10.1053/jars.2001.19979; NELSON DW, 1990, J COMPUT ASSIST TOMO, V14, P804, DOI 10.1097/00004728-199009000-00026; Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947; Deie M, 2006, J PEDIATR ORTHOPED, V26, P79, DOI 10.1097/01.bpo.0000191554.34197.fd; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Kocher MS, 2007, AM J SPORT MED, V35, P712, DOI 10.1177/0363546506296608; Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127; BANDI W, 1959, Helv Chir Acta, V26, P552; DESMET AA, 1990, AM J ROENTGENOL, V155, P549; Dines JS, 2008, ARTHROSCOPY, V24, P62, DOI 10.1016/j.arthro.2007.07.025; Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932; FEDERICO D J, 1990, Arthroscopy, V6, P190, DOI 10.1016/0749-8063(90)90074-N; GILLESPIE HS, 1979, CLIN ORTHOP RELAT R, P125; Kawasaki K, 2003, KNEE, V10, P257, DOI 10.1016/S0968-0160(02)00104-7; Kocher MS, 2001, AM J SPORT MED, V29, P562; LINDHOLM S, 1977, CLIN ORTHOP RELAT R, P256; Magnussen RA, 2009, AM J SPORT MED, V37, P754, DOI 10.1177/0363546508328119; Matsusue Y, 1996, CLIN ORTHOP RELAT R, P166; Mitsuoka T, 1998, ARTHROSCOPY, V14, P630, DOI 10.1016/S0749-8063(98)70063-5; Pascual-Garrido C, 2009, AM J SPORT MED, V37, p125S, DOI 10.1177/0363546509350833; Schenck RC, 1996, J BONE JOINT SURG AM, V78A, P439; SLOUGH JA, 1991, CLIN ORTHOP RELAT R, P122; Tabaddor RR, 2010, J PEDIATR ORTHOPED, V30, P14, DOI 10.1097/BPO.0b013e3181c6318c; TEGNANDER A, 1994, ACTA ORTHOP SCAND, V65, P472, DOI 10.3109/17453679408995495; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Tumpo P, 1997, INT ORTHOP, V21, P355	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN	2015	35	1					82	88				7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AW3MC	WOS:000346189800016		
J	Nguyen, XKT; Lee, J; Shin, EJ; Dang, DK; Jeong, JH; Nguyen, TTL; Nam, Y; Cho, HJ; Lee, JC; Park, DH; Jang, CG; Hong, JS; Nabeshima, T; Kim, HC				Xuan-Khanh Thi Nguyen; Lee, Jaehwi; Shin, Eun-Joo; Dang, Duy-Khanh; Jeong, Ji Hoon; Thuy-Ty Lan Nguyen; Nam, Yunsung; Cho, Hyun-Jong; Lee, Jae-Chul; Park, Dae Hun; Jang, Choon-Gon; Hong, Jau-Shyong; Nabeshima, Toshitaka; Kim, Hyoung-Chun			Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKC delta gene	JOURNAL OF PINEAL RESEARCH			English	Article						dopamine; liposomal melatonin; methamphetamine; mitochondria; oxidative stress; pro-apoptosis; protein kinase C	PROTEIN-KINASE-C; SEROTONIN N-ACETYLTRANSFERASE; VESICULAR MONOAMINE TRANSPORTER-2; NEUROBLASTOMA SH-SY5Y CELLS; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; PARKINSONS-DISEASE; PINEAL-GLAND; METABOLITE N-1-ACETYL-5-METHOXYKYNURAMINE; INDUCED NEUROTOXICITY	We have demonstrated that mitochondrial oxidative damage and PKC overexpression contribute to methamphetamine-induced dopaminergic degeneration. Although it is recognized that antioxidant melatonin is effective in preventing neurotoxicity induced by methamphetamine, its precise mechanism remains elusive. C57BL/6J wild-type mice exhibited a similar degree of dopaminergic deficit when methamphetamine was administered during light and dark phases. Furthermore, dopaminergic neuroprotection by genetic inhibition of PKC during the light phase was comparable to that during the dark phase. Thus, we have focused on the light phase to examine whether melatonin modulates PKC-mediated neurotoxic signaling after multiple high doses of methamphetamine. To enhance the bioavailability of melatonin, we applied liposomal melatonin. Treatment with methamphetamine resulted in hyperthermia, mitochondrial translocation of PKC, oxidative damage (mitochondria>cytosol), mitochondrial dysfunction, pro-apoptotic changes, ultrastructural mitochondrial degeneration, dopaminergic degeneration, and behavioral impairment in wild-type mice. Treatment with liposomal melatonin resulted in a dose-dependent attenuation against degenerative changes induced by methamphetamine in wild-type mice. Attenuation by liposomal melatonin might be comparable to that by genetic inhibition (using PKC(-/-) mice or PKC antisense oligonucleotide). However, liposomal melatonin did not show any additional protective effects on the attenuation by genetic inhibition of PKC. Our results suggest that the circadian cycle cannot be a key factor in modulating methamphetamine toxicity under the current experimental condition and that PKC is one of the critical target genes for melatonin-mediated protective effects against mitochondrial burdens (dysfunction), oxidative stress, pro-apoptosis, and dopaminergic degeneration induced by methamphetamine.	[Xuan-Khanh Thi Nguyen; Shin, Eun-Joo; Dang, Duy-Khanh; Thuy-Ty Lan Nguyen; Nam, Yunsung; Kim, Hyoung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea; [Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Pharmaceut Dosage Form Design Lab, Seoul 156756, South Korea; [Jeong, Ji Hoon] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea; [Cho, Hyun-Jong] Kangwon Natl Univ, Coll Pharm, Chunchon 200701, South Korea; [Lee, Jae-Chul] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 200701, South Korea; [Park, Dae Hun] Dongshin Univ, Dept Oriental Med Mat, Naju, South Korea; [Jang, Choon-Gon] Sungkyunkwan Univ, Sch Pharm, Dept Pharmacol, Suwon, South Korea; [Hong, Jau-Shyong] NIEHS, Neuropharmacol Sect, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA; [Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi, Japan; [Nabeshima, Toshitaka] Japanese Drug Org Appropriate Use & Res, NPO, Nagoya, Aichi, Japan	Shin, EJ (reprint author), Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea.	shinej@kangwon.ac.kr; kimhc@kangwon.ac.kr			Korea Food and Drug Administration [14182MFDS979]	This study was supported by the Korea Food and Drug Administration (14182MFDS979). Duy-Khanh Dang, Thuy-Ty Lan Nguyen, and Yunsung Nam are involved in BK21 PLUS program, National Research Foundation of Korea. Equipment at the Drug Discovery Institute (Kangwon National University) was used for this study.	Dubey V, 2007, EUR J PHARM BIOPHARM, V67, P398, DOI 10.1016/j.ejpb.2007.03.007; Miyazaki I, 2011, GLIA, V59, P435, DOI 10.1002/glia.21112; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Suwanjang W, 2010, J PINEAL RES, V48, P94, DOI 10.1111/j.1600-079X.2009.00731.x; Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090; Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004; Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709; Schaefer M, 2009, J PINEAL RES, V46, P49, DOI 10.1111/j.1600-079X.2008.00614.x; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Imam SZ, 2001, ANN NY ACAD SCI, V939, P366; Nakajima A, 2004, J NEUROSCI, V24, P2212, DOI 10.1523/JNEUROSCI.4847-03.2004; Deng XL, 2000, MOL BRAIN RES, V83, P121, DOI 10.1016/S0169-328X(00)00169-8; Shin EJ, 2012, BEHAV BRAIN RES, V232, P98, DOI 10.1016/j.bbr.2012.04.001; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; MALLO C, 1990, EUR J CLIN PHARMACOL, V38, P297, DOI 10.1007/BF00315035; Hirata H, 1998, SYNAPSE, V30, P150, DOI 10.1002/(SICI)1098-2396(199810)30:2<150::AID-SYN4>3.0.CO;2-B; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Itzhak Y, 2002, PROG NEURO-PSYCHOPH, V26, P1177, DOI 10.1016/S0278-5846(02)00257-9; Kaewsuk S, 2009, NEUROCHEM INT, V55, P397, DOI 10.1016/j.neuint.2009.04.010; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Parameyong A, 2013, J PINEAL RES, V55, P313, DOI 10.1111/jpi.12078; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; WALDHAUSER F, 1984, NEUROENDOCRINOLOGY, V39, P307, DOI 10.1159/000123997; Shin EJ, 2014, MOL NEUROBIOL, V49, P1400, DOI 10.1007/s12035-013-8617-1; CUBELLS JF, 1994, J NEUROSCI, V14, P2260; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Eyerman DJ, 2007, J NEUROCHEM, V103, P1219, DOI 10.1111/j.1471-4159.2007.04837.x; DeMuro RL, 2000, J CLIN PHARMACOL, V40, P781, DOI 10.1177/00912700022009422; Hurtig HI, 2000, NEUROLOGY, V54, P1916; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Kocadagli T, 2014, FOOD CHEM, V153, P151, DOI 10.1016/j.foodchem.2013.12.036; Wisessmith W, 2009, J PINEAL RES, V46, P433, DOI 10.1111/j.1600-079X.2009.00680.x; Shin EJ, 2008, CELL SIGNAL, V20, P645, DOI 10.1016/j.cellsig.2007.11.014; Jung BD, 2010, NEUROCHEM INT, V56, P229, DOI 10.1016/j.neuint.2009.10.005; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Tran HYP, 2012, FREE RADICAL BIO MED, V52, P1159, DOI 10.1016/j.freeradbiomed.2011.12.008; MENENDEZPELAEZ A, 1993, J PINEAL RES, V15, P59, DOI 10.1111/j.1600-079X.1993.tb00511.x; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Granado N, 2011, GLIA, V59, P1850, DOI 10.1002/glia.21229; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Shin EJ, 2009, J NEUROSCI RES, V87, P710, DOI 10.1002/jnr.21880; Niu SD, 2010, J PINEAL RES, V49, P106, DOI 10.1111/j.1600-079X.2010.00771.x; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Bruce-Keller AJ, 1999, J NEUROIMMUNOL, V93, P53, DOI 10.1016/S0165-5728(98)00190-8; Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l; Gibb JW, 1997, J PHARMACOL EXP THER, V283, P630; GOTO M, 1994, MOL BRAIN RES, V21, P349, DOI 10.1016/0169-328X(94)90266-6; Jumnongprakhon P, 2014, NEUROTOX RES, V25, P286, DOI 10.1007/s12640-013-9419-y; Kirjavainen M, 1999, J CONTROL RELEASE, V58, P207, DOI 10.1016/S0168-3659(98)00152-7; Liedtke CM, 1997, AM J PHYSIOL-CELL PH, V273, pC1632; Mattson MP, 2012, J CLIN INVEST, V122, P1195, DOI 10.1172/JCI62835; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Paxinos G, 2008, MOUSE BRAIN STEREOTA; Shin EJ, 2011, NEUROCHEM INT, V59, P39, DOI 10.1016/j.neuint.2011.03.022; Torres-Farfan C, 2006, J PINEAL RES, V40, P64, DOI 10.1111/j.1600-079X.2005.00279.x; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Uz T, 2002, LIFE SCI, V70, P3069, DOI 10.1016/S0024-3205(02)01559-X; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; Wang QS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-124; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yu L, 2002, J NEURAL TRANSM, V109, P1477, DOI 10.1007/s007020200096; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang W, 2006, FASEB J, V20, P2496, DOI 10.1096/fj.06-6006com; Zhu JPQ, 2006, NEUROSCIENCE, V140, P607, DOI 10.1016/j.neuroscience.2006.02.055	75	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	JAN	2015	58	1					86	106		10.1111/jpi.12195		21	Endocrinology & Metabolism; Neurosciences; Physiology	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	AW7YY	WOS:000346478800008		
J	Ikeda, T; Kumashiro, R; Taketani, K; Ando, K; Kimura, Y; Saeki, H; Oki, E; Morita, M; Akahoshi, T; Hashizume, M; Maehara, Y				Ikeda, Tetsuo; Kumashiro, Ryuichi; Taketani, Kenji; Ando, Koji; Kimura, Yasue; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Akahoshi, Tomohiko; Hashizume, Makoto; Maehara, Yoshihiko			Endoscopic evaluation of clinical colorectal anastomotic leakage	JOURNAL OF SURGICAL RESEARCH			English	Article						Endoscopic findings; Anastomotic leakage; Colorectal anastomoses; Double-stapling technique; Colorectal cancer	LOW ANTERIOR RESECTION; DOUBLE STAPLING TECHNIQUE; RANDOMIZED MULTICENTER TRIAL; TOTAL MESORECTAL EXCISION; RECTAL-CANCER SURGERY; RISK-FACTORS; EEA STAPLER; CIRCULAR STAPLER; CARCINOMA; MORBIDITY	Background: Anastomotic leakage (AL) is a major complication after anterior resection. However, its therapeutic strategies and technical risk factors have not been well established. Therefore, we endoscopically evaluated anastomotic regions after laparoscopic colorectal anastomosis using a double-stapling technique (DST) for determination of treatment and investigation of technical factors. Methods: In total, 191 consecutive patients underwent laparoscopic anterior resection with a DST from September 2008-January 2013. Anastomotic regions were endoscopically evaluated in patients suspected to have AL after surgery. Results: Anastomotic dehiscence was observed in 19 patients, and AL was diagnosed in 18 (9.3%). Of the 19 patients, 12 were treated by creation of an intestinal stoma and 7 were treated conservatively based on their clinical status and endoscopic findings. Twenty-three dehiscences were observed among 19 anastomotic regions; all 23 were observed on the circular stapler anastomosis lines. Of these 23 dehiscences, 13 (56.5%) were located at the point at which the anastomosis lines of the circular and linear staplers overlapped, and 10 (43.5%) were located on the circumferential aspect between the overlapping points. Conclusions: Endoscopic evaluation of anastomotic regions is safe and useful for the determination of therapeutic strategies. The DST anastomotic technique itself may be closely related to the development of AL. (C) 2015 Elsevier Inc. All rights reserved.	[Ikeda, Tetsuo; Kumashiro, Ryuichi; Akahoshi, Tomohiko; Hashizume, Makoto] Kyushu Univ, Ctr Integrat Adv Med, Fukuoka 8128582, Japan; [Taketani, Kenji; Ando, Koji; Kimura, Yasue; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Ikeda, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	t-ikeda@surg2.med.kyushu-u.ac.jp			Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan	No financial support was received for this work from any company. This study was supported in part by a grant from the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Myers SR, 2011, SURG ENDOSC, V25, P3043, DOI 10.1007/s00464-011-1667-4; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Xiao L, 2011, WORLD J SURG, V35, P1367, DOI 10.1007/s00268-011-1053-3; Bennis M, 2012, ANN SURG, V255, P504, DOI 10.1097/SLA.0b013e31824485c4; Jestin P, 2008, COLORECTAL DIS, V10, P715, DOI 10.1111/j.1463-1318.2007.01466.x; Kim JS, 2009, J AM COLL SURGEONS, V209, P694, DOI 10.1016/j.jamcollsurg.2009.09.021; Lee WS, 2008, WORLD J SURG, V32, P1124, DOI 10.1007/s00268-007-9451-2; Bertelsen CA, 2010, COLORECTAL DIS, V12, pE76, DOI 10.1111/j.1463-1318.2009.01935.x; Jung SH, 2008, DIS COLON RECTUM, V51, P902, DOI 10.1007/s10350-008-9272-x; COHEN Z, 1983, DIS COLON RECTUM, V26, P231, DOI 10.1007/BF02562484; NANCE FC, 1979, ANN SURG, V189, P587, DOI 10.1097/00000658-197905000-00008; Eberl T, 2008, AM J SURG, V196, P592, DOI 10.1016/j.amjsurg.2007.10.023; Chopra SS, 2009, SURGERY, V145, P182, DOI 10.1016/j.surg.2008.09.012; De Nardi P, 2008, TECH COLOPROCTOL, V12, P69, DOI 10.1007/s10151-008-0401-2; FEINBERG SM, 1986, DIS COLON RECTUM, V29, P885, DOI 10.1007/BF02555370; Kim HJ, 2013, INT J COLORECTAL DIS, V28, P149, DOI 10.1007/s00384-012-1582-8; Kim MJ, 2011, WORLD J SURG, V35, P2806, DOI 10.1007/s00268-011-1286-1; KNIGHT CD, 1980, SURGERY, V88, P710; Marecik SJ, 2007, AM J SURG, V193, P395, DOI 10.1016/j.amjsurg.2006.12.008; MITTAL VK, 1980, SURGERY, V88, P715; Moore JWE, 1996, AUST NZ J SURG, V66, P820, DOI 10.1111/j.1445-2197.1996.tb00757.x; PICCIOCCHI A, 1988, INT SURG, V73, P19; Ramirez MC, 2010, JSLS-J SOC LAPAROEND, V14, P358, DOI 10.4293/108680810X12924466007089; Roumen RMH, 2000, DIS COLON RECTUM, V43, P522, DOI 10.1007/BF02237198; Veenhof AAFA, 2008, ANN SURG, V247, P718, DOI 10.1097/SLA.0b013e31816a7493	25	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					126	134		10.1016/j.jss.2014.07.009		9	Surgery	Surgery	AW4HH	WOS:000346241300016		
J	Sugita, H; Kojima, K; Inokuchi, M; Kato, K				Sugita, Hirofumi; Kojima, Kazuyuki; Inokuchi, Mikito; Kato, Keiji			Long-term outcomes of laparoscopic gastrectomy for gastric cancer	JOURNAL OF SURGICAL RESEARCH			English	Article						Laparoscopic gastrectomy; Gastric cancer; Oncological outcome; Postoperative complication; Recurrence	ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; RECURRENCE RISK; CLINICAL-TRIAL; FOLLOW-UP; SURGERY; MULTICENTER; CARCINOMA	Background: Laparoscopic gastrectomy (LG) has been established as a procedure for the treatment of gastric cancer. However, there have been few reports on the long-term outcomes of LG for gastric cancer. The aim of this study is to investigate the long-term outcomes of LG for gastric cancer. Methods: A total of 278 consecutive patients who underwent LG in our unit between January 1999 and December 2006 were included in this study. Survival, recurrence, and late gastrointestinal complications were analyzed. Results: The median follow-up period was 73.7 mo (6-165 mo). Distal gastrectomy was performed in 229 patients, total gastrectomy in 23 patients, proximal gastrectomy in 15 patients, and pylorus-preserving gastrectomy in 11 patients. Five-year overall and disease-specific survival rates were 91% and 99% for stage IA, 75% and 91% for stage IB, 72% and 88% for stage II, and 40% and 50% for stage III, respectively. Recurrences were detected in 15 (5.4%) patients, including 5 distant lymph node, 5 peritoneal, 4 hematogenous, and 1 locoregional recurrences. Bowel obstruction occurred in 4 (1.4%) patients, and gallstones developed in 37 (15%) patients. Conclusions: This follow-up investigation suggested that LG for gastric cancer is a feasible procedure from the standpoint of long-term oncological outcome and postoperative complications. (C) 2015 Elsevier Inc. All rights reserved.	[Sugita, Hirofumi; Inokuchi, Mikito; Kato, Keiji] Tokyo Med & Dent Univ, Dept Gastr Surg, Tokyo 1138519, Japan; [Kojima, Kazuyuki] Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Tokyo 1138519, Japan	Sugita, H (reprint author), Tokyo Med & Dent Univ, Dept Gastr Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	h-sugita.srg2@tmd.ac.jp					Akatsu T, 2005, WORLD J SURG, V29, P182, DOI 10.1007/s00268-004-7482-5; Kim MC, 2008, ANN SURG ONCOL, V15, P2692, DOI 10.1245/s10434-008-0075-z; Memon MA, 2008, SURG ENDOSC, V22, P1781, DOI 10.1007/s00464-008-9925-9; Gutt CN, 2004, SURG ENDOSC, V18, P898, DOI 10.1007/s00464-003-9233-3; SANO T, 1993, CANCER, V72, P3174, DOI 10.1002/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H; Lee YJ, 2007, J LAPAROENDOSC ADV S, V17, P455, DOI 10.1089/lap.2006.0216; Kim HI, 2011, SURG ENDOSC, V25, P958, DOI 10.1007/s00464-010-1288-3; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Dowson HM, 2008, BRIT J SURG, V95, P909, DOI 10.1002/bjs.6211; Lee SW, 2010, J AM COLL SURGEONS, V211, P33, DOI 10.1016/j.jamcollsurg.2010.03.018; Sugimachi K, 2008, HEPATO-GASTROENTEROL, V55, P496; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Curet MJ, 2004, AM J SURG, V187, P705, DOI 10.1016/j.amjsurg.2003.10.015; Lee JH, 2007, ANN SURG ONCOL, V14, P3148, DOI 10.1245/s10434-007-9446-0; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Feng XY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0514-y; Fujiwara M, 2003, J AM COLL SURGEONS, V196, P75, DOI 10.1016/S1072-7515(02)01539-9; Fukagawa T, 2009, J GASTROINTEST SURG, V13, P886, DOI 10.1007/s11605-009-0832-8; Huscher CG, 2005, ANN SURG, V241, P2132; Inokuchi M, 2012, GASTRIC CANCER, V61, P430; Japanese Gastric Cancer Association, 2010, GASTR CANC TREATM GU; Kim Ki Han, 2012, J Gastric Cancer, V12, P18, DOI 10.5230/jgc.2012.12.1.18; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kojima K, 2013, GASTRIC CANCER, V17, P146; Kojima K, 2008, ANN SURG, V247, P962, DOI 10.1097/SLA.0b013e31816d9526; Kwon Hye Youn, 2013, J Gastric Cancer, V13, P51, DOI 10.5230/jgc.2013.13.1.51; Pak KH, 2012, SURG ENDOSC, V26, P130, DOI 10.1007/s00464-011-1838-3; Rehnberg O, 1985, ANN SURG, V201, P172; Roukos DH, 2001, BRIT J CANCER, V84, P1602, DOI 10.1054/bjoc.2001.1720; Sasako M, 2003, J CLIN ONCOL, V21, p274S, DOI 10.1200/JCO.2003.09.172; Song J, 2010, ANN SURG ONCOL, V17, P1777, DOI 10.1245/s10434-010-0932-4; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3	33	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					190	195		10.1016/j.jss.2014.07.040		6	Surgery	Surgery	AW4HH	WOS:000346241300024		
J	Nakamura, N; Yamashita, Y				Nakamura, Noriko; Yamashita, Yuichi			Malpractice lawsuits and change in work in Japanese surgeons	JOURNAL OF SURGICAL RESEARCH			English	Article						Surgeons; Malpractice lawsuits; Defensive medicine; Support; Legal counsel	DEFENSIVE-MEDICINE; AMERICAN SURGEONS; 2ND VICTIMS; CAREER SATISFACTION; NATIONAL-SURVEY; ADVERSE EVENTS; PHYSICIANS; ERRORS; ENVIRONMENT; BURNOUT	Background: The risk of lawsuits causes surgeons stress and is associated with defensive medicine. It is possible that some surgeons withdraw from surgery because of malpractice lawsuits, although the actual impact of lawsuits is not clear. This study evaluated changes in work and medical practices involved in lawsuits, as well as support they receive. Materials and methods: A total of 115 surgeons who had been involved in lawsuits in Japan were eligible to participate. Participants were surveyed about changes in work because of lawsuits, the influence of lawsuits on medical care, defensive medicine, and their opinions on support they received. Results: A total of 30 surveys were collected. Six surgeons changed work: five had lost their lawsuits and the remaining one had a settlement. Surgeons felt that lawsuits imposed a time burden (100%) and caused emotional strain (96%). Surgeons made a number of conscious changes to their medical care after lawsuits, including over care (27%) and a hesitation to use high-risk treatments (39%). They had positive opinions of support they received from the legal counsel (89%), the hospital director (73%), supervisors (65%), and colleagues (57%). Surgeons who changed work were significantly more likely to engage in defensive medicine, including over care and hesitation, than those who had not changed work. Support from the legal counsel was negatively correlated with over care and hesitation. Conclusions: Given the significant influence of lawsuits on surgeons' practice, medical institutions should provide support to surgeons. Future research is needed to confirm whether legal counsel may prevent defensive medicine. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Noriko; Yamashita, Yuichi] Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Fukuoka 8140180, Japan	Nakamura, N (reprint author), Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	nn0904@fukuoka-u.ac.jp					Ahmadiyeh N, 2010, J AM COLL SURGEONS, V210, P23, DOI 10.1016/j.jamcollsurg.2009.08.011; Anderson RE, 1999, ARCH INTERN MED, V159, P2399, DOI 10.1001/archinte.159.20.2399; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Seys D, 2013, INT J NURS STUD, V50, P678, DOI 10.1016/j.ijnurstu.2012.07.006; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Seabury SA, 2013, HEALTH AFFAIR, V32, P111, DOI 10.1377/hlthaff.2012.0967; Gazoni FM, 2012, ANESTH ANALG, V114, P596, DOI 10.1213/ANE.0b013e318227524e; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Deshpande SP, 2011, ANN SURG, V253, P1011, DOI 10.1097/SLA.0b013e3182153a35; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; McCormick F, 2012, ARCH SURG-CHICAGO, V147, P430, DOI 10.1001/archsurg.2012.84; Aasland OG, 2005, QUAL SAF HEALTH CARE, V14, P13, DOI 10.1136/qshc.2002.003657; Ullstrom S, 2014, BMJ QUAL SAF, V23, P325, DOI 10.1136/bmjqs-2013-002035; O'Leary KJ, 2012, ACAD MED, V87, P142, DOI 10.1097/ACM.0b013e31823f2c86; Edrees HH, 2011, POL ARCH MED WEWN, V121, P101; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; Balch CM, 2011, J AM COLL SURGEONS, V213, P657, DOI 10.1016/j.jamcollsurg.2011.08.005; Pinto A, 2013, BRIT J SURG, V100, P1748, DOI 10.1002/bjs.9308; Guest RS, 2011, ANN SURG ONCOL, V18, P1236, DOI 10.1245/s10434-011-1623-5; Hanazaki K, 2013, SURG TODAY, V43, P1209, DOI 10.1007/s00595-013-0691-5; Hu YY, 2012, ARCH SURG-CHICAGO, V147, P212, DOI 10.1001/archsurg.2011.312; Japan Surgical Society, 2013, SURV REP; Minami CA, 2014, J AM COLL SURGEONS, V218, P271, DOI 10.1016/j.jamcollsurg.2013.09.007; Stangierski A, 2012, ARCH MED SCI, V8, P569, DOI 10.5114/aoms.2012.29413; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	27	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					210	216		10.1016/j.jss.2014.08.029		7	Surgery	Surgery	AW4HH	WOS:000346241300027		
J	Miyashita, T; Tajima, H; Makino, I; Nakagawara, H; Kitagawa, H; Fushida, S; Harmon, JW; Ohta, T				Miyashita, Tomoharu; Tajima, Hidehiro; Makino, Isamu; Nakagawara, Hisatoshi; Kitagawa, Hirohisa; Fushida, Sachio; Harmon, John W.; Ohta, Tetsuo			Metastasis-promoting role of extravasated platelet activation in tumor	JOURNAL OF SURGICAL RESEARCH			English	Article						Platelet aggregation; Epithelial-to-mesenchymal transition; Metastasis; Pancreatic cancer	EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; PANCREATIC-CANCER; BREAST-CANCER; PROGRESSION; CARCINOMA; DISEASE; SNAIL; BETA; EXPRESSION	Background: The last decade has focused attention on the central role of platelets interacting with the tumor cells and the immune system in promoting tumor progression and distant spread through release of growth factors, such as transforming growth factor beta, vascular endothelial growth factor A, and plasminogen activator inhibitor 1, into the tumor microenvironment. We focused on the potential metastasis-promoting role of extravasated platelet aggregation in pancreatic cancer and stroma. Materials and methods: Resected pancreatic cancer specimens from 40 patients were used in this study. To examine the expression and localization of platelet aggregation in the epithelialemesenchymal transition (EMT) region in cancer and stroma, CD42b, Snail1, and E-cadherin were assessed using immunohistochemistry. We determined the correlation of these expressed proteins with clinical features. Results: CD42b expression was detected at the invasive front of the tumor, which was in 73% of the EMT portion, but not in the region of tubular formation. Increased Snail1 and reduction and/or loss of E-cadherin expressions were noted in 85% and 75% of the EMT portion, respectively. There was a significant correlation between CD42b and Snail1 expressions (P = 0.02) and CD42b and reduction and/or loss of E-cadherin expressions (P = 0.008). Conclusions: We demonstrate that extravasated platelet aggregation is associated with the first step in the formation of the EMT. These data suggest a potential role for antiplatelet agents to suppress EMT and metastasis by changing the tumor microenvironment. (C) 2015 Elsevier Inc. All rights reserved.	[Miyashita, Tomoharu; Tajima, Hidehiro; Makino, Isamu; Nakagawara, Hisatoshi; Kitagawa, Hirohisa; Fushida, Sachio; Ohta, Tetsuo] Kanazawa Univ Hosp, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan; [Harmon, John W.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Miyashita, T (reprint author), Kanazawa Univ Hosp, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	tomoharumiya@gmail.com					Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Lowe KL, 2012, THROMB RES, V129, pS30, DOI 10.1016/S0049-3848(12)70013-0; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Erpenbeck L, 2010, BLOOD, V115, P3427, DOI 10.1182/blood-2009-10-247296; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Anitua E, 2007, PLAST RECONSTR SURG, V119, P950, DOI 10.1097/01.prs.0000255543.43695.1d; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Kellouche S, 2007, EXP CELL RES, V313, P486, DOI 10.1016/j.yexcr.2006.10.023; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P712, DOI 10.1055/s-2007-991540; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Hogan NM, 2013, BIOCHEM BIOPH RES CO, V435, P574, DOI 10.1016/j.bbrc.2013.05.013; Karamitopoulou Eva, 2013, Front Oncol, V3, P221, DOI 10.3389/fonc.2013.00221; Kitadai Yasuhiko, 2010, Cancer Microenviron, V3, P109, DOI 10.1007/s12307-009-0032-9; Lowenfels AB, 2004, JPN J CLIN ONCOL, V34, P238, DOI 10.1093/jjco/hyh045; Maillard CM, 2008, CARCINOGENESIS, V29, P2236, DOI 10.1093/carcin/bgn204; Tajima H, 2012, ONCOL LETT, V3, P1186, DOI 10.3892/ol.2012.657; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5471CAN-05-3086	42	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					289	294		10.1016/j.jss.2014.07.037		6	Surgery	Surgery	AW4HH	WOS:000346241300037		
J	Ogawa, F; Satoh, Y; Iyoda, A; Amano, H; Kumagai, Y; Majima, M				Ogawa, Fumihiro; Satoh, Yukitoshi; Iyoda, Akira; Amano, Hideki; Kumagai, Yuji; Majima, Masataka			Clinical impact of lung age on postoperative readmission in non-small cell lung cancer	JOURNAL OF SURGICAL RESEARCH			English	Article						Lung age; Non-small cell lung cancer; Surgical resection; Postoperative complications; Readmission	OBSTRUCTIVE PULMONARY-DISEASE; LENGTH-OF-STAY; FLUTICASONE PROPIONATE; HOSPITAL READMISSION; SURGERY; RESECTION; MORTALITY; COMPLICATIONS; SALMETEROL; SURVIVAL	Background: Recently, the Japanese Respiratory Society (JRS) proposed using lung age (LA) as an indicator of lung function; however, reports regarding the association of LA with the risk of postoperative readmission within 90 d after surgical treatment for non-small cell lung cancer (NSCLC) are limited. Here, we analyze the clinical relationship between LA and readmission within 90 d after surgical treatment for NSCLC. Methods: A total of 979 patients underwent curative resections for NSCLC from January 2000-September 2012 at the Kitasato University Hospital. We selected patients who required readmission because of surgical complications within 90 d of surgery and retrospectively analyzed various clinical data. LA was calculated based on the formula given by the Japanese Respiratory Society, which relies on preoperative respiratory function. We also calculated the age gap (AG) between the calculated LA and the true age (TA). Results: There were 216 patients who needed to be readmitted within 90 d of surgery, 33 (3%) of whom were hospitalized for surgical complications. Twenty-four patients (73%) had respiratory complications, and 7 patients (21%) died. There were significant differences between the readmitted and no readmitted patients in terms of preoperative factors, such as gender, LA, AG, smoking status, and smoking index (P < 0.05). In addition, there were significant differences in intraoperative blood loss, postoperative complications, histologic type, duration of hospitalization, and hospitalization after surgery (P < 0.05). Multivariate analysis using logistic regression indicated that LA, AG, blood loss, and postoperative complications were independent factors that predicted readmission. Additionally, the 5-y survival rates were 78% and 44% for the no readmitted and readmitted groups, respectively (P < 0.001). Conclusions: The AG between TA and LA was significantly associated with postoperative complications and remained an independent predictive factor after multiple regressions. LA was shown to be a useful factor for predicting the risk of surgery-related readmission within 90 d after surgery for NSCLC. (C) 2015 Elsevier Inc. All rights reserved.	[Ogawa, Fumihiro; Amano, Hideki; Kumagai, Yuji; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa 2520374, Japan; [Iyoda, Akira] Toho Univ, Sch Med, Dept Thorac Surg, Tokyo, Japan; [Ogawa, Fumihiro; Kumagai, Yuji] Kitasato Univ, Sch Med, Dept Clin Res Ctr, Sagamihara, Kanagawa 2520374, Japan	Ogawa, F (reprint author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	fumihiro@med.kitasato-u.ac.jp					Aizawa H, 2007, PROG MED, V27, P6; Emick DM, 2006, J GASTROINTEST SURG, V10, P1243, DOI 10.1016/j.gassur.2006.08.016; Wright CD, 2008, ANN THORAC SURG, V85, P1857, DOI 10.1016/j.athoracsur.2008.03.024; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Kent TS, 2011, J AM COLL SURGEONS, V213, P515, DOI 10.1016/j.jamcollsurg.2011.07.009; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025; WELCH HG, 1992, AM J PUBLIC HEALTH, V82, P407, DOI 10.2105/AJPH.82.3.407; Lee HS, 2005, ANN THORAC SURG, V79, P405, DOI 10.1016/j.athoracsur.2004.07.079; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Hendren S, 2011, DIS COLON RECTUM, V54, P1362, DOI 10.1097/DCR.0b013e31822b72d3; Nakagawa M, 2001, CHEST, V120, P705, DOI 10.1378/chest.120.3.705; THOMAS JW, 1991, MED CARE, V29, P377, DOI 10.1097/00005650-199104000-00006; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Brunelli A, 2006, EUR J CARDIO-THORAC, V29, P567, DOI 10.1016/j.ejcts.2006.01.014; Nakamura H, 2008, SURG TODAY, V38, P227, DOI 10.1007/s00595-007-3599-0; FERGUSON MK, 1988, J THORAC CARDIOV SUR, V96, P894; Ansari M Z, 1995, Aust Health Rev, V18, P63; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Ferguson MK, 2008, EUR J CARDIO-THORAC, V34, P1085, DOI 10.1016/j.ejcts.2008.07.037; Ferguson MK, 1999, CHEST, V115, p58S, DOI 10.1378/chest.115.suppl_2.58S; Haruki T, 2010, RESPIROLOGY, V15, P495, DOI 10.1111/j.1440-1843.2010.01708.x; Kawayama Tomotaka, 2008, Int J Chron Obstruct Pulmon Dis, V3, P137; Linden PA, 2005, CHEST, V127, P1984, DOI 10.1378/chest.127.6.1984; MORRIS JF, 1985, PREV MED, V14, P655, DOI 10.1016/0091-7435(85)90085-4; ROOS LL, 1986, MED CARE, V24, P1044, DOI 10.1097/00005650-198611000-00008; Stolz AJ, 2005, EUR J CARDIO-THORAC, V27, P334, DOI 10.1016/j.ejcts.2004.11.004; Wang J, 1999, J THORAC CARDIOV SUR, V117, P581, DOI 10.1016/S0022-5223(99)70338-7	29	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					442	448		10.1016/j.jss.2014.08.028		7	Surgery	Surgery	AW4HH	WOS:000346241300057		
J	Takabayashi, Y; Ishihara, M; Sumi, Y; Takikawa, M; Nakamura, S; Kiyosawa, T				Takabayashi, Yuki; Ishihara, Masayuki; Sumi, Yuki; Takikawa, Makoto; Nakamura, Shingo; Kiyosawa, Tomoharu			Platelet-rich plasma-containing fragmin-protamine micro-nanoparticles promote epithelialization and angiogenesis in split-thickness skin graft donor sites	JOURNAL OF SURGICAL RESEARCH			English	Article						Platelet-rich plasma; Fragmin-protamine micro-nanoparticles; Epithelialization; Angiogenesis; Split-thickness skin graft donor sites	CONTAINING FRAGMIN/PROTAMINE MICROPARTICLES; GROWTH-FACTORS; COATED MATRIX; IN-VIVO; NEOVASCULARIZATION; CARRIERS; SURGERY; HEPARIN; FIBRIN; CELLS	Background: Platelet-rich plasma (PRP) contains multiple growth factors, and fragmin-protamine micro-nanoparticles (F-P M-NPs) significantly enhance and stabilize growth factors. The purpose of this study was to evaluate the effects of PRP-containing F-P M-NPs (PRP&F-P M-NPs) on wound repair in split-thickness skin graft (STSG-) donor sites (DS). Materials and methods: A total of 56 inbred male rats were anesthetized and split-thickness skin graft donor site (STSG-DS) were created with a Padgett dermatome. PRP& F-P M-NPs, F-P M-NPs, PRP, and saline (control) were then intradermally injected evenly into the STSG-DSs. On 3, 4, 5, 7, and 10 d after creation of STSG-DS, skin sample sections were stained with hematoxylin and eosin to evaluate reepithelialization and angiogenesis. Results: Treatment of STSG-DS with PRP& F-P M-NPs effectively promoted epithelialization and new vessel formation compared with those treated with PRP, F-P M-NPs, and control (saline). Conclusions: The intradermal injection of PRP& F-P M-NPs promotes epithelialization and angiogenesis in STSG-DS wounds. (C) 2015 Elsevier Inc. All rights reserved.	[Takabayashi, Yuki; Sumi, Yuki; Kiyosawa, Tomoharu] Natl Def Med Coll, Dept Plast & Reconstruct Surg, Tokorozawa, Saitama 3598513, Japan; [Ishihara, Masayuki; Nakamura, Shingo] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan; [Takikawa, Makoto] Natl Def Med Coll, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan	Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ishihara@ndmc.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Government of Japan [1058500]	The authors acknowledge the expertise and advice of Associate Prof Koichi Fukuda and thank the personnel of the Institute of Laboratory Animals, Graduate School of Medicine, National Defense Medical College for their expert care of animals. This study was partially supported by the Ministry of Education, Culture, Sports, Science and Technology of the Government of Japan (grant no. 1058500).	Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jems.2002.0285; Salmivirta M, 1996, FASEB J, V10, P1270; Nakamura S, 2009, J BIOMED MATER RES A, V91A, P814, DOI 10.1002/jbm.a.32265; Danielsen P, 2008, PLAST RECONSTR SURG, V122, P1431, DOI 10.1097/PRS.0b013e318188202c; LYNCH SE, 1989, J CLIN INVEST, V84, P640, DOI 10.1172/JCI114210; Takikawa M, 2011, DERMATOL SURG, V37, P1721, DOI 10.1111/j.1524-4725.2011.02123.x; Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037; Demirtas Y, 2010, BURNS, V36, P999, DOI 10.1016/j.burns.2009.05.017; Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824; Bitsch M, 2005, SCAND J PLAST RECONS, V39, P162, DOI 10.1080/02844310510006196; Eppley BL, 2006, PLAST RECONSTR SURG, V118, p147E, DOI 10.1097/01.prs.0000239606.92676.cf; Fujita M, 2013, J BIOMED MATER RES B, V101B, P36, DOI 10.1002/jbm.b.32808; Kishimoto S, 2013, ACTA BIOMATER, V9, P4763, DOI 10.1016/j.actbio.2012.08.003; Kishimoto S, 2009, TISSUE ENG PART C-ME, V15, P523, DOI 10.1089/ten.TEC.2008.0492; Kishimoto S, 2009, ARTIF ORGANS, V33, P431, DOI 10.1111/j.1525-1594.2009.00745.x; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Mori Y, 2010, INT J NANOMED, V5, P147; Nakamura S, 2010, J BIOMED MATER RES A, V92A, P1614, DOI 10.1002/jbm.a.32506; Nakamura S, 2012, J ARTIF ORGANS, V15, P375, DOI 10.1007/s10047-012-0658-0; Pan M, 1997, AM J CARDIOL, V80, P1336; Scimeca Christy L, 2010, J Diabetes Sci Technol, V4, P1121; Takikawa M, 2011, J BIOMED MATER RES B, V97B, P373, DOI 10.1002/jbm.b.31824; Takikawa M, 2011, J SURG RES, V170, P189	25	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2015	193	1					483	491		10.1016/j.jss.2014.08.011		9	Surgery	Surgery	AW4HH	WOS:000346241300061		
J	Lallas, A; Moscarella, E; Longo, C; Kyrgidis, A; de Mestier, Y; Vale, G; Guida, S; Pellacani, G; Argenziano, G				Lallas, Aimilios; Moscarella, Elvira; Longo, Caterina; Kyrgidis, Athanassios; de Mestier, Yuka; Vale, Gabrielle; Guida, Stefania; Pellacani, Giovanni; Argenziano, Giuseppe			Likelihood of finding melanoma when removing a Spitzoid-looking lesion in patients aged 12 years or older	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Article						dermoscopy; diagnosis; management; melanoma; Reed nevus; Spitz nevus	EPITHELIOID CELL NEVI; EPILUMINESCENCE MICROSCOPY; VASCULAR STRUCTURES; MALIGNANT-MELANOMA; 7-POINT CHECKLIST; SKIN TUMORS; MANAGEMENT; DERMOSCOPY; CHILDHOOD; ADULTS	Background: Dermoscopy improves the recognition of melanoma and Spitz nevus but occasionally melanoma may exhibit a symmetric pattern mimicking Spitz nevus. Objective: We sought to investigate the likelihood of finding melanoma when excising a symmetric Spitzoid-looking lesion in patients aged 12 years or older. Methods: This study included patients aged 12 years or older with symmetric, Spitzoid-looking lesions that were diagnosed histopathologically as Spitz nevus or melanoma. Demographic, clinical, and dermoscopic variables were included in the analysis. We used x 2 for nonparametric comparisons. Crude odds ratios and 95% confidence intervals were calculated by univariate logistic regression. Results: Of 384 included lesions, 333 (86.7%) were histopathologically diagnosed as Spitz nevus and 51 (13.3%) as melanoma. The risk of melanoma significantly increased with increasing age, being 50% or higher after the age of 50 years. Limitations: Limitations are retrospective design, exclusion of patients younger than 12 years, lack of detailed histopathologic data, and limited sample size. Conclusion: Our results confirm the observation that melanoma may be dermoscopically indistinguishable from Spitz nevi, strongly suggesting that the only safe strategy not to miss melanoma is to excise all Spitzoid-looking lesions in patients aged 12 years or older.	[Lallas, Aimilios; Moscarella, Elvira; Longo, Caterina; Kyrgidis, Athanassios; Argenziano, Giuseppe] IRCCS, Arcispedale Santa Maria Nuova, Skin Canc Unit, Reggio Emilia, Italy; [de Mestier, Yuka] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 1138654, Japan; [Vale, Gabrielle] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Guida, Stefania; Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy	Lallas, A (reprint author), Arcispedale Santa Maria Nuova IRCCS, Skin Canc Unit, Viale Risorgimento 80, I-42100 Reggio Emilia, Italy.	emlallas@gmail.com			Italian Ministry of Health [RF-2010-2316524]	Supported in part by the Italian Ministry of Health (RF-2010-2316524).	Gelbard SN, 2002, J AM ACAD DERMATOL, V47, P224, DOI 10.1067/mjd.2002.121031; Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Argenziano G, 2004, ARCH DERMATOL, V140, P1485, DOI 10.1001/archderm.140.12.1485; KERNEN JA, 1960, CANCER, V13, P612, DOI 10.1002/1097-0142(196005/06)13:3<612::AID-CNCR2820130324>3.0.CO;2-G; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Argenziano G, 2011, DERMATOLOGY, V222, P256, DOI 10.1159/000326109; Luo S, 2011, J AM ACAD DERMATOL, V65, P1087, DOI 10.1016/j.jaad.2011.06.045; Brunetti B, 2005, J EUR ACAD DERMATOL, V19, P391, DOI 10.1111/j.1468-3083.2004.01137.x; Joyce DP, 2013, SURG-J R COLL SURG E, V11, P205, DOI 10.1016/j.surge.2013.01.001; Tlougan BE, 2013, JAMA DERMATOL, V149, P283, DOI 10.1001/jamadermatol.2013.1124; Nino M, 2009, DERMATOLOGY, V218, P48, DOI 10.1159/000161120; Argenziano G, 1999, BRIT J DERMATOL, V141, P788, DOI 10.1046/j.1365-2133.1999.03150.x; Ferrara G, 2005, ARCH DERMATOL, V141, P1381, DOI 10.1001/archderm.141.11.1381; Argenziano G, 2007, J AM ACAD DERMATOL, V56, P508, DOI 10.1016/j.jaad.2006.10.029; SPITZ S, 1948, AM J PATHOL, V24, P591; Argenziano G, 2011, BRIT J DERMATOL, V164, P785, DOI 10.1111/j.1365-2133.2010.10194.x; Bär Michael, 2012, Dermatol Pract Concept, V2, P13, DOI 10.5826/dpc.0201a03.; Cesinaro AM, 2005, AM J DERMATOPATH, V27, P469, DOI 10.1097/01.dad.0000185249.21805.d3; Lallas A, 2013, DERMATOLOGY, V226, P52, DOI 10.1159/000346645; Paradela S, 2013, J EUR ACAD DERMATOL, V27, P1214, DOI 10.1111/j.1468-3083.2012.04686.x; Peris K, 2002, CLIN DERMATOL, V20, P259, DOI 10.1016/S0738-081X(02)00226-2; PETERS MS, 1986, HISTOPATHOLOGY, V10, P1289, DOI 10.1111/j.1365-2559.1986.tb02572.x; PIEPKORN M, 1995, J AM ACAD DERMATOL, V32, P248, DOI 10.1016/0190-9622(95)90135-3; Requena C, 2009, AM J DERMATOPATH, V31, P107, DOI 10.1097/DAD.0b013e3181934218; Schmoeckel C, 2007, J AM ACAD DERMATOL, V56, P753, DOI 10.1016/j.jaad.2006.11.037; STEINER A, 1992, J AM ACAD DERMATOL, V27, P697, DOI 10.1016/0190-9622(92)70240-G; Vollmer RT, 2004, AM J CLIN PATHOL, V121, P872, DOI 10.1309/E14CJ6KRD092DP3M; WEEDON D, 1977, CANCER, V40, P217, DOI 10.1002/1097-0142(197707)40:1<217::AID-CNCR2820400134>3.0.CO;2-2; Zalaudek I, 2013, J AM ACAD DERMATOL, V69, P56, DOI 10.1016/j.jaad.2012.12.974; Zalaudek I, 2010, J AM ACAD DERMATOL, V63, P361, DOI 10.1016/j.jaad.2009.11.698	30	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					47	53		10.1016/j.jaad.2014.09.037		7	Dermatology	Dermatology	AW6UU	WOS:000346404500029		
J	Ito, T; Wada, M; Nagae, K; Nakano-Nakamura, M; Nakahara, T; Hagihara, A; Furue, M; Uchi, H				Ito, Takamichi; Wada, Maiko; Nagae, Konosuke; Nakano-Nakamura, Misa; Nakahara, Takeshi; Hagihara, Akihito; Furue, Masutaka; Uchi, Hiroshi			Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy?	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Article						acral lentiginous melanoma; foot; hand; melanoma; nail; prognosis; sentinel lymph node biopsy	CUTANEOUS MELANOMA; PROGNOSTIC VALUE; THIN MELANOMA; FEATURES	Background: There are significant clinicopathological, genetic, and biological differences between acral lentiginous melanoma (ALM) and other types of melanoma. Objective: We sought to investigate the use of sentinel lymph node (SLN) biopsy for patients with ALM. Methods: This was a retrospective review of 116 patients with primary ALM. Melanoma-specific and disease-free survival were estimated using the Kaplan-Meier method, together with multivariate analyses using the Cox proportional hazards regression model. Results: All patients were Japanese (48 male and 68 female). Metastases in SLN were noted in 13 of 84 patients who underwent SLN biopsy. No patients with thin ALM (<= 1 mm) and only 2 patients with nonulcerated ALM had tumor-positive SLN. Patients with positive SLN had significantly shorter melanoma-specific survival (5-year survival rate, 37.5% vs 84.3%; P < .0001) and disease-free survival (5-year survival, 37.5% vs 77.9%; P = .0024). Among patients with thick (>1 mm) ALM, the influence of SLN positivity on melanoma-specific survival was increased (5-year survival, 22.7% vs 80.8%; P = .0005). Limitations: This was a retrospective study and had a small sample size. Conclusions: SLN biopsy should be considered for patients with thick or ulcerated ALM. For patients with thin or nonulcerated ones, it may be of limited importance.	[Ito, Takamichi; Wada, Maiko; Nagae, Konosuke; Nakano-Nakamura, Misa; Nakahara, Takeshi; Furue, Masutaka; Uchi, Hiroshi] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Hagihara, Akihito] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Fukuoka 8128582, Japan	Ito, T (reprint author), Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takamiti@dermatol.med.kyushu-u.ac.jp			National Cancer Center, Japan; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare, Japan	Supported in part by grants from the National Cancer Center, Japan, and the Ministry of Education, Culture, Sports, Science, and Technology, and the Ministry of Health, Labor, and Welfare, Japan.	Phan A, 2006, BRIT J DERMATOL, V155, P561, DOI 10.1111/j.1365-2133.2006.07368.x; Durbec F, 2012, BRIT J DERMATOL, V166, P727, DOI 10.1111/j.1365-2133.2011.10772.x; Wright BE, 2008, ARCH SURG-CHICAGO, V143, P892, DOI 10.1001/archsurg.143.9.892; Mozzillo N, 2013, ANN SURG ONCOL, V20, P2780, DOI 10.1245/s10434-012-2826-0; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Coit DG, 2013, J NATL COMPR CANC NE, V11, P395; Ito T, 2012, MELANOMA RES, V22, P38, DOI 10.1097/CMR.0b013e32834dcfdf; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Chang JWC, 2004, MELANOMA RES, V14, P537, DOI 10.1097/00008390-200412000-00016; Ranieri JM, 2006, ANN SURG ONCOL, V13, P927, DOI 10.1245/ASO.2006.04.023; Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609; Murali R, 2012, ANN SURG, V255, P128, DOI 10.1097/SLA.0b013e3182306c72; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Gajdos C, 2009, CANCER, V115, P5752, DOI 10.1002/cncr.24660; Muller MGS, 2001, CANCER, V91, P2401; Cochran Alistair J, 2003, Int J Clin Oncol, V8, P139; Egger ME, 2012, AM J SURG, V204, P874, DOI 10.1016/j.amjsurg.2012.05.013; Jung HJ, 2013, JAMA DERMATOL, V149, P1281, DOI 10.1001/jamadermatol.2013.5853; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Nagore E, 2014, J AM ACAD DERMATOL, V70, P858, DOI 10.1016/j.jaad.2013.10.064; Nagore E, 2009, CANCER CAUSE CONTROL, V20, P115, DOI 10.1007/s10552-008-9221-y; Phan A, 2007, BRIT J DERMATOL, V157, P311, DOI 10.1111/j.1365-2133.2007.08031.x; Reed RJ, 1976, NEW CONCEPTS SURG PA	24	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					71	77		10.1016/j.jaad.2014.10.008		7	Dermatology	Dermatology	AW6UU	WOS:000346404500032		
J	Murrell, DF; Marinovic, B; Caux, F; Prost, C; Ahmed, R; Wozniak, K; Amagai, M; Bauer, J; Beissert, S; Borradori, L; Culton, D; Fairley, JA; Fivenson, D; Jonkman, MF; Marinkovich, MP; Woodley, D; Zone, J; Aoki, V; Bernard, P; Bruckner-Tuderman, L; Cianchini, G; Venning, V; Diaz, L; Eming, R; Grando, SA; Hall, RP; Hashimoto, T; Herrero-Gonzalez, JE; Hertl, M; Joly, P; Karpati, S; Kim, J; Kim, SC; Korman, NJ; Kowalewski, C; Lee, SE; Rubenstein, DR; Sprecher, E; Yancey, K; Zambruno, G; Zillikens, D; Doan, S; Daniel, BS; Werth, VP				Murrell, Dedee F.; Marinovic, Branka; Caux, Frederic; Prost, Catherine; Ahmed, Razzaque; Wozniak, Katarzyna; Amagai, Masayuki; Bauer, Johann; Beissert, Stefan; Borradori, Luca; Culton, Donna; Fairley, Janet A.; Fivenson, David; Jonkman, Marcel F.; Marinkovich, M. Peter; Woodley, David; Zone, John; Aoki, Valeria; Bernard, Philippe; Bruckner-Tuderman, Leena; Cianchini, Giuseppe; Venning, Vanessa; Diaz, Luis; Eming, Rudiger; Grando, Sergei A.; Hall, Russell P.; Hashimoto, Takashi; Herrero-Gonzalez, Josep E.; Hertl, Michael; Joly, Pascal; Karpati, Sarolta; Kim, Jaehwan; Kim, Soo Chan; Korman, Neil J.; Kowalewski, Cezary; Lee, Sang Eun; Rubenstein, David R.; Sprecher, Eli; Yancey, Kim; Zambruno, Giovanna; Zillikens, Detlef; Doan, Serge; Daniel, Benjamin S.; Werth, Victoria P.			Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Review						consensus; definitions; mucous membrane pemphigoid; outcome measures; severity score	CONSENSUS; DISEASE	Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.	[Murrell, Dedee F.; Kim, Jaehwan; Daniel, Benjamin S.] Univ New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2317, Australia; [Marinovic, Branka] Univ Zagreb, Dept Dermatol & Venereol, Hosp Ctr & Sch Med, Zagreb 41000, Croatia; [Caux, Frederic] Univ Paris 13, Dept Dermatol, Avicenne Hosp, Bobigny, France; [Prost, Catherine] Univ Paris 13, Dept Dermatol, Dept Histol, Reference Ctr Autoimmune Bullous Dis,Avicenne Hos, Bobigny, France; [Ahmed, Razzaque] Ctr Blistering Dis, Boston, MA USA; [Wozniak, Katarzyna; Kowalewski, Cezary] Med Univ Warsaw, Dept Dermatol & Immunodermatol, Warsaw, Poland; [Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Bauer, Johann] Paracelsus Med Univ Salzburg, Div Mol Dermatol, Dept Dermatol, Salzburg, Austria; [Beissert, Stefan] Univ Dresden, Dept Dermatol, Dresden, Germany; [Borradori, Luca] Univ Hosp Bern, Dept Dermatol, Bern, Switzerland; [Culton, Donna; Diaz, Luis; Rubenstein, David R.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27515 USA; [Fairley, Janet A.] Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA; [Fairley, Janet A.] Dept Vet Affairs Med Ctr, Palo Alto, CA USA; [Fivenson, David] St Joseph Mercy Hlth Syst, Dept Dermatol, Ann Arbor, MI USA; [Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Marinkovich, M. Peter] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Marinkovich, M. Peter] Dept Vet Affairs Palo Alto Healthcare Syst, Ctr Clin Sci Res, Palo Alto, CA USA; [Marinkovich, M. Peter] Dept Vet Affairs Palo Alto Healthcare Syst, Div Dermatol, Palo Alto, CA USA; [Woodley, David] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Zone, John] Univ Utah, Dept Dermatol, Sch Med, Salt Lake City, UT 84112 USA; [Aoki, Valeria] Univ Sao Paulo, Dept Dermatol, BR-05508 Sao Paulo, Brazil; [Bernard, Philippe] Univ Champagne Ardenne, Reims Univ Hosp, Dept Dermatol, Reims, France; [Bruckner-Tuderman, Leena] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany; [Cianchini, Giuseppe; Zambruno, Giovanna] IRCCS, Ist Dermopat Immacolata, Dept Immunodermatol, Rome, Italy; [Cianchini, Giuseppe] IRCCS, Ist Dermopat Immacolata, Lab Mol & Cell Biol, Rome, Italy; [Venning, Vanessa] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England; [Eming, Rudiger] Univ Marburg, Dept Dermatol & Allergol, Univ Hosp, D-35032 Marburg, Germany; [Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Ctr Canc, Irvine, CA 92717 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Res Inst, Irvine, CA 92717 USA; [Hall, Russell P.] Duke Med Ctr, Div Dermatol, Durham, NC USA; [Hashimoto, Takashi] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan; [Herrero-Gonzalez, Josep E.] Inst Hosp Mar Invest Med, Hosp del Mar, Dept Dermatol, Barcelona, Spain; [Hertl, Michael] Univ Hosp, Dept Dermatol, Marburg, Germany; [Joly, Pascal] Rouen Univ Hosp, INSERM U905, INSERM, Dermatol Clin, Rouen, France; [Joly, Pascal] Univ Rouen, Dept Dermatol, Rouen Univ Hosp, F-76821 Mont St Aignan, France; [Karpati, Sarolta] Semmelweis Univ, Dept Dermatol Venereol & Dermatooncol, H-1085 Budapest, Hungary; [Kim, Jaehwan] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Kim, Soo Chan] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Dermatol, Seoul, South Korea; [Kim, Soo Chan] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea; [Korman, Neil J.] Univ Hosp Case Med Ctr, Dept Dermatol, Cleveland, OH USA; [Korman, Neil J.] Univ Hosp Case Med Ctr, Murdough Family Ctr Psoriasis, Cleveland, OH USA; [Lee, Sang Eun] CHA Univ, Dept Dermatol, CHA Bundang Med Ctr, Songnam, South Korea; [Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, Tel Aviv, Israel; [Yancey, Kim] Univ Texas Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA; [Zillikens, Detlef] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Doan, Serge] Hop Bichat Claude Bernard, Dept Ophthalmol, Paris, France; [Doan, Serge] Fdn Adolphe De Rothschild, Paris, France; [Werth, Victoria P.] Univ Penn, Philadelphia Dept Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Werth, Victoria P.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Murrell, DF (reprint author), Univ New S Wales, St George Hosp, Dept Dermatol, Gray St,N8W, Sydney, NSW 2317, Australia.	d.murrell@unsw.edu.au	Aoki, Valeria/H-1415-2012; Amagai, Masayuki/K-5325-2013; Aoki, Valeria/J-2020-2015; 	Aoki, Valeria/0000-0002-9895-574X; Marinovic, Branka/0000-0001-8441-5016	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development); National Institutes of Health [NIH K24-AR 02207]	The International Pemphigus and Pemphigoid Foundation generously supported hiring rooms at the Annual Meetings of the American Academy of Dermatology and European Academy of Dermatology and Venereology as well as audiovisual equipment and open access. The Korean World Congress Committee and the Society for Investigative Dermatology provided meeting rooms. This material is based on work supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) and by the National Institutes of Health (NIH K24-AR 02207) to Dr Werth.	Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Munyangango EM, 2013, BRIT J DERMATOL, V168, P381, DOI 10.1111/bjd.12041; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; Patsatsi A, 2014, ACTA DERM-VENEREOL, V94, P203, DOI 10.2340/00015555-1666; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; Murrell DF, 2012, J AM ACAD DERMATOL, V66, P479, DOI 10.1016/j.jaad.2011.06.032; Escudier M, 2007, BRIT J DERMATOL, V157, P765, DOI 10.1111/j.1365-2133.2007.08106.x; Foster C S, 1986, Trans Am Ophthalmol Soc, V84, P527; Kirtschig G, 2003, COCHRANE DB SYST REV, V1	9	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					168	174		10.1016/j.jaad.2014.08.024		7	Dermatology	Dermatology	AW6UU	WOS:000346404500046		
J	Tamagawa-Mineoka, R; Teramukai, S; Katoh, N				Tamagawa-Mineoka, Risa; Teramukai, Satoshi; Katoh, Norito			Response to "Statistical comments on 'Increased serum levels of interleukin 33 in patients with atopic dermatitis'"	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Letter									[Tamagawa-Mineoka, Risa; Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto 6028566, Japan; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biostat, Kyoto 6028566, Japan	Tamagawa-Mineoka, R (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	risat@koto.kpu-m.ac.jp					Tamagawa-Mineoka R, 2014, J AM ACAD DERMATOL, V70, P882, DOI 10.1016/j.jaad.2014.01.867	1	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					200	200		10.1016/j.jaad.2014.09.026		1	Dermatology	Dermatology	AW6UU	WOS:000346404500061		
J	Kobayashi, K; Sumikawa, Y; Kikuchi, Y; Kan, Y; Kato, J; Satomi, F; Shima, H; Kutomi, G; Yamashita, T				Kobayashi, Keiju; Sumikawa, Yasuyuki; Kikuchi, Yumiko; Kan, Yuji; Kato, Junji; Satomi, Fukino; Shima, Hiroaki; Kutomi, Goro; Yamashita, Toshiharu			Synchronous Paget disease of the breast and axilla	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Letter							PRECURSORS; TOKER; CELLS		[Kobayashi, Keiju; Sumikawa, Yasuyuki; Kikuchi, Yumiko; Kan, Yuji; Kato, Junji; Yamashita, Toshiharu] Sapporo Med Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608543, Japan; [Satomi, Fukino; Shima, Hiroaki; Kutomi, Goro] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido 0608543, Japan	Kobayashi, K (reprint author), Sapporo Med Univ, Sch Med, Dept Dermatol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	k.kobayashi@sapmed.ac.jp					Willman JH, 2005, AM J DERMATOPATH, V27, P185, DOI 10.1097/01.dad.0000158291.20440.13; Eusebi V, 2003, PATHOLOGY GENETICS T, P104; Marucci G, 2002, VIRCHOWS ARCH, V441, P117, DOI 10.1007/s00428-001-0581-x; Montgomery H, 1967, DERMATOPATHOLOGY, V1, P1007; Montgomery H, 1967, DERMATOPATHOLOGY, V2, P1007; Schelfhout VRJ, 2000, J NATL CANCER I, V92, P622, DOI 10.1093/jnci/92.8.622	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					E44	E45		10.1016/j.jaad.2014.09.053		3	Dermatology	Dermatology	AW6UU	WOS:000346404500025		
J	Matsumoto, T; Yokota, K; Sawada, M; Hasegawa, Y; Takeuchi, A; Kono, M; Akiyama, M				Matsumoto, Takaaki; Yokota, Kenji; Sawada, Masaki; Hasegawa, Yoshie; Takeuchi, Aya; Kono, Michihiro; Akiyama, Masashi			Large epidermal cleft formation in verrucous-keratotic malignant melanoma of the heel	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Letter							CONSUMPTION		[Matsumoto, Takaaki; Yokota, Kenji; Sawada, Masaki; Hasegawa, Yoshie; Takeuchi, Aya; Kono, Michihiro; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4668550, Japan	Matsumoto, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tmatsumoto@med.nagoya-u.ac.jp					Braun-Falco M, 2005, HUM PATHOL, V36, P412, DOI 10.1016/j.humpath.2005.02.005; CLARK WH, 1969, CANCER RES, V29, P705; Hantschke M, 2004, AM J SURG PATHOL, V28, P1621, DOI 10.1097/00000478-200412000-00011; Ohata C, 2012, J CUTAN PATHOL, V39, P577, DOI 10.1111/j.1600-0560.2012.01914.x; Silye R, 1998, J PATHOL, V186, P350, DOI 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JAN	2015	72	1					E37	E38		10.1016/j.jaad.2014.09.044		3	Dermatology	Dermatology	AW6UU	WOS:000346404500021		
J	Kim, H; Suzuki, T; Kim, M; Kojima, N; Yoshida, Y; Hirano, H; Saito, K; Iwasa, H; Shimada, H; Hosoi, E; Yoshida, H				Kim, Hunkyung; Suzuki, Takao; Kim, Miji; Kojima, Narumi; Yoshida, Yuko; Hirano, Hirohiko; Saito, Kyoko; Iwasa, Hajime; Shimada, Hiroyuki; Hosoi, Erika; Yoshida, Hideyo			Incidence and Predictors of Sarcopenia Onset in Community-Dwelling Elderly Japanese Women: 4-Year Follow-Up Study	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Sarcopenia; incidence; predictor; elderly women	CHRONIC KIDNEY-DISEASE; BODY-COMPOSITION; PHYSICAL FUNCTION; OLDER-ADULTS; SKELETAL-MUSCLE; RISK-FACTORS; CYSTATIN-C; DIAGNOSTIC-CRITERIA; MOBILITY DISABILITY; SERUM-ALBUMIN	Objectives: Several studies have explored the prevalence and risk factors of sarcopenia, but they have been based on cross-sectional data. The objective of this study was to determine the incidence and predictors of the onset of sarcopenia over 4 years in community-dwelling elderly women. Design: Four-year longitudinal follow-up study. Setting: Urban community in Tokyo, Japan. Participants: A total of 538 nonsarcopenic women older than 75 years. Measurements: Body composition was determined by bioelectrical impedance analysis. Functional fitness measurements, including grip strength, usual walking speed, timed up and go (TUG), and interview surveys were conducted at baseline and 4-year follow-up. Blood samples were obtained to analyze serum albumin and hemoglobin A1c, and kidney function was analyzed using serum creatinine and cystatin C. Sarcopenia was defined based on the criteria suggested by the European Working Group on Sarcopenia in Older People, and the development of all stages, that is, presarcopenia, sarcopenia, and severe sarcopenia as well as the components of sarcopenia skeletal muscle index (SMI), grip strength, and walking speed, were analyzed. Results: The incidence of total sarcopenia was 39.6% (presarcopenia 23.8%, sarcopenia 11.2%, severe sarcopenia 4.6%). Older age was significantly predictive of the development of presarcopenia and severe sarcopenia. Body mass index (BMI) lower than 21.0 kg/m(2) was significantly predictive of the development of all stages of sarcopenia, as well as declines in SMI, grip strength, and walking speed. Slow TUG was a predictor of the development of presarcopenia and severe sarcopenia. Increased calf circumference showed protective effects from the development of all stages of sarcopenia. Greater albumin levels also showed lower risk of declines in SMI, walking speed, and development of presarcopenia. Cystatin C was positively associated with the development of severe sarcopenia (odds ratio 1.83, 95% confidence interval 1.08-3.12). Heart disease and hyperlipidemia history were associated with presarcopenia and sarcopenia, respectively. Conclusion: Age, BMI, calf circumference, and TUG were consistent predictors of the various stages and components of sarcopenia. The data also suggest that cystatin C was associated with higher odds of incident severe sarcopenia, and further study into kidney function and onset of sarcopenia in large populations is needed. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Kim, Hunkyung; Kim, Miji; Kojima, Narumi; Yoshida, Yuko; Hirano, Hirohiko; Saito, Kyoko; Hosoi, Erika; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan; [Suzuki, Takao; Shimada, Hiroyuki] Natl Inst Longev Sci, Obu, Aichi, Japan; [Iwasa, Hajime] Fukushima Med Univ, Sch Med, Fukushima, Japan	Kim, H (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	kimhk@tmig.or.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science [22300243]	This study was funded by a research grant of the Ministry of Health, Labour and Welfare of Japan and a Grant-in-Aid for Scientific Research B of the Japan Society for the Promotion of Science (22300243).	Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Shumway-Cook A, 2000, PHYS THER, V80, P896; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Odden MC, 2006, AM J EPIDEMIOL, V164, P1180, DOI 10.1093/aje/kwj333; Bijlsma AY, 2014, AGE, V36, P275, DOI 10.1007/s11357-013-9556-5; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Landi F, 2012, J GERONTOL A-BIOL, V67, P48, DOI 10.1093/gerona/glr035; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Figueiredo CP, 2014, OSTEOPOROSIS INT, V25, P589, DOI 10.1007/s00198-013-2455-x; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ikizler TA, 1996, KIDNEY INT, V50, P343, DOI 10.1038/ki.1996.323; Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Schalk BWM, 2005, J AM GERIATR SOC, V53, P1331, DOI 10.1111/j.1532-5415.2005.53417.x; Fried LF, 2007, J AM GERIATR SOC, V55, P1578, DOI 10.1111/j.1532-5415.2007.01398.x; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Hida T, 2014, AGING DIS, V5, P226, DOI 10.14336/AD.2014.0500226; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; Liu CK, 2014, J GERONTOL A-BIOL, V69, P301, DOI 10.1093/gerona/glt096; Rosenberg I, 1989, AM J CLIN NUTR, V50, P3; Shin H, 2011, J AGING RES, DOI [10.4061/2011/191896, DOI 10.4061/2011/191896, 10.4061/2011/19189621318048]; Tanaka M, 2004, CLIN BIOCHEM, V37, P27, DOI 10.1016/j.clinbiochem.2003.08.001	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	JAN 1	2015	16	1							85.e1	10.1016/j.jamda.2014.10.006		8	Geriatrics & Gerontology	Geriatrics & Gerontology	AW9PQ	WOS:000346589900021		
J	Kawashima, R; Hiller, DL; Sereda, SL; Antonczak, M; Serger, K; Gannon, D; Ito, S; Otake, H; Yunomae, D; Kobayashi, A; Muller, C; Murata, H; FallCreek, S				Kawashima, Ryuta; Hiller, Deborah Lewis; Sereda, Sheryl L.; Antonczak, Michelle; Serger, Kara; Gannon, Denise; Ito, Shinji; Otake, Hiroshi; Yunomae, Daisaku; Kobayashi, Akihito; Muller, Christopher; Murata, Hiroyuki; FallCreek, Stephanie			SAIDO Learning as a Cognitive Intervention for Dementia Care: A Preliminary Study	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Cognitive intervention; Alzheimer disease; working memory training	RANDOMIZED CONTROLLED-TRIAL; ALZHEIMER-DISEASE; OLDER-ADULTS; THERAPIES; PROGRAM; PEOPLE; STATE	Objectives: The purpose of this study was to examine the beneficial effects on cognitive function by a cognitive intervention program designed for dementia care called Learning Therapy in Japan and SAIDO Learning in the United States (hereinafter "SAIDO Learning," as appropriate). SAIDO Learning is a working memory training program that uses systematized basic problems in arithmetic and language, including reading aloud, as well as writing. Design, Setting, Participants, and Intervention: Twenty-three nursing home residents with dementia were assigned as an intervention group, and another 24 people with dementia at another nursing home were assigned as a control group. Both nursing homes were operated by the same organization, and residents of both nursing homes received essentially the same nursing care. Thirteen and 6 subjects of the intervention and control groups, respectively, were clinically diagnosed as Alzheimer disease (AD). Results: After the 6-month intervention, the participants with AD of the intervention group showed statistically significant improvement in cognitive function, as measured by the Mini-Mental State Examination (MMSE) compared with the control participants. In addition, post hoc analysis revealed that the Frontal Assessment Battery at Bedside (FAB) scores of the intervention group tended to improve after 6-month intervention. Based on MDS scores, improvements in total mood severity scores also were observed, but only in the intervention group of the participants with AD. Conclusion: These results suggest that SAIDO Learning is an effective cognitive intervention and is useful for dementia care. An additional outcome of this intervention, which has not yet been evaluated in detail, appears to be that it promotes greater positive engagement of a diversity of nursing home staff in the residents' individual progress and care needs. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Kawashima, Ryuta; Murata, Hiroyuki] Tohoku Univ, IDAC, Smart Ageing Int Res Ctr, Sendai, Miyagi 9808575, Japan; [Hiller, Deborah Lewis; Sereda, Sheryl L.; Antonczak, Michelle; Serger, Kara; Gannon, Denise] Eliza Jennings Senior Care Network, Cleveland, OH USA; [Ito, Shinji; Otake, Hiroshi; Yunomae, Daisaku; Kobayashi, Akihito; Muller, Christopher] Kumon Educ Japan, Kumon Learning Therapy Ctr, Tokyo, Japan; [FallCreek, Stephanie] Fairhill Partners, Cleveland, OH USA	Kawashima, R (reprint author), Tohoku Univ, IDAC, Aoba Ku, 4-1 Seiryocho, Sendai, Miyagi 9808575, Japan.	ryuta@idac.tohoku.ac.jp			RISTEX, JST, Tokyo, Japan	This study was funded by RISTEX, JST, Tokyo, Japan.	Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Clark F, 1997, JAMA-J AM MED ASSOC, V278, P1321, DOI 10.1001/jama.278.16.1321; Moore S, 2001, NEUROPSYCHOL REHABIL, V11, P245; Hopper T, 2013, AM J SPEECH-LANG PAT, V22, P126, DOI 10.1044/1058-0360(2012/11-0137); [Anonymous], 2013, WORLD ALZH REP 2013; Olazaran J, 2004, NEUROLOGY, V63, P2348; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Dubois B, 2000, NEUROLOGY, V55, P1621; Spector A, 2001, NEUROPSYCHOL REHABIL, V11, P377; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Arkin SM, 1991, AM J ALZHEIMERS CARE, V6, P17, DOI 10.1177/153331759100600404; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kawashima R, 2005, J GERONTOL A-BIOL, V60A, P426; Kawashima Ryuta, 2013, J Prev Med Public Health, V46 Suppl 1, pS22, DOI 10.3961/jpmph.2013.46.S.S22; Perrig W. J., 2009, J COGNITIVE ED PSYCH, V8, P148, DOI DOI 10.1891/1945-8959.8.2.148; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P3646, DOI 10.1002/hbm.22427; Uchida S, 2008, AGE, V30, P21, DOI 10.1007/s11357-007-9044-x; Woods B., 2005, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001120.PUB2	23	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	JAN 1	2015	16	1					56	62		10.1016/j.jamda.2014.10.021		7	Geriatrics & Gerontology	Geriatrics & Gerontology	AW9PQ	WOS:000346589900013		
J	Chen, CY; Matsumoto, K; Nohira, T; Hagiwara, R				Chen, Chih-Yao; Matsumoto, Kazuhiko; Nohira, Toshiyuki; Hagiwara, Rika			Full Utilization of Superior Charge-Discharge Characteristics of Na1.56Fe1.22P2O7 Positive Electrode by Using Ionic Liquid Electrolyte	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							SODIUM RECHARGEABLE BATTERIES; PYROPHOSPHATE CATHODE; ELECTROCHEMICAL PERFORMANCE; 3-DIMENSIONAL VISUALIZATION; ROOM-TEMPERATURE; NA; LITHIUM; NA2FEP2O7; NA3V2(PO4)3; CRYSTAL	Na1.56Fe1.22P2O7 was synthesized via a conventional solid-state method and evaluated as a positive electrode for Na secondary batteries using Na[FSA]-[C(3)C(1)pyrr][FSA] (C(3)C(1)pyrr = N-methyl-N-propylpyrrolidinium and FSA = bis(fluorosulfonyl)amide) ionic liquids (IL) as electrolytes, over the temperature range of 298-363 K. A reversible capacity as high as 108 mAh g(-1) has been achieved for the first time with a thermally stable IL at 363 K. This value is close to the theoretically calculated capacity of 118 mAh g(-1) and is significantly higher than the previously reported values of ca. 85 mAh g(-1) in organic electrolytes at 298 K. The capacity of 108 mAh g(-1) also exceeds the value obtained for Na2FeP2O7 electrodes (94 mAh g(-1)) under the same experimental conditions. Moreover, excellent rate capability and superior cyclability exceeding 3000 cycles have been achieved by using the IL electrolyte over a wide temperature range of 298-363 K. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License (CC BY-NC-ND, http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is not changed in any way and is properly cited. For permission for commercial reuse, please email: oa@electrochem.org. All rights reserved.	[Chen, Chih-Yao; Matsumoto, Kazuhiko; Nohira, Toshiyuki; Hagiwara, Rika] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Chen, CY (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	nohira@energy.kyoto-u.ac.jp; hagiwara@energy.kyoto-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Elements Strategy Initiative to Form Core Research Center"	This study was partly supported by Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST) and Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Elements Strategy Initiative to Form Core Research Center".	ANGENAULT J, 1995, EUR J SOL STATE INOR, V32, P335; Park CS, 2013, J AM CHEM SOC, V135, P2787, DOI 10.1021/ja312044k; Islam MS, 2014, CHEM SOC REV, V43, P185, DOI 10.1039/c3cs60199d; Clark JM, 2014, J MATER CHEM A, V2, P11807, DOI 10.1039/c4ta02383h; Barpanda P, 2013, CHEM MATER, V25, P3480, DOI 10.1021/cm401657c; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Vassilaras P, 2013, J ELECTROCHEM SOC, V160, pA207, DOI 10.1149/2.023302jes; Billaud J, 2014, ENERG ENVIRON SCI, V7, P1387, DOI 10.1039/c4ee00465e; Barpanda P, 2013, J MATER CHEM A, V1, P4194, DOI 10.1039/c3ta10210f; Ding CS, 2013, J POWER SOURCES, V238, P296, DOI 10.1016/j.jpowsour.2013.03.089; Chen CY, 2014, ELECTROCHIM ACTA, V133, P583, DOI 10.1016/j.electacta.2014.04.038; Palomares V, 2013, ENERG ENVIRON SCI, V6, P2312, DOI 10.1039/c3ee41031e; Wongittharom N, 2014, J MATER CHEM A, V2, P5655, DOI 10.1039/c3ta15273a; Wongittharom N, 2014, J MATER CHEM A, V2, P3613, DOI 10.1039/c3ta14423b; Kim SW, 2012, ADV ENERGY MATER, V2, P710, DOI 10.1002/aenm.201200026; MacFarlane DR, 2014, ENERG ENVIRON SCI, V7, P232, DOI 10.1039/c3ee42099j; Yabuuchi N, 2012, NAT MATER, V11, P512, DOI [10.1038/nmat3309, 10.1038/NMAT3309]; Kobayashi G, 2009, ADV FUNCT MATER, V19, P395, DOI 10.1002/adfm.200801522; Barpanda P, 2013, RSC ADV, V3, P3857, DOI 10.1039/c3ra23026k; Barpanda P, 2012, ELECTROCHEM COMMUN, V24, P116, DOI 10.1016/j.elecom.2012.08.028; Casas-Cabanas M, 2012, J MATER CHEM, V22, P17421, DOI 10.1039/c2jm33639a; Honma T, 2013, J POWER SOURCES, V227, P31, DOI 10.1016/j.jpowsour.2012.11.030; Chen CY, 2014, J POWER SOURCES, V246, P783, DOI 10.1016/j.jpowsour.2013.08.027; Jian ZL, 2013, ADV ENERGY MATER, V3, P156, DOI 10.1002/aenm.201200558; Kim H, 2012, J AM CHEM SOC, V134, P10369, DOI 10.1021/ja3038646; Ha KH, 2013, ADV ENERGY MATER, V3, P770, DOI 10.1002/aenm.201200825; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Izumi F, 2007, SOL ST PHEN, V130, P15; Monti D, 2014, J POWER SOURCES, V245, P630, DOI 10.1016/j.jpowsour.2013.06.153; Tripathi R, 2013, ENERG ENVIRON SCI, V6, P2257, DOI 10.1039/c3ee40914g; Komaba S, 2012, INORG CHEM, V51, P6211, DOI 10.1021/ic300357d; Kim H, 2013, ADV FUNCT MATER, V23, P1147, DOI 10.1002/adfm.201201589; Serras P, 2013, CHEM MATER, V25, P4917, DOI 10.1021/cm403679b; Saravanan K, 2013, ADV ENERGY MATER, V3, P444, DOI 10.1002/aenm.201200803; Berthelot R, 2011, NAT MATER, V10, P74, DOI [10.1038/nmat2920, 10.1038/NMAT2920]; Martin JF, 2008, ELECTROCHEM SOLID ST, V11, pA12, DOI 10.1149/1.2801016; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592	37	2	2	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					A176	A180		10.1149/2.0931501jes		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700011		
J	Hasegawa, G; Kitada, A; Kawasaki, S; Kanamori, K; Nakanishi, K; Kobayashi, Y; Kageyama, H; Abe, T				Hasegawa, George; Kitada, Atsushi; Kawasaki, Shota; Kanamori, Kazuyoshi; Nakanishi, Kazuki; Kobayashi, Yoji; Kageyama, Hiroshi; Abe, Takeshi			Impact of Electrolyte on Pseudocapacitance and Stability of Porous Titanium Nitride (TiN) Monolithic Electrode	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							CHARGE STORAGE MECHANISM; DOUBLE-LAYER CAPACITANCE; RAY PHOTOELECTRON-SPECTROSCOPY; ELECTROCHEMICAL CAPACITORS; PROPYLENE CARBONATE; THERMAL-OXIDATION; ACTIVATED CARBONS; LI-O-2 BATTERIES; PHASE-SEPARATION; ION TRANSFER	We report the fabrication of porous titanium nitride (TiN) monoliths through the ammonolysis of porous TiO2 monoliths prepared via the sol-gel process accompanied by phase separation. The obtained TiN monoliths possess good mechanical strength as well as excellent electric conductivity with a superconducting transition at T-c similar to 5.0 K. We have investigated the electrochemical properties of the porous TiN monoliths as an electrode using various electrolytes. The results reveal that the pseudocapacitance of TiN increases in the order of K+ < Na+ < Li+ contrary to the case of EDL capacitance in neutral aqueous electrolytes. It is also found that acidic and strongly basic electrolytes are not suitable due to high corrosivity, while there is no significant deterioration when neutral aqueous electrolytes and organic electrolytes are used. (C) 2014 The Electrochemical Society. All rights reserved.	[Hasegawa, George; Kitada, Atsushi; Kawasaki, Shota; Kobayashi, Yoji; Kageyama, Hiroshi; Abe, Takeshi] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Katsura, Kyoto 6158510, Japan; [Kitada, Atsushi] Kyoto Univ, Grad Sch Engn, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Kanamori, Kazuyoshi; Nakanishi, Kazuki] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Kageyama, Hiroshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Hasegawa, G (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Katsura, Kyoto 6158510, Japan.	h-george@elech.kuic.kyoto-u.ac.jp	Hasegawa, George/A-1653-2014; Kanamori, Kazuyoshi/A-5561-2011; Nakanishi, Kazuki/A-1814-2012; Kageyama, Hiroshi/A-4602-2010; Abe, Takeshi/F-2544-2010; Kitada, Atsushi/H-5819-2015		MEXT [22750203]; CREST, JSPS KAKENHI [26810123]; JSPS from Japan Society for the Promotion of Science (JSPS) [24 . 31]	This work was supported by Grant-in-Aid for Research Activity (No. 22750203) from MEXT, by CREST, JSPS KAKENHI Grant Number 26810123 and from JSPS Fellows (No. 24 . 31 for G.H.) from the Japan Society for the Promotion of Science (JSPS). Authors George Hasegawa and Atsushi Kitada contributed equally to this work.	STOKES RH, 1948, J AM CHEM SOC, V70, P1870, DOI 10.1021/ja01185a065; Avasarala B, 2010, ELECTROCHIM ACTA, V55, P9024, DOI 10.1016/j.electacta.2010.08.035; RITZOULIS G, 1986, J CHEM ENG DATA, V31, P146, DOI 10.1021/je00044a004; Ma RZ, 2005, J PHYS CHEM B, V109, P6210, DOI 10.1021/jp044282r; Feng G, 2010, PHYS CHEM CHEM PHYS, V12, P5468, DOI 10.1039/c000451k; Liang CH, 2010, J ALLOY COMPD, V500, P102, DOI 10.1016/j.jallcom.2010.04.001; Salitra G, 2000, J ELECTROCHEM SOC, V147, P2486, DOI 10.1149/1.1393557; Shiraishi S, 2002, J ELECTROCHEM SOC, V149, pA855, DOI 10.1149/1.1481525; Toupin M, 2004, CHEM MATER, V16, P3184, DOI 10.1021/cm049649j; Wen S, 2004, ELECTROCHIM ACTA, V50, P849, DOI 10.1016/j.electacta.2004.02.056; Lu XH, 2012, NANO LETT, V12, P5376, DOI 10.1021/nl302761z; Zukalova M, 2010, CHEM MATER, V22, P4045, DOI 10.1021/cm100877h; Li FJ, 2013, CHEM COMMUN, V49, P1175, DOI 10.1039/c2cc37042e; Nakayama N, 2007, J POWER SOURCES, V174, P695, DOI 10.1016/j.jpowsour.2007.06.113; SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465; Wang YR, 2012, J MATER CHEM, V22, P15549, DOI 10.1039/c2jm32681g; Lee KT, 2005, ADV FUNCT MATER, V15, P547, DOI 10.1002/adfm.200400186; ERNSBERGER C, 1986, J VAC SCI TECHNOL A, V4, P2784, DOI 10.1116/1.573679; Ponrouch A, 2012, ENERG ENVIRON SCI, V5, P8572, DOI 10.1039/c2ee22258b; Hasegawa G, 2011, J MATER CHEM, V21, P2060, DOI 10.1039/c0jm03793a; Brun N, 2009, ADV FUNCT MATER, V19, P3136, DOI 10.1002/adfm.200900749; OWEN BB, 1961, J PHYS CHEM-US, V65, P2065, DOI 10.1021/j100828a035; Lin R, 2009, J ELECTROCHEM SOC, V156, pA7, DOI 10.1149/1.3002376; Hasegawa G, 2010, J AM CERAM SOC, V93, P3110, DOI 10.1111/j.1551-2916.2010.03831.x; Park J, 2013, CHEM MATER, V25, P3779, DOI 10.1021/cm401794r; Konishi J, 2006, CHEM MATER, V18, P6069, DOI 10.1021/cm0617485; Nakanishi K, 1997, J POROUS MAT, V4, P67, DOI 10.1023/A:1009627216939; Jamnik J, 2003, PHYS CHEM CHEM PHYS, V5, P5215, DOI 10.1039/b309130a; Shi H, 1996, ELECTROCHIM ACTA, V41, P1633, DOI 10.1016/0013-4686(95)00416-5; Xu CJ, 2011, J POWER SOURCES, V196, P7854, DOI 10.1016/j.jpowsour.2011.04.052; MILOSEV I, 1995, SURF INTERFACE ANAL, V23, P529, DOI 10.1002/sia.740230713; Reddy RN, 2006, J POWER SOURCES, V156, P700, DOI 10.1016/j.jpowsour.2005.05.071; Drygas M, 2006, CHEM MATER, V18, P3122, DOI 10.1021/cm060522z; Milosev I, 1997, THIN SOLID FILMS, V303, P246, DOI 10.1016/S0040-6090(97)00069-2; Li GR, 2010, ANGEW CHEM INT EDIT, V49, P3653, DOI 10.1002/anie.201000659; Barbieri O, 2005, CARBON, V43, P1303, DOI 10.1016/j.carbon.2005.01.001; Chowdhury R, 1996, J MATER RES, V11, P1458, DOI 10.1557/JMR.1996.0182; Walsh FC, 2010, ELECTROCHIM ACTA, V55, P6342, DOI 10.1016/j.electacta.2010.05.011; Caballero A, 1996, SURF SCI, V364, P253, DOI 10.1016/0039-6028(96)00659-0; Choi D, 2006, J ELECTROCHEM SOC, V153, pA2298, DOI 10.1149/1.2359692; Dong SM, 2011, ACS APPL MATER INTER, V3, P93, DOI 10.1021/am100951h; ERDEMIR A, 1985, MATER SCI ENG, V69, P89, DOI 10.1016/0025-5416(85)90377-5; Hasegawa G, 2013, CHEM MATER, V25, P3504, DOI 10.1021/cm401933a; Hasegawa G, 2012, J PHYS CHEM C, V116, P26197, DOI 10.1021/jp309010p; Hasegawa G, 2013, PHYS CHEM CHEM PHYS, V15, P8736, DOI 10.1039/c3cp50352f; Hasegawa G., 2012, STUDIES POROUS MONOL; JANSEN ML, 1973, J PHYS CHEM-US, V77, P3089, DOI 10.1021/j100644a013; Jiang Q.W., 2009, CHEM COMMUN, V44, P6720; Juel A, 2000, PHYSICA D, V143, P169, DOI 10.1016/S0167-2789(00)00100-7; Kitada A, 2012, J AM CHEM SOC, V134, P10894, DOI 10.1021/ja302083n; MASSIANI Y, 1990, THIN SOLID FILMS, V191, P305, DOI 10.1016/0040-6090(90)90382-N; Naejus R, 1997, J CHEM THERMODYN, V29, P1503, DOI 10.1006/jcht.1997.0260; Nishida T., 2008, ECS T, V6, P1, DOI 10.1149/1.2831921; PAYNE R, 1972, J PHYS CHEM-US, V76, P2892, DOI 10.1021/j100664a019; Sagane F, 2010, J POWER SOURCES, V195, P7466, DOI 10.1016/j.jpowsour.2010.04.054; SPENGLER W, 1978, PHYS REV B, V17, P1095, DOI 10.1103/PhysRevB.17.1095; Strydom I. leR., 1991, J ELECT SPECTROSC RE, V56, P85; Windisch CF, 1998, J ELECTROCHEM SOC, V145, P1211, DOI 10.1149/1.1838441; Yamaguchi T, 2009, J PHYS CHEM B, V113, P11988, DOI 10.1021/jp903871f; ZHENG JP, 1995, J ELECTROCHEM SOC, V142, pL6, DOI 10.1149/1.2043984	60	2	2	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					A77	A85		10.1149/2.0491501jes		9	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700032		
J	Maeda, K; Arakawa, N; Matsuda, S; Fukui, K; Kuramochi, H				Maeda, Kouji; Arakawa, Naoko; Matsuda, Satoshi; Fukui, Keisuke; Kuramochi, Hidetoshi			Prolonged Life and Fast Secondary Formation of the Electrodes of Lead-Acid Battery during Charge-Discharge Cycle under High-Pressure Crystallization	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							CONDUCTIVITY	To make larger capacity of charge-discharge of lead-acid batteries at high pressure after the initial formation of Plante-type electrodes, we studied the effect of high pressure on prolonged life testing. Electrode life was evaluated by determining the time of detachment of active crystals (Pb, PbOx and PbSO4) or the drop in ampere-hour efficiency during the charge-discharge cycle. Prolonged life testing, active crystals (Pb, PbOx and PbSO4) on the electrodes used in charge-discharge cycles at atmospheric pressure were easily detached when the electric current was increased to 2.7 mA/cm(2), but the electrodes used at 100 MPa remained very tough until 8.0 mA/cm(2) was reached. To increase the electric capacity of electrodes (i.e. in the second formation process), long-term charge-discharge was performed at a high electric current (5.3 mA/cm(2)). Faster second formation of electrodes at this high current was impossible at a charge of 3.6 As under atmospheric pressure, but it was possible at 6 As and 100 MPa. (C) 2014 The Electrochemical Society. All rights reserved.	[Maeda, Kouji; Arakawa, Naoko; Matsuda, Satoshi; Fukui, Keisuke] Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712201, Japan; [Kuramochi, Hidetoshi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Maeda, K (reprint author), Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712201, Japan.	maeda@eng.u-hyogo.ac.jp			Japan Society for the Promotion of Science	We are very thankful to Dr. Masato Moritoki, a world expert in high-pressure technology who has now retired from Kobe Steel Co. He developed the electrical system for the high-pressure apparatus used in our studies. We also thank the Japan Society for the Promotion of Science for continued funding of our research, Kawanish Shinmaywa education foundation, Sumitomo Science Foundation, and Suzuki Foundation.	PAVLOV D, 1992, J ELECTROCHEM SOC, V139, P3075, DOI 10.1149/1.2069034; Maeda K, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012066; Maeda K, 2014, PHYS CHEM CHEM PHYS, V16, P4911, DOI 10.1039/c3cp53353k; Arakawa N, 2013, J CRYST GROWTH, V373, P138, DOI 10.1016/j.jcrysgro.2012.09.040; LAM LT, 1995, J POWER SOURCES, V53, P215, DOI 10.1016/0378-7753(94)01988-8; Ruetschi P, 2004, J POWER SOURCES, V127, P33, DOI 10.1016/j.jpowsour.2003.09.052; NISHIGUCHI N, 1990, J CRYST GROWTH, V99, P1142, DOI 10.1016/S0022-0248(08)80097-8; Maeda K, 2013, J CHEM ENG DATA, V58, P264, DOI 10.1021/je3008233; PAVLOV D, 1987, J APPL ELECTROCHEM, V17, P1075, DOI 10.1007/BF01024373; DIETZ H, 1985, J POWER SOURCES, V14, P305, DOI 10.1016/0378-7753(85)80046-X; Electrochemical Society of Japan, 2010, BATT HDB; Moritoki M., 1984, IND CRYSTALLIZATION, V84, P373; Swogger SW, 2014, J POWER SOURCES, V261, P55, DOI 10.1016/j.jpowsour.2014.03.049	13	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					A21	A25		10.1149/2.0141501jes		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700019		
J	Taniguchi, K; Yoshino, T; Gu, YP; Katsura, Y; Takagi, H				Taniguchi, Kouji; Yoshino, Takafumi; Gu, Yunpeng; Katsura, Yukari; Takagi, Hidenori			Reversible Electrochemical Insertion/Extraction of Mg and Li Ions for Orthorhombic Mo9Se11 with Cluster Structure	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							NONAQUEOUS MAGNESIUM ELECTROCHEMISTRY; LONG CYCLE LIFE; LITHIUM BATTERIES; MOLYBDENUM CHALCOGENIDES; PHYSICAL-PROPERTIES; CATHODE MATERIALS; CRYSTAL-STRUCTURE; ENERGY-STORAGE; CHALLENGES; INSERTION	The reversible electrochemical insertion/extraction of Mg2+ and Li+ into/from a crystalline has been found in orthorhombic Mo9Se11 (o-Mo9Se11), the crystal structure of which is composed of molybdenum cluster units. The insertion/extraction reversibility of bivalent ion, Mg2+, could be ascribed to improvement of slow diffusion in the host lattice through the delocalization effect of electrons induced by cluster structure as supposed in Chevrel phase. The characteristic of Li/Mg-ion half-cell with o-Mo9Se11 cathode, such as discharge curve and theoretical capacity, are discussed based on the electronic structure. A part of discharge curve in the insertion process of Li+ was likely ascribed to the psuedogap structure in the density of state for the electronic band. The reversible capacity of o-MgxMo9Se11 was below 40% of the theoretical capacity deduced from the molecular orbital model, whereas over 80% of that was observed in o-LixMo9Se11. The smaller reversible capacity for Mg2+ could be ascribed to the Coulomb repulsion between bivalent Mg-ions confined in the one-dimensional channel of o-Mo9Se11, which highly prevents ion-insertion for bivalent Mg-ions compared with that for monovalent Li-ions. We suggest that both delocalized electronic structure and high dimensional ion-channel are necessary to realize reversible cathodes of Mg-ion battery with high capacity. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.	[Taniguchi, Kouji] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Taniguchi, Kouji] Kyoto Univ, ESICB, Kyoto 6158520, Japan; [Yoshino, Takafumi; Gu, Yunpeng; Takagi, Hidenori] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Katsura, Yukari; Takagi, Hidenori] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Takagi, Hidenori] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	Taniguchi, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	taniguchi@imr.tohoku.ac.jp	Taniguchi, Kouji/M-8464-2014; Takagi, Hidenori/B-2935-2010	Taniguchi, Kouji/0000-0001-9719-7847; 	MEXT program "Elements Strategy Initiative to Form Core Research Center"; "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", MEXT; Ministry of Education Culture, Sports, Science and Technology, Japan	We acknowledge experimental support from Ube Industries, Ltd. We acknowledge experimental advice by H. Shimotani. This research has been partly carried out at the Fundamental Technology Center, Research Institute of Electrical Communication, Tohoku University. The present work was partially supported by MEXT program "Elements Strategy Initiative to Form Core Research Center" (since 2012), and "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", MEXT; Ministry of Education Culture, Sports, Science and Technology, Japan.	Yoo HD, 2013, ENERG ENVIRON SCI, V6, P2265, DOI 10.1039/c3ee40871j; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Aurbach D, 2003, CHEM REC, V3, P61, DOI 10.1002/tcr.10051; Liu S, 2012, ENERG ENVIRON SCI, V5, P9743, DOI 10.1039/c2ee22987k; Jayaprakash N, 2011, CHEM COMMUN, V47, P12610, DOI 10.1039/c1cc15779e; Levi E, 2006, CHEM MATER, V18, P5492, DOI 10.1021/cm061656f; Amir N, 2007, J POWER SOURCES, V174, P1234, DOI 10.1016/j.jpowsour.2007.06.206; HUGHBANKS T, 1983, J AM CHEM SOC, V105, P1150, DOI 10.1021/ja00343a014; Palomares V, 2012, ENERG ENVIRON SCI, V5, P5884, DOI 10.1039/c2ee02781j; Winter M, 1998, ADV MATER, V10, P725, DOI 10.1002/(SICI)1521-4095(199807)10:10<725::AID-ADMA725>3.0.CO;2-Z; Muldoon J, 2012, ENERG ENVIRON SCI, V5, P5941, DOI 10.1039/c2ee03029b; Xu CJ, 2013, J ELECTROCHEM SOC, V160, pA93, DOI 10.1149/2.008302jes; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Aurbach D, 2007, ADV MATER, V19, P4260, DOI 10.1002/adma.200701495; Slater MD, 2013, ADV FUNCT MATER, V23, P947, DOI 10.1002/adfm.201200691; Levi E, 2010, CHEM MATER, V22, P860; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Rani JV, 2013, J ELECTROCHEM SOC, V160, pA1781, DOI 10.1149/2.072310jes; Cheng FY, 2011, ADV MATER, V23, P1695, DOI 10.1002/adma.201003587; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Aubach D., 2000, NATURE, V407, P724; Aubach D., 2001, J POWER SOURCES, V97-98, P28; Blaha P, 2001, WIEN2K AUGMENTED PLA; Delmas C, 1999, INT J INORG MATER, V1, P11, DOI 10.1016/S1463-0176(99)00003-4; Gautier R, 1997, J ALLOY COMPD, V262, P311, DOI 10.1016/S0925-8388(97)00413-1; GOUGEON P, 1987, J SOLID STATE CHEM, V71, P543, DOI 10.1016/0022-4596(87)90264-7; Gougeon P, 2004, INORG CHEM, V43, P1257, DOI 10.1021/ic035319+; GOUGEON P, 1984, J SOLID STATE CHEM, V51, P218, DOI 10.1016/0022-4596(84)90337-2; Guohua L., 1995, J POWER SOURCES, V54, P519, DOI 10.1016/0378-7753(94)02139-T; Oishi-Tomiyasu R, 2014, J APPL CRYSTALLOGR, V47, P593, DOI 10.1107/S1600576714000922; Pasta M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2139; Salloum D., 2006, Acta Crystallographica, Section E (Structure Reports Online), DOI 10.1107/S1600536806002984; Salloum D, 2005, ACTA CRYSTALLOGR E, V61, pI213, DOI 10.1107/S1600536805028205; TARASCON JM, 1984, J SOLID STATE CHEM, V54, P204, DOI 10.1016/0022-4596(84)90147-6; Wessells CD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1563	35	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					A198	A202		10.1149/2.0941501jes		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700014		
J	Belkhamsa, N; Ouattara, L; Kawachi, A; Tsujimura, M; Isoda, H; Chtaini, A; Ksibi, M				Belkhamsa, Najet; Ouattara, Lassine; Kawachi, Atsushi; Tsujimura, Maki; Isoda, Hiroko; Chtaini, Abdelilah; Ksibi, Mohamed			Electrochemical Analysis of Endocrine Disrupting Chemicals over Carbon Electrode Modified with Cameroon's Clay	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; BISPHENOL-A; LIQUID-CHROMATOGRAPHY; AQUATIC ENVIRONMENT; AQUEOUS-SOLUTION; FIBER ELECTRODE; SPIN-RESONANCE; SURFACE WATERS; WASTE-WATER	A simple and sensitive electroanalytical method was developed to determine the Endocrine Disrupting chemical 4-tert-octylphenol on clay modified carbon paste electrode (Clay/CPE). The electrochemical response of the proposed electrode was studied by means of cyclic and square wave voltammetry. The structural morphology of the modified electrode was characterized by SEM/EDX and XRD techniques. It has been found that the oxidation of 4-tert-octylphenol on the clay/CPE displayed a well-defined oxidation peak. Factors influencing the detection processes were optimized. 4-tert-octylphenoloxidation occurred through a surface process involving its adsorption on the clay/CPE. Under these optimal conditions, a linear relation between concentrations of 4-tert-octylphenoland current response was obtained over the range of 7.26 x 10(-6) to 3.87 x 10(-7) with a detection limit and a quantification limit of 9.2 x 10(-7) M and 3.06 x 10(-6) M, respectively. The correlation coefficient is 0.9963. The modified electrode showed suitable sensitivity, high stability and an accurate detection of 4-tert-octylphenol. The modified electrode also relevant suitable selectivity for various phenolic estrogenic compounds such as 4-Nonylphenol and Bisphenol A. (C) 2014 The Electrochemical Society. All rights reserved.	[Belkhamsa, Najet; Ksibi, Mohamed] Univ Sfax, Lab Water Energy & Environm L3E, ENIS, Sfax 3038, Tunisia; [Ouattara, Lassine] Univ UFR SSMT, Lab Phys Chem, Abidjan 22, Cote Ivoire; [Kawachi, Atsushi; Tsujimura, Maki; Isoda, Hiroko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Chtaini, Abdelilah] Univ Sultan Moulay Sliman, Fac Sci & Technol, Team Mol Electrochem & Inorgan Mat, Beni Mellel, Morocco	Belkhamsa, N (reprint author), Univ Sfax, Lab Water Energy & Environm L3E, ENIS, Sfax 3038, Tunisia.	mohamed.ksibi@tunet.tn			Ministry of High Education, Scientific Research and Technology [11/TM/31]; JST/JICA, SATREPS	This work was partially supported by the Ministry of High Education, Scientific Research and Technology through a Bilateral Agreement Project between Morocco and Tunisia. Project No: 11/TM/31 and JST/JICA, SATREPS Project.	Agui L, 2006, ELECTROCHIM ACTA, V51, P2565, DOI 10.1016/j.electacta.2005.07.051; Anagho S. G., 2013, International Journal of Research in Chemistry and Environment (IJRCE), V3, P1; Andersson H., 2012, SUMMARY REPORT SWEDE; Scavetta E, 2002, ELECTROCHIM ACTA, V47, P2451, DOI 10.1016/S0013-4686(02)00103-2; Benijts T, 2004, ANAL CHEM, V76, P704, DOI 10.1021/ac035062x; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Thorpe KL, 2001, ENVIRON SCI TECHNOL, V35, P2476, DOI 10.1021/es001767u; Inoue K, 2000, J CHROMATOGR B, V749, P17, DOI 10.1016/S0378-4347(00)00351-0; Yang CH, 2004, MICROCHIM ACTA, V148, P87, DOI 10.1007/s00604-004-0240-4; Cespedes R, 2004, ANAL BIOANAL CHEM, V378, P697, DOI 10.1007/s00216-003-2303-5; Olowu RA, 2010, SENSORS-BASEL, V10, P9872, DOI 10.3390/s101109872; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Yoshioka N, 2004, J CHROMATOGR A, V1022, P145, DOI 10.1016/j.chroma.2003.09.021; Stuart EJE, 2011, J PHYS CHEM C, V115, P5530, DOI 10.1021/jp111941s; Huang WS, 2003, ANAL BIOANAL CHEM, V375, P703, DOI 10.1007/s00216-002-1745-5; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Yin HS, 2010, MICROCHIM ACTA, V170, P99, DOI 10.1007/s00604-010-0396-z; Vethaak AD, 2005, CHEMOSPHERE, V59, P511, DOI 10.1016/j.chemosphere.2004.12.053; Fernandez L, 2006, ELECTROCHIM ACTA, V52, P872, DOI 10.1016/j.electacta.2006.06.021; Gurban AM, 2011, TALANTA, V85, P2007, DOI 10.1016/j.talanta.2011.07.045; Quiros L, 2005, ENVIRON TOXICOL CHEM, V24, P389, DOI 10.1897/04-121R.1; Kuramitz H, 2001, CHEMOSPHERE, V45, P37, DOI 10.1016/S0045-6535(01)00032-7; Zhang YP, 2008, CHEMOSPHERE, V73, P848, DOI 10.1016/j.chemosphere.2008.06.001; STALDER CJ, 1983, J AM CHEM SOC, V105, P6318, DOI 10.1021/ja00358a026; Scavetta E, 2003, ELECTROCHIM ACTA, V48, P1347, DOI 10.1016/S0013-4686(02)00847-2; Kuramitz H, 2002, WATER RES, V36, P3323, DOI 10.1016/S0043-1354(02)00040-4; Fernandez L, 2005, ELECTROCHIM ACTA, V50, P1233, DOI 10.1016/j.electacta.2004.08.016; Ngundi MM, 2003, ELECTROCHEM COMMUN, V5, P61, DOI 10.1016/S1388-2481(02)00538-6; LAVIRON E, 1974, J ELECTROANAL CHEM, V52, P355, DOI 10.1016/S0022-0728(74)80448-1; Hernandez M, 2007, ANAL CHIM ACTA, V597, P245, DOI 10.1016/j.aca.2007.06.010; Kuramitz H, 2004, WATER RES, V38, P2331, DOI 10.1016/j.watres.2004.02.023; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P423, DOI 10.1080/10934520902719704; Bellfroid A C, 1999, SCI TOTAL ENVIRON, V225, P101; BETTELHEIM A, 1988, J ELECTROANAL CHEM, V246, P139, DOI 10.1016/0022-0728(88)85056-3; Djoufac W. E., 2006, ANN CHIM-SCI MAT, V31, P75; EGE D, 1985, J AM CHEM SOC, V107, P5644, DOI 10.1021/ja00306a009; FRENZEL W, 1992, ANAL CHIM ACTA, V261, P253, DOI 10.1016/0003-2670(92)80199-H; GHOSH PK, 1983, J AM CHEM SOC, V105, P5691, DOI 10.1021/ja00355a030; Gobi V. K., 1992, J CHEM SOC CHEM COMM, V1, P436; Gomez Y, 2009, ELECTROANAL, V21, P1354, DOI 10.1002/elan.200804524; Guarino AWS, 1997, J BRAZIL CHEM SOC, V8, P581; Hermandz L., 1988, ANALYST, V113, P621; ISO, 2005, WAT QUAL DET SEL A 1, P18857; ITAYA K, 1985, J PHYS CHEM-US, V89, P5565, DOI 10.1021/j100271a051; ITAYA K, 1987, INORG CHEM, V26, P624, DOI 10.1021/ic00251a028; Khan SJ, 2004, WATER SCI TECHNOL, V50, P15; Kharlamova T. A., 1987, RUSS CHEM REV, V56, P29; Mbadcam J. K., 2011, J ENV CHEM ECOTOXICO, V3, P290; Mirkind L. A., 1975, RUSS CHEM REV, V44, P2088; MORAES FC, 2009, H ELECTROANAL, V21, P1091; Pedersen SN, 1999, J CHROMATOGR A, V864, P17, DOI 10.1016/S0021-9673(99)01011-0; Cespedes R, 2005, CHEMOSPHERE, V61, P1710, DOI 10.1016/j.chemosphere.2005.03.082; Piva F, 1998, PURE APPL CHEM, V70, P1647, DOI 10.1351/pac199870091647; Qijin W., 2013, ELECTROANALYTICAL CH, V689, P252; Qiu J., 1997, J ELECTROANAL CHEM, V142, P165; Saad B, 2004, FOOD CHEM, V84, P313, DOI 10.1016/S0308-8146(03)00260-7; Schiliro T, 2009, CHEMOSPHERE, V75, P335, DOI 10.1016/j.chemosphere.2008.12.028; SHI CN, 1989, LANGMUIR, V5, P650, DOI 10.1021/la00087a018; Song CJ, 1999, J ELECTROANAL CHEM, V462, P143, DOI 10.1016/S0022-0728(98)00397-0; Thompson RD, 2001, J AOAC INT, V84, P815; Vermillion F. J., 1964, J ELECTROCHEM SOC, V111, P1396; Wang J., 1989, ELECTROANAL, V1, P176; WHITE JR, 1986, J ELECTROANAL CHEM, V197, P233, DOI 10.1016/0022-0728(86)80152-8; Yang P., 2010, C ENV POLL PUBL HLTH, V1-2, P908; Yi HC, 2001, TALANTA, V55, P1205, DOI 10.1016/S0039-9140(01)00531-8; Zgola-Grze A. skowiak, 2009, CHEMOSPHERE, V75, P513	66	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					B1	B8		10.1149/2.0101501jes		8	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700038		
J	Kure-Chu, SZ; Osaka, K; Yashiro, H; Segawa, H; Wada, K; Inoue, S				Kure-Chu, S. -Z.; Osaka, K.; Yashiro, H.; Segawa, H.; Wada, K.; Inoue, S.			Controllable Fabrication of Networked Three-Dimensional Nanoporous Anodic Alumina Films on Low-Purity Al Materials	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							PHOSPHORIC-ACID; NANOWIRE ARRAYS; AA1050 ALLOY; ANODIZATION; OXIDE; NANOSTRUCTURES; TEMPLATES; GLASS; ELECTRODEPOSITION; INITIATION	Networked three-dimensional (3D) nanoporous alumina nanostructures-consisting of vertical cylindrical stem pore arrays (170-310 nm in diameter) and periodical transverse branched pores (20-80 nm in diameter) interspaced regularly by 190-220 nm across the vertical pore walls-were controllably fabricated from low purity Al materials (99.0%, 99.3%, and 99.56%) by anodization in a phosphoric acidic solution at 110-190 V. The formation of transverse pores depended predominantly on the purity of the Al base materials and the corrosion resistance of the anodic porous alumina films, which can be mainly attributed to anodic and/or chemical dissolution of impurities such as Fe, Cu, Zn, Mg, and Mn incorporated in the Al base materials. Moreover, the effects of the purity of Al materials on the growth and morphology of porous alumina films in oxalic and sulfuric acid solutions were also investigated by a two-step anodization of Al sheets with different purities, namely 99.0%, 99.3%, 99.56%, and 99.999% Al. The alumina films grew more slowly in all electrolytes with decreasing Al purity, which can be attributed to the lower corrosion resistance of the PAA films containing small quantities of Fe oxides and/or hydroxides produced during anodization. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.	[Kure-Chu, S. -Z.; Osaka, K.; Yashiro, H.] Iwate Univ, Dept Chem & Bioengn, Morioka, Iwate 0208551, Japan; [Segawa, H.; Wada, K.; Inoue, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Kure-Chu, SZ (reprint author), Iwate Univ, Dept Chem & Bioengn, Morioka, Iwate 0208551, Japan.	chusongz@iwate-u.ac.jp		Kure-Chu, Song-Zhu/0000-0003-0839-5230			Aguilera A, 2006, SOL ENERG MAT SOL C, V90, P713, DOI 10.1016/j.solmat.2005.04.008; Takai A, 2009, CHEM MATER, V21, P3414, DOI 10.1021/cm9011926; Chu SZ, 2008, J ELECTROCHEM SOC, V155, pD414, DOI 10.1149/1.2895062; Zaraska L, 2010, SURF COAT TECH, V205, P2432, DOI 10.1016/j.surfcoat.2010.09.038; Losic D, 2009, LANGMUIR, V25, P5426, DOI 10.1021/la804281v; KELLER F, 1953, J ELECTROCHEM SOC, V100, P411, DOI 10.1149/1.2781142; Chu SZ, 2005, ADV MATER, V17, P2115, DOI 10.1002/adma.200500401; THOMPSON GE, 1981, NATURE, V290, P230, DOI 10.1038/290230a0; Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y; Friedman AL, 2007, J ELECTROCHEM SOC, V154, pE68, DOI 10.1149/1.2509685; Molchan IS, 2010, ELECTROCHEM COMMUN, V12, P693, DOI 10.1016/j.elecom.2010.03.008; Chung CK, 2011, THIN SOLID FILMS, V519, P4754, DOI 10.1016/j.tsf.2011.01.029; Chu SZ, 2002, CHEM MATER, V14, P4595, DOI 10.1021/cm020272w; Baron-Wiechec A, 2013, ELECTROCHIM ACTA, V113, P302, DOI 10.1016/j.electacta.2013.09.060; Zaraska L, 2010, ELECTROCHIM ACTA, V55, P4377, DOI 10.1016/j.electacta.2009.12.054; Cheng C, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/21/215602; Kemell M, 2007, CHEM MATER, V19, P1816, DOI 10.1021/cm062576e; Caicedo-Martinez CE, 2002, J ELECTROCHEM SOC, V149, pB139, DOI 10.1149/1.1457982; Chu SZ, 2006, J ELECTROCHEM SOC, V153, pB384, DOI 10.1149/1.2218822; Chu S.-Z, 2012, PRIME 2012 OCT 7 12; Chu SZ, 2005, ADV FUNCT MATER, V15, P1343, DOI 10.1002/adfm.200400253; Chu SZ, 2002, CHEM MATER, V14, P266, DOI 10.1021/cm0105918; Chu SZ, 2004, J PHYS CHEM B, V108, P5582, DOI 10.1021/jp0378642; Chung CK, 2012, MATER LETT, V88, P104, DOI 10.1016/j.matlet.2012.08.047; Garcia-Vergara SJ, 2010, ELECTROCHIM ACTA, V55, P3175, DOI 10.1016/j.electacta.2010.01.038; Iglesias-Rubianes L, 2007, ELECTROCHIM ACTA, V52, P7148, DOI 10.1016/j.electacta.2007.05.052; Lee W, 2010, ADV FUNCT MATER, V20, P21, DOI 10.1002/adfm.200901213; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Ono S., 1991, J ELECTROCHEM SOC, V138, pB384; TAKAHASH.H, 1973, J ELECTRON MICROSC, V22, P149; Van Overmeere Q, 2012, ELECTROCHEM SOLID ST, V15, pC1, DOI 10.1149/2.009201esl; Zaraska L, 2014, J SOLID STATE ELECTR, V18, P361, DOI 10.1007/s10008-013-2215-z	32	4	4	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					C24	C34		10.1149/2.0511501jes		11	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700046		
J	Arai, S; Osaki, T				Arai, Susumu; Osaki, Takuma			Fabrication of Copper/Multiwalled Carbon Nanotube Composites Containing Different Sized Nanotubes by Electroless Deposition	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							THERMAL-CONDUCTIVITY; MATRIX COMPOSITES; AQUEOUS-SOLUTION; SINGLE-WALL; COPPER; SURFACTANT; DISPERSION; FIBERS; PARTICLES; MECHANISM	Cu/multiwalled carbon nanotube(MWCNT) composites containing two different sized MWCNTs were fabricated using an electroless deposition technique in aqueous solution. In order to disperse the MWCNTs in the solution, an anionic dispersant of sodium dodecyl sulfate (SDS) and a polymeric dispersant of hydroxypropyl cellulose (HPC) were used. The dispersibility of the MWCNTs in solution was evaluated by measuring the particle size distribution. The zeta potential for the MWCNTs was also evaluated to examine the dispersibility. Uniform Cu/MWCNT composites containing the two different sized MWCNTs were fabricated through the electroless copper deposition process from a solution containing copper ions, a complexing agent, a reducing agent, and two dispersants, SDS and HPC, in addition to the two different sized MWCNTs. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.	[Arai, Susumu; Osaki, Takuma] Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, Nagano 3808553, Japan	Arai, S (reprint author), Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, Nagano 3808553, Japan.	araisun@shinshu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26289270]	This work was supported by a Grant-in Aid for Scientific Research (B) (No. 26289270) from the Japan Society for the Promotion of Science (JSPS).	Akbarpour MR, 2013, MAT SCI ENG A-STRUCT, V572, P83, DOI 10.1016/j.msea.2013.02.039; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; Tan YQ, 2005, J PHYS CHEM B, V109, P14454, DOI 10.1021/jp052217r; Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543; Lu JP, 1997, PHYS REV LETT, V79, P1297, DOI 10.1103/PhysRevLett.79.1297; Yan YH, 2010, CARBON, V48, P2603, DOI 10.1016/j.carbon.2010.03.065; Rajkumar K, 2011, WEAR, V270, P613, DOI 10.1016/j.wear.2011.01.017; Sun Z, 2008, J PHYS CHEM C, V112, P10692, DOI 10.1021/jp8021634; Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u; Chen QD, 2001, J PHYS CHEM B, V105, P618, DOI 10.1021/jp003385g; Khaleghi E, 2012, MATER LETT, V79, P256, DOI 10.1016/j.matlet.2012.03.117; Hertel T, 2005, NANO LETT, V5, P511, DOI 10.1021/nl050069a; Jiang LQ, 2003, CARBON, V41, P2923, DOI 10.1016/S0007-6223(03)00339-7; Yurekli K, 2004, J AM CHEM SOC, V126, P9902, DOI 10.1021/ja047451u; Lin CB, 2011, WEAR, V270, P382, DOI 10.1016/j.wear.2010.11.010; Yoo SJ, 2013, CARBON, V61, P487, DOI 10.1016/j.carbon.2013.04.105; Duan WH, 2011, CHEM SCI, V2, P1407, DOI 10.1039/c0sc00616e; Barisci JN, 2004, ADV FUNCT MATER, V14, P133, DOI 10.1002/adfm.200304500; Grossiord N, 2007, LANGMUIR, V23, P3646, DOI 10.1021/la062684f; Guiderdoni C, 2013, CARBON, V58, P185, DOI 10.1016/j.carbon.2013.02.049; Uddin SM, 2010, COMPOS SCI TECHNOL, V70, P2253, DOI 10.1016/j.compscitech.2010.07.012; Shukla AK, 2013, MAT SCI ENG A-STRUCT, V560, P365, DOI 10.1016/j.msea.2012.09.080; Cho S, 2010, SCRIPTA MATER, V63, P375, DOI 10.1016/j.scriptamat.2010.04.024; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Blanch AJ, 2010, J PHYS CHEM B, V114, P9805, DOI 10.1021/jp104113d; Wei BQ, 2001, APPL PHYS LETT, V79, P1172, DOI 10.1063/1.1396632; Arai S, 2010, J ELECTROCHEM SOC, V157, pD147, DOI 10.1149/1.3280034; Shu J, 1997, IND ENG CHEM RES, V36, P1632, DOI 10.1021/ie9600912; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Berber S, 2000, PHYS REV LETT, V84, P4613, DOI 10.1103/PhysRevLett.84.4613; Cho S, 2012, ACTA MATER, V60, P726, DOI 10.1016/j.actamat.2011.09.056; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Arai S, 2004, ELECTROCHEM SOLID ST, V7, pC25, DOI 10.1149/1.1644354; Arai S, 2013, J ELECTROCHEM SOC, V160, pD380, DOI 10.1149/2.081309jes; Arai S, 2014, ECS J SOLID STATE SC, V3, pP201, DOI 10.1149/2.018406jss; Chu K, 2010, NANOSCALE RES LETT, V5, P868, DOI 10.1007/s11671-010-9577-2; Esumi K., 1995, CARBON, V33, P279; HONMA H, 1994, J ELECTROCHEM SOC, V141, P730, DOI 10.1149/1.2054800; Jenei P, 2011, MAT SCI ENG A-STRUCT, V528, P4690, DOI 10.1016/j.msea.2011.02.066; Jenei P, 2013, COMPOS PART A-APPL S, V51, P71, DOI 10.1016/j.compositesa.2013.04.007; Jiang LQ, 2003, J COLLOID INTERF SCI, V260, P89, DOI 10.1016/S0021-9797(02)00176-5; Park KC, 2008, J PHYS CHEM SOLIDS, V69, P2481, DOI 10.1016/j.jpcs.2008.05.006; Sasaki K., 2012, P 33 JAP S THERM PRO; Shimabayashi S, 1997, COLLOID SURFACE A, V123, P283, DOI 10.1016/S0927-7757(96)03820-4; Steinmetz J, 2005, CARBON, V43, P2397, DOI 10.1016/j.carbon.2005.03.047; Suarez B, 2006, J CHROMATOGR A, V1128, P282, DOI 10.1016/j.chroma.2006.06.052; Takahashi T, 2005, CHEM LETT, V34, P1516, DOI 10.1246/cl.2005.1516; Verwey E. J. W., 1948, THEORY STABILITY LYO	49	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					D68	D73		10.1149/2.0971501jes		6	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700062		
J	Nakaya, K; Nakata, A; Hirai, T; Ogumi, Z				Nakaya, Katsunori; Nakata, Akiyoshi; Hirai, Toshiro; Ogumi, Zempachi			Oxidation of Nickel in AlCl3-1-Butylpyridinium Chloride at Ambient Temperature	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							IMIDAZOLIUM CHLORIDE/ALUMINUM CHLORIDE; MOLTEN-SALT BATTERIES; IONIC LIQUID; SECONDARY CELLS; ALUMINUM ANODES; FELT CATHODES; ELECTROLYTES; BEHAVIOR; ELECTROCHEMISTRY; PERFORMANCE	We have studied in detail the electrochemical reaction of nickel in several kinds of molar ratio-controlled molten salts consisting of AlCl3 and 1-butylpyridinium chloride (BPC) at 40 degrees C. We observed NiCl2 as an oxidation product from nickel on the surface of the electrode in slightly acidic AlCl3/BPC salts with molar ratios of 1.05/1.0 and 1.1/1.0. However, in strongly acidic salt with the ratio of 1.5/1.0, NiCl2 deposits on the electrode less than when in the above salts, and no NiCl2 is observed in basic and neutral salts with the ratio of 1.0/1.0 or less AlCl3 content. This suggests that [NiCl4](2-) ions form as the oxidation of nickel in such neutral and basic AlCl3/BPC salts. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.	[Nakaya, Katsunori; Nakata, Akiyoshi; Hirai, Toshiro; Ogumi, Zempachi] Kyoto Univ, Off Soc Acad Collaborat Innovat, Kyoto 6110011, Japan	Nakaya, K (reprint author), Honda Res & Dev Co Ltd, Automobile R&D Ctr, Hagadai, Tochigi 3213393, Japan.	Katsunori_Nakaya@n.t.rd.honda.co.jp			New Energy and Industrial Technology Department Organization (NEDO) Japan	This work was financially supported by the New Energy and Industrial Technology Department Organization (NEDO) Japan.	Pye S, 1997, J ELECTROCHEM SOC, V144, P1933, DOI 10.1149/1.1837724; Zhou HS, 2010, CHEMSUSCHEM, V3, P1009, DOI 10.1002/cssc.201000123; Yin YX, 2013, ANGEW CHEM INT EDIT, V52, P13186, DOI 10.1002/anie.201304762; Abraham KM, 1996, J ELECTROCHEM SOC, V143, P1, DOI 10.1149/1.1836378; Reddy MA, 2011, J MATER CHEM, V21, P17059, DOI 10.1039/c1jm13535j; Wang JJ, 2012, ENERG ENVIRON SCI, V5, P5163, DOI 10.1039/c1ee01263k; Ellis BL, 2012, CURR OPIN SOLID ST M, V16, P168, DOI 10.1016/j.cossms.2012.04.002; DONAHUE FM, 1992, J APPL ELECTROCHEM, V22, P230, DOI 10.1007/BF01030182; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Liu B, 2013, ACS NANO, V7, P8051, DOI 10.1021/nn4032454; GALE RJ, 1979, INORG CHEM, V18, P2723, DOI 10.1021/ic50200a019; Carlin RT, 1998, J ELECTROCHEM SOC, V145, P1598, DOI 10.1149/1.1838524; CRISP RI, 1995, POLYHEDRON, V14, P2819, DOI 10.1016/0277-5387(95)00139-J; GALE RJ, 1979, INORG CHEM, V18, P1603, DOI 10.1021/ic50196a044; GILBERT B, 1978, J AM CHEM SOC, V100, P2725, DOI 10.1021/ja00477a026; Ito Y, 2011, J POWER SOURCES, V196, P6583, DOI 10.1016/j.jpowsour.2011.03.025; KNUTZ BC, 1993, J ELECTROCHEM SOC, V140, P3374, DOI 10.1149/1.2221098; KNUTZ BC, 1993, J ELECTROCHEM SOC, V140, P3380, DOI 10.1149/1.2221099; Koura N., 1985, KEIKINZOKU, V35, P203; KOURA N, 1993, J ELECTROCHEM SOC, V140, P602, DOI 10.1149/1.2056128; Kozyrin VA, 2013, RUSS J APPL CHEM+, V86, P20, DOI 10.1134/S1070427213010059; Lewis H, 2004, J POWER SOURCES, V136, P307, DOI 10.1016/j.jpowsour.2004.03.041; O'Grady WE, 2011, POWDER DIFFR, V26, P171, DOI 10.1154/1.3591165; Parker JF, 2012, ECS TRANSACTIONS, V41, P23, DOI 10.1149/1.4703919; Pitner WR, 1996, J ELECTROCHEM SOC, V143, P130, DOI 10.1149/1.1836397; Roeper D. F., 2008, ECS T, V11, P29, DOI 10.1149/1.2910230; Roeper DF, 2011, J ELECTROCHEM SOC, V158, pF21, DOI 10.1149/1.3522762; TAKAHASHI S, 1986, DENKI KAGAKU, V54, P257; TAKAMI N, 1993, J ELECTROCHEM SOC, V140, P928, DOI 10.1149/1.2056229; Zu C.-X., 2011, SUPPLEMENTARY MAT ES	30	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					D42	D48		10.1149/2.0401501jes		7	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700058		
J	Fujii, K; Sato, Y; Takase, S; Shimizu, Y				Fujii, Keitaro; Sato, Yasushi; Takase, Satoko; Shimizu, Youichi			Effects of Oxygen Vacancies and Reaction Conditions on Oxygen Reduction Reaction on Pyrochlore-Type Lead-Ruthenium Oxide	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							PROTON-EXCHANGE MEMBRANE; FUEL-CELLS; ELECTROCATALYTIC PROPERTIES; MODIFIED ELECTRODE; ENERGY-CONVERSION; CATALYST; TEMPERATURE; PB2RU2O6.5; OXIDATION; RU	A series of pyrochlore-type lead-ruthenium oxide (Pb2Ru2O7-delta) containing various amounts of oxygen vacancies was prepared by varying the heat-treatment temperature, and the oxygen reduction reaction (ORR) activity as well as the electrochemical redox property in acid and alkaline solution was evaluated using rotating disk electrode. The specific ORR activity was increased with increasing the amount of oxygen vacancies, and linearly correlated to the charge amount of electrochemical redox of Pb2Ru2O7-delta both in acid and alkaline solution. We concluded that the surface oxygen vacancy participates in the electrochemical redox of Pb2Ru2O7-delta, and at the same time, behaves as the active site for ORR. The ORR activity in alkaline solution was much higher than that in acid solution, possibly because of the difference of the facility of electrochemical desorption of adsorbed oxygen species in the ORR process. Additionally, the effect of humidity on the ORR activity was investigated by single cell test. It was revealed that Pb2Ru2O7-delta shows absolutely high ORR activity in dry condition. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License (CC BY-NC-ND, http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is not changed in any way and is properly cited. For permission for commercial reuse, please email: oa@electrochem.org. All rights reserved.	[Fujii, Keitaro; Sato, Yasushi] JX Nippon Oil & Energy Co, Cent Tech Res Lab, Nada Ku, Yokohama, Kanagawa 2310815, Japan; [Takase, Satoko; Shimizu, Youichi] Kyushu Inst Technol, Grad Sch Engn, Dept Appl Chem, Kitakyushu, Fukuoka 8048550, Japan	Fujii, K (reprint author), JX Nippon Oil & Energy Co, Cent Tech Res Lab, Nada Ku, Yokohama, Kanagawa 2310815, Japan.	keitaro.fujii@noe.jx-group.co.jp	Shimizu, Youichi/O-6751-2015	Shimizu, Youichi/0000-0002-2597-4608			Imai H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3430543; ZEN JM, 1994, J ELECTROCHEM SOC, V141, pL51, DOI 10.1149/1.2054877; Schmidt TJ, 1998, J ELECTROCHEM SOC, V145, P2354, DOI 10.1149/1.1838642; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Prakash J, 1999, J ELECTROCHEM SOC, V146, P4145, DOI 10.1149/1.1392605; JASINSKI R, 1964, NATURE, V201, P1212, DOI 10.1038/2011212a0; Ohgi Y, 2012, ELECTROCHIM ACTA, V68, P192, DOI 10.1016/j.electacta.2012.02.059; Bae JM, 1999, J ELECTROCERAM, V3, P37, DOI 10.1023/A:1009962831952; GOODENOUGH JB, 1990, J AM CHEM SOC, V112, P2076, DOI 10.1021/ja00162a006; Takeda T, 2000, J ELECTROCHEM SOC, V147, P1730, DOI 10.1149/1.1393425; Zen JM, 2001, ANAL CHEM, V73, P1169, DOI 10.1021/ac0010781; RANDALL JJ, 1959, J AM CHEM SOC, V81, P2629, DOI 10.1021/ja01520a007; VANTE NA, 1986, NATURE, V323, P431, DOI 10.1038/323431a0; KROGER FA, 1956, SOLID STATE PHYS, V3, P307; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Zhang L, 2006, J POWER SOURCES, V156, P171, DOI 10.1016/j.jpowsour.2005.05.069; Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020; Shimizu Y, 1998, SENSOR ACTUAT B-CHEM, V52, P84, DOI 10.1016/S0925-4005(98)00260-3; Lee J, 2013, CURR APPL PHYS, V13, P309, DOI 10.1016/j.cap.2012.08.008; HOROWITZ HS, 1983, J ELECTROCHEM SOC, V130, P1851, DOI 10.1149/1.2120111; BEYERLEIN RA, 1984, J SOLID STATE CHEM, V51, P253, DOI 10.1016/0022-4596(84)90341-4; BEYERLEIN RA, 1988, J SOLID STATE CHEM, V72, P2, DOI 10.1016/0022-4596(88)90002-3; EGDELL RG, 1983, J CHEM SOC FARAD T 1, V79, P893, DOI 10.1039/f19837900893; England W. A., 1980, Solid State Ionics, V1, DOI 10.1016/0167-2738(80)90007-7; Horowitz H. S., 1978, U. S. Pat, Patent No. 4525; HOROWITZ HS, 1981, MATER RES BULL, V16, P489, DOI 10.1016/0025-5408(81)90112-4; Hrovat M, 2001, MATER RES BULL, V36, P767, DOI 10.1016/S0025-5408(01)00537-2; HSU WY, 1988, APPL PHYS LETT, V52, P792, DOI 10.1063/1.99286; Iwanaga T, 2008, ECS TRANSACTIONS, V16, P955, DOI 10.1149/1.2981935; Liu RL, 2010, ANGEW CHEM, V122, P2619, DOI DOI 10.1002/ANGE.200907289; LONGO JM, 1969, MATER RES BULL, V4, P191, DOI 10.1016/0025-5408(69)90056-7; MEADOWCR.DB, 1970, NATURE, V226, P847, DOI 10.1038/226847a0; Nam KD, 2010, ELECTROCHIM ACTA, V55, P7290, DOI 10.1016/j.electacta.2010.07.048; Ozaki T., 2005, ITE LETT, V6, P335; Sato Y., 2012, U. S. Pat, Patent No. 8129; Sato Y., 2013, U. S. Pat, Patent No. 8543; Shimizu Y., 2006, ECS T, V3, P263, DOI 10.1149/1.2356145; Shimizu Y., 2003, ITE LETT BATTERIES N, V4; SHUKLA AK, 1988, SOLID STATE IONICS, V26, P5, DOI 10.1016/0167-2738(88)90238-X; SLEIGHT AW, 1971, MATER RES BULL, V6, P775, DOI 10.1016/0025-5408(71)90113-9; VANVEEN JAR, 1988, ELECTROCHIM ACTA, V33, P51, DOI 10.1016/0013-4686(88)80031-8; ZEN JM, 1992, J APPL ELECTROCHEM, V22, P140, DOI 10.1007/BF01023815; Zen JM, 2001, J MOL CATAL A-CHEM, V165, P177, DOI 10.1016/S1381-1169(00)00413-1; Zen JM, 2000, ELECTROCHIM ACTA, V45, P1691, DOI 10.1016/S0013-4686(99)00327-8	44	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					F129	F135		10.1149/2.0951501jes		7	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700072		
J	Hosoi, T; Yonekura, T; Sunada, K; Sasaki, K				Hosoi, T.; Yonekura, T.; Sunada, K.; Sasaki, K.			Exchange Current Density of SOFC Electrodes: Theoretical Relations and Partial Pressure Dependencies Rate-Determined by Electrochemical Reactions	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							OXIDE FUEL-CELL; TEMPERATURE DEFECT CHEMISTRY; NI PATTERN ANODES; STABILIZED ZIRCONIA; HETEROGENEOUS EQUILIBRIA; POLARIZATION PHENOMENA; CATHODIC POLARIZATION; PLATINUM-ELECTRODES; MODEL; MICROSTRUCTURE	As a theoretical consideration on electrode defect chemistry, general relations of exchange current density quantitatively representing Solid Oxide Fuel Cell (SOFC) electrode performance are systematically derived as a function of gas partial pressures, equilibrium constants of adsorption and dissociation reactions on electrode surfaces, and electrochemical reaction rate constants for possible elemental reactions at the cathode and the anode, in the case that an electrochemical reaction is the rate-determining electrode reaction. Simplified expressions are also derived, under the condition that one kind of neutral or charged adsorbed species is predominant at the electrode, to derive gas partial pressure dependence of exchange current density for given rate-determining electrochemical reactions. Importance of considering elementary steps is highlighted to derive rate equations and to clarify various dependencies. Partial pressure dependencies of the exchange current density are compiled and discussed by simulating normalized exchange current density values for given partial pressures. The applicability and limitation of the Butler-Volmer type expressions of exchange current density for SOFC electrodes are carefully discussed. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License (CC BY-NC-ND, http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is not changed in any way and is properly cited. For permission for commercial reuse, please email: oa@electrochem.org. All rights reserved.	[Hosoi, T.; Yonekura, T.; Sunada, K.; Sasaki, K.] Kyushu Univ, Fac Engn, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan; [Sasaki, K.] Kyushu Univ, Int Res Ctr Hydrogen Energy, Nishi Ku, Fukuoka 8190395, Japan; [Sasaki, K.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Sasaki, K.] Kyushu Univ, Next Generat Fuel Cell Res Ctr NEXT FC, Nishi Ku, Fukuoka 8190395, Japan	Hosoi, T (reprint author), Kyushu Univ, Fac Engn, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan.	sasaki@mech.kyushu-u.ac.jp			JSPS [23226015]	Financial support by JSPS Grant-in-Aid for Scientific Research (S) (No. 23226015) is gratefully acknowledged. One of the authors (K.S.) (Sasaki) thanks Prof. Dr. M. Mogensen for helpful discussion on the reference 22.	Erdey-Gruz T, 1930, Z PHYS CHEM A-CHEM T, V150, P203; Opitz AK, 2010, SOLID STATE IONICS, V181, P684, DOI 10.1016/j.ssi.2010.03.017; Shearing PR, 2010, J POWER SOURCES, V195, P4804, DOI 10.1016/j.jpowsour.2010.02.047; Nakamura T, 2008, J ELECTROCHEM SOC, V155, pB563, DOI 10.1149/1.2901047; Vogler M, 2009, J ELECTROCHEM SOC, V156, pB663, DOI 10.1149/1.3095477; Vivet N, 2011, J POWER SOURCES, V196, P7541, DOI 10.1016/j.jpowsour.2011.03.060; TAKEDA Y, 1987, J ELECTROCHEM SOC, V134, P2656, DOI 10.1149/1.2100267; Holzer L, 2011, J POWER SOURCES, V196, P7076, DOI 10.1016/j.jpowsour.2010.08.006; Campanari S, 2004, J POWER SOURCES, V132, P113, DOI 10.1016/j.jpowsour.2004.01.043; Kishimoto M, 2011, J POWER SOURCES, V196, P4555, DOI 10.1016/j.jpowsour.2010.12.100; Fleig J, 2007, PHYS CHEM CHEM PHYS, V9, P2713, DOI 10.1039/b618765j; Shikazono N, 2010, J ELECTROCHEM SOC, V157, pB665, DOI 10.1149/1.3330568; Aguiar P, 2004, J POWER SOURCES, V138, P120, DOI 10.1016/j.jpowsour.2004.06.040; Aaberg RJ, 1998, J ELECTROCHEM SOC, V145, P2244, DOI 10.1149/1.1838628; Butler JAV, 1924, T FARADAY SOC, V19, P0734, DOI 10.1039/tf9241900734; Wilson JR, 2011, SCRIPTA MATER, V65, P67, DOI 10.1016/j.scriptamat.2010.09.025; Blaylock DW, 2009, J PHYS CHEM C, V113, P4898, DOI 10.1021/jp806527q; Sasaki K, 1999, J APPL PHYS, V86, P5434, DOI 10.1063/1.371542; Blaylock DW, 2011, TOP CATAL, V54, P828, DOI 10.1007/s11244-011-9704-z; Sasaki K, 2011, J POWER SOURCES, V196, P9130, DOI 10.1016/j.jpowsour.2010.09.122; Iwai H, 2010, J POWER SOURCES, V195, P955, DOI 10.1016/j.jpowsour.2009.09.005; Butler JAV, 1924, T FARADAY SOC, V19, P0729, DOI 10.1039/tf9241900729; Wilson JR, 2006, NAT MATER, V5, P541, DOI 10.1038/nmat1668; Fleig J, 2005, PHYS CHEM CHEM PHYS, V7, P2027, DOI 10.1039/b501086a; WANG DY, 1979, J ELECTROCHEM SOC, V126, P1155, DOI 10.1149/1.2129235; Sasaki K, 2006, J ELECTROCHEM SOC, V153, pA2023, DOI 10.1149/1.2336075; Costamagna P, 2004, CHEM ENG J, V102, P61, DOI 10.1016/j.cej.2004.02.005; Kuklja MM, 2013, PHYS CHEM CHEM PHYS, V15, P5443, DOI 10.1039/c3cp44363a; Bieberle A, 2000, SOLID STATE IONICS, V135, P337, DOI 10.1016/S0167-2738(00)00462-8; Sasaki K, 1999, J APPL PHYS, V86, P5422, DOI 10.1063/1.371541; MIZUSAKI J, 1987, SOLID STATE IONICS, V22, P313, DOI 10.1016/0167-2738(87)90149-4; Joos J, 2011, J POWER SOURCES, V196, P7302, DOI 10.1016/j.jpowsour.2010.10.006; MIZUSAKI J, 1994, J ELECTROCHEM SOC, V141, P1674, DOI 10.1149/1.2054982; Yurkiv V, 2012, ELECTROCHIM ACTA, V59, P573, DOI 10.1016/j.electacta.2011.11.020; Bagotsky VS, 2006, FUNDAMENTALS OF ELECTROCHEMISTRY, 2ND EDITION, P1; Birnbaum U, 1997, ELEC SOC S, V97, P112; Butler J.A.V., 1924, Transactions of the Faraday Society, V19, DOI 10.1039/tf9241900659; Chen K., 2012, J ELECTROCHEM SOC, V159, pB155; Costamagna P., 1998, J ELECTROCHEM SOC, V145, P11; Doraswami U, 2011, SOLID STATE IONICS, V192, P494, DOI 10.1016/j.ssi.2009.10.013; Ehen A., 2010, J ELECTROCHEM SOC, V157, pB1588; Fleig J, 1996, ELECTROCHIM ACTA, V41, P1003, DOI 10.1016/0013-4686(95)00431-9; Hansen J. B., 2008, ELECTROCHEM SOLID ST, V2, pB178; Jiang SP, 1999, SOLID STATE IONICS, V116, P145, DOI 10.1016/S0167-2738(98)00269-0; Kleitz M., 1992, FUNDAMENTAL BARRIERS, P4; Kleitz M, 1996, SOLID STATE IONICS, V92, P65, DOI 10.1016/S0167-2738(96)00464-X; Kolb D. M., 1997, ELECTROCHEMISTRY SOL; Kotomin E. A., 2008, ECS T, V13, P301; Kulikovsky AA, 1999, J ELECTROCHEM SOC, V146, P3981, DOI 10.1149/1.1392580; Lee CG, 1998, J ELECTROCHEM SOC, V145, P2747, DOI 10.1149/1.1838708; Lee YL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224101; Lide D. R., 2004, CRC HDB CHEM PHYS; Maier J., 2004, PHYS CHEM IONIC MAT; Masuda H, 2008, J POWER SOURCES, V177, P303, DOI 10.1016/j.jpowsour.2007.11.069; Meng H, 2004, CHEM ENG SCI, V59, P3331, DOI 10.1016/j.ces.2004.03.039; Merkle R., 2009, ADV ELECTROCATALYSIS; Minh NQ, 1995, SCI TECHNOLOGY CERAM, DOI Elsevier; Mogensen M., 2012, P 10 EUR SOFC FOR LU; Mosleh M, 2009, J ELECTROCHEM SOC, V156, pB441, DOI 10.1149/1.3062941; Nagata S, 2001, J POWER SOURCES, V101, P60, DOI 10.1016/S0378-7753(01)00547-X; Ogura T, 2013, ECS TRANSACTIONS, V57, P2865, DOI 10.1149/05701.2865ecst; OKAMOTO H, 1983, ELECTROCHIM ACTA, V28, P379, DOI 10.1016/0013-4686(83)85137-8; Pizzini S., 1973, FAST ION TRANSPORT S, P461; Sasaki K., 2012, ENCY SUSTAINABILITY, V6, P3886; Sasaki K, 1996, J ELECTROCHEM SOC, V143, P530, DOI 10.1149/1.1836476; Sawyer D. T., 1995, ELECTROCHEMISTRY CHE; Shan YY, 2007, J POWER SOURCES, V165, P196, DOI 10.1016/j.jpowsour.2006.12.022; Singhal S.C., 2003, HIGH TEMPERATURE SOL; Tamamushi R., 2010, ESSENTIAL ELECTROCHE; Vielstich W., 2003, ELECTROCATALYSIS, V2; VOGEL WM, 1970, J ELECTROCHEM SOC, V117, P1512, DOI 10.1149/1.2407361; Weber AZ, 2008, J ELECTROCHEM SOC, V155, pB521, DOI 10.1149/1.2898130; Yonekura T, 2011, ECS TRANSACTIONS, V35, P1007, DOI 10.1149/1.3570081	73	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					F136	F152		10.1149/2.0561501jes		17	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700073		
J	Shimada, H; Takizawa, K; Michibata, H; Hagiwara, A; Ihara, M				Shimada, Hiroyuki; Takizawa, Koichi; Michibata, Hideo; Hagiwara, Akifusa; Ihara, Manabu			Equivalent Circuit Model Analysis of Microstructure-Controlled LSM/ScSZ Composite Cathodes by Powder Slurry Impregnation Method	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							OXIDE FUEL-CELLS; REFERENCE ELECTRODE PLACEMENT; PEROVSKITE-TYPE OXIDES; SOFC AIR ELECTRODE; SR-DOPED LAMNO3; IMPEDANCE SPECTROSCOPY; SPRAY-PYROLYSIS; STABILIZED ZIRCONIA; 3-ELECTRODE METHODS; SOLID ELECTROLYTES	Improved electrochemical performance of strontium-doped lanthanum manganite (LSM)/scandia-stabilized zirconia (ScSZ) composite cathodes for solid oxide fuel cells was accomplished by using the powder slurry impregnation (PSI) method where a prefabricated thin porous ScSZ electrolyte layer is impregnated with LSM/ScSZ powder mixture in slurry. The PSI method enabled control of the electrolyte surface roughness, resulting in a decreased electrode polarization resistance despite a tendency of the ohmic resistance to increase due to the added porous ScSZ electrolyte layer. Resistance separation by electrochemical impedance spectroscopy with an equivalent circuit model (ECM) revealed that the proposed composite cathodes exhibited a significant reduction in the oxygen reduction reaction (ORR) resistance at the triple-phase boundary (TPB). Optimization of the electrolyte surface structure is therefore critical so as not to offset the improvement in the ORR resistance. Furthermore, besides the ECM used to separate the resistances, two ECMs that represent the microstructure of actual composite electrodes were evaluated to clarify the electrode structural factors determining the measured impedance spectra. The analysis revealed that impedance response is influenced by the area ratio of the double-phase boundary to the TPB, although cathode performance is mainly determined by the TPB area and the ionic conduction resistance within composite electrodes. (C) 2014 The Electrochemical Society. All rights reserved.	[Shimada, Hiroyuki; Ihara, Manabu] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, Tokyo 1528552, Japan; [Takizawa, Koichi; Michibata, Hideo; Hagiwara, Akifusa] Tokyo Elect Power Co Ltd, R&D Ctr, Yokohama, Kanagawa 2308510, Japan	Shimada, H (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, Tokyo 1528552, Japan.	mihara@chem.titech.ac.jp	Shimada, Hiroyuki/F-9099-2015	Shimada, Hiroyuki/0000-0001-9793-8625			Winkler J, 1998, J ELECTROCHEM SOC, V145, P1184, DOI 10.1149/1.1838436; Hagiwara A, 2006, SOLID STATE IONICS, V177, P2967, DOI 10.1016/j.ssi.2006.08.021; Huang YY, 2005, J ELECTROCHEM SOC, V152, pA1347, DOI 10.1149/1.1926669; Haanappel VAC, 2005, J POWER SOURCES, V141, P216, DOI 10.1016/j.jpowsour.2004.09.016; Adler SB, 2000, SOLID STATE IONICS, V134, P35, DOI 10.1016/S0167-2738(00)00711-6; Mizusaki J, 1996, J ELECTROCHEM SOC, V143, P3065, DOI 10.1149/1.1837165; RAISTRICK ID, 1990, ELECTROCHIM ACTA, V35, P1579, DOI 10.1016/0013-4686(90)80013-E; KENJO T, 1992, SOLID STATE IONICS, V57, P295, DOI 10.1016/0167-2738(92)90161-H; Uchida H, 1999, J ELECTROCHEM SOC, V146, P1, DOI 10.1149/1.1391555; McIntosh S, 2003, J ELECTROCHEM SOC, V150, pA1305, DOI 10.1149/1.1603246; Hagiwara A, 2007, SOLID STATE IONICS, V178, P1123, DOI 10.1016/j.ssi.2007.05.005; Wang ZW, 2005, SOLID STATE IONICS, V176, P2555, DOI 10.1016/j.ssi.2005.07.013; Jorgensen MJ, 2001, SOLID STATE IONICS, V139, P1, DOI 10.1016/S0167-2738(00)00818-3; Adler SB, 2004, CHEM REV, V104, P4791, DOI 10.1021/cr020724o; Shimada H, 2014, SOLID STATE IONICS, V258, P38, DOI 10.1016/j.ssi.2014.01.036; Huang YY, 2004, J ELECTROCHEM SOC, V151, pA646, DOI 10.1149/1.1652053; Sonn V, 2008, J ELECTROCHEM SOC, V155, pB675, DOI 10.1149/1.2908860; Yasuda I, 1996, SOLID STATE IONICS, V86-8, P1197, DOI 10.1016/0167-2738(96)00287-1; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Esquirol A, 2004, J ELECTROCHEM SOC, V151, pA1847, DOI 10.1149/1.1799391; Fukunaga H, 1996, SOLID STATE IONICS, V86-8, P1179, DOI 10.1016/0167-2738(96)00284-6; Brichzin V, 2000, ELECTROCHEM SOLID ST, V3, P403, DOI 10.1149/1.1391160; Primdahl S, 1999, J ELECTROCHEM SOC, V146, P2827, DOI 10.1149/1.1392015; Shimada H, 2011, J ELECTROCHEM SOC, V158, pB1341, DOI 10.1149/2.037111jes; Jorgensen MJ, 2001, J ELECTROCHEM SOC, V148, pA433, DOI 10.1149/1.1360203; vanHeuveln FH, 1997, J ELECTROCHEM SOC, V144, P126, DOI 10.1149/1.1837374; Primdahl S, 1998, J ELECTROCHEM SOC, V145, P2431, DOI 10.1149/1.1838654; Huang YY, 2004, J ELECTROCHEM SOC, V151, pA1592, DOI 10.1149/1.1789371; Hagiwara A, 2007, SOLID STATE IONICS, V178, P1552, DOI 10.1016/j.ssi.2007.08.009; Kawada T, 2002, J ELECTROCHEM SOC, V149, pE252, DOI 10.1149/1.1479728; Finklea H, 2013, J ELECTROCHEM SOC, V160, pF1055, DOI 10.1149/2.093309jes; Adler SB, 2002, J ELECTROCHEM SOC, V149, pE166, DOI 10.1149/1.1467368; KAWADA T, 1992, SOLID STATE IONICS, V50, P189, DOI 10.1016/0167-2738(92)90218-E; MIZUSAKI J, 1991, J ELECTROCHEM SOC, V138, P1867, DOI 10.1149/1.2085891; Cimenti M, 2007, FUEL CELLS, V7, P364, DOI 10.1002/fuce.200700019; Ullmann H, 2000, SOLID STATE IONICS, V138, P79, DOI 10.1016/S0167-2738(00)00770-0; CLAUSEN C, 1994, SOLID STATE IONICS, V70, P59, DOI 10.1016/0167-2738(94)90287-9; Radhakrishnan R, 2005, J ELECTROCHEM SOC, V152, pA210, DOI 10.1149/1.1829415; Mogensen M, 1996, SOLID STATE IONICS, V86-8, P1151, DOI 10.1016/0167-2738(96)00280-9; YAMAMOTO O, 1987, SOLID STATE IONICS, V22, P241, DOI 10.1016/0167-2738(87)90039-7; Shimada H, 2011, SOLID STATE IONICS, V193, P43, DOI 10.1016/j.ssi.2011.04.010; Bessler WG, 2006, J ELECTROCHEM SOC, V153, pA1492, DOI 10.1149/1.2205150; Kenjo T, 1996, J ELECTROCHEM SOC, V143, pL92, DOI 10.1149/1.1836611; Choi JH, 2001, ELECTROCHIM ACTA, V46, P867, DOI 10.1016/S0013-4686(00)00666-6; Cimenti M, 2007, FUEL CELLS, V7, P377, DOI 10.1002/fuce.200700020; de Levie R., 1963, ELECTROCHIM ACTA, V8, P751, DOI 10.1016/0013-4686(63)80042-0; Dunyushkina LA, 2005, J ELECTROCHEM SOC, V152, pA1668, DOI 10.1149/1.1945729; Fukunaga H., 2007, ELECTROCHEM SOLID ST, V10, P1; Gao M, 2008, KEY ENG MAT, V373-374, P641; Herbstritt D, 2001, ELEC SOC S, V2001, P349; Horita T, 2002, J POWER SOURCES, V106, P224, DOI 10.1016/S0378-7753(01)01017-5; Jiang SP, 2005, J ELECTROCHEM SOC, V152, pA1398, DOI 10.1149/1.1928167; Kamata H, 1998, SOLID STATE IONICS, V106, P237, DOI 10.1016/S0167-2738(97)00495-5; Kawada T, 2006, SOLID STATE IONICS, V177, P3081, DOI 10.1016/j.ssi.2006.08.005; KENJO T, 1991, J ELECTROCHEM SOC, V138, P349, DOI 10.1149/1.2085587; Koyama M, 2001, J ELECTROCHEM SOC, V148, pA795, DOI 10.1149/1.1378290; Marinkovic ZV, 2004, MAT SCI ENG A-STRUCT, V375, P615, DOI 10.1016/j.msea.2003.10.270; OSTERGARD MJL, 1995, ELECTROCHIM ACTA, V40, P1971, DOI 10.1016/0013-4686(94)00332-U; TSUNEYOSHI K, 1989, SOLID STATE IONICS, V35, P263, DOI 10.1016/0167-2738(89)90306-8; VANROOSMALEN JAM, 1992, SOLID STATE IONICS, V52, P303, DOI 10.1016/0167-2738(92)90177-Q	60	2	2	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					F40	F53		10.1149/2.0211501jes		14	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700085		
J	Yamazaki, SI; Asazawa, K; Tanaka, H; Ioroi, T				Yamazaki, Shin-ichi; Asazawa, Koichiro; Tanaka, Hirohisa; Ioroi, Tsutomu			Fe Phthalocyanine-Based Catalyst for the Electro-Oxidation of N,N-Diaminourea and Hydrazine and Its Application in an Anion-Exchange Membrane Fuel Cell	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							ELECTROCATALYTIC OXIDATION; GRAPHITE-ELECTRODES; ELECTROCHEMICAL REACTIONS; ANODE ELECTROCATALYST; RH PORPHYRIN; ALCOHOLS; NI	We present a carbon-supported iron phthalocyanine catalyst for the electro-oxidation of N,N-diaminourea (DAU), a hydrazine derivative. This catalyst can oxidize DAU, which is scarcely oxidized by conventional metal electrodes. The onset potential reaches 0.3 V vs. a reversible hydrogen electrode, and the oxidation current of DAU is comparable to that of hydrazine. The activity of Co phthalocyanine was also examined; the Fe phthalocyanine catalyst exhibited a higher oxidation current for DAU than the Co phthalocyanine catalyst. The dependence of the activity on the concentration of DAU suggests that DAU forms a complex with Fe phthalocyanine. Based on this concentration-dependence and an HPLC (high performance liquid chromatography) analysis of DAU hydrolysis, it was shown that hydrolysis of DAU in an electrolyte solution does not significantly affect the electro-oxidation of DAU by a carbon-supported Fe phthalocyanine. We made an anion-exchange membrane fuel cell that incorporates Fe phthalocyanine as an anode catalyst. This cell delivered considerable electricity when DAU was supplied as a fuel (open circuit potential: 0.59 V, short circuit current: 69 mAcm(-2) at room temperature). (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License (CC BY-NC-ND, http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is not changed in any way and is properly cited. For permission for commercial reuse, please email:oa@electrochem.org. All rights reserved.	[Yamazaki, Shin-ichi; Ioroi, Tsutomu] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan; [Asazawa, Koichiro; Tanaka, Hirohisa] DAIHATSU Motor Co Ltd, Frontier Technol R&D Dept, Ryuo, Shiga 5202593, Japan	Yamazaki, SI (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan.	s-yamazaki@aist.go.jp					ZAGAL JH, 1986, J ELECTROANAL CHEM, V210, P95, DOI 10.1016/0022-0728(86)90316-5; Annen SP, 2010, ANGEW CHEM INT EDIT, V49, P7229, DOI 10.1002/anie.201002234; Sakamoto T, 2013, J POWER SOURCES, V234, P252, DOI 10.1016/j.jpowsour.2013.01.181; Sakamoto T, 2014, J POWER SOURCES, V247, P605, DOI 10.1016/j.jpowsour.2013.08.107; Yamazaki S, 2005, J ELECTROANAL CHEM, V576, P253, DOI 10.1016/j.jelechem.2004.10.022; Bevilacqua M, 2012, ENERG ENVIRON SCI, V5, P8608, DOI 10.1039/c2ee22055e; Zagal JH, 2010, COORDIN CHEM REV, V254, P2755, DOI 10.1016/j.ccr.2010.05.001; Yin WX, 2008, J POWER SOURCES, V182, P520, DOI 10.1016/j.jpowsour.2008.04.028; Yamazaki S, 2010, ELECTROCHIM ACTA, V55, P753, DOI 10.1016/j.electacta.2009.09.028; Geraldo DA, 2008, ELECTROCHIM ACTA, V53, P8051, DOI 10.1016/j.electacta.2008.05.083; Yamada K, 2003, J POWER SOURCES, V115, P236, DOI 10.1016/S0378-7753(03)00008-9; EVANS GE, 1967, SCIENCE, V158, P1148, DOI 10.1126/science.158.3805.1148; Asazawa K, 2007, ANGEW CHEM INT EDIT, V46, P8024, DOI 10.1002/anie.200701334; Recio FJ, 2013, ELECTROCHEM COMMUN, V30, P34, DOI 10.1016/j.elecom.2013.01.024; KARP S, 1962, J AM CHEM SOC, V84, P906, DOI 10.1021/ja00865a006; Yamazaki S, 2006, ANGEW CHEM INT EDIT, V45, P3120, DOI 10.1002/anie.200504379; ZAGAL J, 1982, J ELECTROCHEM SOC, V129, P2242, DOI 10.1149/1.2123483; ZAGAL J, 1982, ELECTROCHIM ACTA, V27, P1373, DOI 10.1016/0013-4686(82)80026-1; Elouarzaki K, 2012, J AM CHEM SOC, V134, P14078, DOI 10.1021/ja304589m; Li XF, 2003, J ELECTROANAL CHEM, V553, P139, DOI 10.1016/S0022-0728(03)00307-3; Yamazaki S, 2012, J POWER SOURCES, V204, P79, DOI 10.1016/j.jpowsour.2011.12.056; Asazawa K, 2009, J POWER SOURCES, V191, P362, DOI 10.1016/j.jpowsour.2009.02.009; Yamazaki S, 2010, CHEM COMMUN, V46, P3607, DOI 10.1039/c003026k; Linares C, 2003, J SOLID STATE ELECTR, V7, P626, DOI 10.1007/s10008-003-0437-1; Ardiles P, 2001, J MOL CATAL A-CHEM, V165, P169, DOI 10.1016/S1381-1169(00)00411-8; Serov A., 2014, ANGEW CHEM IN PRESS; SHUSTINA R, 1989, J CHROMATOGR, V464, P208; Yamada K, 2003, J POWER SOURCES, V122, P132, DOI 10.1016/S0378-7753(03)00440-3; Yamazaki S, 2010, J PHYS CHEM C, V114, P21856, DOI 10.1021/jp107887x; Yamazaki S, 2011, CATAL TODAY, V170, P141, DOI 10.1016/j.cattod.2011.01.045; Yamazaki S, 2012, CHEM COMMUN, V48, P4353, DOI 10.1039/c2cc30888f; Yamazaki S, 2010, PHYS CHEM CHEM PHYS, V12, P8969, DOI 10.1039/b925413g; Yamazaki S, 2011, ELECTROCHEM SOLID ST, V14, pB23, DOI 10.1149/1.3516636; Yamazaki SI, 2009, ELECTROCHEM COMMUN, V11, P1109, DOI 10.1016/j.elecom.2009.03.039; ZAGAL JH, 1985, ELECTROCHIM ACTA, V30, P449, DOI 10.1016/0013-4686(85)80033-5; ZAGAL JH, 1992, COORDIN CHEM REV, V119, P89, DOI 10.1016/0010-8545(92)80031-L; ZAGAL JH, 1980, J ELECTROANAL CHEM, V109, P389, DOI 10.1016/S0022-0728(80)80140-9	37	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					F60	F64		10.1149/2.0531501jes		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700087		
J	Abbott, DF; Petrykin, V; Okube, M; Bastl, Z; Mukerjee, S; Krtil, P				Abbott, Daniel F.; Petrykin, Valery; Okube, Maki; Bastl, Zdenk; Mukerjee, Sanjeev; Krtil, Petr			Selective Chlorine Evolution Catalysts Based on Mg-Doped Nanoparticulate Ruthenium Dioxide	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							RUO2-DOPED NI/CO3O4 ELECTRODES; OXYGEN EVOLUTION; ALKALINE-SOLUTIONS; CATHODIC BEHAVIOR; OXIDE SURFACES; ELECTROCATALYSIS	Nanocrystalline Mg-doped ruthenium dioxide catalysts with the formula Ru1-xMgxO2 (0 <= x <= 20) were synthesized by the sprayfreezing freeze-drying technique. Synthesized materials are of nanoparticulate nature and show a single phase diffraction pattern conforming to a tetragonal oxide of the rutile structural type. Magnesium ions are not distributed homogeneously in the material, but exist in Mg-rich clusters as shown by X-ray absorption spectroscopy. The refinement of the Mg EXAFS functions for materials with low Mg content shows that the magnesium rich clusters contain Mg in a highly strained environment similar to that of the rutile-type structure. The Mg environment shifts to an ilmenite-type inclusion when Mg occupies more than 10% of all cationic positions. All Mg modified materials are active in oxygen evolution and chlorine evolution reactions. Although the Mg containing catalysts show lower overall activities compared with the non-doped ruthenia, they feature enhanced selectivity toward the chlorine evolution process, which is attributed primarily to the opening of a reaction pathway for chlorine evolution associated with presence of Mg modified active sites. (C) 2014 The Electrochemical Society. All rights reserved.	[Abbott, Daniel F.; Petrykin, Valery; Bastl, Zdenk; Krtil, Petr] Acad Sci Czech Republic, J Heyrovsk Inst Phys Chem, Prague, Czech Republic; [Abbott, Daniel F.; Mukerjee, Sanjeev] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Okube, Maki] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan	Abbott, DF (reprint author), Acad Sci Czech Republic, J Heyrovsk Inst Phys Chem, Prague, Czech Republic.	Petr.Krtil@jh-inst.cas.cz	Bastl, Zdenek/H-6747-2014		European Commission [214936]; KEK of Japan [2013R-35, 2009R-29]	This work was supported by the European Commission within the Initial Training Network ELCAT (Project No. 214936). The synchrotron measurement time was provided by the KEK of Japan within the projects 2013R-35 and 2009R-29.	Rossmeisl J, 2007, J ELECTROANAL CHEM, V607, P83, DOI 10.1016/j.jelechem.2006.11.008; Halck NB, 2014, PHYS CHEM CHEM PHYS, V16, P13682, DOI 10.1039/c4cp00571f; Man IC, 2011, CHEMCATCHEM, V3, P1159, DOI 10.1002/cctc.201000397; Trasatti S, 2000, ELECTROCHIM ACTA, V45, P2377, DOI 10.1016/S0013-4686(00)00338-8; Wu X, 2011, INT J HYDROGEN ENERG, V36, P14796, DOI 10.1016/j.ijhydene.2011.01.067; Petrykin V, 2011, CHEM MATER, V23, P200, DOI 10.1021/cm1028782; Petrykin V, 2010, ANGEW CHEM INT EDIT, V49, P4813, DOI 10.1002/anie.200907128; Makarova MV, 2008, ELECTROCHIM ACTA, V53, P2656, DOI 10.1016/j.electacta.2007.01.084; Xiong K, 2013, J APPL ELECTROCHEM, V43, P847, DOI 10.1007/s10800-013-0570-1; KRSTAJIC N, 1995, J ELECTROCHEM SOC, V142, P2675; Gaudet J, 2005, CHEM MATER, V17, P1570, DOI 10.1021/cm0481291; Hansen HA, 2010, PHYS CHEM CHEM PHYS, V12, P283, DOI 10.1039/b917459a; Tretyakov YD, 1999, J MATER CHEM, V9, P19; BURKE LD, 1977, J CHEM SOC FARAD T 1, V73, P1659, DOI 10.1039/f19777301659; Hummelgard C, 2013, MATER SCI ENG B-ADV, V178, P1515, DOI 10.1016/j.mseb.2013.08.018; TRASATTI S, 1984, ELECTROCHIM ACTA, V29, P1503, DOI 10.1016/0013-4686(84)85004-5; Petrykin V, 2009, J PHYS CHEM C, V113, P21657, DOI 10.1021/jp904935e; Bard AJ, 2001, ELECTROCHEMICAL METH; Briggs D., 2003, SURFACE ANAL AUGER X, P326; Exner KS, 2014, ELECTROCHIM ACTA, V120, P460, DOI 10.1016/j.electacta.2013.11.027; Krstajic N, 1998, J APPL ELECTROCHEM, V28, P1291, DOI 10.1023/A:1003444110172; Macounova K, 2008, ELECTROCHIM ACTA, V53, P6126, DOI 10.1016/j.electacta.2007.11.014; Macounova K, 2008, ELECTROCHEM SOLID ST, V11, pF27, DOI 10.1149/1.2978963; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Petrykin V., 2012, CATAL TODAY, V202, P63; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Silva L. M. D., 2000, ELECTROCHIM ACTA, V45, P2719; Silva L. M. D., 2002, J ELECTROANAL CHEM, V532, P141; Silva L.M. D., 2001, ELECTROCHIM ACTA, V46, P1369; Wyckoff R.W.G., 1935, STRUCTURE CRYSTALS	30	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					H23	H31		10.1149/2.0541501jes		9	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700100		
J	Kim, E; Bae, H; Ko, Y; Fujii, K; Park, HJ; Jeong, T; Lee, HJ; Oh, TS; Ha, JS				Kim, Eunsook; Bae, Hyojung; Ko, Younghee; Fujii, Katsushi; Park, Hyung-Jo; Jeong, Tak; Lee, Hyo-Jong; Oh, Tae-Sung; Ha, Jun-Seok			Effect of Double-Layered n-Type GaN on the Photoelectrochemical Properties in NaOH Aqueous Solution	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							HYDROGEN GENERATION; TIME-VARIATION; WATER; PHOTOELECTROLYSIS; PHOTOCURRENT; ELECTROLYTE; ENERGY; CELLS	In this study, photoelectrochemical properties of a double-layered n-type GaN in NaOH aqueous solution were investigated. Several electrical properties such as impedance, photocurrent-voltage property, and photocurrent-time relationship were examined for comparison. After the measurement the electrical properties, the surface of GaN photoelectrodes were observed by field emission scanning electron microscope to confirm the electrolytic corrosion. The results of this study indicate that the double-layered n-GaN electrode increased the photocurrent density compared to the single-layered electrode. Moreover, the surface of the double-layered n-GaN electrode was more stable than that of the single-layered n-GaN, indicating that surface layer preserved the lower layer from photocorrosion, and also its depletion length was enough to help the movement of carriers. These results show that the double-layered n-GaN electrode has more advantages than the single-layered n-GaN electrode. (C) 2014 The Electrochemical Society. All rights reserved.	[Kim, Eunsook; Bae, Hyojung; Ko, Younghee; Ha, Jun-Seok] Chonnam Natl Univ, Sch Appl Chem Engn, Kwangju 500757, South Korea; [Fujii, Katsushi] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Park, Hyung-Jo; Jeong, Tak] Korea Photon Technol Inst, Kwangju 500460, South Korea; [Lee, Hyo-Jong] Dong A Univ, Dept Mat Sci & Engn, Pusan 604714, South Korea; [Oh, Tae-Sung] Hongik Univ, Dept Mat Sci & Engn, Seoul 121791, South Korea	Kim, E (reprint author), Chonnam Natl Univ, Sch Appl Chem Engn, Kwangju 500757, South Korea.	jsha@jnu.ac.kr			National Research Foundation of Korea [2012-0047761, 2012-0008281]	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (Project Nos. 2012-0047761 and 2012-0008281).	Abea R., 2010, J PHOTOCH PHOTOBIO C, V11, P179; Bak T, 2002, INT J HYDROGEN ENERG, V27, P991, DOI 10.1016/S0360-3199(02)00022-8; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Fujii K, 2006, PHYS STATUS SOLIDI C, V3, P2270, DOI 10.1002/pssc.200565171; Nakamura S, 1997, SOLID STATE COMMUN, V102, P237, DOI 10.1016/S0038-1098(96)00722-3; KAINTHLA RC, 1987, J ELECTROCHEM SOC, V134, P841, DOI 10.1149/1.2100583; Nozik AJ, 1996, J PHYS CHEM-US, V100, P13061, DOI 10.1021/jp953720e; Akikusa J, 2002, INT J HYDROGEN ENERG, V27, P863, DOI 10.1016/S0360-3199(01)00191-4; Turner JA, 1999, SCIENCE, V285, P687, DOI 10.1126/science.285.5428.687; Beach JD, 2003, J ELECTROCHEM SOC, V150, pA899, DOI 10.1149/1.1577542; Fujii K, 2005, JPN J APPL PHYS 1, V44, P7433, DOI 10.1143/JJAP.44.7433; Fujii K, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000937; Fujii K, 2010, J PHYS CHEM C, V114, P22727, DOI 10.1021/jp104403s; Fujii K, 2007, JPN J APPL PHYS 1, V46, P6573, DOI 10.1143/JJAP.46.6573; Fujii K, 2005, JPN J APPL PHYS 2, V44, pL543, DOI 10.1143/JJAP.44.L543; Huygens IM, 2000, J ELECTROCHEM SOC, V147, P1797, DOI 10.1149/1.1393436; JOHNSON WC, 1971, IEEE T ELECTRON DEV, VED18, P965, DOI 10.1109/T-ED.1971.17311; Kocha SS, 1995, J ELECTROCHEM SOC, V142, pL238, DOI 10.1149/1.2048511; Koike K, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983450; Liu SY, 2010, J ELECTROCHEM SOC, V157, pB266, DOI 10.1149/1.3270485; Ono M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432116; Sato K, 2009, PHYS STATUS SOLIDI C, V6, pS635, DOI 10.1002/pssc.200880814	22	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	1					H19	H22		10.1149/2.0501501jes		4	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0JZ	WOS:000345979700098		
J	Lee, YS; Niinomi, M; Nakai, M; Narita, K; Cho, K				Lee, Yoon-Seok; Niinomi, Mitsuo; Nakai, Masaaki; Narita, Kengo; Cho, Ken			Predominant factor determining wear properties of beta-type and (alpha plus beta)-type titanium alloys in metal-to-metal contact for biomedical applications	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Ti-6Al-4V; Ti-29Nb-13Ta-4.6Zr; Oxidative; Abrasive; Adhesive; Delamination	DRY SLIDING WEAR; MECHANICAL-PROPERTIES; DELAMINATION; BEHAVIOR; TI-6AL-4V; PARTICLES; CORROSION; COATINGS; IMPLANTS; DIAMOND	The predominant factor determining the wear properties of a new titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ) and a conventional titanium alloy, Ti-6Al-4V extra-low interstitial (Ti64) was investigated for TNTZ and Ti64 combinations in metal-to-metal contacting bioimplant applications. The worn surfaces, wear debris, and subsurface damages were analyzed using a scanning electron microscopy combined with energy-dispersive spectroscopy and electron-back scattered diffraction analysis. The volume loss of TNTZ is found to be larger than that of Ti64, regardless of the mating material. The wear track of TNTZ exhibits the galled regions and severe plastic deformation with large flake-like debris, indicative of delamination wear, which strongly suggests the occurrence of adhesive wear. Whereas, the wear track of Ti64 have a large number of regular grooves and microcuttings with cutting chip-like wear debris and microfragmentation of fine oxide debris, indicative of abrasive wear combined with oxidative wear. This difference in the wear type is caused by severe and mild subsurface deformations of TNTZ and Ti64, respectively. The lower resistance to plastic shearing for TNTZ compared to that of Ti64 induces delamination, resulting in a higher wear rate. (C) 2014 Elsevier Ltd. All rights reserved.	[Lee, Yoon-Seok] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Niinomi, Mitsuo; Nakai, Masaaki; Narita, Kengo; Cho, Ken] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Lee, YS (reprint author), Tohoku Univ, Aoba Ku, 6-6 Aoba, Sendai, Miyagi 9808579, Japan.	yoonseok@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp; nakai@imr.tohoku.ac.jp; narita@imr.tohoku.ac.jp; k_cho@imr.tohoku.ac.jp	Narita, Kengo/C-4332-2015; Nakai, Masaaki/C-1919-2009; Niinomi, Mitsuo/B-5965-2011		New Energy and Industrial Technology Development Organization (NEDO); Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported in part by the Industrial Technology Research Grant Program in 2009 from the New Energy and Industrial Technology Development Organization (NEDO), Grant-in-Aid for Scientific Research (A), Young Scientists (A), Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS), and the Inter-University Cooperative Research Program "Innovation Research for Biosis-Abiosis Intelligent Interface" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Akahori T, 2008, MATER TRANS, V49, P166, DOI 10.2320/matertrans.MRA2007210; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Yang XP, 1999, MACH SCI TECHNOL, V3, P107, DOI 10.1080/10940349908945686; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; SUH NP, 1977, WEAR, V44, P1, DOI 10.1016/0043-1648(77)90081-3; HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0; RAE T, 1986, BIOMATERIALS, V7, P30, DOI 10.1016/0142-9612(86)90085-2; El-Tayeb NSM, 2010, P I MECH ENG J-J ENG, V224, P395, DOI 10.1243/13506501JET703; Leyland A, 2000, WEAR, V246, P1, DOI 10.1016/S0043-1648(00)00488-9; Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X; Kirkpatrick JS, 2005, J SPINAL DISORD TECH, V18, P247; Cvijovic-Alagic I, 2011, CORROS SCI, V53, P796, DOI 10.1016/j.corsci.2010.11.014; Hallab NJ, 2003, CORROS REV, V21, P183; RIGNEY DA, 1992, WEAR, V152, P187, DOI 10.1016/0043-1648(92)90214-S; Ni WY, 2004, APPL PHYS LETT, V85, P4028, DOI 10.1063/1.1811377; BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T; Straffelini G, 1999, WEAR, V236, P328, DOI 10.1016/S0043-1648(99)00292-6; PERRY SS, 1993, J APPL PHYS, V74, P7542, DOI 10.1063/1.354980; WATERHOUSE RB, 1977, WEAR, V45, P355, DOI 10.1016/0043-1648(77)90026-6; Leyland A, 2004, SURF COAT TECH, V177, P317, DOI 10.1016/j.surfcoat.2003.09.011; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Molinari A, 1997, WEAR, V208, P105, DOI 10.1016/S0043-1648(96)07454-6; Czichos H., 1978, TRIBOLOGY SYSTEM APP; DALLY JW, 1990, WEAR, V141, P95, DOI 10.1016/0043-1648(90)90195-G; HOKKIRIGAWA K, 1988, TRIBOL INT, V21, P51, DOI 10.1016/0301-679X(88)90128-4; Hutchings I. M., 1992, TRIBOLOGY FRICTION W; JAHANMIR S, 1974, WEAR, V28, P235, DOI 10.1016/0043-1648(74)90164-1; Kester DJ, 1999, SURF COAT TECH, V113, P268, DOI 10.1016/S0257-8972(99)00003-1; Rabinowicz E., 1995, FRICTION WEAR MAT; Wilson S., 1999, WEAR, P225; Yingjie L., 1985, TRIBOL INT, V18, P107, DOI 10.1016/0301-679X(85)90047-7; ZHANG J, 1993, MAT SCI ENG A-STRUCT, V160, P25, DOI 10.1016/0921-5093(93)90494-Y	32	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2015	41						208	220		10.1016/j.jmbbm.2014.10.005		13	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AW3XW	WOS:000346217400020		
J	Chang, TS; Tone, K; Wu, CH				Chang, Tsung-Sheng; Tone, Kaoru; Wu, Chen-Hui			Past-present-future Intertemporal DEA models	JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY			English	Article						data envelopment analysis; intertemporal; performance evaluation; dynamic; R&D; market value	RESEARCH-AND-DEVELOPMENT; DATA ENVELOPMENT ANALYSIS; PERFORMANCE; MANAGEMENT; EFFICIENCY	It has been well recognized that to thoroughly evaluate a firm's performance, the evaluator must assess not only its past and present records but also future potential. However, to the best of our knowledge, there are no data envelopment analysis (DEA)-type models proposed in the literature that simultaneously take past, present and, especially, future performance indicators into account. Hence, this research aims at developing a new type of DEA model referred to as Intertemporal DEA models that can be used to fully measure a firm's efficiency by explicitly considering its key inputs and outputs involving the past-present-future time span. In this research, the proposed Intertemporal DEA models are applied to the performance evaluation of high-tech Integrated Circuit design companies in Taiwan to demonstrate their advantages over other DEA models that ignore intertemporal efficiency.	[Chang, Tsung-Sheng] Natl Chiao Tung Univ, Hsinchu 30010, Taiwan; [Tone, Kaoru] Natl Grad Inst Policy Studies, Tokyo, Japan; [Wu, Chen-Hui] Natl Dong Hwa Univ, Shoufeng Township, Taiwan	Chang, TS (reprint author), Natl Chiao Tung Univ, Dept Transportat & Logist Management, 1001 Univ Rd, Hsinchu 30010, Taiwan.	tsc@nctu.edu.tw					Linton JD, 2002, R&D MANAGE, V32, P139, DOI 10.1111/1467-9310.00246; Tone K, 2010, OMEGA-INT J MANAGE S, V38, P145, DOI 10.1016/j.omega.2009.07.003; Wu WY, 2006, R&D MANAGE, V36, P531, DOI 10.1111/j.1467-9310.2006.00452.x; Demsetz H, 2001, J CORP FINANC, V7, P209, DOI 10.1016/S0929-1199(01)00020-7; HENDERSON R, 1994, STRATEGIC MANAGE J, V15, P63, DOI 10.1002/smj.4250150906; Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5; Werner BM, 1997, RES TECHNOL MANAGE, V40, P34; Adams R, 2006, INT J MANAG REV, V8, P21, DOI 10.1111/j.1468-2370.2006.00119.x; Hagedoorn J, 2003, RES POLICY, V32, P1365, DOI 10.1016/S0048-7333(02)00137-3; Peterson RA, 2010, J ACAD MARKET SCI, V38, P677, DOI 10.1007/s11747-010-0188-3; Charnes A, 1985, ANN OPER RES, V2, P95; COLSON G, 1980, COMPUT OPER RES, V7, P125, DOI 10.1016/0305-0548(80)90020-9; Connolly RA, 2005, R&D MANAGE, V35, P217, DOI 10.1111/j.1467-9310.2005.00384.x; Cooper W W, 2007, DATA ENVELOPMENT ANA; Duysters G, 2001, J INT BUS STUD, V32, P347, DOI 10.1057/palgrave.jibs.8490956; Fare R, 1996, INTERTEMPORAL PRODUC; FARE R, 1994, AM ECON REV, V84, P66; Hall B. H., 2000, PRODUCTIVITY INNOVAT; Jensen M. C., 2001, J APPL CORPORATE FIN, V14, P8, DOI 10.1111/j.1745-6622.2001.tb00434.x; KEEFER DL, 1983, MANAGE SCI, V29, P595, DOI 10.1287/mnsc.29.5.595; Kerssens-van Drongelen IC, 2000, INT J MANAG REV, V2, P111, DOI 10.1111/1468-2370.00034; KUWAHARA Y, 1990, IEEE T ENG MANAGE, V37, P134, DOI 10.1109/17.53716; LANG LHP, 1994, J POLIT ECON, V102, P1248, DOI 10.1086/261970; SUEYOSHI T, 1995, EUR J OPER RES, V86, P216, DOI 10.1016/0377-2217(94)00179-G	24	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0160-5682	1476-9360		J OPER RES SOC	J. Oper. Res. Soc.	JAN	2015	66	1					16	32		10.1057/jors.2013.139		17	Management; Operations Research & Management Science	Business & Economics; Operations Research & Management Science	AW4XU	WOS:000346281800002		
J	Taniguchi, H; Shimada, M; McIntyre, M				Taniguchi, Hatsumi; Shimada, Mieki; McIntyre, Meredith			Japanese Men's Success in Altered Fatherhood Role in a Foreign Country	JOURNAL OF TRANSCULTURAL NURSING			English	Article						fatherhood; transition; foreign country; phenomenology; Japanese	EXPERIENCES; MOTHERHOOD; TRANSITION; SWEDEN; HEALTH	This study explores the meaning of the lived experience of childbirth and parenting of Japanese men who became fathers in a foreign country. Japanese men have been raised to maintain very strict gender roles, excluding them from sharing with their wives the experience of childbirth and the day-to-day parenting of young children. The study employed a descriptive phenomenological approach with in-depth interviews. Participants included nine Japanese men born and raised in Japan who were living in Honolulu. Three theme categories emerged from the data: making active efforts in preparation for childbirth in a foreign country; challenges in pregnancy, childbirth, child care, and as husbands or partners; and challenges in transition to parenthood. Japanese men successfully altered their transitional and authoritarian gender role to a family orientated social structure, under the influence of Western values, when living in foreign country. By spending more time with their new family, they acknowledged the processes of becoming a father. The ability to adapt their expectations of fatherhood in line with Western values was enhanced by the support of coworkers, their mature age, rich educational background, and the personal financial resources of the male participants in the study.	[Taniguchi, Hatsumi] Kyushu Univ, Fukuoka 8128582, Japan; [Shimada, Mieki] Osaka Univ, Osaka, Japan; [McIntyre, Meredith] Monash Univ, Frankston, Vic, Australia	Taniguchi, H (reprint author), Kyushu Univ, Grad Sch Med, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hatsumi@hs.med.kyushu-u.ac.jp					Greenhalgh R, 2000, BIRTH-ISS PERINAT C, V27, P177, DOI 10.1046/j.1523-536x.2000.00177.x; Draper J, 2002, J ADV NURS, V39, P563, DOI 10.1046/j.1365-2648.2002.02325.x; Ingram J, 2004, MIDWIFERY, V20, P367, DOI 10.1016/j.midw.2004.04.003; Giorgi A, 2005, NURS SCI QUART, V18, P75, DOI 10.1177/0894318404272112; Premberg A, 2008, SCAND J CARING SCI, V22, P56, DOI 10.1111/j.1471-6712.2007.00584.x; Fontenot HB, 2007, JOGNN-J OBST GYN NEO, V36, P175, DOI 10.1111/J.1552-6909.2007.00134.x; Liamputtong P, 2003, MIDWIFERY, V19, P27, DOI 10.1054/midw.2002.0333; Castillo J., 2010, MATERN CHILD HLTH J, V15, P1342; Colaizzi P.F., 1978, EXISTENTIAL PHENOMEN, P48; Diani F, 2003, J Obstet Gynaecol, V23, P615; Genesoni L, 2009, BIRTH-ISS PERINAT C, V36, P305, DOI 10.1111/j.1523-536X.2009.00358.x; Iwata Hiroko, 2003, J Transcult Nurs, V14, P297, DOI 10.1177/1043659603256456; Kaplan W., 2004, INT J CHILDBIRTH ED, V19, P14; Koppel GT, 2001, J REPROD INFANT PSYC, V19, P249; Lincoln Y. S., 1985, NATURALISTIC INQUIRY; Lopez A. K., 2004, QUALITATIVE HLTH RES, V14, P726; Morse J., 2002, README 1 USERS QUALI; Moustakas C., 1994, PHENOMENOLOGICAL RES; Ny P, 2008, MIDWIFERY, V24, P281, DOI 10.1016/j.midw.2006.05.006; Pontes C. M., 2007, MIDWIFERY, V25, P195; Taniguchi H, 2009, NURS HEALTH SCI, V11, P271, DOI 10.1111/j.1442-2018.2009.00452.x; Tummala-Narra Pratyusha, 2004, Am J Psychoanal, V64, P167, DOI 10.1023/B:TAJP.0000027271.27008.60; White G., 2007, BRIT J MIDWIFERY, V15, P39; Wiklund H, 2000, MIDWIFERY, V16, P105, DOI 10.1054/midw.1999.0197	24	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1043-6596	1552-7832		J TRANSCULT NURS	J. Transcult. Nurs.	JAN	2015	26	1					39	46		10.1177/1043659614524231		8	Nursing	Nursing	AW4QN	WOS:000346265900008		
J	Yasaki, H; Onoshima, D; Yasui, T; Yukawa, H; Kaji, N; Baba, Y				Yasaki, Hirotoshi; Onoshima, Daisuke; Yasui, Takao; Yukawa, Hiroshi; Kaji, Noritada; Baba, Yoshinobu			Microfluidic transfer of liquid interface for parallel stretching and stamping of terminal-unmodified single DNA molecules in zigzag-shaped microgrooves	LAB ON A CHIP			English	Article							ATOMIC-FORCE MICROSCOPY; SURFACES; ARRAYS; FLUORESCENCE; BINDING	The molecular stretching of DNA is an indispensable tool for the optical exploration of base sequences and epigenomic changes of DNA at a single molecule level. In stretching terminal-unmodified DNA molecules parallel to each other on solid substrate, the receding meniscus assembly and capillary force through the dewetting process are quite useful. These can be achieved by pulling the substrate out of the DNA solution or sliding a droplet of DNA solution between a pair of substrates. However, currently used methods do not allow control over liquid interface motion and single-molecule DNA positioning. Here, we show a microfluidic device for stretching DNA molecules by syringing through microgrooves. The device can trap single DNA molecules at vertices of the microgrooves, which were designed as parallel zigzag lines. Different zigzag pattern depths, sizes, and shapes were studied to evaluate the adsorption possibility of DNA on the surface. The microfluidic transfer of the liquid interface stretched over 1500 DNA molecules simultaneously. The stretched DNA molecules could be stamped to a silanized surface. The device will therefore serve as a template preparation for high-resolution DNA imaging studies.	[Yasaki, Hirotoshi; Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yasaki, Hirotoshi; Onoshima, Daisuke; Yasui, Takao; Yukawa, Hiroshi; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, FIRST Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Onoshima, Daisuke; Baba, Yoshinobu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Yasaki, H (reprint author), Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	yasaki.hirotoshi@e.mbox.nagoya-u.ac.jp; onoshima-d@nanobio.nagoya-u.ac.jp			Japan Society for the Promotion of Science through its "Funding Program for World-Leading Innovative R&D on Science and Technology"; Japan Society for the Center of Innovation Program from Japan Science and Technology Agency, JST	This research is supported by the Japan Society for the Promotion of Science through its "Funding Program for World-Leading Innovative R&D on Science and Technology". This research is partly supported by the Japan Society for the Center of Innovation Program from Japan Science and Technology Agency, JST.	Aline C., 2011, NANO LETT, V11, P4232; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Hu J, 1996, LANGMUIR, V12, P1697, DOI 10.1021/la950874c; Gentile F, 2012, NANO LETT, V12, P6453, DOI 10.1021/nl3039162; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Kim S, 2012, ANGEW CHEM INT EDIT, V51, P3578, DOI 10.1002/anie.201107714; Allemand JF, 1997, BIOPHYS J, V73, P2064; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Michaeli Y, 2013, CHEM COMMUN, V49, P8599, DOI 10.1039/c3cc42543f; Yokota H, 1999, ANAL CHEM, V71, P4418, DOI 10.1021/ac9902695; Petit CAP, 2003, NANO LETT, V3, P1141, DOI 10.1021/nl034341x; Kim JH, 2007, LANGMUIR, V23, P755, DOI 10.1021/la062505u; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Deng ZX, 2003, NANO LETT, V3, P1545, DOI 10.1021/nl034720q; Guan JJ, 2005, P NATL ACAD SCI USA, V102, P18321, DOI 10.1073/pnas.0506902102; CAI WW, 1995, P NATL ACAD SCI USA, V92, P5164, DOI 10.1073/pnas.92.11.5164; Yasui T, 2011, ANAL CHEM, V83, P6635, DOI 10.1021/ac201184t; Bjork P, 2006, SMALL, V2, P1068, DOI 10.1002/smll.200600126; Cerf A, 2011, ANAL CHEM, V83, P8073, DOI 10.1021/ac202506j; Charlot B, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4863575; Georgette B., 2008, NANO LETT, V8, P1785; Gorman J., 2009, LANGMUIR, V26, P1372, DOI DOI 10.1021/LA902443E; Gueroui Z, 2002, P NATL ACAD SCI USA, V99, P6005, DOI 10.1073/pnas.092561399; Kaji N, 2010, CHEM SOC REV, V39, P948, DOI 10.1039/b900410f; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Li JW, 1998, NUCLEIC ACIDS RES, V26, P4785, DOI 10.1093/nar/26.20.4785; Lin CH, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3474639; Shin M, 2006, NANO LETT, V6, P1334, DOI 10.1021/nl060160u; Woolley AT, 2001, NANO LETT, V1, P345, DOI 10.1021/nl0155476	31	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1473-0197	1473-0189		LAB CHIP	Lab Chip		2015	15	1					135	140		10.1039/c4lc00990h		6	Biochemical Research Methods; Chemistry, Multidisciplinary; Nanoscience & Nanotechnology	Biochemistry & Molecular Biology; Chemistry; Science & Technology - Other Topics	AW7YQ	WOS:000346478100017		
J	Cho, H; Kim, J; Suga, K; Ishigami, T; Park, H; Bang, JW; Seo, S; Choi, M; Chang, PS; Umakoshi, H; Jung, S; Suh, KY				Cho, Hyesung; Kim, Junsoo; Suga, Keishi; Ishigami, Takaaki; Park, Hyunchul; Bang, Jung Won; Seo, Soonmin; Choi, Mansoo; Chang, Pahn-Shick; Umakoshi, Hiroshi; Jung, Sup; Suh, Kahp-Yang			Microfluidic platforms with monolithically integrated hierarchical apertures for the facile and rapid formation of cargo-carrying vesicles	LAB ON A CHIP			English	Article							HYBRID NANOPARTICLES; DRUG-DELIVERY; LIPOSOMES; SIZE; CANCER	We fabricated a simple yet robust microfluidic platform with monolithically integrated hierarchical apertures. This platform showed efficient diffusive mixing of the introduced lipids through approximately 8000 divisions with tiny pores (similar to 5 mu m in diameter), resulting in massive, real-time production of various cargo-carrying particles via multi-hydrodynamic focusing.	[Cho, Hyesung; Choi, Mansoo; Jung, Sup; Suh, Kahp-Yang] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea; [Cho, Hyesung; Bang, Jung Won; Choi, Mansoo] Seoul Natl Univ, Global Frontier Ctr Multiscale Energy Syst, Seoul 151744, South Korea; [Bang, Jung Won; Choi, Mansoo] Seoul Natl Univ, Dept Mech & Aerosp Engn, Div WCU Multiscale Mech Design, Seoul 151744, South Korea; [Kim, Junsoo] Elect & Telecommun Res Inst, Energy Harvesting Devices Res Sect, Taejon 305700, South Korea; [Suga, Keishi; Ishigami, Takaaki; Umakoshi, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Osaka, Japan; [Park, Hyunchul] Korea Inst Sci & Technol, Ctr Mat Architecturing, Seoul 136791, South Korea; [Seo, Soonmin] Gachon Univ, Coll BioNano Technol, Gyeonggi, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Umakoshi, H (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Osaka, Japan.	Hiroshi.Umakoshi@cheng.es.osaka-u.ac.jp; jhs@snu.ac.kr		Park, Hyunchul/0000-0002-4025-6153	Global Frontier R&D Program on Center for Multiscale Energy System - National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea [2011-0031561, 2011-0031577]; International Research & Development Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) of Korea [2011-0031367]; Basic Science Research Program through the NRF - Ministry of Education [2013055323, 2013R1A1A2063019]; Basic Science Research Program through the NRF - Ministry of Education (New & Renewable Energy of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Knowledge Economy) [2011T100100679]	We gratefully acknowledge support from the Global Frontier R&D Program on Center for Multiscale Energy System funded by the National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea (2011-0031561, 2011-0031577). This work was also supported by the International Research & Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Korea (2011-0031367) and Basic Science Research Program through the NRF funded by the Ministry of Education (2013055323, 2013R1A1A2063019 and the New & Renewable Energy of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Knowledge Economy (No. 2011T100100679)). Prof. Kahp-Yang Suh sadly passed away before submission of this communication.	Moon JJ, 2011, NAT MATER, V10, P243, DOI [10.1038/nmat2960, 10.1038/NMAT2960]; van Swaay D, 2013, LAB CHIP, V13, P752, DOI 10.1039/c2lc41121k; Valencia PM, 2010, ACS NANO, V4, P1671, DOI 10.1021/nn901433u; Seth A, 2012, ADV MATER, V24, P3544, DOI 10.1002/adma.201200757; Gillet A, 2009, INT J PHARMACEUT, V380, P174, DOI 10.1016/j.ijpharm.2009.06.027; Sailor MJ, 2012, ADV MATER, V24, P3779, DOI 10.1002/adma.201200653; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Hood RR, 2014, LAB CHIP, V14, P2403, DOI 10.1039/c4lc00334a; Bae WG, 2014, ADV MATER, V26, P675, DOI 10.1002/adma.201303412; Jahn A, 2008, J NANOPART RES, V10, P925, DOI 10.1007/s11051-007-9340-5; Jahn A, 2004, J AM CHEM SOC, V126, P2674, DOI 10.1021/ja0318030; Holme MN, 2012, NAT NANOTECHNOL, V7, P536, DOI [10.1038/nnano.2012.84, 10.1038/NNANO.2012.84]; Suga K, 2013, LANGMUIR, V29, P4830, DOI 10.1021/la304768f; Valencia PM, 2012, NAT NANOTECHNOL, V7, P623, DOI 10.1038/nnano.2012.168; Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Kim YT, 2012, NANO LETT, V12, P3587, DOI 10.1021/nl301253v; Shimanouchi T, 2009, COLLOID SURFACE B, V73, P156, DOI 10.1016/j.colsurfb.2009.05.014; Stachowiak JC, 2008, P NATL ACAD SCI USA, V105, P4697, DOI 10.1073/pnas.0710875105; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; PARASASSI T, 1991, BIOPHYS J, V60, P179; Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010; Cho H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4137; Rhee M, 2011, ADV MATER, V23, pH79, DOI 10.1002/adma.201004333; Trevino Leo, 1994, Journal of Liposome Research, V4, P1017, DOI 10.3109/08982109409018619	26	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1473-0197	1473-0189		LAB CHIP	Lab Chip		2015	15	2					373	377		10.1039/c4lc01096e		5	Biochemical Research Methods; Chemistry, Multidisciplinary; Nanoscience & Nanotechnology	Biochemistry & Molecular Biology; Chemistry; Science & Technology - Other Topics	AW7YL	WOS:000346477500001		
J	Narrog, H				Narrog, Heiko			(Inter)subjectification and its limits in secondary grammaticalization	LANGUAGE SCIENCES			English	Article						(Inter-)subjectification; Grammaticalization; Speech-act orientation; Textual functions; De-(inter)subjectification; Case functions	SUBJECTIFICATION; ENGLISH; SPANISH	It is widely accepted that subjectification and intersubjectification are important processes of semantic change accompanying grammaticalization. However, typical changes of subjectification concern early stages of grammaticalization, and the role of subjectification and intersubjectification in late stages of grammaticalization is not yet fully explored. In this paper, I am looking for (1) regular changes other than (inter)subjectification in secondary grammaticalizations, and (2) counter-examples to the hypothesized directionalities of change. In doing so, I mainly look at the development of core case marking, at the development of elements with textual functions, and at presumptive counter-examples from other areas of grammar that have been proposed in the literature. I conclude that (1) the evolution of textual/discourse-functions is a significant development not captured in the canonical (inter-)subjectification scenario both in terms of concept and in terms of directionality, and (2) that de-subjectification and de-intersubjectification in terms of expressive (inter)subjectivity regularly takes place at later stages of grammaticalization. However, this de-(inter)subjectification mainly accompanies the development of highly paradigmatic and abstract meanings, and concerns a loss of subjectivity in terms of expressiveness. On the other hand, since meanings are increasingly appropriated for the expression of speaker-deixis and internal reasoning, the overall directionality of change can still be understood as speaker-, hearer- and text-orientation, and it might not be appropriate to label the overall development as 'de-subjectification' or 'objectification'. (C) 2014 Elsevier Ltd. All rights reserved.	Tohoku Univ, GSICS, Aoba Ku, Sendai, Miyagi 9808576, Japan	Narrog, H (reprint author), Tohoku Univ, GSICS, Aoba Ku, Kawauchi 41, Sendai, Miyagi 9808576, Japan.	narrog@gmail.com					Aaron JE, 2005, COGN LINGUIST, V16, P607, DOI 10.1515/cogl.2005.16.4.607; Abraham Werner, 2005, ORG GRAMMAR LINGUIST, P1; Adamson Sylvia, 1995, SUBJECTIVITY SUBJECT, P195, DOI 10.1017/CBO9780511554469.010; Anderson S. R., 1977, MECH SYNTACTIC CHANG, P317; Kaltenbock G, 2011, STUD LANG, V35, P852, DOI 10.1075/sl.35.4.03kal; Creissels D, 2008, FOLIA LINGUIST, V42, P1, DOI 10.1515/FLIN.2008.1; TRAUGOTT EC, 1989, LANGUAGE, V65, P31, DOI 10.2307/414841; Fitzmaurice S, 2004, DISCOURSE STUD, V6, P427, DOI 10.1177/1461445604046585; Rhee S, 2012, LANG SCI, V34, P284, DOI 10.1016/j.langsci.2011.10.004; Traugott EC, 2007, J HIST PRAGMAT, V8, P295, DOI 10.1075/jhp.8.2.07clo; Haspelmath M, 1999, LINGUISTICS, V37, P1043, DOI 10.1515/ling.37.6.1043; Breban T, 2008, FOLIA LINGUIST, V42, P259, DOI 10.1515/FLIN.2008.259; Breban Tine, 2006, SUBJECTIFICATION VAR, P241; BRINTON LJ, 2007, METHODS HIST PRAGMAT, V52, P37, DOI 10.1515/9783110197822.37; Coates J, 1983, SEMANTICS MODAL AUXI; Comillie Bert, 2006, BELG J LINGUIST, P20; Cornillie B, 2008, TYPOL ST L, V77, P55; Cornillie Bert, 2004, PRAGMATICS, V14, P1; Cornillie Bert, 2005, ANN REV COGNITIVE LI, V3, P56, DOI 10.1075/arcl.3.05cor; Davidse Kristin, 2010, GRAMMATICALIZATION S; Devos Maud, 2012, AFR LINGUIST, V18; Fitzmaurice Susan, 2004, STUDIES HIST ENGLISH, VII, P131; Ghesquiere Lobke, 2010, SUBJECTIFICATION INT, P277; Ghesquiere Lobke, 2011, THESIS KU LEUVEN; Givon Talmy, 1991, APPROACHES GRAMMATIC, V2, P257; Heine Bernd, 2010, OXFORD HDB LINGUISTI, P401; Heine Bernd, 1991, GRAMMATICALIZATION C; Hengeveld Kees, 2011, OXFORD HDB GRAMMATIC, P580; Herring Susan C., 1991, APPROACHES GRAMMATIC, V1, P253; Jung Hakyung, 2009, GRAMMATICAL CHANGE I, P207; Kinuhata T, 2012, J PRAGMATICS, V44, P798, DOI 10.1016/j.pragma.2012.03.004; Kranich Svenja, 2010, GRAMMATICALIZATION C, P101; Kranich S, 2010, LANG COMPUT, P1, DOI 10.1007/978-3-642-01325-6_1; Kurylowicz Jerzy, 1975, ESQUISSES LINGUIST, V2, p[38, 55]; Langacker R. W., 1990, Cognitive Linguistics, V1, DOI 10.1515/cogl.1990.1.1.5; Langacker RW, 1998, DISCOURSE AND COGNITION: BRIDGING THE GAP, P71; Lapez-Couso Maria Jose, 2010, HIST PRAGMATICS, P127; LEHMANN C, 1986, GEN LINGUIST, V26, P3; Lehmann Christian, 2002, SEM SPRACHW U ERF 9; Narrog H., 2012, MODALITY SUBJECTIVIT; Narrog Heiko, 2010, LINGUISTIC DISCOVERY, V8, P233; Narrog Heiko, 2009, OXFORD HDB CASE, P593; Narrog Heiko, 2012, ENGLISH TEXT CONSTRU, V5, P29; Narrog Heiko, 2014, PERSPECTIVES SEMANTI, P71; Narrog Helko, 2012, GRAMMATICALIZATION I, P21; Norde Muriel, 2009, DEGRAMMATICALIZATION; Nuyts J., 2001, EPISTEMIC MODALITY L; Nuyts Jan, 2012, GRAMMATICALIZATION I; Onociera Noriko, 2007, J HIST PRAGMAT, V8; Palmer F.R., 1990, MODALITY ENGLISH MOD; Quirk R., 1985, COMPREHENSIVE GRAMMA; Trask Robert, 1979, ERGATIVITY THEORY GR, P385; Traugott E, 1980, LANG SCI, V2, P44, DOI 10.1016/S0388-0001(80)80004-0; Traugott E. C., 2002, REGULARITY SEMANTIC; Traugott E. C., 2003, MOTIVES LANGUAGE CHA, P124, DOI DOI 10.1017/CBO9780511486937.009; Traugott E. G., 2003, GRAMMATICALIZATION; Traugott E. G., 1982, PERSPECTIVES HIST LI, P245; Traugott E. G., 1995, SUBJECTIVITY SUBJECT, P31, DOI DOI 10.1017/CBO9780511554469.003; Traugott E. G., 2010, SUBJECTIFICATION INT, P29; Traugott Elizabeth C., 1999, HIST SEMANTICS COGNI, P179; Verhagen Arie, 2005, CONSTRUCTIONS INTERS; Visconti J, 2013, LANG SCI, V36, P7, DOI 10.1016/j.langsci.2012.03.016; Visconti Jacqueline, 2004, CLINE NATURE GRAMMAT, P169; Wright Susan, 1995, SUBJECTIVITY SUBJECT, P151, DOI 10.1017/CBO9780511554469.008	64	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0388-0001	1873-5746		LANG SCI	Lang. Sci.	JAN	2015	47		B		SI		148	160		10.1016/j.langsci.2014.07.010		13	Linguistics; Language & Linguistics	Linguistics	AW7OC	WOS:000346452200003		
J	Kurita, T; Yasuda, S; Amengual, O; Atsumi, T				Kurita, T.; Yasuda, S.; Amengual, O.; Atsumi, T.			The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis	LUPUS			English	Review						Interstitial pneumonia; ciclosporin; tacrolimus; anti-MDA5 antibody	TRANSFER-RNA-SYNTHETASE; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHIES; PEPTIDYL-PROLYL ISOMERASE; DIFFUSE ALVEOLAR DAMAGE; CYCLOSPORINE-A; POLYMYOSITIS-DERMATOMYOSITIS; ANTISYNTHETASE SYNDROME; CORTICOSTEROID-RESISTANT; IMMUNOSUPPRESSANT FK506	Interstitial lung disease (ILD) in patients with polymyositis (PM) and dermatomyositis (DM) is often resistant to treatment and life threatening, being recognized as one of the severest complication in these autoimmune disorders. Patients with clinically amyopathic dermatomyositis (CADM) or those with anti-CADM140/MDA5 antibody are especially prone to develop rapidly progressive interstitial pneumonia. We retrospectively analyzed 46 patients with PM/DM admitted to our hospital and identified DM, rapidly progressive disease, honeycomb lung, CADM and extensive ILD as risk factors for recurrence or death. In the presence of two or more risk factors, the sensitivity and specificity for the prediction of death or relapse were 81.3% and 76.7%, respectively. Calcineurin inhibitors have been widely used as induction and maintenance therapy for PM/DM-associated ILD. Recently we reported the benefit of tacrolimus on the disease-free survival and event-free survival of the patients with PM/DM-associated ILD. Among those patients treated with tacrolimus, poor prognostic factors for death, recurrence or severe adverse event were identified as acute progression of the disease, honeycomb lung, forced vital capacity (FVC) less than 80% and having DM. The potential effectiveness of an intensive therapy protocol with triple therapy that comprises high-dose corticosteroids, calcineurin inhibitors and cyclophosphamide has been reported.	[Kurita, T.; Yasuda, S.; Amengual, O.; Atsumi, T.] Hokkaido Univ, Div Rheumatol Endocrinol & Nephrol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Amengual, O (reprint author), Hokkaido Univ, Div Rheumatol Endocrinol & Nephrol, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	olgaam@med.hokudai.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology	This work was supported by grants from the Japanese Ministry of Health, Labor, and Welfare, and the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Aggarwal R, 2014, ANN RHEUM DIS, V73, P227, DOI 10.1136/annrheumdis-2012-201800; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Kameda H, 2005, J RHEUMATOL, V32, P1719; Nash RA, 2000, BLOOD, V96, P2062; Gono T, 2012, RHEUMATOLOGY, V51, P1336, DOI 10.1093/rheumatology/kes012; Cottin V, 2003, EUR RESPIR J, V22, P245, DOI 10.1183/09031936.03.00026703; Nawata Y, 1999, J RHEUMATOL, V26, P1527; Hervier B, 2012, AUTOIMMUN REV, V12, P210, DOI 10.1016/j.autrev.2012.06.006; TARGOFF IN, 1993, J CLIN INVEST, V91, P2556, DOI 10.1172/JCI116493; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Dumont FJ, 2000, CURR MED CHEM, V7, P731; Nagai K, 2011, MOD RHEUMATOL, V21, P32, DOI 10.1007/s10165-010-0342-2; Taylor DO, 1999, J HEART LUNG TRANSPL, V18, P336, DOI 10.1016/S1053-2498(98)00060-6; Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; KINO T, 1987, J ANTIBIOT, V40, P1256; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Furlan A, 2008, JOINT BONE SPINE, V75, P366, DOI 10.1016/j.jbspin.2007.07.010; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727; Marie I, 2001, J RHEUMATOL, V28, P2230; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Ekberg H, 2010, NEPHROL DIAL TRANSPL, V25, P2004, DOI 10.1093/ndt/gfp778; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Takada K, 2005, AUTOIMMUNITY, V38, P383, DOI 10.1080/08916930500124023; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Kang EH, 2005, RHEUMATOLOGY, V44, P1282, DOI 10.1093/rheumatology/keh723; Lee CS, 2002, CLIN RHEUMATOL, V21, P391, DOI 10.1007/s100670200104; Cavagna L, 2013, J RHEUMATOL, V40, P484, DOI 10.3899/jrheum.121026; Kurasawa K, 2002, CLIN EXP IMMUNOL, V129, P541, DOI 10.1046/j.1365-2249.2002.01933.x; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; Kotani T, 2011, CLIN RHEUMATOL, V30, P1021, DOI 10.1007/s10067-011-1713-6; Webster AC, 2005, BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Kotani T, 2008, J RHEUMATOL, V35, P254; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Sem M, 2009, RHEUMATOLOGY, V48, P968, DOI 10.1093/rheumatology/kep157; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Yamasaki Y, 2007, RHEUMATOLOGY, V46, P124, DOI 10.1093/rheumatology/kel112; Marie I, 2012, RESP MED, V106, P581, DOI 10.1016/j.rmed.2012.01.001; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182; Gono T, 2010, RHEUMATOLOGY, V49, P1354, DOI 10.1093/rheumatology/keq073; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Ye S, 2007, CLIN RHEUMATOL, V26, P1647, DOI 10.1007/s10067-007-0562-9; Betteridge Z, 2007, RHEUMATOLOGY, V46, P1005, DOI 10.1093/rheumatology/kem045; Wilkes MR, 2005, ARTHRITIS RHEUM, V52, P2439, DOI 10.1002/art.21240; BUNN CC, 1986, J EXP MED, V163, P1281, DOI 10.1084/jem.163.5.1281; Chen IJ, 2009, CLIN RHEUMATOL, V28, P639, DOI 10.1007/s10067-009-1110-6; DICKEY BF, 1984, SEMIN ARTHRITIS RHEU, V14, P60, DOI 10.1016/0049-0172(84)90010-6; Fathi M, 2005, CURR OPIN RHEUMATOL, V17, P701, DOI 10.1097/01.bor.0000179949.65895.53; Fujisawa T, 2005, J RHEUMATOL, V32, P58; FUNG JJ, 1991, TRANSPLANT P, V23, P3105; Gono T, 2011, MOD RHEUMATOL, V21, P223, DOI 10.1007/s10165-010-0371-x; GRUHN WB, 1987, J RHEUMATOL, V14, P1045; Haddad EM, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005161.PUB2; Hamaguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060442; Hirakata M, 1999, J IMMUNOL, V162, P2315; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Ishigaki K, 2013, RHEUMATOL INT, V33, P2381, DOI 10.1007/s00296-013-2735-y; Ji SY, 2010, CHINESE MED J-PEKING, V123, P517, DOI 10.3760/cma.j.issn.0366-6999.2010.05.002; Kurita T, RHEUMATOLOGY OXFORD; Le Goff B, 2009, ARTHRIT RHEUM-ARTHR, V61, P108, DOI 10.1002/art.24372; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Marie Isabelle, 2011, Presse Med, V40, pe257, DOI 10.1016/j.lpm.2010.12.012; MATHEWS MB, 1984, J EXP MED, V160, P420, DOI 10.1084/jem.160.2.420; Matsuki Y, 2012, MOD RHEUMATOL, V22, P243, DOI 10.1007/s10165-011-0502-z; Mimori T, 2012, CURR RHEUMATOL REP, V14, P264, DOI 10.1007/s11926-012-0246-6; Morganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212; Nagasaka Kenji, 2003, Mod Rheumatol, V13, P231, DOI 10.3109/s10165-003-0205-1; NISHIKAI M, 1980, ARTHRITIS RHEUM, V23, P881, DOI 10.1002/art.1780230802; Ochi S, 2005, CLIN EXP RHEUMATOL, V23, P707; Park JK, 2012, RHEUMATOL INT, V32, P3587, DOI 10.1007/s00296-011-2220-4; Penninga L, 2013, COCHRANE DB SYST REV, V5; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Suzuki Y, 2009, LUNG, V187, P201, DOI 10.1007/s00408-009-9146-6; Takizawa H, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P1093; Tanaka F, 2000, INTERNAL MED, V39, P428, DOI 10.2169/internalmedicine.39.428; TARGOFF IN, 1992, ARTHRITIS RHEUM, V35, P821, DOI 10.1002/art.1780350718; Tokiyama K, 1990, Ryumachi, V30, P204; Tokiyama K, 1990, RYUMACHI, V30, P209; VARTANYAN O A, 1991, Molekulyarnaya Biologiya (Moscow), V25, P1033; Yamasaki Y, 2011, J RHEUMATOL, V38, P1636, DOI 10.3899/jrheum.101002	85	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	JAN	2015	24	1					3	9		10.1177/0961203314554849		7	Rheumatology	Rheumatology	AW3HR	WOS:000346177700001		
J	Kamide, N				Kamide, Norihiro			Embedding theorems for LTL and its variants	MATHEMATICAL STRUCTURES IN COMPUTER SCIENCE			English	Article							LINEAR TEMPORAL LOGICS; CUT-ELIMINATION; PROOF SYSTEM; COMPLEXITY; CALCULUS	In this paper, we prove some embedding theorems for LTL (linear-time temporal logic) and its variants: viz. some generalisations, extensions and fragments of LTL. Using these embedding theorems, we give uniform proofs of the completeness, cut-elimination and/or decidability theorems for LTL and its variants. The proposed embedding theorems clarify the relationships between some LTL-variations (for example, LTL, a dynamic topological logic, a fixpoint logic, a spatial logic, Prior's logic, Davies' logic and an NP-complete LTL) and some traditional logics (for example, classical logic, intuitionistic logic and infinitary logic).	Teikyo Univ, Fac Sci & Engn, Dept Human Informat Syst, Utsunomiya, Tochigi 3208551, Japan	Kamide, N (reprint author), Teikyo Univ, Fac Sci & Engn, Dept Human Informat Syst, Toyosatodai 1-1, Utsunomiya, Tochigi 3208551, Japan.	drnkamide08@kpd.biglobe.ne.jp					[Anonymous], 2003, ADV COMPUT, DOI DOI 10.1016/S0065-2458(03)58003-2; SISTLA AP, 1985, J ACM, V32, P733, DOI 10.1145/3828.3837; Artemov S. N., 1997, 9705 MSI CORN U; Baratella S, 2003, ANN PURE APPL LOGIC, V123, P135, DOI 10.1016/S0168-0072(03)00021-6; Baratella S, 2004, ARCH MATH LOGIC, V43, P965, DOI 10.1007/s00153-004-0237-z; Clarke E.M., 1999, MODEL CHECKING; Davies R., 1996, Proceedings. 11th Annual IEEE Symposium on Logic in Computer Science (Cat. No.96CH35952), DOI 10.1109/LICS.1996.561317; Demri S, 2002, INFORM COMPUT, V174, P84, DOI 10.1006/inco.2001.3094; Emerson E. A., 1990, HDB THEORETICAL COMP, VB, P995; Etessami K., 1997, Proceedings. 12th Annual IEEE Symposium on Logic in Computer Science (Cat. No.97CB36092), DOI 10.1109/LICS.1997.614950; Feferman S., 1968, SPRINGER VERLAG LECT, V70, P1; Holzmann G. J., 2006, SPIN MODEL CHECKER P; Kamide N, 2009, LECT NOTES COMPUT SC, V5405, P57, DOI 10.1007/978-3-642-02734-5_5; Kamide N., 2010, P 2 INT C AG ART INT, P522; Kamide N, 2010, LECT NOTES ARTIF INT, V6359, P246, DOI 10.1007/978-3-642-16111-7_28; Kamide N, 2010, J APPL LOGIC, V8, P33, DOI 10.1016/j.jal.2009.06.001; Kamide N., 2010, FAR E J APPL MATH, V44, P37; Kamide N, 2010, LECT NOTES ARTIF INT, V6404, P283; Kamide N., 2006, B SECTION LOGIC, V35, P187; Kamide N, 2006, THEOR COMPUT SCI, V353, P165, DOI 10.1016/j.tcs.2005.10.043; Kamide N, 2010, LECT NOTES ARTIF INT, V6404, P263; Kamide N., 2010, P 2 INT C AG ART INT, P536; Kamide N., 2011, LOGIQUE ANAL, V54, P1; Kaneiwa K, 2010, APPL ARTIF INTELL, V24, P896, DOI 10.1080/08839514.2010.514231; Kaneko M., 1997, STUDIA LOGICA, V58, P273, DOI 10.1023/A:1004975724824; KAWAI H, 1987, Z MATH LOGIK, V33, P423, DOI 10.1002/malq.19870330506; Kojima K., 2008, P INT MOD LOG APPL W; Konev B., 2006, Studia Logica, V84, DOI 10.1007/s11225-006-9005-x; Kremer P, 2005, ANN PURE APPL LOGIC, V131, P133, DOI 10.1016/j.apal.2004.06.004; KROGER F, 1977, ACTA INFORM, V8, P243; Lorenzen P., 1951, J SYMBOLIC LOGIC, V16, P81, DOI 10.2307/2266681; Mints G., 2006, Studia Logica, V82, DOI 10.1007/s11225-006-6608-1; Muscholl A, 2005, INT J FOUND COMPUT S, V16, P743, DOI 10.1142/S0129054105003261; Novikov P. S., 1961, INFINISTIC METHODS, P71; Pnueli A., 1977, P 18 IEEE S FDN COMP, P46, DOI DOI 10.1109/SFCS.1977.32; Prior Arthur N., 1957, TIME MODALITY; Takeuti G., 1985, PROOF THEORY; Tanaka Y., 1999, THESIS JAPAN ADV I S; Tanaka Y, 2001, MATH LOGIC QUART, V47, P327, DOI 10.1002/1521-3870(200108)47:3<327::AID-MALQ327>3.0.CO;2-P; Walukiewicz I, 1998, LECT NOTES COMPUT SC, V1443, P140	40	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0960-1295	1469-8072		MATH STRUCT COMP SCI	Math. Struct. Comput. Sci.	JAN	2015	25	1					83	134		10.1017/S0960129514000048		52	Computer Science, Theory & Methods	Computer Science	AW4TT	WOS:000346274000004		
J	Vicente-Suarez, I; Larange, A; Reardon, C; Matho, M; Feau, S; Chodaczek, G; Park, Y; Obata, Y; Gold, R; Wang-Zhu, Y; Lena, C; Zajonc, DM; Schoenberger, SP; Kronenberg, M; Cheroutre, H				Vicente-Suarez, I.; Larange, A.; Reardon, C.; Matho, M.; Feau, S.; Chodaczek, G.; Park, Y.; Obata, Y.; Gold, R.; Wang-Zhu, Y.; Lena, C.; Zajonc, D. M.; Schoenberger, S. P.; Kronenberg, M.; Cheroutre, H.			Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells	MUCOSAL IMMUNOLOGY			English	Article							RETINOIC-ACID; VITAMIN-A; T-CELLS; GM-CSF; GENE-EXPRESSION; B-CELLS; GUT; DIFFERENTIATION; HOMEOSTASIS; GENERATION	Mucosal dendritic cells (DCs) in the intestine acquire the unique capacity to produce retinoic acid (RA), a vitamin A metabolite that induces gut tropism and regulates the functional differentiation of the T cells they prime. Here, we identified a stromal cell (SC) population in the intestinal lamina propria (LP), which is capable of inducing RA production in DCs in a RA-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent fashion. Unlike DCs, LP SCs constitutively expressed the enzymatic machinery to produce RA even in the absence of dietary vitamin A, but were not able to do so in germ-free mice implying regulation by microbiota. Interestingly, DCs promoted GM-CSF production by the SCs indicating a two-way cross-talk between both cell types. Furthermore, RA-producing LP SCs and intestinal DCs localized closely in vivo suggesting that the interactions between both cell types might have an important role in the functional education of migratory DCs and therefore in the regulation of immune responses toward oral and commensal antigens.	[Vicente-Suarez, I.; Larange, A.; Reardon, C.; Feau, S.; Chodaczek, G.; Park, Y.; Gold, R.; Wang-Zhu, Y.; Lena, C.; Schoenberger, S. P.; Kronenberg, M.; Cheroutre, H.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Matho, M.; Zajonc, D. M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Park, Y.] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Obata, Y.] Univ Tokyo, Inst Med Sci, Div Mucosal Barriol, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Obata, Y.] Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chiba, Japan	Cheroutre, H (reprint author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.	hilde@liai.org			NIH R01 [R01AI050265, DP1OD006433]	We thank Dr Noelle for providing us with the F9-RARE-lacZ cell line, Dr Whitsett for the GM-CSF knockout mice, and Dr Buckley for the Pdpn<SUP>hi</SUP> splenic SC line. We thank C. Kim and K.v. Gunst for cell sorting and M. Cheroutre for her contribution. This work was supported by NIH R01 grants: R01AI050265 and DP1OD006433.	Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; PETKOVICH M, 1992, ANNU REV NUTR, V12, P443, DOI 10.1146/annurev.nutr.12.1.443; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Frota-Ruchon A, 2000, CELL TISSUE RES, V302, P397, DOI 10.1007/s004410000281; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; WAGNER M, 1992, DEVELOPMENT, V116, P55; Wagner MA, 1997, METHOD ENZYMOL, V282, P98; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740	31	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	JAN	2015	8	1					141	151		10.1038/mi.2014.51		11	Immunology	Immunology	AW5TB	WOS:000346335600013		
J	Nakanishi, Y; Sato, T; Ohteki, T				Nakanishi, Y.; Sato, T.; Ohteki, T.			Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization	MUCOSAL IMMUNOLOGY			English	Article							INFLAMMATORY BOWEL DISEASES; INTESTINAL MICROBIOTA; CROHNS-DISEASE; GUT MICROBIOTA; IMMUNE-SYSTEM; MICE; HOMEOSTASIS; ACTIVATION; INDUCTION; CELLS	Breakdown of the intestinal epithelial layer's barrier function results in the inflow of commensal flora and improper immune responses against the commensal flora, leading to inflammatory bowel disease (IBD) development. Using a mouse dextran sodium sulfate (DSS)-induced colitis model, we show here that commensal Gram-positive bacteria trigger the mobilization of inflammatory monocytes and macrophages into the colon. Monocytes/macrophages are major producers of tumor necrosis factor-alpha (TNF-alpha), a representative cytokine that aggravates colitis. Notably, pretreating mice with vancomycin, which eliminated Gram-positive bacteria, particularly the Lachnospiraceae family, significantly reduced the severity of the colitis by selectively blocking the recruitment of monocytes/macrophages, but not of other cells. Importantly, vancomycin treatment specifically downregulated the colonic epithelial cell (cEC) expression of C-C chemokine receptor type-2 (CCR2) ligands, which are critical chemokines for monocyte/macrophage mobilization into the inflamed colon. Collectively, these results provide previously undiscovered evidence that Gram-positive commensal bacteria induce colitis by recruiting colitogenic monocytes and macrophages. Our findings may lead to new avenues of treatment for IBD.	[Nakanishi, Y.; Sato, T.; Ohteki, T.] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo, Japan; [Nakanishi, Y.; Ohteki, T.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Sato, T.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Ohteki, T (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo, Japan.	ohteki.bre@mri.tmd.ac.jp			Takeda Science Foundation; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)	We thank H. Kamioka for secretarial support, Drs K. Honda and K. Atarashi for providing bacteria q-PCR methods and helpful suggestions, and Dr K. Tanimoto for sequencing. This work was supported by supported by Takeda Science Foundation (Y.N.) and the Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST; T.O.).	Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Mizushima T, 2013, AM J PATHOL, V183, P1936, DOI 10.1016/j.ajpath.2013.08.012; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Sellon RK, 1998, INFECT IMMUN, V66, P5224; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; Bannon C, 2009, BIOCHEM J, V423, P119, DOI 10.1042/BJ20090392; Eckburg R.B., 2005, SCIENCE, V308, P1635; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113	40	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	JAN	2015	8	1					152	160		10.1038/mi.2014.53		9	Immunology	Immunology	AW5TB	WOS:000346335600014		
J	Asano, F				Asano, Fumihiko			Stability analysis of underactuated compass gait based on linearization of motion	MULTIBODY SYSTEM DYNAMICS			English	Article						Limit cycle walking; Stability; Convergence rate; Compass gait	PRINCIPLE; WALKING; WHEEL	This paper investigates the stability principle underlying an underactuated compass gait generated by strict output following control of the hip-joint angle. First, we introduce a planar underactuated compass-like biped robot with semicircular feet and develop its mathematical model. We then linearize the equation of motion and design an output following control for the relative hip-joint angle of the linearized model. Second, we analytically derive the transition function of the state error for the stance phase based on the state space representation and discuss its physical meaning. We also mathematically show that the collision phase is always stable. Finally, the validity of the theoretical results is verified through numerical simulations.	Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan	Asano, F (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	fasano@jaist.ac.jp			Japan Society for the Promotion of Science (JSPS) [24560542]	This research was partially supported by a Grant-in-Aid for Scientific Research, (C) No. 24560542, provided by the Japan Society for the Promotion of Science (JSPS).	Goswami A, 1998, INT J ROBOT RES, V17, P1282, DOI 10.1177/027836499801701202; Asano F, 2012, IEEE INTL CONF CONTR, P1039, DOI 10.1109/CCA.2012.6402345; Asano F, 2008, IEEE T ROBOT, V24, P1289, DOI 10.1109/TRO.2008.2006234; Asano F, 2009, ROBOTICA, V27, P949, DOI 10.1017/S0263574709005372; Goswami A, 1997, AUTON ROBOT, V4, P273, DOI 10.1023/A:1008844026298; Grizzle JW, 2001, IEEE T AUTOMAT CONTR, V46, P51, DOI 10.1109/9.898695; Asano F., 2011, P IEEE INT C ROB AUT, P557; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McGeer T., 1990, P IEEE INT C ROB AUT, V3, P1640; VUKOBRATOVIC M, 1972, Mathematical Biosciences, V15, P1, DOI 10.1016/0025-5564(72)90061-2	11	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1384-5640	1573-272X		MULTIBODY SYST DYN	Multibody Syst. Dyn.	JAN	2015	33	1					93	111		10.1007/s11044-014-9416-9		19	Mechanics	Mechanics	AW4LH	WOS:000346252100005		
J	Athapaththu, AMRG; Tsuchida, T; Kano, S				Athapaththu, A. M. R. G.; Tsuchida, Takashi; Kano, Seiji			A new geotechnical method for natural slope exploration and analysis	NATURAL HAZARDS			English	Article						Site investigation; Cone resistance; Spatial variability; Apparent cohesion; Friction angle	DYNAMIC CONE PENETROMETER; SPATIAL VARIABILITY; PARAMETERS; STRENGTH	Geotechnical investigation of natural slopes is challengeable especially when natural slopes having higher gradients and access is difficult. Also, it is even more problematic to find the shear strength parameters spatially to evaluate the stability of slopes as most of the methods available to find the shear strength parameters in the literature are uneconomical or such methods cannot be applied in vegetated slopes. Recently, authors have conducted a series of in situ investigations based on the newly developed lightweight dynamic cone penetrometer to examine its applicability in analyzing the slopes covered with weathering remnants of decomposed granite. Six patterns were identified based on the penetration resistance varies with the depth. Spatial variability analysis conducted on different grid spaces showed that the coefficient of variation of cone resistance varies from 0 to 35 %. Semi-variogram analysis showed that the Spherical Models can be used to evaluate the spatial variability of weathering remnants of decomposed granite. A series of laboratory calibration tests based on the lightweight dynamic cone penetration tests and direct shear tests with pore pressure measurements were conducted at different void ratios and degrees of saturation. Based on the laboratory calibration test results, a method to determine the void ratio, e, from the data of q(d) was presented. Based on this, two formulas to evaluate the shear strength parameters, apparent cohesion and friction angle, were established with the cone resistance and degree of saturation. Slight modification was proposed in evaluating the apparent cohesion with respect to the different fine content in the soils. As a whole, the proposed method can be successfully applied to individual slopes to determine the profile thickness and to evaluate the shear strength parameters spatially. Based on this, hazard assessment of individual slopes can be made.	[Athapaththu, A. M. R. G.; Tsuchida, Takashi] Hiroshima Univ, Dept Civil & Environm Engn, Inst Engn, Higashihiroshima 7398527, Japan; [Kano, Seiji] Kure Natl Coll Technol, Kure 7378506, Japan	Athapaththu, AMRG (reprint author), Hiroshima Univ, Dept Civil & Environm Engn, Inst Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	rasika@hiroshima-u.ac.jp	Athapaththu, A.M.R.G./A-2376-2015	Athapaththu, A.M.R.G./0000-0001-9342-2189			Phoon KK, 1999, CAN GEOTECH J, V36, P625, DOI 10.1139/cgj-36-4-625; Tsuchida T, 2011, SOILS FOUND, V51, P497; SOULIE M, 1990, CAN GEOTECH J, V27, P617, DOI 10.1139/t90-076; [Anonymous], 2013, JAP STAND EXPL GEOT, P208; [Anonymous], STAT HDB JAP 2013 ST; ASAOKA A, 1982, J GEOTECH ENG-ASCE, V108, P743; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P403; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P848; Cassan M, 1988, ESSAIS SITU MECHANIQ, V1, P146; Chaigneau L, 2000, ADV GEOTECH ENGN TUN, V3, P103; Chaisson P, 1995, CAN GEOT J, V32, P1; Dissanayake AK, 2002, THESIS HIROSHIMA U J, P8; Futagami T, 2010, WIT T INFORM COMMUNI, V43, P703; Galer MM, 1999, THESIS HIROSHIMA U J, P1; Ito Y, 2006, S APPL REC GEOT INV, P23; Kulhawy FH, 1992, EVALUATION STATIC SO, P95; Langton DD, 1999, GROUND ENG       SEP, P33; Lumb P., 1966, CAN GEOTECH J, V3, P74, DOI DOI 10.1139/T66-009; Nakai S, 2006, SOILS FOUND, V46, P465, DOI 10.3208/sandf.46.465; Orchant CJ, 1988, EL55072 EL POW RES I; Spry MJ, 1988, EL55071 EL POW RES I; Tsuchida T, 2014, SOIL FOUND IN PRESS, V54; Tsuchida T, 2005, 4 INT C CIV ENV ENG, P279; Tsuchida T, 2006, 5 INT C CIV ENV ENG, P67; Tsuchida T, 2006, GEOT DIV ISOPE 2006, V2, P324; Vanmarcke E., 1983, RANDOM FIELDS ANAL S; VANMARCKE EH, 1977, J GEOTECH ENG-ASCE, V103, P1227; Wang GH, 2003, ENG GEOL, V69, P309, DOI 10.1016/S0013-7952(02)00289-2	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	JAN	2015	75	2					1327	1348		10.1007/s11069-014-1384-0		22	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AW6WW	WOS:000346407100017		
J	Samaddar, S; Choi, JH; Misra, BA; Tatano, H				Samaddar, Subhajyoti; Choi, Junho; Misra, Bijay Anand; Tatano, Hirokazu			Insights on social learning and collaborative action plan development for disaster risk reduction: practicing Yonmenkaigi System Method (YSM) in flood-prone Mumbai	NATURAL HAZARDS			English	Article						Social learning; Participatory approach; Flood risks; Mumbai; India	NATURAL-RESOURCE MANAGEMENT; PUBLIC-PARTICIPATION; HAZARD MITIGATION; PERCEPTIONS; ENVIRONMENT; FRAMEWORK; JAPAN	Recent decades have seen an increasing recognition and consensus among researchers and planners in disaster management in the need to foster social learning through public participation, to promote deliberative interaction among stakeholders in order to work together build a relationship to attain a collective action. However, the current participatory methods in disaster management are limited to awareness building, when actual plan preparation is the prime concept yet to be looked at. Additionally, in most of the cases, the local government authorities initiate their disaster management program to community by inviting them to voice their opinions and concerns. The major impediments of such participatory programs are the community's over-dependence on donors and governments (stakeholders) thus will consequently fail to give the community the sense of ownership of the problem. The challenge therefore is, putting the community in the driver's seat instead of only inviting them for consultation on an existing plan about a predetermined issue. In this paper, a participatory workshop method called Yonmenkaigi System Method (YSM) has been employed as a method to integrate the community's concerns and perspectives in the disaster management processes and to develop a collaborative action plan. The method was tested in a flood-prone slum community in Mumbai, India. In the first phase of the workshop, a SWOT analysis was executed to provide an opportunity for the participants to acknowledge each other's prior concerns, perspectives, and views. In the succeeding phases, the method then provided a platform to carry out this awareness in order to create visions through the identification of critical elements of the plan called Yonmenkaigi Chart. Finally, the sharing and debating of each other's visions and perspectives to prepare an executable plan for improved disaster preparedness. This entire process helps the participant develop an action plan based on their prior abilities, strengths and capacities instead of depending heavily on supports from external sources.	[Samaddar, Subhajyoti; Choi, Junho; Tatano, Hirokazu] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Misra, Bijay Anand] Sch Planning & Architecture, New Delhi, India	Samaddar, S (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	samaddar14@gmail.com					Chess C, 1999, ENVIRON SCI TECHNOL, V33, P2685, DOI 10.1021/es980500g; Buckland J, 1999, DISASTERS, V23, P174, DOI 10.1111/1467-7717.00112; Surjan A, 2009, DISASTER PREV MANAG, V18, P418, DOI 10.1108/09653560910984474; Bohra AK, 2006, CURR SCI INDIA, V90, P1188; Vari A, 2003, RISK ANAL, V23, P585, DOI 10.1111/1539-6924.00339; Raaijmakers R, 2008, NAT HAZARDS, V46, P307, DOI 10.1007/s11069-007-9189-z; Pahl-Wostl C, 2004, J COMMUNITY APPL SOC, V14, P193, DOI 10.1002/casp.774; Cundill G, 2012, J ENVIRON MANAGE, V113, P7, DOI 10.1016/j.jenvman.2012.08.021; [Anonymous], 1995, ENVIRON IMPACT ASSES, DOI DOI 10.1016/0195-9255(95)00043-E; Cronin SJ, 2004, NAT HAZARDS, V33, P105, DOI 10.1023/B:NHAZ.0000035021.09838.27; Pelling M, 2007, DISASTERS, V31, P373, DOI 10.1111/j.0361-3666.2007.01014.x; Rowe G, 2000, SCI TECHNOL HUM VAL, V25, P3; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; Patt AG, 2008, GLOBAL ENVIRON CHANG, V18, P458, DOI 10.1016/j.gloenvcha.2008.04.002; Chen LC, 2006, NAT HAZARDS, V37, P209, DOI 10.1007/s11069-005-4669-5; Muro M, 2008, J ENVIRON PLANN MAN, V51, P325, DOI 10.1080/09640560801977190; RENN O, 1993, POLICY SCI, V26, P189, DOI 10.1007/BF00999716; Pahl-Wostl C, 2006, ECOL SOC, V11; Pearce L, 2003, NAT HAZARDS, V28, P211, DOI 10.1023/A:1022917721797; Baan PJ, 2004, INT J RIVER BASIN MA, V2, P113, DOI [10.1080/15715124.2004.9635226, DOI 10.1080/15715124.2004.9635226]; Bajek R, 2008, NAT HAZARDS, V44, P281, DOI 10.1007/s11069-007-9107-4; Bandura A., 1977, SOCIAL LEARNING THEO; Bhagat RB, 2006, POPUL ENVIRON, V27, P337, DOI 10.1007/s11111-006-0028-z; Census of India, 2001, OFF REG GEN; Chatterjee M, 2011, SERIES HEXAGON SERIE, V5; Government of Maharashtra, 2006, REP FACT FIND COMM F; Gupta K., 2007, URBAN WATER J, V4, P183, DOI DOI 10.1080/15730620701464141; Habermas J., 1984, THEORY COMMUNICATIVE, V1; Ikeda S, 2008, NAT HAZARDS, V44, P267, DOI 10.1007/s11069-007-9124-3; Jamwal N, 2007, CONCERN BRIHANMUMBAI; King C, 2002, SYSTEMIC MODEL THEOR; Miles SB, 2011, NAT HAZARDS, V56, P749, DOI 10.1007/s11069-010-9587-5; Misra B, 2012, DISASTER RISK MANAGE; Na J, 2010, P IEEE INT C SYST MA, P1929; Na J, 2009, J NATURAL DISASTER S, V30, P57; National Disaster Management Authority (NIDM) Government of India, 2014, NAT DIS MAN GUID COM; Okada N, 2005, IEEE SYS MAN CYBERN, P640; Okada N, 2013, GROUP DECIS NEGOT, V22, P53, DOI 10.1007/s10726-012-9290-x; Parthasarathy D, 2009, S AFR REV SOCIOL, V40, P109; Samaddar S, 2011, 2 INT C ENV SCI DEV, V4, P104; Samaddar S, 2012, J INTEGR DISASTER RI, V2, P1; Shaw R, 2009, URBAN RISK REDUCTION; Someshwar S, 2009, WORLD BANK 5 URB RES, P1; Stecko S., 2007, EXPOSING VULNERABILI; Surjan A, 2009, URBAN RISK ASIAN PER, P339; Tanaka S, 2004, P 4 ANN IIASA DPRI M; Tatano H, 2010, FLOOD RISKS REDUCTIO, P105; Tran P, 2007, CENTRAL VIET NAM ENV, DOI [10.1016/j.envhaz.2007.03.001, DOI 10.1016/J.ENVHAZ.2007.03.001]; Van der Veen RGW, 2000, DEEPENING BASIS RURA; Yamori K, 2011, J INTEGR DISASTER RI, V1, P48; Yamori K, 2009, J NAT DISASTER SCI, V30, P83	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	JAN	2015	75	2					1531	1554		10.1007/s11069-014-1380-4		24	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AW6WW	WOS:000346407100026		
J	Tasnim, KM; Shibayama, T; Esteban, M; Takagi, H; Ohira, K; Nakamura, R				Tasnim, Khandker Masuma; Shibayama, Tomoya; Esteban, Miguel; Takagi, Hiroshi; Ohira, Koichiro; Nakamura, Ryota			Field observation and numerical simulation of past and future storm surges in the Bay of Bengal: case study of cyclone Nargis	NATURAL HAZARDS			English	Article						Tropical cyclone; Numerical model; Prediction; Storm surge	TROPICAL CYCLONES; WRF MODEL; PREDICTION; TRACK; OCEAN	Storm surges are one of the most important risks to coastal communities around the Bay of Bengal, and it is feared that the threat they pose will increase with climate change in the future. To understand the threats that these events pose, a summary of the field surveys performed in Yangon River Basin after cyclone Nargis in Myanmar in 2008 is presented. Though due to government restrictions survey activities were limited to the area near Yangon city, it was found out that the tide due to the storm surge was probably between 3 and 4 m high and travelled around 50 km upstream of the river mouth of Yangon River. Cyclone Nargis could be accurately reproduced using a numerical model that integrated weather, wave, coastal ocean models, and tide prediction system. The application of such an integrated model is relatively new for storm surge simulation and has never been used for the Bay of Bengal storms. The model was then used to also simulate future cyclones over the Bay of Bengal considering a future climate change scenario.	[Tasnim, Khandker Masuma; Shibayama, Tomoya; Nakamura, Ryota] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Esteban, Miguel] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Takagi, Hiroshi] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Ohira, Koichiro] Chubu Elect Power Co Inc, Nagoya, Aichi, Japan	Tasnim, KM (reprint author), Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	masuma_tasnim@yahoo.com			Japan Society for the Promotion of Science (JSPS) [22404011]; Strategic Research Foundation from Ministry of Education, Culture, Sport, Science and Technology	The present work was supported by the Grants-in-Aid for Scientific Research (B) No. 22404011 from the Japan Society for the Promotion of Science (JSPS) and Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science and Technology. The authors would like to express their gratitude to the anonymous comments of various reviewers (and especially reviewer #2), whose suggestions for improvements helped the authors rethink various parts of the model and greatly improve the final results of this paper.	Allison I., 2009, COPENHAGEN DIAGNOSIS; Webster PJ, 2008, NAT GEOSCI, V1, P488, DOI 10.1038/ngeo257; Bender MA, 2007, MON WEATHER REV, V135, P3965, DOI 10.1175/2007MWR2032.1; Fritz HM, 2010, INDIAN OCEAN TROPICAL CYCLONES AND CLIMATE CHANGE, P295, DOI 10.1007/978-90-481-3109-9_34; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Mohanty UC, 2010, MAR GEOD, V33, P294, DOI 10.1080/01490419.2010.518061; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Meehl GA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Chen CS, 2003, J ATMOS OCEAN TECH, V20, P159, DOI 10.1175/1520-0426(2003)020<0159:AUGFVT>2.0.CO;2; Chen C, 2012, UNSTRUCTURED GRID FI; Chua J-H, 2002, JOINT TYPHOON WARNIN; Flather RA, 1993, CLIMATE SEA LEVEL CH, P229; FRANK NL, 1971, B AM METEOROL SOC, V52, P438, DOI 10.1175/1520-0477(1971)052<0438:TDTCIH>2.0.CO;2; Fritz HM, 2011, P 4 COPRI SOL COAST; Hasegawa K, 2008, P WFEO JFES JSCE JOI; Hiraishi T, 2009, P 19 INT OFFSH POL E; Hiraishi T, 2009, 1192 AIRP RES I; India Meteorological Department, 1979, TRACKS CYCL DEPR BAY; IPCC 4AR, 2007, 4AR IPCC; IPCC 5AR SPM, 2013, 5AR SPM IPCC; JTWC, 2008, TROP CYCL BEST TRACK; Katsura J, 1992, ANN DISAS PREV RES A, V35A, P119; Kumar A, 2011, METEOROL ATMOS PHYS, V114, P123, DOI 10.1007/s00703-011-0161-9; Li WW, 2012, ADV ATMOS SCI, V29, P407, DOI 10.1007/s00376-011-0229-y; Lin NM, 2009, STORM SURGE INUNDATI; Matsumoto K., 2000, J OCEANOGR, V56, P567, DOI DOI 10.1023/A:1011157212596; McPhaden M. J., 2009, EOS T AGU, V90, P53, DOI [10.1029/2009EO070001, DOI 10.1029/2009EO070001]; OBASI GOP, 1994, B AM METEOROL SOC, V75, P1655, DOI 10.1175/1520-0477(1994)075<1655:WRITID>2.0.CO;2; Ohira K, 2012, B AM METEOROL SOC; Okayasu A, 2009, J JPN SOC CIVIL E B2, V2-65, P1386; Pattanaik DR, 2009, J EARTH SYST SCI, V118, P309; Rao BDV, 2011, NAT HAZARDS, DOI [10.1007/s11069-011-9839-z, DOI 10.1007/S11069-011-9839-Z]; Shibayama T, 2010, ANN J CIV ENG OCEAN, V26, P429; Shibayama T, 2009, P 5 APAC, V2, P190; Skamarock W. C., 2005, NCAR TECH NOTES; Surgi N, 2008, P 62 INT HURR C; Tyagi A, 2010, INDIAN OCEAN TROPICAL CYCLONES AND CLIMATE CHANGE, P315, DOI 10.1007/978-90-481-3109-9_36; UNDP Myanmar, 2008, POST NARG JOINT ASS; UNDP Myanmar, 2008, POSTN JOINT ASS JUL; UNISIS, 2008, HURR TROP DAT NO IND; University of Alaska, 2008, GEOGR INF NETW AL	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	JAN	2015	75	2					1619	1647		10.1007/s11069-014-1387-x		29	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AW6WW	WOS:000346407100030		
J	Nishii, W; Kukimoto-Niino, M; Terada, T; Shirouzu, M; Muramatsu, T; Kojima, M; Kihara, H; Yokoyama, S				Nishii, Wataru; Kukimoto-Niino, Mutsuko; Terada, Takaho; Shirouzu, Mikako; Muramatsu, Tomonari; Kojima, Masaki; Kihara, Hiroshi; Yokoyama, Shigeyuki			A redox switch shapes the Lon protease exit pore to facultatively regulate proteolysis	NATURE CHEMICAL BIOLOGY			English	Article							OXYR TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-PRODUCT; CATALYTIC DOMAIN; DISULFIDE BONDS; ATP HYDROLYSIS; LA; DEGRADATION; PEPTIDES	The Lon AAA+ protease degrades damaged or misfolded proteins in its intramolecular chamber. Its activity must be precisely controlled, but the mechanism by which Lon is regulated in response to different environments is not known. Facultative anaerobes in the Enterobacteriaceae family, mostly symbionts and pathogens, encounter both anaerobic and aerobic environments inside and outside the host's body, respectively. The bacteria characteristically have two cysteine residues on the Lon protease (P) domain surface that unusually form a disulfide bond. Here we show that the cysteine residues act as a redox switch of Lon. Upon disulfide bond reduction, the exit pore of the P-domain ring narrows by similar to 30%, thus interrupting product passage and decreasing activity by 80%; disulfide bonding by oxidation restores the pore size and activity. The redox switch (E-o' = -227 mV) is appropriately tuned to respond to variation between anaerobic and aerobic conditions, thus optimizing the cellular proteolysis level for each environment.	[Nishii, Wataru; Kukimoto-Niino, Mutsuko; Terada, Takaho; Shirouzu, Mikako; Muramatsu, Tomonari; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Nishii, Wataru; Terada, Takaho; Muramatsu, Tomonari; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Yokohama, Kanagawa, Japan; [Kukimoto-Niino, Mutsuko; Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Kojima, Masaki] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Kihara, Hiroshi] Himeji Hinomoto Coll, Himeji, Hyogo, Japan	Nishii, W (reprint author), RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan.	wataru.nishii@riken.jp; yokoyama@riken.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17770116]; Targeted Proteins Research Program (TPRP); Platform for Drug Discovery, Informatics, and Structural Life Science, both from MEXT	We thank T. Nishii for assistance with the enzyme preparation and F. Amano (Osaka University of Pharmaceutical Science) for providing the E. coli AB1157 and JK405 strains. We would like to thank the beamline staff at BL26B1 and BL26B2 of SPring-8 for assistance during data collection. We wish to thank T. Nakagawa (UNISOKU, Co., Ltd.) for assistance with stopped-flow experiments. We thank A. Ishii, K. Ake, T. Imada and T. Nakayama for assistance with manuscript preparation. This work was supported in part by a Grant-in-Aid for Scientific Research (17770116) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to W.N.). This work was also supported in part by the Targeted Proteins Research Program (TPRP) and the Platform for Drug Discovery, Informatics, and Structural Life Science, both from MEXT (to S.Y.).	Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Thomas-Wohlever J, 2002, BIOCHEMISTRY-US, V41, P9418, DOI 10.1021/bi0255470; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; Botos I, 2004, J STRUCT BIOL, V146, P113, DOI 10.1016/j.jsb.2003.09.003; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; PHILLIPS TA, 1984, J BACTERIOL, V159, P283; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; FISCHER H, 1993, J BIOL CHEM, V268, P22502; GOFF SA, 1987, J BIOL CHEM, V262, P4508; GOLDBERG AL, 1985, J BIOL CHEM, V260, P2029; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; KROH HE, 1991, J BACTERIOL, V173, P2691; Lee I, 2006, MOL BIOSYST, V2, P477, DOI 10.1039/b6069936j; MAURIZI MR, 1987, J BIOL CHEM, V262, P2696; Nishii W, 2002, EUR J BIOCHEM, V269, P451, DOI 10.1046/j.0014-2956.2001.02668.x; Nishii W, 2005, FEBS LETT, V579, P6846, DOI 10.1016/j.febslet.2005.11.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; VanMelderen L, 1996, J BIOL CHEM, V271, P27730; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; WAXMAN L, 1985, J BIOL CHEM, V260, P2022; Wilson M., 2008, BACTERIOLOGY HUMANS	49	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					46	+		10.1038/nchembio.1688		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW7MR	WOS:000346448600011		
J	Noike, M; Matsui, T; Ooya, K; Sasaki, I; Ohtaki, S; Hamano, Y; Maruyama, C; Ishikawa, J; Satoh, Y; Ito, H; Morita, H; Dairi, T				Noike, Motoyoshi; Matsui, Takashi; Ooya, Koichi; Sasaki, Ikuo; Ohtaki, Shouta; Hamano, Yoshimitsu; Maruyama, Chitose; Ishikawa, Jun; Satoh, Yasuharu; Ito, Hajime; Morita, Hiroyuki; Dairi, Tohru			A peptide ligase and the ribosome cooperate to synthesize the peptide pheganomycin	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID LIGASE; ESCHERICHIA-COLI; RIBONUCLEOTIDE SYNTHETASE; GLUTATHIONE SYNTHETASE; BIOSYNTHESIS; SYSTEM; ATP; CRYSTALLOGRAPHY; PROTEOMICS; DIVERSITY	Peptide antibiotics are typically biosynthesized by one of two distinct machineries in a ribosome-dependent or ribosome-independent manner. Pheganomycin (PGM (1)) and related analogs consist of the nonproteinogenic amino acid (S)-2-(3,5-dihydroxy-4-hydroxymethyl)phenyl-2-guanidinoacetic acid (2) and a proteinogenic core peptide, making their origin uncertain. We report the identification of the biosynthetic gene cluster from Streptomyces cirratus responsible for PGM production. Unexpectedly, the cluster contains a gene encoding multiple precursor peptides along with several genes plausibly encoding enzymes for the synthesis of amino acid 2. We identified PGM1, which has an ATP-grasp domain, as potentially capable of linking the precursor peptides with 2, and validate this hypothesis using deletion mutants and in vitro reconstitution. We document PGM1's substrate permissivity, which could be rationalized by a large binding pocket as confirmed via structural and mutagenesis experiments. This is to our knowledge the first example of cooperative peptide synthesis achieved by ribosomes and peptide ligases using a peptide nucleophile.	[Noike, Motoyoshi; Ooya, Koichi; Sasaki, Ikuo; Satoh, Yasuharu; Ito, Hajime; Dairi, Tohru] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan; [Matsui, Takashi; Ohtaki, Shouta; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Toyama 930, Japan; [Hamano, Yoshimitsu; Maruyama, Chitose] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Tokyo, Japan	Morita, H (reprint author), Toyama Univ, Inst Nat Med, Toyama 930, Japan.	hmortia@inm.u-toyama.ac.jp; dairi@eng.hokudai.ac.jp	Ito, Hajime/D-8337-2012	Ito, Hajime/0000-0003-3852-6721	Japan Society for the Promotion of Science [23108101, 25560397, 25108710]	This study was supported by a Grant-in-Aid for Scientific Research (23108101 and 25560397 to T.D. and 25108710 to H.M.) from the Japan Society for the Promotion of Science. We thank M. Igarashi from the Institute of Microbial Chemistry and S. Taguchi from Hokkaido University for providing us with S. cirratus and apidaecin, respectively.	Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Humphries RM, 2013, CLIN MICROBIOL REV, V26, P759, DOI 10.1128/CMR.00030-13; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Chan AOY, 2012, J AM CHEM SOC, V134, P2589, DOI 10.1021/ja208009r; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/nchembio.1040, 10.1038/NCHEMBIO.1040]; Giessen TW, 2012, FEBS LETT, V586, P2065, DOI 10.1016/j.febslet.2012.01.017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Crone WJK, 2012, CHEM SCI, V3, P3516, DOI 10.1039/c2sc21190d; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huo LJ, 2012, CHEM BIOL, V19, P1278, DOI 10.1016/j.chembiol.2012.08.013; Pan YB, 2013, ANGEW CHEM INT EDIT, V52, P9205, DOI 10.1002/anie.201303429; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; VARA J, 1989, J BACTERIOL, V171, P5872; ANZAI H, 1988, J ANTIBIOT, V41, P226; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Hopwood D. A., 1985, GENE MANIPULATION ST; Jursic BS, 2000, SYNTHESIS-STUTTGART, P1656; Kadi N, 2007, NAT CHEM BIOL, V3, P652, DOI 10.1038/nchembio.2007.23; Kino K, 2010, BIOSCI BIOTECH BIOCH, V74, P129, DOI 10.1271/bbb.90649; Sampei G, 2010, J BIOCHEM, V148, P429, DOI 10.1093/jb/mvq088; SUZUKAKETSUCHIYA K, 1988, J ANTIBIOT, V41, P675; Suzuki M, 2012, ACTA CRYSTALLOGR D, V68, P1535, DOI 10.1107/S0907444912038103; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Taguchi S, 2009, APPL ENVIRON MICROB, V75, P1460, DOI 10.1128/AEM.02096-08; Thoden JB, 2002, J BIOL CHEM, V277, P23898, DOI 10.1074/jbc.M202251200; Thoden JB, 2010, BIOCHEMISTRY-US, V49, P752, DOI 10.1021/bi901599u; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wagner AM, 2011, J AM CHEM SOC, V133, P15139, DOI 10.1021/ja2055098; Wang WR, 1998, BIOCHEMISTRY-US, V37, P15647, DOI 10.1021/bi981405n; YAMAGUCHI H, 1993, J MOL BIOL, V229, P1083, DOI 10.1006/jmbi.1993.1106	46	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					71	+		10.1038/nchembio.1697		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW7MR	WOS:000346448600015		
J	Voiry, D; Goswami, A; Kappera, R; Silva, CDCE; Kaplan, D; Fujita, T; Chen, MW; Asefa, T; Chhowalla, M				Voiry, Damien; Goswami, Anandarup; Kappera, Rajesh; Castro e Silva, Cecilia de Carvalho; Kaplan, Daniel; Fujita, Takeshi; Chen, Mingwei; Asefa, Tewodros; Chhowalla, Manish			Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering	NATURE CHEMISTRY			English	Article							SINGLE-LAYER MOS2; CHEMICALLY EXFOLIATED MOS2; WALLED CARBON NANOTUBES; HYDROGEN EVOLUTION; RESTACKED MOS2; NANOSHEETS; WS2; PHOTOLUMINESCENCE; INTERCALATION; CHEMISTRY	Chemical functionalization of low-dimensional materials such as nanotubes, nanowires and graphene leads to profound changes in their properties and is essential for solubilizing them in common solvents. Covalent attachment of functional groups is generally achieved at defect sites, which facilitate electron transfer. Here, we describe a simple and general method for covalent functionalization of two-dimensional transition metal dichalcogenide nanosheets (MoS2, WS2 and MoSe2), which does not rely on defect engineering. The functionalization reaction is instead facilitated by electron transfer between the electron-rich metallic 1T phase and an organohalide reactant, resulting in functional groups that are covalently attached to the chalcogen atoms of the transition metal dichalcogenide. The attachment of functional groups leads to dramatic changes in the optoelectronic properties of the material. For example, we show that it renders the metallic 1T phase semiconducting, and gives it strong and tunable photoluminescence and gate modulation in field-effect transistors.	[Voiry, Damien; Kappera, Rajesh; Castro e Silva, Cecilia de Carvalho; Chhowalla, Manish] Rutgers State Univ, Piscataway, NJ 08854 USA; [Goswami, Anandarup; Asefa, Tewodros] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Goswami, Anandarup; Asefa, Tewodros] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Kaplan, Daniel] US Army RDECOM ARDEC, Acoust & Networked Sensors Div, Picatinny Arsenal, NJ 07806 USA; [Fujita, Takeshi; Chen, Mingwei] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Fujita, Takeshi] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Chhowalla, M (reprint author), Rutgers State Univ, 607 Taylor Rd, Piscataway, NJ 08854 USA.	manish1@rci.rutgers.edu	Fujita, Takeshi/B-1867-2009; Chen, Mingwei/A-4855-2010	Fujita, Takeshi/0000-0002-2318-0433; Chen, Mingwei/0000-0002-2850-8872	National Science Foundation Division of Graduate Education (NSF DGE) [0903661]; NSF [Chemistry-1004218, DMR-0968937, NanoEHS-1134289]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazil; Japan Science and Technology Agency-PRESTO; Japan Society for Promotion of Science [90363382]	M. Chhowalla, D.V. and R.K. acknowledge financial support from the National Science Foundation Division of Graduate Education (NSF DGE) 0903661. T.A. and A.G. acknowledge financial assistance from the NSF (CAREER Chemistry-1004218, DMR-0968937, NanoEHS-1134289, NSF-Analytical Chemistry Instrumentation Facility and a Special Creativity Grant). C.S. acknowledges the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazil, for a fellowship. T.F. acknowledges partial support from Japan Science and Technology Agency-PRESTO ('New Materials Science and Element Strategy') and Japan Society for Promotion of Science (Grant-in-Aid for Scientific Research on Innovative Areas 'Science of Atomic Layers', 90363382). The authors thank G.S. Hall for ATR-FTIR measurements. G. Recine at New York University Polytechnic is thanked for computing time.	Lukowski MA, 2013, J AM CHEM SOC, V135, P10274, DOI 10.1021/ja404523s; PY MA, 1983, CAN J PHYS, V61, P76; Eda G, 2011, NANO LETT, V11, P5111, DOI 10.1021/nl201874w; Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N; Heising J, 1999, J AM CHEM SOC, V121, P11720, DOI 10.1021/ja991644d; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Voiry D, 2013, NAT MATER, V12, P850, DOI [10.1038/nmat3700, 10.1038/NMAT3700]; Voiry D, 2010, J MATER CHEM, V20, P4385, DOI 10.1039/c0jm00082e; Chakraborty S, 2007, ANGEW CHEM INT EDIT, V46, P4486, DOI 10.1002/anie.200605175; CANFIELD D, 1981, J AM CHEM SOC, V103, P1279, DOI 10.1021/ja00395a076; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; JOENSEN P, 1986, MATER RES BULL, V21, P457, DOI 10.1016/0025-5408(86)90011-5; Chou SS, 2013, J AM CHEM SOC, V135, P4584, DOI 10.1021/ja310929s; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Liang F, 2004, NANO LETT, V4, P1257, DOI 10.1021/nl049428c; Yang D, 1996, J PHYS CHEM SOLIDS, V57, P1113, DOI 10.1016/0022-3697(95)00406-8; Heising J, 1999, J AM CHEM SOC, V121, P638, DOI 10.1021/ja983043c; Ataca C, 2011, J PHYS CHEM C, V115, P13303, DOI 10.1021/jp2000442; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Voiry D, 2013, NANO LETT, V13, P6222, DOI 10.1021/nl403661s; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Englert JM, 2011, NAT CHEM, V3, P279, DOI [10.1038/nchem.1010, 10.1038/NCHEM.1010]; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; AYNSLEY EE, 1964, J CHEM SOC, P704, DOI 10.1039/jr9640000704; Golub AS, 2000, SOLID STATE IONICS, V128, P151, DOI 10.1016/S0167-2738(99)00347-1; Jiang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4389; Khan M. A., 1997, CHEMINFORM, V28, P1779; Quintana M, 2013, ACCOUNTS CHEM RES, V46, P138, DOI 10.1021/ar300138e; Socrates G, 2001, INFRARED RAMAN CHARA; Syrgiannis Z, 2010, ANGEW CHEM INT EDIT, V49, P3322, DOI 10.1002/anie.200906819; Tongay S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02657	32	15	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	JAN	2015	7	1					45	49		10.1038/NCHEM.2108		5	Chemistry, Multidisciplinary	Chemistry	AW6XQ	WOS:000346409400011		
J	Panda, MK; Ghosh, S; Yasuda, N; Moriwaki, T; Mukherjee, GD; Reddy, CM; Naumov, P				Panda, Manas K.; Ghosh, Soumyajit; Yasuda, Nobuhiro; Moriwaki, Taro; Mukherjee, Goutam Dev; Reddy, C. Malla; Naumov, Pance			Spatially resolved analysis of short-range structure perturbations in a plastically bent molecular crystal	NATURE CHEMISTRY			English	Article							HEXACHLOROBENZENE SINGLE CRYSTALS; PHOTOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; ORGANIC-CRYSTALS; ELASTIC-MODULUS; RAMAN-SPECTRA; LIGHT; NANOINDENTATION; DIFFRACTOMETRY; MICRORIBBONS	The exceptional mechanical flexibility observed with certain organic crystals defies the common perception of single crystals as brittle objects. Here, we describe the morphostructural consequences of plastic deformation in crystals of hexachlorobenzene that can be bent mechanically at multiple locations to 360 degrees with retention of macroscopic integrity. This extraordinary plasticity proceeds by segregation of the bent section into flexible layers that slide on top of each other, thereby generating domains with slightly different lattice orientations. Microscopic, spectroscopic and diffraction analyses of the bent crystal showed that the preservation of crystal integrity when stress is applied on the (001) face requires sliding of layers by breaking and re-formation of halogen-halogen interactions. Application of stress on the (100) face, in the direction where pi center dot center dot center dot pi interactions dominate the packing, leads to immediate crystal disintegration. Within a broader perspective, this study highlights the yet unrecognized extraordinary malleability of molecular crystals with strongly anisotropic supramolecular interactions.	[Panda, Manas K.; Naumov, Pance] NYU Abu Dhabi, Abu Dhabi, U Arab Emirates; [Ghosh, Soumyajit; Reddy, C. Malla] Indian Inst Sci Educ & Res IISER Kolkata, Dept Chem Sci, Mohanpur 741246, India; [Yasuda, Nobuhiro; Moriwaki, Taro] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Mukherjee, Goutam Dev] Indian Inst Sci Educ & Res IISER Kolkata, Dept Phys Sci, Mohanpur 741252, India	Reddy, CM (reprint author), Indian Inst Sci Educ & Res IISER Kolkata, Dept Chem Sci, Mohanpur Campus, Mohanpur 741246, India.	cmreddy@iiserkol.ac.in; pance.naumov@nyu.edu	PANDA, MANAS/J-1161-2014; Naumov, Pance/B-7838-2013	PANDA, MANAS/0000-0002-6297-2070; Naumov, Pance/0000-0003-2416-6569	New York University Abu Dhabi	This work was partly carried out with financial support from New York University Abu Dhabi. The micro-X-ray diffraction and micro-IR spectroscopic measurements were performed at BL40XU (X-ray) and BL43IR (IR), SPring-8, with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposals nos. 2013A1052 (X-ray) and 2014A1826 (IR)). The authors thank J. Weston (New York University Abu Dhabi) for his help with the nanoindentation and AFM experiments, A. Basu (IISER Kolkata) for assisting with the micro-Raman spectra and J. Whelan for comments on the manuscript.	Koshima H, 2013, CRYST GROWTH DES, V13, P4330, DOI 10.1021/cg400675r; Kim T, 2014, J AM CHEM SOC, V136, P6617, DOI 10.1021/ja412216z; [Anonymous], 2012, APEX DUO VERS 2 1 4; Sun JK, 2013, ANGEW CHEM INT EDIT, V52, P6653, DOI 10.1002/anie.201301207; Warner M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134302; Reddy CM, 2006, CHEM-EUR J, V12, P2222, DOI 10.1002/chem.200500983; Zhu LY, 2011, CRYST GROWTH DES, V11, P4975, DOI 10.1021/cg200883b; Ghosh S, 2012, ANGEW CHEM INT EDIT, V51, P10319, DOI 10.1002/anie.201204604; Naumov P, 2010, J AM CHEM SOC, V132, P5845, DOI 10.1021/ja100844m; Shtukenberg AG, 2014, ANGEW CHEM INT EDIT, V53, P672, DOI 10.1002/anie.201301223; Kim T, 2013, ANGEW CHEM INT EDIT, V52, P6889, DOI 10.1002/anie.201302323; Kiran MSRN, 2010, CRYST GROWTH DES, V10, P4650, DOI 10.1021/cg1009362; Naumov P, 2013, ANGEW CHEM INT EDIT, V52, P9990, DOI 10.1002/anie.201303757; Yasuda N, 2010, AIP CONF PROC, V1234, P147, DOI 10.1063/1.3463161; Kitagawa D, 2013, ANGEW CHEM INT EDIT, V52, P9320, DOI 10.1002/anie.201304670; Uchida K, 2008, CHEM COMMUN, P326, DOI 10.1039/b715251e; LANGE CW, 1992, J AM CHEM SOC, V114, P4220, DOI 10.1021/ja00037a027; Nath NK, 2014, J AM CHEM SOC, V136, P2757, DOI 10.1021/ja4101497; Zhu LY, 2011, J AM CHEM SOC, V133, P12569, DOI 10.1021/ja201925p; Koshima H, 2012, DYES PIGMENTS, V92, P798, DOI 10.1016/j.dyepig.2011.05.003; Varughese S, 2013, ANGEW CHEM INT EDIT, V52, P2701, DOI 10.1002/anie.201205002; Reddy CM, 2006, CRYST GROWTH DES, V6, P2720, DOI 10.1021/cg060398w; Terao F, 2012, ANGEW CHEM INT EDIT, V51, P901, DOI 10.1002/anie.201105585; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Cui XY, 2013, J AM CHEM SOC, V135, P3395, DOI 10.1021/ja400833r; Yasuda N, 2009, J SYNCHROTRON RADIAT, V16, P352, DOI 10.1107/S090904950900675X; Reddy CM, 2005, CHEM COMMUN, P3945, DOI 10.1039/b505103g; Koshima H, 2012, CHEM LETT, V41, P107, DOI 10.1246/cl.2012.107; Pierpont CG, 2002, P INDIAN AS-CHEM SCI, V114, P247; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.0002; Sahoo SC, 2013, J AM CHEM SOC, V135, P12241, DOI 10.1021/ja404192g; Morimoto M, 2010, J AM CHEM SOC, V132, P14172, DOI 10.1021/ja105356w; Good JT, 2009, SMALL, V5, P2902, DOI 10.1002/smll.200900895; Reddy CM, 2010, CRYSTENGCOMM, V12, P2296, DOI 10.1039/c003466e; Skoko Z, 2010, J AM CHEM SOC, V132, P14191, DOI 10.1021/ja105508b; Milam K, 2010, J PHYS CHEM B, V114, P7791, DOI 10.1021/jp1033454; BATES JB, 1971, SPECTROCHIM ACTA A-M, VA 27, P637, DOI 10.1016/0584-8539(71)80062-4; Boldyreva E. V., 1985, Photometer. Soviet Union Patent, Patent No. 1368654; Bushuyev OS, 2013, ADV MATER, V25, P1796, DOI 10.1002/adma.201204831; Fukuyama Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114608; GEORGE GA, 1970, MOL CRYST LIQ CRYST, V10, P187, DOI 10.1080/15421407008083494; GEORGE GA, 1970, MOL CRYST LIQ CRYST, V10, P115, DOI 10.1080/15421407008083490; JONGENELIS APJM, 1988, J CHEM PHYS, V89, P4023, DOI 10.1063/1.454835; STOLOW RD, 1963, CHEM IND-LONDON, P449; Moriwaki T, 2008, INFRARED PHYS TECHN, V51, P400, DOI 10.1016/j.infrared.2007.12.031; ABAKUMOV GA, 1982, DOKL AKAD NAUK SSSR+, V266, P1407; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Sheldrick G. M., 2013, SHELXL 2013; Sheldrick G. M., 1996, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimida R., 1993, RES B FUKUOKA I TECH, V25, P187; White KM, 1998, J CHEM PHYS, V109, P208, DOI 10.1063/1.476551; Yakobson B. I., 1989, P SIB DEP ACAD SCI U, V51, P6; Zhao YF, 2012, POLYMER, V53, P4855, DOI 10.1016/j.polymer.2012.08.046	54	15	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	JAN	2015	7	1					65	72		10.1038/NCHEM.2123		8	Chemistry, Multidisciplinary	Chemistry	AW6XQ	WOS:000346409400014		
J	Hashimoto, M; Nowadnick, EA; He, RH; Vishik, IM; Moritz, B; He, Y; Tanaka, K; Moore, RG; Lu, DH; Yoshida, Y; Ishikado, M; Sasagawa, T; Fujita, K; Ishida, S; Uchida, S; Eisaki, H; Hussain, Z; Devereaux, TP; Shen, ZX				Hashimoto, Makoto; Nowadnick, Elizabeth A.; He, Rui-Hua; Vishik, Inna M.; Moritz, Brian; He, Yu; Tanaka, Kiyohisa; Moore, Robert G.; Lu, Donghui; Yoshida, Yoshiyuki; Ishikado, Motoyuki; Sasagawa, Takao; Fujita, Kazuhiro; Ishida, Shigeyuki; Uchida, Shinichi; Eisaki, Hiroshi; Hussain, Zahid; Devereaux, Thomas P.; Shen, Zhi-Xun			Direct spectroscopic evidence for phase competition between the pseudogap and superconductivity in Bi2Sr2CaCu2O8+delta	NATURE MATERIALS			English	Article							T-C SUPERCONDUCTOR; HIGH-TEMPERATURE SUPERCONDUCTOR; ORDER; STATE; BI2SR2-XLAXCUO6+DELTA; TRANSITIONS; SYMMETRY; DENSITY	In the high-temperature (T-c) cuprate superconductors, a growing body of evidence suggests that the pseudogap phase(1), existing below the pseudogap temperature T*, is characterized by some broken electronic symmetries distinct from those associated with superconductivity(2-21). In particular, recent scattering experiments have suggested that charge ordering competes with superconductivity(18-21). However, no direct link of an interplay between the two phases has been identified from the important low-energy excitations. Here, we report an antagonistic singularity at T-c in the spectral weight of Bi2Sr2CaCu2O8+delta as compelling evidence for phase competition, which persists up to a high hole concentration p similar to 0.22. Comparison with theoretical calculations confirms that the singularity is a signature of competition between the order parameters for the pseudogap and superconductivity. The observation of the spectroscopic singularity at finite temperatures over a wide doping range provides new insights into the nature of the competitive interplay between the two orders and the complex phase diagram near the pseudogap critical point.	[Hashimoto, Makoto; Moore, Robert G.; Lu, Donghui] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Nowadnick, Elizabeth A.; He, Rui-Hua; Vishik, Inna M.; Moritz, Brian; He, Yu; Tanaka, Kiyohisa; Moore, Robert G.; Devereaux, Thomas P.; Shen, Zhi-Xun] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Nowadnick, Elizabeth A.; He, Rui-Hua; Vishik, Inna M.; He, Yu; Tanaka, Kiyohisa; Devereaux, Thomas P.; Shen, Zhi-Xun] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Nowadnick, Elizabeth A.; He, Rui-Hua; Vishik, Inna M.; He, Yu; Tanaka, Kiyohisa; Shen, Zhi-Xun] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Nowadnick, Elizabeth A.; He, Rui-Hua; Vishik, Inna M.; He, Yu; Tanaka, Kiyohisa; Shen, Zhi-Xun] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [He, Rui-Hua; Hussain, Zahid] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Moritz, Brian] Univ N Dakota, Dept Phys & Astrophys, Grand Forks, ND 58202 USA; [Tanaka, Kiyohisa] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Yoshida, Yoshiyuki; Ishikado, Motoyuki; Eisaki, Hiroshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Ishikado, Motoyuki] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Sasagawa, Takao] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan; [Fujita, Kazuhiro; Ishida, Shigeyuki; Uchida, Shinichi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Fujita, Kazuhiro] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	Hashimoto, M (reprint author), SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA.	mhashi@slac.stanford.edu; zxshen@stanford.edu	Sasagawa, Takao/E-6666-2014; Moritz, Brian/D-7505-2015	Sasagawa, Takao/0000-0003-0149-6696; Moritz, Brian/0000-0002-3747-8484	DOE Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]	We thank S. Kivelson, H. Yao, A. Millis, D. Scalapino, P. Hirshfeld, B. Markiewicz, D-H. Lee, L. Yu, A. Fujimori and N. Nagaosa for fruitful discussions. ARPES experiments were performed at the Stanford Synchrotron Radiation Lightsource, operated by the Office of Basic Energy Science, US DOE. This work is supported by DOE Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under Contract DE-AC02-76SF00515.	Hashimoto M, 2010, NAT PHYS, V6, P414, DOI 10.1038/NPHYS1632; Vishik IM, 2012, P NATL ACAD SCI USA, V109, P18332, DOI 10.1073/pnas.1209471109; Shekhter A, 2013, NATURE, V498, P75, DOI 10.1038/nature12165; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Ma JH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.207002; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; He RH, 2011, SCIENCE, V331, P1579, DOI 10.1126/science.1198415; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Xia J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127002; Cuk T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117003; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Eschrig M, 2000, PHYS REV LETT, V85, P3261, DOI 10.1103/PhysRevLett.85.3261; TALLON JL, 1995, PHYS REV B, V51, P12911, DOI 10.1103/PhysRevB.51.12911; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Ando Y, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.167005, 10.1103/PhysRevLett.88.137005]; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Chang J, 2012, NAT PHYS, V8, P871, DOI [10.1038/nphys2456, 10.1038/NPHYS2456]; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Moon EG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104516; Anukool W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024516; Anzai H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2805; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Fauque B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.197001; Feng DL, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.220501; Zheng GQ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047006; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Mook HA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020506; Tallon JL, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.180501; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Yu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177004	36	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JAN	2015	14	1					37	42		10.1038/NMAT4116		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW7FM	WOS:000346430100011		
J	Matsunami, D; Fujita, A; Takenaka, K; Kano, M				Matsunami, Daichi; Fujita, Asaya; Takenaka, Koshi; Kano, Mika			Giant barocaloric effect enhanced by the frustration of the antiferromagnetic phase in Mn3GaN	NATURE MATERIALS			English	Article							MAGNETIC ENTROPY CHANGE; CURIE-TEMPERATURE; SPIN FLUCTUATIONS; ROOM-TEMPERATURE; PRESSURE; COMPOUND; DIFFRACTION; TRANSITION; MNAS1-XSBX; ALLOYS	First-order phase transitions are accompanied by a latent heat. Consequently, manipulating them by means of an external field causes a caloric effect. Although transitions from antiferromagnetic to paramagnetic states are not controlled by a magnetic field, a large barocaloric effect is expected when strong cross-correlations between the volume and magnetic order occur. Here we examine how geometric frustration in itinerant antiferromagnetic compounds can enhance the barocaloric effect. We study the thermodynamic behaviour of the frustrated antiferromagnet Mn3GaN, and report an entropy change of 22.3 J kg(-1) K-1 that is concomitant with a hydrostatic pressure change of 139 MPa. Furthermore, the calculated value of the adiabatic temperature change reaches 5 K by depressurization of 93 MPa. The giant barocaloric effect in Mn3GaN is caused by a frustration-driven enhancement of the ratio of volume change against the pressure coefficient of the Neel temperature. This mechanism for enhancing the barocaloric effect can form the basis for a new class of materials for solid-state refrigerants.	[Matsunami, Daichi; Kano, Mika] Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Fujita, Asaya] AIST, Green Magnet Mat Res Ctr, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Takenaka, Koshi] Nagoya Univ, Dept Appl Phys, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Matsunami, D (reprint author), Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.	dmatsunami@s.tohoku.ac.jp	Takenaka, Koshi/J-9544-2012		Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers	This work was supported by the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers.	Yuce S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745920; Antropov V, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.140406; Lukashev P, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184414; Bonnot E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.125901; AKAI H, 1993, PHYS REV B, V47, P8739, DOI 10.1103/PhysRevB.47.8739; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Manosa L, 2010, NAT MATER, V9, P478, DOI [10.1038/nmat2731, 10.1038/NMAT2731]; Krenke T, 2005, NAT MATER, V4, P450, DOI 10.1038/nmat1395; BERTAUT EF, 1968, SOLID STATE COMMUN, V6, P251, DOI 10.1016/0038-1098(68)90098-7; Pecharsky VK, 1997, PHYS REV LETT, V78, P4494, DOI 10.1103/PhysRevLett.78.4494; STAUNTON J, 1985, J PHYS F MET PHYS, V15, P1387, DOI 10.1088/0305-4608/15/6/019; Mischenko AS, 2006, SCIENCE, V311, P1270, DOI 10.1126/science.1123811; Fujita A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104416; Moya X, 2013, ADV MATER, V25, P1360, DOI 10.1002/adma.201203823; ANDERSON PW, 1973, MATER RES BULL, V8, P153, DOI 10.1016/0025-5408(73)90167-0; Strassle T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.054407; Strassle T, 2001, J ALLOY COMPD, V323, P392, DOI 10.1016/S0925-8388(01)01094-5; Takenaka K, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/015009; SHIGA M, 1988, J PHYS SOC JPN, V57, P3141, DOI 10.1143/JPSJ.57.3141; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Cakir O, 2013, J MAGN MAGN MATER, V344, P207, DOI 10.1016/j.jmmm.2013.05.057; Castillo-Villa PO, 2013, J APPL PHYS, V113, DOI 10.1063/1.4790140; Deportes J., 1996, J MAGN MAGN MATER, V70, P14; Fujieda S, 2009, MATER TRANS, V50, P483, DOI 10.2320/matertrans.MBW200822; Fujita A., SCR MAT, V67; FUJIWARA H, 1980, REV SCI INSTRUM, V51, P1345, DOI 10.1063/1.1136061; GARCIA J, 1980, J MAGN MAGN MATER, V15-8, P1155, DOI 10.1016/0304-8853(80)90231-0; Goto T, 2001, J ALLOY COMPD, V325, P18, DOI 10.1016/S0925-8388(01)01359-7; Hayashi K, 2000, J PHYS SOC JPN, V69, P4013, DOI 10.1143/JPSJ.69.4013; Kamakura N., 2010, MATER RES SOC S P, V1262, P109; Kamishima K, 2001, PHYS REV B, V63; Kim WS, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.172402; KUBLER J, 1988, J APPL PHYS, V63, P3482; Kudrnovsky J, 2010, J PHYS CONF SER, V200, DOI 10.1088/1742-6596/200/3/032036; Manosa L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1606; Manosa L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830999; Mekata M, 2000, PHYS REV B, V61, P4088, DOI 10.1103/PhysRevB.61.4088; MORIYA T, 1980, SOLID STATE COMMUN, V34, P95, DOI 10.1016/0038-1098(80)91241-7; Moriya T., 1985, SPRINGER SERIES SOLI, V56; Nashima O, 1996, J APPL PHYS, V79, P4647, DOI 10.1063/1.361692; OOMI G, 1987, J MAGN MAGN MATER, V70, P137, DOI 10.1016/0304-8853(87)90381-7; PINSKI FJ, 1986, PHYS REV LETT, V56, P2096, DOI 10.1103/PhysRevLett.56.2096; Saito H., PHYS REV B, V59; SHIGA M, 1988, PHYSICA B & C, V149, P293, DOI 10.1016/0378-4363(88)90256-2; Shiga M., 1994, MAT SCI TECHNOLOGY B, V3B, P159; Strassle T, 2000, PHYSICA B, V276, P944, DOI 10.1016/S0921-4526(99)01288-0; Tohei T, 2003, J APPL PHYS, V94, P1800, DOI 10.1063/1.1587265; Wada H, 2002, MATER TRANS, V43, P73, DOI 10.2320/matertrans.43.73; Wang BS, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/47004	49	16	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JAN	2015	14	1					73	78		10.1038/NMAT4117		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW7FM	WOS:000346430100017		
J	Mabuchi, H; Nohara, A				Mabuchi, Hiroshi; Nohara, Atsushi			THERAPY PCSK9 inhibitors for treating familial hypercholesterolaemia	NATURE REVIEWS ENDOCRINOLOGY			English	Editorial Material							LDL; CHOLESTEROL; DISEASE		[Mabuchi, Hiroshi; Nohara, Atsushi] Kanazawa Univ, Grad Sch Med Sci, Dept Lipidol, Kanazawa, Ishikawa 9208640, Japan	Mabuchi, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Lipidol, Takara Machi 13-1, Kanazawa, Ishikawa 9208640, Japan.	mabuchi@med.kanazawa-u.ac.jp					Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; BROWN MS, 1981, NEW ENGL J MED, V305, P515, DOI 10.1056/NEJM198108273050909; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; Mabuchi H, 2014, ATHEROSCLEROSIS, V236, P54, DOI 10.1016/j.atherosclerosis.2014.06.005; MABUCHI H, 1981, NEW ENGL J MED, V305, P478, DOI 10.1056/NEJM198108273050902; Raal F. J., LANCET	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5029	1759-5037		NAT REV ENDOCRINOL	Nat. Rev. Endocrinol.	JAN	2015	11	1					8	9		10.1038/nrendo.2014.205		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AW6DW	WOS:000346360600003		
J	Tsujimura, A; Taguchi, K; Watanabe, Y; Tatebe, H; Tokuda, T; Mizuno, T; Tanaka, M				Tsujimura, Atsushi; Taguchi, Katsutoshi; Watanabe, Yoshihisa; Tatebe, Harutsugu; Tokuda, Takahiko; Mizuno, Toshiki; Tanaka, Masaki			Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils	NEUROBIOLOGY OF DISEASE			English	Article						alpha-Synudein; Fibril; Aggregate formation; Cathepsin B; Lysosome	CHAPERONE-MEDIATED AUTOPHAGY; NEURONAL CELL-DEATH; PARKINSONS-DISEASE; IN-VITRO; DEGRADATION; TOXICITY; MUTANT; TRANSMISSION; PATHOLOGY; MICE	The formation of intracellular aggregates containing alpha-synuclein (alpha-Syn) is one of the key steps in the progression of Parkinson's disease and dementia with Lewy bodies. Recently, it was reported that pathological a-Syn fibrils can undergo cell-to-cell transmission and form Lewy body-like aggregates. However, little is known about how they form a-Syn aggregates from fibril seeds. Here, we developed an assay to study the process of aggregate formation using fluorescent protein-tagged alpha-Syn-expressing cells and examined the aggregate forming activity of exogenous a-Syn fibrils. alpha-Syn fibril-induced formation of intracellular aggregates was suppressed by a cathepsin B specific inhibitor, but not by a cathepsin D inhibitor. a-Syn fibrils pretreated with cathepsin B in vitro enhanced seeding activity in cells. Knockdown of cathepsin B also reduced fibril-induced aggregate formation. Moreover, using LAMP-1 immunocytochemistry and live-cell imaging, we observed that these aggregates initially occurred in the lysosome. They then rapidly grew larger and moved outside the boundary of the lysosome within one day. These results suggest that the lysosomal protease cathepsin B is involved in triggering intracellular aggregate formation by a-Syn fibrils. (C) 2015 Elsevier Inc.	[Tsujimura, Atsushi; Taguchi, Katsutoshi; Watanabe, Yoshihisa; Tanaka, Masaki] Kyoto Prefectural Univ Med, Dept Basic Geriatr, Kamikyo Ku, Kyoto 6028566, Japan; [Tatebe, Harutsugu; Tokuda, Takahiko; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kamikyo Ku, Kyoto 6028566, Japan	Tanaka, M (reprint author), Kyoto Prefectural Univ Med, Dept Basic Geriatr, Kamikyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	mtanaka@koto.kpu-m.ac.jp			NICHD; National Institutes of Health,; Japan Society for Promotion of Science [YW: 24591272, MT: 25290014]; Japan Science and Technology Agency [MT: AS242Z01075Q]	The anti-LAMP-I antibody developed by J. Thomas August and James E. K. Hildreth was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of NICHD, National Institutes of Health, and maintained by the Department of Biology, University of Iowa.; This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (YW: 24591272 and MT: 25290014) and a grant from the Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency (MT: AS242Z01075Q).	Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Baba M, 1998, AM J PATHOL, V152, P879; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ebrahimi-Fakhari D, 2012, AUTOPHAGY, V8, P281, DOI 10.4161/auto.8.2.18938; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb.mvj037; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Parreno M, 2008, CANCER RES, V68, P6313, DOI 10.1158/0008-5472.CAN-08-1054; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Crabtree D, 2014, J NEUROCHEM, V128, P950, DOI 10.1111/jnc.12497; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; KOGA H, 1991, J BIOCHEM-TOKYO, V110, P179; Marques O., 2012, CELL DEATH DIS, V3, pe350, DOI DOI 10.1038/CDDIS.2012.94; Protter D., 2012, PARKINSONS DIS, V2012, DOI http://dx.doi.org/10.1155/2012/829207; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Sacino AN, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-17; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Taguchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089327; Takahashi K, 2010, BIOCHEM BIOPH RES CO, V391, P382, DOI 10.1016/j.bbrc.2009.11.067; Watanabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052868; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515	52	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JAN	2015	73						244	253		10.1016/j.nbd.2014.10.011		10	Neurosciences	Neurosciences & Neurology	AW5QB	WOS:000346328100022		
J	Nakamura, M; Hayakawa, T; Okamura, A; Kohigashi, M; Fukui, K; Narumoto, J				Nakamura, Mitsuo; Hayakawa, Tomomi; Okamura, Aiko; Kohigashi, Mutsumi; Fukui, Kenji; Narumoto, Jin			Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						coping style; poor me paranoia; remitted paranoid delusion; external attribution	JAPANESE VERSION; RATING-SCALE; PARANOIA; RELIABILITY; PSYCHOSIS; IDEATION; MODEL	Background: If delusions serve as a defense mechanism in schizophrenia patients with paranoia, then they should show normal or high explicit self-esteem and low implicit self-esteem. However, the results of previous studies are inconsistent. One possible explanation for this inconsistency is that there are two types of paranoia, "bad me" (self-blaming) paranoia and "poor me" (non-selfblaming) paranoia. We thus examined implicit and explicit self-esteem and self-blaming tendency in patients with schizophrenia and schizoaffective disorder. We hypothesized that patients with paranoia would show lower implicit self-esteem and only those with non-self-blaming paranoia would experience a discrepancy between explicit and implicit self-esteem. Methods: Participants consisted of patients with schizophrenia and schizoaffective disorder recruited from a day hospital (N=71). Participants were assessed for psychotic symptoms, using the Brief Psychiatric Rating Scale (BPRS), and self-blaming tendency, using the brief COPE. We also assessed explicit self-esteem, using the Rosenberg Self-Esteem Scale (RSES), implicit self-esteem, using Brief Implicit Association Test (BIAT), and discrepancy between explicit and implicit self-esteem. Results: Contrary to our hypothesis, implicit self-esteem in paranoia and nonparanoia showed no statistical difference. As expected, only patients with non-self-blaming paranoia experienced a discrepancy between explicit and implicit self-esteem; other groups showed no such discrepancy. Conclusion: These results suggest that persecutory delusion plays a defensive role in nonself-blaming paranoia.	[Nakamura, Mitsuo; Fukui, Kenji; Narumoto, Jin] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Psychiat, Kyoto 6028566, Japan; [Hayakawa, Tomomi] Gojouyama Hosp, Nara, Japan; [Okamura, Aiko] Yashio Hosp, Saitama, Japan; [Kohigashi, Mutsumi] Kyoto Second Red Cross Hosp, Dept Psychiat, Kyoto, Japan	Nakamura, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med, Dept Psychiat, Kamigyo Ku, Kajii Cho 465, Kyoto 6028566, Japan.	mitsuon4@koto.kpu-m.ac.jp					Flanagan P, 2012, EARLY INTERV PSYCHIA, V6, P138, DOI 10.1111/j.1751-7893.2011.00320.x; Freeman D, 2005, BRIT J PSYCHIAT, V186, P427, DOI 10.1192/bjp.186.5.427; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; LYON HM, 1994, BRIT J PSYCHIAT, V164, P637, DOI 10.1192/bjp.164.5.637; Freeman D, 1998, BRIT J CLIN PSYCHOL, V37, P415; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Teachman BA, 2003, J ABNORM PSYCHOL, V112, P100, DOI 10.1037/0021-843X.112.1.100; Melo SS, 2006, PSYCHOL PSYCHOTHER-T, V79, P271, DOI 10.1348/147608305X52856; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; BENTALL RP, 1989, BRIT J MED PSYCHOL, V62, P355; van der Gaag M, 2006, SCHIZOPHRENIA BULL, V32, pS113, DOI 10.1093/schbul/sb1027; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; BENTALL RP, 1994, BEHAV RES THER, V32, P331, DOI 10.1016/0005-7967(94)90131-7; [Anonymous], ICD 10 CLASS MENT BE; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; Mimura C, 2007, J PSYCHOSOM RES, V62, P589, DOI 10.1016/j.jpsychores.2006.11.004; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Valiente C, 2011, J ABNORM PSYCHOL, V120, P691, DOI 10.1037/a0022856; Chadwick PDJ, 2005, PSYCHOPATHOLOGY, V38, P327, DOI 10.1159/000089453; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Kesting ML, 2011, PSYCHIAT RES, V186, P197, DOI 10.1016/j.psychres.2010.08.036; KINDERMAN P, 1994, BRIT J MED PSYCHOL, V67, P53; Kolakowska T, 1976, BRIEF PSYCHIAT RATIN; Lachar D, 2001, PSYCHOL ASSESSMENT, V13, P384, DOI 10.1037//1040-3590.13.3.384; MacKinnon K, 2011, J BEHAV THER EXP PSY, V42, P54, DOI 10.1016/j.jbtep.2010.05.003; McKay Ryan, 2007, Cogn Neuropsychiatry, V12, P1, DOI 10.1080/13546800500363996; Moritz Steffen, 2006, Cogn Neuropsychiatry, V11, P402, DOI 10.1080/13546800444000263; Rosenberg M., 1965, SOC ADOLESCENT SELF; Vazquez C, 2008, J BEHAV THER EXP PSY, V39, P587, DOI 10.1016/j.jbtep.2008.01.006; Yamauchi T, 2008, JAPANESE J PERSONALI, V17, P182	32	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						33	40		10.2147/NDT.S73906		8	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AX0SP	WOS:000346662600001		
J	Shichinohe, H; Ishihara, T; Takahashi, K; Tanaka, Y; Miyamoto, M; Yamauchi, T; Saito, H; Takemoto, H; Houkin, K; Kuroda, S				Shichinohe, Hideo; Ishihara, Takeshi; Takahashi, Koji; Tanaka, Yoshikazu; Miyamoto, Michiyuki; Yamauchi, Tomohiro; Saito, Hisayasu; Takemoto, Hiroshi; Houkin, Kiyohiro; Kuroda, Satoshi			Bone Marrow Stromal Cells Rescue Ischemic Brain by Trophic Effects and Phenotypic Change Toward Neural Cells	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						bone marrow stromal cells; regenerative medicine; coculture; permanent middle cerebral artery occlusion; neurotrophic factor	MESENCHYMAL STEM-CELLS; MICE CEREBRAL INFARCT; NEUROTROPHIC FACTOR; IN-VITRO; STROKE; EXPRESSION; DIFFERENTIATE; NEURONS; RATS; TRANSPLANTATION	Background. Transplantation of bone marrow stromal cells (BMSCs) may contribute to functional recovery after stroke. This study was designed to clarify their mechanisms, trophic effects of neurotrophic factors, and neural differentiation. Methods. Mouse neurons exposed to glutamate were cocultured with mouse BMSCs. Either neutralizing antibodies against brain-derived neurotrophic factor (BDNF) or nerve growth factor (NGF) or Trk inhibitor K252a was added to explore the mechanism of their protective effects. Fluorescence in situ hybridization (FISH) was used to assess BDNF or NGF mRNA expression in BMSCs. The mice were subjected to permanent focal ischemia, and 7 days later, either BMSCs or the vehicle was stereotactically transplanted into the ipsilateral striatum. The mouse brains were processed for FISH and immunostaining 2 or 4 weeks after transplantation. Results. BMSCs significantly ameliorated glutamate-induced neuronal death. Treatment with anti-BDNF antibody significantly reduced their protective effects. FISH analysis showed that the majority of BMSCs expressed BDNF and NGF mRNA in vitro. BMSC transplantation significantly improved the survival of neurons in peri-infarct areas. FISH analysis revealed that approximately half of BMSCs expressed BDNF and NGF mRNA 2 weeks after transplantation; however, the percentage of BDNF and NGF mRNA-positive cells decreased thereafter. Instead, the percentage of microtubule-associated protein 2-positive BMSCs gradually increased during 4 weeks after transplantation. Conclusions. These findings strongly suggest that BDNF may be a key factor underlying the trophic effects of BMSCs. BMSCs might exhibit the trophic effect in the early stage of cell therapy and the phenotypic change toward neural cells thereafter.	[Shichinohe, Hideo; Miyamoto, Michiyuki; Yamauchi, Tomohiro; Saito, Hisayasu; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Ishihara, Takeshi; Takahashi, Koji; Tanaka, Yoshikazu; Takemoto, Hiroshi] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug, Sapporo, Hokkaido, Japan; [Kuroda, Satoshi] Toyama Univ, Dept Neurosurg, Grad Sch Med & Pharmaceut Sci Educ, Toyama 9300194, Japan	Kuroda, S (reprint author), Toyama Univ, Dept Neurosurg, Grad Sch Med & Pharmaceut Sci Educ, 2630 Sugitani, Toyama 9300194, Japan.	skuroda@med.u-toyama.ac.jp			Ministry of Education, Science and Culture of Japan [23390342, 24390336]	The authors received the following financial support for the research, authorship, and/or publication of this article: This study was supported by Grant-in-aids from the Ministry of Education, Science and Culture of Japan (No. 23390342 and No. 24390336).	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Janowski M, 2010, STEM CELLS DEV, V19, P5, DOI 10.1089/scd.2009.0271; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Gassei K, 2008, REPRODUCTION, V136, P459, DOI 10.1530/REP-08-0241; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; He XY, 2011, CYTOTHERAPY, V13, P46, DOI 10.3109/14653249.2010.510505; Hokari M, 2007, J NEUROSCI RES, V86, P1024; Kohara K, 2003, J NEUROSCI, V23, P6123; Rana OR, 2011, CIRC RES, V108, P1209, DOI 10.1161/CIRCRESAHA.110.234518; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127	28	4	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2015	29	1					80	89		10.1177/1545968314525856		10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW4HL	WOS:000346241700010		
J	Takahashi, Y; Kinoshita, T				Takahashi, Yohei; Kinoshita, Toshinori			Stomatal function has an element of hysteresis	NEW PHYTOLOGIST			English	Editorial Material						abscisic acid (ABA); Arabidopsis; dehydration; expression analysis; memory; stomata	KINASE-PHOSPHATASE PAIR; ABSCISIC-ACID; PROTEIN-KINASES; GUARD-CELLS; ARABIDOPSIS; PHOSPHORYLATION; EXPRESSION; CHANNEL; STRESS		[Takahashi, Yohei; Kinoshita, Toshinori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Kinoshita, Toshinori] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan	Kinoshita, T (reprint author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan.	kinoshita@bio.nagoya-u.ac.jp	Kinoshita, Toshinori/C-2891-2012				Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Darwin F, 1898, BIOL SCI B, V190, P531; Takahashi Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003760; Virlouvet L, 2014, NEW PHYTOL, V205, P596; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	JAN	2015	205	2					455	457		10.1111/nph.13149		3	Plant Sciences	Plant Sciences	AW9NO	WOS:000346584600001		
J	Derba-Maceluch, M; Awano, T; Takahashi, J; Lucenius, J; Ratke, C; Kontro, I; Busse-Wicher, M; Kosik, O; Tanaka, R; Winzell, A; Kallas, A; Lesniewska, J; Berthold, F; Immerzeel, P; Teeri, TT; Ezcurra, I; Dupree, P; Serimaa, R; Mellerowicz, EJ				Derba-Maceluch, Marta; Awano, Tatsuya; Takahashi, Junko; Lucenius, Jessica; Ratke, Christine; Kontro, Inkeri; Busse-Wicher, Marta; Kosik, Ondrej; Tanaka, Ryo; Winzell, Anders; Kallas, Asa; Lesniewska, Joanna; Berthold, Fredrik; Immerzeel, Peter; Teeri, Tuula T.; Ezcurra, Ines; Dupree, Paul; Serimaa, Ritva; Mellerowicz, Ewa J.			Suppression of xylan endotransglycosylase PtxtXyn10A affects cellulose microfibril angle in secondary wall in aspen wood	NEW PHYTOLOGIST			English	Article						endotransglycosylase; growth stresses; hybrid aspen; Populus; secondary cell wall; wood formation; xylan; xylanase	PLANT-CELL-WALL; CARBOHYDRATE-ACTIVE ENZYMES; ARABIDOPSIS-THALIANA; BARLEY-ALEURONE; ARABINOGALACTAN PROTEINS; POLYSACCHARIDE ANALYSIS; SCHIZOPHYLLUM-COMMUNE; CORTICAL MICROTUBULES; GLUCURONOYL ESTERASE; GEL-ELECTROPHORESIS	Certain xylanases from family GH10 are highly expressed during secondary wall deposition, but their function is unknown. We carried out functional analyses of the secondary-wall specific PtxtXyn10A in hybrid aspen (Populus tremulaxtremuloides).PtxtXyn10A function was analysed by expression studies, overexpression in Arabidopsis protoplasts and by downregulation in aspen.PtxtXyn10A overexpression in Arabidopsis protoplasts resulted in increased xylan endotransglycosylation rather than hydrolysis. In aspen, the enzyme was found to be proteolytically processed to a 68kDa peptide and residing in cell walls. Its downregulation resulted in a corresponding decrease in xylan endotransglycosylase activity and no change in xylanase activity. This did not alter xylan molecular weight or its branching pattern but affected the cellulose-microfibril angle in wood fibres, increased primary growth (stem elongation, leaf formation and enlargement) and reduced the tendency to form tension wood. Transcriptomes of transgenic plants showed downregulation of tension wood related genes and changes in stress-responsive genes. The data indicate that PtxtXyn10A acts as a xylan endotransglycosylase and its main function is to release tensional stresses arising during secondary wall deposition. Furthermore, they suggest that regulation of stresses in secondary walls plays a vital role in plant development.	[Derba-Maceluch, Marta; Awano, Tatsuya; Takahashi, Junko; Ratke, Christine; Lesniewska, Joanna; Immerzeel, Peter; Mellerowicz, Ewa J.] UPSC, SLU, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Awano, Tatsuya; Tanaka, Ryo] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Kyoto, Japan; [Lucenius, Jessica; Kontro, Inkeri; Serimaa, Ritva] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Busse-Wicher, Marta; Kosik, Ondrej; Dupree, Paul] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Winzell, Anders; Kallas, Asa; Teeri, Tuula T.; Ezcurra, Ines] Royal Inst Technol KTH, Sch Biotechnol, Stockholm, Sweden; [Lesniewska, Joanna] Univ Bialystok, Dept Bot, PL-15950 Bialystok, Poland; [Berthold, Fredrik] INNVENTIAAB, Stockholm, Sweden	Mellerowicz, EJ (reprint author), UPSC, SLU, Dept Forest Genet & Plant Physiol, Umea, Sweden.	ewa.mellerowicz@slu.se	Teeri, Tuula/E-7509-2013		Formas; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (VINNOVA); Swedish Center for Biomimetic Fiber Engineering - Knut & Alice Wallenberg Foundation; Swedish Center for Biomimetic Fiber Engineering - Foundation for Strategic Research; European projects EDEN [QLK5-CT-2001-00443]; RENEWALL; FORE; Bio4Energy; Wood Ultrastructure Research Centre; SamNordisk Skogsforskning [107]; Japan Society for the Promotion of Science (JSPS KAKENHI) [24580243]; Academy of Finland [1127759]	We thank Kjell Olofsson, Andreas Sjodin and Oskar Skogstrom, Laszlo Bako, Kirsi Leppanen and Gaia Geiss for help with the anatomy, microarrays, protoplasts, X-ray and qPCR analyses, respectively, and Anne Gouget, Lorenz Gerber and Tarek Elhasi for preliminary experiments. Andras Gorzsas from the Vibrational Spectroscopy Platform at Umea University assisted with the FTIR spectroscopic analysis and Cheng Choo Lee at the Umea Electron Microscopy Core Facility with FESEM. Financial sources: Formas (including HemiPop and FuncFiber), Swedish Research Council (VR), Swedish Governmental Agency for Innovation Systems (VINNOVA), Swedish Center for Biomimetic Fiber Engineering (funded by the Knut & Alice Wallenberg Foundation and the Foundation for Strategic Research), European projects EDEN (QLK5-CT-2001-00443) and RENEWALL, FORE, Bio4Energy, Wood Ultrastructure Research Centre, SamNordisk Skogsforskning (project no. 107), Japan Society for the Promotion of Science (JSPS KAKENHI grant no. 24580243) and the Academy of Finland (1127759).	ABE H, 1992, IAWA BULL, V13, P411; Akin E, 1993, AGRON J, V85, P171; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Yoneda A, 2010, PLANT J, V64, P657, DOI 10.1111/j.1365-313X.2010.04356.x; Rogowski A, 2014, J BIOL CHEM, V289, P53, DOI 10.1074/jbc.M113.525295; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444; Stevanic JS, 2009, HOLZFORSCHUNG, V63, P497, DOI 10.1515/HF.2009.094; Stewart D, 1997, PLANTA, V201, P311, DOI 10.1007/s004250050072; Leppanen K, 2011, HOLZFORSCHUNG, V65, P865, DOI 10.1515/HF.2011.108; Gray-Mitsumune M, 2008, PLANT BIOTECHNOL J, V6, P62, DOI 10.1111/j.1467-7652.2007.00295.x; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Reis D, 2004, CR BIOL, V327, P785, DOI 10.1016/j.crvi.2004.04.008; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Frankova L, 2011, PLANT J, V67, P662, DOI 10.1111/j.1365-313X.2011.04625.x; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Dokken KM, 2005, APPL SPECTROSC REV, V40, P301, DOI 10.1080/05704920500230898; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Donaldson LA, 2012, PLANT PHYSIOL, V158, P642, DOI 10.1104/pp.111.184036; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Winzell A, 2010, BIOCHEM BIOPH RES CO, V394, P848, DOI 10.1016/j.bbrc.2010.03.101; Landrein B, 2013, PLANT J, V75, P324, DOI 10.1111/tpj.12188; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; REIS D, 1991, BIOL CELL, V73, P173, DOI 10.1016/0248-4900(91)90100-2; Donaldson L, 2008, IAWA J, V29, P345; Naran R, 2009, CELLULOSE, V16, P661, DOI 10.1007/s10570-009-9324-y; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; PAULL RE, 1983, PLANT PHYSIOL, V72, P382, DOI 10.1104/pp.72.2.382; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Yamamoto H, 2010, WOOD SCI TECHNOL, V44, P149, DOI 10.1007/s00226-009-0262-5; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; Funada Ryo, 2008, V11, P83, DOI 10.1007/70892_008_163; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; THEANDER O, 1986, J AGR FOOD CHEM, V34, P330, DOI 10.1021/jf00068a045; Awano T, 2002, PROTOPLASMA, V219, P106, DOI 10.1007/s007090200011; Banik M, 1996, PLANT MOL BIOL, V31, P1163, DOI 10.1007/BF00040833; BENJAVONGKULCHAI E, 1986, PLANTA, V169, P415, DOI 10.1007/BF00392139; Bevan MW, 2006, NAT BIOTECHNOL, V24, P765, DOI 10.1038/nbt0706-765; Bih FY, 1999, J BIOL CHEM, V274, P22884, DOI 10.1074/jbc.274.32.22884; Biswal AK, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-11; Bromley JR, 2013, PLANT J, V74, P423, DOI 10.1111/tpj.12135; Brummell David A., 2009, New Zealand Journal of Forestry Science, V39, P125; Caspers MPM, 2001, PLANT J, V26, P191, DOI 10.1046/j.0960-7412.2001.01019.x; Chen NJ, 2003, FUNCT PLANT BIOL, V30, P433, DOI 10.1071/FP02208; Cleemput G, 1997, PLANT PHYSIOL, V115, P1619, DOI 10.1104/pp.115.4.1619; Cleemput G, 1997, PLANT PHYSIOL, V113, P377; DARVILL JE, 1980, PLANT PHYSIOL, V66, P1135, DOI 10.1104/pp.66.6.1135; De Backer E, 2010, PLANT PHYSIOL BIOCH, V48, P90, DOI 10.1016/j.plaphy.2009.10.008; Doczi R, 2011, METHODS MOL BIOL, V779, P79, DOI 10.1007/978-1-61779-264-9_5; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2003.00980.x; Gray-Mitsumunel M, 2004, PLANT BIOLOGY, V6, P47, DOI 10.1055/s-2003-44747; Ichinose H, 2010, PLANT BIOTECHNOL-NAR, V27, P259, DOI 10.5511/plantbiotechnology.27.259; IMAMURA T, 1994, PHYTOCHEMISTRY, V37, P1165, DOI 10.1016/S0031-9422(00)89551-5; Jacobs A, 2001, BIOMACROMOLECULES, V2, P894, DOI 10.1021/bm010050b; Jacques E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-163; Johnston SL, 2013, PLANTA, V237, P173, DOI 10.1007/s00425-012-1766-z; Kabel MA, 2007, CARBOHYD POLYM, V69, P94, DOI 10.1016/j.carbpol.2006.09.006; Kosik O, 2012, METHOD ENZYMOL, V510, P51, DOI 10.1016/B978-0-12-415931-0.00004-5; Kosik O, 2011, CARBOHYD RES, V346, P357, DOI 10.1016/j.carres.2010.09.004; Lagerwall JPF, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.69; Larsson M, 2000, J BIOTECHNOL, V80, P143, DOI 10.1016/S0168-1656(00)00258-3; Gandla ML, 2015, PHYTOCHEMISTRY, V112, P210, DOI 10.1016/j.phytochem.2014.06.002; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Mellerowicz EJ, 2012, J EXP BOT, V63, P551, DOI 10.1093/jxb/err339; PAOLILLO DJ, 1991, AM J BOT, V78, P845, DOI 10.2307/2445076; Ruel K., 2006, Maderas: Ciencia y Technologia, V8, P107, DOI 10.4067/S0718-221X2006000200004; Simpson DJ, 2003, J CEREAL SCI, V37, P111, DOI 10.1006/jcrs.2002.0488; Sjodin A, 2006, PLANT J, V48, P806, DOI 10.1111/j.1365-313X.2006.02920.x; SLADE AM, 1989, EUR J BIOCHEM, V185, P533, DOI 10.1111/j.1432-1033.1989.tb15146.x; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Suen DF, 2006, J BIOL CHEM, V282, P625, DOI 10.1074/jbc.M608567200; Suzuki M, 2002, PLANT CELL PHYSIOL, V43, P759, DOI 10.1093/pcp/pcf088; Svedstrom K, 2012, TREES-STRUCT FUNCT, V26, P1793, DOI 10.1007/s00468-012-0748-x; Timell T. E., 1967, Wood Science and Technology, V1, P45; Van Campenhout S, 2007, BIOCHEM BIOPH RES CO, V356, P799, DOI 10.1016/j.bbrc.2007.03.066; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu SSH, 2002, J BIOL CHEM, V277, P49055, DOI 10.1074/jbc.M208804200	102	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	JAN	2015	205	2					666	681		10.1111/nph.13099		16	Plant Sciences	Plant Sciences	AW9NO	WOS:000346584600024		
J	Matsuda, T; Watanuki, S				Matsuda, Takanori; Watanuki, Shoichi			Rhodium-catalysed arylative annulation of 1,4-enynes with arylboronic acids	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							ASYMMETRIC HYDROARYLATION; 1,4-RHODIUM MIGRATION; H ACTIVATION; CYCLIZATION; 1,6-ENYNES; SEQUENCE; OLEFINS; TRANSFORMATIONS; DERIVATIVES; COMPLEXES	The rhodium(I)-catalysed arylative annulation of 1,4-enynes with arylboronic acids was investigated. The reaction was found to proceed via an addition-1,4-rhodium migration-addition sequence, affording the corresponding 1,1-disubstituted 3-(arylmethylene)indanes.	[Matsuda, Takanori; Watanuki, Shoichi] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan	Matsuda, T (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	mtd@rs.tus.ac.jp	Matsuda, Takanori/A-9118-2010	Matsuda, Takanori/0000-0002-9927-3599	JSPS, Japan [25410054]; Sumitomo Foundation	This work was supported by JSPS, Japan (Grant-in-Aid for Scientific Research (C) no. 25410054) and the Sumitomo Foundation.	Chernyak N, 2011, ANGEW CHEM INT EDIT, V50, P2342, DOI 10.1002/anie.201006751; Zhang J, 2013, J AM CHEM SOC, V135, P17270, DOI 10.1021/ja409049t; Sasaki K, 2012, CHEM SCI, V3, P1278, DOI 10.1039/c2sc01093c; Shintani R, 2011, ORG LETT, V13, P350, DOI 10.1021/ol102674z; Matsuda T, 2012, CHEM COMMUN, V48, P2988, DOI 10.1039/c2cc18098g; Shintani R, 2005, J AM CHEM SOC, V127, P54, DOI 10.1021/ja044021v; Miura T, 2005, J AM CHEM SOC, V127, P1094, DOI 10.1021/ja0435079; Thottumkara PP, 2010, ORG LETT, V12, P5640, DOI 10.1021/ol1023807; Miura T, 2006, CHEM-ASIAN J, V1, P868, DOI 10.1002/asia.200600254; Bexrud J, 2010, ORG LETT, V12, P3160, DOI 10.1021/ol101067d; So CM, 2013, J AM CHEM SOC, V135, P10990, DOI 10.1021/ja406169s; Keilitz J, 2013, ORG LETT, V15, P1148, DOI 10.1021/ol400363f; Ishida N, 2013, J AM CHEM SOC, V135, P19103, DOI 10.1021/ja410910s; Shintani R, 2005, ANGEW CHEM INT EDIT, V44, P3909, DOI 10.1002/anie.200500843; Seiser T, 2010, CHEM-EUR J, V16, P3383, DOI 10.1002/chem.200903225; Shintani R, 2010, ANGEW CHEM INT EDIT, V49, P3795, DOI 10.1002/anie.201000937; Fruchey ER, 2013, ORG LETT, V15, P4362, DOI 10.1021/ol4018694; Seiser T, 2009, ANGEW CHEM INT EDIT, V48, P6320, DOI 10.1002/anie.200903189; Shigeno M, 2009, CHEM-EUR J, V15, P12929, DOI 10.1002/chem.200902593; Artok L, 2009, TETRAHEDRON, V65, P9125, DOI 10.1016/j.tet.2009.09.044; Cramer N, 2011, SYNLETT, P449, DOI 10.1055/s-0030-1259536; Fang X., 2009, CHEM COMMUN; Guo LN, 2008, EUR J ORG CHEM, P1418, DOI 10.1002/ejoc.200701043; Ishida N, 2013, CHEM LETT, V42, P1076, DOI 10.1246/cl.130463; Machotta AB, 2007, J AM CHEM SOC, V129, P13455, DOI 10.1021/ja072571y; Marchal E, 2008, TETRAHEDRON LETT, V49, P3713, DOI 10.1016/j.tetlet.2008.04.042; Miura T, 2007, CHEM COMMUN, P217, DOI 10.1039/b609991b; Prakash P, 2013, RSC ADV, V3, P19933, DOI 10.1039/c3ra43191f; Shimada M, 2008, CHEM-ASIAN J, V3, P1035, DOI 10.1002/asia.200700407; Shintani R, 2014, J AM CHEM SOC, V136, P7849, DOI 10.1021/ja5032002; Tobisu M, 2012, CHEM COMMUN, V48, P11437, DOI 10.1039/c2cc36601k; Tran DN, 2013, ANGEW CHEM INT EDIT, V52, P10630, DOI 10.1002/anie.201304919; Wang X, 2010, EUR J ORG CHEM, P5391, DOI 10.1002/ejoc.201000515; Xing P, 2013, TETRAHEDRON LETT, V54, P699, DOI 10.1016/j.tetlet.2012.12.016; Youn SW, 2009, EUR J ORG CHEM, P2597, DOI 10.1002/ejoc.200900001	35	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	3					702	705		10.1039/c4ob02210f		4	Chemistry, Organic	Chemistry	AW8AT	WOS:000346483700009		
J	Hitaoka, S; Chuman, H; Yoshizawa, K				Hitaoka, Seiji; Chuman, Hiroshi; Yoshizawa, Kazunari			A QSAR study on the inhibition mechanism of matrix metalloproteinase-12 by arylsulfone analogs based on molecular orbital calculations	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							INITIO MO CALCULATIONS; OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGE ELASTASE MMP-12; SIALIC-ACID ANALOGS; BINDING-AFFINITY; GELATINASE-A; COMPLEX STRUCTURES; TISSUE INHIBITORS; FREE-ENERGIES; HYDROXAMATE INHIBITORS	A binding mechanism between human matrix metalloproteinase-12 (MMP-12) and eight arylsulfone analogs having two types of carboxylic and hydroxamic acids as the most representative zinc binding group is investigated using a quantitative structure-activity relationship (QSAR) analysis based on a linear expression by representative energy terms (LERE). The LERE-QSAR analysis quantitatively reveals that the variation in the observed (experimental) inhibitory potency among the arylsulfone analogs is decisively governed by those in the intrinsic binding and dispersion interaction energies. The results show that the LERE-QSAR analysis not only can excellently reproduce the observed overall free-energy change but also can determine the contributions of representative free-energy changes. An inter-fragment interaction energy difference (IFIED) analysis based on the fragment molecular orbital (FMO) method (FMO-IFIED) leads to the identification of key residues governing the variation in the inhibitory potency as well as to the understanding of the difference between the interactions of the carboxylic and hydroxamic acid zinc binding groups. The current results that have led to the optimization of the inhibitory potency of arylsulfone analogs toward MMP-12 to be used in the treatment of chronic obstructive pulmonary disease may be useful for the development of a new potent MMP-12 inhibitor.	[Hitaoka, Seiji; Yoshizawa, Kazunari] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190395, Japan; [Hitaoka, Seiji; Yoshizawa, Kazunari] Kyushu Univ, Int Res Ctr Mol Syst, Fukuoka 8190395, Japan; [Chuman, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708505, Japan	Chuman, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, 1-78 Shomachi, Tokushima 7708505, Japan.	hchuman@tokushima-u.ac.jp; kazunari@ms.ifoc.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22245028, 24109014]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); CREST of the Japan Science and Technology Cooperation	We acknowledge Grants-in-Aid for Scientific Research (no. 22245028 and 24109014) from the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) for the MEXT Projects "Integrated Research on Chemical Synthesis" and "Elements Strategy Initiative to Form Core Research Center", and CREST of the Japan Science and Technology Cooperation.	Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Kontogiorgis CA, 2005, CURR MED CHEM, V12, P339; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Lukacova V, 2004, J BIOL CHEM, V279, P14194, DOI 10.1074/jbc.M313474200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Nuti E, 2009, J MED CHEM, V52, P6347, DOI 10.1021/jm900335a; Bren U, 2006, J PHYS CHEM B, V110, P12782, DOI 10.1021/jp056623m; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Fogueri UR, 2013, J PHYS CHEM A, V117, P2269, DOI 10.1021/jp312644t; Hu X, 2004, J MOL GRAPH MODEL, V22, P293, DOI 10.1016/j.jmgm.2003.11.002; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Kruse H, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3700154; Cross JB, 2002, J AM CHEM SOC, V124, P11004, DOI 10.1021/ja0201810; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Faver JC, 2012, PHYS CHEM CHEM PHYS, V14, P7795, DOI 10.1039/c2cp23715f; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Massova I, 1998, FASEB J, V12, P1075; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; NOYES RM, 1962, J AM CHEM SOC, V84, P513, DOI 10.1021/ja00863a002; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.3.CO;2-7; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Watanabe C, 2013, J MOL GRAPH MODEL, V41, P31, DOI 10.1016/j.jmgm.2013.01.006; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Hitaoka S, 2011, J CHEM INF MODEL, V51, P2706, DOI 10.1021/ci2002395; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Rizzo RC, 2004, J MED CHEM, V47, P3065, DOI 10.1021/jm030570k; Bren M, 2007, THEOR CHEM ACC, V117, P535, DOI 10.1007/s00214-007-0264-z; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Bertini I, 2007, J AM CHEM SOC, V129, P2466, DOI 10.1021/ja065156z; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; [Anonymous], CLOGP WIND VER 4 0; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Duchackova L, 2009, CHEM-EUR J, V15, P13399, DOI 10.1002/chem.200901645; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Houk KN, 2003, ANGEW CHEM INT EDIT, V42, P4872, DOI 10.1002/anie.200200565; Antoni C, 2013, J STRUCT BIOL, V182, P246, DOI 10.1016/j.jsb.2013.03.015; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021; Attolino E, 2010, EUR J MED CHEM, V45, P5919, DOI 10.1016/j.ejmech.2010.09.057; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Donini OAT, 2000, J MED CHEM, V43, P4180, DOI 10.1021/jm000040d; Faver JC, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3641894; Florian J, 1999, J PHYS CHEM B, V103, P884, DOI 10.1021/jp983699s; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gupta SP, 2007, CHEM REV, V107, P3042, DOI 10.1021/cr030448t; Ha S, 2000, J COMPUT AID MOL DES, V14, P435, DOI 10.1023/A:1008137707965; Hitaoka S., 2013, CHEM BIO INF J, V13, P30; Hitaoka S, 2013, J PESTIC SCI, V38, P60, DOI 10.1584/jpestics.D12-082; Hitaoka S, 2010, J CHEM INF MODEL, V50, P1796, DOI 10.1021/ci100225b; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; Hou TJ, 2002, J PHYS CHEM B, V106, P5527, DOI 10.1021/jp015516z; Hou TJ, 2002, J COMPUT AID MOL DES, V16, P27, DOI 10.1023/A:1016345810973; Hou TJ, 2001, J PHYS CHEM B, V105, P5304, DOI 10.1021/jp0044476; Hu X, 2003, J MOL GRAPH MODEL, V22, P115, DOI 10.1016/S1093-3263(03)00153-0; Khandelwal A, 2007, J COMPUT AID MOL DES, V21, P131, DOI 10.1007/s10822-007-9104-4; Khandelwal A, 2005, J MED CHEM, V48, P5437, DOI 10.1021/jm049050v; Khandelwal A, 2004, QSAR COMB SCI, V23, P754, DOI 10.1002/qsar.200430896; Khandelwal A, 2005, J PHYS CHEM A, V109, P6387, DOI 10.1021/jp051105x; Khandelwal A, 2007, PROTEINS, V69, P326, DOI 10.1002/prot.21500; Konstantinopoulos PA, 2008, INT J BIOCHEM CELL B, V40, P1156, DOI 10.1016/j.biocel.2007.11.007; Marcial BL, 2012, J PHYS CHEM B, V116, P13644, DOI 10.1021/jp3079748; Markus MA, 2008, J BIOMOL NMR, V41, P55, DOI 10.1007/s10858-008-9236-4; Munei Y, 2011, BIOORG MED CHEM LETT, V21, P141, DOI 10.1016/j.bmcl.2010.11.050; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Pruitt SR, 2013, COMPUT THEOR CHEM, V1021, P70, DOI 10.1016/j.comptc.2013.06.030; SEARLE MS, 1995, J CHEM SOC PERK T 2, P141, DOI 10.1039/p29950000141; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Toba S, 1999, J MED CHEM, V42, P1225, DOI 10.1021/jm980577f; Tuccinardi T, 2008, BIOORGAN MED CHEM, V16, P7749, DOI 10.1016/j.bmc.2008.07.004; Yoshida T, 2010, J CHEM INF MODEL, V50, P850, DOI 10.1021/ci100068w; Yoshida T, 2014, BIOORG MED CHEM LETT, V24, P1037, DOI 10.1016/j.bmcl.2014.01.020; Yoshida T, 2012, J PHYS CHEM B, V116, P10283, DOI 10.1021/jp305476x	96	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	3					793	806		10.1039/c4ob01843e		14	Chemistry, Organic	Chemistry	AW8AT	WOS:000346483700018		
J	Oba, M; Sakata, S; Fujii, T				Oba, Masahiro; Sakata, Susumu; Fujii, Tetsuya			Archaeal polar lipids in subseafloor sediments from the Nankai Trough: Implications for the distribution of methanogens in the deep marine subsurface	ORGANIC GEOCHEMISTRY			English	Article						Polar lipid; Archaeol; Hydroxyarchaeol; Methanogen biomarker; Deep marine sediment; Methane hydrate	RIBOSOMAL-RNA PHYLOGENY; GLYCEROL ETHER LIPIDS; TETRAETHER LIPIDS; CASCADIA MARGIN; METHANOTROPHIC CONSORTIA; BACTERIAL-POPULATIONS; MICROBIAL COMMUNITIES; ANAEROBIC OXIDATION; PRODUCTION-RATES; MEMBRANE-LIPIDS	Although the methane in marine methane hydrates is mainly of microbial origin, information about the distribution of methanogens in subseafloor sediments is limited. To address this issue, we analyzed sediment core samples from two sites in the Nankai Trough, off the Pacific coast of central Japan, including those bearing methane hydrates from depths > 100 m below the seafloor (mbsf), for isopranyl ether-linked polar lipids (i.e. with polar head groups of phosphate, sugar, or both) as biomarkers of archaea, including methanogens. In most samples, including the deepest (381 mbsf), archaeol, and sn-2- and sn-3-hydroxyarchaeols were detected as their hydrolyzed derivatives. Concentrations of these three archaeal lipids correlated strongly with each other, suggesting a common biological source. The delta C-13 values of phytane derived from the phytanyl groups in the archaeal lipids were distinctly higher than those of methane, indicating that methanogens rather than anaerobic methanotrophic archaea were the major biological source. Depth profiles of polar sn-2-hydroxyarchaeol concentration were consistent with those of the potential methane production activity previously estimated from incubation of core sediments from the same sites. This observation, together with results of previous studies showing the presence of sn-2-hydroxyarchaeol mainly in shallow young sediments, strongly suggests that this polar lipid is a valid biomarker for in situ methanogens in sediments. There was a strong correlation between the concentration of polar sn-2-hydroxyarchaeol and that of total organic carbon, suggesting that bulk organic matter concentration is a primary control on the distribution of methanogens in sediments. (C) 2014 Elsevier Ltd. All rights reserved.	[Oba, Masahiro; Sakata, Susumu] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki 3058567, Japan; [Fujii, Tetsuya] Japan Oil Gas & Met Natl Corp JOGMEC, Technol & Res Ctr, Mihama Ku, Chiba 2610025, Japan	Oba, M (reprint author), Tohoku Univ, Inst Geol & Paleontol, Sendai, Miyagi 9808578, Japan.	oba@m.tohoku.ac.jp; su-sakata@aist.go.jp			Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists [00001622]; JSPS grant [23244109]	We are grateful to the Ministry of Economy, Trade and Industry and to the Japan Oil, Gas and Metals National Corporation for providing access to the samples and for permission to publish the data. We thank M. Tanahashi for support in collecting the cores onboard the R/V JOIDES Resolution and for helpful discussions. We thank K. Hiemori for analytical assistance. Comments from K.-U. Hinrichs greatly helped us interpret the sediment lipid signatures. We thank M. Elvert and two anonymous reviewers for valuable comments and constructive suggestions. The work was implemented as part of the Research Consortium for Methane Hydrate Resources in Japan (MH21) and was supported by a Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (no. 00001622) and a JSPS grant (no. 23244109).	Aloisi G, 2002, EARTH PLANET SC LETT, V203, P195, DOI 10.1016/S0012-821X(02)00878-6; Bradley AS, 2009, GEOCHIM COSMOCHIM AC, V73, P102, DOI 10.1016/j.gca.2008.10.005; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; BERNARD BB, 1978, J GEOPHYS RES-OC ATM, V83, P4053, DOI 10.1029/JC083iC08p04053; Koga Y, 1998, BIOSCI BIOTECH BIOCH, V62, P230, DOI 10.1271/bbb.62.230; Mikucki JA, 2003, APPL ENVIRON MICROB, V69, P3311, DOI 10.1128/AEM.69.6.3311-3316.2003; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Xie ST, 2013, P NATL ACAD SCI USA, V110, P6010, DOI 10.1073/pnas.1218569110; Yoshioka H, 2009, GEOCHEM J, V43, P315, DOI 10.2343/geochemj.1.0028; Koga Y, 2008, SYST APPL MICROBIOL, V31, P169, DOI 10.1016/j.syapm.2008.02.005; Logemann J, 2011, BIOGEOSCIENCES, V8, P2547, DOI 10.5194/bg-8-2547-2011; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Lengger SK, 2012, GEOCHIM COSMOCHIM AC, V98, P244, DOI 10.1016/j.gca.2012.05.003; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P997; Lipp JS, 2009, GEOCHIM COSMOCHIM AC, V73, P6816, DOI 10.1016/j.gca.2009.08.003; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; Niemann H, 2008, ORG GEOCHEM, V39, P1668, DOI 10.1016/j.orggeochem.2007.11.003; Deppenmeier U, 1996, ARCH MICROBIOL, V165, P149, DOI 10.1007/BF01692856; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; NICHOLS PD, 1987, ORG GEOCHEM, V11, P451, DOI 10.1016/0146-6380(87)90002-7; Wagner D, 2005, ENVIRON MICROBIOL, V7, P1582, DOI 10.1111/j.1462-2920.2005.00849.x; HARVEY HR, 1986, GEOCHIM COSMOCHIM AC, V50, P795, DOI 10.1016/0016-7037(86)90355-8; Milkov AV, 2005, ORG GEOCHEM, V36, P681, DOI 10.1016/j.orggeochem.2005.01.010; KOGA Y, 1993, MICROBIOL REV, V57, P164; Schouten S, 2010, GEOCHIM COSMOCHIM AC, V74, P3806, DOI 10.1016/j.gca.2010.03.029; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Elvert M, 2005, GEOBIOLOGY, V3, P195, DOI 10.1111/j.1472-4669.2005.00051.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Rossel PE, 2008, ORG GEOCHEM, V39, P992, DOI 10.1016/j.orggeochem.2008.02.021; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; RICE DD, 1981, AAPG BULL, V65, P5; Hinrichs KU, 1999, NATURE, V398, P802; Aquilina A, 2010, ORG GEOCHEM, V41, P414, DOI 10.1016/j.orggeochem.2009.09.009; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Cragg BA, 1996, EARTH PLANET SC LETT, V139, P497, DOI 10.1016/0012-821X(95)00246-9; Fujii T., 2005, P 5 INT C GAS HYDR I, V3, P974; Fujii T., 2009, AAPG MEMOIR, V89, P385; Kaneko M, 2013, CHEM GEOL, V343, P76, DOI 10.1016/j.chemgeo.2013.02.003; Koga Y, 1998, J MOL EVOL, V46, P54, DOI 10.1007/PL00006283; Lengger SK, 2014, GEOBIOLOGY, V12, P212, DOI 10.1111/gbi.12081; Lim KLH, 2012, ARCHAEA, DOI 10.1155/2012/896727; MARTZ R F, 1983, Journal of Microbiological Methods, V1, P53, DOI 10.1016/0167-7012(83)90007-6; NICHOLS PD, 1993, J MICROBIOL METH, V18, P1, DOI 10.1016/0167-7012(93)90066-Q; Niemann H, 2005, BIOGEOSCIENCES, V2, P335; Oba M, 2006, ORG GEOCHEM, V37, P1643, DOI 10.1016/j.orggeochem.2006.09.002; Pancost RD, 2011, ORG GEOCHEM, V42, P1279, DOI 10.1016/j.orggeochem.2011.07.003; Pancost RD, 2001, GEOCHIM COSMOCHIM AC, V65, P1611, DOI 10.1016/S0016-7037(00)00562-7; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PAULY GG, 1986, GEOCHIM COSMOCHIM AC, V50, P1117, DOI 10.1016/0016-7037(86)90392-3; PEASE TK, 1992, GEOCHIM COSMOCHIM AC, V56, P3469, DOI 10.1016/0016-7037(92)90391-U; Rice D.D., 1993, FUTURE ENERGY GASES, P383; Sakata S, 2012, GEOFLUIDS, V12, DOI 10.1111/gfl.12007; Schubotz F., 2010, GEOCHIMICA COSMOCHIM, V75, P4399; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; Sunamura M, 1999, MAR BIOTECHNOL, V1, P562, DOI 10.1007/PL00011811; Takeuchi R., 2005, P 5 INT C GAS HYDR I, P908; TORNABENE TG, 1979, SCIENCE, V203, P51, DOI 10.1126/science.758677; Uchida T., 2009, AM ASS PETROLE UNPUB, V89, P401; White D.C., 1979, METHODOLOGY BIOMASS, P87, DOI 10.1520/STP38143S	68	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0146-6380			ORG GEOCHEM	Org. Geochem.	JAN	2015	78						153	160		10.1016/j.orggeochem.2014.11.006		8	Geochemistry & Geophysics	Geochemistry & Geophysics	AW6OX	WOS:000346389700015		
J	Kashio, A; Sakamoto, T; Karino, S; Kakigi, A; Iwasaki, S; Yamasoba, T				Kashio, Akinori; Sakamoto, Takashi; Karino, Shotaro; Kakigi, Akinobu; Iwasaki, Shinichi; Yamasoba, Tatsuya			Predicting Round Window Niche Visibility via the Facial Recess Using High-Resolution Computed Tomography	OTOLOGY & NEUROTOLOGY			English	Article						Cochlear implant; Computed tomography; Round window niche; Surgical view; Temporal bone anatomy	COCHLEAR IMPLANTATION; TEMPORAL BONE; INSERTION; CHILDREN; ORIENTATION; DIMENSIONS; MEMBRANE; GROWTH; ADULTS	Objective: To predict round window niche (RWN) visibility using high-resolution computed tomography (HRCT). Study design: Case series with chart review. Setting: Academic tertiary care center. Subjects and methods: We retrospectively reviewed 70 cochlear implant ears that underwent presurgical axial HRCT with a surgical video recorder. The visibility of the RWN was classified into three types: 17 as invisible or nearly invisible, 22 as partially visible, and 31 as fully visible. Next, we measured the following three radiologic parameters: 1) the angle of the external auditory canal (EAC) relative to the cochlear basal turn, 2) the width of the facial recess, and 3) the relative location of the facial nerve (FN) to the cochlear basal turn. These were compared with the RWN visibility. Subsequently, to predict the RWN visibility, a line was created parallel to the EAC line and along the anterior lateral FN. The location of the line relative to the round window membrane was compared with the RWN view. Results: In cases that had poor RWN visibility, the angle of the posterior canal wall portion of the EAC relative to the cochlear basal turn was significantly smaller and the location of the FN to the cochlear basal turn was closer. The location of the prediction line to the round window membrane highly predicted the RWN view during the surgery. Conclusion: The RWN visibility and the preoperative HRCT findings showed a high correlation. Drawing the prediction line is a simple and useful way for preoperatively predicting the RWN visibility in cochlear implant surgery.	[Kashio, Akinori; Sakamoto, Takashi; Karino, Shotaro; Kakigi, Akinobu; Iwasaki, Shinichi; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138655, Japan	Kashio, A (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Bunkyo Ku, Hong 7-3-1, Tokyo 1138655, Japan.	kashioa_tky@umin.ac.jp					Roland PS, 2007, LARYNGOSCOPE, V117, P1397, DOI 10.1097/MLG.0b013e318064e891; Adunka O, 2004, ACTA OTO-LARYNGOL, V124, P807, DOI 10.1080/00016480410018179; Pau HW, 2007, LARYNGOSCOPE, V117, P535, DOI 10.1097/MLG.0b013e31802f4169; Bettman RHR, 2003, ORL J OTO-RHINO-LARY, V65, P353, DOI 10.1159/000076054; BIELAMOWICZ SA, 1988, ARCH OTOLARYNGOL, V114, P534; Della Volpe A, 2013, EUR ARCH OTO-RHINO-L, V270, P2641, DOI 10.1007/s00405-012-2297-8; EBY TL, 1986, ANN OTO RHINOL LARYN, V95, P356; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Lee DH, 2012, J CRANIOFAC SURG, V23, P817, DOI 10.1097/SCS.0b013e31824e6ca7; Leong AC, 2013, EUR ARCH OTO-RHINO-L, V270, P1237, DOI 10.1007/s00405-012-2106-4; LITTON WB, 1969, LARYNGOSCOPE, V79, P1584, DOI 10.1288/00005537-196909000-00005; Lloyd SKW, 2010, OTOL NEUROTOL, V31, P902, DOI 10.1097/MAO.0b013e3181db7146; McRackan TR, 2012, OTOL NEUROTOL, V33, P328, DOI 10.1097/MAO.0b013e318245cc9f; SCHULTER FP, 1976, AM J PHYS ANTHROPOL, V44, P453, DOI 10.1002/ajpa.1330440309; SHEEHY JL, 1967, LARYNGOSCOPE, V77, P1502, DOI 10.1288/00005537-196708000-00018; Skarzynski H, 2006, ACTA OTO-LARYNGOL, V126, P934, DOI 10.1080/00016480600606632; SU WY, 1982, LARYNGOSCOPE, V92, P483	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JAN	2015	36	1					E18	E23				6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AW6GP	WOS:000346368200003		
J	Okamura, T; Sakai, Y; Hoshino, H; Iwaya, Y; Tanaka, E; Kobayashi, M				Okamura, Takuma; Sakai, Yasuhiro; Hoshino, Hitomi; Iwaya, Yugo; Tanaka, Eiji; Kobayashi, Motohiro			Superficially located enlarged lymphoid follicles characterise nodular gastritis	PATHOLOGY			English	Article						Helicobacter pylori; high endothelial venule (HEV)-like vessel; lymphoid follicle hyperplasia; nodular gastritis	HELICOBACTER-PYLORI INFECTION; INFLAMMATORY GASTROINTESTINAL-DISEASES; CELL-ADHESION MOLECULE-1; VENULE-LIKE VESSELS; L-SELECTIN; VASCULAR ADDRESSIN; ULCERATIVE-COLITIS; NODE ADDRESSIN; YOUNG-PATIENTS; MADCAM-1	Nodular gastritis is a form of chronic Helicobacter pylori gastritis affecting the gastric antrum and characterised endoscopically by the presence of small nodular lesions resembling gooseflesh. It is generally accepted that hyperplasia of lymphoid follicles histologically characterises nodular gastritis; however, quantitative analysis in support of this hypothesis has not been reported. Our goal was to determine whether nodular gastritis is characterised by lymphoid follicle hyperplasia. The number, size, and location of lymphoid follicles in nodular gastritis were determined and those properties compared to samples of atrophic gastritis. The percentages of high endothelial venule (HEV)-like vessels were also evaluated. The number of lymphoid follicles was comparable between nodular and atrophic gastritis; however, follicle size in nodular gastritis was significantly greater than that seen in atrophic gastritis. Moreover, lymphoid follicles in nodular gastritis were positioned more superficially than were those in atrophic gastritis. The percentage of MECA-79(+) HEV-like vessels was greater in areas with gooseflesh-like lesions in nodular versus atrophic gastritis. Superficially located hyperplastic lymphoid follicles characterise nodular gastritis, and these follicles correspond to gooseflesh-like nodular lesions observed endoscopically. These observations suggest that MECA-79(+) HEV-like vessels could play at least a partial role in the pathogenesis of nodular gastritis.	[Okamura, Takuma; Sakai, Yasuhiro] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan; [Okamura, Takuma; Iwaya, Yugo; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol, Matsumoto, Nagano 390, Japan; [Sakai, Yasuhiro; Hoshino, Hitomi; Kobayashi, Motohiro] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Eiheiji, Fukui 9101193, Japan	Kobayashi, M (reprint author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	motokoba@u-fukui.ac.jp			Japan Society for the Promotion of Science [24590410]	This work was supported in part by a Grant-in-Aid for Scientific Research 24590410 from the Japan Society for the Promotion of Science (to MK). The authors state that there are no conflicts of interests to disclose.	Kobayashi M, 2009, INFLAMM BOWEL DIS, V15, P697, DOI 10.1002/ibd.20827; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Van Zanten SJOV, 1999, GASTROENTEROLOGY, V116, P1217; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Kobayashi M, 2010, METHOD ENZYMOL, V479, P271, DOI 10.1016/S0076-6879(10)79016-9; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Briskin M, 1997, AM J PATHOL, V151, P97; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Maruyama M, 2013, PANCREAS, V42, P53, DOI 10.1097/MPA.0b013e318258ce4c; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Hoshino H, 2011, J HISTOCHEM CYTOCHEM, V59, P572, DOI 10.1369/0022155411404416; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; GENTA RM, 1993, HUM PATHOL, V24, P577, DOI 10.1016/0046-8177(93)90235-9; Carney JA, 2010, AM J SURG PATHOL, V34, P1019, DOI 10.1097/PAS.0b013e3181e1acb0; DEGIACOMO C, 1990, J PEDIATR GASTR NUTR, V11, P310; EASTHAM EJ, 1988, J INFECTION, V16, P77, DOI 10.1016/S0163-4453(88)96205-6; Kamad T, 2007, DIGEST ENDOSC, V19, P180, DOI 10.1111/j.1443-1661.2007.00750.x; Kamada T, 2006, DIGEST ENDOSC, V18, P79, DOI 10.1111/j.1443-1661.2006.00588.x; Kitamura S, 2013, J GASTROEN HEPATOL, V28, P1154, DOI 10.1111/jgh.12180; Kokkola A, 1996, SCAND J GASTROENTERO, V31, P643, DOI 10.3109/00365529609009143; Miyamoto M, 2003, DIGEST DIS SCI, V48, P968, DOI 10.1023/A:1023016000096; Ohara H, 2003, WORLD J GASTROENTERO, V9, P2701; Sado Y, 2006, ACTA HISTOCHEM CYTOC, V39, P89, DOI 10.1267/ahc.06001; Sbeih F, 1996, J CLIN GASTROENTEROL, V22, P227, DOI 10.1097/00004836-199604000-00017; Shiotani A, 2007, J GASTROENTEROL, V42, P610, DOI 10.1007/s00535-007-2073-5; SIPPONEN P, 1992, J CLIN PATHOL, V45, P319, DOI 10.1136/jcp.45.4.319	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0031-3025	1465-3931		PATHOLOGY	Pathology	JAN	2015	47	1					38	44		10.1097/PAT.0000000000000195		7	Pathology	Pathology	AW6DG	WOS:000346359000008		
J	Puntumetakul, R; Yodchaisarn, W; Emasithi, A; Keawduangdee, P; Chatchawan, U; Yamauchi, J				Puntumetakul, Rungthip; Yodchaisarn, Wantanee; Emasithi, Alongkot; Keawduangdee, Petcharat; Chatchawan, Uraiwan; Yamauchi, Junichiro			Prevalence and individual risk factors associated with clinical lumbar instability in rice farmers with low back pain	PATIENT PREFERENCE AND ADHERENCE			English	Article						Delphi study; aberrant movement sign; painful catch sign; prone instability test	SEGMENTAL INSTABILITY; SPINAL INSTABILITY; INTERRATER RELIABILITY; EXERCISE; POPULATION; COMMUNITY	Introduction: Clinical lumbar instability (CLI) is one of the subgroups of chronic non-specific low back pain. Thai rice farmers often have poor sustained postures during a rice planting process and start their farming at an early age. However, individual associated factors of CLI are not known and have rarely been diagnosed in low back pain. This study aimed to determine the prevalence and individual associated factors of CLI in Thai rice farmers. Methods: A cross-sectional survey was conducted among 323 Thai rice farmers in a rural area of Khon Kaen province, Thailand. Face-to-face interviews were conducted using the 13-item Delphi criteria questionnaire, after which an objective examination was performed using aberrant movement sign, painful catch sign, and prone instability test to obtain information. Individual factors such as sex, body mass index, waist-hip ratio, smoking, and number of years of farming experience, were recorded during the face-to-face interview. Results: The prevalence of CLI in Thai rice farmers calculated by the method described in this study was 13% (age 44 +/- 10 years). Number of years of farming experience was found to be significantly correlated with the prevalence of CLI (adjusted odds ratio =2.02, 95% confidence interval =1.03-3.98, P<0.05). Conclusion: This study provides prevalence of CLI in Thai rice farmers. Those with long-term farming experience of at least 30 years have a greater risk of CLI.	[Puntumetakul, Rungthip; Yodchaisarn, Wantanee; Keawduangdee, Petcharat; Chatchawan, Uraiwan] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand; [Emasithi, Alongkot] Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen, Thailand; [Yamauchi, Junichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan	Puntumetakul, R (reprint author), 123 Khon Kaen Univ,Mitraphab Rd, Khon Kaen 40002, Thailand.	rungthiprt@gmail.com			Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Thailand	The authors thank the participants of the study. This study was supported by grants from the Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Thailand.	Abbott JH, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-56; Vieira ER, 2004, J OCCUP REHABIL, V14, P143, DOI 10.1023/B:JOOR.0000018330.46029.05; PANJABI MM, 1992, J SPINAL DISORD, V5, P390; O'Sullivan PB, 2000, MANUAL THER, V5, P2, DOI 10.1054/math.1999.0213; Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0; Kasai Y, 2006, PHYS THER, V86, P1661, DOI 10.2522/ptj.20050281; Fritz JM, 2005, EUR SPINE J, V14, P743, DOI 10.1007/s00586-004-0803-4; Malmqvist S, 2012, J MANIP PHYSIOL THER, V35, P272, DOI 10.1016/j.jmpt.2012.04.004; Marras WS, 2000, ERGONOMICS, V43, P880, DOI 10.1080/001401300409080; Areeudomwong P, 2012, J PHYS THER SCI, V24, P1007; Granata KP, 2000, SPINE, V25, P1398, DOI 10.1097/00007632-200006010-00012; Fillingim RB, 1995, PAIN FORUM, V4, P209; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; Peungsuwan P, 2014, J PHYS THER SCI, V26, P139, DOI 10.1589/jpts.26.139; Hicks GE, 2003, ARCH PHYS MED REHAB, V84, P1858, DOI 10.1016/S0003-9993(03)00365-4; Barrero LH, 2006, SPINE, V31, P2728, DOI 10.1097/01.brs.0000244583.35982.ea; NACHEMSON A, 1964, J BONE JOINT SURG AM, V46, P1077; Beazell James R, 2010, J Man Manip Ther, V18, P9, DOI 10.1179/106698110X12595770849443; Cook C, 2006, MANUAL THER, V11, P11, DOI 10.1016/j.math.2005.01.002; Fritz JM, 1998, PHYS THER, V78, P889; Gupta G, 2013, J COMMUNITY MED HLTH, V3, P249; Keawduangdee P, 2012, HUM FACTOR ERGON MAN, V22, P562, DOI 10.1002/hfm.20375; KIRKALDY-WILLIS W H, 1978, Spine, V3, P319, DOI 10.1097/00007632-197812000-00004; Kumar Senthil P, 2011, N Am J Med Sci, V3, P456, DOI 10.4297/najms.2011.3456; Manchikanti L, 2000, Pain Physician, V3, P167; Puntumetakul R., 2011, J MED THECNOLOGY PHY, V23, P297; Puntumetakul R, 2013, PATIENT PREFER ADHER, V7, P1189, DOI 10.2147/PPA.S50436; Ravenna MM, 2011, ARCH PHYS MED REHAB, V92, P913, DOI 10.1016/j.apmr.2010.12.042; Robinson ME, 2005, J PAIN, V6, P463, DOI 10.1016/j.jpain.2005.02.007; Rosecrance J, 2006, AM J IND MED, V49, P547, DOI 10.1002/ajim.20324; Shiri R, 2010, AM J MED, V123; Taechasubamorn Panada, 2011, Journal of the Medical Association of Thailand, V94, P616; Yamauchi J, 2009, GERIATR GERONTOL INT, V9, P262, DOI 10.1111/j.1447-0594.2009.00530.x; Zvolensky MJ, 2010, ADDICT BEHAV, V35, P1008, DOI 10.1016/j.addbeh.2010.06.019	34	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-889X			PATIENT PREFER ADHER	Patient Prefer. Adherence		2015	9						1	6		10.2147/PPA.S73412		6	Medicine, General & Internal	General & Internal Medicine	AW6AP	WOS:000346352200001		
J	Lucas, RM; Norval, M; Neale, RE; Young, AR; de Gruijl, FR; Takizawa, Y; van der Leun, JC				Lucas, R. M.; Norval, M.; Neale, R. E.; Young, A. R.; de Gruijl, F. R.; Takizawa, Y.; van der Leun, J. C.			The consequences for human health of stratospheric ozone depletion in association with other environmental factors	PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES			English	Review							VITAMIN-D STATUS; SERUM 25-HYDROXYVITAMIN D; BASAL-CELL CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; NONMELANOMA SKIN-CANCER; ULTRAVIOLET-RADIATION EXPOSURE; RESPIRATORY-TRACT INFECTION; POLYMORPHIC LIGHT ERUPTION; MELANOCYTE-STIMULATING HORMONE; UV-INDUCED IMMUNOSUPPRESSION	Due to the implementation of the Montreal Protocol, which has limited, and is now probably reversing, the depletion of the stratospheric ozone layer, only modest increases in solar UV-B radiation at the surface of the Earth have occurred. For many fair-skinned populations, changing behaviour with regard to exposure to the sun over the past half century - more time in the sun, less clothing cover ( more skin exposed), and preference for a tan - has probably contributed more to greater levels of exposure to UV-B radiation than ozone depletion. Exposure to UV-B radiation has both adverse and beneficial effects on human health. This report focuses on an assessment of the evidence regarding these outcomes that has been published since our previous report in 2010. The skin and eyes are the organs exposed to solar UV radiation. Excessive solar irradiation causes skin cancer, including cutaneous malignant melanoma and the non-melanoma skin cancers, basal cell carcinoma and squamous cell carcinoma, and contributes to the development of other rare skin cancers such as Merkel cell carcinoma. Although the incidence of melanoma continues to increase in many countries, in some locations, primarily those with strong sun protection programmes, incidence has stabilised or decreased over the past 5 years, particularly in younger age-groups. However, the incidence of non-melanoma skin cancers is still increasing in most locations. Exposure of the skin to the sun also induces systemic immune suppression that may have adverse effects on health, such as through the reactivation of latent viral infections, but also beneficial effects through suppression of autoimmune reactivity. Solar UV-B radiation damages the eyes, causing cataracts and pterygium. UV-B irradiation of the skin is the main source of vitamin D in many geographic locations. Vitamin D plays a critical role in the maintenance of calcium homeostasis in the body; severe deficiency causes the bone diseases, rickets in children and osteomalacia in adults. Although many studies have implicated vitamin D deficiency in a wide range of diseases, such as cancer and cardiovascular disease, more recent evidence is less compelling, with meta-analyses of supplementation trials failing to show a beneficial effect on the health outcomes that have been tested. It continues to be difficult to provide public health messages to guide safe exposure to the sun that are accurate, simple, and can be used by people with different skin types, in different locations, and for different times of the year or day. There is increasing interest in relating sun protection messages to the UV Index. Current sun protection strategies are outlined and assessed. Climatic factors affect the amount of UV radiation received by the skin and eyes, separately from the effect of ozone depletion. For example, cloud cover can decrease or increase the intensity of UV radiation at Earth's surface and warmer temperatures and changes in precipitation patterns may alter the amount of time people spend outdoors and their choice of clothing. The combination of changes in climate and UV radiation may affect the number of pathogenic microorganisms in surface waters, and could have an impact on food security through effects on plant and aquatic systems. It remains difficult to quantify these effects and their possible importance for human health.	[Lucas, R. M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 2601, Australia; [Lucas, R. M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6008, Australia; [Norval, M.] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Neale, R. E.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Young, A. R.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [de Gruijl, F. R.] Leiden Univ, Med Ctr, Dept Dermatol, NL-2300 RC Leiden, Netherlands; [Takizawa, Y.] Akita Univ, Grad Sch Med, Akita 010, Japan; [Takizawa, Y.] Natl Inst Minamata Dis, Minamata Sh, Kumamoto, Japan; [van der Leun, J. C.] Ecofys, NL-3526 KL Utrecht, Netherlands	Lucas, RM (reprint author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 2601, Australia.	robyn.lucas@anu.edu.au		Neale, Rachel/0000-0001-7162-0854	Australian Government's Ozone Science Strategy; QIMR Berghofer Institute for Medical Research; Japanese Ministry of the Environment	We would like to acknowledge the following people and organizations for their support in the preparation of this paper. Prof Robyn Lucas' participation in the Panel was supported through funding from the Australian Government's Ozone Science Strategy. A/Prof Rachel Neale was supported by the QIMR Berghofer Institute for Medical Research. Prof Yukio Takizawa was sponsored by the Japanese Ministry of the Environment. Ms Tammy Gibbs provided support with the figures in this paper.	Agbai ON, 2014, J AM ACAD DERMATOL, V70, P748, DOI 10.1016/j.jaad.2013.11.038; Albert MR, 2003, J AM ACAD DERMATOL, V48, P909, DOI 10.1067/mjd.2003.272; Allen KL, 2013, INT J EAT DISORDER, V46, P669, DOI 10.1002/eat.22147; Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095; Andersen PA, 2010, ARCH DERMATOL, V146, P1241, DOI 10.1001/archdermatol.2010.327; Andersson K, 2012, AM J EPIDEMIOL, V175, P685, DOI 10.1093/aje/kwr373; Andrady A. L., 2015, PHOTOCH PHOTOBIO SCI, P14; Bogh MKB, 2010, J INVEST DERMATOL, V130, P546, DOI 10.1038/jid.2009.323; Ullrich SE, 2012, J INVEST DERMATOL, V132, P896, DOI 10.1038/jid.2011.405; Correa MD, 2013, INT J DERMATOL, V52, P966, DOI 10.1111/j.1365-4632.2012.05834.x; Surjana D, 2012, J INVEST DERMATOL, V132, P1497, DOI 10.1038/jid.2011.459; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Brondum-Jacobsen P, 2013, INT J EPIDEMIOL, V42, P1486, DOI 10.1093/ije/dyt168; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Dusza SW, 2012, PEDIATRICS, V129, P309, DOI 10.1542/peds.2011-0104; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Gloster HM, 2006, J AM ACAD DERMATOL, V55, P741, DOI 10.1016/j.jaad.2005.08.063; Rizwan M, 2011, BRIT J DERMATOL, V164, P154, DOI 10.1111/j.1365-2133.2010.10057.x; Gulson B, 2010, TOXICOL SCI, V118, P140, DOI 10.1093/toxsci/kfq243; Zittermann A, 2013, EUR HEART J, V34, P1358, DOI 10.1093/eurheartj/ehs468; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Ng RLX, 2013, J IMMUNOL, V190, P5471, DOI 10.4049/jimmunol.1202786; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0; Ensrud KE, 2010, J CLIN ENDOCR METAB, V95, P5266, DOI 10.1210/jc.2010-2317; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Summers CG, 2009, OPTOMETRY VISION SCI, V86, P659, DOI 10.1097/OPX.0b013e3181a5254c; Frangos JE, 2012, J AM ACAD DERMATOL, V67, P387, DOI 10.1016/j.jaad.2011.10.026; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; Handoko HY, 2013, J INVEST DERMATOL, V133, P1803, DOI 10.1038/jid.2013.9; Guinot C, 2010, J EUR ACAD DERMATOL, V24, P1060, DOI 10.1111/j.1468-3083.2010.03592.x; Afzal S, 2013, J INVEST DERMATOL, V133, P629, DOI 10.1038/jid.2012.395; Chou WC, 2013, NAT MED, V19, P924, DOI 10.1038/nm.3194; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Seite S, 2010, BRIT J DERMATOL, V163, P903, DOI 10.1111/j.1365-2133.2010.10018.x; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bhatia S, 2011, CURR ONCOL REP, V13, P488, DOI 10.1007/s11912-011-0197-5; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Norval M, 2010, PHOTOCH PHOTOBIO SCI, V9, P11, DOI 10.1039/b9pp00012g; Libon F, 2013, DERMATOLOGY, V227, P250, DOI 10.1159/000354750; Lou YR, 2011, CARCINOGENESIS, V32, P1078, DOI 10.1093/carcin/bgr074; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Olsen CM, 2010, CANCER EPIDEM BIOMAR, V19, P65, DOI 10.1158/1055-9965.EPI-09-0928; Black AT, 2011, BIOCHEM PHARMACOL, V81, P873, DOI 10.1016/j.bcp.2011.01.014; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Chen AC, 2014, AUSTRALAS J DERMATOL, V55, P169, DOI 10.1111/ajd.12163; Wu Y, 2013, J EUR ACAD DERMATOL, V27, P345, DOI 10.1111/j.1468-3083.2011.04414.x; White JH, 2012, ARCH BIOCHEM BIOPHYS, V523, P58, DOI 10.1016/j.abb.2011.11.006; Rhodes LE, 2013, BRIT J NUTR, V110, P891, DOI 10.1017/S0007114512006071; Bavinck JNB, 2001, J INVEST DERM SYMP P, V6, P207; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Tran B, 2014, AM J CLIN NUTR, V99, P156, DOI 10.3945/ajcn.113.063271; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Mcgee HM, 2011, IMMUNOL CELL BIOL, V89, P767, DOI 10.1038/icb.2010.170; LOWE NJ, 1995, J INVEST DERMATOL, V105, P739, DOI 10.1111/1523-1747.ep12325517; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Miller RW, 1999, CANCER EPIDEM BIOMAR, V8, P153; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Kanavy HE, 2011, SEMIN CUTAN MED SURG, V30, P222, DOI 10.1016/j.sder.2011.08.003; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Xiang F, 2014, JAMA DERMATOL, V150, P1063, DOI 10.1001/jamadermatol.2014.762; Baarnhielm M, 2012, EUR J NEUROL, V19, P955, DOI 10.1111/j.1468-1331.2011.03650.x; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; Ojah RCI, 2012, NUTRIENTS, V4, P399, DOI 10.3390/nu4050399; Ergul S, 2011, ASIAN PAC J CANCER P, V12, P765; WEBB AR, 1989, J CLIN ENDOCR METAB, V68, P882; Artigas JM, 2012, INVEST OPHTH VIS SCI, V53, P4076, DOI 10.1167/iovs.12-9471; Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182; Hernandez-Barrera R, 2008, CLIN EXP DERMATOL, V33, P305, DOI 10.1111/j.1365-2230.2008.02724.x; Linos E, 2012, CANCER CAUSE CONTROL, V23, P133, DOI 10.1007/s10552-011-9862-0; Wallingford SC, 2011, BRIT J DERMATOL, V165, P859, DOI 10.1111/j.1365-2133.2011.10434.x; Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Bogh MKB, 2011, BRIT J DERMATOL, V164, P163, DOI 10.1111/j.1365-2133.2010.10082.x; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Nan HM, 2011, HUM MOL GENET, V20, P3718, DOI 10.1093/hmg/ddr287; Katalinic A, 2012, CANCER-AM CANCER SOC, V118, P5395, DOI 10.1002/cncr.27566; Epe B, 2012, PHOTOCH PHOTOBIO SCI, V11, P98, DOI 10.1039/c1pp05190c; Raasch BA, 2006, BRIT J DERMATOL, V155, P401, DOI 10.1111/j.1365-2133.2006.07234.x; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bais AF, 2015, PHOTOCH PHOTOBIO SCI, V14, P19, DOI 10.1039/c4pp90032d; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Bjorn LO, 2010, J INVEST DERMATOL, V130, P2848, DOI 10.1038/jid.2010.228; Flohil SC, 2013, J INVEST DERMATOL, V133, P913, DOI 10.1038/jid.2012.431; Bhan I, 2012, KIDNEY INT, V82, P84, DOI 10.1038/ki.2012.19; Gatenby P, 2013, CURR OPIN RHEUMATOL, V25, P184, DOI 10.1097/BOR.0b013e32835cfc16; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Peterlik M, 2012, FOOD FUNCT, V3, P784, DOI 10.1039/c2fo10262e; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Battie C, 2013, J DRUGS DERMATOL, V12, P194; Hollis BW, 2005, J NUTR, V135, P317; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Hill VK, 2013, ANNU REV GENOM HUM G, V14, P257, DOI 10.1146/annurev-genom-091212-153429; Brooks BP, 2013, OPHTHALMOLOGY, V120, P1324, DOI 10.1016/j.ophtha.2012.12.044; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Renzaho AMN, 2011, NUTRITION, V27, P868, DOI 10.1016/j.nut.2010.12.014; Sliney DH, 2011, EYE CONTACT LENS, V37, P250, DOI 10.1097/ICL.0b013e31822126d4; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Sheth VM, 2011, J AM ACAD DERMATOL, V65, P689, DOI 10.1016/j.jaad.2010.12.046; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; Brandstedt J, 2012, CANCER CAUSE CONTROL, V23, P1377, DOI 10.1007/s10552-012-9948-3; Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071; Nikolaou V, 2014, BRIT J DERMATOL, V170, P11, DOI [10.1111/bjd.12492, 10.1111/bjd.12712]; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Rhodes LE, 2010, J INVEST DERMATOL, V130, P1411, DOI 10.1038/jid.2009.417; Staples MP, 2006, MED J AUSTRALIA, V184, P6; Dror Y, 2013, J CLIN ENDOCR METAB, V98, P2160, DOI 10.1210/jc.2013-1185; Chaillol I, 2011, MELANOMA RES, V21, P144, DOI 10.1097/CMR.0b013e328343a619; Webb AR, 2010, BRIT J DERMATOL, V163, P1050, DOI 10.1111/j.1365-2133.2010.09975.x; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Beketov MA, 2011, B ENVIRON CONTAM TOX, V87, P231, DOI 10.1007/s00128-011-0342-8; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P1093, DOI 10.1016/j.jaci.2011.07.015; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Oktaria V, 2013, ANN ALLERG ASTHMA IM, V110, P80, DOI 10.1016/j.anai.2012.11.005; Di Girolamo N, 2012, EYE, V26, P202, DOI 10.1038/eye.2011.312; Ibuki Y, 2007, J INVEST DERMATOL, V127, P2236, DOI 10.1038/sj.jid.5700856; Diffey B, 2008, PHOTOCHEM PHOTOBIOL, V84, P371, DOI 10.1111/j.1751-1097.2007.00271.x; Springbett P, 2010, J PHOTOCH PHOTOBIO B, V101, P160, DOI 10.1016/j.jphotobiol.2010.03.006; Linos E, 2011, CANCER CAUSE CONTROL, V22, P1067, DOI 10.1007/s10552-011-9780-1; Farrar MD, 2013, AM J CLIN NUTR, V97, P1210, DOI 10.3945/ajcn.112.052639; Damian DL, 2011, BRIT J DERMATOL, V164, P657, DOI 10.1111/j.1365-2133.2010.10161.x; Chen L, 2012, J AM ACAD DERMATOL, V67, P1013, DOI 10.1016/j.jaad.2012.02.009; Lucas RM, 2013, PHOTOCHEM PHOTOBIOL, V89, P737, DOI 10.1111/php.12044; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Khalesi M, 2013, CANCER EPIDEM BIOMAR, V22, P1483, DOI 10.1158/1055-9965.EPI-13-0424; Sherwin JC, 2013, ACTA OPHTHALMOL, V91, P363, DOI 10.1111/j.1755-3768.2011.02314.x; Potente S, 2011, HEALTH EDUC RES, V26, P39, DOI 10.1093/her/cyq066; Le Marchand L, 2006, AM J EPIDEMIOL, V164, P232, DOI 10.1093/aje/kwj115; Arnold M, 2014, J EUR ACAD DERMATOL, V28, P1170, DOI 10.1111/jdv.12236; McGuigan KG, 2012, J HAZARD MATER, V235, P29, DOI 10.1016/j.jhazmat.2012.07.053; Willer CJ, 2005, BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Rodrigues A, 2013, ANN BEHAV MED, V45, P224, DOI 10.1007/s12160-012-9444-8; Perry PK, 2001, CUTIS, V67, P427; Prokofyeva E, 2012, OPHTHALMIC RES, V47, P171, DOI 10.1159/000329603; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Crispin MK, 2013, J INVEST DERMATOL, V133, P692, DOI 10.1038/jid.2012.359; Navid F, 2012, J IMMUNOL, V188, P735, DOI 10.4049/jimmunol.1100452; Kunisue T, 2012, ENVIRON SCI TECHNOL, V46, P4624, DOI 10.1021/es204415a; Nair-Shalliker V, 2012, INT J CANCER, V131, pE726, DOI 10.1002/ijc.27400; Gordon-Thomson C, 2012, PHOTOCH PHOTOBIO SCI, V11, P1837, DOI 10.1039/c2pp25202c; Schmerling RA, 2011, REV PANAM SALUD PUBL, V30, P431, DOI 10.1590/S1020-49892011001100005; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; Girschik J, 2011, BRIT J DERMATOL, V165, P1051, DOI 10.1111/j.1365-2133.2011.10493.x; Esposito S, 2013, INT J IMMUNOPATH PH, V26, P1; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Berardesca E, 2012, MOL MED REP, V5, P570, DOI 10.3892/mmr.2011.673; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Oellers P, 2013, OPHTHALMOLOGY, V120, P445, DOI 10.1016/j.ophtha.2012.08.010; Doutch JJ, 2012, BIOPHYS J, V102, P1258, DOI 10.1016/j.bpj.2012.02.023; Franceschi S, 1996, INT J CANCER, V67, P24, DOI 10.1002/(SICI)1097-0215(19960703)67:1<24::AID-IJC6>3.3.CO;2-6; Hewer S, 2013, J CLIN NEUROSCI, V20, P634, DOI 10.1016/j.jocn.2012.10.005; Liu D, 2014, J INVEST DERMATOL, V134, P1839, DOI 10.1038/jid.2014.27; Kift R, 2013, BRIT J DERMATOL, V169, P1272, DOI 10.1111/bjd.12518; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Ali D, 2011, TOXICOL LETT, V204, P199, DOI 10.1016/j.toxlet.2011.04.033; Hoyos-Bachiloglu R, 2014, PEDIAT ALLERG IMM-UK, V25, P338, DOI 10.1111/pai.12211; Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; van der Pols JC, 2013, J INVEST DERMATOL, V133, P637, DOI 10.1038/jid.2012.346; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Milliken SVI, 2012, J ALLERGY CLIN IMMUN, V129, P1554, DOI 10.1016/j.jaci.2012.03.001; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Ishikawa Y, 2012, EXP EYE RES, V94, P85, DOI 10.1016/j.exer.2011.11.010; Hatun S, 2005, J NUTR, V135, P218; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Kimlin MG, 2014, AM J EPIDEMIOL, V179, P864, DOI 10.1093/aje/kwt446; Nerich V, 2011, ALIMENT PHARM THER, V33, P940, DOI 10.1111/j.1365-2036.2011.04601.x; Gibbs NK, 2013, PHOTODERMATOL PHOTO, V29, P57, DOI 10.1111/phpp.12021; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Artornsombudh P, 2013, OPHTHALMOLOGY, V120, P1337, DOI 10.1016/j.ophtha.2012.12.020; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Duschek N, 2013, EUR J DERMATOL, V23, P872, DOI 10.1684/ejd.2013.2192; Petersen B, 2013, BRIT J DERMATOL, V168, P1073, DOI 10.1111/bjd.12211; AQUARON R, 1990, OPHTHALMIC PAED GEN, V11, P255, DOI 10.3109/13816819009015711; Arora R, 2012, CURR OPIN VIROL, V2, P489, DOI 10.1016/j.coviro.2012.05.007; Asokan R, 2012, OPHTHAL PHYSL OPT, V32, P39, DOI 10.1111/j.1475-1313.2011.00882.x; Australian Radiation and Nuclear Safety Agency, AUSTR UV LEV MOB PHO; Baade PD, 2011, EXPERT REV ANTICANC, V11, P661, DOI [10.1586/era.11.28, 10.1586/ERA.11.28]; Bais AF, 2011, ATMOS CHEM PHYS, V11, P7533, DOI 10.5194/acp-11-7533-2011; Bak H, 2011, INT J DERMATOL, V50, P832, DOI 10.1111/j.1365-4632.2010.04789.x; Balk SJ, 2011, PEDIATRICS, V127, pE791, DOI 10.1542/peds.2010-3502; Bassil Darina, 2013, Dermatoendocrinol, V5, P274, DOI 10.4161/derm.25111; Basta NO, 2011, PIGM CELL MELANOMA R, V24, P250, DOI 10.1111/j.1755-148X.2010.00791.x; Bearden A, 2013, J CLIN ENDOCR METAB, V98, P1726, DOI 10.1210/jc.2012-4031; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; Bjelakovic G, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007469.PUB2; Bjork A, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-129; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bogh MKB, 2011, EXP DERMATOL, V20, P14, DOI 10.1111/j.1600-0625.2010.01201.x; Bornman J. F., 2015, PHOTOCH PHOTOBIO SCI, P14; Bradford PT, 2010, CANCER EPIDEM BIOMAR, V19, P2401, DOI 10.1158/1055-9965.EPI-10-0503; Brash D E, 1996, J Investig Dermatol Symp Proc, V1, P136; Bryson KJ, 2014, EPIDEMIOL INFECT, V142, P1789, DOI 10.1017/S0950268814000193; Buller DB, 2011, J AM ACAD DERMATOL, V65, pS114, DOI 10.1016/j.jaad.2011.05.033; Byrne SN, 2014, PHOTOCH PHOTOBIO SCI, V13, P840, DOI 10.1039/c4pp00051j; Casale G. R., 2014, HOUSEHOLD PERSON CAR, V9, P45; Cejka C, 2012, PHYSIOL RES, V61, P299; Cejkova J, 2012, HISTOL HISTOPATHOL, V27, P1029; Chandler H, 2011, EYE CONTACT LENS, V37, P259, DOI 10.1097/ICL.0b013e3182240945; Clairwood M., 2013, INT J DERMATOL, V53, P425; Cockburn MG, 2006, CANCER, V106, P1162, DOI 10.1002/cncr.21654; Cohen VML, 2011, J SKIN CANC, V2011, DOI DOI 10.1155/2011/573974; Correa P., 2013, PHOTOCHEM PHOTOBIOL, V12, P1053; Couteau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046187; Sneyd MJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-372; Crump C, 2014, INT J EPIDEMIOL, V43, P793, DOI 10.1093/ije/dyt277; Cust AE, 2011, CANCER CAUSE CONTROL, V22, P885, DOI 10.1007/s10552-011-9762-3; Damian DL, 2010, EXP DERMATOL, V19, pE23, DOI 10.1111/j.1600-0625.2009.00955.x; David Consuelo V, 2013, Cutis, V91, pE1; DeBoyes T, 2010, J DRUGS DERMATOL, V9, P1519; Demetriou SK, 2012, INT J CANCER, V131, P1818, DOI 10.1002/ijc.27440; Dessinioti C, 2010, PHOTOCHEM PHOTOBIOL, V86, P481, DOI 10.1111/j.1751-1097.2010.00735.x; Diaz A, 2012, ARCH DERMATOL, V148, P606, DOI 10.1001/archdermatol.2011.2586; Diffey BL, 2012, PHOTOCHEM PHOTOBIOL, V88, P744, DOI 10.1111/j.1751-1097.2012.01084.x; Dobbinson S, 2012, J AM ACAD DERMATOL, V66, P938, DOI 10.1016/j.jaad.2011.06.015; Dunstone K., 2014, UV RAD ITS EFFECTS U; Eggermont A. M., 2013, LANCET, V383, P816; Emmanuel B, 2012, Ecancermedicalscience, V6, P254, DOI 10.3332/ecancer.2012.254; EPA UV Alert United States Environmental Protection Agency, UV AL; Erickson III D. J., 2015, PHOTOCH PHOTOBIO SCI, P14; Farzan SF, 2013, INT J CANCER, V133, P1713, DOI 10.1002/ijc.28176; Faurschou A, 2012, BRIT J DERMATOL, V167, P391, DOI 10.1111/j.1365-2133.2012.11004.x; Ferlay J., 2001, IARC CANC BASE; Flohil SC, 2012, BRIT J DERMATOL, V167, P22, DOI 10.1111/j.1365-2133.2012.11083.x; Fourtanier A, 2012, PHOTOCH PHOTOBIO SCI, V11, P81, DOI 10.1039/c1pp05152k; Franco-Lie I, 2011, ANN ONCOL, V22, P1443, DOI 10.1093/annonc/mdq598; Fuglede NB, 2011, BRIT J DERMATOL, V165, P349, DOI 10.1111/j.1365-2133.2011.10361.x; Galan I, 2011, GAC SANIT, V25, P44, DOI 10.1016/j.gaceta.2010.07.013; Galkin ON, 1999, J PHOTOCH PHOTOBIO B, V53, P12, DOI 10.1016/S1011-1344(99)00115-3; Gambichler T, 2013, BRIT J DERMATOL, V169, P1288, DOI 10.1111/bjd.12608; Gao N, 2012, PHOTOCHEM PHOTOBIOL, V88, P736, DOI 10.1111/j.1751-1097.2012.01094.x; Geller AC, 2013, J CLIN ONCOL, V31, P4172, DOI 10.1200/JCO.2012.47.3728; Glaser R., 2009, INVEST OPHTH VIS SCI, V123, P1117; Gloster Jr HM, 2006, J AM ACAD DERMATOL, V55, P761; Golu T, 2011, ROM J MORPHOL EMBRYO, V52, P153; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gruber-Wackernagel A, 2014, DERMATOL CLIN, V32, P315, DOI 10.1016/j.det.2014.03.012; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; HALDER RM, 1995, CANCER, V75, P667, DOI 10.1002/1097-0142(19950115)75:2+<667::AID-CNCR2820751409>3.0.CO;2-I; Handel AC, 2014, BRIT J DERMATOL, V171, P588, DOI 10.1111/bjd.13059; Harrison S, 2013, J TROP PEDIATRICS, V59, P403, DOI 10.1093/tropej/fmt042; Harrison SL, 1999, J PAEDIATR CHILD H, V35, P296, DOI 10.1046/j.1440-1754.1999.00362.x; Hart Prue H, 2013, Clin Biochem Rev, V34, P3; Haylett AK, 2011, BRIT J DERMATOL, V164, P407, DOI 10.1111/j.1365-2133.2010.10104.x; Heckman CJ, 2012, J CANCER EDUC, V27, P342, DOI 10.1007/s13187-011-0308-x; Heinrich U, 2011, J NUTR, V141, P1202, DOI 10.3945/jn.110.136465; Hernan MA, 1999, NEUROLOGY, V53, P1711; Hiramoto K, 2012, ARCH DERMATOL RES, V304, P39, DOI 10.1007/s00403-011-1183-3; Hiramoto K, 2013, CLIN EXP DERMATOL, V38, P71, DOI 10.1111/j.1365-2230.2012.04439.x; Hirani V, 2013, J AM GERIATR SOC, V61, P969, DOI 10.1111/jgs.12254; Hofer A, 2011, PHOTOCH PHOTOBIO SCI, V10, P1118, DOI 10.1039/c1pp05009e; Hong ES, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-212; Hu LW, 2013, J OCCUP ENVIRON HYG, V10, P17, DOI 10.1080/15459624.2012.737700; Hughes MCB, 2013, ANN INTERN MED, V158, P781, DOI 10.7326/0003-4819-158-11-201306040-00002; Hughes MP, 2014, CURR DERMATOL REP, V3, P46; Iannacone MR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-417; IARC, 2012, EST CANC INC MORT PR; Institute of Medicine, 2010, I MED NAT AC REP; Jansen R., 2013, J AM ACAD DERMATOL, V69; Jansen R., 2013, J AM ACAD DERMATOL, V69; Jatana S, 2014, WIRES NANOMED NANOBI, V6, P61, DOI 10.1002/wnan.1244; Jobanputra R, 2000, INT J DERMATOL, V39, P826, DOI 10.1046/j.1365-4362.2000.00073.x; Kim EJ, 2011, J INVEST DERMATOL, V131, P1720, DOI 10.1038/jid.2011.106; Kiprono SK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-157; Klein BEK, 2010, ARCH OPHTHALMOL-CHIC, V128, P959, DOI 10.1001/archophthalmol.2010.138; Koo BB, 2012, SLEEP BREATH, V16, P1237, DOI 10.1007/s11325-011-0640-8; Koster B, 2011, SCAND J PUBLIC HEALT, V39, P64, DOI 10.1177/1403494810391526; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; KROMBERG JGR, 1982, S AFR MED J, V61, P383; Kronschlager M, 2012, INVEST OPHTH VIS SCI, V53, P248, DOI 10.1167/iovs.11-8504; Krstic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018492; Kudish AI, 2011, PHOTODERMATOL PHOTO, V27, P236, DOI 10.1111/j.1600-0781.2011.00608.x; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Laishram R., 2010, J PAK ASS DERMATOL, V20, P128; Landers J, 2011, CLIN EXP OPHTHALMOL, V39, P604, DOI 10.1111/j.1442-9071.2011.02532.x; Langan EA, 2010, BRIT J DERMATOL, V163, P451, DOI 10.1111/j.1365-2133.2010.09891.x; Lemus-Deschamps L, 2012, INT J BIOMETEOROL, V56, P727, DOI 10.1007/s00484-011-0474-x; Levine H, 2013, INT J CANCER, V133, P486, DOI 10.1002/ijc.28031; Li J, 2012, BRIT J DERMATOL, V166, P803, DOI [10.1111/j.1365-2133.2012.10805.x, 10.1111/j.1365-2133.2011.10805.x]; Lin SW, 2012, INT J CANCER, V131, pE1015, DOI 10.1002/ijc.27619; Lofgren S, 2012, ACTA OPHTHALMOL, V90, P44, DOI 10.1111/j.1755-3768.2010.01871.x; LUANDE J, 1985, CANCER, V55, P1823, DOI 10.1002/1097-0142(19850415)55:8<1823::AID-CNCR2820550830>3.0.CO;2-X; Lucas R., 2013, AUSTRALAS EPIDEMIOL, V20, P4; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; Ludema C., 2013, AM J EPIDEMIOL, V179, P208; Mabula Joseph B, 2012, BMC Dermatol, V12, P5, DOI 10.1186/1471-5945-12-5; Major JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035112; Makin J, 2011, HEALTH PROMOT J AUST, V22, pS39; Mallet JD, 2014, PHOTOCHEM PHOTOBIOL, V90, P15, DOI 10.1111/php.12161; Manga P, 2013, SAMJ S AFR MED J, V103, P984, DOI [10.7196/samj.7046, 10.7196/SAMJ.7046]; Matthews YJ, 2010, J DERMATOL SCI, V59, P192, DOI 10.1016/j.jdermsci.2010.07.005; McKenzie R, 2012, PHOTOCH PHOTOBIO SCI, V11, P1174, DOI 10.1039/c2pp05403e; McKenzie R, 2013, PHOTOCH PHOTOBIO SCI, V12, P1726, DOI 10.1039/c3pp50041a; Michikawa T, 2013, J GERONTOL A-BIOL, V68, P96, DOI 10.1093/gerona/gls114; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Miller RA, 2011, AGING CELL, V10, P362, DOI 10.1111/j.1474-9726.2010.00668.x; Miolo G, 2011, J PHOTOCH PHOTOBIO B, V103, P35, DOI 10.1016/j.jphotobiol.2011.01.009; Mitchell DL, 2011, PIGM CELL MELANOMA R, V24, P119, DOI 10.1111/j.1755-148X.2010.00789.x; Moan J, 2009, PHOTOCHEM PHOTOBIOL, V85, P1474, DOI 10.1111/j.1751-1097.2009.00607.x; Mody VC, 2012, ACTA OPHTHALMOL, V90, P226, DOI 10.1111/j.1755-3768.2010.01931.x; Mogha A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011423; Morris J, 2011, PHOTOCH PHOTOBIO SCI, V10, P103, DOI 10.1039/c0pp00232a; MOUSAVI F, 2011, IRAN ARCH IRAN MED, V14, P126; Neale RE, 2007, J AM ACAD DERMATOL, V56, P380, DOI 10.1016/j.jaad.2006.08.039; Neale RE, 2013, CANCER EPIDEM BIOMAR, V22, P719, DOI 10.1158/1055-9965.EPI-12-0917-T; Nebbioso M., 2014, J CHILD NEUROL; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Norval M, 1999, J Epidemiol, V9, pS84; Norval M, 2014, PHOTODERMATOL PHOTO, V30, P262, DOI 10.1111/phpp.12106; Norval M, 2011, PHOTOCH PHOTOBIO SCI, V10, P1267, DOI 10.1039/c1pp05105a; Nthumba PM, 2011, ANN PLAS SURG, V66, P313, DOI 10.1097/SAP.0b013e3181e7db9a; Okuno Tsutomu, 2012, J Occup Health, V54, P181; Osuagwu UL, 2014, EYE CONTACT LENS, V40, P28, DOI 10.1097/ICL.0000000000000007; Paller AS, 2011, PEDIATRICS, V128, P92, DOI 10.1542/peds.2010-1079; Parisi AV, 2012, PHOTOCHEM PHOTOBIOL, V88, P1012, DOI 10.1111/j.1751-1097.2012.01111.x; Pearce S. H. S., 2010, BMJ-BRIT MED J, P340; Petersen B, 2014, J INVEST DERMATOL, V134, P2806, DOI 10.1038/jid.2014.223; Petersen B, 2013, PHOTOCH PHOTOBIO SCI, V12, P190, DOI 10.1039/c2pp25127b; Pissavini M, 2013, PHOTODERMATOL PHOTO, V29, P111, DOI 10.1111/phpp.12033; Ponsonby A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1267, DOI 10.1562/2005-02-15-IR-441; Poon TSC, 2005, J INVEST DERMATOL, V125, P840, DOI 10.1111/j.0022-202X.2005.23894.x; Porojnicu AC, 2008, J PHOTOCH PHOTOBIO B, V91, P125, DOI 10.1016/j.jphotobiol.2008.02.007; Principi N, 2013, HUM VACC IMMUNOTHER, V9, P969, DOI 10.4161/hv.23540; Rajiv B., 2014, UV RAD ITS EFFECTS U; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070032; Rees JR, 2013, CLIN INFECT DIS, V57, P1384, DOI 10.1093/cid/cit549; Rees JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099674; Reeve VE, 2006, PHOTOCHEM PHOTOBIOL, V82, P406, DOI 10.1562/2005-09-29-RA-703; Reichrath J., 2014, ADV EXPT MED BIOL; Reinau D, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13520; Rettberg P, 2002, ADV SPACE RES, V30, P1539, DOI 10.1016/S0273-1177(02)00369-1; ROSENTHAL FS, 1988, INVEST OPHTH VIS SCI, V29, P649; Rouhani Panta, 2008, Cancer Control, V15, P248; Rozanowska MB, 2012, PHOTOCHEM PHOTOBIOL, V88, P1303, DOI 10.1111/j.1751-1097.2012.01240.x; Sayre RM, 2013, J AM ACAD DERMATOL, V69, P481, DOI 10.1016/j.jaad.2013.01.047; Schwarz A, 2012, J INVEST DERMATOL, V132, P2762, DOI 10.1038/jid.2012.238; Schwarz T, 2011, EUR J CELL BIOL, V90, P560, DOI 10.1016/j.ejcb.2010.09.011; Shanafelt TD, 2011, BLOOD, V117, P1492, DOI 10.1182/blood-2010-07-295683; Sharma VK, 2013, PHOTOCH PHOTOBIO SCI, V12, P65, DOI 10.1039/c2pp25182e; Sivayathorn A, 1995, CLIN DRUG INVEST S2, V10, P34; Slaper H, 1996, NATURE, V384, P256, DOI 10.1038/384256a0; Sobolewski PS, 2014, J PHOTOCH PHOTOBIO B, V140, P105, DOI 10.1016/j.jphotobiol.2014.07.009; Stang A, 2006, EUR J CANCER, V42, P660, DOI 10.1016/j.ejca.2005.11.027; Staples J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1640; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Storey P, 2013, INVEST OPHTH VIS SCI, V54, P3010, DOI 10.1167/iovs.12-11412; Szilagyi A, 2011, NUTR CANCER, V63, P991, DOI 10.1080/01635581.2011.596641; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3; Tempark T, 2012, PHOTODERMATOL PHOTO, V28, P200, DOI 10.1111/j.1600-0781.2012.00671.x; Teramura T, 2012, CLIN EXP DERMATOL, V37, P904, DOI 10.1111/j.1365-2230.2012.04388.x; Tewari A, 2012, PHOTOCH PHOTOBIO SCI, V11, P216, DOI 10.1039/c1pp05243h; Tewari A, 2013, PHOTOCH PHOTOBIO SCI, V12, P95, DOI 10.1039/c2pp25323b; Thanos SM, 2012, BRIT J DERMATOL, V167, P631, DOI 10.1111/j.1365-2133.2012.11109.x; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Therapeutic Goods Administration, 2013, LIT REV SAF TIT DIOX, P0; Thomas P, 2012, GLOBAL CHANGE BIOL, V18, P2392, DOI 10.1111/j.1365-2486.2012.02706.x; Tryggvadottir L, 2010, ACTA ONCOL, V49, P665, DOI 10.3109/02841861003702528; Turner J, 2013, PHOTOCH PHOTOBIO SCI, V12, P1589, DOI 10.1039/c3pp50059d; van Leeuwen MT, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c570; van der Leun JC, 2008, PHOTOCH PHOTOBIO SCI, V7, P730, DOI 10.1039/b719302e; van der Pols JC, 2011, CANCER EPIDEM BIOMAR, V20, P530, DOI 10.1158/1055-9965.EPI-10-0961; van der Rhee H, 2013, EUR J CANCER, V49, P1422, DOI 10.1016/j.ejca.2012.11.001; van Dijk A, 2013, PHOTOCHEM PHOTOBIOL, V89, P234, DOI 10.1111/j.1751-1097.2012.01223.x; Vernez D, 2012, BRIT J DERMATOL, V167, P383, DOI 10.1111/j.1365-2133.2012.10898.x; Wadhwani AR, 2013, CLIN EXP DERMATOL, V38, P823, DOI 10.1111/ced.12098; Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0; Wang BQ, 2011, J INVEST DERMATOL, V131, P358, DOI 10.1038/jid.2010.283; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052259; Webb AR, 2011, PHOTOCHEM PHOTOBIOL, V87, P741, DOI 10.1111/j.1751-1097.2011.00898.x; Webb AR, 2008, ADV EXP MED BIOL, V624, P72, DOI 10.1007/978-0-387-77574-6_6; WEST SK, 1989, ARCH OPHTHALMOL-CHIC, V107, P875; WHO, 1994, ENV HLTH CRIT 160 UL; Wirohadidjojo YW, 2011, AESTHET PLAST SURG, V35, P1050, DOI 10.1007/s00266-011-9732-x; Wolf P, 2013, PHOTOCH PHOTOBIO SCI, V12, P166, DOI 10.1039/c2pp25187f; Wolf P, 2014, EXP DERMATOL, V23, P428, DOI 10.1111/exd.12427; Yam Jason C. S., 2014, International Ophthalmology, V34, P383, DOI 10.1007/s10792-013-9791-x; Yang L, 2011, CANCER EPIDEM BIOMAR, V20, P1358, DOI 10.1158/1055-9965.EPI-11-0071; Yazar S, 2014, INVEST OPHTH VIS SCI, V55, P4552, DOI 10.1167/iovs.14-14589; Zaidi MR, 2012, CANCER RES, V72, P1591, DOI 10.1158/0008-5472.CAN-11-2586; Zaratti F, 2014, PHOTOCH PHOTOBIO SCI, V13, P980, DOI 10.1039/c4pp00006d; Zhang J, 2012, INVEST OPHTH VIS SCI, V53, P7276, DOI 10.1167/iovs.12-10482; Zhu K., 2013, J BONE MINER RES, V29, P1088; Zivadinov R., 2013, J NEUROL NEUROSURG P	415	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1474-905X	1474-9092		PHOTOCH PHOTOBIO SCI	Photochem. Photobiol. Sci.		2015	14	1					53	87		10.1039/c4pp90033b		35	Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical	Biochemistry & Molecular Biology; Biophysics; Chemistry	AW9HC	WOS:000346567000005		
J	Andrady, AL; Torikai, A; Redhwi, HH; Pandey, KK; Gies, P				Andrady, A. L.; Torikai, A.; Redhwi, H. H.; Pandey, K. K.; Gies, P.			Consequences of stratospheric ozone depletion and climate change on the use of materials	PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES			English	Review							WOOD-PLASTIC COMPOSITES; LOW-DENSITY POLYETHYLENE; POLYVINYL-CHLORIDE PVC; POLYPROPYLENE COMPOSITES; UV PROTECTION; SOLAR-CELLS; WEATHERING PERFORMANCE; MECHANICAL-PROPERTIES; SPECTRAL SENSITIVITY; MARINE-ENVIRONMENT	Materials used in the exterior of buildings and in construction are routinely exposed to solar UV radiation. Especially in the case of wood and plastic building materials, the service life is determined by their weather-induced deterioration. Any further increase in ground-level solar UV radiation, UV-B radiation in particular, will therefore reduce the outdoor service life of these products. Any increase in ambient temperature due to climate change will also have the same effect. However, the existing light-stabilizer technologies are likely to be able to mitigate the additional damaging effects due to increased solar UV radiation and maintain the outdoor lifetimes of these materials at the present levels. These mitigation choices invariably increase the lifetime cost of these products. A reliable estimate of what this additional cost might be for different products is not available at the present time. Personal exposure to UV radiation is reduced both by clothing fabrics and glass windows used in buildings and automobiles. This assessment describes how the recent technical advances in degradation and stabilization techniques impact the lifetimes of plastics and wood products routinely exposed to solar UV radiation and the protection to humans offered by materials against solar UV radiation.	[Andrady, A. L.] N Carolina State Univ, Dept Biomol & Chem Engn, Raleigh, NC 27523 USA; [Torikai, A.] Mat Life Soc Japan, Chuo Ku, Tokyo, Japan; [Redhwi, H. H.] King Fahd Univ Petr & Minerals, Dept Chem Engn, Dhahran 31261, Saudi Arabia; [Pandey, K. K.] Inst Wood Sci & Technol, Bangalore, Karnataka, India; [Gies, P.] Australian Radiat Protect & Nucl Safety Agcy, Melbourne, Vic, Australia	Andrady, AL (reprint author), N Carolina State Univ, Dept Biomol & Chem Engn, Raleigh, NC 27523 USA.	andrady@andrady.com					Abd El-Hady MM, 2013, CARBOHYD POLYM, V92, P400, DOI 10.1016/j.carbpol.2012.08.085; Agresti G, 2013, J SPECTROSC, DOI 10.1155/2013/380536; Akcros, 2010, ADDIT POLYM, V10, P1; Akovali G, 2012, WOODHEAD PUBL MATER, P23; Al-Mahdouri A, 2013, SOL ENERGY, V96, P21, DOI 10.1016/j.solener.2013.06.029; Al-Salem SM, 2009, MATER DESIGN, V30, P1729, DOI 10.1016/j.matdes.2008.07.049; Amar A, 2013, J PHOTOCH PHOTOBIO B, V125, P115, DOI 10.1016/j.jphotobiol.2013.05.012; Andrady A. L., 1996, ADV POLYM SCI, V128, P45; Fabiyi JS, 2008, POLYM DEGRAD STABIL, V93, P1405, DOI 10.1016/j.polymdegradstab.2008.05.024; Jebrane M, 2009, POLYM DEGRAD STABIL, V94, P151, DOI 10.1016/j.polymdegradstab.2008.11.013; Fakin D, 2012, CARBOHYD POLYM, V88, P992, DOI 10.1016/j.carbpol.2012.01.046; Nassen J, 2012, BUILD ENVIRON, V51, P361, DOI 10.1016/j.buildenv.2011.11.011; Abdel-Ghany AM, 2011, RENEW ENERG, V36, P189, DOI 10.1016/j.renene.2010.06.020; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Butylina S, 2012, COMPOS PART A-APPL S, V43, P2087, DOI 10.1016/j.compositesa.2012.07.003; Rashvand M, 2011, PROG ORG COAT, V71, P362, DOI 10.1016/j.porgcoat.2011.04.006; Nornberg B, 2014, EUR POLYM J, V51, P167, DOI 10.1016/j.eurpolymj.2013.11.008; Haillant O, 2011, SOL ENERG MAT SOL C, V95, P1889, DOI 10.1016/j.solmat.2011.02.013; Gustavsson L, 2010, ENERG BUILDINGS, V42, P230, DOI 10.1016/j.enbuild.2009.08.018; Chaochanchaikul K, 2011, POLYM ENG SCI, V51, P1354, DOI 10.1002/pen.21893; Pajchrowski G, 2014, CONSTR BUILD MATER, V52, P428, DOI 10.1016/j.conbuildmat.2013.11.066; Najafi SK, 2013, WASTE MANAGE, V33, P1898, DOI 10.1016/j.wasman.2013.05.017; De Filpo G, 2013, INT BIODETER BIODEGR, V85, P217, DOI 10.1016/j.ibiod.2013.07.007; Geburtig A, 2010, POLYM DEGRAD STABIL, V95, P2118, DOI 10.1016/j.polymdegradstab.2010.06.014; ANDRADY AL, 1995, TAPPI J, V78, P131; Popescu CM, 2011, INT J BIOL MACROMOL, V48, P667, DOI 10.1016/j.ijbiomac.2011.02.009; Krehula LK, 2014, J WOOD CHEM TECHNOL, V34, P39, DOI 10.1080/02773813.2013.827209; Wang Q, 2010, CARBOHYD POLYM, V81, P491, DOI 10.1016/j.carbpol.2010.03.008; Ojeda T, 2011, POLYM DEGRAD STABIL, V96, P703, DOI 10.1016/j.polymdegradstab.2010.12.004; Pandey KK, 2008, POLYM DEGRAD STABIL, V93, P2138, DOI 10.1016/j.polymdegradstab.2008.08.013; Grifoni D, 2011, DYES PIGMENTS, V91, P279, DOI 10.1016/j.dyepig.2011.04.006; Cakir BA, 2012, COLLOID SURFACE A, V414, P132, DOI 10.1016/j.colsurfa.2012.08.015; Nzokou P, 2006, COLOR RES APPL, V31, P425, DOI 10.1002/col.20248; Leu SY, 2012, CONSTR BUILD MATER, V29, P120, DOI 10.1016/j.conbuildmat.2011.09.013; Celina MC, 2013, POLYM DEGRAD STABIL, V98, P2419, DOI 10.1016/j.polymdegradstab.2013.06.024; Vidal R, 2009, INT J LIFE CYCLE ASS, V14, P73, DOI 10.1007/s11367-008-0043-7; Salla J, 2012, J WOOD CHEM TECHNOL, V32, P121, DOI 10.1080/02773813.2011.624665; van Meel PA, 2011, PROG ORG COAT, V72, P686, DOI 10.1016/j.porgcoat.2011.07.011; Naumann A, 2012, INT BIODETER BIODEGR, V75, P28, DOI 10.1016/j.ibiod.2012.08.004; Frias JPGL, 2014, MAR ENVIRON RES, V95, P89, DOI 10.1016/j.marenvres.2014.01.001; Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Lee CH, 2012, HOLZFORSCHUNG, V66, P981, DOI 10.1515/hf-2011-0198; Manceau M, 2011, SOL ENERG MAT SOL C, V95, P1315, DOI 10.1016/j.solmat.2010.09.021; Zhou ZY, 2010, APPL SURF SCI, V256, P4724, DOI 10.1016/j.apsusc.2010.02.081; Heikkila A, 2014, POLYM DEGRAD STABIL, V99, P190, DOI 10.1016/j.polymdegradstab.2013.11.006; Forsthuber B, 2013, WOOD SCI TECHNOL, V47, P281, DOI 10.1007/s00226-012-0487-6; Pablos JL, 2010, POLYM DEGRAD STABIL, V95, P2057, DOI 10.1016/j.polymdegradstab.2010.07.003; Sharratt V, 2009, POLYM DEGRAD STABIL, V94, P1589, DOI 10.1016/j.polymdegradstab.2009.04.010; Chaochanchaikul K, 2013, EXPRESS POLYM LETT, V7, P146, DOI 10.3144/expresspolymlett.2013.14; Kingston C, 2014, CARBON, V68, P33, DOI 10.1016/j.carbon.2013.11.042; Haillant O, 2011, SOL ENERG MAT SOL C, V95, P1284, DOI 10.1016/j.solmat.2010.08.033; Oreski G, 2009, BIOSYST ENG, V103, P489, DOI 10.1016/j.biosystemseng.2009.05.003; Lamnatou C, 2013, RENEW SUST ENERG REV, V27, P175, DOI 10.1016/j.rser.2013.06.052; Grifoni D, 2014, DYES PIGMENTS, V105, P89, DOI 10.1016/j.dyepig.2014.01.027; Gaggino R, 2012, CONSTR BUILD MATER, V35, P468, DOI 10.1016/j.conbuildmat.2012.04.125; Lei Y, 2010, BIORESOURCE TECHNOL, V101, P3665, DOI 10.1016/j.biortech.2009.12.069; Bezati F, 2011, POLYM DEGRAD STABIL, V96, P51, DOI 10.1016/j.polymdegradstab.2010.11.008; Grelier S, 2007, POLYM DEGRAD STABIL, V92, P1520, DOI 10.1016/j.polymdegradstab.2007.05.011; Chang TC, 2010, POLYM DEGRAD STABIL, V95, P1518, DOI 10.1016/j.polymdegradstab.2010.06.012; Sobczak L, 2012, COMPOS SCI TECHNOL, V72, P550, DOI 10.1016/j.compscitech.2011.12.013; Guo CG, 2012, WOOD SCI TECHNOL, V46, P257, DOI 10.1007/s00226-011-0409-z; Hung KC, 2012, POLYM DEGRAD STABIL, V97, P1680, DOI 10.1016/j.polymdegradstab.2012.06.016; Ghaffar SH, 2013, BIOMASS BIOENERG, V57, P264, DOI 10.1016/j.biombioe.2013.07.015; Mihailovic D, 2010, CARBOHYD POLYM, V79, P526, DOI 10.1016/j.carbpol.2009.08.036; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Buratti C, 2012, APPL ENERG, V98, P396, DOI 10.1016/j.apenergy.2012.03.062; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; Lesar B, 2011, POLYM DEGRAD STABIL, V96, P1271, DOI 10.1016/j.polymdegradstab.2011.04.006; Zivkovic V, 2014, WOOD SCI TECHNOL, V48, P239, DOI 10.1007/s00226-013-0601-4; Tolvaj L, 2011, J PHOTOCH PHOTOBIO B, V105, P90, DOI 10.1016/j.jphotobiol.2011.07.005; Andrady AL, 1998, J PHOTOCH PHOTOBIO B, V46, P96, DOI 10.1016/S1011-1344(98)00188-2; Ayrilmis N, 2013, IND CROP PROD, V43, P457, DOI 10.1016/j.indcrop.2012.07.050; Kullavanijaya P, 2005, J AM ACAD DERMATOL, V52, P937, DOI 10.1016/j.jaad.2004.07.063; Tolvaj L., 2012, Acta Silvatica & Lignaria Hungarica, V8, P145; Chou PL, 2008, BIORESOURCE TECHNOL, V99, P1073, DOI 10.1016/j.biortech.2007.02.027; Tuchinda C, 2006, J AM ACAD DERMATOL, V54, P845, DOI 10.1016/j.jaad.2005.11.1082; Arkema, 2010, ADDIT POLYM, V2010, P2; Arkema, 2011, ADDIT POLYM, V2011, P2; Baur SI, 2013, POLYM ADVAN TECHNOL, V24, P97, DOI 10.1002/pat.3056; Bedeloglu A, 2010, RENEW ENERG, V35, P2301, DOI 10.1016/j.renene.2010.02.030; Bhat I., 2010, MATER DESIGN, P31; Bijl P., 2011, POLYM TEST, V30; Clariant, 2013, ADDIT POLYM, V2013, P3; Cristea MV, 2011, PROG ORG COAT, V72, P755, DOI 10.1016/j.porgcoat.2011.08.007; Das BR, 2010, OPEN TEXTILE J, V3, P14, DOI DOI 10.2174/1876520301003010014; Dawson BSW, 2008, J COAT TECHNOL RES, V5, P207, DOI 10.1007/s11998-008-9090-z; Dehbi A, 2010, MATER DESIGN, V31, P864, DOI 10.1016/j.matdes.2009.07.047; Dehbi A, 2012, J APPL POLYM SCI, V124, P2702, DOI 10.1002/app.34928; Dittenber D. B., 2012, COMPOSITES A, V43; Douminge L, 2013, CURR APPL PHYS, V13, P1751, DOI 10.1016/j.cap.2013.06.027; Douminge L, 2010, CURR APPL PHYS, V10, P1211, DOI 10.1016/j.cap.2010.02.045; Binhussain MA, 2013, CONSTR BUILD MATER, V47, P1431, DOI 10.1016/j.conbuildmat.2013.06.031; Espejo C., 2012, J COAT TECHNOL RES, V5, P2017; Evans P. D., 2009, WOOD MAT SCI ENG, V4, P2; Evans PD, 2013, POLYM DEGRAD STABIL, V98, P158, DOI 10.1016/j.polymdegradstab.2012.10.015; Evans PD, 2012, HDB WOOD CHEM WOOD C, P151; Fauchadour D., 2005, PAINTS COAT IND, V21, P88; FerroCorp, 2014, ADDIT POLYM, V1, P4; Forsthuber B, 2010, POLYM DEGRAD STABIL, V95, P746, DOI 10.1016/j.polymdegradstab.2010.02.016; Francois-Heude A, 2014, POLYM DEGRAD STABIL, V100, P10, DOI 10.1016/j.polymdegradstab.2013.12.038; Fufa SM, 2013, PROG ORG COAT, V76, P1543, DOI 10.1016/j.porgcoat.2013.06.008; Fufa SM, 2013, PROG ORG COAT, V76, P1425, DOI 10.1016/j.porgcoat.2013.05.001; Gies P., 2012, MELANOM LETT, V30, P7; Gouda M., 2010, CARBOHYDR POLYM, V80; Heikkila A, 2009, POLYM TEST, V28, P57, DOI 10.1016/j.polymertesting.2008.10.005; Homkhiew C, 2014, IND CROP PROD, V56, P52, DOI 10.1016/j.indcrop.2014.02.034; Hu CS, 2012, J WOOD SCI, V58, P465, DOI 10.1007/s10086-012-1265-7; Imai T, 2012, PROCEDIA ENGINEER, V47, P502, DOI 10.1016/j.proeng.2012.09.194; IPCC, 2010, INT PAN CLIM CHANG W; ISP, 2010, ADDIT POLYM, V2010, P1; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Jin S, 2013, J VINYL ADDIT TECHN, V19, P239, DOI 10.1002/vnl.21315; Johannes F. J. M., 2012, ENERGY BUILD, V50, P298; Kahlen S, 2010, SOL ENERGY, V84, P1567, DOI 10.1016/j.solener.2010.03.021; Kan CW, 2014, MATERIALS, V7, P58, DOI 10.3390/ma7010058; Kempe M., 2013, P 39 IEEE PHOT SPEC; Kempe MD, 2010, SOL ENERG MAT SOL C, V94, P246, DOI 10.1016/j.solmat.2009.09.009; Kim JT, 2013, ENERG BUILDINGS, V63, P108, DOI 10.1016/j.enbuild.2013.03.036; Kopp E. S., 2012, 38 IEEE PHOT SPEC C; Kubba S., 2012, HDB GREEN BUILDING D, P227; Lee-Taylor J, 2010, UV RADIATION IN GLOBAL CLIMATE CHANGE, P1, DOI 10.1007/978-3-642-03313-1_1; Liu XY, 2012, FIBER POLYM, V13, P489, DOI 10.1007/s12221-012-0489-x; Maged H. Z., 2009, EUR POLYM J, V45, P2926; Mitsui K, 2010, J PHOTOCH PHOTOBIO B, V101, P210, DOI 10.1016/j.jphotobiol.2010.07.005; Mohammad R. A., 2012, APPL SURF SCI, V258, P4391; Moretti E, 2014, ENERG BUILDINGS, V70, P23, DOI 10.1016/j.enbuild.2013.11.045; Moule AJ, 2010, CURR OPIN SOLID ST M, V14, P123, DOI 10.1016/j.cossms.2010.06.003; NREL, 2013, NRELTP520060950, P30; Olsson S, 2012, POLYM DEGRAD STABIL, V97, P1779, DOI 10.1016/j.polymdegradstab.2012.06.006; Pandey K. K., 2013, STUDY UV RESISTANCE; Persze L., 2012, J PHOTOCH PHOTOBIO B, P10844; Plastics Europe, 2012, PLAST FACTS; Qiang T, 2014, J CLEAN PROD, V66, P139, DOI 10.1016/j.jclepro.2013.11.074; Ramanujam M, 2012, THERMOCHIM ACTA, V530, P73, DOI 10.1016/j.tca.2011.12.003; Redhwi H. H., 2013, J NANOCOMPOS MAT, V2013, P1; Redhwi HH, 2013, POLYM COMPOSITE, V34, P1878, DOI 10.1002/pc.22594; Rowell RM, 2013, HANDBOOK OF WOOD CHEMISTRY AND WOOD COMPOSITES, 2ND EDITION, P1; Saadat-Monfared A, 2014, COLLOID SURFACE A, V441, P752, DOI 10.1016/j.colsurfa.2012.10.064; Sil D, 2010, SOL ENERGY, V84, P476, DOI 10.1016/j.solener.2009.09.012; Stark N. M., 2009, 4 WOOD FIBR POL COMP; Tolvaj L, 2010, POLYM DEGRAD STABIL, V95, P638, DOI 10.1016/j.polymdegradstab.2009.12.004; Ugur SS, 2011, MATER RES BULL, V46, P1202, DOI 10.1016/j.materresbull.2011.04.005; Volkmer T, 2013, POLYM DEGRAD STABIL, V98, P1118, DOI 10.1016/j.polymdegradstab.2013.03.019; Vollmer S., 2013, International Wood Products Journal, V4, DOI 10.1179/2042645313Y.0000000042; Wang X, 2014, WOOD FIBER SCI, V46, P109; Wilson CA, 2008, TEXT RES J, V78, P95, DOI 10.1177/0040517508089660; Xie KL, 2010, CARBOHYD POLYM, V80, P480, DOI 10.1016/j.carbpol.2009.12.005; Yemele M. C. N., 2010, HOLZFORSCHUNG, V64, P385; Yuan T., 2013, IND CROP PROD, V53, P123; Zhao ZY, 2013, MICROELECTRON RELIAB, V53, P123, DOI 10.1016/j.microrel.2012.08.002; Zivkovic V., 2013, 6 EUR WAETH S NAT AR	151	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1474-905X	1474-9092		PHOTOCH PHOTOBIO SCI	Photochem. Photobiol. Sci.		2015	14	1					170	184		10.1039/c4pp90038c		15	Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical	Biochemistry & Molecular Biology; Biophysics; Chemistry	AW9HC	WOS:000346567000010		
J	Mutoh, K; Nakagawa, Y; Hatano, S; Kobayashi, Y; Abe, J				Mutoh, Katsuya; Nakagawa, Yuki; Hatano, Sayaka; Kobayashi, Yoichi; Abe, Jiro			Entropy-controlled biradical-quinoid isomerization of a pi-conjugated delocalized biradical	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							LINKED CORROLE DIMERS; PI,PI-BIRADICALOID HYDROCARBONS; PHOTODISSOCIATION DYNAMICS; PHOTOCHEMICAL PREPARATION; DIRADICAL CHARACTER; ATOM RECOMBINATION; KEKULE STRUCTURES; GROUND-STATES; CLOSED-SHELL; SINGLET	Biradicaloid species have been extensively studied for their characteristic features in electric conductivity, magnetism, and optical nonlinearity. Theoretical investigations of rigid biradicaloid species have been suggesting that they are represented as a resonance hybrid of open-shell biradical and closed-shell quinoid structures. However, much is still unknown about flexible biradicaloid species whether the activation free energy barrier between these states exists or not. Herein, we investigated the thermal isomerization from the photogenerated unstable biradical to the stable quinoid species observed for the photochromic dimer of a bisimidazolyl radical and found that the large negative activation entropy for the valence isomerization causes the activation free energy barrier between these two states.	[Mutoh, Katsuya; Kobayashi, Yoichi; Abe, Jiro] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Nakagawa, Yuki] Itoh Opt Ind Co Ltd, Gamagori, Aichi 4430041, Japan; [Hatano, Sayaka] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima, Hiroshima 7398526, Japan; [Abe, Jiro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Abe, J (reprint author), Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	jiro_abe@chem.aoyama.ac.jp			Core Research for Evolutionary Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); MEXT, Japan [26107010]	This work was supported partly by the Core Research for Evolutionary Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics'' (No. 26107010) from MEXT, Japan.	Sun Z, 2013, J AM CHEM SOC, V135, P18229, DOI 10.1021/ja410279j; Shimizu A, 2010, J AM CHEM SOC, V132, P14421, DOI 10.1021/ja1037287; Kikuchi A, 2004, J AM CHEM SOC, V126, P6526, DOI 10.1021/ja049423h; Zhu XZ, 2011, J AM CHEM SOC, V133, P16342, DOI 10.1021/ja206060n; Zeng ZB, 2012, J AM CHEM SOC, V134, P14513, DOI 10.1021/ja3050579; Shimizu A, 2009, ANGEW CHEM INT EDIT, V48, P5482, DOI 10.1002/anie.200901382; Yamashita H, 2014, J PHYS CHEM A, V118, P1430, DOI 10.1021/jp5007928; KAHN SD, 1987, J AM CHEM SOC, V109, P1871, DOI 10.1021/ja00240a053; Cho S, 2009, J AM CHEM SOC, V131, P6412, DOI 10.1021/ja900220y; Kishida H, 2010, THIN SOLID FILMS, V519, P1028, DOI 10.1016/j.tsf.2010.08.037; Kubo T, 2005, ANGEW CHEM INT EDIT, V44, P6564, DOI 10.1002/anie.200502303; Hiroto S, 2006, J AM CHEM SOC, V128, P12380, DOI 10.1021/ja062654z; Nakano M, 2005, J PHYS CHEM A, V109, P885, DOI 10.1021/jp046322x; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Bendikov M, 2004, J AM CHEM SOC, V126, P7416, DOI 10.1021/ja048919w; Konishi A, 2010, J AM CHEM SOC, V132, P11021, DOI 10.1021/ja1049737; Grafenstein J, 2000, J PHYS CHEM A, V104, P1748, DOI 10.1021/jp993122q; MONTGOMERY LK, 1986, J AM CHEM SOC, V108, P6004, DOI 10.1021/ja00279a056; Huang JS, 2007, J AM CHEM SOC, V129, P1634, DOI 10.1021/ja066426g; BIJL D, 1959, J CHEM PHYS, V30, P765, DOI 10.1063/1.1730041; BUNKER DL, 1958, J AM CHEM SOC, V80, P5090, DOI 10.1021/ja01552a024; CHRISTIE MI, 1953, PROC R SOC LON SER-A, V216, P152, DOI 10.1098/rspa.1953.0013; FLYNN CR, 1974, J AM CHEM SOC, V96, P3280, DOI 10.1021/ja00817a042; HUTCHISON CA, 1952, J CHEM PHYS, V20, P1485, DOI 10.1063/1.1700786; Kamada K, 2007, ANGEW CHEM INT EDIT, V46, P3544, DOI 10.1002/anie.200605061; Kato D, 2008, CHEM LETT, V37, P694, DOI 10.1246/cl.2008.694; Kikuchi A, 2005, CHEM LETT, V34, P1552, DOI 10.1246/cl.2005.1552; Kikuchi A, 2005, J PHYS CHEM B, V109, P19448, DOI 10.1021/jp052207q; KOLC J, 1973, J AM CHEM SOC, V95, P7391, DOI 10.1021/ja00803a030; Kubo T, 2007, CHEM-ASIAN J, V2, P1370, DOI 10.1002/asia.200700147; Mayer U., 1966, ANGEW CHEM, V78, P303, DOI 10.1002/ange.19660780505; Miyasaka H, 2009, J AM CHEM SOC, V131, P7256, DOI 10.1021/ja809195s; Nakano M, 2006, J PHYS CHEM A, V110, P4238, DOI 10.1021/jp056672z; Nakano M, 1997, PHYS REV A, V55, P1503, DOI 10.1103/PhysRevA.55.1503; Piotrowiak P, 1996, J AM CHEM SOC, V118, P8981, DOI 10.1021/ja961829+; POPP F, 1978, CHEM PHYS LETT, V55, P327, DOI 10.1016/0009-2614(78)87030-4; PORTER G, 1959, NATURE, V184, P446, DOI 10.1038/184446a0; Rebmann A, 1996, J CHEM RES-S, P318; REITZ DC, 1960, J CHEM PHYS, V33, P700, DOI 10.1063/1.1731241; RUSSELL KE, 1953, PROC R SOC LON SER-A, V217, P271, DOI 10.1098/rspa.1953.0062; Satoh Y, 2007, CHEM PHYS LETT, V448, P228, DOI 10.1016/j.cplett.2007.09.081	41	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	2					1151	1155		10.1039/c4cp04606d		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW4FH	WOS:000346236000049		
J	Kothe, A; Wilke, M; Moguilevski, A; Engel, N; Winter, B; Kiyan, IY; Aziz, EF				Kothe, Alexander; Wilke, Martin; Moguilevski, Alexandre; Engel, Nicholas; Winter, Bernd; Kiyan, Igor Yu.; Aziz, Emad F.			Charge transfer to solvent dynamics in iodide aqueous solution studied at ionization threshold	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							RESOLVED PHOTOELECTRON-SPECTROSCOPY; LOW KINETIC-ENERGY; SOLVATED ELECTRONS; PHOTODETACHMENT; WATER; BULK; PHOTOEMISSION; CHEMISTRY; HALIDE; STATE	We explore the early-time electronic relaxation in NaI aqueous solution exposed to a short UV laser pulse. Rather than initiating the charge transfer reaction by resonant photoexcitation of iodide, in the present time-resolved photoelectron spectroscopy study the charge-transfer-to-solvent (CTTS) states are populated via electronic excitation above the vacuum level. By analyzing the temporal evolution of electron yields from ionization of two transient species, assigned to CTTS and its first excited state, we determine both their ultrafast population and relaxation dynamics. Comparison with resonant-excitation studies shows that the highly excited initial states exhibit similar relaxation characteristics as found for resonant excitation. Implications for structure and dynamical response of the hydration cage are discussed.	[Kothe, Alexander; Wilke, Martin; Moguilevski, Alexandre; Engel, Nicholas; Winter, Bernd; Kiyan, Igor Yu.; Aziz, Emad F.] Helmholtz Zentrum Berlin, Inst Methods Mat Dev, Joint Lab Ultrafast Dynam Solut & Interfaces JULi, D-12489 Berlin, Germany; [Aziz, Emad F.] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Aziz, Emad F.] Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Kiyan, IY (reprint author), Helmholtz Zentrum Berlin, Inst Methods Mat Dev, Joint Lab Ultrafast Dynam Solut & Interfaces JULi, Albert Einstein Str 15, D-12489 Berlin, Germany.	igor.kiyan@helmholtz-berlin.de; emad.aziz@helmholtz-berlin.de	Winter, Bernd/D-4657-2011		Helmholtz-Gemeinschaft [VH-NG-635]; European Research Council [279344]	This work was supported by the Helmholtz-Gemeinschaft via the VH-NG-635 grant and the extended investment of 2013 (E.F.A.) and the European Research Council grant No. 279344 (E.F.A.).	Lubcke A, 2010, PHYS CHEM CHEM PHYS, V12, P14629, DOI 10.1039/c0cp00847h; Kloepfer JA, 1998, CHEM PHYS LETT, V298, P120, DOI 10.1016/S0009-2614(98)01210-X; Alizadeh E, 2012, CHEM REV, V112, P5578, DOI 10.1021/cr300063r; Kurahashi N, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871877; Pham VT, 2011, J AM CHEM SOC, V133, P12740, DOI 10.1021/ja203882y; Winter B, 2006, CHEM REV, V106, P1176, DOI 10.1021/cr040381p; CHANIN LM, 1962, PHYS REV, V128, P219, DOI 10.1103/PhysRev.128.219; Winter B, 2008, J AM CHEM SOC, V130, P7130, DOI 10.1021/ja8009742; Siefermann KR, 2010, NAT CHEM, V2, P274, DOI [10.1038/nchem.580, 10.1038/NCHEM.580]; Seidel R, 2011, J PHYS CHEM LETT, V2, P633, DOI 10.1021/jz101636y; Turi L, 2012, CHEM REV, V112, P5641, DOI 10.1021/cr300144z; Lange KM, 2012, PHYS CHEM CHEM PHYS, V14, P5331, DOI 10.1039/c2cp24028a; Hertwig A, 1999, PHYS CHEM CHEM PHYS, V1, P5633, DOI 10.1039/a906950j; Elkins MH, 2013, SCIENCE, V342, P1496, DOI 10.1126/science.1246291; Iglev H, 2005, CHEM PHYS LETT, V403, P198, DOI 10.1016/j.cplett.2005.01.014; Chen XY, 2008, ANNU REV PHYS CHEM, V59, P203, DOI 10.1146/annurev.physchem.58.032806.104702; Kloepfer JA, 2000, J CHEM PHYS, V113, P6288, DOI 10.1063/1.1309011; Buchner F, 2012, PHYS CHEM CHEM PHYS, V14, P5837, DOI 10.1039/c2cp23305c; Kloepfer J. A., 2002, J CHEM PHYS, V117, P776; Kothe A, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4791792; LONG FH, 1994, J PHYS CHEM-US, V98, P7252, DOI 10.1021/j100081a003; Messina F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3119; Sheu WS, 1996, J PHYS CHEM-US, V100, P1295, DOI 10.1021/jp9513531; SHEU WS, 1993, CHEM PHYS LETT, V202, P186, DOI 10.1016/0009-2614(93)85263-N; Shreve AT, 2010, CHEM PHYS LETT, V493, P216, DOI 10.1016/j.cplett.2010.05.059; Suzuki YI, 2011, CHEM SCI, V2, P1094, DOI 10.1039/c0sc00650e; Tang Y, 2010, PHYS CHEM CHEM PHYS, V12, P3653, DOI 10.1039/b925741a; Tang Y, 2010, CHEM PHYS LETT, V494, P111, DOI 10.1016/j.cplett.2010.05.084; Weber R, 2004, J PHYS CHEM B, V108, P4729, DOI 10.1021/jp030776x	29	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	3					1918	1924		10.1039/c4cp02482f		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW7XA	WOS:000346473600046		
J	Takabatake, S; Shikata, T				Takabatake, Shunzo; Shikata, Toshiyuki			Evidence of anti-parallel dimer formation of 4-cyano-4 '-alkyl biphenyls in isotropic cyclohexane solution	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							NEMATIC LIQUID-CRYSTALS; DISPLAYS; BEHAVIOR; PHASES; STATE; 5CB	The formation of anti-parallel dimers of two liquid crystal forming 4-cyano-4'-alkyl biphenyls (nCB, n = 5 (pentyl) and n = 8 (octyl)) was confirmed in an isotropic cyclohexane solution (nCB-cH). In addition to high frequency dielectric relaxation (DR) measurements up to 50 GHz, fluorescence emission (FE) experiments in the wavelength range from 280 to 500 nm were carried out to investigate the molecular dynamics of the nCB molecules. The DR spectra of solutions at intermediate to high concentrations were comprised of two dynamic modes. A fast mode with a relaxation time of ca. 90 ps was assigned to the free rotations of monomeric nCB molecules. The slow mode with a relaxation time of ca. 400 ps was attributed to the dissociation process of the anti-parallel dimers ((nCB)(2)). The Kirkwood factor (g(K)), a measure of the orientational correlation between the dipole moments of the cyano groups, was markedly less than unity for the slow mode, which demonstrated the formation of anti-parallel dimers, (nCB)(2). The equilibrium constant for anti-parallel dimer formation in an isotropic solution, i.e., for the reaction, 2nCB <-> (nCB)(2), which was determined via the DR data increased with an increase in the concentration of nCB. Under extremely dilute conditions, a sharp fluorescence emission signal attributed to the nCB monomer was observed at 325 nm in FE spectrum measurements. However, at the moderate to high concentrations used in the DR measurements where the slow mode was clearly observed, a broad FE signal at 390 nm was observed, which was assigned to excimer emission (including emission from the excited ground state dimers). The relative intensity of the excimer emission to the monomer emission significantly increased with an increase in the concentration. Moreover, the equilibrium constant for the excimer formation reasonably agreed with that for the anti-parallel dimer formation evaluated by the DR data. Consequently, the results of the FE measurements evidently revealed that excimers of nCB and the (nCB)(2) dimers formed in isotropic solution are identical chemical species.	[Takabatake, Shunzo; Shikata, Toshiyuki] Tokyo Univ Agr & Technol, United Grad Sch Agr, Dept Symbiot Sci Environm & Nat Resources, Fuchu, Tokyo 1838509, Japan; [Shikata, Toshiyuki] Tokyo Univ Agr & Technol, Grad Sch Agr, Div Nat Resources & Ecomat, Fuchu, Tokyo 1838509, Japan	Shikata, T (reprint author), Tokyo Univ Agr & Technol, United Grad Sch Agr, Dept Symbiot Sci Environm & Nat Resources, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	shikata@cc.tuat.ac.jp	Shikata, Toshiyuki/D-1055-2013	Shikata, Toshiyuki/0000-0001-6846-4985	Nippon Synthetic Chemical Industry Co., Ltd. (Osaka); JSPS [26288055]	TS is indebted to The Nippon Synthetic Chemical Industry Co., Ltd. (Osaka) for their kind financial support for this study. This work was partially supported by a JSPS Grant-in-Aid for Scientific Research (B) Number 26288055.	Abe K, 2005, J KOREAN PHYS SOC, V46, P220; Kundu SK, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2993255; REYNDERS P, 1990, J AM CHEM SOC, V112, P3929, DOI 10.1021/ja00166a032; Urban S, 1999, PHYS CHEM CHEM PHYS, V1, P4843, DOI 10.1039/a904647j; GRAY GW, 1973, ELECTRON LETT, V9, P130, DOI 10.1049/el:19730096; Shikata T, 2011, PHYS CHEM CHEM PHYS, V13, P16542, DOI 10.1039/c1cp21479a; Ono Y, 2006, J AM CHEM SOC, V128, P10030, DOI 10.1021/ja063990i; Dunmur DA, 2001, J CHEM PHYS, V115, P8681, DOI 10.1063/1.1409365; Berlman I. B., 1971, HDB FLUORESCENCE SPE; Castellano J. A., 2005, STORY LIQUID CRYSTAL; Collings P. J., 1997, INTRO LIQUID CRYSTAL, P51; FOSTER JS, 1988, NATURE, V333, P542, DOI 10.1038/333542a0; Fukunaga H, 2004, J CHEM PHYS, V120, P7792, DOI 10.1063/1.1687681; Ghanadzadeh A, 2003, J MOL LIQ, V102, P365, DOI 10.1016/S0167-7322(02)00161-7; GIERLOTKA S, 1990, EUROPHYS LETT, V12, P341, DOI 10.1209/0295-5075/12/4/010; Gray GW, 1999, J MATER CHEM, V9, P2037, DOI 10.1039/a902682g; HAASE W, 1988, J CHEM PHYS, V89, P3317, DOI 10.1063/1.454939; HEILMEIE.GH, 1968, PR INST ELECTR ELECT, V56, P1162, DOI 10.1109/PROC.1968.6513; IKEDA T, 1990, J PHYS CHEM-US, V94, P6550, DOI 10.1021/j100380a008; Kawamoto H, 2002, P IEEE, V90, P460, DOI 10.1109/JPROC.2002.1002521; Kirkwood J. D., 1937, J CHEM PHYS, V7, P911; Leadbetter A. J., 1975, J PHYS, V36, pC1; Piryatinskii YP, 2000, OPT SPECTROSC+, V89, P860, DOI 10.1134/1.1335034; Satokawa Y., 2008, MACROMOLECULES, V414, P2908; Shabatina TI, 1998, J STRUCT CHEM+, V39, P318, DOI 10.1007/BF02873637; Shikata T, 2014, AIP ADV, V4, DOI 10.1063/1.4884393; Shikata T, 2012, J PHYS CHEM B, V116, P12605, DOI 10.1021/jp308037n; Shikata T, 2014, NIHON REOROJI GAKK, V42, P197; SMITH DPE, 1989, SCIENCE, V245, P43, DOI 10.1126/science.245.4913.43; Williams R., 1963, J PHYS CHEM-US, V39, P382	30	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	3					1934	1942		10.1039/c4cp04933k		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW7XA	WOS:000346473600048		
J	Kanno, M; Ito, Y; Shimakura, N; Koseki, S; Kono, H; Fujimura, Y				Kanno, Manabu; Ito, Yuta; Shimakura, Noriyuki; Koseki, Shiro; Kono, Hirohiko; Fujimura, Yuichi			Ab initio quantum dynamical analysis of ultrafast nonradiative transitions via conical intersections in pyrazine	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							CONFIGURATION-INTERACTION CALCULATIONS; VIBRONICALLY COUPLED SYSTEMS; POLYATOMIC-MOLECULES; ELECTRONIC STATES; EXCITED-STATES; ABSORPTION-SPECTRUM; INTERNAL-CONVERSION; WAVE-PACKET; SPECTROSCOPY; RELAXATION	We theoretically investigated the mechanism of ultrafast nonradiative transition through conical intersections in photoexcited pyrazine by ab initio quantum dynamical calculations. This work was motivated by the recent theoretical and experimental studies that presented conflicting results: the former is the on-the-fly semiclassical surface hopping calculation combined with the time-dependent density functional theory, which showed that nonadiabatic transitions from the optically bright S-2 (B-1(2u), pi pi*) state to the optically dark S-3 ((1)A(u), n pi*) and S-4 (B-1(2g), n pi*) states take place predominantly at the initial stage of electronic relaxation [U. Werner et al., Chem. Phys., 2008, 349, 319]; the latter is the pump-probe photoelectron spectroscopic measurement, which reported the S2 lifetime (22 +/- 3 fs) of nonradiative decay to the almost dark S-1 (B-1(3u), n pi*) state [Y.-I. Suzuki et al., J. Chem. Phys., 2010, 132, 174302]. We constructed adiabatic and diabatic potential energy surfaces of these pi pi* and n pi* states using the multireference configuration interaction method and calculated their diabatic couplings within two-dimensional subspaces spanned by selected ground-state normal coordinates. Contrary to the surface hopping study, our nuclear wave packet simulations demonstrated that nonadiabatic transitions to the S-3 and S-4 states are so small that the conventional two-state (S-1 and S-2) picture is valid. Ultrafast internal conversion of pyrazine, which is deemed to proceed with a 22 fs lifetime, in fact consists of three consecutive steps: (i) the wave packet excited to the S-2 state travels toward the S-2-S-1 conical intersection in 10 fs, (ii) the nonadiabatic transition to the S-1 state progresses at a rapid rate corresponding to a transient lifetime of 7 fs, and (iii) intramolecular vibrational energy redistribution occurs in the S-1 state in about 80 fs after optical excitation. To verify this prediction, time-resolved experiments with a resolution of several fs or shorter are desirable.	[Kanno, Manabu; Kono, Hirohiko; Fujimura, Yuichi] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Ito, Yuta; Shimakura, Noriyuki] Niigata Univ, Dept Chem, Niigata 9502181, Japan; [Koseki, Shiro] Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Sakai, Osaka 5998531, Japan; [Koseki, Shiro] Osaka Prefecture Univ, RIMED, Sakai, Osaka 5998531, Japan; [Fujimura, Yuichi] Natl Chiao Tung Univ, Inst Mol Sci, Dept Appl Chem, Hsinchu 300, Taiwan; [Fujimura, Yuichi] Natl Chiao Tung Univ, Ctr Interdisciplinary Mol Sci, Hsinchu 300, Taiwan	Kanno, M (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	kanno@m.tohoku.ac.jp; shima@emeritus.niigata-u.ac.jp			JSPS KAKENHI [26810002]	M. K. is grateful to Dr W. C. Chung, Dr Y.-I. Suzuki, and Prof. T. Suzuki for valuable discussions. This work was supported in part by JSPS KAKENHI Grant Number 26810002.	WERNER HJ, 1988, J CHEM PHYS, V89, P5803, DOI 10.1063/1.455556; KNOWLES PJ, 1988, CHEM PHYS LETT, V145, P514, DOI 10.1016/0009-2614(88)87412-8; Hu Z, 2012, J PHYS CHEM LETT, V3, P2744, DOI 10.1021/jz301144q; Worth GA, 1996, J CHEM PHYS, V105, P4412, DOI 10.1063/1.472327; Weber P, 1999, J PHYS CHEM A, V103, P9821, DOI 10.1021/jp991403s; Yarkony DR, 1998, ACCOUNTS CHEM RES, V31, P511, DOI 10.1021/ar970113w; STOCK G, 1995, J CHEM PHYS, V103, P6851, DOI 10.1063/1.470689; Worth GA, 1999, CHEM PHYS LETT, V299, P451, DOI 10.1016/S0009-2614(98)01297-4; Suzuki YI, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3395206; INNES KK, 1988, J MOL SPECTROSC, V132, P492, DOI 10.1016/0022-2852(88)90343-8; KNOWLES PJ, 1985, CHEM PHYS LETT, V115, P259, DOI 10.1016/0009-2614(85)80025-7; OKUZAWA Y, 1990, CHEM PHYS LETT, V171, P341, DOI 10.1016/0009-2614(90)85374-L; Kanno M, 2012, J PHYS CHEM A, V116, P11260, DOI 10.1021/jp305284w; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82; STOCK G, 1989, J CHEM PHYS, V90, P7184, DOI 10.1063/1.456248; SCHNEIDER R, 1990, J CHEM PHYS, V92, P1045, DOI 10.1063/1.458167; Chung WC, 2007, PHYS CHEM CHEM PHYS, V9, P2075, DOI 10.1039/b618745e; YAMAZAKI I, 1983, FARADAY DISCUSS, V75, P395, DOI 10.1039/dc9837500395; GROSS P, 1992, J CHEM PHYS, V96, P2834, DOI 10.1063/1.461980; STOCK G, 1990, J CHEM PHYS, V93, P5496, DOI 10.1063/1.459619; Simah D, 1999, J CHEM PHYS, V111, P4523, DOI 10.1063/1.479214; Sala M, 2014, PHYS CHEM CHEM PHYS, V16, P15957, DOI 10.1039/c4cp02165g; TULLY JC, 1990, J CHEM PHYS, V93, P1061, DOI 10.1063/1.459170; Christopher PS, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2346684; Kanno M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108302; Sala M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4875736; Raab A, 1999, J CHEM PHYS, V110, P936, DOI 10.1063/1.478061; Worth GA, 1998, J CHEM PHYS, V109, P3518, DOI 10.1063/1.476947; Tomasello G, 2014, J PHYS CHEM A, V118, P8437, DOI 10.1021/jp5017328; Puzari P, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2393228; WERNER HJ, 1985, J CHEM PHYS, V82, P5053, DOI 10.1063/1.448627; WOYWOD C, 1994, J CHEM PHYS, V100, P1400, DOI 10.1063/1.466618; Yarkony DR, 1996, REV MOD PHYS, V68, P985, DOI 10.1103/RevModPhys.68.985; Yarkony DR, 2012, CHEM REV, V112, P481, DOI 10.1021/cr2001299; Stert V, 2000, J CHEM PHYS, V112, P4460, DOI 10.1063/1.481008; SCHNEIDER R, 1988, CHEM PHYS LETT, V150, P235, DOI 10.1016/0009-2614(88)80034-4; WALKER IC, 1991, CHEM PHYS, V153, P169, DOI 10.1016/0301-0104(91)90017-N; Werner U, 2008, CHEM PHYS, V349, P319, DOI 10.1016/j.chemphys.2008.02.061; KNOWLES PJ, 1992, THEOR CHIM ACTA, V84, P95, DOI 10.1007/BF01117405; SEEL M, 1991, J CHEM PHYS, V95, P7806, DOI 10.1063/1.461816; Baer M, 2006, BORN OPPENHEIMER, P26; BERRY MV, 1984, P ROY SOC LOND A MAT, V392, P45, DOI 10.1098/rspa.1984.0023; CRADOCK S, 1988, J AM CHEM SOC, V110, P2758, DOI 10.1021/ja00217a011; Domcke W., 2004, CONICAL INTERSECTION; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hassan WMI, 2010, PHYS CHEM CHEM PHYS, V12, P5317, DOI 10.1039/b926102h; He RX, 2009, CHEM PHYS LETT, V476, P19, DOI 10.1016/j.cplett.2009.05.043; Kanno M, 2014, CHINESE J PHYS, V52, P617, DOI 10.6122/CJP.52.617; Kanno M., 2011, PROGR ULTRAFAST INTE, V7, P53; Kanno M., 2012, PROGR THEORETICAL CH, V26, P121; KOMMANDEUR J, 1987, ANNU REV PHYS CHEM, V38, P433, DOI 10.1146/annurev.physchem.38.1.433; Levine I. N., 2009, QUANTUM CHEM, P471; Lin CK, 2011, CHEM-ASIAN J, V6, P2977, DOI 10.1002/asia.201100472; Ohtsuki Y., 2001, ADV MULTIPHOTON PROC, V13, P1; Sarkar B, 2009, INT J QUANTUM CHEM, V109, P650, DOI 10.1002/qua.21870; SCHNEIDER R, 1989, CHEM PHYS LETT, V159, P61, DOI 10.1016/S0009-2614(89)87455-X; SEIDNER L, 1992, J CHEM PHYS, V96, P5298, DOI 10.1063/1.462715; Sukharev M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.093004; SUZUKA I, 1979, CHEM PHYS LETT, V64, P333, DOI 10.1016/0009-2614(79)80525-4; Suzuki T., 2014, MULTIPHOTON PROCESSE, V21, P139; UDAGAWA Y, 1980, CHEM PHYS, V46, P237, DOI 10.1016/0301-0104(80)85098-1; WADT WR, 1975, J AM CHEM SOC, V97, P2034, DOI 10.1021/ja00841a008; Werner H. J., 2012, MOLPRO VERSION 2012; Werner U, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3395160	64	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	3					2012	2024		10.1039/c4cp04807e		13	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW7XA	WOS:000346473600056		
J	Hua, L; Iwamura, M; Takeuchi, S; Tahara, T				Hua, Linqiang; Iwamura, Munetaka; Takeuchi, Satoshi; Tahara, Tahei			The substituent effect on the MLCT excited state dynamics of Cu(I) complexes studied by femtosecond time-resolved absorption and observation of coherent nuclear wavepacket motion	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							PHOTOINDUCED STRUCTURAL-CHANGE; VIBRONIC RELAXATION; ENERGY-TRANSFER; X-RAY; COPPER(I); SPECTROSCOPY; EMISSION; SYSTEMS; BIS(2,9-DIMETHYL-1,10-PHENANTHROLINE)COPPER(I); LIGAND	The substituent effect on the excited-state dynamics of bis-diimine Cu(I) complexes was investigated by femtosecond time-resolved absorption spectroscopy with the S-1 <-- S-0 metal-to-ligand charge transfer (MLCT) photoexcitation. The time-resolved absorption of [Cu(phen)(2)](+) (phen = 1,10-phenanthroline) showed a slight intensity increase of the S-1 absorption with a time-constant of 0.1-0.2 ps, reflecting the flattening distortion occurring in the S-1 state. The transient absorption of the 'flattened' S-1 state was clearly observed, although its fluorescence was not observed in the previous fluorescence up-conversion study in the visible region. The flattened S-1 state decayed with a time constant of similar to 2 ps, and the S-0 bleaching recovered accordingly. This clarifies that the S-1 state of [Cu(phen)(2)](+) is predominantly relaxed to the S-0 state by internal conversion. The time-resolved absorption of [Cu(dpphen)(2)](+) (dpphen = 2,9-diphenyl-1,10-phenanthroline) showed a 0.9 ps intensity increase of the S1 absorption due to the flattening distortion, and then exhibited a 11 ps spectral change due to the intersystem crossing. This excited-state dynamics of [Cu(dpphen)(2)](+) is very similar to that of [Cu(dmphen)(2)](+) (dmphen = 2,9-dimethyl-1,10-phenanthroline). In the ultrafast pump-probe measurements with 35 fs time resolution, [Cu(phen)(2)](+) and [Cu(dpphen)(2)](+) exhibited oscillation due to the nuclear wavepacket motions of the initial S-1 state, and the oscillation was damped as the structural change took place. This indicates that the initial S-1 states have well-defined vibrational structures and that the vibrational coherence is retained in their short lifetimes. The present time-resolved absorption study, together with the previous time-resolved fluorescence study, provides a unified view for the ultrafast dynamics of the MLCT excited state of the Cu(I) complexes.	[Hua, Linqiang; Iwamura, Munetaka; Takeuchi, Satoshi; Tahara, Tahei] RIKEN, Mol Spect Lab, Wako, Saitama 3510198, Japan; [Takeuchi, Satoshi; Tahara, Tahei] RIKEN, Ctr Adv Photon RAP, Ultrafast Spect Res Team, Wako, Saitama 3510198, Japan	Tahara, T (reprint author), RIKEN, Mol Spect Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tahei@riken.jp			Japan Society for the promotion of Science (JSPS); JSPS [25248009];  [25104005]	L. H. thanks Japan Society for the promotion of Science (JSPS) for a postdoctoral fellowship. We are grateful to the RIKEN chemical analysis team for elemental analyses of the samples used in this work. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area (No. 25104005) and a Grant-in-Aid for Scientific Research (A) (No. 25248009) from JSPS.	Iwamura M, 2007, J AM CHEM SOC, V129, P5248, DOI 10.1021/ja069300s; Miller MT, 1998, INORG CHEM, V37, P2285, DOI 10.1021/ic971164s; MCGARVEY JJ, 1988, INORG CHEM, V27, P4003, DOI 10.1021/ic00295a021; SCHILT AA, 1959, J INORG NUCL CHEM, V9, P211, DOI 10.1016/0022-1902(59)80224-4; Iwamura M, 2011, J AM CHEM SOC, V133, P7728, DOI 10.1021/ja108645x; Chen LX, 2003, J AM CHEM SOC, V125, P7022, DOI 10.1021/ja0294663; ELSAESSER T, 1991, ANNU REV PHYS CHEM, V42, P83; MCMILLIN DR, 1977, INORG CHEM, V16, P943, DOI 10.1021/ic50170a046; Kume S, 2003, INORG CHEM, V42, P2194, DOI 10.1021/ic034132f; Eggleston MK, 1997, INORG CHEM, V36, P4007, DOI 10.1021/ic970135e; Cunningham CT, 2000, INORG CHEM, V39, P3638, DOI 10.1021/ic000082s; BLASKIE MW, 1980, INORG CHEM, V19, P3519, DOI 10.1021/ic50213a062; Siddique ZA, 2003, INORG CHEM, V42, P6366, DOI 10.1021/ic034412v; Armaroli N, 2001, CHEM SOC REV, V30, P113, DOI 10.1039/b000703j; ICHINAGA AK, 1987, INORG CHEM, V26, P4290, DOI 10.1021/ic00272a030; Penfold TJ, 2013, J PHYS CHEM A, V117, P4591, DOI 10.1021/jp403751m; Shaw GB, 2007, J AM CHEM SOC, V129, P2147, DOI 10.1021/ja067271f; KIRCHHOFF JR, 1983, INORG CHEM, V22, P2380, DOI 10.1021/ic00159a008; Iwamura M, 2014, PHYS CHEM CHEM PHYS, V16, P4143, DOI 10.1039/c3cp54322f; Balzani V., 2007, COORDINATION COMPOUN; Gothard NA, 2012, J PHYS CHEM A, V116, P1984, DOI 10.1021/jp211646p; Gunaratne T, 2003, CHEM COMMUN, P3010, DOI 10.1039/b306900a; Iwamura M, 2009, SPRINGER SERIES CHEM, V92, P382; Kalyanasundaram K., 1992, PHOTOCHEMISTRY POLYP; KLEMENS FK, 1990, NEW J CHEM, V14, P129; Lockard JV, 2010, J PHYS CHEM B, V114, P14521, DOI 10.1021/jp102278u; PARKER WL, 1989, J PHYS CHEM-US, V93, P5692, DOI 10.1021/j100352a012; Ruthkosky M, 1998, COORDIN CHEM REV, V171, P309; Ruthkosky M, 1996, INORG CHEM, V35, P6406, DOI 10.1021/ic960503z; Sarkar N, 1999, J PHYS CHEM A, V103, P4808, DOI 10.1021/jp9906785; SHINOZAKI K, 1994, B CHEM SOC JPN, V67, P2435, DOI 10.1246/bcsj.67.2435; Zgierski MZ, 2003, J CHEM PHYS, V118, P4045, DOI 10.1063/1.1540614	32	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	3					2067	2077		10.1039/c4cp03843f		11	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW7XA	WOS:000346473600061		
J	Matsumoto, K; Shundo, A; Ohno, M; Fujita, S; Saruhashi, K; Miyachi, N; Miyaji, K; Tanaka, K				Matsumoto, Keigo; Shundo, Atsuomi; Ohno, Masashi; Fujita, Shun; Saruhashi, Kowichiro; Miyachi, Nobuhide; Miyaji, Katsuaki; Tanaka, Keiji			Modulation of physical properties of supramolecular hydrogels based on a hydrophobic core	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							PROTEIN SECONDARY STRUCTURE; MOLECULAR-WEIGHT GELATORS; AMINO-ACID; MECHANICAL-PROPERTIES; NILE RED; PEPTIDE; GEL; PH; DERIVATIVES; HETEROGENEITY	We demonstrate herein the variation in viscoelastic properties of supramolecular hydrogels (SMGs) composed of two amphiphiles, N-Palmitoyl-Gly-His (PalGH) and sodium palmitate (PalNa). PalGH molecules in water form lamellar-like assemblies, which stack into sheet-shaped aggregates, resulting in the evolution of three-dimensional network structures. Once PalNa is added to PalGH, the alkyl groups of PalNa incorporate themselves into the hydrophobic cores of PalGH lamellar-like assemblies, resulting in a change in the assembly from lamellar-like to fibrous micelle-like. Consequently, sheet-shaped aggregates turn into flexible fibrils, which form bundles, resulting in network structures. Mixed hydrogel network structures differ in morphology from those in homogenous PalGH and PalNa hydrogels. Changes in the network structure eventually alter the bulk viscoelastic properties of hydrogels. These results demonstrate that the viscoelastic properties of supramolecular hydrogels can be tuned by controlling the aggregation states.	[Matsumoto, Keigo; Tanaka, Keiji] Kyushu Univ, Dept Automot Sci, Fukuoka 8190395, Japan; [Matsumoto, Keigo; Ohno, Masashi; Fujita, Shun; Saruhashi, Kowichiro; Miyachi, Nobuhide; Miyaji, Katsuaki] Nissan Chem Ind Co Ltd, Tokyo 1010054, Japan; [Shundo, Atsuomi; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Shundo, Atsuomi; Tanaka, Keiji] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Matsumoto, K (reprint author), Kyushu Univ, Dept Automot Sci, Fukuoka 8190395, Japan.	matsumotoke@nissanchem.co.jp; a-shundo@cstf.kyushu-u.ac.jp; k-tanaka@cstf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24350061]	The synchrotron radiation facility experiments were performed at BL40B2 in SPring8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal: 2012A1522). We thank Prof. Masahiro Goto and Dr Rie Wakabayashi of Kyushu University for their help with confocal laser scanning microscopy. This research was partly supported by a Grant-in-Aid for Scientific Research (B) (No. 24350061) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adhikari B, 2011, SOFT MATTER, V7, P8913, DOI 10.1039/c1sm05907f; Raeburn J, 2012, SOFT MATTER, V8, P1168, DOI 10.1039/c1sm06929b; Baral A, 2014, LANGMUIR, V30, P929, DOI 10.1021/la4043638; Minkenberg CB, 2009, J AM CHEM SOC, V131, P11274, DOI 10.1021/ja902808q; Dudukovic NA, 2014, LANGMUIR, V30, P4493, DOI 10.1021/la500589f; Lloyd GO, 2009, NAT CHEM, V1, P437, DOI [10.1038/nchem.283, 10.1038/NCHEM.283]; Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q; Wang YL, 2009, LANGMUIR, V25, P13194, DOI 10.1021/la901869t; Penaloza DP, 2013, SOFT MATTER, V9, P5166, DOI 10.1039/c3sm50225b; Yoshida M, 2007, J AM CHEM SOC, V129, P11039, DOI 10.1021/ja0738677; Soukasene S, 2011, ACS NANO, V5, P9113, DOI 10.1021/nn203343z; Ziane S, 2012, EUR CELLS MATER, V23, P147; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Duan PF, 2011, CHEM-EUR J, V17, P6389, DOI 10.1002/chem.201003049; Cheng G, 2011, SOFT MATTER, V7, P1326, DOI 10.1039/c0sm00408a; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Graf G, 2011, J PHYS CHEM B, V115, P10478, DOI 10.1021/jp205414n; Dagdas YS, 2011, SOFT MATTER, V7, P3524, DOI 10.1039/c0sm01089h; Stuart MCA, 2005, J PHYS ORG CHEM, V18, P929, DOI 10.1002/poc.919; Foster JA, 2014, CHEM-EUR J, V20, P279, DOI 10.1002/chem.201303153; Greenfield MA, 2010, LANGMUIR, V26, P3641, DOI 10.1021/la9030969; Shundo A, 2011, CHEM COMMUN, V47, P8844, DOI 10.1039/c1cc12733k; Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e; Meazza L, 2013, NAT CHEM, V5, P42, DOI [10.1038/nchem.1496, 10.1038/NCHEM.1496]; Basit H, 2008, CHEM-EUR J, V14, P6534, DOI 10.1002/chem.200800374; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239; Xu XD, 2010, ACS APPL MATER INTER, V2, P2663, DOI 10.1021/am100484c; Shundo A, 2014, RSC ADV, V4, P36097, DOI 10.1039/c4ra04636f; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Pont G, 2012, SOFT MATTER, V8, P7797, DOI 10.1039/c2sm25918d; Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d; Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q; Lloyd GO, 2011, SOFT MATTER, V7, P75, DOI 10.1039/c0sm00594k; Roy S, 2007, LANGMUIR, V23, P11769, DOI 10.1021/la701558m; Roy S, 2013, CHEM-EUR J, V19, P14950, DOI 10.1002/chem.201301655; Terech P, 2005, J PHYS CHEM B, V109, P12270, DOI 10.1021/jp050666l; Ryan DM, 2011, LANGMUIR, V27, P11145, DOI 10.1021/la202070d; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Chakraborty P, 2014, ACS APPL MATER INTER, V6, P3615, DOI 10.1021/am405868j; Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6; Chen L, 2010, CHEM COMMUN, V46, P6738, DOI 10.1039/c0cc01842b; Wood DM, 2012, CHEM-EUR J, V18, P2692, DOI 10.1002/chem.201102137; Ryu JH, 2010, LANGMUIR, V26, P7086, DOI 10.1021/la904437u; Dong B, 2013, J AM CHEM SOC, V135, P14797, DOI 10.1021/ja4071333; Liu JF, 2014, ACS APPL MATER INTER, V6, P5558, DOI 10.1021/am406007g; Li DX, 2014, CHINESE J CHEM, V32, P123, DOI 10.1002/cjoc.201300814; Hirst AR, 2004, LANGMUIR, V20, P10851, DOI 10.1021/la048178c; Chen L, 2010, LANGMUIR, V26, P13466, DOI 10.1021/la102059x; Hanski S, 2008, MACROMOLECULES, V41, P866, DOI 10.1021/ma7019495; Moran MC, 2011, SOFT MATTER, V7, P2001, DOI 10.1039/c0sm00988a; Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P3641, DOI 10.1002/1521-3773(20021004)41:19<3641::AID-ANIE3641>3.0.CO;2-2; BARRY MD, 1989, INT J PHARM, V53, P139, DOI 10.1016/0378-5173(89)90237-8; Bulter M. H., 2013, LANGMUIR, V19, P10061; Dou XQ, 2013, J MOL LIQ, V180, P129, DOI 10.1016/j.molliq.2013.01.005; Glatter O., 1982, SMALL ANGLE XRAY SCA; Haines SR, 2002, CHEM COMMUN, P2846, DOI 10.1039/b203462j; Kakiuchi N., 2012, US Pat., Patent No. [0,253,012, 0253012]; Kumar DK, 2005, CHEM COMMUN, P4059, DOI 10.1039/B506941F; Merta J., 2006, LANGMUIR, V22, P2465; Pasc A, 2009, TETRAHEDRON LETT, V50, P6183, DOI 10.1016/j.tetlet.2009.08.093; Ratra T., 2010, LANGMUIR, V26, P7761; Rios B. P., 2001, BIOCHEMISTRY-US, V40, P9074; Ryan DM, 2010, SOFT MATTER, V6, P3220, DOI 10.1039/c0sm00018c; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Suzuki M, 2008, CHEM-EUR J, V14, P2133, DOI 10.1002/chem.200701111; Valenti LE, 2011, ANAL BIOCHEM, V410, P118, DOI 10.1016/j.ab.2010.11.006; Wang HM, 2011, SOFT MATTER, V7, P3897, DOI 10.1039/c0sm01405b; Yang C., 2011, J PHYS CHEM B, V116, P633	69	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	3					2192	2198		10.1039/c4cp04395b		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW7XA	WOS:000346473600075		
J	Melgarejo, TA; Kon, T; Gilbertson, RL				Melgarejo, Tomas A.; Kon, Tatsuya; Gilbertson, Robert L.			Molecular and Biological Characterization of Distinct Strains of Jatropha mosaic virus from the Dominican Republic Reveal a Potential to Infect Crop Plants	PHYTOPATHOLOGY			English	Article							LEAF-CURL-VIRUS; WHITEFLY-TRANSMITTED GEMINIVIRUSES; REPLICATION SPECIFICITY DETERMINANTS; CLONED DNA-COMPONENTS; GENETIC DIVERSITY; BIPARTITE GEMINIVIRUSES; BEGOMOVIRUS POPULATIONS; PHYLOGENETIC NETWORKS; PHASEOLUS-VULGARIS; GENOMIC COMPONENTS	In the Dominican Republic (DO), jatropha plants with yellow mosaic symptoms are commonly observed in and around fields of various crop plants. Complete nucleotide sequences of DNA-A and DNA-B components of four bipartite begomovirus isolates associated with symptomatic jatropha plants collected from three geographical locations in the DO were determined. Sequence comparisons revealed highest identities (91 to 92%) with the DNA-A component of an isolate of Jatropha mosaic virus (JMV) from Jamaica, indicating that the bipartite begomovirus isolates from the DO are strains of JMV. When introduced into jatropha seedlings by particle bombardment, the cloned components of the JMV strains from the DO induced stunting and yellow mosaic, indistinguishable from symptoms observed in the field, thereby fulfilling Koch's postulates for the disease. The JMV strains also induced disease symptoms in Nicotiana benthamiana, tobacco, and several cultivars of common bean from the Andean gene pool, including one locally grown in the DO. Asymmetry in the infectivity and symptomatology of pseudo-recombinants provided further support for the strain designation of the JMV isolates from the DO. Thus, JMV in the DO is a complex of genetically distinct strains that have undergone local evolution and have the potential to cause disease in crop plants.	[Melgarejo, Tomas A.; Kon, Tatsuya; Gilbertson, Robert L.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Melgarejo, Tomas A.] Univ Nacl Agr La Molina, Dept Fitopatol, Lima, Peru; [Kon, Tatsuya] Iwate Univ, Fac Agr, Plant Pathol Lab, Morioka, Iwate 020, Japan	Gilbertson, RL (reprint author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	rlgilbertson@ucdavis.edu			Integrated Pest Management-Collaborative Research Support Program (IPM-CRSP); USAID [EPPA-00-04-00016-00]; Ministry of Agriculture of the DO	This research was supported, in part, by the Integrated Pest Management-Collaborative Research Support Program (IPM-CRSP). This project was made possible by the United States Agency for International Development (USAID) and the generous support of the American people through the USAID Cooperative Agreement Number EPPA-00-04-00016-00. We thank the Ministry of Agriculture of the DO for its support; A. Almanzar of Transagricola S. A. (Av. Duarte 269 Navarette, Santiago, DO Apartado 713) for cooperation in collecting the disease samples used in this study and for providing seed of common bean cultivars commercially grown in the DO; and D. Parfitt of the Department of Plant Science at UC Davis and M. Pastor-Corrales of the United States Department of Agriculture-Agricultural Research Service at Beltsville, MD for providing jatropha and common bean seed, respectively.	Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Hou YM, 1998, MOL PLANT MICROBE IN, V11, P208, DOI 10.1094/MPMI.1998.11.3.208; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; BROWN JK, 1992, PLANT DIS, V76, P220; Gao SQ, 2010, ARCH VIROL, V155, P607, DOI 10.1007/s00705-010-0625-0; Barbosa JC, 2009, J GEN PLANT PATHOL, V75, P440, DOI 10.1007/s10327-009-0198-5; Harrison BD, 2002, PHYSIOL MOL PLANT P, V60, P257, DOI 10.1006/pmpp.2002.0404; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Arguello-Astorga GR, 2001, ARCH VIROL, V146, P1465, DOI 10.1007/s007050170072; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Chakraborty S, 2008, J GEN VIROL, V89, P818, DOI 10.1099/vir.0.82873-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; GILBERTSON RL, 1993, J GEN VIROL, V74, P23, DOI 10.1099/0022-1317-74-1-23; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Kon T, 2009, J GEN VIROL, V90, P1001, DOI 10.1099/vir.0.008102-0; FARIA JC, 1994, PHYTOPATHOLOGY, V84, P321, DOI 10.1094/Phyto-84-321; Hou YM, 1996, J VIROL, V70, P5430; FRISCHMUTH T, 1993, VIROLOGY, V196, P666, DOI 10.1006/viro.1993.1523; Garcia-Andres S, 2006, VIROLOGY, V350, P433, DOI 10.1016/j.virol.2006.02.028; Barreto SS, 2013, PHYTOPATHOLOGY, V103, P436, DOI 10.1094/PHYTO-07-12-0174-R; GILBERTSON RL, 1993, PHYTOPATHOLOGY, V83, P709, DOI 10.1094/Phyto-83-709; Mubin M, 2010, VIRUS GENES, V40, P452, DOI 10.1007/s11262-010-0470-y; Silva SJC, 2012, PLANT PATHOL, V61, P457, DOI 10.1111/j.1365-3059.2011.02543.x; Seo YS, 2004, THEOR APPL GENET, V108, P786, DOI 10.1007/s00122-003-1504-9; Morales FJ, 2001, ARCH VIROL, V146, P415, DOI 10.1007/s007050170153; Lima ATM, 2013, J GEN VIROL, V94, P418, DOI 10.1099/vir.0.047241-0; Achten WMJ, 2008, BIOMASS BIOENERG, V32, P1063, DOI 10.1016/j.biombioe.2008.03.003; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Petty ITD, 2000, VIROLOGY, V277, P429, DOI 10.1006/viro.2000.0620; Castillo-Urquiza GP, 2008, ARCH VIROL, V153, P1985, DOI 10.1007/s00705-008-0172-0; Hagen C, 2008, PLANT DIS, V92, P781, DOI 10.1094/PDIS-92-5-0781; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Hill JE, 1998, VIROLOGY, V250, P283, DOI 10.1006/viro.1998.9366; Idris AM, 2008, J VIROL, V82, P1959, DOI 10.1128/JVI.01992-07; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; ROJAS MR, 1993, PLANT DIS, V77, P340; Lole KS, 1999, J VIROL, V73, P152; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Hanley-Bowdoin L, 1999, CRIT REV PLANT SCI, V18, P71, DOI 10.1016/S0735-2689(99)00383-4; Sanchez-Campos S, 2013, VIRUS RES, V173, P286, DOI 10.1016/j.virusres.2013.02.002; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; FONTES EPB, 1994, PLANT CELL, V6, P405; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Narayana D. S. A., 2007, International Journal of Virology, V3, P1; Briddon RW, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-97; Bull SE, 2007, J GEN VIROL, V88, P1624, DOI 10.1099/vir.0.82662-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dominguez M, 2009, PLANT PATHOL, V58, P786, DOI 10.1111/j.1365-3059.2009.02046.x; Fiallo-Olive E, 2010, ARCH VIROL, V155, P2053, DOI 10.1007/s00705-010-0803-0; FIALLOOLIVE E, 2009, PLANT PATHOL, V58, P785; Fiallo-Olive E, 2012, ARCH VIROL, V157, P141, DOI 10.1007/s00705-011-1123-8; Garrido-Ramirez ER, 2000, PHYTOPATHOLOGY, V90, P1224, DOI 10.1094/PHYTO.2000.90.11.1224; GILBERTSON RL, 1991, PLANT DIS, V75, P336; GILBERTSON RL, 1991, PHYTOPATHOLOGY, V81, P980, DOI 10.1094/Phyto-81-980; Hofer P, 1997, MOL PLANT MICROBE IN, V10, P1019, DOI 10.1094/MPMI.1997.10.8.1019; Jovel J, 2004, ARCH VIROL, V149, P829, DOI 10.1007/s00705-003-0235-1; Kashina BD, 2013, ARCH VIROL, V158, P511, DOI 10.1007/s00705-012-1512-7; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Mauricio-Castillo JA, 2014, ARCH VIROL, V159, P2283, DOI 10.1007/s00705-014-2073-8; Monde G, 2010, ARCH VIROL, V155, P1865, DOI 10.1007/s00705-010-0772-3; MORALES FJ, 1993, EUPHYTICA, V67, P59, DOI 10.1007/BF00022725; Moran YM, 2006, PLANT PATHOL, V55, P570, DOI 10.1111/j.1365-3059.2006.01368.x; PAPLOMATAS EJ, 1994, PHYTOPATHOLOGY, V84, P1215, DOI 10.1094/Phyto-84-1215; Ramos PL, 2003, ARCH VIROL, V148, P1697, DOI 10.1007/s00705-003-0136-3; Roye ME, 2006, PLANT PATHOL, V55, P286, DOI 10.1111/j.1365-3059.2005.01300.x; Roye ME, 1997, PLANT DIS, V81, P1251, DOI 10.1094/PDIS.1997.81.11.1251; Saeed M, 2008, VIRUS GENES, V37, P434, DOI 10.1007/s11262-008-0279-0; Salati R, 2002, PHYTOPATHOLOGY, V92, P487, DOI 10.1094/PHYTO.2002.92.5.487; Singh DK, 2008, VIROLOGY, V380, P75, DOI 10.1016/j.virol.2008.07.010; Stewart C, 2014, ARCH VIROL, V159, P2509, DOI 10.1007/s00705-014-2063-x; Surendranath B, 2005, ARCH VIROL, V150, P1833, DOI 10.1007/s00705-005-0542-9; Umaharan P, 1998, PHYTOPATHOLOGY, V88, P1262, DOI 10.1094/PHYTO.1998.88.12.1262; Vaghchhipawala Z, 2011, METHODS MOL BIOL, V678, P65, DOI 10.1007/978-1-60761-682-5_6; Wang HL, 1996, PHYTOPATHOLOGY, V86, P1204, DOI 10.1094/Phyto-86-1204; Wise AA, 2006, METH MOL B, V343, P43; Wyant PS, 2011, ARCH VIROL, V156, P347, DOI 10.1007/s00705-010-0876-9	88	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0031-949X	1943-7684		PHYTOPATHOLOGY	Phytopathology	JAN	2015	105	1					141	153		10.1094/PHYTO-05-14-0135-R		13	Plant Sciences	Plant Sciences	AW6FG	WOS:000346364400015		
J	Tran, T; Kano-Nakata, M; Suralta, R; Menge, D; Mitsuya, S; Inukai, Y; Yamauchi, A				Thiem Thi Tran; Kano-Nakata, Mana; Suralta, Roel Rodriguez; Menge, Daniel; Mitsuya, Shiro; Inukai, Yoshiaki; Yamauchi, Akira			Root plasticity and its functional roles were triggered by water deficit but not by the resulting changes in the forms of soil N in rice	PLANT AND SOIL			English	Article						Ammonium; Chromosome segment substitution lines; Dry matter production; Nitrate; Root plasticity; Water deficit	DRY-MATTER PRODUCTION; FED LOWLAND RICE; SYSTEM DEVELOPMENT; NITROGEN UPTAKE; UPLAND RICE; DROUGHT RESISTANCE; MOISTURE STRESSES; YIELD; QTL; IMPROVEMENT	The functional roles of root plasticity in rice adaptation to drought conditions may vary with soil nitrogen (N) conditions. To examine if: promoted root system plastic development triggered by mild drought stress and enhanced by N application would contribute to the increase in soil water uptake, and if expression of root system plasticity would be affected by different forms of N applied into the soil. Chromosome segment substitution line (CSSL) 50 and Nipponbare genotypes were grown under continuously waterlogged (CWL) and water deficit (WD) conditions. In rootbox (25 cm x 40 cm x 2 cm) experiment, three fertilizer N levels; (30 (low), 60 (standard) and 120 mg N (high) per rootbox) were used while in pot (5 L) experiment, six N forms (NH4 (+)-N alone, NO3 (-)-N alone, combined NH4 (+)-N and NO3 (-)-N with and without dicyandiamide (nitrification inhibitor) were used at the rate of 360 mg N per pot. In both experiments, CSSL50 and Nipponbare had no significant differences in shoot and root growth regardless of N levels and N forms under CWL conditions. However, under WD conditions, CSSL50 had significantly greater dry matter production (DMP) than Nipponbare due to the greater ability of the former for maintaining soil water uptake and photosynthesis. The observed higher water uptake and photosynthesis in CSSL50 under WD was closely related to its promoted root system development due to plasticity, which were significantly greater at high N than at low N level. The extent of promotion in root system development based total root length was not significantly different among N forms. The root system plasticity of CSSL50 in response to WD was expressed at a greater degree with high level of N applied and the functional roles of root plasticity for greater soil water uptake and DMP were due to WD regardless of N forms.	[Thiem Thi Tran; Suralta, Roel Rodriguez; Menge, Daniel; Mitsuya, Shiro; Yamauchi, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Thiem Thi Tran] Vietnam Natl Univ Agr, Fac Agron, Gialamhanoi, Vietnam; [Kano-Nakata, Mana; Inukai, Yoshiaki] Nagoya Univ, Int Cooperat Ctr Agr Educ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Suralta, Roel Rodriguez] Philippine Rice Res Inst PhilRice, Agron Soils & Plant Physiol Div, Sci City Of Munoz 3119, Philippines	Yamauchi, A (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ayama@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [22405042]; Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA), the Science and Technology Research Partnership for Sustainable Development (SATREPS)	We thank Dr. Jonathan M. Niones of the Philippine Rice Research Institute for a critical review and useful comments on our manuscript. This research was funded by the Grant-in-Aid for Scientific Research (No. 22405042) from the Japan Society for the Promotion of Science, and partially supported by the Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA), the Science and Technology Research Partnership for Sustainable Development (SATREPS).	Allahyar F, 2011, INT J AGR CROP SCI, V3-4, P111; Serraj R, 2004, FIELD CROP RES, V88, P115, DOI 10.1016/j.fcr.2003.12.001; Wade LJ, 1999, FIELD CROP RES, V64, P3, DOI 10.1016/S0378-4290(99)00047-7; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Kamoshita A, 2004, PLANT PROD SCI, V7, P406, DOI 10.1626/pps.7.406; Sharma S, 2011, THEOR APPL GENET, V122, P759, DOI 10.1007/s00122-010-1484-5; Laperche A, 2006, THEOR APPL GENET, V113, P1131, DOI 10.1007/s00122-006-0373-4; Landi P, 2010, J EXP BOT, V61, P3553, DOI 10.1093/jxb/erq192; Siopongco JDLC, 2006, PLANT PROD SCI, V9, P141, DOI 10.1626/pps.9.141; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Yadav RS, 2011, J EXP BOT, V62, P397, DOI 10.1093/jxb/erq265; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; Serraj R, 2009, ADV AGRON, V103, P41, DOI 10.1016/S0065-2113(09)03002-8; Guo SW, 2007, J PLANT NUTR SOIL SC, V170, P73, DOI 10.1002/jpln.200625073; Siopongco JDLC, 2008, PLANT PROD SCI, V11, P28; Song WJ, 2011, PLANT SOIL, V343, P357, DOI 10.1007/s11104-011-0723-0; Obara M, 2010, THEOR APPL GENET, V121, P535, DOI 10.1007/s00122-010-1328-3; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Ruta N, 2010, THEOR APPL GENET, V120, P621, DOI 10.1007/s00122-009-1180-5; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Belder P, 2005, PLANT SOIL, V273, P167, DOI 10.1007/s11104-004-7401-4; Kano M, 2011, PLANT SOIL, V342, P117, DOI 10.1007/s11104-010-0675-9; Aulakh MS, 2000, BIOL FERT SOILS, V31, P162, DOI 10.1007/s003740050640; Banoc Dionisio M., 2000, Plant Production Science, V3, P335; Bolan NS, 2004, NZ SOIL NEWS, V42; Castillo EG, 2006, SOIL SCI PLANT NUTR, V52, P496, DOI 10.1111/j.1747-0765.2006.00064.x; Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI DOI 10.1016/J.TPLANTS.2007.08.012; Fageria NK, 2010, 19 WORLD C SOIL SCI, P120; Gao YX, 2010, PLANT SOIL, V331, P193, DOI 10.1007/s11104-009-0245-1; IRRI, 2009, CROPSTAT VERS 7 2; Kamoshita Akihiko, 2000, Plant Production Science, V3, P189; Kano-Nakatal M, 2011, PLANT PROD SCI, V14, P307, DOI 10.1626/pps.14.307; Kano-Nakata M, 2012, METHODOLOGIES ROOT D, P3; Kano-Nakata M, 2013, FIELD CROP RES, V144, P288, DOI 10.1016/j.fcr.2013.01.024; Kato Y, 2007, PLANT PROD SCI, V10, P3, DOI 10.1626/pps.10.3; Kondo M, 2005, J PLANT NUTR, V28, P201, DOI 10.1081/PLN-200047601; KONO Y, 1987, Environment Control in Biology, V25, P141; Niones JM, 2013, PLANT PROD SCI, V16, P205, DOI 10.1626/pps.16.205; Niones JM, 2012, PLANT SOIL, V359, P107, DOI 10.1007/s11104-012-1178-7; OTOO E, 1989, JPN J CROP SCI, V58, P424; Qian XQ, 2004, J PLANT NUTR, V27, P1061, DOI 10.1081/PLN-120037536; Siopongco JDLC, 2005, PLANT PROD SCI, V9, P141; Suralta RR, 2010, PHILIPP AGRIC SCI, V93, P458; Suralta RR, 2010, PLANT SOIL, V332, P87, DOI 10.1007/s11104-009-0275-8; Tran TT, 2014, PLANT SOIL, V378, P139, DOI 10.1007/s11104-013-2013-5; Wang H., 2006, PLANT ENV INTERACTIO, P271, DOI 10.1201/9781420019346.ch10; WEATHERB.MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Yamauchi A., 1996, ROOTS NITROGEN CROPP, P211; YAMAUCHI A, 1988, JPN J CROP SCI, V57, P174; Yang XX, 2012, PLANT CELL PHYSIOL, V53, P495, DOI 10.1093/pcp/pcs003	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	JAN	2015	386	1-2					65	76		10.1007/s11104-014-2240-4		12	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AW8DN	WOS:000346491000005		
J	Seidl-Adams, I; Richter, A; Boomer, KB; Yoshinaga, N; Degenhardt, J; Tumlinson, JH				Seidl-Adams, I.; Richter, A.; Boomer, K. B.; Yoshinaga, N.; Degenhardt, J.; Tumlinson, J. H.			Emission of herbivore elicitor-induced sesquiterpenes is regulated by stomatal aperture in maize (Zea mays) seedlings	PLANT CELL AND ENVIRONMENT			English	Article						Zea mays; diurnal emission; farnesene; GC-FID; herbivore-induced plant volatiles; linolenoyl-L-glutamine; nocturnal emission; quantitative Realtime PCR; stomata; ZmFPPS3; ZmTPS10	GUARD-CELLS; EPIDERMAL STRIPS; PARASITIC WASPS; COTESIA-MARGINIVENTRIS; POTASSIUM-TRANSPORT; SNAPDRAGON FLOWERS; BACTERIAL INVASION; VOLATILE EMISSIONS; ISOPRENE EMISSION; PLANT VOLATILES	Maize seedlings emit sesquiterpenes during the day in response to insect herbivory. Parasitoids and predators use induced volatile blends to find their hosts or prey. To investigate the diurnal regulation of biosynthesis and emission of induced sesquiterpenes, we applied linolenoyl-L-glutamine (LG) to maize seedlings in the morning or evening using a cut-stem assay and tracked farnesene emission, in planta accumulation, as well as transcript levels of farnesyl pyrophosphate synthase 3 (ZmFPPS3) and terpene synthase10 (ZmTPS10) throughout the following day. Independent of time of day of LG treatment, maximum transcript levels of ZmFPPS3 and ZmTPS10 occurred within 3-4h after elicitor application. The similarity between the patterns of farnesene emission and in planta accumulation in light-exposed seedlings in both time courses suggested unobstructed emission in the light. After evening induction, farnesene biosynthesis increased dramatically during early morning hours. Contrary to light-exposed seedlings dark-kept seedlings retained the majority of the synthesized farnesene. Two treatments to reduce stomatal aperture, dark exposure at midday, and abscisic acid treatment before daybreak, resulted in significantly reduced amounts of emitted and significantly increased amounts of in planta accumulating farnesene. Our results suggest that stomata not only play an important role in gas exchange for primary metabolism but also for indirect plant defences. The importance of volatile organic compounds in plant defense against insect herbivores and pathogens is widely recognized, but the mechanisms by which they are synthesized and released are not yet fully understood. Our detailed time course data on gene transcript levels, as well as emitted and in-planta accumulated sesquiterpene levels during light and dark periods, force the conclusion that, in maize, stomata guard cells play a critical role in regulating sesquiterpene emission. This suggests that reduction in the number and size of stomata, whether due to climate change or development of drought resistant varieties, may reduce amounts of emitted volatiles. As a result, these plants would be more vulnerable to insect herbivory, due to reduced capability to recruit natural enemies of the attacking herbivore.	[Seidl-Adams, I.; Yoshinaga, N.; Tumlinson, J. H.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Richter, A.; Degenhardt, J.] Univ Halle Wittenberg, D-06120 Halle, Saale, Germany; [Boomer, K. B.] Bucknell Univ, Dept Math, Lewisburg, PA 17837 USA; [Yoshinaga, N.] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan	Seidl-Adams, I (reprint author), Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA.	ihs103@psu.edu			Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 648]; Japan Society for the Promotion of Science for Young Scientists [01212]	A.R. J.D. and I. SA. were supported by a grant from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 648 'Molecular mechanisms of information processing in plants'). N.Y. was the recipient of the Postdoctoral Fellowship for Research Abroad (no. 01212) from the Japan Society for the Promotion of Science for Young Scientists.	ALFARO RI, 1995, CAN J FOREST RES, V25, P1725, DOI 10.1139/x95-186; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Huffaker A, 2011, PLANT PHYSIOL, V156, P2082, DOI 10.1104/pp.111.179457; McAdam SAM, 2012, ECOL LETT, V15, P1, DOI 10.1111/j.1461-0248.2011.01700.x; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; TURLINGS TCJ, 1991, J CHEM ECOL, V17, P2235, DOI 10.1007/BF00988004; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Niinemets U, 2002, PLANT PHYSIOL, V130, P1371, DOI 10.1104/pp.009670; Chen C, 2012, MOL PLANT, V5, P566, DOI 10.1093/mp/sss039; Turlings TCJ, 2000, J CHEM ECOL, V26, P189, DOI 10.1023/A:1005449730052; HUMBLE GD, 1970, PLANT PHYSIOL, V46, P483, DOI 10.1104/pp.46.3.483; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Kolosova N, 2001, PLANT PHYSIOL, V126, P956, DOI 10.1104/pp.126.3.956; RASCHKE K, 1985, PLANTA, V163, P105, DOI 10.1007/BF00395904; Parent AC, 2008, BIOSYST ENG, V99, P134, DOI 10.1016/j.biosystemseng.2007.10.006; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Yoshinaga N, 2010, J CHEM ECOL, V36, P319, DOI 10.1007/s10886-010-9764-8; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Benelli G, 2012, J PEST SCI, V85, P55, DOI 10.1007/s10340-011-0394-x; WERNER RA, 1995, ENVIRON ENTOMOL, V24, P372; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Pare PW, 1997, PLANT PHYSIOL, V114, P1161; FALL R, 1992, PLANT PHYSIOL, V100, P987, DOI 10.1104/pp.100.2.987; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Assmann SM, 1999, PLANT CELL ENVIRON, V22, P629, DOI 10.1046/j.1365-3040.1999.00408.x; Degenhardt J, 2009, PLANT PHYSIOL, V149, P96, DOI 10.1104/pp.108.128975; Casson SA, 2010, CURR OPIN PLANT BIOL, V13, P90, DOI 10.1016/j.pbi.2009.08.005; Ashour M., 2010, BIOCH PLANT SECONDAR, P258, DOI 10.1002/9781444320503.ch5; Azad AK, 2007, ANN APPL BIOL, V150, P81, DOI 10.1111/j.1744-7348.2006.00111.x; Diehl P., 2013, BREEDING VERSUS ENG; Goodwin S, 2003, PHYSIOL PLANTARUM, V119, P605; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; HUMBLE GD, 1971, PLANT PHYSIOL, V48, P447, DOI 10.1104/pp.48.4.447; HUMBLE GD, 1969, PLANT PHYSIOL, V44, P230, DOI 10.1104/pp.44.2.230; Joyce AL, 2009, J INSECT BEHAV, V22, P12, DOI 10.1007/s10905-008-9149-9; Koellner T., 2013, BMC PLANT BIOL, V13, P15; Koellner T. G., 2009, PHYTOCHEMISTRY, V70, P1139; Koellner Tobias G., 2004, Phytochemistry (Amsterdam), V65, P1895; Koellner T.G., 2008, PLANT CELL, V20, P482; Niinemets U., 2003, J GEOPHYS RES, V108, P1; PALLAGHY CK, 1971, PLANTA, V101, P287, DOI 10.1007/BF00398115; Pandey R, 2007, SCI HORTIC-AMSTERDAM, V113, P74, DOI 10.1016/j.scienta.2007.01.021; RAFFA KF, 1985, ENVIRON ENTOMOL, V14, P552; RASCHKE K, 1971, PLANTA, V101, P296, DOI 10.1007/BF00398116; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Schmelz EA, 2001, PLANTA, V214, P171; SHAH SPJ, 1969, BIOCHEM J, V114, P395; Siekmann G, 2004, J INSECT BEHAV, V17, P459, DOI 10.1023/B:JOIR.0000042535.76279.c7; Stecker T., 2012, SCI AM; Tallman G, 2004, J EXP BOT, V55, P1963, DOI 10.1093/jxb/erh212; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; vansGardingen P. R., 1989, PLANT CELL ENVIRON, V12, P887; Voegeli U., 1988, PLANT PHYSIOL, V88, P1291; WILLMER CM, 1978, PLANTA, V139, P281, DOI 10.1007/BF00388642	69	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	JAN	2015	38	1					23	34		10.1111/pce.12347		12	Plant Sciences	Plant Sciences	AW7FJ	WOS:000346429800004		
J	Yoshida, T; Fujita, Y; Maruyama, K; Mogami, J; Todaka, D; Shinozaki, K; Yamaguchi-Shinozaki, K				Yoshida, Takuya; Fujita, Yasunari; Maruyama, Kyonoshin; Mogami, Junro; Todaka, Daisuke; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Four Arabidopsis AREB/ABF transcription factors function predominantly in gene expression downstream of SnRK2 kinases in abscisic acid signalling in response to osmotic stress	PLANT CELL AND ENVIRONMENT			English	Article						ABF1; transcriptional regulation; transcriptome analysis	PROTEIN-KINASES; BZIP FACTOR; ABA; BINDING; ABRE; TOLERANCE; DROUGHT; ELEMENT; ABI5; IDENTIFICATION	Under osmotic stress conditions such as drought and high salinity, the plant hormone abscisic acid (ABA) plays important roles in stress-responsive gene expression mainly through three bZIP transcription factors, AREB1/ABF2, AREB2/ABF4 and ABF3, which are activated by SNF1-related kinase 2s (SnRK2s) such as SRK2D/SnRK2.2, SRK2E/SnRK2.6 and SRK2I/SnRK2.3 (SRK2D/E/I). However, since the three AREB/ABFs are crucial, but not exclusive, for the SnRK2-mediated gene expression, transcriptional pathways governed by SRK2D/E/I are not fully understood. Here, we show that a bZIP transcription factor, ABF1, is a functional homolog of AREB1, AREB2 and ABF3 in ABA-dependent gene expression in Arabidopsis. Despite lower expression levels of ABF1 than those of the three AREB/ABFs, the areb1 areb2 abf3 abf1 mutant plants displayed increased sensitivity to drought and decreased sensitivity to ABA in primary root growth compared with the areb1 areb2 abf3 mutant. Genome-wide transcriptome analyses revealed that expression of downstream genes of SRK2D/E/I, which include many genes functioning in osmotic stress responses and tolerance such as transcription factors and LEA proteins, was mostly impaired in the quadruple mutant. Thus, these results indicate that the four AREB/ABFs are the predominant transcription factors downstream of SRK2D/E/I in ABA signalling in response to osmotic stress during vegetative growth. Abscisic acid (ABA) plays important roles in osmotic stress-responsive gene expression mainly through three bZIP transcription factors, AREB1, AREB2, and ABF3, which are activated by SnRK2s such as SRK2D, SRK2E, and SRK2I (SRK2D/E/I). However, transcription factors other than the three AREB/ABFs that function downstream of SRK2D/E/I remain obscure. Here, we report that ABF1 is a functional homolog of AREB1, AREB2, and ABF3 in ABA-dependent gene expression from a comparative analysis between the areb1 areb2 abf3 abf1 and areb1 areb2 abf3 mutants. Moreover, genome-wide transcriptome analyses revealed that expression of downstream genes of SRK2D/E/I were mostly impaired in the areb1 areb2 abf3 abf1 quadruple mutant, suggesting that the four AREB/ABFs are the predominant transcription factors downstream of SRK2D/E/I in ABA signaling in response to osmotic stress.	[Yoshida, Takuya; Mogami, Junro; Todaka, Daisuke; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo 1138657, Japan; [Fujita, Yasunari; Maruyama, Kyonoshin] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki 3058686, Japan; [Fujita, Yasunari] Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Plant Stress Biol, Tsukuba, Ibaraki 3058577, Japan; [Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Yamaguchi-Shinozaki, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Maruyama, Kyonoshin/I-9191-2012; Yamaguchi-Shinozaki, Kazuko/K-9004-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [22119004, 24510312]; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency	We thank Y. Tanaka, S. Murasaki, K. Amano, K. Murai and E. Kishi for the technical assistance; K. Yoshiwara for microarray analysis; and E. Toma and M. Toyoshima for skilful editorial assistance. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 22119004 to K.Y.-S.) and Scientific Research (C) (No. 24510312 to Y. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan, and the Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency (to K.Y.-S.).	Ando E, 2013, PLANT PHYSIOL, V162, P1529, DOI 10.1104/pp.113.217984; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; Lopez-Molina L, 2000, PLANT CELL PHYSIOL, V41, P541; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Ito S, 2012, P NATL ACAD SCI USA, V109, P3582, DOI 10.1073/pnas.1118876109; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Mougiou N, 2012, MOL BREEDING, V30, P355, DOI 10.1007/s11032-011-9626-2; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Sharma PD, 2011, MOL BIOL REP, V38, P5147, DOI 10.1007/s11033-010-0664-3; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Bensmihen S, 2005, J EXP BOT, V56, P597, DOI 10.1093/jxb/eri050; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Takahashi Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003760; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444	57	11	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	JAN	2015	38	1					35	49		10.1111/pce.12351		15	Plant Sciences	Plant Sciences	AW7FJ	WOS:000346429800005		
J	Sogo, T; Kumamoto, T; Ishida, H; Hisanaga, A; Sakao, K; Terahara, N; Wada, K; Hou, DX				Sogo, Takayuki; Kumamoto, Takuma; Ishida, Hisako; Hisanaga, Ayami; Sakao, Kozue; Terahara, Norihiko; Wada, Koji; Hou, De-Xing			Comparison of the Inhibitory Effects of Delphinidin and Its Glycosides on Cell Transformation	PLANTA MEDICA			English	Article						delphinidin 3-sambubioside; delphinidin; MEK1; cell transformation	NF-KAPPA-B; SERUM-ALBUMIN; ANTHOCYANINS; HUMANS; RATS; ANTIOXIDANT; BILBERRY; CYANIDIN-3-GLUCOSIDE; CARCINOGENESIS; ABSORPTION	Although anthocyanins are major forms distributed in many plant foods and promising as chemopreventive source, many molecular data are obtained from anthocyanidins, showing their low bioavailability. This study aims to clarify the inhibitory effects of delphinidin glycosides on cell transformation comparing them to those of delphinidin. Screening data revealed that delphinidin 3-sambubioside could directly bind to MAPK/ERK kinase 1. Affinity assay data confirmed that delphinidin 3-sambubioside had higher binding affinity to MAPK/ERK kinase 1 than ERK1/2 and B-Raf. Colony assay data further demonstrated that delphinidin 3-sambubioside inhibited 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation of MAPK/ERK kinase 1 and sequentially suppressed cell transformation. All of these effects caused by delphinidin 3-sambubioside were weaker than those by its aglycon, delphinidin. Our data suggested that the weaker anti-transformation activity of delphinidin glycosides compared to that of their aglycon is due to lower binding affinity to the target molecule MAPK/ERK kinase 1.	[Sogo, Takayuki; Kumamoto, Takuma; Hisanaga, Ayami; Sakao, Kozue; Wada, Koji; Hou, De-Xing] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Ishida, Hisako; Sakao, Kozue; Hou, De-Xing] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Terahara, Norihiko] Minami Kyushu Univ, Fac Hlth & Nutr, Miyazaki, Japan; [Wada, Koji] Univ Ryukyus, Fac Agr, Okinawa, Japan	Hou, DX (reprint author), Kagoshima Univ, United Grad Sch Agr Sci, Korimoto 1-21-24, Kagoshima 8900065, Japan.	hou@chem.agri.kagoshima-u.ac.jp					Kanakis CD, 2006, J MOL STRUCT, V798, P69, DOI 10.1016/j.nolstruc.2006.03.051; Dhar A, 2002, MOL CELL BIOCHEM, V234, P185, DOI 10.1023/A:1015948505117; Felgines C, 2005, J AGR FOOD CHEM, V53, P7721, DOI 10.1021/jf051092k; MORAZZONI P, 1991, ARZNEIMITTEL-FORSCH, V41-1, P128; Cooke D, 2006, INT J CANCER, V119, P2213, DOI 10.1002/ijc.22090; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Kumamoto T, 2009, MOL CELL BIOCHEM, V332, P33, DOI 10.1007/s11010-009-0171-9; Kang NJ, 2008, CANCER PREV RES, V1, P522, DOI 10.1158/1940-6207.CAPR-08-0071; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Miyazawa T, 1999, J AGR FOOD CHEM, V47, P1083, DOI 10.1021/jf9809582; Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Talavera S, 2005, J AGR FOOD CHEM, V53, P3902, DOI 10.1021/jf050145v; Karlsen A, 2010, EUR J NUTR, V49, P345, DOI 10.1007/s00394-010-0092-0; Hou DX, 2004, CARCINOGENESIS, V25, P29, DOI 10.1093/carcin/bgg184; Matsumoto H, 2001, J AGR FOOD CHEM, V49, P1546, DOI 10.1021/jf001246q; Lee KW, 2007, CARCINOGENESIS, V28, P1918, DOI 10.1093/carcin/bgm110; Felgines C, 2003, J NUTR, V133, P1296; Bagchi D, 2004, BIOCHEMISTRY-MOSCOW+, V69, P75, DOI 10.1023/B:BIRY.0000016355.19999.93; Gaulejac NSC, 1999, FOOD RES INT, V32, P327; Terahara N, 2000, BIOSCI BIOTECH BIOCH, V64, P2569, DOI 10.1271/bbb.64.2569; Yue X, 2008, J FOOD SCI, V73, pC494, DOI 10.1111/j.1750-3841.2008.00845.x	25	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	JAN	2015	81	1					26	31		10.1055/s-0034-1383311		6	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AW6YK	WOS:000346411400005		
J	Wang, RW; Kobayashi, Y; Lin, Y; Rauwald, HW; Yao, JB; Fang, L; Qiao, HX; Kuchta, K				Wang, Ruwei; Kobayashi, Yuta; Lin, Yu; Rauwald, Hans Wilhelm; Yao, Jianbiao; Fang, Ling; Qiao, Hongxiang; Kuchta, Kenny			HPLC Quantification of All Five Ginkgolic Acid Derivatives in Ginkgo biloba Extracts using 13:0 Ginkgolic Acid as a Single Marker Compound	PLANTA MEDICA			English	Article						Ginkgo biloba; Ginkgoaceae; ginkgolic acid derivatives; relative correlation factor; HPLC; quantitative analysis	QUALITY	An HPLC quantification method for ginkgolic acid derivatives in Ginkgo biloba leaf extracts was developed. Using 13:0 ginkgolic acid as a marker compound, the relative correlation factors of the four other ginkgolic acid derivatives - namely, 15:0 ginkgolic acid, 15:1 ginkgolic acid, 17:1 ginkgolic acid, and 17:2 ginkgolic acid - to 13:0 ginkgolic acid were determined by HPLC and subsequently used for calculating their contents in ten hydro-ethanolic refined extract samples. In other words, the content of 13:0 ginkgolic acid in the extracts was determined using the isolated compound as an external standard. Subsequently the now known concentration of this compound functioned as an internal standard for the quantification of the other four ginkgolic acid derivatives via the described correlation factors. This HPLC method was validated by two independent control measurements, one with an external standard for every individual compound and one based on the present method with the single marker compound alone. The results did not differ significantly in any of the 10 tested extract samples. The protocol presented here thus not only uses the same reference substance for G. biloba extracts as the current Chinese Pharmacopoeia method but also incorporates the advantages of the current European Pharmacopoeia approach. It is simple, reproducible, and can be used to determine the total contents of ginkgolic acid derivatives in G. biloba leaf extracts.	[Wang, Ruwei; Yao, Jianbiao; Fang, Ling; Qiao, Hongxiang] Zhejiang CONBA Pharmaceut & Drug Res Dev Corp, Hangzhou, Zhejiang, Peoples R China; [Wang, Ruwei; Yao, Jianbiao; Fang, Ling; Qiao, Hongxiang] Pharmaceut Technol, Zhejiang Key Lab Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China; [Kobayashi, Yuta] Shimane Univ, Fac Med, Izumo, Shimane, Japan; [Lin, Yu] Med Corp Soujikai, Osaka, Japan; [Rauwald, Hans Wilhelm; Kuchta, Kenny] Univ Leipzig, Dept Pharmaceut Biol, D-04109 Leipzig, Germany; [Kuchta, Kenny] Sanyo Gakuen Univ, Dept Food & Nutr, Okayama 7038501, Japan	Kuchta, K (reprint author), Sanyo Gakuen Univ, Dept Food & Nutr, Naka Ku, Hirai 1-14-1, Okayama 7038501, Japan.	kkuchta@rz.uni-leipzig.de					van Beek TA, 2009, J CHROMATOGR A, V1216, P2002, DOI 10.1016/j.chroma.2009.01.013; Kanowski S, 1997, PHYTOMEDICINE, V4, P3, DOI 10.1016/S0944-7113(97)80021-9; Hsieh MT, 2010, PLANTA MED, V76, P203, DOI 10.1055/s-0029-1240707; Chen Z. L., 1996, CHINESE PHARM J, V31, P326; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, V1, P392; Cui YY, 1996, CHIN TRADIT HERB DRU, V27, P22; Fuzzati N, 2003, FITOTERAPIA, V74, P247, DOI 10.1016/S0367-326X(03)00040-6; Gao H, 2010, CHINA PRAC MED, V5, P168; Jaggy H, 1997, PHARMAZIE, V52, P735; Lee JS, 2008, PLANTA MED, V74, P532, DOI 10.1055/s-2008-1074497; LEPOITTEVIN JP, 1989, ARCH DERMATOL RES, V281, P227, DOI 10.1007/BF00431055; STICHER O, 1993, PLANTA MED, V59, P2, DOI 10.1055/s-2006-959593; van Beek TA, 2001, J CHROMATOGR A, V930, P109, DOI 10.1016/S0021-9673(01)01194-3; Wang J, 2011, CHINA FOREIGN MED TR, V5, P116; Wu YZ, 2007, PLANTA MED, V73, P624, DOI 10.1055/s-2007-981536; Xie PS, 1999, CHINA J CHIN MAT MED, V24, P3; Yang L, 2003, CHINESE J PHARM ANAL, V23, P241; 杨小明, 2008, [中国中药杂志, China Journal of Chinese Materia Medica], V33, P207; Yao J, 2012, CHIN J PHARM ANAL, V32, P142	19	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	JAN	2015	81	1					71	78		10.1055/s-0034-1383312		8	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AW6YK	WOS:000346411400011		
J	Ng, YZ; Kannan, S; Lane, DP; Fuentes, G; Verma, CS				Ng, Yao Zong; Kannan, Srinivasaraghavan; Lane, David P.; Fuentes, Gloria; Verma, Chandra S.			mAb806 binding to epidermal growth factor receptor: a computational study	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						EGFR; extracellular domain; mAb806; epitope; modeling; MD simulations	MOLECULAR-DYNAMICS SIMULATIONS; CELL LUNG-CANCER; EGF RECEPTOR; CRYPTIC EPITOPES; COMPLEX; ANTIBODIES; MECHANISM; PROTEINS; THERAPY; MODEL	The epidermal growth factor receptor (EGFR) is an important target in the treatment of cancer. A very potent antibody, mAb806, has been developed against overexpressed EGFR and was found to be particularly active in brain tumors. Structural studies reveal that it binds to an epitope on the extracellular region of the EGFR. However, this epitope is cryptic/buried in crystal structures of the active (untethered) and inactive (tethered) EGFR, and it is unclear as to how the antibody interacts with this region. To explore this interaction, we combined molecular docking, steered molecular dynamics, and equilibrium molecular dynamics simulations. Our computational models reveal that the antibody induces local unfolding around the epitope to form the antibody-EGFR complex. In addition, regions in the vicinity of the epitope also modulate the interaction, which are in accordance with several other known antibody-antigen interactions, and offers new possibilities for the design of antibodies with increased potency and specificity for this receptor. Proteins 2015; 83:153-168. (c) 2014 Wiley Periodicals, Inc.	[Ng, Yao Zong; Kannan, Srinivasaraghavan; Fuentes, Gloria; Verma, Chandra S.] ASTAR, Bioinformat Inst, Matrix, Singapore 138671, Singapore; [Lane, David P.] ASTAR, Lab P53, Neuros Immunos, Singapore 138648, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Fuentes, G (reprint author), RIKEN Ctr Life Sci Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	gloria.fuentes@riken.jp; chandra@bii.a-star.edu.sg			Biomedical Research Council (BMRC); Agency for Science, Technology and Research (Astar STAR), Singapore	Grant sponsor: Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A<SUP>star</SUP> STAR), Singapore.	Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Ramamurthy V, 2012, STRUCTURE, V20, P259, DOI 10.1016/j.str.2011.11.016; Forester TR, 1998, J COMPUT CHEM, V19, P102, DOI 10.1002/(SICI)1096-987X(19980115)19:1<102::AID-JCC9>3.0.CO;2-T; Scardino A, 2002, J IMMUNOL, V168, P5900; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Isralewitz B, 1997, BIOPHYS J, V73, P2972; SALEMI S, 1995, J EXP MED, V181, P2253, DOI 10.1084/jem.181.6.2253; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-06-1554; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; Ramalingam SS, 2012, J CLIN ONCOL, V30, P3337, DOI 10.1200/JCO.2011.40.9433; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Izrailev S, 1997, BIOPHYS J, V72, P1568; Voigt M, 2012, NEOPLASIA, V14, P1023, DOI 10.1593/neo.121242; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Johns TG, 2002, INT J CANCER, V98, P398, DOI 10.1002/ijc.10189; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4139; DESLANO WL, 2002, PYMOL MOL GRAPHICS S; desVries SJ, 2007, PROTEINS, V69, P726; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Eswar N., 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506S15; Fuentes G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2888; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P2163, DOI 10.1073/pnas.0530200100; Loureiro ME, 2007, IMMUNOL INVEST, V36, P159, DOI 10.1080/08820130600941179; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marco E, 2007, CHEMMEDCHEM, V2, P1388, DOI 10.1002/cmdc.20070087; Pednekar D, 2009, PROTEINS, V74, P155, DOI 10.1002/prot.22142; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Warnock G., 1997, BR J RHEUMATOL, V36, P1144; Wong JS, 2013, ONCOTARGET, V4, P1019	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	JAN	2015	83	1					153	168		10.1002/prot.24714		16	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW7WF	WOS:000346471600011		
J	Huo, L; Liu, FG; Iwaki, H; Li, TF; Hasegawa, Y; Liu, AM				Huo, Lu; Liu, Fange; Iwaki, Hiroaki; Li, Tingfeng; Hasegawa, Yoshie; Liu, Aimin			Human alpha-amino-beta-carboxymuconate-esemialdehyde decarboxylase (ACMSD): A structural and mechanistic unveiling	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						Tryptophan metabolites; kynurenine; quinolinate synthesis; quaternary structure	EPSILON-SEMIALDEHYDE-DECARBOXYLASE; AIDS DEMENTIA COMPLEX; QUINOLINIC ACID; HUNTINGTONS-DISEASE; CATALYTIC MECHANISM; ALZHEIMERS-DISEASE; AMIDOHYDROLASE SUPERFAMILY; TRYPTOPHAN DEGRADATION; KYNURENINE PATHWAY; CRYSTAL-STRUCTURE	Human -amino--carboxymuconate-epsilon-semialdehyde decarboxylase determines the fate of tryptophan metabolites in the kynurenine pathway by controlling the quinolinate levels for de novo nicotinamide adenine dinucleotide biosynthesis. The unstable nature of its substrate has made gaining insight into its reaction mechanism difficult. Our electron paramagnetic resonance (EPR) spectroscopic study on the Cu-substituted human enzyme suggests that the native substrate does not directly ligate to the metal ion. Substrate binding did not result in a change of either the hyperfine structure or the super-hyperfine structure of the EPR spectrum. We also determined the crystal structure of the human enzyme in its native catalytically active state (at 1.99 angstrom resolution), a substrate analogue-bound form (2.50 angstrom resolution), and a selected active site mutant form with one of the putative substrate binding residues altered (2.32 angstrom resolution). These structures illustrate that each asymmetric unit contains three pairs of dimers. Consistent with the EPR findings, the ligand-bound complex structure shows that the substrate analogue does not directly coordinate to the metal ion but is bound to the active site by two arginine residues through noncovalent interactions. Proteins 2015; 83:178-187. (c) 2014 Wiley Periodicals, Inc.	[Huo, Lu; Liu, Fange; Li, Tingfeng; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Huo, Lu; Liu, Fange; Li, Tingfeng; Liu, Aimin] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Iwaki, Hiroaki; Hasegawa, Yoshie] Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka 5648680, Japan; [Iwaki, Hiroaki; Hasegawa, Yoshie] Kansai Univ, ORDIST, Suita, Osaka 5648680, Japan	Liu, AM (reprint author), Georgia State Univ, Dept Chem, 50 Decatur St, Atlanta, GA 30303 USA.	Feradical@gsu.edu			Georgia Research Alliance Distinguished Scientist Program, NSF [CHE 1309942]; NIH [R01GM107529]; Molecular Basis of Disease Program, Georgia State University; Molecular Basis of Disease Program, Georgia State University, Center for Diagnostics and Therapeutics of Georgia State University	Grant sponsor: Georgia Research Alliance Distinguished Scientist Program, NSF; Grant number: CHE 1309942; Grant sponsor: NIH; Grant number: R01GM107529; Grant sponsor: Molecular Basis of Disease Program, Georgia State University, Center for Diagnostics and Therapeutics of Georgia State University.	Widner B, 2000, J NEURAL TRANSM, V107, P343, DOI 10.1007/s007020050029; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Hobbs ME, 2012, BIOCHEMISTRY-US, V51, P3497, DOI 10.1021/bi300307b; Baran H, 1999, J NEURAL TRANSM, V106, P165, DOI 10.1007/s007020050149; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Garavaglia S, 2009, FEBS J, V276, P6615, DOI 10.1111/j.1742-4658.2009.07372.x; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P167; Schwarcz R, 2010, PROG NEUROBIOL, V90, P230, DOI 10.1016/j.pneurobio.2009.04.005; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Guillemin GJ, 2005, NEUROTOX RES, V7, P103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Owe-Young R, 2008, J NEUROCHEM, V105, P1346, DOI 10.1111/j.1471-4159.2008.05241.x; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Xu ST, 2013, CELL RES, V23, P1296, DOI 10.1038/cr.2013.107; Fukuoka SI, 2002, J BIOL CHEM, V277, P35162, DOI 10.1074/jbc.M200819200; [Anonymous], PYMOL MOL GRAPH SYST; Liu AM, 2006, BIOCHEMISTRY-US, V45, P10407, DOI 10.1021/bi061031v; Huo L, 2012, BIOCHEMISTRY-US, V51, P5811, DOI 10.1021/bi300635b; BEAL MF, 1991, J NEUROSCI, V11, P1649; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; Heyes MP, 1998, FASEB J, V12, P881; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Lahdou I, 2013, HUM IMMUNOL, V74, P60, DOI 10.1016/j.humimm.2012.09.009; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648I; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Liu A, 2014, AMIDOHYDROLASE SUPER, DOI [10.1002/9780470015902.a0020546.pub2, DOI 10.1002/9780470015902.A0020546.PUB2]; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; MEHLER AH, 1956, J BIOL CHEM, V218, P241; Nguyen TT, 2009, BIOCHEMISTRY-US, V48, P8879, DOI 10.1021/bi901046x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Stone T. W., 2001, Journal of Alzheimer's Disease, V3, P355; Williams L, 2006, BIOCHEMISTRY-US, V45, P7453, DOI 10.1021/bi060531l	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	JAN	2015	83	1					178	187		10.1002/prot.24722		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AW7WF	WOS:000346471600013		
J	Yamasaki, T; Yamada, K; Laukka, P				Yamasaki, Teruo; Yamada, Keiko; Laukka, Petri			Viewing the world through the prism of music: Effects of music on perceptions of the environment	PSYCHOLOGY OF MUSIC			English	Article						adjective ratings; landscape; music; perception; physical environment; portable music players	BACKGROUND MUSIC; SHOPPING BEHAVIOR; EVERYDAY LIFE; ATMOSPHERE; INDUCTION; RESPONSES; SETTINGS; EMOTIONS; SOUNDS; STORE	Questionnaire and interview studies suggest that music is valued for its role in managing the listener's impression of the environment, but systematic investigations on the topic are scarce. We present a field experiment wherein participants were asked to rate their impression of four different environments (a quiet residential area, traveling by train in the suburbs, at a busy crossroads, and in a tranquil park area) on bipolar adjective scales, while listening to music (which varied regarding level of perceived activation and valence) or in silence. Results showed that the evaluation of the environment was in general affected in the direction of the characteristics of the music, especially in conditions where the perceived characteristics of the music and environment were incongruent. For example, highly active music increased the activation ratings of environments which were perceived as inactive without music, whereas inactive music decreased the activation ratings of environments which were perceived as highly active without music. Also, highly positive music increased the positivity ratings of the environments. In sum, the findings suggest that music may function as a prism that modifies the impression of one's surroundings. Different theoretical explanations of the results are discussed.	[Yamasaki, Teruo; Yamada, Keiko] Osaka Shoin Womens Univ, Nara 6390298, Japan; [Laukka, Petri] Stockholm Univ, Stockholm, Sweden	Yamasaki, T (reprint author), Osaka Shoin Womens Univ, Fac Psychol, 958 Sekiya, Nara 6390298, Japan.	yamasaki@gamelans.org					Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2011, MUSIC SCI, V15, P174, DOI 10.1177/1029864911401169; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Lim EM, 2006, LANDSCAPE URBAN PLAN, V77, P80, DOI 10.1016/j.landurbplan.2005.01.007; North AC, 2000, J APPL SOC PSYCHOL, V30, P1504, DOI 10.1111/j.1559-1816.2000.tb02533.x; North AC, 1998, J APPL SOC PSYCHOL, V28, P2254, DOI 10.1111/j.1559-1816.1998.tb01370.x; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; ARENI CS, 1993, ADV CONSUM RES, V20, P336; Edworthy J, 2006, ERGONOMICS, V49, P1597, DOI 10.1080/00140130600899104; KELLARIS JJ, 1993, J MARKETING, V57, P114, DOI 10.2307/1252223; De Coensel B, 2011, J ACOUST SOC AM, V129, pEL148, DOI 10.1121/1.3567073; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Pelletier CL, 2004, J MUSIC THER, V41, P192; Spence C, 2010, J SENS STUD, V25, P406, DOI 10.1111/j.1745-459X.2009.00267.x; Liljestrom S, 2013, PSYCHOL MUSIC, V41, P579, DOI 10.1177/0305735612440615; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; Turley LW, 2000, J BUS RES, V49, P193, DOI 10.1016/S0148-2963(99)00010-7; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Garlin FV, 2006, J BUS RES, V59, P755, DOI 10.1016/j.jbusres.2006.01.013; Lonsdale AJ, 2011, BRIT J PSYCHOL, V102, P108, DOI 10.1348/000712610X506831; Heye A, 2010, MUSIC SCI, V14, P95, DOI 10.1177/102986491001400104; Bolivar V. J., 1994, PSYCHOMUSICOLOGY, V13, P28; Bull M, 2001, NEW MEDIA SOC, V3, P179, DOI 10.1177/14614440122226047; Bull Michael, 2007, SOUND MOVES IPOD CUL; Cohen A. J., 1993, CONT MUSIC REV, V9, P163, DOI 10.1080/07494469300640421; DENORA Tia, 2000, MUSIC EVERYDAY LIFE; GABRIELS.A, 1973, SCAND J PSYCHOL, V14, P244, DOI 10.1111/j.1467-9450.1973.tb00118.x; Haake AB, 2011, MUSIC SCI, V15, P107, DOI 10.1177/1029864911398065; Herbert R, 2011, EVERYDAY MUSIC LISTENING: ABSORPTION, DISSOCIATION AND TRANCING, P1; Hoeckner B, 2011, PSYCHOL AESTHET CREA, V5, P146, DOI 10.1037/a0021544; Iwamiya Shin-Ichiro, 1997, Applied Human Science, V16, P115, DOI 10.2114/jpa.16.115; Jacob C., 2009, INT REV RETAIL DISTR, V19, P75; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Kidd GR, 2003, NOISE CONTROL ENG J, V51, P216, DOI 10.3397/1.2839717; Laukka P., 2007, J HAPPINESS STUD, V8, P215, DOI [10.1007/s10902-006-9024-3, DOI 10.1007/S10902-006-9024-3]; Le Guellec H, 2007, PSYCHOL REP, V100, P1255, DOI 10.2466/PR0.100.4.1255-1258; MACINNIS DJ, 1991, J CONSUM RES, V18, P161, DOI 10.1086/209249; Masakura Y., 2005, JAPANESE J PSYCHONOM, V23, P139; Mehrabian A., 1974, APPROACH ENV PSYCHOL; Jolij J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018861; Morin S, 2007, J RETAILING, V83, P115, DOI 10.1016/j.jretai.2006.10.006; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; North A. C., 2009, OXFORD HDB MUSIC PSY, P481; Osgood C.E., 1957, MEASUREMENT MEANING; Saarikallio S., 2007, PSYCHOL MUSIC, V35, P88, DOI DOI 10.1177/0305735607068889; SHEVY M., 2007, PSYCHOMUSICOLOGY, V13, P57; SLOBODA J. A., 2001, MUSIC SCI, V5, P9; Sloboda J. A., 2009, OXFORD HDB MUSIC PSY, P431; Tan SL, 2007, MUSIC PERCEPT, V25, P135, DOI 10.1525/MP.2007.25.2.135; Van den Stock J, 2009, BRAIN TOPOGR, V21, P216, DOI 10.1007/s10548-009-0099-0; Welch RB, 1986, HDB PERCEPTION HUMAN, V1, P1; Wilson S., 2003, PSYCHOL MUSIC, V31, P93, DOI DOI 10.1177/0305735603031001327; Yeoh JPS, 2012, PSYCHOL MUSIC, V40, P709, DOI 10.1177/0305735611408994	54	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0305-7356	1741-3087		PSYCHOL MUSIC	Psychol. Music	JAN	2015	43	1					61	74		10.1177/0305735613493954		14	Psychology, Educational; Psychology, Applied; Music; Psychology, Experimental	Psychology; Music	AW9DS	WOS:000346558400004		
J	Haruya, M; Kano, S				Haruya, Mei; Kano, Shingo			A new look at the corporate capability of personalized medicine development in the pharmaceutical industry	R & D MANAGEMENT			English	Article							COMPANION DIAGNOSTICS; PRODUCT DEVELOPMENT; CHALLENGES; CANCER; CODEVELOPMENT	Despite the recent rise in academic and practitioner interest in the development of personalized medicine in the pharmaceutical industry, no study has yet assessed the corporate capability of such development. This study thus develops a model to illustrate the corporate capability of personalized medicine development (PMD capability) in the pharmaceutical industry. First, we define three key influencing factors for PMD capability, namely new product development (NPD) capability, External drug-CoDx co-development (CoDxD) capability [i.e. the capability of drug-CoDx (companion diagnostics) co-development with external companies], and Internal CoDxD capability (i.e. the capability of drug-CoDx co-development with an internal organization). Then, a research model is developed, and by carrying out a structural equation modeling analysis, we successfully find a good fit of the model and that the critical path to contribute to PMD capability runs from NPD capability via External CoDxD capability rather than via Internal CoDxD capability.	[Haruya, Mei; Kano, Shingo] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Bio Intellectual Property Course, Kashiwa, Chiba 2778561, Japan; [Haruya, Mei] GlaxoSmithKline KK, Tokyo, Japan	Haruya, M (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Bio Intellectual Property Course, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	kk127334@mgs.k.u-tokyo.ac.jp; kano@k.u-tokyo.ac.jp					GRAVES SB, 1993, STRATEGIC MANAGE J, V14, P593, DOI 10.1002/smj.4250140803; Schmidt C, 2012, J NATL CANCER I, V104, P14, DOI 10.1093/jnci/djr535; Su YS, 2009, ASIA PAC J MANAG, V26, P309, DOI 10.1007/s10490-008-9114-3; Tutton R, 2012, SOC SCI MED, V75, P1721, DOI 10.1016/j.socscimed.2012.07.031; Amir-Aslani A, 2010, TECHNOL FORECAST SOC, V77, P203, DOI 10.1016/j.techfore.2009.09.005; Deeds DL, 1997, J BUS VENTURING, V12, P31, DOI 10.1016/S0883-9026(97)84970-1; Hoang H, 2010, STRATEGIC MANAGE J, V31, P734, DOI 10.1002/smj.834; Deeds DL, 1996, J BUS VENTURING, V11, P41, DOI 10.1016/0883-9026(95)00087-9; Heubeck BG, 2000, PSYCHOL REP, V87, P431, DOI 10.2466/PR0.87.6.431-440; Singer DRJ, 2012, PERS MED, V9, P751, DOI 10.2217/PME.12.86; Davis JC, 2009, NAT REV DRUG DISCOV, V8, P279, DOI 10.1038/nrd2825; McClellan KA, 2013, EUR J HUM GENET, V21, P143, DOI 10.1038/ejhg.2012.149; Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/erm.12.59, 10.1586/ERM.12.59]; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Arbuckle J. L., 2007, AMOS 16 0 USERS GUID; Bierly PE, 1996, IEEE T ENG MANAGE, V43, P368, DOI 10.1109/17.543979; Bol Y, 2010, J BEHAV MED, V33, P355, DOI 10.1007/s10865-010-9266-8; Coombs J. E., 1999, J BUSINESS VENTURING, V15, P211; Diagnostics, 2011, DIAGN 2011 M A SURG; FDA, 2011, DRAFT GUID IND FOOD; Jorgensen JT, 2011, DRUG DISCOV TODAY, V16, P891, DOI 10.1016/j.drudis.2011.09.010; Jorgensen JT, 2012, DRUG DEVELOP RES, V73, P390, DOI 10.1002/ddr.21029; Lehrach H, 2012, PERS MED, V9, P105, DOI 10.2217/PME.12.9; Love D, 2012, NEW BIOTECHNOL, V29, P689, DOI 10.1016/j.nbt.2012.06.005; Moore MW, 2012, PERS MED, V9, P485, DOI 10.2217/PME.12.60; PwC, 2009, DIAGN 2009 MOV PERS; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; WINTHER H, 2010, PHARM MED, V24, P363	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0033-6807	1467-9310		R&D MANAGE	R D Manage.	JAN	2015	45	1					94	103		10.1111/radm.12072		10	Business; Management	Business & Economics	AW7WW	WOS:000346473200006		
J	Kasahara, E; Inoue, M				Kasahara, Emiko; Inoue, Masayasu			Cross-talk between HPA-axis-increased glucocorticoids and mitochondrial stress determines immune responses and clinical manifestations of patients with sepsis	REDOX REPORT			English	Article						Sepsis; Lipopolysaccharide; Inflammation; Glucocorticoid; Cytokine; Hypothalamo-pituitary-adrenal axis; Mitochondrial oxidative stress	TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; UNCOUPLING PROTEIN-2; SEPTIC SHOCK; IN-VIVO; BACTERICIDAL ACTIVITY; SIGNALING PATHWAYS; INDUCED MORTALITY; SURVIVING SEPSIS; INNATE IMMUNITY	Various stressors activate the hypothalamo-pituitary-adrenal axis (HPA-axis) that stimulates adrenal secretion of glucocorticoids, thereby playing critical roles in the modulation of immune responses. Transcriptional regulation of nuclear genes has been well documented to underlie the mechanism of glucocorticoid-dependent modulation of cytokine production and immune reactions. Glucocorticoids also regulate inflammatory responses via non-genomic pathways in cytoplasm and mitochondria. Recent studies have revealed that glucocorticoids modulate mitochondrial calcium homeostasis and generation of reactive oxygen species (ROS). Although redox status and ROS generation in inflammatory cells have been well documented to play important roles in defense against pathogens, the roles of glucocorticoids and mitochondria in the modulation of immunological responses remain obscure. This review describes the role of stress-induced activation of the HPA-axis and glucocorticoid secretion by the adrenal gland in mitochondria-dependent signaling pathways that modulate endotoxin-induced inflammatory reactions and innate immunity.	[Kasahara, Emiko] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 5458585, Japan; [Inoue, Masayasu] Hlth Sci Inst, Osaka, Japan	Kasahara, E (reprint author), Osaka City Univ, Dept Physiol, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	kasahara@med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japanese Government [21700698, 24501353]; Sakamoto Research Foundation of Psychiatric Diseases	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (21700698 and 24501353) and The Sakamoto Research Foundation of Psychiatric Diseases.	Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Leonard BE, 2006, NEUROIMMUNOMODULAT, V13, P268, DOI 10.1159/000104854; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Buttgereit F, 2002, STEROIDS, V67, P529, DOI 10.1016/S0039-128X(01)00171-4; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Long F, 2005, STEROIDS, V70, P55, DOI 10.1016/j.steriods.2004.10.004; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Rocha Milagros, 2012, Infectious Disorders - Drug Targets, V12, P161; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; Yan J, 2013, FREE RADICAL BIO MED, V61, P320, DOI 10.1016/j.freeradbiomed.2013.04.015; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060913; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Arsenijevic D, 2000, NAT GENET, V26, P435; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Ayroldi E, 2012, FASEB J, V26, P4805, DOI 10.1096/fj.12-216382; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Putignano P, 2001, EUR J ENDOCRINOL, V145, P165, DOI 10.1530/eje.0.1450165; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; ADER R, 1993, ANNU REV PSYCHOL, V44, P53; Gostner JM, 2013, REDOX REP, V18, P88, DOI 10.1179/1351000213Y.0000000044; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Gilibert S, 2014, J IMMUNOL, V193, P817, DOI 10.4049/jimmunol.1303164; Wang JF, 1996, FREE RADICAL BIO MED, V20, P533, DOI 10.1016/0891-5849(95)02085-3; Kasahara E, 2011, FEBS LETT, V585, P2263, DOI 10.1016/j.febslet.2011.05.049; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Tang SE, 2014, FREE RADICAL BIO MED, V71, P321, DOI 10.1016/j.freeradbiomed.2014.03.034; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Eskandari F, 2002, ANN NY ACAD SCI, V966, P20; Wang Y, 2008, J IMMUNOL, V181, P3441; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Psarra AMG, 2009, BIOCHEM J, V422, P521, DOI 10.1042/BJ20090107; Lowes DA, 2013, BRIT J ANAESTH, V110, P472, DOI 10.1093/bja/aes577; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Lee SR, 2013, PROG BIOPHYS MOL BIO, V112, P44, DOI 10.1016/j.pbiomolbio.2013.04.001; Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Choi HM, 2013, BIOCHEM BIOPH RES CO, V435, P678, DOI 10.1016/j.bbrc.2013.05.042; Dejager L, 2010, J BIOL CHEM, V285, P31073, DOI 10.1074/jbc.M110.154484; Forceville X, 2001, THERAPIE, V56, P653; Frister A, 2014, NEUROMOL MED, V16, P704, DOI 10.1007/s12017-014-8320-z; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Haines B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031739; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Johannes T, 2009, SHOCK, V31, P521, DOI 10.1097/SHK.0b013e318188d198; Kasahara E, 2009, BIOCHEM J, V421, P293, DOI 10.1042/BJ20090286; Kasahara E, 2015, NEUROIMMUNOMODULAT, V22, P279, DOI 10.1159/000368802; Kino T, 2011, CLIN EXP RHEUMATOL, V29, pS32; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, P230, DOI DOI 10.1186/1742-2094-9-230; Lipinska-Gediga M, 2012, INFECTION, V40, P303, DOI 10.1007/s15010-011-0235-0; Orita K, 2010, EXP DERMATOL, V19, P1067, DOI 10.1111/j.1600-0625.2010.01130.x; Paiva CN, 2014, ANTIOXID REDOX SIGN, V20, P1000, DOI 10.1089/ars.2013.5447; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; Sekiyama A, 2005, IMMUNITY, V22, P669, DOI 10.1016/j.immuni.2005.04.006; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Vincent JL, 2008, CRIT CARE, V12, DOI 10.1186/cc6924; Wang HW, 2013, J CLIN IMMUNOL, V33, P649, DOI 10.1007/s10875-012-9852-3; Wang Yi, 2001, Physiological Chemistry and Physics and Medical NMR, V33, P29; Yamada M, 1998, FEBS LETT, V432, P65, DOI 10.1016/S0014-5793(98)00835-7; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang Y, 2008, J NEUROIMMUNOL, V204, P13, DOI 10.1016/j.jneuroim.2008.08.011	97	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1351-0002			REDOX REP	Redox Rep.	JAN	2015	20	1								10.1179/1351000214Y.0000000107		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW8WE	WOS:000346538600001		
J	Takenami, T; Hiruma, H; Kaneko, H; Okamoto, H; Kawakami, T				Takenami, Tamie; Hiruma, Hiromi; Kaneko, Haruka; Okamoto, Hirotsugu; Kawakami, Tadashi			Effects of Sodium Bisulfite With or Without Procaine Derivatives on Axons of Cultured Mouse Dorsal Root Ganglion Neurons	REGIONAL ANESTHESIA AND PAIN MEDICINE			English	Article							PROTEIN-KINASE-II; TRANSIENT NEUROLOGIC SYMPTOMS; SPINAL-ANESTHESIA; CHLOROPROCAINE NEUROTOXICITY; 2-CHLOROPROCAINE; PHOSPHORYLATION; MEPIVACAINE; LIDOCAINE; TAU; BUPIVACAINE	Background and Objectives: Sodium bisulfite (NaHSO3) was clinically used as a preservative agent for local anesthetics but was later suspected to be neurotoxic. However, recent studies reported that NaHSO3 reduces the neurotoxicity of local anesthetics. The purpose of this study was to examine the effects of NaHSO3 with and without procaine on axonal transport in cultured mouse dorsal root ganglion (DRG) neurons. Methods: Experiment 1 served to determine the dose-dependent effects of NaHSO3 on axonal transport (DRG neurons were treated with 0.01, 0.1, 1, 10, or 20 mM of NaHSO3), whereas experiment 2 investigated the effect of 0.1 mM NaHSO3 on the action of local anesthetics on axonal transport (DRG neurons were treated with 1 mM procaine alone, or with 0.1 mM NaHSO3 plus 1 mM procaine). As an additional experiment, DRG neurons were also treated with 1 mM chloroprocaine alone, or with 0.1 mM NaHSO3 plus 1 mM chloroprocaine. In these experiments, we analyzed the percent change in the number of anterogradely and retrogradely transported organelles and recorded changes in neurite morphology using video-enhanced microscopy. Results: In experiment 1, NaHSO3 at more than 1 mM caused cell membrane damage and complete inhibition of axonal transport, whereas 0.1 mM NaHSO3 maintained axonal transport at 40% to 60% of control with intact cell membrane. In experiment 2, 1 mM procaine alone maintained axonal transport at 90% to 100%. However, application of 1 mM procaine-0.1 mM NaHSO3 solution resulted in deformation of neurites and with complete cessation of axonal transport. Likewise, although 1 mM chloroprocaine maintain axonal transport at 80% to 100%, 1 mM chloroprocaine-0.1 mM NaHSO3 arrested axonal transport. Conclusions: NaHSO3 resulted in a dose-dependent damage to the cell membrane and axonal transport, especially when used in combination with procaine or chloroprocaine.	[Takenami, Tamie; Kaneko, Haruka; Okamoto, Hirotsugu] Kitasato Univ, Sch Med, Dept Anesthesiol, Sagamihara, Kanagawa 2520374, Japan; [Hiruma, Hiromi; Kawakami, Tadashi] Kitasato Univ, Sch Med, Dept Physiol, Sagamihara, Kanagawa 2520374, Japan	Takenami, T (reprint author), Kitasato Univ, Sch Med, Dept Anesthesiol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	takenami@med.kitasato-u.ac.jp					MOORE DC, 1982, ANESTH ANALG, V61, P155; Pickering AE, 1999, ANESTHESIOLOGY, V91, P436, DOI 10.1097/00000542-199908000-00018; BUGGY D, 1994, BRIT J ANAESTH, V73, P540, DOI 10.1093/bja/73.4.540; Yamamoto H, 2005, J NEUROCHEM, V94, P1438, DOI 10.1111/j.1471-4159.2005.03307.x; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Taniguchi M, 2004, ANESTHESIOLOGY, V100, P85, DOI 10.1097/00000542-200401000-00016; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47; Takenami T, 2012, CAN J ANESTH, V59, P456, DOI 10.1007/s12630-012-9685-9; FORD DJ, 1987, ANESTH ANALG, V66, P719; Hiller A, 1997, BRIT J ANAESTH, V79, P301; Hodgson PS, 2000, REGION ANESTH PAIN M, V25, P218, DOI 10.1016/S1098-7339(00)90001-4; KALICHMAN MW, 1986, J NEUROPATH EXP NEUR, V45, P566, DOI 10.1097/00005072-198609000-00006; Kanai K, 2001, ANESTHESIOLOGY, V95, P675; Liguori GA, 1998, ANESTHESIOLOGY, V88, P619, DOI 10.1097/00000542-199803000-00010; Lund ET, 2001, J NEUROCHEM, V76, P1221, DOI 10.1046/j.1471-4159.2001.00130.x; More DC, 1984, ANESTH ANALG, V63, P544; Parry MG, 1998, ANAESTHESIA, V53, P382, DOI 10.1046/j.1365-2044.1998.00295.x; Ready LB, 1985, ANESTHESIOLOGY, V63, P646; REISNER LS, 1980, ANESTH ANALG, V59, P452; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Takenami T, 2000, REGION ANESTH PAIN M, V25, P372, DOI 10.1053/rapm.2000.6444; Takenami T, 2004, REGION ANESTH PAIN M, V29, P446, DOI 10.1016/j.rapm.2004.06.013; Takenami T, 2009, REGION ANESTH PAIN M, V34, P189, DOI 10.1097/AAP.0b013e31819a27bd; Tetzlaff J E, 2000, Anesthesiol Clin North America, V18, P217, DOI 10.1016/S0889-8537(05)70161-9; Vaghadia H, 2012, ACTA ANAESTH SCAND, V56, P217, DOI 10.1111/j.1399-6576.2011.02599.x; WANG BC, 1984, ANESTH ANALG, V63, P445	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1098-7339	1532-8651		REGION ANESTH PAIN M	Region. Anesth. Pain Med.	JAN-FEB	2015	40	1					62	67		10.1097/AAP.0000000000000195		6	Anesthesiology	Anesthesiology	AW7ZW	WOS:000346481400012		
J	Yaeda, J; Iwanaga, K; Fujikawa, M; Chan, F; Bezyak, J				Yaeda, Jun; Iwanaga, Kanako; Fujikawa, Mayu; Chan, Fong; Bezyak, Jill			The Use of Evidence-Based Practice Among Japanese Vocational Rehabilitation Professionals	REHABILITATION COUNSELING BULLETIN			English	Article						rehabilitation counselors; professionalism; professional issues; international rehabilitation; rehabilitation counseling; education; rehabilitation	BEHAVIORS; ATTITUDES; PEOPLE	The current study surveyed 94 Japanese vocational rehabilitation (VR) professionals to determine their perceived self-efficacy, perceived benefits, perceived barriers, and readiness to use evidence-based practice (EBP). VR counselors in Japan generally see the potential benefits of using EBP to improve psychosocial and employment outcomes of people with disabilities. However, responses related to knowledge and skills were mixed with higher confidence reported in the ability to understand basic concepts of rehabilitation research designs, methods, and statistics but less confidence in the use of research databases to find empirically supported interventions and in their ability to understand the best evidence information from systematic reviews/meta-analyses. Perceived barriers to EBP were identified, including lack of support for the use of EBP from colleagues and senior management in the agency and not having supervisors who are experienced in EBP. As expected, Japanese VR counselors also reported EBP was not effectively used in VR service delivery practices. Implications for practice, education, and professional development are discussed	[Yaeda, Jun] Univ Tsukuba, Tokyo 1120012, Japan; [Iwanaga, Kanako] Polytech Univ, Tokyo, Japan; [Fujikawa, Mayu] Tohoku Univ, Sendai, Miyagi 980, Japan; [Chan, Fong] Univ Wisconsin, Madison, WI 53706 USA; [Bezyak, Jill] Univ No Colorado, Greeley, CO 80639 USA	Yaeda, J (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Lifespan Dev Sci Program, Masters & Doctoral Course Rehabil Sci,Bunkyo Ku, 3-29-1 Otsuka, Tokyo 1120012, Japan.	jyaeda@human.tsukuba.ac.jp					Sackett DL, 1996, BRIT MED J, V312, P71; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; Chan F, 2009, REHABIL COUNS BULL, V52, P114, DOI 10.1177/0034355208323947; Jette DU, 2003, PHYS THER, V83, P786; Corrigan PW, 2001, PSYCHIATR SERV, V52, P1598, DOI 10.1176/appi.ps.52.12.1598; Kobayashi K, 1998, EUR J CANCER, V34, P810, DOI 10.1016/S0959-8049(97)00395-X; Arokiasamy C. V., 1993, REHABILITATION ED, V7, P77; Bandura A., 1997, SELF EFFICACY EXERCI; Bezyak J., 2010, REHABILITATION ED, V24, P85; Bolton B, 2004, SPR S REHAB, P444; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Chan F., 2011, PROFESSIONAL PRACTIC, P391; Chan F., 2013, DEV VALIDATION EVIDE; Cheing GLY, 2010, INT J REHABIL RES, V33, P88, DOI 10.1097/MRR.0b013e32832e9884; Chronister JA, 2008, J REHABIL, V74, P6; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P251, DOI 10.1037/a0013038; Cohen J., 1988, STAT POWER ANAL BEHA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DePalma Judith A, 2002, Nurs Adm Q, V26, P55; Fujikawa M., 2011, JAPANESE J VOCATIONA, V25, P27; Hasegawa T, 2010, JAPAN LABOR REV, V7, P26; HAYS RD, 1990, BEHAV RES METH INSTR, V22, P167; Hoyt WT, 2006, REHABIL COUNS BULL, V49, P223, DOI 10.1177/00343552060490040401; Law M., 2002, EVIDENCE BASED REHAB; Lui J., 2010, J VOCATIONAL REHABIL, V32, P163; McCluskey A, 2002, AUSTR OCCUPATIONAL T, V49, P63, DOI DOI 10.1046/J.1440-1630.2002.00272.X; Ministry of Health Labor and Welfare, 2011, EMPL STAT DIS FY2011; Ministry of Health Labor and Welfare, 2008, SURV RES EMPL STAT I; Nelson TD, 2007, ADM POLICY MENT HLTH, V34, P319, DOI 10.1007/s10488-006-0111-x; O'Donnell Catherine A, 2004, J Eval Clin Pract, V10, P197, DOI 10.1111/j.1365-2753.2003.00458.x; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rappolt Susan, 2002, J Contin Educ Health Prof, V22, P170, DOI 10.1002/chp.1340220306; Stewart A. L., 1992, MEASURING FUNCTIONIN; Tannenbaum S, 2003, J EVAL CLIN PRACT, V9, P287; Ware JE, 1997, MAP R WINDOWS MULTIT; Winch S, 2005, J ADV NURS, V50, P20, DOI 10.1111/j.1365-2648.2004.03345.x	36	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	JAN	2015	58	2			SI		70	79		10.1177/0034355214527323		10	Rehabilitation	Rehabilitation	AW9JU	WOS:000346574200002		
J	Maldonado, F; Edell, ES; Barron, PJ; Yung, RC				Maldonado, Fabien; Edell, Eric S.; Barron, Patrick J.; Yung, Rex C.			Interventional pulmonology: The tipping point	RESPIROLOGY			English	Editorial Material						bronchoscopy; education; interventional pulmonology; pleural disease; practice	PLEURAL EFFUSIONS; BRONCHOSCOPY; FUTURE		[Maldonado, Fabien; Edell, Eric S.] Mayo Clin, Rochester, MN 55405 USA; [Barron, Patrick J.] Tokyo Med Univ, Tokyo 1608402, Japan; [Barron, Patrick J.] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea	Maldonado, F (reprint author), Mayo Clin, Rochester, MN 55405 USA.						Thomas R, 2014, RESPIROLOGY, V19, P809, DOI 10.1111/resp.12328; Poletti V, 2014, RESPIROLOGY, V19, P645, DOI 10.1111/resp.12309; Ohtani K, 2012, RESPIROLOGY, V17, P261, DOI 10.1111/j.1440-1843.2011.02108.x; Breen DP, 2014, RESPIROLOGY, V19, P970, DOI 10.1111/resp.12339; Fielding DI, 2014, RESPIROLOGY, V19, P472, DOI 10.1111/resp.12279; Gilbert C, 2014, RESPIROLOGY, V19, P636, DOI 10.1111/resp.12301; Mineshita M, 2014, RESPIROLOGY, V19, P1126, DOI 10.1111/resp.12362; Saettele TM, 2014, RESPIROLOGY, V19, P800, DOI 10.1111/resp.12310	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JAN	2015	20	1					11	12		10.1111/resp.12431		2	Respiratory System	Respiratory System	AW7TO	WOS:000346467400005		
J	Joos, GF; Gabazza, EC				Joos, Guy F.; Gabazza, Esteban C.			Is there still hope for single therapies: How do we set up experimental systems to efficiently test combination therapies?	RESPIROLOGY			English	Review						asthma; chronic obstructive pulmonary disease; inhalation therapy; interstitial pulmonary disease	IDIOPATHIC PULMONARY-FIBROSIS; MUC5B PROMOTER POLYMORPHISM; PLACEBO-CONTROLLED TRIAL; TYROSINE KINASE INHIBITOR; SEVERE PERSISTENT ASTHMA; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; ANIMAL-MODELS; ALLERGIC INFLAMMATION; EOSINOPHILIC ASTHMA	Severe asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are chronic lung diseases with a clear need for development of new and more efficient therapy. In preclinical research, the mouse model has been instrumental in advancing our knowledge of the biology and immunology. However, it has been proven rather difficult and time consuming to develop new treatments that can impact on the clinical course of these diseases. Many challenges need to be overcome for upgrading the quality of currently available experimental disease models in order to enhance the translation rate of basic research to clinical practice. Establishment of transgenic mouse overexpressing disease-causing genes may provide tools to discover new pathological pathways and to evaluate the possibility of molecular targeted therapy in chronic lung diseases. Personalized medicine, if developed, might be the solution for disease heterogeneity' and for improving clinical outcome.	[Joos, Guy F.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Gabazza, Esteban C.] Mie Univ, Fac & Grad Sch Med, Dept Immunol, Tsu, Mie, Japan	Joos, GF (reprint author), Ghent Univ Hosp, Dept Resp Med, De Pintelaan 185, B-9000 Ghent, Belgium.	guy.joos@ugent.be			Ghent University BOF-Concerted Action [027]; FWO Flanders; Belspo Interuniversity Attraction Pole [P6/35, P7/30]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	For G.F. Joos: Ghent University BOF-Concerted Action-027, FWO Flanders, Belspo Interuniversity Attraction Pole P6/35 and P7/30. For E.C. Gabazza: Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Albert RK, 2012, NEW ENGL J MED, V366, P1356; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Brusselle GG, 2014, CURR OPIN PULM MED, V20, P95, DOI 10.1097/MCP.0000000000000017; Hardie WD, 2010, CELL CYCLE, V9, P2769, DOI 10.4161/cc.9.14.12268; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Adamali HI, 2012, DRUG DES DEV THER, V6, P261, DOI 10.2147/DDDT.S29928; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI [10.1164/rccm.200711-1754OC, 10.1164/rccm.200711-17540C]; Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Peljto AL, 2013, JAMA-J AM MED ASSOC, V309, P2232, DOI 10.1001/jama.2013.5827; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wei RR, 2014, TRANSL RES, V163, P494, DOI 10.1016/j.trsl.2013.12.006; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Watz H, 2014, LANCET RESP MED, V2, P63, DOI 10.1016/S2213-2600(13)70200-5; Kropski JA, 2013, DIS MODEL MECH, V6, P9, DOI 10.1242/dmm.010736; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Putman RK, 2014, AM J RESP CRIT CARE, V189, P770, DOI 10.1164/rccm.201312-2219PP; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Vestbo J, 2014, AM J RESP CRIT CARE, V189, P1022, DOI 10.1164/rccm.201311-2006PP; Cazzola M, 2012, EUR RESPIR J, V40, P724, DOI 10.1183/09031936.00213711; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Cazzola M, 2012, PHARMACOL REV, V64, P450, DOI 10.1124/pr.111.004580; Potts J, 2013, ANN PHARMACOTHER, V47, P361, DOI 10.1345/aph.1R337; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Wedzicha JA, 2013, CHEST, V143, P1302, DOI 10.1378/chest.12-1489; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Maes T, 2012, AM J RESP CELL MOL, V47, P261, DOI 10.1165/rcmb.2012-0080TR; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Vogelmeier C, 2012, COPD, V9, P111, DOI 10.3109/15412555.2011.641803; Barnes PJ, 2007, EUR RESPIR J, V29, P587, DOI 10.1183/09031936.00080306; Churg A, 2011, AM J RESP CELL MOL, V45, P1111, DOI 10.1165/rcmb.2011-0087PS; Infuhr D, 2005, ALLERGY, V60, P977, DOI 10.1111/j.1398-9995.2005.00832.x; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Datta A, 2011, BRIT J PHARMACOL, V163, P141, DOI 10.1111/j.1476-5381.2011.01247.x; Celli B, 2014, CHEST, V145, P981, DOI 10.1378/chest.13-1579; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Rafii R, 2013, J THORAC DIS, V5, P48, DOI 10.3978/j.issn.2072-1439.2012.12.07; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Barnes PJ, 2007, AM J RESP CRIT CARE, V175, P866, DOI 10.1164/rccm.200702-253ED; Bateman ED, 2014, EUR RESPIR J, V42, P1484; Bel EH, 2013, NEW ENGL J MED, V369, P549, DOI 10.1056/NEJMcp1214826; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Brusselle GG, 2006, PULM PHARMACOL THER, V19, P155, DOI 10.1016/j.pupt.2005.06.001; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P803, DOI 10.1016/j.jaci.2009.11.048; Calverley PMA, 2010, LANCET, V376, P1146; Cottin V., 2014, EUR RESPIR J, V21, P161; D'Alessandro-Gabazza CN, 2012, AM J RESP CELL MOL, V46, P397, DOI 10.1165/rcmb.2011-0158OC; Global Initiative for Asthma, 2014, GLOB IN ASTHM REV; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-04550C; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Loomis-King H, 2013, CURR OPIN PHARMACOL, V13, P377, DOI 10.1016/j.coph.2013.03.015; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rensen ELJ, 2009, ALLERGY, V64, P72, DOI 10.1111/j.1398-9995.2008.01881.x; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Spencer S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007033.pub3; vans Noords JA, 2005, EUR RESPIR J, V26, P214; Wedzicha JA, 2014, LANCET, V1, P199	89	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JAN	2015	20	1					15	23		10.1111/resp.12438		9	Respiratory System	Respiratory System	AW7TO	WOS:000346467400007		
J	Tsuji, T; Tanaka, E; Yasuda, I; Nakatsuka, Y; Kaji, Y; Yasuda, T; Hashimoto, S; Hwang, MH; Hajiro, T; Taguchi, Y				Tsuji, Takahiro; Tanaka, Eisaku; Yasuda, Ikkoh; Nakatsuka, Yoshinari; Kaji, Yusuke; Yasuda, Takehiro; Hashimoto, Seishu; Hwang, Moon Hee; Hajiro, Takashi; Taguchi, Yoshio			Nontuberculous mycobacteria in diffuse panbronchiolitis	RESPIROLOGY			English	Article						bronchiectasis; Japan; mucociliary clearance; prevalence	CYSTIC-FIBROSIS PATIENTS; AVIUM-INTRACELLULARE COMPLEX; LUNG-DISEASE; PULMONARY-DISEASE; BRONCHIECTASIS; CLARITHROMYCIN; INFECTIONS; EPIDEMIOLOGY; PREVALENCE; CLEARANCE	Background and objectiveNontuberculous mycobacterial (NTM) lung disease secondary to cystic fibrosis (CF) has been reported, but there is limited data about NTM prevalence in non-CF bronchiectasis. We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), a disorder also characterized by reduced mucociliary clearance with bronchiectasis. MethodsWe reviewed mycobacterial cultures, patient characteristics and computed tomography findings of 33 patients with DPB between January 2000 and December 2012. Prevalence was based on at least one positive NTM culture. ResultsMean patient age was 51.5 years. During a mean 162.8-month follow-up, the prevalence of NTM in sputum was 21.2% (seven patients). Of the seven positive patients, six had Mycobacterium avium complex, one had M.kansasii and M.chelonae co-cultured with M.avium complex. Three patients were positive twice, and two had positive smears. The mean time from DPB diagnosis to the first positive result was 194.6 months. NTM-positive patients tended to have lower forced expiratory volume in 1s (% predicted) than NTM-negative patients (50.0% vs 77.3%, P=0.03), but there were no radiological or clinical differences between the two groups. ConclusionsOur observations suggest that NTM is found more often in DPB. Defects of mucociliary clearance may predispose individuals to NTM infection. Defects in the mucociliary transport system are assumed to be a predisposing factor to nontuberculous mycobacterial (NTM) infection. We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), which is characterized by mucociliary dysfunction. We detected a high prevalence comparable to rates in cystic fibrosis.	[Tsuji, Takahiro; Tanaka, Eisaku; Yasuda, Ikkoh; Nakatsuka, Yoshinari; Kaji, Yusuke; Yasuda, Takehiro; Hashimoto, Seishu; Hwang, Moon Hee; Hajiro, Takashi; Taguchi, Yoshio] Tenri Hosp, Dept Resp Med, Tenri, Nara 6328552, Japan	Tsuji, T (reprint author), Tenri Hosp, Dept Resp Med, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	takahiro125@gmail.com					AKAI S, 1992, AM REV RESPIR DIS, V146, P781; Aksamit TR, 2002, CLIN CHEST MED, V23, P643, DOI 10.1016/S0272-5231(02)00022-9; Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; CHAN CHS, 1992, POSTGRAD MED J, V68, P896; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Tanaka E, 1997, AM J RESP CRIT CARE, V155, P2041; Poletti V, 2006, EUR RESPIR J, V28, P862, DOI 10.1183/09031936.06.00131805; Fowler SJ, 2006, EUR RESPIR J, V28, P1204, DOI 10.1183/09031936.06.00149805; Wickremasinghe M, 2005, THORAX, V60, P1045, DOI 10.1136/thx.2005.046631; Palwatwichai A, 2002, RESPIROLOGY, V7, P63, DOI 10.1046/j.1440-1843.2002.00367.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; AITKEN ML, 1993, CHEST, V103, P1096, DOI 10.1378/chest.103.4.1096; Koh WJ, 2005, RADIOLOGY, V235, P282, DOI 10.1148/radiol.2351040371; DAUTZENBERG B, 1993, ARCH INTERN MED, V153, P368, DOI 10.1001/archinte.153.3.368; WALLACE RJ, 1994, AM J RESP CRIT CARE, V149, P1335; Binder AM, 2013, AM J RESP CRIT CARE, V188, P807, DOI 10.1164/rccm.201307-1200OC; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; KILBY JM, 1992, CHEST, V102, P70, DOI 10.1378/chest.102.1.70; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829; Grenier P, 1993, J Thorac Imaging, V8, P213, DOI 10.1097/00005382-199322000-00006; IMAI T, 1995, J NUCL MED, V36, P1355; Kikuchi E, 2008, RESPIROLOGY, V13, P221, DOI 10.1111/j.1440-1843.2007.01208.x; KOLLBERG H, 1978, SCAND J RESPIR DIS, V59, P297; Kono C, 2012, SARCOIDOSIS VASC DIF, V29, P19; Levin DL, 2002, CLIN CHEST MED, V23, P603, DOI 10.1016/S0272-5231(02)00009-6; Martinez-Ceron E, 2012, REV CLIN ESP, V212, P127, DOI 10.1016/j.rce.2011.08.002; Morimoto Kozo, 2011, Kekkaku, V86, P547; Nakata K, 1999, ANN REPORT STUDY DIF, P109; Odaka M, 1981, ANN REPORT STUDY INT, P25; Park HY, 2009, J KOREAN MED SCI, V24, P427, DOI 10.3346/jkms.2009.24.3.427	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JAN	2015	20	1					80	86		10.1111/resp.12412		7	Respiratory System	Respiratory System	AW7TO	WOS:000346467400014		
J	Nakagawa, M; Hattori, N; Haruta, Y; Sugiyama, A; Iwamoto, H; Ishikawa, N; Fujitaka, K; Murai, H; Tanaka, J; Kohno, N				Nakagawa, Misa; Hattori, Noboru; Haruta, Yoshinori; Sugiyama, Aya; Iwamoto, Hiroshi; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Murai, Hiroshi; Tanaka, Junko; Kohno, Nobuoki			Effect of increasing respiratory rate on airway resistance and reactance in COPD patients	RESPIROLOGY			English	Article						chronic obstructive pulmonary disease; dyspnoea; forced oscillometry; metronome-paced tachypnoea; reactance	OBSTRUCTIVE PULMONARY-DISEASE; FORCED OSCILLATION TECHNIQUE; DYNAMIC HYPERINFLATION; FLOW LIMITATION; LUNG-DISEASE; EXERTIONAL BREATHLESSNESS; IMPULSE OSCILLOMETRY; EXERCISE; STANDARDIZATION; BRONCHODILATORS	Background and objectiveAirway resistance and reactance measured by forced oscillometry have been used to measure the severity of airway obstruction in chronic obstructive pulmonary disease (COPD) patients. The aims of this study were to assess the effects of tachypnoea on airway resistance and reactance and to correlate these with the severity of dyspnoea. We also evaluated the effects of short-acting (2)-agonist (SABA) on these measurements. MethodsAirway resistance and reactance were measured with an impulse oscillation system (IOS) in 20 COPD and 10 control participants during resting respiration and metronome-paced breathing at 20, 30 and 40 tidal breaths/min. The same measurements were made for COPD patients after SABA inhalation. Dyspnoea was evaluated using the modified Medical Research Council (MRC) scale. ResultsIn patients with COPD, higher respiratory rates increased expiratory and inspiratory resistance at 5Hz (R5), the difference in respiratory resistance at 5Hz and 20Hz (R5-R20), resonant frequency and decreased expiratory reactance. The decreases in expiratory reactance from 20 to 40 tidal breaths/min were significantly correlated with MRC scores. SABA inhalation significantly reduced the effect of increased respiratory rate on the reactance measurements. ConclusionsCharacteristic changes in IOS measurements, particularly expiratory reactance, induced by increased respiratory rates, were correlated with severity of dyspnoea in COPD patients during their daily lives. IOS and paced breathing may be useful for assessing breathlessness in COPD. Airway resistance and reactance were measured with an impulse oscillation system during metronome-paced tachypnoea in COPD patients and healthy controls. In COPD patients, tachypnoea resulted in more negative expiratory X5 values. In addition, these decreased expiratory X5 values induced by tachypnoea were correlated with the severity of dyspnoea in COPD.	[Nakagawa, Misa; Hattori, Noboru; Haruta, Yoshinori; Sugiyama, Aya; Iwamoto, Hiroshi; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Murai, Hiroshi; Kohno, Nobuoki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima 7348551, Japan; [Tanaka, Junko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima 7348551, Japan	Hattori, N (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nhattori@hiroshima-u.ac.jp					Albert P, 2012, THORAX, V67, P701, DOI 10.1136/thoraxjnl-2011-201458; Anderson W J, 2012, J R Coll Physicians Edinb, V42, P111, DOI 10.4997/JRCPE.2012.204; ODONNELL DE, 1993, AM REV RESPIR DIS, V148, P1351; YANAI M, 1992, J APPL PHYSIOL, V72, P1016; Kanda S, 2010, INTERNAL MED, V49, P23, DOI 10.2169/internalmedicine.49.2191; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Bestall JC, 1999, THORAX, V54, P581; O'Donnell DE, 1998, AM J RESP CRIT CARE, V158, P1557; Sugiyama A, 2013, RESP MED, V107, P875, DOI 10.1016/j.rmed.2013.03.005; Dellaca RL, 2004, EUR RESPIR J, V23, P232, DOI 10.1183/09031936.04.00046804; Fujimoto K, 2007, RESPIROLOGY, V12, P93, DOI 10.1111/j.1440-1843.2006.00963.x; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; ODonnell DE, 1997, AM J RESP CRIT CARE, V155, P109; VANNOORD JA, 1991, AM REV RESPIR DIS, V143, P922; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; Gelb AF, 2004, CHEST, V126, P1855, DOI 10.1378/chest.126.6.1855; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770; Kaczka David W., 2011, Critical Reviews in Biomedical Engineering, V39, P337, DOI 10.1615/CritRevBiomedEng.v39.i4.60; Kolsum U, 2009, RESP MED, V103, P136, DOI 10.1016/j.rmed.2008.07.014; Paredi P, 2010, THORAX, V65, P263, DOI 10.1136/thx.2009.120790; Al-Mutairi SS, 2007, CLIN EXP MED, V7, P56, DOI 10.1007/s10238-007-0126-y; Lahaije AJMC, 2013, CLIN PHYSIOL FUNCT I, V33, P62, DOI 10.1111/j.1475-097X.2012.01164.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Brooks SM, 1982, ATS NEWS, V8, P12; BUTLER J, 1960, J CLIN INVEST, V39, P584, DOI 10.1172/JCI104071; Cooper Christopher B, 2006, Am J Med, V119, P21, DOI 10.1016/j.amjmed.2006.08.004; Kitaguchi Y, 2013, RESP MED, V107, P394, DOI 10.1016/j.rmed.2012.11.013; Mineshita M, 2014, RESPIRATION, V87, P45, DOI 10.1159/000350228; Nishida O, 1976, JPN J CLIN PATHOL, V24, P941; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; O'Donnell DE, 1999, AM J RESP CRIT CARE, V160, P542; PuenteMaestu L, 2006, INT J CHRONIC OBSTR, V1, P381; Shiner RJ, 2012, LUNG FUNCTION TESTS, P31; The Japanese Respiratory Society, 2004, SPIROMETRY FLOW VOLU; VANBRABANDT H, 1983, J APPL PHYSIOL, V55, P1733	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JAN	2015	20	1					87	94		10.1111/resp.12387		8	Respiratory System	Respiratory System	AW7TO	WOS:000346467400015		
J	Hasegawa, W; Yamauchi, Y; Yasunaga, H; Sunohara, M; Jo, T; Matsui, H; Fushimi, K; Takami, K; Nagase, T				Hasegawa, Wakae; Yamauchi, Yasuhiro; Yasunaga, Hideo; Sunohara, Mitsuhiro; Jo, Taisuke; Matsui, Hiroki; Fushimi, Kiyohide; Takami, Kazutaka; Nagase, Takahide			Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan	RESPIROLOGY			English	Article						clinical epidemiology; lung transplantation; lymphangioleiomyomatosis; rare lung disease	LUNG TRANSPLANTATION; NATURAL-HISTORY; REGISTRY; PROGRESSION; MANAGEMENT; PROGNOSIS; UK	Background and objectiveLymphangioleiomyomatosis (LAM) is rare, but potentially life threatening owing to respiratory failure. However, knowledge is limited about the condition of hospitalized LAM patients. The objectives of this study were to investigate patient characteristics, comorbidities and causes of death among hospitalized LAM patients in Japan. MethodsUsing a national inpatient database in Japan, information on 280 LAM patients hospitalized between July 2010 and March 2013 was retrospectively collected. We divided the 280 patients into three groups according to their status regarding lung transplantation. ResultsFor the study period, we identified 32 patients who had undergone lung transplantation (after-transplantation' group), 12 patients admitted for lung transplantation (for-transplantation') and 236 patients who had not undergone transplantation (no-transplantation'). Although the clinical features of LAM patients in the no-transplantation' group were similar to previously reported findings, patients hospitalized in connection with transplantation showed the following: the activities of daily living score using the Barthel Index in the after-transplantation' group (89.4) was significantly higher than in the for-transplantation' group (64.6); the mortality rates in the after-transplantation group (3.1%) were significantly lower than in the for-transplantation group (25%). The most frequent comorbidity was pneumothorax, followed by respiratory failure and angiomyolipoma, although there was no significant difference in the prevalence among the three groups. ConclusionsWe determined the clinical features, comorbidities and fatalities in hospitalized LAM patients. Patients with LAM after transplantation had higher activities of daily living scores than those before transplantation, which suggests that lung transplantation may improve activities of daily living. Our study revealed the clinical features, comorbidities and causes of death in hospitalized patients with LAM. Patients with LAM after transplantation had higher activities of daily living scores than those before transplantation, which suggests that lung transplantation could improve the activities of daily life.	[Hasegawa, Wakae; Yamauchi, Yasuhiro; Sunohara, Mitsuhiro; Jo, Taisuke; Takami, Kazutaka; Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo 1138655, Japan; [Yamauchi, Yasuhiro; Jo, Taisuke] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138655, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yamauchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamauchiy-int@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation and grant to the Respiratory Failure Research Group).	McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; Cohen MM, 2005, THORAX, V60, P875, DOI 10.1136/thx.2004.035154; Maurer JR, 2007, J HEART LUNG TRANSPL, V26, P1293, DOI 10.1016/j.healun.2007.09.013; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; Almoosa KF, 2006, CHEST, V129, P1274, DOI 10.1378/chest.129.5.1274; Johnson SR, 2000, THORAX, V55, P1052, DOI 10.1136/thorax.55.12.1052; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Oprescu N, 2013, LUNG, V191, P35, DOI 10.1007/s00408-012-9419-3; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Japanese Lung and Heart-Lung Transplantation Study Group, 2014, REG REP 2014; MAHONEY F I, 1965, Md State Med J, V14, P61; Ohta T, 1974, No Shinkei Geka, V2, P623; Taveira-DaSilva AM, 2010, LYMPHAT RES BIOL, V8, P9, DOI 10.1089/lrb.2009.0024; The International Society for Heart & Lung Transplantation, 2014, REG HEART LUNG REG S; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JAN	2015	20	1					160	165		10.1111/resp.12430		6	Respiratory System	Respiratory System	AW7TO	WOS:000346467400025		
J	El-Shaheny, RN; Yamada, K				El-Shaheny, R. N.; Yamada, K.			The influence of pH and temperature on the stability of flutamide. An HPLC investigation and identification of the degradation product by EI+-MS	RSC ADVANCES			English	Article							PHARMACEUTICAL-PREPARATIONS; ANTICANCER DRUG; TABLETS	The chemical stability of flutamide (FLT) was investigated using a new validated stability-indicating HPLC method. Separation of FLT from its degradation product was achieved on a C-18 column using a mobile phase of methanol-phosphate buffer (0.04 M, pH 4.0) (75 : 25, v/v) with UV-detection at 240 nm. The method exhibited excellent linearity for FLT over the concentration range of 0.2-25.0 mu g mL(-1). FLT was found to be labile to degradation in buffered, acidic and alkaline solutions. The degradation kinetics of FLT in aqueous solutions was evaluated as a function of pH and temperature. Degradation of FLT followed first-order kinetics and Arrhenius behavior over the temperature ranges of 70-100 and 60-90 degrees C under acidic and alkaline conditions, respectively. The pH-rate profile was studied over the pH range of 2.0-12.0 with a maximum stability at pH 3.0-5.0. The activation energies for hydrolysis of FLT were calculated as 79.4 and 52.0 kJ mol(-1) at pH 0.5 (0.3 M HCl) and 12.5 (0.03 M NaOH), respectively. 4-Nitro-3- trifluoromethyl aniline was identified by mass spectrometry to be the degradation product resulting from the hydrolysis of FLT. The proposed HPLC method was validated according to ICH guidelines and applied for the quality control of FLT in commercial tablets with a mean percentage recovery of 100.09 +/- 0.20%.	[El-Shaheny, R. N.; Yamada, K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Nagasaki 8528521, Japan; [El-Shaheny, R. N.] Mansoura Univ, Fac Pharm, Analyt Chem Dept, Mansoura 35516, Egypt	El-Shaheny, RN (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	rania_n2010@yahoo.com			Ministry of Higher Education, Egyptian Government	R.N.E. appreciated financial support received from the Ministry of Higher Education, Egyptian Government for the short-term scientific mission in Nagasaki University-Japan.	Alvarez-Lueje A, 1998, ELECTROANAL, V10, P1043, DOI 10.1002/(SICI)1521-4109(199810)10:15<1043::AID-ELAN1043>3.3.CO;2-M; [Anonymous], 2011, US PHARM; [Anonymous], 2005, VALIDATION ANAL PROC; [Anonymous], 2003, STABILITY TESTING NE; [Anonymous], 1996, STABILITY TESTING PH; Brahman PK, 2012, COLLOID SURFACE A, V396, P8, DOI 10.1016/j.colsurfa.2011.12.015; Anton Smith A., 2009, INT J PHARM TECH RES, V1, P360; British pharmacopoeia Commission, 2013, BRIT PHARMACOPOEIA; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Bujji Babu N., 2011, J PHARM RES, V4, P4556; Deepakumari H. N., 2012, ISRN SPECTROSC, DOI [10.5402/2012/728594, DOI 10.5402/2012/728594]; Florence A. T., 2006, PHYSICOCHEMICAL PRIN, P93; Hammam E, 2004, CAN J CHEM, V82, P1386, DOI 10.1139/V04-104; Miller JN, 2005, STAT CHEMOMETRICS AN, p[39, 107, 256]; Miranda A, 2002, DRUG DEV IND PHARM, V28, P413, DOI 10.1081/DDC-120003002; Nagaraja P., 2002, INDIAN J PHARM SCI, V64, P272; Nagaraja P, 2002, INT J PHARM, V235, P113, DOI 10.1016/S0378-5173(01)00975-9; Nagaraja P, 2000, J PHARMACEUT BIOMED, V23, P617, DOI 10.1016/S0731-7085(00)00319-8; Peckova K, 2011, COLLECT CZECH CHEM C, V76, P1811, DOI 10.1135/cccc2011127; Salgado Herida Regina Nunes, 2005, Acta Farmaceutica Bonaerense, V24, P246; SCHULZ M, 1988, EUR J CLIN PHARMACOL, V34, P633, DOI 10.1007/BF00615229; Sweetman S. C., 2009, MARTINDALE COMPLETE, P725; vanderHouwen OAGJ, 1997, INT J PHARM, V155, P137, DOI 10.1016/S0378-5173(97)00156-7	23	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	5					3206	3214		10.1039/c4ra13617a		9	Chemistry, Multidisciplinary	Chemistry	AW6WC	WOS:000346405200013		
J	Jin, ZY; Zhang, QT; Yuan, SS; Ohno, T				Jin, Zhengyuan; Zhang, Qitao; Yuan, Saisai; Ohno, Teruhisa			Synthesis high specific surface area nanotube g-C3N4 with two-step condensation treatment of melamine to enhance photocatalysis properties	RSC ADVANCES			English	Article							GRAPHITIC CARBON NITRIDE; S-TRIAZINE DERIVATIVES; VISIBLE-LIGHT; NANOSHEETS; OXIDATION; CATALYSTS; WATER	High specific surface area nanotube g-C3N4 was fabricated by a simple two-step condensation method. Photocatalytic activity was evaluated by decomposition of Rhodamine B (Rh B) under visible light. Nanotube g-C3N4 showed 12 times higher photocatalytic activity than bulk g-C3N4. The improvement of photocatalytic activity was mainly due to the higher surface area, the unique morphology and the number of defects.	[Jin, Zhengyuan; Zhang, Qitao; Yuan, Saisai; Ohno, Teruhisa] Kyushu Inst Technol, Fac Engn, Dept Mat Sci, Kitakyushu, Fukuoka 8048550, Japan; [Ohno, Teruhisa] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ohno, Teruhisa] JST, ACT C, Kawaguchi, Saitama 3320012, Japan; [Ohno, Teruhisa] Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Kitakyushu, Fukuoka 8048550, Japan	Ohno, T (reprint author), Kyushu Inst Technol, Fac Engn, Dept Mat Sci, 1-1 Sensuicho, Kitakyushu, Fukuoka 8048550, Japan.	tohno@che.kyutech.ac.jp	YUAN, SAISAI/P-6639-2015		JST PRESTO program; JST ACT-C program	This work was supported by the JST PRESTO program and the JST ACT-C program.	Niu P, 2012, ADV FUNCT MATER, V22, P4763, DOI 10.1002/adfm.201200922; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Sano T, 2013, J MATER CHEM A, V1, P6489, DOI 10.1039/c3ta10472a; Kondo K, 2013, APPL CATAL B-ENVIRON, V142, P362, DOI 10.1016/j.apcatb.2013.05.042; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Yang SB, 2013, ADV MATER, V25, P2452, DOI 10.1002/adma.201204453; Jun YS, 2013, ADV FUNCT MATER, V23, P3661, DOI 10.1002/adfm.201203732; Jin ZY, 2014, APPL CATAL B-ENVIRON, V150, P479, DOI 10.1016/j.apcatb.2013.12.048; Dong GP, 2014, J PHOTOCH PHOTOBIO C, V20, P33, DOI 10.1016/j.jphotochemrev.2014.04.002; Zang YP, 2013, RSC ADV, V3, P13646, DOI 10.1039/c3ra41982g; Yan SC, 2009, LANGMUIR, V25, P10397, DOI 10.1021/la900923z; Shalom M, 2013, J AM CHEM SOC, V135, P7118, DOI 10.1021/ja402521s; Kroke E, 2002, NEW J CHEM, V26, P508, DOI 10.1039/b111062b; Horvath-Bordon E, 2004, DALTON T, P3900, DOI 10.1039/b412517g; Mahajan VK, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/125307; Meng YL, 2011, OPTOELECTRON ADV MAT, V5, P648; Tahir M., 2013, ACS APPL MATER INTER, V6, P1258; Yan S. C., 2010, DALTON T, P1488; Zhao W. B.-N. Peng, 2009, CHEM RES CHINESE U, V25, P412	20	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	6					4026	4029		10.1039/c4ra13355b		4	Chemistry, Multidisciplinary	Chemistry	AW9II	WOS:000346570300012		
J	Nishiwaki, N; Hamada, S; Watanabe, T; Hirao, S; Sawayama, J; Asahara, H; Saigo, K; Kamata, T; Funabashi, M				Nishiwaki, Nagatoshi; Hamada, Sayaka; Watanabe, Tomoe; Hirao, Shotaro; Sawayama, Jun; Asahara, Haruyasu; Saigo, Kazuhiko; Kamata, Toru; Funabashi, Masahiko			Development of a new palladium catalyst supported on phenolic resin	RSC ADVANCES			English	Article							LEAD-ACID-BATTERIES; COUPLING REACTIONS; HECK REACTIONS; PERFORMANCE; CELLULOSE	A phenolic resin-supported palladium catalyst, in which hydroxyl groups contribute to the stabilization of palladium nanoparticles, was developed. The catalyst could be used repeatedly, and thus has a large turn over number (TON). When a composite of polyethylene terephthalate and phenolic resin was employed as a support, the catalyst was easily deformed on demand.	[Nishiwaki, Nagatoshi; Hamada, Sayaka; Watanabe, Tomoe; Hirao, Shotaro; Sawayama, Jun; Asahara, Haruyasu; Saigo, Kazuhiko] Kochi Univ Technol, Sch Environm Sci & Engn, Kochi 7828502, Japan; [Nishiwaki, Nagatoshi; Asahara, Haruyasu] Kochi Univ Technol, Res Ctr Mat Sci & Engn, Kochi 7828502, Japan; [Kamata, Toru; Funabashi, Masahiko] Sumitomo Bakelite Co Ltd, Fujieda, Shizuoka 4260041, Japan	Nishiwaki, N (reprint author), Kochi Univ Technol, Sch Environm Sci & Engn, Kochi 7828502, Japan.	nishiwaki.nagatoshi@kochi-tech.ac.jp					Soomro SS, 2010, J CATAL, V273, P138, DOI 10.1016/j.jcat.2010.05.007; Zhao FY, 2000, CHEM-EUR J, V6, P843, DOI 10.1002/(SICI)1521-3765(20000303)6:5<843::AID-CHEM843>3.0.CO;2-G; Phan NTS, 2006, ADV SYNTH CATAL, V348, P609, DOI 10.1002/adsc.200505473; Reddy KR, 2006, J MOL CATAL A-CHEM, V252, P12, DOI 10.1016/j.molcata.2006.02.024; Pagliaro M, 2012, CHEMCATCHEM, V4, P432, DOI 10.1002/cctc.201100422; Ananikov VP, 2012, ORGANOMETALLICS, V31, P1595, DOI 10.1021/om201120n; Huang L, 2011, INORG CHEM, V50, P2094, DOI 10.1021/ic100824e; Cirtiu CM, 2011, GREEN CHEM, V13, P288, DOI 10.1039/c0gc00326c; Huang X, 2009, CATAL LETT, V133, P192, DOI 10.1007/s10562-009-0156-z; Keshipour S, 2013, CELLULOSE, V20, P973, DOI 10.1007/s10570-012-9852-8; Frollini E., 2012, WILEY ENCY COMPOSITE, V4, P2059; Genelot M, 2013, ADV SYNTH CATAL, V355, P2604, DOI 10.1002/adsc.201300357; Kimura T, 2007, T MRS JAP, V32, P1091; Kimura T, 2011, ELECTROCHEMISTRY, V79, P86; Prockl SS, 2004, ANGEW CHEM INT EDIT, V43, P1881, DOI 10.1002/anie.200353473; Reetz MT, 2004, CHEM COMMUN, P1559, DOI 10.1039/b406719n; Wang Y, 2012, TANZ, P45	17	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	6					4463	4467		10.1039/c4ra14346a		5	Chemistry, Multidisciplinary	Chemistry	AW9II	WOS:000346570300069		
J	Pham, TT; Defago, X; Huynh, QT				Thanh-Trung Pham; Defago, Xavier; Quyet-Thang Huynh			Reliability prediction for component-based software systems: Dealing with concurrent and propagating errors	SCIENCE OF COMPUTER PROGRAMMING			English	Article						Reliability modeling and prediction; Component-based software systems; Error propagation; Software fault tolerance mechanisms; Concurrently present errors	ARCHITECTURE	One of the most important quality attributes of a software system beyond its functional attributes is its reliability. Techniques for predicting reliability of a software system based on the design models can help software architects in evaluating the impact of their design decisions on the system reliability. This can help to make the system more reliable and avoid costs for fixing the implementation. However, existing reliability prediction approaches for component-based software systems are limited in their applicability because they either neglect or do not support modeling explicitly several factors which influence the system reliability: (i) error propagation, (ii) software fault tolerance mechanisms, and (iii) concurrently present errors. In this paper, we present a reliability modeling and prediction approach for component-based software systems that considers explicitly these reliability-relevant factors. Our approach offers a reliability modeling schema whose models are automatically transformed by our reliability prediction tool into Markov models for reliability predictions and sensitivity anajyses. We evaluate our approach in two case studies with reliability predictions and sensitivity analyses. Via these two case studies, we demonstrate its applicability in supporting design decisions. (C) 2014 Elsevier B.V. All rights reserved.	[Thanh-Trung Pham; Defago, Xavier] Japan Adv Inst Sci & Technol JAIST, Sch Informat Sci, Nomi, Ishikawa, Japan; [Quyet-Thang Huynh] Hanoi Univ Sci & Technol, Sch Informat & Commun Technol, Hanoi, Vietnam	Pham, TT (reprint author), Japan Adv Inst Sci & Technol JAIST, Sch Informat Sci, Nomi, Ishikawa, Japan.	thanhtrung.pham@jaist.ac.jp; defago@jaist.ac.jp; thanghq@soict.hut.edu.vn			322 FIVE-JAIST (Vietnam-Japan) program; JSPS KAKENHI Grant [23500060]	This work was supported by 322 FIVE-JAIST (Vietnam-Japan) program and JSPS KAKENHI Grant Number 23500060. We are grateful to Francois Bonnet for his invaluable comments that greatly helped improve this manuscript.	Abdelmoez W., 2004, Proceedings. 10th International Symposium on Software Metrics; Cheung L, 2008, ICSE'08 PROCEEDINGS OF THE THIRTIETH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, P111; Brosch F, 2012, IEEE T SOFTWARE ENG, V38, P1319, DOI 10.1109/TSE.2011.94; Gokhale SS, 2007, IEEE T DEPEND SECURE, V4, P32, DOI 10.1109/TDSC.2007.4; Mohamed A, 2008, INT CONF QUAL SOFTW, P402, DOI 10.1109/QSIC.2008.46; Bernardi S, 2011, SOFTW SYST MODEL, V10, P313, DOI 10.1007/s10270-009-0128-1; Sharma VS, 2007, J SYST SOFTWARE, V80, P493, DOI 10.1016/j.jss.2006.07.021; Hiller M, 2004, IEEE T COMPUT, V53, P512, DOI 10.1109/TC.2004.1275294; Reussner RH, 2003, J SYST SOFTWARE, V66, P241, DOI 10.1016/S0164-1212(02)00080-8; Avizienis A, 2004, IEEE T DEPEND SECURE, V1, P11, DOI 10.1109/TDSC.2004.2; CHEUNG RC, 1980, IEEE T SOFTWARE ENG, V6, P118, DOI 10.1109/TSE.1980.234477; Brosch F., 2011, P JOINT ACM SIGSOFT, P75; Cortellesa V., 2002, P 3 INT WORKSH SOFTW, P302; Cortellessa V, 2007, LECT NOTES COMPUT SC, V4608, P140; DUGAN JB, 1995, SOFTWARE FAULT TOLER, P109; Filieri A, 2010, LECT NOTES COMPUT SC, V6092, P1, DOI 10.1007/978-3-642-13238-4_1; Gokhale SS, 1997, PACIFIC RIM INTERNATIONAL SYMPOSIUM ON FAULT-TOLERANT SYSTEMS, PROCEEDINGS, P167, DOI 10.1109/PRFTS.1997.640143; Goseva-Popstojanova K, 2003, IEEE T SOFTWARE ENG, V29, P946, DOI 10.1109/TSE.2003.1237174; Goseva-Popstojanova K, 2003, COMPUT MATH APPL, V46, P1023, DOI 10.1016/S0898-1221(03)00307-9; Grassi V, 2005, LECT NOTES COMPUT SC, V3549, P279; Hamill M, 2009, IEEE T SOFTWARE ENG, V35, P484, DOI 10.1109/TSE.2009.3; Immonen A, 2008, SOFTW SYST MODEL, V7, P49, DOI 10.1007/s10270-006-0040-x; KANOUN K, 1993, IEEE T RELIAB, V42, P205, DOI 10.1109/24.229488; Lipton MW, 2008, SPRINGER SER RELIAB, P309, DOI 10.1007/978-1-84800-113-8_15; Lyu M. R., 1996, HDB SOFTWARE RELIABI; *OMG, 2008, OMG UN MOD LANG OMG; PHAM TT, 2012, P 12 INT C QUAL SOFT, P106; PHAM TT, 2013, P 8 INT C AV REL SEC, P11; Popic P, 2005, 16th IEEE International Symposium on Software Reliability Engineering, Proceedings, P53, DOI 10.1109/ISSRE.2005.18; Pullum L. L., 2001, SOFTWARE FAULT TOLER; Reussner RH, 2003, FUTURE GENER COMP SY, V19, P627, DOI 10.1016/S0167-739X(02)00173-5; Rodrigues G, 2005, LECT NOTES COMPUT SC, V3442, P111; Sato N., 2007, IEEE INT C SERV COMP, P114, DOI 10.1109/SCC.2007.21; Sharma VS, 2006, ISSRE 2006:17TH INTERNATIONAL SYMPOSIUM ON SOFTWARE RELIABILITY ENGINEERING, PROCEEDINGS, P299; Trivedi K. S., 2001, PROBABILITY STAT REL; Wang WL, 2006, J SYST SOFTWARE, V79, P132, DOI 10.1016/j.jss.2005.09.004; Whittaker J. A., 1993, ACM Transactions on Software Engineering and Methodology, V2, DOI 10.1145/151299.151326; Yacoub S, 2004, IEEE T RELIAB, V53, P465, DOI 10.1109/TR.2004.838034; Zheng Z., 2010, P 32 ACM IEEE INT C, V1, P35, DOI DOI 10.1145/1806799.1806809; 2014, RELIABILITY MODELING	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6423	1872-7964		SCI COMPUT PROGRAM	Sci. Comput. Program.	JAN 1	2015	97		4		SI		426	457		10.1016/j.scico.2014.03.016		32	Computer Science, Software Engineering	Computer Science	AW8YO	WOS:000346545400004		
J	Kunimitsu, Y				Kunimitsu, Yoji			Regional Factors Affecting the Satisfaction of Residents: Evidence from a Structural Equation Model in Japan	SOCIAL INDICATORS RESEARCH			English	Article						Structural equation model; Ordered probit model; Social capital; Economic revitalization	HAPPINESS; INCREASE	To sustain rural areas in Japan, policymakers pay attention to improvement of residents' satisfaction. The present study empirically shows the causative factors for the personal and regional level of residents' satisfaction in their daily lives. The ordered probit model was employed to explain personal factors and to quantify regional differences in the average satisfaction level. Regional differences were then regressed with the regional factors by using a structural equation model. Estimations demonstrated the following results. First, different from previous studies (Tsutsui, 2010), significant differences in regional satisfaction level were measured. Second, these regional differences were influenced by the economic revitalization, represented by job opportunities and average gross regional production; social capital, shown by the level of trust, altruistic norms and human networks; public facilities for basic human needs; and the town's reputation perceived by the person outside. Social capital and reputation from outside had the strong impact on the regional satisfaction level. Third, social capital was low at a town where economic revitalization level was high, showing a tradeoff effect, whereas the construction of public facilities advanced in the town where the revitalization level was high. These tradeoff and supplemental effects can be explained by urbanization as substantial variable.	Natl Inst Rural Engn NARO, Rural Dev Planning Div, Tsukuba, Ibaraki 3058609, Japan	Kunimitsu, Y (reprint author), Natl Inst Rural Engn NARO, Rural Dev Planning Div, 2-1-6 Kannondai, Tsukuba, Ibaraki 3058609, Japan.	ykuni@affrc.go.jp					Aldrich P. D., 2012, BUILDING RESILIENCE; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Helliwell JF, 2006, ECON J, V116, pC34, DOI 10.1111/j.1468-0297.2006.01074.x; Graham C, 2002, J DEV STUD, V38, P100, DOI 10.1080/00220380412331322431; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111; Blanchflower D. G., 2000, 7487 NBER, P1359; Bohnke P, 2008, SOC INDIC RES, V87, P189, DOI 10.1007/s11205-007-9169-4; Cabinet Office of Japan, 2003, QUANT MEAS CIV ACT S; Cabinet Office of Japan, 2008, JAP PUBL CAP STOCKS; Diener Ed, 2004, Psychol Sci Public Interest, V5, P1, DOI 10.1111/j.0963-7214.2004.00501001.x; Frey B. S., 2002, HAPPINESS EC; Frey B. S., 2001, EC I EC J, V110, P918; Hagerty M. R., 2000, J PERS SOC PSYCHOL, V78, P746; [Hakuhodo Hakuhodo project team], 2006, BRAND NAM LOC AR, P11; Hashizume N., 2003, REV RES PROJ RUR AR; Inaba Y., 2005, MARKET SOC BUILDING, P49; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Kunimitsu Y., 2010, STUDIES REGIONAL SCI, V40, P129; Leu R. E., 1997, LEBENSQUALITAT ARMUT; Litchfield J., 2011, J ECON BEHAV ORGAN, V81, P731; Ministry of Agriculture Forestry and Fishery, 2004, REG MED OFF C P, P1; Ministry of Internal Affairs and Communications, INV SIT PUBL FAC; Ohtake F., 2010, HAPPINESS JAPAN, P149; Orr M, 2002, URBAN AFF REV, V37, P397, DOI 10.1177/10780870222185397; Putnam RD, 1993, MAKING DEMOCRACY WOR; Tachibanaki T., 2012, REGIONAL INEQUALITIE, P145; Takano J., 2012, MAN WHO LET POPE EAT; Tandoc EC, 2013, SOC INDIC RES, V113, P537, DOI 10.1007/s11205-012-0109-6; Toyoda H., 1998, STRUCTURAL EQUATION, P88; Tsutsui Y., 2010, HAPPINESS JAPAN, P165; VEENHOVEN R, 2000, J COMP POLICY ANAL, V0002	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	JAN	2015	120	2					483	497		10.1007/s11205-014-0600-3		15	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	AW8FG	WOS:000346495700009		
J	Unno, Y; Shinano, T; Minamisawa, K; Ikeda, S				Unno, Yusuke; Shinano, Takuro; Minamisawa, Kiwamu; Ikeda, Seishi			Bacterial community shifts associated with high abundance of Rhizobium spp. in potato roots under macronutrient-deficient conditions	SOIL BIOLOGY & BIOCHEMISTRY			English	Article						Bacterial community; Fertilization; Potato; Rhizobium; Root-associated bacteria	PLANT-GROWTH; PHYTOSPHERE; PROMOTION; RICE; SOIL	We evaluated the impacts of a macronutrient deficiency on the community structure of root-associated bacteria in potato (Solanum tuberosum) cultivation. Potato plants were cultivated in a long-term experimental field under a nitrogen, phosphorus, or potassium deficiency, and roots were sampled at the early flowering stage. Amplicon libraries of 16S rRNA gene were constructed for root-associated bacteria, and bacterial diversity was analyzed by Means of pyrosequencing. Statistical analyses showed significantly lower species evenness in the nutrient-deficient plots compared with the value in a plot with standard fertilization. Phylogenetic analyses revealed that the abundance of Rhizobium spp. increased dramatically in all plots under a macronutrient deficiency. (C) 2014 Elsevier Ltd. All rights reserved.	[Unno, Yusuke] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Hitsujigaoka Res Stn, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan; [Shinano, Takuro] Natl Agr & Food Res Org, Tohoku Agr Res Ctr, Agr Radiat Res Ctr, Arai, Fukushima 9602156, Japan; [Minamisawa, Kiwamu] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Ikeda, Seishi] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro Res Stn, Memuro, Hokkaido 0820081, Japan	Ikeda, S (reprint author), Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, 9-4 Shinsei Minami, Memuro, Hokkaido 0820081, Japan.	sikeda67@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan; Ministry of Education, Science, Sports and Culture of Japan [23248052, 23380196, 22580074]	We thank R. Ito and Mayumi Hayakawa of the Hokkaido Agricultural Research Center, NARO, Japan, for their technical assistance. This work was supported in part by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries", and by grants (A) 23248052, (B) 23380196 and (C) 22580074 from the Ministry of Education, Science, Sports and Culture of Japan.	Normander B, 2000, APPL ENVIRON MICROB, V66, P4372, DOI 10.1128/AEM.66.10.4372-4377.2000; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; KRAFFCZYK I, 1984, SOIL BIOL BIOCHEM, V16, P315, DOI 10.1016/0038-0717(84)90025-7; Thomas P, 2009, MICROB ECOL, V58, P952, DOI 10.1007/s00248-009-9559-z; Ikeda S, 2010, PLANT CELL PHYSIOL, V51, P1398, DOI 10.1093/pcp/pcq119; Ikeda S, 2009, MICROB ECOL, V58, P703, DOI 10.1007/s00248-009-9566-0; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; Someya N, 2013, MICROBES ENVIRON, V28, P295, DOI 10.1264/jsme2.ME13006; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Ikeda S., 2004, MICROBES ENVIRON, V19, P301, DOI 10.1264/jsme2.19.301; Kawaguchi M, 2010, PLANT CELL PHYSIOL, V51, P1377, DOI 10.1093/pcp/pcq125; Martins G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073013; OHWAKI Y, 1992, SOIL SCI PLANT NUTR, V38, P235; Paterson E, 2000, J EXP BOT, V51, P1449, DOI 10.1093/jexbot/51.349.1449; Thakuria D, 2009, BIOL FERT SOILS, V45, P237, DOI 10.1007/s00374-008-0320-4	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-0717			SOIL BIOL BIOCHEM	Soil Biol. Biochem.	JAN	2015	80						232	236		10.1016/j.soilbio.2014.10.002		5	Soil Science	Agriculture	AW8YS	WOS:000346545800027		
J	Murase, J; Hida, A; Ogawa, K; Nonoyama, T; Yoshikawa, N; Imai, K				Murase, Jun; Hida, Azusa; Ogawa, Kaori; Nonoyama, Toshihiro; Yoshikawa, Nanako; Imai, Katsuhiko			Impact of long-term fertilizer treatment on the microeukaryotic community structure of a rice field soil	SOIL BIOLOGY & BIOCHEMISTRY			English	Article						Algae; Long-term fertilizer treatment; Microeukaryotes; Paddy soil; Protists; rRNA	FATTY-ACID ANALYSIS; RIBOSOMAL-RNA-GENE; EUKARYOTIC COMMUNITIES; PROTISTAN COMMUNITIES; MICROBIAL BIOMASS; PADDY SOILS; DIVERSITY; STRAW; DECOMPOSITION; DGGE	Microeukaryotes play many different functional roles in soil ecosystems, but the environmental factors that shape their community composition are poorly understood. Here we studied the impact of chemical and organic fertilizers on the microeukaryotic soil communities of rice field plots under long-term (82 years) fertilizer management. Terminal restriction fragment polymorphism (T-RFLP) and clone library analyses of 18S rRNA genes and their transcripts obtained from soils subjected to five different fertilizer treatments showed that fertilizer management strongly influenced microeukaryotic community composition in the soils and that its impact was greater than that of water management or seasonality. Among the different chemical fertilizers, the effects of phosphorus fertilizer on community composition were more pronounced than those of either nitrogen or potassium. Soils without phosphorus fertilizer were characterized by a high relative abundance of diatoms and algivorous nematodes whereas in phosphorus-fertilized soils green algae predominated. Different rates of organic fertilizer (rice straw compost) application had distinctive effects on the DNA-based microeukaryotic community, especially its algal composition. Thus, protistan grazers were the largest group in the potentially active community from soils with a higher amount of organic fertilizer application. Our findings provide evidence that long-term fertilization shapes the microeukaryotic community composition of rice field soils. The results imply that fertilizer management of rice field soils is an important determinant of the structure and function of the microbial food web. (C) 2014 Elsevier Ltd. All rights reserved.	[Murase, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Hida, Azusa; Ogawa, Kaori] Nagoya Univ, Sch Agr Sci, Nagoya, Aichi 4648601, Japan; [Nonoyama, Toshihiro; Yoshikawa, Nanako; Imai, Katsuhiko] Aichi Agr Res Ctr, Nagakute, Aichi 4801193, Japan	Murase, J (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	murase@agr.nagoya-u.ac.jp			 [20580061];  [25292207]	We thank Prof. Emeritus M. Kimura, Prof. S. Asakawa, and Dr. T. Watanabe for valuable comments on the study. We are also grateful to the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper. This work was supported by a Grant-in-Aid for Scientific Research (C) 20580061 and (B) 25292207 to J.M.	Nakamura A, 2003, BIOL FERT SOILS, V38, P288, DOI 10.1007/s00374-003-0658-6; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Lentendu G, 2014, MOL ECOL, V23, P3341, DOI 10.1111/mec.12819; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Murase J, 2014, MICROBES ENVIRON, V29, P74, DOI 10.1264/jsme2.ME13128; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001; Murase J, 2012, FEMS MICROBIOL ECOL, V79, P371, DOI 10.1111/j.1574-6941.2011.01224.x; Sun B, 2014, ECOL EVOL, V4, P1073, DOI 10.1002/ece3.1006; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Egert M, 2005, J MICROBIOL METH, V61, P69, DOI 10.1016/j.mimet.2004.11.002; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Ahn JH, 2012, J MICROBIOL, V50, P754, DOI 10.1007/s12275-012-2409-6; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Euringer K, 2008, J MICROBIOL METH, V75, P262, DOI 10.1016/j.mimet.2008.06.012; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Cahyani VR, 2002, SOIL SCI PLANT NUTR, V48, P735; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clarke K. R., 2006, PRIMER V6 USER MANUA; Fell JW, 2006, SOIL BIOL BIOCHEM, V38, P3107, DOI 10.1016/j.soilbio.2006.01.014; Fujita Y, 2006, LIMNOLOGY, V7, P83, DOI 10.1007/s10201-006-0167-z; Hatamoto M, 2008, BIOL FERT SOILS, V44, P527, DOI 10.1007/s00374-007-0239-1; KIKUCHI E, 1975, Reports of the Institute for Agricultural Research Tohoku University, V26, P25; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Kimura M, 2000, BOOK SOIL P, P35; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; Okada H, 2011, SOIL BIOL BIOCHEM, V43, P2142, DOI 10.1016/j.soilbio.2011.06.018; Shiota Y., 1987, SOIL MICROORGANISMS, V29, P3; Sugano A, 2007, SOIL SCI PLANT NUTR, V53, P585, DOI 10.1111/j.1747-0765.2007.00187.x; Yuan HZ, 2013, J SOIL SEDIMENT, V13, P877, DOI 10.1007/s11368-013-0664-8	35	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-0717			SOIL BIOL BIOCHEM	Soil Biol. Biochem.	JAN	2015	80						237	243		10.1016/j.soilbio.2014.10.015		7	Soil Science	Agriculture	AW8YS	WOS:000346545800028		
J	Tada, K				Tada, Kazuya			Thermally robust bulk heterojunction photocells based on PTB7:C-70 composites	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Fullerenes; Conjugated polymers; Photovoltaic devices; Halogen-free solvents; Thermal robustness	POLYMER SOLAR-CELLS; POWER CONVERSION EFFICIENCY; HALOGEN-FREE SOLVENT; OPEN-CIRCUIT VOLTAGE; CONDUCTING POLYMER; BUCKMINSTERFULLERENE; LUMINESCENCE; ENHANCEMENT; TRANSISTORS; C-70	Bulk heterojunction (BHJ) photocells using low energy-gap polymers such as poly[[4,8-bis[(2-ethylhexyl) oxy]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl][3-fluoro-2-[(2-ethylhexyl)carbonyllthieno[3,4-b]thiophen ediyl]] (PTB7) and modified fullerenes such as [6,6]-phenyl-C-71-butyric acid methyl ester (C-70-PCBM) show relatively high power conversion efficiency. It is known that the thermal annealing, which effectively improves the photovoltaic performance of BHJ photocells with semi-crystalline polymers such as poly (3-hexylthiophene), is not applicable to BHJ photocells with amorphous-type polymers such as PTB7. In this study, it is found that PTB7:C70-PCBM BHJ photocells degrade shortly at 80 degrees C, which is within the range of the temperature shock cycling test condition specified in IEC 61646, the international standard for testing thin-film photovoltaic module. On the other hand, the photovoltaic performance of PTB7:C-70 BHJ photocells composite has been found to significantly improve after the thermal annealing at 160 degrees C. The results strikingly indicate not only that the lack of thermal robustness in PTB7:C-70-PCBM BHJ photocells does not mainly arise from the nature of the polymer but the substituents of the fullerene used, but also that neat fullerenes should not be considered as just cheap and nasty substitutes of fullerene derivatives. (C) 2014 Elsevier B.V. All rights reserved.	Univ Hyogo, Div Elect Engn, Himeji, Hyogo 6712201, Japan	Tada, K (reprint author), Univ Hyogo, Div Elect Engn, 2167 Shosha, Himeji, Hyogo 6712201, Japan.	tada@eng.u-hyogo.ac.jp			JSPS KAKENHI [26289094]	This work was partially supported by JSPS KAKENHI Grant number 26289094.	MORITA S, 1992, SOLID STATE COMMUN, V82, P249, DOI 10.1016/0038-1098(92)90636-N; He ZC, 2011, ADV MATER, V23, P4636, DOI 10.1002/adma.201103006; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Chen KS, 2012, ORG ELECTRON, V13, P2870, DOI 10.1016/j.orgel.2012.08.026; Tada K, 2013, SOL ENERG MAT SOL C, V108, P82, DOI 10.1016/j.solmat.2012.09.014; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Lim GH, 2014, ORG ELECTRON, V15, P449, DOI 10.1016/j.orgel.2013.10.025; Yamamoto S, 2012, ADV ENERGY MATER, V2, P229, DOI 10.1002/aenm.201100549; Li G, 2012, NAT PHOTONICS, V6, P153, DOI 10.1038/NPHOTON.2012.11; Guo JC, 2010, J PHYS CHEM B, V114, P742, DOI 10.1021/jp909135k; Tundo P, 2012, PURE APPL CHEM, V84, P411, DOI 10.1351/PAC-CON-12-02-02; Anthopoulos TD, 2005, J APPL PHYS, V98, DOI 10.1063/1.2034083; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Wang T, 2012, ADV FUNCT MATER, V22, P1399, DOI 10.1002/adfm.201102510; Krebs FC, 2010, ENERG ENVIRON SCI, V3, P512, DOI 10.1039/b918441d; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Haddock JN, 2005, ORG ELECTRON, V6, P182, DOI 10.1016/j.orgel.2005.06.002; Servaites JD, 2011, ENERG ENVIRON SCI, V4, P4410, DOI 10.1039/c1ee01663f; [Anonymous], 2008, 61646 IEC; Tada K, 2014, SOL ENERG MAT SOL C, V120, P136, DOI 10.1016/j.solmat.2013.08.033; Schmidt-Hansberg B, 2012, SOL ENERG MAT SOL C, V96, P195, DOI 10.1016/j.solmat.2011.09.059; Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P394, DOI 10.1016/j.solmat.2008.10.004; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Fox J., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.1007/S10864-005-0957-0; Gupta D., 2008, APPL PHYS LETT, V92; Hedley G.J., 2013, NAT COMMUN, P4; R Core Team, 2013, R LANG ENV STAT COMP; Tada K, 2013, SOL ENERG MAT SOL C, V117, P194, DOI 10.1016/j.solmat.2013.06.004; Tada K., 2014, APPL PHYS EXPRESS, V7; YOSHINO K, 1993, JPN J APPL PHYS 2, V32, pL357, DOI 10.1143/JJAP.32.L357	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	JAN	2015	132						15	20		10.1016/j.solmat.2014.07.052		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AW9AE	WOS:000346549400003		
J	Terasako, T; Murakami, T; Hyodou, A; Shirakata, S				Terasako, Tomoaki; Murakami, Toshihiro; Hyodou, Atsushi; Shirakata, Sho			Structural and electrical properties of CuO films and n-ZnO/p-CuO heterojunctions prepared by chemical bath deposition based technique	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						ZnO; CuO; Chemical bath deposition; Heterojunction	OXIDE THIN-FILMS; DEVICES; GROWTH	Structural and electrical properties of the CuO films and the ZnO/CuO heterojunctions prepared by chemical bath deposition (CBD) technique involving thermal annealing process were studied by scanning electron microscope observation, X-ray diffraction, current density-voltage (J-V) and capacitance-voltage (C-V) measurements. The as-grown CuO films showed p-type conduction after annealing in the air at temperatures (T-A) ranging from 200 to 300 degrees C. The n-ZnO/p-CuO heterojunctions were composed of the columnar CuO grains and the ZnO nanorods (NRs) and their J-V curves exhibited rectifying characteristics with large diode ideality, factors (n) and leakage currents. The insertion of the ZnO intermediate layer prepared by dip-coating (denoted by "Dip-coating ZnO") between the ZnO and CuO layers was found to be effective for reducing the n value and suppressing the leakage current. The threshold voltage (V-th), built-in potential (V-bi) and n value of the ZnO/Dip-coating ZnO/CuO heterojunction were strongly dependent on T-A and showed minima around T-A=250-300 degrees C. Taking into account the fact that the rectification ratios of the forward current to the reverse current were very low at the same T-A region, the low V-th and V-bi values are attributed to the tunneling process through the interface states introduced by the structural imperfection. (C) 2014 Elsevier B.V. All rights reserved.	[Terasako, Tomoaki; Murakami, Toshihiro; Shirakata, Sho] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Hyodou, Atsushi] Ehime Univ, Fac Engn, Matsuyama, Ehime 7908577, Japan	Terasako, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	terasako.tomoaki.mz@ehime-u.ac.jp					Castillo SJ, 2001, J PHYS CHEM SOLIDS, V62, P1069, DOI 10.1016/S0022-3697(00)00282-1; Dey KK, 2012, RSC ADV, V2, P1387, DOI 10.1039/c1ra00710f; Minami T, 2000, MRS BULL, V25, P38, DOI 10.1557/mrs2000.149; Kawwam M, 2012, APPL SURF SCI, V258, P9949, DOI 10.1016/j.apsusc.2012.06.055; Kidowaki H, 2012, J PHYS CONF SER, V352, DOI 10.1088/1742-6596/352/1/012022; Saji KJ, 2013, PHYS STATUS SOLIDI A, V210, P1386, DOI 10.1002/pssa.201228293; Nair MTS, 1999, APPL SURF SCI, V150, P143, DOI 10.1016/S0169-4332(99)00239-1; Kilic C, 2002, APPL PHYS LETT, V81, P73, DOI 10.1063/1.1482783; Wang W, 2009, BIOSENS BIOELECTRON, V25, P708, DOI 10.1016/j.bios.2009.08.013; Peng Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4719059; Meyer BK, 2012, PHYS STATUS SOLIDI B, V249, P1487, DOI 10.1002/pssb.201248128; Terasako T, 2013, THIN SOLID FILMS, V549, P292, DOI 10.1016/j.tsf.2013.05.174; Abe H, 2012, PHYS STATUS SOLIDI C, V9, P1396, DOI 10.1002/pssc.201100666; BAEK KK, 1995, SOLID STATE IONICS, V75, P179, DOI 10.1016/0167-2738(94)00172-O; Zainelabdin A, 2012, APPL PHYS A-MATER, V108, P921, DOI 10.1007/s00339-012-6995-2; Minami T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.044101; Morales J, 2004, ELECTROCHIM ACTA, V49, P4589, DOI 10.1016/j.electacta.2004.05.012; Rao GN, 2009, J APPL PHYS, V105, DOI 10.1063/1.3120785; Chatterjee AP, 1999, J MATER SCI, V34, P4225, DOI 10.1023/A:1004694501646; Lian CX, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2983648; Maruyama T, 1998, SOL ENERG MAT SOL C, V56, P85, DOI 10.1016/S0927-0248(98)00128-7; Minami T., 2011, APPL PHYS EXPRESS, V4; Neupane M.P., 2008, SURF INTERFACE ANAL, V41, P259; Ramirez-Ortiza J, 2001, APPL SURF SCI, V174, P177, DOI 10.1016/S0169-4332(00)00822-9; Torvik JT, 1998, APPL PHYS LETT, V72, P945, DOI 10.1063/1.120881; Triboulet R, 2003, PROG CRYST GROWTH CH, V47, P65, DOI 10.1016/j.pcrysgrow.2005.01.003; Verma M, 2010, THIN SOLID FILMS, V518, pE181, DOI 10.1016/j.tsf.2010.03.162	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	JAN	2015	132						74	79		10.1016/j.solmat.2014.08.023		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AW9AE	WOS:000346549400010		
J	Linares, PG; Lopez, E; Ramiro, I; Datas, A; Antolin, E; Shoji, Y; Sogabe, T; Okada, Y; Marti, A; Luque, A				Linares, P. G.; Lopez, E.; Ramiro, I.; Datas, A.; Antolin, E.; Shoji, Y.; Sogabe, T.; Okada, Y.; Marti, A.; Luque, A.			Voltage limitation analysis in strain-balanced InAs/GaAsN quantum dot solar cells applied to the intermediate band concept	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Solar cell; Intermediate band; Quantum dot; Concentrated light; Band anticrossing; GaAsN	ALLOYS	Several attempts have been carried out to manufacture intermediate band solar cells (IBSC) by means of quantum dot (QD) superlattices. This novel photovoltaic concept allows the collection of a wider range of the sunlight spectrum in order to provide higher cell photocurrent while maintaining the open-circuit voltage (V-OC) of the cell. In this work, we analyze InAs/GaAsN QD-IBSCs. In these cells, the dilute nitrogen in the barrier plays an important role for the strain-balance (SB) of the QD layer region that would otherwise create dislocations under the effect of the accumulated strain. The introduction of GaAsN SB layers allows increasing the light absorption in the QD region by multi-stacking more than 100 QD layers. The photo-generated current density (J(L)) versus V-OC was measured under varied concentrated light intensity and temperature. We found that the V-OC of the cell at 20 K is limited by the bandgap of the GaAsN barriers, which has important consequences regarding IBSC bandgap engineering that are also discussed in this work. (C) 2014 Elsevier B.V. All rights reserved.	[Linares, P. G.; Lopez, E.; Ramiro, I.; Datas, A.; Antolin, E.; Marti, A.; Luque, A.] Univ Politecn Madrid, Inst Energia Solar, E-28040 Madrid, Spain; [Shoji, Y.; Sogabe, T.; Okada, Y.] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Linares, PG (reprint author), Univ Politecn Madrid, Inst Energia Solar, E-28040 Madrid, Spain.	p.garcia-linares@ies-def.upm.es	Ramiro, Inigo/K-5543-2015; Datas, Alejandro/M-2490-2014; Antolin, Elisa/M-4097-2014	Datas, Alejandro/0000-0001-5964-3818; Antolin, Elisa/0000-0002-5220-2849	European Commission [283798]; Ayudas para la Formacion de Personal Investigador (FPI) of the Spanish Government [EEBB-BES-2010-037659]	This work has been supported by the European Commission through the Project NGCPV (Grant number 283798). EL acknowledges the Ayudas para la Formacion de Personal Investigador (FPI) of the Spanish Government (EEBB-BES-2010-037659).	Akahane K, 1998, APPL PHYS LETT, V73, P3411, DOI 10.1063/1.122781; Lopez N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028701; Antolin E, 2010, IEEE PHOT SPEC CONF, P65; Shan W, 1999, PHYS REV LETT, V82, P1221, DOI 10.1103/PhysRevLett.82.1221; Mellor A, 2011, PROG PHOTOVOLTAICS, V19, P676, DOI 10.1002/pip.1086; Marti A, 2008, THIN SOLID FILMS, V516, P6716, DOI 10.1016/j.tsf.2007.12.064; Wu J, 2002, SEMICOND SCI TECH, V17, P860, DOI 10.1088/0268-1242/17/8/315; Linares PG, 2011, J APPL PHYS, V109, DOI 10.1063/1.3527912; Marti A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747195; Luque A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821580; Popescu V, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205321; Luque A, 2010, SOL ENERG MAT SOL C, V94, P2032, DOI 10.1016/j.solmat.2010.06.008; Antolin E, 2010, J APPL PHYS, V108, DOI 10.1063/1.3468520; Antolin E, 2010, 2010 35th IEEE Photovoltaic Specialists Conference (PVSC), DOI 10.1109/PVSC.2010.5614224; Kudrawiec R, 2014, PHYS REV APPL, V1, DOI 10.1103/PhysRevApplied.1.034007; Linares PG, 2012, SOL ENERG MAT SOL C, V98, P240, DOI 10.1016/j.solmat.2011.11.015; Linares PG, 2013, IEEE J PHOTOVOLT, V3, P753, DOI 10.1109/JPHOTOV.2013.2241395; Linares P.G., SOL ENERGY MAT SOL C, V108; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Luque A, 2010, IEEE T ELECTRON DEV, V57, P1201, DOI 10.1109/TED.2010.2045681; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Marti A., 2003, NEXT GENERATION PHOT, P140; Marti A, 2001, IEEE T ELECTRON DEV, V48, P2394, DOI 10.1109/16.954482; Mendes M.J., 2009, APPL PHYS LETT, V95; Okada Y., 2011, J APPL PHYS, V109; Oshima R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2973398; Sugawara M., 1999, SELF ASSEMBLED INGAA	27	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	JAN	2015	132						178	182		10.1016/j.solmat.2014.08.041		5	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AW9AE	WOS:000346549400024		
J	Wang, JT; Shi, XL; Zhong, XH; Wang, JN; Pyrah, L; Sanderson, KD; Ramsey, PM; Hirata, M; Tsuri, K				Wang, Jian Tao; Shi, Xiang Lei; Zhong, Xin Hua; Wang, Jian Nong; Pyrah, Leo; Sanderson, Kevin D.; Ramsey, Philip M.; Hirata, Masahiro; Tsuri, Keiko			Morphology control of fluorine-doped tin oxide thin films for enhanced light trapping	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Fluorine-doped tin oxide; Morphology control; Roughness; Light trapping; Solar cells	CHEMICAL-VAPOR-DEPOSITION; TRANSPARENT CONDUCTING FILMS; ATMOSPHERIC-PRESSURE CVD; SILICON SOLAR-CELLS; PHYSICAL-PROPERTIES; OPTICAL-PROPERTIES; SNO2 FILMS; ZINC-OXIDE; GROWTH; MECHANISM	Current development of fluorine doped tin oxide (FTO) films for the enhancement of light trapping is limited by the tradeoff between roughness and transmittance, since none of them can be improved without sacrificing the other. In this study, we report increases in roughness from 13 to 60 nm and haze from 1.2 to 10.3% for FTO films with a thickness of only 300 nm, by inclusion of different additives into the deposition system. Such significant improvements are achieved whilst maintaining a low resistivity and high transmittance. This results from the development of the desired pyramidal grain morphology associated with the strengthening of (110) preferred orientation and concurrent weakening of (200) and/or (301) preferred orientations. Thus, our study provides a general strategy for developing morphology-controlled, FTO films to be compared with current commercial ones with a roughness of 38 nm and a thickness of 800 nm, for improving the light trapping and thus the efficiency of solar cells. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Jian Tao; Shi, Xiang Lei; Zhong, Xin Hua; Wang, Jian Nong] E China Univ Sci & Technol, Sch Mech & Power Engn, Sch Chem & Mol Engn, Nano X Res Ctr, Shanghai 200237, Peoples R China; [Pyrah, Leo; Sanderson, Kevin D.; Ramsey, Philip M.] Pilkington Technol Management Ltd, Pilkington European Tech Ctr, Lathom L40 5UF, Lancs, England; [Hirata, Masahiro; Tsuri, Keiko] Nippon Sheet Glass Co Ltd, R&D, Itami, Hyogo 6648520, Japan	Wang, JN (reprint author), E China Univ Sci & Technol, Sch Mech & Power Engn, Sch Chem & Mol Engn, Nano X Res Ctr, 130 Meilong Rd, Shanghai 200237, Peoples R China.	jnwang@ecust.edu.cn	XH, ZHONG/E-1150-2015	XH, ZHONG/0000-0001-9845-4788	Pilkington Technology Management Limited; National Natural Science Foundation of China [51271077, U1362104]; Shanghai Nanoscience and Nanotechnology Promotion Center [12nm0503300]	Financial supports from Pilkington Technology Management Limited, National Natural Science Foundation of China (Project #: 51271077 and U1362104) and Shanghai Nanoscience and Nanotechnology Promotion Center (Project #: 12nm0503300) are greatly acknowledged.	Tang J, 2011, NAT MATER, V10, P765, DOI [10.1038/nmat3118, 10.1038/NMAT3118]; CHOPRA KL, 1983, THIN SOLID FILMS, V102, P1, DOI 10.1016/0040-6090(83)90256-0; Liang HF, 2007, J MATER SCI, V42, P6388, DOI 10.1007/s10853-006-1255-5; Springer J, 2004, J APPL PHYS, V96, P5329, DOI 10.1063/1.1784555; Agashe C, 2009, SOL ENERG MAT SOL C, V93, P1256, DOI 10.1016/j.solmat.2009.01.021; Tsai CH, 2011, ORG ELECTRON, V12, P2003, DOI 10.1016/j.orgel.2011.08.027; Gao Q, 2013, J ALLOY COMPD, V574, P427, DOI 10.1016/j.jallcom.2013.05.108; SMITH A, 1995, THIN SOLID FILMS, V266, P20, DOI 10.1016/0040-6090(95)06648-9; Ellmer K, 2012, NAT PHOTONICS, V6, P808, DOI [10.1038/nphoton.2012.282, 10.1038/NPHOTON.2012.282]; Porch A, 2004, J APPL PHYS, V96, P4211, DOI 10.1063/1.1786674; Remes Z, 2009, THIN SOLID FILMS, V517, P6287, DOI 10.1016/j.tsf.2009.02.109; Tiwari AN, 2004, PROG PHOTOVOLTAICS, V12, P33, DOI 10.1002/pip.525; Springer J, 2005, SOL ENERG MAT SOL C, V85, P1, DOI 10.1016/j.solmat.2004.02.020; AGASHE C, 1991, J APPL PHYS, V70, P7382, DOI 10.1063/1.349733; van den Donker MN, 2007, SOL ENERG MAT SOL C, V91, P572, DOI 10.1016/j.solmat.2006.11.012; Azens A, 2003, J SOLID STATE ELECTR, V7, P64, DOI 10.1007/s10008-002-0313-4; Noor N, 2013, J MATER CHEM C, V1, P984, DOI 10.1039/c2tc00400c; Kim CY, 2011, THIN SOLID FILMS, V519, P3081, DOI 10.1016/j.tsf.2010.12.096; Agashe C, 1996, J MATER SCI, V31, P2965, DOI 10.1007/BF00356009; Moholkar AV, 2008, SOL ENERG MAT SOL C, V92, P1439, DOI 10.1016/j.solmat.2008.06.010; GORDILLO G, 1994, THIN SOLID FILMS, V252, P61, DOI 10.1016/0040-6090(94)90826-5; Granqvist CG, 2002, THIN SOLID FILMS, V411, P1, DOI 10.1016/S0040-6090(02)00163-3; Tohsophon T, 2008, THIN SOLID FILMS, V516, P4628, DOI 10.1016/j.tsf.2007.06.061; Bartl R., 2006, P EUR PV SOL EN C DR; BELANGER D, 1985, J ELECTROCHEM SOC, V132, P1398; Chae GS, 2001, J APPL PHYS, V90, P411, DOI 10.1063/1.1375021; de Graaf A, 2010, ENRGY PROCED, V2, P41, DOI 10.1016/j.egypro.2010.07.008; Diez-Betriu X, 2012, J ALLOY COMPD, V536, pS445, DOI 10.1016/j.jallcom.2012.01.057; HAMBERG I, 1986, J APPL PHYS, V60, pR123, DOI 10.1063/1.337534; Hartmann P., 1973, CRYSTAL GROWTH INTRO, P367; JARZEBSKI ZM, 1976, J ELECTROCHEM SOC, V123, pC199, DOI 10.1149/1.2133010; Karshoglu R, 2011, J CRYST GROWTH, V327, P22, DOI 10.1016/j.jcrysgro.2011.06.003; Korotkov RY, 2006, THIN SOLID FILMS, V502, P79, DOI 10.1016/j.tsf.2005.07.248; Massalski T. B., 1980, STRUCTURE METALS, P204; Matsui Y, 2007, THIN SOLID FILMS, V515, P2854, DOI 10.1016/j.tsf.2006.07.173; Porch A, 2004, J APPL PHYS, V95, P4734, DOI 10.1063/1.1689735; Sheel DW, 2009, THIN SOLID FILMS, V517, P3061, DOI 10.1016/j.tsf.2008.11.121; van Mol AMB, 1999, J PHYS IV, V9, P165, DOI 10.1051/jp4:1999820; van Mol AMB, 2006, THIN SOLID FILMS, V502, P72, DOI 10.1016/j.tsf.2005.07.247; Volontiru I., 2011, THIN SOLID FILMS, V519, P6258; Wang YF, 2010, INORG CHEM, V49, P1679, DOI 10.1021/ic902092e; Wu YF, 2013, J ALLOY COMPD, V550, P263, DOI 10.1016/j.jallcom.2012.09.147; Yates HM, 2010, THIN SOLID FILMS, V519, P1334, DOI 10.1016/j.tsf.2010.09.037	43	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	JAN	2015	132						578	588		10.1016/j.solmat.2014.09.043		11	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AW9AE	WOS:000346549400080		
J	Ning, SY; Iwasak, TO; Takeuchi, K				Ning, Sheyang; Iwasak, Tomoko Ogura; Takeuchi, Ken			50 nm AlxOy ReRAM program 31% energy, 1.6x endurance, and 3.6x speed improvement by advanced cell condition adaptive verify-reset	SOLID-STATE ELECTRONICS			English	Article						Non-volatile memory; Resistive random access memory; ReRAM; Aluminum oxide; Verify-program; Filament	RANDOM-ACCESS MEMORY; RRAM; LAYER	Two verify-reset schemes are proposed to improve the program energy, endurance and speed of 50 nm AlxOy ReRAM cells. Both of the proposed schemes improve the verify-reset program by adapting the program voltage and pulse width to the variation of ReRAM cell filament status during the verify-reset. In this paper, first, the reset resistance and cell endurance are compared using different reset voltages and reset pulse widths. Then, two proposed verify-reset schemes are introduced independently. The first proposed scheme controlled reset voltage (V-reset) increment demonstrates 32% program energy reduction and 6.7x program speed increase. In this scheme, the reset voltage stress is increased from -1.5 V to -1.65 V, only when the reset-tries fail continuously during verify-reset (hard-to-reset). The second proposed scheme set-before-reset applies the set pulse during verify-reset, to convert the filament from a hard-to-reset state to an easy-to-reset state. With this approach, 31% program energy reduction, 1.6x program endurance and 3.6x program speed increase can be obtained simultaneously. (C) 2014 Elsevier Ltd. All rights reserved.	[Ning, Sheyang; Iwasak, Tomoko Ogura; Takeuchi, Ken] Chuo Univ, Grad Sch Sci & Engn, Dept Elect Elect & Commun Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Ning, Sheyang] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan	Ning, SY (reprint author), Chuo Univ, Grad Sch Sci & Engn, Dept Elect Elect & Commun Engn, Bunkyo Ku, Rm 2844,Bldg 2,Korakuen Campus,1-13-27 Kasuga, Tokyo 1128551, Japan.	ning@takeuchi-lab.org					Kim S, 2009, IEEE T ELECTRON DEV, V56, P3049, DOI 10.1109/TED.2009.2032597; Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Kawahara A, 2013, IEEE J SOLID-ST CIRC, V48, P178, DOI 10.1109/JSSC.2012.2215121; Akinaga H, 2010, P IEEE, V98, P2237, DOI 10.1109/JPROC.2010.2070830; Chen L, 2010, IEEE ELECTR DEVICE L, V31, P356, DOI 10.1109/LED.2010.2041183; Gao B, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P30; Fantini A, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P30, DOI 10.1109/IMW.2013.6582090; Gao B, 2009, IEEE ELECTR DEVICE L, V30, P1326, DOI 10.1109/LED.2009.2032308; Wu Y, 2010, IEEE ELECTR DEVICE L, V31, P1449, DOI 10.1109/LED.2010.2074177; Chowdhury M, 2012, SOLID STATE ELECTRON, V68, P1, DOI 10.1016/j.sse.2011.11.025; Degraeve R., 2012, VLSI, P75; Goux L, 2014, VLSI S, P162; Goux L, 2012, VLSI, P159; Govoreanu B, 2011, P IEEE IEDM DEC, P729; Higuchi K, 2012, IMW, P1; Jung S, 2011, APPL PHYS LETT, V99; Kawahara A., 2013, ISSCC, P220; Liu D, 2010, APPL PHYS LETT, V96; Ning SY, 2014, JPN J APPL PHYS, V53; NING SY, 2013, P IEEE INT MEM WORKS, P56; Sheu SS, 2009, 2009 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P82; Song YL, 2013, VLSI TECHNOLOGY, P102; Tanakamaru S., 2013, ISSCC, P226; Tanakamaru S., 2014, IEEE INT SOL STAT CI, P336; Yang MY, 2013, APPL PHYS LETT, V103; Yang MY, 2013, JPN J APPL PHYS, V52	26	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	JAN	2015	103						64	72		10.1016/j.sse.2014.10.003		9	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AW8ZJ	WOS:000346547400011		
J	Islam, MS; Ishida, M				Islam, Md Shofiqul; Ishida, Makoto			Interface pn junction arrays with high yielded grown p-Si microneedles by vapor-liquid-solid method at low temperature	SOLID-STATE ELECTRONICS			English	Article						pn junction arrays; p-Si microneedles; Vapor liquid solid (VLS) growth; in-situ doping; Low temperature; Vertical active devices	BORON-DOPED SILICON; RESISTIVITY; MICROSTRUCTURE; FABRICATION; DEPENDENCE; DEPOSITION; MECHANISM; DIBORANE; MOBILITY	In this work we report the fabrication and investigation of the properties of interface pn junction arrays formed at the interface of vertically aligned p-Si microneedles and n-Si substrate. Arrays of boron doped p-Si microneedles were grown on n-Si substrate with the maximum yield of 100% by Au-catalysed vapor-liquid-solid (VLS) growth using in-situ doping with the mixed gas of Si2H6 and B2H6 at temperature less than 700 degrees C, which is low as compared to the temperature (1100 degrees C) required by diffusion process to dope Si microneedles after VLS growth. The physical dimension (diameter, length) and position of these p-Si microneedles can be controlled. The variation of growth rate, diameter, conductivity, impurity concentration and hole mobility of these p-Si microneeedles were investigated with the variation of boron doping. The pn junctions, formed with p-Si microneedles having different diameters, were found to exhibit standard diode characteristics. These pn junction embedded Si microneedle arrays might be potential candidate in sensor area applications. Again, low temperature processing would be compatible to integrate these junction arrays with other circuitry on a chip. This work provides one step forward to realize more sophisticated vertical active devices (BJT, MOSFET, etc) with Si microneedles. (C) 2014 Elsevier Ltd. All rights reserved.	[Islam, Md Shofiqul] King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, Jeddah 21589, Saudi Arabia; [Ishida, Makoto] Toyohashi Univ Technol, Dept Elect & Elect Engn, Toyohashi, Aichi 4418580, Japan; [Ishida, Makoto] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan	Islam, MS (reprint author), King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, POB 80204, Jeddah 21589, Saudi Arabia.	msislam@kau.edu.sa			King Abdulaziz University, Saudi Arabia; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	One of the authors (MSI) acknowledges the support from King Abdulaziz University, Saudi Arabia. The authors would like to acknowledge the support by "Grant-in-Aid for Scientific Research" and "Global COE Program" both from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	McCreery D, 2006, IEEE T BIO-MED ENG, V53, P726, DOI 10.1109/TBME.2006.870215; Wilke N, 2005, SENSOR ACTUAT A-PHYS, V123-24, P319, DOI 10.1016/j.sna.2005.05.017; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Asai S, 1996, IEEE T COMPON PACK A, V19, P258, DOI 10.1109/95.506112; Choi HW, 2004, J CRYST GROWTH, V268, P527, DOI 10.1016/j.jcrysgro.2004.04.085; GHOSH S, 1992, J APPL PHYS, V71, P5205, DOI 10.1063/1.350576; Herner SB, 2004, J VAC SCI TECHNOL B, V22, P1, DOI 10.1116/1.1631292; Islam MS, 2005, JPN J APPL PHYS 1, V44, P2161, DOI 10.1143/JJAP.44.2161; Jackson JB, 2007, J APPL PHYS, V102, DOI 10.1063/1.2778290; Kawano T, 2002, SENSOR ACTUAT A-PHYS, V97-8, P709, DOI 10.1016/S0924-4247(02)00008-0; Kawano T, 2004, IEEE IEDM, P1014; Kawano T, 2004, IEEE T ELECTRON DEV, V51, P415, DOI 10.1109/TED.2003.822473; LI SS, 1978, SOLID STATE ELECTRON, V21, P1109, DOI 10.1016/0038-1101(78)90345-3; MAKINO T, 1981, SOLID STATE ELECTRON, V24, P49, DOI 10.1016/0038-1101(81)90211-2; Pan L, 2005, J CRYST GROWTH, V277, P428, DOI 10.1016/j.jcrysgro.2005.01.091; Sze SM, 1985, SEMICONDUCTOR DEVICE, P325; Sze SM, 1981, PHYSICS SEMICONDUCTO, P100; Takei K, 2009, BIOMED MICRODEVICES, V11, P539, DOI 10.1007/s10544-008-9259-3; TSAO KY, 1976, SOLID STATE ELECTRON, V19, P949, DOI 10.1016/0038-1101(76)90108-8	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	JAN	2015	103						90	97		10.1016/j.sse.2014.10.009		8	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AW8ZJ	WOS:000346547400015		
J	Oishi, K; Akai, D; Ishida, M				Oishi, Koji; Akai, Daisuke; Ishida, Makoto			Integration of crystalline orientated gamma-Al2O3 films and complementary metal-oxide-semiconductor circuits on Si(100) substrate	SOLID-STATE ELECTRONICS			English	Article						gamma-Al2O3; Crystallinity; Anneal; CMOS integration	THIN-FILMS; PYROELECTRIC PROPERTIES; EPITAXIAL-GROWTH; BUFFER LAYER; SI; FABRICATION; SI(001)	In this paper, integration of crystalline orientated gamma-Al2O3 films and complementary metal-oxide- semiconductor (CMOS) circuits on Si(1 00) substrate was reported. In this integration processes, crystalline gamma-Al2O3 films need to be preserved their crystallinity during high temperature annealing processes of CMOS fabrication in order to prevent surface condition changes. The gamma-Al2O3 films grown on Si substrates are annealed in the CMOS fabrication process conditions, drive-in annealing at 1150 degrees C in O-2 atmosphere and wet annealing 1000 degrees C in H2O vapor atmosphere. Reflection high energy electron diffraction (RHEED) and x-ray diffraction (XRD) were used to characterize the crystallinity of gamma-Al2O3 films after the annealing processes. Surface conditions of the films are analyzed and observed with X-ray photoelectron spectroscopy (XPS) and scanning electron microscope (SEM). As a result, RHEED patterns of the gamma-Al2O3 films indicated that wet oxidation annealing was a critical process severally inferior surface condition of crystalline gamma-Al2O3 films. XRD, XPS, and SEM investigation unveiled further details of the crystallinity changes on gamma-Al2O3 films for each process. These results indicated passivation films were required to integrate gamma-Al2O3 films with CMOS fabrication process. Therefore we proposed and introduced Si3N4/TEOS passivation films on gamma-Al2O3 films in CMOS fabrication processes. At last, MOSFETs on gamma-Al2O3 integrated Si(1 00) substrate were fabricated and characterized. The designed characteristics of MOSFETs were obtained on gamma-Al2O3 integrated Si substrate. (C) 2014 Elsevier Ltd. All rights reserved.	[Oishi, Koji; Ishida, Makoto] Toyohashi Univ Technol, Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Akai, Daisuke; Ishida, Makoto] Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi 4418580, Japan	Oishi, K (reprint author), Toyohashi Univ Technol, Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	oishi-k@intee.tut.ac.jp	Akai, Daisuke/A-5951-2012	Akai, Daisuke/0000-0003-1178-1255			Akai D, 2004, J CRYST GROWTH, V264, P463, DOI 10.1016/j.jcrysgro.2003.12.048; Akai D, 2003, J CRYST GROWTH, V259, P90, DOI [10.1016/S0022-0248(03)01587-2, 10.1016/S0022-0248()3)01587-2]; Akai D, 2006, SENSOR ACTUAT A-PHYS, V130, P111, DOI 10.1016/j.sna.2005.11.051; Houwman EP, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045006; Yin S, 2012, THIN SOLID FILMS, V520, P4572, DOI 10.1016/j.tsf.2011.11.073; Baek SH, 2011, SCIENCE, V334, P958, DOI 10.1126/science.1207186; Shi C, 2000, THIN SOLID FILMS, V375, P288, DOI 10.1016/S0040-6090(00)01250-5; FARKAS L, 1977, MATER RES BULL, V12, P1213, DOI 10.1016/0025-5408(77)90176-3; Fujishita H, 2010, J PHYS CHEM SOLIDS, V71, P1285, DOI 10.1016/j.jpcs.2010.05.010; Giebeler C., 2009, P SENSOR TEST C 2009, P185; Guo Y, 2007, SOLID STATE COMMUN, V145, P413; Ishida M, 2000, JPN J APPL PHYS 1, V39, P2078, DOI 10.1143/JJAP.39.2078; Ito M, 2008, SENSOR ACTUAT A-PHYS, V145, P278, DOI 10.1016/j.sna.2008.01.014; Kesim MT, 2013, J APPL PHYS, V114, DOI 10.1063/1.4833555; Nguyen CTQ, 2014, THIN SOLID FILMS, V556, P509, DOI 10.1016/j.tsf.2014.01.007; Niu G, 2011, MICROELECTRON ENG, V88, P1232, DOI 10.1016/j.mee.2011.03.028; Oishi K, 2013, 2013 IEEE INTERNATIONAL SYMPOSIUM ON THE APPLICATIONS OF FERROELECTRIC AND WORKSHOP ON THE PIEZORESPONSE FORCE MICROSCOPY (ISAF/PFM), P329, DOI 10.1109/ISAF.2013.6748751; Peng QX, 2013, INFRARED PHYS TECHN, V58, P51, DOI 10.1016/j.infrared.2013.01.003; Sun LL, 2003, MAT SCI ENG B-SOLID, V99, P173, DOI 10.1016/S0921-5107(02)00480-4	19	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	JAN	2015	103						110	114		10.1016/j.sse.2014.08.011		5	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AW8ZJ	WOS:000346547400018		
J	Kawasaki, T; Sugawara, K; Dobroiu, A; Eto, T; Kurita, Y; Kojima, K; Yabe, Y; Sugiyama, H; Watanabe, T; Suemitsu, T; Ryzhii, V; Iwatsuki, K; Fukada, Y; Kani, J; Terada, J; Yoshimoto, N; Kawahara, K; Ago, H; Otsuji, T				Kawasaki, Tetsuya; Sugawara, Kenta; Dobroiu, Adrian; Eto, Takanori; Kurita, Yuki; Kojima, Kazuki; Yabe, Yuhei; Sugiyama, Hiroki; Watanabe, Takayuki; Suemitsu, Tetsuya; Ryzhii, Victor; Iwatsuki, Katsumi; Fukada, Youichi; Kani, Jun-ichi; Terada, Jun; Yoshimoto, Naoto; Kawahara, Kenji; Ago, Hiroki; Otsuji, Taiichi			Graphene-channel FETs for photonic frequency double-mixing conversion over the sub-THz band	SOLID-STATE ELECTRONICS			English	Article						Graphene; FET; Photomixing; Terahertz; Photoresponse	FIELD-EFFECT TRANSISTORS; HIGH-SPEED; CARBON; PHASE	We report on photonic frequency double-mixing conversion utilizing a graphene-channel FET (G-FET). Optoelectronic properties of graphene are exploited to perform single-chip photonic double-mixing functionality, which is greatly advantageous in future broadband technological conversion between optical fiber and sub-terahertz wireless communications. A1 GHz modulation signal on a 125 GHz carrier is electrically input to the gate, whereas a 1.58 mu m dual wavelength CW laser beam having a frequency difference of 112.5 GHz impinges on the G-FET. The G-FET works as a photomixer generating a 112.5 GHz local signal which is then electrically mixed to the 1 GHz modulated 125 GHz carrier signal, resulting in the down-conversion of the 1 GHz signal to a 12.5 GHz intermediate frequency (IF) signal. (C) 2014 Elsevier Ltd. All rights reserved.	[Kawasaki, Tetsuya; Sugawara, Kenta; Dobroiu, Adrian; Eto, Takanori; Kurita, Yuki; Kojima, Kazuki; Yabe, Yuhei; Sugiyama, Hiroki; Watanabe, Takayuki; Suemitsu, Tetsuya; Ryzhii, Victor] Tohoku Univ, RIEC, Sendai, Miyagi 980, Japan; [Iwatsuki, Katsumi; Otsuji, Taiichi] Tohoku Univ, ROEC, Sendai, Miyagi 980, Japan; [Fukada, Youichi; Kani, Jun-ichi; Terada, Jun; Yoshimoto, Naoto] NTT Corp, NIT Access Network Serv Syst Labs, Yokosuka, Kanagawa, Japan; [Kawahara, Kenji; Ago, Hiroki] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 812, Japan	Otsuji, T (reprint author), Tohoku Univ, ROEC, Sendai, Miyagi 980, Japan.	otsuji@riec.tohoku.ac.jp	Ago, Hiroki/A-3405-2011	Ago, Hiroki/0000-0002-4597-9510			Ago H., 2013, APPL PHYS EXPRESS, V6; Vicarelli L, 2012, NAT MATER, V11, P865, DOI [10.1038/nmat3417, 10.1038/NMAT3417]; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Cheng R, 2012, P NATL ACAD SCI USA, V109, P11588, DOI 10.1073/pnas.1205696109; Ryzhii V, 2012, OPTO-ELECTRON REV, V20, P15, DOI 10.2478/s11772-012-0009-y; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Habibpour O, 2013, IEEE T MICROW THEORY, V61, P841, DOI 10.1109/TMTT.2012.2236434; Ito H, 2004, IEEE J SEL TOP QUANT, V10, P709, DOI 10.1109/JSTQE.2004.833883; Suzuki H, 2005, ELECTRON LETT, V41, P355, DOI 10.1049/el:20058425; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/nphoton.2010.186, 10.1038/NPHOTON.2010.186]; Suemitsu T, 2004, IEEE ELECTR DEVICE L, V25, P669, DOI 10.1109/LED.2004.834910; Watanabe T, 2012, SOLID STATE ELECTRON, V78, P109, DOI 10.1016/j.sse.2012.05.047; Mueller T, 2010, NAT PHOTONICS, V4, P297, DOI 10.1038/NPHOTON.2010.40; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Moon JS, 2012, IEEE ELECTR DEVICE L, V33, P1357, DOI 10.1109/LED.2012.2210184; Orlita M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267601; Eto T, 2013, INT THIN FILM TRANS; Geim K., 2007, NAT MATER, V6, P183, DOI DOI 10.1038/NMAT1849; Iwatsuki K, 2013, 6 GLOB S MILL WAV 20; Miyazaki H, 2008, APPL PHYS EXPRESS, V1; Morozov SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016602; Robinson JA, 2011, APPL PHYS LETT, V98; Ryzhii V, 2012, J PHYS D, V45; Takabayashi S, 2012, DIAM RELAT MATER, V22, P118, DOI 10.1016/j.diamond.2011.12.037; Wakabayashi K, 1998, J PHYS SOC JPN, V67, P2089, DOI 10.1143/JPSJ.67.2089; Wang H, 2010, INT EL DEV M, P572; Wu YQ, 2012, INT EL DEV M	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	JAN	2015	103						216	221		10.1016/j.sse.2014.07.009		6	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AW8ZJ	WOS:000346547400036		
J	Choi, HJ; Smith, JS; Shaffrey, CI; Lafage, VC; Schwab, FJ; Ames, CP; Matsumoto, M; Baik, JS; Ha, Y				Choi, Hong June; Smith, Justin S.; Shaffrey, Christopher I.; Lafage, Virginie C.; Schwab, Frank J.; Ames, Christopher P.; Matsumoto, Morio; Baik, Jong Sam; Ha, Yoon			Coronal plane spinal malalignment and Parkinson's disease: prevalence and associations with disease severity	SPINE JOURNAL			English	Article						Parkinson's disease; Spinal deformity; Sagittal alignment; Pelvic parameters; Pelvic tilt; SVA	NONOPERATIVE TREATMENT; ADULT SCOLIOSIS; FOLLOW-UP; ESTROGEN; CAMPTOCORMIA; DEFORMITIES; CONNECTION; DISORDERS; SURGERY; FLEXION	BACKGROUND CONTEXT: Parkinson's disease (PD) is a progressive degenerative disorder of the central nervous system. Patients with PD often present with abnormal posturing. PURPOSE: To investigate coronal plane deformities in patients with PD, and to evaluate the correlation between clinical features, coronal parameters related to spine alignment, and disease severity. STUDY DESIGN: A cross-sectional study. PATIENT SAMPLE: Eighty-nine patients with PD and 89 controls were included. OUTCOME MEASURES: A medical history was collected from the medical records. METHODS: This study was a prospective assessment of consecutive patients with PD. Clinical and demographic parameters were collected from medical records and outpatient interviews. Full-length standing anteroposterior and lateral spine radiographs were used to assess the spinal parameters. The threshold for scoliosis was set at a 10 degrees Cobb angle, and the curve type was classified using Schwab classification. RESULTS: A total of 178 patients (89 in PD and 89 in control groups) were included. Scoliosis was identified in 27 patients (30%) and 22 controls (p=.502). However, coronal imbalance was more common in patients with PD than in controls (11 vs. 0 patients, p=.001). Scoliosis was more common in women than in men (male: female=8: 19, p=.04). Back pain was more common in patients with scoliosis than in those without scoliosis (14 of 27 vs. 17 of 62, p=.036). Schwab Type IV (thoracolumbar major) was the most common type of scoliosis in patients with PD and Type V (lumbar major) was the most common type in controls. With adjustment for patient age and gender, multiple linear regression analysis revealed that severity of PD (Unified Parkinson's Disease Rating Scale, p=.037) and magnitude of global coronal malalignment (p=.003) were associated with the scoliosis Cobb angle (p=.037, B=0.139). Direction of scoliosis and side of global coronal malalignment were not significantly correlated with the laterality of predominant PD symptoms (p>. 05). CONCLUSIONS: Global coronal malalignment is more prevalent in patients with PD than in controls. Greater severity of PD was significantly associated with greater magnitude of scoliosis Cobb angle, even after adjusting for the effects of patient age and gender. However, direction of scoliosis and side of global coronal malalignment were not significantly associated with the dominant laterality of PD symptoms. (C) 2015 Elsevier Inc. All rights reserved.	[Choi, Hong June; Ha, Yoon] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul 120752, South Korea; [Smith, Justin S.; Shaffrey, Christopher I.] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22902 USA; [Lafage, Virginie C.; Schwab, Frank J.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10016 USA; [Ames, Christopher P.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94104 USA; [Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Baik, Jong Sam] Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Neurol, Seoul, South Korea	Ha, Y (reprint author), Yonsei Univ, Coll Med, Dept Neurosurg, 50 Yonsei Ro, Seoul 120752, South Korea.	yoonhaucsf@gmail.com		Lafage, Virginie/0000-0002-0119-7111			Aebi M, 2005, EUR SPINE J, V14, P925, DOI 10.1007/s00586-005-1053-9; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Di Matteo A, 2011, J NEUROL, V258, P740, DOI 10.1007/s00415-010-5822-y; Bloch F, 2006, J NEUROL NEUROSUR PS, V77, P1223, DOI 10.1136/jnnp.2006.087908; Smith JS, 2013, EUR SPINE J, V22, P402, DOI 10.1007/s00586-012-2547-x; Roussouly P, 2013, EUR SPINE J, V22, pS203, DOI 10.1007/s00586-012-2571-x; Schwab F, 2006, SPINE, V31, P2109, DOI 10.1097/01.brs.0000231725.38943.ab; Smith JS, 2009, NEUROSURGERY, V65, P86, DOI 10.1227/01.NEU.0000347005.35282.6C; Saunders-Pullman R, 1999, NEUROLOGY, V52, P1417; Baik JS, 2009, J CLIN NEUROL, V5, P91, DOI 10.3988/jcn.2009.5.2.91; Daniel SK, 2012, INT J NEUROSCI, V122, P523, DOI 10.3109/00207454.2012.685530; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; Kebaish KM, 2011, SPINE, V36, P731, DOI 10.1097/BRS.0b013e3181e9f120; Ashour R, 2006, MOVEMENT DISORD, V21, P1856, DOI 10.1002/mds.21058; Shulman LM, 2002, PARKINSONISM RELAT D, V8, P289, DOI 10.1016/S1353-8020(02)00014-7; Smith JS, 2011, SPINE, V36, P817, DOI 10.1097/BRS.0b013e3181e21783; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Xu LL, 2013, EUR SPINE J, V22, P1326, DOI 10.1007/s00586-013-2678-8; Smith JS, 2009, SPINE, V34, P1693, DOI 10.1097/BRS.0b013e3181ac5fcd; Schabitz WR, 2003, MOVEMENT DISORD, V18, P408, DOI 10.1002/mds.10385; Bridwell KH, 2009, SPINE, V34, P2171, DOI 10.1097/BRS.0b013e3181a8fdc8; Chen YY, 2012, PARKINSONISM RELAT D, V18, P506, DOI 10.1016/j.parkreldis.2012.01.014; DUVOISIN RC, 1975, J NEUROL NEUROSUR PS, V38, P787, DOI 10.1136/jnnp.38.8.787; Gnadinger M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13154; Grimes J D, 1987, Adv Neurol, V45, P353; HERRERAMARSCHITZ M, 1990, J NEUROL NEUROSUR PS, V53, P39, DOI 10.1136/jnnp.53.1.39; Indo T, 1980, Rinsho Shinkeigaku, V20, P40; Jones Phil D, 2010, Age Ageing, V39, P278, DOI 10.1093/ageing/afq005; KANE WJ, 1970, CLIN ORTHOP RELAT R, P216; Levin RM, 2012, ENDOCR PRACT, V18, P591, DOI 10.4158/EP12020.CO; Marder K, 1998, NEUROLOGY, V50, P1141; MARSDEN CD, 1980, ARCH NEUROL-CHICAGO, V37, P253; MARTIN JP, 1965, J NEUROL NEUROSUR PS, V28, P395, DOI 10.1136/jnnp.28.5.395; O'Brien MF, 2005, SPINAL DEFORMITY STU; SERRATRICE G, 1976, NOUV PRESSE MED, V5, P1834; Smith JS, 2009, NEUROSURGERY, V65, P93; Tabamo R E, 2000, Med Health R I, V83, P114; Upadhyaya Cheerag D, 2010, Neurosurg Focus, V28, pE5, DOI 10.3171/2010.1.FOCUS09288	38	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JAN	2015	15	1					115	121		10.1016/j.spinee.2014.07.004		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AW6OP	WOS:000346389000019		
J	Hayashi, H; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Shinmura, K; Yokogawa, N; Ishii, T; Fang, X; Shirai, T; Tsuchiya, H				Hayashi, Hiroyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Shinmura, Kazuya; Yokogawa, Noriaki; Ishii, Takayoshi; Fang, Xiang; Shirai, Toshiharu; Tsuchiya, Hiroyuki			Surgical site infection after total en bloc spondylectomy: risk factors and the preventive new technology	SPINE JOURNAL			English	Article						Surgical site infection; Total en bloc spondylectomy; Iodine-supported spinal instrument; Risk factor; Vertebral tumor; Multivariate analysis	TUMORS CLINICAL ARTICLE; SPINAL TUMORS; METASTASES; TITANIUM; SURGERY; POSTERIOR; ANTERIOR	BACKGROUND CONTEXT: Surgical site infection (SSI) associated with instruments remains a serious and common complication in patients who undergo total en bloc spondylectomy (TES). It is very important that the risk factors for SSI are known to prevent it. PURPOSE: The purpose of the study was to identify independent risk factors for SSI after TES and evaluate the positive effect of iodine-supported spinal instruments in the prevention of SSI after TES. STUDY DESIGN: This is a retrospective clinical study. PATIENT SAMPLE: One hundred twenty-five patients who underwent TES for vertebral tumor were evaluated. OUTCOME MEASURES: Incidence rate of SSI, risk factors for SSI after TES, and safety of iodine-supported spinal instruments were the outcome measures. METHODS: Risk factors for SSI were analyzed using logistic regression. In recent 69 patients with iodine-supported spinal instruments, the thyroid hormone levels in the blood were examined to confirm if iodine from the implant influenced thyroid function. Postoperative radiological evaluations were performed regularly. RESULTS: The rate of SSI was 6.4% (8/125 patients). By multivariate logistic regression, combined anterior and posterior approach and nonuse of iodine-supported spinal instruments were associated with an increased risk of SSI. The rate of SSI without iodine-supported spinal instruments was 12.5%, whereas the rate with iodine-supported spinal instruments was 1.4%. This difference was statistically significant. There were no detected abnormalities of thyroid gland function with the use of iodine-supported instruments. Among the 69 patients with iodine-supported spinal instruments, 2 patients required additional surgery because of instrument failure. However, there were no obvious involvements with the use of iodine-supported spinal instruments. CONCLUSIONS: This study identified combined anterior and posterior approach and nonuse of iodine-supported spinal instruments to be independent risk factors for SSI after TES. Iodine-supported spinal instrument was extremely effective for prevention of SSI in patients with compromised status, and it had no detection of cytotoxic or adverse effects on the patients. (C) 2015 Elsevier Inc. All rights reserved.	[Hayashi, Hiroyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Shinmura, Kazuya; Yokogawa, Noriaki; Ishii, Takayoshi; Fang, Xiang; Shirai, Toshiharu; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa 9208641, Japan	Tsuchiya, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	tsuchi@med.kanazawa-u.ac.jp					Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036; Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611; Jansson KA, 2006, EUR SPINE J, V15, P196, DOI 10.1007/s00586-004-0870-6; Finkelstein JA, 2003, J BONE JOINT SURG BR, V85B, P1045, DOI 10.1302/1301-620X.85B7.14201; Murakami H, 2010, J NEUROSURG-SPINE, V12, P253, DOI 10.3171/2009.9.SPINE09506; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3; Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D; Quan GMY, 2011, EUR SPINE J, V20, P1970, DOI 10.1007/s00586-011-1867-6; Kawahara N, 2009, ORTHOP CLIN N AM, V40, P47, DOI 10.1016/j.ocl.2008.09.004; Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008; Shirai T, 2009, J BIOMED MATER RES B, V91B, P373, DOI 10.1002/jbm.b.31412; Sundaresan N, 2002, SPINE, V27, P1802, DOI 10.1097/01.BRS.0000020309.58137.B0; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Casadei Roberto, 2013, Eur J Orthop Surg Traumatol, V23 Suppl 1, pS93, DOI 10.1007/s00590-012-1160-3; Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22; Kawahara N, 2011, SPINE, V36, P74, DOI 10.1097/BRS.0b013e3181cded6c; Matsumoto M, 2007, J NEUROSURG-SPINE, V6, P600, DOI 10.3171/spi.2007.6.6.15; Roy-Camille R, 1990, TUMORS SPINE, P474; Xu RS, 2009, J NEUROSURG-SPINE, V11, P272, DOI 10.3171/2009.3.SPINE08621	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JAN	2015	15	1					132	137		10.1016/j.spinee.2014.08.007		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AW6OP	WOS:000346389000021		
J	Mori, K; Imai, S; Nishizawa, K; Nakamura, A; Ishida, M; Matsusue, Y				Mori, Kanji; Imai, Shinji; Nishizawa, Kazuya; Nakamura, Akira; Ishida, Mitsuaki; Matsusue, Yoshitaka			Plexiform schwannoma arising from cauda equina	SPINE JOURNAL			English	Editorial Material									[Mori, Kanji; Imai, Shinji; Nishizawa, Kazuya; Nakamura, Akira; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 5202192, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan	Mori, K (reprint author), Shiga Univ Med Sci, Dept Orthopaed Surg, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.						Capone F, 2012, SPINE J, V12, P83, DOI 10.1016/j.spinee.2011.12.001; Sakaura H, 2007, SPINE, V32, pE611	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JAN	2015	15	1					205	206		10.1016/j.spinee.2014.09.005		2	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AW6OP	WOS:000346389000034		
J	Kimura, T; Kaga, Y; Sekita, Y; Fujikawa, K; Nakatani, T; Odamoto, M; Funaki, S; Ikawa, M; Abe, K; Nakano, T				Kimura, Tohru; Kaga, Yoshiaki; Sekita, Yoichi; Fujikawa, Keita; Nakatani, Tsunetoshi; Odamoto, Mika; Funaki, Soichiro; Ikawa, Masahito; Abe, Kuniya; Nakano, Toru			Pluripotent Stem Cells Derived From Mouse Primordial Germ Cells by Small Molecule Compounds	STEM CELLS			English	Article						Primordial germ cells; Embryonic germ cells; Small molecule compound; Induced pluripotent stem cells; DNA methylation; Epigenetic memory	PROMOTER DNA METHYLATION; EPIGENETIC MEMORY; SOMATIC-CELLS; DERIVATION; DEMETHYLATION; INDUCTION; DYNAMICS; ERASURE; MICE; INHIBITION	Primordial germ cells (PGCs) can give rise to pluripotent stem cells known as embryonic germ cells (EGCs) when cultured with basic fibroblast growth factor (bFGF), stem cell factor (SCF), and leukemia inhibitory factor. Somatic cells can give rise to induced pluripotent stem cells (iPSCs) by introduction of the reprogramming transcription factors Oct4, Sox2, and Klf4. The effects of Sox2 and Klf4 on somatic cell reprogramming can be reproduced using the small molecule compounds, transforming growth factor-beta receptor (TGF beta R) inhibitor and Kempaullone, respectively. Here we examined the effects of TGFbR inhibitor and Kempaullone on EGC derivation from PGCs. Treatment of PGCs with TGFbR inhibitor and/or Kempaullone generated pluripotent stem cells under standard embryonic stem cell (ESC) culture conditions without bFGF and SCF, which we termed induced EGCs (iEGCs). The derivation efficiency of iEGCs was dependent on the differentiation stage and sex. DNA methylation levels of imprinted genes in iEGCs were reduced, with the exception of the H19 gene. The promoters of genes involved in germline development were generally hypomethylated in PGCs, but three germline genes showed comparable DNA methylation levels among iEGs, ESCs, and iPSCs. These results show that PGCs can be reprogrammed into pluripotent state using small molecule compounds, and that DNA methylation of these germline genes is not maintained in iEGCs.	[Kimura, Tohru; Kaga, Yoshiaki; Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Kimura, Tohru; Sekita, Yoichi; Nakatani, Tsunetoshi; Funaki, Soichiro; Nakano, Toru] Osaka Univ, Dept Pathol, Suita, Osaka, Japan; [Funaki, Soichiro] Osaka Univ, Sch Med, Dept Gen Thorac Surg, Suita, Osaka, Japan; [Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka, Japan; [Kimura, Tohru; Fujikawa, Keita; Odamoto, Mika] Kitasato Univ, Sch Sci, Mol Embryol Lab, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kimura, Tohru; Sekita, Yoichi; Fujikawa, Keita; Odamoto, Mika] Kitasato Univ, Sch Sci, Lab Stem Cell Biol, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Abe, Kuniya] RIKEN BioResource Ctr, Technol & Dev Team Mammalian Genome Dynam, Tsukuba, Ibaraki, Japan; [Nakano, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Chiyoda Ku, Tokyo, Japan	Kimura, T (reprint author), Kitasato Univ, Sch Sci, Dept Biosci, Lab Mol Embryol,Lab Stem Cell Biol,Minami ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	tkimura@kitasato-u.ac.jp	Ikawa, Masahito/A-5315-2009	Ikawa, Masahito/0000-0001-9859-6217	Ministry of Education, Science, Sports and Culture; CREST of JST	We thank N. Asada for technical assistance and M. Imaizumi for secretarial assistance. We also thank Y. Esaki and S. Nishioka for chimera analysis, Yumiko Koga for microarray analysis, and Drs. S. Ishihara and K. Katagiri for cell sorting. This work was supported in part by the Ministry of Education, Science, Sports and Culture, and by CREST of JST.	Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Koshimizu U, 1996, DEVELOPMENT, V122, P1235; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nagamatsu G, 2013, STEM CELLS, V31, P479, DOI 10.1002/stem.1303; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Kimura T, 2011, HISTOL HISTOPATHOL, V26, P643; Labosky PA, 1994, CIBA F SYMP, V182, P168; LABOSKY PA, 1994, CIBA F SYMP, V182, P157; Nakamura T, 2008, GENES CELLS, V13, P1269, DOI 10.1111/j.1365-2443.2008.01243.x; Nakashima H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105932; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shovlin TC, 2008, DEV BIOL, V313, P674, DOI 10.1016/j.ydbio.2007.11.007; Stevens L C, 1980, Results Probl Cell Differ, V11, P265	44	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JAN	2015	33	1					45	55		10.1002/stem.1838		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AW8ES	WOS:000346494100006		
J	Yamaguchi, YL; Tanaka, SS; Kumagai, M; Fujimoto, Y; Terabayashi, T; Matsui, Y; Nishinakamura, R				Yamaguchi, Yasuka L.; Tanaka, Satomi S.; Kumagai, Maho; Fujimoto, Yuka; Terabayashi, Takeshi; Matsui, Yasuhisa; Nishinakamura, Ryuichi			Sall4 Is Essential for Mouse Primordial Germ Cell Specification by Suppressing Somatic Cell Program Genes	STEM CELLS			English	Article						Primordial germ cells; Spalt-like 4; HDAC; Ifitm1; Mouse	EMBRYONIC STEM-CELLS; OKIHIRO-SYNDROME; CRE RECOMBINASE; IN-VITRO; PLURIPOTENCY; TRANSCRIPTION; MICE; EXPRESSION; LINEAGES; NANOG	The Spalt-like 4 (Sall4) zinc finger protein is a critical transcription factor for pluripotency in embryonic stem cells (ESCs). It is also involved in the formation of a variety of organs, in mice, and humans. We report the essential roles of Sall4 in mouse primordial germ cell (PGC) specification. PGC specification is accompanied by the activation of the stem cell program and repression of the somatic cell program in progenitor cells. Conditional inactivation of Sall4 during PGC specification led to a reduction in the number of PGCs in embryonic gonads. Sall4(del/del) PGCs failed to translocate from the mesoderm to the endoderm and underwent apoptosis. In Sall4(del/del) PGC progenitors, somatic cell program genes (Hoxa1 and Hoxb1) were derepressed, while activation of the stem cell program was not impaired. We demonstrated that in differentiated ESCs, Sall4 bound to these somatic cell program gene loci, which are reportedly occupied by Prdm1 in embryonic carcinoma cells. Given that Sall4 and Prdm1 are known to associate with the histone deacetylase repressor complex, our findings suggest that Sall4 suppresses the somatic cell program possibly by recruiting the repressor complex in conjunction with Prdm1; therefore, it is essential for PGC specification.	[Yamaguchi, Yasuka L.; Tanaka, Satomi S.; Kumagai, Maho; Fujimoto, Yuka; Terabayashi, Takeshi; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tanaka, SS (reprint author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	stanaka@kumamoto-u.ac.jp; ryuichi@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25132711, 21116003]; Japan Society for Promotion of Science [23570258]; Takeda Science Foundation	We are grateful to Patrick Tam and Akira Nakamura for their helpful comments regarding our manuscript, to Toru Nakano for the Pgc7 antibody, to Toshiaki Noce for the mvh antibody, and to Chiyoko Kobayashi for technical assistance. This research was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25132711 to S.S.T. and 21116003 to R.N.), and from the Japan Society for Promotion of Science (23570258 to S.S.T.). Support was also provided by the Takeda Science Foundation (to S.S.T.).	Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Tanimura N, 2013, J BIOL CHEM, V288, P5027, DOI 10.1074/jbc.M112.411173; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Emerson RE, 2010, PATHOLOGY, V42, P344, DOI 10.3109/00313021003767355; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Tanaka SS, 2010, DEV DYNAM, V239, P2851, DOI 10.1002/dvdy.22417; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.10.010; Campolo F, 2013, STEM CELLS, V31, P1408, DOI 10.1002/stem.1392; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.3.CO;2-O; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; BESMER P, 1993, DEVELOPMENT, P125; Fujimoto Y, 2013, DEV CELL, V26, P416, DOI 10.1016/j.devcel.2013.06.018; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Okamura D, 2008, DEV BIOL, V317, P576, DOI 10.1016/j.ydbio.2008.03.002; Tanaka SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057428; Wang BB, 2009, MOL HUM REPROD, V15, P557, DOI 10.1093/molehr/gap046; Yamaguchi YL, 2011, DEV DYNAM, V240, P394, DOI 10.1002/dvdy.22528	53	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JAN	2015	33	1					289	300		10.1002/stem.1853		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AW8ES	WOS:000346494100027		
J	Siringoringo, DM; Fujino, Y				Siringoringo, Dionysius M.; Fujino, Yozo			Seismic response analyses of an asymmetric base-isolated building during the 2011 Great East Japan (Tohoku) Earthquake	STRUCTURAL CONTROL & HEALTH MONITORING			English	Article						building seismic monitoring; asymmetric base-isolated building; building torsional response; 2011 Great East Japan Earthquake; system identification	DYNAMIC STRUCTURAL SYSTEMS; IDENTIFICATION; RECORDS; BRIDGE	Analysis of strong motion recordings of a base-isolated building during the March 11, 2011, Great East Japan (Tohoku) Earthquake is reported in this paper. The building, located in Tokyo Bay area, is an asymmetric L-shaped structure consisting of seven-story and 14-story building with vertical opening. Vibration monitoring system was installed on the building in 2010, and seismic responses were recorded including the strongest shaking (peak ground acceleration 0.80-1.40m/s(2)) experienced during the main shock of March 11, 2011, Great East Japan Earthquake. The building survived the earthquake without structural damage. The study in this paper includes response analysis, system identification, and seismic performance evaluation of the structure, especially performance of base-isolation system. The study shows that despite considerable shift in effective frequency of the building due to the increase in flexibility of isolation system during the main shock, large acceleration was recorded on the superstructure with the peak floor accelerations of nearly 300cm/s(2). Two factors contribute to this cause: one is the characteristics of the building where torsional modes dominate the seismic response of upper stories and the other is resonance, where dominant frequencies of ground motions coincide with the natural frequencies of torsional modes. Moreover, analysis shows that torsional modes were not significantly influenced by performance of base isolation, so that even though the base isolation has functioned properly, the upper stories still experienced large floor accelerations. The paper also discusses long-term observation of seismic responses during aftershocks and various levels of earthquakes between 2010 and 2012. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Siringoringo, Dionysius M.] Univ Tokyo, Dept Civil Engn, Tokyo 1138656, Japan; [Fujino, Yozo] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Siringoringo, DM (reprint author), Univ Tokyo, Dept Civil Engn, Tokyo 1138656, Japan.	dion@bridge.t.u-tokyo.ac.jp			Strategic Research Program of Japan Science and Technology Agency (JST) in the area of advanced integrated sensing technology (CREST) under the title 'Risk Monitoring and Disaster Management of Urban Infrastructure'	This research is financially supported by Strategic Research Program of Japan Science and Technology Agency (JST) in the area of advanced integrated sensing technology (CREST) under the title 'Risk Monitoring and Disaster Management of Urban Infrastructure' (principle investigator: Yozo Fujino). The authors gratefully acknowledge this support. The authors also gratefully acknowledge the valuable discussions on monitoring system with Dr. Katsuaki Konno of Shibaura Institute of Technology and Dr. Takafumi Nishikawa of Nagasaki University. The assistance from NS Consultant Ltd. on the initial design documents and drawing and from Mr. Hisashi Yamasaki, former graduate student on data analysis, is also highly appreciated. The opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect those of the abovementioned institutions.	Nagarajaiah S, 2000, J STRUCT ENG-ASCE, V126, P1177, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1177); SAFAK E, 1989, J ENG MECH-ASCE, V115, P2386; NAGARAJAIAH S, 1993, J STRUCT ENG-ASCE, V119, P2932, DOI 10.1061/(ASCE)0733-9445(1993)119:10(2932); Minami Y, 2013, STRUCT CONTROL HLTH, V20, P1317, DOI 10.1002/stc.1537; Arici Y, 2005, STRUCT CONTROL HLTH, V12, P381, DOI 10.1002/stc.76; Chaudhary MTA, 2008, STRUCT CONTROL HLTH, V15, P1021, DOI 10.1002/stc.249; Chus SY, 2011, STRUCT CONTROL HLTH, V18, P241; Clarks PW, 1997, UCBEERC9718; EISENBERGER M, 1986, ENG STRUCT, V8, P2, DOI 10.1016/0141-0296(86)90013-1; Higashinos M, 2006, CIB SERIES; Hong AL, 2009, STRUCT CONTROL HLTH, V16, P178, DOI 10.1002/stc.289; Hwang JS, 2000, J STRUCT ENG-ASCE, V126, P879, DOI 10.1061/(ASCE)0733-9445(2000)126:8(879); Japan Society of Seismic Isolation, 2012, REP RESP CONTR BUILD; Juang JN, 1997, J GUID CONTROL DYNAM, V20, P492, DOI 10.2514/2.4068; Kanis N, 2013, P 13 WORLD C SEISM I; Konnos K, 2013, J JAPAN ASS EARTHQUA, V13, P314; Lees D., 1980, EARTHQ ENG STRUCT D, V8, P349; Nakamura T, 1988, P 9 WORLD C EARTHQ E, P675; Pans P, 2005, J EARTHQ ENG, V9, P147, DOI DOI 10.1080/13632460509350537; Pans TC, 1983, EARTHQ ENG STRUCT D, V11, P749; PAPAGEORGIOU AS, 1989, EARTHQUAKE ENG STRUC, V18, P1189, DOI 10.1002/eqe.4290180809; SAFAK E, 1989, J ENG MECH-ASCE, V115, P2406; Siringoringo DM, 2006, STRUCT CONTROL HLTH, V13, P226, DOI 10.1002/stc.135; Siringoringo DM, 2008, EARTHQ ENG STRUCT D, V37, P361, DOI 10.1002/eqe.758	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-2255	1545-2263		STRUCT CONTROL HLTH	Struct. Control. Health Monit.	JAN	2015	22	1					71	90		10.1002/stc.1661		20	Construction & Building Technology; Engineering, Civil; Instruments & Instrumentation	Construction & Building Technology; Engineering; Instruments & Instrumentation	AW4SB	WOS:000346269700006		
J	Yamashita, T; Araki, K; Tomifuji, M; Kamide, D; Tanaka, Y; Shiotani, A				Yamashita, Taku; Araki, Koji; Tomifuji, Masayuki; Kamide, Daisuke; Tanaka, Yuya; Shiotani, Akihiro			A traditional Japanese medicine-Hangeshashinto (TJ-14)-alleviates chemoradiation-induced mucositis and improves rates of treatment completion	SUPPORTIVE CARE IN CANCER			English	Article						Chemoradiotherapy; Radiation-induced mucositis; Kampo; Supportive care in cancer treatment	HANGE-SHASHIN-TO; ORAL MUCOSITIS; NECK-CANCER; GASTROINTESTINAL MUCOSITIS; RANDOMIZED-TRIAL; RADIOTHERAPY; CHEMOTHERAPY; PREVENTION; MANAGEMENT; EXTRACT	Oral mucositis induced by radiation or chemoradiation can cause devastating quality of life issues for patients undergoing treatment for head and neck cancer. In this study, we investigated the efficacy of a traditional Japanese medicine-Hangeshashinto (TJ-14)-for (chemo)radiation-induced oral mucositis. Eighty patients who underwent whole neck radiation of > 60 Gy with or without chemotherapy (high-dose cisplatin or low-dose docetaxel) were enrolled in this retrospective study; 40 had received TJ-14 during treatment, and 40 had not (controls). Factors related to alleviation of oral mucositis were identified by multivariate logistic regression analysis. Rates of completion of (chemo)radiation treatments were compared between the patients who received TJ-14 and the control group according to the treatment regimen. The comparison of the nutrition status between groups was also performed. Multivariate analysis indicated that the use of TJ-14 (p = 0.019), gender (p = 0.024), and primary tumor location (p = 0.028) were significant factors associated with the severity of oral mucositis. TJ-14 was associated with a significantly improved rate of completion of chemoradiation with cisplatin (p = 0.002). In the investigation of nutritional status, only serum albumin was significantly maintained better in the TJ-14 group than the control group in terms of mean change before and after (chemo)radiation (p = 0.024). The present study indicates that TJ-14 is effective for ameliorating oral mucositis induced by (chemo)radiation in patients with head and neck cancers. TJ-14 was associated with improved completion rates of chemoradiation treatments with cisplatin. A randomized controlled trial is necessary to confirm the efficacy of TJ-14 for chemoradiation-induced mucositis in head and neck cancer patients.	[Yamashita, Taku; Araki, Koji; Tomifuji, Masayuki; Kamide, Daisuke; Tanaka, Yuya; Shiotani, Akihiro] Natl Def Med Coll, Dept Otorhinolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan	Yamashita, T (reprint author), Natl Def Med Coll, Dept Otorhinolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tkym@ndmc.ac.jp					Scully C, 2004, HEAD NECK-J SCI SPEC, V26, P77, DOI 10.1002/hed.10326; Robertson C, 1998, INT J RADIAT ONCOL, V40, P319, DOI 10.1016/S0360-3016(97)00716-5; Keefe DM, 2007, CANCER, V109, P820, DOI 10.1002/cncr.22484; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Kase Y, 1998, BIOL PHARM BULL, V21, P1277; Sonis ST, 2001, J CLIN ONCOL, V19, P2201; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086; Kase Y, 1997, BIOL PHARM BULL, V20, P954; Russo G, 2008, ONCOLOGIST, V13, P886, DOI 10.1634/theoncologist.2008-0024; WITHERS HR, 1988, ACTA ONCOL, V27, P131; Suwinski R, 2003, INT J RADIAT ONCOL, V56, P399, DOI 10.1016/S0360-3016-(02)04469-3; Cowen D, 1997, INT J RADIAT ONCOL, V38, P697, DOI 10.1016/S0360-3016(97)00076-X; Grycova L, 2007, PHYTOCHEMISTRY, V68, P150, DOI 10.1016/j.phytochem.2006.10.004; Le QT, 2011, J CLIN ONCOL, V29, P2808, DOI 10.1200/JCO.2010.32.4095; Bese NS, 2007, INT J RADIAT ONCOL, V68, P654, DOI 10.1016/j.ijrobp.2007.03.010; Bensinger William, 2008, J Natl Compr Canc Netw, V6 Suppl 1, pS1; Bensinger W, 2008, J NATL COMPR CANC S1, V6, pS22; Bossi P, 2012, J CLIN ONCOL, V30, P564, DOI 10.1200/JCO.2011.39.1136; Bourhis J, 2011, RADIOTHER ONCOL, V100, P56, DOI 10.1016/j.radonc.2011.07.006; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Gibson RJ, 2013, SUPPORT CARE CANCER, V21, P313, DOI 10.1007/s00520-012-1644-z; HATTORI T, 1989, JPN J PHARMACOL, V51, P117, DOI 10.1254/jjp.51.117; Hensley ML, 2009, J CLIN ONCOL, V27, P127, DOI 10.1200/JCO.2008.17.2627; Herrmann T., 1994, Strahlentherapie und Onkologie, V170, P545; Kono T, 2010, WORLD J ONCOL, V1, P232, DOI DOI 10.4021/WJON263W; Peterson DE, 2011, ANN ONCOL S, V22, P78, DOI DOI 10.1093/ANNONC/MDR391; Peterson DE, 2009, ANN ONCOL, V20, P174, DOI 10.1093/annonc/mdp165; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Samosorn S, 2009, BIOORGAN MED CHEM, V17, P3866, DOI 10.1016/j.bmc.2009.04.028; Satoh H, 1999, CANC RES THER CONTRO, V7, P321; Sonis Stephen T, 2004, J Support Oncol, V2, P21; Svanberg A, 2010, J CLIN NURS, V19, P2146, DOI 10.1111/j.1365-2702.2010.03255.x; TAWATA M, 1992, EUR J PHARMACOL, V212, P87, DOI 10.1016/0014-2999(92)90076-G; Wright TH, 2009, CANCER BIOL THER, V8, P923, DOI 10.4161/cbt.8.10.8146	36	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2015	23	1					29	35		10.1007/s00520-014-2315-z		7	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AW8FS	WOS:000346497100007		
J	Miyashita, M; Kawakami, S; Kato, D; Yamashita, H; Igaki, H; Nakano, K; Kuroda, Y; Nakagawa, K				Miyashita, Mitsunori; Kawakami, Sachiko; Kato, Daiki; Yamashita, Hideomi; Igaki, Hiroshi; Nakano, Kimiko; Kuroda, Yujiro; Nakagawa, Keiichi			The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer "fighting against cancer"	SUPPORTIVE CARE IN CANCER			English	Article						Palliative care; Neoplasms; Attitude; Good death; Life prolongation treatment	END-OF-LIFE; CELL LUNG-CANCER; BEREAVED FAMILY-MEMBERS; EARLY PALLIATIVE CARE; ALTERNATIVE MEDICINE; ANTICANCER TREATMENT; ADVANCE DIRECTIVES; NATIONWIDE SURVEY; NEAR-DEATH; CHEMOTHERAPY	The objectives of this study were to compare the importance of components of a good death among cancer patients, the general population, oncologists, and oncology nurses, and explore which patients preferred "fighting against cancer." We conducted a cross-sectional anonymous self-reported survey of cancer patients who visited a radiation oncology outpatient clinic, oncologists, and oncology nurses at the Tokyo University Hospital and a random sample of the general population in the Tokyo metropolitan area. The outcomes were 18 previously developed components of a good death in Japanese cancer care consisting of 57 attributes. Three hundred ten patients, 353 subjects from the general population, 109 oncologists, and 366 oncology nurses participated. The desire to "fight against cancer" was highly significantly different between patients and oncologists (effect size [ES] = -1.40; P = 0.001) and patients and oncology nurses (ES = -1.12; P = 0.001). "Physical and cognitive control" was, similarly, highly significantly different between patients and oncologists (ES = -1.30; P = 0.001) and patients and oncology nurses (ES = -1.06; P = 0.001). Patients who emphasized "maintaining hope and pleasure" (P = 0.0001), "unawareness of death" (P = 0.0001), and "good relationship with family" (P = 0.004) favored "fighting against cancer." The patients, however, who emphasized "physical and psychological comfort" did not significantly favor "fighting against cancer" (P = 0.004). The importance of good death components differed between groups. Medical professionals should be aware of the diversity of values surrounding death and assess the patient's values and discuss them to support his or her quality of life. In addition, the development of care and a medical/social system to maintain hope and pleasure after failure of anticancer treatment is necessary.	[Miyashita, Mitsunori; Nakano, Kimiko] Univ Tokyo, Grad Sch Med, Sch Hlth Sci & Nursing Sci, Dept Adult Nursing Palliat Care Nursing, Tokyo, Japan; [Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Div Palliat Nursing, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawakami, Sachiko] NPO, Canc Net Japan, Tokyo, Japan; [Kawakami, Sachiko; Kato, Daiki; Yamashita, Hideomi; Igaki, Hiroshi; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Radiol, Tokyo 113, Japan; [Kuroda, Yujiro; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Palliat Med, Tokyo 113, Japan	Miyashita, M (reprint author), Tohoku Univ, Grad Sch Med, Div Palliat Nursing, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	miyasita-tky@umin.net; kawakami@cancernet.jp; kiidautoka@yahoo.co.jp; yamachan07291973@yahoo.co.jp; igaki-tky@umin.ac.jp; nakano-k@umin.ac.jp; kuroday-rad@h.u-tokyo.ac.jp; k-nak@fg7.so-net.ne.jp			Japanese Society for the Promotion of Science [20791693]	This research was supported by the Japanese Society for the Promotion of Science, Grant Number 20791693. We thank Susumu Shimazono, Emi Toyoda, Fumiko Takashita, Hiroko Sagawa, and Ai Ishitoya for managing the study.	Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Hyodo I, 2005, J CLIN ONCOL, V23, P2645; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Hirai K, 2006, J PAIN SYMPTOM MANAG, V31, P140, DOI 10.1016/j.jpainsymman.2005.06.012; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.036; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Hashimoto K, 2009, ONCOLOGIST, V14, P752, DOI 10.1634/theoncologist.2008-0257; Hirose T, 2005, INTERNAL MED, V44, P107, DOI 10.2169/internalmedicine.44.107; Otani H, 2011, JPN J CLIN ONCOL, V41, P999, DOI 10.1093/jjco/hyr092; Patrick DL, 2001, J PAIN SYMPTOM MANAG, V22, P717, DOI 10.1016/S0885-3924(01)00333-5; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Bremnes RM, 1995, EUR J CANCER, V31A, P1955, DOI 10.1016/0959-8049(95)00513-7; Hirai K, 2008, ANN ONCOL, V19, P49, DOI 10.1093/annonc/mdm494; Kizawa Y, 2013, AM J HOSP PALLIAT ME, V30, P664, DOI 10.1177/1049909112462860; Emanuel EJ, 1998, LANCET, V351, P21; Morita T, 1999, Am J Hosp Palliat Care, V16, P509, DOI 10.1177/104990919901600306; Nakano K, 2013, PALLIAT SUPPORT CARE, V11, P405, DOI 10.1017/S1478951512000442; Payne SA, 1996, PALLIATIVE MED, V10, P307, DOI 10.1177/026921639601000406; Shirado A, 2013, J PAIN SYMPTOM MANAG, V45, P848, DOI 10.1016/j.jpainsymman.2012.05.014; SLEVIN ML, 1990, BRIT MED J, V300, P1458; Steinhauser KE, 2000, ANN INTERN MED, V132, P825; Steinhauser Karen E., 2000, JAMA (Journal of the American Medical Association), V284, P2476, DOI 10.1001/jama.284.19.2476; Voltz R, 1998, J PAIN SYMPTOM MANAG, V16, P153, DOI 10.1016/S0885-3924(98)00067-0	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2015	23	1					103	110		10.1007/s00520-014-2323-z		8	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AW8FS	WOS:000346497100016		
J	Shimada, A; Mori, I; Maeda, I; Watanabe, H; Kikuchi, N; Ding, HS; Morita, T				Shimada, Akira; Mori, Ichiro; Maeda, Isseki; Watanabe, Hidekazu; Kikuchi, Nobutaka; Ding, Hansheng; Morita, Tatsuya			Physicians' attitude toward recurrent hypercalcemia in terminally ill cancer patients	SUPPORTIVE CARE IN CANCER			English	Article						Hypercalcemia; Attitude; Physician; Survey; Palliative care	PARENTERAL HYDRATION; NATIONWIDE SURVEY; GOOD DEATH; OF-LIFE; MALIGNANCY; CARE; BISPHOSPHONATES; DISCUSSIONS; DELIRIUM; QUALITY	There is no consensus regarding whether cancer-induced hypercalcemia should be treated up until the patient's death. The primary aim of this study was to clarify physicians' attitude toward treating recurrent hypercalcemia in terminally ill cancer patients and associated factors. A nationwide, cross-sectional survey was performed involving 757 physicians of the Japanese Society for Palliative Medicine. Physicians' attitude toward treating hypercalcemia in terminally ill patients was assessed based on the response to the question: do you agree that you provide medical treatment for recurrent hypercalcemia up until a patient's death? As the potential determinants of physicians' attitudes, we examined their characteristics, beliefs about hypercalcemia, and beliefs about a good death. We obtained a total of 380 (50.2 %) analyzable responses. A total of 163 physicians (43 %) agreed that hypercalcemia should be treated up until the patient's death, while the remaining 217 physicians (57 %) disagreed. The independent determinants of the attitude included the following: physicians' specialty, belief that hypercalcemia treatment improves pain, belief that hypercalcemia treatment improves nausea, belief that hypercalcemia treatment improves quality of life, belief that hypercalcemia treatment prolongs life, belief that the effect of hypercalcemia treatment reduces gradually, belief that death with hypercalcemia is less distressing, and the perception that being mentally clear is important for a good death. Japanese physicians had different attitudes toward treating hypercalcemia in terminally ill patients. Physicians' beliefs about the efficacy of medical treatment for hypercalcemia markedly influenced their attitudes. Clarifying evidence on the effect of hypercalcemia treatment on patients' symptoms and prognoses is strongly encouraged.	[Shimada, Akira] Tohoku Univ, Hosp Palliat Care Ctr, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mori, Ichiro] Gratia Hosp Hosp, Osaka 5628567, Japan; [Maeda, Isseki] Osaka Univ, Grad Sch Med, Dept Palliat Med, Suita, Osaka 5650871, Japan; [Watanabe, Hidekazu; Kikuchi, Nobutaka] Tohoku Univ, Grad Sch Med, Div Palliat Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ding, Hansheng] Tohoku Univ, Grad Sch Med, Dept Hlth Adm & Policy, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan	Morita, T (reprint author), Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Kita Ku, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan.	stetsu@med.tohoku.ac.jp; mori.ichi.mail@gmail.com; maeda@pm.med.osaka-u.ac.jp; hwatanabe-thk@umin.ac.jp; nkikuchi@kg8.so-net.ne.jp; dinghansheng@hotmail.com; tmorita@sis.seirei.or.jp			Nippon Foundation	We thank Michiya Ito, Toshimichi Nakaho, Kumiko Suzuki, and Akiko Sukeno for their useful comments to complete this study. This study was supported by a grant for palliative care research from the Nippon Foundation (2004).	Body JJ, 2000, SUPPORT CARE CANCER, V8, P398, DOI 10.1007/s005200050008; Bruera E, 2013, J CLIN ONCOL, V31, P111, DOI 10.1200/JCO.2012.44.6518; Morita T, 2001, J PAIN SYMPTOM MANAG, V22, P997, DOI 10.1016/S0885-3924(01)00360-8; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; REILLY BM, 1994, ARCH INTERN MED, V154, P2299, DOI 10.1001/archinte.154.20.2299; Morita T, 2002, J CLIN ONCOL, V20, P4699, DOI 10.1200/JCO.2003.10.155; Morita T, 2002, J CLIN ONCOL, V20, P758, DOI 10.1200/JCO.20.3.758; Lumachi F, 2009, ANTICANCER RES, V29, P1551; Morita T, 2005, ANN ONCOL, V16, P640, DOI 10.1093/annonc/mdi121; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Akechi T, 2012, J AM GERIATR SOC, V60, P271, DOI 10.1111/j.1532-5415.2012.03895.x; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; BOISAUBIN EV, 1991, AM J MED SCI, V301, P314, DOI 10.1097/00000441-199105000-00004; Bower M, 2005, OXFORD TXB PALLIATIV, P687; Ernst DS, 2006, TXB PALLIATIVE MED, P799; LeGrand SB, 2011, AM J HOSP PALLIAT ME, V28, P515, DOI 10.1177/1049909111414164; Marr HK, 2010, CURR ONCOL, V17, P69; Mundy GR, 1997, AM J MED, V103, P134; Saunders Y, 2004, PALLIATIVE MED, V18, P418, DOI 10.1191/0269216304pm914ra; Yamaguchi T, 2012, J PAIN SYMPTOM MANAG, V43, P1001, DOI 10.1016/j.jpainsymman.2011.06.028	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2015	23	1					177	183		10.1007/s00520-014-2355-4		7	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AW8FS	WOS:000346497100025		
J	Kitazaki, T; Fukuda, Y; Fukahori, S; Oyanagi, K; Soda, H; Nakamura, Y; Kohno, S				Kitazaki, Takeshi; Fukuda, Yuichi; Fukahori, Susumu; Oyanagi, Kazuhiko; Soda, Hiroshi; Nakamura, Yoichi; Kohno, Shigeru			Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy	SUPPORTIVE CARE IN CANCER			English	Article						Aprepitant; Palonosetron; Dexamethasone; CINV; Highly emetogenic chemotherapy; Moderately emetogenic chemotherapy; Lung cancer	MODERATELY EMETOGENIC CHEMOTHERAPY; INDUCED NAUSEA; DOUBLE-BLIND; CONSENSUS CONFERENCE; GUIDELINE UPDATE; PREVENTION	The purpose of the study is to investigate the usefulness of the triplet regimen comprising aprepitant, palonosetron, and dexamethasone in patients treated with highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC). Patients with lung cancer (aged 65.8 +/- 8.4 years) who received carboplatin-based MEC and those treated with cisplatin-based HEC were enrolled. The antiemetic regimen for both types of chemotherapy consisted of aprepitant, palonosetron, and dexamethasone based on the May 2010 guidelines prepared by the Japan Society of Clinical Oncology. The incidence of chemotherapy-induced nausea and vomiting (CINV) and the use of salvage treatment were assessed. The primary endpoints were the percentage of patients with a complete response (CR: no nausea and no salvage treatment) during the entire study period (5 days) after chemotherapy, during the acute phase (day 1), and during the delayed phase (days 2-5). CR rates for the entire period were 86 and 71 % in patients receiving carboplatin-based and cisplatin-based chemotherapy, respectively. CR rates were respectively 98 and 100 % in the acute phase versus 87 and 71 % in the delayed phase. Most of the patients could ingest food throughout the entire period after chemotherapy. Assessment of various risk factors for acute and delayed CINV (gender, age, prior vomiting due to antineoplastic therapy, prior experience of motion sickness, and history of drinking) revealed no significant influence of these factors on the CR rate for the entire period in patients receiving either carboplatin-based or cisplatin-based chemotherapy. The present triple therapy can be recommended for supporting both carboplatin-based and cisplatin-based chemotherapy regimens.	[Kitazaki, Takeshi] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Resp Med, Nagasaki 8528511, Japan; [Fukuda, Yuichi; Fukahori, Susumu; Oyanagi, Kazuhiko; Soda, Hiroshi] Sasebo City Gen Hosp, Dept Resp Med, Sasebo, Nagasaki 8578511, Japan; [Nakamura, Yoichi; Kohno, Shigeru] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan	Kitazaki, T (reprint author), Japanese Red Cross Nagasaki Genbaku Hosp, Dept Resp Med, 3-15 Mori Machi, Nagasaki 8528511, Japan.	tkita@ma.ejnet.ne.jp					Bloechl-Daum B, 2006, J CLIN ONCOL, V24, P4472, DOI 10.1200/JCO.2006.05.6382; Rapoport BL, 2010, SUPPORT CARE CANCER, V18, P423, DOI 10.1007/s00520-009-0680-9; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Majem M, 2011, SUPPORT CARE CANCER, V19, P1983, DOI 10.1007/s00520-010-1042-3; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Roila F, 2010, ANN ONCOL, V21, pv232, DOI 10.1093/annonc/mdq194; Warr DG, 2005, EUR J CANCER, V41, P1278, DOI 10.1016/j.ejca.2005.01.024; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Hatake Kiyohiko, 2011, Gan To Kagaku Ryoho, V38, P1758; Navari Rudolph M, 2003, J Support Oncol, V1, P89; Takahashi T, 2010, CANCER SCI, V101, P2455, DOI 10.1111/j.1349-7006.2010.01689.x; Uchino J, 2012, ASIAN PAC J CANCER P, V13, P4187, DOI 10.7314/APJCP.2012.13.8.4187	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2015	23	1					185	190		10.1007/s00520-014-2339-4		6	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AW8FS	WOS:000346497100026		
J	Hayashi, H; Beppu, T; Okabe, H; Kuroki, H; Nakagawa, S; Imai, K; Nitta, H; Chikamoto, A; Ishiko, T; Baba, H				Hayashi, Hiromitsu; Beppu, Toru; Okabe, Hirohisa; Kuroki, Hideyuki; Nakagawa, Shigeki; Imai, Katsunori; Nitta, Hidetoshi; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo			Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy	SURGERY			English	Article							LIVER RESECTION; HEPATOBILIARY SCINTIGRAPHY; SURGICAL COMPLICATIONS; HEPATIC RESECTION; CLASSIFICATION; REMNANT	Purpose. In this study we examined whether conventional future remnant liver volume (FR volume) or function (FR function) better predicted the operative outcome after major hepatectomy. Methods. Of 510 patients who underwent hepatectomy for various indications, 133 patients with major hepatectomy were enrolled in this study. FR volume and the corresponding FR function routinely were measured with a 99mTc-GSA scintigraphy single-proton emission computed tomography fusion system. FR function was defined as the future remnant liver uptake ratio of 99mTc-GSA per whole liver by single-proton emission computed tomography. FR volume or function in cases with insufficient FR volume or function required for major hepatectomy were defined as marginal. Results. Morbidity, liver dysfunction-related morbidity, and mortality after major hepatectomy occurred in 40 (30%), 10 (7.5 %), and 8(5.7%) patients, respectively. Thirty-two of the 133 patients were diagnosed as marginal using FR volume, but only 11 patients were diagnosed as marginal using FR function. These results indicated that 21 patients (16%) were switched to the safe group using functional assessment. Operative outcomes in patients with safe FR function (n =122) were equivalent to those of patients with safe FR volume (n = 101), but patients with marginal FR function (n = 11) had substantially worse outcomes than patients with marginal FR volumes (n = 32). Logistic regression analysis identified marginal FR function, but not volume, as a risk factor for worse operative outcome after major hepatectomy. Portal vein embolization induced the substantially greater FR function compared with FR volume. Although liver volume equally corresponds to liver function under normal conditions, liver cirrhosis was greatly associated with the major discrepancy (more than 10%) in patients without portal vein embolization. Conclusion. Functional assessment for future remnant liver identified patients who were eligible for curative hepatectomy despite a marginal status based on conventional volumetric assessment. Thus, marginal FR function is a better predictor of operative outcome after major hepatectomy than FR volume, especially in patients with nonhealthy liver.	[Hayashi, Hiromitsu; Beppu, Toru; Okabe, Hirohisa; Kuroki, Hideyuki; Nakagawa, Shigeki; Imai, Katsunori; Nitta, Hidetoshi; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Andreou A, 2013, J GASTROINTEST SURG, V17, P66, DOI 10.1007/s11605-012-2005-4; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Poon RTP, 2002, ANN SURG, V236, P602, DOI 10.1097/01.SLA.0000033038.38956.5E; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Beppu T, 2011, J GASTROENTEROL, V46, P938, DOI 10.1007/s00535-011-0406-x; de Graaf W, 2010, J GASTROINTEST SURG, V14, P369, DOI 10.1007/s11605-009-1085-2; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Paugam-Burtz C, 2009, ANN SURG, V249, P124, DOI 10.1097/SLA.0b013e31819279cd; Kokudo N, 2002, WORLD J SURG, V26, P1342, DOI 10.1007/s00268-002-6262-3; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Hoekstra LT, 2013, ANN SURG, V257, P27, DOI 10.1097/SLA.0b013e31825d5d47; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; de Graaf W, 2011, J NUCL MED, V52, P294, DOI 10.2967/jnumed.110.078360; de Graaf W, 2010, J NUCL MED, V51, P229, DOI 10.2967/jnumed.109.069724; Palavecino M, 2010, SURGERY, V147, P40, DOI 10.1016/j.surg.2009.06.027; Reddy SK, 2011, HPB, V13, P494, DOI 10.1111/j.1477-2574.2011.00330.x	20	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JAN	2015	157	1					20	26		10.1016/j.surg.2014.06.013		7	Surgery	Surgery	AX0BY	WOS:000346619700005		
J	Hirokawa, F; Kubo, S; Nagano, H; Nakai, T; Kaibori, M; Hayashi, M; Takemura, S; Wada, H; Nakata, Y; Matsui, K; Ishizaki, M; Uchiyama, K				Hirokawa, Fumitoshi; Kubo, Shoji; Nagano, Hiroaki; Nakai, Takuya; Kaibori, Masaki; Hayashi, Michihiro; Takemura, Shigekazu; Wada, Hiroshi; Nakata, Yasuyuki; Matsui, Kosuke; Ishizaki, Morihiko; Uchiyama, Kazuhisa			Do patients with small solitary hepatocellular carcinomas without macroscopically vascular invasion require anatomic resection? Propensity score analysis	SURGERY			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; JAPANESE NATIONWIDE SURVEY; HEPATIC RESECTION; LIVER RESECTION; SURGICAL RESECTION; RADIOFREQUENCY ABLATION; TUMOR HEMODYNAMICS; RISK-FACTORS; INTRAHEPATIC RECURRENCE; MICROVASCULAR INVASION	Background. The benefits of anatomic resection in patients with small (<5 cm), solitary hepatocellular carcinomas remain unclear. Outcomes were therefore evaluated in patients who underwent anatomic resection or nonanatomic resection of small solitary hepatocellular carcinomas. Methods. Factors affecting overall survival and disease-free survival were investigated in 330 patients who underwent curative hepatectomy for solitary (<= 5 cm) hepatocellular carcinomas without macroscopic vascular invasion. In addition, a propensity score matching model with 330 patients was constructed to overcome bias, with subgroups analyzed by tumor diameter (<3 cm and 3-5 cm). Results. ICG-R15 >= 25% was confirmed as being independently associated with poorer overall survival and disease-free survival. One-to-one matching of preoperative characteristics yielded 72 pairs of patients receiving anatomic resection and nonanatomic resection, with long-term outcomes, including overall survival and disease-free survival, being similar in these 2 groups. Subgroup analysis showed that, in patients with tumors <3 cm in diameter, short-term outcomes were better in the nonanatomic resection group than in the anatomic resection group, including significantly reduced operation time (P = 02), blood loss (P = .01), blood transfusion (P < .01), complications (particularly bile leakage and abdominal abscess) (P = .04), and postoperative hospital stay (P < .01). Conclusion. Anatomic resection was not superior to nonanatomic resection in survival outcomes in patients with solitary small hepatocellular carcinomas without macroscopic vascular invasion. Rather, postoperative short-term outcomes were more favorable with nonanatomic resection.	[Hirokawa, Fumitoshi; Hayashi, Michihiro; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 5698686, Japan; [Kubo, Shoji; Takemura, Shigekazu] Osaka City Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Osaka 558, Japan; [Nagano, Hiroaki; Wada, Hiroshi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Nakai, Takuya; Nakata, Yasuyuki] Kinki Univ, Sch Med, Dept Surg, Sayama, Osaka 589, Japan; [Kaibori, Masaki; Matsui, Kosuke; Ishizaki, Morihiko] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan	Hirokawa, F (reprint author), Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	sur122@poh.osaka-med.ac.jp					Ariizumi S, 2011, J HEPATO-BIL-PAN SCI, V18, P575, DOI 10.1007/s00534-010-0369-y; Takayama T, 1998, HEPATOLOGY, V28, P1241, DOI 10.1002/hep.510280511; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Kondo K, 2005, J HEPATO-BILIARY-PAN, V12, P399, DOI 10.1007/s00534-005-1009-9; Feng K, 2012, J HEPATOL, V57, P794, DOI [10.1016/j.jhep.2012.05.007, 10.1016/j.jhep.2012.07.022]; LAYER P, 1986, GASTROENTEROLOGY, V91, P41; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; COUINAUD C, 1954, PRESSE MED, V62, P62; Shi M, 2007, ANN SURG, V245, P36, DOI 10.1097/01.sla.0000231758.07868.71; Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Kubo S, 2000, WORLD J SURG, V24, P1559; Kubo S, 2001, ANN INTERN MED, V134, P963; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Asahara Toshimasa, 1998, Hiroshima Journal of Medical Sciences, V47, P99; BERNARDI M, 1993, J SURG ONCOL, P67; CASTAING D, 1989, ANN SURG, V210, P20, DOI 10.1097/00000658-198907000-00003; Hasegawa Kiyoshi, 2014, Ann Surg Oncol, V21 Suppl 3, pS348, DOI 10.1245/s10434-014-3585-x; Huang GT, 2005, ANN SURG, V242, P36, DOI 10.1097/01.sla.0000167925.90380.fe; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kaibori M, 2006, SURGERY, V139, P385, DOI 10.1016/j.surg.2005.08.035; Kim BK, 2008, J SURG ONCOL, V97, P246, DOI 10.1002/jso.20953; Makuuchi M, 2006, WORLD J GASTROENTERO, V12, P828; OGASAWARA K, 1995, SURG TODAY, V25, P43; Regimbeau JM, 2002, SURGERY, V131, P311, DOI 10.1067/msy.2002.121892; Rubin DB, 1997, ANN INTERN MED, V127, P757; Sakon M, 2013, HEPATOL RES, V43, P155, DOI 10.1111/hepr.12001; Sakon M, 2002, ARCH SURG-CHICAGO, V137, P94, DOI 10.1001/archsurg.137.1.94; Sakon M, 2000, J SURG ONCOL, V73, P179, DOI 10.1002/(SICI)1096-9098(200003)73:3<179::AID-JSO13>3.0.CO;2-M; Takano S, 2000, BRIT J SURG, V87, P65, DOI 10.1046/j.1365-2168.2000.01308.x; TANI M, 1994, CANCER CHEMOTH PHARM, V33, pS29, DOI 10.1007/BF00686664; Tomimaru Y, 2012, DIGEST DIS SCI, V57, P1942, DOI 10.1007/s10620-012-2114-7; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Witjes CDM, 2012, J MAGN RESON IMAGING, V36, P641, DOI 10.1002/jmri.23681; Yamada S, 2014, ANN SURG ONCOL, V21, P436, DOI 10.1245/s10434-014-3575-z; YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T; Zavaglia C, 2005, AM J GASTROENTEROL, V100, P2708, DOI 10.1111/j.1572-0241.2005.00289.x; Zinsmelster AR, 2008, AM J GASTROENTEROL, V103, P262, DOI 10.1111/j.1572-0241.2007.01590.x; ZOLI M, 1986, LIVER, V6, P286	43	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JAN	2015	157	1					27	36		10.1016/j.surg.2014.06.080		10	Surgery	Surgery	AX0BY	WOS:000346619700006		
J	Kaibori, M; Shimizu, J; Hayashi, M; Nakai, T; Ishizaki, M; Matsui, K; Kim, YK; Hirokawa, F; Nakata, Y; Noda, T; Dono, K; Nozawa, A; Kwon, M; Uchiyama, K; Kubo, S				Kaibori, Masaki; Shimizu, Junzo; Hayashi, Michihiro; Nakai, Takuya; Ishizaki, Morihiko; Matsui, Kosuke; Kim, Yong Kook; Hirokawa, Fumitoshi; Nakata, Yasuyuki; Noda, Takehiro; Dono, Keizo; Nozawa, Akinori; Kwon, Masanori; Uchiyama, Kazuhisa; Kubo, Shoji			Late-onset bile leakage after hepatic resection	SURGERY			English	Article							LIVER RESECTION; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; RANDOMIZED-TRIAL; HEPATECTOMY; MANAGEMENT; DRAINAGE; TRANSECTION; DISEASES; SYSTEM	Background. Postoperative bile leakage can be a serious complication after hepatic resection. Few studies have analyzed patients according to the time of onset of bile leakage. We analyzed differences between patients with early- and late-onset bile leakage after hepatic resection and assessed clinical characteristics and outcomes in patients with late-onset leakage. Methods. Between 2008 and 2010, 1,009 patients underwent hepatic resection at 4 participating university hospitals and 2 community hospitals. Fifty-two patients (5.1%) with postoperative bile leakage were divided into an early-onset group (<2 weeks after surgery, n = 34) and a late-onset group (>= 2 weeks after surgery, n = 18). Patient characteristics and outcomes were collected prospectively and analyzed retrospectively. Results. The proportion of patients who underwent intra-abdominal placement of a drainage catheter was significantly less in the late-onset group than the early-onset group. All 18 patients in the late-onset group developed intra-abdominal infection, and 2 died of sepsis. The proportion of patients who underwent invasive treatment (abdominal paracentesis, endoscopic biliary drainage, or second hepatic resection) was significantly greater in the late-onset group than in the early-onset group. The time to resolution of bile leakage was significantly greater in the late-onset group than the early-onset group. Conclusion. Patients should be monitored carefully for bile leakage for several weeks after hepatic resection, because late-onset bile leakage can cause serious complications. Intra-abdominal infection should also be treated as soon as possible, because it may induce refractory bile leakage with serious complications.	[Kaibori, Masaki; Ishizaki, Morihiko; Matsui, Kosuke; Kwon, Masanori] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka 5731191, Japan; [Shimizu, Junzo; Kim, Yong Kook] Osaka Rosai Hosp, Dept Surg, Sakai, Osaka, Japan; [Hayashi, Michihiro; Hirokawa, Fumitoshi; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 569, Japan; [Nakai, Takuya; Nakata, Yasuyuki] Kinki Univ, Sch Med, Dept Surg, Sayama, Osaka 589, Japan; [Noda, Takehiro; Dono, Keizo] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka, Japan; [Nozawa, Akinori; Kubo, Shoji] Osaka City Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Osaka 558, Japan	Kaibori, M (reprint author), Kansai Med Univ, Hirakata Hosp, Dept Surg, 2-3-1 Shinmachi, Hirakata, Osaka 5731191, Japan.	kaibori@hirakata.kmu.ac.jp					Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Yamashita Y, 2001, ANN SURG, V233, P45, DOI 10.1097/00000658-200101000-00008; Tanaka S, 2002, J AM COLL SURGEONS, V195, P484, DOI 10.1016/S1072-7515(02)01288-7; KOHNO H, 1992, WORLD J SURG, V16, P966; Nagano Y, 2003, WORLD J SURG, V27, P695, DOI 10.1007/s00268-003-6907-x; Kyoden Y, 2010, J HEPATO-BIL-PAN SCI, V17, P186, DOI 10.1007/s00534-009-0161-z; Itoh S, 2012, SURG TODAY, V42, P1176, DOI 10.1007/s00595-012-0306-6; Capussotti L, 2006, ARCH SURG-CHICAGO, V141, P690, DOI 10.1001/archsurg.141.7.690; Hirokawa F, 2011, AM SURGEON, V77, P539; Sadamori H, 2012, DIGEST SURG, V29, P149, DOI 10.1159/000337313; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Ijichi M, 2000, ARCH SURG-CHICAGO, V135, P1395, DOI 10.1001/archsurg.135.12.1395; Takayama T, 2001, ARCH SURG-CHICAGO, V136, P922, DOI 10.1001/archsurg.136.8.922; Figueras J, 2007, ANN SURG, V245, P536, DOI 10.1097/01.sla.0000245846.37046.57; Ishii H, 2011, DIGEST SURG, V28, P198, DOI 10.1159/000324042; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Liu CL, 2004, ANN SURG, V239, P194, DOI 10.1097/01.sla.0000109153.71725.8c; Bhattacharjya S, 2003, GASTROINTEST ENDOSC, V57, P526, DOI 10.1067/mge.2003.148; Capussotti L, 1998, HEPATO-GASTROENTEROL, V45, P184; Couinaud C., 1957, FOIE ETUDES ANATOMIQ; Fong Y, 1996, AM J SURG, V171, P158, DOI 10.1016/S0002-9610(99)80092-0; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; Hotta T, 2003, HEPATO-GASTROENTEROL, V50, P485; Jarnagin William R, 2002, Ann Surg, V236, P397; Kaibori M, 2006, SURGERY, V139, P385, DOI 10.1016/j.surg.2005.08.035; KUBO S, 1986, WORLD J SURG, V10, P844; Lo CM, 1998, ARCH SURG-CHICAGO, V133, P156, DOI 10.1001/archsurg.133.2.156; Nakayama H, 2003, HEPATO-GASTROENTEROL, V50, P1517; Rudow DL, 2004, LIVER TRANSPLANT, V10, P1428, DOI 10.1002/lt.20280; Strasberg SM, 2000, HPB, V2, P333, DOI DOI 10.1080/136518202760378489; Sugiyama M, 2001, HEPATO-GASTROENTEROL, V48, P1579; Terajima H, 2004, WORLD J SURG, V28, P782, DOI 10.1007/s00268-004-7385-5; Yosihioka R, 2011, WORLD J SURG, V35, P1898	33	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JAN	2015	157	1					37	44		10.1016/j.surg.2014.05.026		8	Surgery	Surgery	AX0BY	WOS:000346619700007		
J	Fukami, Y; Kurumiya, Y; Mizuno, K; Sekoguchi, E; Kobayashi, S				Fukami, Yasuyuki; Kurumiya, Yasuhiro; Mizuno, Keisuke; Sekoguchi, Ei; Kobayashi, Satoshi			Pancreatic arteriovenous malformation with portal vein thrombosis	SURGERY			English	Editorial Material									[Fukami, Yasuyuki; Kurumiya, Yasuhiro; Mizuno, Keisuke; Sekoguchi, Ei; Kobayashi, Satoshi] Toyota Kosei Hosp, Dept Surg, Toyota, Aichi 4700396, Japan	Fukami, Y (reprint author), Toyota Kosei Hosp, Dept Surg, 500-1 Josui Cho, Toyota, Aichi 4700396, Japan.	yasuyuki490225@yahoo.co.jp					Chou SC, 2013, J GASTROINTEST SURG, V17, P1240, DOI 10.1007/s11605-013-2217-2; HALPERN M, 1968, RADIOLOGY, V90, P1143; Song KB, 2012, PANCREAS, V41, P388, DOI 10.1097/MPA.0b013e31822a25cc; Uda O, 1999, SURG TODAY, V29, P462	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JAN	2015	157	1					171	172		10.1016/j.surg.2013.06.054		2	Surgery	Surgery	AX0BY	WOS:000346619700026		
J	Ishikawa, N; Watanabe, G				Ishikawa, Norihiko; Watanabe, Go			Ultra-minimally invasive cardiac surgery: robotic surgery and awake CABG	SURGERY TODAY			English	Review						Endoscopy; Da Vinci surgical system; Anesthesia; Awake surgery; Robotic surgery	CORONARY-ARTERY-BYPASS; THORACIC EPIDURAL-ANESTHESIA; ENDOTRACHEAL GENERAL-ANESTHESIA; CARDIOPULMONARY BYPASS; THERAPEUTIC STRATEGIES; REVASCULARIZATION; EXPERIENCE; PATIENT; OPCAB; SIDE	The recognition of the significant advantages of minimizing surgical trauma has resulted in the development of minimally invasive surgical procedures. Endoscopic surgery confers the benefits of minimally invasive surgery upon patients, and surgical robots have enhanced the ability and precision of surgeons. Consequently, technological advances have facilitated totally endoscopic robotic cardiac surgery, which has allowed surgeons to operate endoscopically, rather than through a median sternotomy, during cardiac surgery. Thus, repairs for structural heart conditions, including mitral valve plasty, atrial septal defect closure, multivessel minimally invasive direct coronary artery bypass grafting and totally endoscopic coronary artery bypass graft surgery (CABG), can be totally endoscopic. On the other hand, general anesthesia remains a risk in patients who have severe carotid artery stenosis before surgery, as well as in those with a history of severe cerebral infarction or respiratory failure. In this study, the potential of a new awake CABG protocol using only epidural anesthesia was investigated for realizing day surgery and was found to be a promising modality for ultra-minimally invasive cardiac surgery. We herein review robot-assisted cardiac surgery and awake off-pump coronary artery bypass grafting as ultra-minimally invasive cardiac surgeries.	[Ishikawa, Norihiko; Watanabe, Go] Kanazawa Univ, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan	Ishikawa, N (reprint author), Kanazawa Univ, Dept Gen & Cardiothorac Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	nori-i@mnx.jp					Mihaljevic T, 2011, J THORAC CARDIOV SUR, V141, P72, DOI 10.1016/j.jtcvs.2010.09.008; Nader ND, 1999, ANN THORAC SURG, V68, P1640, DOI 10.1016/S0003-4975(99)00827-9; Srivastava S, 2010, ANN THORAC SURG, V89, P1873, DOI 10.1016/j.athoracsur.2010.03.014; Karagoz HY, 2000, ANN THORAC SURG, V70, P91, DOI 10.1016/S0003-4975(00)01271-6; Nifong LW, 2005, J THORAC CARDIOV SUR, V129, P1395, DOI 10.1016/j.jtcvs.2004.07.050; Nifong LW, 2003, ANN THORAC SURG, V75, P438, DOI 10.1016/S0003-4975(02)04554-X; Balkhy HH, 2011, ANN THORAC SURG, V92, P821, DOI 10.1016/j.athoracsur.2011.04.103; BLOMBERG S, 1989, ANESTH ANALG, V69, P558; Bonaros N, 2013, ANN THORAC SURG, V95, P803, DOI 10.1016/j.athoracsur.2012.09.071; Calafiore AM, 1998, J THORAC CARDIOV SUR, V115, P763, DOI 10.1016/S0022-5223(98)70353-8; Chakravarthy M, 2005, J CARDIOTHOR VASC AN, V19, P300, DOI 10.1053/j.jvca.2005.03.005; Contini M, 1999, EUR J CARDIO-THORAC, V16, P69; Cooley DA, 2000, ANN THORAC SURG, V70, P1779, DOI 10.1016/S0003-4975(00)02052-X; Gulielmos V, 1999, EUR J CARDIOTHORA S2, V16, P34; Iribarne Alexander, 2011, Future Cardiol, V7, P333, DOI 10.2217/fca.11.23; Karagoz HY, 2003, J THORAC CARDIOV SUR, V125, P1401, DOI 10.1016/S0022-5223(02)73268-6; Kato Y, 2009, EUR J CARDIO-THORAC, V35, P37, DOI 10.1016/j.ejcts.2008.07.067; Kobayashi J, 2009, CIRC J, V73, P1178; Kobayashi Junjiro, 2006, Nihon Geka Gakkai Zasshi, V107, P9; Modi Paul, 2009, Interact Cardiovasc Thorac Surg, V9, P500, DOI 10.1510/icvts.2009.203182; Nifong LW, 2003, ANN THORAC SURG, V75, P43; Nishimi M, 2010, CIRC J, V74, P2750, DOI 10.1253/circj.CJ-10-1023; Rodriguez E, 2006, INT J MED ROBOT COMP, V2, P211, DOI 10.1002/rcs.80; Selnes OA, 1999, LANCET, V353, P1601, DOI 10.1016/S0140-6736(98)07576-X; Sezai Yukiyasu, 2007, Ann Thorac Cardiovasc Surg, V13, P220; Srivastava SP, 2003, ANN THORAC SURG, V76, P46, DOI 10.1016/S0003-4975(03)00034-1; Takayama T, 2010, CIRC J, V74, P2744, DOI 10.1253/circj.CJ-10-1012; Toda Arinobu, 2013, Asian Cardiovasc Thorac Ann, V21, P14, DOI 10.1177/0218492312444908; Watanabe Go, 2008, Interact Cardiovasc Thorac Surg, V7, P910, DOI 10.1510/icvts.2007.173377; Watanabe G, 2011, EUR J CARDIO-THORAC, V40, P788, DOI 10.1016/j.ejcts.2011.01.034; Watanabe Go, 2010, Innovations (Phila), V5, P48, DOI 10.1097/IMI.0b013e3181c46db6; Watanabe G, 2010, SURG TODAY, V40, P491, DOI 10.1007/s00595-009-4167-6; Watanabe Go, 2011, Innovations (Phila), V6, P23, DOI 10.1097/IMI.0b013e31820bfc9b; WILLIAMS LF, 1993, AM J SURG, V165, P459, DOI 10.1016/S0002-9610(05)80941-9; Yachi Tsuyoshi, 2010, Innovations (Phila), V5, P444, DOI 10.1097/IMI.0b013e3181f8b615; Yashiki Noriyoshi, 2005, Innovations (Phila), V1, P83, DOI 10.1097/01.gim.0000198517.54063.74	36	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					1	7		10.1007/s00595-014-0961-x		7	Surgery	Surgery	AW4KS	WOS:000346250700001		
J	Tanaka, K; Yoshitaka, H; Chikazawa, G; Sakaguchi, T; Totsugawa, T; Tamura, K				Tanaka, Koyu; Yoshitaka, Hidenori; Chikazawa, Genta; Sakaguchi, Taichi; Totsugawa, Toshinori; Tamura, Kentaro			Investigation of the surgical complications during thoracic endovascular aortic repair: experiences with 148 consecutive cases treated at a single institution in Japan	SURGERY TODAY			English	Article						Thoracic endovascular aortic repair; Operative complication	ANEURYSM REPAIR; EUROSTAR; COVERAGE	To investigate the risk factors associated with thoracic endovascular aortic repair at The Sakakibara Heart Institute of Okayama in Japan. A total of 148 consecutive patients who underwent thoracic endovascular aortic repair between November 2009 and October 2012 were investigated. The patients' mean age at the time of the operation was 72.8 +/- A 11.7 years. The initial success rate of the procedure was 92.6 %. The 30-day mortality rate was 3.4 %, and the multivariable risk factors for mortality were urgent/emergency surgery and a sternotomy approach. The incidence of permanent stroke was 3.4 %. The multivariable risk factors for stroke included an age over 70 years and cases requiring the debranching procedure. The rate of paraplegia/paraparesis was 5.4 %. The mean follow-up was 14.8 +/- A 9.2 months, and the follow-up rate was 97.3 %. The overall mortality rate was 12.8 %. The survival rates after thoracic endovascular repair were 88.3 % in the first year, 87.0 % in the second year and 69.6 % in the third year. The freedom from aorta-related death rate was 97.1 % at 3 years. Primary technical success was a strong negative predictor of aorta-related death. The use of a debranching technique and sternotomy approach in patients with extensive atherosclerotic changes of the aortic arch were risk factors for major complications of TEVAR. Such patients may benefit from open surgery rather than TEVAR.	[Tanaka, Koyu; Yoshitaka, Hidenori; Chikazawa, Genta; Sakaguchi, Taichi; Totsugawa, Toshinori; Tamura, Kentaro] Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, Okayama 7000804, Japan	Tanaka, K (reprint author), Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, 2-5-1 Nakaichou, Okayama 7000804, Japan.	kochin0726@yahoo.co.jp					Rizvi AZ, 2009, J VASC SURG, V50, P1159, DOI 10.1016/j.jvs.2009.09.002; Shah AA, 2012, ANN THORAC SURG, V94, P1394, DOI 10.1016/j.athoracsur.2012.05.072; Lee WA, 2011, CIRCULATION, V123, P2938, DOI 10.1161/CIRCULATIONAHA.110.965756; Buth J, 2007, J VASC SURG, V46, P1103, DOI 10.1016/j.jvs.2007.08.020; Feezor RJ, 2008, ANN THORAC SURG, V86, P1809, DOI 10.1016/j.athoracsur.2008.09.022; Leurs LJ, 2004, J VASC SURG, V40, P670, DOI 10.1016/j.jvs.2004.07.008; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; Desai ND, 2011, J THORAC CARDIOV SUR, V142, P587, DOI 10.1016/j.jtcvs.2011.02.050; Schlosser FJV, 2009, J VASC SURG, V49, P308, DOI 10.1016/j.jvs.2008.07.093; Eggebrecht H, 2009, CIRCULATION, V120, P276; Geisbusch P, 2011, J VASC SURG, V53, P1528, DOI 10.1016/j.jvs.2011.01.066; Jing-Dong T, 2011, J THORAC CARDIOVASC, V141, P926; Khoynezhad A, 2007, ANN THORAC SURG, V83, P882; Mariscalco G, 2009, ANN THORAC SURG, V88, P1877, DOI 10.1016/j.athoracsur.2009.08.020; Shen-ming W., 2010, CHIN MED J, V15, P1957	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					22	28		10.1007/s00595-014-0840-5		7	Surgery	Surgery	AW4KS	WOS:000346250700004		
J	Sawa, Y; Takayama, M; Mitsudo, K; Nanto, S; Takanashi, S; Komiya, T; Kuratani, T; Tobaru, T; Goto, T				Sawa, Yoshiki; Takayama, Morimasa; Mitsudo, Kazuaki; Nanto, Shinsuke; Takanashi, Shuichiro; Komiya, Tatsuhiko; Kuratani, Toru; Tobaru, Tetsuya; Goto, Tsuyoshi			Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial	SURGERY TODAY			English	Article						Aortic valve stenosis; Transcatheter aortic valve replacement; Aortic valve replacement	OUTCOME SOURCE REGISTRY; EDWARDS SAPIEN VALVE; EUROPEAN REGISTRY; ELDERLY-PATIENTS; NATURAL-HISTORY; HEART-VALVE; IMPLANTATION; SURVIVAL; PROSTHESIS; EXPERIENCE	Transcatheter aortic valve replacement (TAVR) is suggested to be less invasive and/or equally effective in comparison to conventional aortic valve replacement for high-risk symptomatic aortic stenosis patients. We herein report the initial results of a pivotal clinical trial of TAVR in Japan (the PREVAIL JAPAN). Sixty-four aortic stenosis patients (mean age 84.3 +/- A 6.1 years) not suitable for surgery were enrolled at three centers in Japan, with a primary composite endpoint of the 6-month post-procedure improvements in the aortic valve area and New York Heart Association (NYHA) functional classification. A transfemoral approach was used in 37 patients and a transapical approach was used in 27. The device success rate was 91.9 %. After 30 days and 6 months, the rates of mortality from any cause were 8.1 and 11.3 %, respectively. At 6 months, symptomatic stroke was found in 3.1 % of the patients, and silent infarction in 7.8 %. The aortic valve area and mean pressure gradient were significantly improved over time with both approaches (p < 0.001). At 6 months, the NYHA functional classification based on a conventional physician's assessment was improved in 87.9 % of the patients. We found results that were equivalent to those in other major TAVR trials, such as an acceptable 30-day survival (91.9 %), suggesting that balloon-expandable TAVR is effective for small Japanese AS patients classified as high-risk or inoperable.	[Sawa, Yoshiki; Nanto, Shinsuke; Kuratani, Toru] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takayama, Morimasa; Takanashi, Shuichiro; Tobaru, Tetsuya] Sakakibara Heart Inst, Fuchu, Tokyo 1830003, Japan; [Mitsudo, Kazuaki; Komiya, Tatsuhiko; Goto, Tsuyoshi] Kurashiki Cent Hosp, Kurashiki, Okayama 7108602, Japan	Sawa, Y (reprint author), Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sawa@surg1.med.osaka-u.ac.jp			Edwards Lifesciences Limited	We thank Dr. Koichi Maeda for his excellent assistance. Funded by Edwards Lifesciences Limited; ClinicalTrials.gov number, NCT01113983.	Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Maeda K, 2013, CIRC J, V77, P359, DOI 10.1253/circj.CJ-12-0650; Shroyer ALW, 1999, ANN THORAC SURG, V67, P1205, DOI 10.1016/S0003-4975(99)00206-4; LUND O, 1990, CIRCULATION, V82, P124; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; SCHWARZ F, 1982, CIRCULATION, V66, P1105; Sasayama S, 2009, CIRC J, V73, P1255; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Bouma BJ, 1999, HEART, V82, P143; Lester SJ, 1998, CHEST, V113, P1109, DOI 10.1378/chest.113.4.1109; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Akins CW, 2008, J THORAC CARDIOV SUR, V135, P732, DOI 10.1016/j.jtcvs.2007.12.002; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Kappetein AP, 2012, J THORAC CARDIOVASC, V145, P6; Kodali SK, 2011, AM J CARDIOL, V107, P1058, DOI 10.1016/j.amjcard.2010.11.034; MURPHY ES, 1981, CIRCULATION, V64, P184; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Otto C. M., 1968, CIRCULATION S1, V38, P61; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					34	43		10.1007/s00595-014-0855-y		10	Surgery	Surgery	AW4KS	WOS:000346250700006		
J	Fujino, Y; Sendo, H; Oshikiri, T; Sugimoto, T; Tominaga, M				Fujino, Yasuhiro; Sendo, Hiroyoshi; Oshikiri, Taro; Sugimoto, Takemi; Tominaga, Masahiro			A novel surgical technique to prevent pancreatic fistula in distal pancreatectomy using a patch of the falciform ligament	SURGERY TODAY			English	Article						Distal pancreatectomy; Falciform ligament; Pancreatic fistula	RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; CLOSURE; REMNANT; STAPLER; INSTITUTION; MULTICENTER; EXPERIENCE; EFFICACY; DECREASE	Pancreatic fistula (PF) is a serious complication of pancreatectomy and many techniques and devices have been designed to prevent PF and abdominal bleeding after pancreatectomy. We report a modified technique using a patch of the falciform ligament to prevent PF formation after distal pancreatectomy (DP). On completion of DP, the main pancreatic duct is sutured. The remnant pancreas is then closely patched and sutured vertically to the falciform ligament using 3-0 polypropylene suture. We compared the results of this method (group 1) with those of the simple method of covering the remnant pancreas with the falciform ligament (group 2). We performed this method in 14 patients undergoing DP. The rate of grade B or C PF in group 1 (7.1 %) was lower than that in group 2 (46 %). This is a simple and effective method of preventing PF fistula in DP.	[Fujino, Yasuhiro; Sendo, Hiroyoshi; Oshikiri, Taro; Sugimoto, Takemi; Tominaga, Masahiro] Hyogo Canc Ctr, Dept Surg, Akashi, Hyogo 6736558, Japan	Fujino, Y (reprint author), Hyogo Canc Ctr, Dept Surg, 13-70 Kitaoji Cho, Akashi, Hyogo 6736558, Japan.	yasu120@hp.pref.hyogo.jp					Adam U, 2001, ZBL CHIR, V126, P908, DOI 10.1055/s-2001-19149; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Bilimoria MM, 2003, BRIT J SURG, V90, P190, DOI 10.1002/bjs.4032; SUZUKI Y, 1995, ARCH SURG-CHICAGO, V130, P952; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Diener MK, 2008, CLIN TRIALS, V5, P534, DOI 10.1177/1740774508096140; Goh BKP, 2008, ARCH SURG-CHICAGO, V143, P956, DOI 10.1001/archsurg.143.10.956; Makino I, 2013, SURG TODAY, V43, P595, DOI 10.1007/s00595-012-0370-y; Okano K, 2013, SURG TODAY, V43, P141, DOI 10.1007/s00595-012-0235-4; Carter TI, 2013, J GASTROINTEST SURG, V17, P102, DOI 10.1007/s11605-012-1963-x; Suzuki Y, 1999, BRIT J SURG, V86, P608; Kajiyama Y, 1996, BRIT J SURG, V83, P1711, DOI 10.1002/bjs.1800831216; Sheehan MK, 2002, AM SURGEON, V68, P264; Knaebel HP, 2005, BRIT J SURG, V92, P539, DOI 10.1002/bjs.5000; Iannitti DA, 2006, J AM COLL SURGEONS, V203, P857, DOI 10.1016/j.jamcollsurg.2006.08.021; Balcom JH, 2001, ARCH SURG-CHICAGO, V136, P391, DOI 10.1001/archsurg.136.4.391; Kleeff J, 2007, ANN SURG, V245, P573, DOI 10.1097/01.sla.0000251438.43135.fb; Montorsi M, 2012, ANN SURG, V256, P853, DOI 10.1097/SLA.0b013e318272dec0; Fahy BN, 2002, AM J SURG, V183, P237, DOI 10.1016/S0002-9610(02)00790-0; Chamberlain RS, 2009, J SURG RES, V157, P279, DOI 10.1016/j.jss.2009.05.008; Hassenpflug M, 2012, SURGERY, V152, pS164, DOI 10.1016/j.surg.2012.05.026; Kluger Y, 1997, INJURY, V28, P127, DOI 10.1016/S0020-1383(96)00157-X; Lillemoe KD, 1999, ANN SURG, V229, P693, DOI 10.1097/00000658-199905000-00012; MORIURA S, 1995, SURG TODAY, V25, P992; Yoshioka R, 2010, WORLD J SURG, V34, P121, DOI 10.1007/s00268-009-0300-3	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					44	49		10.1007/s00595-014-0942-0		6	Surgery	Surgery	AW4KS	WOS:000346250700007		
J	Nishiwada, S; Ishikawa, H; Tsuji, Y; Nakamura, K; Mukogawa, T; Matsusaka, M; Ko, S; Watanabe, A				Nishiwada, Satoshi; Ishikawa, Hirofumi; Tsuji, Yasuko; Nakamura, Kota; Mukogawa, Tomohide; Matsusaka, Masanori; Ko, Saiho; Watanabe, Akihiko			The Kugel patch method prevents the development of a femoral hernia after inguinal herniorrhaphy	SURGERY TODAY			English	Article						Femoral hernia; Femoral type recurrence; Inguinal type recurrence; Kugel patch method	PLUG TECHNIQUE; REPAIR; HERNIOPLASTY; EXPERIENCE; MORTALITY; SURGERY	A femoral hernia is a relatively rare condition, and no standard surgical methods have so far been established. In this study, we investigated the development of a femoral hernia after inguinal herniorrhaphy. A total of 1,969 patients who underwent surgery for an inguinal hernia from April 1992 to March 2012 were enrolled in this study. The patients were composed of 1,934 (98.2 %) inguinal hernia and 35 (1.8 %) femoral hernia patients. Of these, we retrospectively studied the femoral hernia cases with reference to the use of inguinal herniorrhaphy. Of all 35 femoral hernia cases, six cases (17.1 %) were femoral type recurrences after inguinal herniorrhaphy performed by the conventional or mesh plug methods. The surgical methods used for the 35 cases were mesh plug repair in 15 cases (42.9 %), the Kugel patch method in seven (20.0 %) and conventional repair in 13 patients (37.2 %). Inguinal type recurrences developed in three cases (8.6 %) that were re-repaired by mesh plug repair or sac resection. There were no femoral or inguinal type recurrences after Kugel patch repair for a femoral hernia. The results of this study suggested the importance of repairing all hernia orifices when repairing a groin hernia. The Kugel patch repair method is available for all inguinal region hernias by the same approach, and it seems to be useful for preventing the development of recurrence after surgery.	[Nishiwada, Satoshi; Ishikawa, Hirofumi; Tsuji, Yasuko; Nakamura, Kota; Mukogawa, Tomohide; Ko, Saiho; Watanabe, Akihiko] Nara Prefectural Nara Hosp, Dept Surg, Nara 6310846, Japan; [Matsusaka, Masanori] Nara Prefectural Nara Hosp, Dept Emergency Med, Nara 6310846, Japan	Nishiwada, S (reprint author), Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan.	99066sn@jichi.ac.jp					Alimoglu O, 2006, Hernia, V10, P70, DOI 10.1007/s10029-005-0045-3; AMID PK, 1995, INT SURG, V80, P9; Mikkelsen T, 2002, BRIT J SURG, V89, P486, DOI 10.1046/j.0007-1323.2002.02058.x; Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; BENDAVID R, 1989, WORLD J SURG, V13, P522; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; Lohsiriwat D, 2013, SURG TODAY, V43, P990, DOI 10.1007/s00595-013-0489-5; Kugel RD, 1999, AM J SURG, V178, P298, DOI 10.1016/S0002-9610(99)00181-6; Ates M, 2012, JSLS-J SOC LAPAROEND, V16, P250, DOI 10.4293/108680812X13427982376347; Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Bay-Nielsen Morten, 2006, Hernia, V10, P30, DOI 10.1007/s10029-005-0029-3; Bay-Nielsen M, 2001, AM J SURG, V182, P134, DOI 10.1016/S0002-9610(01)00674-2; BENDAVID R, 1987, SURG GYNECOL OBSTET, V165, P153; Ceriani V, 2005, Hernia, V9, P344, DOI 10.1007/s10029-005-0015-9; Ceriani V, 2006, Hernia, V10, P169, DOI 10.1007/s10029-005-0059-x; CHAMARY VL, 1993, BRIT J SURG, V80, P230, DOI 10.1002/bjs.1800800237; Chan G, 2008, J AM COLL SURGEONS, V207, P360, DOI 10.1016/j.jamcollsurg.2008.04.018; Franz MG, 2008, SURG CLIN N AM, V88, P1, DOI 10.1016/j.suc.2007.10.007; Gianetta E, 2000, ANN SURG, V231, P132, DOI 10.1097/00000658-200001000-00019; GLASSOW F, 1985, AM J SURG, V150, P353, DOI 10.1016/0002-9610(85)90077-7; Hachisuka T, 2003, SURG CLIN N AM, V83, P1189, DOI 10.1016/S0039-6109(03)00120-8; Jorgensen LN, 1996, BRIT J SURG, V83, P1591, DOI 10.1002/bjs.1800831133; Klinge U, 1999, Int J Surg Investig, V1, P219; Koch A, 2005, BRIT J SURG, V92, P1553, DOI 10.1002/bjs.5156; LICHTENS.IL, 1974, AM J SURG, V128, P439, DOI 10.1016/0002-9610(74)90189-5; McVay CB, 1958, ANN SURG, V148, P510; MCVAY CB, 1958, ANN SURG, V148, P499, DOI 10.1097/00000658-195810000-00001; Memon MA, 1998, ANNU REV MED, V49, P95; Peitsch WKJ, 2014, SURG ENDOSC, V28, P671, DOI 10.1007/s00464-013-3208-9; Rutkow IM, 1998, SURGERY, V124, P844, DOI 10.1067/msy.1998.90859; Schouten N, 2012, HERNIA, V16, P387, DOI 10.1007/s10029-012-0904-7; SHULMAN AG, 1992, ANN ROY COLL SURG, V74, P97; Zheng H, 2002, WORLD J SURG, V26, P401, DOI 10.1007/s00268-001-0239-5	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					57	62		10.1007/s00595-014-0880-x		6	Surgery	Surgery	AW4KS	WOS:000346250700009		
J	Fukumoto, K; Taniguchi, T; Usami, N; Kawaguchi, K; Fukui, T; Ishiguro, F; Nakamura, S; Yokoi, K				Fukumoto, Koichi; Taniguchi, Tetsuo; Usami, Noriyasu; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Nakamura, Shota; Yokoi, Kohei			The preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer	SURGERY TODAY			English	Article						Non-small cell lung cancer; Plasma D-dimer level; Prognosis; Surgery	CARCINOEMBRYONIC ANTIGEN; VENOUS THROMBOEMBOLISM; BREAST-CANCER; SURVIVAL; STAGE	The plasma D-dimer (D-dimer) level, a marker of hypercoagulation, has been reported to be associated with survival in several types of cancers. This retrospective study was conducted to evaluate the prognostic significance of the preoperative D-dimer level in patients with completely resected non-small cell lung cancer (NSCLC). A total of 237 completely resected NSCLC patients were included in this study. In addition to age, sex, the smoking status, etc., the association between the preoperative D-dimer level and survival was explored. The patients were divided into three groups according to the D-dimer level: group A (a parts per thousand currency sign0.50 mu g/ml, n = 76), group B (0.51-0.86 mu g/ml, n = 79) and group C (> 0.86 mu g/ml, n = 82). The 5-year overall survival rate was 89.6 % (95 % confidence interval (CI) 77.7-95.3) for group A, 75.1 % (95 % CI 62.3-83.6) for group B and 60.1 % (95 % CI 46.8-71.1) for group C (P (trend) < 0.001). A multivariate survival analysis showed that the D-dimer level (group B vs. group A HR 4.25, group C vs. group A HR 4.11) was an independent significant prognostic factor, in addition to age, sex, the pathological stage and the serum carcinoembryonic antigen level. The preoperative D-dimer level is an independent prognostic factor in patients with completely resected NSCLC.	[Fukumoto, Koichi; Taniguchi, Tetsuo; Usami, Noriyasu; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Nakamura, Shota; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Yokoi, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	k-yokoi@med.nagoya-u.ac.jp	Kawaguchi, Koji/I-7418-2014	Kawaguchi, Koji/0000-0002-5986-9419	takeda Science Foundation	This study was supported in part by a grant from takeda Science Foundation.	Batschauer APB, 2010, ANN ONCOL, V21, P1267, DOI 10.1093/annonc/mdp474; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI [10.3324/haematol.2011.054718, 10.3324/haemato1.2011.054718]; Blackwell K, 2004, CANCER, V101, P77, DOI 10.1002/cncr.20336; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; SACK GH, 1977, MEDICINE, V56, P1, DOI 10.1097/00005792-197756010-00001; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Endoh H, 2013, SURG TODAY, V43, P514, DOI 10.1007/s00595-012-0401-8; Matsuguma H, 2008, J THORAC CARDIOV SUR, V135, P44, DOI 10.1016/j.jtcvs.2007.09.032; Blackwell K, 2000, J CLIN ONCOL, V18, P600; Varki A, 2007, BLOOD, V110, P1723, DOI 10.1182/blood-2006-10-053736; Pabinger I, 2009, ARTERIOSCL THROM VAS, V29, P332, DOI 10.1161/ATVBAHA.108.182188; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; Lim E, 2010, J THORAC CARDIOV SUR, V139, P1441, DOI 10.1016/j.jtcvs.2009.05.048; Morii T, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-250; Taguchi O, 1997, THORAX, V52, P563; Trousseau A, 1865, COMMUNICATION, V5, P281; Zhang PP, 2013, EJSO-EUR J SURG ONC, V39, P951, DOI 10.1016/j.ejso.2013.06.008	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					63	67		10.1007/s00595-014-0894-4		5	Surgery	Surgery	AW4KS	WOS:000346250700010		
J	Hosoda, K; Yamashita, K; Katada, N; Moriya, H; Mieno, H; Sakuramoto, S; Kikuchi, S; Watanabe, M				Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Sakuramoto, Shinichi; Kikuchi, Shiro; Watanabe, Masahiko			Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer	SURGERY TODAY			English	Article						Stomach neoplasms; Prognosis; Borrmann type III; Tumor size; Cytology	GASTROESOPHAGEAL JUNCTION; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; LATE RECURRENCE; PHASE-II; CARCINOMA; SURGERY; S-1; ADENOCARCINOMA; GASTRECTOMY	This study was designed to clarify whether preoperative tumor size is an independent prognostic factor (IPF) for patients with Borrmann type III gastric cancer. The study group comprised 350 patients with Borrmann type III gastric cancer. We performed a log-rank plot analysis to establish the threshold value of preoperative tumor size for the prediction of overall survival (OS). Factors with P < 0.10 on univariate prognostic analyses for OS were put into a Cox's proportional hazards model to identify the IPFs. Peritoneal lavage cytology (CY) was the strongest IPF for patients with Borrmann type III gastric cancer (P < 0.0001). We were able to measure the tumor size preoperatively in 135 patients with negative CY results (CY0). The cutoff tumor size for the prediction of OS was 5.3 cm. A Cox's proportional hazards model showed that pathological lymph-node metastasis (P = 0.007) and preoperative tumor size (P = 0.018) were significant IPFs in the CY0 patients. Patients with a preoperative tumor size of < 5.3 cm had satisfactory outcomes, with a 5-year OS rate of > 80 %. Preoperative tumor size is an IPF for patients with Borrmann type III gastric cancer and CY0. Thus, preoperative tumor size may be a useful factor for deciding on whether neoadjuvant chemotherapy is indicated.	[Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Sakuramoto, Shinichi] Saitama Med Univ, Int Med Ctr, Dept Gastrointestinal Surg, Hidaka, Saitama 3501298, Japan	Hosoda, K (reprint author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	k.hosoda@kitasato-u.ac.jp					Adachi Y, 1996, CANCER, V77, P2445, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2445::AID-CNCR5>3.0.CO;2-L; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Kodera Y, 2012, GASTRIC CANCER, V15, P335, DOI 10.1007/s10120-012-0156-3; Shiraishi N, 2000, CANCER, V89, P255, DOI 10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Mezhir JJ, 2010, ANN SURG ONCOL, V17, P3173, DOI 10.1245/s10434-010-1183-0; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Aoyama T, 2011, GASTRIC CANCER, V14, P274, DOI 10.1007/s10120-011-0038-0; Iwasaki Y, 2013, J SURG ONCOL, V107, P741, DOI 10.1002/jso.23301; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Kodera Y, 2009, EJSO-EUR J SURG ONC, V35, P1158, DOI 10.1016/j.ejso.2009.03.003; Giuliani A, 2003, J EXP CLIN CANC RES, V22, P531; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kodera Y, 1999, J SURG ONCOL, V72, P60, DOI 10.1002/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO;2-1; Kodera Y, 1999, J SURG ONCOL, V72, P4; Maruyama K, 2006, GASTRIC CANCER, V9, P51, DOI DOI 10.1007/S10120-006-0370-Y; Park I, 2013, CANCER CHEMOTH PHARM, V72, P815, DOI 10.1007/s00280-013-2257-z; Saito H, 2006, AM J SURG, V192, P296, DOI 10.1016/j.amjsurg.2006.03.004; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 1992, SHOKAKIGEKA, V15, P159; Shinohara S, 2013, SURG TODAY, V43, P40, DOI 10.1007/s00595-012-0230-9; Sobin LH, 2009, TNM CLASSIFICATION M, P73; Yokota T, 2002, ANTICANCER RES, V22, P3673; Zu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054502	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					68	77		10.1007/s00595-014-1060-8		10	Surgery	Surgery	AW4KS	WOS:000346250700011		
J	Shimada, Y; Kawabe, A; Nakajima, S; Hata, K; Takahashi, Y; Kume, M; Tsukada, K				Shimada, Yutaka; Kawabe, Atsushi; Nakajima, Sanae; Hata, Koichiro; Takahashi, Yuwa; Kume, Makoto; Tsukada, Kazuhiro			A bilateral thoracic approach for esophageal cancer in the prone position	SURGERY TODAY			English	Article						Esophageal cancer; Mediastinal lymph nodes; Prone position; Bilateral thoracic approach	MINIMALLY INVASIVE ESOPHAGECTOMY; DECUBITUS POSITION	Esophagectomy in the prone position has recently been introduced as a less-invasive procedure for treating esophageal cancer. We herein present a case of esophageal squamous cell carcinoma (ESCC) treated with a bilateral thoracic approach in the prone position. The patient was a 69-year-old male diagnosed with middle thoracic ESCC. Computed tomography scans and fluorine-18-fluorodeoxyglucose revealed possible metastasis to the lymph nodes on the left dorsal side of the descending thoracic aorta (DTA). After preoperative chemotherapy, we dissected the lymph node metastasis on the left dorsal DTA using the left thoracic approach, following resection of the ESCC by a right thoracic approach in the same prone position. The postoperative course was uneventful, and the patient was discharged 23 days after surgery. A bilateral thoracic approach for esophageal cancer in the prone position may be a new option for surgically treating esophageal cancer.	[Shimada, Yutaka; Tsukada, Kazuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Surg & Sci, Toyama 9300194, Japan; [Kawabe, Atsushi; Nakajima, Sanae; Hata, Koichiro; Takahashi, Yuwa; Kume, Makoto] Asahi Univ, Murakami Mem Hosp, Dept Surg, Gifu 5008523, Japan	Shimada, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Surg & Sci, Sugitani 2630, Toyama 9300194, Japan.	yshimada@pharm.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT/JSPS KAKENHI) [23390320]	We received research grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT/JSPS KAKENHI Grant Number B: 23390320). We thank Mr. David A Coolidge for editing the English of the manuscript.	Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Yatabe T, 2013, SURG TODAY, V43, P386, DOI 10.1007/s00595-012-0375-6; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; Feng MX, 2012, J AM COLL SURGEONS, V214, P838, DOI 10.1016/j.jamcollsurg.2011.12.047; Cuschieri A, 1992, J R Coll Surg Edinb, V37, P7; Kaisaki S, 2007, SURG TODAY, V37, P243, DOI 10.1007/s00595-006-3349-8	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					91	95		10.1007/s00595-013-0738-7		5	Surgery	Surgery	AW4KS	WOS:000346250700014		
J	Imai, D; Yamashita, Y; Ikegami, T; Toshima, T; Harimoto, N; Yoshizumi, T; Soejima, Y; Shirabe, K; Ikeda, T; Maehara, Y				Imai, Daisuke; Yamashita, Yo-ichi; Ikegami, Toru; Toshima, Takeo; Harimoto, Norifumi; Yoshizumi, Tomoharu; Soejima, Yuji; Shirabe, Ken; Ikeda, Tetsuo; Maehara, Yoshihiko			A "rendezvous technique" for treating a pancreatic fistula after distal pancreatectomy	SURGERY TODAY			English	Article						Rendezvous technique; Distal pancreatectomy; Pancreatic fistula	INTERNATIONAL STUDY-GROUP; ENDOSCOPIC TREATMENT; BILIARY; CLASSIFICATION; MANAGEMENT	Pancreatic fistulae are a major complication of distal pancreatectomy (DP). Some cases of severe pancreatic fistula require invasive procedures. There have been some reports concerning the effectiveness of pancreatic duct drainage through an endoscopic transpapillary approach for pancreatic fistulae. We herein present a case of a pancreatic fistula after DP that was successfully treated with percutaneous pancreatic duct drainage, which was performed using a combined percutaneous and endoscopic approach, named the "rendezvous technique". In our case, we performed distal pancreatectomy with celiac artery resection for a locally advanced pancreatic body cancer. On postoperative day (POD) 7, the drain amylase level increased up to 37,460 IU/l. Computed tomography (CT) revealed peripancreatic fluid collections. On POD 10, we placed a catheter in the main pancreatic duct using the rendezvous technique. CT on POD 14 revealed a decrease in the size of the peripancreatic fluid collection, and contrast imaging from the drains on POD 22 revealed almost complete disappearance of the fluid collection. We withdrew the pigtail catheter on POD 27 and the percutaneous pancreatic duct drain on POD 36. This patient was discharged from our hospital on POD 40. We herein report a new approach called the "rendezvous technique" for the management of pancreatic fistulae after DP that can be used instead of a stressful nasopancreatic tube.	[Imai, Daisuke; Yamashita, Yo-ichi; Ikegami, Toru; Toshima, Takeo; Harimoto, Norifumi; Yoshizumi, Tomoharu; Soejima, Yuji; Shirabe, Ken; Ikeda, Tetsuo; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8120054, Japan	Imai, D (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8120054, Japan.	imai@surg2.med.kyushu-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Makino I, 2013, SURG TODAY, V43, P595, DOI 10.1007/s00595-012-0370-y; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Ikegami T, 2011, SURG TODAY, V41, P1224, DOI 10.1007/s00595-010-4433-7; Vin Y, 2008, J AM COLL SURGEONS, V207, P490, DOI 10.1016/j.jamcollsurg.2008.05.003; Bhasin DK, 2011, J GASTROINTEST SURG, V15, P772, DOI 10.1007/s11605-011-1466-1; Aytekin C, 2006, LIVER TRANSPLANT, V12, P1423, DOI 10.1002/lt.20848; Bakker OJ, 2011, ANN SURG, V253, P961, DOI 10.1097/SLA.0b013e318212e901; Cicek B, 2006, SURG ENDOSC, V20, P1706, DOI 10.1007/s00464-005-0764-7; Costamagna G, 2001, ENDOSCOPY, V33, P317, DOI 10.1055/s-2001-13695; Tsuyuguchi T, 2007, J HEPATO-BILIARY-PAN, V14, P46, DOI 10.1007/s00534-006-1155-8; Yamashita YI, 2007, AM J SURG, V193, P454, DOI 10.1016/j.amjsurg.2006.09.008; Yoshiya S, 2013, TRANSPLANTATION, V95, P1278, DOI 10.1097/TP.0b013e31828a9450	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					96	100		10.1007/s00595-013-0740-0		5	Surgery	Surgery	AW4KS	WOS:000346250700015		
J	Satoh, D; Sadamori, H; Yagi, T; Fujiwara, T				Satoh, Daisuke; Sadamori, Hiroshi; Yagi, Takahito; Fujiwara, Toshiyoshi			Enlarging lymphoepithelial cyst of the pancreas during 12 months of observation: report of a case	SURGERY TODAY			English	Article						Pancreatic lymphoepithelial cysts	CA-19-9 LEVELS	Pancreatic lymphoepithelial cysts (LECs) are rare benign pancreatic cystic lesions, the etiology of which is unknown. We report a case of a pancreatic LEC, discovered incidentally in a 63-year-old man during a follow-up clinic visit for an abdominal aneurysm. Computed tomography showed a multilocular cyst, 60-mm diameter in the body of the pancreas. This cyst increased from 6.0 to 6.5 cm during 12 months of observation. Part of the cyst was also visualized on positron emission tomography imaging. Since a pancreatic cystic neoplasm could not be ruled out, we performed distal pancreatectomy and postoperative pathological examination confirmed that the lesion was an LEC of the pancreas. Despite the conclusive postoperative findings, resection is unavoidable when a true pancreatic neoplasm cannot be excluded.	[Satoh, Daisuke; Sadamori, Hiroshi; Yagi, Takahito; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg Transplant & Surg Oncol, Okayama 7008558, Japan	Satoh, D (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg Transplant & Surg Oncol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ddds4863@gmail.com					Adsay NV, 2002, MODERN PATHOL, V15, P492, DOI 10.1038/modpathol.3880553; Adsay NV, 2000, SEMIN DIAGN PATHOL, V17, P56; CAPPELLARI JO, 1993, DIAGN CYTOPATHOL, V9, P77, DOI 10.1002/dc.2840090117; Fukunaga N, 2009, SURG TODAY, V39, P901, DOI 10.1007/s00595-009-3949-1; Hiroshi M, 2009, JOP J PANCREAS, V10, P694; LUCHTRATH H, 1985, PATHOLOGE, V6, P217; Micke O, 1999, ANTICANCER RES, V19, P2717; MITCHELL ML, 1990, ACTA CYTOL, V34, P462; Nam SJ, 2010, J MAGN RESON IMAGING, V32, P692, DOI 10.1002/jmri.22260; Sobia A, 2009, JOP J PANCREAS, V10, P409; TRUONG LD, 1995, AM J SURG, V170, P27, DOI 10.1016/S0002-9610(99)80247-5; Yamaguchi T, 2008, J HEPATO-BILIARY-PAN, V15, P652, DOI 10.1007/s00534-007-1314-6	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					101	104		10.1007/s00595-014-0960-y		4	Surgery	Surgery	AW4KS	WOS:000346250700016		
J	Uchida, N; Suda, T; Ishiguro, K				Uchida, Naotaka; Suda, Takako; Ishiguro, Kiyosuke			Thyroidectomy in a patient with thyroid storm: report of a case	SURGERY TODAY			English	Article						Thyroidectomy; Thyroid storm	HYPERTHYROIDISM; THYROTOXICOSIS; FAILURE	Thyroid storm is a life-threatening condition that is generally considered to be a contradiction to surgical intervention. We herein describe the case of a 37-year-old patient with a history of Graves' disease who was transferred to Tottori University Hospital with thyroid storm. She had been followed by her family doctor since 2006, but she had stopped taking her medication of her own volition in 2010. About ten days prior to her admission at our hospital, she consulted her family doctor with complaints of dyspnea, palpitations and general fatigue. Subsequent thyroid function tests showed TSH < 0.01 mu U/ml, FT3 25.0 pg/ml and FT4 8.0 ng/dl. She also had acute heart failure, atrial fibrillation and hepatic failure. A diagnosis of thyroid storm was made and she was transferred to our hospital. She received steroids, beta blockade, potassium iodide, and plasma exchange, but her hepatic failure did not resolve and her clinical condition deteriorated. The decision was made to proceed with thyroidectomy. Postoperatively, her hepatic function normalized. Thus, thyroidectomy is a potential therapeutic choice for cases of thyroid storm refractory to medical management.	[Uchida, Naotaka] Tottori Prefectural Kousei Hosp, Dept Surg, Kurayoshi, Tottori 6820804, Japan; [Uchida, Naotaka; Suda, Takako; Ishiguro, Kiyosuke] Tottori Univ Hosp, Dept Breast & Endocrine Surg, Yonago, Tottori 6838504, Japan	Uchida, N (reprint author), Tottori Prefectural Kousei Hosp, Dept Surg, 150 Higashisyouwa Machi, Kurayoshi, Tottori 6820804, Japan.	uchidana@pref.tottori.jp					Akamizu T, 2010, HORUMON TO RINSYO, V58, P641; BURCH HB, 1993, ENDOCRIN METAB CLIN, V22, P263; Bahn RS, 2011, ENDOCR PRACT, V17, P456; Akamizu T, 2012, THYROID, V22, P661, DOI 10.1089/thy.2011.0334; Choudhary AM, 1999, J CLIN GASTROENTEROL, V29, P318, DOI 10.1097/00004836-199912000-00004; Citgez B, 2013, SURG TODAY, V43, P625, DOI 10.1007/s00595-012-0297-3; FONG TL, 1992, J CLIN GASTROENTEROL, V14, P240, DOI 10.1097/00004836-199204000-00010; Satoh T, 2010, HORUMON TO RINSYO, V58, P659; Scholz GH, 2003, THYROID, V13, P933, DOI 10.1089/105072503322511337	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					110	114		10.1007/s00595-013-0754-7		5	Surgery	Surgery	AW4KS	WOS:000346250700018		
J	Muroya, D; Toh, U; Iwakuma, N; Nakagawa, S; Mishima, M; Takahashi, R; Takenaka, M; Shirouzu, K; Agaki, Y				Muroya, Daisuke; Toh, Uhi; Iwakuma, Nobutaka; Nakagawa, Shino; Mishima, Mai; Takahashi, Ryuji; Takenaka, Miki; Shirouzu, Kazuo; Agaki, Yoshito			Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case	SURGERY TODAY			English	Article						Primary breast lymphoma; Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)	FINE-NEEDLE-ASPIRATION; NON-HODGKINS-LYMPHOMA; IMPLANTS; CANCER; EXPERIENCE; PROGNOSIS; PATIENT	Malignant lymphomas of the breast are rare and primary breast lymphoma comprises < 0.5 % of breast malignancies, within which T-cell lymphomas are an even rarer subset. We report a case of primary breast peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). Histology of the biopsied specimen revealed CD2(+), CD3(+), CD4(+), CD5(-), CD7(+), CD8(-), CD20(-), CD25(-), CD30(+), CD56(-), bcl-2(-), EBV-ISH(-), TIA-I(-), and ATLA negative. The patient was treated with six cycles of the CHOP regimen and died 17 months after the diagnosis was made, despite complete remission after conventional chemotherapy. To our knowledge, only 18 cases of primary peripheral T-cell lymphoma of the breast and just one previous case of primary PTCL-NOS of the breast have been reported in Japan.	[Muroya, Daisuke; Toh, Uhi; Iwakuma, Nobutaka; Nakagawa, Shino; Mishima, Mai; Takahashi, Ryuji; Takenaka, Miki; Shirouzu, Kazuo; Agaki, Yoshito] Kurume Univ, Fac Med, Dept Surg, Kurume, Fukuoka 830, Japan	Toh, U (reprint author), Kurume Univ, Fac Med, Dept Surg, 67 Asahi Machi, Kurume, Fukuoka 830, Japan.	utoh@med.kurume-u.ac.jp					Keech JA, 1997, PLAST RECONSTR SURG, V100, P554, DOI 10.1097/00006534-199708000-00065; WISEMAN C, 1972, CANCER, V29, P1705, DOI 10.1002/1097-0142(197206)29:6<1705::AID-CNCR2820290640>3.0.CO;2-I; ARBER DA, 1994, AM J SURG PATHOL, V18, P288, DOI 10.1097/00000478-199403000-00009; Roden AC, 2008, MODERN PATHOL, V21, P455, DOI 10.1038/modpathol.3801024; Jennings WC, 2007, ANN SURG, V245, P784, DOI 10.1097/01.sla.0000254418.90192.59; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Fritzsche FR, 2006, VIRCHOWS ARCH, V449, P561, DOI 10.1007/s00428-006-0287-1; Gaudet G, 2002, LEUKEMIA LYMPHOMA, V43, P115, DOI 10.1080/10428190290000392; Armitage JO, 2007, BLOOD, V110, P29, DOI 10.1182/blood-2007-01-041871; Newman MK, 2008, J PLAST RECONSTR AES, V61, P822, DOI 10.1016/j.bjps.2007.03.027; Hehn ST, 2004, J CLIN ONCOL, V22, P3046, DOI 10.1200/JCO.2004.02.104; Talwalkar SS, 2008, AM J SURG PATHOL, V32, P1299, DOI 10.1097/PAS.0b013e318165eb50; CARBONE PP, 1971, CANCER RES, V31, P1860; ARMITAGE JO, 1989, CANCER, V63, P158, DOI 10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B; Avenia N, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-53; COIFFIER B, 1990, ANN ONCOL, V1, P45; Florentine BD, 2006, CANCER, V107, P406, DOI 10.1002/cncr.21976; Jaffe E, 2008, PATHOLOGY GENETICS T, P158; Jeanneret-Sozzi W, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-86; LIPPMAN SM, 1988, BLOOD, V72, P436; Sabaté J M, 2002, Breast J, V8, P294, DOI 10.1046/j.1524-4741.2002.08509.x; Sahoo S, 2003, ARCH PATHOL LAB MED, V127, P115; SAITO H, 1994, SURG TODAY, V24, P737; Steinfort DP, 2010, J THORAC ONCOL, V5, P804, DOI 10.1097/JTO.0b013e3181d873be; Swerdlow S, 2008, WHO CLASSIFICATION T; Uesato Masaya, 2005, Breast Cancer, V12, P154, DOI 10.2325/jbcs.12.154; Vasei M, 1997, APMIS, V105, P445; WEISENBURGER DD, 1987, HEMATOL ONCOL, V5, P175	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					115	120		10.1007/s00595-013-0808-x		6	Surgery	Surgery	AW4KS	WOS:000346250700019		
J	Miyamoto, Y; Watanabe, M; Ishimoto, T; Baba, Y; Iwagami, S; Sakamoto, Y; Yoshida, N; Masuguchi, S; Ihn, H; Baba, H				Miyamoto, Yuji; Watanabe, Masayuki; Ishimoto, Takatsugu; Baba, Yoshifumi; Iwagami, Shiro; Sakamoto, Yasuo; Yoshida, Naoya; Masuguchi, Shinichi; Ihn, Hironobu; Baba, Hideo			Fascia lata onlay patch for repairing infected incisional hernias	SURGERY TODAY			English	Editorial Material						Incisional hernia; Autogenous patch; Fascia lata	GRAFTS	Abdominal incisional hernias represent the most common wound complication after abdominal surgery and infected abdominal incisional hernias are difficult to manage. We describe a simple, safe and effective method of using a free fascia lata patch to repair a large infected incisional hernia. This procedure involves the following steps: incising the skin and subcutaneous tissue and identifying the edges of the hernia defect; incising each anterior rectus sheath and completely suturing the medial edges of the fascia with 0 polypropylene; creating a fascia lata patch; and overlapping the defect in the anterior rectus fascia with the fascia lata patch as an onlay graft to reinforce the fascial closure. Five patients with infected hernias underwent this procedure, and all postoperative outcomes were satisfactory.	[Miyamoto, Yuji; Watanabe, Masayuki; Ishimoto, Takatsugu; Baba, Yoshifumi; Iwagami, Shiro; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Masuguchi, Shinichi; Ihn, Hironobu] Kumamoto Univ, Grad Sch Med Sci, Dept Dermatol, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	yuji-miyamoto@live.jp; hdobaba@kumamoto-u.ac.jp					Flum DR, 2003, ANN SURG, V237, P129, DOI 10.1097/00000658-200301000-00018; Cobb WS, 2005, SURG CLIN N AM, V85, P91, DOI 10.1016/j.suc.2004.09.006; Seiler CM, 2009, ANN SURG, V249, P576, DOI 10.1097/SLA.0b013e31819ec6c8; DAS SK, 1990, BRIT J PLAST SURG, V43, P315, DOI 10.1016/0007-1226(90)90079-F; Disa JJ, 1996, PLAST RECONSTR SURG, V97, P801, DOI 10.1097/00006534-199604000-00017; GUERREROSANTOS J, 1984, PLAST RECONSTR SURG, V74, P465, DOI 10.1097/00006534-198410000-00001; Moreau PE, 2012, J VISC SURG, V149, pE40, DOI 10.1016/j.jviscsurg.2012.09.001; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; PEACOCK EE, 1975, ANN SURG, V181, P722, DOI 10.1097/00000658-197505000-00029	9	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2015	45	1					121	124		10.1007/s00595-014-0936-y		4	Surgery	Surgery	AW4KS	WOS:000346250700020		
J	Tarui, A; Miyata, E; Tanaka, A; Sato, K; Omote, M; Ando, A				Tarui, Atsushi; Miyata, Erina; Tanaka, Ayumi; Sato, Kazuyuki; Omote, Masaaki; Ando, Akira			Stereoselective Suzuki Coupling Reaction of an alpha-Bromo-alpha-fluoro-beta-lactam	SYNLETT			English	Article						fluorine; beta-lactam; cross-coupling; nickel; 9-BBN	CROSS-COUPLINGS; CHOLESTEROL ABSORPTION; ASYMMETRIC-SYNTHESIS; MEDICINAL CHEMISTRY; ALKYL FLUORIDES; BOND; ELECTROPHILES; ARYLATIONS	A new strategy has been developed for the synthesis of alpha-aryl-alpha-fluoro-beta-lactams via the Suzuki cross-coupling of alpha-bromo-alpha-fluoro-beta-lactam with a range of different aryl-(9-BBN) reagents. This method provides facile access to multisubstituted alpha-fluoro-beta-lactams in a diastereoselective manner. The synthetic utility of alpha-bromo-alpha-fluoro-beta-lactam has been demonstrated by the arylation of alpha-bromo-alpha-fluoro-beta-lactam.	[Tarui, Atsushi; Miyata, Erina; Tanaka, Ayumi; Sato, Kazuyuki; Omote, Masaaki; Ando, Akira] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan	Ando, A (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	tarui-a@pharm.setsunan.ac.jp; aando@pharm.setsunan.ac.jp					Li XG, 2008, TETRAHEDRON-ASYMMETR, V19, P1857, DOI 10.1016/j.tetasy.2008.07.017; Tarui A, 2014, ORG LETT, V16, P2080, DOI 10.1021/ol500631j; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Liang YF, 2014, J AM CHEM SOC, V136, P5520, DOI 10.1021/ja501815p; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Tarui A, 2014, ORG BIOMOL CHEM, V12, P6484, DOI 10.1039/c4ob01184h; O'Hagan D, 2010, J FLUORINE CHEM, V131, P1071, DOI 10.1016/j.jfluchem.2010.03.003; Liu NJ, 2009, TETRAHEDRON LETT, V50, P1982, DOI 10.1016/j.tetlet.2009.02.056; Lundin PM, 2010, J AM CHEM SOC, V132, P11027, DOI 10.1021/ja105148g; KAWECKI R, 1993, TETRAHEDRON LETT, V34, P3087, DOI 10.1016/S0040-4039(00)93386-0; Zultanski SL, 2013, J AM CHEM SOC, V135, P624, DOI 10.1021/ja311669p; Wilsily A, 2012, J AM CHEM SOC, V134, P5794, DOI 10.1021/ja301612y; Kvaerno L, 2005, J MED CHEM, V48, P6035, DOI 10.1021/jm050422p; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Uoto K, 1997, CHEM PHARM BULL, V45, P1793; Tarui A, 2013, TETRAHEDRON, V69, P1559, DOI 10.1016/j.tet.2012.12.002; Tarui A, 2013, J ORG CHEM, V78, P7903, DOI 10.1021/jo401072h; Rosenblum SB, 1998, J MED CHEM, V41, P973, DOI 10.1021/jm970701f; Jiang XJ, 2014, J AM CHEM SOC, V136, P9548, DOI 10.1021/ja504089y; WELCH JT, 1993, J ORG CHEM, V58, P2454, DOI 10.1021/jo00061a019; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Tarui A, 2010, TETRAHEDRON LETT, V51, P2000, DOI 10.1016/j.tetlet.2010.02.023; Sato K, 2005, TETRAHEDRON LETT, V46, P7679, DOI 10.1016/j.tetlet.2005.09.031; Zhang W, 2008, CHEM COMMUN, P5686, DOI 10.1039/b812433g	24	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	1					55	58		10.1055/s-0034-1379637		4	Chemistry, Organic	Chemistry	AW8DZ	WOS:000346492100008		
J	Kageshima, Y; Suzuki, C; Oshiro, K; Amii, H				Kageshima, Yoshiya; Suzuki, Chiharu; Oshiro, Kojun; Amii, Hideki			Highly Controlled Ring-Opening of Siloxydifluorocyclopropanes: A Versatile Route to Cyclic Fluoroketones	SYNLETT			English	Article						fluorine; silicon; cyclopropane; ring-opening; ketone	ORGANIC FLUORINE-COMPOUNDS; GEM-DIFLUOROCYCLOPROPANE DERIVATIVES; STEREOSELECTIVE-SYNTHESIS; DIFLUOROCARBENE SOURCE; REARRANGEMENT; KETONES; CYCLOPROPANES; NUCLEOPHILES; EQUIVALENT; ALCOHOLS	A convenient access to cyclic fluoroketones that involves base-promoted ring-opening of siloxydifluorocyclopropanes is presented. Selective formation of gem-difluorinated cycloalkanones and monofluorinated enones has been achieved.	[Kageshima, Yoshiya; Suzuki, Chiharu; Oshiro, Kojun; Amii, Hideki] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan	Amii, H (reprint author), Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan.	amii@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (JST); 'Element Innovation' Project by Ministry of Education, Culture, Sports, Science and Technology in Japan	Financial support of the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency (JST) (ACT-C: Creation of Advanced Catalytic Transformation for the Sustainable Manufacturing at Low Energy, Low Environmental Load) is acknowledged. This work was partly supported by the 'Element Innovation' Project by the Ministry of Education, Culture, Sports, Science and Technology in Japan. We would like to thank Prof. Hiroshi Sano (Gunma University) for his useful suggestions. The authors thank Ms. Aya Takahashi (Gunma University) for her technical assistance. We are grateful to Central Glass Co., Ltd. for the gift of bromodifluoroacetic acid.	Nihei T, 2014, ORG LETT, V16, P4170, DOI 10.1021/ol5018596; Kosobokov MD, 2014, ORG LETT, V16, P1438, DOI 10.1021/ol5002297; Brahms DLS, 1996, CHEM REV, V96, P1585, DOI 10.1021/cr941141k; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Jin Z, 2012, ALDRICHIM ACTA, V45, P67; Dolbier WR, 2003, CHEM REV, V103, P1071, DOI 10.1021/cr010023b; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P7153, DOI 10.1002/anie.201101691; KUWAJIMA I, 1990, TOP CURR CHEM, V155, P1; Smart BE, 2002, J FLUORINE CHEM, V117, P199, DOI 10.1016/S0022-1139(02)00187-2; TAGUCHI T, 1984, TETRAHEDRON LETT, V25, P5689, DOI 10.1016/S0040-4039(01)91413-3; Zhou QH, 2013, ANGEW CHEM INT EDIT, V52, P3949, DOI 10.1002/anie.201300763; Begue J.-P., 2008, BIOORGANIC MED CHEM; Chambers R.D., 2004, FLUORINE ORGANIC CHE; DOLBIER WR, 1981, J AM CHEM SOC, V103, P2138, DOI 10.1021/ja00398a064; ERBES P, 1992, HELV CHIM ACTA, V75, P766, DOI 10.1002/hlca.19920750313; Gouverneur V., 2012, FLUORINE PHARM MED C; Hiyama T., 2000, ORGANOFLUORINE COMPO; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; ISOGAI K, 1983, B CHEM SOC JPN, V56, P1555, DOI 10.1246/bcsj.56.1555; Itoh T., 2005, ACS SYM SER, V911, P430; Itoh T., 2009, FLUORINE MED CHEM CH, P313, DOI 10.1002/9781444312096.ch12; Kagabu S., 1994, J CHEM SOC P1, V739, P1; Kirsch P., 2004, MODERN FLUOROORGANIC; Kobayashi T, 2003, ORG LETT, V5, P4297, DOI 10.1021/ol035528y; KOBAYASHI Y, 1979, CHEM PHARM BULL, V27, P3123; KOBAYASHI Y, 1981, TETRAHEDRON LETT, V22, P5297, DOI 10.1016/S0040-4039(01)92485-2; KOBAYASHI Y, 1983, CHEM PHARM BULL, V31, P2616; KOBAYASHI Y, 1982, J CHEM SOC PERK T 1, P85, DOI 10.1039/p19820000085; KOBAYASHI Y, 1982, J ORG CHEM, V47, P3232, DOI 10.1021/jo00138a006; MORIKAWA T, 1988, CHEM LETT, P1407, DOI 10.1246/cl.1988.1407; Munemori D, 2014, ORG LETT, V16, P2638, DOI 10.1021/ol500803r; Ni C., 2014, SYNTHESIS-STUTTGART, P842; Nowak I, 2004, ORG LETT, V6, P4767, DOI 10.1021/ol047943b; Ojima I., 2009, FLUORINE MED CHEM CH; Oshiro K, 2010, SYNTHESIS-STUTTGART, P2080, DOI 10.1055/s-0029-1218754; Prakash GKS, 2003, ANGEW CHEM INT EDIT, V42, P5216, DOI 10.1002/anie.200352172; Pravst I, 2005, SYNTHESIS-STUTTGART, P3140, DOI 10.1055/s-2005-918424; Thaharn W., 2012, J ORG CHEM, V77, P8466; Uneyama K., 2006, ORGANOFLUORINE CHEM; USUKI Y, 1992, J CHEM SOC CHEM COMM, P1148, DOI 10.1039/c39920001148; Wu JJ, 2012, EUR J ORG CHEM, P1380, DOI 10.1002/ejoc.201101518; Wu S.-H., 1989, ACTA CHIM SINICA, P253; Xua P., 2015, SYNLETT IN PRESS, DOI [10.1055/s-0034-1378651, DOI 10.1055/S-0034-1378651]	43	4	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	1					63	66		10.1055/s-0034-1379599		4	Chemistry, Organic	Chemistry	AW8DZ	WOS:000346492100010		
J	Owada, S; Tomita, H; Kinjo, T; Ishida, Y; Itoh, T; Sasaki, K; Horiuchi, D; Kimura, M; Sasaki, S; Okumura, K				Owada, Shingen; Tomita, Hirofumi; Kinjo, Takahiko; Ishida, Yuji; Itoh, Taihei; Sasaki, Kenichi; Horiuchi, Daisuke; Kimura, Masaomi; Sasaki, Shingo; Okumura, Ken			CHA(2)DS(2)-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough	THROMBOSIS RESEARCH			English	Article						Dabigatran; Activated partial thromboplastin time; CHA(2)DS(2)-VASc score; HAS-BLED score	DIRECT THROMBIN INHIBITOR; NONVALVULAR ATRIAL-FIBRILLATION; RE-LY TRIAL; COAGULATION ASSAYS; ETEXILATE; PHARMACODYNAMICS; PHARMACOKINETICS; WARFARIN; ROUTINE; STROKE	Introduction: Although dabigatran, an oral direct thrombin inhibitor, does not require routine monitoring, high plasma concentration of dabigatran (PDC) at trough level is shown to be a high risk for bleeding in patients with nonvalvular atrial fibrillation (NVAF). As dabigatran prolongs the activated partial thromboplastin time (APTT), we examined relationships of PDC at trough with APTT and clinical features to identify patients at high risk for major bleeding during dabigatran treatment. Materials and Methods: In the consecutive 48 patients with NVAF taking dabigatran at a daily dose of 220 mg (n = 32) or 300 mg (n = 16), we measured PDC using HEMOCLOT Thrombin Inhibitor assay and APTT ratio to control before (trough) and 2 hours after taking dabigatran. Results: PDC was positively correlated with APTT ratio (R-2 = 0.64, p < 0.0001). Using this regression equation and values of median trough PDC 116 (46.7-269) ng/mL observed in patients with major bleeding in the RE-LY trial, we calculated the expected value of APTT ratio corresponding to the 10th percentile of trough PDC (46.7). It was 1.20. There was a significant increase in trough PDC with increasing CHA(2)DS(2)-VASc score (p = 0.01) and with increasing HAS-BLED score (p = 0.01), especially in CHA(2)DS(2)-VASc score >= 4 and in HAS-BLED score >= 3, respectively. The highest trough PDC was obtained in patient group with CHA(2)DS(2)-VASc score >= 4, HAS-BLED score >= 3, or creatinine clearance <= 80, each combined with trough APTT ratio >= 1.20. Conclusions: This study provides an important clinical implication for identifying patients at high risk for major bleeding during dabigatran treatment in clinical practice. (C) 2014 Elsevier Ltd. All rights reserved.	[Owada, Shingen; Tomita, Hirofumi; Kinjo, Takahiko; Ishida, Yuji; Itoh, Taihei; Sasaki, Kenichi; Kimura, Masaomi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan; [Horiuchi, Daisuke; Sasaki, Shingo] Hirosaki Univ, Grad Sch Med, Dept Adv Management Cardiac Arrhythmias, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@cc.hirosaki-u.ac.jp					Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Douxfils J, 2012, THROMB HAEMOSTASIS, V107, P985, DOI 10.1160/TH11-11-0804; Stangier J, 2008, CLIN PHARMACOKINET, V47, P47; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Huisman MV, 2012, THROMB HAEMOSTASIS, V107, P838, DOI 10.1160/TH11-10-0718; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Hapgood G, 2013, THROMB HAEMOSTASIS, V110, P308, DOI 10.1160/TH13-04-0301; Katoh Hiromasa, 2014, Am J Cardiovasc Dis, V4, P70	15	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JAN	2015	135	1					62	67		10.1016/j.thromres.2014.10.025		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AW7GK	WOS:000346432600012		
J	Wanaka, K; Asada, R; Miyashita, K; Kaneko, M; Endo, H; Yatomi, Y				Wanaka, Keiko; Asada, Reiko; Miyashita, Kumiko; Kaneko, Makoto; Endo, Hirokazu; Yatomi, Yutaka			Novel HIT antibody detection method using Sonoclot (R) coagulation analyzer	THROMBOSIS RESEARCH			English	Article						Heparin induced thrombocytopenia; Blood coagulation activity; Sonoclot; Monoclonal antibody	HEPARIN-INDUCED THROMBOCYTOPENIA	Introduction: Since heparin-induced thrombocytopenia (HIT), caused by the generation of antibodies against platelet factor 4 (PF4)/heparin complexes (HIT antibodies), may induce serious complications due to thrombosis, a prompt diagnosis is desirable. Functional tests with platelet activation to detect HIT antibodies are useful for diagnosis of HIT, in particular C-14-selotonin release assay (SRA). However, they are complicated and so can be performed only in limited laboratories. We tested if a blood coagulation test using Sonoclot (R) analyzer can serve for the detection of HIT antibodies. Materials and Methods: A murine monoclonal antibody (HIT-MoAb) against PF4/heparin complexes was used as an alternative to human HIT antibodies. To themixture of HIT-MoAb and heparin (0.5 U/mL, final), whole blood obtained from a healthy volunteer was added, and then the activated clotting time (ACT), clot rate (CR), and area under the curve (AUC) were measured with Sonoclot (R) analyzer for 30 minutes. Results: The HIT-MoAb (30 to 100 mu g/mL, final) concentration dependently suppressed the anticoagulation activity (prolongation of ACT and decrease of CR and AUC) of heparin. Conclusions: The suppression of anticoagulation effect of heparin by HIT-MoAb was demonstrated by measurements using Sonoclot (R) analyzer. This method may provide a new tool for screening of HIT antibodies. (C) 2014 Elsevier Ltd. All rights reserved.	[Wanaka, Keiko; Asada, Reiko; Miyashita, Kumiko] Res Projects Thrombosis & Haemostasis, Tarumi Ku, Kobe, Hyogo 6550033, Japan; [Wanaka, Keiko; Kaneko, Makoto; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Wanaka, Keiko; Endo, Hirokazu] Kobe Co Med Coll, Kobe, Hyogo 6540142, Japan	Wanaka, K (reprint author), Res Projects Thrombosis & Haemostasis, Tarumi Ku, 3-15-18 Asahigaoka, Kobe, Hyogo 6550033, Japan.	vya10606@nifty.com					HETT DA, 1995, BRIT J ANAESTH, V75, P771; Bakchoul T, 2014, INT J LAB HEMATOL, V36, P296, DOI 10.1111/ijlh.12236; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Asada R, 2013, CLIN APPL THROMB-HEM, V19, P37, DOI 10.1177/1076029612453763; CHONG BH, 1989, BLUT, V58, P53, DOI 10.1007/BF00320647; Gupta V, 2007, AM J NEURORADIOL, V28, P155; KELTON JG, 1994, BLOOD, V83, P3232; RHODES GR, 1977, ANN SURG, V186, P752, DOI 10.1097/00000658-197712000-00017; Warkentin TE, 2013, HEPARIN INDUCED THRO, P272; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; WARKENTIN TE, 1992, J LAB CLIN MED, V120, P371	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JAN	2015	135	1					127	129		10.1016/j.thromres.2014.10.024		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AW7GK	WOS:000346432600023		
J	Banakh, T; Yagasaki, T				Banakh, Taras; Yagasaki, Tatsuhiko			Diffeomorphism groups of non-compact manifolds endowed with the Whitney C-infinity-topology	TOPOLOGY AND ITS APPLICATIONS			English	Article						Diffeomorphism group; The Whitney topology; sigma-Compact manifold; LF-space	SUFFICIENTLY LARGE; HOMOTOPY TYPE; 3-MANIFOLDS; SPACES	Suppose M is a non-compact connected n-manifold without boundary, D(M) is the group of C-infinity-diffeomorphisms of M endowed with the Whitney C-topology and D-0(M) is the identity connected component of D(M), which is an open subgroup in the group D-c(M) subset of D(M) of compactly supported diffeomorphisms of M. It is shown that D0(M) is homeomorphic to N x R-infinity for an l(2)-manifold N whose topological type is uniquely determined by the homotopy type of D-0(M). For instance, Do(M) is homeornorphic to l(2) x R-infinity if n = 1,2 or n = 3 and M is orientable and irreducible. We also show that for any compact connected n-manifold N with non-empty boundary UN the group D-0(N\partial derivative N) is homeomorphic to D-0(N;partial derivative N) x R-infinity, where D-0(N;partial derivative N) is the identity component of the group D(N;partial derivative N) of diffeomorphisms of N that do not move points of the boundary partial derivative N. (C) 2014 Elsevier B.V. All rights reserved.	[Banakh, Taras] Ivan Frank Natl Univ Lviv, Lvov, Ukraine; [Banakh, Taras] Jan Kochanowski Univ Humanities & Sci, Kielce, Poland; [Yagasaki, Tatsuhiko] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 6068585, Japan	Banakh, T (reprint author), Ivan Frank Natl Univ Lviv, Lvov, Ukraine.	t.o.banakh@gmail.com; yagasaki@kit.ac.jp			JSPS [22540081]	The second author was supported by JSPS Grant-in-Aid for Scientific Research (No. 22540081).	Banakh T, 2012, TOPOL APPL, V159, P1475, DOI 10.1016/j.topol.2012.01.011; Banakh T, 2014, TOPOL APPL, V164, P170, DOI 10.1016/j.topol.2013.12.013; Banakh T, 2012, TOHOKU MATH J, V64, P1; Banakh T, 2010, TOPOL APPL, V157, P1091, DOI 10.1016/j.topo1.2010.01.010; Banakh T, 2013, TOPOL APPL, V160, P2272, DOI 10.1016/j.topol.2013.07.023; Banakh T., 2011, TOPOL P, V37, P61; BURGHELE.D, 1974, T AM MATH SOC, V196, P1; BURGHELE.D, 1974, T AM MATH SOC, V196, P37, DOI 10.2307/1997011; Cerf J., 1961, B SOC MATH FRANCE, V89, P227; DOBROWOLSKI T, 1981, TOPOL APPL, V12, P229, DOI 10.1016/0166-8641(81)90001-8; Earle C. J., 1969, J DIFFER GEOM, V3, P19; HAMILTON RS, 1982, B AM MATH SOC, V7, P65, DOI 10.1090/S0273-0979-1982-15004-2; Hatcher A., 2012, 50 YEAR VIEW DIFFEOM; HATCHER AE, 1983, ANN MATH, V117, P553, DOI 10.2307/2007035; HATCHER A, 1976, TOPOLOGY, V15, P343, DOI 10.1016/0040-9383(76)90027-6; Hempel J., 1976, 3 MANIFOLDS ANNALS M, V86; Illman S, 2003, OSAKA J MATH, V40, P409; Ivanov N.V., 2002, HDB GEOMETRIC TOPOLO, P523; Ivanov N.V., 1979, J SOVIET MATH, V12, P115, DOI 10.1007/BF01098421; Ivanov N.V., 1980, P580 LOIVII; Leslie J. A., 1967, TOPOLOGY, V46, P263, DOI 10.1016/0040-9383(67)90038-9; Mine K., 2008, B POLISH ACAD SCI MA, V56, P25, DOI 10.4064/ba56-1-4; Palais R., 1960, COMMENT MATH HELV, V34, P305, DOI 10.1007/BF02565942; Scott G.P., 1970, TOPOLOGY, V9, P97, DOI 10.1016/0040-9383(70)90053-4; Seeley R.T., 1964, P AM MATHEMATICAL SO, V15, P625, DOI DOI 10.2307/2034761; Smale S., 1959, P AM MATH SOC, V10, P621, DOI 10.2307/2033664; WALDHAUS.F, 1968, ANN MATH, V87, P56, DOI 10.2307/1970594	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	JAN 1	2015	179				SI		51	61		10.1016/j.topol.2014.08.015		11	Mathematics, Applied; Mathematics	Mathematics	AW7QE	WOS:000346458900006		
J	Mitsui, Y; Bagchi, M; Marone, PA; Moriyama, H; Bagchi, D				Mitsui, Yukio; Bagchi, Manashi; Marone, Palma Ann; Moriyama, Hiroyoshi; Bagchi, Debasis			Safety and toxicological evaluation of a novel, fermented, peptide-enriched, hydrolyzed swine placenta extract powder	TOXICOLOGY MECHANISMS AND METHODS			English	Article						Acute oral toxicity; Ames' bacterial reverse mutation assay; 28-d sub-chronic toxicity; Horus fermented placenta extract (HFPEP); in vivo micronucleus assay	MULTIPLE COMPARISONS; GROWTH	Placenta is an important organ that connects the developing fetus to allow nutrient uptake, antibody provisions and gas exchange via the blood supply of the mother. We developed a novel, standardized, stable, water-soluble, peptide-enriched hydrolyzed, Horus fermented placenta powder (HFPEP) from healthy, pathogen-free, swine placenta. Earlier studies demonstrated that HFPEP significantly improves physical fatigue, hepatic functions and repair of muscle fibers. We examined the broad safety of HFPEP in various toxicology models in Good Laboratory Practices-approved laboratories. The acute oral toxicity study was conducted in female Sprague-Dawley rats, and the acute oral LD50 was found to be greater than 5000 mg/kg body weight. Ames' bacterial reverse mutation assay was conducted to determine the ability of HFPEP to induce reverse mutation at selected histidine loci in five tester strains of Salmonella typhimurium viz. TA1535, TA1537, TA98, TA100 and TA102 in the presence and absence of a metabolic activation system (S9) at the doses of 50, 15, 4.5, 1.35 and 0.41 mg/ml. No mutagenic potential was observed. Mutagenic potential was also evaluated using in vivo micronucleus test, and no mutagenic potential of HFPEP was observed. Repeated dose 28-d oral toxicity study was performed in male and female rats with 14-d recovery period at the dose levels of 250, 500 or 1000 mg/kg. No abnormal clinical signs or toxicity were detected. No observed adverse effect level of HFPEP was found to be greater than 1000 mg/kg body weight. These studies affirm that HFPEP has broad spectrum safety for human consumption.	[Mitsui, Yukio] Horus Co Ltd, Tokyo, Japan; [Bagchi, Manashi] Dr Herbs LLC, Concord, CA USA; [Marone, Palma Ann] Prod Safety Lab, Dayton, NJ USA; [Moriyama, Hiroyoshi] Teikyo Univ, Fac Pharma Sci, Tokyo 173, Japan; [Bagchi, Debasis] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	Bagchi, D (reprint author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	debasisbagchi@gmail.com			Horus Co., Ltd., Tokyo, Japan	This study was supported by a research grant from Horus Co., Ltd., Tokyo, Japan. Y. M. is the executive director of Horus Co. Ltd., Tokyo, Japan. H. M., D. B. and M. B. are independent consultants who designed the manuscript based on the independent toxicology studies conducted in professional laboratories. Dr. P. A. Marone is the executive director of Eurofins/Product Safety Laboratories, Dayton, NJ, and directed part of the safety studies.	Ames BN, 1977, HDB MUTAGENICITY TES, P1; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Tonello G, 1996, J PHARMACEUT BIOMED, V14, P1555, DOI 10.1016/0731-7085(96)01788-8; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Datta P, 2004, J PHARMACEUT BIOMED, V34, P1091, DOI 10.1016/S0731-7085(03)00654-X; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; FDA, 1987, GOOD LAB PRACT GLP N, P297; Hong HT, 2002, J ETHNOPHARMACOL, V79, P143, DOI 10.1016/S0378-8741(01)00371-3; Kim HJ, 2003, KOREAN J DERMATOLOGY, V41, P1612; Mitsui Y, 2014, J FUNCT FOODS UNPUB; MOSER VC, 1989, J AM COLL TOXICOL, V8, P85; National Research Council, 2011, GUIDE CARE USE LAB A; Ober WB, 1979, J URBAN HEALTH, V55, P591; OECD, 1998, PRINC GOOD LAB PRACT; Pal P, 2002, INT J DERMATOL, V41, P760, DOI 10.1046/j.1365-4362.2002.01524.x; Snedecor G.W., 1980, STAT METHODS; Thomson M., 2008, CURR WOM HLTH REV, V4, P270, DOI DOI 10.2174/157340408786848197; WOLF HK, 1991, AM J PATHOL, V138, P1035; Young SM, 2010, ECOL FOOD NUTR, V49, P467, DOI 10.1080/03670244.2010.524106	21	1	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1537-6516	1537-6524		TOXICOL MECH METHOD	Toxicol. Mech. Methods	JAN	2015	25	1					13	20		10.3109/15376516.2014.971139		8	Toxicology	Toxicology	AW9TO	WOS:000346600500002		
J	Weitzer, S; Hanada, T; Penninger, JM; Martinez, J				Weitzer, Stefan; Hanada, Toshikatsu; Penninger, Josef M.; Martinez, Javier			CLP1 as a novel player in linking tRNA splicing to neurodegenerative disorders	WILEY INTERDISCIPLINARY REVIEWS-RNA			English	Review							CAUSE PONTOCEREBELLAR HYPOPLASIA; PROMOTES TRANSCRIPTION TERMINATION; PLACENTAL RIBONUCLEASE INHIBITOR; EXPORT FACTOR YRA1; ENZYME IN-VIVO; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; POLYADENYLATION FACTOR; POLYNUCLEOTIDE KINASE; EXOSC3 MUTATIONS	Defects in RNA metabolic pathways are well-established causes for neurodegenerative disorders. Several mutations in genes involved in pre-messenger RNA (pre-mRNA) and tRNA metabolism, RNA stability and protein translation have been linked to motor neuron diseases. Our study on a mouse carrying a catalytically inactive version of the RNA kinase CLP1, a component of the tRNA splicing endonuclease complex, revealed a neurological disorder characterized by progressive loss of lower spinal motor neurons. Surprisingly, mutant mice accumulate a novel class of tRNA-derived fragments. In addition, patients with homozygous missense mutations in CLP1 (R140H) were recently identified who suffer from severe motor-sensory defects, cortical dysgenesis and microcephaly, and exhibit alterations in transfer RNA (tRNA) splicing. Here, we review functions of CLP1 in different RNA pathways and provide hypotheses on the role of the tRNA splicing machinery in the generation of tRNA fragments and the molecular links to neurodegenerative disorders. We further immerse the biology of tRNA splicing into topics of (t)RNA metabolism and oxidative stress, putting forward the idea that defects in tRNA processing leading to tRNA fragment accumulation might trigger the development of neurodegenerative diseases. (C) 2014 JohnWiley & Sons, Ltd.	[Weitzer, Stefan; Penninger, Josef M.; Martinez, Javier] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria; [Hanada, Toshikatsu] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TK Project, Kyoto, Japan	Penninger, JM (reprint author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at; javier.martinez@imba.oeaw.ac.at	Penninger, Josef/I-6860-2013				Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.V.I.14300; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Hallais M, 2013, NAT STRUCT MOL BIOL, V20, P1358, DOI 10.1038/nsmb.2720; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Popow J, 2014, NATURE, V511, P104, DOI 10.1038/nature13284; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Nawrot B, 2011, CELL MOL LIFE SCI, V68, P4023, DOI 10.1007/s00018-011-0773-8; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Kasher PR, 2011, HUM MOL GENET, V20, P1574, DOI 10.1093/hmg/ddr034; Prives C, 1999, J PATHOL, V187, P112; Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Namavar Y, 2011, EUR J HUM GENET, V19, P724, DOI 10.1038/ejhg.2011.8; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Desai KK, 2014, NUCLEIC ACIDS RES, V42, P3931, DOI 10.1093/nar/gkt1375; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; PEEBLES CL, 1979, CELL, V18, P27, DOI 10.1016/0092-8674(79)90350-7; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Riley KJL, 2007, BIOCHEM BIOPH RES CO, V363, P381, DOI 10.1016/j.bbrc.2007.08.181; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; AMITSUR M, 1987, EMBO J, V6, P2499; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; BERNIER L, 1987, J NEUROSCI, V7, P2703; Biancheri R, 2013, J NEUROL, V260, P1866, DOI 10.1007/s00415-013-6896-0; Bierhals T, 2013, EUR J MED GENET, V56, P325, DOI 10.1016/j.ejmg.2013.03.009; Chang JR, 2011, NEURODEGENER DIS, V9, P68, DOI [10.1159/000329999, DOI 10.1159/000329999]; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; Czech A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003767; desPlanell-Saguer M, 2009, HUM MOL GENET, V18, P2115; Dikfidan A, 2014, MOL CELL, V54, P975, DOI 10.1016/j.molcel.2014.04.005; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Garcia MA, 2012, MOL BIOSYST, V8, P2605, DOI 10.1039/c2mb25092f; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Ghazy MA, 2012, NUCLEIC ACIDS RES, V40, P1214, DOI 10.1093/nar/gkr801; Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Haddad R, 2012, NUCLEIC ACIDS RES, V40, P1226, DOI 10.1093/nar/gkr800; Holbein S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029139; Hurto RL, 2011, ADV EXP MED BIOL, V722, P137, DOI 10.1007/978-1-4614-0332-6_9; Johnson SA, 2011, NAT STRUCT MOL BIOL, V18, P1164, DOI 10.1038/nsmb.2126; Kawaji Hideya, 2008, V452, P125, DOI 10.1007/978-1-60327-159-2_6; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; LASKI FA, 1983, J BIOL CHEM, V258, P1974; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Lopez-Sanchez I, 2014, FEBS LETT, V588, P692, DOI 10.1016/j.febslet.2014.01.040; Mei YD, 2010, CELL CYCLE, V9, P2936, DOI 10.4161/cc.9.15.12316; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Riley KJL, 2007, BIOCHEMISTRY-US, V46, P2480, DOI 10.1021/bi061480v; ROBERTSO.HD, 1972, J BIOL CHEM, V247, P5243; Rudnik-Schoneborn S, 2013, NEUROLOGY, V80, P438, DOI 10.1212/WNL.0b013e31827f0f66; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schwabova J, 2013, J NEUROGENET, V27, P163, DOI 10.3109/01677063.2013.814651; Tanabe S, 1996, BLOOD, V88, P3535; vansEs MA, 2011, ANN NEUROL, V70, P964; vansTol H, 1987, EMBO J, V6, P35; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; WEREMOWICZ S, 1990, GENOMICS, V8, P717, DOI 10.1016/0888-7543(90)90260-2; Zanni G, 2013, NEUROGENETICS, V14, P247, DOI 10.1007/s10048-013-0371-z; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410	111	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-7004	1757-7012		WIRES RNA	Wiley Interdiscip. Rev.-RNA	JAN-FEB	2015	6	1					47	63		10.1002/wrna.1255		17	Cell Biology	Cell Biology	AW5UH	WOS:000346338700003		
J	Hayashi, K; Araki, N; Koizumi, M; Suzuki, O; Seo, Y; Naka, N; Isohashi, F; Myoui, A; Yoshioka, Y; Teshima, T; Ueda, T; Yoshikawa, H; Ogawa, K				Hayashi, Kazuhiko; Araki, Nobuhito; Koizumi, Masahiko; Suzuki, Osamu; Seo, Yuji; Naka, Norifumi; Isohashi, Fumiaki; Myoui, Akira; Yoshioka, Yasuo; Teshima, Teruki; Ueda, Takafumi; Yoshikawa, Hideki; Ogawa, Kazuhiko			Long-term results of intraoperative extracorporeal irradiation of autogenous bone grafts on primary bone and soft tissue malignancies	ACTA ONCOLOGICA			English	Letter							ENDOPROSTHETIC REPLACEMENT; PROXIMAL TIBIA; LIMB-SALVAGE; TUMORS; OSTEOSARCOMA; RESECTION; SARCOMAS; RECONSTRUCTION; REIMPLANTATION; OUTCOMES		[Hayashi, Kazuhiko; Suzuki, Osamu; Seo, Yuji; Isohashi, Fumiaki; Yoshioka, Yasuo; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan; [Naka, Norifumi; Myoui, Akira; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan; [Teshima, Teruki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka, Japan; [Araki, Nobuhito] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthopaed Surg, Osaka, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Koizumi, Masahiko] Osaka Univ, Grad Sch Med, Radiat Oncol Lab, Osaka, Japan	Hayashi, K (reprint author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan.	hayashi@radonc.med.osaka-u.ac.jp					Abudu A, 1999, INT ORTHOP, V23, P291, DOI 10.1007/s002640050374; Grimer RJ, 1999, J BONE JOINT SURG BR, V81B, P488, DOI 10.1302/0301-620X.81B3.9234; MANKIN HJ, 1992, ORTHOPEDICS, V15, P1147; Pisters PWT, 2007, J CLIN ONCOL, V25, P1003, DOI 10.1200/JCO.2006-09.8525; Poffyn B, 2011, INT ORTHOP, V35, P889, DOI 10.1007/s00264-010-1098-1; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; SPIRA E, 1968, ISRAEL J MED SCI, V4, P1015; Tan PX, 2012, EJSO-EUR J SURG ONC, V38, P1171, DOI 10.1016/j.ejso.2012.07.003; Myers GJC, 2007, J BONE JOINT SURG BR, V89B, P1632, DOI 10.1302/0301-620X.89B12.19481; Araki N, 1999, CLIN ORTHOP RELAT R, P196; Kim JD, 2011, J SURG ONCOL, V104, P187, DOI 10.1002/jso.21902; Davidson AW, 2005, J BONE JOINT SURG BR, V87B, P851, DOI 10.1302/0301-620X.87B6.15950; Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50; Farfalli GL, 2012, ORTHOPEDICS, V35, pE391, DOI 10.3928/01477447-20120222-25; Mendenhall WM, 2009, AM J CLIN ONCOL-CANC, V32, P436, DOI 10.1097/COC.0b013e318173a54f; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Myers GJC, 2007, J BONE JOINT SURG BR, V89B, P521, DOI 10.1302/0301-620X.89B4.18631; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; Puri A, 2012, J BONE JOINT SURG BR, V94B, P982, DOI 10.1302/0301-620X.94B7.28916	19	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0284-186X	1651-226X		ACTA ONCOL	Acta Oncol.	JAN	2015	54	1					138	U156		10.3109/0284186X.2014.930172		4	Oncology	Oncology	AW9IX	WOS:000346571700020		
J	Elad, S; Raber-Durlacher, JE; Brennan, MT; Saunders, DP; Mank, AP; Zadik, Y; Quinn, B; Epstein, JB; Blijlevens, NMA; Waltimo, T; Passweg, JR; Correa, MEP; Dahllof, G; Garming-Legert, KUE; Logan, RM; Potting, CMJ; Shapira, MY; Soga, Y; Stringer, J; Stokman, MA; Vokurka, S; Wallhult, E; Yarom, N; Jensen, SB				Elad, Sharon; Raber-Durlacher, Judith E.; Brennan, Michael T.; Saunders, Deborah P.; Mank, Arno P.; Zadik, Yehuda; Quinn, Barry; Epstein, Joel B.; Blijlevens, Nicole M. A.; Waltimo, Tuomas; Passweg, Jakob R.; Correa, M. Elvira P.; Dahllof, Goran; Garming-Legert, Karin U. E.; Logan, Richard M.; Potting, Carin M. J.; Shapira, Michael Y.; Soga, Yoshihiko; Stringer, Jacqui; Stokman, Monique A.; Vokurka, Samuel; Wallhult, Elisabeth; Yarom, Noam; Jensen, Siri Beier			Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)	SUPPORTIVE CARE IN CANCER			English	Review						Oral; Dental; Hygiene; Hematology; Hematopoietic stem cell transplantation; Cancer	VERSUS-HOST-DISEASE; SALIVARY-GLAND HYPOFUNCTION; RECEIVING CANCER-THERAPY; MUCOSAL COATING AGENTS; CLINICAL-PRACTICE; OROFACIAL PAIN; MANAGEMENT STRATEGIES; MUCOSITIS; XEROSTOMIA; GUIDELINES	Hematology-oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations. The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.	[Elad, Sharon] Univ Rochester, Med Ctr, Div Oral Med, Eastman Inst Oral Hlth, Rochester, NY 14620 USA; [Elad, Sharon] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Strong Mem Hosp, Rochester, NY 14620 USA; [Raber-Durlacher, Judith E.] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands; [Raber-Durlacher, Judith E.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Med Dent Interact, Amsterdam, Netherlands; [Raber-Durlacher, Judith E.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; [Raber-Durlacher, Judith E.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Brennan, Michael T.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Saunders, Deborah P.] North East Canc Ctr, Dept Dent Oncol, Sudbury, ON, Canada; [Mank, Arno P.] Univ Amsterdam, Acad Med Ctr, Dept Hematol & Oncol, NL-1105 AZ Amsterdam, Netherlands; [Zadik, Yehuda] Israel Def Forces Med Corps, Israeli Air Force Gen Surgeon Headquarters, Jerusalem, Israel; [Zadik, Yehuda] Hebrew Univ Jerusalem, Dept Oral Med, Hadassah Sch Dent Med, Jerusalem, Israel; [Quinn, Barry] Chelsea & Westminster NHS Fdn Trust, Dept Canc & Palliat Care, London, England; [Quinn, Barry] Univ Surrey, Dept Canc Nursing, Guildford GU2 5XH, Surrey, England; [Epstein, Joel B.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Epstein, Joel B.] City Hope Natl Med Ctr, Div Otolaryngol & Head & Neck Surg, Duarte, CA USA; [Blijlevens, Nicole M. A.] Radboud Univ Nijmegen, Med Ctr, Dept Haematol, NL-6525 ED Nijmegen, Netherlands; [Waltimo, Tuomas] Univ Basel, Univ Kliniken Zahnmed, Klin Pravent Zahnmed & Orale Mikrobiol, Basel, Switzerland; [Passweg, Jakob R.] Univ Spital Basel, Bereich Innere Med, Klin Hamatol, Basel, Switzerland; [Correa, M. Elvira P.] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Pathol, Dent Ambulatory Hematolgy & Hemotherapy Ctr, Campinas, SP, Brazil; [Dahllof, Goran] Karolinska Inst, Div Pediat Dent, Dept Dent Med, Huddinge, Sweden; [Garming-Legert, Karin U. E.] Karolinska Inst, Div Orofacial Diagnost & Surg Oral Med & Pathol, Dept Dent Med, Huddinge, Sweden; [Logan, Richard M.] Univ Adelaide, Sch Dent, Adelaide, SA, Australia; [Potting, Carin M. J.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [Shapira, Michael Y.] Hadassah Hebrew Univ Hosp, BMT & Canc Immunotherapy Dept, Jerusalem, Israel; [Soga, Yoshihiko] Okayama Univ Hosp, Cent Clin Dept, Div Hosp Dent, Okayama, Japan; [Stringer, Jacqui] Christie NHS Trust, Haematol Transplant Unit, Manchester M20 4BX, Lancs, England; [Stokman, Monique A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiotherapy, Groningen, Netherlands; [Stokman, Monique A.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Vokurka, Samuel] Univ Hosp Plzen, Dept Haematol Oncol, Plzen, Pilsen, Czech Republic; [Wallhult, Elisabeth] Sahlgrens Univ Hosp, Dept Internal Med, Sect Haematol & Coagulat, Gothenburg, Sweden; [Yarom, Noam] Chaim Sheba Med Ctr, Dept Oral & Maxillofacial Surg, IL-52621 Tel Hashomer, Israel; [Yarom, Noam] Tel Aviv Univ, Sch Dent Med, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel; [Jensen, Siri Beier] Univ Copenhagen, Sect Oral Med Clin Oral Physiol Oral Pathol & Ana, Dept Odontol, Fac Hlth Sci, Copenhagen, Denmark	Elad, S (reprint author), Univ Rochester, Med Ctr, Div Oral Med, Eastman Inst Oral Hlth, 625 Elmwood Ave, Rochester, NY 14620 USA.	SElad@URMC.Rochester.edu	Blijlevens, N.M.A./H-8012-2014; Logan, Richard/P-4080-2014		T&K Corporation, Tokyo, Japan	This study was partly conducted by an unrestricted fund donated by the T&K Corporation, Tokyo, Japan.	Addy M, 2008, PERIODONTOL 2000, V48, P54, DOI 10.1111/j.1600-0757.2008.00253.x; American Academy of Pediatric Dentistry Clinical Affairs Committee American Academy of Pediatric Dentistry Council on Clinical Affairs, 2005, PEDIAT DENT, V27, P170; Parulekar W, 1998, ORAL ONCOL, V34, P63, DOI 10.1016/S1368-8375(97)00065-1; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6; Peterson DE, 2013, SUPPORT CARE CANCER, V21, P327, DOI 10.1007/s00520-012-1562-0; Treister N, 2012, BLOOD, V120, P3407, DOI 10.1182/blood-2012-05-393389; Raber-Durlacher JE, 2010, ORAL ONCOL, V46, P452, DOI 10.1016/j.oraloncology.2010.03.012; Boer CC, 2010, BONE MARROW TRANSPL, V45, P705, DOI 10.1038/bmt.2009.237; Ruescher TJ, 1998, CANCER, V82, P2275, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.3.CO;2-8; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Peterson DE, 2010, SUPPORT CARE CANCER, V18, P1089, DOI 10.1007/s00520-010-0898-6; Migliorati CA, 2010, SUPPORT CARE CANCER, V18, P1099, DOI 10.1007/s00520-010-0882-1; Epstein JB, 2009, ORAL SURG ORAL MED O, V107, P301, DOI 10.1016/j.tripleo.2008.12.006; Epstein JB, 2010, ORAL ONCOL, V46, P77, DOI 10.1016/j.oraloncology.2009.11.008; Stiff P, 2001, BONE MARROW TRANSPL, V27, pS3, DOI 10.1038/sj.bmt.1702863; Yarom N, 2013, SUPPORT CARE CANCER, V21, P3209, DOI 10.1007/s00520-013-1869-5; Epstein JB, 2007, J DENT RES, V86, P506; Hong CHL, 2010, SUPPORT CARE CANCER, V18, P1007, DOI 10.1007/s00520-010-0873-2; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Raber-Durlacher JE, 2013, SUPPORT CARE CANCER, V21, P1621, DOI 10.1007/s00520-012-1706-2; Bellm LA, 2000, SUPPORT CARE CANCER, V8, P33; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; McGuire DB, 2013, SUPPORT CARE CANCER, V21, P3165, DOI 10.1007/s00520-013-1942-0; Hovan AJ, 2010, SUPPORT CARE CANCER, V18, P1081, DOI 10.1007/s00520-010-0902-1; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Jensen SB, 2013, SUPPORT CARE CANCER, V21, P3223, DOI 10.1007/s00520-013-1884-6; Van Strydonck DAC, 2005, J CLIN PERIODONTOL, V32, P305, DOI 10.1111/j.1600-051X.2005.00681.x; Elad S, 2010, SUPPORT CARE CANCER, V18, P993, DOI 10.1007/s00520-010-0900-3; Sivolella S, 2013, ANTICANCER RES, V33, P1793; [Anonymous], 2008, PEDIAT DENT S, V30, P219; Lalla RV, 2010, SUPPORT CARE CANCER, V18, P985, DOI 10.1007/s00520-010-0892-z; Epstein JB, 2007, SUPPORT CARE CANCER, V15, P357, DOI 10.1007/s00520-006-0160-4; Epstein JB, 2010, SUPPORT CARE CANCER, V18, P1023, DOI 10.1007/s00520-010-0897-7; Barasch A, 2006, SUPPORT CARE CANCER, V14, P528, DOI 10.1007/s00520-006-0066-1; Migliorati C, 2013, SUPPORT CARE CANCER, V21, P333, DOI 10.1007/s00520-012-1605-6; Yamagata K, 2012, BONE MARROW TRANSPL, V47, P725, DOI 10.1038/bmt.2011.171; Ship JA, 2007, J ORAL REHABIL, V34, P724, DOI 10.1111/j.1365-2842.2006.01718.x; Greinix HT, 1998, BLOOD, V92, P3098; Kashiwazaki H, 2012, SUPPORT CARE CANCER, V20, P367, DOI 10.1007/s00520-011-1116-x; Raber-Durlacher JE, 2013, SUPPORT CARE CANCER, V21, P343, DOI 10.1007/s00520-012-1594-5; Shen PY, 2011, J DENT, V39, P518, DOI 10.1016/j.jdent.2011.05.002; Saunders DP, 2013, SUPPORT CARE CANCER, V21, P3191, DOI 10.1007/s00520-013-1871-y; AXELSSON P, 1987, J CLIN PERIODONTOL, V14, P205, DOI 10.1111/j.1600-051X.1987.tb00968.x; Bagesund M, 2000, BONE MARROW TRANSPL, V26, P775, DOI 10.1038/sj.bmt.1702556; Benoliel R, 2007, J DENT RES, V86, P491; Bradley LL, 2003, ORAL HLTH CANC THERA; Bystricka E, 2012, BONE MARROW TRANSPL, V47, P149, DOI 10.1038/bmt.2011.19; Castellarin P, 2012, BIOL BLOOD MARROW TR, V18, P1573, DOI 10.1016/j.bbmt.2012.04.009; Chaushu G, 2000, CANCER, V88, P984, DOI 10.1002/(SICI)1097-0142(20000301)88:5<984::AID-CNCR6>3.0.CO;2-0; CHAUSHU G, 1995, ORAL SURG ORAL MED O, V79, P164, DOI 10.1016/S1079-2104(05)80276-8; Council on Clinical Affairs, 2013, PEDIAT DENT, V35, pE185; de Souza RF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007395.pub2; Durey K, 2009, BRIT DENT J, V206, DOI 10.1038/sj.bdj.2009.304; Elad S, 2003, SUPPORT CARE CANCER, V11, P674, DOI 10.1007/s00520-003-0499-8; Elad S, 2010, ORAL COMPLICATIONS C, P129; Elad S, 2006, CLIN TRANSPLANT, V20, P318, DOI 10.1111/j.1399-0012.2005.00484.x; Epstein J, 2008, ORAL HLTH CANC THERA; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Glenny AM, 2010, EUR J CANCER, V46, P1399, DOI 10.1016/j.ejca.2010.01.023; GREENBERG MS, 1982, ORAL SURG ORAL MED O, V53, P32, DOI 10.1016/0030-4220(82)90483-2; Hoffmann T, 2001, Clin Oral Investig, V5, P89; Laaksonen M, 2011, J DENT RES, V90, P1177, DOI 10.1177/0022034511414156; Mawardi H, 2011, BONE MARROW TRANSPL, V46, P884, DOI 10.1038/bmt.2011.77; McGuire DB, 2006, SUPPORT CARE CANCER, V14, P541, DOI 10.1007/s00520-006-0051-8; Meier JKH, 2011, CLIN ORAL INVEST, V15, P127, DOI 10.1007/s00784-010-0450-6; Mohty M, 2010, HEMATOL-AM SOC HEMAT, P229, DOI 10.1182/asheducation-2010.1.229; Newbrun E, 2001, J Dent Educ, V65, P1078; Nicolatou-Galitis O, 2013, SUPPORT CARE CANCER, V21, P357, DOI 10.1007/s00520-012-1613-6; PETERSON DE, 1981, ORAL SURG ORAL MED O, V51, P390, DOI 10.1016/0030-4220(81)90148-1; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Qutob AF, 2013, SUPPORT CARE CANCER, V21, P1113, DOI 10.1007/s00520-012-1633-2; Rankin K Vendrell, 2009, Tex Dent J, V126, P389; RANSIER A, 1995, CANCER NURS, V18, P393; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Sambunjak D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008829.pub2; Schubert MM, 2008, DENT CLIN N AM; Schubert Mark M, 2008, Dent Clin North Am, V52, P79, DOI 10.1016/j.cden.2007.10.004; Van Strydonck Daniëlle A C, 2012, J Clin Periodontol, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Sonis Stephen T, 2007, J Support Oncol, V5, P3; Strietzel FP, 2011, ARTHRITIS RHEUM-US, V63, P180, DOI 10.1002/art.27766; Zadik Y, 2012, CHEMOTHERAPY INDUCED, P95	82	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2015	23	1					223	236		10.1007/s00520-014-2378-x		14	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AW8FS	WOS:000346497100029		
J	Lipinski, MJ; Baker, NC; Escarcega, RO; Torguson, R; Chen, F; Aldous, SJ; Christ, M; Collinson, PO; Goodacre, SW; Mair, J; Inoue, K; Lotze, U; Sebbane, M; Cristol, JP; Freund, Y; Chenevier-Gobeaux, C; Meune, C; Eggers, KM; Pracon, R; Schreiber, DH; Wu, AHB; Ordonez-Llanos, J; Jaffe, AS; Twerenbold, R; Mueller, C; Waksman, R				Lipinski, Michael J.; Baker, Nevin C.; Escarcega, Ricardo O.; Torguson, Rebecca; Chen, Fang; Aldous, Sally J.; Christ, Michael; Collinson, Paul O.; Goodacre, Steve W.; Mair, Johannes; Inoue, Kenji; Lotze, Ulrich; Sebbane, Mustapha; Cristol, Jean-Paul; Freund, Yonathan; Chenevier-Gobeaux, Camille; Meune, Christophe; Eggers, Kai M.; Pracon, Radoslaw; Schreiber, Donald H.; Wu, Alan H. B.; Ordonez-Llanos, Jordi; Jaffe, Allan S.; Twerenbold, Raphael; Mueller, Christian; Waksman, Ron			Comparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysis	AMERICAN HEART JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; CARDIAC TROPONIN; EMERGENCY-DEPARTMENT; DIAGNOSTIC PERFORMANCE; I ASSAY; IMPLEMENTATION; OUTPERFORMS; STANDARD; RULE	Background Multiple studies have evaluated the diagnostic and prognostic performance of conventional troponin (cTn) and high-sensitivity troponin (hs-cTn). We performed a collaborative meta-analysis comparing cTn and hs-cTn for diagnosis of acute myocardial infarction (AMI) and assessment of prognosis in patients with chest pain. Methods MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE were searched for studies assessing both cTn and hs-cTn in patients with chest pain. Study authors were contacted and many provided previously unpublished data. Results From 17 included studies, there were 8,644 patients. Compared with baseline cTn, baseline hs-cTn had significantly greater sensitivity (0.884 vs 0.749, P < .001) and negative predictive value (NPV; 0.964 vs 0.935, P < .001), whereas specificity (0.816 vs 0.938, P < .001) and positive predictive value (0.558 vs 0.759, P < .001) were significantly reduced. Based on summary receiver operating characteristic curves, test performance for the diagnosis of AMI was not significantly different between baseline cTn and hs-cTn (0.90 [95% CI 0.85-0.95] vs 0.92 [95% CI 0.90-0.94]). In a subanalysis of 6 studies that alternatively defined AMI based on hs-cTn, cTn had lower sensitivity (0.666, P < .001) and NPV (0.906, P < .001). Elevation of baseline hs-cTn, but negative baseline cTn, was associated with increased risk of death or nonfatal myocardial infarction during follow-up (P < .001) compared with both negative. Conclusion High-sensitivity troponin has significantly greater early sensitivity and NPV for the diagnosis of AMI at the cost of specificity and positive predictive value, which may enable early rule in/out of AMI in patients with chest pain. Baseline hs-cTn elevation in the setting of negative cTn is also associated with increased nonfatal myocardial infarction or death during follow-up.	[Lipinski, Michael J.; Baker, Nevin C.; Escarcega, Ricardo O.; Torguson, Rebecca; Chen, Fang; Waksman, Ron] MedStar Washington Hosp Ctr, MedStar Heart Inst, MedStar Cardiovasc Res Network, Washington, DC 20010 USA; [Aldous, Sally J.] Christchurch Hosp, Dept Cardiol, Christchurch, New Zealand; [Christ, Michael] Paracelsus Med Univ, Dept Emergency & Crit Care Med, Nurnberg, Germany; [Collinson, Paul O.] St George Hosp, Clin Blood Sci Lab, London, England; [Goodacre, Steve W.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Mair, Johannes] Med Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria; [Inoue, Kenji] Juntendo Univ, Dept Cardiol, Nerima Hosp, Tokyo 113, Japan; [Lotze, Ulrich] DRK Manniske Krankenhaus Bad Frankenhausen, Dept Internal Med, Frankenhausen, Germany; [Sebbane, Mustapha] Ctr Hosp Reg Univ Lapeyronie, Dept Urgences, Montpellier, France; [Cristol, Jean-Paul] Ctr Hosp Reg Univ Lapeyronie, Dept Biochim, Montpellier, France; [Freund, Yonathan] Univ Paris 06, Hosp Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, Paris, France; [Chenevier-Gobeaux, Camille] Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Clin Chem Lab, Paris, France; [Meune, Christophe] Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Dept Cardiol, Paris, France; [Meune, Christophe] Univ Paris 13, Dept Cardiol, Avicenne Hosp, Bobigny, France; [Eggers, Kai M.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Pracon, Radoslaw] Natl Insititute Cardiol, Dept Coronary & Struct Heart Dis, Warsaw, Poland; [Schreiber, Donald H.] Stanford Univ, Sch Med, Div Emergency Med, Stanford, CA 94305 USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ordonez-Llanos, Jordi] Hosp Santa Creu & Sant Pau, Serv Bioquim Clin, Barcelona, Spain; [Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Biochem & Mol Biol Dept, E-08193 Barcelona, Spain; [Jaffe, Allan S.] Mayo Clin, Coll Med, Div Cardiol, Rochester, MN USA; [Jaffe, Allan S.] Mayo Clin, Coll Med, Dept Pathol & Lab Med, Rochester, MN USA; [Twerenbold, Raphael; Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Twerenbold, Raphael] Univ Herz Zentrum Bad Krozingen, Bad Krozingen, Germany	Waksman, R (reprint author), MedStar Washington Hosp Ctr, 110 Irving St,Suite 4B-1, Washington, DC 20010 USA.	ron.waksman@medstar.net			Roche Diagnostics; St Jude Medical and Medtronic; Brahms Thermofisher; Abbott Diagnostics; Abbott Laboratories; Singulex, Inc; Roche Laboratories; Alere; Beckman Coulter; European Union; Swiss National Science Foundation; Swiss Heart Foundation; Basel University; University Hospital Basel; Cardiovascular Research Foundation Basel; Stanley Thomas Johnson Foundation; Abbott; Brahms; Buhlmann; Critical Diagnostics; Nanosphere; Pronota; Roche; Siemens; 8sense	M.J.L., N.C.B., R.O.E., R. Torguson, F.C., S.J.A., S.W.G., K.I., M.S., J.P.C., Y.F., R. Twerenbold, R.W.: none; M.C.: research support and speaker's honoraria from Roche Diagnostics; P.O.C.: consultant for Philips Health Care Incubator and Siemens Point of Care; J.M.: consultant for Philips Health Care Incubator; U.L.: study fees from St Jude Medical and Medtronic, lecture honoraria from St Jude Medical, Medtronic, Sanofi, Aventis, Boehringer Ingelheim, and Bristol: Myers Squibb; C.C.G.: honoraria from Brahms Thermofisher; C. Meune: grant support from Roche Diagnostics and Brahms Thermofisher, and lecture fees from Roche Diagnostics; K.M.E.: honoraria from Siemens Healthcare Diagnostics and consultant for Abbott Laboratories and Fiomi Diagnostics; R.P.: research grant from Abbott Diagnostics; DHS: research grant from Abbott Laboratories and Singulex, Inc; A.H.B.W.: research grant from Singulex, Inc, Roche Laboratories, Alere, and Beckman Coulter, and travel support from Abbott Laboratories; J.O.L.: research support and consultant honoraria from Abbott Diagnostics, Alere, and Roche Diagnostics; A.S.J.: consultant for Roche Laboratories, Radiometer, Abbott Laboratories, Alere Criticical Diagnostics, Ortho Diagnostics, Beckman Coulter, and Amgen; C. Mueller: research support from the European Union, Swiss National Science Foundation, Swiss Heart Foundation, Basel University, University Hospital Basel, Cardiovascular Research Foundation Basel, Stanley Thomas Johnson Foundation, Abbott, ALERE, Beckman Coulter, Brahms, Buhlmann, Critical Diagnostics, Nanosphere, Pronota, Roche, Siemens, and 8sense, and speaker or consulting honoraria from Abbott, ALERE, BG Medicine, Bio Merieux, Brahms, Massachusetts General Hospital, Novartis, Roche, and Siemens.	Aldous SJ, 2011, ANN CLIN BIOCHEM, V48, P249, DOI 10.1258/acb.2010.010220; Aldous SJ, 2012, CLIN CHEM LAB MED, V50, P727, DOI [10.1515/cclm.2011.830, 10.1515/CCLM.2011.830]; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121403; Meune C, 2011, ARCH CARDIOVASC DIS, V104, P4, DOI 10.1016/j.acvd.2010.11.002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Eggers KM, 2012, CLIN CHIM ACTA, V413, P1135, DOI 10.1016/j.cca.2012.03.011; Aldous SJ, 2011, ANN CLIN BIOCHEM, V48, P241, DOI 10.1258/acb.2010.010219; [Anonymous], 2013, TROP ASS AN CHAR; Sebbane M, 2013, AM J EMERG MED, V31, P1302, DOI 10.1016/j.ajem.2013.04.033; Inoue K, 2011, CIRC J, V75, P2813, DOI 10.1253/circj.CJ-11-0598; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Christ M, 2010, AM J MED, V123, P1134, DOI 10.1016/j.amjmed.2010.07.015; Thygesen K, 2007, EUR HEART J, V28, P2525; Goodacre S, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17010; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Aldous SJ, 2012, CAN MED ASSOC J, V184, pE260, DOI 10.1503/cmaj.110773; Body Richard, 2011, J Am Coll Cardiol, V58, P1332, DOI 10.1016/j.jacc.2011.06.026; Collinson PO, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17150; Freund Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10270; Haaf P, 2013, EUR HEART J, V35, P365; Hammerer-Lercher A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000204; Jaffe AS, 2013, REV ESP CARDIOL, V66, P687, DOI 10.1016/j.rec.2013.04.020; Lotze Ulrich, 2011, Vasc Health Risk Manag, V7, P509, DOI 10.2147/VHRM.S21753; Melki D, 2011, SCAND CARDIOVASC J, V45, P198, DOI 10.3109/14017431.2011.565792; Mills NL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1533; Pracon R, 2012, KARDIOL POL, V70, P131; Santalo M, 2013, AM J MED, V126, P709, DOI 10.1016/j.amjmed.2013.03.003; Schreiber DH, 2012, CLIN BIOCHEM, V45, P1295, DOI 10.1016/j.clinbiochem.2012.06.005; Whiting PF, 2012, ANN INTERN MED, V155; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	36	9	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.	JAN	2015	169	1					6	+		10.1016/j.ahj.2014.10.007		17	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW2NE	WOS:000346124400004		
J	Mori, S; Kita, J; Kato, M; Shimoda, M; Kubota, K				Mori, Shozo; Kita, Junji; Kato, Masato; Shimoda, Mitsugi; Kubota, Keiichi			Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy	AMERICAN JOURNAL OF SURGERY			English	Article						Liver resection; Liver transplantation; Recurrence; Tumor marker; Inflammation	C-REACTIVE PROTEIN; LEVELS PREDICT SURVIVAL; LIVER-TRANSPLANTATION; COLORECTAL-CANCER; CLINICAL-OUTCOMES; ALPHA-FETOPROTEIN; CIRRHOSIS; RESECTION; SURGERY; IMPACT	BACKGROUND: We investigated whether a preoperative scoring system (the "CRP-AFP Score [CAS]'') based on the serum levels of C-reactive protein and alpha-fetoprotein would predict outcome in patients undergoing hepatectomy for hepatocellular carcinoma. METHODS: The CAS was defined as follows: patients with an elevated level of both C-reactive protein (>.3 mg/dL) and alpha-fetoprotein (>20 ng/mL) were assigned a score of 2, and patients showing one or none of these abnormalities were assigned a score of 1 or 0, respectively. RESULTS: A total of 349 patients were identified. Pathologic findings, in terms of tumor size, histologic grade, vascular invasion, intrahepatic metastasis, and recurrence rate, worsened as the CAS increased. CAS 2 patients had a poorer 5-year overall survival than CAS 0 or 1 patients (32.2% vs 59.7% vs 49.2%, respectively; P < .001). CONCLUSIONS: The CAS is an informative scoring system that can predict outcome in patients with hepatocellular carcinoma after hepatectomy. (C) 2015 Elsevier Inc. All rights reserved.	[Mori, Shozo; Kita, Junji; Kato, Masato; Shimoda, Mitsugi; Kubota, Keiichi] Dokkyo Med Univ, Dept Surg Gastroenterol, Shimotsuga, Tochigi 3210293, Japan	Mori, S (reprint author), Dokkyo Med Univ, Dept Surg Gastroenterol, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan.	s-mori@dokkyomed.ac.jp					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Hsu YC, 2013, HEPATOLOGY, V58, P150, DOI 10.1002/hep.26300; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Ansar W, 2013, IMMUNOL RES, V56, P131, DOI 10.1007/s12026-013-8384-0; Shirabe K, 2011, BRIT J SURG, V98, P261, DOI 10.1002/bjs.7311; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Morris-Stiff G, 2008, EJSO-EUR J SURG ONC, V34, P727, DOI 10.1016/j.ejso.2008.01.016; Nitta H, 2013, WORLD J SURG, V37, P1034, DOI 10.1007/s00268-013-1957-1; Yamamoto K, 2009, ANN SURG ONCOL, V16, P2795, DOI 10.1245/s10434-009-0618-y; Riordan SM, 2006, J HEPATOL, V45, P744, DOI 10.1016/j.jhep.2006.08.001; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Nathan H, 2009, ANN SURG, V249, P799, DOI 10.1097/SLA.0b013e3181a38eb5; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Mortensen C, 2012, EUR J GASTROEN HEPAT, V24, P619, DOI 10.1097/MEG.0b013e328351db6e; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; Nakazawa T, 2013, EUR J GASTROEN HEPAT, V25, P683, DOI 10.1097/MEG.0b013e32835d913b; Ishizuka M, 2012, ANN SURG ONCOL, V19, P3422, DOI 10.1245/s10434-012-2384-5; Campillo B, 1999, EUR J GASTROEN HEPAT, V11, P755, DOI 10.1097/00042737-199907000-00013; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Furukawa H, 2010, J HEPATO-BIL-PAN SCI, V17, P533, DOI 10.1007/s00534-009-0168-5; Kostner AH, 2013, SCI WORLD J, DOI 10.1155/2013/931972; Mazzoferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Nagaoka S, 2007, LIVER INT, V27, P1091, DOI 10.1111/j.1478-3231.2007.01550.x; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Volkova E, 2011, BRIT J CANCER, V104, P51, DOI 10.1038/sj.bjc.6606005; Zhong JH, 2012, EJSO-EUR J SURG ONC, V38, P286, DOI 10.1016/j.ejso.2012.01.006	38	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2015	209	1					187	193		10.1016/j.amjsurg.2014.02.015		7	Surgery	Surgery	AW2MB	WOS:000346121100029		
J	Okajima, C; Arii, S; Tanaka, S; Matsumura, S; Ban, D; Ochiai, T; Irie, T; Kudo, A; Nakamura, N; Tanabe, M				Okajima, Chisato; Arii, Shigeki; Tanaka, Shinji; Matsumura, Satoshi; Ban, Daisuke; Ochiai, Takanori; Irie, Takumi; Kudo, Atsushi; Nakamura, Noriaki; Tanabe, Minoru			Prognostic role of Child-Pugh score 5 and 6 in hepatocellular carcinoma patients who underwent curative hepatic resection	AMERICAN JOURNAL OF SURGERY			English	Article						Hepatocellular carcinoma; Child-Pugh score; Prognosis; Milan criteria	CLASS-B; HEPATECTOMY; CIRRHOSIS; TRANSPLANTATION; SURVIVAL; RECURRENCE; RISK	BACKGROUND: It is unclear whether Child-Pugh score discriminates a prognosis of the Child-Pugh A patients who underwent hepatic resection for hepatocellular carcinoma. METHODS: Between April 2000 and March 2011, 361 patients with Child-Pugh A who underwent curative hepatectomy were divided into 2 groups: Child-Pugh score 5 points group (CPS5) and ChildPugh score 6 points group (CPS6); both CPS5 (n = 274) and CPS6 (n = 87) groups were compared. RESULTS: Overall survival rates (1/2/5 years of the CPS5 and CPS6 groups were 90.9%/82.5%/ 62.4% and 80.6%/68.0%/47.6%, respectively) and disease-free survival rates (67.6%/51.8%/30.1% and 36.9%/16.0%/5.9%, respectively) showed that the CPS5 group was significantly better than the CPS6 group. Multivariate analysis revealed that Child-Pugh score at overall survival (P = .0125) and disease-free survival (P = .0103) was a significant prognostic factor. CONCLUSIONS: The overall survival and disease-free survival in Child-Pugh A showed quite a difference between the CPS5 and CPS6 groups. However, CPS5 and CPS6 may be a useful prognostic marker of hepatocellular carcinoma patients with hepatic resection. (C) 2015 Elsevier Inc. All rights reserved.	[Okajima, Chisato; Arii, Shigeki; Tanaka, Shinji; Matsumura, Satoshi; Ban, Daisuke; Ochiai, Takanori; Irie, Takumi; Kudo, Atsushi; Nakamura, Noriaki; Tanabe, Minoru] Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, Tokyo 1138519, Japan	Okajima, C (reprint author), Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	okajima.msrg@tmd.ac.jp; sh-arii@hamamatsuh.ro-fuku.go.jp					Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014; Wang J, 2010, WORLD J SURG, V34, P2434, DOI 10.1007/s00268-010-0664-4; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Kaibori M, 2009, AM J SURG, V198, P39, DOI 10.1016/j.amjsurg.2008.07.051; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Yeh CN, 2002, J SURG ONCOL, V81, P195, DOI 10.1002/jso.10178; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Bilimoria MM, 2001, ARCH SURG-CHICAGO, V136, P528, DOI 10.1001/archsurg.136.5.528; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Koniaris LG, 2011, ANN SURG, V254, P537, DOI [DOI 10.1097/SLA.0B013E31822CA66F, http:// dx. doi. org/ 10.1097/ SLA. 0b013e31822ca66f]; Koniaris LG, 2011, ANN SURG, V254, P527, DOI 10.1097/SLA.0b013e31822ca66f; Kuroda S, 2011, WORLD J SURG, V35, P834, DOI 10.1007/s00268-010-0929-y; Lau H, 1997, BRIT J SURG, V84, P1255; Margarit C, 2005, LIVER TRANSPLANT, V11, P1242, DOI 10.1002/lt.20398; Nagasue N, 1999, ANN SURG, V229, P84, DOI 10.1097/00000658-199901000-00011; Nakahara H, 2005, WORLD J SURG, V29, P734, DOI 10.1007/s00268-005-7750-z; Nakamura Y, 2011, SURGERY, V150, P250, DOI 10.1016/j.surg.2011.06.001; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015; Wayne JD, 2002, ANN SURG, V235, P730	24	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2015	209	1					199	205		10.1016/j.amjsurg.2014.03.009		7	Surgery	Surgery	AW2MB	WOS:000346121100031		
J	Kamruzzaman, M; Makino, Y; Oshita, S				Kamruzzaman, Mohammed; Makino, Yoshio; Oshita, Seiichi			Non-invasive analytical technology for the detection of contamination, adulteration, and authenticity of meat, poultry, and fish: A review	ANALYTICA CHIMICA ACTA			English	Review						Non-destructive method; Hyperspectral imaging; Meat; Poultry; Fish; Adulteration; Contamination; Authenticity	HYPERSPECTRAL IMAGING-SYSTEM; INFRARED REFLECTANCE SPECTROSCOPY; SKIN TUMOR-DETECTION; DISEASED CHICKEN IDENTIFICATION; ESCHERICHIA-COLI CONTAMINATION; AUTOMATIC NEMATODE DETECTION; LEAST-SQUARES REGRESSION; FILLETS GADUS-MORHUA; VIABLE COUNT TVC; MULTISPECTRAL IMAGES	The requirement of real-time monitoring of food products has encouraged the development of non-destructive measurement systems. Hyperspectral imaging is a rapid, reagentless, non-destructive analytical technique that integrates traditional spectroscopic and imaging techniques into one system to attain both spectral and spatial information from an object that cannot be achieved with either digital imaging or conventional spectroscopic techniques. Recently, this technique has emerged as one of the most powerful and inspiring techniques for assessing different meat species and building chemical images to show the distribution maps of constituents in a direct and easy manner. After presenting a brief description of the fundamentals of hyperspectral imaging, this paper reviews the potential applications of hyperspectral imaging for detecting the adulteration, contamination, and authenticity of meat, poultry, and fish. These applications envisage that hyperspectral imaging can be considered as a promising non-invasive analytical technique for predicting the contamination, adulteration, and authenticity of meat, poultry, and fish in a real-time mode. (C) 2014 Elsevier B.V. All rights reserved.	[Kamruzzaman, Mohammed; Makino, Yoshio; Oshita, Seiichi] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138654, Japan; [Kamruzzaman, Mohammed] Bangladesh Agr Univ, Fac Agr Engn & Technol, Dept Food Technol & Rural Ind, Mymensingh 2202, Bangladesh	Kamruzzaman, M (reprint author), Bangladesh Agr Univ, Fac Agr Engn & Technol, Dept Food Technol & Rural Ind, Mymensingh 2202, Bangladesh.	mohammed.kamruzzaman@bau.edu.bd; amakino@mail.ecc.u-tokyo.ac.jp	Makino, Yoshio/A-3678-2015	Makino, Yoshio/0000-0002-8635-8382	Japan Society for the Promotion of Science [P13395]; JSPS [13F03395]	The authors would like to acknowledge the financial support provided by the Japan Society for the Promotion of Science (No. P13395) and a Grant-in-Aid for Scientific Research (JSPS No. 13F03395).	Cheng JH, 2014, INNOV FOOD SCI EMERG, V21, P179, DOI 10.1016/j.ifset.2013.10.013; Kamruzzaman M, 2012, INNOV FOOD SCI EMERG, V16, P316, DOI 10.1016/j.ifset.2012.07.007; Liu YL, 2003, MEAT SCI, V65, P1107, DOI 10.1016/S0309-1740(02)00328-5; Kim I, 2004, T ASAE, V47, P1785; Wu D, 2012, ANAL CHIM ACTA, V726, P57, DOI 10.1016/j.aca.2012.03.038; Wu D, 2013, INNOV FOOD SCI EMERG, V19, P1, DOI 10.1016/j.ifset.2013.04.014; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Sivertsen AH, 2011, J FOOD SCI, V76, pS77, DOI 10.1111/j.1750-3841.2010.01928.x; Sivertsen AH, 2011, J FOOD ENG, V103, P317, DOI 10.1016/j.jfoodeng.2010.10.030; Fuentes A, 2013, INNOV FOOD SCI EMERG, V19, P210, DOI 10.1016/j.ifset.2013.05.001; Nychas GJE, 2008, MEAT SCI, V78, P77, DOI [10.1016/j.meatsci.2007.06.020, 10.1016/j.meatsei.2007.06.020]; Huang L, 2013, FOOD RES INT, V54, P821, DOI 10.1016/j.foodres.2013.08.011; Nicolai BM, 2007, POSTHARVEST BIOL TEC, V46, P99, DOI 10.1016/j.postharvbio.2007.06.024; ElMasry G, 2011, FOOD RES INT, V44, P2624, DOI 10.1016/j.foodres.2011.05.001; Kamruzzaman M, 2012, INNOV FOOD SCI EMERG, V16, P218, DOI 10.1016/j.ifset.2012.06.003; Valous NA, 2010, TRENDS FOOD SCI TECH, V21, P26, DOI 10.1016/j.tifs.2009.09.003; ElMasry G, 2008, J AGR FOOD CHEM, V56, P7672, DOI 10.1021/jf801074s; Wu D, 2013, TALANTA, V111, P39, DOI 10.1016/j.talanta.2013.03.041; Elmasry G, 2012, CRIT REV FOOD SCI, V52, P689, DOI 10.1080/10408398.2010.507908; Kong SG, 2004, APPL OPTICS, V43, P824, DOI 10.1364/AO.43.000824; Ellis DI, 2001, TRENDS FOOD SCI TECH, V12, P414, DOI 10.1016/S0924-2244(02)00019-5; Park B, 2006, J FOOD ENG, V75, P340, DOI 10.1016/j.jfoodeng.2005.03.060; Wu D, 2013, INNOV FOOD SCI EMERG, V19, P15, DOI 10.1016/j.ifset.2013.04.016; Wu D, 2013, J FOOD ENG, V119, P680, DOI 10.1016/j.jfoodeng.2013.06.039; Alomar D, 2003, MEAT SCI, V63, P441, DOI 10.1016/S0309-1740(02)00101-8; Feng YZ, 2013, TALANTA, V109, P74, DOI 10.1016/j.talanta.2013.01.057; Elmasry G, 2012, CRIT REV FOOD SCI, V52, P999, DOI 10.1080/10408398.2010.543495; Qiao J, 2007, J FOOD ENG, V83, P10, DOI 10.1016/j.jfoodeng.2007.02.038; Sivertsen AH, 2012, J FOOD ENG, V111, P675, DOI 10.1016/j.jfoodeng.2012.02.036; Feng YZ, 2012, CRIT REV FOOD SCI, V52, P1039, DOI 10.1080/10408398.2011.651542; Kamruzzaman M, 2012, ANAL CHIM ACTA, V714, P57, DOI 10.1016/j.aca.2011.11.037; Grau R, 2011, FOOD RES INT, V44, P331, DOI 10.1016/j.foodres.2010.10.011; Liu D, 2014, FOOD BIOPROCESS TECH, V7, P307, DOI 10.1007/s11947-013-1193-6; Segtnan VH, 2009, J NEAR INFRARED SPEC, V17, P247, DOI 10.1255/jnirs.851; Barbin DF, 2013, INNOV FOOD SCI EMERG, V18, P226, DOI 10.1016/j.ifset.2012.12.011; Park B, 2007, BIOSYST ENG, V96, P323, DOI 10.1016/j.biosystemseng.2006.11.012; Feng YZ, 2013, TALANTA, V105, P244, DOI 10.1016/j.talanta.2012.11.042; Ellis DI, 2004, ANAL CHIM ACTA, V514, P193, DOI 10.1016/j.aca.2004.03.060; Kamruzzaman M, 2011, J FOOD ENG, V104, P332, DOI 10.1016/j.jfoodeng.2010.12.024; Reich G, 2005, ADV DRUG DELIVER REV, V57, P1109, DOI 10.1016/j.addr.2005.01.020; Kamruzzaman M, 2013, TALANTA, V103, P130, DOI 10.1016/j.talanta.2012.10.020; Yoon SC, 2011, COMPUT ELECTRON AGR, V79, P159, DOI 10.1016/j.compag.2011.09.008; Feng YZ, 2013, FOOD CHEM, V138, P1829, DOI 10.1016/j.foodchem.2012.11.040; Nakariyakul S, 2009, J FOOD ENG, V94, P358, DOI 10.1016/j.jfoodeng.2009.04.001; Wu JH, 2012, J FOOD ENG, V109, P267, DOI 10.1016/j.jfoodeng.2011.10.004; Tao FF, 2012, MEAT SCI, V90, P851, DOI 10.1016/j.meatsci.2011.11.028; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Barbin DF, 2012, ANAL CHIM ACTA, V719, P30, DOI 10.1016/j.aca.2012.01.004; Peng YK, 2011, J FOOD ENG, V102, P163, DOI 10.1016/j.jfoodeng.2010.08.014; ElMasry G, 2011, J FOOD ENG, V103, P333, DOI 10.1016/j.jfoodeng.2010.10.031; Barbin D, 2012, MEAT SCI, V90, P259, DOI 10.1016/j.meatsci.2011.07.011; Ivorra E, 2013, J FOOD ENG, V117, P342, DOI 10.1016/j.jfoodeng.2013.02.022; Chao KL, 2010, TRENDS FOOD SCI TECH, V21, P129, DOI 10.1016/j.tifs.2009.08.001; Park B, 2004, J FOOD PROCESS ENG, V27, P311, DOI 10.1111/j.1745-4530.2004.00464.x; Brewer MS, 2012, MEAT SCI, V91, P385, DOI 10.1016/j.meatsci.2012.02.024; Kobayashi K, 2010, J NEAR INFRARED SPEC, V18, P301, DOI 10.1255/jnirs.896; Wang W, 2011, SENSOR LETT, V9, P1024, DOI 10.1166/sl.2011.1359; Zhu FL, 2013, FOOD BIOPROCESS TECH, V6, P2931, DOI 10.1007/s11947-012-0825-6; Sone I, 2012, J FOOD ENG, V109, P482, DOI 10.1016/j.jfoodeng.2011.11.001; ElMasry G, 2012, J FOOD ENG, V110, P127, DOI 10.1016/j.jfoodeng.2011.11.028; Qiao J, 2007, MEAT SCI, V76, P1, DOI 10.1016/j.meatsci.2006.06.031; Kamruzzaman M, 2013, FOOD CHEM, V141, P389, DOI 10.1016/j.foodchem.2013.02.094; Segtnan VH, 2009, J AGR FOOD CHEM, V57, P1705, DOI 10.1021/jf802080s; Siripatrawan U, 2011, TALANTA, V85, P276, DOI 10.1016/j.talanta.2011.03.061; Ariana Diwan P., 2008, Sensing and Instrumentation for Food Quality and Safety, V2, DOI 10.1007/s11694-008-9058-9; Barbin D. F., 2012, FOOD CHEM, V138, P1162; Barbin D. F., 2012, INNOV FOOD SCI EMERG, V17, P180; Bublitz C. G., 1992, Journal of Aquatic Food Product Technology, V1, P75, DOI 10.1300/J030v01n02_08; Chao K, 2007, SENSING INSTRUMENTAT, V1, P62, DOI 10.1007/s11694-007-9008-y; Chao K, 2007, POULTRY SCI, V86, P2450, DOI 10.3382/ps.2006-00467; Chao K, 2008, APPL ENG AGRIC, V24, P475; ElMasry G., 2012, J FOOD ENG, V117, P235; Heia K, 2007, J FOOD SCI, V72, pE11, DOI 10.1111/j.1750-3841.2006.00212.x; Heitschmidt GW, 2007, T ASABE, V50, P1427; Kim I, 2006, LECT NOTES COMPUT SC, V3973, P770; Lawrence KC, 2003, J NEAR INFRARED SPEC, V11, P269; Liu Z, 2007, J CHEMOMETR, V21, P88, DOI 10.1002/cem.1038; Naganathan GK, 2008, COMPUT ELECTRON AGR, V64, P225, DOI 10.1016/j.compag.2008.05.020; Naganathan Govindarajan Konda, 2008, Sensing and Instrumentation for Food Quality and Safety, V2, DOI 10.1007/s11694-008-9051-3; Nakariyakul S., 2008, OPTICAL ENG, V47; Nakariyakul S, 2004, P SOC PHOTO-OPT INS, V5271, P128, DOI 10.1117/12.517443; Nakariyakul S, 2007, APPL OPTICS, V46, P357, DOI 10.1364/AO.46.000357; Park B, 2007, T ASABE, V50, P2275; Park B., 2007, SENSING INSTRUMENTAT, V1, P45, DOI 10.1007/s11694-007-9006-0; Park B, 2002, T ASAE, V45, P2017; Park B. S., 2011, Sensing and Instrumentation for Food Quality and Safety, V5, P25, DOI 10.1007/s11694-011-9107-7; Qiao J., 2007, INT J FOOD ENG, V3, P6; Khojastehnazhand M, 2014, FOOD RES INT, V56, P25, DOI 10.1016/j.foodres.2013.12.018; Taghizadeh Masoud, 2009, Sensing and Instrumentation for Food Quality and Safety, V3, DOI 10.1007/s11694-009-9088-y; Verbeke W, 2011, MEAT SCI, V88, P619, DOI 10.1016/j.meatsci.2011.02.016; Weeranantanaphan J, 2011, J NEAR INFRARED SPEC, V19, P61, DOI 10.1255/jnirs.924; Windham W. R., 2005, International Journal of Poultry Science, V4, P657; Windham W. R., 2005, International Journal of Poultry Science, V4, P959; Windham WR, 2003, T ASAE, V46, P1733; Wold JP, 2001, APPL SPECTROSC, V55, P1025, DOI 10.1366/0003702011952929; Yang CC, 2005, COMPUT ELECTRON AGR, V49, P255, DOI 10.1016/j.compag.2005.05.002; Yang CC, 2010, POULTRY SCI, V89, P1252, DOI 10.3382/ps.2008-00561; Yang CC, 2006, T ASABE, V49, P245; Yoon SC, 2007, T ASABE, V50, P1433	100	6	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						19	29		10.1016/j.aca.2014.08.043		11	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000002		
J	Banu, K; Shimura, T; Sadeghi, S				Banu, Khaleda; Shimura, Takayoshi; Sadeghi, Saman			Selective detection and recovery of gold at tannin-immobilized non-conducting electrode	ANALYTICA CHIMICA ACTA			English	Article						Non-conducting electrode; Selective detection; Selective recovery; Permselective diffusion; Gold; Tannin	TRANSITION-METAL COMPLEXES; ANTIOXIDANT ACTIVITY; ELECTROCHEMICAL OXIDATION; HYDROGEN-PEROXIDE; BAYBERRY TANNIN; BIOSORPTION; ADSORPTION; FLAVONOIDS; REDUCTION; MEMBRANE	A tannin-immobilized glassy carbon electrode (TIGC) was prepared via electrochemical oxidation of the naturally occurring polyphenolic mimosa tannin, which generated a non-conducting polymeric film (NCPF) on the electrode surface. The fouling of the electrode surface by the electropolymerized film was evaluated by monitoring the electrode response of ferricyanide ions as a redox marker. The NCPF was permselective to HAuCl4, and the electrochemical reduction of HAuCl4 to metallic gold at the TIGC electrode was evaluated by recording the reduction current during cyclic voltammetry measurement. In the mixed electrolyte containing HAuCl4 along with FeCl3 and/or CuCl2, the NCPF remained selective toward the electrochemical reduction of HAuCl4 into the metallic state. The chemical reduction of HAuCl4 into metallic gold was also observed when the NCPF was inserted into an acidic gold solution overnight. The adsorption capacity of Au(III) on tannin-immobilized carbon fiber was 29 +/- 1.45 mg g(-1) at 60 degrees C. In the presence of excess Cu(II) and Fe(III), tannin-immobilized NCPF proved to be an excellent candidate for the selective detection and recovery of gold through both electrochemical and chemical processes. (C) 2014 Elsevier B.V. All rights reserved.	[Banu, Khaleda; Sadeghi, Saman] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Banu, Khaleda; Shimura, Takayoshi] Osaka Univ, Ctr Adv Sci & Innovat, Venture Business Lab, Suita, Osaka 5650871, Japan; [Shimura, Takayoshi] Osaka Univ, Grad Sch Engn, Div Adv Sci & Biotechnol, Dept Mat & Life Sci, Suita, Osaka 565, Japan	Banu, K (reprint author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	kbanu@ucla.edu; samsadeghi@mednet.ucla.edu			VBL, Osaka University	The authors thank Yasuo Kanematsu, Hiroshi Uyama, Susumu Kuwabata, and Samuele Giovando for their interest, suggestions and support for this research. The authors acknowledge the ICP Facility in the Department of Environmental Health Sciences, UCLA and Research Center for Ultra-Precision Science and Technology of Osaka University for the ICP-MS and XPS measurements, respectively. K. Banu acknowledges financial support from VBL, Osaka University.	Sengil IA, 2009, J HAZARD MATER, V166, P1488, DOI 10.1016/j.jhazmat.2008.12.071; Faridbod F, 2008, SENSORS-BASEL, V8, P2331, DOI 10.3390/s8042331; Liao XP, 2004, IND ENG CHEM RES, V43, P2222, DOI 10.1021/ie0340894; Sangeetha NS, 2014, ANAL CHIM ACTA, V828, P34, DOI 10.1016/j.aca.2014.04.041; Firuzi O, 2005, BBA-GEN SUBJECTS, V1721, P174, DOI 10.1016/j.bbagen.2004.11.001; Amarowicz R, 2007, EUR J LIPID SCI TECH, V109, P549, DOI 10.1002/ejlt.200700145; FAGAN DT, 1985, ANAL CHEM, V57, P2759, DOI 10.1021/ac00291a006; Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8; Ferraz PAL, 2001, J ELECTROANAL CHEM, V507, P275, DOI 10.1016/S0022-0728(01)00439-9; Chaudhuri P, 2001, J AM CHEM SOC, V123, P2213, DOI 10.1021/ja003831d; Mack C, 2007, BIOTECHNOL ADV, V25, P264, DOI 10.1016/j.biotechadv.2007.01.003; Kuramitz H, 2001, CHEMOSPHERE, V45, P37, DOI 10.1016/S0045-6535(01)00032-7; Banu K, 2012, NEW J CHEM, V36, P2112, DOI 10.1039/c2nj40478h; Cui JR, 2008, J HAZARD MATER, V158, P228, DOI 10.1016/j.jhazmat.2008.02.001; Robinson BH, 2009, SCI TOTAL ENVIRON, V408, P183, DOI 10.1016/j.scitotenv.2009.09.044; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Paleologos EK, 2002, ANAL CHIM ACTA, V458, P241, DOI 10.1016/S0003-2670(01)01579-3; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Ma HW, 2006, J MEMBRANE SCI, V278, P373, DOI 10.1016/j.memsci.2005.11.022; Hotta H, 2002, ANAL BIOCHEM, V303, P66, DOI 10.1006/abio.2002.5577; Banu K, 2011, NEW J CHEM, V35, P1503, DOI 10.1039/c1nj20107g; Janeiro P, 2004, ANAL CHIM ACTA, V518, P109, DOI 10.1016/j.aca.2004.05.038; Feng SL, 2002, ANAL CHIM ACTA, V455, P187, DOI 10.1016/S0003-2670(01)01602-6; Banu K, 2011, NEW J CHEM, V35, P1031, DOI 10.1039/c0nj00916d; Barlett P., 1993, J ELECTROANAL CHEM, V362, P1, DOI 10.1016/0022-0728(93)80001-X; Cotelle Nicole, 2001, Current Topics in Medicinal Chemistry, V1, P569, DOI 10.2174/1568026013394750; Guerrieri R., 2009, BIOSENS BIOELECTRON, V24, P1550; Kaurinovic B., 2012, LIPID PEROXIDATION, P155; Kursun S., 2011, J APPL POLYM SCI, V1, P406; Panchompoo J., 2012, NEW J CHEM, V5, P1265; PIERPONT CG, 1981, COORDIN CHEM REV, V38, P45, DOI 10.1016/S0010-8545(00)80499-3; Pleskov V.Y., 2002, RUSS J ELECTROCHEM+, V38, P1275; Wang R, 2005, IND ENG CHEM RES, V44, P4221, DOI 10.1021/ie049069w; Yuqing Miao, 2004, Trends Biotechnol, V22, P227, DOI 10.1016/S0167-7799(04)00078-2; Zhou DL, 2013, ELECTROCHIM ACTA, V108, P390, DOI 10.1016/j.electacta.2013.06.129	36	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						207	213		10.1016/j.aca.2014.09.030		7	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000015		
J	Okabayashi, S; Sakata, S; Hirata, T				Okabayashi, Satoki; Sakata, Shuhei; Hirata, Takafumi			Isotopic analysis of tungsten using multiple collector-inductively coupled plasma-mass spectrometer coupled with electrothermal vaporization technique	ANALYTICA CHIMICA ACTA			English	Article						Electrothermal vaporization; Multiple collector-inductively coupled mass spectrometry; tungsten isotope; radigenic isotope ratio; fractionation law	HF-W CHRONOMETRY; CORE FORMATION; ICP-MS; RAPID ACCRETION; SPRAY CHAMBER; SOLAR-SYSTEM; SAMPLES; TERRESTRIAL; METEORITES; PRECISION	We have developed a micro-electrothermal vaporization (mETV) device for the multiple collector-ICP-mass spectrometry (mETV-MC-ICPMS) to improve analytical precision in the W-182/W-183 and W-184/W-183 ratio measurements from nanogram quantities of W. The W solution was loaded onto the Re-filament, and the gradual evaporation of W was achieved by controlling the incident current onto the Re filament. With the W evaporation under the Ar atmosphere, the measured W isotope ratios became erroneous mainly due to the contribution of signal spikes. In strike contrast, signal intensity profile became smooth when the He ambient/carrier gas was employed, and this resulted in better precision in the isotope ratio measurements. The measured W isotope ratio data obtained with present mETV technique were significantly deviated from the ratio data obtained with solution nebulization technique, mainly due to the contribution of the isotope fractionation effect through the evaporation process. Rigorous testing for the correction of the isotope fractionation processes revealed that the Rayleigh fractionation law, rather than the conventional exponential law, provided the most reliable ratio data (1.851720 +/- 0.000018 for W-182/W-183 and 2.141248 +/- 0.000028 for W-184/W-183 ratios), which agreed well with the ratio data obtained through the conventional solution nebulization technique (1.851718 +/- 0.000039 for W-182/W-183 and 2.141248 +/- 0.000022 for W-184/W-183). Moreover, mass dependency for the mass fractionation law suggested that W was evaporated as oxides (WO3), rather than the metallic form (W), from the Re filament, and therefore, information concerning the chemical form of the analytes could also be derived by the ETV technique developed in this study. The data presented here demonstrate clearly that the ETV sample introduction technique has a potential to become a sensitive tool for the precise isotope analysis for the MC-ICPMS technique. (C) 2014 Elsevier B.V. All rights reserved.	[Okabayashi, Satoki; Sakata, Shuhei; Hirata, Takafumi] Kyoto Univ, Lab Planetary Sci Kyoto, Sakyo Ku, Kyoto, Japan	Okabayashi, S (reprint author), Akita Univ, Dept Engn & Resource Sci, Tegata Gakuen Machi 1-1, Akita 010, Japan.	okabayashi-s@gipc.akita-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [12J00631, A26247094]	The authors are grateful to Dr. Yusuke Fukami and Mr. Yuichiro Nagai (Tokyo Institute of Technology) for technical suggestion. Dr. Seiji Maruyama (Kyoto Fission-track Co. Ltd.) is acknowledged for his valuable advice. This study was partly supported by a Grant-in-Aid for JSPS Fellow (12J00631) and was supported by a Grant-in-Aid for Scientific Research (A26247094) for Takafumi Hirata from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Irisawa K, 2009, GEOCHEM J, V43, P395; Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1369, DOI 10.1039/a901649j; HART SR, 1989, INT J MASS SPECTROM, V89, P287, DOI 10.1016/0168-1176(89)83065-4; Kleine T, 2008, EARTH PLANET SC LETT, V270, P106, DOI 10.1016/j.epsl.2008.03.013; Vockenhuber C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.172501; Lee DC, 2005, EARTH PLANET SC LETT, V237, P21, DOI 10.1016/j.epsl.2005.06.033; Okabayashi S, 2011, J ANAL ATOM SPECTROM, V26, P1393, DOI 10.1039/c0ja00200c; Douglas DN, 2011, J ANAL ATOM SPECTROM, V26, P1294, DOI 10.1039/c0ja00144a; WALDER AJ, 1993, J ANAL ATOM SPECTROM, V8, P19, DOI 10.1039/ja9930800019; Irisawa K, 2006, J ANAL ATOM SPECTROM, V21, P1387, DOI 10.1039/b607945h; Hirata T, 2003, J ANAL ATOM SPECTROM, V18, P1283, DOI 10.1039/b305127g; Qin LP, 2008, EARTH PLANET SC LETT, V273, P94, DOI 10.1016/j.epsl.2008.06.018; Aramendia M, 2009, ANAL CHIM ACTA, V648, P23, DOI 10.1016/j.aca.2009.06.027; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Yang L, 2009, MASS SPECTROM REV, V28, P990, DOI 10.1002/mas.20251; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; Ohno T, 2004, BUNSEKI KAGAKU, V53, P631, DOI 10.2116/bunsekikagaku.53.631; Markowski A, 2006, EARTH PLANET SC LETT, V242, P1, DOI 10.1016/j.epsl.2005.11.048; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; VOLKENING J, 1991, INT J MASS SPECTROM, V107, P361, DOI 10.1016/0168-1176(91)80070-4; Badiei HR, 2012, SPECTROCHIM ACTA B, V77, P19, DOI 10.1016/j.sab.2012.07.025; Beard BL, 1999, GEOCHIM COSMOCHIM AC, V63, P1653, DOI 10.1016/S0016-7037(99)00089-7; Cairns WRL, 2004, J ANAL ATOM SPECTROM, V19, P286, DOI 10.1039/b314255h; Fukami Y., 2010, THESIS TOKYO I TECHN; HIRATA T, 1989, ANAL CHEM, V61, P2263, DOI 10.1021/ac00195a011; Hirata T., 2012, ISOTOPIC ANAL, P93; Hirata T, 2002, J ANAL ATOM SPECTROM, V17, P204, DOI 10.1039/b107737f; Hirata T, 1996, ANALYST, V121, P1407, DOI 10.1039/an9962101407; Ho C Y, 1974, J PHYS CHEM REF DATA, V3; Hu B, 2007, APPL SPECTROSC REV, V42, P203, DOI 10.1080/05704920601184317; NIXON DE, 1974, ANAL CHEM, V46, P210, DOI 10.1021/ac60338a018; Palme H., 1982, P 12 LUN PLAN SCI C, P949; Peschel BU, 2006, SPECTROCHIM ACTA B, V61, P42, DOI 10.1016/j.sab.2005.11.007; Pisonero J, 2008, MASS SPECTROM REV, V27, P609, DOI 10.1002/mas.20180; Sanchez R, 2014, J ANAL ATOM SPECTROM, V29, P242, DOI 10.1039/c3ja50146a; SHARP BL, 1988, J ANAL ATOM SPECTROM, V3, P939, DOI 10.1039/ja9880300939; Thomas R. J., 2013, PRACTICAL GUIDE ICP; Todoli JL, 2003, J ANAL ATOM SPECTROM, V18, P1185, DOI 10.1039/b212698b; Touboul M., 2011, INT J MASS SPECTROM, V309, P109; Yanping H., 1994, J ANAL ATOM SPECTROM, V9, P701, DOI 10.1039/ja9940900701	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						469	476		10.1016/j.aca.2014.11.002		8	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000047		
J	Ezoe, R; Imasaka, T; Imasaka, T				Ezoe, Ryota; Imasaka, Tomoko; Imasaka, Totaro			Determination of triacetone triperoxide using ultraviolet femtosecond multiphoton ionization time-of-flight mass spectrometry	ANALYTICA CHIMICA ACTA			English	Article						Multiphoton ionization; Mass spectrometry; Molecular ion; Triacetone triperoxide; Explosive	GAS CHROMATOGRAPHY/MASS SPECTROMETRY; ION MOBILITY SPECTROMETRY; ALDOL CONDENSATION; BASIS-SETS; ELECTRON; ACETONE; LASER; ENERGIES; PULSE	Triacetone triperoxide (TATP), an explosive compound, was measured using gas chromatography combined with multiphoton ionization time-of-flight mass spectrometry (GC/MPI-TOFMS). By decreasing the pulse width of a femtosecond laser from 80 to 35 fs, a molecular ion was drastically enhanced and was measured as one of the major ions in the mass spectrum. The detection limits obtained using the molecular (M center dot+) and fragment (C2H3O+) ions were similar or slightly superior to those obtained using conventional mass spectrometry based on electron and chemical ionization. In order to improve the reliability, an isotope of TATP, i.e., TATP-d18, was synthesized and used as an internal standard in the trace analysis of TATP in a sample of human blood. TATP could be identified in a two-dimensional display, even though numerous interfering compounds were present in the sample. Acetone, which is frequently used as a solvent in sampling TATP, produced a chemical species with a retention time nearly identical to that of TATP and provided a C2H3O+ fragment ion that was employed for measuring a chromatogram of TATP in conventional MS. This compound, the structure of which was assigned as phorone, was clearly differentiated from TATP based on a molecular ion observable in MPI-TOFMS. (C) 2014 Elsevier B.V. All rights reserved.	[Ezoe, Ryota; Imasaka, Totaro] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Imasaka, Tomoko] Kyushu Univ, Grad Sch Design, Chem Lab, Minami Ku, Fukuoka 8158540, Japan; [Imasaka, Totaro] Kyushu Univ, Div Optoelect & Photon, Ctr Future Chem, Nishi Ku, Fukuoka 8190395, Japan	Imasaka, T (reprint author), Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	imasaka@cstf.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [23245017, 24510227, 26220806]	The authors wish to thank Jun Nagano, a physician at the Institute of Health Science, Kyushu University for collecting a human blood sample. We also thank Noboru Itouyama for helpful discussions regarding the chemical reactions involved in the formation of phorone in human blood. This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant numbers 23245017, 24510227, 26220806). The quantum chemical calculations were mainly carried out using the computer facilities at the Research Institute for Information Technology, Kyushu University.	Romolo FS, 2013, FORENSIC SCI INT, V224, P96, DOI 10.1016/j.forsciint.2012.11.005; Imasaka T, 2013, ANAL BIOANAL CHEM, V405, P6907, DOI 10.1007/s00216-013-6960-8; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Burks RM, 2009, ANAL BIOANAL CHEM, V395, P301, DOI 10.1007/s00216-009-2968-5; Rasanen RM, 2008, ANAL CHIM ACTA, V623, P59, DOI 10.1016/j.aca.2008.05.076; POPLE JA, 1978, INT J QUANTUM CHEM, V14, P545, DOI 10.1002/qua.560140503; Buttigieg GA, 2003, FORENSIC SCI INT, V135, P53, DOI 10.1016/S0379-0728(03)00175-0; Di Cosimo JI, 1998, J MOL CATAL A-CHEM, V130, P177, DOI 10.1016/S1381-1169(97)00204-5; Matsui T, 2012, ANAL SCI, V28, P445; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; POPLE JA, 1987, J CHEM PHYS, V87, P5968, DOI 10.1063/1.453520; Conant JB, 1921, ORG SYNTH, V1, P45; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kumihashi M., 2008, J FORENSIC SCI T S12, P122; Ladbeck R.S., 2006, ANAL CHEM, V78, P8150; LIPPERT S, 1991, J MOL CATAL, V69, P199, DOI 10.1016/0304-5102(91)80145-S; Matsumoto J, 2003, ANAL SCI, V19, P379, DOI 10.2116/analsci.19.379; Matyas R, 2007, SCI TECHNOL ENERG MA, V68, P111; REICHLE WT, 1980, J CATAL, V63, P295, DOI 10.1016/0021-9517(80)90082-2; Rodriguez I.C., 2006, CHEM COMMUN, V953, P2968; SALVAPATI GS, 1989, J MOL CATAL, V54, P9, DOI 10.1016/0304-5102(89)80134-8; Schramm E, 2008, APPL SPECTROSC, V62, P238, DOI 10.1366/000370208783575483; Shimizu T, 2010, ANAL CHEM, V82, P3441, DOI 10.1021/ac1003773; Sigman ME, 2006, RAPID COMMUN MASS SP, V20, P2851, DOI 10.1002/rcm.2678; Yamaguchi S, 2009, RAPID COMMUN MASS SP, V23, P3101, DOI 10.1002/rcm.4225	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						508	513		10.1016/j.aca.2014.10.045		6	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000052		
J	Medina-Plaza, C; Garcia-Cabezon, C; Garcia-Hernandez, C; Bramorski, C; Blanco-Val, Y; Martin-Pedrosa, F; Kawai, T; de Saja, JA; Rodriguez-Mendez, ML				Medina-Plaza, C.; Garcia-Cabezon, C.; Garcia-Hernandez, C.; Bramorski, C.; Blanco-Val, Y.; Martin-Pedrosa, F.; Kawai, T.; de Saja, J. A.; Rodriguez-Mendez, M. L.			Analysis of organic acids and phenols of interest in the wine industry using Langmuir-Blodgett films based on functionalized nanoparticles	ANALYTICA CHIMICA ACTA			English	Article						Langmuir-Blodgett; Gold nanoparticle; Phenolic compounds; Organic acids	CYCLIC VOLTAMMETRY; GOLD NANOPARTICLES; ANTIOXIDANT CAPACITY; MODIFIED ELECTRODE; GRAPE JUICES; SENSOR	A chemically modified electrode consisting of Langmuir-Blodgett (LB) films of n-dodecanethiol functionalized gold nanoparticles (SDODAuNP-LB), was investigated as a voltammetric sensor of organic and phenolic acids of interest in the wine industry. The nanostructured films demonstrated interfacial properties being able to detect the main organic acids present in grapes and wines (tartaric, malic, lactic and citric). Compared to a bare ITO electrode, the modified electrodes exhibited a shift of the reduction potential in the less positive direction and a marked enhancement in the current response. Moreover, the increased electrocatalytic properties made it possible to distinguish between the different dissociable protons of polyprotic acids. The SDODAuNP-LB sensor was also able to provide enhanced responses toward aqueous solutions of phenolic acids commonly found in wines (caffeic and gallic acids). The presence of nanoparticles increased drastically the sensitivity toward organic acids and phenolic compounds. Limits of detection as low as 10(-6) mol L-1 were achieved. Efficient catalytic activity was also observed in mixtures of phenolic acid/tartaric in the range of pHs typically found in wines. In such mixtures, the electrode was able to provide simultaneous information about the acid and the phenol concentrations with a complete absence of interferences. The excellent sensing properties shown by these sensors could be attributed to the electrocatalytic properties of the nanoparticles combined with the high surface to volume ratio and homogeneity provided by the LB technique used for the immobilization. Moreover, the LB technique also provided an accurate method to immobilize the gold nanoparticles giving rise to stable and reproducible sensors showing repeatability lower than 2% and reproducibility lower than 4% for all the compounds analyzed. (C) 2014 Elsevier B.V. All rights reserved.	[Medina-Plaza, C.; Garcia-Hernandez, C.; Bramorski, C.; Rodriguez-Mendez, M. L.] Univ Valladolid, Engineers Sch, Dept Inorgan Chem, Valladolid 4701, Spain; [Garcia-Cabezon, C.; Blanco-Val, Y.; Martin-Pedrosa, F.] Univ Valladolid, Engineers Sch, Dept Mat Sci, Valladolid 4701, Spain; [Kawai, T.] Tokyo Univ Sci, Dept Ind Chem, Tokyo 162, Japan; [de Saja, J. A.] Univ Valladolid, Dept Condensed Matter Phys, Valladolid 4701, Spain	Rodriguez-Mendez, ML (reprint author), Univ Valladolid, Engineers Sch, Dept Inorgan Chem, Paseo del Cauce 59, Valladolid 4701, Spain.	mluz@eii.uva.es	Martin, Fernando/L-5609-2014; MEDINA PLAZA, CRISTINA/H-6869-2015; Garcia-Hernandez, Celia/H-6877-2015; Rodriguez-Mendez, Maria Luz/A-8059-2015; Garcia, Cristina/H-8821-2015; BLANCO, YOLANDA/H-8916-2015; De Saja, Jose Antonio/I-1750-2015	Martin, Fernando/0000-0002-3110-3358; Rodriguez-Mendez, Maria Luz/0000-0002-9760-362X; Garcia, Cristina/0000-0003-0524-5931; BLANCO, YOLANDA/0000-0001-8555-2709; De Saja, Jose Antonio/0000-0001-7252-2949	CICYT [AGL2012-33535]; Junta de Castilla y Leon [VA-032U13]; PIF-UVa	Financial support of the CICYT (Grant AGL2012-33535), Junta de Castilla y Leon (VA-032U13) and PIF-UVa is gratefully acknowledged.	Capone S, 2014, LANGMUIR, V30, P1190, DOI 10.1021/la404542u; Abou Samra M, 2011, FOOD CHEM, V125, P622, DOI 10.1016/j.foodchem.2010.08.076; Huang XJ, 2007, SENSOR ACTUAT B-CHEM, V122, P659, DOI 10.1016/j.snb.2006.06.022; Ferreira M, 2006, ELECTROCHIM ACTA, V52, P434, DOI 10.1016/j.electacta.2006.05.025; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Fan MK, 2011, ANAL CHIM ACTA, V693, P7, DOI 10.1016/j.aca.2011.03.002; Matemadombo F, 2012, SENSOR ACTUAT B-CHEM, V166, P457, DOI 10.1016/j.snb.2012.02.088; Arteaga JF, 2012, MOLECULES, V17, P5126, DOI 10.3390/molecules17055126; Apetrei C, 2011, SENSORS-BASEL, V11, P1328, DOI 10.3390/s110201328; Kilmartin PA, 2001, J AGR FOOD CHEM, V49, P1957, DOI 10.1021/jf001044u; Campbell FW, 2010, ANAL BIOANAL CHEM, V396, P241, DOI 10.1007/s00216-009-3063-7; Bianchini C, 2014, FOOD CHEM, V156, P81, DOI 10.1016/j.foodchem.2014.01.074; Mudnic I, 2010, FOOD CHEM, V119, P1205, DOI 10.1016/j.foodchem.2009.08.038; Ali K, 2010, PHYTOCHEM REV, V9, P357, DOI 10.1007/s11101-009-9158-0; Kilmartin PA, 2002, AM J ENOL VITICULT, V53, P294; Soyer Y, 2003, J FOOD COMPOS ANAL, V16, P629, DOI 10.1016/S0889-1575(03)00065-6; Yakovleva KE, 2007, APPL BIOCHEM MICRO+, V43, P661, DOI 10.1134/S0003683807060166; Apetrei IM, 2012, FOOD RES INT, V45, P244, DOI 10.1016/j.foodres.2011.10.034; Fu YY, 2014, ELECTROCHIM ACTA, V120, P314, DOI 10.1016/j.electacta.2013.12.082; Bortolomeazzi R, 2007, FOOD CHEM, V100, P1481, DOI 10.1015/j.foodchem.2005.11.039; Wang L, 2011, BIOSENS BIOELECTRON, V30, P151, DOI 10.1016/j.bios.2011.09.003; Alonso-Lomillo MA, 2009, ANAL CHIM ACTA, V633, P51, DOI 10.1016/j.aca.2008.11.033; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; White RJ, 2009, CHEM SOC REV, V38, P481, DOI 10.1039/b802654h; Baghbamidi SE, 2013, CHINESE J CATAL, V34, P1869, DOI 10.1016/S1872-2067(12)60655-X; BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655; Cabanis J. C., 1998, OENOLOGIE TECHNIQUE; Escobar JD, 2013, FOOD CHEM, V138, P814, DOI 10.1016/j.foodchem.2012.11.078; Gay-Martin M., 2012, ELECTROCHIM ACTA, V68, P88; Giuliani E., 2011, BIOSENS BIOELECTRON, V26, P4715; Lee Jungmin, 2014, Food Sci Nutr, V2, P1, DOI 10.1002/fsn3.74; Lima MD, 2014, FOOD CHEM, V161, P94, DOI 10.1016/j.foodchem.2014.03.109; Nomenclature, 1978, NOM SYMB UN THEIR US; Organisation Internationale de la Vigne et du Vin Recueil des methods internationals d'analyse des vins et des mouts, 2011, 8 ASS GEN 21 JUN 201; Pingarron JM, 2008, ELECTROCHIM ACTA, V53, P5848, DOI 10.1016/j.electacta.2008.03.005; Prehn R, 2012, CURR ANAL CHEM, V8, P472; Sanders TA, 2014, MATER LETT, V120, P159, DOI 10.1016/j.matlet.2014.01.056; Schmitt RE, 2012, INT J ELECTROCHEM SC, V7, P10835; Supian F. L., 2014, ADV MATER, V825, P520; Teissedre P. L., 2013, NATURAL PRODUCTS	40	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						572	578		10.1016/j.aca.2014.10.046		7	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000060		
J	Kamichatani, W; Inoue, Y; Yamamoto, A				Kamichatani, Waka; Inoue, Yoshinori; Yamamoto, Atsushi			Separation properties of saccharides on a hydrophilic stationary phase having hydration layer formed zwitterionic copolymer	ANALYTICA CHIMICA ACTA			English	Article						Saccharide; Water-holding adsorbent; Zwitterionic copolymer; Normal-phase partition chromatography; Hydrophilic stationary phase; Hydration layer	PERFORMANCE LIQUID-CHROMATOGRAPHY; WATER-SOLUBLE COMPOUNDS; AUTOMATED CHROMATOGRAPHY; EXCHANGE RESINS; ANOMERS; MONOSACCHARIDES; SUGARS	A novel water-holding adsorbent bonded with a zwitterionic polymer, diallylamine-maleic acid copolymer, was developed. With this adsorbent, hydrophilic solutes are partitioned by a hydration layer that forms on the zwitterions, as a main separating force. When the adsorbent was used to separate saccharides by normal-phase partition chromatography, the saccharides eluted in the order, mono-, diand trisaccharide. The elution profile for mono- and di-saccharides was similar but not identical to that on anion exchange columns. This indicated that the adsorbent exhibited a complex retention behavior by the existence of both anion and cation exchange moieties in the functional polymer. Selecting Na+ as a counter-ion of the maleate moiety enhanced the retention of saccharide. When used in an high performance liquid chromatography ( HPLC) system with gradient elution, the adsorbent enabled the simultaneous analysis of mono-, di- and oligosaccharides. (C) 2014 Elsevier B.V. All rights reserved.	[Kamichatani, Waka; Inoue, Yoshinori] Nippon Filcon Co Ltd, Inagi, Tokyo 2068577, Japan; [Inoue, Yoshinori; Yamamoto, Atsushi] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan	Kamichatani, W (reprint author), Nippon Filcon Co Ltd, AdSep Business Promot Dept, 2220 Ohmaru, Inagi, Tokyo 2068577, Japan.	w-kamichatani@filcon.co.jp	kamichatani, Waka/L-5393-2015				Hemstrom P, 2006, J SEP SCI, V29, P1784, DOI 10.1002/jssc.200600199; [Anonymous], SHOD APPL DAT SHOD H; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; ALPERT AJ, 1990, J CHROMATOGR, V499, P177, DOI 10.1016/S0021-9673(00)96972-3; Jian WY, 2010, J SEP SCI, V33, P681, DOI 10.1002/jssc.200900692; Ikegami T, 2008, J CHROMATOGR A, V1184, P474, DOI 10.1016/j.chroma.2008.01.075; Jandera P, 2011, ANAL CHIM ACTA, V692, P1, DOI 10.1016/j.aca.2011.02.047; Dejaegher B, 2010, J SEP SCI, V33, P698, DOI 10.1002/jssc.200900742; Gika H, 2012, ANAL BIOANAL CHEM, V404, P701, DOI 10.1007/s00216-012-6015-6; Buszewski B, 2012, ANAL BIOANAL CHEM, V402, P231, DOI 10.1007/s00216-011-5308-5; Churms SC, 1996, J CHROMATOGR A, V720, P75, DOI 10.1016/0021-9673(95)00306-1; BINDER H, 1980, J CHROMATOGR, V189, P414, DOI 10.1016/S0021-9673(00)80322-2; Fu Q, 2010, ANAL METHODS-UK, V2, P217, DOI 10.1039/b9ay00151d; GOULDING RW, 1975, J CHROMATOGR, V103, P229, DOI 10.1016/S0021-9673(00)87215-5; HAMAGUCHI K, 1962, J AM CHEM SOC, V84, P1329, DOI 10.1021/ja00867a001; Havlicek J., 1974, CHROMATOGRAPHIA, V7, P361, DOI 10.1007/BF02269351; HONDA S, 1984, J CHROMATOGR, V291, P317, DOI 10.1016/S0021-9673(00)95034-9; HONDA S, 1984, ANAL BIOCHEM, V140, P1, DOI 10.1016/0003-2697(84)90130-1; Inoue Y, 2011, CHROMATOGRAPHIA, V73, P849, DOI 10.1007/s10337-011-1965-y; JONSSON P, 1967, ANAL CHEM, V39, P1156, DOI 10.1021/ac60254a042; JONSSON P, 1967, J CHROMATOGR, V26, P194, DOI 10.1016/S0021-9673(01)98853-3; KAHLE V, 1980, J CHROMATOGR, V191, P121, DOI 10.1016/S0021-9673(00)86371-2; Kamichatani W, 2012, J SEP SCI, V35, P2834, DOI 10.1002/jssc.201200429; Kamichatani W, 2011, ANAL SCI, V27, P885; Kunin R., 1958, ION EXCHANGE RESINS; OSHIMA R, 1980, J CHROMATOGR, V192, P452, DOI 10.1016/S0021-9673(80)80025-2; PAART E, 1970, CARBOHYD RES, V15, P111, DOI 10.1016/S0008-6215(00)80299-2; Samuelson O., 1966, CARBOHYD RES, V3, P89, DOI 10.1016/S0008-6215(00)82300-9; Samuelson O., 1963, ION EXCHANGE SEPARAT; SOGA T, 1992, J CHROMATOGR, V625, P151, DOI 10.1016/0021-9673(92)85196-Z	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	JAN 1	2015	853						602	607		10.1016/j.aca.2014.09.025		6	Chemistry, Analytical	Chemistry	AU5MT	WOS:000345652000064		
J	Arai, A; Arai, Y				Arai, Asuna; Arai, Yumiko			Self-assessed driving behaviors associated with age among middle-aged and older adults in Japan	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Driving behavior; Self-assessment; Aging; Middle age; Older adult	COMPETENCE; DEMENTIA; DISEASE; AVOIDANCE; DRIVERS; SAFETY; HEALTH	With the increasing number of older drivers, road traffic safety is an urgent public health issue. It is not easy for older drivers or their relatives to detect early signs of dangerous driving behaviors. We examine the types of driving behavior that increase in frequency with age. We surveyed people aged 40 and over among the general public in Japan using a self-administered questionnaire on sociodemographic factors, driving status, frequency of driving, 12-items on physical symptoms possibly related to driving performance, and 28-items on driving behaviors. Multiple logistic regression models were used to estimate the odds ratios (OR) of occurrence of each of the 28 driving behaviors for a 5-year increase in age. Significant associations with a 5-year increase in age after adjusting for confounding factors were found for the following directly unsafe driving behaviors: (1) little or no sign of attempts to avoid dangerous situations (OR for a 5-year increase in age = 1.38, 95% CI: 1.18-1.63); (2) lack of attention to other people and cars (1.33, 1.12-1.60); (3) improper maneuvering around curves (1.33, 1.09-1.65); and (4) improper or no turn signals (1.33, 1.06-1.69). Information about these driving behaviors should be given to drivers and their stakeholders and used to caution participants when implementing educational programs for older drivers. Self-assessment of driving ability in older drivers provides useful information to raise awareness of their driving performance. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Arai, Asuna; Arai, Yumiko] NCGG, Dept Gerontol Policy, Obu, Aichi 4748511, Japan; [Arai, Asuna] Hokkaido Univ, Grad Sch Med, Dept Hlth Care Policy, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Arai, Y (reprint author), NCGG, Dept Gerontol Policy, 35 Gengo, Obu, Aichi 4748511, Japan.	asunar@med.hokudai.ac.jp; yarai903@ncgg.go.jp			JSPS KAKENHI Grant [23591741]; Ministry of Health, Labour and Welfare, Japan [H19-025]	This project was funded by research grants from JSPS KAKENHI Grant Number 23591741 (Principal Investigator: Dr. Yumiko Arai) and the Ministry of Health, Labour and Welfare, Japan (No. H19-025; Principal Investigator: Dr. Yumiko Arai). The funding sources did not have any specific involvement in this study.	Alzheimer's Association, 2007, DRIV DEM FACT SHEET; American Automobile Association Foundation for Traffic Safety, 2010, DRIV 65 PLUS CHECK Y; American Medical Association, 2003, PHYS GUID ASS COUNS; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; PERSSON D, 1993, GERONTOLOGIST, V33, P88; Freund B, 2005, J GEN INTERN MED, V20, P240, DOI 10.1111/j.1525-1497.2005.40069.x; Dobbs AR, 1997, ALZ DIS ASSOC DIS, V11, P8, DOI 10.1097/00002093-199706001-00003; Arai Y, 2008, INT J GERIATR PSYCH, V23, P433, DOI 10.1002/gps.1977; Molnar LJ, 2010, J SAFETY RES, V41, P367, DOI 10.1016/j.jsr.2010.06.003; Meng A, 2012, ACCIDENT ANAL PREV, V49, P322, DOI 10.1016/j.aap.2012.01.023; Anstey KJ, 2006, J AM GERIATR SOC, V54, P121, DOI 10.1111/j.1532-5415.2005.00471.x; Wild K, 2003, ALZ DIS ASSOC DIS, V17, P27, DOI 10.1097/00002093-200301000-00004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Arai A., 2006, JAPAN MED J, V4272, P44; Arai A, 2010, INT J GERIATR PSYCH, V25, P1239, DOI 10.1002/gps.2457; Arai Y, 2005, J AM GERIATR SOC, V53, P1641, DOI 10.1111/j.1532-5415.2005.53487_10.x; Arai Y., 2010, SUPPORT MANUAL FAMIL; Araiy Y, 2010, INT J GERIATR PSYCH, V25, P896, DOI 10.1002/gps.2589; Bieliauskas LA, 2005, BRAIN INJURY, V19, P221, DOI 10.1080/02699050400017213; Boot WR, 2014, GERONTOLOGY, V60, P90, DOI 10.1159/000354212; Burke M., 2003, PRIMARY CARE OLDER A; Family Caregiver Alliance, 2002, DEM AND DRIV; Moser C. A., 1989, SURVEY METHODS SOCIA; National Police Agency, 2006, KOUR UNT KANS KIOK H; National Police Agency, 2010, SEC SAF PLEAS TRAFF; National Police Agency, 2013, TRAFF ACC SIT 2012; Ragland DR, 2004, GERONTOLOGIST, V44, P237; The Hartford, 2007, CROSSR FAM CONV ALZH; Tuokko HA, 2007, AGE AGEING, V36, P389, DOI 10.1093/ageing/afm032; Uc EY, 2006, J NEUROL SCI, V251, P35, DOI 10.1016/j.jns.2006.08.011; Walker J. G., 2008, J GERONTOL B-PSYCHOL, V63b, P75; World Health Organization, 2013, GLOB STAT REP ROAD S	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2015	60	1					39	44		10.1016/j.archger.2014.10.017		6	Geriatrics & Gerontology	Geriatrics & Gerontology	AW1TH	WOS:000346072400006		
J	Okubo, Y; Seino, S; Yabushita, N; Osuka, Y; Jung, S; Nemoto, M; Figueroa, R; Tanaka, K				Okubo, Yoshiro; Seino, Satoshi; Yabushita, Noriko; Osuka, Yosuke; Jung, Songee; Nemoto, Miyuki; Figueroa, Rafael; Tanaka, Kiyoji			Longitudinal association between habitual walking and fall occurrences among community-dwelling older adults: Analyzing the different risks of falling	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Falling; Elderly; Walking; Risk	PHYSICAL-ACTIVITY; INJURIOUS FALLS; ELDERLY PEOPLE; PREVENTION; FRACTURES; HEALTH; BALANCE; WOMEN	The purpose of this longitudinal study was to examine the association between habitual walking and multiple or injurious falls (falls) among community-dwelling older adults, by considering the relative risk of falling. A cohort of Japanese community-dwelling older adults (n = 535) aged 60-91 years (73.1 +/- 6.6 year, 157 men and 378 women) who underwent community-based health check-ups from 2008 to 2012 were followed until 2013. Incidence rate of falls between walkers and non-walkers was compared separately by the number of risk factors (Groups R0, R1, R2, R3 and R4+). The Cox proportional hazard model was used to assess the association between habitual walking and falls separately by lower( R < 2) and higher- (R >= 2) risk groups. In Groups R0 and R1, the incidence of falls was lower in walkers than non-walkers; however, in Groups R2, R3, and R4+, the incidence of falls was higher in walkers. The Cox proportional hazard model showed that habitual walking was not significantly associated with falls (hazard ratio (HR): 0.88, 95% confidence interval (CI): 0.48-1.62) among the lower risk group but that it was significantly associated with increased falls (HR: 1.89, 95% CI: 1.04-3.43) among the higher risk group. The significant interaction between habitual walking and higher risk of falling was found (P < 0.05). When individuals have two or more risk factors for falling, caution is needed when recommending walking because walking can actually increase their risk of experiencing multiple or injurious falls. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Okubo, Yoshiro; Figueroa, Rafael] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Okubo, Yoshiro; Seino, Satoshi; Osuka, Yosuke; Nemoto, Miyuki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Seino, Satoshi] Tokyo Metropolitan Geriatr Hosp, Itabashi Ku, Tokyo 1730015, Japan; [Seino, Satoshi] Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan; [Yabushita, Noriko; Osuka, Yosuke; Jung, Songee; Nemoto, Miyuki; Tanaka, Kiyoji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	Okubo, Y (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	Yoshiro_okubo@yahoo.co.jp			Japan Society for the Promotion of Science (JSPS) [12J01824]	We would like to express our deep gratitude to all of the study participants, municipality workers, volunteers, and staff members who contributed to this study. This study was supported by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for JSPS Fellows (# 12J01824).	Ageing WHO, 2008, WHO GLOB REP FALLS P; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664; [Anonymous], 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004441.PUB2; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.149.7.1628; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735; Faulkner KA, 2009, OSTEOPOROSIS INT, V20, P2025, DOI 10.1007/s00198-009-0909-y; MURRAY MP, 1969, J GERONTOL, V24, P169; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Gregg EW, 2000, J AM GERIATR SOC, V48, P883; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; BROWN M, 1993, AGING-CLIN EXP RES, V5, P427; Campbell AJ, 2010, CLIN GERIATR MED, V26, P719, DOI 10.1016/j.cger.2010.06.004; Etman A, 2012, AGE AGEING, V41, P190, DOI 10.1093/ageing/afr178; Haga H, 1996, JAPANESE J PUBLIC HL, V43, P983; Japanese Ministry of Education Culture Sports Science and Technology, 2013, NAT SURV PHYS FITN S; Japanese Ministry of Health Labour and Welfare, 2007, COMPR SURV LIV COND; Japanese Ministry of Health Labour and Welfare, 2013, WHIT PAP AG SOC; Japanese Ministry of Health Labour and Welfare, 2012, NAT HLTH NUTR SURV; KANEKO M, 1991, CAN J SPORT SCI, V16, P223; Kim MJ, 2010, GERIATR GERONTOL INT, V10, P302, DOI 10.1111/j.1447-0594.2010.00614.x; Kloseck M, 2008, J REHABIL RES DEV, V45, P1125, DOI 10.1682/JRRD.2007.08.0135; Lord SR, 2006, AGE AGEING, V35, P42, DOI 10.1093/ageing/afl085; Okubo Y, 2011, JPN J PHYS FIT SPORT, V60, P239; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Seino S, 2010, JPN J PHYS FIT SPORT, V59, P415; Stevens JA, 1997, ANN EPIDEMIOL, V7, P54, DOI 10.1016/S1047-2797(96)00110-X; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VETTER NJ, 1992, BRIT MED J, V304, P888; Voukelatos A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-888; Wijlhuizen Gert Jan, 2007, Prev Med, V44, P260, DOI 10.1016/j.ypmed.2006.11.003	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2015	60	1					45	51		10.1016/j.archger.2014.10.008		7	Geriatrics & Gerontology	Geriatrics & Gerontology	AW1TH	WOS:000346072400007		
J	Kiyoshige, Y; Watanabe, E				Kiyoshige, Yoshiro; Watanabe, Emi			Fatty degeneration of gluteus minimus muscle as a predictor of falls	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Fatty degeneration; Gluteal muscle; Falls	POSTERIOR SEGMENTS; ANTERIOR; GAIT; HIP	The cause of falls is multifactorial, however, hip fractures in elderly would be prevented if accidental falls are predictable. We assessed magnetic resonance images of 38 patients with groin pain after taking a fall whose fracture could not be detected by plain X-rays, and 45 patients with no episode of falls. Their ages were over 65 years. Fatty degeneration of muscles, gluteus maximus, gluteus medius, gluteus minimus, obturator externus, adductor longus, rectus femoris and iliopsoas muscles, were evaluated by Goutallier's staging. Odds ratio was calculated by a logistic regression analysis allocating dependent variable for falls and independent variables for Goutallier's stage, age and gender. The fatty degeneration of gluteus maximus muscle was generalized, while that of gluteus minimus muscle was unevenly distributed, especially in anterior area. Gluteus minimus muscle initiated its fatty degeneration earlier than gluteus medius muscle. Odds ratio of falling was 3.2 (95% confidence intervals: 1, 14, 8.94) for Goutallier' stage of the gluteus medius muscle. Fatty degeneration of gluteus medius muscle has a crucial role in providing stability of the pelvis including hip joint. Evaluating fatty streaks in the gluteus minimus muscle could help give early indication to those who have a higher risk of falling. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kiyoshige, Yoshiro] Yamagata Prefectural Univ Hlth Sci, Dept Phys Therapy, Yamagata 9902212, Japan; [Kiyoshige, Yoshiro] Saiseikai Yamagata Hosp, Dept Orthopaed Surg, Yamagata 9908545, Japan; [Watanabe, Emi] Saiseikai Yamagata Hosp, Dept Radiol, Yamagata 9908545, Japan	Kiyoshige, Y (reprint author), Yamagata Prefectural Univ Hlth Sci, Dept Phys Therapy, 260 Kamiyanagi, Yamagata 9902212, Japan.	ykiyosige@yachts.ac.jp					Engelken F, 2014, J ARTHROPLASTY, V29, P149, DOI 10.1016/j.arth.2013.04.045; Retchford TH, 2013, J MUSCULOSKEL NEURON, V13, P1; Semciw AI, 2013, J ELECTROMYOGR KINES, V23, P858, DOI 10.1016/j.jelekin.2013.03.007; Gerber C, 2000, J BONE JOINT SURG AM, V82A, P505; Pfirrmann CWA, 2005, RADIOLOGY, V235, P969, DOI 10.1148/radiol..2353040403; Beck M, 2000, J BONE JOINT SURG BR, V82B, P358, DOI 10.1302/0301-620X.82B3.10356; Goutallier DBJ, 1990, SURG SHOULDER, P11; Lee J., 2008, GRAYS ANATOMY, P1368; Semciw AI, 2014, GAIT POSTURE, V39, P822, DOI 10.1016/j.gaitpost.2013.11.008	9	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2015	60	1					59	61		10.1016/j.archger.2014.07.013		3	Geriatrics & Gerontology	Geriatrics & Gerontology	AW1TH	WOS:000346072400009		
J	Ogata, S; Hayashi, C; Sugiura, K; Hayakawa, K				Ogata, Soshiro; Hayashi, Chisato; Sugiura, Keiko; Hayakawa, Kazuo			Association between subjective memory complaints and impaired higher-level functional capacity in people aged 60 years or older	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Subjective memory complaints; Memory disorders; Mild cognitive impairment; Functional capacity; Activities of daily living; Independent living	WHITE-MATTER LESIONS; COGNITIVE PERFORMANCE; COMMUNITY; POPULATION; DECLINE; DEPRESSION; INDIVIDUALS; COMPETENCE; SIMULATION; IMPUTATION	Objective: We aimed to investigate the association between subjective memory complaints and higher-level functional capacity in either people with long-term care needs or those who require help to maintain functional capacity. Methods: We conducted a cross-sectional study among participants aged 60 years or older. We measured subjective memory complaints, higher-level functional capacity, and depressive symptoms, and then estimated odds ratios (ORs) by multiple logistic analysis. Subjective memory complaints were used as the predictor variable, higher-level functional capacity as the outcome variable, and age, depressive symptoms, medical history of diabetes and hypertension, frequency of going out, falling within a year, and body mass index as possible confounders. We assessed higher-level functional capacity using the Tokyo Metropolitan Institute of Gerontology (TMIG) index of competence score <= 5 as a cut-off (which is associated with higher one-year mortality rates). Results: We conducted analyses using 501 people aged 60 years or older. Among women, subjective memory complaints were associated with impaired higher-level functional capacity after adjustment for age and depressive symptoms (OR = 3.36; 95% confidence interval [CI], 1.59-7.08). Among the men, subjective memory complaints were not significantly associated with impaired higher-level functional capacity after adjustment for age and depressive symptoms (OR = 1.91; 95% CI, 0.88-4.12). Conclusions: Subjective memory complaints among women can indicate impaired higher-level functional capacity and may suggest higher one-year mortality rates. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ogata, Soshiro; Hayakawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, Suita, Osaka 565, Japan; [Hayashi, Chisato] Osaka City Univ, Grad Sch Nursing, Dept Publ Hlth Nursing, Osaka, Japan; [Sugiura, Keiko] Senri Kinran Univ, Fac Nursing, Suita, Osaka, Japan	Ogata, S (reprint author), 1-5-17 Asahi Machi,Abeno Ku, Osaka 5450051, Japan.	sob0405@sahs.med.osaka-u.ac.jp			Osaka City University; Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) in Japan	We are deeply grateful to Research Institute for Healthcare Arataka, Arataka Home Nursing, and Arataka Outpatient Services that helped us to collect data. We also would like to thank Akari Sugai whose mathematical comments made enormous contribution to the present study. We would like to express Osaka City University subsidized by the Program to Support Female Researchers because this work was partially supported by the system to staff research supporter of Osaka City University subsidized by the Program to Support Female Researchers realized by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) in Japan.	Iwasa H, 2009, INT J GERIATR PSYCH, V24, P1192, DOI 10.1002/gps.2245; Sugiura Y, 2013, ARCH GERONTOL GERIAT, V57, P319, DOI 10.1016/j.archger.2013.06.006; Kim JM, 2003, DEMENT GERIATR COGN, V15, P218, DOI 10.1159/000068783; Abdulrab K, 2008, EUR PSYCHIAT, V23, P321, DOI 10.1016/j.eurpsy.2008.02.004; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Sawada H, 2000, J NEUROL NEUROSUR PS, V68, P653, DOI 10.1136/jnnp.68.5.653; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; van Buuren S, 2011, J STAT SOFTW, V45, P1; Minett TSC, 2005, AM J GERIAT PSYCHIAT, V13, P665, DOI 10.1176/appi.ajgp.13.8.665; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Ogata S, 2014, J EPIDEMIOL, V24, P31, DOI 10.2188/jea.JE20130070; Laws SM, 2002, MOL PSYCHIATR, V7, P768, DOI 10.1038/sj.mp.4001083; LESHER EL, 1994, J CLIN PSYCHOL, V50, P256, DOI 10.1002/1097-4679(199403)50:2<256::AID-JCLP2270500218>3.0.CO;2-E; Clarnette RM, 2001, INT J GERIATR PSYCH, V16, P168, DOI 10.1002/1099-1166(200102)16:2<168::AID-GPS291>3.0.CO;2-D; Wang PN, 2000, J AM GERIATR SOC, V48, P295; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Blazer DG, 2001, J GERONTOL A-BIOL, V56, pM785; Bonner-Jackson A, 2012, AM J GERIAT PSYCHIAT, V20, P584, DOI 10.1097/JGP.0b013e3182203c32; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57, DOI 10.1046/j.1444-1586.2002.00023.x; Iwasa H, 2008, ARCH GERONTOL GERIAT, V47, P139, DOI 10.1016/j.archger.2007.07.008; Jacinto AF, 2014, CLINICS, V69, P194, DOI 10.6061/clinics/2014(03)09; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; MONTEJO P, 2011, ARCH GERONTOL GERIAT, V54, P298; Okamoto N, 2006, ARCH GERONTOL GERIAT, V42, P175, DOI 10.1016/j.archger.2005.06.012; Pohjasvaara Tarja Ilona, 2007, J Stroke Cerebrovasc Dis, V16, P251, DOI 10.1016/j.jstrokecerebrovasdis.2007.08.001; R Core Team, 2014, R LANG ENV STAT COMP	28	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2015	60	1					201	205		10.1016/j.archger.2014.10.015		5	Geriatrics & Gerontology	Geriatrics & Gerontology	AW1TH	WOS:000346072400032		
J	Sekino, M; Ohsaki, H; Takiyama, Y; Yamamoto, K; Matsuzaki, T; Yasumuro, Y; Nishikawa, A; Maruo, T; Hosomi, K; Saitoh, Y				Sekino, Masaki; Ohsaki, Hiroyuki; Takiyama, Yoshihiro; Yamamoto, Keita; Matsuzaki, Taiga; Yasumuro, Yoshihiro; Nishikawa, Atsushi; Maruo, Tomoyuki; Hosomi, Koichi; Saitoh, Youichi			Eccentric Figure-Eight Coils for Transcranial Magnetic Stimulation	BIOELECTROMAGNETICS			English	Article						transcranial magnetic stimulation; coil; brain; medical application; eddy current	MOTOR CORTEX STIMULATION; INTRACTABLE DEAFFERENTATION PAIN; PARKINSONS-DISEASE; ELECTRIC-FIELD; BRAIN; DESIGN; REDUCTION; CURRENTS; TISSUES; EEG	Previously we proposed an eccentric figure-eight coil that can cause threshold stimulation in the brain at lower driving currents. In this study, we performed numerical simulations and magnetic stimulations to healthy subjects for evaluating the advantages of the eccentric coil. The simulations were performed using a simplified spherical brain model and a realistic human brain model. We found that the eccentric coil required a driving current intensity of approximately 18% less than that required by the concentric coil to cause comparable eddy current densities within the brain. The eddy current localization of the eccentric coil was slightly higher than that of the concentric coil. A prototype eccentric coil was designed and fabricated. Instead of winding a wire around a bobbin, we cut eccentric-spiral slits on the insulator cases, and a wire was woven through the slits. The coils were used to deliver magnetic stimulation to healthy subjects; among our results, we found that the current slew rate corresponding to motor threshold values for the concentric and eccentric coils were 86 and 78A/mu s, respectively. The results indicate that the eccentric coil consistently requires a lower driving current to reach the motor threshold than the concentric coil. Future development of compact magnetic stimulators will enable the treatment of some intractable neurological diseases at home. Bioelectromagnetics. 35:55-65, 2015. (c) 2014 Wiley Periodicals, Inc.	[Sekino, Masaki; Ohsaki, Hiroyuki; Takiyama, Yoshihiro; Yamamoto, Keita] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Tokyo, Japan; [Sekino, Masaki; Matsuzaki, Taiga; Yasumuro, Yoshihiro; Nishikawa, Atsushi; Maruo, Tomoyuki; Hosomi, Koichi; Saitoh, Youichi] Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Suita, Osaka, Japan; [Ohsaki, Hiroyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba, Japan; [Matsuzaki, Taiga] Teijin Pharma Ltd, Home Healthcare Res & Dev Planning Dept, Tokyo, Japan; [Yasumuro, Yoshihiro] Kansai Univ, Fac Environm Urban Engn, Dept Civil Environm & Appl Syst Engn, Suita, Osaka, Japan; [Nishikawa, Atsushi] Shinshu Univ, Fac Text Sci & Technol, Bioengn Course, Div Mech Engn & Robot, Ueda, Nagano 386, Japan	Sekino, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138656, Japan.	sekino@bee.t.u-tokyo.ac.jp			Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; General Insurance Association of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Teijin Pharma Limited	Grant sponsor: Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and General Insurance Association of Japan; grant sponsor: Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; grant sponsor: Teijin Pharma Limited.	BISCHOFF C, 1994, ELECTROEN CLIN NEURO, V93, P15, DOI 10.1016/0168-5597(94)90086-8; Hsu KH, 2001, IEEE T BIO-MED ENG, V48, P1162; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; TOFTS PS, 1990, PHYS MED BIOL, V35, P1119, DOI 10.1088/0031-9155/35/8/008; Han BH, 2003, MED BIOL ENG COMPUT, V41, P516, DOI 10.1007/BF02345312; UENO S, 1990, IEEE T MAGN, V26, P1539, DOI 10.1109/20.104438; Chauveau N, 2004, HUM BRAIN MAPP, V21, P86, DOI 10.1002/hbm.10152; Kato T, 2011, IEEE ENG MED BIO, P1985, DOI 10.1109/IEMBS.2011.6090559; PASCUALLEONE A, 1994, NEUROLOGY, V44, P892; Maruo T, 2013, BRAIN STIMUL, V6, P884, DOI 10.1016/j.brs.2013.05.002; Saitoh Y, 2007, J NEUROSURG, V107, P555, DOI 10.3171/JNS-07/09/0555; Gutierrez D, 2004, IEEE T BIO-MED ENG, V51, P2113, DOI 10.1109/TBME.2004.836507; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Lu M, 2009, IEEE T MAGN, V45, P1662, DOI 10.1109/TMAG.2009.2012770; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Lu M, 2008, IEEE T MAGN, V44, P1438, DOI 10.1109/TMAG.2007.916022; Lin VWH, 2000, IEEE T BIO-MED ENG, V47, P600, DOI 10.1109/10.841332; Padberg F, 2009, EXP NEUROL, V219, P2, DOI 10.1016/j.expneurol.2009.04.020; UENO S, 1988, J APPL PHYS, V64, P5862, DOI 10.1063/1.342181; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; BARKER AT, 1985, LANCET, V1, P1106; Dawson T. W., 1996, Applied Computational Electromagnetics Society Journal, V11; De Sauvage RC, 2010, J MED DEVICES, V4; Epstein CM, 2008, BRAIN STIMUL, V1, P128, DOI 10.1016/j.brs.2008.02.002; Epstein CM, 2002, J CLIN NEUROPHYSIOL, V19, P376, DOI 10.1097/00004691-200208000-00010; Fadini T, 2009, CLIN NEUROPHYSIOL, V120, P1174, DOI 10.1016/j.clinph.2009.02.176; GRANDORI F, 1991, IEEE T BIO-MED ENG, V38, P180, DOI 10.1109/10.76385; Kato T, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676426; Lomarev MP, 2006, MOVEMENT DISORD, V21, P325, DOI 10.1002/mds.20713; Lontis ER, 2006, J CLIN NEUROPHYSIOL, V23, P463, DOI 10.1097/01.wnp.0000229944.63011.a1; Lopes da Silva FH, 1991, BRAIN TOPOGR, V4, P133; Malmivuo J, 1997, IEEE T BIO-MED ENG, V44, P196, DOI 10.1109/10.554766; MANO Y, 1993, J ELECTROMYOGR KINES, V3, P245, DOI 10.1016/1050-6411(93)90014-N; Okada A., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), DOI 10.1109/ICCME.2012.6275591; Pashut T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002022; Roth Y, 2014, BRAIN STIMUL, V7, P194, DOI 10.1016/j.brs.2013.09.004; Ruohonen J, 1998, MED BIOL ENG COMPUT, V36, P297, DOI 10.1007/BF02522474; Saitoh Y, 2000, J NEUROSURG, V92, P150, DOI 10.3171/jns.2000.92.1.0150; Sekino M., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), DOI 10.1109/ICCME.2012.6275592; Sekino M, 2006, IEEE T MAGN, V42, P3575, DOI 10.1109/TMAG.2006.879821; Weyh T, 2005, CLIN NEUROPHYSIOL, V116, P1477, DOI 10.1016/j.clinph.2005.02.002; Wheeler H.A., 1942, Proceedings of the Institute of Radio Engineers, V30, DOI 10.1109/JRPROC.1942.232015; Yasumuro Y., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), DOI 10.1109/ICCME.2012.6275590; Zangen A, 2005, CLIN NEUROPHYSIOL, V116, P775, DOI 10.1016/j.clinph.2004.11.008	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-8462	1521-186X		BIOELECTROMAGNETICS	Bioelectromagnetics	JAN	2015	36	1					55	65		10.1002/bem.21886		11	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	AW1AU	WOS:000346023800006		
J	Zakaria, MR; Hirata, S; Hassan, MA				Zakaria, Mohd Rafein; Hirata, Satoshi; Hassan, Mohd Ali			Hydrothermal pretreatment enhanced enzymatic hydrolysis and glucose production from oil palm biomass	BIORESOURCE TECHNOLOGY			English	Article						Oil palm biomass; Hydrothermal pretreatment; Tannic acid; Specific surface area; Enzymatic hydrolysis	GAS-SHIFT REACTION; FORMIC-ACID; DILUTE-ACID; WATER; INHIBITORS; FROND; XYLOOLIGOSACCHARIDES; SACCHARIFICATION; FRACTIONATION; BIOREFINERY	The present works investigate hydrothermal pretreatment of oil palm empty fruit bunch and oil palm frond fiber in a batch tube reactor system with temperature and time range from 170 to 250 degrees C and 10 to 20 min, respectively. The behavior of soluble sugars, acids, furans, and phenols dramatically changed over treatment severities as determined by HPLC. The cellulose-rich treated solids were analyzed by SEM, WAXD, and BET surface area. Enzymatic hydrolysis was performed from both pretreated slurries and washed solid, and data obtained suggested that tannic acid derived from lignin degradation was a potential cellulase inhibitor. Both partial removal of hemicellulose and migration of lignin during hydrothermal pretreatment caused structural changes on the cellulose-hemicellulose-lignin matrix, resulting in the opening and expansion of specific surface area and pore volume. The current results provided important factors that maximize conversion of cellulose to glucose from oil palm biomass by hydrothermal process. (C) 2014 Elsevier Ltd. All rights reserved.	[Zakaria, Mohd Rafein; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan; [Zakaria, Mohd Rafein; Hassan, Mohd Ali] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Upm Serdang 43400, Selangor, Malaysia; [Hassan, Mohd Ali] Univ Putra Malaysia, Fac Engn, Dept Proc & Food Engn, Upm Serdang 43400, Selangor, Malaysia	Zakaria, MR (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	rafein-zakaria@aist.go.jp		ZAKARIA, MOHD RAFEIN/0000-0002-2698-615X	Science and Technology Research Partnership for Sustainable Development (SATREPS), under Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)	This work was partly supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS), under Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA). Special thanks to Mr. Yoshihito Suwa for the technical assistance and Dr. Tamotsu Hoshino for HPLC analysis.	Moller M, 2011, CHEMSUSCHEM, V4, P566, DOI 10.1002/cssc.201000341; Teramoto Y, 2008, BIOTECHNOL BIOENG, V99, P75, DOI 10.1002/bit.21522; Tejirian A, 2011, ENZYME MICROB TECH, V48, P239, DOI 10.1016/j.enzmictec.2010.11.004; Kim Y, 2011, ENZYME MICROB TECH, V48, P408, DOI 10.1016/j.enzmictec.2011.01.007; Ximenes E, 2011, ENZYME MICROB TECH, V48, P54, DOI 10.1016/j.enzmictec.2010.09.006; Yasaka Y, 2006, J PHYS CHEM A, V110, P11082, DOI 10.1021/jp0626768; Qing Q, 2010, BIORESOURCE TECHNOL, V101, P9624, DOI 10.1016/j.biortech.2010.06.137; Zakaria MR, 2014, APPL BIOCHEM BIOTECH, V173, P1778, DOI 10.1007/s12010-014-0964-5; Ishiguro M, 2014, BIORESOURCE TECHNOL, V153, P322, DOI 10.1016/j.biortech.2013.12.015; Nitsos CK, 2013, CHEMSUSCHEM, V6, P110, DOI 10.1002/cssc.201200546; Ximenes E, 2010, ENZYME MICROB TECH, V46, P170, DOI 10.1016/j.enzmictec.2009.11.001; Sabiha-Hanim S, 2011, BIORESOURCE TECHNOL, V102, P1234, DOI 10.1016/j.biortech.2010.08.017; Ho AL, 2014, BIORESOURCE TECHNOL, V152, P526, DOI 10.1016/j.biortech.2013.10.114; Hong JY, 2013, BIORESOURCE TECHNOL, V146, P176, DOI 10.1016/j.biortech.2013.07.058; Xiao LP, 2013, BIORESOURCE TECHNOL, V135, P73, DOI 10.1016/j.biortech.2012.08.143; Kim Y, 2013, BIORESOURCE TECHNOL, V135, P30, DOI 10.1016/j.biortech.2012.10.130; Zakaria MR, 2014, BIORESOURCE TECHNOL, V169, P236, DOI 10.1016/j.biortech.2014.06.095; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; Goh CS, 2010, BIORESOURCE TECHNOL, V101, P7362, DOI 10.1016/j.biortech.2010.04.048; Goh CS, 2012, BIORESOURCE TECHNOL, V110, P662, DOI 10.1016/j.biortech.2012.01.083; Gong C S, 1999, Adv Biochem Eng Biotechnol, V65, P207; Kont R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-135; Overend R.P., 1989, WOOD PROCESSING UTIL, P395; Pu YQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-15; Segal L., 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003]; Sluiter A., 2008, NRELTP51042623 LAB A; Yoshida K, 2004, J PHYS CHEM A, V108, P7479, DOI 10.1021/jp047086t; Zahari MAKM, 2014, J CLEAN PROD, V65, P252, DOI 10.1016/j.jclepro.2013.10.007	28	8	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	JAN	2015	176						142	148		10.1016/j.biortech.2014.11.027		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AW0LE	WOS:000345982900019		
J	Suzuki, T; Seta, K; Nishikawa, C; Hara, E; Shigeno, T; Nakajima-Kambe, T				Suzuki, Toshihiro; Seta, Kohei; Nishikawa, Chiaki; Hara, Eri; Shigeno, Toshiya; Nakajima-Kambe, Toshiaki			Improved ethanol tolerance and ethanol production from glycerol in a streptomycin-resistant Klebsiella variicola mutant obtained by ribosome engineering	BIORESOURCE TECHNOLOGY			English	Article						Glycerol; Ethanol tolerance; Ribosome engineering; Klebsiella variicola; Ethanol production	CORN STEEP LIQUOR; ESCHERICHIA-COLI; ANTIBIOTIC OVERPRODUCTION; ANAEROBIC FERMENTATION; BUTANOL TOLERANCE; COELICOLOR A3(2); BIODIESEL-WASTE; PROTEIN S12; RPSL; STRAIN	To improve the ethanol tolerance of the Klebsiella variicola strain TB-83, we obtained the streptomycin-resistant, ethanol-tolerant mutant strain TB-83D by a ribosome engineering approach. Strain TB-83D was able to grow in the presence of 7% (v/v) ethanol and it showed higher ethanol production than strain TB-83. Examination of various culture conditions revealed that yeast extract was essential for ethanol production and bacterial growth. In addition, ethanol production was elevated to 32 g/L by the addition of yeast extract; however, ethanol production was inhibited by formate accumulation. With regard to cost reduction, the use of corn steep liquor (CSL) markedly decreased the formate concentration, and 34 g/L ethanol was produced by combining yeast extract with CSL. Our study is the first to improve ethanol tolerance and productivity by a ribosome engineering approach, and we found that strain TB-83D is effective for ethanol production from glycerol. (C) 2014 Elsevier Ltd. All rights reserved.	[Suzuki, Toshihiro; Seta, Kohei; Nishikawa, Chiaki; Hara, Eri; Nakajima-Kambe, Toshiaki] Univ Tsukuba, Fac Life & Environm Sci Bioind Sci, Tsukuba, Ibaraki 3058572, Japan; [Shigeno, Toshiya] Tsukuba Inst Environm Microbiol, Tsukuba, Ibaraki 3001271, Japan	Nakajima-Kambe, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci Bioind Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	nakajima.toshiaki.ga@u.tsukuba.ac.jp			Environment Research and Technology Development Fund (ERTDF) from the Ministry of the Environment, Government of Japan [3K123007]	We thank the Nagasaki Prefectural Institute for Environmental Research and Public Health for providing bBDF waste. This work was supported by the Environment Research and Technology Development Fund (ERTDF) (3K123007) from the Ministry of the Environment, Government of Japan.	Oh BR, 2011, BIORESOURCE TECHNOL, V102, P3918, DOI 10.1016/j.biortech.2010.12.007; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Ito T, 2005, J BIOSCI BIOENG, V100, P260, DOI 10.1263/jbb.100.260; Shima J, 1996, J BACTERIOL, V178, P7276; Choi WJ, 2011, APPL MICROBIOL BIOT, V89, P1255, DOI 10.1007/s00253-010-3076-3; Tanaka Y, 2009, APPL ENVIRON MICROB, V75, P4919, DOI 10.1128/AEM.00681-09; Yazdani SS, 2007, CURR OPIN BIOTECH, V18, P213, DOI 10.1016/j.copbio.2007.05.002; Durnin G, 2009, BIOTECHNOL BIOENG, V103, P148, DOI 10.1002/bit.22246; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Maddipati P, 2011, BIORESOURCE TECHNOL, V102, P6494, DOI 10.1016/j.biortech.2011.03.047; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Okamoto-Hosoya Y, 2003, MICROBIOL-SGM, V149, P3299, DOI 10.1099/mic.0.26490-0; Suzuki T, 2014, NEW BIOTECHNOL, V31, P246, DOI 10.1016/j.nbt.2014.03.005; Xi YL, 2013, BIORESOURCE TECHNOL, V136, P775, DOI 10.1016/j.biortech.2013.03.107; Chi ZY, 2007, PROCESS BIOCHEM, V42, P1537, DOI 10.1016/j.procbio.2007.08.008; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Zingaro KA, 2013, METAB ENG, V15, P196, DOI 10.1016/j.ymben.2012.07.009; Horng YT, 2010, J IND MICROBIOL BIOT, V37, P707, DOI 10.1007/s10295-010-0714-9; Hosoya Y, 1998, ANTIMICROB AGENTS CH, V42, P2041; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; Liu Z, 2013, APPL MICROBIOL BIOT, V97, P4361, DOI 10.1007/s00253-012-4290-y; Cheng Li, 2013, Energies, V6, DOI 10.3390/en6094739; Chin WC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-130; Georgieva TI, 2007, CENT EUR J BIOL, V2, P364, DOI 10.2478/s11535-007-0026-x; Hosokawa K, 2002, ENVIRON MICROBIOL, V4, P703, DOI 10.1046/j.1462-2920.2002.00348.x; Kivisto A, 2010, BIORESOURCE TECHNOL, V101, P8671, DOI 10.1016/j.biortech.2010.06.066; Kurosawa K, 2006, APPL ENVIRON MICROB, V72, P71, DOI 10.1128/AEM.72.1.71-77.2006; Li LX, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-123; Mu Y., 2006, BIOTECHNOL LETT, V28, P1124; Nwachukwu RES, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-20; Oh BR, 2012, PROCESS BIOCHEM, V47, P156, DOI 10.1016/j.procbio.2011.10.011; Sambrook J, 2001, MOL CLONING LAB MANU; Sudha Rani K., 1999, WORLD J MICROB BIOT, V15, P173; Wong MS, 2014, APPL ENVIRON MICROB, V80, P3276, DOI 10.1128/AEM.03863-13	34	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	JAN	2015	176						156	162		10.1016/j.biortech.2014.10.153		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AW0LE	WOS:000345982900021		
J	Ninomiya, K; Kohori, A; Tatsumi, M; Osawa, K; Endo, T; Kakuchi, R; Ogino, C; Shimizu, N; Takahashi, K				Ninomiya, Kazuaki; Kohori, Asami; Tatsumi, Mai; Osawa, Koji; Endo, Takatsugu; Kakuchi, Ryohei; Ogino, Chiaki; Shimizu, Nobuaki; Takahashi, Kenji			Ionic liquid/ultrasound pretreatment and in situ enzymatic saccharification of bagasse using biocompatible cholinium ionic liquid	BIORESOURCE TECHNOLOGY			English	Article						Cholinium; Ionic liquid; Pretreatment; In situ saccharification; Lignocellulose	LIGNOCELLULOSIC BIOMASS; BIOFUEL PRODUCTION; CELLULOSE; HYDROLYSIS; BIOMATERIALS; ENHANCEMENT; DISSOLUTION; SUGARS; MEDIA; ACID	Choline acetate (ChOAc), a cholinium ionic liquid (IL), showed almost the same bagasse pretreatment capability as 1-ethyl-3-methylimidazolium acetate (EmimOAc), a conventional imidazolium IL used for biomass pretreatment. Moreover, ChOAc showed less of an inhibitory effect on cellulase than EmimOAc. Thus, ChOAc was used for IL/ultrasound-assisted pretreatment and in situ enzymatic saccharification, where IL was not washed out from the pretreated bagasse but diluted with the addition of a buffer solution. When in situ saccharification was performed for 48 h in the presence of 10% ChOAc, the cellulose and hemicellulose saccharification percentages were 80% and 72%, respectively. When ChOAc was increased to 20%, the saccharification percentages were 72% and 53%, respectively. However, the values were just 28% and 2%, respectively, in case of 20% EmimOAc. A glucose/xylose solution free from IL and ChOAc aqueous solution without these sugars could be recovered separately by electrodialysis of the hydrolysate of in situ saccharification. (C) 2014 Elsevier Ltd. All rights reserved.	[Ninomiya, Kazuaki; Shimizu, Nobuaki] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Kohori, Asami; Tatsumi, Mai; Osawa, Koji; Endo, Takatsugu; Kakuchi, Ryohei; Takahashi, Kenji] Kanazawa Univ, Inst Sci & Engn, Fac Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Ogino, Chiaki] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takahashi, K (reprint author), Kanazawa Univ, Inst Sci & Engn, Fac Nat Syst, Kanazawa, Ishikawa 9201192, Japan.	ktkenji@staff.kanazawa-u.ac.jp	Ninomiya, Kazuaki/C-3364-2015; Kakuchi, Ryohei/C-8209-2015; Endo, Takatsugu/I-3916-2013		Advanced Low Carbon Technology Research and Development Program (ALCA) from Japan Science and Technology Agency [2100040]; Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COIstream) from Japan Science and Technology Agency; Cross-ministerial Strategic Innovation Promotion Program (SIP) from Japan Science and Technology Agency	This study was supported in part by an Advanced Low Carbon Technology Research and Development Program (ALCA) (Grant number 2100040) from Japan Science and Technology Agency. This study was supported in part by a Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COIstream) from Japan Science and Technology Agency. This study was supported in part by a Cross-ministerial Strategic Innovation Promotion Program (SIP) from Japan Science and Technology Agency.	Adney B, 2008, TECHNICAL REPORT; Liu QP, 2012, GREEN CHEM, V14, P304, DOI 10.1039/c2gc16128a; Yu YH, 2008, CHEM-EUR J, V14, P11174, DOI 10.1002/chem.200800620; Kamiya N, 2008, BIOTECHNOL LETT, V30, P1037, DOI 10.1007/s10529-008-9638-0; Wahlstrom R, 2014, BIOTECHNOL BIOENG, V111, P726, DOI 10.1002/bit.25144; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Dadi AP, 2006, BIOTECHNOL BIOENG, V95, P904, DOI 10.1002/bit.21047; Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107; Petkovic M, 2010, GREEN CHEM, V12, P643, DOI 10.1039/b922247b; Li L, 2012, RSC ADV, V2, P11712, DOI 10.1039/c2ra22128d; [Anonymous], 1988, METHOD ENZYMOL; Fukaya Y, 2007, GREEN CHEM, V9, P1155, DOI 10.1039/b706571j; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Brandt A, 2013, GREEN CHEM, V15, P550, DOI 10.1039/c2gc36364j; Abels C, 2013, BIORESOURCE TECHNOL, V149, P58, DOI 10.1016/j.biortech.2013.09.012; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Yang F, 2010, CARBOHYD POLYM, V81, P311, DOI 10.1016/j.carbpol.2010.02.031; Xu JX, 2014, BIORESOURCE TECHNOL, V157, P166, DOI 10.1016/j.biortech.2014.01.102; Shi J, 2013, GREEN CHEM, V15, P2579, DOI 10.1039/c3gc40545a; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Hu SQ, 2007, TETRAHEDRON LETT, V48, P5613, DOI 10.1016/j.tetlet.2007.06.051; Ninomiya K, 2013, BIOCHEM ENG J, V71, P25, DOI 10.1016/j.bej.2012.11.012; Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI [10.1002/bit.23045, 10.1002/btpr.566]; Ninomiya K, 2013, CHEM ENG J, V215, P811, DOI 10.1016/j.cej.2012.11.020; Ninomiya K, 2013, BIORESOURCE TECHNOL, V128, P188, DOI 10.1016/j.biortech.2012.10.097; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; Janesko BG, 2011, PHYS CHEM CHEM PHYS, V13, P11393, DOI 10.1039/c1cp20072k; Ouellet M, 2011, GREEN CHEM, V13, P2743, DOI 10.1039/c1gc15327g; Feng DX, 2011, APPL MICROBIOL BIOT, V91, P399, DOI 10.1007/s00253-011-3263-x; Engel P, 2010, GREEN CHEM, V12, P1959, DOI 10.1039/c0gc00135j; Hou XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059145; Konda NVSNM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-86; Remsing RC, 2006, CHEM COMMUN, P1271, DOI 10.1039/b600586c; Sluiter A, 2012, TECHNICAL REPORT; Sun N, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-39	35	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	JAN	2015	176						169	174		10.1016/j.biortech.2014.11.038		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AW0LE	WOS:000345982900023		
J	Asada, C; Sasaki, C; Takamatsu, T; Nakamura, Y				Asada, Chikako; Sasaki, Chizuru; Takamatsu, Tomoki; Nakamura, Yoshitoshi			Conversion of steam-exploded cedar into ethanol using simultaneous saccharification, fermentation and detoxification process	BIORESOURCE TECHNOLOGY			English	Article						Steam explosion; Simultaneous saccharification and fermentation; Cedar; Saccharomyces cerevisiae BA11; Ureibacillus thermosphaericus A1	UREIBACILLUS-THERMOSPHAERICUS; ENZYMATIC-HYDROLYSIS; FUEL ETHANOL; PRETREATMENT; WASTE; FRACTIONATION; OPTIMIZATION; SOFTWOOD; CORN	In this study, we investigated the simultaneous saccharification, fermentation and detoxification SSDF process of steam-exploded cedar using a detoxification microorganism, Ureibacillus thermosphaericus A1, to facilitate efficient ethanol production. Steam explosion was applied as a pretreatment before enzymatic saccharification followed by alcohol fermentation. The highest glucose conversion rate was observed in the sample pretreated with a steam pressure of 45 atm for 5 min. Alcohol production by a heat-tolerant yeast, Saccharomyces cerevisiae BA11, was inhibited strongly by inhibitory materials present in the steam-exploded cedar, such as formic acid, furfural, and 5-hydroxymethylfurfural. The maximum amount of ethanol, i.e., 0.155 g ethanol/g dry steam-exploded cedar, which corresponded to 74% of the theoretical ethanol yield, was obtained using the SSDF when U. thermosphaericus A1 degraded the inhibitory materials. A fed batch SSDF culture, in which U. thermosphaericus A1 was used to maintain low concentrations of inhibitory materials, was effective for increasing the ethanol concentration. (C) 2014 Elsevier Ltd. All rights reserved.	[Asada, Chikako; Sasaki, Chizuru; Takamatsu, Tomoki; Nakamura, Yoshitoshi] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan	Nakamura, Y (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Life Syst, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan.	ynakamu@bio.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25281048]	The authors thank Dr. Shinagawa (Bioacademia Co. Ltd., Japan) for providing S. cerevisiae BA11 and Prof. Ohshima (Kyushu University) for providing U. thermosphaericus A1. This investigation was partially supported by a Grant-in-Aid for Scientific Research (B) (No. 25281048) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akita H, 2012, BIOTECHNOL LETT, V34, P1693, DOI 10.1007/s10529-012-0952-1; Davis L, 2006, BIOMASS BIOENERG, V30, P809, DOI 10.1016/j.biombioe.2005.05.003; Romani A, 2011, BIORESOURCE TECHNOL, V102, P5896, DOI 10.1016/j.biortech.2011.02.070; Akita H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-43; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; ZACCHI G, 1989, BIOTECHNOL BIOENG, V34, P223, DOI 10.1002/bit.260340211; Sannigrahi P, 2011, ENERG ENVIRON SCI, V4, P1306, DOI 10.1039/c0ee00378f; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Palmqvist E, 1997, ENZYME MICROB TECH, V20, P286, DOI 10.1016/S0141-0229(96)00130-5; Okuda N, 2008, J BIOSCI BIOENG, V106, P128, DOI 10.1263/jbb.106.128; OVEREND RP, 1987, PHILOS T R SOC A, V321, P523, DOI 10.1098/rsta.1987.0029; Chum HL, 2014, BIOFUEL BIOPROD BIOR, V8, P205, DOI 10.1002/bbb.1448; Lim WS, 2013, BIORESOURCE TECHNOL, V140, P306, DOI 10.1016/j.biortech.2013.04.103; Sun ZY, 2013, BIORESOURCE TECHNOL, V128, P87, DOI 10.1016/j.biortech.2012.10.082; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Jonsson LJ, 1998, APPL MICROBIOL BIOT, V49, P691; Asada C, 2012, BIOCHEM ENG J, V60, P25, DOI 10.1016/j.bej.2011.09.013; Asada C, 2011, CARBOHYD POLYM, V85, P196, DOI 10.1016/j.carbpol.2011.02.020; Gagne A, 2001, CAN J MICROBIOL, V47, P908, DOI 10.1139/cjm-47-10-908; Garmakhany A. D., 2013, J SCI FOOD AGR, V94, P1607; HEITZ M, 1991, BIORESOURCE TECHNOL, V35, P23, DOI 10.1016/0960-8524(91)90078-X; Hirooka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062875; Kumar L, 2012, BIORESOURCE TECHNOL, V121, P190, DOI 10.1016/j.biortech.2012.06.049; Lee WG, 2000, BIOTECHNOL PROGR, V16, P302, DOI 10.1021/bp990130f; Ramachandriya KD, 2013, BIORESOURCE TECHNOL, V147, P168, DOI 10.1016/j.biortech.2013.08.048; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Sasaki C, 2014, BIOSCI BIOTECH BIOCH, V78, P160, DOI 10.1080/09168451.2014.877818; Shen JC, 2011, BIORESOURCE TECHNOL, V102, P9111, DOI 10.1016/j.biortech.2011.04.001; Weiqi Wei, 2013, Bioresour Technol, V128, P725, DOI 10.1016/j.biortech.2012.08.130; Yemis O, 2012, BIORESOURCE TECHNOL, V109, P215, DOI 10.1016/j.biortech.2012.01.031	30	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	JAN	2015	176						203	209		10.1016/j.biortech.2014.11.039		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AW0LE	WOS:000345982900028		
J	Li, ZL; Yoshida, N; Wang, AJ; Nan, J; Liang, B; Zhang, CF; Zhang, DD; Suzuki, D; Zhou, X; Xiao, ZX; Katayama, A				Li, Zhiling; Yoshida, Naoko; Wang, Aijie; Nan, Jun; Liang, Bin; Zhang, Chunfang; Zhang, Dongdong; Suzuki, Daisuke; Zhou, Xue; Xiao, Zhixing; Katayama, Arata			Anaerobic mineralization of 2,4,6-tribromophenol to CO2 by a synthetic microbial community comprising Clostridium, Dehalobacter, and Desulfatiglans	BIORESOURCE TECHNOLOGY			English	Article						2,4,6-Tribromophenol; Anaerobic mineralization; Synthetic anaerobe community; The optimized conditions	REDUCTIVE DECHLORINATION; PENTACHLOROPHENOL PCP; ESTUARINE SEDIMENTS; SEWAGE-SLUDGE; DEHALOGENATION; BIODEGRADATION; CULTURES; TETRACHLOROETHENE; CONSORTIA; KINETICS	Anaerobic mineralization of 2,4,6-tribromophenol (2,4,6-TBP) was achieved by a synthetic anaerobe community comprising a highly enriched culture of Dehalobacter sp. phylotype FTH1 acting as a reductive debrominator; Clostridium sp. strain Ma13 acting as a hydrogen supplier via glucose fermentation; and a novel 4-chlorophenol-degrading anaerobe, Desulfatiglans parachlorophenolica strain DS. 2,4,6-TBP was debrominated to phenol by the combined action of Ma13 and FTH1, then mineralized into CO2 by sequential introduction of DS, confirmed using [ring-C-14(U)] phenol. The optimum concentrations of glucose, SO42-, and inoculum densities were 0.5 or 2.5 mM, 1.0 or 2.5 mM, and the densities equivalent to 10(4) copies mL(-1) of the 16S rRNA genes, respectively. This resulted in the complete mineralization of 23 mu M 2,4,6-TBP within 35 days (0.58 mu mol L-1 d(-1)). Thus, using a synthetic microbial community of isolates or highly enriched cultures would be an efficient, optimizable, low-cost strategy for anaerobic bioremediation of halogenated aromatics. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Zhiling; Wang, Aijie; Nan, Jun] Harbin Inst Technol, SKLUWRE, HIT, State Key Lab Urban Water Resources & Environm, Harbin 150090, Peoples R China; [Li, Zhiling; Zhang, Chunfang; Suzuki, Daisuke; Katayama, Arata] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshida, Naoko] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Syowa Ku, Nagoya, Aichi 4668555, Japan; [Wang, Aijie; Liang, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Environm Biotechnol, Beijing 100085, Peoples R China; [Zhang, Dongdong; Xiao, Zhixing; Katayama, Arata] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zhou, Xue; Katayama, Arata] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Katayama, A (reprint author), Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	a-katayama@esi.nagoya-u.ac.jp			University Grant for "Design of cascade utilization system for unused biological resources in the Tokai area" from the Ministry of Education, Culture, Sports, Science and Technology of Japan [B2: 20310041, B2: 23310055, B2: 26281040]; New Energy and Industrial Technology Development Organization, Japan; Harbin Institute of Technology, China [HIT.NSRIF.2015092]; China Postdoctoral Science Foundation, China [2014M550196]	This study was supported by a University Grant for "Design of cascade utilization system for unused biological resources in the Tokai area," Grants-in-Aid for Scientific Research (B2: 20310041, B2: 23310055, and B2: 26281040) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the New Energy and Industrial Technology Development Organization, Japan, the innovation fund of Harbin Institute of Technology, China (HIT.NSRIF.2015092), as well as the China Postdoctoral Science Foundation, China (2014M550196).	Ahn YB, 2003, APPL ENVIRON MICROB, V69, P4159, DOI 10.1128/AEM.69.7.4159-4166.2003; Aktas O, 2012, BIORESOURCE TECHNOL, V103, P286, DOI 10.1016/j.biortech.2011.09.119; Uhnakova B, 2009, CHEMOSPHERE, V76, P826, DOI 10.1016/j.chemosphere.2009.04.016; Li ZL, 2013, ENVIRON SCI TECHNOL, V47, P1534, DOI 10.1021/es303784f; Yoshida N, 2009, APPL ENVIRON MICROB, V75, P2400, DOI 10.1128/AEM.02112-08; Lacroix E, 2014, APPL ENVIRON MICROB, V80, P3858, DOI 10.1128/AEM.00493-14; Li ZL, 2010, BIOTECHNOL BIOENG, V107, P775, DOI 10.1002/bit.22841; Sim WJ, 2009, CHEMOSPHERE, V77, P552, DOI 10.1016/j.chemosphere.2009.07.006; Suzuki D, 2014, INT J SYST EVOL MICR, V64, P3081, DOI 10.1099/ijs.0.064360-0; Chang BV, 1998, CHEMOSPHERE, V36, P537, DOI 10.1016/S0045-6535(97)10012-1; Ronen Z, 2000, APPL ENVIRON MICROB, V66, P2372, DOI 10.1128/AEM.66.6.2372-2377.2000; De Roy K, 2014, ENVIRON MICROBIOL, V16, P1472, DOI 10.1111/1462-2920.12343; Zu L, 2012, BIORESOURCE TECHNOL, V110, P153, DOI 10.1016/j.biortech.2012.01.131; Boyle AW, 1999, APPL ENVIRON MICROB, V65, P1133; Chang BV, 1999, J ENVIRON SCI HEAL B, V34, P491, DOI 10.1080/03601239909373210; Christof H., 1999, FEMS MICROBIOL REV, V22, P383; HAGGBLOM MM, 1992, FEMS MICROBIOL LETT, V103, P29; Mazur CS, 2001, ENVIRON SCI TECHNOL, V35, P4783, DOI 10.1021/es0110372; Mazur CS, 2003, BIODEGRADATION, V14, P285, DOI 10.1023/A:1024765706617; MOHN WW, 1992, APPL ENVIRON MICROB, V58, P1367; Smatlak CR, 1996, ENVIRON SCI TECHNOL, V30, P2850, DOI 10.1021/es9602455; United State Environmental Pollution Agency (USEPA), 2003, EPA816F03016; Yamada T, 2008, BIOSCI BIOTECH BIOCH, V72, P1264, DOI 10.1271/bbb.70755; Yang S, 2009, BIOTECHNOL BIOENG, V102, P81, DOI 10.1002/bit.22032; Yoshida N, 2013, BIORESOURCE TECHNOL, V130, P478, DOI 10.1016/j.biortech.2012.11.139	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	JAN	2015	176						225	232		10.1016/j.biortech.2014.10.097		8	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AW0LE	WOS:000345982900031		
J	Saitoh, Y; Gotoh, M; Katagiri, S; Ohyashiki, K				Saitoh, Yuu; Gotoh, Moritaka; Katagiri, Seiichiro; Ohyashiki, Kazuma			Diffuse large B-cell lymphoma resembling a metastatic liver tumour	BRITISH JOURNAL OF HAEMATOLOGY			English	Article									[Saitoh, Yuu; Gotoh, Moritaka; Katagiri, Seiichiro; Ohyashiki, Kazuma] Tokyo Med Univ, Dept Haematol, Tokyo 1608402, Japan	Saitoh, Y (reprint author), Tokyo Med Univ, Dept Haematol, Tokyo 1608402, Japan.	yusaitoh@tokyo-med.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JAN	2015	168	1					1	1		10.1111/bjh.13163		1	Hematology	Hematology	AW2YD	WOS:000346151600001		
J	Reiche, HM; Carpenter, JS; Stein, F; Tomida, T; Vogel, SC				Reiche, H. M.; Carpenter, J. S.; Stein, F.; Tomida, T.; Vogel, S. C.			Metallurgical studies with the HIPPO diffractometer at LANSCE	CANADIAN METALLURGICAL QUARTERLY			English	Article						Low carbon steel; Texture memory effect; Nanocomposites; Multilayer; Variant selection; Creep furnace; Neutron diffraction	NB NANOLAMELLAR COMPOSITES; BONDING ARB PROCESS; FE-AL SYSTEM; ENGINEERING MATERIALS; NEUTRON-DIFFRACTION; PHASE-EQUILIBRIA; HIGH-STRENGTH; TEXTURE; INTERFACES; EVOLUTION	Advantages of neutron diffraction for metallurgical studies are highlighted with research examples performed on the High Pressure -Preferred Orientation diffractometerat the Los Alamos Neutron Science Center. The previously inconclusive crystallographic structure of the Fe-Al epsilon-phase, stable between 1095 and 1231 degrees C, was determined by in situ neutron diffraction to have the formula Fe5Al8 with a body centred cubic structure of the Hume-Rothery Cu5Zn8 type at 1120 degrees C. As a second example, the effect of variations in accumulative roll bonding processing parameters on interfacial structure, hardness, and thermal stability are explored for lamellar Cu-Nb multilayers with individual layer thicknesses of 20 nm. Furthermore, we derive an explanation for observed texture memory effects during the alpha ->gamma ->alpha transformation cycle in a 0.1% C-1% Mn hot rolled steel sheet from the double Kurdjumov-Sachs relationship. Finally, we present in situ results of a Zr-2.5Nb sample heated into the beta-field and subsequently compressed by 20% via our recently developed creep furnace which uniquely allows deconvolution of the effects of heating, phase transformations, deformation and cooling on the texture evolution.	[Reiche, H. M.; Vogel, S. C.] Los Alamos Natl Lab, Los Alamos Neutron Scattering Ctr, Los Alamos, NM 87545 USA; [Carpenter, J. S.] Los Alamos Natl Lab, Mat Sci & Technol Div, Los Alamos, NM 87545 USA; [Stein, F.] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany; [Tomida, T.] Nippon Steel & Sumitomo Met Corp, Steel Res Labs, Tech Res & Dev Bur, Amagasaki, Hyogo 6600891, Japan	Reiche, HM (reprint author), Los Alamos Natl Lab, Los Alamos Neutron Scattering Ctr, Los Alamos, NM 87545 USA.	reiche@lanl.gov			US Department of Energy's Office of Basic Energy Science; Center for Materials at Irradiation and Mechanical Extremes, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences [2008LANL1026]; DOE [DE-AC52-06NA25396]	This work benefited from the Lujan Neutron Scattering Center at the Los Alamos Neutron Science Center which was funded by the US Department of Energy's Office of Basic Energy Science. The authors gratefully acknowledge support from the Center for Materials at Irradiation and Mechanical Extremes, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number 2008LANL1026. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated by the US Department of Energy, Office of Science. The Los Alamos National Laboratory is operated by the Los Alamos National Security LLC under the DOE Contract DE-AC52-06NA25396.	Carpenter JS, 2014, METALL MATER TRANS A, V45A, P2192, DOI 10.1007/s11661-013-2162-4; Saito Y, 1998, SCRIPTA MATER, V39, P1221, DOI 10.1016/S1359-6462(98)00302-9; Ino T, 2004, NUCL INSTRUM METH A, V525, P496, DOI 10.1016/j.nima.2004.02.003; Santisteban JR, 2006, J APPL CRYSTALLOGR, V39, P812, DOI 10.1107/S0021889806042245; Pirling T, 2006, MAT SCI ENG A-STRUCT, V437, P139, DOI 10.1016/j.msea.2006.04.083; Wang XL, 2006, PHYSICA B, V385, P673, DOI 10.1016/j.physb.2006.06.103; Wenk HR, 2010, POWDER DIFFR, V25, P283, DOI 10.1154/1.3479004; Lisowski PW, 2006, NUCL INSTRUM METH A, V562, P910, DOI 10.1016/j.nima.2006.02.178; Carpenter JS, 2012, ACTA MATER, V60, P1576, DOI 10.1016/j.actamat.2011.11.045; Stein F, 2007, INT J MATER RES, V98, P580, DOI 10.3139/146.101512; Han WZ, 2013, ADV MATER, V25, P6975, DOI 10.1002/adma.201303400; TAYLOR A, 1958, J PHYS CHEM SOLIDS, V6, P16, DOI 10.1016/0022-3697(58)90213-0; Beyerlein IJ, 2013, J MATER RES, V28, P1799, DOI 10.1557/jmr.2013.21; Reiche HM, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4708619; Saito Y, 1999, ACTA MATER, V47, P579, DOI 10.1016/S1359-6454(98)00365-6; Carpenter JS, 2013, PHILOS MAG, V93, P718, DOI 10.1080/14786435.2012.731527; Beyerlein IJ, 2012, JOM-US, V64, P1192, DOI 10.1007/s11837-012-0431-0; Bourke MAM, 2002, APPL PHYS A-MATER, V74, pS1707, DOI 10.1007/s003390201747; Ducher R, 2003, Z METALLKD, V94, P396; Eumann M, 2008, INTERMETALLICS, V16, P834, DOI 10.1016/j.intermet.2008.04.001; Gwyer A.G.C., 1908, Zeitschrift fur Anorganische Chemie, V57, DOI 10.1002/zaac.19080570106; Harjo S., 2011, MATER SCI FORUM, V681, P443, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/MSF.681.443; Kirstein O, 2008, ADV MAT RES, V41-42, P439, DOI 10.4028/www.scientific.net/AMR.41-42.439; Kurdjumow G, 1930, Z PHYS, V64, P325, DOI 10.1007/BF01397346; Osawa A., 1933, SCI REP TOHOKU IMP U, V22, P803; Palm M, 1997, J ALLOY COMPD, V252, P192, DOI 10.1016/S0925-8388(96)02719-3; Stein F, 2010, INTERMETALLICS, V18, P150, DOI 10.1016/j.intermet.2009.07.006; Tomida T, 2013, ACTA MATER, V61, P2828, DOI 10.1016/j.actamat.2013.01.015; Vogel S., 2013, MAT SCI, V2013; Vogel SC, 2006, REV MINERAL GEOCHEM, V63, P27, DOI 10.2138/rmg.2006.63.2; Vogel SC, 2004, POWDER DIFFR, V19, P65, DOI 10.1154/1.1649961; Vogel SC, 2010, APPL PHYS A-MATER, V99, P607, DOI 10.1007/s00339-010-5619-y; Zheng SJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2651; Zheng SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04226	34	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0008-4433	1879-1395		CAN METALL QUART	Can. Metall. Q.	JAN	2015	54	1					2	8		10.1179/1879139514Y.0000000157		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AW2NT	WOS:000346126000002		
J	Andocs, G; Meggyeshazi, N; Balogh, L; Spisak, S; Maros, ME; Balla, P; Kiszner, G; Teleki, I; Kovago, C; Krenacs, T				Andocs, Gabor; Meggyeshazi, Nora; Balogh, Lajos; Spisak, Sandor; Maros, Mate Elod; Balla, Peter; Kiszner, Gergo; Teleki, Ivett; Kovago, Csaba; Krenacs, Tibor			Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia	CELL STRESS & CHAPERONES			English	Article						Modulated electrohyperthermia; Damage-associated molecular pattern; Calreticulin; Heat shock protein; High-mobility group box1 protein	CELL-DEATH; PHOTODYNAMIC THERAPY; ANTITUMOR IMMUNITY; BREAST-CANCER; HYPERTHERMIA; STRESS; HSP70; IMMUNOGENICITY; CALRETICULIN; CHEMOTHERAPY	In modulated electrohyperthermia (mEHT) the enrichment of electric field and the concomitant heat can selectively induce cell death in malignant tumors as a result of elevated glycolysis, lactate production (Warburg effect), and reduced electric impedance in cancer compared to normal tissues. Earlier, we showed in HT29 colorectal cancer xenografts that the mEHT-provoked programmed cell death was dominantly caspase independent and driven by apoptosis inducing factor activation. Using this model here, we studied the mEHT-related cell stress 0-, 1-, 4-, 8-, 14-, 24-, 48-, 72-, 120-, 168- and 216-h post-treatment by focusing on damage-associated molecular pattern (DAMP) signals. Significant cell death response upon mEHT treatment was accompanied by the early upregulation (4-h post-treatment) of heat shock protein (Hsp70 and Hsp90) mRNA levels. In situ, the treatment resulted in spatiotemporal occurrence of a DAMP protein signal sequence featured by the significant cytoplasmic to cell membrane translocation of calreticulin at 4 h, Hsp70 between 14 and 24 h and Hsp90 between 24- and 216-h post-treatment. The release of high-mobility group box1 protein (HMGB1) from tumor cell nuclei from 24-h post-treatment and its clearance from tumor cells by 48 h was also detected. Our results suggest that mEHT treatment can induce a DAMP-related signal sequence in colorectal cancer xenografts that may be relevant for promoting immunological cell death response, which need to be further tested in immune-competent animals.	[Andocs, Gabor] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 930, Japan; [Meggyeshazi, Nora; Maros, Mate Elod; Balla, Peter; Kiszner, Gergo; Teleki, Ivett; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Balogh, Lajos] Frederic Joliot Curie Natl Res Inst Radiobiol & R, Budapest, Hungary; [Spisak, Sandor] MTA SE Mol Med Res Grp, Budapest, Hungary; [Kovago, Csaba] Szent Istvan Univ, Fac Vet Sci, Dept Pharmacol & Toxicol, Budapest, Hungary; [Krenacs, Tibor] MTA SE Tumor Progress Res Grp, Budapest, Hungary	Krenacs, T (reprint author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Ulloi Ut 26, H-1085 Budapest, Hungary.	krenacst@gmail.com			 [TET_10-1-2011-0914]	The authors are utterly grateful to Edith Parsch, Renata Papp, and Sandor Kiss for their technical assistance. This work was supported by TET_10-1-2011-0914 grant in Hungary.	Feyerabend T, 2001, INT J RADIAT ONCOL, V49, P1317, DOI 10.1016/S0360-3016(00)01514-5; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Frey B, 2012, INT J HYPERTHER, V28, P528, DOI 10.3109/02656736.2012.677933; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Gehrmann M, 2008, CELL STRESS CHAPERON, V13, P1, DOI 10.1007/s12192-007-0006-0; Andocs G, 2009, ELECTROMAGN BIOL MED, V28, P148, DOI 10.1080/15368370902724633; Andocs G, 2009, STRAHLENTHER ONKOL, V185, P120, DOI 10.1007/s00066-009-1903-1; Schildkopf P, 2010, BIOCHEM BIOPH RES CO, V391, P1014, DOI 10.1016/j.bbrc.2009.12.008; Ladoire S, 2014, ANTIOXID REDOX SIGN, V20, P1098, DOI 10.1089/ars.2012.5133; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; Mace TA, 2012, INT J HYPERTHER, V28, P9, DOI 10.3109/02656736.2011.616182; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Mroz P, 2011, EXPERT REV CLIN IMMU, V7, P75, DOI [10.1586/eci.10.81, 10.1586/ECI.10.81]; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)0060-X; Pfister K, 2007, CANCER, V110, P926, DOI 10.1002/cncr.22864; Guo ZS, 2013, AM J CANCER RES, V3, P1; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Mantel F, 2010, STRAHLENTHER ONKOL, V186, P587, DOI 10.1007/s00066-010-2154-x; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Fiorentini G, 2006, IN VIVO, V20, P721; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Zou Y, 2003, MED ENG PHYS, V25, P79, DOI 10.1016/S1350-4533(02)00194-7; Multhoff G, 2012, STRAHLENTHER ONKOL, V188, P312, DOI 10.1007/s00066-012-0206-0; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; D'Eliseo D, 2013, CELL STRESS CHAPERON, V18, P801, DOI 10.1007/s12192-013-0422-2; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Multhoff G, 2011, CELL STRESS CHAPERON, V16, P251, DOI 10.1007/s12192-010-0247-1; Garg AD, 2014, CELL DEATH DIFFER, V21, P26, DOI 10.1038/cdd.2013.48; Blad B, 1996, PHYSIOL MEAS, V17, pA105, DOI 10.1088/0967-3334/17/4A/015; Blad B, 1999, J MED ENG TECHNOL, V23, P57; Blank Martin, 2009, Pathophysiology, V16, P71, DOI 10.1016/j.pathophys.2009.01.006; Fiorentini Giammaria, 2006, J Cancer Res Ther, V2, P41; Hager ED, 1999, ANTICANCER RES, V19, P3403; Horvath I, 2010, NATURE, V463, P436, DOI 10.1038/463436a; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Martins I, 2012, AUTOPHAGY, V8, P413, DOI [10.4161/auto.19009, 10.4161/auto.8.3.19009]; Meggyeshazi N, 2014, STRAHLENTHER ONKOL, V190, P815, DOI 10.1007/s00066-014-0617-1; Sachamitr P, 2012, EXPERT REV CLIN IMMU, V8, P547, DOI 10.1586/ECI.12.45; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356	42	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	JAN	2015	20	1					37	46		10.1007/s12192-014-0523-6		10	Cell Biology	Cell Biology	AW0PG	WOS:000345994600005		
J	Zhou, QJ; Gao, Y; Wang, F; An, DM; Li, Y; Zou, YL; Li, ZP; Wang, WB				Zhou, Qingjun; Gao, Yuan; Wang, Fang; An, Dongmin; Li, Yan; Zou, Yunling; Li, Zepeng; Wang, Weibo			Novel cobalt-free cathode material (Nd0.9La0.1)(2)(Ni0.74Cu0.21Al0.05)O4+delta for intermediate-temperature solid oxide fuel cells	CERAMICS INTERNATIONAL			English	Article						Thermal expansion; Electrical conductivity; Solid oxide fuel cells; Cobalt-free cathode; Impedance spectroscopy	PR2NIO4-BASED MIXED CONDUCTOR; IT-SOFC; ELECTROCHEMICAL PERFORMANCE; CRYSTAL-STRUCTURE; PEROVSKITE OXIDE; (PR0.9LA0.1)(2)(NI0.74CU0.21GA0.05)O4+DELTA; LNBACO(2)O(5+DELTA); GD; ND	The Ruddlesden-Popper phase, (Nd0.9La0.1)(2)(Ni0.74Cu0.21Al0.05)O4+delta (NLNCA), has been investigated as an alternative cathode material for intermediate-temperature solid oxide fuel cells (IT-SOFCs). Its electrical conductivity is 51-60 S cm(-1) over the temperature range of 650-800 degrees C. The average thermal-expansion coefficient (TEC) value of NLNCA is 13.2 x 10(-6) K-1. The area specific resistance (ASR) of the NLNCA cathode measured on a Sm0 2Ce0.8O1.9 (SDC) electrolyte reaches a relatively low value of 0.048 Omega cm(2) at 800 degrees C. A maximum power density of 521 mW cm(-2) is obtained at 800 degrees C for single-cell with thickness of similar to 300 mu m SDC electrolyte. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Zhou, Qingjun; Gao, Yuan; An, Dongmin; Li, Yan; Zou, Yunling; Li, Zepeng; Wang, Weibo] Civil Aviat Univ China, Coll Sci, Tianjin 300300, Peoples R China; [Wang, Fang] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan	Zhou, QJ (reprint author), Civil Aviat Univ China, Coll Sci, Tianjin 300300, Peoples R China.	qjzhou@cauc.edu.cn			Fundamental Research Funds for the Central Universities [ZXH2012D016]; Training Programs for Innovation and Entrepreneurship [IECAUC14055]; Natural Science Foundation of China [51002183, 51102277, 11304380]; Significant Pre-research Funds of Civil Aviation University of China [3122013P001]; Tianjin Reasearch Program of Application Foundation and Advanced Technology [13JCQNJC07100]; Funds of Tianjin Natural Science [13CYBJC16000]	This work was supported by the Fundamental Research Funds for the Central Universities (ZXH2012D016), Training Programs for Innovation and Entrepreneurship (IECAUC14055), the Natural Science Foundation of China (51002183, 51102277, and 11304380), the Significant Pre-research Funds of Civil Aviation University of China (3122013P001), Tianjin Reasearch Program of Application Foundation and Advanced Technology (13JCQNJC07100), the Funds of Tianjin Natural Science (13CYBJC16000).	Huang C, 2010, J POWER SOURCES, V195, P5176, DOI 10.1016/j.jpowsour.2010.02.080; Qiu L, 2003, SOLID STATE IONICS, V158, P55, DOI 10.1016/S0167-2738(02)00757-9; CHICK LA, 1990, MATER LETT, V10, P6, DOI 10.1016/0167-577X(90)90003-5; Park SD, 2000, NATURE, V404, P265; Zhou QJ, 2008, J POWER SOURCES, V185, P754, DOI 10.1016/j.jpowsour.2008.07.064; Sun LP, 2012, INT J HYDROGEN ENERG, V37, P11955, DOI 10.1016/j.ijhydene.2012.05.112; Chen Y, 2013, INT J BIOL MACROMOL, V52, P52, DOI 10.1016/j.ijbiomac.2012.09.005; Steele BCH, 2000, SOLID STATE IONICS, V129, P95, DOI 10.1016/S0167-2738(99)00319-7; Li Q, 2012, INT J HYDROGEN ENERG, V37, P2552, DOI 10.1016/j.ijhydene.2011.11.014; Kim JH, 2008, J ELECTROCHEM SOC, V155, pB385, DOI 10.1149/1.2839028; Wei B, 2008, J POWER SOURCES, V176, P1, DOI 10.1016/j.jpowsour.2007.09.120; Wang YX, 2014, CERAM INT, V40, P7321, DOI 10.1016/j.ceramint.2013.12.074; Zhang K, 2008, ACTA MATER, V56, P4876, DOI 10.1016/j.actamat.2008.06.004; Zhang Y, 2008, SOLID STATE IONICS, V179, P250, DOI 10.1016/j.ssi.2008.02.008; Xia CR, 2002, ADV MATER, V14, P521, DOI 10.1002/1521-4095(20020404)14:7<521::AID-ADMA521>3.3.CO;2-3; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Zhou QJ, 2010, ELECTROCHEM COMMUN, V12, P285, DOI 10.1016/j.elecom.2009.12.016; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Yashima M, 2010, J AM CHEM SOC, V132, P2385, DOI 10.1021/ja909820h; Zhou QJ, 2012, INT J HYDROGEN ENERG, V37, P11963, DOI 10.1016/j.ijhydene.2012.05.114; Zhou W, 2008, ELECTROCHEM COMMUN, V10, P1647, DOI 10.1016/j.elecom.2008.08.033; Zhou QJ, 2012, CURR APPL PHYS, V12, P1092, DOI 10.1016/j.cap.2012.01.012; Yashima M, 2008, J AM CHEM SOC, V130, P2762, DOI 10.1021/ja711478h; Peng SJ, 2013, INT J HYDROGEN ENERG, V38, P10552, DOI 10.1016/j.ijhydene.2013.06.073; Xia CR, 2002, SOLID STATE IONICS, V149, P11, DOI 10.1016/S0167-2738(02)00131-5; Wang YF, 2011, J POWER SOURCES, V196, P3104, DOI 10.1016/j.jpowsour.2010.11.106; Wei B, 2006, J EUR CERAM SOC, V26, P2827, DOI 10.1016/j.jeurceramsoc.2005.06.047; Tu HY, 1999, SOLID STATE IONICS, V117, P277, DOI 10.1016/S0167-2738(98)00428-7; Zhao K, 2012, J SOLID STATE ELECTR, V16, P9, DOI 10.1007/s10008-010-1270-y	29	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	JAN	2015	41	1	A				639	643		10.1016/j.ceramint.2014.08.114		5	Materials Science, Ceramics	Materials Science	AW3XK	WOS:000346216300076		
J	Ozawa, A; Shimizu, A; Nishiyabu, R; Kubo, Y				Ozawa, Ayumi; Shimizu, Ai; Nishiyabu, Ryuhei; Kubo, Yuji			Thermo-responsive white-light emission based on tetraphenylethylene- and rhodamine B-containing boronate nanoparticles	CHEMICAL COMMUNICATIONS			English	Article							METAL-ORGANIC FRAMEWORK; AGGREGATION-INDUCED EMISSION; WIDE TEMPERATURE-RANGE; LUMINESCENT THERMOMETER; EMITTING MATERIALS; ENERGY-TRANSFER; SOLID-STATE; FLUORESCENCE; SENSOR; DYES	Boronate nanoparticles with built-in tetraphenylethylene (TPE) have been prepared. Their emissive color tuning by altering the amount of rhodamine B grafted onto the surface gave white-light emissive nanoparticles. They showed reversible and thermo-responsive emission in the temperature range of 5-65 degrees C in water, which enabled them to serve as a bright nanothermometer.	[Ozawa, Ayumi; Shimizu, Ai; Nishiyabu, Ryuhei; Kubo, Yuji] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan	Kubo, Y (reprint author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, 1-1 Minami Ohsawa, Hachioji, Tokyo 1920397, Japan.	yujik@tmu.ac.jp	Nishiyabu, Ryuhei/I-9440-2014	Nishiyabu, Ryuhei/0000-0002-2351-1917	Ministry of Education, Science, Sports and Culture of Japan [24350075]	We thank JASCO for assistance in measuring the emission quantum yield of solid-state BPs. This research was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture of Japan (no. 24350075).	Abbel R, 2009, CHEM COMMUN, P1697, DOI 10.1039/b822943k; ADAMS AD, 2007, Patent No. 2007100610; Jiang YN, 2014, ACS APPL MATER INTER, V6, P4650, DOI 10.1021/am501106x; Noguchi T, 2014, CHEM-EUR J, V20, P381, DOI 10.1002/chem.201304031; Li LG, 2012, ACS MACRO LETT, V1, P1335, DOI 10.1021/mz300440q; Tang C, 2013, MACROMOL CHEM PHYS, V214, P314, DOI 10.1002/macp.201200305; Cui YJ, 2014, CHEM COMMUN, V50, P719, DOI 10.1039/c3cc47225f; Abbel R, 2009, J AM CHEM SOC, V131, P833, DOI 10.1021/ja807996y; Liu L, 2008, ORG LETT, V10, P4581, DOI 10.1021/ol801855s; Praveen VK, 2014, ANGEW CHEM INT EDIT, V53, P365, DOI 10.1002/anie.201306787; Nishiyabu R, 2012, CHEMPLUSCHEM, V77, P201, DOI 10.1002/cplu.201100008; Hong YN, 2009, CHEM COMMUN, P4332, DOI 10.1039/b904665h; Liu Y, 2011, J AM CHEM SOC, V133, P660, DOI 10.1021/ja107086y; Hu R, 2014, CHEM SOC REV, V43, P4494, DOI 10.1039/c4cs00044g; Wang SP, 2002, J PHYS CHEM B, V106, P11203, DOI 10.1021/jp026445m; Abbel R, 2009, CHEM-EUR J, V15, P9737, DOI 10.1002/chem.200900620; Park C, 2010, TETRAHEDRON LETT, V51, P1960, DOI 10.1016/j.tetlet.2010.02.009; Shustova NB, 2012, J AM CHEM SOC, V134, P15061, DOI 10.1021/ja306042w; Vijayakumar C, 2011, CHEM SCI, V2, P291, DOI 10.1039/c0sc00343c; Bairi P, 2013, ACS APPL MATER INTER, V5, P5478, DOI 10.1021/am4013566; Rao XT, 2013, J AM CHEM SOC, V135, P15559, DOI 10.1021/ja407219k; Wu HB, 2009, CHEM SOC REV, V38, P3391, DOI 10.1039/b816352a; Wang XD, 2013, CHEM SOC REV, V42, P7834, DOI 10.1039/c3cs60102a; Chang SC, 2012, POLYMER, V53, P4399, DOI 10.1016/j.polymer.2012.08.026; Chandrasekharan N, 2001, J AM CHEM SOC, V123, P9898, DOI 10.1021/ja016153j; Chen CY, 2011, CHEM COMMUN, V47, P994, DOI 10.1039/c0cc04450d; Kajiwara Y, 2013, J MATER CHEM C, V1, P4437, DOI 10.1039/c3tc30276h; Shustova NB, 2013, J AM CHEM SOC, V135, P13326, DOI 10.1021/ja407778a; Tang L, 2009, CHEM COMMUN, P4974, DOI 10.1039/b907382e; Zhao ZJ, 2012, J MATER CHEM, V22, P23726, DOI 10.1039/c2jm31949g; D'Vries RF, 2013, J MATER CHEM C, V1, P6316, DOI 10.1039/c3tc30858h; Jaque D, 2014, NANOMEDICINE-UK, V9, P1047, DOI [10.2217/nnm.14.59, 10.2217/NNM.14.59]; Gather MC, 2011, ADV MATER, V23, P233, DOI 10.1002/adma.201002636; Brites CDS, 2012, NANOSCALE, V4, P4799, DOI 10.1039/c2nr30663h; Zhang X, 2009, NAT CHEM, V1, P623, DOI [10.1038/nchem.368, 10.1038/NCHEM.368]; Giansante C, 2012, J PHYS CHEM C, V116, P21706, DOI 10.1021/jp3073188; Matsushima Y, 2012, J MATER CHEM, V22, P24124, DOI 10.1039/c2jm34797k; Liu NN, 2012, CHEM COMMUN, V48, P4908, DOI 10.1039/c2cc30448a; Mellerup SK, 2014, ORGANOMETALLICS, V33, P5483, DOI 10.1021/om500757r; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Pais VF, 2014, CHEM-EUR J, V20, P7638, DOI 10.1002/chem.201402027; Noguchi T, 2012, CHEM COMMUN, V48, P8090, DOI 10.1039/c2cc33262k; Feng J, 2011, ANGEW CHEM INT EDIT, V50, P8072, DOI 10.1002/anie.201102390; Farinola GM, 2011, CHEM SOC REV, V40, P3467, DOI 10.1039/c0cs00204f; Tseng KP, 2011, ANGEW CHEM INT EDIT, V50, P7032, DOI 10.1002/anie.201101945; Fujiwara S, 2014, GREEN CHEM, V16, P3230, DOI 10.1039/c4gc00383g; Brewster RE, 2001, CHEM COMMUN, P1134, DOI 10.1039/b102156g; Gai FY, 2012, NANOSCALE, V4, P6041, DOI 10.1039/c2nr31194a; Gervais C, 2002, J ORGANOMET CHEM, V657, P75, DOI 10.1016/S0022-328X(02)01586-3; Ghosh S, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/4/045704; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Lee SY, 2009, CHEM-EUR J, V15, P6103, DOI 10.1002/chem.200900683; Liu Y, 2011, CHEM-EUR J, V17, P14736, DOI 10.1002/chem.201102613; Luo WJ, 2014, CHEM COMMUN, V50, P11942, DOI 10.1039/c4cc05120c; Ma ML, 2014, J MATER CHEM C, V2, P1085, DOI 10.1039/c3tc32001d; Malinge J, 2012, ANGEW CHEM INT EDIT, V51, P8534, DOI 10.1002/anie.201203374; Neelakandan PP, 2014, CHEM SCI, V5, P908, DOI 10.1039/c3sc53172d; Nishiyabu R, 2013, CHEM COMMUN, V49, P9869, DOI 10.1039/c3cc45739g; Ross D, 2001, ANAL CHEM, V73, P4117, DOI 10.1021/ac010370l; Wang H, 2013, J MATER CHEM C, V1, P5367, DOI 10.1039/c3tc31097c; Zeng Q, 2007, CHEM COMMUN, P70, DOI 10.1039/b613522f; Zhang X, 2013, CHEM COMMUN, V49, P8178, DOI 10.1039/c3cc44875d	62	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	1					118	121		10.1039/c4cc07405j		4	Chemistry, Multidisciplinary	Chemistry	AU9JW	WOS:000345909400022		
J	Ito, S; Tokimaru, Y; Nozaki, K				Ito, S.; Tokimaru, Y.; Nozaki, K.			Isoquinolino[4,3,2-de]phenanthridine: synthesis and its use in 1,3-dipolar cycloadditions to form nitrogen-containing polyaromatic hydrocarbons	CHEMICAL COMMUNICATIONS			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AZOMETHINE YLIDES; DIPOLAR CYCLOADDITION; TERMINAL ALKYNES; N-HETEROACENES; FAMILY; 2,3-DIHYDROISOXAZOLES; FULLEROPYRROLIDINES; ORGANIZATION; DERIVATIVES	The synthesis of the novel azomethine ylide, isoquinolino[4,3,2-de]phenanthridine, and its use in 1,3-dipolar cycloaddition with various alkenes and alkynes to form the corresponding fused pyrrolidines and pyrroles is reported.	[Ito, S.; Tokimaru, Y.; Nozaki, K.] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Ito, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ito_shingo@chembio.t.u-tokyo.ac.jp; nozaki@chembio.t.u-tokyo.ac.jp	Ito, Shingo/D-3001-2011; Nozaki, Kyoko/E-8779-2010	Ito, Shingo/0000-0003-1776-4608; 	"Nanotechnology Platform" of MEXT, Japan [12024046]	A part of this work was supported by "Nanotechnology Platform" (No. 12024046) of MEXT, Japan. The authors would like to thank Prof. Eiichi Nakamura, Dr Koji Harano, and Ms Utako Takeda (The University of Tokyo) for the preparative HPLC separation of compound 9.	Adrio J, 2014, CHEM COMMUN, V50, P12434, DOI 10.1039/c4cc04381b; Albrecht M, 2008, SYNTHESIS-STUTTGART, P2451, DOI 10.1055/s-2008-1067128; Zhou J, 2012, ANGEW CHEM INT EDIT, V51, P12293, DOI 10.1002/anie.201206578; Lauria A, 2014, EUR J ORG CHEM, V2014, P3289, DOI 10.1002/ejoc.201301695; Najera C, 2003, CURR ORG CHEM, V7, P1105, DOI 10.2174/1385272033486594; He B, 2014, CHEM MATER, V26, P3920, DOI 10.1021/cm5018272; Bunz UHF, 2013, ANGEW CHEM INT EDIT, V52, P3810, DOI 10.1002/anie.201209479; Goto K, 2012, ANGEW CHEM INT EDIT, V51, P10333, DOI 10.1002/anie.201204863; Lee DJ, 2014, J AM CHEM SOC, V136, P11606, DOI 10.1021/ja5061609; Amblard F, 2009, CHEM REV, V109, P4207, DOI 10.1021/cr9001462; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Wei JF, 2010, ANGEW CHEM INT EDIT, V49, P8209, DOI 10.1002/anie.201002369; Tong CH, 2012, ORG LETT, V14, P494, DOI 10.1021/ol2030839; Wu DQ, 2009, J AM CHEM SOC, V131, P9620, DOI 10.1021/ja902420u; MAGGINI M, 1993, J AM CHEM SOC, V115, P9798, DOI 10.1021/ja00074a056; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Adrio J, 2011, CHEM COMMUN, V47, P6784, DOI 10.1039/c1cc10779h; Wu DQ, 2009, ORG LETT, V11, P5686, DOI 10.1021/ol902366y; Vaid TP, 2011, J AM CHEM SOC, V133, P15838, DOI 10.1021/ja205738z; Pandey G, 2006, CHEM REV, V106, P4484, DOI 10.1021/cr050011g; Kanemasa S, 2010, HETEROCYCLES, V82, P87, DOI 10.3987/REV-10-666; Prato M, 1998, ACCOUNTS CHEM RES, V31, P519, DOI 10.1021/ar970210p; Bunz UHF, 2009, CHEM-EUR J, V15, P6780, DOI 10.1002/chem.200900990; Takase M, 2013, J AM CHEM SOC, V135, P8031, DOI 10.1021/ja402371f; Kou Y, 2011, ANGEW CHEM INT EDIT, V50, P8753, DOI 10.1002/anie.201103493; Coldham I, 2005, CHEM REV, V105, P2765, DOI 10.1021/cr040004c; Berger R, 2014, ANGEW CHEM INT EDIT, V53, P10520, DOI 10.1002/anie.201403302; Chen XP, 2011, CHEM-EUR J, V17, P9920, DOI 10.1002/chem.201101483; Diederich F., 1993, HELV CHIM ACTA, V76, P2443; DOSTAL J, 1994, B SOC CHIM BELG, V103, P343; FREEMAN JP, 1983, CHEM REV, V83, P241, DOI 10.1021/cr00055a002; Jin TN, 2012, CHEMCATCHEM, V4, P1217, DOI 10.1002/cctc.201200193; Jung H.-J., 2011, US Pat, Patent No. [2011/0240977, 20110240977]; Krautler B, 1996, TETRAHEDRON, V52, P5033, DOI 10.1016/0040-4020(96)00111-1; Lim J.-O., 2011, US Pat, Patent No. [2011/0240978, 20110240978]; Lopez-Calle E, 2003, EUR J ORG CHEM, P1438; Markaryan S. A., 1987, ARM KHIM ZH, V40, P334; Mehrabi H, 2014, SYNTHETIC COMMUN, V44, P76, DOI 10.1080/00397911.2013.789525; Nagasaka Y, 2011, CHEM LETT, V40, P1437, DOI 10.1246/cl.2011.1437; Padwa A., 2002, SYNTHETIC APPL 1 3 D; Padwa A., 1984, 1 3 DIPOLAR CYCLOADD; RADLOWSK.C, 1970, J PHYS CHEM-US, V74, P3043, DOI 10.1021/j100710a004; RIGAUDY J, 1966, TETRAHEDRON LETT, P2431; RUBIN Y, 1993, J AM CHEM SOC, V115, P344, DOI 10.1021/ja00054a049; Schaefer T., 2008, PCT Int. Pat, Patent No. [WO2008119666, 2008119666]; SEIDL H, 1969, CHEM BER-RECL, V102, P904, DOI 10.1002/cber.19691020324; Tagmatarchis N, 2003, SYNLETT, P768; Tan Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1896; Topinka T., 1994, CHEM COMMUN, V59, P2641; Wendeborn F., 2008, PCT Int. Pat, Patent No. [WO2008031743, 2008031743]	50	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	1					221	224		10.1039/c4cc06643j		4	Chemistry, Multidisciplinary	Chemistry	AU9JW	WOS:000345909400049		
J	Kuncewicz, J; Ohtani, B				Kuncewicz, Joanna; Ohtani, Bunsho			Titania photocatalysis through two-photon band-gap excitation with built-in rhodium redox mediator	CHEMICAL COMMUNICATIONS			English	Article							VISIBLE-LIGHT IRRADIATION; DOPED SRTIO3; TRANSITION-METALS; ELECTRON MEDIATOR; TIO2; MECHANISM; EVOLUTION; ANTIMONY	Titania particles modified with an extremely small amount (<0.01 mol%) of a rhodium species exhibited photocatalytic activity for the oxidative decomposition of acetaldehyde in air under visible-light irradiation. The reaction proceeded via a two-photon band-gap excitation mechanism resembling the Z-scheme with an external redox couple, using a built-in Rh(III)-Rh(IV) redox couple.	[Kuncewicz, Joanna] Jagiellonian Univ, Fac Chem, PL-30011 Krakow, Poland; [Ohtani, Bunsho] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan	Kuncewicz, J (reprint author), Jagiellonian Univ, Fac Chem, Ul R Ingardena 3, PL-30011 Krakow, Poland.	kuncewic@chemia.uj.edu.pl			Ministry of Science and Higher Education in Poland [IP 2012030572]	This work was supported by the Ministry of Science and Higher Education in Poland within Iuventus Plus grant (No. IP 2012030572).	Abe R, 2010, J PHOTOCH PHOTOBIO C, V11, P179, DOI 10.1016/j.jphotochemrev.2011.02.003; Furuhashi K, 2013, J PHYS CHEM C, V117, P19101, DOI 10.1021/jp407040p; Iwashina K, 2011, J AM CHEM SOC, V133, P13272, DOI 10.1021/ja2050315; Konta R, 2004, J PHYS CHEM B, V108, P8992, DOI 10.1021/jp049556p; Kang HW, 2013, INT J HYDROGEN ENERG, V38, P823, DOI 10.1016/j.ijhydene.2012.10.073; Umebayashi T, 2002, APPL PHYS LETT, V81, P454, DOI 10.1063/1.1493647; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; Savio AKPD, 2013, CERAM INT, V39, P2753, DOI 10.1016/j.ceramint.2012.09.042; Sasaki Y, 2009, J PHYS CHEM C, V113, P17536, DOI 10.1021/jp907128k; Sayama K, 2002, J PHOTOCH PHOTOBIO A, V148, P71, DOI 10.1016/S1010-6030(02)00070-9; Irie H, 2003, CHEM LETT, V32, P772, DOI 10.1246/cl.2003.772; Shen PC, 2013, CHEM ENG J, V223, P200, DOI 10.1016/j.cej.2013.03.030; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Nosaka Y, 2011, J PHYS CHEM C, V115, P21283, DOI 10.1021/jp2070634; Niishiro R, 2007, J PHYS CHEM C, V111, P17420, DOI 10.1021/jp074707k; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Sasaki Y, 2008, J CATAL, V259, P133, DOI 10.1016/j.jcat.2008.07.017; Ghuman KK, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/47/475501; MATSUMOTO Y, 1982, J PHYS CHEM-US, V86, P3581, DOI 10.1021/j100215a018; Oropeza FE, 2011, CHEM PHYS LETT, V515, P249, DOI 10.1016/j.cplett.2011.09.017; Song KN, 2013, J ALLOY COMPD, V551, P118, DOI 10.1016/j.jallcom.2012.09.077	21	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	2					298	301		10.1039/c4cc07049f		4	Chemistry, Multidisciplinary	Chemistry	AW0IK	WOS:000345975000011		
J	Feng, L; Rudolf, M; Trukhina, O; Slanina, Z; Uhlik, F; Lu, X; Torres, T; Guldi, DM; Akasaka, T				Feng, Lai; Rudolf, Marc; Trukhina, Olga; Slanina, Zdenek; Uhlik, Filip; Lu, Xing; Torres, Tomas; Guldi, Dirk M.; Akasaka, Takeshi			Tuning intramolecular electron and energy transfer processes in novel conjugates of La-2@C-80 and electron accepting subphthalocyanines	CHEMICAL COMMUNICATIONS			English	Article							SCANDIUM ION; DONOR; METALLOFULLERENE; THERMOCHEMISTRY; FULLERENES; SYSTEMS	A series of two conjugates with La-2@C-80 and subphthalocyanine (SubPc) have been prepared and characterized by means of cyclic voltammetry, absorption, fluorescence, and femtosecond resolved transient absorption spectroscopy. The strong electron-donating character of La-2@C-80 is essential to power an intramolecular electron-transfer in the La-2@C-80-SubPc conjugates upon photoexcitation.	[Feng, Lai] Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China; [Feng, Lai] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215006, Peoples R China; [Feng, Lai; Akasaka, Takeshi] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Rudolf, Marc; Guldi, Dirk M.] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Rudolf, Marc; Guldi, Dirk M.] Univ Erlangen Nurnberg, Interdisciplinary Ctr Mol Mat, D-91058 Erlangen, Germany; [Trukhina, Olga; Torres, Tomas] Univ Autonoma Madrid, Dept Organ Chem, E-28049 Madrid, Spain; [Trukhina, Olga; Torres, Tomas] IMDEA Nanosci, Madrid 28049, Spain; [Slanina, Zdenek] Natl Chung Cheng Univ, Dept Chem & Biochem, Chiayi 62117, Taiwan; [Uhlik, Filip] Charles Univ Prague, Dept Phys & Macromol Chem, Prague 12843 2, Czech Republic; [Lu, Xing] Huazhong Univ Sci & Technol, Coll Mat Sci & Engn, Wuhan 430074, Peoples R China; [Akasaka, Takeshi] Fdn Adv Int Sci, Tsukuba, Ibaraki 3050821, Japan; [Akasaka, Takeshi] Tokyo Gakugei Univ, Dept Chem, Koganei, Tokyo 1848501, Japan	Feng, L (reprint author), Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China.	fenglai@suda.edu.cn; tomas.torres@uam.es; dirk.guldi@fau.de; akasaka@tara.tsukuba.ac.jp	Torres, Tomas/H-9796-2014; Guldi, Dirk/G-1422-2015	Torres, Tomas/0000-0001-9335-6935; 	NSFC [51372158]; NSF of Jiangsu Province [BK2012611]; Jiangsu Specially Appointed Professor Program [SR10800113]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Project for Jiangsu Scientific and Technological Innovation Team; Spanish MEC and MICINN [CTQ2011-24187/BQU, PRI-PIBUS-2011-1128]; Deutsche Forschungsgemeinschaft [GU 517/14-1]; Comunidad de Madrid [S2013/MIT-2841]	This work is financially supported by the NSFC (51372158), the NSF of Jiangsu Province (BK2012611), the Jiangsu Specially Appointed Professor Program (SR10800113), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Project for Jiangsu Scientific and Technological Innovation Team (2013), Spanish MEC and MICINN (CTQ2011-24187/BQU and PRI-PIBUS-2011-1128), the Deutsche Forschungsgemeinschaft (GU 517/14-1) and the Comunidad de Madrid (S2013/MIT-2841, FOTOCARBON).	Fukuzumi S, 2001, J AM CHEM SOC, V123, P12458, DOI 10.1021/ja016335d; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Lu X, 2012, CHEM SOC REV, V41, P7723, DOI 10.1039/c2cs35214a; Reed CA, 2000, SCIENCE, V289, P101, DOI 10.1126/science.289.5476.101; Rudolf M, 2013, J AM CHEM SOC, V135, P11165, DOI 10.1021/ja403763e; Guldi DM, 2002, CHEM SOC REV, V31, P22, DOI 10.1039/b106962b; de la Torre G, 2013, CHEM SOC REV, V42, P8049, DOI 10.1039/c3cs60140d; Bottari G, 2010, CHEM REV, V110, P6768, DOI 10.1021/cr900254z; Delgado JL, 2010, CHEM COMMUN, V46, P4853, DOI 10.1039/c003088k; Feng L, 2012, J AM CHEM SOC, V134, P12190, DOI 10.1021/ja3039695; Kirner S, 2014, ADV MATER, V26, P1482, DOI 10.1002/adma.201304928; Claessens CG, 2014, CHEM REV, V114, P2192, DOI 10.1021/cr400088w; Popov AA, 2013, CHEM REV, V113, P5989, DOI 10.1021/cr300297r; Boghossian AA, 2011, ENERG ENVIRON SCI, V4, P3834, DOI 10.1039/c1ee01363g; Cao XY, 2002, J MOL STRUC-THEOCHEM, V581, P139, DOI 10.1016/S0166-1280(01)00751-5; Takano Y, 2012, J AM CHEM SOC, V134, P19401, DOI 10.1021/ja307341g; Romero-Nieto C, 2012, CHEM COMMUN, V48, P4953, DOI 10.1039/c2cc31167d; Cai T, 2005, CHEM COMMUN, P3594, DOI 10.1039/b503333k; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gonzalez- Rodriguez D, 2004, J AM CHEM SOC, V126, P6301, DOI 10.1021/ja039883v; Hammes-Schiffer S, 2009, ACCOUNTS CHEM RES, V42, P1881, DOI 10.1021/ar9001284; Ince M, 2014, CHEM-EUR J, V20, P2016, DOI 10.1002/chem.201303639; Ohkubo K, 2007, CHEM COMMUN, P589, DOI 10.1039/b612613h; WASIELEWSKI MR, 1992, CHEM REV, V92, P435, DOI 10.1021/cr00011a005; Yamada M, 2009, CHEM-EUR J, V15, P10533, DOI 10.1002/chem.200900993	26	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	2					330	333		10.1039/c4cc08072f		4	Chemistry, Multidisciplinary	Chemistry	AW0IK	WOS:000345975000019		
J	Egi, M; Shimizu, K; Kamiya, M; Ota, Y; Akai, S				Egi, Masahiro; Shimizu, Kaori; Kamiya, Marin; Ota, Yuya; Akai, Shuji			Central-axial-central chirality transfer: asymmetric synthesis of highly substituted indenes bearing a stereogenic quaternary carbon center from optically active propargyl alcohols	CHEMICAL COMMUNICATIONS			English	Article							C-H ACTIVATION; GOLD-CATALYZED CYCLOISOMERIZATION; ENANTIOSELECTIVE SYNTHESIS; ARYLBORONIC ACIDS; INTRAMOLECULAR CYCLIZATION; REGIOSELECTIVE SYNTHESIS; FUNCTIONALIZED INDENES; CLAISEN REARRANGEMENT; CASCADE REACTIONS; TANDEM REACTIONS	An asymmetric synthesis of highly substituted indenes 3, bearing a quaternary stereogenic carbon center, has been developed via the central-axial-central chirality transfer from optically active propargyl alcohols 1. This transformation involves the addition/rearrangement of 1 and ynamides 2 to give tetra-substituted allenes 4 and further cyclization of 4.	[Egi, Masahiro; Shimizu, Kaori; Kamiya, Marin; Ota, Yuya; Akai, Shuji] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Yada, Shizuoka 4228526, Japan	Egi, M (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Yada, Shizuoka 4228526, Japan.	egi@u-shizuoka-ken.ac.jp			 [24590016]	M.E. gratefully acknowledges financial support in the form of the Grant-in-Aid for Scientific Research (C) (No. 24590016).	Alcalde E, 2008, ORG BIOMOL CHEM, V6, P3795, DOI 10.1039/b808641a; Patureau FW, 2011, J AM CHEM SOC, V133, P2154, DOI 10.1021/ja110650m; Tran DN, 2011, ANGEW CHEM INT EDIT, V50, P11098, DOI 10.1002/anie.201105766; Zhou F, 2009, ORG LETT, V11, P1405, DOI 10.1021/ol9001015; Ma ZX, 2012, ORG LETT, V14, P5736, DOI 10.1021/ol302743k; Tobisu M, 2009, J ORG CHEM, V74, P5471, DOI 10.1021/jo901045g; Rao WD, 2012, J AM CHEM SOC, V134, P10811, DOI 10.1021/ja304964s; Zhu ZB, 2013, CHEM COMMUN, V49, P2272, DOI 10.1039/c3cc37258h; Sherry BD, 2004, J AM CHEM SOC, V126, P15978, DOI 10.1021/ja044502k; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P4456, DOI 10.1002/anie.201109183; Vidhani DV, 2013, ORG LETT, V15, P4462, DOI 10.1021/ol4019985; Zhao JB, 2012, ORG LETT, V14, P1668, DOI 10.1021/ol300158d; Yang SD, 2009, ANGEW CHEM INT EDIT, V48, P3999, DOI 10.1002/anie.200900368; Shi XY, 2013, ORG LETT, V15, P1476, DOI 10.1021/ol400198q; Zhang XX, 2009, ORG LETT, V11, P4990, DOI 10.1021/ol901981s; Meng B, 2012, ORG LETT, V14, P2674, DOI 10.1021/ol3006985; Wang CM, 2009, GREEN CHEM, V11, P843, DOI 10.1039/b900042a; Campolo D, 2013, CHEM SOC REV, V42, P8434, DOI 10.1039/c3cs60182j; Liu CR, 2012, CHEM COMMUN, V48, P10913, DOI 10.1039/c2cc36048a; Sajna KV, 2012, J ORG CHEM, V77, P5345, DOI 10.1021/jo300705f; Lo VKY, 2010, CHEM COMMUN, V46, P213, DOI 10.1039/b914516h; Yang JT, 2000, J ORG CHEM, V65, P6739, DOI 10.1021/jo991140y; Miura T, 2007, ANGEW CHEM INT EDIT, V46, P7101, DOI 10.1002/anie.200701505; Guo SH, 2008, ORG BIOMOL CHEM, V6, P2064, DOI 10.1039/b804888f; Liu ZS, 2006, J AM CHEM SOC, V128, P10352, DOI 10.1021/ja0629110; Hashimoto T, 2013, NAT CHEM, V5, P240, DOI [10.1038/nchem.1567, 10.1038/NCHEM.1567]; Cao T, 2012, ANGEW CHEM INT EDIT, V51, P2448, DOI 10.1002/anie.201107417; Chai Z, 2012, J AM CHEM SOC, V134, P3615, DOI 10.1021/ja2102407; Trillo B, 2009, CHEM-EUR J, V15, P3336, DOI 10.1002/chem.200900164; Zhou F, 2011, J ORG CHEM, V76, P1491, DOI 10.1021/jo1023574; Majetich G, 2010, J NAT PROD, V73, P284, DOI 10.1021/np9004695; Evano G, 2010, ANGEW CHEM INT EDIT, V49, P2840, DOI 10.1002/anie.200905817; Panteleev J, 2011, ORG LETT, V13, P5314, DOI 10.1021/ol202176g; Alt HG, 2000, CHEM REV, V100, P1205, DOI 10.1021/cr9804700; Park EJ, 2008, J AM CHEM SOC, V130, P17268, DOI 10.1021/ja808080h; Liu L, 2012, J ORG CHEM, V77, P3997, DOI 10.1021/jo300367q; Jeker OF, 2012, ANGEW CHEM INT EDIT, V51, P3474, DOI 10.1002/anie.201109175; Kern N, 2012, J ORG CHEM, V77, P4323, DOI 10.1021/jo300294r; Liu HJ, 2009, J AM CHEM SOC, V131, P7212, DOI 10.1021/ja901528b; Zhu ZB, 2008, CHEM-EUR J, V14, P10219, DOI 10.1002/chem.200801370; Wang Y, 2005, ORG LETT, V7, P1675, DOI 10.1021/ol0475764; Li ZJ, 2012, J AM CHEM SOC, V134, P15497, DOI 10.1021/ja3061529; Jia XD, 2012, ANGEW CHEM INT EDIT, V51, P9870, DOI 10.1002/anie.201204716; Ogasawara M, 2009, TETRAHEDRON-ASYMMETR, V20, P259, DOI 10.1016/j.tetasy.2008.11.039; Yu SC, 2011, CHEM COMMUN, V47, P5384, DOI 10.1039/c0cc05640e; Oh DC, 2006, ORG LETT, V8, P1021, DOI 10.1021/ol052686b; Muralirajan K, 2011, ANGEW CHEM INT EDIT, V50, P4169, DOI 10.1002/anie.201100229; Chatterjee PN, 2010, J ORG CHEM, V75, P4413, DOI 10.1021/jo100189z; Kuninobu Y, 2006, J AM CHEM SOC, V128, P202, DOI 10.1021/ja054216i; Lin GY, 2007, J ORG CHEM, V72, P6753, DOI 10.1021/jo0707939; Liu CR, 2010, ORG LETT, V12, P3832, DOI 10.1021/ol101524w; Partridge BM, 2012, ANGEW CHEM INT EDIT, V51, P11795, DOI 10.1002/anie.201203198; Wang DW, 2011, ORG LETT, V13, P2618, DOI 10.1021/ol200714h; Zhu XZ, 2009, J AM CHEM SOC, V131, P13596, DOI 10.1021/ja905626b; Huang W, 2008, J ORG CHEM, V73, P6845, DOI 10.1021/jo801210n; Lee JH, 2007, ANGEW CHEM INT EDIT, V46, P912, DOI 10.1002/anie.200604006; Asikainen M, 2012, TETRAHEDRON, V68, P5492, DOI 10.1016/j.tet.2012.04.086; Brekan JA, 2010, J AM CHEM SOC, V132, P1472, DOI 10.1021/ja909669e; Brummond KM, 2007, SYNTHESIS-STUTTGART, P795, DOI 10.1055/s-2007-965963; CLAESSON A, 1979, J CHEM SOC CHEM COMM, P524, DOI 10.1039/c39790000524; Deutsch C, 2007, SYNLETT, P1790, DOI 10.1055/s-2007-98256; Dube, 2006, J AM CHEM SOC, V128, P12062; Forrat VJ, 2006, CHEM-EUR J, V12, P4431, DOI 10.1002/chem.200501397; Frederick MO, 2003, ORG LETT, V5, P2663, DOI 10.1021/ol030061c; Horvath A, 2004, CHEM COMMUN, P964, DOI 10.1039/b316482a; Hu B, 2008, ORG LETT, V10, P5481, DOI 10.1021/ol802301e; Li BF, 2010, BIOORG MED CHEM LETT, V20, P2629, DOI 10.1016/j.bmcl.2010.02.055; Liu L, 2006, SYNLETT, P1245, DOI 10.1055/s-2006-932473; Bahadur K, 2013, ORG LETT, V15, P4288, DOI 10.1021/ol4019908; Marion N, 2006, ANGEW CHEM INT EDIT, V45, P3647, DOI 10.1002/anie.200600571; Martinez A, 2010, ANGEW CHEM INT EDIT, V49, P4633, DOI 10.1002/anie.201001089; Shintani R, 2005, CHEM LETT, V34, P1294, DOI 10.1246/cl.2005.1294; Wang BQ, 2006, COORDIN CHEM REV, V250, P242, DOI 10.1016/j.ccr.2005.05.012; Wang SY, 2009, ORG LETT, V11, P2615, DOI 10.1021/ol901033h; Yadav VK, 2007, CHEM COMMUN, P2281, DOI 10.1039/b700246g; Yamazaki S, 2010, J ORG CHEM, V75, P5216, DOI 10.1021/jo1009855	76	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	2					380	383		10.1039/c4cc08034c		4	Chemistry, Multidisciplinary	Chemistry	AW0IK	WOS:000345975000032		
J	Nishihara, R; Suzuki, H; Hoshino, E; Suganuma, S; Sato, M; Saitoh, T; Nishiyama, S; Iwasawa, N; Citterio, D; Suzuki, K				Nishihara, Ryo; Suzuki, Hideyuki; Hoshino, Emi; Suganuma, Sakura; Sato, Moritoshi; Saitoh, Tsuyoshi; Nishiyama, Shigeru; Iwasawa, Naoko; Citterio, Daniel; Suzuki, Koji			Bioluminescent coelenterazine derivatives with imidazopyrazinone C-6 extended substitution	CHEMICAL COMMUNICATIONS			English	Article							GREEN FLUORESCENT PROTEIN; RENILLA-RENIFORMIS; LUCIFERIN ANALOGS; ENERGY-TRANSFER; LIVING SUBJECTS; IN-VIVO; CHEMILUMINESCENCE; OPLOPHORUS; SUBSTRATE; VARIANTS	Three novel coelenterazine (CTZ) derivatives with extension at the C-6 position of the imidazopyrazinone structure show significant bioluminescence emission with known renilla luciferase variants, indicating a promising method to develop CTZ derivatives with superior optical properties compared to hitherto reported compounds.	[Nishihara, Ryo; Hoshino, Emi; Iwasawa, Naoko; Citterio, Daniel; Suzuki, Koji] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Suzuki, Hideyuki; Suganuma, Sakura; Sato, Moritoshi] Keio Univ, Fac Sci & Technol, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Saitoh, Tsuyoshi; Nishiyama, Shigeru] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Suzuki, K (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	suzuki@applc.keio.ac.jp			JSPS [24225001]	This work was supported by JSPS KAKENHI Grant Number 24225001. We thank Nissan Analysis and Research Center for supporting NMR measurements. We thank Dr Takahiro Nakajima of The University of Tokyo for supporting our bioluminescence measurements.	Woo JC, 2008, PROTEIN SCI, V17, P725, DOI 10.1110/ps.073355508; Teranishi K, 1997, ANAL BIOCHEM, V249, P37, DOI 10.1006/abio.1997.2150; Shimomura O, 2000, LUMINESCENCE, V15, P51, DOI 10.1002/(SICI)1522-7243(200001/02)15:1<51::AID-BIO555>3.0.CO;2-J; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Wu C, 2001, TETRAHEDRON LETT, V42, P2997, DOI 10.1016/S0040-4039(01)00340-9; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.3.CO;2-D; Stepanyuk GA, 2010, ANAL BIOANAL CHEM, V398, P1809, DOI 10.1007/s00216-010-4106-9; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Sun YQ, 2012, ANGEW CHEM INT EDIT, V51, P8428, DOI 10.1002/anie.201203565; Yang YM, 2012, ANGEW CHEM INT EDIT, V51, P3125, DOI 10.1002/anie.201107919; Shao Q, 2009, CHEM COMMUN, P4028, DOI 10.1039/b908346d; Inouye S, 1997, BIOCHEM BIOPH RES CO, V233, P349, DOI 10.1006/bbrc.1997.6452; TERANISHI K, 1990, B CHEM SOC JPN, V63, P3132, DOI 10.1246/bcsj.63.3132; Fujio S, 2004, TETRAHEDRON LETT, V45, P8531, DOI 10.1016/j.tetlet.2004.09.106; GOTO T, 1968, Pure and Applied Chemistry, V17, P421, DOI 10.1351/pac196817030421; HART RC, 1979, BIOCHEMISTRY-US, V18, P2204, DOI 10.1021/bi00578a011; Imai Y, 2001, J PHOTOCH PHOTOBIO A, V146, P95, DOI 10.1016/S1010-6030(01)00554-8; Kojima R, 2013, ANGEW CHEM INT EDIT, V52, P1175, DOI 10.1002/anie.201205151; Nakamura H, 1997, TETRAHEDRON LETT, V38, P6405, DOI 10.1016/S0040-4039(97)01438-X; Newton H. E., 1952, BIOLUMINESCENCE; QI CF, 1992, J CHEM SOC PERK T 1, P1607, DOI 10.1039/p19920001607; Saito R, 1998, CHEM LETT, P95; Saito R, 2011, B CHEM SOC JPN, V84, P90, DOI 10.1246/bcsj.20100185; Shimomura O., 2012, BIOLUMINESCENCE CHEM; Teranishi K, 1999, LUMINESCENCE, V14, P297; Teranishi K, 2001, LUMINESCENCE, V16, P367, DOI 10.1002/bio.668	30	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	2					391	394		10.1039/c4cc06886f		4	Chemistry, Multidisciplinary	Chemistry	AW0IK	WOS:000345975000035		
J	Hakata, Y; Tsuchiya, S; Michiue, H; Ohtsuki, T; Matsui, H; Miyazawa, M; Kitamatsu, M				Hakata, Y.; Tsuchiya, S.; Michiue, H.; Ohtsuki, T.; Matsui, H.; Miyazawa, M.; Kitamatsu, M.			A novel leucine zipper motif-based hybrid peptide delivers a functional peptide cargo inside cells	CHEMICAL COMMUNICATIONS			English	Article							ARGININE-RICH PEPTIDES; INTRACELLULAR DELIVERY; PROTEIN TRANSDUCTION; PENETRATING PEPTIDES; MEMBRANE	A hybrid comprising an autophagy-inducing peptide (AIP) and a cell-penetrating peptide (CPP) connected via heterodimeric leucine zippers was generated and delivered into cells. The hybrid successfully induced autophagy without significant cell death, while the same AIP directly connected to a CPP caused both autophagy and significant cell death.	[Hakata, Y.; Miyazawa, M.] Kinki Univ, Fac Med, Dept Immunol, Sayama, Osaka 5898511, Japan; [Tsuchiya, S.; Kitamatsu, M.] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Michiue, H.; Matsui, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Physiol, Kita Ku, Okayama 7008558, Japan; [Ohtsuki, T.] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Kita Ku, Okayama 7008530, Japan	Hakata, Y (reprint author), Kinki Univ, Fac Med, Dept Immunol, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	hakata@med.kindai.ac.jp; kitamatu@apch.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25410181, 25460573]	Financial support from two Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (No. 25410181 and 25460573) is acknowledged. The authors are grateful for assistance from Mami Nakashima with the measurement of fluorescence spectra and from Feifei Wang with fluorescence microscopy.	Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050253q; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Hitsuda T, 2012, BIOMATERIALS, V33, P4665, DOI 10.1016/j.biomaterials.2012.02.049; Hansen MB, 2011, CHEMBIOCHEM, V12, P2294, DOI 10.1002/cbic.201100481; Kondo E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1952; Wendt H, 1997, BIOCHEMISTRY-US, V36, P204, DOI 10.1021/bi961672y	11	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	2					413	416		10.1039/c4cc07459a		4	Chemistry, Multidisciplinary	Chemistry	AW0IK	WOS:000345975000041		
J	Raja, R; Sudhagar, P; Devadoss, A; Terashima, C; Shrestha, LK; Nakata, K; Jayavel, R; Ariga, K; Fujishima, A				Raja, R.; Sudhagar, P.; Devadoss, Anitha; Terashima, C.; Shrestha, L. K.; Nakata, K.; Jayavel, R.; Ariga, K.; Fujishima, A.			Pt-free solar driven photoelectrochemical hydrogen fuel generation using 1T MoS2 co-catalyst assembled CdS QDs/TiO2 photoelectrode	CHEMICAL COMMUNICATIONS			English	Article							PHOTOCATALYTIC H-2 EVOLUTION; VISIBLE-LIGHT IRRADIATION; SINGLE-LAYER MOS2; WATER; HETEROSTRUCTURES; GRAPHENE; NANOCOMPOSITE; NANOSHEETS; CATALYSTS; CELLS	The solar-to-hydrogen generation from the TiO2-CdS-ZnS-MoS2 (TCZM) heterointerface was demonstrated. We found that a Pt-free CdS quantum dot-sensitized TiO2 mesoporous electrode with a metallic-type 1T MoS2 co-catalyst resulted in 0.11 ml cm(-2) h(-1) H-2 fuel generation in unassisted potential mode, which was strikingly improved to 1.47 ml cm(-2) h(-1) under 1 V applied potential.	[Raja, R.; Jayavel, R.] Anna Univ, Ctr Nanosci & Technol, Madras 600025, Tamil Nadu, India; [Sudhagar, P.; Devadoss, Anitha; Terashima, C.; Nakata, K.; Fujishima, A.] Tokyo Univ Sci, PIRC, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Shrestha, L. K.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Sudhagar, P (reprint author), Tokyo Univ Sci, PIRC, Res Inst Sci & Technol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	vedichi@gmail.com; rjvel@annauniv.edu	ARIGA, Katsuhiko/H-2695-2011; PITCHAIMUTHU, SUDHAGAR/C-9842-2012; Nakata, Kazuya/D-7633-2011	Nakata, Kazuya/0000-0002-6648-8534	JSPS; National Institute for Materials Science (NIMS), Japan; Anna University, India	One of the corresponding authors P. S. appreciates the JSPS for providing a post-doctoral fellowship. R. R. thanks the National Institute for Materials Science (NIMS), Japan and Anna University, India for the NIMS internship award.	Lukowski MA, 2013, J AM CHEM SOC, V135, P10274, DOI 10.1021/ja404523s; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Cowan AJ, 2010, J PHYS CHEM C, V114, P4208, DOI 10.1021/jp909993w; Hensel J, 2010, NANO LETT, V10, P478, DOI 10.1021/nl903217w; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Eda G, 2011, NANO LETT, V11, P5111, DOI 10.1021/nl201874w; Min YL, 2014, J MATER CHEM A, V2, P2578, DOI 10.1039/c3ta14240j; Zong X, 2008, J AM CHEM SOC, V130, P7176, DOI 10.1021/ja8007825; Merki D, 2011, ENERG ENVIRON SCI, V4, P3878, DOI 10.1039/c1ee01970h; Rodenas P, 2013, ADV ENERGY MATER, V3, P176, DOI 10.1002/aenm.201200255; Zong X, 2010, J PHYS CHEM C, V114, P1963, DOI 10.1021/jp904350e; Antoniadou M, 2014, CHEM ENG J, V254, P245, DOI 10.1016/j.cej.2014.05.106; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Das S, 2014, CRIT REV SOLID STATE, V39, P231, DOI 10.1080/10408436.2013.836075; Li YG, 2013, CATAL SCI TECHNOL, V3, P2214, DOI 10.1039/c3cy00207a; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Voiry D, 2013, NANO LETT, V13, P6222, DOI 10.1021/nl403661s; Zhang K, 2013, CATAL SCI TECHNOL, V3, P1672, DOI 10.1039/c3cy00018d; Zhang J, 2012, NANO LETT, V12, P4584, DOI 10.1021/nl301831h; Maitra U, 2013, ANGEW CHEM INT EDIT, V52, P13057, DOI 10.1002/anie.201306918; Devadoss A, 2014, PHYS CHEM CHEM PHYS, V16, P21237, DOI 10.1039/c4cp03262d; Gaur APS, 2013, J PHYS CHEM C, V117, P26262, DOI 10.1021/jp407377g; Gonzalez-Pedro V., 2013, J PHYS CHEM C, V118, P891; Jia TT, 2014, CHEM COMMUN, V50, P1185, DOI 10.1039/c3cc47301e; Jin-nouchi Y, 2010, CHEMPHYSCHEM, V11, P3592, DOI 10.1002/cphc.201000593; KAMAT PV, 1987, J PHYS CHEM-US, V91, P396, DOI 10.1021/j100286a029; Kim K., 2013, SCI REP, V3; Morales-Guio C. G., 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4059, DOI 10.1038/NC0MMS4059;]; Sudhagar P, 2014, GREEN ENERGY TECHNOL, P89, DOI 10.1007/978-1-4471-6473-9_5; Trevisan R, 2013, J PHYS CHEM LETT, V4, P141, DOI 10.1021/jz301890m; Xu Q., 2000, J PHYS CHEM SOLIDS, V61, P829	32	1	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	3					522	525		10.1039/c4cc07304e		4	Chemistry, Multidisciplinary	Chemistry	AW1RU	WOS:000346068200017		
J	Hagiwara, K; Akita, M; Yoshizawa, M				Hagiwara, Keita; Akita, Munetaka; Yoshizawa, Michito			An aqueous molecular tube with polyaromatic frameworks capable of binding fluorescent dyes	CHEMICAL SCIENCE			English	Article							CARBON NANOTUBES; ELECTRONIC-PROPERTIES; SELECTIVE SYNTHESIS; ANTHRACENE SHELLS; FULLERENES; CAPSULE; ENCAPSULATION; MACROCYCLES; DERIVATIVES; SYSTEMS	An aqueous molecular tube composed of polyaromatic frameworks with peripheral hydrophilic groups was prepared. The new tube has a well-defined hydrophobic cavity with a diameter of similar to 1 nm and quantitatively binds two molecules of fluorescent coumarin dyes in aqueous solutions. The bound coumarin dimers in a stacked fashion exhibit unusual excimer-like emissions in the confined space through efficient host-guest energy transfer.	[Hagiwara, Keita; Akita, Munetaka; Yoshizawa, Michito] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Yoshizawa, M (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yoshizawa.m.ac@m.titech.ac.jp	Yoshizawa, Michito/A-4631-2013; Akita, Munetaka/C-5614-2011	Akita, Munetaka/0000-0001-7007-9621	Japan Society for the Promotion of Science (JSPS) through a "Funding Program for Next-Generation World-Leading Researchers (NEXT Program)"; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS	This work was supported by the Japan Society for the Promotion of Science (JSPS) through a "Funding Program for Next-Generation World-Leading Researchers (NEXT Program)" and by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through Grants-in-Aid for Scientific Research on Innovative Areas " Soft Molecular Systems". K. H. thanks the JSPS for a Research Fellowship for Young Scientists.	Kishi N, 2011, J AM CHEM SOC, V133, P11438, DOI 10.1021/ja2037029; Omachi H, 2012, ACCOUNTS CHEM RES, V45, P1378, DOI 10.1021/ar300055x; Kishi N, 2013, J AM CHEM SOC, V135, P12976, DOI 10.1021/ja406893y; Amouri H, 2012, CHEM REV, V112, P2015, DOI 10.1021/cr200345v; Yagi A, 2012, J AM CHEM SOC, V134, P2962, DOI 10.1021/ja300001g; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kishi N, 2013, CHEM-EUR J, V19, P6313, DOI 10.1002/chem.201204010; Li Z, 2012, CHEM-EUR J, V18, P8358, DOI 10.1002/chem.201200155; Takaba H, 2009, ANGEW CHEM INT EDIT, V48, P6112, DOI 10.1002/anie.200902617; Sakai N, 2008, ACCOUNTS CHEM RES, V41, P1354, DOI 10.1021/ar700229r; Tahara K, 2006, CHEM REV, V106, P5274, DOI 10.1021/cr050556a; Suzuki A, 2013, ANGEW CHEM INT EDIT, V52, P8120, DOI 10.1002/anie.201302789; Iyoda M, 2011, ANGEW CHEM INT EDIT, V50, P10522, DOI 10.1002/anie.201006198; Zhang G, 2014, CHEM SOC REV, V43, P1934, DOI 10.1039/c3cs60358j; Hitosugi S, 2013, ORG LETT, V15, P3199, DOI 10.1021/ol400982r; Smulders MMJ, 2013, CHEM SOC REV, V42, P1728, DOI 10.1039/c2cs35254k; Yoshizawa M, 2014, CHEM SOC REV, V43, P1885, DOI 10.1039/c3cs60315f; Cook TR, 2013, CHEM REV, V113, P734, DOI 10.1021/cr3002824; Nakanishi Y, 2014, ANGEW CHEM INT EDIT, V53, P3102, DOI 10.1002/anie.201311268; Isobe H, 2013, CHEM SCI, V4, P1293, DOI 10.1039/c3sc22181d; Yamago S, 2010, ANGEW CHEM INT EDIT, V49, P757, DOI 10.1002/anie.200905659; Jasti R, 2008, J AM CHEM SOC, V130, P17646, DOI 10.1021/ja807126u; Iwamoto T, 2011, J AM CHEM SOC, V133, P8354, DOI 10.1021/ja2020668; Li ZT, 2014, CHEM COMMUN, V50, P2841, DOI 10.1039/c3cc49535c; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Iwamoto T, 2014, ANGEW CHEM INT EDIT, V53, P6430, DOI 10.1002/anie.201403624; Sisto TJ, 2011, J AM CHEM SOC, V133, P15800, DOI 10.1021/ja205606p; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340; Kawase T, 2006, CHEM REV, V106, P5250, DOI 10.1021/cr0509657; Kishi N, 2014, ANGEW CHEM INT EDIT, V53, P3604, DOI 10.1002/anie.201311251; Iwamoto T, 2011, ANGEW CHEM INT EDIT, V50, P8342, DOI 10.1002/anie.201102302; Arici E, 2000, MACROMOL CHEM PHYSIC, V201, P2083, DOI 10.1002/1521-3935(20001001)201:15<2083::AID-MACP2083>3.0.CO;2-V; Cheng JA, 2005, J POLYM RES, V12, P53, DOI 10.1007/s10965-004-1730-0; Dresselhaus M, 2001, CARBON NANOTUBES SYN; Grave C, 2002, EUR J ORG CHEM, P3075; Hagiwara K, 2012, CHEM COMMUN, V48, P7678, DOI 10.1039/c2cc31383a; Hitosugi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1505; Kondo K, 2013, ANGEW CHEM INT EDIT, V52, P2308, DOI 10.1002/anie.201208643; Lin WY, 2008, EUR J ORG CHEM, P3821, DOI 10.1002/ejoc.200800327; SEMMELHA.MF, 1971, J AM CHEM SOC, V93, P5908, DOI 10.1021/ja00751a062; Steed J. W., 2009, SUPRAMOLECULAR CHEM; Yamashina M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5662; Yazaki K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6179	43	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					259	263		10.1039/c4sc02377c		5	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600026		
J	Ji, W; Wang, Y; Tanabe, I; Han, XX; Zhao, B; Ozaki, Y				Ji, Wei; Wang, Yue; Tanabe, Ichiro; Han, Xiaoxia; Zhao, Bing; Ozaki, Yukihiro			Semiconductor-driven "turn-off" surface-enhanced Raman scattering spectroscopy: application in selective determination of chromium(VI) in water	CHEMICAL SCIENCE			English	Article							CHARGE-TRANSFER CONTRIBUTION; HEXAVALENT CHROMIUM; ELECTRON-TRANSFER; ELECTROCHEMICAL DETECTION; TIO2 NANOPARTICLES; NANOTUBE ARRAYS; SERS; NANOSTRUCTURES; MOLECULES; POLLUTANTS	Semiconductor materials have been successfully used as surface-enhanced Raman scattering (SERS)-active substrates, providing SERS technology with a high flexibility for application in a diverse range of fields. Here, we employ a dye-sensitized semiconductor system combined with semiconductor-enhanced Raman spectroscopy to detect metal ions, using an approach based on the "turn-off" SERS strategy that takes advantage of the intrinsic capacity of the semiconductor to catalyze the degradation of a Raman probe. Alizarin red S (ARS)-sensitized colloidal TiO2 nanoparticles (NPs) were selected as an example to show how semiconductor-enhanced Raman spectroscopy enables the determination of Cr(VI) in water. Firstly, we explored the SERS mechanism of ARS-TiO2 complexes and found that the strong electronic coupling between ARS and colloidal TiO2 NPs gives rise to the formation of a ligand-to-metal charge transfer (LMCT) transition, providing a new electronic transition pathway for the Raman process. Secondly, colloidal TiO2 nanoparticles were used as active sites to induce the self-degradation of the Raman probe adsorbed on their surfaces in the presence of Cr(VI). Our data demonstrate the potential of ARS-TiO2 complexes as a SERS-active sensing platform for Cr(VI) in an aqueous solution. Remarkably, the method proposed in this contribution is relatively simple, without requiring complex pretreatment and complicated instruments, but provides high sensitivity and excellent selectivity in a high-throughput fashion. Finally, the ARS-TiO2 complexes are successfully applied to the detection of Cr(VI) in environmental samples. Thus, the present work provides a facile method for the detection of Cr(VI) in aqueous solutions and a viable application for semiconductor-enhanced Raman spectroscopy based on the chemical enhancement they contribute.	[Ji, Wei; Wang, Yue; Tanabe, Ichiro; Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan; [Wang, Yue; Han, Xiaoxia; Zhao, Bing] Jilin Univ, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China	Ozaki, Y (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan.	zhaob@mail.jlu.edu.cn; ozaki@kwansei.ac.jp	Tanabe, Ichiro/O-1767-2013; Han, Xiao Xia/G-6607-2013; ZHAO, Bing/P-2447-2014	Tanabe, Ichiro/0000-0002-6580-3029; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Society for Promotion of Science (JSPS) [P13332]	This work was supported by a Support Project to Assist Private Universities in Developing Bases for Research (Research Centre for Single Molecule Vibrational Spectroscopy) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are grateful to Dr Tamitake Itoh (National Institute of Advanced Industrial Science and Technology, Japan) for helpful discussions. W. J. acknowledges the support from the Japanese Society for Promotion of Science (JSPS, P13332).	Chen HQ, 2012, TALANTA, V99, P404, DOI 10.1016/j.talanta.2012.05.071; Musumeci A, 2009, J AM CHEM SOC, V131, P6040, DOI 10.1021/ja808277u; Ji W, 2011, CHEM COMMUN, V47, P2426, DOI 10.1039/c0cc03697h; Wang YF, 2009, J RAMAN SPECTROSC, V40, P1072, DOI 10.1002/jrs.2241; Alessandri I, 2013, J AM CHEM SOC, V135, P5541, DOI 10.1021/ja401666p; Wang XT, 2012, PHYS CHEM CHEM PHYS, V14, P5891, DOI 10.1039/c2cp40080d; Ji W, 2012, J PHYS CHEM C, V116, P24829, DOI 10.1021/jp308805n; BAHNEMANN D, 1984, J PHYS CHEM-US, V88, P709, DOI 10.1021/j150648a018; Wen CY, 2013, CHEM COMMUN, V49, P3049, DOI 10.1039/c3cc37877b; Jin W, 2014, ANALYST, V139, P235, DOI 10.1039/c3an01614e; Vincent JB, 2000, ACCOUNTS CHEM RES, V33, P503, DOI 10.1021/ar990073r; Quagliano LG, 2004, J AM CHEM SOC, V126, P7393, DOI 10.1021/ja031640f; Huber R, 2000, J PHYS CHEM B, V104, P8995, DOI 10.1021/jp9944381; Yang LB, 2008, J PHYS CHEM C, V112, P20095, DOI 10.1021/jp8074145; Saha R, 2011, J COORD CHEM, V64, P1782, DOI 10.1080/00958972.2011.583646; Yong L, 2006, ANAL CHEM, V78, P7582, DOI 10.1021/ac060707p; Li XH, 2010, ADV FUNCT MATER, V20, P2815, DOI 10.1002/adfm.201000792; Lombardi JR, 2014, J PHYS CHEM C, V118, P11120, DOI 10.1021/jp5020675; Xue XX, 2012, J PHYS CHEM C, V116, P8792, DOI 10.1021/jp2122196; Ling X, 2010, NANO LETT, V10, P553, DOI 10.1021/nl903414x; Hurst SJ, 2011, J PHYS CHEM C, V115, P620, DOI 10.1021/jp1096162; Xu WG, 2012, P NATL ACAD SCI USA, V109, P9281, DOI 10.1073/pnas.1205478109; KATZ SA, 1993, J APPL TOXICOL, V13, P217, DOI 10.1002/jat.2550130314; Wang XT, 2011, J AM CHEM SOC, V133, P16518, DOI 10.1021/ja2057874; SPERLING M, 1992, ANAL CHEM, V64, P3101, DOI 10.1021/ac00048a007; Booker S. M., 2000, ENV HLTH PERSPECT, V108, P402; de Souza ML, 2010, VIB SPECTROSC, V54, P137, DOI 10.1016/j.vibspec.2010.07.010; Finkelstein-Shapiro D, 2010, J PHYS CHEM B, V114, P14642, DOI 10.1021/jp1023718; Gardner M, 2002, ANALYST, V127, P153, DOI 10.1039/b109374f; Ghosh HN, 1999, J PHYS CHEM B, V103, P10382, DOI 10.1021/jp9918611; Han XX, 2014, ANGEW CHEM INT EDIT, V53, P2481, DOI 10.1002/anie.201310123; MARINO DF, 1981, ANAL CHEM, V53, P294, DOI 10.1021/ac00225a039; Iorio Y. D., 2008, J PHYS CHEM C, V112, P16532, DOI 10.1021/jp8040742; Jayaweera PM, 2006, SURF SCI, V600, pL297, DOI 10.1016/j.susc.2006.08.027; Jena BK, 2008, TALANTA, V76, P161, DOI 10.1016/j.talanta.2008.02.027; Liu GD, 2007, ENVIRON SCI TECHNOL, V41, P8129, DOI 10.1021/es071726z; Lombardi JR, 2009, ACCOUNTS CHEM RES, V42, P734, DOI 10.1021/ar800249y; Ma S, 2011, J PHYS CHEM LETT, V2, P671, DOI 10.1021/jz2001562; Pan DH, 2005, J PHYS CHEM B, V109, P16390, DOI 10.1021/jp058043v; Qiu C, 2012, J PHYS CHEM LETT, V3, P651, DOI 10.1021/jz201694s; Redfern PC, 2003, J PHYS CHEM B, V107, P11419, DOI 10.1021/jp0303669; Shoute LCT, 2002, J CHEM PHYS, V117, P842, DOI 10.1063/1.1483848; Tsuyumoto I, 2011, ANAL CHEM, V83, P7566, DOI 10.1021/ac201606c; WHO, 2011, GUID DRINK WAT QUAL; Wu XY, 2013, ANAL METHODS-UK, V5, P560, DOI 10.1039/c2ay25989c; Zhang XH, 1999, ANAL CHEM, V71, P3046, DOI 10.1021/ac9813585	46	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					342	348		10.1039/c4sc02618g		7	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600038		
J	Sanji, T; Motoshige, A; Komiyama, H; Kakinuma, J; Ushikubo, R; Watanabe, S; Iyoda, T				Sanji, Takanobu; Motoshige, Asahi; Komiyama, Hideaki; Kakinuma, Junko; Ushikubo, Rie; Watanabe, Satoru; Iyoda, Tomokazu			Transition-metal-free controlled polymerization for poly(p-aryleneethynylene)s	CHEMICAL SCIENCE			English	Article							CONJUGATED POLYMERS; CARBONYL-COMPOUNDS; DEVICES; ETHYNYLENE)S; REACTIVITY; CATALYST	A transition-metal-free controlled polymerization for the attainment of poly(p-aryleneethynylene)s is developed. The polymerization of 1-pentafluorophenyl-4-[(trimethylsilyl)ethynyl]benzene with a catalytic amount of fluoride anions proceeds in a chain-growth-like manner to afford polymers with controlled molecular weights and low polydispersity indexes. The mechanism involves a pentacoordinated fluorosilicate as a key intermediate. The anionic "living" nature of this process is applied to block copolymerization and also surface-terminated polymerization.	[Sanji, Takanobu; Motoshige, Asahi; Komiyama, Hideaki; Kakinuma, Junko; Ushikubo, Rie; Watanabe, Satoru; Iyoda, Tomokazu] Japan Sci & Technol Agcy JST, Tokyo Inst Technol, Iyoda Supraintegrated Mat Project iSIM, Exploratory Res Adv Technol ERATO,Midori Ku, Yokohama, Kanagawa 2268503, Japan	Sanji, T (reprint author), Japan Sci & Technol Agcy JST, Tokyo Inst Technol, Iyoda Supraintegrated Mat Project iSIM, Exploratory Res Adv Technol ERATO,Midori Ku, 4259-S2-3 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	sanji.t.aa@m.titech.ac.jp	Iyoda, Tomokazu/F-4731-2015	Iyoda, Tomokazu/0000-0002-9393-5387			Tour JM, 1996, CHEM REV, V96, P537, DOI 10.1021/cr9500287; Bunz UHF, 2000, CHEM REV, V100, P1605, DOI 10.1021/cr990257j; Holmes RR, 1996, CHEM REV, V96, P927, DOI 10.1021/cr950243n; Sanji T, 2014, J AM CHEM SOC, V136, P10238, DOI 10.1021/ja505282z; Hong WJ, 2012, J AM CHEM SOC, V134, P19425, DOI 10.1021/ja307544w; Okamoto K, 2011, POLYM CHEM-UK, V2, P2424, DOI 10.1039/c1py00171j; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Bumm LA, 1996, SCIENCE, V271, P1705, DOI 10.1126/science.271.5256.1705; Quinonero D, 2002, ANGEW CHEM INT EDIT, V41, P3389, DOI 10.1002/1521-3773(20020916)41:18<3389::AID-ANIE3389>3.0.CO;2-S; Chinchilla R, 2007, CHEM REV, V107, P874, DOI 10.1021/cr050992x; Yokozawa T, 2009, CHEM REV, V109, P5595, DOI 10.1021/cr900041c; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Kang SS, 2013, J AM CHEM SOC, V135, P4984, DOI 10.1021/ja401740m; Zou W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/33/335301; CHUIT C, 1993, CHEM REV, V93, P1371, DOI 10.1021/cr00020a003; Wang YF, 2006, J AM CHEM SOC, V128, P2536, DOI 10.1021/ja056074y; HIYAMA T, 1983, J ORG CHEM, V48, P912, DOI 10.1021/jo00154a043; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; Carsten B, 2011, CHEM REV, V111, P1493, DOI 10.1021/cr100320w; Brooke GM, 1997, J FLUORINE CHEM, V86, P1, DOI 10.1016/S0022-1139(97)00006-7; Yokozawa T, 2013, CHEM COMMUN, V49, P8281, DOI 10.1039/c3cc43603a; Brook M. A., 1999, SILICON ORGANIC ORGA; Bunz UHF, 2001, ACCOUNTS CHEM RES, V34, P998, DOI 10.1021/ar010092c; Deck PA, 2001, MACROMOLECULES, V34, P9, DOI 10.1021/ma001424g; Denmark SE, 2001, J AM CHEM SOC, V123, P9488, DOI 10.1021/ja016552e; Dutta T, 2009, J AM CHEM SOC, V131, P17321, DOI 10.1021/ja9068134; Dutta T, 2008, J AM CHEM SOC, V130, P452, DOI 10.1021/ja710564b; Hadano S, 2013, CHEM LETT, V42, P71, DOI 10.1246/cl.2013.71; Kim JP, 2001, MACROMOLECULES, V34, P7817, DOI 10.1021/ma010439r; Kitazawa T, 2006, CHEM LETT, V35, P1002, DOI 10.1246/cl.2006.1002; Lattan II R. B., 2005, ORG LETT, V7, P3227; NAKAMURA E, 1976, ANGEW CHEM INT EDIT, V15, P498, DOI 10.1002/anie.197604982; Sun L, 2014, CHEM SOC REV, V43, P7378, DOI 10.1039/c4cs00143e; Terrier F, 2013, MODERN NUCLEOPHILIC AROMATIC SUBSTITUTION, P1, DOI 10.1002/9783527656141; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; Woody KB, 2007, MACROMOLECULES, V40, P4470, DOI 10.1021/ma062667x	36	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					492	496		10.1039/c4sc02872d		5	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600057		
J	Wang, ZW; Wang, H; Tse, JS; Iitaka, T; Ma, YM				Wang, Ziwei; Wang, Hui; Tse, John S.; Iitaka, Toshiaki; Ma, Yanming			Stabilization of H-3(+) in the high pressure crystalline structure of HnCl (n=2-7)	CHEMICAL SCIENCE			English	Article							POLYHYDRIDES; HYDROGEN; LITHIUM	The particle-swarm optimization method has been used to predict the stable high pressure structures up to 300 GPa of hydrogen-rich group 17 chlorine (HnCl, n = 2-7) compounds. In comparison to the group 1 and 2 hydrides, the structural modification associated with increasing pressure and hydrogen concentration is much less dramatic. The polymeric HCl chains already present in the low temperature phase under ambient pressure persist in all the high pressure structures. No transfer of electrons from the chlorine atoms into the interstitial sites is found. This indicates the chemical bonding at high pressure in group 17 elements is fundamentally different from the alkali and alkaline elements. It is found that almost perfectly triangular H-3(+) ions can be stabilized in the crystalline structure of H5Cl.	[Wang, Ziwei; Wang, Hui; Tse, John S.; Ma, Yanming] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Tse, John S.] Univ Saskatchewan, Dept Phys & Engn Phys, Saskatoon, SK S7N 5B2, Canada; [Tse, John S.; Ma, Yanming] Beijing Computat Sci Res Ctr, Beijing 10084, Peoples R China; [Iitaka, Toshiaki] RIKEN, Computat Astrophys Lab, Wako, Saitama 3510198, Japan	Wang, H (reprint author), Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China.	huiwang@jlu.edu.cn	Ma, Yanming/A-7297-2008	Ma, Yanming/0000-0003-3711-0011	NSFC [11104104, 11474126, 11474128, 91022029]; China 973 Program [2011CB808200]; Program for New Century Excellent Talents in University; Ministry of Education, Changjiang Scholar and Innovative Research Team in University [IRT1132]; MEXT of Japan [20103001-20103005]; RIKEN iTHES project; Natural Sciences and Engineering Research Council of Canada (NSERC)	The authors appreciatively acknowledge the financial support by NSFC under Grant nos. 11104104, 11474126, 11474128, and 91022029, China 973 Program under Grant no. 2011CB808200, the 2013 Program for New Century Excellent Talents in University, 2012 Changjiang Scholar of Ministry of Education, Changjiang Scholar and Innovative Research Team in University (Grant no. IRT1132). T.I. was supported by MEXT of Japan (Grant nos. 20103001-20103005) and the RIKEN iTHES project. Part of the calculations were performed in the computing facilities at RIKEN Integrated Cluster of Clusters system (Japan) and the High Performance Computing Center of Jilin University. The work at the University of Saskatchewan was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant.	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Togo A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134106; Li PF, 2010, J PHYS CHEM C, V114, P21745, DOI 10.1021/jp108136r; Zurek E, 2009, P NATL ACAD SCI USA, V106, P17640, DOI 10.1073/pnas.0908262106; Hooper J, 2013, J PHYS CHEM C, V117, P2982, DOI 10.1021/jp311571n; Parlinski K, 1997, PHYS REV LETT, V78, P4063, DOI 10.1103/PhysRevLett.78.4063; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Klimes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195131; Lv JA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.015503; Ma Y, 2007, SOLID STATE COMMUN, V143, P161, DOI 10.1093/j.ssc.2007.04.043; Shamp A, 2012, INORG CHEM, V51, P9333, DOI 10.1021/ic301045v; Hooper J, 2012, J PHYS CHEM C, V116, P13322, DOI 10.1021/jp303024h; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Zhu L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.145501; Lonie DC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054107; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Guillaume CL, 2011, NAT PHYS, V7, P211, DOI [10.1038/nphys1864, 10.1038/NPHYS1864]; Wang YC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094116; Tang W, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084204; Li YW, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064104; Hooper J, 2012, CHEM-EUR J, V18, P5013, DOI 10.1002/chem.201103205; Wang YC, 2012, COMPUT PHYS COMMUN, V183, P2063, DOI 10.1016/j.cpc.2012.05.008; Wang ZW, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869145; Strobel TA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144102; Henkelman G, 2006, COMP MATER SCI, V36, P354, DOI 10.1016/j.commatsci.2005.04.010; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; CARNEY GD, 1980, MOL PHYS, V39, P923, DOI 10.1080/00268978000100791; Gao GY, 2010, P NATL ACAD SCI USA, V107, P1317, DOI 10.1073/pnas.0908342107; Hogness TR, 1925, PHYS REV, V26, P0044, DOI 10.1103/PhysRev.26.44; MARTIN DW, 1961, ASTROPHYS J, V134, P1012, DOI 10.1086/147232; SANDOR E, 1967, NATURE, V213, P171, DOI 10.1038/213171a0	31	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					522	526		10.1039/c4sc02802c		5	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600061		
J	Ohkubo, K; Kohno, N; Yamada, Y; Fukuzumi, S				Ohkubo, Kei; Kohno, Naoki; Yamada, Yusuke; Fukuzumi, Shunichi			Laser-induced pinpoint hydrogen evolution from benzene and water using metal free single-walled carbon nanotubes with high quantum yields	CHEMICAL SCIENCE			English	Article							REDUCED GRAPHENE OXIDE; PHOTOCATALYTIC H-2-PRODUCTION ACTIVITY; ADVANCED ENERGY-CONVERSION; ELECTRON-SPIN RESONANCE; VISIBLE-LIGHT; 2-PHENYL-4-(1-NAPHTHYL)QUINOLINIUM ION; ARTIFICIAL PHOTOSYNTHESIS; ELECTROCHEMICAL REDUCTION; METHANOL OXIDATION; TIO2 NANOPARTICLES	Metal-free photocatalytic hydrogen evolution occurred efficiently in benzene containing single-walled carbon nanotubes under laser irradiation at 532 nm with an extremely high turnover number of 2 000 000 and a high quantum yield of 130%. The rate of hydrogen evolution increased with increasing laser intensity to exhibit a fourth power dependence, suggesting that hydrogen was evolved via four-photon processes in which the coupling of two radical anions derived from benzene is the rate determining step and the benzene radical anion is produced by electron transfer from benzene to the doubly excited state of single-walled carbon nanotubes, which requires two photons. Polymerisation of benzene was induced by the photogenerated C6H6 center dot-, accompanied by hydrogen evolution, resulting in a leverage effect to increase the quantum yield of hydrogen evolution to well over the 25% expected for the four-photon process. Laser- induced hydrogen evolution also occurred in water containing single-walled carbon nanotubes. In contrast to the case of benzene, water was not oxidized but hydrogen evolution from water was accompanied by the multi-oxidation of single-walled carbon nanotubes. The yield of hydrogen based on one mole of single-walled carbon nanotubes with 1.4 nm diameter and 1-5 mm length was determined to be 2 700 000%, when oxidations of single-walled carbon nanotubes occurred to produce the polyhydroxylated product.	[Ohkubo, Kei; Kohno, Naoki; Yamada, Yusuke; Fukuzumi, Shunichi] Osaka Univ, ALCA, Japan Sci & Technol Agcy JST, Dept Mat & Life Sci,Grad Sch Engn, Suita, Osaka 5650871, Japan	Fukuzumi, S (reprint author), Osaka Univ, ALCA, Japan Sci & Technol Agcy JST, Dept Mat & Life Sci,Grad Sch Engn, Suita, Osaka 5650871, Japan.	fukuzumi@chem.eng.osaka-u.ac.jp	Fukuzumi, Shunichi /E-4728-2010; Yamada, Yusuke/D-3359-2013; Ohkubo, Kei/E-5127-2012	Ohkubo, Kei/0000-0001-8328-9249	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26620154, 26288037, 24350069, 25600025]; JST, Japan	This work was supported by Grants-in-Aid (nos 26620154 and 26288037 to K. O. and nos 24350069 and 25600025 to Y.Y.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and an ALCA project from JST, Japan (to S.F.). We acknowledge Research Centre for Ultra-Precision Science & Technology in Osaka University for TEM measurements.	Amao Y, 2003, SOL ENERG MAT SOL C, V79, P103, DOI 10.1016/S0927-0248(02)00373-2; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Zhang N, 2013, J CATAL, V299, P210, DOI 10.1016/j.jcat.2012.11.021; Meng FK, 2013, J AM CHEM SOC, V135, P10286, DOI 10.1021/ja404851s; Maeda K, 2013, ACS CATAL, V3, P1486, DOI 10.1021/cs4002089; Xiang QJ, 2011, NANOSCALE, V3, P3670, DOI 10.1039/c1nr10610d; Xiang QJ, 2011, J PHYS CHEM C, V115, P7355, DOI 10.1021/jp200953k; Iwasita T, 2002, ELECTROCHIM ACTA, V47, P3663, DOI 10.1016/S0013-4686(02)00336-5; Kavan L, 2011, CHEMPHYSCHEM, V12, P47, DOI 10.1002/cphc.201000882; Yamada Y, 2012, ENERG ENVIRON SCI, V5, P6111, DOI 10.1039/c2ee03106j; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Yamada Y, 2013, J PHYS CHEM C, V117, P13143, DOI 10.1021/jp403925v; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Miyauchi Y, 2013, J MATER CHEM C, V1, P6499, DOI 10.1039/c3tc00947e; Iwase A, 2011, J AM CHEM SOC, V133, P11054, DOI 10.1021/ja203296z; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Mukherji A, 2011, ACS NANO, V5, P3483, DOI 10.1021/nn102469e; Kotani H, 2011, CHEM-EUR J, V17, P2777, DOI 10.1002/chem.201002399; Sahaym U, 2008, J MATER SCI, V43, P5395, DOI 10.1007/s10853-008-2749-0; Kamat PV, 2011, J PHYS CHEM LETT, V2, P242, DOI 10.1021/jz101639v; Xiang QJ, 2012, J AM CHEM SOC, V134, P6575, DOI 10.1021/ja302846n; MORTENSEN J, 1984, ANGEW CHEM INT EDIT, V23, P84, DOI 10.1002/anie.198400841; Wang JJ, 2014, J MATER CHEM A, V2, P7960, DOI 10.1039/c4ta00275j; Lingampalli SR, 2014, J MATER CHEM A, V2, P7702, DOI 10.1039/c4ta01445f; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Fukuzumi S, 2013, CHEMSUSCHEM, V6, P1834, DOI 10.1002/cssc.201300361; Turi L, 2012, CHEM REV, V112, P5641, DOI 10.1021/cr300144z; DARWENT JR, 1982, COORDIN CHEM REV, V44, P83, DOI 10.1016/S0010-8545(00)80518-4; KIWI J, 1979, J AM CHEM SOC, V101, P7214, DOI 10.1021/ja00518a015; Zhang J, 2007, ANGEW CHEM INT EDIT, V46, P7319, DOI 10.1002/anie.200702466; Li Q, 2011, J AM CHEM SOC, V133, P10878, DOI 10.1021/ja2025454; Fukuzumi S, 2012, J MATER CHEM, V22, P24284, DOI 10.1039/c2jm32926c; Yang J, 2014, J MATER CHEM A, V2, P5979, DOI 10.1039/c3ta14151a; Lee DH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.175502; Zhang YH, 2011, ACS NANO, V5, P7426, DOI 10.1021/nn202519j; Wang S, 2014, J MATER CHEM A, V2, P7439, DOI 10.1039/c4ta00354c; Heller DA, 2009, NAT NANOTECHNOL, V4, P114, DOI [10.1038/nnano.2008.369, 10.1038/NNANO.2008.369]; Chen FK, 2013, J MATER CHEM A, V1, P4316, DOI 10.1039/c3ta01491f; Schafer S, 2014, NANO LETT, V14, P3138, DOI 10.1021/nl5003729; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Muroya Y, 2010, J PHYS CHEM LETT, V1, P331, DOI 10.1021/jz900225a; Chen T, 2013, MATER TODAY, V16, P272, DOI 10.1016/j.mattod.2013.07.002; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Guldi DM, 2005, ACCOUNTS CHEM RES, V38, P38, DOI 10.1021/ar040222s; Dell RM, 2001, J POWER SOURCES, V100, P2, DOI 10.1016/S0378-7753(01)00894-1; Rolison DR, 2003, SCIENCE, V299, P1698, DOI 10.1126/science.1082332; Chen YB, 2014, ACCOUNTS CHEM RES, V47, P2273, DOI 10.1021/ar400314b; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Lin YH, 2014, ACCOUNTS CHEM RES, V47, P1097, DOI 10.1021/ar400250z; Batista EA, 2003, ELECTROCHEM COMMUN, V5, P843, DOI 10.1016/j.elecom.2003.08.010; Li JT, 2014, J AM CHEM SOC, V136, P8438, DOI 10.1021/ja503508g; HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102; Fukuzumi S, 2013, J PHYS CHEM LETT, V4, P3458, DOI 10.1021/jz401560x; Zhang N, 2012, NANOSCALE, V4, P5792, DOI 10.1039/c2nr31480k; Rolison DR, 2009, CHEM SOC REV, V38, P226, DOI 10.1039/b801151f; Keller N, 2002, ANGEW CHEM INT EDIT, V41, P1885, DOI 10.1002/1521-3773(20020603)41:11<1885::AID-ANIE1885>3.0.CO;2-5; Shearer CJ, 2014, ADV MATER, V26, P2295, DOI 10.1002/adma.201305254; Yang CY, 2013, J AM CHEM SOC, V135, P17831, DOI 10.1021/ja4076748; Yamada Y, 2011, J AM CHEM SOC, V133, P16136, DOI 10.1021/ja206079e; KOOSER RG, 1969, J CHEM PHYS, V50, P5243, DOI 10.1063/1.1671041; Fan WQ, 2011, J PHYS CHEM C, V115, P10694, DOI 10.1021/jp2008804; Mu B, 2014, ACCOUNTS CHEM RES, V47, P979, DOI 10.1021/ar400162w; Jiang DL, 2004, J AM CHEM SOC, V126, P12084, DOI 10.1021/ja048912e; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; LEHN JM, 1977, NOUV J CHIM, V1, P449; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Dai LM, 2012, SMALL, V8, P1130, DOI 10.1002/smll.201101594; Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1; Calvert J. G., 1966, PHOTOCHEMISTRY, P783; Dai F., 2014, NAT COMMUN, V5, P4605; Dai LM, 2013, ACCOUNTS CHEM RES, V46, P31, DOI 10.1021/ar300122m; Diaz-Velasquez J.J., 2006, APPL CATAL A-GEN, V311, P51; Fourdrin C, 2013, ENVIRON SCI TECHNOL, V47, P9530, DOI 10.1021/es401490t; Fukuzumi S, 2008, EUR J INORG CHEM, P1351, DOI 10.1002/ejic.200701369; Gao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03606; Goettmann F, 2006, ANGEW CHEM INT EDIT, V45, P4467, DOI 10.1002/anie.200600412; GRATZEL M, 1981, ACCOUNTS CHEM RES, V14, P376; Hu H, 2003, J AM CHEM SOC, V125, P14893, DOI 10.1021/ja0356737; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; JONES JB, 1982, CARBON, V20, P379, DOI 10.1016/0008-6223(82)90036-7; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; Kamat P. V., 2009, J PHYS CHEM C, V113, P15437; Kotani H, 2007, PHYS CHEM CHEM PHYS, V9, P1487, DOI [10.1039/b612794k, 10.1039/b61279k]; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Maeda Y, 2013, J AM CHEM SOC, V135, P6356, DOI 10.1021/ja402199n; MEERHOLZ K, 1989, J AM CHEM SOC, V111, P2325, DOI 10.1021/ja00188a069; Oskoui MS, 2014, RSC ADV, V4, P19569, DOI 10.1039/c4ra01328j; Pastina B, 1999, J PHYS CHEM A, V103, P209, DOI 10.1021/jp983865w; Rao C. N. R., 2011, RSC NANOSCI NANOTECH, V18, P1; Rao CNR, 2002, ACCOUNTS CHEM RES, V35, P998, DOI 10.1021/ar0101584; SEGAL BG, 1965, J CHEM PHYS, V43, P4191, DOI 10.1063/1.1696676; Stevens MG, 1998, CHEM COMMUN, P2679, DOI 10.1039/a806604c; Zuttel A., 2008, HYDROGEN FUTURE ENER	94	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					666	674		10.1039/c4sc02269f		9	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600080		
J	Iwashina, K; Iwase, A; Kudo, A				Iwashina, Katsuya; Iwase, Akihide; Kudo, Akihiko			Sensitization of wide band gap photocatalysts to visible light by molten CuCl treatment	CHEMICAL SCIENCE			English	Article							ELECTRONIC-STRUCTURE; OPTICAL-PROPERTIES; SOLID-SOLUTIONS; H-2 EVOLUTION; WATER; CU5TA11O30; IRRADIATION; CU3TA7O19; NIOBATE; NA	Cu(I)-substituted metal oxide photocatalysts were prepared using molten CuCl treatment of wide band gap photocatalysts. The Cu(I)-substituted metal oxide photocatalysts possessed a new absorption band in the visible light region and showed photocatalytic activity for hydrogen evolution from an aqueous solution containing sulfur sacrificial reagents under visible light irradiation. Notably, the Cu(I)-K2La2Ti3O10 and Cu(I)-NaTaO3 photocatalysts showed relatively high activities for hydrogen evolution and gave apparent quantum yields of 0.18% at 420 nm. These photocatalysts responded up to 620 nm. Thus, Cu(I)-substitution using a molten CuCl treatment was an effective strategy for sensitizing a metal oxide photocatalyst with a wide band gap to visible light.	[Iwashina, Katsuya; Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Yamazaki, Chiba 2788510, Japan	Kudo, A (reprint author), Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	a-kudo@rs.kagu.tus.ac.jp	Iwase, Akihide/E-9218-2010	Iwase, Akihide/0000-0002-6395-9556	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [24107001, 24107004, 2406]	This work was supported by a Grant in Aid (no. 24107001 and 24107004) for Science Research on Innovative Areas (Area no. 2406) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan.	Kato H, 2002, J PHYS CHEM B, V106, P12441, DOI 10.1021/jp025974n; Kudo A, 2004, CHEM LETT, V33, P1534, DOI 10.1246/cl.2004.1534; Fuoco L, 2012, J PHYS CHEM C, V116, P10490, DOI 10.1021/jp300267v; Ikeda S, 1998, CHEM MATER, V10, P72, DOI 10.1021/cm970221c; Tsuji I, 2005, J PHYS CHEM B, V109, P7323, DOI 10.1021/jp044722e; DOMEN K, 1990, CATAL LETT, V4, P339, DOI 10.1007/BF00765319; Hosogi Y, 2004, CHEM LETT, V33, P28, DOI 10.1246/cl.2004.28; Kato H, 2001, J PHYS CHEM B, V105, P4285, DOI 10.1021/jp004386b; Palasyuk O, 2010, INORG CHEM, V49, P10571, DOI 10.1021/ic101529n; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; WAGNER CD, 1975, FARADAY DISCUSS, V60, P291, DOI 10.1039/dc9756000291; Joshi UA, 2011, J PHYS CHEM C, V115, P13534, DOI 10.1021/jp204631a; Palasyuk O, 2010, J SOLID STATE CHEM, V183, P814, DOI 10.1016/j.jssc.2010.01.030; Kudo A, 1999, J AM CHEM SOC, V121, P11459, DOI 10.1021/ja992541y; Joshi UA, 2012, J PHYS CHEM LETT, V3, P1577, DOI 10.1021/jz300477r; Inoue S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245211; DOMEN K, 1986, J CHEM SOC CHEM COMM, P356, DOI 10.1039/c39860000356; Hosogi Y, 2008, J MATER CHEM, V18, P647, DOI 10.1039/b715679k; JAHNBERG L, 1982, J SOLID STATE CHEM, V41, P286, DOI 10.1016/0022-4596(82)90148-7; Kato H, 2013, CATAL SCI TECHNOL, V3, P3147, DOI 10.1039/c3cy00557g; Kimura T., 2011, ADV CERAMICS SYNTHES, P90; McIntyre N. S., 1975, ANAL CHEM, V47, P2208, DOI DOI 10.1021/AC60363A034; Mitsuyama T, 2008, B CHEM SOC JPN, V81, P401, DOI 10.1246/bcsj.81.401; Nozaki R, 2001, J PHYS CHEM B, V105, P7950, DOI 10.1021/jp010839g; Palasyuk O, 2012, J SOLID STATE CHEM, V191, P263, DOI 10.1016/j.jssc.2012.03.023; Sahoo PP, 2013, INORG CHEM, V52, P4443, DOI 10.1021/ic302649s	26	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					687	692		10.1039/c4sc01829j		6	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600082		
J	Horie, M; Ousaka, N; Taura, D; Yashima, E				Horie, Miki; Ousaka, Naoki; Taura, Daisuke; Yashima, Eiji			Chiral tether-mediated stabilization and helix-sense control of complementary metallo-double helices	CHEMICAL SCIENCE			English	Article							ARTIFICIAL DOUBLE HELICES; DOUBLE-STRANDED HELICATE; RING-CLOSING METATHESIS; PEPTIDE NUCLEIC-ACID; SP CARBON CHAINS; ACETYLIDE COMPLEXES; CROSS-LINKING; ENANTIOSELECTIVE SYNTHESIS; MOLECULAR DESIGN; BUILDING-BLOCKS	A series of novel Pt-II-linked double helices were prepared by inter- or intrastrand ligand-exchange reactions of the complementary duplexes composed of chiral or achiral amidine dimer and achiral carboxylic acid dimer strands joined by trans-Pt-II-acetylide complexes with PPh3 ligands using chiral and achiral chelating diphosphines. The structure and stability of the Pt-II-linked double helices were highly dependent on the diphosphine structures. An interstrand ligand exchange took place with chiral and achiral 1,3-diphosphine-based ligands, resulting in trans-Pt-II-bridged double helices, whose helical structures were quite stable even in dimethyl sulfoxide (DMSO) due to the interstrand cross-link, whereas a 1,2-diphosphine-based ligand produced non-cross-linked cis-Pt-II-linked duplexes, resulting from an intrastrand ligand-exchange that readily dissociated into single strands in DMSO. When enantiopure 1,3-diphosphine- based ligands were used, the resulting trans-Pt-II-bridged double helices adopted a preferred-handed helical sense biased by the chirality of the bridged diphosphines. Interestingly, the interstrand ligand exchange with racemic 1,3-diphosphine toward an optically-active Pt-II-linked duplex, composed of chiral amidine and achiral carboxylic acid strands, was found to proceed in a diastereoselective manner, thus forming complete homochiral trans-Pt-II-bridged double helices via a unique chiral self-sorting.	[Horie, Miki; Taura, Daisuke; Yashima, Eiji] Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ousaka, Naoki] Nagoya Univ, Venture Business Lab, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Yashima, E (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	yashima@apchem.nagoya-u.ac.jp	OUSAKA, Naoki/P-7705-2014		Japan Society for the Promotion of Science; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS [10192]	This work was supported in part by Grant-in-Aid for Scientific Research (S) from the Japan Society for the Promotion of Science and by the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology, Japan. M. H. expresses her thanks for a JSPS Research Fellowship for Young Scientists (no. 10192).	Albrecht M, 2011, ANGEW CHEM INT EDIT, V50, P2850, DOI 10.1002/anie.201006448; Shiotsuki M, 2011, POLYM CHEM-UK, V2, P1044, DOI 10.1039/c0py00333f; Katagiri H, 2006, ANGEW CHEM INT EDIT, V45, P1741, DOI 10.1002/anie.200504326; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Haketa Y, 2011, CHEM-EUR J, V17, P1485, DOI 10.1002/chem.201002748; Fuentes N, 2012, ANGEW CHEM INT EDIT, V51, P13036, DOI 10.1002/anie.201206259; Stang PJ, 1997, ACCOUNTS CHEM RES, V30, P502, DOI 10.1021/ar9602011; Howson SE, 2011, DALTON T, V40, P10268, DOI 10.1039/c1dt11423a; Haldar D, 2009, CHEM SOC REV, V38, P363, DOI 10.1039/b803553a; WITTUNG P, 1994, NATURE, V368, P561, DOI 10.1038/368561a0; Sugimoto T, 2007, J AM CHEM SOC, V129, P270, DOI 10.1021/ja067613h; Fujiki M, 2001, MACROMOL RAPID COMM, V22, P539, DOI 10.1002/1521-3927(20010501)22:8<539::AID-MARC539>3.0.CO;2-K; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Maeda T, 2008, J AM CHEM SOC, V130, P7938, DOI 10.1021/ja711447s; Piguet C, 1997, CHEM REV, V97, P2005, DOI 10.1021/cr960053s; Brulikova L, 2012, CURR MED CHEM, V19, P364; Goto H, 2006, J AM CHEM SOC, V128, P7176, DOI 10.1021/ja062171v; Sanford AR, 2004, EUR J BIOCHEM, V271, P1416, DOI 10.1111/j.1432-1033.2004.04062.x; Sadowy AL, 2008, ORGANOMETALLICS, V27, P6321, DOI 10.1021/om800633h; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Takahashi S, 2000, MACROMOL SYMP, V156, P69, DOI 10.1002/1521-3900(200007)156:1<69::AID-MASY69>3.0.CO;2-X; Schwartz E, 2011, POLYM CHEM-UK, V2, P33, DOI 10.1039/c0py00246a; Hua YR, 2013, J AM CHEM SOC, V135, P14401, DOI 10.1021/ja4074744; Woods CR, 1996, ANGEW CHEM INT EDIT, V35, P1830, DOI 10.1002/anie.199618301; Nielsen PE, 1999, ACCOUNTS CHEM RES, V32, P624, DOI 10.1021/ar980010t; Haldar D, 2006, ANGEW CHEM INT EDIT, V45, P5483, DOI 10.1002/anie.200600698; Flint DG, 2002, CHEM BIOL, V9, P391, DOI 10.1016/S1074-5521(02)00109-6; Maeda C, 2007, COORDIN CHEM REV, V251, P2743, DOI 10.1016/j.ccr.2007.02.017; Furusho Y, 2011, CHEM-EUR J, V17, P13954, DOI 10.1002/chem.201102511; Maeda K, 2006, J AM CHEM SOC, V128, P7639, DOI 10.1021/ja060858+; Furusho Y, 2009, J POLYM SCI POL CHEM, V47, P5195, DOI 10.1002/pola.23596; LEHN JM, 1987, P NATL ACAD SCI USA, V84, P2565, DOI 10.1073/pnas.84.9.2565; Zhang DW, 2012, CHEM REV, V112, P5271, DOI 10.1021/cr300116k; Onitsuka K, 2003, TOP CURR CHEM, V228, P39, DOI 10.1007/b11005; Gan Q, 2012, J AM CHEM SOC, V134, P15656, DOI 10.1021/ja3064364; de Hatten X, 2012, J AM CHEM SOC, V134, P19170, DOI 10.1021/ja308055s; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Yamamoto S, 2013, ANGEW CHEM INT EDIT, V52, P6849, DOI 10.1002/anie.201302560; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Stahl J, 2007, J AM CHEM SOC, V129, P8282, DOI 10.1021/ja0716103; Goto H, 2009, J AM CHEM SOC, V131, P4710, DOI 10.1021/ja808585y; KOERT U, 1990, NATURE, V346, P339, DOI 10.1038/346339a0; Ikeda M, 2006, J AM CHEM SOC, V128, P6806, DOI 10.1021/ja0619096; Gan Q, 2008, ANGEW CHEM INT EDIT, V47, P1715, DOI 10.1002/anie.200704938; Juwarker H, 2010, CHEM SOC REV, V39, P3664, DOI 10.1039/b926162c; Pijper D, 2008, SOFT MATTER, V4, P1349, DOI 10.1039/b801886c; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.3.CO;2-M; Furusho Y, 2007, CHEM REC, V7, P1, DOI 10.1002/tcr.20097; Goto H, 2007, J AM CHEM SOC, V129, P9168, DOI 10.1021/ja0730359; Furusho Y, 2011, MACROMOL RAPID COMM, V32, P136, DOI 10.1002/marc.201000533; Ito H, 2008, J AM CHEM SOC, V130, P14008, DOI 10.1021/ja806194e; Takashima S, 2012, CHEM COMMUN, V48, P3330, DOI 10.1039/c2cc00063f; Guichard G, 2011, CHEM COMMUN, V47, P5933, DOI 10.1039/c1cc11137j; Miwa K, 2010, NAT CHEM, V2, P444, DOI [10.1038/nchem.649, 10.1038/NCHEM.649]; Albrecht M, 2001, CHEM REV, V101, P3457, DOI 10.1021/cr0103672; Safont-Sempere MM, 2011, CHEM REV, V111, P5784, DOI 10.1021/cr100357h; Seebach D, 2004, CHEM BIODIVERS, V1, P1111, DOI 10.1002/cbdv.200490087; Howson SE, 2012, NAT CHEM, V4, P31, DOI 10.1038/nchem.1206; Tanaka Y, 2005, ANGEW CHEM INT EDIT, V44, P3867, DOI 10.1002/anie.200501028; Amemiya R, 2008, ORG BIOMOL CHEM, V6, P26, DOI 10.1039/b713700a; Kumita JR, 2000, P NATL ACAD SCI USA, V97, P3803, DOI 10.1073/pnas.97.8.3803; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Yamada H, 2010, CHEM COMMUN, V46, P3487, DOI 10.1039/c002170a; Yashima E, 2008, ACCOUNTS CHEM RES, V41, P1166, DOI 10.1021/ar800091w; Bergman YE, 2009, ORG LETT, V11, P4438, DOI 10.1021/ol901803d; SanchezQuesada J, 1996, J AM CHEM SOC, V118, P277, DOI 10.1021/ja953243d; Kim HJ, 2008, CHEM-EUR J, V14, P3883, DOI 10.1002/chem.200800056; Leung SYL, 2012, J AM CHEM SOC, V134, P1047, DOI 10.1021/ja208444c; Berl V, 2000, NATURE, V407, P720; Yamada H, 2012, J AM CHEM SOC, V134, P9506, DOI 10.1021/ja303701d; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; CONSTABLE EC, 1992, TETRAHEDRON, V48, P10013, DOI 10.1016/S0040-4020(01)89035-9; Rodler F, 2011, CHEM COMMUN, V47, P7953, DOI 10.1039/c1cc12520f; Ito H, 2011, J AM CHEM SOC, V133, P3419, DOI 10.1021/ja108514t; Campbell K, 2003, J ORGANOMET CHEM, V683, P379, DOI 10.1016/S0022-328X(03)00792-7; Hasegawa T, 2007, ANGEW CHEM INT EDIT, V46, P5885, DOI 10.1002/anie.200701735; Lam JWY, 2005, ACCOUNTS CHEM RES, V38, P745, DOI 10.1021/ar040012f; Totsingan F, 2010, MACROMOLECULES, V43, P2692, DOI 10.1021/ma902797f; Berni E, 2008, CHEM COMMUN, P1968, DOI 10.1039/b719712h; Boal AK, 2007, J AM CHEM SOC, V129, P6986, DOI 10.1021/ja071148m; Campbell K, 2004, ANGEW CHEM INT EDIT, V43, P5967, DOI 10.1002/anie.200461139; CARRANO CJ, 1978, J AM CHEM SOC, V100, P5371, DOI 10.1021/ja00485a019; Coles SJ, 2003, CHEM COMMUN, P568, DOI 10.1039/b210847j; D'Amato R, 2001, J ORGANOMET CHEM, V627, P13, DOI 10.1016/S0022-328X(00)00791-9; Saha R, 2005, DALTON T, P2760, DOI 10.1039/b505484b; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; DIETRICHBUCHECKER CO, 1990, ANGEW CHEM INT EDIT, V29, P1154, DOI 10.1002/anie.199011541; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Furusho Y, 2006, ORG LETT, V8, P2583, DOI 10.1021/ol0608294; Furusho Y, 2007, CHEM COMMUN, P3174, DOI 10.1039/b705347a; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Goto H, 2007, J AM CHEM SOC, V129, P109, DOI 10.1021/ja065477a; Green M. M., 1999, Angewandte Chemie (International Edition), V38, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3138::AID-ANIE3138>3.0.CO;2-C; Guetz C., 2014, ANGEW CHEM INT EDIT, V53, P1693; Hecht S., 2007, FOLDAMERS STRUCTURE; Hecht S, 2003, ANGEW CHEM INT EDIT, V42, P6021, DOI 10.1002/anie.200352983; Huc I, 2004, EUR J ORG CHEM, P17, DOI 10.1002/ejoc.200300495; Hutin M, 2007, J AM CHEM SOC, V129, P8774, DOI 10.1021/ja070320j; Iida H, 2010, J ORG CHEM, V75, P417, DOI 10.1021/jo902158v; Inai Y, 2007, CHEM REC, V7, P191, DOI 10.1002/tcr.20116; Keegan J, 2001, CHEM COMMUN, P2192, DOI 10.1039/b106981k; KHAN MS, 1994, J MATER CHEM, V4, P1227, DOI 10.1039/jm9940401227; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Masood MA, 1998, ANGEW CHEM INT EDIT, V37, P928, DOI 10.1002/(SICI)1521-3773(19980420)37:7<928::AID-ANIE928>3.0.CO;2-T; Ousaka N, 2009, J AM CHEM SOC, V131, P3820, DOI 10.1021/ja8091714; Owen GR, 2004, ORGANOMETALLICS, V23, P5893, DOI 10.1021/om049354f; Saraogi I., 2009, CHEM SOC REV, V38, P1726; Sauvage J.-P., 1999, MOL CATENANES ROTAXA; Smaldone RA, 2010, J POLYM SCI POL CHEM, V48, P927, DOI 10.1002/pola.23848; Stewart J. J. P., 2012, MOPAC2012 STEWART CO; Szafert S, 2006, CHEM REV, V106, pPR1, DOI 10.1021/cr068016g; Telfer SG, 2004, ANGEW CHEM INT EDIT, V43, P581, DOI 10.1002/anie.200352833; Walensky L. D., 2004, SCIENCE, V305, P466; Yam VWW, 2002, ACCOUNTS CHEM RES, V35, P555, DOI 10.1021/ar0000758; Yamada H, 2012, J AM CHEM SOC, V134, P7250, DOI 10.1021/ja301430h	115	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.		2015	6	1					714	723		10.1039/c4sc02275k		10	Chemistry, Multidisciplinary	Chemistry	AU9HD	WOS:000345901600085		
J	Ishigaki, T; Zaike, Y; Nojima, M; Kobayashi, S; Ohno, N; Uchimaru, K; Tojo, A; Nakauchi, H; Watanabe, N				Ishigaki, Tomohiro; Zaike, Yuji; Nojima, Masanori; Kobayashi, Seiichiro; Ohno, Nobuhiro; Uchimaru, Kaoru; Tojo, Arinobu; Nakauchi, Hiromitsu; Watanabe, Nobukazu			Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						adult T-cell leukemia/lymphoma (ATL); flow cytometry; HAS-Flow; human T-cell leukemia virus type 1 (HTLV-1)	REAL-TIME PCR; PROVIRAL LOAD QUANTIFICATION; VIRUS TYPE-I; LEUKEMIA-LYMPHOMA; HTLV-1; QUANTITATION; CARRIERS; COUNT	Background: The absolute number of adult T-cell leukemia/lymphoma (ATL) cells in peripheral blood is an essential indicator to evaluate disease status. However, microscopically counting ATL cells based on morphology requires experience and tends to be inaccurate due to the rarity of ATL. Methods: Based on our research showing that acute-type ATL cells are specifically enriched in the CD4+/CD7- (CD7N) fraction, a new analytical method to accurately quantify ATL cells was established using an internal bead standard and simple four-color flow cytometry. This method was verified by comparison with microscopic examination of 49 peripheral blood samples and used to follow up patients. Results: A strong correlation was observed between the number of CD7N cells measured by flow cytometry and the number of abnormal lymphocytes measured microscopically by experienced technicians [Pearson's R, 0.963; Spearman's rho, 0.921; intercorrelation coefficient, 0.962]. The linear regression coefficient was close to 1 (beta=1.013). Our method could detect 1 cell/mu L, and the limit of quantitation was between 2.9 and 9.8 cells/mu L. The frequency of CD7N cells among CD4+ cells changed during chemotherapy, which reflected differences between chemosensitive and chemoresistant cases. Kaplan-Meier analysis with a log-rank test showed that patients with decreased CD7N proportion after chemotherapy had significantly longer disease-specific survival (p=0.003). Conclusions: Our newly established method quantified tumor cells in patients with acute-type ATL. Furthermore, this method was useful for assessing the efficacy of chemo-therapy, and the change of the CD7N proportion could be more important to predict prognosis.	[Ishigaki, Tomohiro] Univ Tokyo, Inst Med Sci, Clin FACS Core Lab, Minato Ku, Tokyo 1088639, Japan; [Ishigaki, Tomohiro; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo 1088639, Japan; [Zaike, Yuji] Univ Tokyo, Res Hosp, Dept Lab Med, Inst Med Sci, Tokyo 1088639, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci, Div Adv Med Promot, Tokyo 1088639, Japan; [Kobayashi, Seiichiro; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tokyo 1088639, Japan; [Ohno, Nobuhiro; Uchimaru, Kaoru; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Res Hosp, Tokyo 1088639, Japan; [Watanabe, Nobukazu] Univ Tokyo, Inst Med Sci, Clin FACS Core Lab, Tokyo 1088639, Japan	Ishigaki, T (reprint author), Univ Tokyo, Inst Med Sci, Clin FACS Core Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ishigaki@ims.u-tokyo.ac.jp					Altamirano NA, 2010, J VIROL METHODS, V170, P160, DOI 10.1016/j.jviromet.2010.08.021; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Waters A, 2011, J CLIN VIROL, V52, P38, DOI 10.1016/j.jcv.2011.05.022; Schnizlein-Bick CT, 2000, CLIN DIAGN LAB IMMUN, V7, P336, DOI 10.1128/CDLI.7.3.336-343.2000; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Weil R, 1999, J VIROL, V73, P3709; Ohshima K, 2007, CANCER SCI, V98, P772, DOI 10.1111/j.1349-7006.2007.00456.x; Moens B, 2009, J CLIN MICROBIOL, V47, P3682, DOI 10.1128/JCM.00781-09; Kamihira S, 2003, CLIN LAB HAEMATOL, V25, P111, DOI 10.1046/j.1365-2257.2003.00503.x; Kamihira S, 2010, CANCER SCI, V101, P2361, DOI 10.1111/j.1349-7006.2010.01720.x; Araki K, 2000, CLIN EXP IMMUNOL, V119, P259; BOROWITZ MJ, 1993, AM J CLIN PATHOL, V100, P534; de Souza JG, 2010, J VIROL METHODS, V166, P65, DOI 10.1016/j.jviromet.2010.02.021; Kobayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053728; Leblond V, 1997, TRANSPLANTATION, V64, P1453, DOI 10.1097/00007890-199711270-00014; MOTOI T, 1988, JPN J CANCER RES, V79, P593; Sadamori N, 1996, LEUKEMIA LYMPHOMA, V22, P415, DOI 10.3109/10428199609054779; Shao HP, 2010, AM J CLIN PATHOL, V133, P592, DOI 10.1309/AJCPS1K0OHLJYWWV; Takenouchi H, 2011, INT J CANCER, V128, P1335, DOI 10.1002/ijc.25450; Tian YM, 2011, CANCER SCI, V102, P569, DOI 10.1111/j.1349-7006.2010.01833.x	20	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JAN	2015	53	1					85	93		10.1515/cclm-2014-0183		9	Medical Laboratory Technology	Medical Laboratory Technology	AW0ZX	WOS:000346021000017		
J	Asazawa, H; Kamada, Y; Takeda, Y; Takamatsu, S; Shinzaki, S; Kim, Y; Nezu, R; Kuzushita, N; Mita, E; Kato, M; Miyoshi, E				Asazawa, Hitomi; Kamada, Yoshihiro; Takeda, Yuri; Takamatsu, Shinji; Shinzaki, Shinichiro; Kim, Youkoku; Nezu, Riichiro; Kuzushita, Noriyoshi; Mita, Eiji; Kato, Michio; Miyoshi, Eiji			Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						alpha-fetoprotein (AFP); fucosylation; lectin antibody ELISA kit; protein induced by vitamin K antagonist II (PIVKA-II)	LECTIN-ANTIBODY ELISA; ALPHA-FETOPROTEIN; PANCREATIC-CANCER; N-GLYCANS; MARKER; ELECTROPHORESIS; GLYCOPROTEINS; REEVALUATION; PROGNOSIS; BILE	Background: Fucosylation is one of the most important glycosylation events involved in cancer and inflammation. We previously developed a lectin antibody ELISA kit to measure fucosylated haptoglobin (Fuc-Hpt), which we identified as a novel cancer biomarker. In this study, we investigated Fuc-Hpt as a biomarker in chronic liver diseases, especially in hepatocellular carcinoma (HCC). Methods: We measured serum Fuc-Hpt levels using our ELISA kit in 318 patients with chronic liver diseases, including 145 chronic hepatitis (CH) patients, 81 liver cirrhosis (LC) patients, and 92 HCC patients. During a long-term follow-up period of 7 years (1996-2003), Fuc-Hpt levels were measured at three different time points in 19 HCC patients. Serum Fuc-Hpt levels were also examined with a short-term follow-up period of 3 years (2009-2012) in 13 HCC patients. Results: Fuc-Hpt levels increased with liver disease progression. Patients with LC and HCC showed significantly increased Fuc-Hpt levels in comparison to CH patients or healthy volunteers. Fuc-Hpt levels tended to be higher in HCC patients than in LC patients. Fuc-Hpt was better than a-fetoprotein (AFP) and AFP-L3 for predicting HCC [diagnosed by computed tomography (CT) or ultrasound] in LC patients with long-term follow-up. More than 80% of LC patients with long-term follow-up showed increased Fuc-Hpt during hepatocarcinogenesis, and 38% of early-stage HCC patients with short-term follow-up showed a gradual increase in Fuc-Hpt before imaging diagnosis. Conclusions: These results suggest that Fuc-Hpt is a novel and potentially useful biomarker for predicting liver disease progression and HCC development.	[Asazawa, Hitomi; Kamada, Yoshihiro; Takeda, Yuri; Takamatsu, Shinji; Shinzaki, Shinichiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Investigat, Suita, Osaka 5650871, Japan; [Kim, Youkoku; Nezu, Riichiro] Osaka Rosai Hosp, Dept Surg, Osaka, Japan; [Kuzushita, Noriyoshi; Mita, Eiji; Kato, Michio] Osaka Natl Hosp, Dept Gastroenterol Hepatol, Osaka, Japan	Miyoshi, E (reprint author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Investigat, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.oska-u.ac.jp			Japan Society for the Promotion of Science [21249038]	This study was supported by a Grant-in-Aid for Scientific Research (A), No. 21249038 from the Japan Society for the Promotion of Science and performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, and Science.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; BREBOROWICZ J, 1981, SCAND J IMMUNOL, V14, P15, DOI 10.1111/j.1365-3083.1981.tb00179.x; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Matsumoto H, 2010, CLIN CHEM LAB MED, V48, P505, DOI 10.1515/CCLM.2010.095; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Hashimoto S, 2004, CANCER, V101, P2825, DOI 10.1002/cncr.20713; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Kamada Y, 2013, CLIN CHIM ACTA, V417, P48, DOI 10.1016/j.cca.2012.12.014; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; Debruyne EN, 2010, CLIN CHEM, V56, P823, DOI 10.1373/clinchem.2009.139295; Kormoczi GF, 2006, EUR J CLIN INVEST, V36, P202, DOI 10.1111/j.1365-2362.2006.01617.x; AOYAGI Y, 1995, GLYCOCONJUGATE J, V12, P194, DOI 10.1007/BF00731319; Nakagawa T, 2010, J PROTEOME RES, V9, P4888, DOI 10.1021/pr100414r; Takeda Y, 2012, CANCER-AM CANCER SOC, V118, P3036, DOI 10.1002/cncr.26490; TAKETA K, 1983, ANN NY ACAD SCI, V417, P61, DOI 10.1111/j.1749-6632.1983.tb32849.x	20	3	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JAN	2015	53	1					95	102		10.1515/cclm-2014-0427		8	Medical Laboratory Technology	Medical Laboratory Technology	AW0ZX	WOS:000346021000018		
J	Kumagai, S; Amano, T; Takashima, H; Waseda, K; Kurita, A; Ando, H; Maeda, K; Ito, Y; Ishii, H; Hayashi, M; Yoshikawa, D; Suzuki, S; Tanaka, A; Matsubara, T; Murohara, T				Kumagai, Soichiro; Amano, Tetsuya; Takashima, Hiroaki; Waseda, Katsuhisa; Kurita, Akiyoshi; Ando, Hirohiko; Maeda, Kazuyuki; Ito, Yoshitaka; Ishii, Hideki; Hayashi, Mutsuharu; Yoshikawa, Daiji; Suzuki, Susumu; Tanaka, Akihito; Matsubara, Tatsuaki; Murohara, Toyoaki			Impact of cigarette smoking on coronary plaque composition	CORONARY ARTERY DISEASE			English	Article						cigarette smoking; coronary plaque tissue components; integrated backscatter intravascular ultrasound; lipid profiles; percutaneous coronary intervention	BACKSCATTER INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; TISSUE CHARACTERIZATION; DEPENDENT DILATATION; INSULIN-RESISTANCE; STATIN THERAPY; HEART-DISEASE; IN-VIVO; CESSATION; MORTALITY	Objectives Cigarette smoking is associated with atherosclerosis and is an important risk factor for cardiovascular disease. We evaluated the impact of cigarette smoking on coronary plaque composition using integrated backscatter intravascular ultrasound (IB-IVUS). Methods A total of 143 consecutive patients undergoing percutaneous coronary intervention were enrolled. A history of illness, as well as smoking habits, was obtained by interview. Participants were asked to report whether they were current smokers, had quit smoking, or had never smoked. According to interview s, patients were divided into the following three groups: current, former, and never smokers. Conventional and IB-IVUS tissue characterization analyses were carried out. Three-dimensional analyses were carried out to determine plaque volume and the volume of each plaque component (lipid, fibrous, and calcified). Results IB-IVUS analysis indicated that the patients in the current smoker group had significantly increased percent lipid volume and significantly decreased percent fibrous volume (P = 0.01 and 0.03). Logistic regression analysis showed that the current smoking state (odds ratio 3.51, 95% confidence interval 1.02-12.10, P = 0.04) was independently associated with the presence of lipid-rich plaques, which was defined as the upper 75th percentile of the study population. Conclusion Smoking is independently associated with lipid-rich plaques, contributing to the increasing risk for plaque vulnerability. Coron Artery Dis 26:60-65 (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Kumagai, Soichiro; Amano, Tetsuya; Takashima, Hiroaki; Waseda, Katsuhisa; Kurita, Akiyoshi; Ando, Hirohiko; Maeda, Kazuyuki; Ito, Yoshitaka] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi 4801195, Japan; [Ishii, Hideki; Hayashi, Mutsuharu; Yoshikawa, Daiji; Suzuki, Susumu; Tanaka, Akihito; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan	Kumagai, S (reprint author), Aichi Med Univ, Dept Cardiol, 1-1 Karimata, Nagakute, Aichi 4801195, Japan.	kumagais@aichi-med-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lightwood JM, 1997, CIRCULATION, V96, P1089; Hiro T, 2010, CIRC J, V74, P1165, DOI 10.1253/circj.CJ-09-0766; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Fang Q, 2003, AM J PHYSIOL-HEART C, V284, pH528, DOI 10.1152/ajpheart.00752.2002; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Sargent RP, 2004, BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; van Berkel TFM, 1999, EUR HEART J, V20, P1773, DOI 10.1053/euhj.1999.1658; Miyagi M, 2010, NEPHROL DIAL TRANSPL, V25, P175, DOI 10.1093/ndt/gfp423; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Okubo M, 2008, ULTRASOUND MED BIOL, V34, P655, DOI 10.1016/j.ultrasmedbio.2007.09.015; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Amano T, 2011, ATHEROSCLEROSIS, V218, P110, DOI 10.1016/j.atherosclerosis.2011.05.030; Amano T, 2011, CIRC J, V75, P157, DOI 10.1253/circj.CJ-10-0612; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Amano T, 2008, JACC-CARDIOVASC IMAG, V1, P39, DOI 10.1016/j.jcmg.2007.09.003; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Chalon S, 2000, CLIN PHARMACOL THER, V67, P391, DOI 10.1067/mcp.2000.105153; Chen T, 2012, CLIN CARDIOL, V35, P570, DOI 10.1002/clc.22004; Cooper R G, 2008, Indian J Physiol Pharmacol, V52, P11; Critchley J, 2003, COCHRANE DB SYST REV, V4; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; SALONEN JT, 1980, BRIT HEART J, V43, P463	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	JAN	2015	26	1					60	65		10.1097/MCA.0000000000000168		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW3AX	WOS:000346158800012		
J	Nishi, H; Nagano, T; Kameyama, T; Kuwabata, S; Torimoto, T				Nishi, Hiroyasu; Nagano, Takahito; Kameyama, Tatsuya; Kuwabata, Susumu; Torimoto, Tsukasa			Well-controlled synthesis of wurtzite-type Cu2ZnSnS4 nanoparticles using multiple sulfur sources via a two-step heating process	CRYSTENGCOMM			English	Article							SEMICONDUCTOR QUANTUM DOTS; SOLAR-CELLS; NANOCRYSTALS; CONFINEMENT; MECHANISM; NANORODS; CUINS2	Wurtzite-type copper zinc tin sulfide (Cu2ZnSnS4) nanoparticles were prepared in dodecanethiol (DDT) solutions by reacting corresponding metal acetates with a mixture of sulfur compounds with different reactivities, elemental sulfur (S) and dibutylthiourea (DBTU), via a two-step heat treatment. Initial heating at 200 degrees C enabled the nucleation of metal sulfide nanoparticles composed of two crystal phases, and subsequent heat treatment at 240 degrees C resulted in the formation of Cu2ZnSnS4 nanoparticles with a wurtzite-type crystal structure. The resulting particles had rod shapes with a stoichiometric composition, the size and shape of which could be controlled by changing both the reaction time and the molar ratio of S and DBTU used in a sulfur precursor. In contrast, spherical Cu2ZnSnS4 nanoparticles with a kesterite-type crystal structure were produced by reaction with pure S as a precursor. The electronic energy levels of the conduction band and valence band edges were determined for wurtzite-type Cu2ZnSnS4 nanoparticles by photoelectrochemical measurement, the individual levels being comparable to those of kesterite-type ones. The light-electricity conversion efficiency varied remarkably depending on the kind of crystal structure: wurtzite-type Cu2ZnSnS4 particles exhibited an efficiency superior to that of the particles with a kesterite-type crystal structure.	[Nishi, Hiroyasu; Nagano, Takahito; Kameyama, Tatsuya; Torimoto, Tsukasa] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Nishi, H (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	nishi-h@iis.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science [26810043]	This work was supported by a Funding Program for Next Generation World-Leading Researchers (NEXT Program) and a Grant-in-Aid for Young Scientists (B) (no. 26810043) from the Japan Society for the Promotion of Science.	Liao HC, 2013, J MATER CHEM A, V1, P337, DOI 10.1039/c2ta00151a; Luther JM, 2011, NAT MATER, V10, P361, DOI [10.1038/nmat3004, 10.1038/NMAT3004]; Zou Y, 2013, J AM CHEM SOC, V135, P18377, DOI 10.1021/ja405962k; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Guo Q, 2010, J AM CHEM SOC, V132, P17384, DOI 10.1021/ja108427b; Liu WC, 2013, J MATER CHEM A, V1, P3182, DOI 10.1039/c3ta00357d; Khrypunov G, 2006, SOL ENERG MAT SOL C, V90, P664, DOI 10.1016/j.solmat.2005.04.003; Regulacio MD, 2012, CHEM-EUR J, V18, P3127, DOI 10.1002/chem.201103635; Khare A, 2011, CHEM COMMUN, V47, P11721, DOI 10.1039/c1cc14687d; Li M, 2012, J PHYS CHEM C, V116, P26507, DOI 10.1021/jp307346k; Ramasamy K, 2012, CHEM COMMUN, V48, P5703, DOI 10.1039/c2cc30792h; Thompson MJ, 2013, J PHYS CHEM LETT, V4, P3918, DOI 10.1021/jz402048p; Lu XT, 2011, CHEM COMMUN, V47, P3141, DOI 10.1039/c0cc05064d; Singh A, 2012, J AM CHEM SOC, V134, P2910, DOI 10.1021/ja2112146; Kanehara M, 2012, CHEM-EUR J, V18, P9230, DOI 10.1002/chem.201201159; Barkhouse DAR, 2012, PROG PHOTOVOLTAICS, V20, P6, DOI 10.1002/pip.1160; Wang K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499284; Han SK, 2012, ANGEW CHEM INT EDIT, V51, P6365, DOI 10.1002/anie.201202128; Kruszynska M, 2010, J AM CHEM SOC, V132, P15976, DOI 10.1021/ja103828f; Law M, 2008, J AM CHEM SOC, V130, P5974, DOI 10.1021/ja800040c; Guo QJ, 2009, J AM CHEM SOC, V131, P11672, DOI 10.1021/ja904981r; Chang J, 2013, CRYSTENGCOMM, V15, P5612, DOI 10.1039/c3ce40284c; Kameyama T, 2010, J MATER CHEM, V20, P5319, DOI 10.1039/c0jm00454e; Yi LX, 2010, CRYSTENGCOMM, V12, P4124, DOI 10.1039/c0ce00026d; Nishi H, 2014, PHYS CHEM CHEM PHYS, V16, P672, DOI 10.1039/c3cp53946f; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Nozik AJ, 2010, CHEM REV, V110, P6873, DOI 10.1021/cr900289f; Delbos S., 2012, EPJ PHOTOVOLTAICS, V3, P35004, DOI DOI 10.1051/EPJPV/2012008; Mott D., 2010, CHEM MATER, V1, P261; Nishi H, 2013, J PHYS CHEM C, V117, P21055, DOI 10.1021/jp405008m; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822	31	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1466-8033			CRYSTENGCOMM	Crystengcomm		2015	17	1					174	182		10.1039/c4ce01852d		9	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AW0TP	WOS:000346006700020		
J	Reboul, J; Yoshida, K; Furukawa, S; Kitagawa, S				Reboul, Julien; Yoshida, Kenji; Furukawa, Shuhei; Kitagawa, Susumu			Reductive coordination replication of V2O5 sacrificial macrostructures into vanadium-based porous coordination polymers	CRYSTENGCOMM			English	Article							METAL-ORGANIC FRAMEWORKS; L-ASCORBIC-ACID; OXALIC-ACID; DISSOLUTION; ION; HETEROSTRUCTURES; ARCHITECTURES; FLEXIBILITY; COMPOSITES; CHEMISTRY	Vanadium-based porous coordination polymers (or metal-organic frameworks) possess both porous and electronic properties, which make these new materials appealing for applications in molecular separation, sensing and heterogeneous catalysis. Their integration into systems that fully exploit their intrinsic properties requires versatile methods allowing assembly of the PCP crystals into well-defined films, patterns, fibers or the formation of heterostructures. In this contribution, polycrystalline macrostructures and heterostructures made of [V(OH)ndc](n) (ndc = 1,4-naphthalenedicarboxylate) PCP crystals were synthesized through a dissolution-recrystallization process, so-called coordination replication, where a pre-shaped V2O5 sacrificial phase was replaced by well-intergrown PCP crystals in the presence of H(2)ndc as an organic linker and under a reductive environment. In this process, V2O5 acts both as the metal source and as the template that provides the shape to the resulting mesoscopic polycrystalline architecture. Ascorbic acid, acting as the reducing agent, both promotes the dissolution of the sacrificial V2O5 phase and provides the V-III species required for the construction of the [V(OH)ndc](n) framework. Two-dimensional patterns were successfully synthesized by applying this procedure.	[Reboul, Julien; Furukawa, Shuhei; Kitagawa, Susumu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Yoshida, Kenji; Kitagawa, Susumu] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Reboul, J (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan.	shuhei.furukawa@icems.kyoto-u.ac.jp; kitagawa@icems.kyoto-u.ac.jp	Kitagawa, Susumu/C-2468-2009; Furukawa, Shuhei/D-9681-2012		MEXT, Japan [24108720, 25708010]; World Premier International Research Center Initiative (WPI), MEXT, Japan	This work was supported by a Grant-in-Aid for Scientific Research (no. 24108720 for Innovative Areas "Coordination Programming" Area 2107 and no. 25708010 for Wakate A) from MEXT, Japan. iCeMS is supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan. The authors thank CeMI for assistance with electron microscopy.	Kozachuk O, 2013, EUR J INORG CHEM, V2013, P4546, DOI 10.1002/ejic.201300591; Wang Y, 2006, ADV FUNCT MATER, V16, P1133, DOI 10.1002/adfm.200500662; Khaletskaya K, 2013, J AM CHEM SOC, V135, P10998, DOI 10.1021/ja403108x; Van der Voort P, 2014, NEW J CHEM, V38, P1853, DOI 10.1039/c3nj01130e; Ni Z, 2006, J AM CHEM SOC, V128, P12394, DOI 10.1021/ja0635231; Shekhah O, 2011, CHEM SOC REV, V40, P1081, DOI 10.1039/c0cs00147c; Furukawa S, 2014, CHEM SOC REV, V43, P5700, DOI 10.1039/c4cs00106k; Comotti A, 2008, J AM CHEM SOC, V130, P13664, DOI 10.1021/ja802589u; Wilkins PC, 2006, INORG CHEM, V45, P1471, DOI 10.1021/ic050749g; Livage J, 1996, SOLID STATE IONICS, V86-8, P935, DOI 10.1016/0167-2738(96)00336-0; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhan WW, 2013, J AM CHEM SOC, V135, P1926, DOI 10.1021/ja311085e; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Falcaro P, 2014, CHEM SOC REV, V43, P5513, DOI 10.1039/c4cs00089g; Petkov V, 2002, J AM CHEM SOC, V124, P10157, DOI 10.1021/ja026143y; Liu YY, 2013, INORG CHEM, V52, P113, DOI 10.1021/ic301338a; Livage J, 1997, J SOL-GEL SCI TECHN, V8, P857, DOI 10.1023/A:1018367014752; Li L, 2010, J MATER CHEM, V20, P7131, DOI 10.1039/c0jm00558d; Leclerc H, 2011, J PHYS CHEM C, V115, P19828, DOI 10.1021/jp206655y; Hamon L, 2011, J PHYS CHEM C, V115, P2047, DOI 10.1021/jp1092724; Liu YY, 2014, CHEM MATER, V26, P1119, DOI 10.1021/cm4034319; Barthelet K, 2002, ANGEW CHEM INT EDIT, V41, P281, DOI 10.1002/1521-3773(20020118)41:2<281::AID-ANIE281>3.0.CO;2-Y; Botto IL, 1997, MATER CHEM PHYS, V50, P267, DOI 10.1016/S0254-0584(97)01940-8; Wu YN, 2011, ANGEW CHEM INT EDIT, V50, P12518, DOI 10.1002/anie.201104597; Leus K, 2010, CHEM COMMUN, V46, P5085, DOI 10.1039/c0cc01506g; Mai LQ, 2010, NANO LETT, V10, P4750, DOI 10.1021/nl103343w; Putnis A, 2009, REV MINERAL GEOCHEM, V70, P87, DOI 10.2138/rmg.2009.70.3; Stassen I, 2013, CRYSTENGCOMM, V15, P9308, DOI 10.1039/c3ce41025k; Reboul J, 2012, NAT MATER, V11, P717, DOI [10.1038/nmat3359, 10.1038/NMAT3359]; Liu YY, 2012, EUR J INORG CHEM, P2819, DOI 10.1002/ejic.201101099; STUMM W, 1990, REV GEOPHYS, V28, P53, DOI 10.1029/RG028i001p00053; Panias D, 1996, HYDROMETALLURGY, V42, P257, DOI 10.1016/0304-386X(95)00104-O; Belik A. A., 2007, ACTA CRYSTALLOGR C, V63, P37; Bruyere VIE, 1999, J COLLOID INTERF SCI, V209, P207, DOI 10.1006/jcis.1998.5876; Centrone A, 2010, SMALL, V6, P1598, DOI 10.1002/smll.201000773; KHAN MMT, 1968, J AM CHEM SOC, V90, P6011, DOI 10.1021/ja01024a013; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; KUSTIN K, 1973, INORG CHEM, V12, P1404, DOI 10.1021/ic50124a038; Nakahama M, 2014, CHEM LETT, V43, P1052, DOI 10.1246/cl.140291; Rodenas LAG, 1997, INORG CHEM, V36, P6423; Sakka S., 2005, HDB SOL GEL SCI TECH; SELLERS RM, 1984, FARADAY DISCUSS, V77, P265, DOI 10.1039/dc9847700265; Vassilev K. G., 2000, CH COMPT REND ACAD B, V53, P51	43	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1466-8033			CRYSTENGCOMM	Crystengcomm		2015	17	2					323	330		10.1039/c4ce01501k		8	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AW3GB	WOS:000346173200015		
J	Kaneko, M; Machida, S; Hoshi, Y; Kurosaka, D				Kaneko, Muneyoshi; Machida, Shigeki; Hoshi, Yuya; Kurosaka, Daijiro			Alterations of Photopic Negative Response of Multifocal Electroretinogram in Patients with Glaucoma	CURRENT EYE RESEARCH			English	Article						Glaucoma; multifocal ERG; multifocal PhNR; photopic negative response; retinal ganglion cells	OPEN-ANGLE GLAUCOMA; FLASH ELECTRORETINOGRAM; OSCILLATORY POTENTIALS; GANGLION-CELLS; HUMAN RETINA; FIELD; ERG; TOPOGRAPHY; ATROPHY; EYES	Purpose: To determine the effect of glaucoma on the multifocal electroretinograms (ERGs) (mfERGs) elicited by low-frequency stimuli. Methods: Forty-four patients with open-angle glaucoma and 15 normal subjects were studied. The stimulus frequency was 6.25 Hz, and the stimulus was a circle with a 6.8 degrees radius that was centered on the fovea (center). MfERGs were also elicited by a quarter of an annulus placed around the macula (superior/temporal; inferior/temporal; superior/nasal; and inferior/nasal quadrants). The radius of the inner border of the annulus was 6.8 degrees and that of the outer border was 20 degrees. The actual sensitivity was determined by standard automated perimetry. The thickness of the ganglion cell complex (GCC) was measured by optical coherence tomography. Results: The mfERGs consisted of a negative wave (N1) followed by a positive wave (P1), and followed by a slow negative wave (N2). There were no significant differences in the response densities of N1 and P1 between the normal control and glaucomatous eyes in any areas. The N2 response density was significantly reduced with the severity of glaucoma in the center. There was a significant reduction even at an early stage of glaucoma compared to control values. In the center, the N2 response density was significantly correlated with the GCC thickness and mean sensitivity. However, in other stimulus areas, there was no significant reduction of any components of the mfERGs. Conclusions: These results suggest that the N2 component of the slow-sequence mfERGs is affected by glaucoma in the central retinal area. Regional variations in the contribution of the retinal ganglion cell activity to the N2 should be considered when examining the mfERGs in glaucoma patients.	[Kaneko, Muneyoshi; Machida, Shigeki; Hoshi, Yuya; Kurosaka, Daijiro] Iwate Med Univ, Sch Med, Dept Ophthalmol, Morioka, Iwate 0208505, Japan	Machida, S (reprint author), Iwate Med Univ, Sch Med, Dept Ophthalmol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	smachida57@gmail.com			Ministry of Education, Science and Culture in Japan [24592677]	This study was supported by a Grant-in-Aid for Scientific Research C from Ministry of Education, Science and Culture in Japan No. 24592677 (MK) and 24592677 (SM).	Anderson DR, 1999, AUTOMATED STATIC PER, P121; Machida S, 2004, AM J OPHTHALMOL, V137, P938, DOI 10.1016/j.ajo.2003.10.023; Rangaswamy NV, 2003, INVEST OPHTH VIS SCI, V44, P3233, DOI 10.1167/iovs.03-0009; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P2201, DOI 10.1167/iovs.07-0887; Viswanathan S, 2000, INVEST OPHTH VIS SCI, V41, P2797; Raz-Prag D, 2010, P NATL ACAD SCI USA, V107, P12710, DOI 10.1073/pnas.0913472107; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Tan Ou, 2009, Ophthalmology, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Hood DC, 1997, VISUAL NEUROSCI, V14, P533; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341; Distler C, 1996, VISION RES, V36, P2381, DOI 10.1016/0042-6989(96)00005-3; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P5636, DOI 10.1167/iovs.08-1946; Machida S, 2010, BRIT J OPHTHALMOL, V94, P202, DOI 10.1136/bjo.2009.161166; Nakamura H, 2011, AM J OPHTHALMOL, V151, P494, DOI 10.1016/j.ajo.2010.09.018; Machida S, 2011, J OPHTHALMOL, DOI 10.1155/2011/564131; Kondo M, 2008, INVEST OPHTH VIS SCI, V49, P3544, DOI 10.1167/iovs.08-1798; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DRASDO N, 1989, VISION RES, V29, P985, DOI 10.1016/0042-6989(89)90113-2; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Kondo M, 1998, INVEST OPHTH VIS SCI, V39, P574; Machida S, 2012, J OPHTHALMOL, DOI 10.1155/2012/397178; Machida S, 2014, CURR EYE RES; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; Miyata K, 2007, INVEST OPHTH VIS SCI, V48, P820, DOI 10.1167/iovs.06-0845; Nagata M, 1963, JPN J OPHTHALMOL, V7, P96; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; SUTTER EE, 1991, SIAM J COMPUT, V20, P686, DOI 10.1137/0220043; Tamada K, 2010, CURR EYE RES, V35, P155, DOI 10.3109/02713680903447926; Wang J, 2012, INVEST OPHTH VIS SCI, V53, P1315, DOI 10.1167/iovs.11-8461	36	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	JAN	2015	40	1					77	86		10.3109/02713683.2014.915575		10	Ophthalmology	Ophthalmology	AW0IA	WOS:000345973700009		
J	Higa, M; Yamaura, Y; Koizumi, I; Yabuhara, Y; Senzaki, M; Ono, S				Higa, Motoki; Yamaura, Yuichi; Koizumi, Itsuro; Yabuhara, Yuki; Senzaki, Masayuki; Ono, Satoru			Mapping large-scale bird distributions using occupancy models and citizen data with spatially biased sampling effort	DIVERSITY AND DISTRIBUTIONS			English	Article						Imperfect detection; Maxlike; multispecies occupancy model; opportunistic citizen data; pseudo-absence data; spatially biased sampling effort	SPECIES DISTRIBUTION MODELS; PSEUDO-ABSENCE DATA; CHANGE IMPACTS; CONSERVATION; MAXENT; DETECTABILITY; CHALLENGES; ABUNDANCE; SCIENCE	AimAlthough data collected by citizen scientists have received a great deal of attention for assessing species distributions over large extents, their sampling efforts are usually spatially biased. We assessed whether the bias of spatially varied sampling effort for opportunistic citizen data can be corrected using occupancy models that incorporate observation processes. LocationHokkaido Island, northern Japan. MethodsWe applied occupancy models for citizen data with spatially biased sampling effort to model and map large-scale distributions of 52 forest and 23 grassland/wetland bird species. We used estimated species richness (summed occupancy probabilities among the species) as the aggregated distributional patterns of each species group and compared them among two occupancy models (i.e. single-species and multispecies occupancy models), two conventional logistic regression models and Maxlike, which do not explicitly deal with observation processes. ResultsConventional logistic regression models and Maxlike predicted inappropriate patterns, such as forest species preferring lowland non-forested areas where most of the data were collected. Occupancy models, however, showed more appropriate results, indicating that forest species preferred lowland forested areas. The prediction by logistic models was somewhat improved by the use of spatially biased non-detection data as the absence data; however, estimates of species richness were still much lower than those of occupancy models. Differences in model outputs were evident for the forest species but not for grassland/wetland species because citizen data covered virtually all environmental niches for grassland/wetland species. Results of the single-species and multispecies occupancy models were nearly identical, but in some cases, estimates from the single-species models were not converged or deviated notably from those of other species compared with estimates by the multispecies model. Main conclusionsWe found that citizen data with spatially biased sampling effort can be appropriately utilized for large-scale biodiversity distribution modelling with the use of occupancy models, which encourages data collection by citizen scientists.	[Higa, Motoki; Yamaura, Yuichi; Yabuhara, Yuki; Senzaki, Masayuki] Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Koizumi, Itsuro] Hokkaido Univ, Creat Res Inst, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Ono, Satoru] Hokkaido Res Org, Environm & Geol Res Dept, Inst Environm Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan	Higa, M (reprint author), Kochi Univ, Fac Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	mhiga@air.ocn.ne.jp	Yamaura, Yuichi/A-3638-2012	Yamaura, Yuichi/0000-0001-9355-4413	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan [D-1201]; JSPS KAKENHI [23780153, 25252030]	We are very grateful to Dr. Marc Kery and two anonymous referees for valuable comments on the manuscript. This research was supported by the Environmental Research and Technology Development Fund (D-1201) of the Ministry of the Environment, Japan. Y. Yamaura was supported by JSPS KAKENHI Grants 23780153 and 25252030.	Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Yamaura Y, 2013, ORNITHOL SCI, V12, P73; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; SAUER JR, 1994, AUK, V111, P50; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Kery M, 2010, CONSERV BIOL, V24, P1388, DOI 10.1111/j.1523-1739.2010.01479.x; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Botts EA, 2011, BIODIVERS CONSERV, V20, P119, DOI 10.1007/s10531-010-9950-6; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Yamaura Y, 2011, J APPL ECOL, V48, P67, DOI 10.1111/j.1365-2664.2010.01922.x; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Butchart S. H. M., 2010, SCIENCE, V328, P164; Chandler RE, 2013, J R STAT SOC C-APPL, V62, P1, DOI 10.1111/rssc.12000; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Franklin J., 2009, MAPPING SPECIES DIST; Gelman A., 2007, DATA ANAL USING REGR; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Ono S., 2013, HOKKAIDO WILDLIFE DI, V39, P31; Plummer M, 2013, JAGS JUST ANOTHER GI; R Core Team, 2013, R LANG ENV STAT COMP; Royle J. A., 2009, HIER MOD INF EC; Su Y. S., 2013, R2JAGS PACKAGE RUNNI; Takada M., 2009, LANDSCAPE ECOLOGY MA, V14, P145	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1366-9516	1472-4642		DIVERS DISTRIB	Divers. Distrib.	JAN	2015	21	1					46	54		10.1111/ddi.12255		9	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	AW3JI	WOS:000346182200005		
J	Hosaka, S; Murayama, N; Satsukawa, M; Shimizu, M; Uehara, S; Fujino, H; Iwasaki, K; Iwano, S; Uno, Y; Yamazaki, H				Hosaka, Shinya; Murayama, Norie; Satsukawa, Masahiro; Shimizu, Makiko; Uehara, Shotaro; Fujino, Hideki; Iwasaki, Kazuhide; Iwano, Shunsuke; Uno, Yasuhiro; Yamazaki, Hiroshi			Evaluation of 89 Compounds for Identification of Substrates for Cynomolgus Monkey CYP2C76, a New Bupropion/Nifedipine Oxidase	DRUG METABOLISM AND DISPOSITION			English	Article							IMMUNOCHEMICAL DETECTION; CYTOCHROME-P450 ENZYMES; CATALYTIC-ACTIVITY; LIVER-MICROSOMES; DRUG-METABOLISM; BUPROPION; HUMANS; HYDROXYLATION; OXIDATION; RATS	Cynomolgus monkeys are widely used in preclinical studies during drug development because of their evolutionary closeness to humans, including their cytochrome P450s (P450s). Most cynomolgus monkey P450s are almost identical (>= 90%) to human P450s; however, CYP2C76 has low sequence identity (approximately 80%) to any human CYP2Cs. Although CYP2C76 has no ortholog in humans and is partly responsible for species differences in drug metabolism between cynomolgus monkeys and humans, a broad evaluation of potential substrates for CYP2C76 has not yet been conducted. In this study, a screening of 89 marketed compounds, including human CYP2C and non-CYP2C substrates or inhibitors, was conducted to find potential CYP2C76 substrates. Among the compounds screened, 19 chemicals were identified as substrates for CYP2C76, including substrates for human CYP1A2 (7-ethoxyresorufin), CYP2B6 (bupropion), CYP2D6 (dextromethorphan), and CYP3A4/5 (dextromethorphan and nifedipine), and inhibitors for CYP2B6 (sertraline, clopidogrel, and ticlopidine), CYP2C8 (quercetin), CYP2C19 (ticlopidine and nootkatone), and CYP3A4/5 (troleandomycin). CYP2C76 metabolized a wide variety of the compounds with diverse structures. Among them, bupropion and nifedipine showed high selectivity to CYP2C76. As for nifedipine, CYP2C76 formed methylhydroxylated nifedipine, which was not produced by monkey CYP2C9, CYP2C19, or CYP3A4, as identified by mass spectrometry and estimated by a molecular docking simulation. This unique oxidative metabolite formation of nifedipine could be one of the selective marker reactions of CYP2C76 among the major CYP2Cs and CYP3As tested. These results suggest that monkey CYP2C76 contributes to bupropion hydroxylation and formation of different nifedipine oxidative metabolites as a result of its relatively large substrate cavity.	[Hosaka, Shinya; Murayama, Norie; Shimizu, Makiko; Uehara, Shotaro; Iwano, Shunsuke; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan; [Hosaka, Shinya; Satsukawa, Masahiro] Kaken Pharmaceut Co Ltd, Pharmacokinet & Safety Res Dept, Shizuoka, Japan; [Fujino, Hideki] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo, Japan; [Iwano, Shunsuke] Novartis Pharma KK, Tokyo, Japan; [Iwasaki, Kazuhide; Uno, Yasuhiro] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan	Yamazaki, H (reprint author), Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261			Akabane T, 2010, DRUG METAB DISPOS, V38, P308, DOI 10.1124/dmd.109.028829; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Takahashi M, 2009, J PHARM SCI-US, V98, P4343, DOI 10.1002/jps.21708; Hesse LM, 2000, DRUG METAB DISPOS, V28, P1176; Daigo S, 2002, PHARMACOGENETICS, V12, P299, DOI 10.1097/00008571-200206000-00005; Shimada T, 1997, ARCH TOXICOL, V71, P401, DOI 10.1007/s002040050403; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Chiou WL, 2002, PHARMACEUT RES, V19, P868, DOI 10.1023/A:1016169202830; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Pekthong D, 2012, DRUG METAB DISPOS, V40, P32, DOI 10.1124/dmd.111.041368; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Chovan JP, 2007, XENOBIOTICA, V37, P459, DOI 10.1080/00498250701245250; Coles R, 2007, J CHROMATOGR B, V857, P67, DOI 10.1016/j.jchromb.2007.07.007; Iwata H, 1998, BIOCHEM PHARMACOL, V55, P1315, DOI 10.1016/S0006-2952(97)00643-6; Koyanagi T, 2014, XENOBIOTICA IN PRESS; Koyanagi T, 2014, XENOBIOTICA, V44, P893, DOI 10.3109/00498254.2014.903532; Uehara S, 2014, XENOBIOTICA, V44, P769, DOI 10.3109/00498254.2014.895882; Uehara S, 2011, J PHARMACOL EXP THER, V339, P654, DOI 10.1124/jpet.111.185009; Uno Y, 2011, BASIC CLIN PHARMACOL, V109, P315, DOI 10.1111/j.1742-7843.2011.00740.x; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2010, CURR DRUG METAB, V11, P142; Uno Y, 2007, XENOBIOTICA, V37, P30, DOI 10.1080/00498250600968275; Yeniceli D, 2011, TALANTA, V84, P19, DOI 10.1016/j.talanta.2010.11.063	25	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	JAN	2015	43	1					27	33		10.1124/dmd.114.061275		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW3KQ	WOS:000346186000004		
J	Tega, Y; Akanuma, S; Kubo, Y; Hosoya, K				Tega, Yuma; Akanuma, Shin-ichi; Kubo, Yoshiyuki; Hosoya, Ken-ichi			Involvement of the H+/Organic Cation Antiporter in Nicotine Transport in Rat Liver	DRUG METABOLISM AND DISPOSITION			English	Article							ORGANIC CATIONS; METABOLISM; MECHANISMS; SMOKING; CLONING	Nicotine is an addictive alkaloid in cigarette smoke and is responsible for tobacco dependence. It is important to consider the blood-to-liver transport of nicotine to understand the nicotine elimination from the body because most of the nicotine is converted to inactive metabolites by cytochrome P450 localized in the endoplasmic reticulum of the hepatocytes. In this study, the blood-to-liver transport of nicotine was investigated by means of an in vivo portal vein injection technique in rats, and the in vitro uptake by freshly isolated rat hepatocytes was used to clarify its mechanism. The results obtained showed that the in vivo blood-to-liver transport of [H-3] nicotine was significantly inhibited by 50 mM nicotine and pyrilamine, suggesting involvement of a carrier-mediated transport process in the blood-to-liver transport of nicotine. The in vitro uptake study using freshly isolated rat hepatocytes showed a time- and concentration-dependent uptake of [H-3] nicotine with a K-m value of 141 mu M, and the uptake was increased under alkaline extracellular conditions. In addition, intracellular acidification caused an increase in [H-3] nicotine uptake, suggesting that the influx transport of nicotine is driven by an oppositely directed H+ gradient in hepatocytes. Moreover, [H-3] nicotine uptake was strongly inhibited in the presence of cationic drugs, such as pyrilamine, whereas only weak inhibitory effects were shown by substrates of typical organic cation transporters, such as tetraethylammonium, 1-methyl-4-phenylpyridinium, choline, and L-carnitine. In conclusion, a carrier-mediated system controlling the blood-to-liver transport of nicotine appears to be present on the sinusoidal membrane of hepatocytes. The pattern of inhibition and ion dependence is suggestive of an H+/organic cation antiporter-mediated nicotine transport system.	[Tega, Yuma; Akanuma, Shin-ichi; Kubo, Yoshiyuki; Hosoya, Ken-ichi] Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	Hosoya, K (reprint author), Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Sugitani, Toyama 9300194, Japan.	hosoyak@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science (JSPS)	This study was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS).	HUGHES JR, 1984, PSYCHOPHARMACOLOGY, V83, P82, DOI 10.1007/BF00427428; Syed BA, 2013, NAT REV DRUG DISCOV, V12, P97, DOI 10.1038/nrd3914; Hiasa M, 2006, AM J PHYSIOL-CELL PH, V291, pC678, DOI 10.1152/ajpcell.00090.2006; Tega Y, 2013, NEUROCHEM INT, V62, P173, DOI 10.1016/j.neuint.2012.11.014; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Engel K, 2005, MOL PHARMACOL, V68, P1397, DOI 10.1124/mol.105.016832; Ray R, 2009, J NEUROGENET, V23, P252, DOI 10.1080/01677060802572887; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Okura T, 2008, DRUG METAB DISPOS, V36, P2005, DOI 10.1124/dmd.108.022087; Nakajima M, 2000, CLIN PHARMACOL THER, V67, P57, DOI 10.1067/mcp.2000.103957; BENOWITZ NL, 1994, CLIN PHARMACOL THER, V56, P483; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Fukada A, 2002, J PHARMACOL EXP THER, V302, P532, DOI 10.1124/jpet.102.034629; Fukada Atsuko, 2002, Drug Metab Pharmacokinet, V17, P554, DOI 10.2133/dmpk.17.554; Gourlay SG, 1997, CLIN PHARMACOL THER, V62, P453, DOI 10.1016/S0009-9236(97)90124-7; Li L, 2013, J PHARMACOL EXP THER, V347, P746, DOI 10.1124/jpet.113.208256; TSUJI A, 1990, J PHARMACOL EXP THER, V253, P315	19	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	JAN	2015	43	1					89	92		10.1124/dmd.114.061002		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW3KQ	WOS:000346186000012		
J	Canet, MJ; Merrell, MD; Harder, BG; Maher, JM; Wu, TD; Lickteig, AJ; Jackson, JP; Zhang, DD; Yamamoto, M; Cherrington, NJ				Canet, Mark J.; Merrell, Matthew D.; Harder, Bryan G.; Maher, Jonathan M.; Wu, Tongde; Lickteig, Andrew J.; Jackson, Jonathan P.; Zhang, Donna D.; Yamamoto, Masayuki; Cherrington, Nathan J.			Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene	DRUG METABOLISM AND DISPOSITION			English	Article							HEPATOBILIARY TRANSPORTER EXPRESSION; CELL LUNG-CARCINOMA; DIFFERENTIAL REGULATION; LIVER-DISEASE; PPAR-ALPHA; MRP3 GENE; RAT-LIVER; BILE-ACID; NRF2; ACTIVATION	The ATP-binding cassette (ABC) family of transporters, including ABCC3, is a large family of efflux pumps that plays a pivotal role in the elimination of xenobiotics from the body. ABCC3 has been reported to be induced during hepatic stress conditions and through the progression of some forms of cancer. Several lines of evidence have implicated the transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in this induction. However, although rodent models have been investigated, a functional antioxidant response element (ARE) in the human ABCC3 gene has not been identified. The purpose of this study was to identify and characterize the ARE(s) responsible for mediating the Nrf2-dependent induction of the human ABCC3 gene. A high-throughput chromatin immunoprecipitation-sequencing analysis performed in A549 cells revealed a specific interaction between Nrf2 and the eighth intron of the human ABCC3 gene rather than the more prototypical flanking region of the gene. Subsequent in silico analysis of the intron identified two putative ARE elements that contained the core consensus ARE sequence commonly found in several Nrf2-responsive genes. Functional characterization of these two AREs using luciferase-reporter constructs with ARE mutant constructs revealed that one of these putative AREs is functionally active. Finally, DNA pull-down assays confirmed specific binding of these intronic AREs by Nrf2 in vitro. Our findings identify a functional Nrf2 response element within the eighth intron of the ABCC3 gene, which may provide mechanistic insight into the induction of ABCC3 during antioxidant response stimuli.	[Canet, Mark J.; Merrell, Matthew D.; Harder, Bryan G.; Wu, Tongde; Lickteig, Andrew J.; Jackson, Jonathan P.; Zhang, Donna D.; Cherrington, Nathan J.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Maher, Jonathan M.; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 980, Japan	Cherrington, NJ (reprint author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, 1703 East Mabel, Tucson, AZ 85721 USA.	cherrington@pharmacy.arizona.edu	Yamamoto, Masayuki/A-4873-2010		National Institutes of Health [AI083927, ES006694, HD062489]; National Institute of Environmental Health Science Toxicology Training [ES007091]; National Science Foundation of Arizona	This work was supported by the National Institutes of Health [Grants AI083927, ES006694, and HD062489], National Institute of Environmental Health Science Toxicology Training [Grant ES007091], and the National Science Foundation of Arizona.	Adachi Tatsuhiko, 2007, J Exp Ther Oncol, V6, P335; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Young LC, 2001, CLIN CANCER RES, V7, P1798; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Tanaka Y, 2009, TOXICOL SCI, V108, P247, DOI 10.1093/toxsci/kfp020; Aleksunes LM, 2008, TOXICOL APPL PHARM, V226, P74, DOI 10.1016/j.taap.2007.08.022; [Anonymous], 2010, MAGN FRING FIELDS; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; Hardwick RN, 2011, DRUG METAB DISPOS, V39, P2395, DOI 10.1124/dmd.111.041012; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Maher JM, 2005, DRUG METAB DISPOS, V33, P956, DOI 10.1124/dmd.105.003798; Maher JM, 2008, TOXICOL SCI, V106, P319, DOI 10.1093/toxsci/kfn177; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Nies AT, 2001, INT J CANCER, V94, P492, DOI 10.1002/ijc.1498; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; Slitt AL, 2003, DRUG METAB DISPOS, V31, P1176, DOI 10.1124/dmd.31.9.1176; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Mahaffey CM, 2009, FREE RADICAL BIO MED, V46, P1650, DOI 10.1016/j.freeradbiomed.2009.03.023; NGUYEN T, 1994, J BIOL CHEM, V269, P13656; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Ikeda H, 2002, BIOCHEM J, V364, P563, DOI 10.1042/BJ20011756; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Mahaffey CM, 2012, J THORAC ONCOL, V7, P34, DOI 10.1097/JTO.0b013e318233d753; Merrell MD, 2008, J BIOCHEM MOL TOXIC, V22, P128, DOI 10.1002/jbt.20225; Sasaki H, 2012, MOL MED REP, V6, P705, DOI 10.3892/mmr.2012.979; Sun Y, 2008, INT J BIOCHEM CELL B, V40, P1775, DOI 10.1016/j.biocel.2008.01.006; Zheng R, 2006, MOL CELL ENDOCRINOL, V259, P10, DOI 10.1016/j.mce.2006.07.004	36	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	JAN	2015	43	1					93	99		10.1124/dmd.114.060103		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW3KQ	WOS:000346186000013		
J	Takabatake, H; Yasui, M; Nakagawa, Y; Kishida, A				Takabatake, Hideo; Yasui, Masaaki; Nakagawa, Yoshihisa; Kishida, Akiko			Response to short communication on 'Relaxation method for pounding action between adjacent buildings at expansion joint' [1]	EARTHQUAKE ENGINEERING & STRUCTURAL DYNAMICS			English	Editorial Material									[Takabatake, Hideo; Kishida, Akiko] Kanazawa Inst Technol, Inst Disaster & Environm Sci, Dept Architecture, Hakusan City, Ishikawa 9240838, Japan; [Yasui, Masaaki] Struct Design OBAYASHI CORP, Osaka, Japan; [Nakagawa, Yoshihisa] UNION SYST INC, Osaka, Japan	Takabatake, H (reprint author), Kanazawa Inst Technol, Inst Disaster & Environm Sci, Dept Architecture, 3-1 Yatsukaho, Hakusan City, Ishikawa 9240838, Japan.	hideo@neptune.kanazawa-it.ac.jp					Jankowski R, 2005, EARTHQ ENG STRUCT D, V34, P595, DOI 10.1002/eqe.434; Khatiwada S, EARTHQUAKE ENG STRUC; Takabatake H, 2014, EARTHQ ENG STRUCT D, V43, P1381, DOI 10.1002/eqe.2402	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0098-8847	1096-9845		EARTHQ ENG STRUCT D	Earthq. Eng. Struct. Dyn.	JAN	2015	44	1					163	165		10.1002/eqe.2510		3	Engineering, Civil; Engineering, Geological	Engineering	AW1AF	WOS:000346022000010		
J	Miyashita, T; Hoshino, Y				Miyashita, Tomomi; Hoshino, Yoichiro			Interploid and intraploid hybridizations to produce polyploid Haskap (Lonicera caerulea var. emphyllocalyx) plants	EUPHYTICA			English	Article						Caprifoliaceae; Interploid cross; Intraploid cross; Lonicera caerulea; Haskap; Polyploid	BLUE HONEYSUCKLE; ENDOSPERM DEVELOPMENT; FLOWERING PLANTS; SEED DEVELOPMENT; DNA-CONTENT; CHROMOSOME; IDENTIFICATION; MECHANISMS; COLCHICINE; EVOLUTION	We produced polyploid Haskap (Lonicera caerulea var. emphyllocalyx) plants by performing interploid and intraploid crosses of wild accessions. Embryo rescue in a tetraploid (4x) x diploid (2x) cross produced triploid plants; reciprocal 2x x 4x cross failed to produce viable seeds. Intraploidy crosses of 4x x 4x produced mostly tetraploids but also several hexaploid (6x) and octoploid (8x) plants. Using hexaploids obtained from this cross, we examined reciprocal 4x-6x crosses and found that both produced pentaploid plants. An octoploid was produced by applying colchicine to a tetraploid; a 4x x 8x cross using this plant and aided by embryo rescue culture produced three hexaploid plants, with an aneuploid number of chromosomes. Several plants obtained in this study flowered and set fruits. We discuss the overall efficiency of producing polyploid plants in interploid and intraploid crosses.	[Miyashita, Tomomi; Hoshino, Yoichiro] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido 0600811, Japan	Hoshino, Y (reprint author), Hokkaido Univ, Field Sci Ctr Northen Biosphere, Kita Ku, Kita 11,Nishi 10, Sapporo, Hokkaido 0600811, Japan.	hoshino@exfarm.agr.hokudai.ac.jp	HOSHINO, Yoichiro/A-5115-2012	HOSHINO, Yoichiro/0000-0003-3828-0696	Takeda Scientific Foundation; Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan	The authors thank Dr. K. Sahara and Dr. F. Shibata for their valuable suggestions on chromosome observation. We are grateful to Professor H. Nakashima for plant management support. We also gratefully acknowledge H. Hori, H. Tamura, M. Ikuta, H. Nakano, S. Takamushi, and T. Takahashi for technical assistance on the University farms. This work was supported in part by grants from Takeda Scientific Foundation and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan.	Ammal EKJ, 1952, KEW B, V4, P539; Anetai M, 1996, REP HOKKAIDO I PUBLI, V46, P34; Anikina EV, 1988, CHEM NAT COMPD, V24, P512, DOI 10.1007/BF00598552; Notsuka K, 2000, J JPN SOC HORTIC SCI, V69, P543; Svarcova Irena, 2007, Biomedical Papers (Olomouc), V151, P163; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Chaovanalikit A, 2004, J AGR FOOD CHEM, V52, P848, DOI 10.1021/jf030509o; Miyashita T, 2010, SCI HORTIC-AMSTERDAM, V125, P692, DOI 10.1016/j.scienta.2010.05.032; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; MACHIDA K, 1995, PHYTOCHEMISTRY, V39, P111, DOI 10.1016/0031-9422(94)00853-L; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolysis.33.010802.150437; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Thompson MM, 2003, ACTA HORTIC, P65; Thompson MM, 2006, J AM POMOL SOC, V60, P164; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Shibata F, 2002, CHROMOSOMA, V111, P184, DOI 10.1007/s00412-002-0197-1; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Gao S. L., 1996, Plant Cell Tissue and Organ Culture, V47, P73, DOI 10.1007/BF02318968; Hara H, 1983, CONTRIBUTIONS FLORA, P79; Hayashi M, 2007, BREEDING SCI, V57, P165, DOI 10.1270/jsbbs.57.165; JOHNSTON SA, 1980, THEOR APPL GENET, V57, P5, DOI 10.1007/BF00276002; Lewis W. H., 1980, Polyploidy. Biological relevance. Part I. Polyploidy and plant evolution., P103; LIN BY, 1984, GENETICS, V107, P103; Mishiba KI, 2000, ANN BOT-LONDON, V85, P665, DOI 10.1006/anbo.2000.1122; Miyashita T, 2009, PLANT CELL TISS ORG, V98, P291, DOI 10.1007/s11240-009-9562-6; Miyashita T, 2011, J PLANT RES, V124, P1, DOI 10.1007/s10265-010-0341-6; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Plekhanova MN, 2000, ACTA HORTIC, P159; Plekhanova M. N., 1992, Botanicheskii Zhurnal, V77, P1; Plekhanova MN, 2007, B APPL BOT GENET PL, V161, P57; Poyarkova AI, 2000, FLORA USSR, V23, P446; Rehder A, 1903, MISSOURI BOT GARDEN, V14, P27; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sasnauskas A, 2007, ACTA HORTIC, P405; Sato T, 1985, WILD LIFE REP, V2, P47; Sharma G, 2013, GENET RESOUR CROP EV, V60, P503, DOI 10.1007/s10722-012-9852-4; Solovyeva LV, 2003, CYTOL GENET, V37, P30; Suzuki T, 2007, ACTA HORTIC, P389; Takada M, 2003, RES B HOKKAIDO U FAR, V33, P21; Takada M, 2001, THESIS HOKKAIDO U JA, P1; Tanaka S, 1994, B HOKKAIDO PREFECTUR, V67, P29; Tanaka T, 1998, J JPN SOC FOOD SCI, V45, P129; Terahara N, 1993, J HOME EC JPN, V44, P197; Thompson MM, 2007, J AM POMOL SOC, V61, P25; Tiwari S, 2010, BMC PLANT BIOL, V10, P70; Wakana A, 2005, J FAC AGR KYUSHU U, V50, P93; Zhang WQ, 2010, SCI HORTIC-AMSTERDAM, V125, P396, DOI 10.1016/j.scienta.2010.04.038	48	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	JAN	2015	201	1					15	27		10.1007/s10681-014-1159-4		13	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	AW1AP	WOS:000346023200002		
J	Turki, N; Shehzad, T; Harrabi, M; Okuno, K				Turki, Nejla; Shehzad, Tariq; Harrabi, Moncef; Okuno, Kazutoshi			Detection of QTLs associated with salinity tolerance in durum wheat based on association analysis	EUPHYTICA			English	Article						Quantitative trait loci; Triticum durum; SSR markers; Linkage disequilibrium	TRITICUM-AESTIVUM L.; SALT TOLERANCE; LINKAGE DISEQUILIBRIUM; BREAD WHEAT; POPULATION-STRUCTURE; MOLECULAR MARKERS; AEGILOPS-TAUSCHII; ION DISTRIBUTION; HEXAPLOID WHEAT; SEEDLING STAGE	Salinity is globally a major constraint for crop production. Breeding for salinity tolerance is an effective approach to improve crop production and productivity under saline conditions provided it is based on a good understanding of the genetic control of salinity tolerance. This study deals with mapping QTLs for salinity tolerance in durum wheat (Triticum durum) by association analysis using SSR markers. A total of 119 varieties were treated in 100 mM of NaCl solution and the salinity tolerance indices (STI) for several traits were calculated as parameters to assess salinity tolerance. Among the traits assessed, the increased proportion of dead leaves (%DL) was the most suitable parameter for assessment of salinity tolerance in durum varieties at early vegetative stages because of a broader range of variation among varieties and narrower range of variation within varieties compared to other traits. The QTL associated with salinity tolerance using %DL as a parameter was detected on chromosome 4B. An additional 11 QTLs associated with seven parameters using STI of other traits were detected on chromosomes 3A, 5A, 5B, 6A and 7A.	[Turki, Nejla; Shehzad, Tariq; Okuno, Kazutoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Plant Genet & Breeding Sci, Tsukuba, Ibaraki 3058572, Japan; [Shehzad, Tariq; Okuno, Kazutoshi] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan; [Harrabi, Moncef] Natl Inst Agron INAT, Lab Genet & Plant Breeding, Tunis, Tunisia	Okuno, K (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Plant Genet & Breeding Sci, Tsukuba, Ibaraki 3058572, Japan.	okuno.kazutoshi.fu@u.tsukuba.ac.jp			JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development), Japan	This research was carried out by GRANDE project supported by JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development), Japan.	Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Ma LQ, 2007, EUPHYTICA, V153, P109, DOI 10.1007/s10681-006-9247-8; Tommasini L, 2007, THEOR APPL GENET, V115, P697, DOI 10.1007/s00122-007-0601-6; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Poustini K, 2004, FIELD CROP RES, V85, P125, DOI 10.1016/S0378-4290(03)00157-6; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Roder MS, 1998, GENETICS, V149, P2007; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Pritchard JK, 2000, GENETICS, V155, P945; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Guyomarc'h H, 2002, THEOR APPL GENET, V104, P1164, DOI 10.1007/s00122-001-0827-7; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; Gupta PK, 2002, CURR SCI INDIA, V83, P113; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Dubcovsky J, 1996, THEOR APPL GENET, V92, P448, DOI 10.1007/BF00223692; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.093476; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Ashraf M, 1996, J AGRON CROP SCI, V176, P91, DOI 10.1111/j.1439-037X.1996.tb00451.x; AZHAR FM, 1989, J AGRON CROP SCI, V163, P33, DOI 10.1111/j.1439-037X.1989.tb00734.x; Belaid A, 2000, DURUM WHEAT IMPROVEM, V40, P35; de Leon JLD, 2011, EUPHYTICA, V181, P371, DOI 10.1007/s10681-011-0463-5; Flowers TJ, 1997, ACTA PHYSIOL PLANT, V19, P427, DOI 10.1007/s11738-997-0039-0; Garcia-Suarez JV, 2010, CEREAL RES COMMUN, V38, P163, DOI 10.1556/CRC.38.2010.2.2; Goudarzi M, 2008, J AGR SOC SCI, V1, P35; Hagemann M, 1997, CYANOBACTERIAL NITRO, P156; Hayashi H, 1998, STRESS RESPONSES OF PHOTOSYNTHETIC ORGANISMS, P133; Koebner RMD, 1996, PLANT BREEDING, V115, P81, DOI 10.1111/j.1439-0523.1996.tb00878.x; Lindsay MP, 2004, FUNCT PLANT BIOL, V31, P1105, DOI 10.1071/FP04111; MAAS EV, 1986, IRRIGATION SCI, V7, P1; Morancho J, 1995, DURUM WHEAT QUALITY, V22, P213; Noori SAS, 2000, GENET RESOUR CROP EV, V47, P285, DOI 10.1023/A:1008749312148; PEARSON GEORGE A., 1959, AGRON JOUR, V51, P654; Rashid A, 1999, J AGRON CROP SCI, V182, P199, DOI 10.1046/j.1439-037x.1999.00295.x; SCHACHTMAN DP, 1992, THEOR APPL GENET, V84, P714, DOI 10.1007/BF00224174; Singh S. P., 1994, Indian Journal of Plant Physiology, V37, P37; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Song QJ, 2002, THEOR APPL GENET, V104, P286, DOI 10.1007/s001220100698; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; USDA-ARS, 2008, RES DAT BIBL SAL TOL; Weir BS, 1996, GENETIC DATA ANAL; Westcot D.W., 1985, 29 FAO UN; Xu Y, 2013, PLANT BREEDING, V132, P276, DOI 10.1111/pbr.12048; Yu H, 2013, GENOMICS, V2, P20	65	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	JAN	2015	201	1					29	41		10.1007/s10681-014-1164-7		13	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	AW1AP	WOS:000346023200003		
J	Pariasca-Tanaka, J; Lorieux, M; He, C; McCouch, S; Thomson, MJ; Wissuwa, M				Pariasca-Tanaka, Juan; Lorieux, Mathias; He, Chunlin; McCouch, Susan; Thomson, Michael J.; Wissuwa, Matthias			Development of a SNP genotyping panel for detecting polymorphisms in Oryza glaberrima/O. sativa interspecific crosses	EUPHYTICA			English	Article						O. glaberrima; SNP; Competitive Allele-Specific PCR markers; Genotyping panel; NERICA	NERICA VARIETIES; RICE; UPLAND; STEUD; LANDRACES; PROGENIES; QTLS	Oryza glaberrima accessions harbor genes for tolerance to abiotic stresses such as mineral deficiency in problem soils. This genetic potential could be exploited in interspecific crosses with Oryza sativa, as in the case of the 'New Rice for Africa' (NERICA) varieties; however, to attain this goal it would be desirable to develop a high-throughput marker system to specifically detect O. glaberrima introgressions in an O. sativa background. Therefore, a single nucleotide polymorphism (SNP) genotyping analysis of an O. glaberrima accession (CG14) with two O. sativa lines (WAB56-104 and WAB181-18) was performed on a genome-wide basis. Comparison of CG14 and the WAB lines resulted in a set of 9,523 polymorphic SNPs which would be suitable to detect O. glaberrima introgressions in upland NERICAs. In addition, a set of 1,540 polymorphic SNPs between O. glaberrima versus O. sativa was identified. A subset of SNPs which were evenly distributed in the genome was then used to design a flexible and cost-effective SNP genotyping panel using the Competitive Allele-Specific PCR technology (KASP). This SNP genotyping panel consists of 2,015 SNPs successfully converted into KASP markers, providing 745 polymorphic SNPs for the parents O. glaberrima CG14/O. sativa WAB56-104 (upland NERICA), and 752 for O. glaberrima TOG5681/O. sativa IR64 (lowland NERICA). KASP markers were successfully validated by mapping O. glaberrima introgressions in NERICA-derived breeding lines. This new SNP genotyping panel will be useful in modern breeding applications such as QTL mapping and/or marker-assisted selection.	[Pariasca-Tanaka, Juan; Lorieux, Mathias] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Lorieux, Mathias] Int Ctr Trop Agr CIAT, Inst Rech Dev, DIADE Res Unit, Cali 6713, Colombia; [He, Chunlin] CIMMYT, Generat Challenge Programme, Mexico City 06600, DF, Mexico; [McCouch, Susan] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA; [Thomson, Michael J.] Int Rice Res Inst, Los Banos, Laguna, Philippines	Wissuwa, M (reprint author), JIRCAS, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	wissuwa@affrc.go.jp		Thomson, Michael/0000-0003-1868-6867			Lorieux M, 2003, THEOR APPL GENET, V107, P691, DOI 10.1007/s00122-003-1285-1; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; [Anonymous], KBIOSCIENCE KASP VER, P8; Semagn K, 2007, AFR J BIOTECHNOL, V6, P2014; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Fukuta Y, 2012, BREEDING SCI, V62, P27, DOI 10.1270/jsbbs.62.27; Lorieux M, 2000, THEOR APPL GENET, V100, P593, DOI 10.1007/s001229900061; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; Agnoun Y., 2012, International Journal of Biology, V4, P19; Futakuchi K, 2012, PLANT PROD SCI, V15, P151, DOI 10.1626/pps.15.151; Futakuchi K., 2009, Agricultural Journal, V4, P96; Gutierrez AG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-6; Jones MP, 1997, BREEDING SCI, V47, P395; Koide Y, 2013, PLANT BREEDING, V132, P259, DOI 10.1111/pbr.12052; SANO Y, 1984, J APPL ECOL, V21, P245, DOI 10.2307/2403050; Sié M., 2005, International Rice Commission Newsletter, V54, P47; Tobita S, 2003, P 2 INT S PHOSPH DYN, P70; Tung CW, 2010, RICE, V3, P205, DOI 10.1007/s12284-010-9056-5; Wright MH, 2010, BIOINFORMATICS, V26, P2952, DOI 10.1093/bioinformatics/btq533; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	24	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	JAN	2015	201	1					67	78		10.1007/s10681-014-1183-4		12	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	AW1AP	WOS:000346023200006		
J	Pelucchi, C; Lunet, N; Boccia, S; Zhang, ZF; Praud, D; Boffetta, P; Levi, F; Matsuo, K; Ito, H; Hu, JF; Johnson, KC; Ferraroni, M; Yu, GP; Peleteiro, B; Malekzadeh, R; Derakhshan, MH; Ye, WM; Zaridze, D; Maximovitch, D; Aragones, N; Martin, V; Pakseresht, M; Pourfarzi, F; Bellavia, A; Orsini, N; Wolk, A; Mu, L; Arzani, D; Kurtz, RC; Lagiou, P; Trichopoulos, D; Muscat, J; La Vecchia, C; Negri, E				Pelucchi, Claudio; Lunet, Nuno; Boccia, Stefania; Zhang, Zuo-Feng; Praud, Delphine; Boffetta, Paolo; Levi, Fabio; Matsuo, Keitaro; Ito, Hidemi; Hu, Jinfu; Johnson, Kenneth C.; Ferraroni, Monica; Yu, Guo-Pei; Peleteiro, Barbara; Malekzadeh, Reza; Derakhshan, Mohammad H.; Ye, Weimin; Zaridze, David; Maximovitch, Dmitry; Aragones, Nuria; Martin, Vicente; Pakseresht, Mohammadreza; Pourfarzi, Farhad; Bellavia, Andrea; Orsini, Nicola; Wolk, Alicja; Mu, Lina; Arzani, Dario; Kurtz, Robert C.; Lagiou, Pagona; Trichopoulos, Dimitrios; Muscat, Joshua; La Vecchia, Carlo; Negri, Eva			The stomach cancer pooling (StoP) project: study design and presentation	EUROPEAN JOURNAL OF CANCER PREVENTION			English	Article						consortia; epidemiology; pooled analysis; risk factors; stomach neoplasms	HELICOBACTER-PYLORI INFECTION; CONTROL CONSORTIUM PANC4; GASTRIC-CANCER; POOLED ANALYSIS; EPIDEMIOLOGY CONSORTIUM; ALCOHOL-DRINKING; REPLACEMENT THERAPY; INTERNATIONAL HEAD; CHINESE POPULATION; PANCREATIC-CANCER	Gastric cancer affects about one million people per year worldwide, being the second leading cause of cancer mortality. The study of its etiology remains therefore a global issue as it may allow the identification of major targets, besides eradication of Helicobacter pylori infection, for primary prevention. It has however received little attention, given its comparatively low incidence in most high-income countries. We introduce a consortium of epidemiological investigations named the Stomach cancer Pooling (StoP) Project'. Twenty-two studies agreed to participate, for a total of over 9000 cases and 23 000 controls. Twenty studies have already shared the original data set. Of the patients, 40% are from Asia, 43% from Europe, and 17% from North America; 34% are women and 66% men; the median age is 61 years; 56% are from population-based case-control studies, 41% from hospital-based ones, and 3% from nested case-control studies derived from cohort investigations. Biological samples are available from 12 studies. The aim of the StoP Project is to analyze the role of lifestyle and genetic determinants in the etiology of gastric cancer through pooled analyses of individual-level data. The uniquely large data set will allow us to define and quantify the main effects of each risk factor of interest, including a number of infrequent habits, and to adequately address associations in subgroups of the population, as well as interaction within and between environmental and genetic factors. Further, we will carry out separate analyses according to different histotypes and subsites of gastric cancer, to identify potential different risk patterns and etiological characteristics. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Pelucchi, Claudio; Praud, Delphine; La Vecchia, Carlo; Negri, Eva] IRCCS Ist Ric Farmacol Mario Negri, Dept Epidemiol, I-20156 Milan, Italy; [Praud, Delphine; Ferraroni, Monica; La Vecchia, Carlo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Boccia, Stefania; Arzani, Dario] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy; [Boccia, Stefania] IRCCS San Raffaele Pisana, Rome, Italy; [Lunet, Nuno; Peleteiro, Barbara] Univ Porto ISPUP, Inst Publ Hlth, Oporto, Portugal; [Lunet, Nuno; Peleteiro, Barbara] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Zhang, Zuo-Feng] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Zhang, Zuo-Feng] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Rockville Ctr, New York, NY 10065 USA; [Mu, Lina] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Muscat, Joshua] Penn State Coll Med, Hershey, PA USA; [Levi, Fabio] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Canc Epidemiol Unit, Lausanne, Switzerland; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Hu, Jinfu] Publ Hlth Agcy Canada, Social Determinants & Sci Integrat Directorate, Sci Integrat Div, Calgary, AB, Canada; [Johnson, Kenneth C.] Univ Ottawa, Dept Epidemiol & Community Hlth, Ottawa, ON, Canada; [Pakseresht, Mohammadreza] Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada; [Malekzadeh, Reza; Derakhshan, Mohammad H.; Pakseresht, Mohammadreza; Pourfarzi, Farhad] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran; [Pourfarzi, Farhad] Ardabil Univ Med Sci, Dept Community Med, Ardebil, Iran; [Derakhshan, Mohammad H.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bellavia, Andrea; Orsini, Nicola; Wolk, Alicja] Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, S-10401 Stockholm, Sweden; [Zaridze, David; Maximovitch, Dmitry] Russian NN Blokhin Canc Res Ctr, Dept Epidemiol & Prevent, Moscow, Russia; [Aragones, Nuria] Inst Salud Carlos III, Natl Ctr Epidemiol, Environm & Canc Epidemiol Unit, Madrid, Spain; [Aragones, Nuria; Martin, Vicente] CIBERESP, Madrid, Spain; [Aragones, Nuria] IIS Puerta Hierro, Majadahonda, Spain; [Martin, Vicente] Univ Leon, E-24071 Leon, Spain; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Yu, Guo-Pei] Peking Univ, Med Informat Ctr, Beijing, Peoples R China	La Vecchia, C (reprint author), IRCCS Ist Ric Farmacol Mario Negri, Dept Epidemiol, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	carlo.lavecchia@marionegri.it	Martin, Vicente/A-1597-2008; Aragones, Nuria/O-5962-2015; 	Martin, Vicente/0000-0003-0552-2804; Aragones, Nuria/0000-0003-0983-2156; Malekzadeh, Reza/0000-0003-1043-3814; Peleteiro, Barbara/0000-0002-0579-9988; Ferraroni, Monica/0000-0002-4542-4996; Lunet, Nuno/0000-0003-1870-1430; La Vecchia, Carlo/0000-0003-1441-897X	Italian Ministry of Health	This project is supported by the Italian Ministry of Health (Bando Giovani Ricercatori 2011-2012). The authors thank the European Cancer Prevention (ECP) organization for providing support to the first meeting of the StoP Project (Milan, 11 June 2013).	Bonequi P, 2013, CANCER CAUSE CONTROL, V24, P217, DOI 10.1007/s10552-012-0110-z; Zaridze D, 1999, INT J CANCER, V82, P473, DOI 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K; Derakhshan MH, 2008, GUT, V57, DOI 10.1136/gut.2007.137364; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Derakhshan MH, 2009, GUT, V58, P16, DOI 10.1136/gut.2008.161331; Zaridze D, 2000, CANCER CAUSE CONTROL, V11, P363, DOI 10.1023/A:1008907924938; Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301; Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007; Bertuccio P, 2011, ANN ONCOL, V22, P1420, DOI 10.1093/annonc/mdq613; Pakseresht M, 2011, CANCER CAUSE CONTROL, V22, P725, DOI 10.1007/s10552-011-9744-5; Lunet N, 2007, EUR J CANCER PREV, V16, P312, DOI 10.1097/01.cej.0000236255.95769.22; BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409; Lunet N, 2003, INT J CANCER, V106, P953, DOI 10.1002/ijc.11306; Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019; Pelucchi C, 2009, ANN ONCOL, V20, P160, DOI 10.1093/annonc/mdn536; de Martel C, 2006, DIGEST DIS SCI, V51, P2292, DOI 10.1007/s10620-006-9210-5; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Franceschi S, 1999, CANCER CAUSE CONTROL, V10, P583, DOI 10.1023/A:1008907227706; Bosetti C, 2013, ANN ONCOL, V24, P2903, DOI 10.1093/annonc/mdt336; Lucenteforte E, 2008, NUTR CANCER, V60, P577, DOI 10.1080/01635580802054512; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; La Vecchia C, 1999, CANCER CAUSE CONTROL, V10, P157; Kamper-Jorgensen M, 2013, ANN ONCOL, V24, P2245, DOI 10.1093/annonc/mdt218; Galeone C, 2010, CANCER EPIDEM BIOMAR, V19, P1723, DOI 10.1158/1055-9965.EPI-10-0191; Peleteiro B, 2012, EUR J CANCER PREV, V21, P118, DOI 10.1097/CEJ.0b013e32834a7f66; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Mu LN, 2005, INT J CANCER, V116, P972, DOI 10.1002/ijc.21137; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Boccia S, 2008, AM J EPIDEMIOL, V167, P505, DOI 10.1093/aje/kwm344; Boccia S, 2013, EUR J CANCER PREV, V22, P489, DOI 10.1097/CEJ.0b013e3283603480; Burgio MR, 2013, CANCER EPIDEM BIOMAR, V22, P2148, DOI 10.1158/1055-9965.EPI-13-0591; Beral V, 1997, LANCET, V350, P1047; De Feo E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-494; Deandrea S, 2010, EUR J CANCER PREV, V19, P18, DOI 10.1097/CEJ.0b013e328330eb1a; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Harris H, 2013, OA EPIDEMIOL, V1, P16; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V61, P1; Ioannidis JPA, 2013, CANCER EPIDEM BIOMAR, V22, P3, DOI 10.1158/1055-9965.EPI-12-1144; Lagiou P, 2004, CANCER CAUSE CONTROL, V15, P67, DOI 10.1023/B:CACO.0000016619.18041.b0; LAVECCHIA C, 1995, INT J CANCER, V60, P748; Lunet Nuno, 2004, Gastric Cancer, V7, P172; Malvezzi M, 2010, ANN EPIDEMIOL, V20, P898, DOI 10.1016/j.annepidem.2010.08.013; Mao Y, 2002, EUR J CANCER PREV, V11, P27, DOI 10.1097/00008469-200202000-00005; Pourfarzi F, 2009, INT J CANCER, V125, P1953, DOI 10.1002/ijc.24499; Setiawan Veronica Wendy, 2005, Asian Pac J Cancer Prev, V6, P387; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Shibata A, 2006, STOMACH CANC CANC EP, P707; World Cancer Research Fund and American Institute for Cancer Research (WCRF/AICR), 2007, STOM FOOD NUTR PHYS, P265; Ye WM, 1999, INT J CANCER, V83, P223, DOI 10.1002/(SICI)1097-0215(19991008)83:2<223::AID-IJC13>3.0.CO;2-M; Zhang ZF, 1999, CANCER DETECT PREV, V23, P357, DOI 10.1046/j.1525-1500.1999.99041.x	53	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-8278	1473-5709		EUR J CANCER PREV	Eur. J. Cancer Prev.	JAN	2015	24	1					16	23		10.1097/CEJ.0000000000000017		8	Oncology	Oncology	AW0EO	WOS:000345963600003		
J	Morihara, D; Watanabe, H; Takata, K; Iwashita, H; Tsuchiya, N; Kunimoto, H; Kuno, S; Fukunaga, A; Yotsumoto, K; Tanaka, T; Sakurai, K; Hirano, G; Yokoyama, K; Nishizawa, S; Yoshikane, M; Anan, A; Takeyama, Y; Kitamura, Y; Iwata, K; Irie, M; Shakado, S; Sohda, T; Sakisaka, S				Morihara, Daisuke; Watanabe, Hiroshi; Takata, Kazuhide; Iwashita, Hideyuki; Tsuchiya, Naoaki; Kunimoto, Hideo; Kuno, Shizuka; Fukunaga, Atsushi; Yotsumoto, Kaoru; Tanaka, Takashi; Sakurai, Kunitoshi; Hirano, Genryu; Yokoyama, Keiji; Nishizawa, Shinya; Yoshikane, Makoto; Anan, Akira; Takeyama, Yasuaki; Kitamura, Yuji; Iwata, Kaoru; Irie, Makoto; Shakado, Satoshi; Sohda, Tetsuro; Sakisaka, Shotaro			Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						anemia; pegylated interferon; renal impairment; ribavirin; telaprevir	CHRONIC HEPATITIS-C; RIBAVIRIN COMBINATION THERAPY; VIRUS GENOTYPE 1B; PLUS RIBAVIRIN; PEGYLATED INTERFERON; TRIPLE THERAPY; PEGINTERFERON; INFECTION; HCV; ASSOCIATION	Background Telaprevir (TVR) plays a major role in renal damage and anemia associated with TVR/pegylated interferon/ribavirin therapy for chronic hepatitis C. Adjusting the TVR starting dose may reduce these adverse effects. We aimed to determine whether adjusting the starting dose according to renal function reduces TVR-associated renal damage and anemia and affects the sustained virological response (SVR). Patients and methods Our study included 112 patients infected with hepatitis C genotype 1 treated with pegylated interferon/ribavirin/TVR triple therapy. The TVR starting dose adjusted according to renal function was calculated as TVR/unadjusted estimated glomerular filtration rate (eGFR) ratio=TVR/(eGFR x body surface area/1.73). Results A TVR/unadjusted eGFR ratio of 32 or greater was a predictor of renal impairment and anemia in multivariate analysis (odds ratio 12.09, P< 0.001, and OR 4.14, P< 0.001, respectively). Patients with a TVR/unadjusted eGFR ratio of 32 or greater developed significant renal impairment and anemia (P< 0.001 and P=0.002, respectively). SVR was significantly reduced in patients with a TVR/unadjusted eGFR ratio less than 23 versus 23 or greater (66.7 and 87.2%, respectively, P=0.045). SVR tended to increase stepwise [< 23.0 (66.7%), >= 23 to < 32 (84.8%), and >= 32 (89.6%), respectively]. The TVR/unadjusted eGFR ratio was correlated significantly with the serum TVR concentration (r=0.541, P< 0.001). Conclusion Adjusting the TVR starting dose according to the TVR/unadjusted eGFR ratio decreased adverse effects and affected the SVR rate. The TVR starting dose should be adjusted by a TVR/unadjusted eGFR ratio of 23 or greater to less than 32 to safely achieve SVR. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Morihara, Daisuke; Tsuchiya, Naoaki; Kunimoto, Hideo; Fukunaga, Atsushi; Tanaka, Takashi; Sakurai, Kunitoshi; Hirano, Genryu; Yokoyama, Keiji; Nishizawa, Shinya; Anan, Akira; Takeyama, Yasuaki; Kitamura, Yuji; Iwata, Kaoru; Irie, Makoto; Shakado, Satoshi; Sohda, Tetsuro; Sakisaka, Shotaro] Fukuoka Univ, Fac Med, Dept Gastroenterol, Fukuoka 8140180, Japan; [Morihara, Daisuke; Shakado, Satoshi; Sakisaka, Shotaro] Fukuoka Univ, Fac Med, Div Adv Clin Res Viral Hepatitis & Liver Canc, Fukuoka 8140180, Japan; [Watanabe, Hiroshi; Kuno, Shizuka; Yoshikane, Makoto] Japanese Red Cross Fukuoka Hosp, Dept Hepatol, Fukuoka, Japan; [Takata, Kazuhide; Yotsumoto, Kaoru] Hakujyuji Hosp, Dept Med, Fukuoka, Japan; [Iwashita, Hideyuki] Fukuoka City Med Assoc Hosp, Dept Gastroenterol, Fukuoka, Japan	Morihara, D (reprint author), Fukuoka Univ, Fac Med, Dept Gastroenterol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	morihara@minf.med.fukuoka-u.ac.jp					Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Furusyo N, 2014, J ANTIMICROB CHEMOTH, V69, P483, DOI 10.1093/jac/dkt371; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; [Anonymous], 1994, HEPATOLOGY 1, V20, P15; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; DUBOIS D, 1989, NUTRITION, V5, P303; Du Bois D, 1989, Nutrition, V5, P303; Fukuda K, 2014, HEPATOL RES, V44, P1165, DOI 10.1111/hepr.12229; Jinzo Nihon, 2013, NIHON JINZO GAKKAI S, V55, P585; Karino T, 2014, J Viral Hepat, V21, P341; Mauss S, 2014, HEPATOLOGY, V59, P46, DOI 10.1002/hep.26602; Sezaki H, 2013, HEPATOL RES, V44, pE163; Suzuki F, 2013, HEPATOL RES, V43, P691, DOI 10.1111/hepr.12009	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-691X	1473-5687		EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	JAN	2015	27	1					55	64		10.1097/MEG.0000000000000208		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU9KN	WOS:000345911600009		
J	Fujimoto, H; Watanabe, S; Okamoto, T; Hama, T; Takuda, H				Fujimoto, Hitoshi; Watanabe, Shohei; Okamoto, Takahiko; Hama, Takayuki; Takuda, Hirohiko			Photographic study of hydrodynamics of drops of aqueous polymer solution impinging on hot solid	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Weber number; Strobe photography; Polymer quenchant; Droplet dynamics; Quenching	HEAT-TRANSFER; SURFACES; IMPACT; STATE	Spray-cooling methods are utilized in quench hardening and throughout the metal-forming industry. Aqueous solutions of water-soluble polymers are the typical quenchant. Although the impact behavior of the droplets has a great influence on the heat transfer between the hot metal surface and quenchant, the hydrodynamics of drops of aqueous polymer solutions are rarely studied. In this study, the collision of drops of an aqueous solution of polymer with a hot sapphire solid surface was investigated using strobe photography. A solution of 10 wt% polyoxyethylene polyoxypropylene glycol, with an average molecular weight of approximately 20,000, was used as the test polymer quenchant. Experiments were conducted with drop diameters in the range 2.09-2.42 mm, impact velocities from 0.83 to 1.25 m/s, and surface temperatures of 200, 350, and 500 degrees C. The effect of varying the temperature and the dimensionless Weber number on the collision behavior and drop evolution was investigated. Microscopic observations revealed that polymer residue remained on the surface when the temperature of the solid was equal to or less than 350 degrees C. At 500 degrees C, drops impacting on the surface at low Weber numbers deformed into a thin disc, recoiled, and finally rebounded off the solid in a spray of mist. No polymer residue remained. The residence times of the rebounding drops after impact increased with the Weber number. In addition, the measured residence times were slightly longer than some experimentally determined formulae for simple compound liquid drops predict. (C) 2014 Elsevier Inc. All rights reserved.	[Fujimoto, Hitoshi; Watanabe, Shohei; Hama, Takayuki; Takuda, Hirohiko] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan; [Okamoto, Takahiko] Daido Chem Ind Co Ltd, Technol Res Lab, Nara 6391037, Japan	Fujimoto, H (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	h-fujimoto@energy.kyoto-u.ac.jp	Fujimoto, Hitoshi/D-5741-2013	Fujimoto, Hitoshi/0000-0001-6772-1097			AKAO F, 1980, T IRON STEEL I JPN, V20, P737; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; Hatta N, 1997, J FLUID ENG-T ASME, V119, P692, DOI 10.1115/1.2819300; WACHTERS LH, 1966, CHEM ENG SCI, V21, P1047, DOI 10.1016/0009-2509(66)85100-X; Bertola V, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2112667; Bertola V, 2004, EXP FLUIDS, V37, P653, DOI 10.1007/s00348-004-0852-9; Bertola V, 2009, INT J HEAT MASS TRAN, V52, P1786, DOI 10.1016/j.ijheatmasstransfer.2008.09.028; FREEMAN PI, 1960, POLYMER, V1, P20, DOI 10.1016/0032-3861(60)90004-5; Fujimoto H, 2010, INT J MULTIPHAS FLOW, V36, P620, DOI 10.1016/j.ijmultiphaseflow.2010.04.004; Fujimoto H., 2012, ASME J FLUIDS ENG, V134; Fujimoto H, 2000, INT J HEAT MASS TRAN, V43, P1673, DOI 10.1016/S0017-9310(99)00234-3; Rein M, 2002, CISM COUR L, P185; REIN M, 1993, FLUID DYN RES, V12, P61, DOI 10.1016/0169-5983(93)90106-K; Sinha A.K., 1991, ASM HDB, V4; Tensi H.M., 1994, P INT HEAT TREAT C E; Totten G. E., 1993, HDB QUENCHANTS QUENC; UEDA T, 1979, B JSME, V22, P724	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						66	74		10.1016/j.expthermflusci.2014.08.010		9	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900008		
J	Maeda, Y; Hosokawa, S; Baba, Y; Tomiyama, A; Ito, Y				Maeda, Yasunari; Hosokawa, Shigeo; Baba, Yuji; Tomiyama, Akio; Ito, Yoshihiro			Generation mechanism of micro-bubbles in a pressurized dissolution method	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Micro-bubble; Pressurized dissolution method; Cavitation; Bubble diameter; Bubble number density; Multiphase flow	MICROBUBBLE; WATER	Micro-bubbles are in use in many industrial fields such as water treatment, purification of lake water, chemical engineering, washing processes and housing equipment by virtues of their large interfacial area concentration and long residence time in liquid. A pressurized dissolution method based on decompression of liquid with dissolved gas is one of promising methods for generating fine micro-bubbles at high number density. Since the mechanism of micro-bubble generation is not clarified yet, design and improvement of micro-bubble generators are based on trial and error. In this study, effects of liquid volume flux at a decompression nozzle and dissolved gas concentration in the upstream region of the nozzle on diameter and number density of generated micro-bubbles are examined to understand generation mechanism of micro-bubbles in a pressurized dissolution method. The diameter and the number density of micro-bubbles are measured by using phase Doppler anemometry (PDA) in the downstream region of the nozzle, and the flow patterns in the nozzle are visualized by using a high-speed camera. The experimental results show that diameter and number density of generated micro-bubbles depend on cavitation pattern at the nozzle, and that cavitation bubbles containing not only vapor but also non-condensable gas become micro-bubbles due to their shrink caused by condensation of the vapor in the downstream region of the nozzle. (C) 2014 Elsevier Inc. All rights reserved.	[Maeda, Yasunari; Hosokawa, Shigeo; Baba, Yuji; Tomiyama, Akio] Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ito, Yoshihiro] Panasonic Corp, Housing Syst Business Grp, Kadoma, Osaka 5718686, Japan	Hosokawa, S (reprint author), Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	hosokawa@mech.kobe-u.ac.jp					Xu JH, 2006, AICHE J, V52, P2254, DOI 10.1002/aic.10824; Thiemann A, 2011, ULTRASON SONOCHEM, V18, P595, DOI 10.1016/j.ultsonch.2010.10.004; Makuta T, 2006, J FLUID MECH, V548, P113, DOI 10.1017/S0022112005007470; Kaneko Y, 2005, EUR RADIOL, V15, P1415, DOI 10.1007/s00330-005-2663-7; Sadatomi M, 2005, EXP THERM FLUID SCI, V29, P615, DOI 10.1016/j.exphermflusci.2004.08.006; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Sakashita H, 2010, INT J HEAT MASS TRAN, V53, P1554, DOI 10.1016/j.ijheatmasstransfer.2009.11.028; Takahashi M, 2003, J PHYS CHEM B, V107, P2171, DOI 10.1021/jp02210z; Chu LB, 2008, PROCESS SAF ENVIRON, V86, P389, DOI 10.1016/j.psep.2008.02.005; Arakawa T, 2008, SENSOR ACTUAT A-PHYS, V143, P58, DOI 10.1016/j.sna.2007.06.038; CRUM LA, 1979, NATURE, V278, P148, DOI 10.1038/278148a0; Fujikawa S, 2003, INT J MULTIPHAS FLOW, V29, P1221, DOI 10.1016/S0301-9322(03)00106-X; Fujiwara A., 2003, P ASME JSME 2003 4 J, P469; Hirai S., ELECT ELECT ENG, V4; Hosokawa S., 2010, T JSME, V76, P53; Leighton T.G., 1994, ACOUSTIC BUBBLES; Maeda Yasuanri, 2010, Japanese Journal of Multiphase Flow, V24, DOI 10.3811/jjmf.24.462; Matsumoto M, 2010, CHEM ENG RES DES, V88, P1624, DOI 10.1016/j.cherd.2010.02.007; Oliveira C., 2009, INT J MINER PROCESS, V96, P36; Park JS, 2009, HORTTECHNOLOGY, V19, P212; Serizawa A., 2003, 3 EUR JAP 2 PHAS FLO, P21; Shintaku H, 2008, EXP THERM FLUID SCI, V32, P1132, DOI 10.1016/j.expthermflusci.2008.01.004; Tajima K., 2008, ERGONOMIA IJE HF, V30, P137	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						201	207		10.1016/j.expthermflusci.2014.09.010		7	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900023		
J	Shoji, E; Nakaoku, R; Komiya, A; Okajima, J; Maruyama, S				Shoji, Eita; Nakaoku, Ryota; Komiya, Atsuki; Okajima, Junnosuke; Maruyama, Shigenao			Quantitative visualization of boundary layers by developing quasi-common-path phase-shifting interferometer	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Quantitative visualization; Boundary layer; Interferometer; Phase-shifting technique	BACKGROUND-ORIENTED SCHLIEREN; RAINBOW SCHLIEREN; TEMPERATURE-MEASUREMENT; DIFFUSION-COEFFICIENTS; SPECKLE PHOTOGRAPHY; FLOW VISUALIZATION; NATURAL-CONVECTION; SYSTEM; FIELDS	The objective of this study is to achieve accurate and quantitative visualization of the boundary layer using a novel optical system that offers a large visualization area, fewer disturbance effects, integration with a wind tunnel and high phase, spatial and temporal resolution. A novel optical configuration was proposed to realize these features. In addition, high phase and spatial resolution could be realized by introducing a phase-shifting image processing technique. Finally, a novel prism was specially designed to implement the phase-shifting technique. In this study, the proposed system was evaluated by using it to quantitatively visualize boundary layers around a circular cylinder and over a flat plate. The effect of a tripwire on the flow was visualized by an interferogram. In the experiments on flow over a flat plate, the temperature distributions in the thermal boundary layer were measured accurately, and the velocity distributions were estimated from the measured temperature distributions. The experimental data were compared with a semi-analytical solution. Good agreement was obtained, and the relative error was within 5.0% in the temperature measurement. (C) 2014 Elsevier Inc. All rights reserved.	[Shoji, Eita; Nakaoku, Ryota] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Komiya, Atsuki; Okajima, Junnosuke; Maruyama, Shigenao] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan	Shoji, E (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	eita@pixy.ifs.tohoku.ac.jp	Okajima, Junnosuke/G-5959-2015	Okajima, Junnosuke/0000-0003-3857-474X	 [13J06125]	This work was supported by a Grant-in-Aid for JSPS Fellows [13J06125].	Agrawal AK, 1998, APPL OPTICS, V37, P479, DOI 10.1364/AO.37.000479; Alvarez-Herrera C, 2009, OPT LASER TECHNOL, V41, P233, DOI 10.1016/j.optlastec.2008.07.004; BRUNING JH, 1974, APPL OPTICS, V13, P2693, DOI 10.1364/AO.13.002693; Komiya A, 2006, EXP THERM FLUID SCI, V30, P535, DOI 10.1016/j.expthermflusci.2005.11.001; [Anonymous], 1970, ADV HEAT TRANSFER; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; HOWES WL, 1984, APPL OPTICS, V23, P2449; FARRELL PV, 1984, APPL OPTICS, V23, P1055; Elsinga GE, 2004, EXP FLUIDS, V36, P309, DOI [10.1007/S00348-003-0724-8, 10.1007/s00348-003-0724-8]; Meier GEA, 2002, EXP FLUIDS, V33, P181, DOI 10.1007/s00348-002-0450-7; Torres JF, 2012, OPT LASER ENG, V50, P1287, DOI 10.1016/j.optlaseng.2012.03.006; Hargather MJ, 2012, OPT LASER ENG, V50, P8, DOI 10.1016/j.optlaseng.2011.05.012; Sourgen F, 2012, OPT LASER ENG, V50, P29, DOI 10.1016/j.optlaseng.2011.07.012; ONUMA K, 1993, J CRYST GROWTH, V129, P706, DOI 10.1016/0022-0248(93)90507-S; Batchelor G. K., 2000, INTRO FLUID DYNAMICS; Born M., 1999, PRINCIPLES OPTICS EL; CHEVALERIAS R, 1957, J OPT SOC AM, V47, P703, DOI 10.1364/JOSA.47.000703; Eckert E. R., 1976, MEASUREMENTS HEAT TR; Eckert E. R. G., 1961, INT J HEAT MASS TRAN, V2, P106, DOI 10.1016/0017-9310(61)90019-9; Eckert ERG, 1987, ANAL HEAT MASS TRANS; Goldstein R., 1960, INT J HEAT MASS TRAN, V1, P208, DOI 10.1016/0017-9310(60)90023-5; Goldstein R J, 1996, FLUID MECH MEASUREME; GOLDSTEIN RJ, 1995, EXP THERM FLUID SCI, V10, P416, DOI 10.1016/0894-1777(94)00071-F; GREENBERG PS, 1995, APPL OPTICS, V34, P3810, DOI 10.1364/AO.34.003810; Hecht E., 2002, OPTICS; HOWES WL, 1985, APPL OPTICS, V24, P816; Incropera F., 2011, FUNDAMENTALS HEAT MA; Knight R.W., 1991, J ELECTRON PACKAGING, V113, P313, DOI DOI 10.1115/1.2905412]; Leopold F., 2009, J FLOW VISUAL IMAGE, V16; Lomas C.G., 2011, FUNDAMENTALS HOT WIR; Malacara D., 2007, OPTICAL SHOP TESTING; Maruyama S., 2004, LIGHT ENERGY ENG; Maruyama S, 1999, EXP THERM FLUID SCI, V19, P34, DOI 10.1016/S0894-1777(99)00003-5; Maruyama S, 2002, J CRYST GROWTH, V245, P278, DOI 10.1016/S0022-0248(02)01574-9; Mayinger F., 1994, OPTICAL MEASUREMENTS; MCLARNON FR, 1979, IND ENG CHEM FUND, V18, P97, DOI 10.1021/i160070a002; MCLARNON FR, 1982, J ELECTROCHEM SOC, V129, P2201, DOI 10.1149/1.2123475; Meier G., 2000, HINTERGRUND SCHLIERE; MERZKIRCH W., 1987, FLOW VISUALIZATION; Ota M, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/104011; Prescott R., 1951, J AERONAUT SCI I AER, V18; Raffel M., 1998, PARTICLE IMAGE VELOC; Rohsenow W.M., 1986, HDB HEAT TRANSFER FU, V53; Schlichting H., 2000, BOUNDARY LAYER THEOR; Settles G.S., 2001, SCHLIEREN SHADOWGRAP; Shoji E, 2012, INT J HEAT MASS TRAN, V55, P7460, DOI 10.1016/j.ijheatmasstransfer.2012.07.039; Vest C. M., 1979, HOLOGRAPHIC INTERFER, V1; WATT DW, 1987, EXP FLUIDS, V5, P401; Webb R.L., 1994, PRINCIPLE ENHANCED H; Zukauskas A., 1987, ADV HEAT TRANSFER, V18, P87	50	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						231	240		10.1016/j.expthermflusci.2014.08.016		10	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900027		
J	Arai, T; Furuya, M; Kanai, T; Shirakawa, K				Arai, Takahiro; Furuya, Masahiro; Kanai, Taizo; Shirakawa, Kenetsu			Concurrent upward liquid slug dynamics on both surfaces of annular channel acquired with liquid film sensor	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Two-phase flow; Annular channel; Liquid film sensor; Disturbance wave; Ripple wave	2-PHASE FLOW	The interfacial behavior of upward liquid film flow is an important phenomenon to evaluate interfacial transfer accompanying the entrainment and deposition of droplets. This research focuses on a vertical annular channel, and an air-water liquid film flow experiment was conducted under atmospheric pressure conditions. The diameters of inner and outer pipes in the annular channel were 12 and 18 mm respectively. The experiment featured multi-point electrode sensors installed in both the inner and outer pipe surface at the same height, and the ability to measure the liquid film distribution on both surfaces in the annular channel simultaneously. As for the sensor structure, 10 x 32 measuring points were arranged in a lattice pattern on the sensor surface and the spatial resolution was 2 x 2 mm, hence the liquid film thickness distribution could be measured rapidly, at over 1250 slices per second. Since the sensor was manufactured by a flexible multilayer substrate, it was applicable to a cylindrical channel surface. In the experiment, water was supplied from the inner pipe surface and uniformly distributed in the circumferential direction, whereupon liquid film distributions were measured 300 mm downstream from the water supply position. The time series data of the liquid film distribution demonstrated circumferential distributions of liquid film thickness and interfacial wave velocity. When the superficial gas velocity was smaller than 20 m/s, a liquid film formed on both inner and outside pipe surfaces, regardless of the superficial liquid velocity. With increasing superficial gas velocity, the film thickness of the outer pipe surface became thinner than that of the inner pipe surface. Measurement of the liquid film thickness on both surfaces of the annular channel also showed that a liquid slug with wavelength of several millimeters passed concurrently through both surfaces in the annular channel. (C) 2014 Elsevier Inc. All rights reserved.	[Arai, Takahiro; Furuya, Masahiro; Kanai, Taizo; Shirakawa, Kenetsu] Cent Res Inst Elect Power Ind, Komae, Tokyo 2018511, Japan	Arai, T (reprint author), Cent Res Inst Elect Power Ind, 2-11-1 Iwato Kita, Komae, Tokyo 2018511, Japan.	t-arai@criepi.denken.or.jp; furuya@criepi.denken.or.jp; t-kanai@criepi.denken.orjp; sirakawa@criepi.denken.or.jp		Furuya, Masahiro/0000-0002-1221-2874			Sawant P, 2008, NUCL ENG DES, V238, P3528, DOI 10.1016/j.nucengdes.2008.06.013; Damsohn M, 2010, NUCL ENG DES, V240, P3126, DOI 10.1016/j.nucengdes.2010.05.032; Damsohn M, 2009, FLOW MEAS INSTRUM, V20, P1, DOI 10.1016/j.flowmeasinst.2008.06.006; Prasser HM, 1998, FLOW MEAS INSTRUM, V9, P111, DOI 10.1016/S0955-5986(98)00015-6; Wolf A, 2001, CHEM ENG SCI, V56, P3221, DOI 10.1016/S0009-2509(00)00546-7; Arai T., 2010, PROOFS CATEGORIES CO, P1; AZZOPARDI BJ, 1986, NUCL ENG DES, V92, P121, DOI 10.1016/0029-5493(86)90240-2; Hall-Yaylor N., 1963, CHEM ENG SCI, V18, P532; Hewitt G.F., 1990, ASME FED, V99, P41; Kataoka I., 1982, ANL82; MISHIMA K, 1984, INT J HEAT MASS TRAN, V27, P723; SEKOGUCHI K, 1989, INT J MULTIPHAS FLOW, V15, P295, DOI 10.1016/0301-9322(89)90002-5	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						337	345		10.1016/j.expthermflusci.2014.05.018		9	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900038		
J	Katoh, K; Wakimoto, T; Yamamoto, Y; Ito, T				Katoh, Kenji; Wakimoto, Tatsuro; Yamamoto, Yasufumi; Ito, Takahiro			Dynamic wetting behavior of a triple-phase contact line in several experimental systems	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Dynamic wetting; Dynamic contact angle; Capillary rise; Axisymmetric droplet; Two-dimensional meniscus; Capillary number	NAVIER BOUNDARY-CONDITION; CAPILLARY TUBES; DROP SIZE; ANGLE; FLOW; TENSION; SURFACE	Dynamic wetting behavior was investigated experimentally. First, the movement of a liquid column in a capillary tube was observed. Using the measured dynamic contact angles dependent on the contact line velocity, the solution of the modified Lucas-Washburn equation predicts the time variance of the liquid height in the capillary efficiently. Second, the dynamic contact angles were measured for a two-dimensional meniscus and an axisymmetric droplet to detect the influence of contact line curvature. The measured angles coincide well with each other for a two-dimensional meniscus and droplets of various radii. The dynamic wetting behavior is independent of the triple-phase contact line curvature. The dynamic contact angles measured in this study distribute widely from 10 degrees to 170 degrees. The results cannot be arranged by a single function of contact line velocity proposed by Hoffmann. It is suggested that the roughness or impurities on the solid surface could play an important role on the dynamic wetting behavior. (C) 2014 Elsevier Inc. All rights reserved.	[Katoh, Kenji; Wakimoto, Tatsuro] Osaka City Univ, Dept Mech Engn, Osaka, Japan; [Yamamoto, Yasufumi] Kansai Univ, Dept Mech Engn, Suita, Osaka, Japan; [Ito, Takahiro] Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648601, Japan	Katoh, K (reprint author), Osaka City Univ, Dept Mech Engn, Osaka, Japan.	katoh@mech.eng.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23560203]	This work was supported by the Grant-in-Aid for Scientific Research (No. 23560203) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adamson A.W., 1990, PHYSICAL CHEM SURFAC, P1; Siebold A, 2000, COLLOID SURFACE A, V161, P81, DOI 10.1016/S0927-7757(99)00327-1; Bonn D, 2009, REV MOD PHYS, V81, P739, DOI 10.1103/RevModPhys.81.739; Blake TD, 2006, J COLLOID INTERF SCI, V299, P1, DOI 10.1016/j.jcis.2006.03.051; HOFFMAN RL, 1975, J COLLOID INTERF SCI, V50, P228, DOI 10.1016/0021-9797(75)90225-8; Amirfazli A, 1998, J COLLOID INTERF SCI, V205, P1, DOI 10.1006/jcis.1998.5562; Qian TZ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016306; Duvivier D, 2013, LANGMUIR, V29, P10132, DOI 10.1021/la4017917; Xue HT, 2006, CHEM PHYS LETT, V432, P326, DOI 10.1016/j.cplett.2006.10.017; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; COX RG, 1986, J FLUID MECH, V168, P169, DOI 10.1017/S0022112086000332; O'Loughlin M, 2013, J COLLOID INTERF SCI, V411, P257, DOI 10.1016/j.jcis.2013.05.077; JOOS P, 1990, J COLLOID INTERF SCI, V136, P189, DOI 10.1016/0021-9797(90)90089-7; Chakraborty D, 2012, LANGMUIR, V28, P16701, DOI 10.1021/la303603c; Chebbi R, 2007, J COLLOID INTERF SCI, V315, P255, DOI 10.1016/j.jcis.2007.06.073; Hilpert M, 2009, J COLLOID INTERF SCI, V337, P138, DOI 10.1016/j.jcis.2009.04.058; Katoh K., 2010, J JPN SOC EXP MECH, V10, ps62; Katoh K., 2006, T JSME B, V72, P1287; Katoh K., 2004, SURFACTANT SCI SERIE, V119, P375; Min Q, 2011, J COLLOID INTERF SCI, V362, P221, DOI 10.1016/j.jcis.2011.06.029; Ralston J, 2008, ANNU REV MATER RES, V38, P23, DOI 10.1146/annurev.matsci.38.060407.130231; Shimizu T., 2006, PHYS DATA DICT, P390; Tadmor R, 2008, SURF SCI, V602, pL108, DOI 10.1016/j.susc.2008.05.018; Yamamoto Y, 2013, INT J MULTIPHAS FLOW, V51, P22, DOI 10.1016/j.ijmultiphaseflow.2012.12.002; Yamamoto Y, 2014, INT J MULTIPHAS FLOW, V59, P106, DOI 10.1016/j.ijmultiphaseflow.2013.10.018	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						354	360		10.1016/j.expthermflusci.2014.05.006		7	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900040		
J	Jinbo, Y; Ogasawara, T; Takahira, H				Jinbo, Yoshinori; Ogasawara, Toshiyuki; Takahira, Hiroyuki			Influence of the nonequilibrium phase transition on the collapse of inertia nonspherical bubbles in a compressible liquid	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Bubble collapse; Shock wave; Nonequilibrium phase transition; Cavitation; Ghost fluid method; Liquid jet	GHOST FLUID METHOD; CAVITATION BUBBLES; 2-PHASE FLOW; SHOCK; DYNAMICS	In this work, we investigate the shock wave-inertial vapor bubble interactions by taking the nonequilibrium phase transition at the interface, fluid compressibility, and axisymmetric bubble deformations including jet penetration into account. We use the level set method (Sussman et al., 1994) and the ghost fluid method (Fedkiw et al., 1999), which were improved so as to consider the nonequilibrium phase transition (jinbo & Takahira, 2012). The numerical treatments for heat and mass fluxes through interfaces due to the phase transition are implemented, satisfying the conservation laws of mass, momentum, and energy at the interface and preventing the interface from becoming diffused. The influence of surface tension is also considered in the method. The improved method is applied to the shock-bubble interaction under the experimental conditions by Sankin et al. (2005). The pressure waveform of the incident shock wave is comprised of a leading compressive wave with a peak pressure of 39 MPa and a pulse duration of around 1 mu s, followed by a trailing tensile wave of -8 MPa in peak pressure with a pulse duration of around 2 mu s which is determined from the experiment. The liquid-jet formation and the generation of shock waves from the collapsing nonspherical bubble are simulated successfully by taking the nonequilibrium phase transition and surface tension into account. The validity of the simulation is shown by comparing the numerical results (e.g. the intensity of the shock wave generated by the bubble collapse and displacement of the bubble centroid) with those obtained from the experiments (Sankin et al., 2005; Klaseboer et al., 2007). We investigate the effects of the phase of bubble oscillations when the incident shock wave impinges on the spherically-shrinking bubble, on the shock wave radiated from the bubble collapse. It is also shown that when the nonequilibrium phase transition at the interface of nonspherically collapsing bubbles is considered, the minimum bubble radius and the maximum space-averaged pressure value inside the bubble reached during its collapse decreases and increases, respectively, compared with those in the case without the phase transition. (C) 2014 Elsevier Inc. All rights reserved.	[Jinbo, Yoshinori] Hokkaido Univ, Div Mech & Space Engn, Japan Soc Promot Sci, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ogasawara, Toshiyuki; Takahira, Hiroyuki] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Jinbo, Y (reprint author), Hokkaido Univ, Div Mech & Space Engn, Japan Soc Promot Sci, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	jinbo_y@eng.hokudai.ac.jp; oga@me.osakafu-u.ac.jp; takahira@me.osakafu-u.ac.jp			JSPS KAKENHI [25289034];  [25.2710]	This work was partly supported by Grant-in-Aid for JSPS Fellows Grant Number 25.2710 and JSPS KAKENHI Grant Number 25289034.	Sankin GN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.034501; Fedkiw RP, 1999, J COMPUT PHYS, V152, P457, DOI 10.1006/jcph.1999.6136; Kobayashi K, 2011, PHYS MED BIOL, V56, P6421, DOI 10.1088/0031-9155/56/19/016; Enright D, 2002, J COMPUT PHYS, V183, P83, DOI 10.1006/jcph.2002.7166; Brujan EA, 2001, J FLUID MECH, V433, P251; Adalsteinsson D, 1999, J COMPUT PHYS, V148, P2, DOI 10.1006/jcph.1998.6090; Akhatov I, 2001, PHYS FLUIDS, V13, P2805, DOI 10.1063/1.1401810; Caiden R, 2001, J COMPUT PHYS, V166, P1, DOI 10.1006/jcph.2000.6624; Kodama T, 2000, APPL PHYS B-LASERS O, V70, P139, DOI 10.1007/s003400050022; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; FUJIKAWA S, 1980, J FLUID MECH, V97, P481, DOI 10.1017/S0022112080002662; Klaseboer E, 2007, J FLUID MECH, V593, P33, DOI 10.1017/S002211200700852X; Saurel R, 2008, J FLUID MECH, V607, P313, DOI 10.1017/S0022112008002061; Bourne NK, 1999, PHILOS T R SOC A, V357, P295; Brennen C.E., 1995, CAVITATION BUBBLE DY; Jinbo Y., 2012, AIP C P, P139; Jinbo Y., 2012, T JPN SOC MECH ENG-B, V78, P1302; Nigmatulin R.I., 1991, DYNAMICS MULTIPHASE, V1; Nigmatulin R.I., 1991, DYNAMICS MULTIPHASE, V1; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Takahira H., 2011, P AJK FLUIDS ENG C 2; Takahira H, 2008, FLUID DYN RES, V40, P510, DOI 10.1016/j.fluiddyn.2007.12.004; Yoshizawa S, 2009, MED BIOL ENG COMPUT, V47, P851, DOI 10.1007/s11517-009-0471-y	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	JAN	2015	60						374	384		10.1016/j.expthermflusci.2014.07.021		11	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AU7WT	WOS:000345809900043		
J	Hashimoto, K				Hashimoto, Kenji			Tropisetron and its targets in Alzheimer's disease	EXPERT OPINION ON THERAPEUTIC TARGETS			English	Editorial Material						5-hydroxytryptamine 3 receptor; Alzheimer's disease; encenicline; inflammation; mild cognitive impairment; tropisetron; alpha 7 nicotinic receptor; beta-amyloid	NICOTINIC ACETYLCHOLINE-RECEPTOR; SCHIZOPHRENIA; DEFICITS; MODEL; COGNITION; PET	Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Despite this, there are no drugs for preventing the onset of AD. Preclinical studies suggest that the interaction between amyloid-beta peptides (A beta) and the alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) plays a key role in AD pathology, and that alpha 7 nAChR agonists could act as potential therapeutic drugs for AD. A recent study demonstrated that tropisetron, a potent alpha 7 nAChR agonist and serotonin 5-hydroxytryptamine3 receptor antagonist, also bound to the ectodomain of amyloid precursor protein. Furthermore, tropisetron promoted greater improvements in memory than current AD therapeutic drugs, such as memantine and donepezil. Positron emission tomography studies detected A beta deposition and inflammation in the brains of subjects with amnestic mild cognitive impairment (MCI) before the onset of AD. Given the role of alpha 7 nAChR in A beta deposition and inflammation, tropisetron represents an attractive potential therapeutic drug to delay or prevent MCI and AD. Additionally as this drug is used internationally to treat chemotherapy-induced emesis, its safety record is already known.	Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Alzheimer's Disease International, 2013, WORLD ALZH REP 2013; Koike K, 2005, SCHIZOPHR RES, V76, P67, DOI 10.1016/j.schres.2004.12.016; Zhang XY, 2012, AM J PSYCHIAT, V169, P974, DOI 10.1176/appi.ajp.2012.11081289; Friedrich MJ, 2014, JAMA-J AM MED ASSOC, V311, P1596, DOI 10.1001/jama.2014.3891; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Deutsch SI, 2014, PROG NEURO-PSYCHOPH, V54, P131, DOI 10.1016/j.pnpbp.2014.05.011; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HY, 2010, BIOL PSYCHIAT, V67, P522, DOI 10.1016/j.biopsych.2009.09.031; Noroozian M, 2013, PSYCHOPHARMACOLOGY, V228, P595, DOI 10.1007/s00213-013-3064-2; Setoguchi D, 2011, INT IMMUNOPHARMACOL, V11, P2073, DOI 10.1016/j.intimp.2011.08.022; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Ishikawa M, 2011, CURR PHARM DESIGN, V17, P121; Srivareerat M, 2011, NEUROBIOL AGING, V32, P834, DOI 10.1016/j.neurobiolaging.2009.04.015; Cohen AD, 2014, NEUROBIOL DIS, V72, P117, DOI 10.1016/j.nbd.2014.05.001; Forum Pharmaceuticals Inc, 2014, EN PHARM IN COGN PHA; Rahimian R, 2014, EUR J CLIN INVEST, V43, P1039; Shiina A, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-27; Spilman P, 2014, BRAIN RES, V1551, P25, DOI 10.1016/j.brainres.2013.12.029; Toyohara Jun, 2010, Open Med Chem J, V4, P37, DOI 10.2174/1874104501004010037	20	6	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1472-8222	1744-7631		EXPERT OPIN THER TAR	Expert Opin. Ther. Targets	JAN	2015	19	1					1	5		10.1517/14728222.2014.983901		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW3EQ	WOS:000346169200001		
J	Noda, NA; Ohtsuka, H; Zheng, H; Sano, Y; Ando, M; Shinozaki, T; Guan, W				Noda, N. -A.; Ohtsuka, H.; Zheng, H.; Sano, Y.; Ando, M.; Shinozaki, T.; Guan, W.			Strain rate concentration and dynamic stress concentration for double-edge-notched specimens subjected to high-speed tensile loads	FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES			English	Article						dynamic stress; finite element method; notch; strain rate; stress concentration; Polycarbonate; Time-Temperature Superposition Principle	FORMULAS USEFUL; HOLE	Engineering plastics provide superior performance to ordinary plastics for wide range of the use. For polymer materials, dynamic stress and strain rate may be major factors to be considered when the strength is evaluated. Recently, high-speed tensile test is being recognized as a standard testing method to confirm the strength under dynamic loads. In this study, therefore, high-speed tensile test is analysed by the finite element method; then, the maximum dynamic stress and strain rate are discussed with varying the tensile speed and maximum forced displacement. The maximum strain rate increases with increasing the tensile speed u/t, but the strain rate concentration factor K-t(epsilon) over dot(t) = (epsilon) over dot(yA)(t)/(epsilon) over dot(ynom)(t)is found to be constant independent of tensile speed, which is defined as the maximum strain rate (epsilon) over dot(yA,max) appearing at the notch root over the average nominal strain rate at the minimum section (epsilon) over dot(ynom)(t). It is found that the strain rate at the notch root depends on the dynamic stress rate at the notch root and independent of the notch root radius rho. It is found that the difference between the static and dynamic maximum stress concentration (sigma(yA,max) - sigma(yA,st)) at the notch root is proportional to the tensile speed when u/t = 5000 mm/s. Strain rate concentration factors are also discussed with varying the notch depth and specimen length. Based on the elastic strain rate concentration factor, the master curve is obtained useful for understanding the impact fracture of polycarbonate for the wide range of temperature and impact speed.	[Noda, N. -A.; Ohtsuka, H.; Zheng, H.; Sano, Y.; Ando, M.; Shinozaki, T.; Guan, W.] Kyushu Inst Technol, Dept Mech Engn, Kitakyushu, Fukuoka 8048550, Japan	Noda, NA (reprint author), Kyushu Inst Technol, Dept Mech Engn, 1-1 Sensui Cho, Kitakyushu, Fukuoka 8048550, Japan.	noda@mech.kyutech.ac.jp					Altenhof W, 2004, INT J IMPACT ENG, V30, P255, DOI 10.1016/S0734-743X(03)00068-X; Ando M., 2014, T JPN SOC MECH ENG, V80; Noda NA, 2002, J TEST EVAL, V30, P369; NODA NA, 1995, INT J FATIGUE, V17, P163, DOI 10.1016/0142-1123(95)98937-X; Aya T., 1995, J JAPAN SOC TECHNOLO, V36, P665; Chatani A., 1972, MATERIAL, V21, P636; GEORGIADIS HG, 1995, ACTA MECH, V111, P1, DOI 10.1007/BF01187724; Honma S., 2004, PLASTICS, V55, P174; Inoue H., 1997, T JPN SOC MECH ENG, V63, P2478; Kawata K., 1972, ISAS REPORT U TOKYO, V8, P377; Matsumoto H., 1966, T JPN SOC MECH ENG, V32, P709; MSC. Software, 1997, MSC SOFTW MARC; Murakami Y., 1981, T JAPAN SOC MECH ENG, V47, P1194; Naitoh M., 1984, T JPN SOC MECH ENG, V33, P801; Noda NA, 1999, FATIGUE FRACT ENG M, V22, P1071; Noda N.-A., 2010, FATIGUE NOTCH STRENG; RADIN J, 1988, INT J IMPACT ENG, V7, P229, DOI 10.1016/0734-743X(88)90028-0; Takeda N., 1997, T JSME A, V63, P2472; Tanimura S., 1997, T JAPAN SOC MECH E A, V63, P2466; Van Gurp M., 1998, RHEOL B, V67, P5	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-758X	1460-2695		FATIGUE FRACT ENG M	Fatigue Fract. Eng. Mater. Struct.	JAN	2015	38	1					125	138		10.1111/ffe.12228		14	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	AW1FE	WOS:000346035000011		
J	Nakagawa, K; Hara, H				Nakagawa, K.; Hara, H.			Investigation of radical locations in various sesame seeds by CW EPR and 9-GHz EPR imaging	FREE RADICAL RESEARCH			English	Article						EPR; imaging; sesame; antioxidant; free radicals; food; irradiation	ANTIOXIDANT ACTIVITY; FRACTIONS	We investigated the location of radical in various sesame seeds using continuous-wave (CW) electron paramagnetic resonance (EPR) and 9-GHz EPR imaging. CW EPR detected persistent radicals (single line) for various sesame seeds. The EPR linewidth of black sesame seeds was narrower than that of the irradiated white sesame seeds. A very small signal was detected for the white sesame seeds. Two-dimensional (2D) imaging using a 9-GHz EPR imager showed that radical locations vary for various sesame seeds. The paramagnetic species in black sesame seeds were located on the seed coat (skin) and in the hilum region. The signal with the highest intensity was obtained from the hilum part. A very low-intensity image was observed for the white sesame seeds. In addition, the 2D imaging of the irradiated white sesame seeds showed that free radicals were located throughout the entire seed. For the first time, CW EPR and 9-GHz EPR imaging showed the exact location of radical species in various sesame seeds.	[Nakagawa, K.] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori 0368564, Japan; [Hara, H.] Bruker BioSpin KK, Kanagawa Ku, Yokohama, Kanagawa, Japan	Nakagawa, K (reprint author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, 66-1 Hon Cyo, Hirosaki, Aomori 0368564, Japan.	nakagawa@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24650247, 25282124]	Part of this research was supported by a Grant-in-Aid for Exploratory Research (24650247) and for Scientific Research (B) (25282124) from the Japan Society for the Promotion of Science (JSPS) (K.N.).	LIU KJ, 1993, P NATL ACAD SCI USA, V90, P5438, DOI 10.1073/pnas.90.12.5438; Chang LW, 2002, FOOD CHEM, V78, P347, DOI 10.1016/S0308-8146(02)00119-X; Xu J, 2005, FOOD CHEM, V91, P79, DOI 10.1016/j.foodchem.2004.05.051; NAMIKI M, 1995, FOOD REV INT, V11, P281; Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009; Nakagawa K, 2012, J OLEO SCI, V61, P451, DOI 10.5650/jos.61.451; Zielinski H, 2000, J AGR FOOD CHEM, V48, P2008, DOI 10.1021/jf990619o; Bussandri A, 1999, APPL MAGN RESON, V17, P577; Eaton G.R., 1991, EPR IMAGING IN VIVO; Epel B, 2013, ELECTRON PARAMAG RES, V23, P180, DOI 10.1039/9781849734837-00180; Halliwell B, 1997, NUTR REV, V55, pS44; Leveque PP, 2008, ISR J CHEM, V48, P19, DOI 10.1560/IJC.48.1.19; Nakagawa K, 2014, FREE RADICAL RES, V48, P679, DOI 10.3109/10715762.2014.900174; NAKAGAWA K, 1994, PHOTOCHEM PHOTOBIOL, V60, P199, DOI 10.1111/j.1751-1097.1994.tb05091.x; Nakagawa K, 2014, SPECTROCHIM ACTA A, V131, P342, DOI 10.1016/j.saa.2014.04.100	15	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	JAN	2015	49	1					1	6		10.3109/10715762.2014.967691		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW3GK	WOS:000346174200001		
J	Okaniwa, N; Sasaki, M; Mizushima, T; Ogasawara, N; Funaki, Y; Joh, T; Kasugai, K				Okaniwa, N.; Sasaki, M.; Mizushima, T.; Ogasawara, N.; Funaki, Y.; Joh, T.; Kasugai, K.			eNOS plays an important role in the regulation of colonic inflammation: A novel therapeutic target and a predictive marker for the prognosis of ulcerative colitis	FREE RADICAL RESEARCH			English	Article						eNOS over-expression; inflammatory bowel disease; gene-polymorphism; intractable case; endothelial adhesion molecules	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL CELL-INTERACTIONS; COA REDUCTASE INHIBITOR; BOWEL-DISEASE; TRANSGENIC MICE; DEFICIENT MICE; IN-VIVO; OVEREXPRESSION; REPERFUSION; ADHESION	Background. We reported that deficiency of the eNOS protein exacerbates colitis induced by dextran sodium sulfate (DSS-induced colitis). However, the role of eNOS in colitis remains controversial. Therefore, we studied how over-expression of eNOS affected this inflammatory condition, using vascular endothelial cells and mice as in vitro and in vivo models, respectively. Furthermore, we investigated the influence of a polymorphism in the eNOS gene on the clinical features of ulcerative colitis (UC). Methods. We examined the effect of eNOS overexpression on the expression of adhesion molecules in the endothelium and assessed the degree of DSS-induced colitis in e NOS transgenic (eNOS-Tg) mice. We also investigated the relationship between a polymorphism in the e NOS gene and clinical features of patients with UC. Results. The expression of adhesion molecules, under inflammatory conditions, was attenuated in e NOS gene-transfected vascular endothelial cells, as measured by western blot analysis. Symptoms of DSS-induced colitis were likewise attenuated in eNOS-Tg mice, which exhibited lower weight loss, mortality, histological damage (by inflammation score and crypt damage score), and colonic myeloperoxidase activity, tumor necrosis factor-alpha expression, and MAdCAM-1 expression than in wild-type mice. Furthermore, there was a significant relationship between intractable cases of UC and a polymorphism in the eNOS gene promoter (c.-786 T > C) that decreases eNOS expression. Conclusion. The eNOS gene plays an important role in the regulation of colonic inflammation. The level of eNOS expression may be a predictive marker for prognosis of UC, and eNOS expression may be a novel therapeutic target.	[Okaniwa, N.; Sasaki, M.; Ogasawara, N.; Funaki, Y.; Kasugai, K.] Aichi Med Univ, Dept Gastroenterol, Sch Med, Nagakute, Aichi 4801195, Japan; [Mizushima, T.] Gifu Prefectual Tajimi Hosp, Dept Gastroenterol, Gifu, Japan; [Joh, T.] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan	Sasaki, M (reprint author), Aichi Med Univ, Dept Gastroenterol, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	msasaki@aichi-med-u.ac.jp					Nakayama M, 1999, CIRCULATION, V99, P2864; Yamamoto T, 2013, CURR OPIN GASTROEN, V29, P216, DOI 10.1097/MOG.0b013e32835b9a40; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943; Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Amin-Hanjani S, 2001, STROKE, V32, P980; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662; Ishihara T, 2009, J PHARMACOL EXP THER, V328, P152, DOI 10.1124/jpet.108.144451; Souza HS, 1999, GUT, V45, P856; Binion DG, 1998, LANCET, V352, P1742, DOI 10.1016/S0140-6736(98)05050-8; Ohashi Y, 1998, J CLIN INVEST, V102, P2061, DOI 10.1172/JCI4394; Forstermann U, 1998, FASEB J, V12, P773; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Kawashima S, 2004, J PHARMACOL SCI, V96, P411, DOI 10.1254/jphs.FMJ04006X6; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Briskin M, 1997, AM J PATHOL, V151, P97; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Kaminski A, 2004, AM J PATHOL, V164, P2241, DOI 10.1016/S0002-9440(10)63780-7; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Dijkstra G, 1998, J PATHOL, V186, P416, DOI 10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Sasaki M, 2003, J PHARMACOL EXP THER, V305, P78, DOI 10.1124/jpet.102.044099; Schirbel A, 2010, J DIGEST DIS, V11, P266, DOI 10.1111/j.1751-2980.2010.00449.x; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Aroca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094558; Binion DG, 2000, FREE RADICAL BIO MED, V29, P881, DOI 10.1016/S0891-5849(00)00391-9; Chen F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00184; Edgar K, 2012, INVEST OPHTH VIS SCI, V53, P6833, DOI 10.1167/iovs.12-9797; GRISHAM MB, 1990, METHOD ENZYMOL, V186, P729; Guihot G, 2000, AMINO ACIDS, V18, P229, DOI 10.1007/s007260050020; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; Huang SS, 2006, CIRC J, V70, P1070, DOI 10.1253/circj.70.1070; International HapMap Priject, RS2070744 INT MAPMAP; KITAHORA T, 1995, J GASTROENTEROL, V30, P5; Matsushita H, 2001, CIRC RES, V89, P793, DOI 10.1161/hh2101.098443; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Naito Y, 2006, INT J MOL MED, V17, P997; National Center for Biotechnology Ingormation, 41322052SNPNCBI; Oshima T, 2001, BMC Gastroenterol, V1, P5, DOI 10.1186/1471-230X-1-5; Parkes M, 1998, CLIN EXP IMMUNOL, V113, P28, DOI 10.1046/j.1365-2249.1998.00625.x; Prideaux L, 2014, J GASTROEN HEPATOL, V27, P1266; Sasaki M, 2003, FREE RADICAL BIO MED, V35, P1679, DOI 10.1016/j.freeradbiomed.2003.09.016; Shen C, 2007, CLIN IMMUNOL, V122, P53, DOI 10.1016/j.clim.2006.09.007; SUEMATSU M, 1994, AM J PHYSIOL, V266, pH2410; Uchiyama K, 2013, DIGEST DIS SCI, V58, P1235, DOI 10.1007/s10620-012-2508-6; Wang Jian, 2002, Arterioscler Thromb Vasc Biol, V22, pe1, DOI 10.1161/01.ATV.0000016248.51577.1F; Yu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031495	52	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	JAN	2015	49	1					35	44		10.3109/10715762.2014.977788		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW3GK	WOS:000346174200005		
J	Kasahara, S; Saito, H				Kasahara, Satoshi; Saito, Hiroshi			Effect of loading parameters on motor performance during a dynamic weight-shift task	GAIT & POSTURE			English	Article						Postural control; Weight shifting; Standing; Visual feedback; Movement accuracy; Learning	BALANCE CONTROL; UPRIGHT STANCE; CHRONIC STROKE; BEARING; WEIGHTBEARING; PERCEPTION; ACCURACY; PATTERNS; FEEDBACK; WOMEN	Controlling weight shift (WS) is essential to performing motions safely and smoothly during daily and athletic activities. This study investigated the impact of loading parameters on the motor performance and difficulty level of a dynamic WS task performed while standing. Twelve healthy young adults (21.2 +/- 0.9 years, 53.5 +/- 7.4 kg) were asked to match the target and their weight loads using visual feedback displayed on a computer monitor. Motor performance was estimated by assessment of loading accuracy and pace of motor skill acquisition, measured as a proxy of difficulty level, was estimated by assessment of learning rate. As predicted, both loading accuracy values decreased with increasing target frequency. Notably, the interaction of loading size and frequency had a significant effect on loading accuracy, which was increasingly impaired as the weight load increased at frequencies greater than 0.5 Hz. Moreover, the pace of motor skill acquisition in a dynamic WS task while standing was affected by the weight-load speed independently of the weight-load size. These results indicate that loading accuracy is affected by both the weight-load size and frequency and that 0.5 Hz is a critical frequency at which the difficulty level increases during dynamic WS tasks while standing in healthy youths. These findings suggest that the adequacy of the initial settings used regarding loading size and frequency is an important consideration in rehabilitative and athletic training aimed at evaluating and improving WS while standing. (C) 2014 Elsevier B.V. All rights reserved.	[Kasahara, Satoshi; Saito, Hiroshi] Hokkaido Univ, Fac Hlth Sci, Dept Rehabil Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Kasahara, S (reprint author), Hokkaido Univ, Fac Hlth Sci, Dept Rehabil Sci, Kita Ku, West 5,North 12, Sapporo, Hokkaido 0600812, Japan.	kasahara@cme.hokudai.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan [21700518]	The authors would like to thank Toshihiko Hirose, Musashi Mizutori, and Mitsuhisa Toduka for their assistance with data collection. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (21700518).	Latash ML, 2003, EXP BRAIN RES, V150, P314, DOI 10.1007/s00221-003-1419-3; Hurkmans HL, 2012, ARCH PHYS MED REHAB, V93, P565, DOI 10.1016/j.apmr.2011.11.019; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Tsaklis PV, 2012, TOP STROKE REHABIL, V19, P23, DOI 10.1310/tsr1901-23; Girgenrath M, 2004, EXP BRAIN RES, V158, P415, DOI 10.1007/s00221-004-1915-0; Fontana TL, 2005, AUST J PHYSIOTHER, V51, P259; Bertucco M, 2010, NEUROSCIENCE, V171, P205, DOI 10.1016/j.neuroscience.2010.08.023; Gouglidis V, 2011, EXP AGING RES, V37, P46, DOI 10.1080/0361073X.2010.507431; Feldman LS, 2009, SURGERY, V146, P381, DOI 10.1016/j.surg.2009.02.021; Jongman V, 2012, STUD HEALTH TECHNOL, V181, P93, DOI 10.3233/978-1-61499-121-2-93; Hatzitaki V, 2007, EXP BRAIN RES, V182, P525, DOI 10.1007/s00221-007-1007-z; Genthon N, 2005, J BIOMECH, V38, P2037, DOI 10.1016/j.jbiomech.2004.09.024; Yang F, 2011, J BIOMECH, V44, P2243, DOI 10.1016/j.jbiomech.2011.05.039; BOHANNON RW, 1989, PERCEPT MOTOR SKILL, V69, P875; Buchanan JJ, 2003, BEHAV BRAIN RES, V143, P121, DOI 10.1016/S0166-4328(03)00038-X; CHRIST CB, 1993, J ORTHOP SPORT PHYS, V18, P502; Cohen J., 1988, STAT POWER ANAL BEHA; Dickstein R, 2010, AM J PHYS MED REHAB, V89, P287, DOI 10.1097/PHM.0b013e3181c9d86e; DIETZ V, 1993, EXP BRAIN RES, V93, P352; Ferris LA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023385; Hustedt JW, 2012, ORTHOPEDICS, V35, pE1061, DOI 10.3928/01477447-20120621-23; Ko YG, 2003, J MOTOR BEHAV, V35, P325; LISBERGER SG, 1981, J NEUROPHYSIOL, V46, P229; Nashner LM, 1989, PROG BRAIN RES, P411; Ribeiro T, 2012, EUR J PHYS REHAB MED, V48, P1; Smith AJJ, 2012, J ELECTROMYOGR KINES, V22, P914, DOI 10.1016/j.jelekin.2012.03.010; Sousa CO, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-48; Sutton P, 2007, INJURY, V38, P163, DOI 10.1016/j.injury.2006.06.013; Widener GL, 2009, ARCH PHYS MED REHAB, V90, P602, DOI 10.1016/j.apmr.2008.10.027	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JAN	2015	41	1					100	105		10.1016/j.gaitpost.2014.09.009		6	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	AW2MQ	WOS:000346122800018		
J	Brustio, PR; Magistro, D; Liubicich, ME				Brustio, Paolo R.; Magistro, Daniele; Liubicich, Monica E.			Changes in temporal parameters during performance of the Step Test in older adults	GAIT & POSTURE			English	Article						Step Test; Temporal parameters; Older adults	STAIR NEGOTIATION; MOBILITY LIMITATIONS; GAIT; POPULATION; DESCENT; WALKING; PEOPLE; YOUNG; AGE; EXERCISE	The purpose of this cross-sectional study was to examine the changes in the temporal parameters measured during the performance of the Step Test, to evaluate the relationship between age and these measurements and to determine their relationships to aerobic endurance, muscular strength and mobility in a sample of older adults. Eighty-eight older adults (mean age = 73.0 years, SD = 5.4) participated in the study. During the Step Test, we collected measurements of the following temporal parameters using the Optojump system: step number, support time and executive time. We also evaluated the performance of the Six-Minute Walk Test, the 30-Second Chair Rise Test and the Timed Up and Go Test. We observed a significant decrease in the step number and an increase in the support time and executive time (p = .001) during each minute of the test. The results revealed that the relationship between age and Step Test performance was attenuated when we controlled for potential confounding variables. Controlling for age, gender and BMI, variance in support time during the Step Test was accounted for by variance in 30-Second Chair Rise Test performance (partial r = -.224). Moreover, variance in executive time was accounted for by variance in 30-Second Chair Rise Test (partial r = .234) and Timed Up and Go Test performance (partial r = -.259). Understanding the factors that are associated with the performance of the Step Test may provide new insights into the development of specific intervention programmes for older adults. (C) 2014 Elsevier B.V. All rights reserved.	[Brustio, Paolo R.; Liubicich, Monica E.] Univ Turin, SUISM, I-10124 Turin, Italy; [Brustio, Paolo R.; Magistro, Daniele] Univ Turin, Dept Psychol, I-10124 Turin, Italy; [Magistro, Daniele] Tohoku Univ, IDAC, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	Magistro, D (reprint author), Tohoku Univ, IDAC, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	paoloriccardo.brustio@unito.it; danielemagistro@gmail.com; monica.liubicich@unito.it		Magistro, Daniele/0000-0002-2554-3701	JSPS	This article is dedicated to the memory of Professor Silvia Ciairano. The authors would like to express their thanks to the JSPS Postdoctoral Fellowship Programme for Foreigner Researchers FY2012.	American College of Sports Medicine, 2013, ACSMS GUID EX TEST P; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Brach JS, 2010, GAIT POSTURE, V31, P175, DOI 10.1016/j.gaitpost.2009.10.002; Bennell K, 2011, ARTHRIT CARE RES, V63, pS350, DOI 10.1002/acr.20538; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Barbieri FA, 2014, GAIT POSTURE, V39, P985, DOI 10.1016/j.gaitpost.2013.12.021; Callisaya ML, 2008, J GERONTOL A-BIOL, V63, P165; Magistro D, 2014, GERONTOLOGIST, V54, P611, DOI 10.1093/geront/gnt039; Oh-Park M, 2011, ARCH PHYS MED REHAB, V92, P2006, DOI 10.1016/j.apmr.2011.07.193; Verlinden VJA, 2013, GAIT POSTURE, V37, P500, DOI 10.1016/j.gaitpost.2012.09.005; Tiedemann AC, 2007, J GERONTOL A-BIOL, V62, P1259; Mian OS, 2007, GAIT POSTURE, V25, P9, DOI 10.1016/j.gaitpost.2005.12.014; Novak AC, 2011, GAIT POSTURE, V33, P54, DOI 10.1016/j.gaitpost.2010.09.024; Novak AC, 2011, GAIT POSTURE, V34, P384, DOI 10.1016/j.gaitpost.2011.06.007; Startzell JK, 2000, J AM GERIATR SOC, V48, P567; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Benedetti MG, 2007, CLIN BIOMECH, V22, P567, DOI 10.1016/j.clinbiomech.2007.01.010; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; LeBrasseur NK, 2008, J AM GERIATR SOC, V56, P2118, DOI 10.1111/j.1532-5415.2008.01953.x; Collen Fiona M, 2005, Physiother Res Int, V10, P81, DOI 10.1002/pri.29; Demura S, 2008, GERIATR GERONTOL INT, V8, P180, DOI 10.1111/j.1447-0594.2008.00468.x; Hollman JH, 2013, GAIT POSTURE, V38, P316, DOI 10.1016/j.gaitpost.2012.12.014; Morris M, 2004, OPTIMIZING EXERCISE; Pedrosa R, 2009, REV BRAS FISIOTER, V13, P252, DOI 10.1590/S1413-35552009005000030; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Rikli RE, 2013, SENIOR FITNESS TEST; Shin S, 2010, ARCH GERONTOL GERIAT, V50, pE51, DOI 10.1016/j.archger.2009.05.007; ternational Standards Organization, 2010, 72502 ISOTR	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JAN	2015	41	1					217	221		10.1016/j.gaitpost.2014.10.006		5	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	AW2MQ	WOS:000346122800038		
J	Yamamoto, A; Sasagawa, S; Oba, N; Nakazawa, K				Yamamoto, Akio; Sasagawa, Shun; Oba, Naoko; Nakazawa, Kimitaka			Behavioral effect of knee joint motion on body's center of mass during human quiet standing	GAIT & POSTURE			English	Article						Posture control; Quiet standing; Inverted pendulum model; Knee joint; COM kinematics	INVERTED PENDULUM MODEL; HUMAN STANCE; LEG JOINTS; ANKLE; HIP	The balance control mechanism during upright standing has often been investigated using single-or double-link inverted pendulum models, involving the ankle joint only or both the ankle and hip joints, respectively. Several studies, however, have reported that knee joint motion during quiet standing cannot be ignored. This study aimed to investigate the degree to which knee joint motion contributes to the center of mass (COM) kinematics during quiet standing. Eight healthy adults were asked to stand quietly for 30 s on a force platform. Angular displacements and accelerations of the ankle, knee, and hip joints were calculated from kinematic data obtained by a motion capture system. We found that the amplitude of the angular acceleration was smallest in the ankle joint and largest in the hip joint (ankle < knee < hip). These angular accelerations were then substituted into three biomechanical models with or without the knee joint to estimate COM acceleration in the anterior-posterior direction. Although the "without-knee'' models greatly overestimated the COM acceleration, the COM acceleration estimated by the "with-knee'' model was similar to the actual acceleration obtained from force platform measurement. These results indicate substantial effects of knee joint motion on the COM kinematics during quiet standing. We suggest that investigations based on the multi-joint model, including the knee joint, are required to reveal the physiologically plausible balance control mechanism implemented by the central nervous system. (C) 2014 Elsevier B.V. All rights reserved.	[Yamamoto, Akio; Sasagawa, Shun; Oba, Naoko; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Sasagawa, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	sasagawa@idaten.c.u-tokyo.ac.jp			 [23300198];  [25870164]	We thank Dr. Masahiro Shinya for helpful programming advice. This research was supported by a Grant-in-Aid for Scientific Research (B) (23300198) and a Grant-in-Aid for Young Scientists (B) (25870164).	Gunther M, 2009, J BIOMECH, V42, P2739, DOI 10.1016/j.jbiomech.2009.08.014; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Sasagawa S, 2009, NEUROSCI LETT, V450, P27, DOI 10.1016/j.neulet.2008.11.027; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; Masani K, 2007, NEUROSCI LETT, V422, P202, DOI 10.1016/j.neulet.2007.06.019; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Gunther M, 2011, ARCH APPL MECH, V81, P283, DOI 10.1007/s00419-010-0414-y; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Drake RL, 2005, GRAYS ANATOMY STUDEN, P538; Ferrari A, 2010, GAIT POSTURE, V31, P540, DOI 10.1016/j.gaitpost.2010.02.009; Gunther M, 2011, GAIT POSTURE, V33, P412, DOI 10.1016/j.gaitpost.2010.12.014; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Winter D. A., 2009, BIOMECHANICS MOTOR C	15	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JAN	2015	41	1					291	294		10.1016/j.gaitpost.2014.08.016		4	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	AW2MQ	WOS:000346122800051		
J	Yoda, Y; Takeshima, H; Niwa, T; Kim, JG; Ando, T; Kushima, R; Sugiyama, T; Katai, H; Noshiro, H; Ushijima, T				Yoda, Yukie; Takeshima, Hideyuki; Niwa, Tohru; Kim, Jeong Goo; Ando, Takayuki; Kushima, Ryoji; Sugiyama, Toshiro; Katai, Hitoshi; Noshiro, Hirokazu; Ushijima, Toshikazu			Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer	GASTRIC CANCER			English	Article						Epigenetics; DNA methylation; Genetic alterations; Gastric cancer; Cancer-related pathway	ISLAND METHYLATOR PHENOTYPE; ABERRANT DNA METHYLATION; CPG ISLAND; PROMOTER METHYLATION; HELICOBACTER-PYLORI; PHASE-II; CARCINOMA; EVEROLIMUS; INACTIVATION; ASSOCIATION	The profiles of genetic and epigenetic alterations in cancer-related pathways are considered to be useful for selection of patients likely to respond to specific drugs, including molecular-targeted and epigenetic drugs. In this study, we aimed to characterize such profiles in gastric cancers (GCs). Genetic alterations of 55 cancer-related genes were analyzed by a benchtop next-generation sequencer. DNA methylation statuses were analyzed by a bead array with 485,512 probes. The WNT pathway was activated by mutations of CTNNB1 in 2 GCs and potentially by aberrant methylation of its negative regulators, such as DKK3, NKD1, and SFRP1, in 49 GCs. The AKT/mTOR pathway was activated by mutations of PIK3CA and PTPN11 in 4 GCs. The MAPK pathway was activated by mutations and gene amplifications of ERBB2, FLT3, and KRAS in 11 GCs. Cell-cycle regulation was affected by aberrant methylation of CDKN2A and CHFR in 13 GCs. Mismatch repair was affected by a mutation of MLH1 in 1 GC and by aberrant methylation of MLH1 in 2 GCs. The p53 pathway was inactivated by mutations of TP53 in 19 GCs and potentially by aberrant methylation of its downstream genes in 38 GCs. Cell adhesion was affected by mutations of CDH1 in 2 GCs. Genes involved in cancer-related pathways were more frequently affected by epigenetic alterations than by genetic alterations. The profiles of genetic and epigenetic alterations are expected to be useful for selection of the patients who are likely to benefit from specific drugs.	[Yoda, Yukie; Takeshima, Hideyuki; Niwa, Tohru; Kim, Jeong Goo; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan; [Yoda, Yukie; Noshiro, Hirokazu] Saga Univ, Fac Med, Dept Surg, Saga 840, Japan; [Kim, Jeong Goo] Catholic Univ Korea, Dept Surg, Coll Med, Seoul, South Korea; [Ando, Takayuki; Sugiyama, Toshiro] Toyama Univ, Dept Internal Med 3, Toyama 930, Japan; [Kushima, Ryoji] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Kushima, Ryoji] Natl Canc Ctr, Clin Lab, Tokyo, Japan; [Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	Ushijima, T (reprint author), Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan.	tushijim@ncc.go.jp			Foundation for Promotion of Cancer Research; National Cancer Center Research and Development Fund; Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science (JSPS); A3 Foresight Program from the Japan Society for the Promotion of Science	Y.Y. is a recipient of Research Resident Fellowships from the Foundation for Promotion of Cancer Research. This work was supported by the National Cancer Center Research and Development Fund, by a Grant-in-Aid for the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS), and by the A3 Foresight Program from the Japan Society for the Promotion of Science.	Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Yamashita S, 2009, DNA RES, V16, P275, DOI 10.1093/dnares/dsp017; Kantarjian H, 2006, CANCER, V106, P1794, DOI 10.1002/cncr.21792; Shigematsu Y, 2012, ONCOL LETT, V4, P268, DOI 10.3892/ol.2012.708; Yu J, 2009, CANCER, V115, P49, DOI 10.1002/cncr.23989; Oue N, 2003, CANCER SCI, V94, P901, DOI 10.1111/j.1349-7006.2003.tb01373.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Ruan WJ, 2007, CANCER BIOL THER, V6, P354; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Lee SJ, 2013, INVEST NEW DRUG, V31, P1580, DOI 10.1007/s10637-013-0022-0; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Duval A, 2002, CANCER RES, V62, P2447; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Yoon DH, 2012, BRIT J CANCER, V106, P1039, DOI 10.1038/bjc.2012.47; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Beaver JA, 2012, FUTURE ONCOL, V8, P651, DOI [10.2217/fon.12.49, 10.2217/FON.12.49]; Byun DS, 2001, CANCER RES, V61, P7034; Dedeurwaerder S, 2010, EPIGENOMICS, V3, P771; Gullapalli RR, 2012, CLIN LAB MED, V32, P585, DOI 10.1016/j.cll.2012.07.005; Kikuyama M, 2012, CANCER LETT, V322, P204, DOI 10.1016/j.canlet.2012.03.016; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603	40	7	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					65	76		10.1007/s10120-014-0348-0		12	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500007		
J	Saigusa, S; Tanaka, K; Mohri, Y; Ohi, M; Shimura, T; Kitajima, T; Kondo, S; Okugawa, Y; Toiyama, Y; Inoue, Y; Kusunoki, M				Saigusa, Susumu; Tanaka, Koji; Mohri, Yasuhiko; Ohi, Masaki; Shimura, Tadanobu; Kitajima, Takahito; Kondo, Satoru; Okugawa, Yoshinaga; Toiyama, Yuji; Inoue, Yasuhiro; Kusunoki, Masato			Clinical significance of RacGAP1 expression at the invasive front of gastric cancer	GASTRIC CANCER			English	Article						RacGAP1; Gastric cancer; Invasive front; Poor prognosis	GTPASE-ACTIVATING PROTEIN; HUMAN BREAST-TUMORS; COLORECTAL-CANCER; INTESTINAL-TYPE; MESENCHYMAL TRANSITION; PROGNOSTIC MARKER; RHO-GTPASES; RAC; PROGRESSION; CYTOKINESIS	Rac GTPase activating protein 1 (RacGAP1) plays a regulatory role in cell growth, transformation and metastasis. The aim of this study was to clarify the association between RacGAP1 expression and clinical outcome in patients with gastric cancer. A total of 232 gastric cancer patients in our institute who underwent surgery without preoperative treatments were enrolled in this study. We investigated RacGAP1 expression using immunohistochemistry (IHC) and evaluated IHC scores calculated by the percentage of positive cells and intensity and its expression at the invasive front. RACGAP1 expression was also assessed. RacGAP1 expression was observed in the nuclei of gastric cancer cells. Evaluation by IHC score showed no significant correlations with clinicopathological variables except for histological differentiation. In transcriptional analyses, RACGAP1 expression was elevated in diffuse type gastric cancer than intestinal type without a significant difference. We observed significant correlations of RacGAP1 protein expression at the invasive front with older age, tumor size, lymph node metastasis, lymphatic invasion, vascular invasion and advanced stage. Patients with RacGAP1 protein expression at the invasive front had significantly poorer prognosis than those without it (P < 0.0001). In multivariate analysis, lymph node metastasis, distant metastasis and positive RacGAP1 expression at the invasive front were independent prognostic factors (lymph node metastasis: P = 0.0106; distant metastasis: P = 0.0012; RacGAP1: P = 0.0011). RacGAP1 expression at the invasive front in gastric cancer was significantly correlated with factors reflecting tumor progression and poor prognosis. Our data suggest that RacGAP1 might play important roles in the progression of gastric cancer.	[Saigusa, Susumu; Tanaka, Koji; Mohri, Yasuhiko; Ohi, Masaki; Shimura, Tadanobu; Kitajima, Takahito; Kondo, Satoru; Okugawa, Yoshinaga; Toiyama, Yuji; Inoue, Yasuhiro; Kusunoki, Masato] Mie Univ Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan	Saigusa, S (reprint author), Mie Univ Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	saigusa@clin.medic.mie-u.ac.jp					Akishima-Fukasawa Y, 2011, HISTOPATHOLOGY, V59, P470, DOI 10.1111/j.1365-2559.2011.03964.x; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Zhang ZY, 2013, CANCER LETT, V336, P34, DOI 10.1016/j.canlet.2013.04.021; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Gomceli I, 2012, WORLD J GASTROENTERO, V18, P5164, DOI 10.3748/wjg.v18.i37.5164; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Cao C, 2012, MOL CANCER RES, V10, P892, DOI 10.1158/1541-7786.MCR-12-0169; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Pliarchopoulou K, 2013, CANCER CHEMOTH PHARM, V71, P245, DOI 10.1007/s00280-012-2002-z; Ke HL, 2013, J NEURO-ONCOL, V113, P327, DOI 10.1007/s11060-013-1121-7; Kotoula V, 2013, VIRCHOWS ARCH, V462, P141, DOI 10.1007/s00428-012-1357-1; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775; Kaneko S, 2001, BRIT J CANCER, V84, P400, DOI 10.1054/bjoc.2000.1602; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Konishi K, 2010, CANCER SCI, V101, P2269, DOI 10.1111/j.1349-7006.2010.01674.x; PARSONNET J, 1991, J NATL CANCER I, V83, P640, DOI 10.1093/jnci/83.9.640; Saigusa S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0620-x; Tsutsumi S, 2011, J SURG ONCOL, V103, P669, DOI 10.1002/jso.21880; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035	35	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					84	92		10.1007/s10120-014-0355-1		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500009		
J	Shimura, T; Tanaka, K; Toiyama, Y; Okigami, M; Ide, S; Kitajima, T; Kondo, S; Saigusa, S; Ohi, M; Araki, T; Inoue, Y; Uchida, K; Mohri, Y; Mizoguchi, A; Kusunoki, M				Shimura, Tadanobu; Tanaka, Koji; Toiyama, Yuji; Okigami, Masato; Ide, Shozo; Kitajima, Takahito; Kondo, Satoru; Saigusa, Susumu; Ohi, Masaki; Araki, Toshimitsu; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Mizoguchi, Akira; Kusunoki, Masato			In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy	GASTRIC CANCER			English	Article						Paclitaxel; Peritoneal metastatic xenograft; Gastric cancer; Two-photon laser scanning microscopy	MULTIPHOTON MICROSCOPY; INTRAPERITONEAL CHEMOTHERAPY; CELL-LINES; TAXOL; PHASE; MICE; S-1; MECHANISM	We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal xenografts to chemotherapy of metastatic gastric cancer using intravital TPLSM. Red fluorescent protein-expressing gastric cancer cells (NUGC4) were inoculated into the peritoneal cavity of green fluorescent protein nude mice. Laparotomy revealed that 2 weeks after inoculation, macroscopic peritoneal metastatic nodules were formed. The first intravital TPLSM session revealed that they were composed of red tumor cell clusters and green surrounding stroma. Paclitaxel was administered intraperitoneally after the first TPLSM three times a week for 7 days in the treatment group. At the second laparotomy, there were significantly fewer and smaller nodules in the treated mice than in the controls. The second intravital TPLSM session showed tumor cell fragmentation, swelling, and nuclear condensation in the metastatic nodules-a response to chemotherapy. There were multinuclear tumor cells in the paclitaxel-treated living mice. Our method may become a powerful tool for evaluating the efficacy of novel anti-gastric cancer drugs in a preclinical murine model with minimum interindividual variation.	[Shimura, Tadanobu; Tanaka, Koji; Toiyama, Yuji; Okigami, Masato; Ide, Shozo; Kitajima, Takahito; Kondo, Satoru; Saigusa, Susumu; Ohi, Masaki; Araki, Toshimitsu; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan; [Mizoguchi, Akira] Mie Univ Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie, Japan	Shimura, T (reprint author), Mie Univ Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	t-shimura@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 25462052, 30586764]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 25462052 to K.T.; 30586764 to M.K.).	Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Wang BG, 2010, J MICROSC-OXFORD, V238, P1, DOI 10.1111/j.1365-2818.2009.03330.x; Kawano H, 2008, NAT METHODS, V5, P373, DOI 10.1038/nmeth0508-373; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; LONG BH, 1994, CANCER RES, V54, P4355; Ishigami H, 2009, ONCOLOGY-BASEL, V76, P311, DOI 10.1159/000209277; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Illidge TM, 2000, CELL BIOL INT, V24, P621, DOI 10.1006/cbir.2000.0557; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; EISEMAN JL, 1994, CANCER CHEMOTH PHARM, V34, P465, DOI 10.1007/BF00685656; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Ustione A, 2011, J MICROSC-OXFORD, V243, P221, DOI 10.1111/j.1365-2818.2011.03532.x; Tanaka K, 2012, ONCOL REP, V28, P1822, DOI 10.3892/or.2012.1983; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Beerling E, 2011, J CELL SCI, V124, P299, DOI 10.1242/jcs.072728; Chang YF, 1996, CANCER, V77, P14, DOI 10.1002/(SICI)1097-0142(19960101)77:1<14::AID-CNCR4>3.0.CO;2-N; Fushida Sachio, 2002, Gan To Kagaku Ryoho, V29, P2164; Kim SM, 2005, EXP CELL RES, V308, P18, DOI 10.1016/j.yexcr.2005.04.002; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Le Devedec SE, 2011, METHODS MOL BIOL, V769, P331, DOI 10.1007/978-1-61779-207-6_22; Mohamed F, 2003, EUR J SURG ONCOL, V29, P261, DOI 10.1053/ejso.2002.1397; Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5; Ohashi N, 2005, INT J ONCOL, V27, P637; Stepien A, 2010, ACTA HISTOCHEM, V112, P62, DOI 10.1016/j.acthis.2008.09.002; Tanaka K, 2012, MICROSC RES TECHNIQ, V75, P307, DOI 10.1002/jemt.21059; Zhou HB, 2003, WORLD J GASTROENTERO, V9, P442	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					109	118		10.1007/s10120-013-0334-y		10	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500012		
J	Sawada, T; Yashiro, M; Sentani, K; Oue, N; Yasui, W; Miyazaki, K; Kai, K; Fushida, S; Fujimura, T; Ohira, M; Kakeji, Y; Natsugoe, S; Shirabe, K; Nomura, S; Shimada, Y; Tomita, N; Hirakawa, K; Maehara, Y				Sawada, Tetsuji; Yashiro, Masakazu; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Miyazaki, Kohji; Kai, Keita; Fushida, Sachio; Fujimura, Takashi; Ohira, Masaichi; Kakeji, Yoshihiro; Natsugoe, Shoji; Shirabe, Ken; Nomura, Sachiyo; Shimada, Yutaka; Tomita, Naohiro; Hirakawa, Kosei; Maehara, Yoshihiko			New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee	GASTRIC CANCER			English	Article						Gastric cancer; G-factor; Molecular staging; TNM classification	ENDOTHELIAL GROWTH-FACTOR; COLORECTAL-CANCER; REG-IV; ADJUVANT CHEMOTHERAPY; VEGF EXPRESSION; P53; CARCINOMA; SURVIVAL; SYSTEM; S-1	The G-Project committee was erected by the Japan Society for Gastroenterological Carcinogenesis with an aim of establishing a new classification scheme based on molecular biological characteristics that would supplement the conventional TNM classification to better predict outcome. In a literature search involving 822 articles on gastric cancer, eight molecules including p53, vascular endothelial growth factor (VEGF)-A, VEGF-C, matrix metalloproteinase-7 (MMP-7), human epidermal growth factor receptor 2, Regenerating islet-derived family, member 4, olfactomedin-4 and Claudin-18 were selected as candidates to be included in the new molecular classification scheme named G-factor. A total of 210 cases of gastric cancer who underwent curative R0 resection were registered from four independent facilities. Immunohistochemical staining for the aforementioned molecules was performed for the surgically resected specimens of the 210 cases to investigate the correlation between clinicopathological factors and expression of each molecule. No significant correlation was observed between the immunostaining expression of any of the eight factors and postoperative recurrence. However, the expressions of p53 and MMP-7 were significantly correlated with overall survival (OS). When 210 gastric cancer patients were divided into three groups based on the expression of p53 and MMP-7 (G0 group: negative for both p53 and MMP-7, n = 69, G1 group: positive for either p53 or MMP-7, n = 97, G2 group: positive for both of the molecules, n = 44), G2 group demonstrated significantly higher recurrence rate (59 %) compared to 38 % in G0 (p = 0.047). The multivariate regression analysis revealed that G2 group was independently associated with a shorter disease-free survival (DFS) (hazard ratio 1.904, 95 % CI 1.098-3.303; p = 0.022), although the association with OS was not significant. Stage II patients among the G2 group had significantly inferior prognosis both in terms of OS and DFS when compared with those among the G0/G1 group, with survival curves similar to those of Stage III cases. G-factor based on the expression of p53 and MMP-7 was found to be a promising factor to predict outcome of Stage II/III gastric cancer, and possibly to help select the treatment for Stage II cancer, thus supplementing the conventional TNM system.	[Sawada, Tetsuji; Yashiro, Masakazu; Ohira, Masaichi; Hirakawa, Kosei] Osaka City Univ Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka, Japan; [Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan; [Miyazaki, Kohji] Saga Univ Fac Med, Dept Surg, Saga, Japan; [Kai, Keita] Saga Univ Fac Med, Dept Pathol & Microbiol, Saga, Japan; [Fushida, Sachio; Fujimura, Takashi] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, Kanazawa, Ishikawa, Japan; [Kakeji, Yoshihiro] Kobe Univ, Div Gastrointestinal Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan; [Natsugoe, Shoji] Kagoshima Univ Sch Med, Digest Surg Surg Oncol, Kagoshima, Japan; [Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Nomura, Sachiyo] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan; [Shimada, Yutaka] Toyama Univ, Dept Surg & Sci, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan; [Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Div Lower GI, Nishinomiya, Hyogo, Japan	Sawada, T (reprint author), Osaka City Univ Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	t_sawada@osaka-ekisaikai.jp					Ajisaka H, 2004, HEPATO-GASTROENTEROL, V51, P900; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; Goldstraw P, 2013, J CLIN ONCOL, V31, P984, DOI 10.1200/JCO.2012.42.7922; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018; Ross JS, 2001, CANCER INVEST, V19, P554, DOI 10.1081/CNV-100103852; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Siemer S, 2005, J UROLOGY, V173, P33, DOI 10.1097/01.ju.0000146719.43269.e8; Sanada Y, 2006, J PATHOL, V208, P633, DOI 10.1002/path.1922; Kakeji Y, 2002, J EXP CLIN CANC RES, V21, P125; Tanigawa N, 1997, J CLIN ONCOL, V15, P826; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Resnick MB, 2004, CLIN CANCER RES, V10, P3069, DOI 10.1158/1078-0432.CCR-03-0462; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kologlu M, 2000, AM J SURG, V179, P521, DOI 10.1016/S0002-9610(00)00385-8; Maeda K, 1998, ONCOLOGY-BASEL, V55, P594, DOI 10.1159/000011918; Maehara Y, 1999, BRIT J CANCER, V79, P1255, DOI 10.1038/sj.bjc.6690201; Mejia A, 2012, J SURG ONCOL, V105, P468, DOI 10.1002/jso.21858; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin Leslie H, 2003, Semin Surg Oncol, V21, P19, DOI 10.1002/ssu.10017; White JD, 2002, CANCER RES, V62, P1669; Zhang YJ, 2008, J GASTROEN HEPATOL, V23, P856, DOI 10.1111/j.1440-1746.2007.05140.x	25	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					119	128		10.1007/s10120-014-0338-2		10	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500013		
J	Haga, Y; Ikejiri, K; Wada, Y; Ikenaga, M; Takeuchi, H				Haga, Yoshio; Ikejiri, Koji; Wada, Yasuo; Ikenaga, Masakazu; Takeuchi, Hitoshi			Preliminary study of surgical audit for overall survival following gastric cancer resection	GASTRIC CANCER			English	Article						Stomach; Carcinoma; Surgery; Survival rate; Prediction	QUALITY IMPROVEMENT PROGRAM; PREDICTION SCORING SYSTEM; STRESS E-PASS; PHYSIOLOGICAL ABILITY; SURGERY; MORTALITY; RISK; MORBIDITY; CARCINOMA; OUTCOMES	Previous studies for surgical audit have focused on short-term outcomes, such as perioperative mortality. There has been no gold standard how to evaluate quality of care for long-term outcomes in surgical oncology. This preliminary study aims to propose a method for surgical audit targeting long-term outcome following gastrectomy for gastric cancer. We prospectively investigated a set of variables relating to physiologic conditions, tumor characteristics and operations in patients who underwent gastrectomy for gastric cancer between June 2005 and July 2008 in 18 referral hospitals in Japan. Overall survival (OS) is the endpoint. Cox hazard regression analysis was used to generate a model to predict OS. The calibration and discrimination power of the model were assessed using the Hosmer-Lemeshow (H-L) test and area under the receiver-operating characteristic curve (AUC), respectively. The ratio of observed-to-estimated 5-year OS rates (OE ratio) was defined as a measure of quality. Among 762 patients analyzed, 697 (91 %) completed the 5-year follow-up. The constructed model for OS exhibited a good discrimination power (AUC, 95 % confidence interval 0.89, 0.86-0.91), which was significantly better than that for the UICC stage (0.81, 0.77-0.84). This model also demonstrated a good calibration power (H-L: chi (2) = 27.2, df = 8, P = 0.77). The OE ratios among the participating hospitals revealed no significant variation between 0.74 and 1.1. The current study suggests the possibility of surgical audit for postoperative OS in gastric cancer. Further studies including high-volume centers will be necessary to validate this idea.	[Haga, Yoshio] Natl Hosp Org Kumamoto Med Ctr, Inst Clin Res, Kumamoto 8600008, Japan; [Haga, Yoshio] Kumamoto Univ, Dept Int Med Cooperat, Grad Sch Med Sci, Kumamoto, Japan; [Ikejiri, Koji] NHO Kyushu Med Ctr, Dept Surg, Fukuoka, Japan; [Wada, Yasuo] NHO Himeji Med Ctr, Dept Surg, Himeji, Hyogo, Japan; [Ikenaga, Masakazu] NHO Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Takeuchi, Hitoshi] NHO Iwakuni Clin Ctr, Dept Surg, Iwakuni, Japan	Haga, Y (reprint author), Natl Hosp Org Kumamoto Med Ctr, Inst Clin Res, 1-5 Ninomaru, Kumamoto 8600008, Japan.	epass2006@ybb.ne.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Degiuli M, 2010, BRIT J SURG, V97, P643, DOI 10.1002/bjs.6936; Ott K, 2011, LANGENBECK ARCH SURG, V396, P743, DOI 10.1007/s00423-010-0738-7; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460; Sierra A, 2003, ANN SURG ONCOL, V10, P219, DOI 10.1245/ASO.2003.07.009; Hanna GB, 2012, ARCH SURG-CHICAGO, V147, P738, DOI 10.1001/archsurg.2012.983; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Haga Y, 2011, ANN SURG, V253, P194, DOI 10.1097/SLA.0b013e3181f66199; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Haga Y, 1999, SURG TODAY, V29, P219; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 2008, ANN SURG, V248, P329, DOI 10.1097/SLA.0b013e3181823485; Haga Y, 2004, SURGERY, V135, P586, DOI 10.1016/j.surg.2003.11.012; Association Japanese Gastric Cancer, 1998, GASTRIC CANCER, V1, P10; Bando E, 2002, ANN SURG ONCOL, V9, P775, DOI 10.1245/ASO.2002.10.011; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; Costa MLV, 2006, ANN SURG ONCOL, V13, P843, DOI 10.1245/ASO.2006.05.040; Deng JY, 2010, ANN SURG ONCOL, V17, P1043, DOI 10.1245/s10434-009-0863-0; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/01.SLA.0000027082.79556.55; Haga Y, 2012, J SURG ONCOL, V106, P898, DOI 10.1002/jso.23160; Haga Y, 2002, ARCH SURG-CHICAGO, V137, P481, DOI 10.1001/archsurg.137.4.481; Haga Y, 2012, GASTRIC CANCER, V15, P7, DOI 10.1007/s10120-011-0052-2; Haga Y, 2014, WORLD J SURG, V38, P1177, DOI 10.1007/s00268-013-2383-0; Haga Y, 2011, DIS COLON RECTUM, V54, P1293, DOI 10.1097/DCR.0b013e3182271a54; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Lamb P, 2008, ANN ROY COLL SURG, V90, P235, DOI 10.1308/003588408X261546; Nakamura T, 2010, COX PROPORTIONAL HAZ; Sobin LH, 2009, TNM CLASSIFICATION M	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					138	146		10.1007/s10120-014-0343-5		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500015		
J	Nakada, K; Ikeda, M; Takahashi, M; Kinami, S; Yoshida, M; Uenosono, Y; Kawashima, Y; Oshio, A; Suzukamo, Y; Terashima, M; Kodera, Y				Nakada, Koji; Ikeda, Masami; Takahashi, Masazumi; Kinami, Shinichi; Yoshida, Masashi; Uenosono, Yoshikazu; Kawashima, Yoshiyuki; Oshio, Atsushi; Suzukamo, Yoshimi; Terashima, Masanori; Kodera, Yasuhiro			Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients	GASTRIC CANCER			English	Article						Postgastrectomy syndrome; Questionnaires; Quality of life; Gastrectomy	ROUX-EN-Y; TOTAL GASTRECTOMY; POUCH RECONSTRUCTION; GASTRIC-SURGERY; RATING-SCALE; DISEASE; CANCER; RELIABILITY; CARCINOMA; VALIDITY	Lack of a suitable instrument to comprehensively assess symptoms, living status, and quality of life in postgastrectomy patients prompted the authors to develop postgastrectomy syndrome assessment scale (PGSAS)-45. PGSAS-45 consists of 45 items in total: 8 items from SF-8, 15 items from GSRS, and an additional 22 items selected by 47 gastric surgeons. Using the PGSAS-45, a multi-institutional survey was conducted to determine the prevalence of postgastrectomy syndrome and its impact on everyday life among patients who underwent various types of gastrectomy. Eligible data were obtained from 2,368 patients operated and followed at 52 institutions in Japan. Of these, data from 1,777 patients were used in the current study in which symptom subscales of the PGSAS-45 were determined. We also considered the characteristics of the postgastrectomy syndrome and to what extent these symptoms influence patients' living status and quality of life (QOL). By factor analysis, 23 symptom-related items of PGSAS-45 were successfully clustered into seven symptom subscales that represent esophageal reflux, abdominal pain, meal-related distress, indigestion, diarrhea, constipation, and dumping. These seven symptom subscales and two other subscales measuring quality of ingestion and dissatisfaction for daily life, respectively, had good internal consistency in terms of Cronbach's alpha (0.65-0.88). PGSAS-45 provides a valid and reliable integrated index for evaluation of symptoms, living status, and QOL in gastrectomized patients.	[Nakada, Koji] Jikei Univ Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan; [Ikeda, Masami] Asama Gen Hosp, Dept Surg, Saku, Japan; [Takahashi, Masazumi] Yokohama Municipal Citizens Hosp, Div Gastroenterol Surg, Yokohama, Kanagawa, Japan; [Kinami, Shinichi] Kanazawa Med Sch, Dept Surg Oncol, Kanazawa, Ishikawa, Japan; [Yoshida, Masashi] Int Univ Hlth & Welf, Mita Hosp, Surg & Digest Dis Ctr, Tokyo, Japan; [Uenosono, Yoshikazu] Kagoshima Univ Grad Sch Med, Dept Digest Surg, Kagoshima, Japan; [Kawashima, Yoshiyuki] Saitama Canc Ctr, Div Gastroenterol Surg, Saitama, Japan; [Oshio, Atsushi] Waseda Univ, Fac Letters Arts & Sci, Tokyo, Japan; [Suzukamo, Yoshimi] Tohoku Univ Grad Sch Med, Dept Phys Med & Rehabil, Sendai, Miyagi, Japan; [Terashima, Masanori] Shizuoka Canc Ctr, Div Gastr Surg, Shizuoka, Japan; [Kodera, Yasuhiro] Nagoya Univ Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi, Japan	Nakada, K (reprint author), Jikei Univ Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan.	nakada@jikei.ac.jp		Oshio, Atsushi/0000-0002-2936-2916	Jikei University; Japanese Society for Gastro-surgical Pathophysiology	This study was supported by a grant from Jikei University and the Japanese Society for Gastro-surgical Pathophysiology. This study was conducted by JPGSWP and registered to UMIN-CTR #000002116 entitled as "A study to observe correlation between resection and reconstruction procedures employed for gastric neoplasms and development of postgastrectomy syndrome." The results of this study were presented at Digestive Disease Week 2013, Orland, FL, USA [30]. The authors thank all the physicians who participated in this study and the patients whose cooperation made this study possible.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Kono K, 2003, AM J SURG, V185, P150, DOI 10.1016/S0002-9610(02)01211-4; Borgaonkar MR, 2000, GUT, V47, P444, DOI 10.1136/gut.47.3.444; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Karanicolas PJ, 2011, J GASTROINTEST SURG, V15, P682, DOI 10.1007/s11605-011-1421-1; Nunobe S, 2007, INT J CLIN ONCOL, V12, P433, DOI 10.1007/s10147-007-0706-6; Svedlund J, 1997, WORLD J SURG, V21, P422; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003; Huang CC, 2007, DIGEST SURG, V24, P59, DOI 10.1159/000100920; Vickery CW, 2001, EUR J CANCER, V37, P966, DOI 10.1016/S0959-8049(00)00417-2; Kobayashi D, 2011, WORLD J SURG, V35, P357, DOI 10.1007/s00268-010-0860-2; Lehnert T, 2004, BRIT J SURG, V91, P528, DOI 10.1002/bjs.4512; Namikawa T, 2010, WORLD J SURG, V34, P1022, DOI 10.1007/s00268-010-0452-1; Nakamura M, 2005, SURG TODAY, V35, P535, DOI 10.1007/s00595-005-2988-5; Lee MS, 2012, SURG ENDOSC, V26, P1539, DOI 10.1007/s00464-011-2064-8; EAGON JC, 1992, SURG CLIN N AM, V72, P445; Bolton JS, 2011, SURG CLIN N AM, V91, P1105, DOI 10.1016/j.suc.2011.07.001; CARVAJAL SH, 1994, GASTROENTEROL CLIN N, V23, P261; Cooperman A M, 1981, Surg Annu, V13, P139; Endo S, 2006, SURGERY, V139, P493, DOI 10.1016/j.surg.2005.08.013; HARJU E, 1990, INT SURG, V75, P27; Hayami M, 2012, WORLD J SURG, V36, P373, DOI 10.1007/s00268-011-1379-x; JAY BS, 1977, GASTROINTEST RADIOL, V2, P239, DOI 10.1007/BF02256501; Katai Hitoshi, 2006, Int J Clin Oncol, V11, P357, DOI 10.1007/s10147-006-0613-2; Maruyama K, 2006, GASTRIC CANCER, V9, P51, DOI DOI 10.1007/S10120-006-0370-Y; Moyer CA, 1998, DIGEST DIS, V16, P315, DOI 10.1159/000016881; Nakada K, 2013, GASTROENTEROLOGY S1, V144, pS; Nakane Y, 2001, HEPATO-GASTROENTEROL, V48, P903; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Takiguchi S, 2012, GASTRIC CANCER, V15, P198, DOI 10.1007/s10120-011-0098-1	30	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					147	158		10.1007/s10120-014-0344-4		12	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500016		
J	Kumagai, K; Hiki, N; Nunobe, S; Sekikawa, S; Chiba, T; Kiyokawa, T; Jiang, XH; Tanimura, S; Sano, T; Yamaguchi, T				Kumagai, Koshi; Hiki, Naoki; Nunobe, Souya; Sekikawa, Sayuri; Chiba, Takehiro; Kiyokawa, Takashi; Jiang, Xiaohua; Tanimura, Shinya; Sano, Takeshi; Yamaguchi, Toshiharu			Totally laparoscopic pylorus-preserving gastrectomy for early gastric cancer in the middle stomach: technical report and surgical outcomes	GASTRIC CANCER			English	Article						Laparoscopic surgery; Gastrectomy; Pylorus; Postoperative complications	DISTAL GASTRECTOMY; LYMPHADENECTOMY; PRESERVATION; ANASTOMOSIS	The feasibility, safety, and improved quality of postoperative life following laparoscopy-assisted pylorus-preserving gastrectomy (LAPPG) with a hand-sewn anastomosis via a mini-laparotomy for early gastric cancer (EGC) have been previously established. Here we describe the surgical procedure of totally laparoscopic pylorus-preserving gastrectomy (TLPPG) using an intracorporeal delta-shaped anastomosis technique, and the short-term surgical outcomes of 60 patients with EGC in the middle stomach are reported. After lymphadenectomy and mobilization of the stomach, intraoperative gastroscopy was performed in order to verify the location of the tumor, and then the distal and proximal transecting lines were established, 5 cm from the pyloric ring and just proximal to Demel's line, respectively. Following transection of the stomach, a delta-shaped intracorporeal gastrogastrostomy was made with linear staplers. There were no intraoperative complications or conversions to open surgery. Mean operation time and blood loss were 259 min and 28 mL, respectively. Twelve patients (20.0 %) experienced postoperative complications classified as grade II using the Clavien-Dindo classification, with the most frequent complication being gastric stasis (6 cases, 10.0 %). The incidence of severe complications classified as grade III or above was 1.7 %; only one patient required reoperation and intensive care due to postoperative intraabdominal bleeding and subsequent multiple organ failure. TLPPG with an intracorporeal delta-shaped anastomosis was found to be a safe procedure, although it tended to require a longer operating time than the well-established LAPPG with a hand-sewn gastrogastrostomy.	[Kumagai, Koshi; Hiki, Naoki; Nunobe, Souya; Sekikawa, Sayuri; Chiba, Takehiro; Kiyokawa, Takashi; Jiang, Xiaohua; Tanimura, Shinya; Sano, Takeshi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan; [Jiang, Xiaohua] Southeast Univ, Zhongda Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Hiki, N (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	naoki.hiki@jfcr.or.jp					Kunisaki C, 2006, ANN SURG ONCOL, V13, P221, DOI 10.1245/ASO.2006.04.028; Kim JJ, 2008, SURG ENDOSC, V22, P436, DOI 10.1007/s00464-007-9446-y; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; [Anonymous], 2011, GASTRIC CANC, V14, P101; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Jiang XH, 2011, SURG ENDOSC, V25, P1182, DOI 10.1007/s00464-010-1336-z; Song KY, 2008, J GASTROINTEST SURG, V12, P1015, DOI 10.1007/s11605-008-0484-0; Jiang XH, 2011, ANN SURG, V253, P928, DOI 10.1097/SLA.0b013e3182117b24; Hiki N, 2005, LANGENBECK ARCH SURG, V390, P442, DOI 10.1007/s00423-005-0573-4; Horiuchi T, 2001, SURG ENDOSC-ULTRAS, V15, P325, DOI 10.1007/s004640000341; Imada T, 1998, SURGERY, V123, P165, DOI 10.1016/S0039-6060(98)70254-5; Lee SW, 2010, SURG ENDOSC, V24, P1774, DOI 10.1007/s00464-009-0803-x; Nakane Y, 2002, BRIT J SURG, V89, P220, DOI 10.1046/j.0007-1323.2001.01984.x; Nishikawa K, 2002, SURGERY, V131, P613, DOI 10.1067/msy.2002.124630; Shimoyama S, 2003, ARCH SURG-CHICAGO, V138, P1235, DOI 10.1001/archsurg.138.11.1235; Shinohara H, 2002, EUR J SURG, V168, P55, DOI 10.1080/110241502317307580; Urushihara T, 2004, SURG ENDOSC, V18, P964, DOI 10.1007/s00464-003-8192-z; Uyama I, 1999, GASTRIC CANCER, V2, P186, DOI 10.1007/s101200050044; Uyama I, 1999, SURG LAPARO ENDO PER, V9, P418, DOI 10.1097/00019509-199912000-00010; Zhang DL, 1998, ARCH SURG-CHICAGO, V133, P993, DOI 10.1001/archsurg.133.9.993	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					183	187		10.1007/s10120-014-0337-3		5	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500021		
J	Abe, S; Oda, I; Nakajima, T; Suzuki, H; Nonaka, S; Yoshinaga, S; Sekine, S; Taniguchi, H; Kushima, R; Iwasa, S; Saito, Y; Katai, H				Abe, Seiichiro; Oda, Ichiro; Nakajima, Takeshi; Suzuki, Haruhisa; Nonaka, Satoru; Yoshinaga, Shigetaka; Sekine, Shigeki; Taniguchi, Hirokazu; Kushima, Ryoji; Iwasa, Satoru; Saito, Yutaka; Katai, Hitoshi			A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer	GASTRIC CANCER			English	Article						Early gastric cancer; Endoscopic submucosal dissection; Expanded criteria; Local recurrence; Distant metastasis	LYMPH-NODE METASTASIS; RESECTION; OUTCOMES; FEASIBILITY; CRITERIA; TRIAL	Currently in Japan, differentiated-type gastric submucosal invasive cancers < 500 mu m with negative lymphovascular involvement are included in expanded pathological criteria for curative endoscopic treatment. This categorization is based on a retrospective examination of surgical resection cases in which patients suitable for such expanded criteria were determined to have a negligible risk of lymph node metastasis. We performed endoscopic submucosal dissection on a 66-year-old man with early gastric cancer in June 2004, and pathology revealed a well-differentiated adenocarcinoma, 16 x 8 mm in size, minute submucosal invasion depth (100 mu m), and negative lymphovascular invasion or ulceration as well as tumor-free margins, so the case was diagnosed as a curative resection. In this case, however, local recurrence and distant metastasis resulted in August 2011. The patient received systemic chemotherapy but died of gastric cancer 23 months after recurrence.	[Abe, Seiichiro; Oda, Ichiro; Nakajima, Takeshi; Suzuki, Haruhisa; Nonaka, Satoru; Yoshinaga, Shigetaka; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Chuo Ku, Tokyo 1040045, Japan; [Sekine, Shigeki; Taniguchi, Hirokazu; Kushima, Ryoji] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Iwasa, Satoru] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	Abe, S (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	seabe@ncc.go.jp					Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Toyonaga T, 2013, SURG ENDOSC, V27, P1000, DOI 10.1007/s00464-012-2555-2; Ahn JY, 2011, GASTROINTEST ENDOSC, V74, P485, DOI 10.1016/j.gie.2011.04.038; Takizawa K, 2013, JPN J CLIN ONCOL, V43, P87, DOI 10.1093/jjco/hys189; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Kosaka T, 2014, DIGEST ENDOSC, V26, P183, DOI 10.1111/den.12099; Oda I, 2012, GASTRIC CANCER, V15, P451, DOI 10.1007/s10120-012-0159-0; Kurokawa Y, 2009, JPN J CLIN ONCOL, V39, P464, DOI 10.1093/jjco/hyp041; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Goto O, 2009, ENDOSCOPY, V41, P118, DOI 10.1055/s-0028-1119452; Abe S, 2013, ENDOSCOPY, V45, P703, DOI 10.1055/s-0033-1344396; Choi Ji Yoon, 2011, J Gastric Cancer, V11, P46, DOI 10.5230/jgc.2011.11.1.46; Feng XY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0514-y; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Oda I, 2013, DIGEST ENDOSC, DOI [10.1111/den.12141, DOI 10.1111/DEN.1214]; Oya H, 2012, GASTRIC CANCER, V15, P221, DOI 10.1007/s10120-011-0111-8; Sasaki A, 2003, SCAND J GASTROENTERO, V38, P153; Tanabe S, 2013, GASTRIC CANC	20	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	JAN	2015	18	1					188	192		10.1007/s10120-014-0341-7		5	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	AW0GF	WOS:000345968500022		
J	Kato, N; Iwase, A; Sugita, A; Goto, M; Nakahara, T; Nakamura, T; Kondo, M; Osuka, S; Mori, M; Saito, A; Kikkawa, F				Kato, Nao; Iwase, Akira; Sugita, Atsuko; Goto, Maki; Nakahara, Tatsuo; Nakamura, Tomoko; Kondo, Mika; Osuka, Satoko; Mori, Masahiko; Saito, Ai; Kikkawa, Fumitaka			Anti-Mullerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study	GYNECOLOGICAL ENDOCRINOLOGY			English	Article						Anti-Mullerian hormone; fecundability; infertility treatment; long-term fertility; ovarian reserve	FOLLICLE-STIMULATING-HORMONE; ANTIMULLERIAN HORMONE; OVARIAN RESERVE; LIVE-BIRTH; INHIBIN-B; FOLLOW-UP; MARKER; CHEMOTHERAPY; DEFINITION; MECHANISMS	Anti-Mullerian hormone (AMH) is a relatively novel method for examining the ovarian reserve that reflects female reproductive function. In the era in which the number of women delaying attempts to conceive has increased, a good predictor for long-term fecundability has been explored. We performed the retrospective cohort study to investigate whether initial serum AMH levels are useful for predicting long-term fertility during infertility treatments. We recruited 149 women in the retrospective cohort, and 52 women were gravid during the follow-up period. According to the multiple logistic analyses, only age was found to have a significant correlation with pregnancy success in all women. In women >= 38 years, significantly higher serum AMH levels were detected in the pregnant group (median = 2.83 ng/mL, range = 1.11-6.29 ng/mL) than the non-pregnant group (median = 1.22 ng/mL, range = 0-9.46 ng/mL; p = 0.015). None of the women with serum AMH levels <0.7 ng/mL were pregnant during treatment. AMH may be used to identify poor pregnancy prospects in women who are above 38 years.	[Kato, Nao; Iwase, Akira; Sugita, Atsuko; Goto, Maki; Nakahara, Tatsuo; Nakamura, Tomoko; Kondo, Mika; Osuka, Satoko; Mori, Masahiko; Saito, Ai; Kikkawa, Fumitaka] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Iwase, Akira] Nagoya Univ Hosp, Dept Maternal & Perinatal Med, Nagoya, Aichi, Japan	Iwase, A (reprint author), Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akiwase@med.nagoya-u.ac.jp					Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; La Marca A, 2011, REPROD BIOMED ONLINE, V22, P341, DOI 10.1016/j.rbmo.2010.11.005; Steiner AZ, 2011, OBSTET GYNECOL, V117, P798, DOI 10.1097/AOG.0b013e3182116bc8; Bancsi LFJMM, 2003, FERTIL STERIL, V79, P1091, DOI 10.1016/S0015-0282(03)00078-5; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Brodin T, 2013, J CLIN ENDOCR METAB, V98, P1107, DOI 10.1210/jc.2012-3676; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Iwase A, 2010, FERTIL STERIL, V94, P2846, DOI 10.1016/j.fertnstert.2010.06.010; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Hagen CP, 2012, FERTIL STERIL, V98, P1602, DOI 10.1016/j.fertnstert.2012.08.008; Pigny P, 2006, J CLIN ENDOCR METAB, V91, P941, DOI 10.1210/jc.2005-2076; Sugita A, 2013, FERTIL STERIL, V100, P516, DOI 10.1016/j.fertnstert.2013.03.032; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Hirokawa W, 2011, HUM REPROD, V26, P904, DOI 10.1093/humrep/der006; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Baird DD, 2012, AM J EPIDEMIOL, V175, P245, DOI 10.1093/aje/kwr439; Fong SL, 2008, HUM REPROD, V23, P674, DOI 10.1093/humrep/dem392; Iwase A, 2013, EUR J OBSTET GYN R B, V167, P194, DOI 10.1016/j.ejogrb.2012.11.021; Li L, 2010, WIEN KLIN WOCHENSCHR, V122, P519, DOI 10.1007/s00508-010-1426-x; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; Murto T, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-61; te Velde Egbert R., 2002, Human Reproduction Update, V8, P141, DOI 10.1093/humupd/8.2.141; Wu CH, 2009, J ASSIST REPROD GEN, V26, P383, DOI 10.1007/s10815-009-9332-8; Yarde F, 2013, FERTIL STERIL, V100, P831, DOI 10.1016/j.fertnstert.2013.05.009	27	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0951-3590	1473-0766		GYNECOL ENDOCRINOL	Gynecol. Endocrinol.	JAN	2015	31	1					22	25		10.3109/09513590.2014.943720		4	Endocrinology & Metabolism; Obstetrics & Gynecology	Endocrinology & Metabolism; Obstetrics & Gynecology	AW3GI	WOS:000346174000005		
J	Ito-Yamaguchi, A; Suganuma, R; Kumagami, A; Hashimoto, S; Yoshida-Komiya, H; Fujimori, K				Ito-Yamaguchi, Akiko; Suganuma, Ryota; Kumagami, Atsuko; Hashimoto, Shigeatsu; Yoshida-Komiya, Hiromi; Fujimori, Keiya			Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome	GYNECOLOGICAL ENDOCRINOLOGY			English	Article						AR; endometrium; insulin resistance; metformin; PCOS	STEROID-RECEPTORS; WOMEN; COREGULATORS; HYPERPLASIA; PREGNANCY; PCOS	Objective: To evaluate effects of metformin on endocrine, metabolic parameters and endometrial androgen receptor (AR) expression in polycystic ovary syndrome (PCOS). Design: Prospective observational study. Methods: We analyzed blood samples from 10 PCOS patients, of whom endometrium was also analyzed in five patients. Before and after three months of metformin treatment, endocrine, glucose metabolic parameters and the endometrial AR expressions were assessed. The relative expression levels of AR were examined by immunohistochemistry. Main outcome measures: The group post-treatment mean of homeostasis model assessment insulin resistance (HOMA-IR) for all patients was significantly lower than the pretreatment. Ovulation was restored in five out of 10 patients. The group post-treatment means of luteinizing hormone (LH) and HOMA-IR for the five ovulatory patients were significantly lower. The relative expression levels of endometrial AR were decreased in four out of the five patients as compared with pretreatment. In the four patients, one or more of the parameters, HOMA-IR, LH or free testosterone, decreased compared with pretreatment. Conclusion: Metformin was effective in decreasing HOMA-IR, LH, free testosterone and the relative expression levels of AR. Furthermore, metformin might improve the systemic and local environment of the uterus caused by hyperandrogenemia in PCOS patients with insulin resistance.	[Ito-Yamaguchi, Akiko; Suganuma, Ryota; Kumagami, Atsuko; Yoshida-Komiya, Hiromi; Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Ito-Yamaguchi, Akiko] Ohta Nishinouchi Hosp, Fukushima, Japan; [Kumagami, Atsuko] Meirikai Cent Gen Hosp, Tokyo, Japan; [Hashimoto, Shigeatsu] Fukushima Med Univ, Dept Diabetol Endocrinol & Metab, Fukushima, Japan	Ito-Yamaguchi, A (reprint author), Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan.	may_child_3747@ybb.ne.jp			Japan Society for the Promotion of Science [20791155]	The authors report no declarations of interest. This work was supported by Grant-in-Aid for Young Scientists in Japan Society for the Promotion of Science (no. 20791155).	MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Ortega-Gonzalez C, 2005, J CLIN ENDOCR METAB, V90, P1360, DOI 10.1210/jc.2004-1965; NOYES RW, 1950, FERTIL STERIL, V1, P3; Palomba S, 2010, HUM REPROD, V25, P1005, DOI 10.1093/humrep/dep466; Villavicencio A, 2006, GYNECOL ONCOL, V103, P307, DOI 10.1016/j.ygyno.2006.03.029; Moghetti P, 2000, J CLIN ENDOCR METAB, V85, P139, DOI 10.1210/jc.85.1.139; Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005; ADAMS J, 1986, BRIT MED J, V293, P355; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; Glueck CJ, 2001, FERTIL STERIL, V75, P46, DOI 10.1016/S0015-0282(00)01666-6; Palomba S, 2009, ENDOCR REV, V30, P1, DOI 10.1210/er.2008-0030; Quezada S, 2006, FERTIL STERIL, V85, P1017, DOI 10.1016/j.fertnstert.2005.09.053; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Zhang L, 2010, FERTIL STERIL, V93, P2295, DOI 10.1016/j.fertnstert.2009.01.096; Apparao KBC, 2002, BIOL REPROD, V66, P297, DOI 10.1095/biolreprod66.2.297; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Maliqueo M, 2003, FERTIL STERIL, V80, P812, DOI 10.1016/S0015-0282(03)00978-7; Balen A, 2001, HUM REPROD UPDATE, V7, P522, DOI 10.1093/humupd/7.6.522; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Jakubowicz DJ, 2001, J CLIN ENDOCR METAB, V86, P1126, DOI 10.1210/jc.86.3.1126; Legro RS, 2007, AM J OBSTET GYNECOL, V196; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; Palomba S, 2006, HUM REPROD, V21, P457, DOI 10.1093/humrep/dei351; Shen ZQ, 2008, OBSTET GYNECOL, V112, P465, DOI 10.1097/AOG.0b013e3181719b92; Yanai H, 2004, STATCEL USEFULL ADD; Zawadzki JK, 1992, POLYCYSTIC OVARY SYN, P337	26	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0951-3590	1473-0766		GYNECOL ENDOCRINOL	Gynecol. Endocrinol.	JAN	2015	31	1					44	47		10.3109/09513590.2014.951321		4	Endocrinology & Metabolism; Obstetrics & Gynecology	Endocrinology & Metabolism; Obstetrics & Gynecology	AW3GI	WOS:000346174000010		
J	Akimoto, K				Akimoto, Kazuhiro			ANNUAL AND WEEKLY CYCLES OF RADIOACTIVITY CONCENTRATION OBSERVED IN FUKUSHIMA CITY	HEALTH PHYSICS			English	Article						cesium; environmental transport; fallout; radioactivity; airborne	CHERNOBYL; RADIONUCLIDES; RESUSPENSION; ACCIDENT; FALLOUT; PLANT; ZONE	Weekly cycles in the radioactivity concentration of radiocesium measured in Fukushima City, Japan, are found embedded in an annual cycle of the same. The radioactivity concentration and fallout of radiocesium measured in Fukushima City during the period from June 2011 until July 2013 are analyzed to evaluate mainly their time dependences. Although on average the two quantities decrease at paces much faster than those of local dose rates, both of them show annual cycles, peaking during winter and spring and bottoming otherwise. These annual cycles, which are somewhat out of phase compared to those in Europe, are formed due to weathering. However, the local radioactivity concentration shows weekly cycles also, increasing on weekdays and decreasing at weekends. The causes of these weekly cycles are presumably vehicular traffic and precipitation. Therefore, both human and natural activities are playing important roles at different timescales on atmospheric migration of radiocesium deposited in Fukushima City.	Teikyo Univ, Sch Sci & Engn, Utsunomiya, Tochigi 3208551, Japan	Akimoto, K (reprint author), Teikyo Univ, Sch Sci & Engn, Utsunomiya, Tochigi 3208551, Japan.	akimoto@ees.teikyo-u.ac.jp					Aarkrog A, 1988, R549 RIS NAT LAB; Akimoto Kazuhiro, 2012, Radioisotopes, V61, P373, DOI 10.3769/radioisotopes.61.373; Akimoto K, 2013, J SOC REMEDIATION RA, V1, P15; Bondarkov MD, 2011, HEALTH PHYS, V101, P442, DOI 10.1097/HP.0b013e318229df28; Cerveny RS, 1998, NATURE, V394, P561, DOI 10.1038/29043; Faybishenko B, 2004, DOE NRC EPA USGS WOR; GARGER EK, 1994, J AEROSOL SCI, V25, P745, DOI 10.1016/0021-8502(94)90041-8; Garger EK, 1996, HEALTH PHYS, V70, P18, DOI 10.1097/00004032-199601000-00004; GARGER EK, 1992, ATOM ENERGY+, V72, P510, DOI 10.1007/BF00760908; GARLAND JA, 1994, J AEROSOL SCI, V25, P793, DOI 10.1016/0021-8502(94)90047-7; IAEA, 2012, FUK DAIICH STAT REP; van der A R. J., 2008, J GEOPHYS RES, V113, DOI [10.1029/2007jd009021, DOI 10.1029/2007JD009021]	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	JAN	2015	108	1					32	38		10.1097/HP.0000000000000172		7	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW1SR	WOS:000346070700004		
J	Tsubokura, M; Kato, S; Nomura, S; Morita, T; Sugimoto, A; Gilmour, S; Kami, M; Oikawa, T; Kanazawa, Y				Tsubokura, Masaharu; Kato, Shigeaki; Nomura, Shuhei; Morita, Tomohiro; Sugimoto, Amina; Gilmour, Stuart; Kami, Masahiro; Oikawa, Tomoyoshi; Kanazawa, Yukio			ABSENCE OF INTERNAL RADIATION CONTAMINATION BY RADIOACTIVE CESIUM AMONG CHILDREN AFFECTED BY THE FUKUSHIMA DAIICHI NUCLEAR POWER PLANT DISASTER	HEALTH PHYSICS			English	Article						Cs-134; Cs-137; contamination; internal; health effects	CHERNOBYL ACCIDENT; EXPOSURE; CS-137; RADIOCESIUM; INGESTION; UKRAINE; ADULTS; OBLAST; JAPAN; FOOD	Chronic internal radiation contamination accounts for a substantial fraction of long-term cumulative radiation exposure among residents in radiation-contaminated areas. However, little information is available on ongoing chronic internal radiation contamination among residents near the crippled Fukushima Daiichi nuclear power plant. Using a whole body counter, internal radiation contamination levels among elementary and middle school students who commute to 22 schools located within Minamisoma city were assessed between May and July 2013 (26 to 28 mo after the disaster). Of 3,299 elementary and middle school students in the city, 3,255 individuals (98%) were screened through school health check-ups. Not a single student was detected with internal radiation contamination due to radioactive cesium. The study found no risk of chronic internal radiation exposure among residents near the crippled nuclear power plant. Current food inspection by local governments, volunteers, and farmers has been functioning well within Fukushima prefecture. However, food management by screening suspected contamination along with whole body counter screening are key public health interventions and should be continued to avoid further internal radiation exposure in radiation-contaminated areas.	[Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo 1088639, Japan; [Tsubokura, Masaharu; Morita, Tomohiro; Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Minamisoma, Japan; [Tsubokura, Masaharu; Kato, Shigeaki] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Sugimoto, Amina] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Fac Publ Hlth & Policy, London WC1, England; [Gilmour, Stuart] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan	Tsubokura, M (reprint author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tsubokura-tky@umin.ac.jp					Bromet EJ, 2007, HEALTH PHYS, V93, P516; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Ruhm W, 1999, HEALTH PHYS, V77, P373; Takatsuji T, 2000, HEALTH PHYS, V78, P86, DOI 10.1097/00004032-200001000-00014; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Likhtarev IA, 2000, HEALTH PHYS, V79, P341, DOI 10.1097/00004032-200010000-00002; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Tonnessen A, 2002, J TRAUMA STRESS, V15, P453, DOI 10.1023/A:1020961604434; Aoki M, 2013, JAPAN TIMES; Balonov MI, 2007, RADIAT PROT DOSIM, V127, P491, DOI 10.1093/rpd/ncm301; Harasawa K, 2012, LANCET, V379, P2240, DOI 10.1016/S0140-6736(12)60978-7; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; International Commission on Radiological Protection, 1992, ANN ICRP, V67; McCurry J, 2011, LANCET, V378, P1061; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Normile D, 2013, SCIENCE, V340, P678, DOI 10.1126/science.340.6133.678; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Taira Y, 2012, RADIAT PROT DOSIM, V151, P537, DOI 10.1093/rpd/ncs040; Taira Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045816; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267	26	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	JAN	2015	108	1					39	43		10.1097/HP.0000000000000167		5	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW1SR	WOS:000346070700005		
J	Kamei, O; Ojima, M; Yoshitake, T; Ono, K; Nishijima, K; Kai, M				Kamei, Osamu; Ojima, Mitsuaki; Yoshitake, Takayasu; Ono, Koji; Nishijima, Kohjiro; Kai, Michiaki			CALCULATING PATIENT-SPECIFIC ORGAN DOSES FROM ADULT BODY CT SCANS BY MONTE CARLO ANALYSIS USING MALE-INDIVIDUAL VOXEL PHANTOMS	HEALTH PHYSICS			English	Article						computed tomography; dose; absorbed; medical radiation; phantom	COMPUTATIONAL DOSIMETRY SYSTEM; ANTHROPOMORPHIC PHANTOMS; SIZE; SIMULATIONS; MODELS	Computed tomography (CT) dose calculators such as the WAZA-ARI are useful for estimating the radiation dose from CT examination. This study determined correction coefficients for estimating organ doses to patients of any size attended to in daily clinical practice. To this end, the authors constructed voxel phantoms based on the CT images of patients of different size and simulated radiation transport in CT examinations to obtain organ doses using Monte Carlo simulation. The results show that the linear relationship between effective diameter and organ dose can predict patient-specific organ doses. The effective diameter-based prediction can provide accuracy within an error of +/- 10%, whereas an error of >20% was observed only in the liver and bladder. These results may contribute to practical irradiation dose calculation from a CT examination depending on individual patient size within a certain degree of accuracy.	[Kamei, Osamu] Oita Univ Nursing & Hlth Sci, Grad Sch, Oita 8701201, Japan; [Nishijima, Kohjiro] Oita Univ Nursing & Hlth Sci, Dept Hlth Sci, Oita 8701201, Japan; [Ojima, Mitsuaki] Shin Beppu Hosp, Beppu, Oita 8740833, Japan; [Ono, Koji] Tokyo Healthcare Univ, Meguro Ku, Tokyo 1528558, Japan; [Yoshitake, Takayasu] Oia Prefectural Hosp, Oita 870851, Japan	Kai, M (reprint author), Oita Univ Nursing & Hlth Sci, Grad Sch, Dept Hlth Sci, 2944-9 Megusuno, Oita 8701201, Japan.	kai@oita-nhs.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [23591825]	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23591825.	Petoussi-Henss N, 2002, PHYS MED BIOL, V47, P89, DOI 10.1088/0031-9155/47/1/307; DeMarco JJ, 2005, PHYS MED BIOL, V50, P3989, DOI 10.1088/0031-9155/50/17/005; Turner AC, 2009, MED PHYS, V36, P2154, DOI 10.1118/1.3117683; Fujii K, 2009, BRIT J RADIOL, V82, P1010, DOI 10.1259/bjr/13320880; Iwase H, 2002, J NUCL SCI TECHNOL, V39, P1142, DOI 10.3327/jnst.39.1142; [Anonymous], 2011, 204 AAPM; Stamm G, 2002, ROFO-FORTSCHR RONTG, V174, P1570, DOI 10.1055/s-2002-35937; Turner AC, 2011, MED PHYS, V38, P820, DOI 10.1118/1.3533897; DeMarco JJ, 2007, PHYS MED BIOL, V52, P2583, DOI 10.1088/0031-9155/52/9/017; Ban N, 2011, RADIAT PROT DOSIM, V146, P244, DOI 10.1093/rpd/ncr161; Cranley K, 1997, 78 IPEM; DeMarco JJ, 1998, MED PHYS, V25, P1, DOI 10.1118/1.598167; International Commission on Radiological Protection, 2007, ANN ICRP, V103, P37; Jones DG, 1991, NRPBR250; Ogden K, 2004, HEALTH PHYS, V86, P397, DOI 10.1097/00004032-200404000-00009; Ono K, 2011, HEALTH PHYS, V100, P491, DOI 10.1097/HP.0b013e3181f497ef; Sato K, 2007, RADIAT PROT DOSIM, V123, P337, DOI 10.1093/rpd/ncl101; Takahashi F, 2011, RADIAT PROT DOSIM, V146, P241, DOI 10.1093/rpd/ncr160; Takahashi F, 2011, PROGR NUC SCI TECH, V2, P153; Takahashi F, 2011, PROG NUCL SCI TECHNO, V1, P517	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	JAN	2015	108	1					44	52		10.1097/HP.0000000000000170		9	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW1SR	WOS:000346070700006		
J	Liu, HR; Guo, J; Wei, SL; Lv, SY; Feng, W; Cui, J; Hasegawa, T; Hongo, H; Yang, Y; Li, XZ; Oda, K; Amizuka, N; Li, MQ				Liu, Hongrui; Guo, Jie; Wei, Shanliang; Lv, Shengyu; Feng, Wei; Cui, Jian; Hasegawa, Tomoka; Hongo, Hiromi; Yang, Yang; Li, Xiangzhi; Oda, Kimimitsu; Amizuka, Norio; Li, Minqi			Expression of matrix Gla protein and osteocalcin in the developing tibial epiphysis of mice	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Matrix Gla protein; Osteocalcin; Epiphysis; Articular cartilage; Develop	GAMMA-CARBOXYGLUTAMIC ACID; VASCULAR CALCIFICATION; EXTRACELLULAR-MATRIX; TISSUE DISTRIBUTION; GENE-EXPRESSION; MESSENGER-RNA; SPARUS-AURATA; IN-VITRO; BONE; CELL	This study aimed to investigate the expression of matrix Gla protein (MGP) and osteocalcin (OCN) in the tibial epiphysis of developing mice. At 1, 2, 3, and 4 weeks after birth, tibiae were removed and processed for histochemical observations and western blot analyses under anesthesia. To evaluate bone volume, the specimens were scanned with Micro CT Scanner from the articular cartilage through the growth plate, along the long axis of tibia. At 1 week after birth, OCN reactivity was faint in the region of vascular invasion, while hardly any MGP reactivity was discernible. Subsequently, MGP reactivity was seen on the cartilaginous lacunar walls of hypertrophic chondrocytes, while OCN reactivity was evenly found not only in the bone matrix, but also in the cartilaginous lacunar walls and on the bone surfaces. Furthermore, double-immunostaining clearly showed that MGP reactivity appeared closer to the cartilage matrix than OCN reactivity until postnatal week 3. Interestingly, the immunoreactivities for MGP and OCN both showed tidemarks in the articular cartilage at postnatal week 4, and MGP reactivity was more intense than OCN reactivity. Statistical analyses showed an overall upward trend in MGP and OCN expression levels during tibial epiphysis development, even though OCN was more abundant than MGP at every time-point. Taken together, our findings suggest that the expression of MGP and OCN increased gradually in the murine developing tibial epiphysis, and the two mineral-associated proteins may occur at the same location during a particular period, but at different levels.	[Liu, Hongrui; Guo, Jie; Lv, Shengyu; Feng, Wei; Cui, Jian; Li, Minqi] Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Jinan 250012, Peoples R China; [Wei, Shanliang] Guangxi Med Univ, Coll Stomatol, Dept Oral & Maxillofacial Surg, Nanning, Peoples R China; [Hasegawa, Tomoka; Hongo, Hiromi; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan; [Yang, Yang; Li, Xiangzhi] Shandong Univ, Sch Med, Dept Cell Biol, Jinan 250012, Peoples R China; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata, Japan	Li, MQ (reprint author), Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Wenhua West Rd 44-1, Jinan 250012, Peoples R China.	liminqi@sdu.edu.cn			National Nature Science Foundation of China [81271965, 81311140173]; Specialized Research Fund for the Doctoral Program of Higher Education [20120131110073]	This study was partially supported by the National Nature Science Foundation of China (grant No. 81271965; 81311140173) and Specialized Research Fund for the Doctoral Program of Higher Education (grant No. 20120131110073) to Li M. The Ministry of Education, Culture, Sports, Science & Technology and Japanese Society for the Promotion of Science to Amizuka N.	Amizuka N, 2009, J ELECTRON MICROSC, V58, P55, DOI 10.1093/jmicro/dfp008; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Oda K, 1999, J BIOCHEM-TOKYO, V126, P694; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952; Pombinho AR, 2004, CELL TISSUE RES, V315, P393, DOI 10.1007/s00441-003-0830-1; Li MQ, 2013, HISTOL HISTOPATHOL, V28, P327; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; Yoshikawa K, 2013, CLIN EXP NEPHROL, V17, P882, DOI 10.1007/s10157-013-0785-9; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; HALE JE, 1988, J BIOL CHEM, V263, P5820; FRASER JD, 1988, J BIOL CHEM, V263, P11033; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990; BARONE LM, 1991, J CELL BIOCHEM, V46, P351, DOI 10.1002/jcb.240460410; BRONCKERS ALJJ, 1985, COLLAGEN REL RES, V5, P273; Cancela ML, 2001, J BONE MINER RES, V16, P1611, DOI 10.1359/jbmr.2001.16.9.1611; Dan Harel, 2012, Front Endocrinol (Lausanne), V3, P79, DOI 10.3389/fendo.2012.00079; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Groot C G, 1986, Bone, V7, P379; Kawamura K, 2006, PLAST RECONSTR SURG, V117, P1471, DOI 10.1097/01.prs.0000197883.17428.22; Kim JG, 2006, MENOPAUSE, V13, P467, DOI 10.1097/01.gme.0000182803.06762.fb; Li MQ, 2006, MICROSC RES TECHNIQ, V69, P73, DOI 10.1002/jemt.20272; LOESER RF, 1991, CONNECT TISSUE RES, V26, P135, DOI 10.3109/03008209109152432; LUO GB, 1995, J BONE MINER RES, V10, P325; Mori K, 1998, FEBS LETT, V433, P19, DOI 10.1016/S0014-5793(98)00870-9; Ortiz-Delgado JB, 2005, HISTOCHEM CELL BIOL, V124, P123, DOI 10.1007/s00418-005-0015-y; Pinto JP, 2003, BONE, V32, P201, DOI 10.1016/S8756-3282(02)00981-X; Suttie J.W., 1984, HDB VITAMINS NUTRITI, P147	33	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	JAN	2015	30	1					77	85				9	Cell Biology; Pathology	Cell Biology; Pathology	AW2YN	WOS:000346152600008		
J	Brooke-Smith, M; Figueras, J; Ullah, S; Rees, M; Vauthey, JN; Hugh, TJ; Garden, OJ; Fan, ST; Crawford, M; Makuuchi, M; Yokoyama, Y; Buchler, M; Weitz, J; Padbury, R				Brooke-Smith, Mark; Figueras, Joan; Ullah, Shahid; Rees, Myrddin; Vauthey, Jean-Nicolas; Hugh, Thomas J.; Garden, O. James; Fan, Sheung Tat; Crawford, Michael; Makuuchi, Masatoshi; Yokoyama, Yukihiro; Buechler, Marcus; Weitz, Juergen; Padbury, Robert			Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study	HPB			English	Article							ABDOMINAL DRAINAGE; HEPATIC RESECTION; HEPATECTOMY; MANAGEMENT; COMPLICATIONS; METASTASES; TRIAL	BackgroundThe International Study Group for Liver Surgery (ISGLS) proposed a definition for bile leak after liver surgery. A multicentre international prospective study was designed to evaluate this definition. MethodsData collected prospectively from 949 consecutive patients on specific datasheets from 11 international centres were collated centrally. ResultsBile leak occurred in 69 (7.3%) of patients, with 31 (3.3%), 32 (3.4%) and 6 (0.6%) classified as grade A, B and C, respectively. The grading system of severity correlated with the Dindo complication classification system (P < 0.001). Hospital length of stay was increased when bile leak occurred, from a median of 7 to 15 days (P < 0.001), as was intensive care stay (P < 0.001), and both correlated with increased severity grading of bile leak (P < 0.001). 96% of bile leaks occurred in patients with intra-operative drains. Drain placement did not prevent subsequent intervention in the bile leak group with a 5-15 times greater risk of intervention required in this group (P < 0.001). ConclusionThe ISGLS definition of bile leak after liver surgery appears robust and intra-operative drain usage did not prevent the need for subsequent drain placement.	[Brooke-Smith, Mark; Ullah, Shahid; Padbury, Robert] Flinders Med Ctr, Bedford Pk, SA 5065, Australia; [Brooke-Smith, Mark; Ullah, Shahid; Padbury, Robert] Flinders Univ South Australia, Bedford, SA, Australia; [Figueras, Joan] Josep Trueta Hosp, Girona, Spain; [Rees, Myrddin] North Hampshire Hosp, Basingstoke, Hants, England; [Vauthey, Jean-Nicolas] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hugh, Thomas J.] Royal N Shore Hosp, Sydney, NSW, Australia; [Garden, O. James] Royal Edinburgh Infirm, Edinburgh, Midlothian, Scotland; [Fan, Sheung Tat] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Crawford, Michael] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Tokyo, Japan; [Yokoyama, Yukihiro] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Buechler, Marcus; Weitz, Juergen] Tech Univ Dresden, Dept Surg, D-01062 Dresden, Germany	Brooke-Smith, M (reprint author), Flinders Med Ctr, Dept Surg & Specialty Serv, Bedford Pk, SA 5065, Australia.	Mark.Brooke-Smith@health.sa.gov.au					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Wicherts DA, 2013, BRIT J SURG, V100, P808, DOI 10.1002/bjs.9088; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; BELGHITI J, 1993, ANN SURG, V218, P748, DOI 10.1097/00000658-199312000-00008; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Zimmitti G, 2013, J AM COLL SURGEONS, V217, P1028, DOI 10.1016/j.jamcollsurg.2013.07.392; Coolsen MME, 2013, HPB, V15, P245, DOI 10.1111/j.1477-2574.2012.00572.x; Lam VWT, 2014, HPB, V16, P101, DOI 10.1111/hpb.12083; Sun HC, 2006, BRIT J SURG, V93, P422, DOI 10.1002/bjs.5260; Ishii H, 2011, DIGEST SURG, V28, P198, DOI 10.1159/000324042; Petrowsky H, 2004, ANN SURG, V240, P1074, DOI 10.1097/01.sla.0000146149.17411.c5; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Liu CL, 2004, ANN SURG, V239, P194, DOI 10.1097/01.sla.0000109153.71725.8c; de Castro SMM, 2005, J GASTROINTEST SURG, V9, P1163, DOI 10.1016/j.gassur.2005.08.010; Erdogan D, 2008, DIGEST SURG, V25, P60, DOI 10.1159/000118024; Fong Y, 1996, AM J SURG, V171, P158, DOI 10.1016/S0002-9610(99)80092-0	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1365-182X	1477-2574		HPB	HPB	JAN	2015	17	1					46	51		10.1111/hpb.12322		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW1WH	WOS:000346078600008		
J	Orr, P; Fusiek, G; Niewczas, P; Booth, CD; Dysko, A; Kawano, F; Nishida, T; Beaumont, P				Orr, Philip; Fusiek, Grzegorz; Niewczas, Pawel; Booth, Campbell D.; Dysko, Adam; Kawano, Fumio; Nishida, Tomonori; Beaumont, Phil			Distributed Photonic Instrumentation for Power System Protection and Control	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Distributed protection; optical fiber sensors; power system protection; smart grids	VOLTAGE SENSOR	We report on recent developments in hybrid optical protection schemes that make use of passive fiber Bragg grating-based transducers for the distributed measurement of voltage and current. In addition to the details of the hybrid optical sensor technology, and its full integration with a commercial busbar protection relay, we report on the first-time laboratory demonstration of a centralized three-ended unit protection scheme featuring hybrid optical sensors capable of passive and wide-area coverage. Furthermore, we discuss the impact of this technology on present and future protection applications that may be improved or enabled by the proposed scheme.	[Orr, Philip; Fusiek, Grzegorz; Niewczas, Pawel; Booth, Campbell D.; Dysko, Adam] Univ Strathclyde, Inst Energy & Environm, Glasgow G1 1XW, Lanark, Scotland; [Kawano, Fumio; Nishida, Tomonori] Toshiba Co Ltd, Tokyo 1058001, Japan; [Beaumont, Phil] Toshiba Int Europe, Uxbridge UB11 1EZ, Middx, England	Orr, P (reprint author), Univ Strathclyde, Inst Energy & Environm, Glasgow G1 1XW, Lanark, Scotland.	philip.orr@strath.ac.uk; fumio.kawano@toshiba.co.jp			Engineering and Physical Sciences Research Council, U.K.; Toshiba Corporation, Tokyo, Japan	This work was supported in part by the Engineering and Physical Sciences Research Council, U.K., and in part by Toshiba Corporation, Tokyo, Japan. The Associate Editor coordinating the review process was Dr. Carlo Muscas.	Pan F, 2011, SENSORS-BASEL, V11, P6593, DOI 10.3390/s110706593; NING YN, 1995, REV SCI INSTRUM, V66, P3097, DOI 10.1063/1.1145537; [Anonymous], 2012, ATPS3 PROT REL TEST; [Anonymous], 2012, ALSTOM NXT PHASE COS; [Anonymous], 2012, GRB100 BUSB PROT; Kersey AD, 1997, J LIGHTWAVE TECHNOL, V15, P1442, DOI 10.1109/50.618377; MELTZ G, 1989, OPT LETT, V14, P823, DOI 10.1364/OL.14.000823; Bonhert K., 2005, OPT LASER ENG, V43, P511; Carta A, 2009, IEEE T INSTRUM MEAS, V58, P3723, DOI 10.1109/TIM.2009.2019319; Dziuda L, 2007, SENSOR ACTUAT A-PHYS, V136, P184, DOI 10.1016/j.sna.2006.11.003; Dziuda L, 2005, OPT ENG, V44, DOI 10.1117/1.1926947; Fusiek G., 2007, P 24 IEEE INSTR MEAS, P1; Fusiek G, 2005, OPT ENG, V44, DOI 10.1117/1.1873392; Hall I., 2003, P IEEE POW TECH C BO, P8; Horak J., 2014, CURRENT TRANSFORMER; Mackiewicz RE, 2006, TRANS DISTRIB CONF, P376, DOI 10.1109/TDC.2006.1668522; Mendez A, 2007, P SOC PHOTO-OPT INS, V6619, P61905, DOI 10.1117/12.738334; Moghadas A., 2010, P 4 ANN IEEE SYST C, P165; Niewczas P., 2006, P 5 IEEE SENS C DAEG, P295; Niewczas P, 2007, IEEE INSTRU MEAS MAG, V10, P18, DOI 10.1109/MIM.2007.339552; Orr P., 2011, P IEEE POW EN SOC GE, P1; Orr P., 2009, P 44 INT U POW ENG C, P1; Orr P, 2011, J LIGHTWAVE TECHNOL, V29, P3387, DOI 10.1109/JLT.2011.2169044; Orr P., 2012, P 11 INT C DEV POW S, P155; Orr P, 2013, 2013 IEEE INTERNATIONAL WORKSHOP ON APPLIED MEASUREMENTS FOR POWER SYSTEMS (AMPS), P63, DOI 10.1109/AMPS.2013.6656227; Phadke A. G., 2009, COMPUTER RELAYING PO; Tang X., 2011, P ADV POW SYST AUT P, P210	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JAN	2015	64	1					19	26		10.1109/TIM.2014.2329740		8	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AW1YU	WOS:000346085800003		
J	Aungier, SR; Ohmori, H; Clinton, M; Mabbott, NA				Aungier, Susan R.; Ohmori, Hitoshi; Clinton, Michael; Mabbott, Neil A.			MicroRNA-100-5p indirectly modulates the expression of Il6, Ptgs1/2 and Tlr4 mRNA in the mouse follicular dendritic cell-like cell line, FL-Y	IMMUNOLOGY			English	Article						follicular dendritic cell; microRNA; mmu-miR-100-5p; mRNA; spleen	LYMPHOTOXIN-BETA-RECEPTOR; AUTOIMMUNE-DISEASE; PROSTAGLANDIN E-2; LYMPHOID-TISSUES; DOWN-REGULATION; UP-REGULATION; B-CELLS; RESPONSES; IMMUNE; DIFFERENTIATION	Follicular dendritic cells (FDC) are important stromal cells within the B-cell follicles and germinal centres (GC) of secondary lymphoid tissues. FDC trap and retain native antigens on their surfaces in the form of immune complexes that they display to B cells, in order to select those cells with the highest antigen affinity. MicroRNAs are short, non-coding RNAs that are approximately 18-25 nucleotides in length that regulate gene expression at the post-transcriptional level by repressing the translation of target genes. In the current study, in vivo and in vitro systems were used to identify microRNAs that were potentially expressed by FDC. Constitutive lymphotoxin- receptor (LTR) stimulation is required to maintain FDC in their differentiated state. We show that the rapid de-differentiation of spleen FDC that accompanied LTR-blockade, coincided with a significant decrease in the expression of mmu-miR-100-5p, mmu-miR-138-5p and mmu-miR-2137. These microRNAs were shown to be expressed in the FDC-like cell line, FL-YB, and specific inhibition of mmu-miR-100-5p significantly enhanced expression of Il6, Ptgs1/2 and Tlr4 mRNA in this cell line. The expression of Il6, Ptgs1/2 and Tlr4 by FDC play important roles in regulating GC size and promoting high-affinity antibody responses, so it is plausible that mmu-miR-100-5p may help to regulate the expression of these genes during GC reactions.	[Aungier, Susan R.; Clinton, Michael; Mabbott, Neil A.] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Aungier, Susan R.; Clinton, Michael; Mabbott, Neil A.] Univ Edinburgh, R D SVS, Easter Bush EH25 9RG, Midlothian, Scotland; [Ohmori, Hitoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan	Mabbott, NA (reprint author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	neil.mabbott@roslin.ed.ac.uk		Mabbott, Neil/0000-0001-7395-1796			Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Gunn MD, 1998, NATURE, V391, P799; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; El Shikh MEM, 2007, J IMMUNOL, V179, P4444; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Liu B, 2006, J IMMUNOL, V177, P6880; Fang YF, 1998, J IMMUNOL, V160, P5273; Mabbott NA, 2011, IMMUNOLOGY, V133, P482, DOI 10.1111/j.1365-2567.2011.03461.x; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Magari M, 2011, J IMMUNOL, V187, P4210, DOI 10.4049/jimmunol.1100934; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Baumjohann D, 2014, CURR OPIN IMMUNOL, V28, P6, DOI 10.1016/j.coi.2014.01.003; McCulloch L, 2013, IMMUNOLOGY, V138, P246, DOI 10.1111/imm.12031; Assier E, 2010, JOINT BONE SPINE, V77, P532, DOI 10.1016/j.jbspin.2010.07.007; Chen P, 2013, MOL CELL BIOCHEM, V383, P49, DOI 10.1007/s11010-013-1753-0; Cho Whajung, 2013, Immune Netw, V13, P75, DOI 10.4110/in.2013.13.2.75; Eadon MT, 2014, IMMUNOLOGY, V143, P363, DOI 10.1111/imm.12314; FORCE WR, 1995, J IMMUNOL, V155, P5280; Gubian S, 2012, EXIMIR R FUNCTIONS N; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Nishikawa Y, 2006, J IMMUNOL, V177, P5204; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Yamane F, 2014, J LEUKOCYTE BIOL, V95, P19, DOI 10.1189/jlb.0613311	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	JAN	2015	144	1					34	44		10.1111/imm.12342		11	Immunology	Immunology	AW1ES	WOS:000346033900004		
J	Mizutani, N; Nabe, T; Yoshino, S				Mizutani, Nobuaki; Nabe, Takeshi; Yoshino, Shin			IgE/antigen-mediated enhancement of IgE production is a mechanism underlying the exacerbation of airway inflammation and remodelling in mice	IMMUNOLOGY			English	Article						airway hyper-responsiveness; asthma; biphasic increase in airway resistance; IgE; inflammation; remodelling	SEVERE ALLERGIC-ASTHMA; MAST-CELLS; IN-VIVO; NEUTROPHILIC INFLAMMATION; MONOCLONAL-ANTIBODY; HYPERRESPONSIVENESS; BASOPHILS; RESPONSES; HYPERPLASIA; OMALIZUMAB	IgE is known to enhance some antibody responses to specific antigens, but whether this contributes to allergic asthma remains unclear. We have previously found that repeated antigen challenges in mice sensitized with antigen-specific IgE monoclonal antibody (mAb) exacerbated airway inflammation and remodelling accompanied by increased levels of endogenous antigen-specific IgE and IgG1. Here, we investigated whether IgE/antigen-mediated enhancement of endogenous IgE production contributes to the exacerbation of airway inflammation and remodelling. BALB/c mice passively sensitized with ovalbumin (OVA) -specific IgE mAb were challenged with OVA intratracheally seven times; anti-IgE mAb was intraperitoneally administered 1day before the fourth challenge. Treatment with anti-IgE mAb inhibited the increased level of endogenous OVA-specific IgE in serum, but not OVA-specific IgG1, and a biphasic increase in airway resistance at the fourth challenge. Furthermore, a biphasic increase in airway resistance, airway hyper-responsiveness to methacholine, OVA-specific IgE and IgG1 production, and infiltrations by neutrophils and eosinophils in the lungs at the seventh challenge were suppressed by treatment; airway remodelling, such as goblet cell hyperplasia and sub-epithelial fibrosis, was also reduced. In addition, the production of interleukin-17A, interleukin-33 and CXCL1 in the lungs related to these IgE-mediated responses was decreased by treatment. Collectively, we found that the mechanism leading to the exacerbation of allergic asthma is closely related to IgE/antigen-mediated enhancement of IgE production, suggesting that this may create a vicious circle leading to the chronic status in asthmatic patients having levels of antigen-specific IgE ready to form complexes with antigen.	[Mizutani, Nobuaki; Yoshino, Shin] Kobe Pharmaceut Univ, Dept Pharmacol, Kobe, Hyogo 6588558, Japan; [Nabe, Takeshi] Kyoto Pharmaceut Univ, Dept Pharmacol, Kyoto 607, Japan; [Nabe, Takeshi] Setsunan Univ, Fac Pharmaceut Sci, Dept Toxicol, Osaka, Japan	Mizutani, N (reprint author), Kobe Pharmaceut Univ, Dept Pharmacol, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan.	mizutani@kobepharma-u.ac.jp					Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Tkaczyk C, 2002, MOL IMMUNOL, V38, P1289, DOI 10.1016/S0161-5890(02)00077-9; ROCHE WR, 1989, LANCET, V1, P520; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Mizutani N, 2013, IMMUNOLOGY, V139, P205, DOI 10.1111/imm.12071; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; EBINA M, 1993, AM REV RESPIR DIS, V148, P720; PENNOCK BE, 1979, J APPL PHYSIOL, V46, P399; Mizutani N, 2012, J IMMUNOL, V188, P5694, DOI 10.4049/jimmunol.1103176; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Mizutani N, 2012, IMMUNOL LETT, V141, P235, DOI 10.1016/j.imlet.2011.10.010; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Falcone FH, 2000, BLOOD, V96, P4028; HOSSAIN S, 1970, J PATHOL, V101, P171, DOI 10.1002/path.1711010212; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; DesMonchy JG, 1985, AM REV RESPIR DIS, V131, P373; Getahun A, 2005, J IMMUNOL, V175, P1473; GUSTAVSSON S, 1994, J IMMUNOL, V152, P4793; HAAKFRENDSCHO M, 1994, IMMUNOLOGY, V82, P306; HEYMAN B, 1993, EUR J IMMUNOL, V23, P1739, DOI 10.1002/eji.1830230754; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Nabe T, 2013, BRIT J PHARMACOL, V169, P462, DOI 10.1111/bph.12154; PAUWELS R, 1989, CLIN EXP ALLERGY, V19, P395, DOI 10.1111/j.1365-2222.1989.tb02404.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	JAN	2015	144	1					107	115		10.1111/imm.12355		9	Immunology	Immunology	AW1ES	WOS:000346033900010		
J	Munakata, S; Yamamoto, T				Munakata, Satoru; Yamamoto, Toshiya			Incidence of Serous Tubal Intraepithelial Carcinoma (STIC) by Algorithm Classification in Serous Ovarian Tumor Associated with PAX8 Expression in Tubal Epithelia: A Study of Single Institution in Japan	INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY			English	Article						Serous ovarian tumor; Serous tubal intraepithelial carcinoma; PAX8; Immunohistochemistry; Japanese institution	REDUCING SALPINGO-OOPHORECTOMY; FALLOPIAN-TUBE; BRCA2 MUTATION; CANCER; WOMEN; RISK; CARRIERS; GENE; REPRODUCIBILITY; FREQUENCY	Serous ovarian carcinoma is now hypothesized to originate from fallopian tube epithelium (FTE). We investigated the FTE abnormalities in the patients with epithelial ovarian tumors. Our study included 55 cases of serous tumors (24 carcinomas, 8 borderline tumors, and 23 adenomas), 14 mucinous carcinomas, 22 endometrioid carcinomas, 5 clear cell carcinomas, and 2 malignant Brenner tumors. FTE was diagnosed by the diagnostic algorithm, which combines the data of morphology, and p53, Ki-67 immunostaining, as serous tubal intraepithelial carcinoma, serous tubal intraepithelial lesion, p53 signature, and normal/reactive. Serous tubal intraepithelial carcinoma, serous tubal intraepithelial lesion, p53 signature, and normal/reactive were observed in 5, 3, 0, and 16 cases in serous carcinoma; 0, 3, 0, and 5 cases in serous borderline tumor; 0, 1, 1, and 21 cases in serous adenoma; 0, 0, 1, and 13 cases in mucinous carcinoma; 0, 0, 3, and 19 cases in endometrioid carcinoma; 0, 0, 0, and 5 cases in clear cell carcinoma; and 0, 1, 0, and 1 case in malignant Brenner tumor. Among tumors of serous histology and between carcinomas, FTE abnormalities differed significantly (P<0.05). Serous tubal intraepithelial carcinomas were only found in serous carcinoma. The incidence of secretory cell proliferation (SCP) was examined by PAX8 expression. The rate of SCP was extremely high in serous carcinoma (96%). Among tumors of serous histology and between carcinomas, an incidence of SCP differed significantly (P<0.05). Patients with SCP were significantly older (P<0.0001). Our observations were concordant with the hypothesis of serous ovarian carcinogenesis. The SCP has a meaningful association with serous ovarian cancer.	[Munakata, Satoru] Sakai City Hosp, Dept Pathol, Sakai, Osaka 5900064, Japan; [Yamamoto, Toshiya] Sakai City Hosp, Dept Obstet & Gynecol, Sakai, Osaka 5900064, Japan	Munakata, S (reprint author), Sakai City Hosp, Dept Pathol, Sakai Ku, 1-1-1 Minami Yasui Cho, Sakai, Osaka 5900064, Japan.	munak-s@sakai-hospital.jp					Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Obata K, 1998, CANCER RES, V58, P2095; Vang R, 2012, INT J GYNECOL PATHOL, V31, P243, DOI 10.1097/PGP.0b013e31823b8831; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; POLEEV A, 1992, DEVELOPMENT, V116, P611; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Beral V, 2008, LANCET, V371, P303; Tang SG, 2012, INT J GYNECOL PATHOL, V31, P103, DOI 10.1097/PGP.0b013e31822ea955; Ozcan A, 2011, MODERN PATHOL, V24, P751, DOI 10.1038/modpathol.2011.3; Laury AR, 2011, AM J SURG PATHOL, V35, P1759, DOI 10.1097/PAS.0b013e318233b0f7; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; Powell CB, 2005, J CLIN ONCOL, V23, P127, DOI 10.1200/JCO.2005.04.109; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Visvanathan K, 2011, AM J SURG PATHOL, V35, P1766, DOI 10.1097/PAS.0b013e31822f58bc; Carlson JW, 2010, INT J GYNECOL PATHOL, V29, P310, DOI 10.1097/PGP.0b013e3181c713a8; Rebbeck TR, 2009, J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Singer G, 2003, J NATL CANCER I, V95, P484; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; CASAGRANDE JT, 1979, LANCET, V2, P170; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Catasus L, 2004, HUM PATHOL, V35, P1360, DOI 10.1016/j.humpath.2004.07.019; Ushijima K, 2009, J GYNECOL ONCOL, V20, P67, DOI 10.3802/jgo.2009.20.2.67; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Barber HRK, 1993, OVARIAN CARCINOMA ET; Brewer MA, 2003, CLIN CANCER RES, V9, P20; Crum Christopher P, 2007, Clin Med Res, V5, P35, DOI 10.3121/cmr.2007.702; Finch Amy, 2012, Womens Health (Lond Engl), V8, P543, DOI 10.2217/whe.12.41; Leunen K, 2006, INT J GYNECOL CANCER, V16, P183, DOI 10.1111/j.1525-1438.2006.00287.x; Maeda D, 2010, VIRCHOWS ARCH, V457, P597, DOI 10.1007/s00428-010-0979-4; Olopade Olufunmilayo I, 2004, Breast J, V10 Suppl 1, pS5, DOI 10.1111/j.1524-4741.2004.101S3.x	35	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-1691	1538-7151		INT J GYNECOL PATHOL	Int. J. Gynecol. Pathol.	JAN	2015	34	1					9	18		10.1097/PGP.0000000000000108		10	Obstetrics & Gynecology; Pathology	Obstetrics & Gynecology; Pathology	AW2XP	WOS:000346150300003		
J	Wada, T; Yasunaga, H; Inokuchi, R; Horiguchi, H; Fushimi, K; Matsubara, T; Nakajima, S; Yahagi, N				Wada, Tomoki; Yasunaga, Hideo; Inokuchi, Ryota; Horiguchi, Hiromasa; Fushimi, Kiyohide; Matsubara, Takehiro; Nakajima, Susumu; Yahagi, Naoki			Relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator	INTERNATIONAL JOURNAL OF STROKE			English	Article						hospital volume; ischemic stroke; population-based study; recombinant tissue plasminogen activator; stroke facilities; thrombolysis	INPATIENT SAMPLE 1999; INTRAVENOUS ALTEPLASE; THROMBOLYTIC THERAPY; SYSTEMATIC ANALYSIS; CONTROLLED-TRIAL; GLOBAL BURDEN; 0.6 MG/KG; MORTALITY; DISEASE; PREDICTORS	Background There is controversy whether the annual number of acute ischemic stroke patients receiving stroke thrombolysis per hospital (hospital volume) is associated with outcomes in these patients. Aims The study aims to assess the relationship between hospital volume and early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator. Methods Patients with acute ischemic stroke treated with recombinant tissue plasminogen activator from July 1, 2010 to March 31, 2012 were identified in the Japanese Diagnosis Procedure Combination database. Hospital volume was categorized into three levels (low, medium, and high volume) to obtain approximately equal numbers of patients in each group. Primary outcomes were seven-day mortality and functional independence (modified Rankin Scale score of 0 to 2) at discharge. Univariate analyses and multivariate logistic regression analyses fitted with generalized estimating equations were performed. Results We identified 7476 eligible patients, including 2339 (31.3%) treated in low-volume hospitals (1-7 patients annually), 2670 (35.7%) in medium-volume hospitals (8-16 patients annually), and 2467 (33.0%) in high-volume hospitals (17-48 patients annually). Seven-day mortality and functional independence at discharge were comparable among the three hospital volume groups (P = 0.17 for seven-day mortality; P = 0.22 for functional independence at discharge). The comparability between groups persisted after multivariate adjustment. Conclusion Hospital volume was not significantly associated with seven-day mortality or functional independence at discharge in acute ischemic stroke patients treated with recombinant tissue plasminogen activator in Japan.	[Wada, Tomoki; Inokuchi, Ryota; Matsubara, Takehiro; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 1138655, Japan; [Yasunaga, Hideo] Univ Tokyo, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Care Informat, Tokyo, Japan	Wada, T (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	wadat-eme@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031]; Ministry of Education, Culture, Sports, Science and Technology [22390131]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Teckhnology Policy, Japan [0301002001001]	This study was funded by a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (No. H22-Policy-031); a Grant-in-Aid for Scientific Research B (No. 22390131) from the Ministry of Education, Culture, Sports, Science and Technology; and a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Teckhnology Policy, Japan (No. 0301002001001).	Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Halm EA, 2002, ANN INTERN MED, V137, P511; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Heuschmann PU, 2004, JAMA-J AM MED ASSOC, V292, P1831, DOI 10.1001/jama.292.15.1831; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Bateman BT, 2006, STROKE, V37, P440, DOI 10.1161/01.STR.0000199851.24668.f1; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792e3; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; Schumacher HC, 2007, ANN EMERG MED, V50, P99, DOI 10.1016/j.annemergmed.2007.01.021; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Inoue T, 2014, STROKE, V44, P3142; Ohta T, 1974, No Shinkei Geka, V2, P623; Ono K, 2007, NEUROL MED CHIR TOKY, V47, P297; Ronning OM, 1998, STROKE, V29, P58; Saposnik G, 2005, STROKE, V36, P147, DOI 10.1161/01.STR.0000150492.12838.66; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Stroke Unit Trialists' Collaboration, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; MARLER JR, 1995, NEW ENGL J MED, V333, P1581	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	JAN	2015	10	1					73	78		10.1111/ijs.12311		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW3AA	WOS:000346156500021		
J	Nakajima, M; Inatomi, Y; Yonehara, T; Watanabe, M; Ando, Y				Nakajima, Makoto; Inatomi, Yuichiro; Yonehara, Toshiro; Watanabe, Masaki; Ando, Yukio			Outcome in patients admitted outside regular hospital working hours: Does time until regular working hours matter?	INTERNATIONAL JOURNAL OF STROKE			English	Article						acute stroke therapy; ischemic stroke; outcome; rehabilitation; stroke facilities; stroke teams	COMPREHENSIVE STROKE CENTERS; ISCHEMIC-STROKE; CASE-FATALITY; EARLY REHABILITATION; WEEKEND; ADMISSION; MORTALITY; TRIAL; CARE; MOBILIZATION	Aims The aim of this study was to investigate whether stratifying patients according to the time period from admission to the start of regular working hours would help detect a weekend effect in acute stroke patients. Methods Ischemic stroke patients admitted between October 2002 and March 2012 were analyzed. Working hours were defined as 9:00-17:00 on weekdays. Patients were divided into those admitted during working hours (no-wait group) and three other groups according to the time from admission to working hours: <= 24 h (short-wait group), 24-48 h (medium-wait group), and >48 h (long-wait group). The modified Rankin Scale score and mortality at three-months were compared among the groups. Results Of 5625 patients, 3323 (59%) were admitted outside working hours. The proportion of patients with an mRS score 0-1 at three-months showed a decreasing trend with the time period before working hours: 47% (no-wait group), 42% (short-wait group), 42% (medium-wait group), and 38% (long-wait group), respectively (P < 0.001). When the no-wait group was used as a reference, the odds ratio for modified Rankin Scale score 0-1 was 0.88 (95% confidence interval, 0.75-1.04) in the short-wait group, 0.86 (0.69-1.07) in the medium-wait group, and 0.67 (0.53-0.85) in the long-wait group after adjusting for sex, age, premorbid mRS score, previous morbidity, stroke severity, and vascular risk factors. Mortality at three-months was not different between the no-wait group and the other groups. Conclusion A weekend effect might be evident if patients were stratified according to the time period from admission until working hours.	[Nakajima, Makoto; Inatomi, Yuichiro; Yonehara, Toshiro] Saiseikai Kumamoto Hosp, Dept Neurol, Stroke Ctr, Kumamoto, Japan; [Nakajima, Makoto; Watanabe, Masaki; Ando, Yukio] Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto 8608556, Japan	Nakajima, M (reprint author), Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nakazima@fc.kuh.kumamoto-u.ac.jp					Langhorne P, 2010, CEREBROVASC DIS, V29, P352, DOI 10.1159/000278931; Hasegawa Y, 2005, CEREBROVASC DIS, V20, P325, DOI 10.1159/000087932; Sundseth A, 2012, STROKE, V43, P2389, DOI 10.1161/STROKEAHA.111.646687; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Jauss M, 2009, EUR J NEUROL, V16, P1165, DOI 10.1111/j.1468-1331.2009.02656.x; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Albright KC, 2009, CEREBROVASC DIS, V27, P107, DOI 10.1159/000177916; Bernhardt J, 2013, INT J STROKE, V8, P5, DOI 10.1111/ijs.12020; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Kazley AS, 2010, ARCH NEUROL-CHICAGO, V67, P39, DOI 10.1001/archneurol.2009.286; Indredavik B, 1999, STROKE, V30, P917; Turin TC, 2008, CEREBROVASC DIS, V26, P606, DOI 10.1159/000165114; Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Brewer L, 2013, QJM-INT J MED, V106, P11, DOI 10.1093/qjmed/hcs174; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Kim SC, 2012, J CLIN NEUROL, V8, P265, DOI 10.3988/jcn.2012.8.4.265; Martinez-Martinez MM, 2012, EUR J NEUROL, V19, P1140, DOI 10.1111/j.1468-1331.2012.03692.x; Niewada M, 2012, NEUROL NEUROCHIR POL, V46, P15, DOI 10.5114/ninp.2012.27209; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; Turin TC, 2009, EUR J NEUROL, V16, P843, DOI 10.1111/j.1468-1331.2009.02605.x	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	JAN	2015	10	1					79	84		10.1111/ijs.12351		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW3AA	WOS:000346156500022		
J	Kawada, T				Kawada, T.			Effect of aspirin for ischemic stroke in patients with dialysis	INTERNATIONAL JOURNAL OF STROKE			English	Letter									[Kawada, T.] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Drew DA, 2014, AM J KIDNEY DIS, V63, P547, DOI 10.1053/j.ajkd.2014.01.009; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Chen CY, 2014, INT J STROKE, V9, P580, DOI 10.1111/ijs.12254	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	JAN	2015	10	1					E9	E9		10.1111/ijs.12377		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW3AA	WOS:000346156500006		
J	Sotiropoulos, I; Silva, J; Kimura, T; Rodrigues, AJ; Costa, P; Almeida, OFX; Sousa, N; Takashima, A				Sotiropoulos, Ioannis; Silva, Joana; Kimura, Tetsuya; Rodrigues, Ana Joao; Costa, Patricio; Almeida, Osborne F. X.; Sousa, Nuno; Takashima, Akihiko			Female Hippocampus Vulnerability to Environmental Stress, a Precipitating Factor in Tau Aggregation Pathology	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Chaperones; hippocampus; memory; mice; stress; tau aggregates	ALZHEIMERS-DISEASE; SEX-DIFFERENCES; MOUSE MODEL; IN-VIVO; CONFORMATIONAL-CHANGE; ESTROUS CYCLICITY; CHAPERONE CYCLE; NEURONAL LOSS; PROTEIN; MICE	Tau-mediated neurodegeneration is a central event in Alzheimer's disease (AD) and other tauopathies. Consistent with suggestions that lifetime stress may be a clinically-relevant precipitant of AD pathology, we previously showed that stress triggers Tau hyperphosphorylation and accumulation; however, little is known about the etiopathogenic interaction of chronic stress with other AD risk factors, such as sex and aging. This study focused on how these various factors converge on the cellular mechanisms underlying Tau aggregation in the hippocampus of chronically stressed male and female (middle-aged and old) mice expressing the most commonly found disease-associated Tau mutation in humans, P301L-Tau. We report that environmental stress triggers memory impairments in female, but not male, P301L-Tau transgenic mice. Furthermore, stress elevates levels of caspase-3-truncated Tau and insoluble Tau aggregates exclusively in the female hippocampus while it also alters the expression of the molecular chaperones Hsp90, Hsp70, and Hsp105, thus favoring accumulation of Tau aggregates. Our findings provide new insights into the molecular mechanisms through which clinically-relevant precipitating factors contribute to the pathophysiology of AD. Our data point to the exquisite sensitivity of the female hippocampus to stress-triggered Tau pathology.	[Sotiropoulos, Ioannis; Kimura, Tetsuya; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan; [Kimura, Tetsuya; Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Dept Aging Neurobiol, Obu, Japan; [Sotiropoulos, Ioannis; Silva, Joana; Rodrigues, Ana Joao; Costa, Patricio; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Sotiropoulos, Ioannis; Silva, Joana; Rodrigues, Ana Joao; Costa, Patricio; Sousa, Nuno] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Almeida, Osborne F. X.] Max Planck Inst Psychiat, D-80804 Munich, Germany	Sotiropoulos, I (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal.	ioannis@ecsaude.uminho.pt		Sousa, Nuno/0000-0002-8755-5126	Japanese Society for the Promotion of Science; Portuguese Foundation for Science Technology; Max Planck Society; European Union FP7 Project SwitchBox; National Center for Geriatrics and Gerontology [23-39]; Strategic Research Program for Brain Science; Ministry of Education, Science, Sports and Culture of Japan	This study was supported by the Japanese Society for the Promotion of Science (IS), the Portuguese Foundation for Science & Technology (IS, AJR, NS), the Max Planck Society (OFXA), and the European Union FP7 Project SwitchBox (OFXA and NS). AT is supported by Research Funding for Longevity Sciences (23-39) from National Center for Geriatrics and Gerontology, the Strategic Research Program for Brain Science ("Integrated Research on Neuropsychiatric Disorders") and a Grant-in-Aid for Scientific Research on Innovative Areas ("Brain Environment") from the Ministry of Education, Science, Sports and Culture of Japan. The authors thank Y. Yoshike, N. Sahara, D. Fischer, R. Stoffel and P. Ludovico for technical help and critical comments at various stages of this work.	Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200; Launer LJ, 1999, NEUROLOGY, V52, P78; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Wilson RS, 2007, NEUROLOGY, V69, P1911, DOI 10.1212/01.wnl.0000271087.67782.cb; Rohn TT, 2008, J NEUROSCI, V28, P3051, DOI 10.1523/JNEUROSCI.5620-07.2008; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Sotiropoulos I, 2008, NEUROSCI BIOBEHAV R, V32, P1161, DOI 10.1016/j.neubiorev.2008.05.007; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Kang KI, 1999, P NATL ACAD SCI USA, V96, P1439, DOI 10.1073/pnas.96.4.1439; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Berenbaum SA, 2011, FRONT NEUROENDOCRIN, V32, P183, DOI 10.1016/j.yfrne.2011.03.001; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Nasreddine ZS, 1999, ANN NEUROL, V45, P704, DOI 10.1002/1531-8249(199906)45:6<704::AID-ANA4>3.0.CO;2-X; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JC1200420640; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dalla C, 2011, CURR TOP BEHAV NEURO, V8, P97, DOI 10.1007/7854_2010_94; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Tortosa E, 2009, J ALZHEIMERS DIS, V17, P319, DOI 10.3233/JAD-2009-1049; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Kendler KS, 1999, AM J PSYCHIAT, V156, P837; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Allen B, 2002, J NEUROSCI, V22, P9340; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; de Calignon A, 2012, NAT, V464, P1201; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Dubal DB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-24; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Gandy S, 2000, EXP GERONTOL, V35, P503, DOI 10.1016/S0531-5565(00)00116-9; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Patchev VK, 1998, MOL NEUROBIOL, V16, P63, DOI 10.1007/BF02740603; Riedemann T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-2; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Weiner MF, 1997, BIOL PSYCHIAT, V42, P1030, DOI 10.1016/S0006-3223(97)00165-0; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiike Y, 2012, AGING CELL, V11, P51, DOI 10.1111/j.1474-9726.2011.00756.x	60	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	43	3					763	774		10.3233/JAD-140693		12	Neurosciences	Neurosciences & Neurology	AU8PG	WOS:000345858000007		
J	Ogawa, R; Abe-Yoshizumi, R; Kishi, T; Homma, M; Kojima, S				Ogawa, Ryo; Abe-Yoshizumi, Rei; Kishi, Takaaki; Homma, Michio; Kojima, Seiji			Interaction of the C-Terminal Tail of FliF with FliG from the Na+-Driven Flagellar Motor of Vibrio alginolyticus	JOURNAL OF BACTERIOLOGY			English	Article							CONSERVED CHARGED RESIDUES; MS RING COMPLEX; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; PERIPLASMIC REGION; MEMBRANE TOPOLOGY; GENERATING UNITS; MARINE BACTERIUM; ROTARY MOTOR; BASAL BODY	Rotation of the polar flagellum of Vibrio alginolyticus is driven by a Na+-type flagellar motor. FliG, one of the essential rotor proteins located at the upper rim of the C ring, binds to the membrane-embedded MS ring. The MS ring is composed of a single membrane protein, FliF, and serves as a foundation for flagellar assembly. Unexpectedly, about half of the Vibrio FliF protein produced at high levels in Escherichia coli was found in the soluble fraction. Soluble FliF purifies as an oligomer of similar to 700 kDa, as judged by analytical size exclusion chromatography. By using fluorescence correlation spectroscopy, an interaction between a soluble FliF multimer and FliG was detected. This binding was weakened by a series of deletions at the C-terminal end of FliF and was nearly eliminated by a 24-residue deletion or a point mutation at a highly conserved tryptophan residue (W575). Mutations in FliF that caused a defect in FliF-FliG binding abolish flagellation and therefore confer a nonmotile phenotype. As data from in vitro binding assays using the soluble FliF multimer correlate with data from in vivo functional analyses, we conclude that the C-terminal region of the soluble form of FliF retains the ability to bind FliG. Our study confirms that the C-terminal tail of FliF provides the binding site for FliG and is thus required for flagellation in Vibrio, as reported for other species. This is the first report of detection of the FliF-FliG interaction in the Na+-driven flagellar motor, both in vivo and in vitro.	[Ogawa, Ryo; Abe-Yoshizumi, Rei; Kishi, Takaaki; Homma, Michio; Kojima, Seiji] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Kojima, S (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	z47616a@cc.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [20051009]; Japan Society for the Promotion of Science (JSPS) KAKENHI [24117004, 23247024]	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI grant number 20051009 to S.K. and Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers 24117004 and 23247024 to M.H.	Lloyd SA, 1996, J BACTERIOL, V178, P223; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Blair DF, 2003, FEBS LETT, V545, P86, DOI 10.1016/S0014-5793(03)00397-1; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Li N, 2011, GENES CELLS, V16, P985, DOI 10.1111/j.1365-2443.2011.01545.x; Kojima S, 2011, J MOL BIOL, V414, P62, DOI 10.1016/j.jmb.2011.09.019; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Li N, 2011, J BACTERIOL, V193, P3773, DOI 10.1128/JB.00113-11; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; IRIKURA VM, 1993, J BACTERIOL, V175, P802; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Lloyd SA, 1999, NATURE, V400, P472; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Okunishi I, 1996, J BACTERIOL, V178, P2409; DEMOT R, 1994, MOL MICROBIOL, V12, P333; KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; KAWAGISHI I, 1994, MICROBIOL-UK, V140, P2355; Kubori T, 1997, J BACTERIOL, V179, P813; Asai Y, 1997, J BACTERIOL, V179, P5104; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; CHUN SY, 1988, SCIENCE, V239, P276, DOI 10.1126/science.2447650; DEAN GE, 1984, J BACTERIOL, V159, P991; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi0354051; Levenson R, 2012, BIOCHEMISTRY-US, V51, P5052, DOI 10.1021/bi3004582; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; OOSAWA K, 1994, J BACTERIOL, V176, P3683; Sato K, 2000, J BIOL CHEM, V275, P5718, DOI 10.1074/jbc.275.8.5718; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; STADER J, 1986, J BACTERIOL, V166, P244; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; UENO T, 1994, J MOL BIOL, V236, P546, DOI 10.1006/jmbi.1994.1164; ZHOU JD, 1995, J MOL BIOL, V251, P237, DOI 10.1006/jmbi.1995.0431	47	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	JAN	2015	197	1					63	72		10.1128/JB.02271-14		10	Microbiology	Microbiology	AW1KP	WOS:000346048700009		
J	Chiba, S; Ito, K				Chiba, Shinobu; Ito, Koreaki			MifM Monitors Total YidC Activities of Bacillus subtilis, Including That of YidC2, the Target of Regulation	JOURNAL OF BACTERIOLOGY			English	Article							MEMBRANE-PROTEIN BIOGENESIS; COLI INNER MEMBRANE; SYNTHASE SUBUNIT-C; ESCHERICHIA-COLI; TRANSLOCATION CHANNEL; TRANSLATION ARREST; SECYEG TRANSLOCASE; SPOIIIJ GENE; INSERTION; SECRETION	The YidC/Oxa1/Alb3 family proteins are involved in membrane protein biogenesis in bacteria, mitochondria, and chloroplasts. Recent studies show that YidC uses a channel-independent mechanism to insert a class of membrane proteins into the membrane. Bacillus subtilis has two YidC homologs, SpoIIIJ (YidC1) and YidC2 (YqjG); the former is expressed constitutively, while the latter is induced when the SpoIIIJ activity is compromised. MifM is a substrate of SpoIIIJ, and its failure in membrane insertion is accompanied by stable ribosome stalling on the mifM-yidC2 mRNA, which ultimately facilitates yidC2 translation. While mutational inactivation of SpoIIIJ has been known to induce yidC2 expression, here, we show that the level of this induction is lower than that observed when the membrane insertion signal of MifM is defective. Moreover, this partial induction of YidC2 translation is lowered further when YidC2 is overexpressed in trans. These results suggest that YidC2 is able to insert MifM into the membrane and to release its translation arrest. Thus, under SpoIIIJ-deficient conditions, YidC2 expression is subject to MifM-mediated autogenous feedback repression. Our results show that YidC2 uses a mechanism that is virtually identical to that used by SpoIIIJ; Arg75 of YidC2 in its intramembrane yet hydrophilic cavity is functionally indispensable and requires negatively charged residues of MifM as an insertion substrate. From these results, we conclude that MifM monitors the total activities of the SpoIIIJ and the YidC2 pathways to control the synthesis of YidC2 and to maintain the cellular capability of the YidC mode of membrane protein biogenesis.	[Chiba, Shinobu; Ito, Koreaki] Kyoto Sangyo Univ, Fac Life Sci, Kamigamo, Kyoto, Japan	Chiba, S (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Kamigamo, Kyoto, Japan.	schiba@cc.kyoto-su.ac.jp			MEXT; JSPS	This work was supported by grants from MEXT and a JSPS Grant-in-Aid for Scientific Research (to S.C. and K.I.), as well as by the Private University Strategic Research Foundation Support Program from MEXT (to K.I.).	ANDERSSON H, 1993, EMBO J, V12, P683; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro1845; [Anonymous], 1991, METHODS ENZYMOL; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Samuelson JC, 2000, NATURE, V406, P637; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Geng YP, 2014, J BACTERIOL, V196, P1318, DOI 10.1128/JB.01084-13; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI 10.1146/annurev-biophys-050511-102312; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; ERRINGTON J, 1992, J GEN MICROBIOL, V138, P2609; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Murakami T, 2002, J BACTERIOL, V184, P1998, DOI 10.1128/JB.10.1128/JB.184.7.1998-2004.2002; Nakamori K, 2014, FEBS LETT, V588, P3098, DOI 10.1016/j.febslet.2014.06.038; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Saito A, 2011, P NATL ACAD SCI USA, V108, P13740, DOI 10.1073/pnas.1108376108; Saller MJ, 2011, PROTEOMICS, V11, P270, DOI 10.1002/pmic.201000435; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Tjalsma H, 2003, J BIOL CHEM, V278, P15622, DOI 10.1074/jbc.M301205200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431	54	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	JAN	2015	197	1					99	107		10.1128/JB.02074-14		9	Microbiology	Microbiology	AW1KP	WOS:000346048700013		
J	Nukazawa, K; Kazama, S; Watanabe, K				Nukazawa, Kei; Kazama, So; Watanabe, Kozo			A hydrothermal simulation approach to modelling spatial patterns of adaptive genetic variation in four stream insects	JOURNAL OF BIOGEOGRAPHY			English	Article						AFLP; distributed runoff model; genetic diversity; genome scan; landscape genetics; local adaptation; selection	HABITAT SUITABILITY; LANDSCAPE GENETICS; POPULATION-STRUCTURE; MOLECULAR MARKERS; KINEMATIC WAVES; GENOME SCANS; SELECTION; FLOW; TEMPERATURE; DIVERGENCE	AimA central question in landscape genetics is how local adaptation among heterogeneous environments leads to genetic variation in natural populations. This article has two aims: (1) to examine associations between non-neutral genetic diversity of stream insect populations and environmental heterogeneity simulated by a hydrothermal model; and (2) to establish a novel framework for simulating the spatial distribution of adaptive genetic variation at catchment scale. LocationNatori River basin, north-eastern Japan. MethodsA distributed hydrothermal model was used to simulate current velocity, water depth and water temperature throughout the basin. We used empirical genetic data from 6-21 non-neutral amplified fragment length polymorphism (AFLP) loci in four target stream insect species found at 45 sampling sites. We constructed multiple regression models using allele frequencies at the non-neutral loci as objective variables and the hydrothermal and geographical parameters as candidate explanatory variables. ResultsOf the four species, one caddisfly species provided strong evidence of local adaptation to the annual maximum water temperature. Assuming a priori that the regression models were applicable throughout the study area, we visualized the geographical distributions of genetically similar groups - UPGMA (unweighted pair group method with arithmetic mean) clusters based on genetic distance - and local genetic diversity along the simulated hydrothermal gradients. The UPGMA clusters of two caddisfly species (Hydropsyche orientalis and Stenopsyche marmorata) showed clear spatial turnover along an elevational gradient. Local genetic diversities of these species showed lower genetic diversity in lowland areas. Main conclusionsThe predicted spatial patterns along an elevational gradient could be explained by a hypothetical mechanism whereby lowland habitats only accommodate genotypes adapted to severe thermal conditions. Our approach of combining a hydrothermal simulation with genome-wide scans of non-neutral loci is promising for the identification of evolutionary associations of adaptive loci to the temporal regime of hydrothermal conditions, such as maxima and temporal variability.	[Nukazawa, Kei; Kazama, So] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nukazawa, Kei] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-12587 Berlin, Germany; [Watanabe, Kozo] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime 7908577, Japan	Nukazawa, K (reprint author), Tohoku Univ, Grad Sch Engn, Aoba 6-6-06, Sendai, Miyagi 9808579, Japan.	kei.nukazawa@gmail.com	Watanabe, Kozo/F-7388-2010	Watanabe, Kozo/0000-0002-7062-595X	Ministry of Education, Science, Sports and Culture [24254003, 25241024, 25289172, 26820196, 26630247]; Japan Society for the Promotion of Science (JSPS) Research Fellowship [256493]	This research was partly supported by the Ministry of Education, Science, Sports and Culture through a Grant-in-Aid for Scientific Research (grant nos 24254003, 25241024, 25289172, 26820196 and 26630247) and Japan Society for the Promotion of Science (JSPS) Research Fellowship (grant no. 256493). The Ministry of Land, Infrastructure and Transport and Tourism (MLIT), Miyagi Prefectural Government and Sendai City provided the discharge data and water temperature data at the Kamafusa and Okura dams.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Nukazawa K, 2011, ECOL MODEL, V222, P3718, DOI 10.1016/j.ecolmodel.2011.09.005; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Ahmadi-Nedushan B, 2006, RIVER RES APPL, V22, P503, DOI 10.1002/rra.918; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; REYNOLDS J, 1983, GENETICS, V105, P767; Fourcade Y, 2013, MOL ECOL, V22, P2065, DOI 10.1111/mec.12158; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Reed DH, 2001, EVOLUTION, V55, P1095; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Yaegashi S, 2014, FRESHW SCI, V33, P172, DOI 10.1086/675076; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Holderegger R, 2008, PLANT ECOL DIVERS, V1, P273, DOI 10.1080/17550870802338420; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P281, DOI 10.1098/rspa.1955.0088; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Brouat C, 2004, MOL ECOL, V13, P1815, DOI 10.1111/j.1365-294X.2004.02206.x; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Wright S, 1943, GENETICS, V28, P114; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Jacobsen D, 1997, FRESHWATER BIOL, V38, P247, DOI 10.1046/j.1365-2427.1997.00210.x; AOYA K, 1987, Japanese Journal of Limnology, V48, P41; Booker DJ, 2004, RIVER RES APPL, V20, P167, DOI 10.1002/rra.742; Bovee KD, 1982, 12 USDI FISH WILDL S; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fread D. L., 1993, HDB HYDROLOGY, P105, DOI DOI 10.5-10.13; Jiang C, 1999, THEOR APPL GENET, V99, P1106, DOI 10.1007/s001220051315; Kaplan EH, 1997, SOCIO EC PLANNING SC, V31, P281, DOI 10.1016/S0038-0121(97)00011-6; Kazama S, 2007, ECOL MODEL, V209, P392, DOI 10.1016/j.ecolmodel.2007.06.029; Kimura T., 1961, FLOOD RUNOFF ANAL ME; Kondo J, 1997, J ATMOS SCI, V54, P498, DOI 10.1175/1520-0469(1997)054<0498:SHFFTE>2.0.CO;2; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Liggett J. A., 1975, BASIC EQUATIONS UNST, P29; Liggett J. A., 1975, NUMERICAL METHODS SO, P29; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P317, DOI 10.1098/rspa.1955.0089; Lowry DB, 2010, BIOL LETTERS, V6, P502, DOI 10.1098/rsbl.2009.0969; Martinec J., 1960, IAHS PUBL, V51, P468; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Ragab R, 2001, HYDROL EARTH SYST SC, V5, P554; Rambaut A., 2009, FIGTREE; U. S. Fish and Wildlife Service, 1981, STANDARDS DEV HABITA; U.S. Fish and Wildlife Service, 1980, HABITAT EVALUATION P; Wang YH, 2008, LANDSCAPE ECOL, V23, P989, DOI 10.1007/s10980-008-9262-3; Watanabe K, 2010, AQUAT CONSERV, V20, P574, DOI 10.1002/aqc.1124; Watanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093055; Wilcock HR, 2007, FRESHWATER BIOL, V52, P1907, DOI 10.1111/j.1365-2427.2007.01818.x	60	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-0270	1365-2699		J BIOGEOGR	J. Biogeogr.	JAN	2015	42	1					103	113		10.1111/jbi.12392		11	Ecology; Geography, Physical	Environmental Sciences & Ecology; Physical Geography	AW1SH	WOS:000346069700010		
J	Sekiguchi, A; Nakai, A; Okuda, N; Inde, Y; Takeshita, T				Sekiguchi, Atsuko; Nakai, Akihito; Okuda, Naotaka; Inde, Yusuke; Takeshita, Toshiyuki			Consecutive Cervical Length Measurements as a Predictor of Preterm Cesarean Section in Complete Placenta Previa	JOURNAL OF CLINICAL ULTRASOUND			English	Article						cervical length; placenta previa; preterm delivery; antepartum hemorrhage; ultrasonography	RISK; DELIVERY; HEMORRHAGE; GESTATION; LABOR	BackgroundTo evaluate whether consecutive cervical length measurements can predict preterm cesarean section in women with complete placenta previa. MethodsSeventy-one women with complete placenta previa were retrospectively categorized into women who delivered preterm due to massive hemorrhage (the preterm cesarean section group, n=28) and those delivered at term (the control group, n=43). Maternal characteristics, delivery outcomes, and cervical lengths serially measured at least every 2 weeks from 24 weeks' gestation until delivery were compared. The relationship between cervical length and preterm cesarean section was analyzed. ResultsCervical length gradually decreased with advancing gestational age. After 26 weeks' gestation, this decrease was significantly more rapid in the preterm cesarean section group. Cervical length before cesarean section in the preterm cesarean section group was significantly shorter than that in the control group. Just before cesarean section, 71.4% of the preterm cesarean section group presented with cervical lengths of 35 mm, whereas only 34.9% of the control group had cervical lengths of 35 mm (odds ratio 4.67, 95% confidence interval 1.66-13.10, p=0.006). ConclusionsIn women with complete placenta previa, decrease in cervical length to 35 mm was associated with increased risk of preterm cesarean section due to massive hemorrhage. (c) 2014 Wiley Periodicals, Inc. J Clin Ultrasound43:17-22, 2015	[Sekiguchi, Atsuko; Nakai, Akihito; Okuda, Naotaka; Inde, Yusuke; Takeshita, Toshiyuki] Tama Nagayama Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tama Ku, Tokyo 2068512, Japan	Sekiguchi, A (reprint author), Tama Nagayama Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tama Ku, Nagayama 1-7-1, Tokyo 2068512, Japan.						Ghi T, 2009, ULTRASOUND OBST GYN, V33, P209, DOI 10.1002/uog.6301; Stafford IA, 2010, OBSTET GYNECOL, V116, P595, DOI 10.1097/AOG.0b013e3181ea2deb; Fukushima K, 2012, J OBSTET GYNAECOL RE, V38, P192, DOI 10.1111/j.1447-0756.2011.01669.x; To MS, 2001, ULTRASOUND OBST GYN, V18, P200, DOI 10.1046/j.1469-0705.2001.00437.x; Zaitoun MM, 2011, ARCH GYNECOL OBSTET, V284, P867, DOI 10.1007/s00404-010-1737-1; Hasegawa J, 2011, J CLIN ULTRASOUND, V39, P458, DOI 10.1002/jcu.20849; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Crane JMG, 2000, AM J PERINAT, V17, P101, DOI 10.1055/s-2000-9269; Cunningham FG, 2010, WILLIAMS OBSTET; Hayashi Masako, 2010, Journal of Nippon Medical School, V77, P80; Hibbard JU, 2000, OBSTET GYNECOL, V96, P972, DOI 10.1016/S0029-7844(00)01074-7; Oppenheimer Lawrence, 2007, J Obstet Gynaecol Can, V29, P261; Salihu HM, 2003, AM J OBSTET GYNECOL, V188, P1305, DOI 10.1067/mob.2003.303; Yoshimatsu K, 2002, GYNECOL OBSTET INVES, V53, P149, DOI 10.1159/000058366	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JAN	2015	43	1					17	22		10.1002/jcu.22205		6	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AW1QU	WOS:000346065300003		
J	Kondoh, E; Konishi, M; Kariya, Y; Konishi, I				Kondoh, Eiji; Konishi, Mitsunaga; Kariya, Yoshitaka; Konishi, Ikuo			Ultrasonographic Visualization of Bleeding Sites Can Help Control Postpartum Hemorrhage Using Intrauterine Balloon Tamponade	JOURNAL OF CLINICAL ULTRASOUND			English	Article						balloon tamponade; bleeding sites; post partum hemorrhage; ultrasonography; uterine atony	MANAGEMENT	Identification of precise bleeding sites is generally important to control hemorrhage. Nevertheless, the optimal technique to detect the bleeding sites has not yet been fully defined for patients with life-threatening post partum hemorrhage. We describe that ultrasonographic visualization of bleeding sites can help control post partum hemorrhage using intrauterine balloon tamponade. (c) 2014 Wiley Periodicals, Inc. J Clin Ultrasound43:23-25, 2015	[Kondoh, Eiji; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Kyoto, Japan; [Konishi, Mitsunaga; Kariya, Yoshitaka] Mino Ladies Clin, Osaka, Japan	Kondoh, E (reprint author), Kyoto Univ, Dept Gynecol & Obstet, Kyoto, Japan.						American College of Obstetricians and Gynecologists, 2006, OBSTET GYNECOL, V108, P1039; Kawamura A, 2013, J OBSTET GYNAECOL RE, V39, P733, DOI 10.1111/j.1447-0756.2012.02017.x; Seidler M, 2013, J CLIN ULTRASOUND, V41, P457, DOI 10.1002/jcu.22050; BISSET RAL, 1987, J CLIN ULTRASOUND, V15, P269, DOI 10.1002/jcu.1870150410; Condous GS, 2003, OBSTET GYNECOL, V101, P767, DOI 10.1016/S0029-7844(03)00046-2; Kawamura Y, 2014, J OBSTET GYNAECOL RE, V40, P67, DOI 10.1111/jog.12123	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JAN	2015	43	1					23	25		10.1002/jcu.22228		3	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AW1QU	WOS:000346065300004		
J	Kayashima, K				Kayashima, Kenji			Diagnostic Criteria of Pediatric Internal Jugular Phlebectasia	JOURNAL OF CLINICAL ULTRASOUND			English	Letter							CHILDREN		Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Kitakyushu, Fukuoka 8068501, Japan	Kayashima, K (reprint author), Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Kitakyushu, Fukuoka 8068501, Japan.						Eksioglu AS, 2013, J CLIN ULTRASOUND, V41, P486, DOI 10.1002/jcu.22075; Eksioglu AS, 2014, EUR J RADIOL, V83, P673, DOI 10.1016/j.ejrad.2013.12.021; Hung T, 2008, J VASC SURG, V47, P1337, DOI 10.1016/j.jvs.2007.12.040; Jeon CW, 2002, YONSEI MED J, V43, P329	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JAN	2015	43	1					47	47		10.1002/jcu.22237		1	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AW1QU	WOS:000346065300008		
J	Shimbo, M; Watanabe, H; Kimura, S; Terada, M; Iino, T; Iino, K; Ito, H				Shimbo, Mai; Watanabe, Hiroyuki; Kimura, Shunsuke; Terada, Mai; Iino, Takako; Iino, Kenji; Ito, Hiroshi			Obstructed Bi-leaflet Prosthetic Mitral Valve Imaging with Real-time Three-dimensional Transesophageal Echocardiography	JOURNAL OF CLINICAL ULTRASOUND			English	Article						prosthetic mitral valve; thrombus; 3D transesophageal echocardiography; prosthetic valve dysfunction	RING THROMBOSIS	Real-time three-dimensional transesophageal echocardiography (RT3D-TEE) can provide unique visualization and better understanding of the relationship among cardiac structures. Here, we report the case of an 85-year-old woman with an obstructed mitral prosthetic valve diagnosed promptly by RT3D-TEE, which clearly showed a leaflet stuck in the closed position. The opening and closing angles of the valve leaflets measured by RT3D-TEE were compatible with those measured by fluoroscopy. Moreover, RT3D-TEE revealed, in the ring of the prosthetic valve, thrombi that were not visible on fluoroscopy. RT3D-TEE might be a valuable diagnostic technique for prosthetic mitral valve thrombosis. (c) 2014 Wiley Periodicals, Inc. J Clin Ultrasound43:64-67, 2015	[Shimbo, Mai; Watanabe, Hiroyuki; Kimura, Shunsuke; Terada, Mai; Iino, Takako; Iino, Kenji; Ito, Hiroshi] Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, Akita 010, Japan	Watanabe, H (reprint author), Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, Akita 010, Japan.						Ozkan M, 2000, J AM COLL CARDIOL, V35, P1881, DOI 10.1016/S0735-1097(00)00654-9; Kronzon I, 2009, J AM COLL CARDIOL, V53, P1543, DOI 10.1016/j.jacc.2008.12.059; Ozkan M, 2013, AM J CARDIOL, V112, P977, DOI 10.1016/j.amjcard.2013.05.032; Gursoy OM, 2013, ECHOCARDIOGR-J CARD, V30, pE198, DOI 10.1111/echo.12246; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Durrleman N, 2004, J THORAC CARDIOV SUR, V127, P1388, DOI 10.1016/j.jtcvs.2003.12.013; Singh P, 2009, ECHOCARDIOGR-J CARD, V26, P1236, DOI 10.1111/j.1540-8175.2009.01079.x	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JAN	2015	43	1					64	67		10.1002/jcu.22167		4	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AW1QU	WOS:000346065300013		
J	Inoue, A; Morita, K; Tanaka, T; Arao, Y; Sawada, Y				Inoue, Akira; Morita, Kazuya; Tanaka, Tatsuya; Arao, Yoshihiko; Sawada, Yasutake			Effect of screw design on fiber breakage and dispersion in injection-molded long glass-fiber-reinforced polypropylene	JOURNAL OF COMPOSITE MATERIALS			English	Article						Fiber-reinforced plastics; injection molding; fiber breakage; fiber dispersion; screw design; shear stress	MOLDING PROCESS; COMPOSITES; POLYAMIDE; THERMOPLASTICS; PARAMETERS; LENGTH	Fiber breakage occurs during the injection molding of fiber-reinforced thermoplastics, resulting in the deterioration of the mechanical properties of the molded parts. In this paper, we propose an effective screw geometry for improving both fiber dispersion and residual fiber length. The proposition is based on the results of our study in which we evaluated five types of screws by investigating the molded specimens. We found that the screw geometry in the compression zone dominantly affected the residual fiber length, and that the choice of an appropriate geometry for the melting and mixing processes was the most important factor for improving both fiber dispersion and residual fiber length. Our experimental observations were compared with the results of flow analysis and consistency was observed. We also discuss the effects of the screw size on the quality of the molded parts.	[Inoue, Akira; Sawada, Yasutake] TOYO Machinery & Met Co Ltd, Dept Dev, Technol Dev Div, Akashi, Hyogo 6740091, Japan; [Morita, Kazuya; Tanaka, Tatsuya; Arao, Yoshihiko] Doshisha Univ, Dept Energy & Mech Engn, Fac Engn, Kyotanabe, Kyoto, Japan	Inoue, A (reprint author), TOYO Machinery & Met Co Ltd, Dept Dev, Technol Dev Div, 523-1 Fukusato,Futamicho, Akashi, Hyogo 6740091, Japan.	a-inoue@toyo-mm.co.jp					Thomason JL, 2001, COMPOS PART A-APPL S, V32, P313, DOI 10.1016/S1359-835X(00)00124-X; Lafranche E, 2007, EXPRESS POLYM LETT, V1, P456, DOI 10.3144/expresspolymlett.2007.64; Thomason JL, 2006, POLYM COMPOSITE, V27, P552, DOI 10.1002/pc.20226; Zhang G, 2005, COMPOS SCI TECHNOL, V65, P2240, DOI 10.1016/j.compscitech.2005.04.050; Thomason JL, 2001, COMPOS SCI TECHNOL, V61, P2007, DOI 10.1016/S0266-3538(01)00062-8; Rezaei F, 2008, POLYM-PLAST TECHNOL, V47, P351, DOI 10.1080/03602550801897323; Bereaux Y, 2008, INT J MATER FORM, V1, P827, DOI 10.1007/s12289-008-0263-1; Berton M, 2010, P POL PROC SOC 26 AN; Hassan A, 2011, J REINF PLAST COMP, V30, P1233, DOI 10.1177/0731684411417917; Ho MH, 2011, ADV MATER RES-SWITZ, V284-286, P550, DOI 10.4028/www.scientific.net/AMR.284-286.550; Ichinose N, 2011, POLYM COMPOSITE, V32, P1617, DOI 10.1002/pc.21200; Katayama T, 2001, JPN SOC MECH ENG, V67, P995; Kruder G, 1990, SPE ANTEC TECH PAPER, V36, P74; Mizuno Y., 1993, Journal of the Society of Materials Science, Japan, V42; Morimoto S, 2010, POLYPROPYLENE COMPOU, V2010-I, P1; Ogawa T, 1995, J JAPANESE SOC POLYM, V7, P315; Plumley T, 1994, SPE ANTEC TECH PAPER, V40, P332; Rohde M, 2010, P POL PROC SOC 26 AN; Schemme M., 2005, EATC AUT SEM 5 6 JUL; Schijve W, 2002, INT AVK C REINF PLAS; Singh R, 1998, POLYM COMPOSITE, V19, P37, DOI 10.1002/pc.10073; Tanaka K, 2010, INT J MOD PHYS B, V24, P2555, DOI 10.1142/S0217979210065258; Thomason JL, 2002, COMPOS PART A-APPL S, V33, P1641, DOI 10.1016/S1359-835X(02)00179-3; Thomason JL, 2006, POLYM COMPOSITE, V27, P532; VERBRAAK CPJM, 1989, POLYM ENG SCI, V29, P479, DOI 10.1002/pen.760290708; Watanabe, 1998, JPN SOC MECH ENG, V64, P1976; Yang C, 2010, POLYM COMPOSITE, V31, P1899, DOI 10.1002/pc.20986; Yilmazer U, 2002, POLYM COMPOSITE, V23, P61, DOI 10.1002/pc.10412	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	JAN	2015	49	1					75	84		10.1177/0021998313514872		10	Materials Science, Composites	Materials Science	AW3KF	WOS:000346184700007		
J	Michikawa, T; Ueda, K; Takeuchi, A; Kinoshita, M; Hayashi, H; Ichinose, T; Nitta, H				Michikawa, Takehiro; Ueda, Kayo; Takeuchi, Ayano; Kinoshita, Makoto; Hayashi, Hiromi; Ichinose, Takamichi; Nitta, Hiroshi			Impact of short-term exposure to fine particulate matter on emergency ambulance dispatches in Japan	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							CASE-CROSSOVER ANALYSES; AMBIENT AIR-POLLUTION; NEW-YORK-CITY; TIME-SERIES; HOSPITAL ADMISSIONS; CARDIOVASCULAR-DISEASE; DEPARTMENT VISITS; DAILY MORTALITY; RISK-FACTORS; ROOM VISITS	Background Evidence of an association between fine particulate matter (PM2.5) and morbidity is limited in Asia. We used a case-crossover design to evaluate the association between short-term exposure to PM2.5 and emergency ambulance dispatches (as a proxy of acute health outcomes), and to calculate the extent to which a 10 mu g/m(3) decrease in PM2.5 concentrations would reduce the number of ambulance dispatches. Methods We used data on emergency ambulance dispatches in Fukuoka City, Japan between 2005 and 2010. Emergency ambulance services are publicly funded and cover the entire city. After excluding ambulance dispatches related to external injuries and pregnancy/childbirth, we analysed data on the remaining 176 123 dispatches. We also collected records of daily concentrations of PM2.5 from one ambient air pollution monitoring station. ORs per 10 mu g/m(3) increase in PM2.5 were estimated using conditional logistic regression controlled for ambient temperature and relative humidity. Results During the study period, the average daily concentration of PM2.5 was 20.3 mu g/m(3). Exposure to PM2.5 was associated with emergency ambulance dispatches in general (lag0-1; OR=1.008 (95% CI 1.002 to 1.014)) and with dispatches due to respiratory diseases (lag0-1; OR=1.027 (1.007 to 1.048)). No association was observed for dispatches due to cardiovascular diseases. We estimated that a 10 mu g/m(3) decrease in PM2.5 concentrations would have led to approximately 260 (estimated range=70-460) fewer ambulance dispatches in Fukuoka for 2012. Conclusions Providing further evidence on the short-term health effects of PM2.5 exposure, we found that exposure was associated with an increased number of emergency ambulance dispatches. The effect was, however, relatively small.	[Michikawa, Takehiro; Ueda, Kayo; Takeuchi, Ayano; Nitta, Hiroshi] Natl Inst Environm Studies, Environm Epidemiol Sect, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Kinoshita, Makoto; Hayashi, Hiromi] Environm Bur Fukuoka City, Fukuoka, Japan; [Ichinose, Takamichi] Oita Univ Nursing & Hlth Sci, Dept Hlth Sci, Oita, Japan	Michikawa, T (reprint author), Natl Inst Environm Studies, Environm Epidemiol Sect, Ctr Environm Hlth Sci, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	tmichikawa@nies.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25241015]	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25241015).	Anderson Jonathan O, 2012, J Med Toxicol, V8, P166, DOI 10.1007/s13181-011-0203-1; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Hajat S, 2002, INT J EPIDEMIOL, V31, P825, DOI 10.1093/ije/31.4.825; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-70; Zhu K, 2007, J AIR WASTE MANAGE, V57, P1499, DOI 10.3155/1047-3289.57.12.1499; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; DeGaetano AT, 2004, ATMOS ENVIRON, V38, P1547, DOI 10.1016/j.atmosenv.2003.12.020; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.edu.0000181315.18836.9d; Milojevic A, 2014, HEART, V100, P1093, DOI 10.1136/heartjnl-2013-304963; Slaughter JC, 2005, J EXPO ANAL ENV EPID, V15, P153, DOI 10.1038/sj.jea.7500382; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Patel MM, 2013, ENVIRON RES, V121, P71, DOI 10.1016/j.envres.2012.10.012; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Chauhan AJ, 2003, BRIT MED BULL, V68, P95, DOI 10.1093/bmb/ldg022; Malig BJ, 2013, AM J EPIDEMIOL, V178, P58, DOI 10.1093/aje/kws451; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Straney L, 2014, J EPIDEMIOL COMMUN H, V68, P6, DOI 10.1136/jech-2013-202955; Ueda K, 2009, J AIR WASTE MANAGE, V59, P1212, DOI 10.3155/1047-3289.59.10.1212; Darrow LA, 2011, J EXPO SCI ENV EPID, V21, P10, DOI 10.1038/jes.2009.49; Delfino RJ, 1997, AM J RESP CRIT CARE, V155, P568; Fukuoka Fire Prevention Bureau, 2014, FIR PREV ANN REP 201; Hagihara A, 2013, INTERN EMERG MED, V8, P431, DOI 10.1007/s11739-013-0956-4; Japanese Ministry of the Environment, 2014, ENV QUAL STAND JAP A; Kaneyasu N, 2011, J JPN SOC ATMOS ENV, V46, P111; Kaneyasu N, 2010, J JPN SOC ATMOS ENV, V45, P227; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Neuberger M, 2013, INT J ENV RES PUB HE, V10, P4728, DOI 10.3390/ijerph10104728; Ng CFS, 2014, J EPIDEMIOL, V24, P15, DOI 10.2188/jea.JE20130051; Saitama Prefecture Japan, PRIC TAG PUBL ADM; Stieb DM, 1998, AM J EPIDEMIOL, V148, P666; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; United States Environmental Protection Agency, NAT AMB AIR QUAL STA; WHO W. H. O., 2005, AIR QUAL GUID GLOB U; Yamagami M, 2013, J JPN SOC ATMOS ENV, V48, P196	38	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	JAN	2015	69	1					86	91		10.1136/jech-2014-203961		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AW3BT	WOS:000346161300030		
J	Tripathi, MK; Sahu, KC; Karapetsas, G; Sefiane, K; Matar, OK				Tripathi, M. K.; Sahu, K. C.; Karapetsas, G.; Sefiane, K.; Matar, O. K.			Non-isothermal bubble rise: non-monotonic dependence of surface tension on temperature	JOURNAL OF FLUID MECHANICS			English	Article						drops and bubbles; multiphase flow; thermocapillarity	LARGE MARANGONI NUMBERS; THERMOCAPILLARY-DRIVEN MOTION; SELF-REWETTING FLUIDS; STATIONARY BUBBLE; HEAT-TRANSFER; LONG BUBBLES; GAS BUBBLE; MIGRATION; GRADIENT; DROP	We study the motion of a bubble driven by buoyancy and thermocapillarity in a tube with a non-uniformly heated walls, containing a so-called 'self-rewetting fluid'; the surface tension of the latter exhibits a parabolic dependence on temperature, with a well-defined minimum. In the Stokes flow limit, we derive the conditions under which a spherical bubble can come to rest in a self-rewetting fluid whose temperature varies linearly in the vertical direction, and demonstrate that this is possible for both positive and negative temperature gradients. This is in contrast to the case of simple fluids whose surface tension decreases linearly with temperature, for which bubble motion is arrested only for negative temperature gradients. In the case of self-rewetting fluids, we propose an analytical expression for the position of bubble arrestment as a function of other dimensionless numbers. We also perform direct numerical simulation of axisymmetric bubble motion in a fluid whose temperature increases linearly with vertical distance from the bottom of the tube; this is done for a range of Bond and Galileo numbers, as well as for various parameters that govern the functional dependence of surface tension on temperature. We demonstrate that bubble motion can be reversed and then arrested only in self-rewetting fluids, and not in linear fluids, for sufficiently small Bond numbers. We also demonstrate that considerable bubble elongation is possible under significant wall confinement, and for strongly self-rewetting fluids and large Bond numbers. The mechanisms underlying the phenomena observed are elucidated by considering how the surface tension dependence on temperature affects the thermocapillary stresses in the flow.	[Tripathi, M. K.; Sahu, K. C.] Indian Inst Technol Hyderabad, Dept Chem Engn, Yeddumailaram 502205, Andhra Pradesh, India; [Karapetsas, G.] Univ Thessaly, Dept Mech Engn, Volos 38334, Greece; [Matar, O. K.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England; [Sefiane, K.] Univ Edinburgh, Sch Engn, Edinburgh EH9 3JL, Midlothian, Scotland; [Sefiane, K.] Kyushu Univ, Int Inst Carbon Neutral Energy Res I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Matar, OK (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.	o.matar@imperial.ac.uk	Karapetsas, George/F-5815-2010; 	Karapetsas, George/0000-0002-3486-7484; Tripathi, Manoj/0000-0001-9744-000X	Engineering and Physical Sciences Research Council, UK [EP/K003976/1]; Indian National Science Academy	O.K.M. wishes to thank the Engineering and Physical Sciences Research Council, UK, for their support through the MEMPHIS Programme Grant (number EP/K003976/1). K.C.S. would also like to thank Indian National Science Academy for their financial support. We thank the anonymous referee for providing an alternative derivation (included in the appendix A) of the creeping flow calculation given in 3.	ACRIVOS A, 1990, J FLUID MECH, V212, P95, DOI 10.1017/S0022112090001884; Balasubramaniam R, 2000, PHYS FLUIDS, V12, P733, DOI 10.1063/1.870330; Ding H, 2007, J COMPUT PHYS, V226, P2078, DOI 10.1016/j.jcp.2007.06.028; Savino R, 2009, INT J HEAT FLUID FL, V30, P380, DOI 10.1016/j.ijheatfluidflow.2009.01.009; Ma C, 2011, INT J MULTIPHAS FLOW, V37, P1045, DOI 10.1016/j.ijmultiphaseflow.2011.06.005; Liu HH, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013010; Nas S, 2006, INT J HEAT MASS TRAN, V49, P2265, DOI 10.1016/j.ijheatmasstransfer.2005.12.009; YOUNG NO, 1959, J FLUID MECH, V6, P350, DOI 10.1017/S0022112059000684; Karapetsas G, 2014, LANGMUIR, V30, P4310, DOI 10.1021/la5002682; Nas S, 2003, INT J MULTIPHAS FLOW, V29, P1117, DOI 10.1016/S0301-9322(03)00084-3; VOCHTEN R, 1973, J COLLOID INTERF SCI, V42, P320, DOI 10.1016/0021-9797(73)90295-6; Ahmed S, 1999, J HEAT TRANS-T ASME, V121, P80, DOI 10.1115/1.2825972; Abe Y, 2004, ANN NY ACAD SCI, V1027, P269, DOI 10.1196/annals.1324.022; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; HajHariri H, 1997, PHYS FLUIDS, V9, P845, DOI 10.1063/1.869182; Hu YX, 2014, INT J HEAT MASS TRAN, V70, P496, DOI 10.1016/j.ijheatmasstransfer.2013.11.031; McGillis WR, 1996, J HEAT TRANS-T ASME, V118, P103, DOI 10.1115/1.2824021; Balasubramaniam R, 1996, INT J MULTIPHAS FLOW, V22, P593, DOI 10.1016/0301-9322(95)00075-5; BALASUBRAMANIAM R, 1987, J COLLOID INTERF SCI, V119, P531, DOI 10.1016/0021-9797(87)90300-6; Balasubramaniam R, 2004, PHYS FLUIDS, V16, P3131, DOI 10.1063/1.1768091; Balasubramaniam R, 1998, INT J MULTIPHAS FLOW, V24, P679, DOI 10.1016/S0301-9322(97)00075-X; Borcia R, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056309; Brady PT, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3529442; CHEN JC, 1992, AIAA J, V30, P993, DOI 10.2514/3.11019; CHEN JN, 1991, J FLUID MECH, V233, P405, DOI 10.1017/S002211209100054X; Crespo A, 1998, INT J MULTIPHAS FLOW, V24, P685, DOI 10.1016/S0301-9322(97)00076-1; HASAN M., 1989, J THERMOPHYS HEAT TR, V3, P87, DOI 10.2514/3.131; Herrmann M., 2008, P SUMM PROGR 2008 CT, P155; Keh HJ, 2002, INT J MULTIPHAS FLOW, V28, P1149, DOI 10.1016/S0301-9322(02)00018-6; Leal L. G., 1992, LAMINAR FLOW CONVECT; Leshansky AM, 2001, J FLUID MECH, V443, P377; Leshansky AM, 2001, J COLLOID INTERF SCI, V240, P544, DOI 10.1006/jcis.2001.7659; LIMBOURGFONTAINE MC, 1986, NATURWISSENSCHAFTEN, V73, P360, DOI 10.1007/BF00367265; Mahesri S, 2014, HEAT MASS TRANSFER, V50, P363, DOI 10.1007/s00231-013-1269-x; Mazouchi A, 2001, PHYS FLUIDS, V13, P1594, DOI 10.1063/1.1369604; Mazouchi A, 2000, PHYS FLUIDS, V12, P542, DOI 10.1063/1.870260; MERRITT RM, 1993, J COLLOID INTERF SCI, V155, P200, DOI 10.1006/jcis.1993.1026; MEYYAPPAN M, 1987, J COLLOID INTERF SCI, V115, P206, DOI 10.1016/0021-9797(87)90025-7; NAHME R., 1940, ING ARCH, V11, P191, DOI 10.1007/BF02086920; PETRE G, 1984, J COLLOID INTERF SCI, V98, P261, DOI 10.1016/0021-9797(84)90503-4; Popinet S, 2003, J COMPUT PHYS, V190, P572, DOI 10.1016/S0021-9991(03)00298-5; Savino R, 2013, ACTA ASTRONAUT, V89, P179, DOI 10.1016/j.actaastro.2013.03.020; Subramanian R. S., 2002, PHYS FLUIDS MICROGRA, P149; SUBRAMANIAN R. S., 1992, TRANSPORT PROCESSES, P1; SUBRAMANIAN RS, 1981, AICHE J, V27, P646, DOI 10.1002/aic.690270417; SUBRAMANIAN RS, 1983, ADV SPACE RES, V3, P145, DOI 10.1016/0273-1177(83)90239-9; Sussman M, 1997, J FLUID MECH, V341, P269, DOI 10.1017/S0022112097005570; SUZUKI K., 2005, P KSME JSME JOINT C, P21; Tripathi MK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04771; Welch SWJ, 1998, J COLLOID INTERF SCI, V208, P500, DOI 10.1006/jcis.1998.5883; WILSON SK, 1993, PHYS FLUIDS A-FLUID, V5, P2064, DOI 10.1063/1.858544; Wu ZB, 2012, ACTA MECH, V223, P609, DOI 10.1007/s00707-011-0587-7; Wu ZB, 2013, J MATH PHYS, V54, DOI 10.1063/1.4792476; Yariv E, 2006, PHYS FLUIDS, V18, DOI [10.1063/1.2218767, 10.1063/1.221876]; Zhang L, 2001, J FLUID MECH, V448, P197; Zhao JF, 2010, MICROGRAVITY SCI TEC, V22, P295, DOI 10.1007/s12217-010-9193-x	56	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	JAN	2015	763						82	108		10.1017/jfm.2014.659		27	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AW2ZO	WOS:000346155300004		
J	Tanaka, M; Wakayama, K				Tanaka, Mitsuhiro; Wakayama, Kyoichi			A numerical study on the energy transfer from surface waves to interfacial waves in a two-layer fluid system	JOURNAL OF FLUID MECHANICS			English	Article						internal waves; surface gravity waves	GENERAL THEORY; GRAVITY-WAVES; RESONANCE	Interaction between surface and interfacial waves with continuous energy spectra in a two-layer density stratified fluid system is investigated numerically. For an initial wave field which consists only of the surface waves all propagating in the same direction, it is confirmed that the spectra S-s(k) of the surface waves and S-i(k) of the interfacial waves change significantly due to the recently found class 3 triad resonance. When the bulk of the surface wave spectrum S-s(k) is initially located well above the critical wavenumber k(crit), below which the class 3 triad resonance is prohibited, S-s(k) downshifts gradually toward the lower wavenumber during the initial stage of evolution. However, this downshift halts when the peak of S-s(k) reaches around k(crit), and after that a steep peak forms in S-s(k) around k(crit). It is confirmed that the timescale of the spectral evolution is of O(1/epsilon(2)) (epsilon is a characteristic non-dimensional wave amplitude) in most of the k space, consistent with the prediction of the wave turbulence theory for a system with a decay-type dispersion relation. However, it is also found that the timescale of the formation and growth of the sharp peak in S-s(k) around k(crit) is of O(1/epsilon), i.e. the timescale of the deterministic three-wave resonance.	[Tanaka, Mitsuhiro; Wakayama, Kyoichi] Gifu Univ, Fac Engn, Gifu 5011193, Japan	Tanaka, M (reprint author), Gifu Univ, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	tanaka@gifu-u.ac.jp					Alam MR, 2009, J FLUID MECH, V624, P225, DOI 10.1017/S002211200800548X; Ambrosi D, 2000, WAVE MOTION, V31, P71, DOI 10.1016/S0165-2125(99)00024-4; Alam MR, 2012, J FLUID MECH, V691, P267, DOI 10.1017/jfm.2011.473; OSBORNE AR, 1980, SCIENCE, V208, P451, DOI 10.1126/science.208.4443.451; HASSELMANN K, 1962, J FLUID MECH, V12, P481, DOI 10.1017/S0022112062000373; FUNAKOSHI M, 1983, J PHYS SOC JPN, V52, P1982, DOI 10.1143/JPSJ.52.1982; BALL D. K., 1964, J FLUID MECH, V19, P465; BENNEY DJ, 1977, STUD APPL MATH, V56, P81; BENNEY DJ, 1976, STUD APPL MATH, V55, P93; CRAIK A. D. D., 1985, WAVE INTERACTIONS FL; DOMMERMUTH DG, 1987, J FLUID MECH, V184, P267, DOI 10.1017/S002211208700288X; MCGOLDRICK R. F., 1965, J FLUID MECH, V21, P305; Nazarenko S, 2011, LECT NOTES PHYS, V825, P1, DOI 10.1007/978-3-642-15942-8; PHILLIPS OM, 1960, J FLUID MECH, V9, P193, DOI 10.1017/S0022112060001043; Turner J. S., 1973, BUOYANCY EFFECTS FLU; WEST BJ, 1987, J GEOPHYS RES-OCEANS, V92, P11803, DOI 10.1029/JC092iC11p11803; Zakharov V. E., 1992, KOLMOGOROV SPECTRA T	17	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	JAN	2015	763						202	217		10.1017/jfm.2014.668		16	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AW2ZO	WOS:000346155300008		
J	Feldman, O; Kinoshita, K; Bull, P				Feldman, Ofer; Kinoshita, Ken; Bull, Peter			Culture or Communicative Conflict? The Analysis of Equivocation in Broadcast Japanese Political Interviews	JOURNAL OF LANGUAGE AND SOCIAL PSYCHOLOGY			English	Article						political interviews; television; media discourse; theory of equivocation; Japan		The focus of this article is on equivocation in Japanese televised interviews, broadcast over a 14-month period in 2012-2013 (before and after the general election of December 16, 2012). An analysis was conducted of responses to questions by three different groups (national politicians, local politicians, and nonpoliticians). Results showed a striking level of equivocation by both national and local politicians, who together equivocated significantly more than nonpoliticians. Furthermore, national-level Diet members equivocated significantly more than local politicians, and both coalition groupings when in power were significantly more likely to equivocate than when in opposition. The results were interpreted in terms of the situational theory of communicative conflict and also in terms of cultural norms characteristic of Japanese politics and society. The failure to consider the role of such norms, it is proposed, represents an important omission in the original theory of equivocation.	[Feldman, Ofer; Kinoshita, Ken] Doshisha Univ, Fac Policy Studies, Kyoto 6028580, Japan; [Bull, Peter] Univ York, York YO10 5DD, N Yorkshire, England	Feldman, O (reprint author), Doshisha Univ, Fac Policy Studies, Kamigyo Ku, Keisuikan 228, Kyoto 6028580, Japan.	ofeldman@mail.doshisha.ac.jp					Bavelas J. B., 1988, J LANG SOC PSYCHOL, V7, P137; Bavelas J. B., 1990, EQUIVOCAL COMMUNICAT; Bull P., 1993, POLITICAL PSYCHOL, V4, P651; Bull P, 1996, BRIT J SOC PSYCHOL, V35, P267; Bull P, 2008, J LANG SOC PSYCHOL, V27, P333, DOI 10.1177/0261927X08322475; Bull P. E., 1994, J LANG SOC PSYCHOL, V13, P115; Bull Peter, 2003, MICROANALYSIS POLITI; Clayman Steven E., 2002, NEWS INTERVIEW JOURN; Day R, 1991, GRAND INQUISITOR; Feldman O, 2004, TALKING POLITICS JAP; Feldman O, 2011, JAPANESE POLITICS TODAY: FROM KARAOKE TO KABUKI DEMOCRACY, P183; Furo H, 2001, TURN TAKING ENGLISH; Harris S., 1991, BROADCAST TALK, P76; Heritage J., 1991, TALK SOCIAL STRUCTUR, P93; Heritage John, 1985, HDB DISCOURSE ANAL, P95; Hu Y, 1999, STUDY QUESTION EVASI; Huang Y., 2009, DIALOGUE ANAL 11, P155; Jucker J., 1986, NEWS INTERVIEWS PRAG; Tanaka Lidia, 2004, GENDER LANGUAGE CULT; Weizman E, 2008, DIALOGUE STUD, V3, P1; Yokota M, 1994, ISSUES APPL LINGUIST, V5, P353	21	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0261-927X	1552-6526		J LANG SOC PSYCHOL	J. Lang. Soc. Psychol.	JAN	2015	34	1					65	89		10.1177/0261927X14557567		25	Communication; Linguistics; Psychology, Social	Communication; Linguistics; Psychology	AW0EZ	WOS:000345964800004		
J	Yin, K; Zhang, ZX; Li, XW; Yang, L; Tachibana, K; Hirano, SI				Yin, Kun; Zhang, Zhengxi; Li, Xiaowei; Yang, Li; Tachibana, Kazuhiro; Hirano, Shin-ichi			Polymer electrolytes based on dicationic polymeric ionic liquids: application in lithium metal batteries	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							NANOPARTICLE HYBRID ELECTROLYTES; GEL ELECTROLYTES; THERMAL-PROPERTIES; DENDRITE FORMATION; CELLS; MEMBRANES; METHACRYLATE; CHALLENGES; CONDUCTION; MORPHOLOGY	Polymeric ionic liquids (PILs) have stirred up great interest for their potential applications as electrolyte hosts in lithium metal batteries (LMBs) because of their desirable performance. In this work, PIL-based gel polymer electrolytes applied in lithium metal batteries (LMBs) at low-medium temperatures (25 degrees C, 30 degrees C and 40 degrees C) are first reported. A novel imidazolium-tetraalkylammonium-based dicationic polymeric ionic liquid, poly(N, N, N-trimethyl-N-(1-vinlyimidazolium-3-ethyl)-ammonium bis(trifluoromethanesulfonyl) imide) is successfully synthesized, and its structure and purity are confirmed by H-1 NMR, FTIR and elemental analysis. Subsequently, the ternary gel polymer electrolytes are prepared by blending the as-synthesized dicationic PIL as the polymer host with 1,2-dimethyl-3-ethoxyethyl imidazolium bis(trifluoromethanesulfonyl) imide (IM(2o2)11TFSI) ionic liquid and LiTFSI salt in different weight ratios. The PIL-LiTFSI-IM(2o2) 11TFSI electrolytes reveal low glass transition temperatures around -54 degrees C and high thermal stability to about 330 degrees C. Moreover, the ternary gel polymer electrolytes show good ion conductivity around 10(-4) S cm(-1) at low-medium temperatures, high electrochemical stability and good interfacial stability with lithium metal. Particularly, the Li/LiFePO4 cells assembled with polymer electrolytes at a rate of 0.1 C are able to deliver discharge capacities of about 160 mA h g(-1), 140 mA h g(-1) and 120 mA h g(-1) at 40 degrees C, 30 degrees C and 25 degrees C, respectively, with excellent capacity retention, as well as exhibiting acceptable rate capability. These findings reveal that dicationic PIL-based electrolytes have great potential for use as safe electrolytes in LMBs.	[Yin, Kun; Zhang, Zhengxi; Li, Xiaowei; Yang, Li] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China; [Tachibana, Kazuhiro] Yamagata Univ, Fac Engn, Dept Chem & Chem Engn, Yamagata 9928510, Japan; [Yang, Li; Hirano, Shin-ichi] Shanghai Jiao Tong Univ, Hirano Inst Mat Innovat, Shanghai 200240, Peoples R China	Zhang, ZX (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.	zhengxizhang@sjtu.edu.cn; liyangce@sjtu.edu.cn			National Natural Science Foundation of China [21373136]	The authors are indebted to the National Natural Science Foundation of China (Grants no. 21373136) and Hitachi Chemical Co. Ltd. We thank the Instrumental Analysis Center of Shanghai Jiao Tong University for Materials Characterization.	Isken P, 2013, J POWER SOURCES, V225, P157, DOI 10.1016/j.jpowsour.2012.09.098; Chen XJ, 2012, J MATER CHEM, V22, P18018, DOI 10.1039/c2jm33273f; Tatsuma T, 2001, ELECTROCHIM ACTA, V46, P1201, DOI 10.1016/S0013-4686(00)00706-4; Cha EH, 2004, ELECTROCHIM ACTA, V50, P335, DOI 10.1016/j.electaca.2004.01.101; Dobbelin M, 2012, CHEM MATER, V24, P1583, DOI 10.1021/cm203790z; Lu YY, 2012, ADV MATER, V24, P4430, DOI 10.1002/adma.201201953; Stephan AM, 2006, EUR POLYM J, V42, P21, DOI 10.1016/j.eurpolymj.2005.09.017; Appetecchi GB, 2010, J POWER SOURCES, V195, P3668, DOI 10.1016/j.jpowsour.2009.11.146; Bandomir J, 2014, MACROMOL CHEM PHYS, V215, P716, DOI 10.1002/macp.201400009; Marcilla R, 2004, J POLYM SCI POL CHEM, V42, P208, DOI 10.1002/pola.11015; Liao C, 2013, ELECTROCHIM ACTA, V87, P889, DOI 10.1016/j.electacta.2012.10.027; Gerbaldi C, 2012, J MEMBRANE SCI, V423, P459, DOI 10.1016/j.memsci.2012.08.057; Chen H, 2009, MACROMOLECULES, V42, P4809, DOI 10.1021/ma900713e; Li MT, 2013, J MEMBRANE SCI, V447, P222, DOI 10.1016/j.memsci.2013.07.007; Zewde BW, 2013, CHEMSUSCHEM, V6, P1400, DOI 10.1002/cssc.201300296; Ferrari S, 2010, J POWER SOURCES, V195, P559, DOI 10.1016/j.jpowsour.2009.08.015; Li MT, 2014, ELECTROCHIM ACTA, V123, P296, DOI 10.1016/j.electacta.2013.12.179; Lu YY, 2014, ANGEW CHEM INT EDIT, V53, P488, DOI 10.1002/anie.201307137; Cui ZY, 2008, J MEMBRANE SCI, V325, P957, DOI 10.1016/j.memsci.2008.09.022; Shin JH, 2005, J ELECTROCHEM SOC, V152, pA978, DOI 10.1149/1.1890701; Pont AL, 2009, J POWER SOURCES, V188, P558, DOI 10.1016/j.jpowsour.2008.11.115; Yin K, 2014, J POWER SOURCES, V258, P150, DOI 10.1016/j.jpowsour.2014.02.057; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Fernicola A, 2007, J POWER SOURCES, V174, P342, DOI 10.1016/j.jpowsour.2007.09.013; Tatsuma T, 1999, J ELECTROANAL CHEM, V472, P142, DOI 10.1016/S0022-0728(99)00294-6; Idris NH, 2012, J POWER SOURCES, V201, P294, DOI 10.1016/j.jpowsour.2011.10.141; Li MT, 2012, POLYM INT, V61, P259, DOI 10.1002/pi.3181; Li MT, 2011, J POWER SOURCES, V196, P8662, DOI 10.1016/j.jpowsour.2011.06.059; YOSHIMATSU I, 1988, J ELECTROCHEM SOC, V135, P2422, DOI 10.1149/1.2095351; Yoon H, 2013, ENERG ENVIRON SCI, V6, P979, DOI 10.1039/c3ee23753b; Yoshizawa M, 2002, POLYM ADVAN TECHNOL, V13, P589, DOI 10.1002/pat.261; Wu F, 2011, ADV MATER, V23, P5081, DOI 10.1002/adma.201103161; Rosso M, 2006, ELECTROCHIM ACTA, V51, P5334, DOI 10.1016/j.electacta.2006.02.004; Fergus JW, 2010, J POWER SOURCES, V195, P4554, DOI 10.1016/j.jpowsour.2010.01.076; Quartarone E, 2011, CHEM SOC REV, V40, P2525, DOI 10.1039/c0cs00081g; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Yuan JY, 2013, PROG POLYM SCI, V38, P1009, DOI 10.1016/j.progpolymsci.2013.04.002; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Balducci A, 2011, J POWER SOURCES, V196, P9719, DOI 10.1016/j.jpowsour.2011.07.058; Brandrup J., 1999, POLYM HDB; Green MD, 2011, MACROMOL CHEM PHYS, V212, P2522, DOI 10.1002/macp.201100389; Jankovic L, 2011, APPL CLAY SCI, V51, P438, DOI 10.1016/j.clay.2011.01.006; Jin YD, 2012, IND ENG CHEM RES, V51, P11011, DOI 10.1021/ie300849u; MATSUI T, 1995, ELECTROCHIM ACTA, V40, P2165, DOI 10.1016/0013-4686(95)00158-B; Ohno H, 1998, CHEM LETT, P751, DOI 10.1246/cl.1998.751; Osaka T, 1997, J ELECTROANAL CHEM, V421, P153, DOI 10.1016/S0022-0728(96)04870-X; Peled E, 1997, J ELECTROCHEM SOC, V144, pL208, DOI 10.1149/1.1837858	47	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	1					170	178		10.1039/c4ta05106h		9	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW0EI	WOS:000345962800023		
J	Ma, W; Kim, JJ; Tsvetkov, N; Daio, T; Kuru, Y; Cai, ZH; Chen, Y; Sasaki, K; Tuller, HL; Yildiz, B				Ma, Wen; Kim, Jae Jin; Tsvetkov, Nikolai; Daio, Takeshi; Kuru, Yener; Cai, Zhuhua; Chen, Yan; Sasaki, Kazunari; Tuller, Harry L.; Yildiz, Bilge			Vertically aligned nanocomposite La0.8Sr0.2CoO3/(La0.5Sr0.5)(2)CoO4 cathodes - electronic structure, surface chemistry and oxygen reduction kinetics	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							OXIDE FUEL-CELLS; THIN-FILM ELECTRODES; CONDUCTING ELECTRODES; SCREW DISLOCATION; STRAIN CONTROL; METAL-OXIDES; ENHANCEMENT; GROWTH; PEROVSKITES; SEGREGATION	The hetero-interfaces between the perovskite (La1-xSrx)CoO3 (LSC113) and the Ruddlesden-Popper (La1-xSrx)(2)CoO4 (LSC214) phases have recently been reported to exhibit fast oxygen exchange kinetics. Vertically aligned nanocomposite (VAN) structures offer the potential for embedding a high density of such special interfaces in the cathode of a solid oxide fuel cell in a controllable and optimized manner. In this work, VAN thin films with hetero-epitaxial interfaces between LSC113 and LSC214 were prepared by pulsed laser deposition. In situ scanning tunneling spectroscopy established that the LSC214 domains in the VAN structure became electronically activated, by charge transfer across interfaces with adjacent LSC113 domains above 250 degrees C in 10 (3) mbar of oxygen gas. Atomic force microscopy and X-ray photoelectron spectroscopy analysis revealed that interfacing LSC214 with LSC113 also provides for a more stable cation chemistry at the surface of LSC214 within the VAN structure, as compared to single phase LSC214 films. Oxygen reduction kinetics on the VAN cathode was found to exhibit approximately a 10-fold enhancement compared to either single phase LSC113 and LSC214 in the temperature range of 320-400 degrees C. The higher reactivity of the VAN surface to the oxygen reduction reaction is attributed to enhanced electron availability for charge transfer and the suppression of detrimental cation segregation. The instability of the LSC113/214 hetero-structure surface chemistry at temperatures above 400 degrees C, however, was found to lead to degraded ORR kinetics. Thus, while VAN structures hold great promise for offering highly ORR reactive electrodes, efforts towards the identification of more stable heterostructure compositions for high temperature functionality are warranted.	[Ma, Wen; Tsvetkov, Nikolai; Kuru, Yener; Cai, Zhuhua; Chen, Yan; Yildiz, Bilge] MIT, Lab Electrochem Interfaces, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Kim, Jae Jin; Kuru, Yener; Tuller, Harry L.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Daio, Takeshi; Sasaki, Kazunari] Kyushu Univ, Dept Mech Engn, Fukuoka 8190395, Japan	Yildiz, B (reprint author), MIT, Lab Electrochem Interfaces, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	byildiz@mit.edu	Chen, Yan/A-1257-2014; Tsvetkov, Nikolai/I-4339-2015	Chen, Yan/0000-0001-6063-023X; 	US-DOE Basic Energy Sciences at MIT [DE-SC0002633]; Progress-100 program at Kyushu University; Kwanjeong Educational Foundation	This work was supported by the US-DOE Basic Energy Sciences, Grant no. DE-SC0002633 at MIT. The cross sectional SEM, X-ray diffraction, X-ray photoelectron spectroscopy and Auger electron spectroscopy measurements were performed at the Center of Materials Science and Engineering, an NSF MRSEC facility at MIT. T. D. and K. S. acknowledge financial support from the Progress-100 program at Kyushu University. JJK thanks the Kwanjeong Educational Foundation for fellowship support.	Dupin JC, 2000, PHYS CHEM CHEM PHYS, V2, P1319, DOI 10.1039/a908800h; Crumlin EJ, 2012, ENERG ENVIRON SCI, V5, P6081, DOI 10.1039/c2ee03397f; Greiner MT, 2012, NAT MATER, V11, P76, DOI [10.1038/nmat3159, 10.1038/NMAT3159]; Merkle R, 2008, ANGEW CHEM INT EDIT, V47, P3874, DOI 10.1002/anie.200700987; Chen Y, 2012, ENERG ENVIRON SCI, V5, P7979, DOI 10.1039/c2ee21463f; Baumann FS, 2006, SOLID STATE IONICS, V177, P1071, DOI 10.1016/j.ssi.2006.02.045; Jalili H, 2011, J PHYS CHEM LETT, V2, P801, DOI 10.1021/jz200160b; Petric A, 2000, SOLID STATE IONICS, V135, P719, DOI 10.1016/S0167-2738(00)00394-5; Heel A, 2010, J POWER SOURCES, V195, P6709, DOI 10.1016/j.jpowsour.2010.04.006; Bi ZX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3257175; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Januschewsky J, 2009, ADV FUNCT MATER, V19, P3151, DOI 10.1002/adfm.200900362; Adler SB, 2004, CHEM REV, V104, P4791, DOI 10.1021/cr020724o; Yoon J, 2009, ADV FUNCT MATER, V19, P3868, DOI 10.1002/adfm.200901338; Sase M, 2008, SOLID STATE IONICS, V178, P1843, DOI 10.1016/j.ssi.2007.11.039; Lee W, 2013, J AM CHEM SOC, V135, P7909, DOI 10.1021/ja3125349; HAWLEY M, 1991, SCIENCE, V251, P1587, DOI 10.1126/science.251.5001.1587; Cai ZH, 2012, CHEM MATER, V24, P1116, DOI 10.1021/cm203501u; [Anonymous], 1998, SOLID STATE IONICS; Hayd J, 2013, J ELECTROCHEM SOC, V160, pF351, DOI 10.1149/2.017304jes; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Jung W, 2011, ADV ENERGY MATER, V1, P1184, DOI 10.1002/aenm.201100164; Peters C, 2008, J ELECTROCHEM SOC, V155, pB730, DOI 10.1149/1.2909552; Brandon NP, 2003, ANNU REV MATER RES, V33, P183, DOI 10.1146/annurev.matsci.33.022802.094122; Chen AP, 2013, ACTA MATER, V61, P2783, DOI 10.1016/j.actamat.2012.09.072; van der Heide PAW, 2002, SURF INTERFACE ANAL, V33, P414, DOI 10.1002/sia.1227; Meng F, 2013, ACCOUNTS CHEM RES, V46, P1616, DOI 10.1021/ar400003q; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Han JW, 2012, ENERG ENVIRON SCI, V5, P8598, DOI 10.1039/c2ee03592h; Su Q, 2013, J POWER SOURCES, V242, P455, DOI 10.1016/j.jpowsour.2013.05.137; Kubicek M, 2011, J ELECTROCHEM SOC, V158, pB727, DOI 10.1149/1.3581114; Kuklja MM, 2013, PHYS CHEM CHEM PHYS, V15, P5443, DOI 10.1039/c3cp44363a; Morin SA, 2010, SCIENCE, V328, P476, DOI 10.1126/science.1182977; [Anonymous], 2001, NIST DATABASE 82; Cai ZH, 2011, J AM CHEM SOC, V133, P17696, DOI 10.1021/ja2059445; Crumlin EJ, 2010, J PHYS CHEM LETT, V1, P3149, DOI 10.1021/jz101217d; Kushima A, 2011, PHYS CHEM CHEM PHYS, V13, P2242, DOI 10.1039/c0cp01603a; Deskins NA, 2010, J PHYS CHEM C, V114, P5891, DOI 10.1021/jp101155t; Fleig J, 2002, SOLID STATE IONICS, V150, P181, DOI 10.1016/S0167-2738(02)00274-6; la O' GJ, 2010, ANGEW CHEM INT EDIT, V49, P5344, DOI 10.1002/anie.201001922; Chueh WC, 2012, ANNU REV CHEM BIOMOL, V3, P313, DOI 10.1146/annurev-chembioeng-073009-101000; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Wachsman ED, 2011, SCIENCE, V334, P935, DOI 10.1126/science.1204090; Chen Y, 2013, ADV ENERGY MATER, V3, P1221, DOI 10.1002/aenm.201300025; Chen Y., 2014, IN PREPARATION; Ganduglia-Pirovano MV, 2007, SURF SCI REP, V62, P219, DOI 10.1016/j.surfrep.2007.03.002; Jung W, 2008, J ELECTROCHEM SOC, V155, pB1194, DOI 10.1149/1.2976212; Kakihana M, 1999, B CHEM SOC JPN, V72, P1427, DOI 10.1246/bcsj.72.1427; Lebedev OI, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.104421; Lee KT, 2005, J ELECTROCHEM SOC, V152, pA197, DOI 10.1149/1.1828243; Li YG, 2010, CHEM MATER, V22, P5537, DOI 10.1021/cm101546t; MaCmanus-Driscoll JL, 2008, NAT MATER, V7, P314, DOI 10.1038/nmat2124; Sase M, 2008, J ELECTROCHEM SOC, V155, pB793, DOI 10.1149/1.2928612; Tsvetkov N, 2014, J MATER CHEM A, V2, P14690, DOI 10.1039/c4ta01889c; van Berkel F. P. F., 2006, P 7 EUR SOL OX FUEL, P1; Vashook VV, 2000, SOLID STATE IONICS, V138, P99, DOI 10.1016/S0167-2738(00)00774-8; Wang SY, 2010, CHEM MATER, V22, P776, DOI 10.1021/cm9014139; Yashiro K, 2009, ELECTROCHEM SOLID ST, V12, pB135, DOI 10.1149/1.3170903	58	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	1					207	219		10.1039/c4ta04993d		13	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW0EI	WOS:000345962800027		
J	Zheng, YH; Rosa, L; Thai, T; Ng, SH; Gomez, DE; Ohshima, H; Bach, U				Zheng, Yuanhui; Rosa, Lorenzo; Thai, Thibaut; Ng, Soon Hock; Gomez, Daniel E.; Ohshima, Hiroyuki; Bach, Udo			Asymmetric gold nanodimer arrays: electrostatic self-assembly and SERS activity	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							ENHANCED RAMAN-SCATTERING; SURFACE-PLASMON RESONANCES; NANOPARTICLE DIMERS; SINGLE GOLD; SILVER NANOPARTICLES; DNA; NANOSTRUCTURES; PLACEMENT; CLUSTERS; NANOCRYSTALS	A simple, scalable, low-cost and high-throughput nanofabrication method is developed to produce discrete gold nanoparticle (AuNP) dimer arrays. This method involves a two-step electrostatic self-assembly: (1) electrostatic immobilization of negatively charged AuNPs onto a positively charged surface and (2) electrostatic adsorption of a positively charged AuNP onto each pre-assembled AuNP. The latter requires a careful control of the electrostatic energy barrier originating from the interactions between the charged AuNPs and surfaces. This can readily be achieved by tuning the ionic strength of the self-assembly media. We calculate the interaction energies for immobilizing a single positively charged AuNP onto each pre-assembled NP at different ionic strengths and present successful experimental results on the synthesis of high-yield symmetric and asymmetric AuNP dimers (dimer yield: similar to 85%). A theoretical and experimental investigation of their optical properties is conducted to correlate the spectral properties of these dimers with their structure. We also study the SERS activity of the as-synthesized AuNP dimers using benzenethiol as a model analyte. It is found that, with the increase of the size dissimilarity between the two NPs in the dimers, the Raman intensities of the analyte increase gradually. This trend is completely different from those of both single AuNPs and AuNP aggregates with identical particle size.	[Zheng, Yuanhui; Gomez, Daniel E.; Bach, Udo] Commonwealth Sci & Ind Res Org, Mat Sci & Engn, Clayton, Vic 3169, Australia; [Zheng, Yuanhui; Thai, Thibaut; Ng, Soon Hock; Bach, Udo] Melbourne Ctr Nanofabricat, Clayton, Vic 3168, Australia; [Rosa, Lorenzo] Swinburne Univ Technol, Ctr Microphoton H34, Hawthorn, Vic 3122, Australia; [Thai, Thibaut; Ng, Soon Hock; Bach, Udo] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia; [Ohshima, Hiroyuki] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan	Zheng, YH (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.	Yuanhui.Zheng@unsw.edu.au; Udo.Bach@monash.edu	Bach, Udo/F-3880-2012; Rosa, Lorenzo/B-7728-2012	Rosa, Lorenzo/0000-0002-9210-5680	Australian Research Council; UNSW; Australian Postdoctoral Fellowship; Commonwealth Scientific and Industrial Research Organization through an OCE Science Leader position;  [DP110101767]	The authors acknowledge financial support from the Australian Research Council through an Australian Research Fellowship (UB), a UNSW Vice-chancellor Fellowship (YZ) an Australian Postdoctoral Fellowship (D.E.G) and a Discovery Project DP110101767 (D.E.G). Further financial support has been received from Commonwealth Scientific and Industrial Research Organization through an OCE Science Leader position (UB). This work was performed at the Melbourne Centre for Nanofabrication (MCN) in the Victorian Node of the Australian National Fabrication Facility (ANFF). Part of this work was performed on the swinSTAR supercomputer at Swinburne University of Technology.	Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Chen G, 2009, J AM CHEM SOC, V131, P4218, DOI 10.1021/ja900809z; Hao E, 2004, J CHEM PHYS, V120, P357, DOI 10.1063/1.1629280; Zheng YH, 2011, ANGEW CHEM INT EDIT, V50, P4398, DOI 10.1002/anie.201006991; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Lim DK, 2010, NAT MATER, V9, P60, DOI [10.1038/nmat2596, 10.1038/NMAT2596]; Li WY, 2009, NANO LETT, V9, P485, DOI 10.1021/nl803621x; Kuo CH, 2011, PHYS CHEM CHEM PHYS, V13, P3649, DOI 10.1039/c0cp02615h; Bell SEJ, 2009, PHYS CHEM CHEM PHYS, V11, P7455, DOI 10.1039/b906049a; Cheng YN, 2011, LANGMUIR, V27, P7884, DOI 10.1021/la200840m; Xu PF, 2013, SMALL, V9, P228, DOI 10.1002/smll.201201721; Zheng YH, 2013, ADV FUNCT MATER, V23, P1519, DOI 10.1002/adfm.201202073; JOO TH, 1987, J RAMAN SPECTROSC, V18, P57, DOI 10.1002/jrs.1250180111; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Ikeda K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2786982; Alexander KD, 2009, J RAMAN SPECTROSC, V40, P2171, DOI 10.1002/jrs.2392; Tsai DH, 2011, J AM CHEM SOC, V133, P8884, DOI 10.1021/ja203328j; Busson MP, 2011, NANO LETT, V11, P5060, DOI 10.1021/nl2032052; Sheikholeslami S, 2010, NANO LETT, V10, P2655, DOI 10.1021/nl101380f; Saunders SR, 2011, J PHYS CHEM C, V115, P4603, DOI 10.1021/jp200116a; Lalander CH, 2010, ACS NANO, V4, P6153, DOI 10.1021/nn101431k; Pazos-Perez N, 2012, ANGEW CHEM INT EDIT, V51, P12688, DOI 10.1002/anie.201207019; Krug JT, 1999, J AM CHEM SOC, V121, P9208, DOI 10.1021/ja992058n; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Sardar R, 2007, J AM CHEM SOC, V129, P5356, DOI 10.1021/ja070933w; Yin YD, 2001, J AM CHEM SOC, V123, P771, DOI 10.1021/ja0031873; Negre CFA, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/12/125304; Near R, 2012, NANO LETT, V12, P2158, DOI 10.1021/nl300622p; Juluri BK, 2011, ACS NANO, V5, P5838, DOI 10.1021/nn201595x; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Hofmann A, 2011, LANGMUIR, V27, P15165, DOI 10.1021/la2028498; Jensen T, 1999, J CLUST SCI, V10, P295, DOI 10.1023/A:1021977613319; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Davis TJ, 2010, NANO LETT, V10, P2618, DOI 10.1021/nl101335z; Barrow SJ, 2011, NANO LETT, V11, P4180, DOI 10.1021/nl202080a; Ma LC, 2007, NANO LETT, V7, P439, DOI 10.1021/nl062727c; Ruiz-Chica AJ, 2004, NUCLEIC ACIDS RES, V32, P579, DOI 10.1093/nar/gkh232; ROTHENHAUSLER B, 1988, NATURE, V332, P615, DOI 10.1038/332615a0; Chak CP, 2009, ACS NANO, V3, P2129, DOI 10.1021/nn9005895; Cheng L, 2011, J PHYS CHEM LETT, V2, P2258, DOI 10.1021/jz201011b; Davis T. J., 2009, PHYS REV B, V79, P10; Ditlbacher H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257403; Fernandez-Dominguez AI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266807; GHOMI M, 1990, INT J BIOCHEM, V22, P691, DOI 10.1016/0020-711X(90)90003-L; Kumagai S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189566; Li W., 2010, ANGEW CHEM, V122, P168; Nishijima Y., 2013, APPL PHYS A, V113, P1; Rivera TP, 2009, MICROELECTRON ENG, V86, P1089, DOI 10.1016/j.mee.2008.11.015; Schumacher T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1334; Thomas Jr G.J., 1993, ADV BIOPHYS CHEM, V3, P1	52	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	1					240	249		10.1039/c4ta05307a		10	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW0EI	WOS:000345962800030		
J	Tsui, LK; Saito, M; Homma, T; Zangari, G				Tsui, Lok-kun; Saito, Mikiko; Homma, Takayuki; Zangari, Giovanni			Trap-state passivation of titania nanotubes by electrochemical doping for enhanced photoelectrochemical performance	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							ANODIC TIO2 NANOTUBES; ANATASE TIO2; LITHIUM INTERCALATION; PHOTOCURRENT TRANSIENTS; ENERGY-CONVERSION; INTERFACE STATES; AQUEOUS-SOLUTION; WATER-CONTENT; INSERTION; ARRAYS	TiO2 nanotubes are widely investigated materials for photoelectrochemical water splitting, but the presence of trap states limits their performance by facilitating the recombination of electron/hole pairs. In this investigation we unequivocally demonstrate that the photocurrent improvement observed in TiO2 nanotubes after performing electrochemical doping with hydrogen or lithium ions is due to trap state passivation. Specifically, electrochemical impedance spectroscopy evidences that trap state defects disappear upon electrochemical doping, concurrent with an increase in the electron lifetime and faster photocurrent transients. This results in a two-fold enhancement in the photocurrent under simulated sunlight at 1.0 V vs. SCE. Li intercalation was confirmed and the structure as well as the composition of the modified nanotubes was elucidated by GDOES, XPS, and TEM.	[Tsui, Lok-kun; Zangari, Giovanni] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22904 USA; [Tsui, Lok-kun; Zangari, Giovanni] Univ Virginia, CESE, Charlottesville, VA 22904 USA; [Saito, Mikiko; Homma, Takayuki] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo 1620041, Japan; [Homma, Takayuki] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Zangari, G (reprint author), Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22904 USA.	gz3e@virginia.edu			ARCS Foundation; National Science Foundation [CMMI-1229603]	We acknowledge the support from the ARCS Foundation and from the National Science Foundation Grant no. CMMI-1229603.	Yahia SAA, 2012, J ELECTROCHEM SOC, V159, pK83, DOI 10.1149/2.077204jes; Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Wei W, 2013, J MATER CHEM A, V1, P8160, DOI 10.1039/c3ta11273j; Ghicov A, 2006, ELECTROCHEM COMMUN, V8, P528, DOI 10.1016/j.elecom.2006.01.015; van de Krol R, 1999, J ELECTROCHEM SOC, V146, P3150, DOI 10.1149/1.1392447; Tighineanu A, 2010, CHEM PHYS LETT, V494, P260, DOI 10.1016/j.cplett.2010.06.022; Hahn R, 2007, PHYS STATUS SOLIDI A, V204, P1281, DOI 10.1002/pssa.200674310; Sodergren S, 1997, J PHYS CHEM B, V101, P3087, DOI 10.1021/jp9639399; BARD AJ, 1980, J AM CHEM SOC, V102, P3671, DOI 10.1021/ja00531a001; Tsui LK, 2013, J PHYS CHEM C, V117, P6979, DOI 10.1021/jp400318n; Liu N, 2014, NANO LETT, V14, P3309, DOI 10.1021/nl500710j; CAVA RJ, 1986, J SOLID STATE CHEM, V65, P63, DOI 10.1016/0022-4596(86)90089-7; Zhang ZH, 2014, ACS APPL MATER INTER, V6, P691, DOI 10.1021/am404848n; Chen XB, 2011, SCIENCE, V331, P746, DOI 10.1126/science.1200448; Macak JM, 2007, ADV MATER, V19, P3027, DOI 10.1002/adma.200602549; Beranek R, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2140085; Naldoni A, 2012, J AM CHEM SOC, V134, P7600, DOI 10.1021/ja3012676; Kumar CP, 2006, J PHYS CHEM B, V110, P5223, DOI 10.1021/jp057053t; HAGFELDT A, 1995, J ELECTROANAL CHEM, V381, P39, DOI 10.1016/0022-0728(94)03622-A; Meekins BH, 2009, ACS NANO, V3, P3437, DOI 10.1021/nn900897r; Chen B, 2013, LANGMUIR, V29, P5911, DOI 10.1021/la400586r; Bisquert J, 2000, J PHYS CHEM B, V104, P2287, DOI 10.1021/jp993148h; Lu XH, 2012, NANO LETT, V12, P1690, DOI 10.1021/nl300173j; Zuo F, 2010, J AM CHEM SOC, V132, P11856, DOI 10.1021/ja103843d; Tang JW, 2008, J AM CHEM SOC, V130, P13885, DOI 10.1021/ja8034637; Das C, 2011, NANOSCALE, V3, P3094, DOI 10.1039/c1nr10539f; Zaban A, 2003, CHEMPHYSCHEM, V4, P859, DOI 10.1002/cphc.200200615; Sun CH, 2011, J PHYS CHEM C, V115, P25590, DOI 10.1021/jp210472p; van de Krol R, 1999, J PHYS CHEM B, V103, P7151, DOI 10.1021/jp9909964; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Boschloo GK, 1997, J ELECTROCHEM SOC, V144, P1311, DOI 10.1149/1.1837590; Berger T, 2005, J PHYS CHEM B, V109, P6061, DOI 10.1021/jp0404293; Kang U, 2013, APPL CATAL B-ENVIRON, V140, P233, DOI 10.1016/j.apcatb.2013.04.003; Wagemaker M, 2007, J AM CHEM SOC, V129, P4323, DOI 10.1021/ja067733p; Kang Q, 2013, J MATER CHEM A, V1, P5766, DOI 10.1039/c3ta10689f; SCHWARZBURG K, 1991, APPL PHYS LETT, V58, P2520, DOI 10.1063/1.104839; Oskam G, 1996, J ELECTROCHEM SOC, V143, P2531, DOI 10.1149/1.1837043; Wu QL, 2012, J PHYS CHEM C, V116, P18669, DOI 10.1021/jp3072266; Altomare M, 2013, CHEM-EUR J, V19, P5841, DOI 10.1002/chem.201203544; Yang HG, 2004, J PHYS CHEM B, V108, P3492, DOI 10.1021/jp0377782; Wang DA, 2011, NANO LETT, V11, P3649, DOI 10.1021/nl2015262; Raghunath P, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4799800; Tsui LK, 2014, ELECTROCHIM ACTA, V121, P203, DOI 10.1016/j.electacta.2013.12.163; Ke SC, 2006, J PHYS CHEM B, V110, P11628, DOI 10.1021/jp0612578; Chen XB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01510; International Centre for Diffraction Data, 2009, ICDD DDVIEW VERS 4 8; Lide W. H. D., 2014, CRC HDB CHEM PHYS, P4; Mazare A, 2011, ELECTROCHEM COMMUN, V13, P1030, DOI 10.1016/j.elecom.2011.06.019; Morgan B. J., 2009, PHYS REV B, V80, P2; Oskam G, 1996, PHYS REV LETT, V76, P1521, DOI 10.1103/PhysRevLett.76.1521; Reiman KH, 2006, ELECTROCHEM COMMUN, V8, P517, DOI 10.1016/j.elecom.2006.01.017; Tsui LK, 2014, J ELECTROCHEM SOC, V161, pD3066, DOI 10.1149/2.010407jes; ZACHAUCHRISTIANSEN B, 1988, SOLID STATE IONICS, V28, P1176, DOI 10.1016/0167-2738(88)90352-9	53	3	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	1					360	367		10.1039/c4ta05620e		8	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW0EI	WOS:000345962800044		
J	Kwon, O; Hirayama, M; Suzuki, K; Kato, Y; Saito, T; Yonemura, M; Kamiyama, T; Kanno, R				Kwon, Ohmin; Hirayama, Masaaki; Suzuki, Kota; Kato, Yuki; Saito, Toshiya; Yonemura, Masao; Kamiyama, Takashi; Kanno, Ryoji			Synthesis, structure, and conduction mechanism of the lithium superionic conductor Li10+delta Ge1+delta P2-delta S12	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							J-PARC; LI10GEP2S12; ELECTROLYTES	A solid solution of the lithium superionic conductor Li10+delta Ge1+delta P2-delta S12 (0 <= delta <= 0.35) was synthesized and its structure and ionic conductivity were examined. The highest ionic conductivity value of 1.42 x 10(-2) S cm(-1) was obtained at 300 K with a sintered pellet of the sample having the highest solid solution lithium content of delta = 0.35. The Arrhenius conductivity curves obtained for this material exhibited a gradual change in slope over the temperature range of 193-373 K and the activation energy for ionic conduction decreased from 26 kJ mol(-1) below 373 K to 7 kJ mol(-1) above 573 K, which is typical of highly ionic conducting solids. The crystal structures of the solid solutions were determined using neutron diffraction, and conduction pathways were visualized through analysis by applying the maximum entropy method. The lithium distribution was found to disperse significantly throughout a one-dimensional conduction pathway as the temperature was increased from 4.8 K to 750 K. In addition, two-dimensional distribution of lithium along the ab plane became apparent at high temperatures, suggesting that the conduction mechanism changes from one-dimensional to three-dimensional with increasing temperature.	[Kwon, Ohmin; Hirayama, Masaaki; Suzuki, Kota; Kanno, Ryoji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Yokohama, Kanagawa 2268502, Japan; [Kato, Yuki; Saito, Toshiya] Toyota Motor Co Ltd, Higashifuji Tech Ctr, Battery Res Div, Susono, Shizuoka 4101193, Japan; [Yonemura, Masao; Kamiyama, Takashi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Neutron Sci Lab, Tsukuba, Ibaraki 3050801, Japan	Kanno, R (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	kanno@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	Post-LiEAD project of the New Energy and Industrial Technology Development Organization (NEDO), Japan; RISING project of NEDO; Japan Synchrotron Radiation Research Institute (JASRI) [2011A1612, 2011B1697]; Japan Proton Accelerator Research Complex (J-Parc) [2010B0065, 2012A0107, 2012B0110, 2013A0133]	This research was supported by the Post-LiEAD project of the New Energy and Industrial Technology Development Organization (NEDO), Japan. The program used for the MEM analysis was developed through the support of the RISING project of NEDO. Synchrotron and neutron radiation data were obtained through projects approved by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal nos 2011A1612 and 2011B1697) and the Japan Proton Accelerator Research Complex (J-Parc) (Proposal nos 2010B0065, 2012A0107, 2012B0110, and 2013A0133).	Adams S, 2012, J MATER CHEM, V22, P7687, DOI 10.1039/c2jm16688g; Mo YF, 2012, CHEM MATER, V24, P15, DOI 10.1021/cm203303y; Kuhn A, 2013, PHYS CHEM CHEM PHYS, V15, P11620, DOI 10.1039/c3cp51985f; Kato Y, 2014, J POWER SOURCES, V271, P60, DOI 10.1016/j.jpowsour.2014.07.159; Du FM, 2014, J PHYS CHEM C, V118, P10590, DOI 10.1021/jp5000039; Hori S, 2014, FARADAY DISCUSS, V176, P83, DOI 10.1039/c4fd00143e; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Oishi R, 2009, NUCL INSTRUM METH A, V600, P94, DOI 10.1016/j.nima.2008.11.056; Izumi F, 2007, SOL ST PHEN, V130, P15; Kato Y, 2012, ELECTROCHEMISTRY, V80, P749, DOI 10.5796/electrochemistry.80.749; Kuhn A, 2014, PHYS CHEM CHEM PHYS, V16, P14669, DOI 10.1039/c4cp02046d; Garcia B, 2004, ELECTROCHIM ACTA, V49, P4583, DOI 10.1016/j.electacta.2004.04.041; Ishigaki T, 2009, NUCL INSTRUM METH A, V600, P189, DOI 10.1016/j.nima.2008.11.137; Bron P, 2013, J AM CHEM SOC, V135, P15694, DOI 10.1021/ja407393y; CHADWICK AV, 1983, SOLID STATE IONICS, V8, P209, DOI 10.1016/0167-2738(83)90018-8; Ishikawa Y., 2014, Z 3D TXB Z CODE POWD; Izumi Fujio, 2010, Journal of the Vacuum Society of Japan, V53, DOI 10.3131/jvsj2.53.706; Ohtomo T, 2013, J POWER SOURCES, V233, P231, DOI 10.1016/j.jpowsour.2013.01.090; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Stallworth PE, 1999, J POWER SOURCES, V81, P739, DOI 10.1016/S0378-7753(99)00144-5; Torii S., 2011, J PHYS SOC JPN, V80, pSB020; West A. R., 1988, SOLID STATE CHEM ITS, P482; Xu XX, 2011, CHEM MATER, V23, P3798, DOI 10.1021/cm103665w; Zhang J., 2014, Z MEM TXB Z CODE POW	24	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	1					438	446		10.1039/c4ta05231e		9	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW0EI	WOS:000345962800053		
J	Humphries, TD; Ley, MB; Frommen, C; Munroe, KT; Jensen, TR; Hauback, BC				Humphries, Terry D.; Ley, Morten B.; Frommen, Christoph; Munroe, Keelie T.; Jensen, Torben R.; Hauback, Bjorn C.			Crystal structure and in situ decomposition of Eu(BH4)(2) and Sm(BH4)(2)	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							HYDROGEN STORAGE MATERIALS; MECHANOCHEMICAL SYNTHESIS; THERMAL-PROPERTIES; DICHOTOMY METHOD; BOROHYDRIDE; METAL; POLYMORPHISM; Y(BH4)(3); LICE(BH4)(3)CL; LIBH4	Synthesis of halide free rare earth metal (RE) borohydride complexes is demonstrated by the metathesis reaction of trivalent RE metal chlorides and LiBH4 in ethereal solution, combined with solvent extraction using dimethyl sulfide. The crystal structures of Eu(BH4)(2) and Sm(BH4)(2) are orthorhombic (space group Pbcn) and are shown to be related to the structure of Sr(BH4)(2) by Rietveld refinement. Further, the thermal decomposition of these materials has been studied by in situ synchrotron radiation powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, mass spectrometry and Sieverts measurements. The decomposition pathway of these solvent extracted materials has been compared against materials prepared by mechano-chemistry, the process of which is simplified by the absence of chloride impurities.	[Humphries, Terry D.; Frommen, Christoph; Hauback, Bjorn C.] Inst Energy Technol, Dept Phys, NO-2027 Kjeller, Norway; [Humphries, Terry D.] Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Ley, Morten B.; Munroe, Keelie T.; Jensen, Torben R.] Aarhus Univ, CMC, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Ley, Morten B.; Munroe, Keelie T.; Jensen, Torben R.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark	Humphries, TD (reprint author), Inst Energy Technol, Dept Phys, POB 40, NO-2027 Kjeller, Norway.	terry_humphries81@hotmail.com; trj@chem.au.dk; bjorn.hauback@ife.no	Humphries, Terry/A-2042-2014	Humphries, Terry/0000-0003-1015-4495	Research Council of Norway through the FRIENERGI program; Research Council of Norway through the SYNKNOYT program; Danish National Research Foundation, Centre for Materials Crystallography [DNRF93]; Danish Council for Strategic Research via the research project HyFillFast; Danish Research Council for Nature and Universe (Danscatt)	We would like to thank the project teams at the Swiss Norwegian Beam Line (SNBL) at the European Synchrotron Research Facility (ESRF), Grenoble, France; Petra, Germany and MAXLab, Sweden. Financial support is acknowledged from The Research Council of Norway through the FRIENERGI and SYNKNOYT programs. We also thank Jorn Eirik Olsen for the preparation of sample S2. The work was supported by the Danish National Research Foundation, Centre for Materials Crystallography (DNRF93), the Danish Council for Strategic Research via the research project HyFillFast, and the Danish Research Council for Nature and Universe (Danscatt). We are grateful to the Carlsberg Foundation.	Ley MB, 2012, CHEM MATER, V24, P1654, DOI 10.1021/cm300792t; Marks S, 2012, J AM CHEM SOC, V134, P16983, DOI 10.1021/ja308077t; Favre-Nicolin V, 2002, J APPL CRYSTALLOGR, V35, P734, DOI 10.1107/S0021889802015236; Cerny R, 2010, J PHYS CHEM C, V114, P1357, DOI 10.1021/jp908397w; Olsen JE, 2013, RSC ADV, V3, P10764, DOI 10.1039/c3ra40435h; Unemoto A, 2014, ADV FUNCT MATER, V24, P2267, DOI 10.1002/adfm.201303147; Ravnsbaek DB, 2013, INORG CHEM, V52, P10877, DOI 10.1021/ic400862s; Soulie JP, 2002, J ALLOY COMPD, V346, P200, DOI 10.1016/S0925-8388(02)00521-2; Zuttel A, 2003, J POWER SOURCES, V118, P1, DOI 10.1016/S0378-7753(03)00054-5; Boultif A, 2004, J APPL CRYSTALLOGR, V37, P724, DOI 10.1107/S0021889804014876; Ley MB, 2012, J PHYS CHEM C, V116, P21267, DOI 10.1021/jp307762g; Li HW, 2011, ENERGIES, V4, P185, DOI 10.3390/en4010185; Frommen C, 2010, J ALLOY COMPD, V496, P710, DOI 10.1016/j.jallcom.2010.02.180; Ravnsbaek DB, 2010, INORG CHEM, V49, P3801, DOI 10.1021/ic902279k; Jensen TR, 2010, J APPL CRYSTALLOGR, V43, P1456, DOI 10.1107/S0021889810038148; Frommen C, 2011, J PHYS CHEM C, V115, P23591, DOI 10.1021/jp205105j; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; EYLEM C, 1992, CHEM MATER, V4, P1038, DOI 10.1021/cm00023a022; Huot J, 2013, PROG MATER SCI, V58, P30, DOI 10.1016/j.pmatsci.2012.07.001; Ley MB, 2014, MATER TODAY, V17, P122, DOI 10.1016/j.mattod.2014.02.013; BERNSTEIN ER, 1975, CHEM PHYS, V10, P215, DOI 10.1016/0301-0104(75)87037-6; BOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987, DOI 10.1107/S0021889891006441; Gennari FC, 2013, J ALLOY COMPD, V581, P192, DOI 10.1016/j.jallcom.2013.07.012; Gross KJ, RECOMMENDED BEST PRA; Hagemann H., 2010, DALTON T, P6006; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; James B. D., 1970, PROG INORG CHEM, V11, P99, DOI 10.1002/9780470166123.ch3; Larson A. C., 2000, LOS ALAMOS NATL LAB, P86; Ley M. B., 2014, DALTON T, P13333; Olsen J. E., 2013, RSC ADV, V4, P1570; Olsen JE, 2011, J ALLOY COMPD, V509, pL228, DOI 10.1016/j.jallcom.2011.03.166; Pistidda C, 2010, J ALLOY COMPD, V508, P212, DOI 10.1016/j.jallcom.2010.07.226; Remhof A, 2012, SCRIPTA MATER, V66, P280, DOI 10.1016/j.scriptamat.2011.11.010; SHAWKLEIN LJ, 1992, J MATER RES, V7, P329, DOI 10.1557/JMR.1992.0329; Thiel CW, 2011, J LUMIN, V131, P386, DOI 10.1016/j.jlumin.2010.09.025; Vogel S., 2002, ADV XRAY ANAL, V45, P31	36	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	2					691	698		10.1039/c4ta04080e		8	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW1XN	WOS:000346082100030		
J	Zhang, ZX; Sadakane, M; Noro, S; Murayama, T; Kamachi, T; Yoshizawa, K; Ueda, W				Zhang, Zhenxin; Sadakane, Masahiro; Noro, Shin-ichiro; Murayama, Toru; Kamachi, Takashi; Yoshizawa, Kazunari; Ueda, Wataru			Selective carbon dioxide adsorption of epsilon-Keggin-type zincomolybdate-based purely inorganic 3D frameworks	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							METAL-ORGANIC FRAMEWORKS; MONTE-CARLO-SIMULATION; IONIC-CRYSTALS; SORPTION PROPERTIES; BUILDING-BLOCKS; CO2; ZEOLITE; MOLECULES; SEPARATION; CATALYST	Polyoxometalate-based 3D frameworks, Na1.5H11.4[ZnMo12O40{Zn-2}]center dot 5.5H(2)O and (NH4)(1.5)H-8.5-[ZnMo12O40{Zn-2}]center dot 6H(2)O, are synthesized in moderate yields. Rotation of the reactor under hydrothermal conditions is essential to improve the yield. The materials show zeolite-like selective molecule adsorption properties. Depending on the micropore aperture size of the materials, small molecules can be adsorbed in the materials, while large molecules cannot. The enthalpy of adsorption and DFT calculation indicate that the materials strongly interact with CO2, but weakly interact with CH4, due to electrostatic interactions between the materials and molecules. CO2/CH4 co-sorption experiments show that the materials can selectively adsorb CO2, and CO2 adsorption selectivity of the material with sodium cations is higher than that of the material with ammonium cations. The material with sodium ions can be utilized for gas chromatographic separation of CH4 and CO2.	[Zhang, Zhenxin; Murayama, Toru; Ueda, Wataru] Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Sadakane, Masahiro] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Sadakane, Masahiro] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Noro, Shin-ichiro] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan; [Noro, Shin-ichiro] Hokkaido Univ, Creat Res Inst CRIS, Sapporo, Hokkaido 0010021, Japan; [Kamachi, Takashi; Yoshizawa, Kazunari] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190395, Japan; [Kamachi, Takashi; Yoshizawa, Kazunari] Kyushu Univ, Int Res Ctr Mol Syst, Fukuoka 8190395, Japan	Zhang, ZX (reprint author), Hokkaido Univ, Catalysis Res Ctr, Kita Ku, N-21,W-10, Sapporo, Hokkaido 0010021, Japan.	ueda@cat.hokudai.ac.jp	Noro, Shin-ichiro/E-1322-2012; Sadakane, Masahiro/D-7220-2011		Ministry of Education, Culture, Sports, Science, and Technology, Japan [2324-6135]; PRESTO; JST; Nippon Sheet Glass Foundation for Materials Science and Engineering (NSG Foundation); Ministry of Education, Culture, Sports, Science and Technology, Japan [24550068]; JSPS [22245028, 24109014]; MEXT	This work was financially supported by a Grant-in-Aid for Scientific Research (A) (grant no. 2324-6135) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. M.S. thanks PRESTO, JST and Nippon Sheet Glass Foundation for Materials Science and Engineering (NSG Foundation) for financial support. S.N. thanks a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant no. 24550068). K.Y. thanks Grants-in-Aid (grant nos 22245028 and 24109014) for Scientific Research from JSPS and MEXT and the MEXT Projects of "Integrated Research on Chemical Synthesis" and "Elements Strategy Initiative for Catalysts and Batteries".	Aguado S, 2009, MICROPOR MESOPOR MAT, V120, P170, DOI 10.1016/j.micromeso.2008.08.062; Hill CL, 1998, CHEM REV, V98, P1, DOI 10.1021/cr960395y; Dolbecq A, 2005, EUR J INORG CHEM, P3009; Rodriguez-Albelo LM, 2009, J AM CHEM SOC, V131, P16078, DOI 10.1021/ja905009e; Xu XL, 2008, J NAT GAS CHEM, V17, P391; Akten ED, 2003, ENERG FUEL, V17, P977, DOI 10.1021/ef0300038; Khan NA, 2013, J HAZARD MATER, V244, P444, DOI 10.1016/j.jhazmat.2012.11.011; Sadakane M, 2009, ANGEW CHEM INT EDIT, V48, P3782, DOI 10.1002/anie.200805792; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Song J, 2011, J AM CHEM SOC, V133, P16839, DOI 10.1021/ja203695h; Nohra B, 2011, J AM CHEM SOC, V133, P13363, DOI 10.1021/ja201165c; Sadakane M, 2008, ANGEW CHEM INT EDIT, V47, P2493, DOI 10.1002/anie.200705448; Mitchell SG, 2010, NAT CHEM, V2, P308, DOI [10.1038/nchem.581, 10.1038/NCHEM.581]; Uchida S, 2002, ANGEW CHEM INT EDIT, V41, P2814, DOI 10.1002/1521-3773(20020802)41:15<2814::AID-ANIE2814>3.0.CO;2-I; Boultif A, 2004, J APPL CRYSTALLOGR, V37, P724, DOI 10.1107/S0021889804014876; Zhu XB, 2014, INT J HYDROGEN ENERG, V39, P13902, DOI 10.1016/j.ijhydene.2014.01.040; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Zhang ZX, 2014, INORG CHEM, V53, P903, DOI 10.1021/ic4022849; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Du NY, 2012, ENERG ENVIRON SCI, V5, P7306, DOI 10.1039/c1ee02668b; Long DL, 2010, ANGEW CHEM INT EDIT, V49, P1736, DOI 10.1002/anie.200902483; Neumann MA, 2003, J APPL CRYSTALLOGR, V36, P356, DOI 10.1107/S0021889802023348; D'Alessandro DM, 2010, ANGEW CHEM INT EDIT, V49, P6058, DOI 10.1002/anie.201000431; Uchida S, 2007, CHEM MATER, V19, P4694, DOI 10.1021/cm071565y; Zhang ZX, 2014, INORG CHEM, V53, P7309, DOI 10.1021/ic500630h; Sun CY, 2009, J AM CHEM SOC, V131, P1883, DOI 10.1021/ja807357r; Kierzkowska AM, 2013, CHEMSUSCHEM, V6, P1130, DOI 10.1002/cssc.201300178; Eguchi R, 2012, ANGEW CHEM INT EDIT, V51, P1635, DOI 10.1002/anie.201107906; Ferey G, 2011, CHEM SOC REV, V40, P550, DOI 10.1039/c0cs00040j; Cronin L, 2012, CHEM SOC REV, V41, P7325; David W. I. F., 2006, STRUCTURE DETERMINAT, V47; Delley B., 2000, J PHYS CHEM-US, V113, P7759; Dubinin M., 1975, PROGR SURFACE MEMBRA, V9, P1; Eguchi R, 2012, J PHYS CHEM C, V116, P16105, DOI 10.1021/jp305890s; Kamiya Y., 2013, HETEROPOLY COMPOUN 2, V7; Li XQ, 2011, ACTA PHARMACOL SIN, V32, P217, DOI 10.1038/aps.2010.187; Liu D., 2013, CHEM COMMUN, P3673; MCCLELLA.AL, 1967, J COLLOID INTERF SCI, V23, P577, DOI 10.1016/0021-9797(67)90204-4; Ogasawara Y., 2007, J PHYS CHEM C, V6, P8218; Sadakane M, 2007, ANGEW CHEM INT EDIT, V46, P1493, DOI 10.1002/anie.200603923; Tagami H, 2009, ANGEW CHEM INT EDIT, V48, P6160, DOI 10.1002/anie.200902681; Mizuno N, 2006, CHEM LETT, V35, P688, DOI 10.1246/cl.2006.688; Uchida S., 2004, J AM CHEM SOC, V6, P1602; Uchida S, 2010, ANGEW CHEM INT EDIT, V49, P9930, DOI 10.1002/anie.201005176; Young R.A., 1995, RIETVELD METHOD; Zeitler TR, 2012, J PHYS CHEM C, V116, P3492, DOI 10.1021/jp208596e; Zhang JF, 2014, CHEM ENG SCI, V113, P54, DOI 10.1016/j.ces.2014.04.001; Zhang Z., 2014, DALTON T, P13584; Zukal A, 2010, PHYS CHEM CHEM PHYS, V12, P5240, DOI 10.1039/b924938a	50	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	2					746	755		10.1039/c4ta05496b		10	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW1XN	WOS:000346082100037		
J	Sonoda, T; Maruo, T; Yamasaki, Y; Tsunoji, N; Takamitsu, Y; Sadakane, M; Sano, T				Sonoda, Takushi; Maruo, Toshihiro; Yamasaki, Yoshitaka; Tsunoji, Nao; Takamitsu, Yasuyuki; Sadakane, Masahiro; Sano, Tsuneji			Synthesis of high-silica AEI zeolites with enhanced thermal stability by hydrothermal conversion of FAU zeolites, and their activity in the selective catalytic reduction of NOx with NH3	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							STRUCTURE-DIRECTING AGENTS; INTERZEOLITE CONVERSION; H-ZSM-5 ZEOLITES; CHA ZEOLITE; PERFORMANCE; MEMBRANES; DEHYDRATION; PHOSPHORUS; CRACKING; CATIONS	High-silica AEI zeolites with Si/Al ratios of 13-20 were synthesized by FAU interzeolite conversion, in which tetraethylphosphonium (TEP) cations as a structure-directing agent (SDA) and NaF or NH4F as a fluoride source were added to the starting gels. During the thermal treatment of the AEI zeolites, TEP cations in the zeolitic pores decomposed to yield the P-modified AEI zeolites with various P/Al ratios. The thermal stability of the P-modified AEI zeolite was higher than that of the non-modified AEI zeolite synthesized using the N, N-diethyl-2,6-dimethylpiperidinium cation as an SDA. The framework structure of the P-modified AEI zeolite was maintained after calcination at 1000 degrees C for 1 h, indicating an enhanced thermal stability by phosphorus modification. The catalytic performance of Cu-loaded AEI zeolites with different P/Al ratios in the selective catalytic reduction (SCR) of NOx with NH3 was also investigated. The NO conversion was found to increase with decreasing P/Al ratio. No decrease in the NO conversion was observed after hydrothermal treatment at 900 degrees C for 4 h, indicating the high potential of the P-modified AEI zeolite for NH3-SCR of NOx.	[Sonoda, Takushi; Maruo, Toshihiro; Yamasaki, Yoshitaka; Tsunoji, Nao; Sadakane, Masahiro; Sano, Tsuneji] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Takamitsu, Yasuyuki] Tosoh Corp, Inorgan Mat Res Lab, Yamaguchi 7468501, Japan	Sano, T (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	tsano@hiroshima-u.ac.jp	Sano, Tsuneji/C-1233-2012; Tsunoji, Nao/A-2627-2013; Sadakane, Masahiro/D-7220-2011				Guan B, 2014, APPL THERM ENG, V66, P395, DOI 10.1016/j.applthermaleng.2014.02.021; Wagner P, 2000, J AM CHEM SOC, V122, P263, DOI 10.1021/ja990722u; Moliner M, 2012, CHEM COMMUN, V48, P8264, DOI 10.1039/c2cc33992g; Simancas R, 2014, J AM CHEM SOC, V136, P3342, DOI 10.1021/ja411915c; Inoue T, 2009, MICROPOR MESOPOR MAT, V122, P149, DOI 10.1016/j.micromeso.2009.02.027; Nedyalkova R, 2013, TOP CATAL, V56, P550, DOI 10.1007/s11244-013-0015-4; Xue NH, 2010, J PHYS CHEM C, V114, P15763, DOI 10.1021/jp106621d; Damodaran K, 2006, MICROPOR MESOPOR MAT, V95, P296, DOI 10.1016/j.micromeso.2006.05.034; Zhang XY, 2012, SCIENCE, V336, P1684, DOI 10.1126/science.1221111; Gao F, 2013, TOP CATAL, V56, P1441, DOI 10.1007/s11244-013-0145-8; LISCHKE G, 1991, J CATAL, V132, P229, DOI 10.1016/0021-9517(91)90259-7; Kalipcilar H, 2002, CHEM MATER, V14, P3458, DOI 10.1021/cm020248i; Liu FD, 2014, CHEM COMMUN, V50, P8445, DOI 10.1039/c4cc01098a; Kwak JH, 2010, J CATAL, V275, P187, DOI 10.1016/j.jcat.2010.07.031; Maruo T, 2014, CHEM LETT, V43, P302, DOI 10.1246/cl.130996; van der Bij HE, 2014, PHYS CHEM CHEM PHYS, V16, P9892, DOI 10.1039/c3cp54791d; Blasco T, 2006, J CATAL, V237, P267, DOI 10.1016/j.jcat.2005.11.011; Simancas R, 2010, SCIENCE, V330, P1219, DOI 10.1126/science.1196240; Blakeman PG, 2014, CATAL TODAY, V231, P56; Itakura M, 2008, CHEM LETT, V37, P908, DOI 10.1246/cl.2008.908; Sato K, 2012, J MEMBRANE SCI, V409, P82, DOI 10.1016/j.memsci.2012.03.032; Derewinski M, 2014, J PHYS CHEM C, V118, P6122, DOI 10.1021/jp4053677; Xue NH, 2007, J CATAL, V248, P20, DOI 10.1016/j.jcat.2007.02.022; Ye Q, 2012, APPL CATAL A-GEN, V427, P24, DOI 10.1016/j.apcata.2012.03.026; Cundy CS, 2005, MICROPOR MESOPOR MAT, V82, P1, DOI 10.1016/j.micromeso.2005.02.016; Dorset DL, 2006, J AM CHEM SOC, V128, P8862, DOI 10.1021/ja061206o; Flanigen E. M., 1978, U.S. Patent, Patent No. [US 4,073,865, 4073865]; Guth J. L., 1993, J P 9 INT ZEOL C, P215; Hernandez-Rodriguez M, 2012, J AM CHEM SOC, V134, P13232, DOI 10.1021/ja306013k; Jon H, 2006, MICROPOR MESOPOR MAT, V96, P72, DOI 10.1016/j.micromeso.2006.06.024; Sugita M., 2011, Japanese Patent Disclosure, Patent No. 121045; Yamanaka N, 2013, B CHEM SOC JPN, V86, P1333, DOI 10.1246/bcsj.20130189; Zones S. I., 1999, U.S. Patent, Patent No. [5,958,370, 5958370]	33	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	2					857	865		10.1039/c4ta05621c		9	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AW1XN	WOS:000346082100050		
J	Niko, Y; Moritomo, H; Sugihara, H; Suzuki, Y; Kawamata, J; Konishi, GI				Niko, Yosuke; Moritomo, Hiroki; Sugihara, Hiroyuki; Suzuki, Yasutaka; Kawamata, Jun; Konishi, Gen-ichi			A novel pyrene-based two-photon active fluorescent dye efficiently excited and emitting in the 'tissue optical window (650-1100 nm)'	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							NEAR-INFRARED WINDOW; LIVING CELLS; IN-VIVO; PHOTOPHYSICAL PROPERTIES; CROSS-SECTIONS; QUANTUM YIELDS; ABSORPTION; PROBE; DESIGN; MITOCHONDRIA	The development of two-photon (TP) active fluorophores remains an important issue. Dyes that can be excited and fluoresce efficiently in the ` tissue optical window' (650-1100 nm) are especially in demand to maximize the underlying performance of two-photon fluorescence microscopy (TPFM) as an advanced optical technique. Ideally, such dyes would be compatible with the 1050 nm femtosecond fibre laser, which has recently been developed as an inexpensive excitation source to make the TPFM technique universal. In this work, we designed and synthesized a novel pyrene-based acceptor-pi-acceptor (A-pi-A) dye, PY, which exhibited outstanding properties such as bright fluorescence (lambda(em) = 650 nm and FFL Phi(FL) = 0.80) and a large two-photon absorption cross-section (1100 GM (1 GM = 10(-50) cm(4) per photon per molecule) at 950 nm and 380 GM at 1050 nm) in the tissue optical window. In living mitochondria, PY provided more sensitive microscopic images than current dyes and showed great potential to be a building block of TP active fluorescent probes for the 1050 nm fibre laser. We believe that the exceptional properties of PY will be extended to other fluorescent probes through further chemical modification.	[Niko, Yosuke; Konishi, Gen-ichi] Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528552, Japan; [Moritomo, Hiroki; Suzuki, Yasutaka; Kawamata, Jun] Yamaguchi Univ, Grad Sch Med, Yoshida, Yamaguchi 7538512, Japan; [Sugihara, Hiroyuki] Yamaguchi Univ, Grad Sch Sci & Engn, Yoshida, Yamaguchi 7538512, Japan; [Konishi, Gen-ichi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	Kawamata, J (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, 2-12-1 Ookayama, Tokyo 1528552, Japan.	j-kawa@yamaguchi-u.ac.jp; konishi.g.aa@m.titech.ac.jp	Konishi, Gen-ichi/F-1320-2010		JSPS Fellowship; Ministry of Education, Culture, Sports, Science and Technology, Japan [23350068]	We thank the JSPS Fellowship for Young Scientists (to Y. N.). This work was supported by a Grant-in-Aid for Scientific Research (no. 23350068) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and Yamaguchi Prefecture Contracted R&D for the Industrial Cluster of Next Generation from Yamaguchi Prefectural Industrial Technology Institute, Japan.	Niko Y, 2013, J ORG CHEM, V78, P3196, DOI 10.1021/jo400128c; Niko Y, 2014, CHEM-ASIAN J, V9, P1797, DOI 10.1002/asia.201402088; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; Sinkeldam RW, 2010, CHEM REV, V110, P2579, DOI 10.1021/cr900301e; Figueira-Duarte TM, 2011, CHEM REV, V111, P7260, DOI 10.1021/cr100428a; Licha K, 2005, ADV DRUG DELIVER REV, V57, P1087, DOI 10.1016/j.addr.2005.01.021; Tani S, 2012, CURR PHARM BIOTECHNO, V13, P2649; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Niko Y, 2014, RSC ADV, V4, P36480, DOI 10.1039/c4ra06282e; Kim HM, 2008, J ORG CHEM, V73, P5127, DOI 10.1021/jo800363v; Hou JT, 2014, CHEM COMMUN, V50, P8640, DOI 10.1039/c4cc02673j; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; De Meulenaere E, 2012, CHEM SCI, V3, P984, DOI 10.1039/c2sc00771a; Jiang N, 2013, CHEM COMMUN, V49, P10620, DOI 10.1039/c3cc46143b; Yao S, 2010, J ORG CHEM, V75, P3965, DOI 10.1021/jo100554j; Yan P, 2012, P NATL ACAD SCI USA, V109, P20443, DOI 10.1073/pnas.1214850109; Soujanya T, 1996, J PHYS CHEM-US, V100, P3507, DOI 10.1021/jp9526509; MES GF, 1984, J AM CHEM SOC, V106, P6524, DOI 10.1021/ja00334a011; Jing J, 2012, CHEM SCI, V3, P3315, DOI 10.1039/c2sc20764h; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Lee SK, 2005, ORG LETT, V7, P323, DOI 10.1021/ol047658s; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; Niko Y, 2013, CHEM-EUR J, V19, P9760, DOI 10.1002/chem.201301020; Robinson JT, 2012, J AM CHEM SOC, V134, P10664, DOI 10.1021/ja303737a; Yang ZG, 2014, CHEM SOC REV, V43, P4563, DOI 10.1039/c4cs00051j; Uchimura M, 2010, ADV MATER, V22, P4473, DOI 10.1002/adma.201001046; Wang X, 2013, CHEM SCI, V4, P2551, DOI 10.1039/c3sc50369k; Yan P, 2008, J ORG CHEM, V73, P6587, DOI 10.1021/jo800852h; Zhang XF, 2013, J ORG CHEM, V78, P9153, DOI 10.1021/jo401379g; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Zhang T, 2011, J AM CHEM SOC, V133, P20120, DOI 10.1021/ja207689k; Kim JH, 2007, ANGEW CHEM INT EDIT, V46, P5779, DOI 10.1002/anie.200700767; Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257; Masanta G, 2012, CHEM COMMUN, V48, P3518, DOI 10.1039/c2cc00034b; Klymchenko AS, 2012, RSC ADV, V2, P11876, DOI 10.1039/c2ra21544f; Hirosawa S, 2012, CHEM COMMUN, V48, P4845, DOI 10.1039/c2cc30603d; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Zheng YC, 2014, J MATER CHEM B, V2, P2301, DOI 10.1039/c3tb21860k; Divya KP, 2014, CHEM SCI, V5, P3469, DOI 10.1039/c4sc00736k; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Subha R, 2013, J PHYS CHEM C, V117, P20905, DOI 10.1021/jp404124c; Reisch A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5089; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Niko Y, 2012, J ORG CHEM, V77, P3986, DOI 10.1021/jo300317r; Massin J, 2013, CHEM SCI, V4, P2833, DOI 10.1039/c3sc22325f; Li P, 2014, CHEM COMMUN, V50, P7184, DOI 10.1039/c4cc01390e; Berezin MY, 2011, J PHYS CHEM B, V115, P11530, DOI 10.1021/jp207618e; Dufresne S, 2010, J PHYS CHEM C, V114, P13106, DOI 10.1021/jp104026y; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Li K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01150; Mery S, 2003, J MATER CHEM, V13, P1622, DOI 10.1039/b211867j; Niko Y, 2012, J SYN ORG CHEM JPN, V70, P918; Pu Y, 2013, J APPL PHYS, V114, DOI 10.1063/1.4825319; Tominaga M., 2014, CHEM LETT IN PRESS; Turro N. J., 2010, MODERN MOL PHOTOCHEM, P289; Turro N. J., 2010, MODERN MOL PHOTOCHEM, p[261, 303]; Wolleschensky R, 1998, APPL PHYS B-LASERS O, V67, P87, DOI 10.1007/s003400050479; Xie N, 2014, J MATER CHEM B, V2, P502, DOI 10.1039/c3tb21251c; Yao S., 2012, EUR J ORG CHEM, V17, P3199; Zhang H, 2013, J MATER CHEM B, V1, P5450, DOI 10.1039/c3tb20646g	60	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B		2015	3	2					184	190		10.1039/c4tb01404a		7	Materials Science, Biomaterials	Materials Science	AW1PG	WOS:000346061000004		
J	He, JY; Ma, N; Zhu, S; Komatsu, K; Li, ZY; Fu, WM				He, Jing-Yu; Ma, Na; Zhu, Shu; Komatsu, Katsuko; Li, Zhi-Yuan; Fu, Wei-Ming			The genus Codonopsis (Campanulaceae): a review of phytochemistry, bioactivity and quality control	JOURNAL OF NATURAL MEDICINES			English	Review						Codonopsis; Phytochemistry; Bioactivity; Quality control	PYRROLIDINE ALKALOIDS; RADIX CODONOPSIS; STRUCTURAL-CHARACTERIZATION; LANCEOLATA ROOTS; TANGSHEN OLIV; GROWTH-FACTOR; AERIAL PARTS; HPLC-UV; PILOSULA; CELLS	Codonopsis, in the family Campanulaceae, is a genus containing 42 species of dicotyledonous herbaceous perennial plants, predominantly found in Central, East and South Asia. Several Codonopsis species are widely used in traditional medicine and are considered to have multiple medicinal properties. Among the Codonopsis species, Codonopsis pilosula (Franch.) Nannf. and C. lanceolata (Sieb. et Zucc.) Benth. & Hook. f. ex Trautv. are more popular than others according to the findings, especially phytochemical and bioactive studies. Phytochemical research shows that Codonopsis species contain mainly polyacetylenes, phenylpropanoids, alkaloids, triterpenoids and polysaccharides, which contribute to multiple bioactivities. However, the mechanisms of their bioactivities need to be further elucidated. The less popular Codonopsis species remain to be studied and exploited. In addition, although a series of methods for the quality evaluation of Codonopsis species have been developed, a feasible and reliable approach to the efficacious and safe use of various Codonopsis species is still needed, with considering botanical origin, chemical constituents and bioactive effects. This review aims to provide up-to-date and comprehensive information on the phytochemistry, bioactivity and quality control of medicinal plants in the genus Codonopsis and to highlight current gaps in knowledge, which is useful for the wider development of the Codonopsis genus.	[He, Jing-Yu; Ma, Na; Li, Zhi-Yuan; Fu, Wei-Ming] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou 511458, Guangdong, Peoples R China; [Zhu, Shu; Komatsu, Katsuko] Toyama Univ, Inst Nat Med, Div Pharmacognosy, Dept Med Resources, Toyama 9300194, Japan	Fu, WM (reprint author), Chinese Acad Sci, Guangzhou Inst Adv Technol, 1121 Haibin Rd, Guangzhou 511458, Guangdong, Peoples R China.	wm.fu@giat.ac.cn					Aga EB, 2012, CHIN J NAT MEDICINES, V10, P366, DOI 10.3724/SP.J.1009.2012.00366; Ishida S, 2008, J NAT MED, V62, P236, DOI 10.1007/s11418-007-0219-7; Ma XQ, 2014, ANALYST, V139, P505, DOI 10.1039/c3an01561k; Ichikawa M, 2009, J NAT MED-TOKYO, V63, P52, DOI 10.1007/s11418-008-0294-4; Kim EY, 2014, ARCH PHARM RES, V37, P1148, DOI 10.1007/s12272-014-0335-3; Lee KW, 2005, BIOL PHARM BULL, V28, P854, DOI 10.1248/bpb.28.854; Tsai TH, 2008, CHEM PHARM BULL, V56, P1546, DOI 10.1248/cpb.56.1546; Qiao CF, 2007, J FOOD DRUG ANAL, V15, P258; Mei RQ, 2008, HELV CHIM ACTA, V91, P90, DOI 10.1002/hlca.200890018; Xu LP, 2008, PLANTA MED, V74, P1412, DOI 10.1055/s-2008-1081318; Li BX, 2012, VIB SPECTROSC, V62, P17, DOI 10.1016/j.vibspec.2012.05.001; He JY, 2014, J NAT MED-TOKYO, V68, P326, DOI 10.1007/s11418-013-0801-0; Lee KT, 2002, J AGR FOOD CHEM, V50, P4190, DOI 10.1021/jf011647l; Gao XM, 2012, J CHIN CHEM SOC-TAIP, V59, P540, DOI 10.1002/jccs.201100525; Cha A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/141395; Lee YG, 2007, J ETHNOPHARMACOL, V112, P180, DOI 10.1016/j.jep.2007.02.026; Hu QF, 2012, HELV CHIM ACTA, V95, P349, DOI 10.1002/hlca.201100339; Ushijima M, 2008, CHEM PHARM BULL, V56, P308, DOI 10.1248/cpb.56.308; Wang L, 2011, FOOD CHEM TOXICOL, V49, P149, DOI 10.1016/j.fct.2010.10.010; Yang CX, 2013, CARBOHYD POLYM, V98, P886, DOI 10.1016/j.carbpol.2013.06.079; Song D, 2008, HELV CHIM ACTA, V91, P1984, DOI 10.1002/hlca.200890213; Balasubramani SP, 2010, FITOTERAPIA, V81, P503, DOI 10.1016/j.fitote.2010.01.002; Balasubramani SP, 2011, 3 BIOTECH, V1, P11, DOI 10.1007/s13205-010-0001-5; Byeon SE, 2009, J ETHNOPHARMACOL, V123, P185, DOI 10.1016/j.jep.2009.02.014; [曹永凯 Cao Yongkai], 2012, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V23, P678; Chang YK, 1986, YAKHAK HOEJI, V30, P1; Chen F. F., 2013, CHINESE HERBAL MED, V5, P307; [陈恒冲 Chen Hengchong], 2010, [中国药房, China Pharmacy], V21, P2172; Chen M, 2000, CHIN TRADIT HERB DRU, V31, P280; Chen M, 2000, CHIN TRADIT HERB DRU, V31, P254; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, VI, P264; Choi HK, 2013, EVID-BASED COMPL ALT, V2013, P210; [封士兰 Feng Shilan], 2005, [中成药, Chinese Traditional Patent Medicine], V27, P745; Fu PP, 2008, LISHIZHEN MED MAT ME, V19, P2414; Fu RZ, 1999, PLANTA MED, V65, P648, DOI 10.1055/s-1999-14091; Guo WL, 2006, PLANT CELL REP, V25, P896, DOI 10.1007/s00299-006-0131-8; [韩春姬 Han Chunji], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P564; Han GR, 1990, CHIN J CHIN MAT MED, V15, P553; Han L, 2010, J N PHARM, V7, P17; He B, 2011, PEDIATR SURG INT, V27, P1203, DOI 10.1007/s00383-011-2935-z; He JY, 2014, PHYTOCHEM ANALYSIS, V25, P213, DOI 10.1002/pca.2494; He JY, 2014, J NAT MED-TOKYO, V68, P112, DOI 10.1007/s11418-013-0780-1; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; [贺庆 HE Qing], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P10; He Q., 2004, J CHIN PHARM SCI, V13, P212; Hong DY, 2011, FLORA CHINA, V19, P513; Hu QF, 2012, B KOREAN CHEM SOC, V33, P278, DOI 10.5012/bkcs.2012.33.1.278; Jiang PF, 1992, NAT PROD RES DEV, V2, P31; [净晶 Jing Jing], 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P2340; Kim E, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/405158; Kim MH, 2009, ARCH PHARM RES, V32, P1441, DOI 10.1007/s12272-009-2014-3; Li C, 1993, J YUNNAN U, V15, P86; Li CY, 2009, J CHROMATOGR A, V1216, P2124, DOI 10.1016/j.chroma.2008.10.080; [李香善 LI Xiangshan], 2007, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V22, P306; Li ZH, 2005, J GANSU COLL TRADIT, V22, P45; 梁志敏, 2007, [中国中药杂志, China Journal of Chinese Materia Medica], V32, P1363; Liu JH, 2003, ACTA PHARMACOL SIN, V24, P913; Liu L, 1989, PHARM CLIN CHIN MAT, V5, P11; Liu L, 1990, PHARM CLIN CHIN MAT, V6, P20; LIU T, 1988, Planta Medica, V54, P472, DOI 10.1055/s-2006-962513; Liu X, 2008, J INSTRUM ANAL, V27, P86; Liu XH, 2010, PHARM TODAY, V20, P13; Lu YR, 1989, CHIN J CHIN MAT MED, V14, P36; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2726; NAMBA T, 1992, Shoyakugaku Zasshi, V46, P156; NAMBA T, 1992, Shoyakugaku Zasshi, V46, P165; Nanjing University of Chinese Medicine, 2006, ZHONG YAO DA CI DIAN, P2578; Ng TB, 2004, J ETHNOPHARMACOL, V93, P285, DOI 10.1016/j.jep.2004.03.040; Pan SY, 1992, PHARM CLIN CHIN MAT, V8, P22; Pang WR, 2008, WORLD J INTEGR TRADI, V3, P89; 彭程, 2010, [中成药, Chinese Traditional Patent Medicine], V32, P1248; [戚欢阳 QI Huanyang], 2011, [中药材, Journal of Chinese Medicinal Materials], V34, P546; [Qiu Bin 邱斌], 2010, [天然产物研究与开发, Natural Product R & D], V22, P445; Ren J, 2013, PHYTOCHEM LETT, V6, P567, DOI 10.1016/j.phytol.2013.07.008; [宋丹 SONG Dan], 2008, [中国中药杂志, China Journal of Chinese Materia Medica], V33, P2133; Song D., 2008, J EMERG TRADIT CHIN, V17, P963; [宋丹 SONG Dan], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1136; Sukrong S, 2007, BIOL PHARM BULL, V30, P1284, DOI 10.1248/bpb.30.1284; Sun QW, 2007, LISHIZHEN MED MAT ME, V18, P1931; Sun YX, 2008, INT J BIOL MACROMOL, V43, P279, DOI 10.1016/j.ijbiomac.2008.06.009; Tashkhodzhaev B, 2004, CHEM NAT COMPD+, V40, P618, DOI 10.1007/s10600-005-0059-1; Trinh TT, 2003, J CHEM, V41, P119; Tsai KH, 2013, FOOD CHEM, V138, P1856, DOI 10.1016/j.foodchem.2012.11.056; Wakana D, 2013, CHEM PHARM BULL, V61, P1315; Wakana D, 2011, J NAT MED-TOKYO, V65, P18, DOI 10.1007/s11418-010-0447-0; [汪建红 Wang Jianhong], 2012, [天然产物研究与开发, Natural Product R & D], V24, P1035; Wang JZ, 1996, NAT PROD RES DEV, V8, P8; [王文永 WANG Wenyong], 2011, [中药材, Journal of Chinese Medicinal Materials], V34, P553; WANG Z-T, 1988, Shoyakugaku Zasshi, V42, P339; Wang ZT, 1995, BIOCHEM SYST ECOL, V23, P809, DOI 10.1016/0305-1978(95)00082-8; World Health Organization, 2000, WHO GEN GUID METH RE; Wu BF, 2008, LI SZ MED MAT MEDIA, V19, P280; [谢光波 XIE Guangbo], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P1321; Xu AX, 2006, CHIN J MOD APPL PHAR, V23, P729; Xu GJ, 1994, SPECIES SYSTEMATIZAT, V1, P5; Xu Q, 2008, GUANGXI MED J, V30, P1834; [闫彦芳 Yan Yanfang], 2006, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V29, P826; [杨丰榕 Yang Fengrong], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P2876; Yoo CS, 2013, TROP J PHARM RES, V12, P705, DOI 10.4314/tjpr.v12i5.7; Yoo HH, 2002, PHARMACOLOGY, V33, P85; Yoo KY, 2011, INT J NEUROSCI, V121, P503, DOI 10.3109/00207454.2011.580867; [俞星 Yu Xing], 2011, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V37, P1090; Yuan Z, 2006, CHINESE CHEM LETT, V17, P1460; YUDA M, 1990, PHYTOCHEMISTRY, V29, P1989, DOI 10.1016/0031-9422(90)85053-I; Zhang L, 2007, ZHONGGUO ZUZHI GONGC, V11, P5742; Zhang L., 2009, ASIAN JOURNAL OF TRA, V4, P210; Zhang RX, 1993, J LANZHOU MED COLL, V19, P14; Zhang RX, 1992, J LANZHOU MED COLL, V18, P161; Zhang YJ, 2010, FITOTERAPIA, V81, P157, DOI 10.1016/j.fitote.2009.08.011; Zhao B, 2013, BIOCHEM SYST ECOL, V46, P26, DOI 10.1016/j.bse.2012.09.004; Zhao JH, 2012, J MED SCI YANBIAN U, V35, P22; 赵晓华, 2007, [中成药, Chinese Traditional Patent Medicine], V29, P1046; Zhu EY, 2001, J CHIN PHARM U, V32, P94	113	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					1	21		10.1007/s11418-014-0861-9		21	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300001		
J	Zhu, S; Yu, XL; Wu, YQ; Shiraishi, F; Kawahara, N; Komatsu, K				Zhu, Shu; Yu, Xiaoli; Wu, Yuqiu; Shiraishi, Fumio; Kawahara, Nobuo; Komatsu, Katsuko			Genetic and chemical characterization of white and red peony root derived from Paeonia lactiflora	JOURNAL OF NATURAL MEDICINES			English	Article						Paeonia lactiflora; White peony root; Red peony root; Internal transcribed spacer of nrDNA (ITS) sequence; Chemical composition; Paeoniflorin; Pentagalloylglucose	INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; RETICULATE EVOLUTION; NUCLEOTIDE-SEQUENCE; BIOGEOGRAPHY; PLANTS; GENUS; RADIX; RDNA; CONSTITUENTS	Two kinds of peony roots-white peony root (WPR) and red peony root (RPR)-are used for different remedies in traditional Chinese medicine; however, most of them are derived from the same botanical origin, Paeonia lactiflora. The difference between WPR and RPR has been debated for a long time. This study attempted to clarify the genetic and chemical characteristics of WPR and RPR in order to provide a scientific dataset for their identification and effective use. The nucleotide sequence of nrDNA internal transcribed spacer (ITS) and the contents of 8 main bioactive constituents were analyzed from specimens of P. lactiflora, P. veitchii and two related species as well as crude drug samples of WPR, RPR and peony root produced in Japan. Of the samples derived from P. lactiflora, the WPR produced in the southern parts of China and the RPR produced in the northern parts of China were clearly divided into two subgroups within the P. lactiflora group based on similarity of the ITS sequences. The nucleotides at positions 69, 458 and 523 upstream of the ITS sequence served as molecular markers to discriminate between WPR and RPR. Quantitative analysis indicated that the RPR samples obviously contained a higher content of paeoniflorin and paeonol, but a lower content of albiflorin than the WPR produced in the southern parts of China and peony root produced in Japan. The WPR available from Chinese markets was usually processed by sulfur fumigation, which resulted in an extremely low content of paeoniflorin. This study indicated that WPR and RPR were not only geographically isolated, but also genetically and chemically separated. The ITS sequence provided a genetic index for their identification.	[Zhu, Shu; Yu, Xiaoli; Wu, Yuqiu; Shiraishi, Fumio; Komatsu, Katsuko] Toyama Univ, Inst Nat Med, Div Pharmacognosy, Dept Med Resources, Toyama 9300194, Japan; [Kawahara, Nobuo] Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Tsukuba, Ibaraki 3050843, Japan	Zhu, S (reprint author), Toyama Univ, Inst Nat Med, Div Pharmacognosy, Dept Med Resources, 2630 Sugitani, Toyama 9300194, Japan.	szhu@inm.u-toyama.ac.jp; katsukok@inm.u-toyama.ac.jp			MEXT/JSPS KAKENHI [21406004, 24406005]; Ministry of Health, Labor and Welfare of Japan [H22-SOYAKUSOGO-General-013]	We thank Dr. Javzan Batkhuu, National University of Mongolia and Dr. Chinbat Sanchir, Institute of Biology, Mongolian Academy of Science, Mr. Morikazu Murakami and the staff of Toyama Prefectural Medicinal Plants Center, Dr. Shengli Wei, Beijing University of Chinese Medicine, and Dr. Kyoko Takahashi, Osaka University for kind help in sample collection. We thank Dr. Kohei Kazuma, Institute of Natural Medicine, University of Toyama for measurement of paeoniflorin sulphonate by LC/MS. This work was supported by MEXT/JSPS KAKENHI Grant Nos. 21406004 and 24406005, and in part by a grant from the Ministry of Health, Labor and Welfare of Japan (H22-SOYAKUSOGO-General-013).	Wu SH, 2010, CHEM BIODIVERS, V7, P90, DOI 10.1002/cbdv.200800148; Pan J, 2007, AM J BOT, V94, P400, DOI 10.3732/ajb.94.3.400; TAKAIWA F, 1985, PLANT MOL BIOL, V4, P355, DOI 10.1007/BF02418257; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Xu SJ, 2009, J CHROMATOGR A, V1216, P2163, DOI 10.1016/j.chroma.2008.04.064; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Cai SQ, 2011, PHARMACOGNOSY, P130; He JY, 2014, J NAT MED-TOKYO, V68, P112, DOI 10.1007/s11418-013-0780-1; Japan Kampo Medicinal Manufacturers Association, 2013, SURV REP ANN CONS HE, P8; Kitani Y, 2011, BIOL PHARM BULL, V34, P717, DOI 10.1248/bpb.34.717; Luo NC, 2013, NAT PROD COMMUN, V8, P487; Mikage M, 2009, KAMPO MED, V60, P419; Namba T, 1993, ENCY WAKAN YAKU TRAD, VI, P102; Sang T, 1997, MOL BIOL EVOL, V14, P994; SCHIEBEL K, 1989, NUCLEIC ACIDS RES, V17, P2852, DOI 10.1093/nar/17.7.2852; Sukrong S, 2007, BIOL PHARM BULL, V30, P1284, DOI 10.1248/bpb.30.1284; Sun Yan-Lin, 2011, Journal of Plant Biotechnology, V38, P234; The Ministry of Health Labour and Welfare, 2011, JAP PHARM, P1704; The State Pharmacopoeia Commission of China, 2010, PHARMACOPOEIA PEOPLE, V1, P306; Wang Q, 2005, CHROMATOGRAPHIA, V62, P581, DOI 10.1365/s10337-005-0660-2	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					35	45		10.1007/s11418-014-0857-5		11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300003		
J	Matsumoto, M; Hirayama, M; Ohtomi, N; Ohno, T; Nomura, Y; Iida, O; Sugimura, K; Kawahara, N; Tsuchida, T; Mikage, M				Matsumoto, Masashi; Hirayama, Manabu; Ohtomi, Norihiro; Ohno, Takeshi; Nomura, Yukihiro; Iida, Osamu; Sugimura, Koji; Kawahara, Nobuo; Tsuchida, Takashi; Mikage, Masayuki			Influence of genetic factors on the ephedrine alkaloid composition ratio of Ephedra plants	JOURNAL OF NATURAL MEDICINES			English	Article						Ephedra sinica Stapf; Ephedrine; Pseudoephedrine; Cultivation; Division; Cuttage	PSEUDOEPHEDRINE	We investigated the ephedrine alkaloid [(-)-ephedrine and (+)-pseudoephedrine] composition ratio of a crude Chinese herbal drug described in the Japanese Pharmacopoeia 'Ephedra herb (Chinese name: Mahuang)'. There were marked changes in the alkaloid composition ratio of wild plants in areas where both male and female clusters coexisted. However, in genetically homogeneous areas with the growth of male or female clusters alone, all of the coefficients of the regression lines were positive, but each gradient varied. This suggests that the alkaloid composition ratio has a clear tendency in each individual. Based on this, we cultivated individuals for vegetative propagation, and evaluated the alkaloid content ratio. Those propagated by separating the roots showed a specific tendency regardless of the cultivation area (Wakayama, Tanegashima). Those propagated by separating the herbaceous stem showed a specific tendency regardless of the soil or harvest time. In addition, we surveyed the (-)-ephedrine content ratio of 3- to 6-year-old strains. There was a high positive correlation coefficient between the previous and subsequent years. These findings suggest that the ephedrine alkaloid composition ratio of Ephedra herb depends on genetic factors, but not on environmental factors or the growth period.	[Matsumoto, Masashi; Tsuchida, Takashi] Kracie Pharma Ltd, Takaoka, Toyama 9330856, Japan; [Matsumoto, Masashi; Hirayama, Manabu; Ohtomi, Norihiro; Ohno, Takeshi; Nomura, Yukihiro; Mikage, Masayuki] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Iida, Osamu; Sugimura, Koji] Natl Inst Biomed Innovat, Tanegashima Div, Res Ctr Med Plant Resources, Kagoshima 8913604, Japan; [Kawahara, Nobuo] Natl Inst Biomed Innovat, Tsukuba Div, Res Ctr Med Plant Resourses, Tsukuba, Ibaraki 3050843, Japan	Matsumoto, M (reprint author), Kracie Pharma Ltd, 3-1 Kanebo Machi, Takaoka, Toyama 9330856, Japan.	matsumoto_masashi@phm.kracie.co.jp; iidao@nibio.go.jp; kawahara@nibio.go.jp; mikage@p.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [13575010, 17405014]	Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (nos. 13575010, 17405014) supported this study.	AKIBA K, 1979, FOLIA PHARMACOL JPN, V75, P383, DOI 10.1254/fpj.75.383; HIKINO H, 1980, CHEM PHARM BULL, V28, P2900; Cheng Da-Dun, 1992, ZHONGGUO YAOKE DAXUE, V23, P82; Chiaki Nagase, 1996, CLIN REPORT, V30, P633; Editorial Committee of Guidelines for Good Agricultural Practice of Chinese Crude Drugs, 2006, GUID GOOD AGR PRACT, P840; LAITINEN LA, 1982, EUR J CLIN PHARMACOL, V23, P107, DOI 10.1007/BF00545963; LIU YM, 1993, PLANTA MED, V59, P376, DOI 10.1055/s-2006-959706; Liu Z, 2009, ZHONG CAO YAO, V40, P771; Society of Japanese Pharmacopoeia, 2011, JAP PHARM, P1589; Tanaka Toshihiro, 1995, Natural Medicines, V49, P418; The Society for Antibacterial and Antifungal Agents Japan, 1999, 21 CENT HERB MED KAM, P87; Wang LL, 2010, J NAT MED-TOKYO, V64, P63, DOI 10.1007/s11418-009-0374-0; Zhang J. S., 1989, Acta Pharmaceutica Sinica, V24, P865	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					63	67		10.1007/s11418-014-0863-7		5	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300006		
J	Oshima, N; Zaima, K; Kamakura, H; Hamato, A; Yamamoto, Y; Kang, DH; Yokokura, T; Goda, Y; Hakamatsuka, T; Maruyama, T				Oshima, Naohiro; Zaima, Kazumasa; Kamakura, Hiroyuki; Hamato, Akane; Yamamoto, Yutaka; Kang, Dong Hyo; Yokokura, Tsuguo; Goda, Yukihiro; Hakamatsuka, Takashi; Maruyama, Takuro			Identification of marker compounds for Japanese Pharmacopoeia non-conforming jujube seeds from Myanmar	JOURNAL OF NATURAL MEDICINES			English	Article						Jujube Seed; Ziziphus jujuba var. spinosa; Ziziphus mauritiana; Purity test; Oleanolic acid	ALKALOIDS; ROOT	Jujube Seed is a crude drug defined as the seed of Ziziphus jujuba Miller var. spinosa Hu ex H.F. Chou (Rhamnaceae) in the Japanese Pharmacopoeia (JP). Most of the jujube seed in the Japanese markets is imported from China, with the rest obtained from other Asian countries. Here we confirmed the botanical origins of jujube seeds from both China and Myanmar by a DNA sequencing analysis. We found that the botanical origins of the crude drugs from China and Myanmar were Z. jujuba and Z. mauritiana, respectively. Although the jujube seed from China conforms to the JP, that from Myanmar does not. A method for discriminating jujube seeds from China and Myanmar using a chemical approach is thus desirable, and here we sought to identify a compound specific to Z. jujuba. Jujuboside A (1) was identified as a compound specific to Z. jujuba. To establish a purity test of Jujube Seed in the JP against Z. mauritiana, we fractionated the extract of Z. mauritiana seeds and identified frangufoline (2) and oleanolic acid (4) as the marker compounds specific to Z. mauritiana. Thin-layer chromatography (TLC) and gas chromatography-mass spectrometry analyses revealed that the latter compound was useful for testing by TLC analysis. The established TLC conditions were as follows: chromatographic support, silica gel; developing solvent, n-hexane:EtOAc:HCOOH = 10:5:1; developing length, 7 cm; visualization, diluted sulfuric acid; R (f) value, 0.43 (oleanolic acid).	[Oshima, Naohiro; Zaima, Kazumasa; Kamakura, Hiroyuki; Goda, Yukihiro; Hakamatsuka, Takashi; Maruyama, Takuro] Natl Inst Hlth Sci, Div Pharmacognosy, Phytochem & Narcot, Setagaya Ku, Tokyo 1588501, Japan; [Hamato, Akane; Yamamoto, Yutaka; Kang, Dong Hyo] Tochimoto Tenkaido Co Ltd, Tamba, Hyogo 6693315, Japan; [Yokokura, Tsuguo] Nippon Funmatsu Yakuhin Co Ltd, Yao, Osaka 5810813, Japan	Maruyama, T (reprint author), Natl Inst Hlth Sci, Div Pharmacognosy, Phytochem & Narcot, Setagaya Ku, I-18-1 Kamiyoga, Tokyo 1588501, Japan.	t-maruya@nihs.go.jp			Health and Labour Sciences Research Grants in Japan	This work was supported by Health and Labour Sciences Research Grants in Japan.	Panseeta P, 2011, PHYTOCHEMISTRY, V72, P909, DOI 10.1016/j.phytochem.2011.03.003; Wang LE, 2008, PHARMACOL BIOCHEM BE, V90, P399, DOI 10.1016/j.pbb.2008.03.022; [Anonymous], COMMUNICATION; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Razborsek MI, 2008, CHROMATOGRAPHIA, V67, P433, DOI 10.1365/s10337-008-0533-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Crude Drugs Committee of Japan Kampo Medicines Manufacturers Association, 2013, 2 JAP KAMP MED MAN A, P4; Han BH, 1990, SAENGHWAHAK NYUSU, V10, P239; Hu HB, 2011, ARCH PHARM RES, V34, P1097, DOI 10.1007/s12272-011-0707-x; Jiang JG, 2007, NAT PROD RES, V21, P310, DOI 10.1080/14786410701192827; TSCHESCH.R, 1968, TETRAHEDRON LETT, P2993	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					68	75		10.1007/s11418-014-0864-6		8	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300007		
J	Murata, K; Matsumura, S; Yoshioka, Y; Ueno, Y; Matsuda, H				Murata, Kazuya; Matsumura, Shinichi; Yoshioka, Yuri; Ueno, Yoshihiro; Matsuda, Hideaki			Screening of beta-secretase and acetylcholinesterase inhibitors from plant resources	JOURNAL OF NATURAL MEDICINES			English	Article						Dementia; beta-secretase; Black pepper; Curry leaf; Turmeric	ALZHEIMERS-DISEASE; CURCUMIN; CELLS; DONEPEZIL; EFFICACY; BACE2; MICE	The therapeutic agents for dementia are limited due to the complex system underlying the mechanisms. Taking a preventive point of view, we focused on the inhibition of beta-secretase and acetylcholinesterase (AChE). In addition, plant resources including herbs and spices have been widely consumed, and further, may be consumed for a long period over a lifetime. Considering this background, we screened beta-secretase and AChE inhibitors from curry spices. Amongst them, curry leaf, black pepper, and turmeric extracts were effective to inhibit beta-secretase. Furthermore, black pepper and turmeric extracts were also effective to inhibit AChE. Having these results in hand, we focused on the investigation of beta-secretase inhibitors since the inhibitor of this enzyme has not previously been well investigated. As a result, alpha- and beta-caryophyllene, beta-caryophyllene oxide (from curry leaf), piperine (from black pepper), curcumin, demethoxycurcumin, and bisdemethoxycurcumin (from turmeric) were successfully identified as low molecular inhibitors. This is the first report to determine alpha- and beta-caryophyllene, beta-caryophyllene oxide, and piperine as beta-secretase inhibitors. These compounds may pass through the blood brain barrier since their molecular weights are relatively low.	[Murata, Kazuya; Ueno, Yoshihiro; Matsuda, Hideaki] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan; [Matsumura, Shinichi; Yoshioka, Yuri] Inabata Koryo Co Ltd, Yodogawa, Osaka 5320027, Japan	Matsuda, H (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	matsuda@phar.kindai.ac.jp					Akatsu H, 2002, J NEUROL SCI, V196, P63, DOI 10.1016/S0022-510X(02)00028-X; Winblad B, 2006, DEMENT GERIATR COGN, V21, P353, DOI 10.1159/000091790; Zhu ZY, 2010, J NEUROCHEM, V114, P374, DOI 10.1111/j.1471-4159.2010.06751.x; Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Marston A, 2002, PHYTOCHEM ANALYSIS, V13, P51, DOI 10.1002/pca.623; Shimmyo Y, 2008, NEUROREPORT, V19, P1329, DOI 10.1097/WNR.0b013e32830b8ae1; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Rogers SL, 2000, EUR NEUROPSYCHOPHARM, V10, P195, DOI 10.1016/S0924-977X(00)00067-5; Gevaert T, 2007, NEUROUROL URODYNAM, V26, P440, DOI 10.1002/nau.20343; Sasaki H, 2010, BIOORG MED CHEM LETT, V20, P4558, DOI 10.1016/j.bmcl.2010.06.021; Asai M, 2006, J NEUROCHEM, V96, P533, DOI 10.1111/j.1471-4159.2005.03576.x; Casas S, 2010, AM J PHYSIOL-ENDOC M, V299, pE1087, DOI 10.1152/ajpendo.00420.2010; Giovanni SD, 2008, EUR J PHARM SCI, V33, P109; Huang HC, 2014, J RECEPT SIG TRANSD, V34, P26, DOI 10.3109/10799893.2013.848891; Wang X, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-88	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					123	129		10.1007/s11418-014-0859-3		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300013		
J	Narukawa, Y; Komori, M; Niimura, A; Noguchi, H; Kiuchi, F				Narukawa, Yuji; Komori, Miyuki; Niimura, Akiko; Noguchi, Hitomi; Kiuchi, Fumiyuki			Two new diterpenoids from Leonotis leonurus R. Br.	JOURNAL OF NATURAL MEDICINES			English	Article						Leonotis leonurus; Labiatae; Diterpenoids; Estrogen sulfotransferase; Inhibitor	LABDANE DITERPENOIDS; OCYMIFOLIA	Two new diterpenoids, 14 alpha-hydroxy-9 alpha,13 alpha-epoxylabd-5(6)-en-7-on-16,15-olide (1) and 13 xi-hydroxylabd-5(6),8(9)-dien-7-on-16,15-olide (2) along with six known diterpenoids were isolated from the aerial parts of Leonotis leonurus R. Br. These structures were determined on the basis of spectroscopic analyses. Some of the isolated compounds showed weak to moderate estrogen sulfotransferase inhibitory activity.	[Narukawa, Yuji; Komori, Miyuki; Niimura, Akiko; Noguchi, Hitomi; Kiuchi, Fumiyuki] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan	Kiuchi, F (reprint author), Keio Univ, Fac Pharm, Minato Ku, I-5-30 Shibakoen, Tokyo 1058512, Japan.	kiuchi-fm@pha.keio.ac.jp			MEXT; Keio Gijuku Academic Development Funds	This work was supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities and Keio Gijuku Academic Development Funds.	Piozzi F, 2007, HETEROCYCLES, V74, P31; Mnonopi N, 2011, J ETHNOPHARMACOL, V138, P67, DOI 10.1016/j.jep.2011.08.041; Bienvenu E, 2002, PHYTOMEDICINE, V9, P217, DOI 10.1078/0944-7113-00103; Wu HK, 2013, PHYTOCHEMISTRY, V91, P229, DOI 10.1016/j.phytochem.2012.02.021; HABTEMARIAM S, 1994, J NAT PRODUCTS, V57, P1570, DOI 10.1021/np50113a017; Hussein AA, 2003, MAGN RESON CHEM, V41, P147, DOI 10.1002/mrc.1136; Iwarsson Mattias, 2003, Kew Bulletin, V58, P597, DOI 10.2307/4111146; Kaplan ER, 1968, J CHEM SOC C, V3, P262; Narukawa Y, 2014, J NAT MED-TOKYO, V68, P125, DOI 10.1007/s11418-013-0781-0; Narukawa Yuji, 2001, Natural Medicines, V55, P79; Obikeze KC, 2008, S AFR J CHEM-S-AFR T, V61, P119; Rigano D, 2006, J NAT PROD, V69, P836, DOI 10.1021/np0505420; Takeda T, 1999, CHEM PHARM BULL, V47, P284; Tasdemir D, 1997, J NAT PROD, V60, P874, DOI 10.1021/np9700782	14	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					130	134		10.1007/s11418-014-0868-2		5	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300014		
J	Liu, J; Nakamura, S; Xu, B; Matsumoto, T; Ohta, T; Fujimoto, K; Ogawa, K; Fukaya, M; Miyake, S; Yoshikawa, M; Matsuda, H				Liu, Jiang; Nakamura, Seikou; Xu, Bin; Matsumoto, Takahiro; Ohta, Tomoe; Fujimoto, Katsuyoshi; Ogawa, Keiko; Fukaya, Masashi; Miyake, Shiori; Yoshikawa, Masayuki; Matsuda, Hisashi			Chemical structures of constituents from the flowers of Osmanthus fragrans var. aurantiacus	JOURNAL OF NATURAL MEDICINES			English	Article						Osmanthus fragrans var. aurantiacus; Floraosmanoside; Floraosmanolactone; Megastigmane; gamma-Decalactone; Medicinal flower	NITRIC-OXIDE PRODUCTION; ACYLATED SUCROSES; PRUNUS-MUME; FRAXINUS-EXCELSIOR; PHENOLIC-COMPOUNDS; CAMELLIA-JAPONICA; ALDOSE REDUCTASE; CANANGA-ODORATA; BUDS; MELANOGENESIS	Three new megastigmane glycosides named floraosmanosides I-III and a new gamma-decalactone named floraosmanolactone I together with 16 known constituents were isolated from the flowers of Osmanthus fragrans var. aurantiacus cultivated in Guangxi Zhuang Autonomous Region, China. The chemical structures of the new compounds were elucidated on the basis of chemical and physicochemical evidence. Among them, ligustroside and (+)-pinoresinol significantly inhibited nitric oxide production in lipopolysaccharide-activated RAW264.7 macrophages.	[Liu, Jiang] Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu 611130, Peoples R China; [Nakamura, Seikou; Xu, Bin; Matsumoto, Takahiro; Ohta, Tomoe; Fujimoto, Katsuyoshi; Ogawa, Keiko; Fukaya, Masashi; Miyake, Shiori; Yoshikawa, Masayuki; Matsuda, Hisashi] Kyoto Pharmaceut Univ, Dept Pharmacognosy, Yamashina Ku, Kyoto 6078412, Japan	Matsuda, H (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacognosy, Yamashina Ku, Kyoto 6078412, Japan.	matsuda@mb.kyoto-phu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [26460135]	This work was supported in part by a Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities and by JSPS KAKENHI Grant Number 26460135.	Fujimoto K, 2014, J NAT MED-TOKYO, V68, P481, DOI 10.1007/s11418-014-0818-z; DEYAMA T, 1987, CHEM PHARM BULL, V35, P1785; Kwak JH, 2009, ARCH PHARM RES, V32, P1681, DOI 10.1007/s12272-009-2203-0; Nakamura S, 2013, J NAT MED-TOKYO, V67, P799, DOI 10.1007/s11418-013-0750-7; Hegazy MEF, 2012, CHEM PHARM BULL, V60, P363, DOI 10.1248/cpb.60.363; Nakamura S, 2013, BIOORGAN MED CHEM, V21, P779, DOI 10.1016/j.bmc.2012.11.038; Tanaka T, 2007, CHEM PHARM BULL, V55, P899, DOI 10.1248/cpb.55.899; KOBAYASHI H, 1987, CHEM PHARM BULL, V35, P3309; Matsumoto T, 2014, ORG LETT, V16, P3076, DOI 10.1021/ol501182v; GUO WF, 1993, PHYTOCHEMISTRY, V33, P1373, DOI 10.1016/0031-9422(93)85093-7; Nakamura S, 2013, PHYTOCHEMISTRY, V92, P128, DOI 10.1016/j.phytochem.2013.04.012; Bai NS, 2013, ACS SYM SER, V1127, P115; Bai NS, 2010, J NAT PROD, V73, P2, DOI 10.1021/np9003118; Dieskau AP, 2011, EUR J ORG CHEM, P5291, DOI 10.1002/ejoc.201100717; FUJI K, 1985, J AM CHEM SOC, V107, P6404, DOI 10.1021/ja00308a049; Hosokawa A, 2004, CHEM PHARM BULL, V52, P1265, DOI 10.1248/cpb.52.1265; INOUYE H, 1975, PHYTOCHEMISTRY, V14, P2029, DOI 10.1016/0031-9422(75)83119-0; Jackson HL, 2005, ORG PROCESS RES DEV, V9, P830, DOI 10.1021/op050137f; KIKUCHI M, 1989, YAKUGAKU ZASSHI, V109, P366; Lee DG, 2011, J KOREAN SOC APPL BI, V54, P206, DOI 10.3839/jksabc.2011.034; Lee DG, 2010, J KOREAN SOC APPL BI, V53, P371, DOI 10.3839/jksabc.2010.057; Lee DG, 2011, ARCH PHARM RES, V34, P2029, DOI 10.1007/s12272-011-1204-y; Linares-Palomino PJ, 2006, FLAVOUR FRAG J, V21, P659, DOI 10.1002/ffj.1643; Liu J, 2013, TETRAHEDRON LETT, V54, P32, DOI 10.1016/j.tetlet.2012.10.052; Matsumoto T, 2014, J NAT PROD, V77, P990, DOI 10.1021/np401091f; Matsumoto T, 2014, J NAT MED-TOKYO, V68, P709, DOI 10.1007/s11418-014-0843-y; Matsunami K, 2010, CHEM PHARM BULL, V58, P438; Nakai T, 2005, BIOSCI BIOTECH BIOCH, V69, P2401, DOI 10.1271/bbb.69.2401; Nakamura S, 2012, CHEM PHARM BULL, V60, P752, DOI 10.1248/cpb.60.752; Nakamura S, 2012, J NAT PROD, V75, P1425, DOI 10.1021/np3001078; Sae-Wong C, 2011, J ETHNOPHARMACOL, V136, P488, DOI 10.1016/j.jep.2011.01.013; Sakamoto S, 2009, HETEROCYCLES, V77, P557, DOI 10.3987/COM-08-S(F)3; Yang CP, 2013, INT J MOL SCI, V14, P9168, DOI 10.3390/ijms14059168; Yoo KH, 2013, ONCOL LETT, V5, P386, DOI 10.3892/ol.2012.985; Yu Y, 2010, HELV CHIM ACTA, V93, P763, DOI 10.1002/hlca.200900291	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					135	141		10.1007/s11418-014-0869-1		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300015		
J	Matsumoto, T; Nakamura, S; Fujimoto, K; Ohta, T; Ogawa, K; Yoshikawa, M; Onishi, E; Fukaya, M; Matsuda, H				Matsumoto, Takahiro; Nakamura, Seikou; Fujimoto, Katsuyoshi; Ohta, Tomoe; Ogawa, Keiko; Yoshikawa, Masayuki; Onishi, Eri; Fukaya, Masashi; Matsuda, Hisashi			Structure of diarylheptanoids with antiallergic activity from the rhizomes of Curcuma comosa	JOURNAL OF NATURAL MEDICINES			English	Article						Curcuma comosa; Diarylheptanoids; Antiallergic activity; Thai traditional medicine	HISTAMINE-RELEASE INHIBITORS; FLOWER BUDS; MEDICINAL FOODSTUFFS; TRITERPENE SAPONINS; ZINGIBER-OFFICINALE; CAMELLIA-SINENSIS; CANANGA-ODORATA; RBL-2H3 CELLS; TNF-ALPHA; CONSTITUENTS	The methanolic extract from the dried rhizomes of Curcuma comosa cultivated in Thailand was found to inhibit the release of beta-hexosaminidase as a maker of degranulation from rat basophil leukemia (RBL-2H3) cells. Two new diarylheptanoids, diarylcomosols IV and V, were isolated from the methanolic extract. The chemical structures of the new compounds were elucidated on the basis of chemical and physicochemical evidence. The isolated diarylheptanoids showed inhibitory activity, and the structural requirements of the active constituents for the inhibition were clarified.	[Matsumoto, Takahiro; Nakamura, Seikou; Fujimoto, Katsuyoshi; Ohta, Tomoe; Ogawa, Keiko; Yoshikawa, Masayuki; Onishi, Eri; Fukaya, Masashi; Matsuda, Hisashi] Kyoto Pharmaceut Univ, Dept Pharmacognosy, Yamashina Ku, Kyoto 6078412, Japan	Matsuda, H (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacognosy, Yamashina Ku, Kyoto 6078412, Japan.	matsuda@mb.kyoto-phu.ac.jp			JSPS KAKENHI [25460144]	This work was supported in part by JSPS KAKENHI Grant Number 25460144.	SMITE E, 1993, PHYTOCHEMISTRY, V32, P365, DOI 10.1016/S0031-9422(00)94995-1; Yokosuka A, 2002, J NAT PROD, V65, P283, DOI 10.1021/np010470m; Matsuda H, 2003, BIOORG MED CHEM LETT, V13, P3197, DOI 10.1016/S0960-894X(03)00710-8; Nakamura S, 2013, BIOORGAN MED CHEM, V21, P779, DOI 10.1016/j.bmc.2012.11.038; Li J, 2010, J NAT PROD, V73, P1667, DOI 10.1021/np100392m; Li J, 2011, BIOORG MED CHEM LETT, V21, P5363, DOI 10.1016/j.bmcl.2011.07.012; Matsuda H, 2004, BIOORGAN MED CHEM, V12, P5891, DOI 10.1016/j.bmc.2004.08.027; Shin D, 2002, J NAT PROD, V65, P1315, DOI 10.1021/np020099i; Jantaratnotai N, 2006, LIFE SCI, V78, P571, DOI 10.1016/j.lfs.2005.04.065; KIKUZAKI H, 1991, PHYTOCHEMISTRY, V30, P3647, DOI 10.1016/0031-9422(91)80085-F; Ma JP, 2004, PHYTOCHEMISTRY, V65, P1137, DOI 10.1016/j.phytochem.2004.03.007; Matsuda H, 2010, CHEM PHARM BULL, V58, P1617, DOI 10.1248/cpb.58.1617; Matsuda H., 2002, BIOORGAN MED CHEM, V10, P3123; Matsuda H, 2009, CHEM PHARM BULL, V57, P487, DOI 10.1248/cpb.57.487; Matsumoto T, 2014, J NAT PROD, V77, P990, DOI 10.1021/np401091f; Matsumoto T, 2014, J NAT MED-TOKYO, V68, P709, DOI 10.1007/s11418-014-0843-y; Matsumoto T, 2013, BIOORGAN MED CHEM, V21, P5178; Morikawa T, 2007, CHEM PHARM BULL, V55, P293, DOI 10.1248/cpb.55.293; Qu Y, 2009, J NAT MED-TOKYO, V63, P102, DOI 10.1007/s11418-008-0282-8; Sodsai A, 2007, INT IMMUNOPHARMACOL, V7, P524, DOI 10.1016/j.intimp.2006.12.013; Veith M, 1996, TETRAHEDRON, V52, P6601, DOI 10.1016/0040-4020(96)00298-0; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P877; Yoshikawa M, 2007, CHEM PHARM BULL, V55, P598, DOI 10.1248/cpb.55.598; Yoshizumi S, 1998, YAKUGAKU ZASSHI, V118, P188	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					142	147		10.1007/s11418-014-0870-8		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300016		
J	Kadokura, K; Suruga, K; Tomita, T; Hiruma, W; Yamada, M; Kobayashi, A; Takatsuki, A; Nishio, T; Oku, T; Sekino, Y				Kadokura, Kazunari; Suruga, Kohei; Tomita, Tsuyoshi; Hiruma, Wataru; Yamada, Motoyuki; Kobayashi, Akio; Takatsuki, Akira; Nishio, Toshiyuki; Oku, Tadatake; Sekino, Yoshihiro			Novel urushiols with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity from the leaves of Rhus verniciflua	JOURNAL OF NATURAL MEDICINES			English	Article						Rhus verniciflua; Anacardiaceae; Leaves; Urushiol; HIV-1 reverse transcriptase inhibitory activity	ABSOLUTE-CONFIGURATION; STOKES; PROTECTS; ANTIOXIDANT; EXTRACT; CELLS	Two novel urushiols, 1 and 2, and two known urushiols, 3 and 4, were isolated from the leaves of Rhus verniciflua and were examined for their human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitory activity. The novel urushiols were found to be 1,2-dihydroxyphenyl-3-[7'(E),9'(Z),11'(Z)-pentadecatrienyl]-14'-ol (1) and 1,2-dihydroxyphenyl-3-[8'(Z),10'(E),12'(E)-pentadecatrienyl]-14'-ol (2) by spectroscopic analyses. The absolute configuration at C-14' in 1 and 2 was determined to be a racemic mixture of (R) and (S) isomers by ozonolysis. Compound 2 (IC50: 12.6 A mu M) showed the highest HIV-1 RT inhibitory activity among the four urushiols, being 2.5-fold more potent than the positive control, adriamycin (IC50: 31.9 A mu M). Although the known urushiols were isolated from the sap and leaves of R. verniciflua, 1 was exclusively present in the leaves, and higher amounts of 2 were found in the leaves than in the sap. Present findings indicate that the leaves of R. verniciflua represent a new biological resource from which novel and known urushiols may be prepared, and the possible use of novel urushiols as bioactive products.	[Kadokura, Kazunari; Suruga, Kohei; Tomita, Tsuyoshi; Hiruma, Wataru; Yamada, Motoyuki; Sekino, Yoshihiro] Kibun Foods Inc, Food Mat Ctr R & D, Inagi, Tokyo 2060812, Japan; [Kobayashi, Akio] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Takatsuki, Akira] Hosei Univ, Fac Biosci & Appl Chem, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Nishio, Toshiyuki; Oku, Tadatake] Nihon Univ, Dept Chem & Life Sci, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Kadokura, K (reprint author), Kibun Foods Inc, Food Mat Ctr R & D, 86 Yanokuchi, Inagi, Tokyo 2060812, Japan.	kazunari_kadokura@kibun.co.jp					Tewtrakul S, 2002, CHEM PHARM BULL, V50, P630, DOI 10.1248/cpb.50.630; Kim JS, 2010, FOOD CHEM, V120, P539, DOI 10.1016/j.foodchem.2009.10.051; Choi W, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/874276; HIRAI N, 1994, BIOSCI BIOTECH BIOCH, V58, P1679; Hoye TR, 2007, NAT PROTOC, V2, P2451, DOI 10.1038/nprot.2007.354; Song MY, 2010, EXP MOL MED, V42, P628, DOI 10.3858/emm.2010.42.9.062; Hong DH, 1999, ARCH PHARM RES, V22, P638, DOI 10.1007/BF02975339; ElSohly MA, 1982, J NAT PRODUCTS, V45, P532, DOI [10.1021/np50023a004, DOI 10.1021/NP50023A004]; Jeong GS, 2011, BIOL PHARM BULL, V34, P97, DOI 10.1248/bpb.34.97; Kim JS, 2011, J MED PLANTS RES, V5, P2617; Kim MJ, 1997, KOREAN J PLANT RES, V10, P227; Kim S, 2011, J PHARM PHARMACOL, V63, P1358, DOI 10.1111/j.2042-7158.2011.01342.x; Numura N, 1998, J JPN OIL CHEM SCI, V47, P171; Vogl O, 1994, PROGR PACIFIC POLYM, V3, P423	14	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					148	153		10.1007/s11418-014-0871-7		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300017		
J	Kakiuchi, N; Atsumi, T; Higuchi, M; Kamikawa, S; Miyako, H; Wakita, Y; Ohtsuka, I; Hayashi, S; Hishida, A; Kawahara, N; Nishizawa, M; Yamagishi, T; Kadota, Y				Kakiuchi, Nobuko; Atsumi, Toshiyuki; Higuchi, Mari; Kamikawa, Shohei; Miyako, Haruka; Wakita, Yuriko; Ohtsuka, Isao; Hayashi, Shigeki; Hishida, Atsuyuki; Kawahara, Nobuo; Nishizawa, Makoto; Yamagishi, Takashi; Kadota, Yuichi			Diversity in aconitine alkaloid profile of Aconitum plants in Hokkaido contrasts with their genetic similarity	JOURNAL OF NATURAL MEDICINES			English	Article						Aconite; Alkaloid; Hokkaido; Phylogeny; Resource	RANUNCULACEAE; CHLOROPLAST; PHYLOGENY; DNA	Aconite tuber is a representative crude drug for warming the body internally in Japanese Kampo medicine and Chinese traditional medicine. The crude drug is used in major prescriptions for the aged. Varieties of Aconitum plants are distributed throughout the Japanese Islands, especially Hokkaido. With the aim of identifying the medicinal potential of Aconitum plants from Hokkaido, 107 specimens were collected from 36 sites in the summer of 2011 and 2012. Their nuclear DNA region, internal transcribed spacer (ITS), and aconitine alkaloid contents were analyzed. Phylogenic analysis of ITS by maximum parsimony analysis showed that the majority of the specimens were grouped into one cluster (cluster I), separated from the other cluster (cluster II) consisting of alpine specimens. The aconitine alkaloid content of the tuberous roots of 76 specimens showed 2 aspects-specimens from the same collection site showed similar aconitine alkaloid profiles, and cluster I specimens from different habitats showed various alkaloid profiles. Environmental pressure of each habitat is presumed to have caused the morphology and aconitine alkaloid profile of these genetically similar specimens to diversify.	[Kakiuchi, Nobuko; Atsumi, Toshiyuki; Higuchi, Mari; Kamikawa, Shohei; Miyako, Haruka; Wakita, Yuriko; Ohtsuka, Isao] Kyusyu Univ Hlth & Welf, Nobeoka, Miyazaki 8828508, Japan; [Hayashi, Shigeki; Hishida, Atsuyuki; Kawahara, Nobuo] Res Ctr Med Plant Resources, Nayoro, Hokkaido 0960065, Japan; [Nishizawa, Makoto] Tokyo Univ Agr, Abashiri, Hokkaido 0992493, Japan; [Yamagishi, Takashi] Kitami Inst Technol, Kitami, Hokkaido 0908507, Japan; [Kadota, Yuichi] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan	Kakiuchi, N (reprint author), Kyusyu Univ Hlth & Welf, Nobeoka, Miyazaki 8828508, Japan.	kakiuchi@phoenix.ac.jp			Kyusyu University of Health and Welfare	This research was partly supported by a special grant to TA from Kyusyu University of Health and Welfare.	HIKINO H, 1980, J PHARMACOBIO-DYNAM, V3, P514; Ameri A, 1998, PROG NEUROBIOL, V56, P211, DOI 10.1016/S0301-0082(98)00037-9; Kawasaki R, 2011, J NAT MED-TOKYO, V65, P111, DOI 10.1007/s11418-010-0466-x; Long C, 2004, PLANTA MED, V70, P1080, DOI 10.1055/s-2004-832651; Japan Kampo Medicine Manufactures Association, 2011, REP INV ANN CRUD DRU; Japanese Pharmacopoeia, 2011, JAP PHARM; Kadosaki M, 2002, ARROW POISONS USED A; Kadota T, 1987, REVISION ACONITUM SU; Kadota Y, 2003, HOPPO SANSO, V20, P9; Kazuma Kohei, 2013, Chudoku Kenkyu, V26, P97; Kita Y, 1995, J PLANT RES, V108, P429, DOI 10.1007/BF02344231; Kita Y, 2000, PLANT SYST EVOL, V225, P1, DOI 10.1007/BF00985455; Namba T, 1961, SHOYAKUGAKU ZASSHI, V15, P197; Okada H, 2005, THESIS TOKYO U AGR; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SATO H, 1979, TOHOKU J EXP MED, V128, P175; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAMURA MICHIO, 1959, ACTA PHYTOTAX ET GEOBOT, V18, P68; Wada K, 2002, YAKUGAKU ZASSHI, V122, P929, DOI 10.1248/yakushi.122.929; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	JAN	2015	69	1					154	164		10.1007/s11418-014-0867-3		11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW1JR	WOS:000346046300018		
J	Yasuda, K; Obora, Y				Yasuda, Kaoru; Obora, Yasushi			NbCl5-mediated amidation of olefins with nitriles to secondary amides	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Niobium; Amidation; Nitrile; Olefin	CATALYZED INTERMOLECULAR HYDROAMINATION; LIQUID-HYDROGEN FLUORIDE; SOLVENT-FREE CONDITIONS; ONE-POT SYNTHESIS; RITTER REACTION; ORGANIC-REACTIONS; MOLECULAR-IODINE; N-FORMYLATION; AMINES; DERIVATIVES	NbCl5-mediated amidation of olefins with nitriles was successfully achieved. Various aliphatic, cyclic, and aromatic olefins, and various aliphatic and aromatic nitriles were used in this reaction to give secondary amides in high yields. (C) 2014 Elsevier B.V. All rights reserved.	[Yasuda, Kaoru; Obora, Yasushi] Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan	Obora, Y (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan.	obora@kansai-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Kansai University; MEXT	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Kansai University, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2010-2014).	Seo S, 2008, ORG LETT, V10, P317, DOI 10.1021/ol702788j; Suto Y, 2008, TETRAHEDRON LETT, V49, P5732, DOI 10.1016/j.tetlet.2008.07.075; Satoh Y, 2012, ORGANOMETALLICS, V31, P5235, DOI 10.1021/om300669s; Ko S, 2003, ORG LETT, V5, P2687, DOI 10.1021/ol034862r; Reddy BVS, 2010, TETRAHEDRON LETT, V51, P4827, DOI 10.1016/j.tetlet.2010.07.032; Allen CL, 2009, TETRAHEDRON LETT, V50, P4262, DOI 10.1016/j.tetlet.2009.05.021; Qian CW, 2010, J ORGANOMET CHEM, V695, P747, DOI 10.1016/j.jorganchem.2009.12.010; Basavaprabhu H, 2012, ORG BIOMOL CHEM, V10, P2528, DOI 10.1039/c2ob06916d; Anxionnat B, 2009, TETRAHEDRON LETT, V50, P3470, DOI 10.1016/j.tetlet.2009.02.208; Lin JP, 2013, CHEM COMMUN, V49, P5313, DOI 10.1039/c3cc41690a; Colombo MI, 2002, J CHEM EDUC, V79, P484; Callens E, 2006, TETRAHEDRON LETT, V47, P8699, DOI 10.1016/j.tetlet.2006.10.023; Ranu BC, 2003, SYNTHETIC COMMUN, V33, P297, DOI 10.1081/SCC-120015715; Han C, 2005, J AM CHEM SOC, V127, P10039, DOI 10.1021/ja0527976; Shi ZZ, 2013, ANGEW CHEM INT EDIT, V52, P5393, DOI 10.1002/anie.201301426; Cobley CJ, 2000, TETRAHEDRON LETT, V41, P2467, DOI 10.1016/S0040-4039(00)00181-7; Zweifel T, 2009, ANGEW CHEM INT EDIT, V48, P559, DOI 10.1002/anie.200804757; Allen CL, 2011, CHEM SOC REV, V40, P3405, DOI 10.1039/c0cs00196a; Shekhar AC, 2009, TETRAHEDRON LETT, V50, P7099, DOI 10.1016/j.tetlet.2009.10.006; Lundberg H, 2012, CHEM-EUR J, V18, P3822, DOI 10.1002/chem.201104055; Sharma S, 2012, ORG LETT, V14, P906, DOI 10.1021/ol2034228; Hosseini-Sarvari M, 2006, J ORG CHEM, V71, P6652, DOI 10.1021/jo060847z; MURAHASHI SI, 1986, J AM CHEM SOC, V108, P7846, DOI 10.1021/ja00284a066; Wang X, 2004, ORGANOMETALLICS, V23, P1649, DOI 10.1021/om0498549; Jiang HF, 2011, ORG LETT, V13, P1028, DOI 10.1021/ol103081y; Sevov CS, 2012, J AM CHEM SOC, V134, P11960, DOI 10.1021/ja3052848; Zhang Y, 2010, ORGANOMETALLICS, V29, P1374, DOI 10.1021/om901020h; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Benson F R, 1949, J AM CHEM SOC, V71, P4128, DOI DOI 10.1021/JA01180A075; Cao P, 2012, ORGANOMETALLICS, V31, P921, DOI 10.1021/om200964u; Cazorla C, 2011, TETRAHEDRON, V67, P8615, DOI 10.1016/j.tet.2011.09.055; CLARKE T, 1964, J AM OIL CHEM SOC, V41, P78, DOI 10.1007/BF02661912; GLIKMANS G, 1966, B SOC CHIM FR, P1376; Guerinot A., 2012, EUR J ORG CHEM, V19; Guo ZW, 2013, RSC ADV, V3, P25103, DOI 10.1039/c3ra44736g; Hanzawa Y, 2012, J OLEO SCI, V61, P715, DOI 10.5650/jos.61.715; Kazantsev OA, 2010, RUSS J APPL CHEM+, V83, P1062, DOI 10.1134/S1070427210060261; Kuszpit MR, 2011, J ORG CHEM, V76, P2913, DOI 10.1021/jo200101q; Lin XF, 2009, J CHEM RES, P638, DOI 10.3184/030823409X12526892025900; Liu LF, 2011, SYNTHETIC COMMUN, V41, P553, DOI 10.1080/00397911003629416; Mukhopadhyay M, 1997, J ORG CHEM, V62, P1843, DOI 10.1021/jo960557q; NORELL JR, 1970, J ORG CHEM, V35, P1619, DOI 10.1021/jo00830a077; NORELL JR, 1970, J ORG CHEM, V35, P1611, DOI 10.1021/jo00830a076; Qian H, 2005, ORG LETT, V7, P2635, DOI 10.1021/ol050745f; Qu GR, 2012, RSC ADV, V2, P6161, DOI 10.1039/c2ra20941a; Ramalingan C, 2007, J ORG CHEM, V72, P4536, DOI 10.1021/jo070297k; RITTER JJ, 1948, J AM CHEM SOC, V70, P4045, DOI 10.1021/ja01192a022; Roberts SW, 2012, ORG PROCESS RES DEV, V16, P2058, DOI 10.1021/op3000042; Ronn R, 2008, BIOORGAN MED CHEM, V16, P2955, DOI 10.1016/j.bmc.2007.12.041; Watson J.A., 2009, ORG LETT, V11, P2667; WERRY J, 1989, TETRAHEDRON, V45, P5015, DOI 10.1016/S0040-4020(01)81081-4; Zhang NN, 2012, ORG BIOMOL CHEM, V10, P9429, DOI 10.1039/c2ob26668g	52	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	JAN 1	2015	775						33	38				6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AW1KY	WOS:000346049500006		
J	Adachi, N; Fukuhara, K; Nakasa, T; Shibuya, H; Okuhara, A; Kato, T; Ochi, M				Adachi, Nobuo; Fukuhara, Kohei; Nakasa, Tomoyuki; Shibuya, Hayatoshi; Okuhara, Atsushi; Kato, Tomohiro; Ochi, Mitsuo			Conservative treatment of severe clubfoot using a novel functional dynamic splint	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						clubfoot; conservative treatment; dynamic splint	IDIOPATHIC CLUBFOOT; PONSETI METHOD; TALIPES EQUINOVARUS; CONGENITAL CLUBFOOT; FOLLOW-UP; FOOT; MANAGEMENT; RECURRENCE; CHILDHOOD; CLUBFEET	Forty-six severe clubfeet in 29 patients were treated by serial castings, followed by a newly developed dynamic splint. The mean period of splint usage was 59.9 months and the mean period of follow-up was 81.5 months. Of the patients, 76.1% were satisfied, 87.0% had no functional deficit, and 84.8% had no pain. Radiographical evaluation showed good correction. The mean dorsiflexion angle was -0.8 degrees at the end of cast treatment and 13.6 degrees at the time of the final follow-up. This study clearly showed the effectiveness of a functional dynamic splint for the correction of equinus in cases of severe clubfoot. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Adachi, Nobuo; Nakasa, Tomoyuki; Shibuya, Hayatoshi; Okuhara, Atsushi; Kato, Tomohiro; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan; [Fukuhara, Kohei] Fukuhara Orthopaed Hosp, Hiroshima, Japan	Adachi, N (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nadachi@hiroshima-u.ac.jp					LAAVEG SJ, 1980, J BONE JOINT SURG AM, V62, P23; Zionts LE, 2010, J AM ACAD ORTHOP SUR, V18, P486; Herzenberg JE, 2002, J PEDIATR ORTHOPED, V22, P517, DOI 10.1097/01.BPO.0000018893.25321.FE; Haft GF, 2007, J BONE JOINT SURG AM, V89A, P487, DOI 10.2106/JBJS.F.00169; Abdelgawad AA, 2007, J PEDIATR ORTHOP B, V16, P98; DIMEGLIO A, 1995, J PEDIATR ORTHOP B, V4, P129; Ippolito E, 2003, J BONE JOINT SURG AM, V85A, P1286; Dobbs MB, 2004, J BONE JOINT SURG AM, V86A, P22; PONSETI IV, 1963, J BONE JOINT SURG AM, V45, P261; SIMONS GW, 1987, ORTHOP CLIN N AM, V18, P667; Cummings RJ, 1994, CLUBFOOT PRESENT VIE, P104; Desai Lajja, 2010, Iowa Orthop J, V30, P15; Dobbs MB, 2003, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000065837.77325.19; Dobbs MB, 2009, CLIN ORTHOP RELAT R, V467, P1146, DOI 10.1007/s11999-009-0734-9; Driano AN, 1998, J PEDIATR ORTHOPED, V18, P346, DOI 10.1097/00004694-199805000-00014; Hattori T, 2003, J PEDIATR ORTHOP B, V12, P59, DOI 10.1097/01.bpb.0000043722.21564.b5; IKEDA K, 1992, J PEDIATR ORTHOPED, V12, P217; Jowett C R, 2011, J Bone Joint Surg Br, V93, P1160, DOI 10.1302/0301-620X.93B9.26947; Kite JH, 1964, THE CLUBFOOT; Beatson T R, 1966, J Bone Joint Surg Br, V48, P40; Ponseti IV, 1997, INT ORTHOP, V21, P137, DOI 10.1007/s002640050137; PONSETI IV, 1992, J BONE JOINT SURG AM, V74A, P448; PONSETI IV, 1994, J ORTHOP SPORT PHYS, V20, P1; Roye BD, 2004, PEDIATR REV, V25, P124, DOI 10.1542/pir.25-4-124; Roye BD, 2001, J PEDIATR ORTHOPED, V21, P42; Siapkara A, 2007, J BONE JOINT SURG BR, V89B, P995, DOI 10.1302/0301-620X.89B8; WIENTROUB S, 1991, J PEDIATR ORTHOPED, V11, P485; Wisbrun W., 1932, ARCH ORTHOP UNFALL C, V31, P451, DOI 10.1007/BF02562104; YAMAMOTO H, 1990, J BONE JOINT SURG BR, V72, P460	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2015	24	1					11	17		10.1097/BPB.0000000000000127		7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AU9MF	WOS:000345916500003		
J	Oda, R; Fujiwara, H; Ichimaru, K; Morihara, T; Ikeda, T; Kubo, T				Oda, Ryo; Fujiwara, Hiroyoshi; Ichimaru, Kozo; Morihara, Toru; Ikeda, Takumi; Kubo, Toshikazu			Chronic slipping of bilateral distal humeral epiphyses in a gymnastist	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						bilateral; distal humeral epiphyses; gymnast; separation	FRACTURE-SEPARATION; FEMORAL EPIPHYSIS; PHYSEAL INJURIES; FOLLOW-UP	In children, fracture-separation of the epiphyseal plate near the elbow joint is a common occurrence. However, separation of the distal humeral epiphysis is very rare, and in most cases, it is caused by high-impact trauma. In all reported cases, there has been a clear mechanism of injury. We report a case of an 11-year-old male patient who sustained separation of the distal humeral epiphyses bilaterally after 2 years of gymnastics, without a clear mechanism of injury. This patient had been using the vault since he was 9 years old, although children of that age do not normally perform on the vault. When gymnasts place their hands on the vault with their elbows flexed and subsequently extend their elbows to push off, the biomechanical load is placed equally on the right and left arms. Consequently, this type of repeated stress induces injury to the epiphyseal cartilages bilaterally, resulting in chronic progression of separation of the distal humeral epiphyses. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Oda, Ryo; Fujiwara, Hiroyoshi; Ichimaru, Kozo; Morihara, Toru; Ikeda, Takumi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan	Oda, R (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	roda@koto.kpu-m.ac.jp					ABE M, 1995, J PEDIATR ORTHOPED, V15, P426; Caine D, 2006, BRIT J SPORT MED, V40, P749, DOI 10.1136/bjsm.2005.017822; BRIGHT RW, 1974, J BONE JOINT SURG AM, VA 56, P688; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P46; HANSMAN CF, 1962, AMER J ROENTGENOL RA, V88, P476; Kawamoto K, 2006, J PEDIATR ORTHOP B, V15, P126; King MA, 2005, J BIOMECH, V38, P145, DOI 10.1016/j.jbiomech.2004.02.039; PODESTA L, 1993, ARCH PHYS MED REHAB, V74, P1216; PURI R, 1985, J BONE JOINT SURG BR, V67, P14; RUO G Y, 1987, Clinical Radiology, V38, P635; Tudisco C, 2006, INJURY, V37, P843, DOI 10.1016/j.injury.2006.02.018; Weiner D, 1996, J PEDIATR ORTHOP B, V5, P67	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2015	24	1					67	70		10.1097/BPB.0000000000000125		4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AU9MF	WOS:000345916500014		
J	Oka, Y; Obata, T; Nishimura, Y; Nakamura, T				Oka, Y.; Obata, T.; Nishimura, Y.; Nakamura, T.			High-Temperature Cycling Performance of LiNi1/3Co1/3Mn1/3O2 Cathode with DLC Protective Film	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							LITHIUM ION BATTERY; 55 DEGREES-C; LIMN2O4 CATHODE; IMPLANTATION; DEPOSITION; LINI0.5MN1.5O4; STABILITY; LAYER	Diamond-like carbon film (DLC) is selected as a cathode-protective film because it has chemical inertness, mechanical hardness, and high electrical resistivity. For this study, a DLC protective film was deposited onto a cathode electrode rather than individual cathode particles. A hybrid process of plasma-based ion implantation and deposition was applied to a uniform deposition of the DLC protective film, even at low processing temperature on the cathode electrode having complex surface geometry and low melting point binder. The electrochemical performance of the DLC-coated LiNi1/3Co1/3Mn1/3O2 cathode was studied using galvano-static charge-discharge cycling at high operating temperature, compared to those of the pristine LiNi1/3Co1/3Mn1/3O2 cathode. The electrochemical stability of the DLC-coated electrode was discussed. The DLC film provides good protection against cathode/electrolyte interface degradation. (C) The Author(s) 2014. Published by ECS. All rights reserved.	[Oka, Y.; Obata, T.; Nakamura, T.] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Nishimura, Y.] Kurita Seisakusho Co Ltd, Ujitawara, Kyoto 6100221, Japan	Oka, Y (reprint author), Univ Hyogo, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	oka@eng.u-hyogo.ac.jp			Japan Science and Technology Agency (JST)	The authors are thankful to Tanaka Chemical Corp. which provided the active materials and the cathode electrodes. The authors also thank Y. Doi, K. Kawauchi, Y. Nakajima, M. Shima, and K. Tsutsumi of JEOL for help taking SEM images, AES data, and XPS data, and N. Suiya, K. Yasunaga, and K. Yasuda of the Wakasa-Wan Energy Research Center for help taking TEM images. This research was supported by Strategic International Research Cooperation Program, Japan Science and Technology Agency (JST).	Liu DQ, 2007, MATER CHEM PHYS, V105, P362, DOI 10.1016/j.matchemphys.2007.04.073; Li XW, 2012, MATER LETT, V66, P168, DOI 10.1016/j.matlet.2011.08.075; Hao XG, 2013, J ELECTROCHEM SOC, V160, pA3162, DOI 10.1149/2.025305jes; Tu J, 2007, J ALLOY COMPD, V432, P313, DOI 10.1016/j.jallcom.2006.06.016; Li YD, 2011, J ALLOY COMPD, V509, P957, DOI 10.1016/j.jallcom.2010.08.154; Lee DJ, 2011, J POWER SOURCES, V196, P7742, DOI 10.1016/j.jpowsour.2011.04.007; Chang HH, 2008, J POWER SOURCES, V185, P466, DOI 10.1016/j.jpowsour.2008.07.021; Kim JW, 2014, J POWER SOURCES, V254, P190, DOI 10.1016/j.jpowsour.2013.12.119; Fan YK, 2007, ELECTROCHIM ACTA, V52, P3870, DOI 10.1016/j.electacta.2006.10.063; Lee JH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.10MB05; Nishimura Y, 2003, NUCL INSTRUM METH B, V206, P696, DOI 10.1016/S0168-583X(03)00830-9; Oka Y, 2007, NUCL INSTRUM METH B, V257, P702, DOI 10.1016/j.nimb.2007.02.083; Oka Y, 2006, IEEE T PLASMA SCI, V34, P1183, DOI 10.1109/TPS.2006.878380; Oka Y., 2013, 224 ECS M, p#862; Oka Y, 2007, SURF COAT TECH, V201, P6647, DOI 10.1016/j.surfcoat.2006.09.027; Oka Y, 2008, DIAM RELAT MATER, V17, P405, DOI 10.1016/j.diamond.2008.01.056; Smith AJ, 2011, J ELECTROCHEM SOC, V158, pA1136, DOI 10.1149/1.3625232; Smith A.J., 2011, SOLID STATE LETT, V14, pA39; Wua H. M., 2010, J POWER SOURCES, V195, P2909; Yatsuzuka M., 2009, FRONTIER APPL PLASMA, V2, P43	20	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651	1945-7111		J ELECTROCHEM SOC	J. Electrochem. Soc.		2015	162	2					A3032	A3037		10.1149/2.0051502jes		6	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	AW0KP	WOS:000345981400005		
J	Sakai, H; Velickovic, B				Sakai, Hiroshi; Velickovic, Boban			STATIONARY REFLECTION PRINCIPLES AND TWO CARDINAL TREE PROPERTIES	JOURNAL OF THE INSTITUTE OF MATHEMATICS OF JUSSIEU			English	Article						stationary sets; reflection; tree property; large cardinals	FORCING AXIOM; MAXIMUM; SETS	We study the consequences of stationary and semi-stationary set reflection. We show that the semi-stationary reflection principle implies the Singular Cardinal Hypothesis, the failure of the weak square principle, etc. We also consider two cardinal tree properties introduced recently by Weiss, and prove that they follow from stationary and semi-stationary set reflection augmented with a weak form of Martin's Axiom. We also show that there are some differences between the two reflection principles, which suggests that stationary set reflection is analogous to supercompactness, whereas semi-stationary set reflection is analogous to strong compactness.	[Sakai, Hiroshi] Kobe Univ, Dept Comp Sci & Syst Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Velickovic, Boban] Univ Paris Diderot, Inst Math Jussieu Paris Rive Gauche, F-75205 Paris 13, France	Sakai, H (reprint author), Kobe Univ, Dept Comp Sci & Syst Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	hsakai@people.kobe-u.ac.jp; boban@math.univ-paris-diderot.fr			Exchange INFTY Research Networking Programme (E.S.F.) [2744]; binational PHC Sakura [27604XE]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23740076]	This work is supported by the Exchange Grant 2744 from the INFTY Research Networking Programme (E.S.F.) and by a binational grant PHC Sakura 27604XE. The first author was supported by Grant-in-Aid for Young Scientists (B) No. 23740076 of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	BAUMGARTNER JE, 1991, ANN PURE APPL LOGIC, V54, P195, DOI 10.1016/0168-0072(91)90047-P; FOREMAN M, 1988, ANN MATH, V127, P1, DOI 10.2307/1971415; JECH THOMAS J., 1973, ANN MATH LOGIC, V5, P165, DOI 10.1016/0003-4843(73)90014-4; Kanamori A., 2003, SPRINGER MONOGRAPHS; Krueger J, 2005, J SYMBOLIC LOGIC, V70, P767, DOI 10.2178/jsl/1122038913; MAGIDOR M, 1974, P AM MATH SOC, V42, P279, DOI 10.2307/2039718; Sakai H, 2008, J SYMBOLIC LOGIC, V73, P181, DOI 10.2178/jsl/1208358748; Shelah S., 1994, OXFORD LOGIC GUIDES, V29; Shelah S., 1998, PERSPECTIVES MATH LO; SHELAH S, 1987, J SYMBOLIC LOGIC, V52, P360, DOI 10.2307/2274385; Silver J., 1975, P INT C MATH VANC BC, V1, P265; TODORCEVIC S, 1993, NATO ADV SCI INST SE, V411, P385; Velickovic B., 1992, ADV MATH, V94, P56; Viale M, 2011, ADV MATH, V228, P2672, DOI 10.1016/j.aim.2011.07.016; Weiss Cristoph, 2010, THESIS LUDWIG MAXIMI	15	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1474-7480	1475-3030		J INST MATH JUSSIEU	J. Inst. Math. Jussieu	JAN	2015	14	1					69	85		10.1017/S1474748013000315		17	Mathematics	Mathematics	AW2FT	WOS:000346104200002		
J	Noriyuki, A; Masaharu, K				Noriyuki, Abe; Masaharu, Kaneda			LOEWY SERIES OF PARABOLICALLY INDUCED G(1)T-VERMA MODULES	JOURNAL OF THE INSTITUTE OF MATHEMATICS OF JUSSIEU			English	Article						Loewy series; parabolic induction; graded induction; rigidity; Frobenius kernel	CONJECTURE; ALGEBRAS; PATTERNS	We show that the modules for the Frobenius kernel of a reductive algebraic group over an algebraically closed field of positive characteristic p induced from the p-regular blocks of its paraboli subgroups can be Z-graded. In particular, we obtain that the modules induced from the simple modules of p-regular highest weights are rigid and determine their Loewy series, assuming the Lusztig conjecture on their reducible characters for the reductive algebraic groups, which is now a theorem for large p. We say that a module is rigid if and only if it admits a unique filtration of minimal length with each subquotient semisimple, in which case the filtration is called the Loewy series	[Noriyuki, Abe] Hokkaido Univ, Creat Res Inst CRIS, Sapporo, Hokkaido 060, Japan; [Masaharu, Kaneda] Osaka City Univ, Dept Math, Osaka, Japan	Noriyuki, A (reprint author), Hokkaido Univ, Creat Res Inst CRIS, Sapporo, Hokkaido 060, Japan.	abenori@math.sci.hokudai.ac.jp; kaneda@sci.osaka-cu.ac.jp			JSPS [23740004, 23540023]	Supported in part by JSPS Grants in Aid for Scientific Research 23740004 AN and 23540023 KM.	ANDERSEN HH, 1989, P LOND MATH SOC, V59, P74; Andersen H. H., 1994, ASTERISQUE, V220; Beilinson A, 1996, J AM MATH SOC, V9, P473, DOI 10.1090/S0894-0347-96-00192-0; Atiyah M. F., 1969, INTRO COMMUTATIVE AL; Fiebig P, 2011, J AM MATH SOC, V24, P133; HASHIMOTO Y, 2006, REPRESENTATIONS ALGE, V413, P43; Jantzen J.C., 2003, REPRESENTATIONS ALGE; Kaneda M., ARXIV09112568V2MATHR; Kaneda M., 2009, J ALGEBRA, V322, P237; Kaneda M, 2012, CONTEMP MATH, V565, P105, DOI 10.1090/conm/565/11182; Kashiwara M, 1996, DUKE MATH J, V84, P771, DOI 10.1215/S0012-7094-96-08424-0; Kato S., 1995, ADV MATH, V55, P103; KAZHDAN D., 1994, J AM MATH SOC, V7, P335, DOI 10.2307/2152762; Kazhdan D., 1993, J AM MATH SOC, V6, P949, DOI 10.1090/S0894-0347-1993-99999-X; LUSZTIG G, 1995, P R SOC-MATH PHYS SC, V450, P731; LUSZTIG G, 1994, P R SOC-MATH PHYS SC, V445, P231, DOI 10.1098/rspa.1994.0058; LUSZTIG G, 1980, ADV MATH, V37, P121, DOI 10.1016/0001-8708(80)90031-6; Matsumura H., 1990, COMMUTATIVE RING THE	18	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1474-7480	1475-3030		J INST MATH JUSSIEU	J. Inst. Math. Jussieu	JAN	2015	14	1					185	220		10.1017/S1474748014000012		36	Mathematics	Mathematics	AW2FT	WOS:000346104200006		
J	Yoshihara, H; Yoshinobu, M				Yoshihara, Hiroshi; Yoshinobu, Masahiro			Measurement of the in-plane shear modulus of medium-density fibreboard by torsional and flexural vibration tests	MEASUREMENT			English	Article						Finite element analysis (FEA); Flexural vibration (FV) test; In-plane shear modulus (IPSM); Medium-density fibreboard (MDF); Out-of-plane shear modulus (OPSM); Torsional vibration (TV) test	YOUNGS MODULUS; SAWN TIMBER; WOOD; MDF; RIGIDITY; DEPTH; RATIO; BEAMS	The in-plane shear modulus (IPSM) of medium-density fibreboard (MDF) was obtained via a torsional vibration (TV) test using the specimen with various configurations and a subsequent numerical analysis. Because the out-of-plane shear modulus (OPSM) of MDF was much lower than the IPSM, the difference between the IPSM and OPSM had to be considered in the TV test. Therefore, the OPSM value was measured from the flexural vibration (FV) tests, and it was applied for the calculation of the IPSM value. The experimental and numerical results indicated that the TV test is effective to obtain the IPSM of MDF accurately under various configurations of the specimen. (C) 2014 Elsevier Ltd. All rights reserved.	[Yoshihara, Hiroshi; Yoshinobu, Masahiro] Shimane Univ, Fac Sci & Engn, Matsue, Shimane 6908504, Japan	Yoshihara, H (reprint author), Shimane Univ, Fac Sci & Engn, Nishikawazu Cho 1060, Matsue, Shimane 6908504, Japan.	yosihara@riko.shimane-u.ac.jp			'JSPS' - 'Japan' KAKENHI [24580246]	This work was supported by 'JSPS' - 'Japan' KAKENHI Grant Number 24580246.	Akiyama K., 2007, DOBOKU GAKKAI RONBUN, V63, P232, DOI 10.2208/jsceja.63.232; Matsumoto N, 2009, ENG FRACT MECH, V76, P2748, DOI 10.1016/j.engfracmech.2009.04.007; Han SM, 1999, J SOUND VIB, V225, P935, DOI 10.1006/jsvi.1999.2257; Obataya E, 2000, J MATER SCI, V35, P2993, DOI 10.1023/A:1004782827844; Yoshihara H, 2011, BIORESOURCES, V6, P4871; Yoshihara H, 2009, CONSTR BUILD MATER, V23, P3537, DOI [10.1016/j.conbuildmat.2009.06.041, 10.1016/j.conbuildmat.2009.06,041]; Nairn JA, 2009, INT J FRACTURE, V155, P167, DOI 10.1007/s10704-009-9338-3; HEARMON RFS, 1946, REV MOD PHYS, V18, P409, DOI 10.1103/RevModPhys.18.409; BECKER HF, 1973, HOLZ ROH WERKST, V31, P207, DOI 10.1007/BF02613843; Goens E, 1931, ANN PHYS-BERLIN, V11, P649; Murty A. V. Krishna, 1970, AIAA J, V66, P34; NAKAO T, 1984, MOKUZAI GAKKAISHI, V30, P877; NAKAO T, 1987, WOOD FIBER SCI, V19, P332; OHLSSON S, 1992, J STRUCT ENG-ASCE, V118, P2677, DOI 10.1061/(ASCE)0733-9445(1992)118:10(2677); Sebera V, 2014, EUR J WOOD WOOD PROD, V72, P407, DOI 10.1007/s00107-014-0780-1; Sobue N, 2000, MOKUZAI GAKKAISHI, V46, P242; Sobue N, 1999, MOKUZAI GAKKAISHI, V45, P289; Suzuki N., 1982, B FAC AGR MIE U, V65, P41; Tonosaki M, 2010, MOKUZAI GAKKAISHI, V56, P79; Wilczynski A, 2007, HOLZFORSCHUNG, V61, P717, DOI 10.1515/HF.2007.116; Yoshihara H, 2011, WOOD RES-SLOVAKIA, V56, P311; Yoshihara H., 2014, HOLZFORSCHU IN PRESS; Yoshihara H, 2012, HOLZFORSCHUNG, V66, P207, DOI 10.1515/HF.2011.118; Yoshihara H, 2013, HOLZFORSCHUNG, V67, P941, DOI 10.1515/hf-2013-0016; Yoshihara H., 2006, J SOC MAT SCI JPN, V55, P349, DOI 10.2472/jsms.55.349; Yoshihara H, 2012, BIORESOURCES, V7, P1337	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	JAN	2015	60						33	38		10.1016/j.measurement.2014.09.066		6	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AU8PZ	WOS:000345859900005		
J	Fujita, W; Mukumbuta, L; Chavuma, R; Ohashi, K				Fujita, Wakako; Mukumbuta, Lubinda; Chavuma, Roy; Ohashi, Kazutomo			Quality of partogram monitoring at a primary health centre in Zambia	MIDWIFERY			English	Article						Partogram; Zambia; Compliance; Monitoring of labour; Quality	BIRTH OUTCOMES; LABOR; DELIVERY; CARE	Background: the World Health Organization (WHO) recommends using a partogram to reduce maternal and neonatal mortality, especially in developing countries. Some previous studies conducted in African countries suggested that appropriate use of a partogram with standardised monitoring was associated with good labour outcomes. However, the compliance rates of recording differed among the monitoring items on the partogram and the quality of monitoring has not been examined adequately. Objective: to examine the compliance for each monitoring item on the WHO partogram and the quality of the monitoring. Design: a retrospective and observation study. Methods: a retrospective review of partograms (n=200) was undertaken in a health centre in Lusaka, Zambia. We excluded referral cases, admission with full dilatation, birth before arrival, childbirth within 30 minutes, and false labour. Finally, 125 partograms were examined to assess the recording compliance for each monitoring item. An observation study in the delivery room and interviews with midwives were also conducted to examine the quality of monitoring for labour. The research ethics committee of the Division of Health Sciences, Osaka University Graduate School of Medicine and the Biomedical Research Ethics Committee of the University of Zambia approved the study. Findings: the lowest recording rate of the frequency of uterine contractions at the time of admission was 69.6%. The highest compliance rates in the active phase were found for the descent of the fetal head and cervix dilatation at 97.6% and 97.3%, respectively. The lowest rate was found for the mother's pulse rate at 25.5%, whereas 27.1% of the women admitted in the latent phase were diagnosed as entering the active phase in the acceleration phase. In addition, the methods of abdominal palpation for assessing uterine contractions and intermittent feral heart rare monitoring were nor appropriate. Key conclusions and implications: Zambian midwives have acquired sufficient understanding regarding the usefulness of the WHO partogram. However, there were differences in the compliance rates for each monitoring item due to a lack of medical devices and inappropriate monitoring skill. To improve labour outcomes with the WHO partogram, it is necessary to improve the recording and compliance rates for each monitoring item, as well as to upgrade the quality of monitoring. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujita, Wakako] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Mukumbuta, Lubinda] Railway Hosp, Lusaka, Zambia; [Chavuma, Roy] Univ Teaching Hosp Zambia, Lusaka, Zambia; [Ohashi, Kazutomo] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Fujita, W (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12 Nishi 5, Sapporo, Hokkaido 0600812, Japan.	w_fujita@hs.hokudai.ac.jp; lmukumbuta@yahoo.com; rchavuma@gmail.com; ohashi@sahs.med.osaka-u.ac.jp					Rahnama P, 2006, INT J GYNECOL OBSTET, V92, P217, DOI 10.1016/j.ijgo.2005.12.016; KWAST BE, 1994, LANCET, V343, P1399; [Anonymous], 2010, J MIDWIFERY WOM HEAL, V55, P397; Lundgren I, 2013, SEX REPROD HEALTHC, V4, P141, DOI 10.1016/j.srhc.2013.09.001; Gans-Lartey F, 2013, MIDWIFERY, V29, P461, DOI 10.1016/j.midw.2012.03.002; Hofmeyr GJ, 2009, INT J GYNECOL OBS S1, V107, P21; Japanese Midwives Association, 2009, GUID MAT HOM; Kasahara S., 2004, JPN J NURS RES, V37, P309; Kasahara S., 2010, IT HLTH CARE, V5, P124; Lavender T., 2012, COCHRANE DB SYST REV, V8; Mathai M, 2009, CLIN OBSTET GYNECOL, V52, P256, DOI 10.1097/GRF.0b013e3181a4f163; Nyamtema AS, 2008, INT J GYNECOL OBSTET, V100, P37, DOI 10.1016/j.ijgo.2007.06.049; Ogwang S., 2009, AFR HEALTH SCI, V9, P27; World Health Organization, 2008, MIDW ED MOD MAN PROL	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-6138	1532-3099		MIDWIFERY	Midwifery	JAN	2015	31	1					191	196		10.1016/j.midw.2014.08.008		6	Nursing	Nursing	AW1LR	WOS:000346051500027		
J	Hagiwara, K; Fujita, H; Kasahara, Y; Irisawa, Y; Obika, S; Kuwahara, M				Hagiwara, Kenta; Fujita, Hiroto; Kasahara, Yuuya; Irisawa, Yuuta; Obika, Satoshi; Kuwahara, Masayasu			In vitro selection of DNA-based aptamers that exhibit RNA-like conformations using a chimeric oligonucleotide library that contains two different xeno-nucleic acids	MOLECULAR BIOSYSTEMS			English	Article							ELECTROPHORESIS-SYSTEMATIC EVOLUTION; SYNTHETIC GENETIC POLYMERS; CAPILLARY-ELECTROPHORESIS; G-QUADRUPLEX; EXPONENTIAL ENRICHMENT; FOLDING TOPOLOGY; SELEX SELECTION; HUMAN THROMBIN; AFFINITY; LIGANDS	We successfully generated chimeric DNA aptamers that contained six nucleoside analogs of 2'-O,4'-C-methylene bridged/locked nucleic acid (2',4'-BNA/LNA) in the primer region and multiple guanosine analogs of 2'-deoxy-2'-fluoro-ribonucleic acid (FNA) in the non-primer region using capillary electrophoresis-systematic evolution of ligands by exponential enrichment (CE-SELEX). Active species enrichment became saturated only after five selection rounds, and we obtained DNA-based xeno-nucleic acid (XNA) aptamers that had high binding affinities for the target human thrombin, with dissociation constant (K-d) values of >= 10 nanomolar. Based on sequence and circular dichroism (CD) analyses, these XNA aptamers exhibited RNA-like conformations, which could cause DNA-based strands to adopt structurally diverse conformations.	[Hagiwara, Kenta; Fujita, Hiroto; Irisawa, Yuuta; Kuwahara, Masayasu] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma 3768515, Japan; [Kasahara, Yuuya; Obika, Satoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kasahara, Yuuya; Obika, Satoshi] Natl Inst Biomed Innovat NIBIO, Ibaraki, Osaka 5670085, Japan	Kuwahara, M (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gunma 3768515, Japan.	mkuwa@gunma-u.ac.jp			Japan Science and Technology Agency (JST) [AS2525029M]; Japan Society for the Promotion of Science (JSPS) [25350962]	This study was partly supported by a Grant for Adaptable and Seamless Technology Transfer Program through Target-driven R & D, No. AS2525029M, from Japan Science and Technology Agency (JST), and by a Grant-in-Aid for Scientific Research (C), No. 25350962, from the Japan Society for the Promotion of Science (JSPS).	Li Z, 2014, NUCLEIC ACIDS RES, V42, P4068, DOI 10.1093/nar/gkt1312; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Peyrin E, 2009, J SEP SCI, V32, P1531, DOI 10.1002/jssc.200900061; Peng CG, 2007, NUCLEIC ACIDS RES, V35, P4977, DOI 10.1093/nar/gkm520; Kasahara Y, 2013, ANAL CHEM, V85, P4961, DOI 10.1021/ac400058z; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Berezovski M, 2005, ANAL CHEM, V77, P1526, DOI 10.1021/ac048577c; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P3099, DOI 10.1002/anie.200806244; Ono T, 1997, NUCLEIC ACIDS RES, V25, P4581, DOI 10.1093/nar/25.22.4581; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Dominick PK, 2004, J AM CHEM SOC, V126, P5050, DOI 10.1021/ja039192z; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Yang J, 2013, ANAL CHEM, V85, P1525, DOI 10.1021/ac302721j; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Kasahara Y, 2013, BIOORG MED CHEM LETT, V23, P1288, DOI 10.1016/j.bmcl.2012.12.093; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Mendonsa SD, 2005, J AM CHEM SOC, V127, P9382, DOI 10.1021/ja052405n; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Drabovich AP, 2006, ANAL CHEM, V78, P3171, DOI 10.1021/ac060144h; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Pinheiro VB, 2012, CURR OPIN CHEM BIOL, V16, P245, DOI [10.1016/j.cbpa.2012.05.198, 10.1016/j.cbpa.2012.05.108]; Herdewijn P, 2010, CHEM BIODIVERS, V7, P1, DOI 10.1002/cbdv.200900185; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Jing M, 2013, ANAL CHEM, V85, P10761, DOI 10.1021/ac401875h; Mosing RK, 2005, ANAL CHEM, V77, P6107, DOI 10.1021/ac050836q; Cella LN, 2010, ANAL CHEM, V82, P2042, DOI 10.1021/ac902791q; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Ichida JK, 2005, J AM CHEM SOC, V127, P2802, DOI 10.1021/ja045364w; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; AURUP H, 1992, BIOCHEMISTRY-US, V31, P9636, DOI 10.1021/bi00155a016; Barciszewski Jan, 2009, V535, P165, DOI 10.1007/978-1-59745-557-2_10; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; Keniry MA, 2001, BIOPOLYMERS, V56, P123; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Kuwahara M, 2010, MOLECULES, V15, P8229, DOI 10.3390/molecules15118229; Li YL, 2008, ELECTROPHORESIS, V29, P2570, DOI 10.1002/elps.200700798; Pradhan D, 2011, CHEM-EUR J, V17, P2405, DOI 10.1002/chem.201001961; Robeyns K, 2008, NUCLEIC ACIDS RES, V36, P1407, DOI 10.1093/nar/gkm1132; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Tatarinova O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089383	47	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.	JAN	2015	11	1					71	76		10.1039/c4mb00436a		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU9FQ	WOS:000345897600006		
J	Choi, J; Cho, DW; Tojo, S; Fujitsuka, M; Majima, T				Choi, Jungkweon; Cho, Dae Won; Tojo, Sachiko; Fujitsuka, Mamoru; Majima, Tetsuro			Configurational changes of heme followed by cytochrome c folding reaction	MOLECULAR BIOSYSTEMS			English	Article							RESOLVED CIRCULAR-DICHROISM; ELECTRON-TRANSFER; PULSE-RADIOLYSIS; RESONANCE RAMAN; SPEED LIMIT; TRANSIENT ABSORPTION; PROTEIN; DYNAMICS; TIME; SPECTROSCOPY	Although the folding kinetics of cytochrome c (Cyt-c), ferric or ferrous Cyt-c, has been extensively investigated as a paradigm for a protein folding reaction using various time-resolved spectroscopic techniques, the configurational change of heme associated with the folding reaction from a ferric Cyt-c to a ferrous Cyt-c induced by one-electron reduction has not been elucidated. To address this issue, we investigated the configurational change of heme in the Cyt-c folding process induced by one-electron reduction using a combination of time-resolved resonance Raman spectroscopy and pulse radiolysis. The results presented herein reveal that the reduction of ferric Cyt-c and the ligation of Met80 occur simultaneously within a timescale of approximately 2 mu s, and that the ligand binding and exchange of heme depend on the initial configuration of the heme. The rapid ligation of Met80 observed in this study may be attributed to the intramolecular diffusion of Met80 into ferrous Cyt-c with a 5-coordinated high-spin configuration. Conversely, the ligand exchange of a ferrous Cyt-c with a 6-coordinated low-spin configuration was significantly slower.	[Choi, Jungkweon; Tojo, Sachiko; Fujitsuka, Mamoru; Majima, Tetsuro] Osaka Univ, Inst Sci & Ind Res SANKEN, Osaka 5670047, Japan; [Cho, Dae Won] Korea Univ, Dept Adv Mat Chem, Sejong 339700, South Korea	Choi, J (reprint author), Osaka Univ, Inst Sci & Ind Res SANKEN, Mihogaoka 8-1, Osaka 5670047, Japan.	jkchoi@sanken.osaka-u.ac.jp; majima@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japanese Government [24550188, 25220806, 25288035]	We thank the members of the Research Laboratory for Quantum Beam Science of ISIR, Osaka University, for running the linear accelerator. This work has been partly supported by a Grant-in-Aid for Scientific Research (Project 24550188, 25220806, and 25288035) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japanese Government.	Chen EF, 1998, BIOCHEMISTRY-US, V37, P5589, DOI 10.1021/bi972369f; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Abel CJ, 2007, BIOCHEMISTRY-US, V46, P4090, DOI 10.1021/bi0622930; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Chan CK, 1997, P NATL ACAD SCI USA, V94, P1779, DOI 10.1073/pnas.94.5.1779; Chen EF, 1999, J AM CHEM SOC, V121, P3811, DOI 10.1021/ja983169+; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; Fujikawa M, 2012, J BIOL CHEM, V287, P35702, DOI 10.1074/jbc.M112.395079; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Choi J, 2012, J AM CHEM SOC, V134, P13430, DOI 10.1021/ja304904p; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Thirumalai D, 2013, CURR OPIN STRUC BIOL, V23, P22, DOI 10.1016/j.sbi.2012.11.010; Grills DC, 2014, J AM CHEM SOC, V136, P5563, DOI 10.1021/ja501051s; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Droghetti E, 2006, BIOPHYS J, V91, P3022, DOI [10.1529/biophysj.105.079749, 10.1529/biophysj.106.079749]; Choi J, 2011, PHYS CHEM CHEM PHYS, V13, P5651, DOI 10.1039/c0cp02689a; Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Choi J, 2011, J PHYS CHEM B, V115, P3127, DOI 10.1021/jp106588d; Choi J, 2008, CHEMPHYSCHEM, V9, P2708, DOI 10.1002/cphc.200800280; HU SZ, 1993, BIOPHYS J, V64, pA157; JORDAN T, 1995, PROTEIN SCI, V4, P716; Kawai K, 2003, CHEM COMMUN, P2840, DOI 10.1039/b310579b; Kawai K, 2002, TETRAHEDRON LETT, V43, P89, DOI 10.1016/S0040-4039(01)02064-0; Kawai K, 2003, J PHYS CHEM B, V107, P12838, DOI 10.1021/jp034621; Kim J., 2008, J PHYS CHEM B, V113, P260; KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976; Konno T, 1998, PROTEIN SCI, V7, P975; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; Stevens JA, 2010, J PHYS CHEM B, V114, P1498, DOI 10.1021/jp910013f; Winkler JR, 2004, CURR OPIN CHEM BIOL, V8, P169, DOI 10.1016/j.cpba.2004.02.009; Yeh SR, 1998, ACCOUNTS CHEM RES, V31, P727, DOI 10.1021/ar970084p; Yeh SR, 1998, BIOPHYS J, V74, pA128	36	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.	JAN	2015	11	1					218	222		10.1039/c4mb00551a		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU9FQ	WOS:000345897600021		
J	Okamoto, T; Mandai, M; Matsumura, N; Yamaguchi, K; Kondoh, H; Amano, Y; Baba, T; Hamanishi, J; Abiko, K; Kosaka, K; Murphy, SK; Mori, S; Konishi, I				Okamoto, Takako; Mandai, Masaki; Matsumura, Noriomi; Yamaguchi, Ken; Kondoh, Hiroshi; Amano, Yasuaki; Baba, Tsukasa; Hamanishi, Junzo; Abiko, Kaoru; Kosaka, Kenzo; Murphy, Susan K.; Mori, Seiichi; Konishi, Ikuo			Hepatocyte Nuclear Factor-1 beta (HNF-1 beta) Promotes Glucose Uptake and Glycolytic Activity in Ovarian Clear Cell Carcinoma	MOLECULAR CARCINOGENESIS			English	Article						ovarian clear cell carcinoma; HNF1; glucose metabolism	DISTINCT-HISTOLOGIC-TYPE; OXIDATIVE STRESS; ENERGY-METABOLISM; POOR-PROGNOSIS; CANCER-CELLS; REGULATING GLYCOLYSIS; LIFE-SPAN; MARKER; IDENTIFICATION; EXPRESSION	Ovarian clear cell carcinoma (OCCC) is a morphologically and biologically distinct subtype of ovarian carcinomas that often arises in ovarian endometriosis. We previously reported that a unique carcinogenic environment, especially iron-induced oxidative stress in endometriotic cysts may promote development of OCCC. We also identified a gene expression profile characteristic of OCCC (the OCCC signature). This 320-gene OCCC signature is enriched in genes associated with stress response and sugar metabolism. However, the biological implication of this profile is unclear. In this study, we have focused on the biological role of the HNF-1 gene within the OCCC signature, which was previously shown to be overexpressed in OCCC. Suppression of HNF-1 in the HNF-1-overexpressing human ovarian cancer cell line RMG2 using short hairpin RNA resulted in a significant increase in proliferation. It also facilitated glucose uptake, glycolytic activity, and lactate secretion along with increased expression of the glucose transporter-1 (GLUT-1) gene and several key enzymes in the glycolytic process. Conversely, forced expression of HNF-1 in the serous ovarian cancer cell line, Hey, resulted in slowed cellular growth and repressed glycolytic activity. These data suggest that HNF-1 represses cell growth, and at the same time, it promotes aerobic glycolysis which is known as the Warburg effect. As the Warburg effect is regarded as a characteristic metabolic process in cancer which may contribute to cell survival under hypoxic conditions or in a stressful environment, overexpression of HNF-1 may play an inevitable role in the occurrence of OCCC in stressful environment. (c) 2013 Wiley Periodicals, Inc.	[Okamoto, Takako; Mandai, Masaki; Matsumura, Noriomi; Yamaguchi, Ken; Amano, Yasuaki; Baba, Tsukasa; Hamanishi, Junzo; Abiko, Kaoru; Kosaka, Kenzo; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto, Japan; [Okamoto, Takako; Murphy, Susan K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27710 USA; [Kondoh, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan; [Mori, Seiichi] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan	Mandai, M (reprint author), 54 Kawaharacho,Sakyo Ku, Kyoto 6068507, Japan.			Murphy, Susan/0000-0001-8298-7272			Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Kao YC, 2012, HISTOPATHOLOGY, V61, P760, DOI 10.1111/j.1365-2559.2012.04267.x; BACH I, 1991, NUCLEIC ACIDS RES, V19, P3553, DOI 10.1093/nar/19.13.3553; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kobayashi H, 2007, INT J GYNECOL CANCER, V17, P37, DOI 10.1111/j.1525-1438.2006.00754.x; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Kato N, 2008, VIRCHOWS ARCH, V452, P175, DOI 10.1007/s00428-007-0543-z; Kondoh H, 2005, CANCER RES, V65, P177; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Bingham C, 2004, NEPHROL DIAL TRANSPL, V19, P2703, DOI 10.1093/ndt/gfh348; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084; Kato N, 2007, DIAGN CYTOPATHOL, V35, P193, DOI 10.1002/dc.20623; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Fadare O, 2012, APPL IMMUNOHISTO M M, V20, P580, DOI 10.1097/PAI.0b013e31824973d1; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Matsumura N, 2010, CANCER SCI, V101, P2658, DOI 10.1111/j.1349-7006.2010.01736.x; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Kobayashi H, 2009, INT J CLIN ONCOL, V14, P378, DOI 10.1007/s10147-009-0931-2; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85; Mentis AFA, 2010, ASIAN PAC J CANCER P, V11, P1437; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Shi DY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-32; Stany MP, 2011, PLOS ONE, V6; Wakasugi M, 2007, BIOCHEM BIOPH RES CO, V364, P771, DOI 10.1016/j.bbrc.2007.10.063	37	8	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-1987	1098-2744		MOL CARCINOGEN	Mol. Carcinog.	JAN	2015	54	1					35	49		10.1002/mc.22072		15	Biochemistry & Molecular Biology; Oncology	Biochemistry & Molecular Biology; Oncology	AW2ZZ	WOS:000346156400004		
J	Yanaga, K; Sotome, K; Suhara, H; Maekawa, N				Yanaga, Konomi; Sotome, Kozue; Suhara, Hiroto; Maekawa, Nitaro			A new species of Lepidostroma (Agaricomycetes, Lepidostromataceae) from Japan	MYCOSCIENCE			English	Article						Basidiolichen; Cultural features; Morphological observations; Phylogenetic analyses	MAXIMUM-LIKELIHOOD; CLAVARIOID FUNGI; PHYLOGENY; BASIDIOMYCOTA; BASIDIOLICHEN; GENERA	A new basidiolichen species, Lepidostroma asianum (Agaricomycetes, Lepidostromatales, Lepidostromataceae), is described based on basidiomata collected from red clay in southwestern Japan. This is the first report of a species in the genus Lepidostroma from Asia. The species is characterized by producing pale orange to reddish-orange, cylindrical to slightly fusiform basidiomata that taper toward the apex and by cylindrical to suballantoid basidiospores measuring 7.0-10.0 x 3.5-5.0 mm. In addition, it is associated with a green alga and forms a film-like thallus. Lepidostroma asianum differs from all previously-described species in its unique combination of these characteristics. Phylogenetic analyses of partial nuclear large subunit and small subunit rRNA gene sequences also differentiated it from other species. The cultural features of a Lepidostroma species are also provided for the first time. (C) 2014 Published by Elsevier B.V. on behalf of the Mycological Society of Japan.	[Yanaga, Konomi] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Sotome, Kozue; Maekawa, Nitaro] Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, Tottori 6808553, Japan; [Suhara, Hiroto] Miyazaki Prefectural Wood Utilizat Res Ctr, Miyakonojo, Miyazaki 8850037, Japan	Maekawa, N (reprint author), Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, 4-101 Koyama, Tottori 6808553, Japan.	kin-maek@muses.tottori-u.ac.jp			Japan Society for Promotion of Science [22-56481]; Global Center of Excellence (COE) Program "Advanced Utilization of Fungus/Mushroom Resource for Sustainable Society in Harmony with Nature" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This research was partially supported by a Grant-in-Aid (No. 22-56481) from the Japan Society for Promotion of Science and the Global Center of Excellence (COE) Program "Advanced Utilization of Fungus/Mushroom Resource for Sustainable Society in Harmony with Nature" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Suhara H, 2003, MYCOTAXON, V86, P335; Redhead SA, 2002, MYCOTAXON, V83, P19; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; VILGALYS R, 1990, J BACTERIOL, V172, P4238; Hodkinson BP, 2012, MYCOL PROG, V11, P827, DOI 10.1007/s11557-011-0800-z; Moncalvo JM, 2006, MYCOLOGIA, V98, P937, DOI 10.3852/mycologia.98.6.937; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; DAMS E, 1988, NUCLEIC ACIDS RES, V16, pR87; Ertz D, 2008, AM J BOT, V95, P1548, DOI 10.3732/ajb.0800232; Farris J.S., 1994, NEW SPECIES SYNDROME, V10, P315, DOI DOI 10.1111/J.1096-0031.1994.TB00181.X; Fischer E, 2007, BOT J LINN SOC, V155, P457; Geml J, 2012, FUNGAL BIOL-UK, V116, P388, DOI 10.1016/j.funbio.2011.12.009; Hodkinson BP, 2014, FUNGAL DIVERS, V64, P165, DOI 10.1007/s13225-013-0267-0; Hosaka Kentaro, 2008, Bulletin of the National Museum of Nature and Science Series B-Botany, V34, P161; Imazeki R., 1989, COLORED ILLUSTRATION, VII; Lutzoni Francois, 1995, Cryptogamic Botany, V5, P71; Lutzoni FM, 1997, SYST BIOL, V46, P373, DOI 10.2307/2413688; MAGDEFRAU K, 1967, MITTEILUNGEN I COLOM, V1, P11; MARTIN GW, 1940, LILLOA, V5, P191; NAKASONE K, 1990, MYCOLOGIA MEMOIR, V15; Nylander J.A.A., 2004, MRMODELTEST 2 3 PROG; Oberwinkler F, 1984, NOVA HEDWIGIA S, V79, P739; OBERWINKLER F, 1970, BERICHTE DTSCH BOT G, V4, P139; Oberwinlder F., 2001, MYCOTA, VIX, P211; PETERSEN RH, 1986, AUST J BOT, V34, P217, DOI 10.1071/BT9860217; PETERSEN RH, 1967, AM MIDL NAT, V77, P205, DOI 10.2307/2423440; REDHEAD SA, 1987, ARCTIC ALPINE MYCOLO, V2, P319; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sulzbacher MA, 2012, BRYOLOGIST, V115, P601, DOI 10.1639/0007-2745-115.4.601; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					1	9		10.1016/j.myc.2014.01.011		9	Mycology	Mycology	AW0ZA	WOS:000346018700001		
J	Ushijima, S; Nagasawa, E; Kigawa, S; Maekawa, N				Ushijima, Shuji; Nagasawa, Eiji; Kigawa, Shiro; Maekawa, Nitaro			A new species of Dactylosporina (Physalacriaceae, Agaricales) from Japan	MYCOSCIENCE			English	Article						Agaricomycetidae; Echinulate basidiospores; Taxonomy; Xerula/Oudemansiella complex	OUDEMANSIELLA	Dactylosporina brunneomarginata sp. nov., belonging to the family Physalacriaceae (Agaricales) is described and illustrated. This fungus differs from previously described species of Dactylosporina macroscopically by its viscid pileus and stipe surface when wet, the lamellae with dark brown edges, and microscopically by its gloeocystidioid pileo-, cheilo-, and caulocystidia with olive to yellow-brown oily content. This is the first report on Dactylosporina from Asia. (C) 2014 The Mycological Society of Japan. Published by Elsevier B. V. All rights reserved.	[Ushijima, Shuji; Maekawa, Nitaro] Tottori Univ, Fungus Mushroom Resource & Res Ctr, Fac Agr, Tottori 6808553, Japan; [Nagasawa, Eiji] Tottori Mycol Inst, Tottori 6891125, Japan	Ushijima, S (reprint author), Tottori Univ, Fungus Mushroom Resource & Res Ctr, Fac Agr, Koyama 4-101, Tottori 6808553, Japan.	ushishu@muses.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	The authors are very grateful to Noriko Matsumoto (Hiratsuka City Museum) and Takamichi Orihara (Kanagawa Prefectural Museum of Natural History) for loaning valuable specimens. This work was supported by the Grant-in-Aid for the Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Wartchow F, 2010, MYCOTAXON, V113, P119, DOI 10.5248/113.119; Capelari Marina, 2005, Hoehnea, V32, P381; BOEKHOUT T, 1986, PERSOONIA, V13, P45; CLEMENCON H, 1979, Sydowia, V32, P74; Dorfelt H, 1985, FEDDES REPERT, V96, P235, DOI DOI 10.1002/FEDR.19800910403; Kigawa S, 1997, KINOKORUI HYOHON MOK, P25; Petersen RH, 2010, NOVA HEDWIGIA, V137; SINGER ROLF, 1964, DARWINIANA [BUENOS AIRES], V13, P145	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					10	13		10.1016/j.myc.2014.01.012		4	Mycology	Mycology	AW0ZA	WOS:000346018700002		
J	Meeboon, J; Takamatsu, S				Meeboon, Jamjan; Takamatsu, Susumu			Erysiphe viburni-plicati and Podosphaera photiniae, two new species of Erysiphales (Ascomycota) from Japan	MYCOSCIENCE			English	Article						Erysiphaceae; Photinia villosa; Phylogeny; Taxonomy; Viburnum plicatum	POWDERY MILDEW; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; SEQUENCES; JAPONICA; DNA	Two new species of the Erysiphales, Erysiphe viburni-plicati and Podosphaera photiniae, are described and illustrated in this paper. These two fungi were first reported in 1977 and 1996 as Podosphaera spp. from Japan, but have not yet been formally described and named. We performed detailed morphological re-examinations and phylogenetic analyses based on new specimens. The results clearly show that these fungi are new, hitherto undescribed species. Molecular analyses of E. viburni-plicati indicate that this fungus belongs to the genus Erysiphe, not to Podosphaera, although it has chasmothecia with a single ascus. This result reveals that monoascus-type chasmothecia are not confined to Podosphaera and Cystotheca as they are also formed by some Erysiphe species. (C) 2014 The Mycological Society of Japan. Published by Elsevier B.V. All rights reserved.	[Meeboon, Jamjan; Takamatsu, Susumu] Mie Univ, Grad Sch, Dept Bioresources, Tsu, Mie 5148507, Japan; [Meeboon, Jamjan] Dept Agr, Bangkok, Thailand	Takamatsu, S (reprint author), Mie Univ, Grad Sch, Dept Bioresources, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	takamatu@bio.mie-u.ac.jp			Japan Society of the Promotion of Science [23580061]; MONBUKAGAKU SHO: MEXT (Ministry of Education, Culture, Science, and Technology) Scholarship of the Japanese Government	The authors thank Dr. Uwe Braun for his helpful comments on the previous version of the manuscript. This work was financially supported in part by a Grant-in-Aid for Scientific Research (No. 23580061) from the Japan Society of the Promotion of Science to ST and MONBUKAGAKU SHO: MEXT (Ministry of Education, Culture, Science, and Technology) Scholarship of the Japanese Government awarded to JM.	Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Hirose S, 2005, MYCOL RES, V109, P912, DOI 10.1017/S0953756205003527; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Takamatsu S, 2010, PERSOONIA, V24, P38, DOI 10.3767/003158510X494596; Meeboon J, 2013, MYCOSCIENCE, V54, P69, DOI 10.1016/j.myc.2012.07.003; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114; Mori Y, 2000, MYCOLOGIA, V92, P74, DOI 10.2307/3761452; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1006/clad.1999.0121; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Braun U, 1987, BEIH NOVA HEDWIGIA, V89, P1; Braun U, 2000, SCHLECHTENDALIA, V4, P1; Braun U., 2012, CBS BIODIVERSITY SER, V11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hirata Tetsuya, 1996, Mycoscience, V37, P283, DOI 10.1007/BF02461299; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KUNOH H, 1977, PHYSIOL PLANT PATHOL, V10, P191, DOI 10.1016/0048-4059(77)90022-4; Maddison DR, 2000, MACCLADE VERSION 4 A; Sato Y, 1996, ANN PHYTOPATHOLOGICA, V62, P264; Shiroya Y, 2008, MYCOSCIENCE, V49, P199, DOI 10.1007/s10267-008-0410-z; Sikes DS, 2001, BETA SOFTWARE VERSIO; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Takamatsu Susumu, 2001, Mycoscience, V42, P135, DOI 10.1007/BF02463987; Takamatsu Susumu, 1999, Mycoscience, V40, P259, DOI 10.1007/BF02463963; TAKAMATSU S, 1977, T MYCOL SOC JPN, V18, P197; Walsh SP, 1991, BIOTECHNIQUES, V10, P506; White T. J., 1990, PCR PROTOCOLS	26	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					14	23		10.1016/j.myc.2014.01.010		10	Mycology	Mycology	AW0ZA	WOS:000346018700003		
J	Nonaka, K; Kaneta, T; Omura, S; Masuma, R				Nonaka, Kenichi; Kaneta, Taichi; Omura, Satoshi; Masuma, Rokuro			Mariannaea macrochlamydospora, a new hyphomycete (Nectriaceae) from soil in the Bonin Islands, Japan	MYCOSCIENCE			English	Article						Anamorph; New species; Oceanic island; Phylogeny; Soil-inhabiting fungi	CORDYCEPS; FUNGI; TAXA	Mariannaea macrochlamydospora, a new hyphomycete classified in the Nectriaceae (Ascomycota), was isolated from a soil sample collected in the Bonin Islands, Japan. It is characterized by a yellow to brownish colony, verticillate conidiophores and imbricate chains of fusiform conidia. Morphologically, the species is similar to M. elegans, M. aquaticola and M. samuelsii, but differs from them in phylogeny and with respect to conidia or phialides morphology. Chlamydospores of this species are also larger than those of all other species of Mariannaea. (C) 2014 The Mycological Society of Japan. Published by Elsevier B.V. All rights reserved.	[Nonaka, Kenichi; Omura, Satoshi; Masuma, Rokuro] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Nonaka, Kenichi; Kaneta, Taichi; Masuma, Rokuro] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan	Nonaka, K (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	ken@lisci.kitasato-u.ac.jp			Quality Assurance Framework of Higher Education from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	This study was supported, in part, by funds from the Quality Assurance Framework of Higher Education from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. We thank Mr. T. Ono (Ogasawara Subtropical Agriculture Center) for identifying the plants and supplying soil samples from Chichi-jima, the Bonin Islands, Tokyo, Japan.	Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Cai L, 2010, MYCOL PROG, V9, P337, DOI 10.1007/s11557-009-0641-1; Gams W, 2009, MYCOTAXON, V110, P89, DOI 10.5248/110.89; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grafenhan T, 2011, STUD MYCOL, P79, DOI 10.3114/sim.2011.68.04; Liu ZY, 2002, MYCOL RES, V106, P1100, DOI 10.1017/S0953756202006378; Atlas R. M., 2010, HDB MICROBIOLOGICAL; Kornerup A., 1978, METHUEN HDB COLOUR; Liang Z.Q., 1991, ACTA MYCOL SIN, V10, P104; Matsushima T, 1995, MATSUSHIMA MYCOLOGIC, V8; Nonaka K, 2013, MYCOSCIENCE, V54, P42, DOI 10.1016/j.myc.2012.07.002; Nonaka K, 2013, MYCOLOGIA, V105, P1202, DOI 10.3852/12-132; Nonaka K, 2012, MYCOSCIENCE, V53, P312, DOI 10.1007/s10267-011-0159-7; PITT J., 1979, GENUS PENICILLIUM IT; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Samson RA, 1974, STUDIES MYCOLOGY CBS, V6, P1, DOI DOI 10.1016/S0007-1536(75)80098-2; SAMSON RA, 1988, MYCOLOGIA, V80, P131, DOI 10.2307/3807507; SAMUELS GJ, 1989, MYCOLOGIA, V81, P347, DOI 10.2307/3760073; SAMUELS G J, 1991, Sydowia, V43, P249; WEBER G F S, 1989, Sydowia, V41, P360	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					29	33		10.1016/j.myc.2014.02.001		5	Mycology	Mycology	AW0ZA	WOS:000346018700005		
J	Suzuki, RO; Degawa, Y; Suzuki, SN; Hosoya, T				Suzuki, Ryo O.; Degawa, Yousuke; Suzuki, Satoshi N.; Hosoya, Tsuyoshi			Local-and regional-scale spatial patterns of two fungal pathogens of Miscanthus sinensis in grassland communities	MYCOSCIENCE			English	Article						Metapopulation; Naemacyclus culmigenus; Spatial analysis; Sporisorium kusanoi	EMERGING INFECTIOUS-DISEASES; TROPICAL RAIN-FOREST; PLANT-PATHOGEN; ECTOMYCORRHIZAL FUNGI; RESISTANCE VARIATION; BIENNIAL PLANT; NEW-ZEALAND; HOST; DYNAMICS; METAPOPULATION	We studied the spatio-temporal patterns in two fungal pathogens, Sporisorium kusanoi, along with Naemacyclus culmigenus, of the Japanese pampas grass (Miscanthus sinensis) in grassland communities on the Sugadaira plateau, Japan. Their disease symptoms emerged early in June, increased rapidly during the month and peaked early in July. We checked their presence at 11 sites (the regional-scale census) and recorded their presence in 6000 1 x 1-m subplots within a 60 x 100-m area at the specific site (the local-scale census). Sporisorium kusanoi and N. culmigenus were observed at eight and one sites in the regional-scale census, and in 987 and 2708 subplots in the local-scale census, respectively. The respective spatial distributions of S. kusanoi and N. culmigenus aggregated at the spatial scales of 13 m and 33 m. However, the spatial positions of the two fungi were slightly repulsive each other. Our results found that S. kusanoi was widely distributed within the region, whereas N. culmigenus was restricted within the specific site but had a higher frequency compared to S. kusanoi. The contrasting spatial patterns of the two pathogens may reflect differences in their dispersal processes. (C) 2014 The Mycological Society of Japan. Published by Elsevier B.V. All rights reserved.	[Suzuki, Ryo O.; Degawa, Yousuke] Univ Tsukuba, Sugadaira Montane Res Ctr, Nagano 3862204, Japan; [Suzuki, Satoshi N.] Univ Tokyo, Univ Tokyo Chichibu Forest, Grad Sch Agr & Life Sci, Chichibu, Saitama 3680034, Japan; [Hosoya, Tsuyoshi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Suzuki, RO (reprint author), Univ Tsukuba, Sugadaira Montane Res Ctr, 1278-294 Sugadaira Kogen Ueda, Nagano 3862204, Japan.	rsuzuki@sugadaira.tsukuba.ac.jp					ALEXANDER HM, 1988, J ECOL, V76, P91, DOI 10.2307/2260456; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Dovciak M, 2001, J ECOL, V89, P280, DOI 10.1046/j.1365-2745.2001.00545.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Suzuki RO, 2003, J ECOL, V91, P114, DOI 10.1046/j.1365-2745.2003.00745.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P229, DOI 10.1111/j.1095-8312.1978.tb00014.x; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Kennedy PG, 2007, J ECOL, V95, P1338, DOI 10.1111/j.1365-2745.2007.01306.x; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Debski I, 2002, ECOLOGY, V83, P2005; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Bardgett RD, 2010, ABOVEGROUND BELOWGRO; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; Burdon JJ, 1995, J ECOL, V83, P979, DOI 10.2307/2261179; BURDON JJ, 1989, ANNU REV ECOL SYST, V20, P119; Cano C, 2005, MYCOLOGIA, V97, P1201, DOI 10.3852/mycologia.97.6.1201; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cole RG, 1999, J ECOL, V87, P963, DOI 10.1046/j.1365-2745.1999.00418.x; Dale MR, 1999, SPATIAL PATTERN ANAL; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; GADGIL PD, 1984, NEW ZEAL J FOR SCI, V14, P179; GarciaGuzman G, 1996, NEW PHYTOL, V132, P459, DOI 10.1111/j.1469-8137.1996.tb01866.x; Hosoya T, 2013, MYCOSCIENCE, V54, P433, DOI 10.1016/j.myc.2013.02.002; JENNERSTEN O, 1988, OIKOS, V51, P163, DOI 10.2307/3565638; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Pelissier R, 1998, J TROP ECOL, V14, P1, DOI 10.1017/S0266467498000017; Pickles BJ, 2010, NEW PHYTOL, V186, P755, DOI 10.1111/j.1469-8137.2010.03204.x; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Real LA, 1996, ECOLOGY, V77, P1011, DOI 10.2307/2265572; SAKAI AK, 1983, AM NAT, V122, P489, DOI 10.1086/284151; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Suzuki R, 2009, J PLANT RES, V122, P81, DOI 10.1007/s10265-008-0198-0; Suzuki RO, 2012, J TROP ECOL, V28, P281, DOI 10.1017/S0266467412000168; Suzuki RO, 2005, ANN BOT-LONDON, V96, P1009, DOI 10.1093/aob/mci253; Thrall PH, 2000, PLANT PATHOL, V49, P767, DOI 10.1046/j.1365-3059.2000.00523.x; Webster J., 2007, INTRO FUNGI	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					42	48		10.1016/j.myc.2014.02.004		7	Mycology	Mycology	AW0ZA	WOS:000346018700007		
J	Hashimoto, A; Sato, G; Matsuda, T; Hirayama, K; Hatakeyama, S; Harada, Y; Shirouzu, T; Tanaka, K				Hashimoto, Akira; Sato, Genki; Matsuda, Takahiro; Hirayama, Kazuyuki; Hatakeyama, Satoshi; Harada, Yukio; Shirouzu, Takashi; Tanaka, Kazuaki			Molecular taxonomy of Dinemasporium and its allied genera	MYCOSCIENCE			English	Article						Coelomycetes; Diarimella; Phylogeny; Stauronema; Systematics	BAYESIAN PHYLOGENETIC INFERENCE; BAMBUSICOLOUS FUNGI; STELLATE CONIDIA; MIXED MODELS; SP-NOV; GENUS; JAPAN; PSEUDOLACHNELLA; ASTEROSPORIUM; PROSTHEMIUM	The taxonomic relationships of three coelomycetous genera, Dinemasporium, Diarimella and Stauronema, were assessed. A total of 43 isolates/specimens of Dinemasporium-like fungi were examined by phylogenetic analysis of internal transcribed spacer sequences of the nuclear rRNA gene and morphological comparisons. Species highly consistent with Diarimella or Stauronema generic concepts failed to form monophyletic groups, but were scattered within the Dinemasporium clade. Diarimella and Stauronema are therefore treated as synonyms of Dinemasporium. An expanded generic concept of Dinemasporium is proposed to accommodate species having conidia with bipolar and lateral appendages (formerly Stauronema) or branched multiple appendages (formerly Diarimella), as well as typical Dinemasporium species having conidia with bipolar unbranched appendages. Eight new species of Dinemasporium - D. ambiguum, D. bambusicola, D. iriomotense, D. japonicum, D. parastrigosum, D. pseudodecipiens, D. rishiriense and D. sasae - are described and illustrated. (C) 2014 The Mycological Society of Japan. Published by Elsevier B.V. All rights reserved.	[Hashimoto, Akira; Sato, Genki; Matsuda, Takahiro; Hirayama, Kazuyuki; Hatakeyama, Satoshi; Harada, Yukio; Tanaka, Kazuaki] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Shirouzu, Takashi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Tanaka, K (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	k-tanaka@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25440199]; Hirosaki University Grant for Exploratory Research by Young Scientists	This work was partially supported by funding from the Japan Society for the Promotion of Science (JSPS, 25440199) and a Hirosaki University Grant for Exploratory Research by Young Scientists (2008-2013). We thank the following individuals for their help with collection of fungal specimens: H. Araki, C. Takeuchi, S. Yamamoto and H. Yonezawa. We also wish to thank Vadim A. Mel'nik for reviewing the draft manuscript. The authors gratefully acknowledge the editor and reviewers for their insightful comments.	Barber PA, 2011, PERSOONIA, V27, P90, DOI 10.3767/003158511X617381; Tanaka K, 2010, BOTANY, V88, P1057, DOI 10.1139/B10-078; Kamiyama M, 2009, MYCOSCIENCE, V50, P438, DOI 10.1007/s10267-009-0497-x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Walker DM, 2012, MOL PHYLOGENET EVOL, V64, P500, DOI 10.1016/j.ympev.2012.05.005; Crous PW, 2012, PERSOONIA, V28, P126, DOI 10.3767/003158512X652624; Tanaka K, 2011, PERSOONIA, V26, P85, DOI 10.3767/003158511X576666; Endo Mai, 2008, Nippon Kingakukai Kaiho, V49, P115; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Duan JX, 2007, FUNGAL DIVERS, V26, P205; Ellis JB, 1882, B TORREY BOT CLUB, V9, P18, DOI 10.2307/2477532; Hatakeyama S, 2008, MYCOSCIENCE, V49, P211, DOI 10.1007/s10267-008-0409-5; KALANI IK, 1964, CURR SCI INDIA, V33, P622; Krohn K, 2008, EUR J ORG CHEM, P5638, DOI 10.1002/ejoc.200800688; Leveille JH, 1846, ANN SCI NATURELLES B, V3, P249; Minnis AM, 2012, PERSOONIA, V29, P11, DOI 10.3767/003158512X658766; Nag Raj TR, 1993, COELOMYCETOUS ANAMOR; Nag Raj TR, 1981, BIOL CONIDIAL FUNGI, V1, P43; Nylander JAA, 2004, MRMODELTEST V2 PROGR; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccardo PA, 1884, SYLLOGE FUNGORUM OMN, V3; Sato G, 2008, MYCOSCIENCE, V49, P392, DOI 10.1007/s10267-008-0439-z; Spegazzini C, 1880, ANALES SOC CIENTIFIC, V10, P5; Sutton BC, 1980, COELOMYCETES FUNGI I; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Sydow H., 1916, ANN MYCOL, V14, P177; Vujanovic V, 1998, CAN J BOT, V76, P2037; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yamaguchi Yuichi, 2005, Mycoscience, V46, P367, DOI 10.1007/s10267-005-0254-8; Yonezawa H, 2008, MYCOSCIENCE, V49, P152, DOI 10.1007/s10267-007-0398-9; Zhao RL, 2004, FUNGAL DIVERS, V15, P255	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					86	101		10.1016/j.myc.2014.04.001		16	Mycology	Mycology	AW0ZA	WOS:000346018700013		
J	Gafforov, Y; Hoshino, T				Gafforov, Yusufjon; Hoshino, Tamotsu			Remarks on Typhula sp in Uzbekistan	MYCOSCIENCE			English	Article						Central Asia; Rind cell pattern; Sclerotium; Snow mold; Typhula subvariabilis	FUNGI; LIMITS	We examined three specimens of sclerotia from Tashkent Province, Uzbekistan collected in April 1957. Phylogenetic results suggested that the collected fungi were highest homology (98.0%) to snow mold, Typhula sp. in Iran. Rind cells of collected fungi were lobate and gently rough closely morphologically similar to Typhula subvariabilis. (C) 2014 The Mycological Society of Japan. Published by Elsevier B.V. All rights reserved.	[Gafforov, Yusufjon] Acad Sci Uzbek, Inst Gene Pool Plants & Anim, Mycol Herbarium, Tashkent 100125, Uzbekistan; [Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr BRRC, Hiroshima 7390046, Japan; [Hoshino, Tamotsu] Hiroshima Univ, Grad Sch Adv Sci Mater, Hiroshima 7398530, Japan	Hoshino, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr BRRC, Kagamiyama 3-11-32, Hiroshima 7390046, Japan.	tamotsu.hoshino@aist.go.jp	Gafforov, Yusufjon/C-5507-2015	Gafforov, Yusufjon/0000-0003-3076-4709	Erasmus Mundus A2 CASIA	YG thanks Erasmus Mundus A2 CASIA to support this study. The authors are deeply grateful to Dr. Naoyuki Matsumoto, Hokkaido University for correcting and improving the manuscript.	Olariaga I, 2009, MYCOL PROG, V8, P351, DOI 10.1007/s11557-009-0608-2; Hoshino Tamotsu, 2012, Fungal Biology Reviews, V26, P102, DOI 10.1016/j.fbr.2012.08.003; Barry R, 2011, GLOBAL CRYOSPHERE PR; Bernicchia A, 2001, SYDOWIA, V53, P1; BERTHIER J, 1974, Bulletin Mensuel de la Societe Linneenne de Lyon, V43, P182; Berthier J, 1973, THESIS U CLAUDE BERN; Berthier J, 1976, NUMERO SPECIAL B SOC, V45, P1; Corner EJH, 1950, MONOGRAPH CLAVARIA A; Corner EJH, 1970, VERLAG J CRAMER LE S; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Ginns JH, 1986, COMPENDIUM PLANT DIS; Hansen L., 1997, NORDIC MACROMYCETES, V3; Hoshino T., 2007, Rostaniha, V8, P35; Hoshino T, 2009, MYCOSCIENCE, V50, P26, DOI 10.1007/s10267-008-0452-2; Khurana JPS, 1980, MYCOLOGIA, V72, P708; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knudsen H, 2012, FUNGA NORDICA AGARIC, P299; Legon NW, 2005, CHECKLIST BRIT IRISH; Parmasto EH, 1965, OPREDELITEL ROGATIKV; Potatosova VG, 1960, BOT J, V45, P567; REMSBERG RUTH E., 1940, MYCOLOGIA, V32, P52, DOI 10.2307/3754544; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Shvartsman SR, 1964, FLORA SPOROVYKH RAST; Smith J. D., 1989, FUNGAL DIS AMENITY T; Thind KS, 1961, CLAVARIACEAE INDIA; Thompson JD, 1994, NUCLEIC ACIDS RES, V18, P7213; Tkachenko OB, 2013, PLANT MICROBE ADAPTA, P293; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Ziller WG, 1961, LIST PATHOGENS PINUS	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	JAN	2015	56	1					109	113		10.1016/j.myc.2014.04.003		5	Mycology	Mycology	AW0ZA	WOS:000346018700015		
J	Matsuura, S; Shaw, R				Matsuura, Shohei; Shaw, Rajib			Exploring the possibilities of school-based recovery and community building in Toni District, Kamaishi	NATURAL HAZARDS			English	Article						School-based recovery; Disaster education; Disaster resilient community building	DISASTER EDUCATION; HAZARD MITIGATION; MANAGEMENT; VULNERABILITY; PREPAREDNESS; FAMILY	The damages that the East Japan Earthquake and Tsunami (EJET) brought upon the education sector did not only affect schools, but also had a significant impact on the whole community. This is because communities in Japan commonly consider schools as a central public facility that local residents have attended and are familiar with. Many schools also function as evacuation centers during emergencies. Therefore, there is strong implication of schools having a potential role in facilitating the overall recovery and community building by bringing communities back together through the school-community linkages. This paper attempts to discuss on the possibilities of exploring the "school-based recovery" concept, which is being promoted by the Ministry of Education, Culture, Sports, Science and Technology with a specific case study in Toni District, Kamaishi City in Iwate Prefecture. A series of surveys were conducted in which the results show that school-community linkage prior to EJET played a critical part for residents to effectively respond to the disaster. Because of this, this linkage must be promptly restored and strengthened to proceed with recovery and to build disaster resilient communities. Survey results extracted specific means for school and community recovery, including joint disaster risk reduction activities, regional education, as well as opening up the school facilities for it to become a multifunctional facility that can serve the whole community. Looking at both short-term recovery and the longer-term community building needs, the paper provides an insight that in addition to recovery, the concept can also help communities in building new networks and solving chronic social problems such as population drainage essential for sustainable community building.	[Matsuura, Shohei; Shaw, Rajib] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan	Matsuura, S (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	matsuura.shohei2014@gmail.com			Church World Service (CWS) Asia-Pacific; MERCY Malaysia	The authors would like to express their appreciation to Church World Service (CWS) Asia-Pacific and MERCY Malaysia for funding this research. In addition, extensive support was provided by Kamaishi Board of Education, leaders of Toni Town Associations, Toni Community Center, Toni ES/JHS and the Toni residents.	Aldrich D. P., 2012, BUILDING RESILIENCE; Ingram JC, 2006, ENVIRON SCI POLICY, V9, P607, DOI 10.1016/j.envsci.2006.07.006; Bouillion LM, 2001, J RES SCI TEACH, V38, P878, DOI 10.1002/tea.1037; Mathbor GM, 2007, INT SOC WORK, V50, P357, DOI 10.1177/0020872807076049; BERKE PR, 1993, DISASTERS, V17, P93, DOI 10.1111/j.1467-7717.1993.tb01137.x; Israel GD, 2001, RURAL SOCIOL, V66, P43; Moore S, 2004, FAM COMMUNITY HEALTH, V27, P204; Morrow BH, 1999, DISASTERS, V23, P1, DOI 10.1111/1467-7717.00102; Pearce L, 2003, NAT HAZARDS, V28, P211, DOI 10.1023/A:1022917721797; Bajek R, 2008, NAT HAZARDS, V44, P281, DOI 10.1007/s11069-007-9107-4; Central Education Council MEXT, 2012, MEXT 2012 DRAFT PLAN; Chamlee-Wright E., 2010, CULTURAL POLITICAL E; Dufty N, 2009, AUST J EMERG MANAG, V24, P13; Fujiga M, 2012, CHARACTERISTICS ISSU; Fujioka T, 2008, JOETSU U ED B, V27; Ikeda H, 2001, ED COMMUNITY HDB SEE; Kamaishi City Government, 2011, SIT REP DIS DAM E JA; Kaneyoshi T, 2004, 10 YEARS RECOVERY FI; Katada T, 2008, SOLUTIONS COASTAL DI, DOI [10.1061/40978(313)4, DOI 10.1061/40978(313)4]; Kobayashi F, 2011, NOSON KEIKAKU GAKKAI, V30; Masten A, 2008, ECOL SOC; Miller B, 1993, J RES RURAL ED, V9, P84; Ministry of Education Culture Sports Science and Technology (MEXT) Japan, 2012, 208 REP REL 14 SEPT; Nakagawa Yuko, 2004, INT J MASS EMERGENCI, V22, P5; National Institute for Educational Research, 2008, ENH DIS MAN FUNCT SC; National Institute for Educational Research, 2011, RES FACT SURV DRR FU; Nishida Y, 1999, SOCIAL SCI GREAT HAN, P79; Norris F, 2007, AM J COMMUN PSYCHOL, V41, P127; Oikawa Y, 2013, E JAPAN TSUNAMI EART, P165; Paton D., 2001, DISASTER PREVENTION, V10, P270, DOI DOI 10.1108/EUM0000000005930; Petal M, 2008, CONCEPT NOTE FORMAL; Provenzo E, 1995, HURRICANE ANDREW PUB; Ronan K, 2005, PROMOTING COMMUNITY, P49; RUBIN CB, 1985, PUBLIC ADMIN REV, V45, P57, DOI 10.2307/3134998; Saito Y, 2011, CITY LIFE MAGAZINE; Sakagawa S, 2004, SCH CTR LOCAL COMMUN, p[121, 273]; Sakurai A, 2013, KOKUSAI KYORYOKURON, V20; Shaw R, 2011, COMM ENV DISAST RISK, V7, P1, DOI 10.1108/S2040-7262(2011)0000007007; Shiwaku K, 2011, DISASTER ED, P72; Takeuchi Y, 2011, COMM ENV DISAST RISK, V7, P77, DOI 10.1108/S2040-7262(2011)0000007010; Yamamoto T, 2012, DISASTER INFRASTRUCT, V3, P27; Yamashita F, 2011, TSUNAMI TENDENKO HIS, P52; Yamori K, 2012, SHIZENSAIGAI KAGAKU	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	JAN	2015	75	1					613	633		10.1007/s11069-014-1344-8		21	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AW0HI	WOS:000345971600028		
J	Perera, EDP; Hiroe, A; Shrestha, D; Fukami, K; Basnyat, DB; Gautam, S; Hasegawa, A; Uenoyama, T; Tanaka, S				Perera, E. D. P.; Hiroe, A.; Shrestha, D.; Fukami, K.; Basnyat, D. B.; Gautam, S.; Hasegawa, A.; Uenoyama, T.; Tanaka, S.			Community-based flood damage assessment approach for lower West Rapti River basin in Nepal under the impact of climate change	NATURAL HAZARDS			English	Article						MRI-AGCM precipitation; Climate change; Flood hazards; Flood damage assessment; Inundation modeling	SEA-LEVEL RISE; NETHERLANDS	The West Rapti River (WRR), one of the dynamic and economically important basins of Nepal, was focused in this study to understand the impact of climate change in localized scale. The adopted methodology was a community-based field survey followed by a hydrological modeling to estimate present and future flood damages for households and agriculture. Flood disaster occurred in 2007 was simulated and discussed. High-resolution atmospheric general circulation model's precipitation outputs for emission scenario A1B were utilized with their bias corrections to obtain the precipitation patterns over lower WRR basin for Present (1979-2003) and Future (2075-2099) periods. A conceptual hydrologic model was employed to obtain the time series of daily river runoffs for the above-mentioned time durations followed by frequency analyses for probable flood discharges of 25- and 50-year return periods. Flood inundation simulations of 50-year return period events for Present and Future were carried out with the rainfall-runoff-inundation model followed by a flood damage assessment for household and agriculture based on the inundation simulation results, and field survey data over the target area and potential flood damages were discussed. Integration of hydrological modeling and socioeconomic approach to foresee potential flood damages was achieved, and the adopted damage assessment methodology was systematically explained. The total increments of household and agriculture damages due to climate change were estimated for Present as 1.80 and 1.95, and for Future, it was 2.40 and 2.27, respectively, compared to 2007 flood disaster. Future flood frequencies, intensities, and consequent damages in the area show a significant increment compared to the present situation despite limitations and uncertainties.	[Perera, E. D. P.; Hasegawa, A.; Uenoyama, T.] UNESCO, Int Ctr Water Hazard & Risk Management ICHARM, PWRI, Tsukuba, Ibaraki 3058516, Japan; [Hiroe, A.] Publ Works Res Inst, Ctr Adv Engn Struct Assessment & Res CAESAR, Tsukuba, Ibaraki, Japan; [Shrestha, D.; Basnyat, D. B.] Nepal Dev Res Inst, Kathmandu, Nepal; [Fukami, K.] Natl Inst Land & Infrastruct Management, Tsukuba, Ibaraki, Japan; [Gautam, S.] Welthungerhilfe Nepal, Kathmandu, Nepal; [Tanaka, S.] Kyoto Univ, Disaster Prevent Res Inst, Water Resources Res Ctr, Kyoto, Japan	Perera, EDP (reprint author), UNESCO, Int Ctr Water Hazard & Risk Management ICHARM, PWRI, 1-6 Minamihara, Tsukuba, Ibaraki 3058516, Japan.	duminda.pradeep@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This work was conducted under the framework of the "assessment of the impact of climate change on flood disaster risk and its reduction measures over the globe and specific vulnerable areas" of Japan supported by the Innovative Program of Climate Change Projection for the 21st Century (KAKUSHIN) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. Expertise support for inundation modeling given by Dr. Takahiro Sayama at ICHARM is gratefully acknowledged by the authors.	Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Jonkman SN, 2008, ECOL ECON, V66, P77, DOI 10.1016/j.ecolecon.2007.12.022; Nicholls RJ, 2002, PHYS CHEM EARTH, V27, P1455, DOI 10.1016/S1474-7065(02)00090-6; Brouwer R, 2004, ECOL ECON, V50, P1, DOI 10.1016/j.ecolecon.2004.01.020; Baidya SK, 2007, CLIMATE PROFILE OBSE; Central Bureau of Statistics, 2001, STAT YB NEP; Chen H, 2012, STOCH ENV RES RISK A, V26, P847, DOI 10.1007/s00477-011-0524-2; Chow V.T., 1988, APPL HYDROLOGY; Department of Irrigation Nepal, 2014, SIKT IRR PROJ; Department of Water Induced Disaster Prevention, 2007, DIS REV 2006 SER; Department of Water Induced Disaster Prevention, 2004, DIS REV 1983 2004; Dilley M, 2005, DISAST RISK MANAGE, P1; Dutta D, 2003, P 2 INT C NEW TECHN, P229; Food and Agriculture Organization, 2004, COMP FOOD AGR IND 20; Gautam DK, 2013, J INTEGR DISASTER RI, V3, P1, DOI [10.5595/idrim.2013.0061, DOI 10.5595/IDRIM.2013.0061]; Inomata H, 2007, J ADV RIVER ENG, V13, P433; Inomata H, 2009, ANN J HYDRAUL ENG, V55, P247; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Jarvis A., 2008, EOS T AGU, V89, P93, DOI DOI 10.1029/2008EO100001; Jonge TD, 1996, APPL GEOGRAPHIC INFO, V235, P299; Kamiguchi Kenji, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.60; Kitoh A., 2009, HYDROLOGICAL RES LET, V3, P49, DOI DOI 10.3178/HRL.3.49; Ministry of Agriculture and Development-Nepal, 2012, STAT INF NEP AGR 201; Ministry of Finance-Nepal, 2005, EC SURV FISC YEAR 20; Mizuta R, 2012, J METEOROL SOC JPN A, V90A, P232; Osti R, 2008, 4122 PWRI; Parker DJ, 1992, INT C PREP MIT NAT D; Parry M, 2001, GLOBAL ENVIRON CHANG, V11, P181, DOI 10.1016/S0959-3780(01)00011-5; Sayama T, 2011, HYDROLOG SCI J, V57, P298; Sugiura T, 2009, 7 ISE 8 HIC CHIL; United Nations Development Program, 2009, NEP DIS REP; United Nations Office for the Coordination of Humanitarian Affairs, 2009, 2 UN OFF CORD HUM AF; Vaze J, 2011, HYDROL PROCESS, V25, P18, DOI 10.1002/hyp.7812; Wobus C, 2014, J FLOOD RISK MANAG, V7, P217, DOI 10.1111/jfr3.12043; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	JAN	2015	75	1					669	699		10.1007/s11069-014-1339-5		31	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AW0HI	WOS:000345971600031		
J	Imai, H; Matsumoto, H; Miyakoshi, E; Okumura, S; Fujiwara, H; Kimura, A				Imai, Hirohiko; Matsumoto, Hironobu; Miyakoshi, Erika; Okumura, Shintaro; Fujiwara, Hideaki; Kimura, Atsuomi			Regional fractional ventilation mapping in spontaneously breathing mice using hyperpolarized Xe-129 MRI	NMR IN BIOMEDICINE			English	Article						hyperpolarized gas; xenon; lung MRI; fractional ventilation	MAGNETIC-RESONANCE MICROSCOPY; GAS MRI; QUANTITATIVE MEASUREMENT; COMPUTED TOMOGRAPHY; MOUSE MODEL; HE-3 MRI; LUNG; EMPHYSEMA; SYSTEM	The feasibility of ventilation imaging with hyperpolarized (HP) Xe-129 MRI has been investigated for quantitative and regional assessment of ventilation in spontaneously breathing mice. The multiple breath ventilation imaging technique was modified to the protocol of spontaneous inhalation of HP Xe-129 delivered continuously from a Xe-129 polarizer. A series of Xe-129 ventilation images was obtained by varying the number of breaths before the Xe-129 lung imaging. The fractional ventilation, r, was successfully evaluated for spontaneously breathing mice. An attempt was made to detect ventilation dysfunction in the emphysematous mouse lung induced by intratracheal administration of porcine pancreatic elastase (PPE). As a result, the distribution of fractional ventilation could be visualized by the r map. Significant dysfunction of ventilation was quantitatively identified in the PPE-treated group. The whole-lung r value of 0.34 +/- 0.01 for control mice (N=4) was significantly reduced, to 0.25 +/- 0.07, in PPE-treated mice (N=4) (p=0.038). This study is the first application of multiple breath ventilation imaging to spontaneously breathing mice, and shows that this methodology is sensitive to differences in the pulmonary ventilation. This methodology is expected to improve simplicity as well as noninvasiveness when assessing regional ventilation in small rodents. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Imai, Hirohiko; Matsumoto, Hironobu; Miyakoshi, Erika; Okumura, Shintaro; Fujiwara, Hideaki; Kimura, Atsuomi] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Suita, Osaka 5650871, Japan	Kimura, A (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	kimura@sahs.med.osaka-u.ac.jp			Ministry of Education, Culture, Science, Sports, and Technology of Japan [23700534, 24300163]	This work was supported in part by Grants-in-Aid for Scientific Research (grant numbers: 23700534 and 24300163) from The Ministry of Education, Culture, Science, Sports, and Technology of Japan.	Alsaids H, 2008, P 16 ANN M ISMRM TOR, P2668; Deninger AJ, 2002, MAGNET RESON MED, V48, P223, DOI 10.1002/mrm.10206; Lilburn DML, 2013, J MAGN RESON, V229, P173, DOI 10.1016/j.jmr.2012.11.014; Santyr GE, 2008, MAGN RESON MED, V59, P1304, DOI 10.1002/mrm.21582; Beckmann N, 2007, NMR BIOMED, V20, P154, DOI 10.1002/nbm.1153; Couch MJ, 2012, MAGN RESON MED, V68, P1623, DOI 10.1002/mrm.24152; Moller HE, 2002, MAGN RESON MED, V47, P1029, DOI 10.1002/mrm.10173; Fain SB, 2007, J MAGN RESON IMAGING, V25, P910, DOI 10.1002/jmri.20876; Mugler JP, 2013, J MAGN RESON IMAGING, V37, P313, DOI 10.1002/jmri.23844; Patz S, 2007, EUR J RADIOL, V64, P335, DOI 10.1016/j.ejrad.2007.08.008; Banniers E, 2009, INVEST RADIOL, V44, P1; Chen BT, 2005, MAGNET RESON MED, V53, P69, DOI 10.1002/mrm.20307; Driehuys B, 2008, ILAR J, V49, P35; Emami K, 2010, MAGN RESON MED, V63, P137, DOI 10.1002/mrm.22186; Emamis K, 2011, P 19 ANN M ISMRM MON, P894; Emamis K, 2012, P 20 ANN M ISMRM MEL, P3997; Emami K, 2013, MAGN RESON MED, V70, P1353, DOI 10.1002/mrm.24582; Emami K, 2012, NMR BIOMED, V25, P1015, DOI 10.1002/nbm.2763; Ford NL, 2007, J APPL PHYSIOL, V102, P2046, DOI 10.1152/japplphysiol.00629.2006; Hori Y, 2009, MAGN RESON MED SCI, V8, P73; Iguchi S, 2013, MAGN RESON MED, V70, P207, DOI 10.1002/mrm.24452; Imai F, 2011, MAGN RESON MED SCI, V10, P33; Imai H, 2010, MAGN RESON MED, V64, P929, DOI 10.1002/mrm.22437; Imai H, 2011, NMR BIOMED, V24, P1343, DOI 10.1002/nbm.1697; Imai H, 2008, CONCEPT MAGN RESON B, V33B, P192, DOI 10.1002/cmr.b.20117; Ishii M, 2012, J APPL PHYSIOL, V112, P135, DOI 10.1152/japplphysiol.01181.2010; Ishiis M, 2010, P JOINT ANN M ISMRM, P2546; Lourettes SA, 2011, P 19 ANN M ISMRM MON, P887; Mongkolwisetwaras P, 2011, P 19 ANN M ISMRM MON, P900; Mosbah K, 2010, MAGN RESON MED, V63, P1669, DOI 10.1002/mrm.22391; Narazaki Michiko, 2006, Magn Reson Med Sci, V5, P119, DOI 10.2463/mrms.5.119; Nouls J, 2011, CONCEPT MAGN RESON B, V39B, P78, DOI 10.1002/cmr.b.20192; Peled S, 1996, MAGNET RESON MED, V36, P340, DOI 10.1002/mrm.1910360303; Salhi Z, 2012, MAGN RESON MED, V67, P1758, DOI 10.1002/mrm.23154; Spector ZZ, 2005, MAGNET RESON MED, V53, P1341, DOI 10.1002/mrm.20514; Stupar V, 2007, NMR BIOMED, V20, P104, DOI 10.1002/nbm.1086; Tetsumoto S, 2013, AM J RESP CELL MOL, V49, P592, DOI 10.1165/rcmb.2012-0350OC; Xins Y, 2011, P 19 ANN M ISMRM MON, P892; Zureks M, 2011, METHOD MOL BIOL, P459	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JAN	2015	28	1					24	29		10.1002/nbm.3222		6	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	AW0LG	WOS:000345983100004		
J	Sadahiro, S; Suzuki, T; Tanaka, A; Okada, K; Saito, G; Kamijo, A; Akiba, T; Kawada, S				Sadahiro, Sotaro; Suzuki, Toshiyuki; Tanaka, Akira; Okada, Kazutake; Saito, Gota; Kamijo, Akemi; Akiba, Takeshi; Kawada, Shuichi			Phase II Study of Preoperative Concurrent Chemoradiotherapy with S-1 plus Bevacizumab for Locally Advanced Resectable Rectal Adenocarcinoma	ONCOLOGY			English	Article						Rectal cancer; Chemoradiotherapy; Phase II study; S-1; Bevacizumab	TUMOR SHRINKAGE; CANCER; CAPECITABINE; RADIATION; RADIOTHERAPY; CHEMORADIATION; 5-FLUOROURACIL; FLUOROURACIL; LEUCOVORIN; REGRESSION	Objective: A single-arm phase II clinical trial was conducted to evaluate the safety and efficacy of preoperative chemoradiotherapy (CRT) with concurrent S-1, bevacizumab, and radiation in patients with locally advanced rectal cancer (LARC), Methods: Fifty-two patients with LARC were enrolled. A total dose of 45 Gy was delivered in 25 fractions over 5 weeks, S-1 was administered orally twice a day on days 1-14 and 22-35, and bevacizumab was administered on days 1, 15, and 29. Surgical resection was scheduled 8 weeks (6-10 weeks) after completing the CRT. Results: All 52 patients underwent R0 radical surgery. Sphincter preservation was possible in 38 (73.1%) patients. A pathologic complete response was obtained in 10 (19.2%) patients, a pathologic downstaging was achieved in 37(71.2%) patients, and the tumor shrinkage rate was 77.1%. The only grade 3 adverse events were leukopenia and rash in 1 (1.9%) patient. The rate of postoperative complications was 28.8%. Anastomotic leakage occurred in 9 (23.7%) of the 38 patients who underwent sphincter-preserving surgery. Perineal wound dehiscence developed in 2 (14.3%) of the 14 patients who received an abdominoperineal resection. Conclusions: Adding bevacizumab to S-1 clearly increased the incidence of wound-related complications, with no distinct enhancement of tumor response. (C) 2014 S. Karger AG, Basel	[Sadahiro, Sotaro; Suzuki, Toshiyuki; Tanaka, Akira; Okada, Kazutake; Saito, Gota; Kamijo, Akemi] Tokai Univ, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Akiba, Takeshi; Kawada, Shuichi] Tokai Univ, Dept Radiol, Isehara, Kanagawa 2591193, Japan	Sadahiro, S (reprint author), Tokai Univ, Dept Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	sadahiro@is.icc.u-tokai.ac.jp					MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Suzuki T, 2013, INT J RADIAT ONCOL, V85, P1232, DOI 10.1016/j.ijrobp.2012.09.031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; [Anonymous], FIN RES BEV SAF POST; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Spigel DR, 2012, CLIN COLORECTAL CANC, V11, P45, DOI 10.1016/j.clcc.2011.04.002; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Schoffski P, 2004, ANTI-CANCER DRUG, V15, P85, DOI 10.1097/01.cad.0000114631.91268.39; Sanghera P, 2008, CLIN ONCOL-UK, V20, P176, DOI 10.1016/j.clon.2007.11.013; Lee CG, 2000, CANCER RES, V60, P5565; Suzuki T, 2004, JPN J CLIN ONCOL, V34, P740, DOI 10.1093/jjco/hyh140; Gorski DH, 1999, CANCER RES, V59, P3374; Suzuki T, 2014, J SURG ONCOL, V109, P659, DOI 10.1002/jso.23550; Gasparini G, 2012, ANGIOGENESIS, V15, P141, DOI 10.1007/s10456-011-9250-0; Crane CH, 2010, INT J RADIAT ONCOL, V76, P824, DOI 10.1016/j.ijrobp.2009.02.037; Chan AK, 2010, INT J RADIAT ONCOL, V76, P1413, DOI 10.1016/j.ijrobp.2009.03.048; Das P, 2006, INT J RADIAT ONCOL, V66, P1378; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Kim DY, 2007, INT J RADIAT ONCOL, V67, P378, DOI 10.1016/j.ijrobp.2006.08.063; Marijnen CA, 2008, J CLIN ONCOL S, V26, P15040; Sadahiro S, 2011, ONCOLOGY-BASEL, V81, P306, DOI 10.1159/000334580; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Velenik V, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-105; Willett CG, 2007, CLIN CANCER RES, V13, p6903S, DOI 10.1158/1078-0432.CCR-07-1158; Yerushalmi R, 2006, J SURG ONCOL, V93, P529, DOI 10.1002/jso.20503	25	2	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0030-2414	1423-0232		ONCOLOGY-BASEL	Oncology		2015	88	1					49	56		10.1159/000367972		8	Oncology	Oncology	AW2KR	WOS:000346117000005		
J	Fujiwara, H; Takahashi, Y; Takano, M; Miyamoto, M; Nakamura, K; Kaneta, Y; Hanaoka, T; Ohwada, M; Sakamoto, T; Hirakawa, T; Fujiwara, K; Suzuki, M				Fujiwara, Hiroyuki; Takahashi, Yoshifumi; Takano, Masashi; Miyamoto, Morikazu; Nakamura, Kazuto; Kaneta, Yoshibumi; Hanaoka, Tatsuya; Ohwada, Michitaka; Sakamoto, Takanori; Hirakawa, Takashi; Fujiwara, Keiichi; Suzuki, Mitsuaki			Evaluation of Endometrial Cytology: Cytohistological Correlations in 1,441 Cancer Patients	ONCOLOGY			English	Article						Endometrial cancer; Endometrial cytology; Endometrial screening; Endometrial pathology	POSTMENOPAUSAL WOMEN; FRACTIONAL CURETTAGE; CARCINOMA; ADENOCARCINOMA; FEASIBILITY; POPULATION; THICKNESS; DIAGNOSIS; ACCURACY; SAMPLER	Background: Endometrial cytology by direct intrauterine sampling is the most common test for an initial evaluation of the endometrium in Japan. However, its diagnostic value for endometrial cancer remains unknown. Here, we assess the correlation between cytopathology and histopathology to evaluate the diagnostic value of cytology for endometrial cancer. Methods: Patients with histologically confirmed endometrial cancer and controls with a normal endometrium confirmed by hysterectomy had all undergone preoperative endometrial cytology between 2001 and 2010 at our eight institutions and were retrospectively analyzed. The cytological results were compared by clinical stage, histological type, differentiation, and sampling instrument. Results: We analyzed 1,441 endometrial cancer and 1,361 control cases. Endometrial cytology detected cancer in 1,279 (916 positive and 363 suspicious) cases with a sensitivity (positive plus suspicious cases) of 88.8% and a specificity of 98.5%. The positive rate was high in advanced-stage, nonendometrioid, and undifferentiated cases, but there was no significant difference in sensitivity between these clinical conditions. Conclusion: Endometrial cytology shows a relatively high sensitivity and specificity for endometrial cancer, and neither statistical measure is significantly affected by clinical stage, histological type, differentiation, sample numbers, or sampling instrument. These findings form a superior dataset for evaluating the efficacy of endometrial cytology. (C) 2014 S. Karger AG, Basel	[Fujiwara, Hiroyuki; Takahashi, Yoshifumi; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Takano, Masashi; Miyamoto, Morikazu] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama 359, Japan; [Nakamura, Kazuto] Gunma Univ Hosp, Dept Obstet & Gynecol, Maebashi, Gumma, Japan; [Kaneta, Yoshibumi] Saitama Med Ctr, Dept Obstet & Gynecol, Urawa, Saitama, Japan; [Hanaoka, Tatsuya; Fujiwara, Keiichi] Saitama Med Univ Int Med Ctr, Dept Gynecol Oncol, Hidaka, Japan; [Ohwada, Michitaka] Int Univ Hlth & Welf, Dept Obstet & Gynecol, Nasushiobara, Japan; [Sakamoto, Takanori] Dokkyo Med Univ, Dept Obstet & Gynecol, Mibu, Tochigi, Japan; [Hirakawa, Takashi] Gunma Prefectural Canc Ctr, Dept Gynecol, Ota, Japan	Fujiwara, H (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	fujiwara@jichi.ac.jp					Vuento MH, 1999, BRIT J OBSTET GYNAEC, V106, P14, DOI 10.1111/j.1471-0528.1999.tb08079.x; GUIDO RS, 1995, J REPROD MED, V40, P553; BISTOLETTI P, 1988, ACTA OBSTET GYN SCAN, V67, P343, DOI 10.1111/j.1600-0412.1988.tb07812.x; Buccoliero AM, 2007, CYTOPATHOLOGY, V18, P241, DOI 10.1111/j.1365-2303.2007.00463.x; BYRNE AJ, 1990, ACTA CYTOL, V34, P373; Ciatto S, 1995, TUMORI, V81, P334; Frable WJ, 2008, CANCER CYTOPATHOL, V114, P219, DOI 10.1002/cncr.23705; Gerber B, 2001, EUR J CANCER, V37, P64, DOI 10.1016/S0959-8049(00)00356-7; GOLDCHMIT R, 1993, OBSTET GYNECOL, V82, P727; Kipp BR, 2008, CANCER CYTOPATHOL, V114, P228, DOI 10.1002/cncr.23636; Kobayashi T, 2010, DIAGNOSTIC CYTOPATHO, P689; Kondo E, 2008, CYTOPATHOLOGY, V19, P28, DOI 10.1111/j.1365-2303.2007.00509.x; LAPOLLA JP, 1990, AM J OBSTET GYNECOL, V163, P1055; LaPolla JP, 1990, AM J OBSTET GYNECOL, V163, P1059; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Nakagawa-Okamura C, 2002, ACTA CYTOL, V46, P277, DOI 10.1159/000326722; Nishimura Y, 2005, CANCER CYTOPATHOL, V105, P8, DOI 10.1002/cncr.20787; Robertson G, 2003, MED J AUSTRALIA, V178, P657; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith RA, 2014, CA-CANCER J CLIN, V64, P31, DOI 10.3322/caac.21212; Smith-Bindman R, 2004, ULTRASOUND OBST GYN, V24, P558, DOI 10.1002/uog.1704; STOVALL TG, 1991, OBSTET GYNECOL, V77, P954; Tajima M, 1998, CYTOPATHOLOGY, V9, P369; Tanriverdi HA, 2004, MED SCI MONITOR, V10, pCR271; Yanoh K, 2009, CYTOPATHOLOGY, V20, P388, DOI 10.1111/j.1365-2303.2008.00581.x; Yanoh K, 2012, ACTA CYTOL, V56, P233, DOI 10.1159/000336258; Yanoh Kenji, 2014, Acta Cytol, V58, P153, DOI 10.1159/000357769	27	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0030-2414	1423-0232		ONCOLOGY-BASEL	Oncology		2015	88	2					86	94		10.1159/000368162		9	Oncology	Oncology	AW2KU	WOS:000346117300003		
J	Kato, H; Wakabayashi, H; Naito, Y; Kato, S; Nakagawa, T; Matsumine, A; Sudo, A				Kato, Hiroaki; Wakabayashi, Hiroki; Naito, Yohei; Kato, Sho; Nakagawa, Taro; Matsumine, Akihiko; Sudo, Akihiro			Anti-Tumor Necrosis Factor Therapy Inhibits Lung Metastasis in an Osteosarcoma Cell Line	ONCOLOGY			English	Article						Tumor necrosis factor-alpha; Osteosarcoma; 143B cells; Lung metastasis; Infliximab	SUPPRESSES BONE METASTASIS; OVARIAN-CANCER CELLS; FACTOR RECEPTOR P55; TNF-ALPHA; EXPRESSION; ANTIBODY; GROWTH; MICE; RHO	Background: Osteosarcoma is the most common primary malignancy of bone, and patients often develop pulmonary metastases. In a previous study, tumor necrosis factor (TNF)-alpha treatment of human osteosarcoma cells increases their metastatic ability in an animal model. TNF-alpha can act as a tumor necrosis factor and also as a tumor-promoting factor. In the present study, the effect of a TNF-alpha inhibitor on osteosarcoma aggressiveness and pulmonary metastases was investigated in vitro and in vivo. Methods: The effect of infliximab, a TNF-alpha inhibitor, on a metastatic osteosarcoma 143B cell growth and motility was investigated in vitro. An orthotopic xenograft model of 143B cell growth and spontaneous metastasis in SCID mice was used to assess the in vivo effect of infliximab. Results: Infliximab greatly reduced cell motility and pulmonary metastases in 143B cells. The mechanism of pulmonary metastasis inhibition involved decreased expression of CXC chemokine receptor 4 (CXCR4), Rho (small GTPase protein), and its effector. Conclusions: These results suggest a novel role for TNF-alpha inhibition in the reduction or prevention of pulmonary metastases of osteosarcoma in this animal model. TNF-alpha inhibition may become a preventive therapeutic option for the pulmonary metastases of osteosarcoma. (C) 2014 S. Karger AG, Basel	[Kato, Hiroaki; Wakabayashi, Hiroki; Naito, Yohei; Kato, Sho; Nakagawa, Taro; Matsumine, Akihiko; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthoped Surg, Tsu, Mie 5148507, Japan	Wakabayashi, H (reprint author), Mie Univ, Grad Sch Med, Dept Orthoped Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	whiroki@clin.medic.mie-u.ac.jp					Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093; Hamaguchi T, 2011, BIOCHEM BIOPH RES CO, V407, P525, DOI 10.1016/j.bbrc.2011.03.051; Moore RJ, 1999, NAT MED, V5, P828; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Kitakata H, 2002, CANCER RES, V62, P6682; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; Cho SG, 2009, J CELL BIOCHEM, V107, P1139, DOI 10.1002/jcb.22216; Harting MT, 2006, J PEDIATR SURG, V41, P194, DOI 10.1016/j.jpedsurg.2005.10.089; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Tomita Y, 2004, INT J CANCER, V112, P927, DOI 10.1002/ijc.20493; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; OROSZ P, 1993, J EXP MED, V177, P1391, DOI 10.1084/jem.177.5.1391; Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; Gibbs CP, 2001, J BONE JOINT SURG AM, V83A, P1728; KAWASHIMA A, 1994, VIRCHOWS ARCH, V424, P547	23	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0030-2414	1423-0232		ONCOLOGY-BASEL	Oncology		2015	88	3					139	146		10.1159/000368414		8	Oncology	Oncology	AW2LB	WOS:000346117900002		
J	Zaitsu, Y; Oki, E; Ando, K; Ida, S; Kimura, Y; Saeki, H; Morita, M; Hirahashi, M; Oda, Y; Maehara, Y				Zaitsu, Yoko; Oki, Eiji; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Saeki, Hiroshi; Morita, Masaru; Hirahashi, Minako; Oda, Yoshinao; Maehara, Yoshihiko			Loss of Heterozygosity of PTEN (Encoding Phosphate and Tensin Homolog) Associated with Elevated HER2 Expression Is an Adverse Prognostic Indicator in Gastric Cancer	ONCOLOGY			English	Article						Loss of heterozygosity of PTEN; HER2; Gastric cancer	TUMOR-SUPPRESSOR GENE; MICROSATELLITE INSTABILITY; TRASTUZUMAB RESISTANCE; AKT PHOSPHORYLATION; ERBB RECEPTORS; CARCINOMA; PATHWAY; PROGRESSION; MUTATION; INVOLVEMENT	Objective: PTEN (the encoding phosphate and tensin homolog) is a well-known cancer suppressor gene and its mutation and loss of heterozygosity (LOH) occurs in various types of carcinomas. This study aimed to examine the association between LOH of PTEN and prognosis in HER2-expressing and nonexpressing gastric cancer patients. Methods: Fresh-frozen tumor samples of 221 gastric cancer patients with a primary diagnosis of gastric carcinoma were examined for LOH of PTEN. The results were compared with pathological parameters and the HER2 status. To elucidate the role of LOH of PTEN, the activation of the PI3K/AKT pathway was examined immunohistochemically using a phosphorylation-specific antibody. Results: LOH of PTEN was observed in 20% of the patients (39 of 195 cases). LOH of PTEN was associated with vascular involvement (25 of 39 cases; p = 0.0083), equivocal to positive staining for HER2 (p = 0.0080), and phosphoAkt expression (p = 0.0067). Patients with HER2-expressing gastric cancer with LOH of PTEN had a significantly worse prognosis (p = 0.0050). Conclusions: Although HER2 expression itself was not a prognostic factor, the combination of HER2 expression and LOH of PTEN exacerbates the malignant potential of gastric cancer through its proliferative function. (C) 2014 S. Karger AG, Basel	[Zaitsu, Yoko; Oki, Eiji; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Saeki, Hiroshi; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Hirahashi, Minako; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan	Oki, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Higashi Ku, Fukuoka 8128582, Japan.	okieiji@surg2.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We acknowledge Y. Kubota and T. Shishino for their expert technical assistance. We thank Academia Japan for editing the English language in this paper.	Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Di Cristofano A, 1998, NAT GENET, V19, P348; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Kobayashi I, 2006, PATHOBIOLOGY, V73, P8, DOI 10.1159/000093087; Kang YH, 2002, LAB INVEST, V82, P285; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Yang L, 2003, WORLD J GASTROENTERO, V9, P35; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Smith JS, 2001, J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Neve RM, 2001, ANN ONCOL, V12, P9, DOI 10.1023/A:1011199404516; Waterman H, 1999, EMBO J, V18, P3348, DOI 10.1093/emboj/18.12.3348; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Maehara Y, 2001, MUTAT RES-DNA REPAIR, V461, P249, DOI 10.1016/S0921-8777(00)00061-6; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Nishida Y, 2014, GASTRIC CANC; Oda S, 1997, NUCLEIC ACIDS RES, V25, P3415, DOI 10.1093/nar/25.17.3415; Oki E, 2006, J GASTROEN HEPATOL, V21, P814, DOI 10.1111/j.1440-1746.2005.04028.x; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Shen-Li Hong, 2010, Cancer Biol Ther, V10, P1194, DOI 10.4161/cbt.10.11.13814; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137	35	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0030-2414	1423-0232		ONCOLOGY-BASEL	Oncology		2015	88	3					189	194		10.1159/000368984		6	Oncology	Oncology	AW2LB	WOS:000346117900008		
J	Kitsuwan, N; Leelasetakul, M; Oki, E				Kitsuwan, Nattapong; Leelasetakul, Maesaporn; Oki, Eiji			Median-pump wavelength assignment scheme for optical networks with parametric wavelength conversion	OPTICAL SWITCHING AND NETWORKING			English	Article						Optical packet switching; Wavelength assignment; Wavelength conversion	CONVERTERS; SWITCH	This paper proposes a wavelength assignment scheme for optical networks with parametric wavelength conversion to minimize the number of wavelength converters when the number of wavelengths is given. Wavelength conversion is needed to reduce the number of wavelengths required in the network, since the number of wavelengths is limited. A parametric wavelength converter (PWC) can be used to reduce the number of wavelength converters because of its multiple wavelengths conversion function. PWC uses the pump wavelength to define original and converted wavelengths. The setting of the pump wavelength affects the converted wavelengths. Thus, the number of transmission wavelengths depends on the position of the pump wavelength. The proposed scheme is a heuristic scheme that considers the position of pump wavelength. An output wavelength that sets the pump wavelength near to the middle of the transmission wavelength band is selected. The proposed scheme designs each PWC to maximize the number of wavelength conversions supported. Numerical results with our examined networks indicate up to 37% reduction in the total number of converters required, compared to a scheme that the position of pump wavelength is not considered. Moreover, the reduction is 42% reduction compared to an optical network with single channel wavelength converters. (C) 2014 Elsevier B.V. All rights reserved.	[Kitsuwan, Nattapong; Leelasetakul, Maesaporn; Oki, Eiji] Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan	Kitsuwan, N (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.						Kitsuwan N, 2011, J LIGHTWAVE TECHNOL, V29, P1659, DOI 10.1109/JLT.2011.2142175; Kitsuwan N, 2010, J OPT COMMUN NETW, V2, P558, DOI 10.1364/JOCN.2.000558; Antoniades N, 1999, J LIGHTWAVE TECHNOL, V17, P1113, DOI 10.1109/50.774242; Eramo V, 2000, J LIGHTWAVE TECHNOL, V18, P1818, DOI 10.1109/50.908743; Eshoul A.E., 2004, P CAN C EL COMP ENG, V2, P965; He J, 2011, J OPT COMMUN NETW, V3, P411, DOI 10.1364/JOCN.3.000411; He J., 2009, P INFOCOM 2009 APR; Huhnkuk L., 2007, P ICTON 07 JUL; NAGATSU N, 1995, IEICE T COMMUN, VE78B, P597; Nagatsu N, 1996, IEEE J SEL AREA COMM, V14, P893, DOI 10.1109/49.510912; Nunna S., 2012, IEICE COMMUN EXPRESS, V1, P66; Okonkwo C., 2008, IEEE COMMUN LETT, V12; Orlowski S., 2007, P INOC 2007 APR; Shimizu S., 2006, P ICC 2006 JUN; Simmons J.M., 2002, P OFC 02 MARCH; Sun X., 2003, P CONTEL 2003 JUN	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1573-4277	1872-9770		OPT SWITCH NETW	Opt. Switch. Netw.	JAN	2015	15						10	17		10.1016/j.osn.2014.05.009		8	Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AW3UR	WOS:000346212000002		
J	Pavarangkoon, P; Kitsuwan, N; Oki, E				Pavarangkoon, Praphan; Kitsuwan, Nattapong; Oki, Eiji			A routing and wavelength assignment scheme in multi-carrier-distributed optical mesh networks with wavelength reuse	OPTICAL SWITCHING AND NETWORKING			English	Article						Wavelength division multiplexing; Multi-carrier light source; Optical carrier regeneration; Routing; Wavelength assignment	LIGHT-SOURCE	This paper proposes a routing and wavelength assignment (RWA) scheme that minimizes the number of required wavelengths for wavelength-reusable multi-carrier-distributed (WRMD) mesh networks. These networks have two unique features. First, only one light source, called the multi-carrier light source (MCLS), is required, which eases the difficulty of controlling many light source devices. Second, optical carriers are reused to improve the efficiency of wavelength usage. Since there are differences between the WRMD network and the conventional network, an efficient RWA scheme for the WRMD network is needed for wavelength-resource-efficient lightpath establishment. To realize efficient wavelength usage, we first formulate the RWA problem as an integer linear programming (ILP) problem of obtaining the minimum number of required wavelengths to satisfy the given requests. For large-scale networks, the ILP approach is not practical solution times. A heuristic RWA scheme is introduced in this paper to solve the RWA problem. Simulation results show that the proposed heuristic scheme with two carrier regenerations for the WRMD network approaches the near-optimum number of wavelengths. In addition, the optimum placement of the MCLS node is shown to reduce the number of required wavelengths for lightpath establishment, and achieve the optimum number of wavelengths. (C) 2014 Elsevier B.V. All rights reserved.	[Pavarangkoon, Praphan; Kitsuwan, Nattapong; Oki, Eiji] Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan	Pavarangkoon, P (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	praphan@uec.ac.jp; kitsuwan@uec.ac.jp; eiji.oki@uec.ac.jp					Miyagawa Y, 2006, ELECTRON LETT, V42, P655, DOI 10.1049/el:20061072; Lin RP, 2011, J LIGHTWAVE TECHNOL, V29, P2337, DOI 10.1109/JLT.2011.2159482; Fujiwara M, 2003, J LIGHTWAVE TECHNOL, V21, P2705, DOI 10.1109/JLT.2003.819147; Sharma M, 1997, J LIGHTWAVE TECHNOL, V15, P917, DOI 10.1109/50.588660; Cai YP, 2009, J LIGHTWAVE TECHNOL, V27, P4897, DOI 10.1109/JLT.2009.2029539; Yamamoto T, 2009, J LIGHTWAVE TECHNOL, V27, P4297, DOI 10.1109/JLT.2009.2023368; Matsuura M, 2010, IEEE PHOTONIC TECH L, V22, P808, DOI 10.1109/LPT.2010.2046154; Cavendish D., 2004, IEEE GLOBECOM, V2, P1016, DOI 10.1109/GLOCOM.2004.1378112; Keri M., 2011, IEEE OSA OPT COMMUN, V3, P281; Keri M., 2014, IET NETW; Matsuura M., 2010, INT S WEAR COMP ISWC, P1, DOI 10.1109/ISWC.2010.5665867; Matsuura M., 2013, IEEE ICC, P3889; Oki E., 2012, LINEAR PROGRAMMING A; Sitorus B., 2012, IEICE COMMUN EXPRESS, V1, P125, DOI [10.1587/comex.1.125, DOI 10.1587/COMEX.1.125]	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1573-4277	1872-9770		OPT SWITCH NETW	Opt. Switch. Netw.	JAN	2015	15						97	110		10.1016/j.osn.2014.07.001		14	Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AW3UR	WOS:000346212000010		
J	Hossen, M; Hanawa, M				Hossen, Monir; Hanawa, Masanori			Multi-OLT and multi-wavelength PON-based open access network for improving the throughput and quality of services	OPTICAL SWITCHING AND NETWORKING			English	Article						Open access network; PON; FTTH; Multi-OLT PON; Hybrid networks	BANDWIDTH ALLOCATION ALGORITHM; WIRELESS SENSOR NETWORKS; LONG-REACH PONS; DYNAMIC BANDWIDTH; EPON; SCHEME; IPACT	Passive optical network (PON) provides enough bandwidth for combining multiple service providers' in addition to the fiber to the home (FTTH) network. Multiple optical line terminals (multi-OLT) PON-based hybrid network is an efficient access network that provides an effective solution for reducing the computational complexity of data packet processing of multiple service providers having different packet lengths and data rates. However, in the multi-OLT PON-based hybrid networks, data transmission in the single upstream channel requires a complicated dynamic bandwidth allocation (DBA) algorithm for improving the bandwidth sharing efficiency among the multiple service providers. In this paper, we propose a new network architecture for a PON-based open access network (OAN) where every optical network unit (ONU) of the PON will be shared by all the service providers and in the central office multiple OLTs will be connected to handle the data packets of multiple service providers. In the upstream direction, we propose to use multiple wavelengths for modulating the data packets of multiple service providers and to avoid the requirement of a complicated DBA algorithm. The simulation results show that the multi-OLT and multi-wavelength PON-based OAN (MM-OAN) provides higher bandwidth utilization, higher upstream efficiency and higher throughput with a lower overhead to data ratio and jitter than the single-OLT and single wavelength PON-based OAN (SS-OAN). The overall throughput of the proposed scheme has been increased more than by a factor equal to the number of wavelengths employed than that of the SS-OAN. (C) 2014 Elsevier B.V. All rights reserved.	[Hossen, Monir; Hanawa, Masanori] Univ Yamanashi, Kofu, Yamanashi, Japan	Hanawa, M (reprint author), Univ Yamanashi, Kofu, Yamanashi, Japan.	hanawa@ieee.org					McGarry MP, 2008, IEEE COMMUN SURV TUT, V10, P46, DOI 10.1109/COMST.2008.4625804; Helmy A, 2012, J OPT COMMUN NETW, V4, P210, DOI 10.1364/JOCN.4.000210; Aurzada F, 2008, J OPT NETW, V7, P25, DOI 10.1364/JON.7.000025; Rajendran V, 2006, WIREL NETW, V12, P63, DOI 10.1007/s11276-006-6151-z; Kazovsky LG, 2007, J LIGHTWAVE TECHNOL, V25, P3428, DOI 10.1109/JLT.2007.907748; Kramer G, 2002, IEEE COMMUN MAG, V40, P74, DOI 10.1109/35.983911; Kanonakis K, 2010, IEEE J SEL AREA COMM, V28, P838, DOI 10.1109/JSAC.2010.100809; Buttaboni A, 2013, J LIGHTWAVE TECHNOL, V31, P1149, DOI 10.1109/JLT.2013.2242045; Hwang IS, 2008, COMPUT COMMUN, V31, P1814, DOI 10.1016/j.comcom.2007.11.021; Mercian A, 2013, J LIGHTWAVE TECHNOL, V31, P2018, DOI 10.1109/JLT.2013.2262766; Batagelj B., 2012, P 3 INT C ACC NETW A, P62; Effenberger FJ, 2010, PROC SPIE, V7621, DOI 10.1117/12.847108; Forzati M., 2010, P ICTON 2010 JUL, P1; Hossen M., 2012, P 18 AS PAC C COMM A, P372; Hossen M, 2013, ARAB J SCI ENG, V38, P2115, DOI 10.1007/s13369-013-0571-8; Hossen M, 2013, J OPT COMMUN NETW, V5, P802, DOI 10.1364/JOCN.5.000802; Lannoo B, 2007, J OPT NETW, V6, P677, DOI 10.1364/JON.6.000677; Lannoo B, 2007, 2007 FOURTH INTERNATIONAL CONFERENCE ON BROADBAND COMMUNICATIONS, NETWORKS & SYSTEMS, VOLS 1 AND 2, P486, DOI 10.1109/BROADNETS.2007.4550473; Matson M., 2006, STUDY LOCAL OPEN ACC; PMC-Sierra, PAS6300 PROD BRIEF; Rawshan F., 2013, P 2013 INT C EL INF, P1; Rawshan F., 2012, P IEEE INT C UB FUT, P276; McGarry MP, 2012, J LIGHTWAVE TECHNOL, V30, P2271, DOI 10.1109/JLT.2012.2196023; Uzawa H., 2011, P GLOB TEL C GLOBECO, P1; Willinger W., 1996, ROYAL STAT LECT NOTE, V4, P339	25	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1573-4277	1872-9770		OPT SWITCH NETW	Opt. Switch. Netw.	JAN	2015	15						148	159		10.1016/j.osn.2014.09.001		12	Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AW3UR	WOS:000346212000014		
J	Moriya, Y; Uzawa, N; Morita, T; Mogushi, K; Miyaguchi, K; Takahashi, KI; Michikawa, C; Sumino, J; Tanaka, H; Harada, K				Moriya, Yujiro; Uzawa, Narikazu; Morita, Takuma; Mogushi, Kaoru; Miyaguchi, Ken; Takahashi, Ken-Ichiro; Michikawa, Chieko; Sumino, Jun; Tanaka, Hiroshi; Harada, Kiyoshi			The high-temperature requirement factor A3 (HtrA3) is associated with acquisition of the invasive phenotype in oral squamous cell carcinoma cells	ORAL ONCOLOGY			English	Article						Oral; Squamous cell carcinoma; Microarray; Laser microdissection; Carcinogenesis; HtrA3	HUMAN SERINE-PROTEASE; NECK-CANCER; TROPHOBLAST INVASION; ENDOMETRIAL CANCER; PROGRESSION MODEL; EXPRESSION; HEAD; PROTEINS; PLACENTATION; TARGETS	Objectives: Previous studies have identified several genes involved in the carcinogenesis of oral cancer; however, the detailed mechanisms underlying this process have not been elucidated. Previously, we established a database of the transcriptional progression profile of oral carcinogenesis and identified 15 candidate genes with continuously increasing or decreasing expression (Sumino et al., 2013). Materials and Methods: In the present study, using this database, we attempted to identify genes that may specifically contribute to progression from oral dysplastic lesions to invasive tumours. Results: We identified 4 candidate genes. Using a literature survey, we narrowed down the candidates and focused on the high-temperature requirement factor A3 (HtrA3). Quantitative real-time reverse transcription polymerase chain reaction and immunohistochemical analysis confirmed that HtrA3 expression significantly increased during this process. In addition, high HtrA3 expression was significantly associated with decreased disease-free survival (P = 0.045) and overall survival (P = 0.003). Multivariate Cox proportional hazards analysis found that high HtrA3 expression significantly correlated with overall survival (P = 0.018). Conclusion: The findings of this study demonstrated that the HtrA3 is likely to be associated with the acquisition of the invasive phenotype in oral squamous cell carcinoma cells and may be a potential prognostic marker for oral cancer. (C) 2014 Elsevier Ltd. All rights reserved.	[Moriya, Yujiro; Uzawa, Narikazu; Morita, Takuma; Takahashi, Ken-Ichiro; Michikawa, Chieko; Sumino, Jun; Harada, Kiyoshi] Tokyo Med & Dent Univ, Div Maxillofacial & Neck Reconstruct, Tokyo 1138549, Japan; [Mogushi, Kaoru; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Dept Computat Biol, Tokyo 1138549, Japan; [Miyaguchi, Ken] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Tokyo 1138549, Japan	Uzawa, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Div Maxillofacial & Neck Reconstruct, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	1022mfs@tmd.ac.jp; n-uzawa.mfs@tmd.ac.jp; morimfs@tmd.ac.jp; mogushi@bioinfo.tmd.ac.jp; miyaguchi@bioinfo.tmd.ac.jp; ken514.mfs@tmd.ac.jp; c-michikawa.mfs@tmd.ac.jp; jun_sumino@ybb.ne.jp; tanaka@bioinfo.tmd.ac.jp; haradak.mfs@tmd.ac.jp			Scientific Research from the Ministry of Education, Science, Sport and Culture, Japan [24659888]	We express our appreciation to hospital staffs of diagnostic oral pathology for their technical assistance and advice. This study was supported by Scientific Research from the Ministry of Education, Science, Sport and Culture, Japan (No. 24659888).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; Mendez E, 2002, CANCER, V95, P1482, DOI 10.1002/cncr.10875; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Sumino J, 2013, INT J CANCER, V132, P540, DOI 10.1002/ijc.27702; Zurawa-Janicka D, 2012, ONCOL REP, V28, P1838, DOI 10.3892/or.2012.1988; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ha PK, 2003, CLIN CANCER RES, V9, P3058; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Califano J, 1996, CANCER RES, V56, P2488; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Singh H, 2013, J CANCER, V4, P152, DOI 10.7150/jca.5702; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; ELNAGGAR AK, 1995, CANCER RES, V55, P2656; Irie Tarou, 2004, Medical Electron Microscopy, V37, P89; Mao Li, 2012, Chin J Dent Res, V15, P83; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Nie GY, 2006, BIOL REPROD, V74, P366, DOI 10.1095/biolreprod.105.047324; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Stafford ND, 2008, SCOTTBROWNS OTORHINO, P2351; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375	1879-0593		ORAL ONCOL	Oral Oncol.	JAN	2015	51	1					84	89		10.1016/j.oraloncology.2014.10.001		6	Oncology; Dentistry, Oral Surgery & Medicine	Oncology; Dentistry, Oral Surgery & Medicine	AW3UG	WOS:000346210900016		
J	Shimizu, M; Ogawa, D; Okamura, K; Kawazu, T; Chikui, T; Yoshiura, K				Shimizu, Mayumi; Ogawa, Dai; Okamura, Kazutoshi; Kawazu, Toshiyuki; Chikui, Toru; Yoshiura, Kazunori			Dentigerous cysts with calcification mimicking odontogenic tumors: differential diagnosis by CT	ORAL RADIOLOGY			English	Article						Dentigerous cyst; Odontogenic tumors; Calcification; Diagnosis; CT	FEATURES; FIBROMA	This study aimed at clarifying whether we can differentiate dentigerous cysts with calcified substances from other odontogenic tumors that include calcification and the crown of an unerupted tooth by CT findings. We retrospectively selected histopathologically confirmed cases that included calcified substances and the crown of an unerupted tooth inside. There were 22 cases with eight pathological categories. Besides seven odontogenic tumors, we included dentigerous cysts, which were usually recognized without calcification within the lesions. We divided the cases into two groups: 14 cases of odontogenic tumors and 8 cases of dentigerous cysts. Cases were analyzed for various CT findings such as continuity with the alveolar crest, bone sclerosis around the lesion, and sizes and shapes of high CT value substances, as well as demographic factors. Comparisons between the groups for each analytical factor were performed. Dentigerous cysts with dystrophic calcification showed unique CT findings such as bone sclerosis around the lesion, continuity with the alveolar crest, and small scattered calcified substances near the crown of an unerupted tooth, compared with typical dentigerous cysts and other odontogenic tumors. On the other hand, odontogenic tumors showed various patterns in the location and distribution of high CT value substances, and we could only differentiate odontoma using its very high CT values. Although the patterns of calcification were not the main characteristic findings, it may be possible to differentiate dentigerous cysts with dystrophic calcification from odontogenic tumors by their other characteristic CT findings, and unnecessary extensive surgery can also be avoided.	[Shimizu, Mayumi; Okamura, Kazutoshi; Kawazu, Toshiyuki; Chikui, Toru; Yoshiura, Kazunori] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Ogawa, Dai] Osaka Univ, Dept Periodontol, Fac Dent Sci, Suita, Osaka 5650871, Japan	Shimizu, M (reprint author), Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	shimizu@rad.dent.kyushu-u.ac.jp					Bravo M, 2005, INT J PEDIATR OTORHI, V69, P1685, DOI 10.1016/j.ijporl.2005.03.055; Marton IJ, 2000, ORAL MICROBIOL IMMUN, V15, P139, DOI 10.1034/j.1399-302x.2000.150301.x; Philipsen HP, 2000, ORAL ONCOL, V36, P17, DOI 10.1016/S1368-8375(99)00061-5; Asaumi J, 2004, EUR J RADIOL, V51, P252, DOI 10.1016/j.ejrad.2003.09.009; Becker T, 2012, DENTOMAXILLOFAC RAD, V41, P533, DOI 10.1259/dmfr/19253953; Bharatha A, 2010, CAN ASSOC RADIOL J, V61, P133, DOI 10.1016/j.carj.2010.01.001; BUCHNER A, 1991, J ORAL MAXIL SURG, V49, P330, DOI 10.1016/0278-2391(91)90365-S; Cho YA, 2011, J ORAL PATHOL MED, V40, P243, DOI 10.1111/j.1600-0714.2010.00968.x; DARE A, 1994, ORAL SURG ORAL MED O, V77, P662, DOI 10.1016/0030-4220(94)90331-X; Gopalakrishnan R, 2006, ORAL SURG ORAL MED O, V102, P773, DOI 10.1016/j.tripleo.2005.09.029; Iida S, 2006, ORAL SURG ORAL MED O, V101, P356, DOI 10.1016/j.tripleo.2005.08.037; KAFFE I, 1994, ORAL SURG ORAL MED O, V78, P811, DOI 10.1016/0030-4220(94)90101-5; Kaushal Seema, 2012, J Oral Maxillofac Pathol, V16, P110, DOI 10.4103/0973-029X.92985; Kramer LR, 1992, INT HISTOLOGICAL CLA, P34; Li TJ, 2003, AM J SURG PATHOL, V27, P372, DOI 10.1097/00000478-200303000-00011; Lin HP, 2013, J ORAL PATHOL MED, V42, P462, DOI 10.1111/jop.12042; Lin HP, 2011, J FORMOS MED ASSOC, V110, P27, DOI 10.1016/S0929-6646(11)60005-3; Sumi M, 1997, AM J ROENTGENOL, V169, P599; Triantafillidou K, 2012, OR SURG OR MED OR PA, V114, P193, DOI 10.1016/j.tripleo.2011.07.033; Uchiyama Y, 2012, BRIT J RADIOL, V85, P548, DOI 10.1259/bjr/19841479; Venkateswarlu M, 2012, BRIT J RADIOL, V85, pE14, DOI 10.1259/bjr/65485502; Yoshiura K, 1997, ORAL SURG ORAL MED O, V83, P712, DOI 10.1016/S1079-2104(97)90325-5; Yoshiura K, 1998, DENTOMAXILLOFAC RAD, V27, P12, DOI 10.1038/sj.dmfr.4600305	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	JAN	2015	31	1					14	22		10.1007/s11282-014-0173-5		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW3FW	WOS:000346172700002		
J	Otonari-Yamamoto, M; Sano, T; Okano, T; Wakoh, M				Otonari-Yamamoto, Mika; Sano, Tsukasa; Okano, Tomohiro; Wakoh, Mamoru			Association between osseous changes of the condyle and temporomandibular joint (TMJ) fluid in osteoarthritis	ORAL RADIOLOGY			English	Article						Temporomandibular joint; MRI; Joint fluid; Osteoarthritis; Pain	IMAGES REFLECT SYNOVITIS; INTERNAL DERANGEMENT; DISK DISPLACEMENT; PROINFLAMMATORY CYTOKINES; MR EVIDENCE; ASYMPTOMATIC VOLUNTEERS; SYMPTOMATIC PATIENTS; MANDIBULAR CONDYLE; EFFUSION; PAIN	Our previous study showed that the temporomandibular joint (TMJ) with disk displacement without reduction had the largest amount of TMJ fluid and revealed a correlation between the amount of fluid and pain. However, the amount of TMJ fluid in joints with osteoarthritis was not the largest, despite representing the last stage of internal derangement. The reason could be the presence of different types of pathologic conditions in osteoarthritis. Each type of osseous change could be associated with a characteristic pathosis that influences the amount of fluid. The purpose of this study was to analyze the correlation between osseous changes and TMJ fluid in joints with osteoarthritis. The study evaluated 57 joints in 39 patients diagnosed with osteoarthritis on magnetic resonance images. The grading system of Larheim et al. was used to categorize the amounts of TMJ fluid. Osseous changes were divided into four groups on proton density-weighted images: erosion, marginal proliferation, deformity, and erosion and marginal proliferation. There were significant differences in the amounts of fluid among the four osseous change groups (P = 0.0001). The erosion group showed the largest amount of fluid among the groups (P < 0.01). There were significant differences in the amounts of fluid between painful and non-painful joints in the erosion, marginal proliferation, and deformity groups (P < 0.001). The types of osseous changes appeared to be associated with the TMJ fluid amounts in joints with osteoarthritis. There was an association between TMJ fluid and pain in some osseous groups.	[Otonari-Yamamoto, Mika; Sano, Tsukasa; Wakoh, Mamoru] Tokyo Dent Coll, Dept Oral & Maxillofacial Radiol, Mihama Ku, Chiba 2618502, Japan; [Sano, Tsukasa; Okano, Tomohiro] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Radiol, Tokyo 142, Japan	Otonari-Yamamoto, M (reprint author), Tokyo Dent Coll, Dept Oral & Maxillofacial Radiol, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	myamamoto@tdc.ac.jp					Adame CG, 1998, J ORAL MAXIL SURG, V56, P314, DOI 10.1016/S0278-2391(98)90106-9; Kaneyama K, 2002, BRIT J ORAL MAX SURG, V40, P418, DOI 10.1016/S0266-4356(02)00215-2; Takahashi T, 1998, ORAL SURG ORAL MED O, V85, P135, DOI 10.1016/S1079-2104(98)90415-2; Larheim TA, 2001, RADIOLOGY, V218, P428; Kaneyama K, 2010, J ORAL MAXIL SURG, V68, P1088, DOI 10.1016/j.joms.2009.10.027; Segami N, 2002, ORAL SURG ORAL MED O, V94, P515, DOI 10.1067/moe.2002.126697; SCHELLHAS KP, 1989, AM J ROENTGENOL, V153, P93; TASAKI MM, 1993, RADIOLOGY, V186, P723; Larheim TA, 2001, INT J ORAL MAX SURG, V30, P113, DOI 10.1054/ijom.2000.0018; AREND WP, 1990, ARTHRITIS RHEUM, V33, P305, DOI 10.1002/art.1780330302; Roh HS, 2012, J CRANIO MAXILL SURG, V40, P283, DOI 10.1016/j.jcms.2011.04.006; Segami N, 2001, ORAL SURG ORAL MED O, V92, P341, DOI 10.1067/moe.2001.117808; WESTESSON PL, 1984, ORAL SURG ORAL MED O, V57, P17, DOI 10.1016/0030-4220(84)90251-2; Emshoff R, 2003, J AM DENT ASSOC, V134, P705; DEBONT LGM, 1993, INT J ORAL MAX SURG, V22, P71, DOI 10.1016/S0901-5027(05)80805-7; DEBONT LGM, 1986, J ORAL MAXIL SURG, V44, P634; Takahashi T, 1999, J ORAL MAXIL SURG, V57, P1187, DOI 10.1016/S0278-2391(99)90483-4; de Oliveira JX, 2013, BRAZ ORAL RES, V27, P37, DOI 10.1590/S1806-83242012005000028; deBont LGM, 1997, ORAL SURG ORAL MED O, V83, P72, DOI 10.1016/S1079-2104(97)90094-9; Emshoff R, 2003, J ORAL MAXIL SURG, V61, P35, DOI 10.1053/joms.2003.50006; Farrar W B, 1971, N Y J Dent, V41, P348; Haley DP, 2001, J AM DENT ASSOC, V132, P476; Igarashi C, 2009, NIHON GAKUKANSETSU K, V21, P216; Iizuka T, 2001, CONCEPT DIFFERENTIAL, P1; Imoto K, 2011, ORAL SURG ORAL MED O, V112, P243, DOI 10.1016/j.tripleo.2011.03.004; Isberg A., 2001, OSTEOARTHROSIS OSTEO, P103; KATZBERG RW, 1983, RADIOLOGY, V146, P107; Katzberg RW, 1993, PATHOLOGY DIAGNOSIS, P25; Kubota E, 1997, J ORAL MAXIL SURG, V55, P20, DOI 10.1016/S0278-2391(97)90438-9; Larheim TA, 2001, INT J ORAL MAX SURG, V30, P104, DOI 10.1054/ijom.2000.0017; Manfredini D, 2003, ORAL SURG ORAL MED O, V96, P521, DOI 10.1016/S1097-2104(03)00475-X; Murakami K, 1996, BRIT J ORAL MAX SURG, V34, P220, DOI 10.1016/S0266-4356(96)90273-9; Petersson A, 1975, Dentomaxillofac Radiol, V4, P76, DOI 10.1259/dmfr.1975.0056; Rudisch A, 2001, ORAL SURG ORAL MED O, V92, P566, DOI 10.1067/moe.2001.116817; Sandler DM, 1998, J ORAL MAXILLOFAC SU, V56, P534; Sano T, 2001, J ORAL REHABIL, V28, P1; Segami N, 2003, ORAL SURG ORAL MED O, V95, P761, DOI 10.1067/moe.2003.243; SHAFER DM, 1994, J ORAL MAXIL SURG, V52, P786, DOI 10.1016/0278-2391(94)90217-8; TOLLER PA, 1973, BRIT DENT J, V134, P223, DOI 10.1038/sj.bdj.4802982; WESTESSON PL, 1992, AM J ROENTGENOL, V159, P559; Westesson P L, 1993, Adv Dent Res, V7, P137; Widmer C., 2004, J EVID BASED DENT PR, V4, P150, DOI 10.1016/j.jebdp.2004.03.010; Wilkes CH, 1989, ARCH OTOLARYNGOL, V115, P39; Yamamoto M, 2003, J COMPUT ASSIST TOMO, V27, P694, DOI 10.1097/00004728-200309000-00006; Yano K, 2004, CRANIO, V22, P64	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	JAN	2015	31	1					41	48		10.1007/s11282-014-0185-1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW3FW	WOS:000346172700006		
J	Amemiya, T; Yamada, H; Kawashima, S; Sawada, K; Ejima, K; Matsumoto, K; Arai, Y; Honda, K				Amemiya, Toshihiko; Yamada, Hisaya; Kawashima, Shoji; Sawada, Kunihiko; Ejima, Kenichiro; Matsumoto, Kunihito; Arai, Yoshinori; Honda, Kazuya			Reduction of moving artifacts caused by breathing in rats for in vivo micro-computed tomography	ORAL RADIOLOGY			English	Article						Micro-computed tomography; Motion artifact; In vivo; Bone imaging	TEMPOROMANDIBULAR-JOINT; CT; DIFFERENTIATION	This study developed software for the reduction of moving artifacts caused by breathing in rats by means of teeth tracking when CT images were taken using in vivo micro-computed tomography (micro-CT). Raw projection data from the CT of teeth in rats were chosen retrospectively, and then correlated with moving artifacts caused by breathing. An m-mode image was reconstructed from the projection data and used to calculate motion as a function of position. The projection data were corrected and the CT images were reconstructed using the corrected projection data. The reconstructed CT images were sharper than the original CT images. There was fog in the periodontal ligament space in the original images because of motion artifacts. The images were clearer after processing. The artifacts caused by breathing in in vivo micro-CT images of rat teeth were reduced using this software.	[Amemiya, Toshihiko; Yamada, Hisaya] Nihon Univ, Grad Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Kawashima, Shoji; Sawada, Kunihiko; Ejima, Kenichiro; Matsumoto, Kunihito; Honda, Kazuya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, Tokyo 1018310, Japan; [Arai, Yoshinori] Nihon Univ, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan	Arai, Y (reprint author), Nihon Univ, Sch Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	deto10003@g.nihon-u.ac.jp; mhg01033@nifty.com			JSPS KAKENHI Grant [22592199]	This work was supported by JSPS KAKENHI Grant Number 22592199.	Gunduz K, 2013, ORAL RADIOL, V29, P6, DOI 10.1007/s11282-012-0098-9; Koide M, 2013, ENDOCRINOLOGY, V154, P773, DOI 10.1210/en.2012-1928; Yamaguchi T, 2009, J BONE MINER RES, V24, P2056, DOI [10.1359/jbmr.090603, 10.1359/JBMR.090603]; Gonzales C, 2009, ANGLE ORTHOD, V79, P703, DOI 10.2319/071308-366.1; Honda K, 2001, ORAL SURG ORAL MED O, V91, P239, DOI 10.1067/moe.2001.111942; Min S, 2008, ORAL SURG ORAL MED O, V106, P892, DOI 10.1016/j.tripleo.2008.04.012; Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Arai Y, 2007, DENT JPN, V43, P109; Arai Y, 2005, ORAL RADIOL, V21, P14, DOI 10.1007/s11282-005-0024-5; Araki M, 2006, ORAL RADIOL, V22, P27, DOI 10.1007/s11282-006-0044-9; BEPPU S, 1976, BRIT HEART J, V38, P911; Honda K, 2004, DENTOMAXILLOFAC RAD, V33, P391, DOI 10.1259/dmfr/54316470; Ito K, 2001, CLIN ORAL IMPLAN RES, V12, P539, DOI 10.1034/j.1600-0501.2001.120516.x; Kochi G, 2009, ORAL SURG ORAL MED O, V107, P42; Ninomiya T, 2011, EUR J PHARMACOL, V650, P396, DOI 10.1016/j.ejphar.2010.10.021; Tanimoto H, 2009, ORAL RADIOL, V25, P149, DOI 10.1007/s11282-009-0019-8; Terakado M, 2000, ORAL SURG ORAL MED O, V89, P509, DOI 10.1016/S1079-2104(00)70133-8	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	JAN	2015	31	1					59	64		10.1007/s11282-014-0172-6		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW3FW	WOS:000346172700008		
J	Ikawa, T; Kaneko, H; Masuda, S; Ishitsubo, E; Tokiwa, H; Akai, S				Ikawa, Takashi; Kaneko, Hideki; Masuda, Shigeaki; Ishitsubo, Erika; Tokiwa, Hiroaki; Akai, Shuji			Trifluoromethanesulfonyloxy-group-directed regioselective (3+2) cycloadditions of benzynes for the synthesis of functionalized benzo-fused heterocycles	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							GENERATED NITRILE OXIDES; 1,3-DIPOLAR CYCLOADDITION; ARYNE CHEMISTRY; PROMOTED CYCLOCONDENSATION; NUCLEOPHILIC ADDITIONS; CLICK CHEMISTRY; MILD CONDITIONS; FACILE; BENZISOXAZOLES; DERIVATIVES	Highly regioselective (3 + 2) cycloadditions of (trifluoromethanesulfonyloxy)benzynes [(triflyloxy)-benzynes] with 1,3-dipoles followed by cross-coupling reactions provided multisubstituted benzo-fused heterocycles. The triflyloxy group at the 3-position of benzynes, and even that at the remote 4-position, greatly affected the regiocontrol of the cycloaddition. These groups also served to install other substituents at their ipso-positions.	[Ikawa, Takashi; Kaneko, Hideki; Masuda, Shigeaki; Akai, Shuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Ishitsubo, Erika; Tokiwa, Hiroaki] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan	Ikawa, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ikawa@phys.osaka-u.ac.jp; akai@phs.osaka-u.ac.jp			JSPS KAKENHI [23790017, 25460018]; Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT; Hoansha foundation	This work was supported by the JSPS KAKENHI (grant numbers 23790017 and 25460018), the Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT and the Hoansha foundation.	Yoshida H, 2006, J AM CHEM SOC, V128, P11040, DOI 10.1021/ja064157o; Liu ZJ, 2008, J ORG CHEM, V73, P219, DOI 10.1021/jo7O2O62n; Dubey A, 2011, BIOORG MED CHEM LETT, V21, P569, DOI 10.1016/j.bmcl.2010.10.057; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; Bronner SM, 2012, J AM CHEM SOC, V134, P13966, DOI 10.1021/ja306723r; Dubrovskiy AV, 2013, ORG BIOMOL CHEM, V11, P191, DOI 10.1039/c2ob26673c; Takagi A, 2013, TETRAHEDRON, V69, P4338, DOI 10.1016/j.tet.2013.03.016; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Ikawa T, 2013, J ORG CHEM, V78, P2965, DOI 10.1021/jo302802b; Hoffmann RW, 2013, ANGEW CHEM INT EDIT, V52, P2655, DOI 10.1002/anie.201209041; Egbe DAM, 2003, MACROMOLECULES, V36, P9303, DOI 10.1021/ma030339g; Lu C, 2012, J ORG CHEM, V77, P2279, DOI 10.1021/jo2025064; Zhang FZ, 2009, ORG LETT, V11, P1587, DOI 10.1021/ol9002338; Liu ZJ, 2006, J ORG CHEM, V71, P3198, DOI 10.1021/jo0602221; Im GYJ, 2010, J AM CHEM SOC, V132, P17933, DOI 10.1021/ja1086485; Shi F, 2008, ORG LETT, V10, P2409, DOI 10.1021/ol800675u; Ramgren SD, 2011, ANGEW CHEM INT EDIT, V50, P2171, DOI 10.1002/anie.201007325; Takagi A, 2013, ORG BIOMOL CHEM, V11, P8145, DOI [10.1039/c3ob41787e, 10.1039/c3Ob41787e]; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Sanz R, 2008, ORG PREP PROCED INT, V40, P215; Fang YS, 2011, J ORG CHEM, V76, P8840, DOI 10.1021/jo201605v; Yoshida H, 2010, B CHEM SOC JPN, V83, P199, DOI 10.1246/bcsj.20090245; Dai MJ, 2008, TETRAHEDRON LETT, V49, P6613, DOI 10.1016/j.tetlet.2008.09.019; Worlikar SA, 2011, CURR ORG CHEM, V15, P3214; Zeni G, 2006, CHEM REV, V106, P4644, DOI 10.1021/cr0683966; Goetz AE, 2014, J ORG CHEM, V79, P846, DOI 10.1021/jo402723e; Rezaei Z, 2009, EUR J MED CHEM, V44, P3064, DOI 10.1016/j.ejmech.2008.07.012; Mesganaw T, 2012, ORG LETT, V14, P2918, DOI 10.1021/ol301275u; Raminelli C, 2006, J ORG CHEM, V71, P4689, DOI 10.1021/jo060523a; Kirkham JD, 2010, CHEM COMMUN, V46, P5154, DOI 10.1039/c0cc01345e; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; Jin T, 2007, ANGEW CHEM INT EDIT, V46, P3323, DOI 10.1002/anie.200700101; Yoshioka E, 2012, TETRAHEDRON, V68, P179, DOI 10.1016/j.tet.2011.10.072; Cheong PHY, 2010, J AM CHEM SOC, V132, P1267, DOI 10.1021/ja9098643; FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Goetz AE, 2013, NAT CHEM, V5, P54, DOI [10.1038/nchem.1504, 10.1038/NCHEM.1504]; Macklin TK, 2005, ORG LETT, V7, P2519, DOI 10.1021/ol050393c; Wu CR, 2013, ASIAN J ORG CHEM, V2, P116, DOI 10.1002/ajoc.201200142; Yoshida H, 2007, ORG LETT, V9, P3367, DOI 10.1021/ol071347a; Campbell-Verduyn L, 2008, ORG BIOMOL CHEM, V6, P3461, DOI 10.1039/b812403e; Baraznenok I. L., 2000, TETRAHEDRON, V56, P3077; Bode JW, 2003, ORG LETT, V5, P391, DOI 10.1021/ol027283f; Bode JW, 2003, TETRAHEDRON LETT, V44, P3555, DOI 10.1016/S0040-4039(03)00614-2; COOPER GD, 1961, J ORG CHEM, V26, P4171, DOI 10.1021/jo01068a646; Crossley JA, 2010, TETRAHEDRON LETT, V51, P2271; Dubrovskiy AV, 2010, ORG LETT, V12, P1180, DOI 10.1021/ol902921s; Dubrovskiy AV, 2013, ACS COMB SCI, V15, P193, DOI 10.1021/co300159g; Dyke AM, 2006, SYNTHESIS-STUTTGART, P4093, DOI 10.1055/s-2006-950370; Eicher T., 2003, CHEM HETEROCYCLES; Frisch M.J., 2009, GAUSSIAN; Hayashi S, 2009, J MED CHEM, V52, P610, DOI 10.1021/jm7012979; HIMESHIMA Y, 1983, CHEM LETT, P1211, DOI 10.1246/cl.1983.1211; Holden C, 2014, ANGEW CHEM INT EDIT, V53, P5746, DOI 10.1002/anie.201402405; Ikawa T, 2012, J SYN ORG CHEM JPN, V70, P1123; Katrizky A. R., 2000, HDB HETEROCYCLIC CHE; KIEHLMANN E, 1989, CAN J CHEM, V67, P335, DOI 10.1139/v89-055; Li P, 2011, ORG LETT, V13, P3340, DOI 10.1021/ol201086g; Luning U, 2002, EUR J ORG CHEM, P3294; MATSUMOTO T, 1993, SYNLETT, P843; Matsuura T, 2003, SYNLETT, P1746, DOI 10.1055/s-2003-41436; Patel D, 2011, CHEMMEDCHEM, V6, P1011, DOI 10.1002/cmdc.201100077; Reed E., 1985, J CHEM PHYS, V83, P735, DOI DOI 10.1063/1.449486; RITTER K, 1993, SYNTHESIS-STUTTGART, P735; Spiteri C, 2010, ORG LETT, V12, P3368, DOI 10.1021/ol101150t; Spiteri C, 2010, ORG BIOMOL CHEM, V8, P2537, DOI 10.1039/b927235f; Trost B. M., 1992, COMPREHENSIVE ORGANI, V4, P483; Viault G, 2011, EUR J ORG CHEM, P1233, DOI 10.1002/ejoc.201001627; Yoshida H, 2001, CHEM COMMUN, P1880, DOI 10.1039/b103745p; Yoshida H., 2013, ANGEW CHEM INT EDIT, V32, P8629	70	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	2					520	526		10.1039/c4ob01627k		7	Chemistry, Organic	Chemistry	AW1KO	WOS:000346048600024		
J	Asahi, M; Kobayashi, M; Matsui, H; Nakahira, K				Asahi, Miho; Kobayashi, Masaki; Matsui, Hiroto; Nakahira, Kunimitsu			Differential mechanisms of action of the novel gamma-aminobutyric acid receptor antagonist ectoparasiticides fluralaner (A1443) and fipronil	PEST MANAGEMENT SCIENCE			English	Article						fluralaner; A1443; GABA; ligand-gated ion channel; parasiticide; receptor	GATED CHLORIDE CHANNEL; GABA RECEPTORS; RESISTANCE; INSECTICIDE; ACARICIDE; MUTATION; GENE	BACKGROUND: Fluralaner (A1443) is an isoxazoline ectoparasiticide that is a novel antagonist of gamma-aminobutyric acid (GABA) receptors (GABARs), with a potency comparable to that of fipronil, a phenylpyrazole ectoparasiticide. To clarify the biological effectiveness of fluralaner against fipronil-resistant pests, differences in the actions of fluralaner and fipronil on GABARs that possess resistance to dieldrin (rdl)-type mutations were evaluated. RESULTS: Fipronil had neither pest control nor GABAR-antagonistic activities against two-spotted spider mites (Tetranychus urticae) that had two different rdl-type amino acids (A(301) -> H and T-350 -> A: Drosophila melanogaster GABAR numbering) and against small brown planthoppers (Laodelphax striatellus) that had a novel rdl-type (A(283) -> N) mutation in GABARs. In contrast, fluralaner showed not only high pest control activities against these pests, but also excellent antagonistic activities for these rdl-type GABARs. CONCLUSION: The findings indicate that rdl-type fipronil-resistant pests do not show cross-resistance to fluralaner owing to the differential actions of fluralaner and fipronil on the GABAR. (C) 2014 Society of Chemical Industry	[Asahi, Miho; Kobayashi, Masaki; Matsui, Hiroto; Nakahira, Kunimitsu] Nissan Chem Ind Co Ltd, Biol Res Labs, Shiraoka Saitama 3490294, Japan	Nakahira, K (reprint author), Nissan Chem Ind Co Ltd, Biol Res Labs, Shiraoka Saitama 3490294, Japan.	nakahira@nissanchem.co.jp					Garcia-Reynaga P, 2013, CHEM RES TOXICOL, V26, P514, DOI 10.1021/tx400055p; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Le Goff G, 2005, J NEUROCHEM, V92, P1295, DOI 10.1111/j.1747-4159.2004.02922.x; Zhao XL, 2003, J PHARMACOL EXP THER, V306, P914, DOI 10.1124/jpet.103.051839; Chen LG, 2006, P NATL ACAD SCI USA, V103, P5185, DOI 10.1073/pnas.0600370103; Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131; HOSIE AM, 1995, BRIT J PHARMACOL, V115, P909; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Nakao T, 2010, PESTIC BIOCHEM PHYS, V97, P262, DOI 10.1016/j.pestbp.2010.03.006; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Hiragaki S, 2012, NEUROTOXICOLOGY, V33, P307, DOI 10.1016/j.neuro.2012.01.016; Mita T, 2005, Isoxazoline-substituted benzamide compound and noxious organism control agent, Patent No. [WO 2005-085126, 2005085126]; Narahashi T, 2010, PESTIC BIOCHEM PHYS, V97, P149, DOI 10.1016/j.pestbp.2009.07.008; Overmeer WPJ, 1985, WORLD CROP PESTS S A, V1B, P183; Ozoe Y, 1998, ADV INSECT PHYSL, V44, P211; Wang YH, 2008, PEST MANAG SCI, V64, P1050, DOI 10.1002/ps.1606; Wolff Mark A., 1998, Invertebrate Neuroscience, V3, P305, DOI 10.1007/BF02577690; Zheng Y, 2003, INSECT BIOCHEM MOLEC, V33, P595, DOI 10.1016/S0965-1748(03)00038-9	19	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-498X	1526-4998		PEST MANAG SCI	Pest Manag. Sci.	JAN	2015	71	1					91	95		10.1002/ps.3768		5	Agronomy; Entomology	Agriculture; Entomology	AW1FA	WOS:000346034600012		
J	Tsuzuki, S; Shinoda, W; Matsugami, M; Umebayashi, Y; Ueno, K; Mandai, T; Seki, S; Dokko, K; Watanabe, M				Tsuzuki, Seiji; Shinoda, Wataru; Matsugami, Masaru; Umebayashi, Yasuhiro; Ueno, Kazuhide; Mandai, Toshihiko; Seki, Shiro; Dokko, Kaoru; Watanabe, Masayoshi			Structures of [Li(glyme)](+) complexes and their interactions with anions in equimolar mixtures of glymes and Li[TFSA]: analysis by molecular dynamics simulations	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							TEMPERATURE IONIC LIQUIDS; LITHIUM-SULFUR BATTERIES; SENSITIZED SOLAR-CELLS; ELECTROCHEMICAL PROPERTIES; PHYSICOCHEMICAL PROPERTIES; PROPYLENE CARBONATE; SALT COMPLEXES; ELECTROLYTE; EFFICIENCY; STABILITY	Molecular dynamics simulations of equimolar mixtures of glymes (triglyme and tetraglyme) and Li[TFSA] (lithium bis(trifluoromethylsulfonyl) amide) show that the glyme chain length affects the coordination geometries of Li+, which induces the changes in interactions between the [Li(glyme)](+) complex and [TFSA](-) anions and diffusion of ions in the equimolar mixtures.	[Tsuzuki, Seiji] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, RICS, Tsukuba, Ibaraki 3058568, Japan; [Shinoda, Wataru] Nagoya Univ, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Matsugami, Masaru] Kumamoto Natl Coll Technol, Koshi, Kumamoto 8611102, Japan; [Umebayashi, Yasuhiro] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Ueno, Kazuhide; Mandai, Toshihiko; Dokko, Kaoru; Watanabe, Masayoshi] Yokohama Natl Univ, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Seki, Shiro] CRIEPI, Komae, Tokyo 2018511, Japan	Tsuzuki, S (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, RICS, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	s.tsuzuki@aist.go.jp	Dokko, Kaoru/A-4005-2013; WATANABE, Masayoshi/M-4816-2014	Dokko, Kaoru/0000-0002-9622-4345; WATANABE, Masayoshi/0000-0003-4092-6150	ALCA program of the Japan Science and Technology Agency (JST)	This work was supported by the ALCA program of the Japan Science and Technology Agency (JST).	Allen M. P., 1987, COMPUTER SIMULATION; Soetens JC, 1998, J PHYS CHEM A, V102, P1055, DOI 10.1021/jp972457+; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Takeuchi M, 2009, J MOL LIQ, V148, P99, DOI 10.1016/j.molliq.2009.07.003; CHUM HL, 1975, J AM CHEM SOC, V97, P3264, DOI 10.1021/ja00844a081; Tsuzuki S, 2012, CHEMPHYSCHEM, V13, P1664, DOI 10.1002/cphc.201100870; Sato T, 2004, ELECTROCHIM ACTA, V49, P3603, DOI 10.1016/j.electacta.2004.03.030; Park JW, 2013, J PHYS CHEM C, V117, P20531, DOI 10.1021/jp408037e; Ryan DM, 2002, J ELECTROCHEM SOC, V149, pA371, DOI 10.1149/1.1454137; Zhang C, 2014, J PHYS CHEM B, V118, P5144, DOI 10.1021/jp501319e; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Tamura T, 2010, J POWER SOURCES, V195, P6095, DOI 10.1016/j.jpowsour.2009.11.061; Martyna GJ, 1996, MOL PHYS, V87, P1117, DOI 10.1080/00268979600100761; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; Yoshida K, 2011, J PHYS CHEM C, V115, P18384, DOI 10.1021/jp206881t; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Park JW, 2013, J PHYS CHEM C, V117, P4431, DOI 10.1021/jp400153m; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Ji XL, 2009, NAT MATER, V8, P500, DOI [10.1038/nmat2460, 10.1038/NMAT2460]; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Borgel V, 2009, J POWER SOURCES, V189, P331, DOI 10.1016/j.jpowsour.2008.08.099; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Pappenfus TM, 2004, J ELECTROCHEM SOC, V151, pA209, DOI 10.1149/1.1635384; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Tsuzuki S, 2009, J PHYS CHEM B, V113, P10641, DOI 10.1021/jp811128b; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Garcia B, 2004, ELECTROCHIM ACTA, V49, P4583, DOI 10.1016/j.electacta.2004.04.041; Matsumoto H, 2005, J POWER SOURCES, V146, P45, DOI 10.1016/j.jpowsour.2005.03.103; Ueno K, 2013, J PHYS CHEM C, V117, P20509, DOI 10.1021/jp407158y; Wang P, 2003, J PHYS CHEM B, V107, P13280, DOI 10.1021/jp0355399; Kubo W, 2003, J PHYS CHEM B, V107, P4374, DOI 10.1021/jp034248x; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Tsuzuki S, 2013, CHEMPHYSCHEM, V14, P1993, DOI 10.1002/cphc.201200843; Evers S., 2012, ACCOUNTS CHEM RES, V46, P1135; Seki S, 2011, J ELECTROCHEM SOC, V158, pA769, DOI 10.1149/1.3582822; Shinoda W, 2003, J COMPUT CHEM, V24, P920, DOI 10.1002/jcc.10249; Tachikawa N., 2011, CHEM COMMUN, V8157	42	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	1					126	129		10.1039/c4cp04718d		4	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW4FD	WOS:000346235600010		
J	McLean, B; Li, H; Stefanovic, R; Wood, RJ; Webber, GB; Ueno, K; Watanabe, M; Warr, GG; Page, A; Atkin, R				McLean, Ben; Li, Hua; Stefanovic, Ryan; Wood, Ross J.; Webber, Grant B.; Ueno, Kazuhide; Watanabe, Masayoshi; Warr, Gregory G.; Page, Alister; Atkin, Rob			Nanostructure of [Li(G4)] TFSI and [Li(G4)] NO3 solvate ionic liquids at HOPG and Au(111) electrode interfaces as a function of potential	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							ATOMIC-FORCE MICROSCOPY; ELECTRICAL DOUBLE-LAYER; IN-SITU STM; SUM-FREQUENCY GENERATION; NEAR-SURFACE STRUCTURE; ALKYL CHAIN-LENGTH; DIFFERENTIAL CAPACITANCE; EQUIMOLAR COMPLEXES; TEMPERATURE; GLYME	Atomic force microscopy (AFM) force measurements have been used to study the solvate ionic liquid (IL) double layer nanostructure at highly ordered pyrolytic graphite (HOPG) and Au(111) electrode surfaces as a function of potential. Two solvate ILs are investigated, [Li(G4)] TFSI and [Li(G4)] NO3. Normal force versus apparent separation data indicates that both solvate ILs adopt a multilayered morphology at the electrode interface, similar to conventional ILs. Calculations of adsorption free energies indicate that at 0 V the ion layer in contact with the electrode surface is enriched in the more surface active cations. When a positive or negative surface bias is applied, the concentration of counterions in the innermost layer increases, and higher push- through forces are required to displace near surface layers, indicating a stronger interfacial structure. Generally, [Li(G4)] TFSI has a better defined structure than [Li(G4)] NO3 on both electrode surfaces due to stronger cohesive interactions within layers. Interfacial structure is also better defined for both solvate ILs on HOPG than Au(111) due to the greater surface roughness of Au(111). Further, at all negative potentials on both surfaces, a small final step is observed, consistent with either compression of the complex cation adsorbed structure or desolvation of the glyme from the Li+.	[McLean, Ben; Li, Hua; Stefanovic, Ryan; Wood, Ross J.; Webber, Grant B.; Page, Alister; Atkin, Rob] Univ Newcastle, Discipline Chem, Callaghan, NSW 2308, Australia; [Ueno, Kazuhide; Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Warr, Gregory G.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Atkin, R (reprint author), Univ Newcastle, Discipline Chem, Callaghan, NSW 2308, Australia.	Rob.Atkin@newcastle.edu.au	WATANABE, Masayoshi/M-4816-2014; Atkin, Rob/E-8471-2010; WEBBER, GRANT/G-7437-2013	WATANABE, Masayoshi/0000-0003-4092-6150; WEBBER, GRANT/0000-0001-8303-6081	ARC Discovery Project [DP120102708]; ARC Future Fellowship [FT120100313]; JST-ALCA; NEDO of Japan	This research was supported by an ARC Discovery Project (DP120102708) and an ARC Future Fellowship (FT120100313) for RA, and by JST-ALCA and NEDO of Japan for MW. The authors thank Paul FitzGerald for measuring the SAXS/WAXS patterns of [Li(G4)] TFSI and [Li(G4)] NO<INF>3</INF>.	Abedin S.Z.E., 2007, ACCOUNTS CHEM RES, V40, P1106, DOI 10.1021/ar700049w; Hayes R, 2009, J PHYS CHEM B, V113, P7049, DOI 10.1021/jp902837s; OSHEA SJ, 1994, CHEM PHYS LETT, V223, P336, DOI 10.1016/0009-2614(94)00458-7; HORN RG, 1988, J PHYS CHEM-US, V92, P3531, DOI 10.1021/j100323a042; Hayes R, 2014, J PHYS CHEM C, V118, P13998, DOI 10.1021/jp503429k; Romero C, 2006, J PHYS CHEM B, V110, P6213, DOI 10.1021/jp0565150; Moon H, 2014, J PHYS CHEM C, V118, P20246, DOI 10.1021/jp506772f; Li H, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/28/284115; Oldham KB, 2008, J ELECTROANAL CHEM, V613, P131, DOI 10.1016/j.jelechem.2007.10.017; Hayes R, 2011, J PHYS CHEM C, V115, P6855, DOI 10.1021/jp200544b; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Murphy T, 2014, PHYS CHEM CHEM PHYS, V16, P13182, DOI 10.1039/c4cp01570c; Chen S, 2013, J PHYS CHEM B, V117, P3186, DOI 10.1021/jp310267x; Segura JJ, 2013, PHYS CHEM CHEM PHYS, V15, P3320, DOI 10.1039/c3cp44163f; Addicoat MA, 2013, J COMPUT CHEM, V34, P2591, DOI 10.1002/jcc.23420; Yoshida K, 2012, J ELECTROCHEM SOC, V159, pA1005, DOI 10.1149/2.050207jes; Lockett V, 2010, PHYS CHEM CHEM PHYS, V12, P12499, DOI 10.1039/c0cp00170h; Wakeham D, 2011, PHYS CHEM CHEM PHYS, V13, P20828, DOI 10.1039/c1cp22351h; Wakeham D, 2009, J PHYS CHEM B, V113, P5961, DOI 10.1021/jp900815q; Black JM, 2013, NANO LETT, V13, P5954, DOI 10.1021/nl4031083; Nanjundiah C, 1997, J ELECTROCHEM SOC, V144, P3392, DOI 10.1149/1.1838024; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Lauw Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.117801; Alam MT, 2008, J PHYS CHEM C, V112, P2601, DOI 10.1021/jp7098043; Chapman DL, 1913, PHILOS MAG, V25, P475, DOI 10.1080/14786440408634187; Hayes R, 2011, PHYS CHEM CHEM PHYS, V13, P3237, DOI 10.1039/c0cp01137a; Zhou H, 2012, ACS NANO, V6, P9818, DOI 10.1021/nn303355b; Endres F, 2012, FARADAY DISCUSS, V154, P221, DOI 10.1039/c1fd00050k; Maali A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086105; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Perkin S, 2011, CHEM COMMUN, V47, P6572, DOI 10.1039/c1cc11322d; Aliaga C, 2008, J PHYS CHEM C, V112, P3064, DOI 10.1021/jp709753r; Hayes R, 2011, PHYS CHEM CHEM PHYS, V13, P13544, DOI 10.1039/c1cp21080g; Atkin R, 2011, PHYS CHEM CHEM PHYS, V13, P6849, DOI 10.1039/c0cp02846k; Carstens T, 2012, ELECTROCHIM ACTA, V82, P48, DOI 10.1016/j.electacta.2012.01.111; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Atkin R, 2009, J PHYS CHEM C, V113, P13266, DOI 10.1021/jp9026755; Hayes R, 2010, PHYS CHEM CHEM PHYS, V12, P1709, DOI 10.1039/b920393a; Borisenko N, 2006, J PHYS CHEM B, V110, P6250, DOI 10.1021/jp057337d; Labuda A, 2012, LANGMUIR, V28, P5319, DOI 10.1021/la300557u; Zhang X, 2012, CHEM COMMUN, V48, P582, DOI 10.1039/c1cc15463j; Atkin R, 2007, J PHYS CHEM C, V111, P5162, DOI 10.1021/jp067420g; Li H, 2013, PHYS CHEM CHEM PHYS, V15, P14624, DOI 10.1039/c3cp52421c; Fedorov MV, 2014, CHEM REV, V114, P2978, DOI 10.1021/cr400374x; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Dragoni D, 2012, CHEMPHYSCHEM, V13, P1772, DOI 10.1002/cphc.201100947; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Carstens T, 2014, J PHYS CHEM C, V118, P10833, DOI 10.1021/jp501260t; JENKINS HDB, 1979, J CHEM EDUC, V56, P576; Endres F, 2002, CHEMPHYSCHEM, V3, P144, DOI 10.1002/1439-7641(20020215)3:2<144::AID-CPHC144>3.3.CO;2-R; Kornyshev AA, 2007, J PHYS CHEM B, V111, P5545, DOI 10.1021/jp067857o; Lockett V, 2008, J PHYS CHEM C, V112, P7486, DOI 10.1021/jp7100732; Elbourne A, 2013, CHEM COMMUN, V49, P6797, DOI 10.1039/c3cc42844c; Perkin S, 2010, PHYS CHEM CHEM PHYS, V12, P1243, DOI 10.1039/b920571c; Mezger M, 2008, SCIENCE, V322, P424, DOI 10.1126/science.1164502; Hoth J, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/28/284110; Tsuzuki S, 2013, CHEMPHYSCHEM, V14, P1993, DOI 10.1002/cphc.201200843; Ralston J, 2005, PURE APPL CHEM, V77, P2149, DOI 10.1351/pac200577122149; BIGGIN S, 1982, J PHYS C SOLID STATE, V15, pL305, DOI 10.1088/0022-3719/15/11/001; Frisch M. J., 2009, GAUSSIAN 09 REV D01; Galinski M, 2006, ELECTROCHIM ACTA, V51, P5567, DOI 10.1016/j.electacta.2006.03.016; Gouy G., 1910, CR HEBD ACAD SCI, V149, P654; Hayes R., 2012, INTERFACE IONIC LIQU, V2, P51; Israelachvili J. N., 1992, INTERMOLECULAR SURFA; Gorlov M, 2008, DALTON T, P2655, DOI 10.1039/b716419j; Lim R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.246101; Lim R, 2002, LANGMUIR, V18, P6116, DOI 10.1021/la011789+; Lim RYH, 2004, LANGMUIR, V20, P4916, DOI 10.1021/la036200g; Payal RS, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/28/284101; ROVERE M, 1986, REP PROG PHYS, V49, P1001, DOI 10.1088/0034-4885/49/9/002; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stern O, 1924, Z ELKTROCHEM ANGEW P, V30, P508; Su Y.-Z., 2009, ANGEW CHEM, V121, P5250; von Helmholtz H., 1879, WIEDEMANNS ANN, V7, P337	76	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	1					325	333		10.1039/c4cp04522j		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW4FD	WOS:000346235600034		
J	Kim, DW; Li, OL; Saito, N				Kim, Dae-Wook; Li, Oi Lun; Saito, Nagahiro			Enhancement of ORR catalytic activity by multiple heteroatom-doped carbon materials	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							OXYGEN REDUCTION REACTION; HIGH ELECTROCATALYTIC ACTIVITY; SOLUTION PLASMA PROCESS; NITROGEN; NANOTUBES; ARRAYS	Heteroatom-doped carbon matrices have been attracting significant attention due to their superior electrochemical stability, light weight and low cost. Hence, in this study, various types of heteroatom, including single dopants of N, B and P and multiple dopants of B-N and P-N with a carbon matrix were synthesized by an innovative method named the solution plasma process. The heteroatom was doped into the carbon matrix during the discharge process by continuous dissociation and recombination of precursors. The chemical bonding structure, ORR activity and electrochemical performance were compared in detail for each single dopant and multiple dopants. According to the Raman spectra, the carbon structures were deformed by the doped heteroatoms in the carbon matrix. In comparison with N-doped structures (NCNS), the ORR potential of PN-doped structures (PNCNS) was positively shifted from -0.27 V to -0.24 V. It was observed that doping with N decreased the bonding between P and C in the matrix. The multiple doping induced additional active sites for ORR which further enhanced ORR activity and stability. Therefore, PNCNS is a promising metal-free catalyst for ORR at the cathode in a fuel cell.	[Kim, Dae-Wook; Li, Oi Lun; Saito, Nagahiro] Nagoya Univ, Dept Mat Phys & Energy Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Li, Oi Lun; Saito, Nagahiro] Nagoya Univ, Green Mobil Collaborat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Saito, Nagahiro] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Saito, N (reprint author), Nagoya Univ, Dept Mat Phys & Energy Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hiro@rd.numse.nagoya-u.ac.jp	Saito, Nagahiro/I-6113-2014	Saito, Nagahiro/0000-0001-8757-3933			Pootawang P, 2011, MATER LETT, V65, P1037, DOI 10.1016/j.matlet.2011.01.009; Kang J, 2014, J POWER SOURCES, V261, P156, DOI 10.1016/j.jpowsour.2014.03.072; Feng YX, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155454; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Tang YF, 2009, J AM CHEM SOC, V131, P13200, DOI 10.1021/ja904595t; Kang J, 2013, CARBON, V60, P292, DOI 10.1016/j.carbon.2013.04.040; Yu DS, 2010, J AM CHEM SOC, V132, P15127, DOI 10.1021/ja105617z; Wang YJ, 2011, CHEM REV, V111, P7625, DOI 10.1021/cr100060r; Bratescu MA, 2011, J PHYS CHEM C, V115, P24569, DOI 10.1021/jp207447c; Kim DW, 2014, PHYS CHEM CHEM PHYS, V16, P14905, DOI 10.1039/c4cp01406e; Zhang LP, 2011, J PHYS CHEM C, V115, P11170, DOI 10.1021/jp201991j; Matter PH, 2006, J CATAL, V239, P83, DOI 10.1016/j.jcat.2006.01.022; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Liu RL, 2011, J AM CHEM SOC, V133, P10372, DOI 10.1021/ja203776f; Kang J, 2013, NANOSCALE, V5, P6874, DOI 10.1039/c3nr01229h; Wang SY, 2011, J AM CHEM SOC, V133, P5182, DOI 10.1021/ja1112904; Liu G, 2009, APPL CATAL B-ENVIRON, V93, P156, DOI 10.1016/j.apcatb.2009.09.025; Choi CH, 2012, J MATER CHEM, V22, P12107, DOI 10.1039/c2jm31079a; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Liu RL, 2010, ANGEW CHEM INT EDIT, V49, P2565, DOI 10.1002/anie.200907289; Parvez K, 2012, ACS NANO, V6, P9541, DOI 10.1021/nn302674k; Chen JY, 2014, CHEM COMMUN, V50, P557, DOI 10.1039/c3cc47519k; Ghosh K, 2009, CARBON, V47, P1565, DOI 10.1016/j.carbon.2009.02.007; Doi S., 2007, J ELECTROCHEM SOC, V154, P362; Hu Z., 2008, PURE APPL CHEM, V80, P2003; Jensen BW, 2008, SCIENCE, V321, P671; Kim DW, 2014, RSC ADV, V4, P16813, DOI 10.1039/c4ra02380c; Kim JY, 2011, INT J HYDROGEN ENERG, V36, P4557, DOI 10.1016/j.ijhydene.2010.05.016; Lim S., 2006, PHYS REV B, V73, P1; Liu Y., 2007, J ELECTROCHEM SOC, V154, P664; van Dommele S, 2008, CARBON, V46, P138, DOI 10.1016/j.carbon.2007.10.034; van Dommele S, 2006, CHEM COMMUN, P4859, DOI 10.1039/b610208e	33	9	9	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	1					407	413		10.1039/c4cp03868a		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW4FD	WOS:000346235600042		
